Citrus Sinensis ID: 018712
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 351 | 2.2.26 [Sep-21-2011] | |||||||
| Q41328 | 354 | Pto-interacting protein 1 | N/A | no | 0.894 | 0.887 | 0.808 | 1e-152 | |
| O80719 | 365 | Probable receptor-like pr | no | no | 0.883 | 0.849 | 0.738 | 1e-134 | |
| O49339 | 366 | PTI1-like tyrosine-protei | no | no | 0.757 | 0.726 | 0.764 | 1e-119 | |
| B9DFG5 | 408 | PTI1-like tyrosine-protei | no | no | 0.749 | 0.644 | 0.750 | 1e-117 | |
| Q8H1G6 | 361 | PTI1-like tyrosine-protei | no | no | 0.752 | 0.731 | 0.748 | 1e-117 | |
| P93749 | 365 | Probable protein kinase A | no | no | 0.868 | 0.835 | 0.608 | 1e-108 | |
| Q8RWW0 | 744 | Receptor-like serine/thre | no | no | 0.754 | 0.356 | 0.476 | 7e-65 | |
| Q9SX31 | 708 | Proline-rich receptor-lik | no | no | 0.706 | 0.350 | 0.492 | 2e-63 | |
| Q9FE20 | 456 | Serine/threonine-protein | no | no | 0.886 | 0.682 | 0.430 | 8e-63 | |
| Q9ZUE0 | 720 | Proline-rich receptor-lik | no | no | 0.706 | 0.344 | 0.475 | 1e-60 |
| >sp|Q41328|PTI1_SOLLC Pto-interacting protein 1 OS=Solanum lycopersicum GN=PTI1 PE=1 SV=2 | Back alignment and function desciption |
|---|
Score = 538 bits (1387), Expect = e-152, Method: Compositional matrix adjust.
Identities = 254/314 (80%), Positives = 286/314 (91%)
Query: 1 MSCFGCCEEDDIRKASKNGPFVPNNPAGNPGGFYVKEAPAKEMKTVTVQPIAVPVISVDE 60
MSCF CC++DD+ +A+ NGPF+ +N AGN GG E+ +E +TV +QPIAVP I+VDE
Sbjct: 1 MSCFSCCDDDDMHRATDNGPFMAHNSAGNNGGQRATESAQRETQTVNIQPIAVPSIAVDE 60
Query: 61 LKEKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKN 120
LK+ TDNFG+ +LIGEGSYGRVY GVL+SGRAAAIKKLDSSKQPD+EFLAQVSMVSRLK+
Sbjct: 61 LKDITDNFGSKALIGEGSYGRVYHGVLKSGRAAAIKKLDSSKQPDREFLAQVSMVSRLKD 120
Query: 121 ENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAA 180
ENVVEL+GY VDG RVLAYE+A GSLHDILHG+KGVKGA+PGPVLSWAQRVKIAVGAA
Sbjct: 121 ENVVELLGYCVDGGFRVLAYEYAPNGSLHDILHGRKGVKGAQPGPVLSWAQRVKIAVGAA 180
Query: 181 RGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFG 240
+GLEYLHEKA+P IIHR+IKSSN+LLFDDD+AKI+DFDLSNQAPD AARLHSTRVLGTFG
Sbjct: 181 KGLEYLHEKAQPHIIHRDIKSSNILLFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFG 240
Query: 241 YHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVK 300
YHAPEYAMTGQ+SSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATP+LSEDKVK
Sbjct: 241 YHAPEYAMTGQLSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPRLSEDKVK 300
Query: 301 QCVDTKLGGEYPPK 314
QCVD +L +YPPK
Sbjct: 301 QCVDARLNTDYPPK 314
|
A serine-threonine kinase involved in the hypersensitive response (HR)-mediated signaling cascade. Solanum lycopersicum (taxid: 4081) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|O80719|Y2706_ARATH Probable receptor-like protein kinase At2g47060 OS=Arabidopsis thaliana GN=At2g47060 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 478 bits (1229), Expect = e-134, Method: Compositional matrix adjust.
Identities = 237/321 (73%), Positives = 267/321 (83%), Gaps = 11/321 (3%)
Query: 1 MSCFGCC-EEDDIRKASKNG-------PFVPNNPAGNPGGFYVKEAPAKEMKTVTVQPIA 52
MSCFGCC E+DD+ K + G F P N A + E K V +QPI
Sbjct: 1 MSCFGCCGEDDDMHKTADYGGRHNQAKHFPPGNDARH---HQASETAQKGPPVVKLQPIE 57
Query: 53 VPVISVDELKEKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQV 112
VP+I ELKE TD+FG+NSLIGEGSYGRVY+GVL + +AIKKLDS+KQPD EFLAQV
Sbjct: 58 VPIIPFSELKEATDDFGSNSLIGEGSYGRVYYGVLNNDLPSAIKKLDSNKQPDNEFLAQV 117
Query: 113 SMVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQR 172
SMVSRLK++N V+L+GY VDG R+L+YE A+ GSLHDILHG+KGVKGA+PGPVLSW QR
Sbjct: 118 SMVSRLKHDNFVQLLGYCVDGNSRILSYEFANNGSLHDILHGRKGVKGAQPGPVLSWYQR 177
Query: 173 VKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHS 232
VKIAVGAARGLEYLHEKA P IIHR+IKSSNVLLF+DD+AKI+DFDLSNQAPD AARLHS
Sbjct: 178 VKIAVGAARGLEYLHEKANPHIIHRDIKSSNVLLFEDDVAKIADFDLSNQAPDMAARLHS 237
Query: 233 TRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATP 292
TRVLGTFGYHAPEYAMTGQ+++KSDVYSFGVVLLELLTGRKPVDH LPRGQQSLVTWATP
Sbjct: 238 TRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHRLPRGQQSLVTWATP 297
Query: 293 KLSEDKVKQCVDTKLGGEYPP 313
KLSEDKVKQCVD +LGG+YPP
Sbjct: 298 KLSEDKVKQCVDARLGGDYPP 318
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O49339|PTI12_ARATH PTI1-like tyrosine-protein kinase 2 OS=Arabidopsis thaliana GN=PTI12 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 427 bits (1099), Expect = e-119, Method: Compositional matrix adjust.
Identities = 205/268 (76%), Positives = 235/268 (87%), Gaps = 2/268 (0%)
Query: 50 PIAVPVISVDELKEKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSS--KQPDQE 107
PI VP +SVDE+KEKTDNFG+ SLIGEGSYGRVY+ L G+A A+KKLD + + + E
Sbjct: 53 PIEVPPLSVDEVKEKTDNFGSKSLIGEGSYGRVYYATLNDGKAVALKKLDVAPEAETNTE 112
Query: 108 FLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVL 167
FL QVSMVSRLK+EN+++LVGY VD LRVLAYE A+ GSLHDILHG+KGV+GA+PGP L
Sbjct: 113 FLNQVSMVSRLKHENLIQLVGYCVDENLRVLAYEFATMGSLHDILHGRKGVQGAQPGPTL 172
Query: 168 SWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAA 227
W RVKIAV AARGLEYLHEK +P +IHR+I+SSNVLLF+D AK++DF+LSNQAPD A
Sbjct: 173 DWLTRVKIAVEAARGLEYLHEKVQPPVIHRDIRSSNVLLFEDYQAKVADFNLSNQAPDNA 232
Query: 228 ARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLV 287
ARLHSTRVLGTFGYHAPEYAMTGQ++ KSDVYSFGVVLLELLTGRKPVDHT+PRGQQSLV
Sbjct: 233 ARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLV 292
Query: 288 TWATPKLSEDKVKQCVDTKLGGEYPPKA 315
TWATP+LSEDKVKQCVD KL GEYPPK+
Sbjct: 293 TWATPRLSEDKVKQCVDPKLKGEYPPKS 320
|
Probable tyrosine-protein kinase involved in oxidative burst-mediated signaling leading to specific genes expression. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 0 EC: . EC: 2 |
| >sp|B9DFG5|PTI13_ARATH PTI1-like tyrosine-protein kinase 3 OS=Arabidopsis thaliana GN=PTI13 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 422 bits (1084), Expect = e-117, Method: Compositional matrix adjust.
Identities = 199/265 (75%), Positives = 232/265 (87%), Gaps = 2/265 (0%)
Query: 51 IAVPVISVDELKEKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQ--EF 108
I VP +S+DELKEKTDNFG+ SLIGEGSYGR Y+ L+ G+A A+KKLD++ +P+ EF
Sbjct: 96 IDVPALSLDELKEKTDNFGSKSLIGEGSYGRAYYATLKDGKAVAVKKLDNAAEPESNVEF 155
Query: 109 LAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLS 168
L QVS VS+LK++N VEL GY V+G R+LAYE A+ GSLHDILHG+KGV+GA+PGP L
Sbjct: 156 LTQVSRVSKLKHDNFVELFGYCVEGNFRILAYEFATMGSLHDILHGRKGVQGAQPGPTLD 215
Query: 169 WAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAA 228
W QRV+IAV AARGLEYLHEK +P +IHR+I+SSNVLLF+D AKI+DF+LSNQ+PD AA
Sbjct: 216 WIQRVRIAVDAARGLEYLHEKVQPAVIHRDIRSSNVLLFEDFKAKIADFNLSNQSPDMAA 275
Query: 229 RLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVT 288
RLHSTRVLGTFGYHAPEYAMTGQ++ KSDVYSFGVVLLELLTGRKPVDHT+PRGQQSLVT
Sbjct: 276 RLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVT 335
Query: 289 WATPKLSEDKVKQCVDTKLGGEYPP 313
WATP+LSEDKVKQCVD KL GEYPP
Sbjct: 336 WATPRLSEDKVKQCVDPKLKGEYPP 360
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 0 EC: . EC: 2 |
| >sp|Q8H1G6|PTI11_ARATH PTI1-like tyrosine-protein kinase 1 OS=Arabidopsis thaliana GN=PTI11 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 421 bits (1081), Expect = e-117, Method: Compositional matrix adjust.
Identities = 199/266 (74%), Positives = 234/266 (87%), Gaps = 2/266 (0%)
Query: 50 PIAVPVISVDELKEKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSS--KQPDQE 107
PI VP +S+DE+KEKT+NFG+ +LIGEGSYGRVY+ L G A A+KKLD + + D E
Sbjct: 50 PIEVPPLSLDEVKEKTENFGSKALIGEGSYGRVYYATLNDGVAVALKKLDVAPEAETDTE 109
Query: 108 FLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVL 167
FL+QVSMVSRLK+EN+++L+G+ VDG LRVLAYE A+ GSLHDILHG+KGV+GA+PGP L
Sbjct: 110 FLSQVSMVSRLKHENLIQLLGFCVDGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPTL 169
Query: 168 SWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAA 227
W RVKIAV AARGLEYLHEK++P +IHR+I+SSNVLLF+D AKI+DF+LSNQAPD A
Sbjct: 170 DWITRVKIAVEAARGLEYLHEKSQPPVIHRDIRSSNVLLFEDYKAKIADFNLSNQAPDNA 229
Query: 228 ARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLV 287
ARLHSTRVLGTFGYHAPEYAMTGQ++ KSDVYSFGVVLLELLTGRKPVDHT+PRGQQSLV
Sbjct: 230 ARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLV 289
Query: 288 TWATPKLSEDKVKQCVDTKLGGEYPP 313
TWATP+LSEDKVKQC+D KL +YPP
Sbjct: 290 TWATPRLSEDKVKQCIDPKLKADYPP 315
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 0 EC: . EC: 2 |
| >sp|P93749|Y2197_ARATH Probable protein kinase At2g41970 OS=Arabidopsis thaliana GN=At2g41970 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 391 bits (1004), Expect = e-108, Method: Compositional matrix adjust.
Identities = 199/327 (60%), Positives = 250/327 (76%), Gaps = 22/327 (6%)
Query: 1 MSCFGCCEEDDIRKASKNGPFVPNNPAGNP--GGFYVKE----------APAKEMKTVTV 48
M C G +E+ + N P N AGNP GG E APAK V
Sbjct: 1 MFCCGGADEEPAGPPA-NQYAAPPNKAGNPNFGGGNRGEPRNPNAPRSGAPAK------V 53
Query: 49 QPIAVPVISVDELKEKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLD--SSKQPDQ 106
PI +P +++DEL NFG +LIGEGSYGRV+ G + G A AIKKLD SS++PD
Sbjct: 54 LPIEIPSVALDELNRMAGNFGNKALIGEGSYGRVFCGKFK-GEAVAIKKLDASSSEEPDS 112
Query: 107 EFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPV 166
+F +Q+S+VSRLK+++ VEL+GY ++ R+L Y+ A+KGSLHD+LHG+KGV+GA+PGPV
Sbjct: 113 DFTSQLSVVSRLKHDHFVELLGYCLEANNRILIYQFATKGSLHDVLHGRKGVQGAEPGPV 172
Query: 167 LSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDA 226
L+W QRVKIA GAA+GLE+LHEK +P I+HR+++SSNVLLFDD +AK++DF+L+N + D
Sbjct: 173 LNWNQRVKIAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFVAKMADFNLTNASSDT 232
Query: 227 AARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSL 286
AARLHSTRVLGTFGYHAPEYAMTGQ++ KSDVYSFGVVLLELLTGRKPVDHT+P+GQQSL
Sbjct: 233 AARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSL 292
Query: 287 VTWATPKLSEDKVKQCVDTKLGGEYPP 313
VTWATP+LSEDKVKQC+D KL ++PP
Sbjct: 293 VTWATPRLSEDKVKQCIDPKLNNDFPP 319
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q8RWW0|ALE2_ARATH Receptor-like serine/threonine-protein kinase ALE2 OS=Arabidopsis thaliana GN=ALE2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 247 bits (631), Expect = 7e-65, Method: Compositional matrix adjust.
Identities = 134/281 (47%), Positives = 181/281 (64%), Gaps = 16/281 (5%)
Query: 51 IAVPVISVDELKEKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQP-DQEFL 109
++V ++ EL++ TD F ++GEG +GRVY G + G A+K L Q D+EF+
Sbjct: 332 LSVKTFTLSELEKATDRFSAKRVLGEGGFGRVYQGSMEDGTEVAVKLLTRDNQNRDREFI 391
Query: 110 AQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSW 169
A+V M+SRL + N+V+L+G ++G R L YE GS+ LH L W
Sbjct: 392 AEVEMLSRLHHRNLVKLIGICIEGRTRCLIYELVHNGSVESHLHEG----------TLDW 441
Query: 170 AQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAAR 229
R+KIA+GAARGL YLHE + PR+IHR+ K+SNVLL DD K+SDF L+ +A + +
Sbjct: 442 DARLKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQH 501
Query: 230 LHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTW 289
+ STRV+GTFGY APEYAMTG + KSDVYS+GVVLLELLTGR+PVD + P G+++LVTW
Sbjct: 502 I-STRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRRPVDMSQPSGEENLVTW 560
Query: 290 ATPKLS-EDKVKQCVDTKLGGEYPPKAIAKVRKKKFITSEC 329
A P L+ + ++Q VD L G Y +AKV I S C
Sbjct: 561 ARPLLANREGLEQLVDPALAGTYNFDDMAKVAA---IASMC 598
|
Required during the differentiation of the protoderm into shoots epidermis and cuticle. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SX31|PERK9_ARATH Proline-rich receptor-like protein kinase PERK9 OS=Arabidopsis thaliana GN=PERK9 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 243 bits (619), Expect = 2e-63, Method: Compositional matrix adjust.
Identities = 129/262 (49%), Positives = 174/262 (66%), Gaps = 14/262 (5%)
Query: 55 VISVDELKEKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLD-SSKQPDQEFLAQVS 113
+ S +EL + T+ F +L+GEG +G VY G+L GR A+K+L Q D+EF A+V
Sbjct: 364 LFSYEELVKATNGFSQENLLGEGGFGCVYKGILPDGRVVAVKQLKIGGGQGDREFKAEVE 423
Query: 114 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRV 173
+SR+ + ++V +VG+ + G R+L Y++ S L+ LHG+K V L WA RV
Sbjct: 424 TLSRIHHRHLVSIVGHCISGDRRLLIYDYVSNNDLYFHLHGEKSV--------LDWATRV 475
Query: 174 KIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHST 233
KIA GAARGL YLHE PRIIHR+IKSSN+LL D+ A++SDF L+ A D + +T
Sbjct: 476 KIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLEDNFDARVSDFGLARLALDCNTHI-TT 534
Query: 234 RVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPK 293
RV+GTFGY APEYA +G+++ KSDV+SFGVVLLEL+TGRKPVD + P G +SLV WA P
Sbjct: 535 RVIGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDTSQPLGDESLVEWARPL 594
Query: 294 LSE----DKVKQCVDTKLGGEY 311
+S ++ D KLGG Y
Sbjct: 595 ISHAIETEEFDSLADPKLGGNY 616
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FE20|PBS1_ARATH Serine/threonine-protein kinase PBS1 OS=Arabidopsis thaliana GN=PBS1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 241 bits (614), Expect = 8e-63, Method: Compositional matrix adjust.
Identities = 145/337 (43%), Positives = 196/337 (58%), Gaps = 26/337 (7%)
Query: 1 MSCFGCCEEDDIRKAS-----------KNGPFVPNNPAGNP-GGFYVKEAPAKEMKTVTV 48
M CF C + D K + ++ P V NN +G P GG + K +
Sbjct: 1 MGCFSCFDSSDDEKLNPVDESNHGQKKQSQPTVSNNISGLPSGGEKLSSKTNGGSKRELL 60
Query: 49 QP------IAVPVISVDELKEKTDNFGTNSLIGEGSYGRVYFGVLRS-GRAAAIKKLDSS 101
P IA + EL T NF ++ +GEG +GRVY G L S G+ A+K+LD +
Sbjct: 61 LPRDGLGQIAAHTFAFRELAAATMNFHPDTFLGEGGFGRVYKGRLDSTGQVVAVKQLDRN 120
Query: 102 K-QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKG 160
Q ++EFL +V M+S L + N+V L+GY DG R+L YE GSL D LH K
Sbjct: 121 GLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKE 180
Query: 161 AKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220
A L W R+KIA GAA+GLE+LH+KA P +I+R+ KSSN+LL + K+SDF L+
Sbjct: 181 A-----LDWNMRMKIAAGAAKGLEFLHDKANPPVIYRDFKSSNILLDEGFHPKLSDFGLA 235
Query: 221 NQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280
P STRV+GT+GY APEYAMTGQ++ KSDVYSFGVV LEL+TGRK +D +P
Sbjct: 236 KLGPTGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSEMP 295
Query: 281 RGQQSLVTWATPKLSE-DKVKQCVDTKLGGEYPPKAI 316
G+Q+LV WA P ++ K + D +L G +P +A+
Sbjct: 296 HGEQNLVAWARPLFNDRRKFIKLADPRLKGRFPTRAL 332
|
Protein kinase required for plant defense mechanism mediated by the disease resistance (R) protein RPS5. In case of infection by Pseudomonas syringae, RPS5 specifically recognizes the avrPphB type III effector avirulence protein and triggers a defense reaction. AvrPphB may trigger RPS5-mediated defense mechanism via the cleavage of PBS1. Both kinase activity and cleavage by avrPphB are independently required to trigger the RPS5-mediated resistance. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZUE0|PEK12_ARATH Proline-rich receptor-like protein kinase PERK12 OS=Arabidopsis thaliana GN=PERK12 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 233 bits (595), Expect = 1e-60, Method: Compositional matrix adjust.
Identities = 124/261 (47%), Positives = 177/261 (67%), Gaps = 13/261 (4%)
Query: 56 ISVDELKEKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDS-SKQPDQEFLAQVSM 114
S +EL E T F +++GEG +G VY G L+ G+ A+K+L + S Q D+EF A+V +
Sbjct: 359 FSYEELAEITQGFARKNILGEGGFGCVYKGTLQDGKVVAVKQLKAGSGQGDREFKAEVEI 418
Query: 115 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVK 174
+SR+ + ++V LVGY + R+L YE+ S +L LHGK G+ PVL W++RV+
Sbjct: 419 ISRVHHRHLVSLVGYCISDQHRLLIYEYVSNQTLEHHLHGK-GL------PVLEWSKRVR 471
Query: 175 IAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTR 234
IA+G+A+GL YLHE P+IIHR+IKS+N+LL D+ A+++DF L+ + D STR
Sbjct: 472 IAIGSAKGLAYLHEDCHPKIIHRDIKSANILLDDEYEAQVADFGLA-RLNDTTQTHVSTR 530
Query: 235 VLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKL 294
V+GTFGY APEYA +G+++ +SDV+SFGVVLLEL+TGRKPVD T P G++SLV WA P L
Sbjct: 531 VMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELVTGRKPVDQTQPLGEESLVEWARPLL 590
Query: 295 ----SEDKVKQCVDTKLGGEY 311
+ + +DT+L Y
Sbjct: 591 LKAIETGDLSELIDTRLEKRY 611
|
Regulates the auxin-related MAX (More Axillary Growth) pathway during the shoot branching. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 351 | ||||||
| 225432163 | 360 | PREDICTED: pto-interacting protein 1 [Vi | 0.891 | 0.869 | 0.834 | 1e-152 | |
| 170676254 | 354 | Pto kinase interactor 1 [Capsicum annuum | 0.894 | 0.887 | 0.815 | 1e-151 | |
| 350537875 | 354 | pto-interacting protein 1 [Solanum lycop | 0.894 | 0.887 | 0.808 | 1e-150 | |
| 357442089 | 476 | Pto kinase interactor [Medicago truncatu | 0.891 | 0.657 | 0.799 | 1e-148 | |
| 357442087 | 361 | Pto kinase interactor [Medicago truncatu | 0.891 | 0.867 | 0.799 | 1e-148 | |
| 255548287 | 362 | Serine/threonine-protein kinase PBS1, pu | 0.891 | 0.864 | 0.796 | 1e-146 | |
| 225437716 | 362 | PREDICTED: pto-interacting protein 1 [Vi | 0.891 | 0.864 | 0.796 | 1e-146 | |
| 359811321 | 361 | pto-interacting protein 1-like [Glycine | 0.891 | 0.867 | 0.792 | 1e-145 | |
| 1586940 | 370 | Ser/Thr kinase | 0.891 | 0.845 | 0.777 | 1e-143 | |
| 224130874 | 362 | predicted protein [Populus trichocarpa] | 0.888 | 0.861 | 0.789 | 1e-143 |
| >gi|225432163|ref|XP_002267003.1| PREDICTED: pto-interacting protein 1 [Vitis vinifera] gi|297736804|emb|CBI26005.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 543 bits (1399), Expect = e-152, Method: Compositional matrix adjust.
Identities = 263/315 (83%), Positives = 288/315 (91%), Gaps = 2/315 (0%)
Query: 1 MSCFGCCEEDDIRKASKNGPFVPNNPA-GNPGGFYVKEAP-AKEMKTVTVQPIAVPVISV 58
MSCF CCEEDDI KAS GP+V NN A G+ G +++ EA + + +TV V PIAV ISV
Sbjct: 1 MSCFSCCEEDDIHKASDTGPYVANNSAVGHNGNYHMTEASRSNDTQTVDVLPIAVSAISV 60
Query: 59 DELKEKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRL 118
DELKE TDNFG +LIGEGSYGRVY G+L++G+AAAIKKLDSSKQPDQEFLAQVSMVSRL
Sbjct: 61 DELKEITDNFGQQALIGEGSYGRVYHGLLKTGQAAAIKKLDSSKQPDQEFLAQVSMVSRL 120
Query: 119 KNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVG 178
KNENVVELVGY VDG LRV+AYE+AS GSLHDILHG+KGVKGA+PGPVLSW+QRVKIAVG
Sbjct: 121 KNENVVELVGYSVDGGLRVVAYEYASNGSLHDILHGRKGVKGAQPGPVLSWSQRVKIAVG 180
Query: 179 AARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGT 238
AA+GLEYLHEKA P IIHR+IKSSNVLLFDDD+AKI+DFDLSNQAPD+AARLHSTRVLGT
Sbjct: 181 AAKGLEYLHEKARPHIIHRDIKSSNVLLFDDDVAKIADFDLSNQAPDSAARLHSTRVLGT 240
Query: 239 FGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDK 298
FGYHAPEYAMTGQ+SSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDK
Sbjct: 241 FGYHAPEYAMTGQLSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDK 300
Query: 299 VKQCVDTKLGGEYPP 313
VKQCVDT+LGGEYPP
Sbjct: 301 VKQCVDTRLGGEYPP 315
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|170676254|gb|ACB30366.1| Pto kinase interactor 1 [Capsicum annuum] | Back alignment and taxonomy information |
|---|
Score = 541 bits (1395), Expect = e-151, Method: Compositional matrix adjust.
Identities = 256/314 (81%), Positives = 286/314 (91%)
Query: 1 MSCFGCCEEDDIRKASKNGPFVPNNPAGNPGGFYVKEAPAKEMKTVTVQPIAVPVISVDE 60
MSCF CCE+DD+ +AS NGPF+ +N AGN GG + E+ KE +TV +QPIAVP I+VDE
Sbjct: 1 MSCFSCCEDDDMNRASDNGPFMAHNSAGNNGGLHATESAQKEPQTVNIQPIAVPSIAVDE 60
Query: 61 LKEKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKN 120
LK+ TDNFG+ +LIGEGSYGRVY GVL+SGRAAAIKKLDSSKQPD+EFLAQVSMVSRLK+
Sbjct: 61 LKDITDNFGSKALIGEGSYGRVYHGVLKSGRAAAIKKLDSSKQPDREFLAQVSMVSRLKD 120
Query: 121 ENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAA 180
ENVVEL+GY VDG RVLAYE+A GSLHDILHG+KGVKGA+PGPVLSW QRVKIAVGAA
Sbjct: 121 ENVVELLGYCVDGGFRVLAYEYAPNGSLHDILHGRKGVKGAQPGPVLSWVQRVKIAVGAA 180
Query: 181 RGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFG 240
+GLEYLHEKA+P IIHR+IKSSN+LLFDDD+AKI+DFDLSNQAPD AARLHSTRVLGTFG
Sbjct: 181 KGLEYLHEKAQPHIIHRDIKSSNILLFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFG 240
Query: 241 YHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVK 300
YHAPEYAMTGQ+SSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATP+LSEDKVK
Sbjct: 241 YHAPEYAMTGQLSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPRLSEDKVK 300
Query: 301 QCVDTKLGGEYPPK 314
QCVD +L +YPPK
Sbjct: 301 QCVDARLNTDYPPK 314
|
Source: Capsicum annuum Species: Capsicum annuum Genus: Capsicum Family: Solanaceae Order: Solanales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|350537875|ref|NP_001233803.1| pto-interacting protein 1 [Solanum lycopersicum] gi|75319610|sp|Q41328.2|PTI1_SOLLC RecName: Full=Pto-interacting protein 1; Short=Pti1; AltName: Full=Pto kinase interactor 1 gi|3668069|gb|AAC61805.1| Pto kinase interactor 1 [Solanum lycopersicum] | Back alignment and taxonomy information |
|---|
Score = 538 bits (1387), Expect = e-150, Method: Compositional matrix adjust.
Identities = 254/314 (80%), Positives = 286/314 (91%)
Query: 1 MSCFGCCEEDDIRKASKNGPFVPNNPAGNPGGFYVKEAPAKEMKTVTVQPIAVPVISVDE 60
MSCF CC++DD+ +A+ NGPF+ +N AGN GG E+ +E +TV +QPIAVP I+VDE
Sbjct: 1 MSCFSCCDDDDMHRATDNGPFMAHNSAGNNGGQRATESAQRETQTVNIQPIAVPSIAVDE 60
Query: 61 LKEKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKN 120
LK+ TDNFG+ +LIGEGSYGRVY GVL+SGRAAAIKKLDSSKQPD+EFLAQVSMVSRLK+
Sbjct: 61 LKDITDNFGSKALIGEGSYGRVYHGVLKSGRAAAIKKLDSSKQPDREFLAQVSMVSRLKD 120
Query: 121 ENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAA 180
ENVVEL+GY VDG RVLAYE+A GSLHDILHG+KGVKGA+PGPVLSWAQRVKIAVGAA
Sbjct: 121 ENVVELLGYCVDGGFRVLAYEYAPNGSLHDILHGRKGVKGAQPGPVLSWAQRVKIAVGAA 180
Query: 181 RGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFG 240
+GLEYLHEKA+P IIHR+IKSSN+LLFDDD+AKI+DFDLSNQAPD AARLHSTRVLGTFG
Sbjct: 181 KGLEYLHEKAQPHIIHRDIKSSNILLFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFG 240
Query: 241 YHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVK 300
YHAPEYAMTGQ+SSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATP+LSEDKVK
Sbjct: 241 YHAPEYAMTGQLSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPRLSEDKVK 300
Query: 301 QCVDTKLGGEYPPK 314
QCVD +L +YPPK
Sbjct: 301 QCVDARLNTDYPPK 314
|
Source: Solanum lycopersicum Species: Solanum lycopersicum Genus: Solanum Family: Solanaceae Order: Solanales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357442089|ref|XP_003591322.1| Pto kinase interactor [Medicago truncatula] gi|355480370|gb|AES61573.1| Pto kinase interactor [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 531 bits (1368), Expect = e-148, Method: Compositional matrix adjust.
Identities = 251/314 (79%), Positives = 285/314 (90%), Gaps = 1/314 (0%)
Query: 1 MSCFGCCEEDDIRKASKNG-PFVPNNPAGNPGGFYVKEAPAKEMKTVTVQPIAVPVISVD 59
MSCFGCCEED+ KA+++G P+V NPAGN G ++ + + +TV VQPI VP I D
Sbjct: 116 MSCFGCCEEDEFHKAAESGGPYVVKNPAGNDGNYHASDTAKQGAQTVKVQPIEVPEIQAD 175
Query: 60 ELKEKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLK 119
ELKE TDNFG +SLIGEGSYGRVY+GVL+SG+AAAIKKLD+SKQPD+EFLAQVSMVSRLK
Sbjct: 176 ELKEVTDNFGQDSLIGEGSYGRVYYGVLKSGQAAAIKKLDASKQPDEEFLAQVSMVSRLK 235
Query: 120 NENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGA 179
++N V+L+GY VDG R+LAYE AS GSLHDILHG+KGVKGA+PGPVL+WAQRVKIAVGA
Sbjct: 236 HDNFVQLLGYCVDGNSRILAYEFASNGSLHDILHGRKGVKGAQPGPVLTWAQRVKIAVGA 295
Query: 180 ARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTF 239
ARGLEYLHEKA+P IIHR+IKSSNVL+FDDD+AKI+DFDLSNQAPD AARLHSTRVLGTF
Sbjct: 296 ARGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF 355
Query: 240 GYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKV 299
GYHAPEYAMTGQ+++KSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKV
Sbjct: 356 GYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKV 415
Query: 300 KQCVDTKLGGEYPP 313
+QCVDT+LGGEYPP
Sbjct: 416 RQCVDTRLGGEYPP 429
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357442087|ref|XP_003591321.1| Pto kinase interactor [Medicago truncatula] gi|355480369|gb|AES61572.1| Pto kinase interactor [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 530 bits (1366), Expect = e-148, Method: Compositional matrix adjust.
Identities = 251/314 (79%), Positives = 285/314 (90%), Gaps = 1/314 (0%)
Query: 1 MSCFGCCEEDDIRKASKNG-PFVPNNPAGNPGGFYVKEAPAKEMKTVTVQPIAVPVISVD 59
MSCFGCCEED+ KA+++G P+V NPAGN G ++ + + +TV VQPI VP I D
Sbjct: 1 MSCFGCCEEDEFHKAAESGGPYVVKNPAGNDGNYHASDTAKQGAQTVKVQPIEVPEIQAD 60
Query: 60 ELKEKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLK 119
ELKE TDNFG +SLIGEGSYGRVY+GVL+SG+AAAIKKLD+SKQPD+EFLAQVSMVSRLK
Sbjct: 61 ELKEVTDNFGQDSLIGEGSYGRVYYGVLKSGQAAAIKKLDASKQPDEEFLAQVSMVSRLK 120
Query: 120 NENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGA 179
++N V+L+GY VDG R+LAYE AS GSLHDILHG+KGVKGA+PGPVL+WAQRVKIAVGA
Sbjct: 121 HDNFVQLLGYCVDGNSRILAYEFASNGSLHDILHGRKGVKGAQPGPVLTWAQRVKIAVGA 180
Query: 180 ARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTF 239
ARGLEYLHEKA+P IIHR+IKSSNVL+FDDD+AKI+DFDLSNQAPD AARLHSTRVLGTF
Sbjct: 181 ARGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF 240
Query: 240 GYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKV 299
GYHAPEYAMTGQ+++KSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKV
Sbjct: 241 GYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKV 300
Query: 300 KQCVDTKLGGEYPP 313
+QCVDT+LGGEYPP
Sbjct: 301 RQCVDTRLGGEYPP 314
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255548287|ref|XP_002515200.1| Serine/threonine-protein kinase PBS1, putative [Ricinus communis] gi|223545680|gb|EEF47184.1| Serine/threonine-protein kinase PBS1, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 523 bits (1348), Expect = e-146, Method: Compositional matrix adjust.
Identities = 250/314 (79%), Positives = 282/314 (89%), Gaps = 1/314 (0%)
Query: 1 MSCFGCCEEDDIRKASKNG-PFVPNNPAGNPGGFYVKEAPAKEMKTVTVQPIAVPVISVD 59
MSCFGCCEEDD+ KA+ +G P+ + AGN GG++ E + + V +QPI VP ISVD
Sbjct: 1 MSCFGCCEEDDMHKAADSGGPYPVKSSAGNVGGYHASETAPRGAQAVKIQPIEVPSISVD 60
Query: 60 ELKEKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLK 119
ELKE TDNFG NSLIGEGSYGRVY+G+L+SG+AAAIKKLD+SKQPD EFLAQVSMVSRLK
Sbjct: 61 ELKEVTDNFGINSLIGEGSYGRVYYGILKSGQAAAIKKLDASKQPDDEFLAQVSMVSRLK 120
Query: 120 NENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGA 179
+EN V+L+GY VDG RVLAYE AS GSLHDILHG+KGVKGA+PGPVLSW QRVKIAVGA
Sbjct: 121 HENFVQLLGYCVDGNSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGA 180
Query: 180 ARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTF 239
A+GLEYLHEKA+P IIHR+IKSSNVL+FDDD+AKI+DFDLSNQAPD AARLHSTRVLGTF
Sbjct: 181 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF 240
Query: 240 GYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKV 299
GYHAPEYAMTGQ+++KSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKV
Sbjct: 241 GYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKV 300
Query: 300 KQCVDTKLGGEYPP 313
+QCVDT+L G+YPP
Sbjct: 301 RQCVDTRLQGDYPP 314
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225437716|ref|XP_002280340.1| PREDICTED: pto-interacting protein 1 [Vitis vinifera] gi|297744052|emb|CBI37022.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 523 bits (1346), Expect = e-146, Method: Compositional matrix adjust.
Identities = 250/314 (79%), Positives = 282/314 (89%), Gaps = 1/314 (0%)
Query: 1 MSCFGCCEEDDIRKASKNG-PFVPNNPAGNPGGFYVKEAPAKEMKTVTVQPIAVPVISVD 59
MSCFGCCE+DDI A ++G PF NPAGN GG+ + K + V VQPIAVP I D
Sbjct: 1 MSCFGCCEDDDIHTAPESGNPFAAKNPAGNDGGYRHTDPAPKGTQAVKVQPIAVPPIPFD 60
Query: 60 ELKEKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLK 119
ELKE TDNFGT++LIGEGSYGRVY+G+L++G+AAAIKKLD+SKQPD+EFLAQVSMVSRLK
Sbjct: 61 ELKEITDNFGTSALIGEGSYGRVYYGLLKNGQAAAIKKLDASKQPDEEFLAQVSMVSRLK 120
Query: 120 NENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGA 179
++N VEL+GY VDG R+LAYE AS GSLHDILHG+KGVKGA+PGP+LSWAQRVKIAVGA
Sbjct: 121 HDNFVELIGYCVDGGSRILAYEFASNGSLHDILHGRKGVKGAQPGPILSWAQRVKIAVGA 180
Query: 180 ARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTF 239
ARGL+YLHEKA P IIHR+IKSSNVLLFDDD+AKI+DFDLSNQAPD AARLHSTRVLGTF
Sbjct: 181 ARGLDYLHEKASPHIIHRDIKSSNVLLFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF 240
Query: 240 GYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKV 299
GYHAPEYAMTGQ+++KSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKV
Sbjct: 241 GYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKV 300
Query: 300 KQCVDTKLGGEYPP 313
+QCVDT+LG +YPP
Sbjct: 301 RQCVDTRLGQDYPP 314
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359811321|ref|NP_001241285.1| pto-interacting protein 1-like [Glycine max] gi|223452480|gb|ACM89567.1| serine/threonine protein kinase [Glycine max] gi|255639418|gb|ACU20004.1| unknown [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 522 bits (1344), Expect = e-145, Method: Compositional matrix adjust.
Identities = 249/314 (79%), Positives = 281/314 (89%), Gaps = 1/314 (0%)
Query: 1 MSCFGCCEEDDIRKASKNG-PFVPNNPAGNPGGFYVKEAPAKEMKTVTVQPIAVPVISVD 59
MSCF CCEEDD+ KA+++G P+V NPAGN G + E + + V QPI VP IS D
Sbjct: 1 MSCFSCCEEDDLHKAAESGGPYVVKNPAGNDGNYLASETAKQGTQPVKPQPIEVPNISAD 60
Query: 60 ELKEKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLK 119
ELKE TDNFG ++LIGEGSYGRVY+GVL+S AAAIKKLD+SKQPD+EFLAQVSMVSRLK
Sbjct: 61 ELKEVTDNFGQDALIGEGSYGRVYYGVLKSELAAAIKKLDASKQPDEEFLAQVSMVSRLK 120
Query: 120 NENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGA 179
+EN V+L+GY +DG R+LAYE AS GSLHDILHG+KGVKGA+PGPVL+WAQRVKIAVGA
Sbjct: 121 HENFVQLLGYCIDGSSRILAYEFASNGSLHDILHGRKGVKGAQPGPVLTWAQRVKIAVGA 180
Query: 180 ARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTF 239
ARGLEYLHEKA+P IIHR+IKSSNVL+FDDD+AKI+DFDLSNQAPD AARLHSTRVLGTF
Sbjct: 181 ARGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF 240
Query: 240 GYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKV 299
GYHAPEYAMTGQ+++KSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKV
Sbjct: 241 GYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKV 300
Query: 300 KQCVDTKLGGEYPP 313
+QCVDT+LGGEYPP
Sbjct: 301 RQCVDTRLGGEYPP 314
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|1586940|prf||2205248A Ser/Thr kinase | Back alignment and taxonomy information |
|---|
Score = 513 bits (1320), Expect = e-143, Method: Compositional matrix adjust.
Identities = 244/314 (77%), Positives = 278/314 (88%), Gaps = 1/314 (0%)
Query: 1 MSCFGCCEEDDIRKASKNGPFVPNNPAGNPGGFYVKEAPAKEMKTVTVQPIAVPVISVDE 60
MSCF CC++DD+ +A+ NGPF+ +N AGN GG E+ +E +TV +QPIAVP I+VDE
Sbjct: 1 MSCFSCCDDDDMHRATDNGPFMAHNSAGNNGGQRATESAQRETQTVNIQPIAVPSIAVDE 60
Query: 61 LKEKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKN 120
LK+ TDNFG+ +LIGEGSYGRVY GVL+SGRAAAIKKLDSSKQPD+EFLAQVSMVSRLK+
Sbjct: 61 LKDITDNFGSKALIGEGSYGRVYHGVLKSGRAAAIKKLDSSKQPDREFLAQVSMVSRLKD 120
Query: 121 ENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAA 180
ENVVEL+GY VDG RVLAYE+A GSLHDILHG+KGVKGA+PGPVLSWAQRVKIAVGAA
Sbjct: 121 ENVVELLGYCVDGGFRVLAYEYAPNGSLHDILHGRKGVKGAQPGPVLSWAQRVKIAVGAA 180
Query: 181 RGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFG 240
+GLEYLHEKA+P IIHR+IKSSN+LLFDDD+AKI+DFDLSNQAPD AARLHSTRVLGTFG
Sbjct: 181 KGLEYLHEKAQPHIIHRDIKSSNILLFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFG 240
Query: 241 YHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVK 300
YHAPEYAMTGQ+SSKSDVYSFGVVLLELLTGRKPVDHTLPRG + + +LSEDKVK
Sbjct: 241 YHAPEYAMTGQLSSKSDVYSFGVVLLELLTGRKPVDHTLPRGNR-VCYLGNARLSEDKVK 299
Query: 301 QCVDTKLGGEYPPK 314
QCVD +L +YPPK
Sbjct: 300 QCVDARLNTDYPPK 313
|
Source: Solanum lycopersicum Species: Solanum lycopersicum Genus: Solanum Family: Solanaceae Order: Solanales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224130874|ref|XP_002320946.1| predicted protein [Populus trichocarpa] gi|222861719|gb|EEE99261.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 512 bits (1319), Expect = e-143, Method: Compositional matrix adjust.
Identities = 247/313 (78%), Positives = 279/313 (89%), Gaps = 1/313 (0%)
Query: 1 MSCFGCCEEDDIRKASKNG-PFVPNNPAGNPGGFYVKEAPAKEMKTVTVQPIAVPVISVD 59
MSCFGCCEEDD++KA+ NG P+ + AG+ G ++ E + + V +QPI VP ISVD
Sbjct: 1 MSCFGCCEEDDVQKAADNGGPYAVKSSAGHVGNYHASETAPRGPQAVKIQPIEVPAISVD 60
Query: 60 ELKEKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLK 119
ELKE T NFGT+SLIGEGSYGRVY+GVL+S +AAAIKKLD+SKQPD EFLAQVSMVSRLK
Sbjct: 61 ELKEVTVNFGTDSLIGEGSYGRVYYGVLKSEQAAAIKKLDASKQPDDEFLAQVSMVSRLK 120
Query: 120 NENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGA 179
+EN V+L+GY VDG RVLAYE AS GSLHDILHG+KGVKGA+PGPVL+W QRVKIAVGA
Sbjct: 121 HENFVQLLGYCVDGGSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLTWPQRVKIAVGA 180
Query: 180 ARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTF 239
A+GLEYLHEKA+PRIIHR+IKSSNVL+FDDD+AKI+DFDLSNQAPD AARLHSTRVLGTF
Sbjct: 181 AKGLEYLHEKADPRIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF 240
Query: 240 GYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKV 299
GYHAPEYAMTGQ+++KSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKV
Sbjct: 241 GYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKV 300
Query: 300 KQCVDTKLGGEYP 312
KQCVD +L GE P
Sbjct: 301 KQCVDARLQGECP 313
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 351 | ||||||
| TAIR|locus:2088990 | 364 | AT3G17410 [Arabidopsis thalian | 0.908 | 0.876 | 0.731 | 3.9e-124 | |
| TAIR|locus:2023767 | 363 | AT1G48210 [Arabidopsis thalian | 0.908 | 0.878 | 0.724 | 3.5e-123 | |
| TAIR|locus:2098083 | 361 | AT3G62220 [Arabidopsis thalian | 0.908 | 0.883 | 0.715 | 5.4e-118 | |
| TAIR|locus:2023752 | 364 | AT1G48220 [Arabidopsis thalian | 0.908 | 0.876 | 0.631 | 1.4e-105 | |
| TAIR|locus:2081277 | 408 | AT3G59350 [Arabidopsis thalian | 0.897 | 0.772 | 0.629 | 9.8e-103 | |
| TAIR|locus:2054502 | 366 | AT2G30740 [Arabidopsis thalian | 0.769 | 0.737 | 0.727 | 2e-102 | |
| TAIR|locus:2009115 | 361 | AT1G06700 [Arabidopsis thalian | 0.854 | 0.831 | 0.666 | 6.9e-102 | |
| TAIR|locus:2054492 | 338 | AT2G30730 [Arabidopsis thalian | 0.806 | 0.837 | 0.666 | 4.5e-98 | |
| TAIR|locus:2064557 | 365 | AT2G41970 [Arabidopsis thalian | 0.900 | 0.865 | 0.582 | 3.3e-95 | |
| TAIR|locus:2132168 | 725 | AT4G02010 [Arabidopsis thalian | 0.754 | 0.365 | 0.5 | 4.7e-64 |
| TAIR|locus:2088990 AT3G17410 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1220 (434.5 bits), Expect = 3.9e-124, P = 3.9e-124
Identities = 234/320 (73%), Positives = 266/320 (83%)
Query: 1 MSCFGCCEE-DDIRKASKNGPFVPNNPAGNPGGFYVKEAPAKEMKTVTVQPIAVPVISVD 59
M CFGCC +D R+ S+ GP +N G GG + + P K + + +QPI+V I D
Sbjct: 1 MGCFGCCGGGEDFRRVSETGPKPVHNTGGYNGGHHQRADPPKNLPVIQMQPISVAAIPAD 60
Query: 60 ELKEKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLK 119
EL++ TDN+G+ SLIGEGSYGRV++G+L+SG+AAAIKKLDSSKQPDQEFLAQVSMVSRL+
Sbjct: 61 ELRDITDNYGSKSLIGEGSYGRVFYGILKSGKAAAIKKLDSSKQPDQEFLAQVSMVSRLR 120
Query: 120 NENVVELVGYYVDGPLRVLAYEHASKGSLHDILHXXXXXXXXXXXXXLSWAQRVKIAVGA 179
ENVV L+GY VDGPLRVLAYE+A GSLHDILH LSW QRVKIAVGA
Sbjct: 121 QENVVALLGYCVDGPLRVLAYEYAPNGSLHDILHGRKGVKGAQPGPVLSWHQRVKIAVGA 180
Query: 180 ARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTF 239
ARGLEYLHEKA P +IHR+IKSSNVLLFDDD+AKI+DFDLSNQAPD AARLHSTRVLGTF
Sbjct: 181 ARGLEYLHEKANPHVIHRDIKSSNVLLFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF 240
Query: 240 GYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKV 299
GYHAPEYAMTG +S+KSDVYSFGVVLLELLTGRKPVDHTLPRGQQS+VTWATPKLSEDKV
Sbjct: 241 GYHAPEYAMTGTLSTKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSVVTWATPKLSEDKV 300
Query: 300 KQCVDTKLGGEYPPKAIAKV 319
KQCVD +L GEYPPKA+AK+
Sbjct: 301 KQCVDARLNGEYPPKAVAKL 320
|
|
| TAIR|locus:2023767 AT1G48210 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1211 (431.4 bits), Expect = 3.5e-123, P = 3.5e-123
Identities = 231/319 (72%), Positives = 263/319 (82%)
Query: 1 MSCFGCCEEDDIRKASKNGPFVPNNPAGNPGGFYVKEAPAKEMKTVTVQPIAVPVISVDE 60
MSCFG C +D R A+ GP +NPAG GG Y + P + +QPI+VP I VDE
Sbjct: 1 MSCFGWCGSEDFRNATDTGPRPAHNPAGYNGGHYQRADPPMNQPVIPMQPISVPAIPVDE 60
Query: 61 LKEKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKN 120
L++ TDN+G+ +LIGEGSYGRV++GVL+SG AAAIKKLDSSKQPDQEFL+Q+SMVSRL++
Sbjct: 61 LRDITDNYGSKTLIGEGSYGRVFYGVLKSGGAAAIKKLDSSKQPDQEFLSQISMVSRLRH 120
Query: 121 ENVVELVGYYVDGPLRVLAYEHASKGSLHDILHXXXXXXXXXXXXXLSWAQRVKIAVGAA 180
+NV L+GY VDGPLRVLAYE A KGSLHD LH ++W QRVKIAVGAA
Sbjct: 121 DNVTALMGYCVDGPLRVLAYEFAPKGSLHDTLHGKKGAKGALRGPVMTWQQRVKIAVGAA 180
Query: 181 RGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFG 240
RGLEYLHEK P++IHR+IKSSNVLLFDDD+AKI DFDLS+QAPD AARLHSTRVLGTFG
Sbjct: 181 RGLEYLHEKVSPQVIHRDIKSSNVLLFDDDVAKIGDFDLSDQAPDMAARLHSTRVLGTFG 240
Query: 241 YHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVK 300
YHAPEYAMTG +SSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVK
Sbjct: 241 YHAPEYAMTGTLSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVK 300
Query: 301 QCVDTKLGGEYPPKAIAKV 319
QCVD +L GEYPPKA+ K+
Sbjct: 301 QCVDARLLGEYPPKAVGKL 319
|
|
| TAIR|locus:2098083 AT3G62220 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1162 (414.1 bits), Expect = 5.4e-118, P = 5.4e-118
Identities = 229/320 (71%), Positives = 259/320 (80%)
Query: 1 MSCFGCCEEDDIRKASKNGPF-VPNNPAGNPGGFYVKEAPAKEMKTVTVQPIAVPVISVD 59
MSCFGCC EDD+ A+ G + GN G E K ++V VQPI V I D
Sbjct: 1 MSCFGCCREDDLPGANDYGGHNMTKQSGGNDGRRNGSETAQKGAQSVKVQPIEVAAILAD 60
Query: 60 ELKEKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLK 119
EL E T++FGTNSLIGEGSY RVY GVL++G+ AAIKKLDS+KQP++EFLAQVSMVSRLK
Sbjct: 61 ELIEATNDFGTNSLIGEGSYARVYHGVLKNGQRAAIKKLDSNKQPNEEFLAQVSMVSRLK 120
Query: 120 NENVVELVGYYVDGPLRVLAYEHASKGSLHDILHXXXXXXXXXXXXXLSWAQRVKIAVGA 179
+ N VEL+GY VDG R+L +E A GSLHDILH LSW QRVKIAVGA
Sbjct: 121 HVNFVELLGYSVDGNSRILVFEFAQNGSLHDILHGRKGVKGAKPGPLLSWHQRVKIAVGA 180
Query: 180 ARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTF 239
ARGLEYLHEKA P +IHR+IKSSNVL+FD+D+AKI+DFDLSNQAPD AARLHSTRVLGTF
Sbjct: 181 ARGLEYLHEKANPHVIHRDIKSSNVLIFDNDVAKIADFDLSNQAPDMAARLHSTRVLGTF 240
Query: 240 GYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKV 299
GYHAPEYAMTGQ+S+KSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKV
Sbjct: 241 GYHAPEYAMTGQLSAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKV 300
Query: 300 KQCVDTKLGGEYPPKAIAKV 319
KQCVD++LGG+YPPKA+AK+
Sbjct: 301 KQCVDSRLGGDYPPKAVAKL 320
|
|
| TAIR|locus:2023752 AT1G48220 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1045 (372.9 bits), Expect = 1.4e-105, P = 1.4e-105
Identities = 202/320 (63%), Positives = 248/320 (77%)
Query: 1 MSCFGCCEEDDIRKASKNGPFVPNNPAGNPGGFYVKEAPAKEMKTVTVQPIAVPVISVDE 60
MSCFG C +D+R + GP +N G G + + P V +QPIAVP I VDE
Sbjct: 1 MSCFGWCGSEDVRNPADTGPSQAHNSIGYNGRHHQRADPPMNQPVVNMQPIAVPAIPVDE 60
Query: 61 LKEKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKN 120
L++ T+NF + L+G+GSYGRV++GVL+SG+ AAIKKL +KQPDQEFL+QVSMVSRL +
Sbjct: 61 LEDITENFSSEVLVGKGSYGRVFYGVLKSGKEAAIKKLYPTKQPDQEFLSQVSMVSRLHH 120
Query: 121 ENVVELVGYYVDGPLRVLAYEHASKGSLHDILHXXXXXXXXXXXXXLSWAQRVKIAVGAA 180
ENVV L+ Y VDGPLRVLAYE A+ G+LHD+LH ++W +RVKIA+GAA
Sbjct: 121 ENVVALMAYCVDGPLRVLAYEFATYGTLHDVLHGQTGVIGALQGPVMTWQRRVKIALGAA 180
Query: 181 RGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRV-LGTF 239
RGLEYLH+K P++IHR+IK+SN+LLFDDDIAKI DFDL +QAP+ A RLHS R+ LG
Sbjct: 181 RGLEYLHKKVNPQVIHRDIKASNILLFDDDIAKIGDFDLYDQAPNMAGRLHSCRMALGAS 240
Query: 240 GYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKV 299
H PE+AMTG +++KSDVYSFGVVLLELLTGRKPVD TLPRGQQ+LVTWATPKLS+DKV
Sbjct: 241 RSHCPEHAMTGILTTKSDVYSFGVVLLELLTGRKPVDRTLPRGQQNLVTWATPKLSKDKV 300
Query: 300 KQCVDTKLGGEYPPKAIAKV 319
KQCVD +L GEYPPKA+AK+
Sbjct: 301 KQCVDARLLGEYPPKAVAKL 320
|
|
| TAIR|locus:2081277 AT3G59350 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1018 (363.4 bits), Expect = 9.8e-103, P = 9.8e-103
Identities = 202/321 (62%), Positives = 241/321 (75%)
Query: 3 CFGCCEEDDIRKASKNGPFVPNNPAGNPGGFYVKEAPAKEMKTVTVQP--IAVPVISVDE 60
C C E+ + P + N G + ++ A +P I VP +S+DE
Sbjct: 48 CCACHVEEPYHSSENEHLRSPKHH--NDFGHHTRKPQAAVKPDALKEPPSIDVPALSLDE 105
Query: 61 LKEKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQ--EFLAQVSMVSRL 118
LKEKTDNFG+ SLIGEGSYGR Y+ L+ G+A A+KKLD++ +P+ EFL QVS VS+L
Sbjct: 106 LKEKTDNFGSKSLIGEGSYGRAYYATLKDGKAVAVKKLDNAAEPESNVEFLTQVSRVSKL 165
Query: 119 KNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHXXXXXXXXXXXXXLSWAQRVKIAVG 178
K++N VEL GY V+G R+LAYE A+ GSLHDILH L W QRV+IAV
Sbjct: 166 KHDNFVELFGYCVEGNFRILAYEFATMGSLHDILHGRKGVQGAQPGPTLDWIQRVRIAVD 225
Query: 179 AARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGT 238
AARGLEYLHEK +P +IHR+I+SSNVLLF+D AKI+DF+LSNQ+PD AARLHSTRVLGT
Sbjct: 226 AARGLEYLHEKVQPAVIHRDIRSSNVLLFEDFKAKIADFNLSNQSPDMAARLHSTRVLGT 285
Query: 239 FGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDK 298
FGYHAPEYAMTGQ++ KSDVYSFGVVLLELLTGRKPVDHT+PRGQQSLVTWATP+LSEDK
Sbjct: 286 FGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDK 345
Query: 299 VKQCVDTKLGGEYPPKAIAKV 319
VKQCVD KL GEYPPKA+AK+
Sbjct: 346 VKQCVDPKLKGEYPPKAVAKL 366
|
|
| TAIR|locus:2054502 AT2G30740 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1015 (362.4 bits), Expect = 2.0e-102, P = 2.0e-102
Identities = 198/272 (72%), Positives = 227/272 (83%)
Query: 50 PIAVPVISVDELKEKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQ--E 107
PI VP +SVDE+KEKTDNFG+ SLIGEGSYGRVY+ L G+A A+KKLD + + + E
Sbjct: 53 PIEVPPLSVDEVKEKTDNFGSKSLIGEGSYGRVYYATLNDGKAVALKKLDVAPEAETNTE 112
Query: 108 FLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHXXXXXXXXXXXXXL 167
FL QVSMVSRLK+EN+++LVGY VD LRVLAYE A+ GSLHDILH L
Sbjct: 113 FLNQVSMVSRLKHENLIQLVGYCVDENLRVLAYEFATMGSLHDILHGRKGVQGAQPGPTL 172
Query: 168 SWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAA 227
W RVKIAV AARGLEYLHEK +P +IHR+I+SSNVLLF+D AK++DF+LSNQAPD A
Sbjct: 173 DWLTRVKIAVEAARGLEYLHEKVQPPVIHRDIRSSNVLLFEDYQAKVADFNLSNQAPDNA 232
Query: 228 ARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLV 287
ARLHSTRVLGTFGYHAPEYAMTGQ++ KSDVYSFGVVLLELLTGRKPVDHT+PRGQQSLV
Sbjct: 233 ARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLV 292
Query: 288 TWATPKLSEDKVKQCVDTKLGGEYPPKAIAKV 319
TWATP+LSEDKVKQCVD KL GEYPPK++AK+
Sbjct: 293 TWATPRLSEDKVKQCVDPKLKGEYPPKSVAKL 324
|
|
| TAIR|locus:2009115 AT1G06700 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1010 (360.6 bits), Expect = 6.9e-102, P = 6.9e-102
Identities = 206/309 (66%), Positives = 244/309 (78%)
Query: 36 KEAP-AK-EMKTVTVQPIAVPVISVDELKEKTDNFGTNSLIGEGSYGRVYFGVLRSGRAA 93
K AP AK E+K + PI VP +S+DE+KEKT+NFG+ +LIGEGSYGRVY+ L G A
Sbjct: 35 KPAPVAKHEVKKEAL-PIEVPPLSLDEVKEKTENFGSKALIGEGSYGRVYYATLNDGVAV 93
Query: 94 AIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDI 151
A+KKLD + + D EFL+QVSMVSRLK+EN+++L+G+ VDG LRVLAYE A+ GSLHDI
Sbjct: 94 ALKKLDVAPEAETDTEFLSQVSMVSRLKHENLIQLLGFCVDGNLRVLAYEFATMGSLHDI 153
Query: 152 LHXXXXXXXXXXXXXLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDI 211
LH L W RVKIAV AARGLEYLHEK++P +IHR+I+SSNVLLF+D
Sbjct: 154 LHGRKGVQGAQPGPTLDWITRVKIAVEAARGLEYLHEKSQPPVIHRDIRSSNVLLFEDYK 213
Query: 212 AKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTG 271
AKI+DF+LSNQAPD AARLHSTRVLGTFGYHAPEYAMTGQ++ KSDVYSFGVVLLELLTG
Sbjct: 214 AKIADFNLSNQAPDNAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTG 273
Query: 272 RKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKVRKKKFITSECSN 331
RKPVDHT+PRGQQSLVTWATP+LSEDKVKQC+D KL +YPPKA+AK+ + + C
Sbjct: 274 RKPVDHTMPRGQQSLVTWATPRLSEDKVKQCIDPKLKADYPPKAVAKLAA---VAALCVQ 330
Query: 332 ISFAEFNIN 340
AEF N
Sbjct: 331 YE-AEFRPN 338
|
|
| TAIR|locus:2054492 AT2G30730 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 974 (347.9 bits), Expect = 4.5e-98, P = 4.5e-98
Identities = 190/285 (66%), Positives = 228/285 (80%)
Query: 37 EAPAKEMKTVTVQPIAVPVISVDELKEKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIK 96
+ P K + PI VP +SVDE+ E+TDNFG NSLIGEGSYGRVY+ L G+A A+K
Sbjct: 16 QKPQDLAKPKEILPIIVPSLSVDEVNEQTDNFGPNSLIGEGSYGRVYYATLNDGKAVALK 75
Query: 97 KLDSSKQPDQ--EFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHX 154
KLD + + + EFL+QVSMVSRLK+EN+++LVGY VD LRVLAYE A+ GSLHDILH
Sbjct: 76 KLDLAPEDETNTEFLSQVSMVSRLKHENLIQLVGYCVDENLRVLAYEFATMGSLHDILHG 135
Query: 155 XXXXXXXXXXXXLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKI 214
L W RVKIAV AARGLEYLHEK +P++IHR+I+SSN+LLFDD AKI
Sbjct: 136 RKGVQDALPGPTLDWITRVKIAVEAARGLEYLHEKVQPQVIHRDIRSSNILLFDDYQAKI 195
Query: 215 SDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
+DF+LSNQ+PD AARL STRVLG+FGY++PEYAMTG+++ KSDVY FGVVLLELLTGRKP
Sbjct: 196 ADFNLSNQSPDNAARLQSTRVLGSFGYYSPEYAMTGELTHKSDVYGFGVVLLELLTGRKP 255
Query: 275 VDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKV 319
VDHT+PRGQQSLVTWATPKLSED V++CVD KL GEY PK++AK+
Sbjct: 256 VDHTMPRGQQSLVTWATPKLSEDTVEECVDPKLKGEYSPKSVAKL 300
|
|
| TAIR|locus:2064557 AT2G41970 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 947 (338.4 bits), Expect = 3.3e-95, P = 3.3e-95
Identities = 191/328 (58%), Positives = 242/328 (73%)
Query: 1 MSCFGCCEEDDIRKASKNGPFVPNNPAGNP--GGFYVKE-----APAKEMKTVTVQPIAV 53
M C G +E+ + N P N AGNP GG E AP + V PI +
Sbjct: 1 MFCCGGADEEPAGPPA-NQYAAPPNKAGNPNFGGGNRGEPRNPNAP-RSGAPAKVLPIEI 58
Query: 54 PVISVDELKEKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLD--SSKQPDQEFLAQ 111
P +++DEL NFG +LIGEGSYGRV+ G + G A AIKKLD SS++PD +F +Q
Sbjct: 59 PSVALDELNRMAGNFGNKALIGEGSYGRVFCGKFK-GEAVAIKKLDASSSEEPDSDFTSQ 117
Query: 112 VSMVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHXXXXXXXXXXXXXLSWAQ 171
+S+VSRLK+++ VEL+GY ++ R+L Y+ A+KGSLHD+LH L+W Q
Sbjct: 118 LSVVSRLKHDHFVELLGYCLEANNRILIYQFATKGSLHDVLHGRKGVQGAEPGPVLNWNQ 177
Query: 172 RVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLH 231
RVKIA GAA+GLE+LHEK +P I+HR+++SSNVLLFDD +AK++DF+L+N + D AARLH
Sbjct: 178 RVKIAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFVAKMADFNLTNASSDTAARLH 237
Query: 232 STRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWAT 291
STRVLGTFGYHAPEYAMTGQ++ KSDVYSFGVVLLELLTGRKPVDHT+P+GQQSLVTWAT
Sbjct: 238 STRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWAT 297
Query: 292 PKLSEDKVKQCVDTKLGGEYPPKAIAKV 319
P+LSEDKVKQC+D KL ++PPKA+AK+
Sbjct: 298 PRLSEDKVKQCIDPKLNNDFPPKAVAKL 325
|
|
| TAIR|locus:2132168 AT4G02010 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 653 (234.9 bits), Expect = 4.7e-64, P = 4.7e-64
Identities = 137/274 (50%), Positives = 184/274 (67%)
Query: 50 PIAVPVISVDELKEKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSS-KQPDQEF 108
P + +S +ELKE T NF + S++GEG +G+VY G+L G A AIKKL S Q D+EF
Sbjct: 362 PASTRFLSYEELKEATSNFESASILGEGGFGKVYRGILADGTAVAIKKLTSGGPQGDKEF 421
Query: 109 LAQVSMVSRLKNENVVELVGYYV--DGPLRVLAYEHASKGSLHDILHXXXXXXXXXXXXX 166
++ M+SRL + N+V+LVGYY D +L YE GSL LH
Sbjct: 422 QVEIDMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLEAWLHGPLGLNCP----- 476
Query: 167 LSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDA 226
L W R+KIA+ AARGL YLHE ++P +IHR+ K+SN+LL ++ AK++DF L+ QAP+
Sbjct: 477 LDWDTRMKIALDAARGLAYLHEDSQPSVIHRDFKASNILLENNFNAKVADFGLAKQAPEG 536
Query: 227 AARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSL 286
STRV+GTFGY APEYAMTG + KSDVYS+GVVLLELLTGRKPVD + P GQ++L
Sbjct: 537 RGNHLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENL 596
Query: 287 VTWATPKLSE-DKVKQCVDTKLGGEYPPKAIAKV 319
VTW P L + D++++ VD++L G+YP + +V
Sbjct: 597 VTWTRPVLRDKDRLEELVDSRLEGKYPKEDFIRV 630
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| O80719 | Y2706_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.7383 | 0.8831 | 0.8493 | no | no |
| Q41328 | PTI1_SOLLC | 2, ., 7, ., 1, 1, ., 1 | 0.8089 | 0.8945 | 0.8870 | N/A | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.979 |
| 3rd Layer | 2.7.11 | 0.983 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 351 | |||
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-47 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-45 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 1e-44 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 9e-43 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 3e-42 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 1e-41 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 6e-40 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 1e-35 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 1e-35 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 7e-34 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 4e-29 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 9e-29 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 1e-28 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 5e-28 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 1e-26 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 2e-26 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 1e-25 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 3e-25 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 3e-25 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 4e-25 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 2e-24 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 2e-24 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-24 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 6e-24 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 7e-24 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 9e-24 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 9e-24 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 4e-23 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 4e-23 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 7e-23 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-22 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 3e-22 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 4e-22 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 7e-22 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 1e-21 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 1e-21 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 1e-21 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 5e-21 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 6e-21 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 6e-21 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 7e-21 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 2e-20 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 2e-20 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-20 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 3e-20 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 4e-20 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 5e-20 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 5e-20 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 5e-20 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 6e-20 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 1e-19 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 2e-19 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 2e-19 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-19 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 2e-19 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 3e-19 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 4e-19 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 4e-19 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 6e-19 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 7e-19 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 7e-19 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 7e-19 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 8e-19 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 1e-18 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 1e-18 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 2e-18 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-18 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 2e-18 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 3e-18 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 3e-18 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 4e-18 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 4e-18 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 5e-18 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 5e-18 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 5e-18 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 5e-18 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 6e-18 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 6e-18 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 7e-18 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 8e-18 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 9e-18 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 1e-17 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 1e-17 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 1e-17 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-17 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 3e-17 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 3e-17 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 3e-17 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 3e-17 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 4e-17 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 4e-17 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 4e-17 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 7e-17 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 8e-17 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 9e-17 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 1e-16 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 2e-16 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-16 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 2e-16 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-16 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-16 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 2e-16 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 2e-16 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 2e-16 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 4e-16 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 5e-16 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 5e-16 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 5e-16 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 5e-16 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 6e-16 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 7e-16 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 7e-16 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 8e-16 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 1e-15 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 1e-15 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 1e-15 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 2e-15 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 2e-15 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 3e-15 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 3e-15 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 3e-15 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 4e-15 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 5e-15 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 6e-15 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 6e-15 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 7e-15 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 8e-15 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 1e-14 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 2e-14 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 2e-14 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 3e-14 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 4e-14 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 6e-14 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 6e-14 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 7e-14 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 7e-14 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 8e-14 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 1e-13 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-13 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 2e-13 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 3e-13 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 3e-13 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 4e-13 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 7e-13 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 9e-13 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 1e-12 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 1e-12 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 2e-12 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 2e-12 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 2e-12 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 2e-12 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 2e-12 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 3e-12 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 3e-12 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 4e-12 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 5e-12 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 6e-12 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 9e-12 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 1e-11 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 1e-11 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 2e-11 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 2e-11 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 2e-11 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 2e-11 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 3e-11 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 3e-11 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 3e-11 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 3e-11 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 4e-11 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 4e-11 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 6e-11 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 7e-11 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 7e-11 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 8e-11 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 8e-11 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 8e-11 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 8e-11 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 1e-10 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 1e-10 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 3e-10 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 4e-10 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 5e-10 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 6e-10 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 8e-10 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 1e-09 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 1e-09 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 1e-09 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 2e-09 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 2e-09 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-09 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 2e-09 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 2e-09 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-09 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 3e-09 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 3e-09 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 3e-09 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 3e-09 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 3e-09 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 3e-09 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 4e-09 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 4e-09 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 5e-09 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 5e-09 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 7e-09 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 7e-09 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 8e-09 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 9e-09 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 1e-08 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 1e-08 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 1e-08 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 1e-08 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-08 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 2e-08 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 3e-08 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 3e-08 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 3e-08 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 4e-08 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 4e-08 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 4e-08 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 5e-08 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 5e-08 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 5e-08 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 6e-08 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 7e-08 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 7e-08 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 7e-08 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 8e-08 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 8e-08 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 9e-08 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 9e-08 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 9e-08 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 1e-07 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 2e-07 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 2e-07 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 2e-07 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 2e-07 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-07 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-07 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 2e-07 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 2e-07 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 3e-07 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 3e-07 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 3e-07 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 4e-07 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 4e-07 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 5e-07 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 5e-07 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 7e-07 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 9e-07 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 1e-06 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 1e-06 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 1e-06 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 1e-06 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 2e-06 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 2e-06 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 2e-06 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 3e-06 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 3e-06 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 4e-06 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 4e-06 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 5e-06 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 5e-06 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 5e-06 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 8e-06 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 9e-06 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 9e-06 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 1e-05 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 1e-05 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 2e-05 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 2e-05 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 2e-05 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 3e-05 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 3e-05 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 4e-05 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 5e-05 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 6e-05 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 7e-05 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 8e-05 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 1e-04 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 2e-04 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 2e-04 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 2e-04 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 4e-04 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 6e-04 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 7e-04 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 0.001 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 0.001 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 0.002 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 0.003 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 0.003 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 0.004 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 0.004 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 0.004 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 159 bits (405), Expect = 1e-47
Identities = 67/200 (33%), Positives = 101/200 (50%), Gaps = 18/200 (9%)
Query: 74 IGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPD--QEFLAQVSMVSRLKNENVVELVGYY 130
+GEG +G VY + +G+ AIK + +E L ++ ++ +L + N+V+L G +
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 131 VDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKA 190
D L E+ GSL D+L +G LS + ++I + GLEYLH
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKENEG--------KLSEDEILRILLQILEGLEYLHSN- 111
Query: 191 EPRIIHRNIKSSNVLLFDDD-IAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE-YAM 248
IIHR++K N+LL D+ K++DF LS + L + GT Y APE
Sbjct: 112 --GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIV--GTPAYMAPEVLLG 167
Query: 249 TGQMSSKSDVYSFGVVLLEL 268
G S KSD++S GV+L EL
Sbjct: 168 KGYYSEKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 155 bits (394), Expect = 2e-45
Identities = 69/213 (32%), Positives = 105/213 (49%), Gaps = 22/213 (10%)
Query: 71 NSLIGEGSYGRVYFGVLR-----SGRAAAIKKLDSSKQPDQ--EFLAQVSMVSRLKNENV 123
+GEG++G VY G L+ A+K L Q EFL + ++ +L + NV
Sbjct: 4 GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNV 63
Query: 124 VELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGL 183
V+L+G + + E+ G L L K P LS + + A+ ARG+
Sbjct: 64 VKLLGVCTEEEPLYIVMEYMEGGDLLSYLR--------KNRPKLSLSDLLSFALQIARGM 115
Query: 184 EYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS-NQAPDAAARLHSTRVLGTFGYH 242
EYL K IHR++ + N L+ ++ + KISDF LS + D R ++ +
Sbjct: 116 EYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKL--PIRWM 170
Query: 243 APEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 274
APE G+ +SKSDV+SFGV+L E+ T G +P
Sbjct: 171 APESLKEGKFTSKSDVWSFGVLLWEIFTLGEQP 203
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 153 bits (390), Expect = 1e-44
Identities = 66/213 (30%), Positives = 107/213 (50%), Gaps = 21/213 (9%)
Query: 71 NSLIGEGSYGRVYFGVLR-----SGRAAAIKKLDSSKQPDQ--EFLAQVSMVSRLKNENV 123
+GEG++G VY G L+ A+K L Q EFL + ++ +L + N+
Sbjct: 4 GKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNI 63
Query: 124 VELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGL 183
V+L+G + ++ E+ G L D L + LS + + A+ ARG+
Sbjct: 64 VKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRP-------KELSLSDLLSFALQIARGM 116
Query: 184 EYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS-NQAPDAAARLHSTRVLGTFGYH 242
EYL K IHR++ + N L+ ++ + KISDF LS + D ++ ++ +
Sbjct: 117 EYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKL--PIRWM 171
Query: 243 APEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 274
APE G+ +SKSDV+SFGV+L E+ T G +P
Sbjct: 172 APESLKEGKFTSKSDVWSFGVLLWEIFTLGEEP 204
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 148 bits (377), Expect = 9e-43
Identities = 68/209 (32%), Positives = 105/209 (50%), Gaps = 12/209 (5%)
Query: 74 IGEGSYGRVYFGVLRSG----RAAAIKKLDSSKQPDQ--EFLAQVSMVSRLKNENVVELV 127
+GEG++G VY G L+ A+K L ++ +FL + ++ +L + NVV L+
Sbjct: 3 LGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLL 62
Query: 128 GYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLH 187
G + L E+ G L D L + V + LS + A+ A+G+EYL
Sbjct: 63 GVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA 122
Query: 188 EKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS-NQAPDAAARLHSTRVLGTFGYHAPEY 246
K + +HR++ + N L+ +D + KISDF LS + D R + L + APE
Sbjct: 123 SK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIR-WMAPES 178
Query: 247 AMTGQMSSKSDVYSFGVVLLELLT-GRKP 274
G +SKSDV+SFGV+L E+ T G P
Sbjct: 179 LKDGIFTSKSDVWSFGVLLWEIFTLGATP 207
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 147 bits (373), Expect = 3e-42
Identities = 69/210 (32%), Positives = 109/210 (51%), Gaps = 21/210 (10%)
Query: 74 IGEGSYGRVYFGVLR-----SGRAAAIKKL--DSSKQPDQEFLAQVSMVSRLKNENVVEL 126
+GEG++G VY G L+ + A+K L +S++ +EFL + S++ +L + N+V L
Sbjct: 7 LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRL 66
Query: 127 VGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYL 186
+G G + E+ G L D L K G L+ +++A+ A+G+EYL
Sbjct: 67 LGVCTQGEPLYIVTEYMPGGDLLDFLR--------KHGEKLTLKDLLQMALQIAKGMEYL 118
Query: 187 HEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ-APDAAARLHSTRVLGTFGYHAPE 245
K +HR++ + N L+ ++ + KISDF LS D R L APE
Sbjct: 119 ESK---NFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWM-APE 174
Query: 246 YAMTGQMSSKSDVYSFGVVLLELLT-GRKP 274
G+ +SKSDV+SFGV+L E+ T G +P
Sbjct: 175 SLKDGKFTSKSDVWSFGVLLWEIFTLGEQP 204
|
Length = 258 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 145 bits (369), Expect = 1e-41
Identities = 72/219 (32%), Positives = 108/219 (49%), Gaps = 19/219 (8%)
Query: 74 IGEGSYGRVYFGVLRS-GRAAAIKKL---DSSKQPDQEFLAQVSMVSRLKNENVVELVGY 129
+G GS+G VY + G+ A+K L + DQ ++ ++ RL + N+V L+
Sbjct: 7 LGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLIDA 66
Query: 130 YVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEK 189
+ D L E+ G L D L LS + KIA+ RGLEYLH
Sbjct: 67 FEDKDHLYLVMEYCEGGDLFDYLSRGG---------PLSEDEAKKIALQILRGLEYLHSN 117
Query: 190 AEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMT 249
IIHR++K N+LL ++ + KI+DF L+ + +++ L + +GT Y APE +
Sbjct: 118 ---GIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTT--FVGTPWYMAPEVLLG 172
Query: 250 GQM-SSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLV 287
G K DV+S GV+L ELLTG+ P Q L+
Sbjct: 173 GNGYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLI 211
|
Length = 260 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 141 bits (357), Expect = 6e-40
Identities = 64/205 (31%), Positives = 96/205 (46%), Gaps = 18/205 (8%)
Query: 73 LIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQ--VSMVSRLKNENVVELVGY 129
+GEGS+G+VY ++G+ AIK + K + ++ +LK+ N+V L
Sbjct: 6 KLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYDV 65
Query: 130 YVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEK 189
+ D L E+ G L D+L + LS + LEYLH K
Sbjct: 66 FEDEDKLYLVMEYCEGGDLFDLLKKRGR---------LSEDEARFYLRQILSALEYLHSK 116
Query: 190 AEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMT 249
I+HR++K N+LL +D K++DF L+ Q +T V GT Y APE +
Sbjct: 117 ---GIVHRDLKPENILLDEDGHVKLADFGLARQLDP--GEKLTTFV-GTPEYMAPEVLLG 170
Query: 250 GQMSSKSDVYSFGVVLLELLTGRKP 274
D++S GV+L ELLTG+ P
Sbjct: 171 KGYGKAVDIWSLGVILYELLTGKPP 195
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 130 bits (328), Expect = 1e-35
Identities = 65/204 (31%), Positives = 100/204 (49%), Gaps = 18/204 (8%)
Query: 74 IGEGSYGRVYFG-VLRSGRAAAIKKLDSSKQPDQEFLAQ-VSMVSRLKNENVVELVG-YY 130
IG+G +G VY R+G+ AIK + + +E + + ++ + K+ N+V+ G Y
Sbjct: 8 IGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYL 67
Query: 131 VDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKA 190
L + E S GSL D+L L+ +Q + +GLEYLH
Sbjct: 68 KKDELW-IVMEFCSGGSLKDLLKSTNQT--------LTESQIAYVCKELLKGLEYLHSN- 117
Query: 191 EPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTG 250
IIHR+IK++N+LL D K+ DF LS Q D AR ++GT + APE
Sbjct: 118 --GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKAR---NTMVGTPYWMAPEVINGK 172
Query: 251 QMSSKSDVYSFGVVLLELLTGRKP 274
K+D++S G+ +EL G+ P
Sbjct: 173 PYDYKADIWSLGITAIELAEGKPP 196
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 129 bits (328), Expect = 1e-35
Identities = 57/209 (27%), Positives = 103/209 (49%), Gaps = 20/209 (9%)
Query: 73 LIGEGSYGRVYFGVLR-SGRAAAIKKLD---SSKQPDQEFLAQVSMVSRLKNENVVELVG 128
L+G GS+G VY + + +G A+K ++ S++ + ++ ++S L++ N+V G
Sbjct: 7 LLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYG 66
Query: 129 YYVDGPLRVL--AYEHASKGSLHDILHGKKGVKGAKPGPVL-SWAQRVKIAVGAARGLEY 185
D L E+ S GSL +L + P PV+ + +++ GL Y
Sbjct: 67 SERDEEKNTLNIFLEYVSGGSLSSLLKKFGKL----PEPVIRKYTRQI------LEGLAY 116
Query: 186 LHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245
LH I+HR+IK +N+L+ D + K++DF + + D + V GT + APE
Sbjct: 117 LHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPE 173
Query: 246 YAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
+ +D++S G ++E+ TG+ P
Sbjct: 174 VIRGEEYGRAADIWSLGCTVIEMATGKPP 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 125 bits (315), Expect = 7e-34
Identities = 70/204 (34%), Positives = 116/204 (56%), Gaps = 17/204 (8%)
Query: 72 SLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYV 131
+ IG+G +G V G R G+ A+K L Q FLA+ S+++ L++ N+V+L+G +
Sbjct: 12 ATIGKGEFGDVMLGDYR-GQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVL 70
Query: 132 DGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAE 191
G + E+ +KGSL D L ++ V++ AQ++ A+ G+EYL EK
Sbjct: 71 QGNPLYIVTEYMAKGSLVDYLR-------SRGRAVITLAQQLGFALDVCEGMEYLEEK-- 121
Query: 192 PRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQ 251
+HR++ + NVL+ +D +AK+SDF L A +A+ S ++ + APE +
Sbjct: 122 -NFVHRDLAARNVLVSEDLVAKVSDFGL---AKEASQGQDSGKL--PVKWTAPEALREKK 175
Query: 252 MSSKSDVYSFGVVLLELLT-GRKP 274
S+KSDV+SFG++L E+ + GR P
Sbjct: 176 FSTKSDVWSFGILLWEIYSFGRVP 199
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 4e-29
Identities = 65/220 (29%), Positives = 107/220 (48%), Gaps = 42/220 (19%)
Query: 73 LIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQE---FLAQVSMVSRLKNENVVELVG 128
IG+GS+G+VY G+ +K++D S ++E L +V ++ +L + N+++
Sbjct: 7 QIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYE 66
Query: 129 YYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGP---VLSWAQRVKIAVGAARGLEY 185
+ + + E+A G L + KK K KP P +L W V++ + L+Y
Sbjct: 67 SFEEKGKLCIVMEYADGGDLSQKI--KKQKKEGKPFPEEQILDWF--VQLCLA----LKY 118
Query: 186 LHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTR-----VLGTFG 240
LH + +I+HR+IK N+ L + + K+ DF +S L ST V+GT
Sbjct: 119 LHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKV-------LSSTVDLAKTVVGTPY 168
Query: 241 YHAPE------YAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
Y +PE Y + KSD++S G VL EL T + P
Sbjct: 169 YLSPELCQNKPY------NYKSDIWSLGCVLYELCTLKHP 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 114 bits (285), Expect = 9e-29
Identities = 68/218 (31%), Positives = 99/218 (45%), Gaps = 24/218 (11%)
Query: 72 SLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQE----FLAQVSMVSRLK-NENVVEL 126
+GEGS+G VY R + A+K L + + FL ++ +++ L N+V+L
Sbjct: 6 RKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKL 63
Query: 127 VGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYL 186
++ D L E+ GSL D+L L ++ LEYL
Sbjct: 64 YDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQI------LSALEYL 117
Query: 187 HEKAEPRIIHRNIKSSNVLL-FDDDIAKISDFDLSNQAPDAAARLHSTR----VLGTFGY 241
H K IIHR+IK N+LL D + K+ DF L+ PD + +GT GY
Sbjct: 118 HSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGY 174
Query: 242 HAPEYAM---TGQMSSKSDVYSFGVVLLELLTGRKPVD 276
APE + SS SD++S G+ L ELLTG P +
Sbjct: 175 MAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFE 212
|
Length = 384 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (278), Expect = 1e-28
Identities = 64/206 (31%), Positives = 106/206 (51%), Gaps = 18/206 (8%)
Query: 73 LIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQ---EFLAQVSMVSRLKNENVVELVG 128
LIG G++G VY G+ L +G AIK++ K ++ + ++ ++ LK+ N+V+ +G
Sbjct: 7 LIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIG 66
Query: 129 YYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHE 188
+ E+A GSL I+ K GP + +GL YLHE
Sbjct: 67 SIETSDSLYIILEYAENGSLRQIIK--------KFGP-FPESLVAVYVYQVLQGLAYLHE 117
Query: 189 KAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAM 248
+ +IHR+IK++N+L D + K++DF ++ + D + S V+GT + APE
Sbjct: 118 QG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDAS--VVGTPYWMAPEVIE 172
Query: 249 TGQMSSKSDVYSFGVVLLELLTGRKP 274
S+ SD++S G ++ELLTG P
Sbjct: 173 MSGASTASDIWSLGCTVIELLTGNPP 198
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 5e-28
Identities = 65/213 (30%), Positives = 108/213 (50%), Gaps = 18/213 (8%)
Query: 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKK--LDSSKQPDQEFLAQVSMVSRLKNEN 122
+ ++G+GS G VY + +G+ A+KK +D ++ ++ L ++ + ++
Sbjct: 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPY 60
Query: 123 VVELVG-YYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAAR 181
VV+ G +Y +G + + E+ GSL D+L + P PVL+ IA +
Sbjct: 61 VVKCYGAFYKEGEIS-IVLEYMDGGSLADLLKKVGKI----PEPVLA-----YIARQILK 110
Query: 182 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGY 241
GL+YLH K IIHR+IK SN+L+ KI+DF +S + + +T V GT Y
Sbjct: 111 GLDYLHTKR--HIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ-CNTFV-GTVTY 166
Query: 242 HAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
+PE S +D++S G+ LLE G+ P
Sbjct: 167 MSPERIQGESYSYAADIWSLGLTLLECALGKFP 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 1e-26
Identities = 67/214 (31%), Positives = 102/214 (47%), Gaps = 31/214 (14%)
Query: 74 IGEGSYGRVYFGVLR--SGR--AAAIKKL--DSSKQPDQEFLAQVSMVSRLKNENVVELV 127
+G G++G V GV SG+ A+K L + +EFL + S++++L + +V L+
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 128 GYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLH 187
G G +L E A G L L ++ + + + A +V A G+ YL
Sbjct: 63 GVCK-GEPLMLVMELAPLGPLLKYLKKRREIPVSD---LKELAHQV------AMGMAYLE 112
Query: 188 EKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFG------Y 241
K +HR++ + NVLL + AKISDF +S A S T +
Sbjct: 113 SK---HFVHRDLAARNVLLVNRHQAKISDFGMSR-----ALGAGSDYYRATTAGRWPLKW 164
Query: 242 HAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 274
+APE G+ SSKSDV+S+GV L E + G KP
Sbjct: 165 YAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKP 198
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 2e-26
Identities = 71/247 (28%), Positives = 124/247 (50%), Gaps = 27/247 (10%)
Query: 68 FGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVEL 126
F +GEGSYG VY + + +G+ AIK + ++ QE + ++S++ + + +V+
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVV-PVEEDLQEIIKEISILKQCDSPYIVKY 63
Query: 127 VG-YYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEY 185
G Y+ + L ++ E+ GS+ DI+ L+ + I +GLEY
Sbjct: 64 YGSYFKNTDLWIVM-EYCGAGSVSDIMKIT--------NKTLTEEEIAAILYQTLKGLEY 114
Query: 186 LHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245
LH + IHR+IK+ N+LL ++ AK++DF +S Q D A+ ++ V+GT + APE
Sbjct: 115 LHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNT--VIGTPFWMAPE 169
Query: 246 YAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLP-RGQQSLVTWATPKLSE-------- 296
++K+D++S G+ +E+ G+ P P R + P LS+
Sbjct: 170 VIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPEF 229
Query: 297 -DKVKQC 302
D VK+C
Sbjct: 230 NDFVKKC 236
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 1e-25
Identities = 71/207 (34%), Positives = 112/207 (54%), Gaps = 19/207 (9%)
Query: 74 IGEGSYGRVYFGVLR-SGRAAAIK--KLDSSKQPDQEFLAQVSMVSRLKNENVVELVG-Y 129
+G G+ G V + R +G+ A+K +L+ ++ ++ L ++ ++ + + +V G +
Sbjct: 9 LGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAF 68
Query: 130 YVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEK 189
Y +G + + E+ GSL IL K V+G P +L KIAV +GL YLHEK
Sbjct: 69 YNNGDI-SICMEYMDGGSLDKIL---KEVQGRIPERILG-----KIAVAVLKGLTYLHEK 119
Query: 190 AEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMT 249
+IIHR++K SN+L+ K+ DF +S Q ++ A+ T V GT Y APE
Sbjct: 120 H--KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAK---TFV-GTSSYMAPERIQG 173
Query: 250 GQMSSKSDVYSFGVVLLELLTGRKPVD 276
S KSD++S G+ L+EL TGR P
Sbjct: 174 NDYSVKSDIWSLGLSLIELATGRFPYP 200
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 3e-25
Identities = 70/234 (29%), Positives = 126/234 (53%), Gaps = 39/234 (16%)
Query: 74 IGEGSYGRVYFGVLRSGRAAAIK--KLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYV 131
IGEG +G V G +G+ A+K K D + Q FL + +++++L ++N+V L+G +
Sbjct: 14 IGEGEFGAVLQGEY-TGQKVAVKNIKCDVTAQA---FLEETAVMTKLHHKNLVRLLGVIL 69
Query: 132 DGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAE 191
L ++ E SKG+L + L + ++S Q ++ ++ A G+EYL K
Sbjct: 70 HNGLYIVM-ELMSKGNLVNFLRTRGRA-------LVSVIQLLQFSLDVAEGMEYLESK-- 119
Query: 192 PRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQ 251
+++HR++ + N+L+ +D +AK+SDF L+ + ++++ + APE +
Sbjct: 120 -KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG---VDNSKL--PVKWTAPEALKHKK 173
Query: 252 MSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVD 304
SSKSDV+S+GV+L E+ + GR P PK+S +VK+CV+
Sbjct: 174 FSSKSDVWSYGVLLWEVFSYGRAPY----------------PKMSLKEVKECVE 211
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 3e-25
Identities = 62/207 (29%), Positives = 106/207 (51%), Gaps = 16/207 (7%)
Query: 74 IGEGSYGRVYFGVLRS-GRAAAIKKLDSSK---QPDQEFLAQVSMVSRLKNENVVELVGY 129
IG+GS+G V+ V ++ R A+K++D SK + +E + + ++++L + ++
Sbjct: 8 IGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYES 67
Query: 130 YVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEK 189
++D + E+A G LH +L ++G +P L Q + + GL +LH K
Sbjct: 68 FLDKGKLNIVMEYAENGDLHKLLKMQRG----RP---LPEDQVWRFFIQILLGLAHLHSK 120
Query: 190 AEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMT 249
+I+HR+IKS N+ L D KI D ++ D + ++GT Y +PE
Sbjct: 121 ---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT--NFANTIVGTPYYLSPELCED 175
Query: 250 GQMSSKSDVYSFGVVLLELLTGRKPVD 276
+ KSDV++ GVVL E TG+ P D
Sbjct: 176 KPYNEKSDVWALGVVLYECCTGKHPFD 202
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 4e-25
Identities = 73/215 (33%), Positives = 96/215 (44%), Gaps = 29/215 (13%)
Query: 73 LIGEGSYGRVYFGVLRSGR---------AAAIKKLDSSKQPD--QEFLAQVSMVSRLKNE 121
+G+GS FGV+R G A+K L S K D +FL + +++ L +E
Sbjct: 2 KLGDGS-----FGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHE 56
Query: 122 NVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAAR 181
N++ L G + PL + E A GSL D L K G L AV A
Sbjct: 57 NLIRLYGVVLTHPLM-MVTELAPLGSLLDRLR--KDALGHFLISTLC-----DYAVQIAN 108
Query: 182 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGT-FG 240
G+ YL K R IHR++ + N+LL DD KI DF L P L F
Sbjct: 109 GMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFA 165
Query: 241 YHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 274
+ APE T S SDV+ FGV L E+ T G +P
Sbjct: 166 WCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEP 200
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 2e-24
Identities = 63/222 (28%), Positives = 110/222 (49%), Gaps = 31/222 (13%)
Query: 74 IGEGSYGRVYFGVLRSGRA------AAIKKLDSSKQPD--QEFLAQVSMVSRLKNENVVE 125
+GEG++G+V+ G A+K L + D ++F + +++ ++EN+V+
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 126 LVGYYVDGPLRVLAYEHASKGSLHDIL--HGKKGVKGAKPGPV---LSWAQRVKIAVGAA 180
G +G ++ +E+ G L+ L HG P L+ +Q ++IAV A
Sbjct: 73 FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132
Query: 181 RGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHST---RVLG 237
G+ YL A +HR++ + N L+ D + KI DF +S +++T RV G
Sbjct: 133 SGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRD-------VYTTDYYRVGG 182
Query: 238 T----FGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 274
+ PE M + +++SDV+SFGVVL E+ T G++P
Sbjct: 183 HTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 99.5 bits (248), Expect = 2e-24
Identities = 59/201 (29%), Positives = 104/201 (51%), Gaps = 13/201 (6%)
Query: 73 LIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPD--QEFLAQVSMVSRLKNENVVELVGYY 130
IG+G++G VY GVL+ A+K S+ PD ++FL + ++ + + N+V+L+G
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61
Query: 131 VDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKA 190
V + E GSL L KK L+ + +++++ AA G+EYL K
Sbjct: 62 VQKQPIYIVMELVPGGSLLTFLRKKKNR--------LTVKKLLQMSLDAAAGMEYLESK- 112
Query: 191 EPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTG 250
IHR++ + N L+ ++++ KISDF +S + + + APE G
Sbjct: 113 --NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYG 170
Query: 251 QMSSKSDVYSFGVVLLELLTG 271
+ +S+SDV+S+G++L E +
Sbjct: 171 RYTSESDVWSYGILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 99.4 bits (248), Expect = 2e-24
Identities = 63/214 (29%), Positives = 105/214 (49%), Gaps = 20/214 (9%)
Query: 67 NFGTNSLIGEGSYGRVYFGVLR--SGRAAAIKKLDSSKQPDQE---FLAQVSMVSRLKNE 121
+F +G+GSYG VY V R + A+K++D +E + ++ +++ + +
Sbjct: 1 DFKVLKKLGKGSYGSVY-KVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHP 59
Query: 122 NVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPV-LSWAQRVKIAVGAA 180
N++ ++DG + E+A G L + K K K P W +I +
Sbjct: 60 NIISYKEAFLDGNKLCIVMEYAPFGDLSKAI--SKRKKKRKLIPEQEIW----RIFIQLL 113
Query: 181 RGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFG 240
RGL+ LHE+ +I+HR++KS+N+LL +D+ KI D +S A+ +GT
Sbjct: 114 RGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAK----TQIGTPH 166
Query: 241 YHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
Y APE S KSD++S G +L E+ T P
Sbjct: 167 YMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPP 200
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 99.2 bits (248), Expect = 6e-24
Identities = 78/299 (26%), Positives = 129/299 (43%), Gaps = 38/299 (12%)
Query: 54 PVISVDELKEKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQV 112
++S + +E N IGEG+ G VY R +G+ AIKK+ KQ + + ++
Sbjct: 10 DIVSEGDPRELYKNL---EKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEI 66
Query: 113 SMVSRLKNENVVELVG-YYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQ 171
++ K+ N+V+ Y V L V E+ GSL DI+ ++ Q
Sbjct: 67 LIMKDCKHPNIVDYYDSYLVGDELWV-VMEYMDGGSLTDIITQNF--------VRMNEPQ 117
Query: 172 RVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLH 231
+ +GLEYLH + +IHR+IKS N+LL D K++DF + Q ++ +
Sbjct: 118 IAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRN 174
Query: 232 STRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP-VDHTLPRGQQSLVTWA 290
S V+GT + APE K D++S G++ +E+ G P + R + T
Sbjct: 175 S--VVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKG 232
Query: 291 TPKLSE---------DKVKQC--VDTKLGGEYPPKAIAK-VRKKKFITSECSNISFAEF 337
P L D + +C D + + A+ + + F+ C FA
Sbjct: 233 IPPLKNPEKWSPEFKDFLNKCLVKDPEK------RPSAEELLQHPFLKKACPKEEFAPL 285
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 98.7 bits (246), Expect = 7e-24
Identities = 64/221 (28%), Positives = 110/221 (49%), Gaps = 36/221 (16%)
Query: 73 LIGEGSYGRVYFGV-LRSGRAAAIKKLD----SSKQPDQEFLAQVSMVSRLKNE------ 121
LIG+G+YGRVY + + +G A+K+++ + + D Q MV L++E
Sbjct: 8 LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDS---RQKDMVKALRSEIETLKD 64
Query: 122 ----NVVELVGYYVDGPLRVLAYEHASKGSLHDIL--HGKKGVKGAKPGPVLSWAQRVKI 175
N+V+ +G+ + E+ GS+ L +G+ + V + ++V
Sbjct: 65 LDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGR-----FEEQLVRFFTEQV-- 117
Query: 176 AVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRV 235
GL YLH K I+HR++K+ N+L+ D I KISDF +S ++ D + +
Sbjct: 118 ----LEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSM 170
Query: 236 LGTFGYHAPEYAMTGQM--SSKSDVYSFGVVLLELLTGRKP 274
G+ + APE + S+K D++S G V+LE+ GR+P
Sbjct: 171 QGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 98.7 bits (246), Expect = 9e-24
Identities = 67/222 (30%), Positives = 111/222 (50%), Gaps = 29/222 (13%)
Query: 74 IGEGSYGRVYFGVL------RSGRAAAIKKLDSSKQPD--QEFLAQVSMVSRLKNENVVE 125
+GEG++G+VY G L S + AIK L + +P QEF + ++S L++ N+V
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72
Query: 126 LVGYYV-DGPLRVLAYEHASKGSLH----------DILHGKKGVKGAKPGPVLSWAQRVK 174
L+G + P +L +E+ + G LH D+ L + +
Sbjct: 73 LLGVCTKEQPTCML-FEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSS---LDCSDFLH 128
Query: 175 IAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAA-RLHST 233
IA+ A G+EYL + +HR++ + N L+ + KISDF LS A R+ S
Sbjct: 129 IAIQIAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSK 185
Query: 234 RVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 274
+L + PE + G+ +++SD++SFGVVL E+ + G +P
Sbjct: 186 SLL-PVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQP 226
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 98.6 bits (246), Expect = 9e-24
Identities = 60/208 (28%), Positives = 97/208 (46%), Gaps = 23/208 (11%)
Query: 74 IGEGSYGRVYFGVL-----RSGRAAAIKKLDSSKQPDQ--EFLAQVSMVSRLKNENVVEL 126
+GEG +G+V +G A+K L+ S + +F ++ ++ L +EN+V+
Sbjct: 12 LGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKY 71
Query: 127 VG--YYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLE 184
G G L E+ GSL D L + ++ + + + +G++
Sbjct: 72 KGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHR--------DQINLKRLLLFSSQICKGMD 123
Query: 185 YLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAP--DAAARLHSTRVLGTFGYH 242
YL + R IHR++ + N+L+ +D+ KISDF L+ P + F Y
Sbjct: 124 YLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY- 179
Query: 243 APEYAMTGQMSSKSDVYSFGVVLLELLT 270
APE T + SS SDV+SFGV L EL T
Sbjct: 180 APECLRTSKFSSASDVWSFGVTLYELFT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 96.2 bits (239), Expect = 4e-23
Identities = 65/204 (31%), Positives = 106/204 (51%), Gaps = 17/204 (8%)
Query: 74 IGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDG 133
+G G +G V+ G A+K L + FL + ++ +L+++ +V+L +
Sbjct: 14 LGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVSEE 73
Query: 134 PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPR 193
P+ ++ E+ SKGSL D L K G G L V +A A G+ Y+
Sbjct: 74 PIYIVT-EYMSKGSLLDFL--KDG-----EGRALKLPNLVDMAAQVAAGMAYIERM---N 122
Query: 194 IIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTF--GYHAPEYAMTGQ 251
IHR+++S+N+L+ D + KI+DF L+ D ++ R F + APE A+ G+
Sbjct: 123 YIHRDLRSANILVGDGLVCKIADFGLARLIEDNE---YTARQGAKFPIKWTAPEAALYGR 179
Query: 252 MSSKSDVYSFGVVLLELLT-GRKP 274
+ KSDV+SFG++L EL+T GR P
Sbjct: 180 FTIKSDVWSFGILLTELVTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 96.5 bits (241), Expect = 4e-23
Identities = 61/208 (29%), Positives = 104/208 (50%), Gaps = 24/208 (11%)
Query: 73 LIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQ-EFLAQ-VSMVSRLKNENVVELVGY 129
IG+GS+G VY + R+ + AIK +D + D+ E + Q + +S+ ++ + + G
Sbjct: 8 CIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGS 67
Query: 130 YVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAV---GAARGLEYL 186
++ G + E+ GS D+L KPG + IA GLEYL
Sbjct: 68 FLKGSKLWIIMEYCGGGSCLDLL---------KPGKL----DETYIAFILREVLLGLEYL 114
Query: 187 HEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEY 246
HE+ IHR+IK++N+LL ++ K++DF +S Q ++ ++ +GT + APE
Sbjct: 115 HEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTF--VGTPFWMAPEV 169
Query: 247 AMTGQMSSKSDVYSFGVVLLELLTGRKP 274
K+D++S G+ +EL G P
Sbjct: 170 IKQSGYDEKADIWSLGITAIELAKGEPP 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 95.9 bits (238), Expect = 7e-23
Identities = 63/204 (30%), Positives = 108/204 (52%), Gaps = 17/204 (8%)
Query: 74 IGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDG 133
+G+G +G V+ G AIK L + FL + ++ +L++E +V+L +
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE 73
Query: 134 PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPR 193
P+ ++ E+ SKGSL D L G+ G L Q V +A A G+ Y+
Sbjct: 74 PIYIVT-EYMSKGSLLDFLKGEMGK-------YLRLPQLVDMAAQIASGMAYVERM---N 122
Query: 194 IIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTF--GYHAPEYAMTGQ 251
+HR+++++N+L+ ++ + K++DF L+ D ++ R F + APE A+ G+
Sbjct: 123 YVHRDLRAANILVGENLVCKVADFGLARLIEDNE---YTARQGAKFPIKWTAPEAALYGR 179
Query: 252 MSSKSDVYSFGVVLLELLT-GRKP 274
+ KSDV+SFG++L EL T GR P
Sbjct: 180 FTIKSDVWSFGILLTELTTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 94.4 bits (235), Expect = 2e-22
Identities = 62/210 (29%), Positives = 106/210 (50%), Gaps = 23/210 (10%)
Query: 73 LIGEGSYGRVYFGV-LRSGRAAAIK--KLDSSKQPDQEFLAQ----VSMVSRLKNENVVE 125
L+G GS+G VY G+ L G A+K L Q QE + Q ++++S+L++ N+V+
Sbjct: 7 LLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQ 66
Query: 126 LVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEY 185
+G + + E GSL +L G+ P PV+ R + GLEY
Sbjct: 67 YLGTEREEDNLYIFLELVPGGSLAKLL----KKYGSFPEPVIRLYTRQILL-----GLEY 117
Query: 186 LHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245
LH++ +HR+IK +N+L+ + + K++DF ++ Q + S + G+ + APE
Sbjct: 118 LHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQV-VEFSFAKSFK--GSPYWMAPE 171
Query: 246 YAM-TGQMSSKSDVYSFGVVLLELLTGRKP 274
G +D++S G +LE+ TG+ P
Sbjct: 172 VIAQQGGYGLAADIWSLGCTVLEMATGKPP 201
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 93.6 bits (233), Expect = 3e-22
Identities = 63/212 (29%), Positives = 108/212 (50%), Gaps = 32/212 (15%)
Query: 74 IGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYV-- 131
+G G +G V+ G+ + A+K L ++FLA+ ++ +L++ +++L Y V
Sbjct: 14 LGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQL--YAVCT 71
Query: 132 -DGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKA 190
+ P+ ++ E GSL + L G G L Q + +A A G+ YL +
Sbjct: 72 LEEPIYIVT-ELMKYGSLLEYLQGGAGRA-------LKLPQLIDMAAQVASGMAYLEAQ- 122
Query: 191 EPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARL-----HSTRVLGTF--GYHA 243
IHR++ + NVL+ +++I K++DF L AR+ + R F + A
Sbjct: 123 --NYIHRDLAARNVLVGENNICKVADFGL--------ARVIKEDIYEAREGAKFPIKWTA 172
Query: 244 PEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 274
PE A+ + S KSDV+SFG++L E++T GR P
Sbjct: 173 PEAALYNRFSIKSDVWSFGILLTEIVTYGRMP 204
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 94.0 bits (234), Expect = 4e-22
Identities = 66/224 (29%), Positives = 109/224 (48%), Gaps = 24/224 (10%)
Query: 55 VISVDELKEKTDNFGTNSLIGEGSYGRVYFG-VLRSGRAAAIKKLDSSKQPDQEFL-AQV 112
V+ + + DNF IGEGS G V +GR A+KK+D KQ +E L +V
Sbjct: 11 VVDPGDPRSYLDNFVK---IGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEV 67
Query: 113 SMVSRLKNENVVELVG-YYVDGPLRVLAYEHASKGSLHDIL-HGKKGVKGAKPGPVLSWA 170
++ ++ N+VE+ Y V L V+ E G+L DI+ H + ++
Sbjct: 68 VIMRDYQHPNIVEMYSSYLVGDELWVV-MEFLEGGALTDIVTHTR-----------MNEE 115
Query: 171 QRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARL 230
Q + + + L +LH + +IHR+IKS ++LL D K+SDF Q R
Sbjct: 116 QIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRR 172
Query: 231 HSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
S ++GT + APE ++ D++S G++++E++ G P
Sbjct: 173 KS--LVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 92.9 bits (231), Expect = 7e-22
Identities = 59/198 (29%), Positives = 100/198 (50%), Gaps = 13/198 (6%)
Query: 74 IGEGSYGRVYFGVLRSGRAAAIKKLDS-SKQPDQEFLAQVSMVSRLKNENVVELVGYYVD 132
+G G +G V+ G+ ++ AIK L S Q+F +V + RL++++++ L
Sbjct: 14 LGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSV 73
Query: 133 GPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEP 192
G + E KGSL L + G VL A + +A A G+ YL E+
Sbjct: 74 GEPVYIITELMEKGSLLAFL-------RSPEGQVLPVASLIDMACQVAEGMAYLEEQ--- 123
Query: 193 RIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQM 252
IHR++ + N+L+ +D + K++DF L+ + ++ + + APE A G
Sbjct: 124 NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKI--PYKWTAPEAASHGTF 181
Query: 253 SSKSDVYSFGVVLLELLT 270
S+KSDV+SFG++L E+ T
Sbjct: 182 STKSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 92.4 bits (229), Expect = 1e-21
Identities = 65/204 (31%), Positives = 107/204 (52%), Gaps = 17/204 (8%)
Query: 74 IGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDG 133
+G+G +G V+ G AIK L + FL + ++ +L+++ +V L +
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVSEE 73
Query: 134 PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPR 193
P+ ++ E KGSL D L K+G G L Q V +A A G+ Y+
Sbjct: 74 PIYIVT-EFMGKGSLLDFL--KEG-----DGKYLKLPQLVDMAAQIADGMAYIERM---N 122
Query: 194 IIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTF--GYHAPEYAMTGQ 251
IHR+++++N+L+ D+ + KI+DF L+ D ++ R F + APE A+ G+
Sbjct: 123 YIHRDLRAANILVGDNLVCKIADFGLARLIEDNE---YTARQGAKFPIKWTAPEAALYGR 179
Query: 252 MSSKSDVYSFGVVLLELLT-GRKP 274
+ KSDV+SFG++L EL+T GR P
Sbjct: 180 FTIKSDVWSFGILLTELVTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 92.4 bits (230), Expect = 1e-21
Identities = 65/210 (30%), Positives = 107/210 (50%), Gaps = 28/210 (13%)
Query: 74 IGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDG 133
+G G +G V+ G A+K L + FL + ++ +L+++ +V+L +
Sbjct: 14 LGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEE 73
Query: 134 -PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEP 192
P+ ++ E+ SKGSL D L +G K L Q V +A A G+ YL +
Sbjct: 74 EPIYIVT-EYMSKGSLLDFLKSGEGKK-------LRLPQLVDMAAQIAEGMAYLESR--- 122
Query: 193 RIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARL-----HSTRVLGTF--GYHAPE 245
IHR++ + N+L+ ++ + KI+DF L ARL ++ R F + APE
Sbjct: 123 NYIHRDLAARNILVGENLVCKIADFGL--------ARLIEDDEYTAREGAKFPIKWTAPE 174
Query: 246 YAMTGQMSSKSDVYSFGVVLLELLT-GRKP 274
A G+ + KSDV+SFG++L E++T GR P
Sbjct: 175 AANYGRFTIKSDVWSFGILLTEIVTYGRVP 204
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.3 bits (230), Expect = 1e-21
Identities = 62/227 (27%), Positives = 105/227 (46%), Gaps = 23/227 (10%)
Query: 61 LKEKTDNFGTNSLIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLK 119
L + T F +IGEG+YG+VY ++G+ AIK +D + ++E + +++ +
Sbjct: 1 LPDPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYS 60
Query: 120 N-ENVVELVGYYVDGPLRV------LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQR 172
N N+ G ++ L E GS+ D++ G + +++
Sbjct: 61 NHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAY--- 117
Query: 173 VKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHS 232
I RGL YLHE ++IHR+IK N+LL + K+ DF +S Q R ++
Sbjct: 118 --ILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNT 172
Query: 233 TRVLGTFGYHAPE-----YAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
+GT + APE ++SDV+S G+ +EL G+ P
Sbjct: 173 --FIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPP 217
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 90.9 bits (226), Expect = 5e-21
Identities = 71/214 (33%), Positives = 102/214 (47%), Gaps = 18/214 (8%)
Query: 74 IGEGSYGRVYFGV-LRSGRAAAIKKLDSSK-QPDQEFLAQ-VSMVSRLKNENVVELVGYY 130
IG G+ VY + L + AIK++D K Q + L + V +S+ + NVV+ +
Sbjct: 9 IGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSF 68
Query: 131 VDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKA 190
V G L + S GSL DI +K + P L A + +GLEYLH
Sbjct: 69 VVGDELWLVMPYLSGGSLLDI------MKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG 122
Query: 191 EPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTR--VLGTFGYHAPEYAM 248
+ IHR+IK+ N+LL +D KI+DF +S D R R +GT + APE M
Sbjct: 123 Q---IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPE-VM 178
Query: 249 TGQM--SSKSDVYSFGVVLLELLTGRKPVDHTLP 280
K+D++SFG+ +EL TG P P
Sbjct: 179 EQVHGYDFKADIWSFGITAIELATGAAPY-SKYP 211
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 90.9 bits (226), Expect = 6e-21
Identities = 71/229 (31%), Positives = 111/229 (48%), Gaps = 24/229 (10%)
Query: 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPD--QEFLAQVSMVSRLKNEN 122
+ S +GEG+ G V L+ +G A+K + + PD ++ L ++ + K+
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60
Query: 123 VVELVGYYVDGPLRVL--AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRV--KIAVG 178
+V+ G ++D + A E+ GSL D ++ K +G + G ++V KIA
Sbjct: 61 IVKYYGAFLDESSSSIGIAMEYCEGGSL-DSIYKKVKKRGGRIG------EKVLGKIAES 113
Query: 179 AARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGT 238
+GL YLH + +IIHR+IK SN+LL K+ DF +S + ++ A T GT
Sbjct: 114 VLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLA---GTFT-GT 166
Query: 239 FGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLV 287
Y APE S SDV+S G+ LLE+ R P P G+ L
Sbjct: 167 SFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFP---PEGEPPLG 212
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 91.4 bits (227), Expect = 6e-21
Identities = 75/212 (35%), Positives = 105/212 (49%), Gaps = 33/212 (15%)
Query: 74 IGEGSYGRVYFGV-LRSGRAAAIKKLD-SSKQPD---QEFLAQVSMVSRLKNENVVELVG 128
IG GS+G VYF +R+ AIKK+ S KQ + Q+ + +V + +L++ N +E G
Sbjct: 23 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKG 82
Query: 129 YYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAV---GAARGLEY 185
Y+ L E+ GS DIL K KP Q V+IA GA +GL Y
Sbjct: 83 CYLREHTAWLVMEYCL-GSASDILEVHK-----KP------LQEVEIAAICHGALQGLAY 130
Query: 186 LHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245
LH IHR+IK+ N+LL + K++DF A+ + +GT + APE
Sbjct: 131 LHSHER---IHRDIKAGNILLTEPGTVKLADFG------SASLVSPANSFVGTPYWMAPE 181
Query: 246 --YAM-TGQMSSKSDVYSFGVVLLELLTGRKP 274
AM GQ K DV+S G+ +E L RKP
Sbjct: 182 VILAMDEGQYDGKVDVWSLGITCIE-LAERKP 212
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 90.0 bits (223), Expect = 7e-21
Identities = 76/242 (31%), Positives = 127/242 (52%), Gaps = 33/242 (13%)
Query: 74 IGEGSYGRVYFGVLRSGRAAAIK--KLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYV 131
IG+G +G V G R G A+K K D++ Q FLA+ S++++L++ N+V+L+G V
Sbjct: 14 IGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQA---FLAEASVMTQLRHSNLVQLLGVIV 69
Query: 132 D--GPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEK 189
+ G L ++ E+ +KGSL D L ++ VL +K ++ +EYL
Sbjct: 70 EEKGGLYIVT-EYMAKGSLVDYLR-------SRGRSVLGGDCLLKFSLDVCEAMEYLEAN 121
Query: 190 AEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMT 249
+HR++ + NVL+ +D++AK+SDF L+ + A+ T L + APE
Sbjct: 122 ---NFVHRDLAARNVLVSEDNVAKVSDFGLTKE----ASSTQDTGKL-PVKWTAPEALRE 173
Query: 250 GQMSSKSDVYSFGVVLLELLT------GRKPVDHTLPR---GQQSLVTWATPKLSEDKVK 300
+ S+KSDV+SFG++L E+ + R P+ +PR G + P + D +K
Sbjct: 174 KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPVVYDVMK 233
Query: 301 QC 302
QC
Sbjct: 234 QC 235
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 2e-20
Identities = 73/234 (31%), Positives = 113/234 (48%), Gaps = 24/234 (10%)
Query: 55 VISVDELKEKTDNFGTNSLIGEGSYGRVY-FGVLRSGRAAAIKKLDSSKQPDQEFLAQVS 113
++ ++ L + TD + IG+G+YG+VY + G AA+K LD D+E A+ +
Sbjct: 11 MLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYN 70
Query: 114 MVSRLKNE-NVVELVG------YYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPV 166
++ L N NVV+ G V G L L E + GS+ +++ G G
Sbjct: 71 ILQSLPNHPNVVKFYGMFYKADKLVGGQLW-LVLELCNGGSVTELVKGL-----LICGQR 124
Query: 167 LSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDA 226
L A I GA GL++LH RIIHR++K +N+LL + K+ DF +S Q
Sbjct: 125 LDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQL--T 179
Query: 227 AARLHSTRVLGTFGYHAPEYAMTGQM-----SSKSDVYSFGVVLLELLTGRKPV 275
+ RL +GT + APE Q ++ DV+S G+ +EL G P+
Sbjct: 180 STRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPL 233
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 2e-20
Identities = 57/204 (27%), Positives = 96/204 (47%), Gaps = 20/204 (9%)
Query: 74 IGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVD- 132
+G G +G V+ G R AIK + + +F+ + ++ +L + N+V+L G
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQ 71
Query: 133 GPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEP 192
P+ ++ E+ + G L + L +KG G +L V +EYL
Sbjct: 72 RPIFIV-TEYMANGCLLNYLRERKGKLGT--EWLLDMCSDV------CEAMEYLESNG-- 120
Query: 193 RIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGT---FGYHAPEYAMT 249
IHR++ + N L+ +D++ K+SDF L+ D T GT + PE
Sbjct: 121 -FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDD----QYTSSQGTKFPVKWAPPEVFDY 175
Query: 250 GQMSSKSDVYSFGVVLLELLTGRK 273
+ SSKSDV+SFGV++ E+ + K
Sbjct: 176 SRFSSKSDVWSFGVLMWEVFSEGK 199
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 89.4 bits (221), Expect = 2e-20
Identities = 72/263 (27%), Positives = 127/263 (48%), Gaps = 32/263 (12%)
Query: 55 VISVDELKEKTDNFGTNSLIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQVS 113
++SV + K+K F IG+G+ G VY + + +G+ AI++++ +QP +E +
Sbjct: 12 IVSVGDPKKKYTRF---EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEI 68
Query: 114 MVSRL-KNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQR 172
+V R KN N+V + Y+ G + E+ + GSL D++ + Q
Sbjct: 69 LVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV----------TETCMDEGQI 118
Query: 173 VKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ-APDAAARLH 231
+ + LE+LH ++IHR+IKS N+LL D K++DF Q P+ + R
Sbjct: 119 AAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR-- 173
Query: 232 STRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLP-RGQQSLVTWA 290
+ ++GT + APE K D++S G++ +E++ G P + P R + T
Sbjct: 174 -STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNG 232
Query: 291 TPKLS---------EDKVKQCVD 304
TP+L D + +C+D
Sbjct: 233 TPELQNPEKLSAIFRDFLNRCLD 255
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 88.5 bits (220), Expect = 3e-20
Identities = 60/212 (28%), Positives = 100/212 (47%), Gaps = 25/212 (11%)
Query: 74 IGEGSYGRVYFGV-LRSGRAAAIKKL---DSSKQPDQEFLAQVSMVSRLKNENVVELVGY 129
IG G++G+VY V L +G A+K++ D+ + +E ++ ++ LK+ N+V+ G
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGV 67
Query: 130 YVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEK 189
V + E+ S G+L ++L G +L + GL YLH
Sbjct: 68 EVHREKVYIFMEYCSGGTLEELLEH---------GRILDEHVIRVYTLQLLEGLAYLHSH 118
Query: 190 AEPRIIHRNIKSSNVLLFDDDIAKISDFD----LSNQAPDAAARLHSTRVLGTFGYHAPE 245
I+HR+IK +N+ L + + K+ DF L N + S GT Y APE
Sbjct: 119 ---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLA--GTPAYMAPE 173
Query: 246 YAMTGQMSSK---SDVYSFGVVLLELLTGRKP 274
G+ +D++S G V+LE+ TG++P
Sbjct: 174 VITGGKGKGHGRAADIWSLGCVVLEMATGKRP 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 88.8 bits (220), Expect = 4e-20
Identities = 69/246 (28%), Positives = 121/246 (49%), Gaps = 23/246 (9%)
Query: 55 VISVDELKEKTDNFGTNSLIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQVS 113
++SV + K+K F IG+G+ G VY + + +G+ AIK+++ +QP +E +
Sbjct: 11 IVSVGDPKKKYTRFEK---IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEI 67
Query: 114 MVSR-LKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQR 172
+V R K+ N+V + Y+ G + E+ + GSL D++ + Q
Sbjct: 68 LVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV----------TETCMDEGQI 117
Query: 173 VKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ-APDAAARLH 231
+ + LE+LH ++IHR+IKS N+LL D K++DF Q P+ + R
Sbjct: 118 AAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR-- 172
Query: 232 STRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLP-RGQQSLVTWA 290
+ ++GT + APE K D++S G++ +E++ G P + P R + T
Sbjct: 173 -STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNG 231
Query: 291 TPKLSE 296
TP+L
Sbjct: 232 TPELQN 237
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 88.6 bits (219), Expect = 5e-20
Identities = 68/244 (27%), Positives = 124/244 (50%), Gaps = 23/244 (9%)
Query: 55 VISVDELKEKTDNFGTNSLIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLA-QV 112
++S+ + K+K + IG+G+ G V+ + + +G+ AIK+++ KQP +E + ++
Sbjct: 11 IVSIGDPKKKYTRY---EKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEI 67
Query: 113 SMVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQR 172
++ LKN N+V + ++ G + E+ + GSL D++ + AQ
Sbjct: 68 LVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVV----------TETCMDEAQI 117
Query: 173 VKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ-APDAAARLH 231
+ + LE+LH ++IHR+IKS NVLL D K++DF Q P+ + R
Sbjct: 118 AAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKR-- 172
Query: 232 STRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLP-RGQQSLVTWA 290
+ ++GT + APE K D++S G++ +E++ G P + P R + T
Sbjct: 173 -STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNG 231
Query: 291 TPKL 294
TP+L
Sbjct: 232 TPEL 235
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.7 bits (218), Expect = 5e-20
Identities = 66/206 (32%), Positives = 97/206 (47%), Gaps = 18/206 (8%)
Query: 74 IGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQ-VSMVSRLKNENVVELVGYYV 131
IG G+YG VY + +G AIK + D E + Q +SM+ ++ N+V G Y+
Sbjct: 11 IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYL 70
Query: 132 DGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAE 191
+ E+ GSL DI GP LS Q + +GL YLHE
Sbjct: 71 RRDKLWIVMEYCGGGSLQDIYQ-------VTRGP-LSELQIAYVCRETLKGLAYLHET-- 120
Query: 192 PRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYA---M 248
IHR+IK +N+LL +D K++DF +S Q A+ S +GT + APE A
Sbjct: 121 -GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKS--FIGTPYWMAPEVAAVER 177
Query: 249 TGQMSSKSDVYSFGVVLLELLTGRKP 274
G K D+++ G+ +EL + P
Sbjct: 178 KGGYDGKCDIWALGITAIELAELQPP 203
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 88.6 bits (219), Expect = 5e-20
Identities = 69/244 (28%), Positives = 121/244 (49%), Gaps = 23/244 (9%)
Query: 55 VISVDELKEKTDNFGTNSLIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQVS 113
++SV + K+K F IG+G+ G VY + + +G+ AIK+++ +QP +E +
Sbjct: 11 IVSVGDPKKKYTRF---EKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEI 67
Query: 114 MVSRL-KNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQR 172
+V R KN N+V + Y+ G + E+ + GSL D++ + Q
Sbjct: 68 LVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV----------TETCMDEGQI 117
Query: 173 VKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ-APDAAARLH 231
+ + L++LH ++IHR+IKS N+LL D K++DF Q P+ + R
Sbjct: 118 AAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR-- 172
Query: 232 STRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLP-RGQQSLVTWA 290
+ ++GT + APE K D++S G++ +E++ G P + P R + T
Sbjct: 173 -STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNG 231
Query: 291 TPKL 294
TP+L
Sbjct: 232 TPEL 235
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 6e-20
Identities = 65/236 (27%), Positives = 117/236 (49%), Gaps = 29/236 (12%)
Query: 73 LIGEGSYGRVYFGV-LRSGRAAAIK--KLDSSKQPDQEFLAQVSMVSRLKN---ENVVEL 126
LIG G+YG VY G + +GR A+K LD+ + +V+++S+L+ N+ +
Sbjct: 8 LIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKY 67
Query: 127 VGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAV---GAARGL 183
G Y+ GP + E+A GS+ ++ K GP+ A++ I+V L
Sbjct: 68 YGSYLKGPRLWIIMEYAEGGSVRTLM---------KAGPI---AEKY-ISVIIREVLVAL 114
Query: 184 EYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHA 243
+Y+H+ +IHR+IK++N+L+ + K+ DF ++ A + +GT + A
Sbjct: 115 KYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVA--ALLNQNSSKRSTFVGTPYWMA 169
Query: 244 PEYAMTGQM-SSKSDVYSFGVVLLELLTGRKPV-DHTLPRGQQSLVTWATPKLSED 297
PE G+ +K+D++S G+ + E+ TG P D R + P+L ++
Sbjct: 170 PEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLEDN 225
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 1e-19
Identities = 57/216 (26%), Positives = 106/216 (49%), Gaps = 19/216 (8%)
Query: 74 IGEGSYGRVYFGVL------RSGRAAAIKKL-DSSKQPDQEFLAQVSMVSRLKNENVVEL 126
+GEG++G+V+ + A+K L ++S+ Q+F + +++ L+++++V
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72
Query: 127 VGYYVDGPLRVLAYEHASKGSLHDIL--HGK-----KGVKGAKPGPVLSWAQRVKIAVGA 179
G +G ++ +E+ G L+ L HG G + PG L+ Q + IA
Sbjct: 73 YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQ-LTLGQMLAIASQI 131
Query: 180 ARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTF 239
A G+ YL A +HR++ + N L+ + KI DF +S R +
Sbjct: 132 ASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 188
Query: 240 GYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 274
+ PE + + +++SD++SFGVVL E+ T G++P
Sbjct: 189 RWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 2e-19
Identities = 78/269 (28%), Positives = 126/269 (46%), Gaps = 23/269 (8%)
Query: 74 IGEGSYGRVYFGVL-RSGRAAAIKKLDSSKQPDQ--EFLAQVSMVSRLKNENVVELVGYY 130
IG+GS+G VY G+ R+ AIK +D + D+ + +++++S+ + + G Y
Sbjct: 12 IGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSY 71
Query: 131 VDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKA 190
+ G + E+ GS D+L KPGP L I +GL+YLH +
Sbjct: 72 LKGTKLWIIMEYLGGGSALDLL---------KPGP-LEETYIATILREILKGLDYLHSE- 120
Query: 191 EPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTG 250
R IHR+IK++NVLL + K++DF ++ Q D ++ +GT + APE
Sbjct: 121 --RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTD--TQIKRNTFVGTPFWMAPEVIKQS 176
Query: 251 QMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDK----VKQCVDTK 306
K+D++S G+ +EL G P P L+ +P E + K+ V+
Sbjct: 177 AYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGQYSKPFKEFVEAC 236
Query: 307 LGGEYPPKAIAK-VRKKKFITSECSNISF 334
L + + AK + K KFIT SF
Sbjct: 237 LNKDPRFRPTAKELLKHKFITRYTKKTSF 265
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 86.7 bits (214), Expect = 2e-19
Identities = 76/269 (28%), Positives = 127/269 (47%), Gaps = 23/269 (8%)
Query: 74 IGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQ--EFLAQVSMVSRLKNENVVELVGYY 130
IG+GS+G V+ G+ R+ + AIK +D + D+ + +++++S+ + V + G Y
Sbjct: 12 IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71
Query: 131 VDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKA 190
+ + E+ GS D+L +PGP L Q I +GL+YLH +
Sbjct: 72 LKDTKLWIIMEYLGGGSALDLL---------EPGP-LDETQIATILREILKGLDYLHSEK 121
Query: 191 EPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTG 250
+ IHR+IK++NVLL + K++DF ++ Q D ++ +GT + APE
Sbjct: 122 K---IHRDIKAANVLLSEHGEVKLADFGVAGQLTD--TQIKRNTFVGTPFWMAPEVIKQS 176
Query: 251 QMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDK----VKQCVDTK 306
SK+D++S G+ +EL G P P L+ P E +K+ V+
Sbjct: 177 AYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEAC 236
Query: 307 LGGEYPPKAIAK-VRKKKFITSECSNISF 334
L E + AK + K KFI S+
Sbjct: 237 LNKEPSFRPTAKELLKHKFIVRFAKKTSY 265
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 86.7 bits (215), Expect = 2e-19
Identities = 60/211 (28%), Positives = 104/211 (49%), Gaps = 20/211 (9%)
Query: 74 IGEGSYGRVYFGVLR-SGRAA----AIKKL--DSSKQPDQEFLAQVSMVSRLKNENVVEL 126
+G G++G VY GV G AIK L ++S + ++E L + +++ + + +VV L
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74
Query: 127 VGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYL 186
+G + L + G L D + K G++ +L+W ++ A+G+ YL
Sbjct: 75 LGICL-SSQVQLITQLMPLGCLLDYVRNHKDNIGSQY--LLNWCVQI------AKGMSYL 125
Query: 187 HEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEY 246
EK R++HR++ + NVL+ KI+DF L+ H+ + A E
Sbjct: 126 EEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALES 182
Query: 247 AMTGQMSSKSDVYSFGVVLLELLT-GRKPVD 276
+ + KSDV+S+GV + EL+T G KP +
Sbjct: 183 ILHRIYTHKSDVWSYGVTVWELMTFGAKPYE 213
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 86.1 bits (213), Expect = 2e-19
Identities = 59/204 (28%), Positives = 103/204 (50%), Gaps = 17/204 (8%)
Query: 74 IGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDG 133
+G G +G V+ G AIK L + FLA+ +++ +L++ +V L
Sbjct: 14 LGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVTQE 73
Query: 134 PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPR 193
P+ ++ E+ GSL D L +G+K L+ + + +A A G+ ++ K
Sbjct: 74 PIYIIT-EYMENGSLVDFLKTPEGIK-------LTINKLIDMAAQIAEGMAFIERK---N 122
Query: 194 IIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTF--GYHAPEYAMTGQ 251
IHR+++++N+L+ + KI+DF L+ D ++ R F + APE G
Sbjct: 123 YIHRDLRAANILVSETLCCKIADFGLARLIEDNE---YTAREGAKFPIKWTAPEAINYGT 179
Query: 252 MSSKSDVYSFGVVLLELLT-GRKP 274
+ KSDV+SFG++L E++T GR P
Sbjct: 180 FTIKSDVWSFGILLTEIVTYGRIP 203
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 85.7 bits (212), Expect = 3e-19
Identities = 63/223 (28%), Positives = 106/223 (47%), Gaps = 22/223 (9%)
Query: 60 ELKEKTDNFGTNSLIGEGSYGRVYFGV-LRSGRAAAIKKL----DSSKQPDQEFLAQVSM 114
E + + D G ++G+G+YG VY L + AIK++ QP E ++++
Sbjct: 2 EYEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHE---EIAL 58
Query: 115 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVK 174
S LK+ N+V+ +G + + E GSL +L K G ++ + +++
Sbjct: 59 HSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQI- 117
Query: 175 IAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFD-DDIAKISDFDLSNQAPDAAARLHST 233
GL+YLH+ +I+HR+IK NVL+ + KISDF S + A +
Sbjct: 118 -----LEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRL--AGINPCTE 167
Query: 234 RVLGTFGYHAPEYAMTGQ--MSSKSDVYSFGVVLLELLTGRKP 274
GT Y APE G + +D++S G ++E+ TG+ P
Sbjct: 168 TFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPP 210
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 85.0 bits (210), Expect = 4e-19
Identities = 61/202 (30%), Positives = 103/202 (50%), Gaps = 18/202 (8%)
Query: 73 LIGEGSYGRVYFGVLRSGRAAAIK--KLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYY 130
L+G+G++G V+ G L+ A+K K D ++ +FL++ ++ + + N+V+L+G
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61
Query: 131 VDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKA 190
+ E G L KK L Q VK A+ AA G+ YL K
Sbjct: 62 TQRQPIYIVMELVPGGDFLSFLRKKK--------DELKTKQLVKFALDAAAGMAYLESK- 112
Query: 191 EPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGT--FGYHAPEYAM 248
IHR++ + N L+ ++++ KISDF +S Q D ++S+ L + APE
Sbjct: 113 --NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDG---IYSSSGLKQIPIKWTAPEALN 167
Query: 249 TGQMSSKSDVYSFGVVLLELLT 270
G+ SS+SDV+S+G++L E +
Sbjct: 168 YGRYSSESDVWSYGILLWETFS 189
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 4e-19
Identities = 61/209 (29%), Positives = 102/209 (48%), Gaps = 13/209 (6%)
Query: 63 EKTDNFGTNSLIGEGSYGRVYFGVL-RSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNE 121
E+TD + L G G YG VY GV + A+K L +EFL + +++ +K+
Sbjct: 4 ERTDITMKHKL-GGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHP 62
Query: 122 NVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAAR 181
N+V+L+G P + E + G+L D L ++ + VL + +A +
Sbjct: 63 NLVQLLGVCTREPPFYIITEFMTYGNLLDYL--RECNRQEVNAVVL-----LYMATQISS 115
Query: 182 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGY 241
+EYL +K IHR++ + N L+ ++ + K++DF LS H+ +
Sbjct: 116 AMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF-PIKW 171
Query: 242 HAPEYAMTGQMSSKSDVYSFGVVLLELLT 270
APE + S KSDV++FGV+L E+ T
Sbjct: 172 TAPESLAYNKFSIKSDVWAFGVLLWEIAT 200
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 85.5 bits (212), Expect = 6e-19
Identities = 62/216 (28%), Positives = 112/216 (51%), Gaps = 23/216 (10%)
Query: 73 LIGEGSYGRV----YFGVLRSGR--AAAIKKL--DSSKQPDQEFLAQVSMVSRL-KNENV 123
+GEG++G+V G+ A+K L D++++ + ++++ M+ + K++N+
Sbjct: 19 PLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNI 78
Query: 124 VELVGYYV-DGPLRVLAYEHASKGSLHDILHGK-------KGVKGAKPGPVLSWAQRVKI 175
+ L+G +GPL V+ E+A+ G+L D L + P L+ V
Sbjct: 79 INLLGVCTQEGPLYVVV-EYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSF 137
Query: 176 AVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRV 235
A ARG+E+L K + IHR++ + NVL+ +D + KI+DF L+ +T
Sbjct: 138 AYQVARGMEFLASK---KCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNG 194
Query: 236 LGTFGYHAPEYAMTGQM-SSKSDVYSFGVVLLELLT 270
+ APE A+ ++ + +SDV+SFGV+L E+ T
Sbjct: 195 RLPVKWMAPE-ALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 7e-19
Identities = 61/203 (30%), Positives = 101/203 (49%), Gaps = 17/203 (8%)
Query: 74 IGEGSYGRVYFGVLRS-GRAAAIKKLDSSKQPDQEFL-AQVSMVSRLKNENVVELVGYYV 131
IGEGS G V ++S G+ A+KK+D KQ +E L +V ++ ++ENVVE+ Y+
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87
Query: 132 DGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAE 191
G + E G+L DI+ + ++ Q + + + L LH +
Sbjct: 88 VGDELWVVMEFLEGGALTDIVTHTR----------MNEEQIAAVCLAVLKALSVLHAQG- 136
Query: 192 PRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQ 251
+IHR+IKS ++LL D K+SDF Q R S ++GT + APE
Sbjct: 137 --VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKS--LVGTPYWMAPELISRLP 192
Query: 252 MSSKSDVYSFGVVLLELLTGRKP 274
+ D++S G++++E++ G P
Sbjct: 193 YGPEVDIWSLGIMVIEMVDGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 84.9 bits (210), Expect = 7e-19
Identities = 60/224 (26%), Positives = 108/224 (48%), Gaps = 34/224 (15%)
Query: 73 LIGEGSYGRVYFG----VLRSGRA---AAIKKLD--SSKQPDQEFLAQVSMVSRLKNENV 123
+G G++G VY G +L G A+K L ++ Q +EFL + ++S + N+
Sbjct: 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNI 61
Query: 124 VELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAK-PGPVLSWAQRVKIAVGAARG 182
V+L+G + + + E G D+L + + + P+L+ + + I + A+G
Sbjct: 62 VKLLGVCLLNEPQYIIMELMEGG---DLLSYLRDARVERFGPPLLTLKELLDICLDVAKG 118
Query: 183 LEYLHEKAEPRIIHRNIKSSNVLLFDDD-----IAKISDFDL------SNQAPDAAARLH 231
YL + IHR++ + N L+ + + KI DF L S+ L
Sbjct: 119 CVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLL 175
Query: 232 STRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 274
R + APE + G+ +++SDV+SFGV++ E+LT G++P
Sbjct: 176 PVR------WMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQP 213
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 7e-19
Identities = 73/269 (27%), Positives = 128/269 (47%), Gaps = 23/269 (8%)
Query: 74 IGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQ--EFLAQVSMVSRLKNENVVELVGYY 130
IG+GS+G V+ G+ R+ + AIK +D + D+ + +++++S+ + V + G Y
Sbjct: 12 IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71
Query: 131 VDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKA 190
+ G + E+ GS D+L + GP + Q + +GL+YLH +
Sbjct: 72 LKGTKLWIIMEYLGGGSALDLL---------RAGPFDEF-QIATMLKEILKGLDYLHSEK 121
Query: 191 EPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTG 250
+ IHR+IK++NVLL + K++DF ++ Q D ++ +GT + APE
Sbjct: 122 K---IHRDIKAANVLLSEQGDVKLADFGVAGQLTD--TQIKRNTFVGTPFWMAPEVIQQS 176
Query: 251 QMSSKSDVYSFGVVLLELLTGRKPVDHTLP-RGQQSLVTWATPKLSED---KVKQCVDTK 306
SK+D++S G+ +EL G P P R + P L+ + K+ +D
Sbjct: 177 AYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLTGEFSKPFKEFIDAC 236
Query: 307 LGGEYPPKAIAK-VRKKKFITSECSNISF 334
L + + AK + K KFI S+
Sbjct: 237 LNKDPSFRPTAKELLKHKFIVKNAKKTSY 265
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 84.3 bits (209), Expect = 8e-19
Identities = 62/217 (28%), Positives = 108/217 (49%), Gaps = 30/217 (13%)
Query: 71 NSLIGEGSYGRVYFGVLR-SGR---AAAIKKLDSSKQPDQ--EFLAQVSMVSRLKNENVV 124
+IG G +G V G L+ G+ AIK L + Q +FL + S++ + + N++
Sbjct: 9 EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNII 68
Query: 125 ELVGYYVDG-PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGL 183
L G P+ ++ E+ GSL L G + Q V + G A G+
Sbjct: 69 RLEGVVTKSRPVMIIT-EYMENGSLDKFLRENDGK--------FTVGQLVGMLRGIASGM 119
Query: 184 EYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTR-----VLGT 238
+YL +E +HR++ + N+L+ + + K+SDF LS + D+ A ++T+ + T
Sbjct: 120 KYL---SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEAT-YTTKGGKIPIRWT 175
Query: 239 FGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 274
APE + +S SDV+SFG+V+ E+++ G +P
Sbjct: 176 ----APEAIAYRKFTSASDVWSFGIVMWEVMSYGERP 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 84.3 bits (209), Expect = 1e-18
Identities = 58/213 (27%), Positives = 98/213 (46%), Gaps = 26/213 (12%)
Query: 74 IGEGSYGRVYFGVLRS------GRAAAIKKL--DSSKQPDQEFLAQVSMVSRLKNENVVE 125
+G+GS+G VY G+ + AIK + ++S + EFL + S++ +VV
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 126 LVGYYVDGPLRVLAYEHASKGSLHDILHGKK-GVKGAKPGPVLSWAQRVKIAVGAARGLE 184
L+G G ++ E +KG L L ++ + + + +++A A G+
Sbjct: 74 LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133
Query: 185 YLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDF----DLSNQ---APDAAARLHSTRVLG 237
YL K + +HR++ + N ++ +D KI DF D+ L R
Sbjct: 134 YLAAK---KFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLL-PVR--- 186
Query: 238 TFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT 270
+ APE G ++KSDV+SFGVVL E+ T
Sbjct: 187 ---WMAPESLKDGVFTTKSDVWSFGVVLWEMAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 84.0 bits (208), Expect = 1e-18
Identities = 62/217 (28%), Positives = 104/217 (47%), Gaps = 25/217 (11%)
Query: 74 IGEGSYGRVYFGVLR------SGRAAAIKKL--DSSKQPDQEFLAQVSMVSRLKNENVVE 125
+G G++G VY G+ R A+K L S+Q + +FL + ++S+ ++N+V
Sbjct: 14 LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVR 73
Query: 126 LVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPV----LSWAQRVKIAVGAAR 181
L+G + R + E + G L K ++ +P P L+ + A A+
Sbjct: 74 LIGVSFERLPRFILLELMAGGDL------KSFLRENRPRPERPSSLTMKDLLFCARDVAK 127
Query: 182 GLEYLHEKAEPRIIHRNIKSSNVLLFD---DDIAKISDFDLSNQAPDAAARLHSTRVLGT 238
G +YL E IHR+I + N LL +AKI+DF ++ A+ R +
Sbjct: 128 GCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLP 184
Query: 239 FGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 274
+ PE + G +SK+DV+SFGV+L E+ + G P
Sbjct: 185 IKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMP 221
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 2e-18
Identities = 65/222 (29%), Positives = 110/222 (49%), Gaps = 20/222 (9%)
Query: 55 VISVDELKEKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFL-AQV 112
V+S + +E D+F IGEGS G V + +G+ A+KK+D KQ +E L +V
Sbjct: 14 VVSPGDPREYLDSFIK---IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEV 70
Query: 113 SMVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQR 172
++ +ENVV++ Y+ G + E G+L DI+ + ++ Q
Sbjct: 71 VIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTDIVTHTR----------MNEEQI 120
Query: 173 VKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHS 232
+ + R L YLH + +IHR+IKS ++LL D K+SDF Q + S
Sbjct: 121 ATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKS 177
Query: 233 TRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
++GT + APE ++ D++S G++++E++ G P
Sbjct: 178 --LVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPP 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.6 bits (207), Expect = 2e-18
Identities = 53/209 (25%), Positives = 100/209 (47%), Gaps = 22/209 (10%)
Query: 74 IGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQE-FLAQVSMVSRLKNENVVELV-GYY 130
+G+G++G+VY + +G AA K + + + E F+ ++ ++S K+ N+V L Y+
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 131 VDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKA 190
+ L +L E G+L I+ ++ + L+ Q + L +LH
Sbjct: 73 YENKLWIL-IEFCDGGALDSIM-----LELERG---LTEPQIRYVCRQMLEALNFLHSH- 122
Query: 191 EPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTG 250
++IHR++K+ N+LL D K++DF +S + + + +GT + APE
Sbjct: 123 --KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDT--FIGTPYWMAPEVVACE 178
Query: 251 QMSS-----KSDVYSFGVVLLELLTGRKP 274
K+D++S G+ L+EL P
Sbjct: 179 TFKDNPYDYKADIWSLGITLIELAQMEPP 207
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 2e-18
Identities = 65/217 (29%), Positives = 106/217 (48%), Gaps = 19/217 (8%)
Query: 74 IGEGSYGRVYFGVL-----RSGRAAAIKKLDSSKQPDQ--EFLAQVSMVSRLKNENVVEL 126
+GE ++G++Y G L + AIK L P Q EF + S+++ L + N+V L
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCL 72
Query: 127 VGYYVDGPLRVLAYEHASKGSLHDIL-----HGKKGVKGAKPGPV---LSWAQRVKIAVG 178
+G + +E+ ++G LH+ L H G + G V L + IA+
Sbjct: 73 LGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQ 132
Query: 179 AARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGT 238
A G+EYL + +H+++ + N+L+ + KISD LS + A + L
Sbjct: 133 IAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLP 189
Query: 239 FGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 274
+ PE M G+ SS SD++SFGVVL E+ + G +P
Sbjct: 190 IRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQP 226
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 84.0 bits (208), Expect = 3e-18
Identities = 68/209 (32%), Positives = 101/209 (48%), Gaps = 27/209 (12%)
Query: 74 IGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQ---EFLAQVSMVSRLKNENVVEL--- 126
IGEG+YG VY SG A+KK+ + D L +++++ L++ N+VEL
Sbjct: 15 IGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEV 74
Query: 127 -VGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEY 185
VG ++D V+ Y SL D + P P S +Q + + RGL+Y
Sbjct: 75 VVGKHLDSIFLVMEYCEQDLASLLDNM----------PTP-FSESQVKCLMLQLLRGLQY 123
Query: 186 LHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245
LHE IIHR++K SN+LL D KI+DF L+ A T + T Y APE
Sbjct: 124 LHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAK--PMTPKVVTLWYRAPE 178
Query: 246 --YAMTGQMSSKSDVYSFGVVLLELLTGR 272
T ++ D+++ G +L ELL +
Sbjct: 179 LLLGCTTYTTA-IDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 83.6 bits (206), Expect = 3e-18
Identities = 58/213 (27%), Positives = 107/213 (50%), Gaps = 15/213 (7%)
Query: 74 IGEGSYGRVYFGVL------RSGRAAAIKKL-DSSKQPDQEFLAQVSMVSRLKNENVVEL 126
+GEG++G+V+ + A+K L D+S ++F + +++ L++E++V+
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72
Query: 127 VGYYVDGPLRVLAYEHASKGSLHDIL--HGKKGVKGAKPGPV--LSWAQRVKIAVGAARG 182
G V+G ++ +E+ G L+ L HG V A+ L+ +Q + IA A G
Sbjct: 73 YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAG 132
Query: 183 LEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYH 242
+ YL A +HR++ + N L+ ++ + KI DF +S + +
Sbjct: 133 MVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWM 189
Query: 243 APEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 274
PE M + +++SDV+S GVVL E+ T G++P
Sbjct: 190 PPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP 222
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 83.6 bits (206), Expect = 4e-18
Identities = 72/213 (33%), Positives = 107/213 (50%), Gaps = 32/213 (15%)
Query: 74 IGEGSYGRVYFGV-LRSGRAAAIKKLD-SSKQPD---QEFLAQVSMVSRLKNENVVELVG 128
IG GS+G VYF +R+ AIKK+ S KQ + Q+ + +V + R+K+ N +E G
Sbjct: 33 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKG 92
Query: 129 YYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAV---GAARGLEY 185
Y+ L E+ GS D+L K KP Q V+IA GA +GL Y
Sbjct: 93 CYLREHTAWLVMEYCL-GSASDLLEVHK-----KP------LQEVEIAAITHGALQGLAY 140
Query: 186 LHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245
LH +IHR+IK+ N+LL + K++DF ++ A A + +GT + APE
Sbjct: 141 LHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASPANS------FVGTPYWMAPE 191
Query: 246 YAMT---GQMSSKSDVYSFGVVLLELLTGRKPV 275
+ GQ K DV+S G+ +EL + P+
Sbjct: 192 VILAMDEGQYDGKVDVWSLGITCIELAERKPPL 224
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 4e-18
Identities = 65/227 (28%), Positives = 110/227 (48%), Gaps = 36/227 (15%)
Query: 74 IGEGSYGRVY----------------FGVLRSGR----AAAIKKLDSSKQPDQEFLAQVS 113
+GEG +G V+ F V R GR A I + D++K +FL +V
Sbjct: 13 LGEGQFGEVHLCEVVNPQDLPTLQFPFNV-RKGRPLLVAVKILRPDANKNARNDFLKEVK 71
Query: 114 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDIL----------HGKKGVKGAKP 163
++SRLK+ N++ L+G VD + E+ G L+ L +G V A
Sbjct: 72 ILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHC 131
Query: 164 GPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS-NQ 222
P +S++ + +A+ A G++YL + +HR++ + N L+ ++ KI+DF +S N
Sbjct: 132 LPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGMSRNL 188
Query: 223 APDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELL 269
R+ VL + A E + G+ ++ SDV++FGV L E+L
Sbjct: 189 YAGDYYRIQGRAVL-PIRWMAWECILMGKFTTASDVWAFGVTLWEIL 234
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 5e-18
Identities = 66/255 (25%), Positives = 113/255 (44%), Gaps = 43/255 (16%)
Query: 40 AKEMKTVTVQPIAVPVISVDELKEKTDNFGTNSLIGEGSYGRVYFG-VLRSGRAAAIKKL 98
+K K++T+ I + LKE ++I G G Y G +++G +K++
Sbjct: 677 SKVSKSITINDI------LSSLKE-------ENVISRGKKGASYKGKSIKNGMQFVVKEI 723
Query: 99 DSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGV 158
+ +A + +L++ N+V+L+G L +E+ +L ++L
Sbjct: 724 NDVNSIPSSEIADMG---KLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN---- 776
Query: 159 KGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFD 218
LSW +R KIA+G A+ L +LH + P ++ N+ +++ D
Sbjct: 777 --------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIII---DGKDEPHLR 825
Query: 219 LSNQAP---DAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPV 275
LS D + S Y APE T ++ KSD+Y FG++L+ELLTG+ P
Sbjct: 826 LSLPGLLCTDTKCFISS-------AYVAPETRETKDITEKSDIYGFGLILIELLTGKSPA 878
Query: 276 DHTLPRGQQSLVTWA 290
D S+V WA
Sbjct: 879 DAEF-GVHGSIVEWA 892
|
Length = 968 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.6 bits (205), Expect = 5e-18
Identities = 57/215 (26%), Positives = 98/215 (45%), Gaps = 38/215 (17%)
Query: 74 IGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEF----LAQVSMVSRLKNENVVELVG 128
IGEG+YG+VY ++G A+KK+ + F + ++ ++ +L++ N+V L
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKIRME-NEKEGFPITAIREIKLLQKLRHPNIVRLKE 65
Query: 129 YYVDGPLRVLAYEHASKGSL--------HDI--LHGKKGVKGAKPGPVLSWAQRVKIAVG 178
KGS+ HD+ L VK + +Q
Sbjct: 66 IVTSKG----------KGSIYMVFEYMDHDLTGLLDSPEVK-------FTESQIKCYMKQ 108
Query: 179 AARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGT 238
GL+YLH I+HR+IK SN+L+ +D + K++DF L+ + ++ RV+ T
Sbjct: 109 LLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI-T 164
Query: 239 FGYHAPEYAM-TGQMSSKSDVYSFGVVLLELLTGR 272
Y PE + + + D++S G +L EL G+
Sbjct: 165 LWYRPPELLLGATRYGPEVDMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 83.2 bits (205), Expect = 5e-18
Identities = 71/212 (33%), Positives = 106/212 (50%), Gaps = 33/212 (15%)
Query: 74 IGEGSYGRVYFGV-LRSGRAAAIKKLD-SSKQPD---QEFLAQVSMVSRLKNENVVELVG 128
IG GS+G VYF + A+KK+ S KQ + Q+ + +V + +LK+ N +E G
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88
Query: 129 YYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAV---GAARGLEY 185
Y+ L E+ GS D+L K KP Q V+IA GA +GL Y
Sbjct: 89 CYLKEHTAWLVMEYCL-GSASDLLEVHK-----KP------LQEVEIAAITHGALQGLAY 136
Query: 186 LHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245
LH +IHR+IK+ N+LL + K++DF ++++ A + +GT + APE
Sbjct: 137 LHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSPANS------FVGTPYWMAPE 187
Query: 246 YAMT---GQMSSKSDVYSFGVVLLELLTGRKP 274
+ GQ K DV+S G+ +E L RKP
Sbjct: 188 VILAMDEGQYDGKVDVWSLGITCIE-LAERKP 218
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 5e-18
Identities = 61/215 (28%), Positives = 118/215 (54%), Gaps = 17/215 (7%)
Query: 67 NFGTNSLIGEGSYGRVYFGVLRS-GRAAAIKKLDSSKQPDQEFLA---QVSMVSRLKNEN 122
+ IGEGS+G++Y +S IK++D +K P +E A +V +++++K+ N
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPN 60
Query: 123 VVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARG 182
+V + + + E+ G L ++ ++GV ++ +LSW V+I++G
Sbjct: 61 IVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSE-DQILSWF--VQISLG---- 113
Query: 183 LEYLHEKAEPRIIHRNIKSSNVLLFDDD-IAKISDFDLSNQAPDAAARLHSTRVLGTFGY 241
L+++H++ +I+HR+IKS N+ L + +AK+ DF ++ Q D+ ++ +GT Y
Sbjct: 114 LKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYT--CVGTPYY 168
Query: 242 HAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVD 276
+PE ++K+D++S G VL EL T + P +
Sbjct: 169 LSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFE 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 6e-18
Identities = 62/221 (28%), Positives = 116/221 (52%), Gaps = 33/221 (14%)
Query: 74 IGEGSYGRVY----FGVLRSGR----AAAIKKL--DSSKQPDQEFLAQVSMVSRL-KNEN 122
+GEG +G+V +G+ +S A+K L +++ + + ++++ ++ + K++N
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79
Query: 123 VVELVGYYV-DGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGP------------VLSW 169
++ L+G +GPL V+ E+A+KG+L + L ++ PGP LS+
Sbjct: 80 IINLLGVCTQEGPLYVIV-EYAAKGNLREFLRARR-----PPGPDYTFDITKVPEEQLSF 133
Query: 170 AQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAAR 229
V A ARG+EYL + R IHR++ + NVL+ +D++ KI+DF L+ D
Sbjct: 134 KDLVSCAYQVARGMEYLESR---RCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYY 190
Query: 230 LHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT 270
++ + APE + +SDV+SFG+++ E+ T
Sbjct: 191 KKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 6e-18
Identities = 72/213 (33%), Positives = 106/213 (49%), Gaps = 35/213 (16%)
Query: 74 IGEGSYGRVYFGV-LRSGRAAAIKKLD-SSKQPD---QEFLAQVSMVSRLKNENVVELVG 128
IG GS+G VYF +R+ AIKK+ S KQ + Q+ + +V + +L++ N ++ G
Sbjct: 23 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82
Query: 129 YYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAV---GAARGLEY 185
Y+ L E+ GS D+L K KP Q V+IA GA +GL Y
Sbjct: 83 CYLREHTAWLVMEYCL-GSASDLLEVHK-----KP------LQEVEIAAVTHGALQGLAY 130
Query: 186 LHEKAEPRIIHRNIKSSNVLLFDDDIAKISDF-DLSNQAPDAAARLHSTRVLGTFGYHAP 244
LH +IHR++K+ N+LL + + K+ DF S AP + +GT + AP
Sbjct: 131 LHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-------ANXFVGTPYWMAP 180
Query: 245 EYAMT---GQMSSKSDVYSFGVVLLELLTGRKP 274
E + GQ K DV+S G+ +E L RKP
Sbjct: 181 EVILAMDEGQYDGKVDVWSLGITCIE-LAERKP 212
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 81.9 bits (202), Expect = 7e-18
Identities = 54/208 (25%), Positives = 98/208 (47%), Gaps = 19/208 (9%)
Query: 74 IGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDG 133
IG G +G V+ G R AIK + +++F+ + ++ +L + +V+L G +
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTER 71
Query: 134 PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPR 193
L +E G L D L ++G S + + + G+ YL
Sbjct: 72 SPICLVFEFMEHGCLSDYLRAQRG--------KFSQETLLGMCLDVCEGMAYLESSN--- 120
Query: 194 IIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGT---FGYHAPEYAMTG 250
+IHR++ + N L+ ++ + K+SDF ++ D T GT + +PE
Sbjct: 121 VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDD----QYTSSTGTKFPVKWSSPEVFSFS 176
Query: 251 QMSSKSDVYSFGVVLLELLT-GRKPVDH 277
+ SSKSDV+SFGV++ E+ + G+ P ++
Sbjct: 177 KYSSKSDVWSFGVLMWEVFSEGKTPYEN 204
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 8e-18
Identities = 75/246 (30%), Positives = 124/246 (50%), Gaps = 28/246 (11%)
Query: 50 PIAVPVISVDELKEKTDNFGTNSLIGEGSYGRVYFGVL--RSGRAAAIKKLDSSKQPDQE 107
P++ I D + +D + IG+G+YG+V F VL ++G AA+K LD D+E
Sbjct: 2 PLSGKTIIFDSFPDPSDTWEIIETIGKGTYGKV-FKVLNKKNGSKAAVKILDPIHDIDEE 60
Query: 108 FLAQVSMVSRLKNE-NVVELVGYY-----VDGPLRVLAYEHASKGSLHDILHG--KKGVK 159
A+ +++ L + NVV+ G Y +G L E + GS+ D++ G K+G +
Sbjct: 61 IEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGER 120
Query: 160 GAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDL 219
+P ++++ I A GL++LH + IHR++K +N+LL + K+ DF +
Sbjct: 121 MEEP--IIAY-----ILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGV 170
Query: 220 SNQAPDAAARLHSTRVLGTFGYHAPEY-AMTGQMSS----KSDVYSFGVVLLELLTGRKP 274
S Q + RL +GT + APE A Q+ S + DV+S G+ +EL G P
Sbjct: 171 SAQL--TSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPP 228
Query: 275 VDHTLP 280
+ P
Sbjct: 229 LADLHP 234
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 9e-18
Identities = 74/235 (31%), Positives = 113/235 (48%), Gaps = 23/235 (9%)
Query: 74 IGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQ-VSMVSRLKNENVVELVGYYV 131
IG G+YG VY + +G AAIK + D + Q + M+ K+ N+V G Y+
Sbjct: 17 IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYL 76
Query: 132 DGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAE 191
+ E GSL DI H GP LS +Q ++ +GL YLH K +
Sbjct: 77 RRDKLWICMEFCGGGSLQDIYH--------VTGP-LSESQIAYVSRETLQGLYYLHSKGK 127
Query: 192 PRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMT-- 249
+HR+IK +N+LL D+ K++DF +S Q A+ S +GT + APE A
Sbjct: 128 ---MHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKS--FIGTPYWMAPEVAAVER 182
Query: 250 -GQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVT---WATPKLSEDKVK 300
G + D+++ G+ +EL + P+ P L+T + PKL +DK+K
Sbjct: 183 KGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKL-KDKMK 236
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 1e-17
Identities = 57/207 (27%), Positives = 93/207 (44%), Gaps = 14/207 (6%)
Query: 73 LIGEGSYGRVYF----GVLRSGRAA--AIKKLDSSKQPD--QEFLAQVSMVSRLKNENVV 124
+G G +G V+ G+ G +K L +K + EF ++ M +L ++NVV
Sbjct: 12 TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVV 71
Query: 125 ELVGYYVDGPLRVLAYEHASKGSLHDILH-GKKGVKGAKPGPVLSWAQRVKIAVGAARGL 183
L+G + + E+ G L L K + KP P LS Q+V + A G+
Sbjct: 72 RLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPP-LSTKQKVALCTQIALGM 130
Query: 184 EYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHA 243
++L + R +HR++ + N L+ K+S LS + L + A
Sbjct: 131 DHL---SNARFVHRDLAARNCLVSSQREVKVSLLSLSKD-VYNSEYYKLRNALIPLRWLA 186
Query: 244 PEYAMTGQMSSKSDVYSFGVVLLELLT 270
PE S+KSDV+SFGV++ E+ T
Sbjct: 187 PEAVQEDDFSTKSDVWSFGVLMWEVFT 213
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 1e-17
Identities = 66/216 (30%), Positives = 115/216 (53%), Gaps = 23/216 (10%)
Query: 74 IGEGSYGRVYF----GVLRSGRA----AAIKKL--DSSKQPDQEFLAQVSMVSRL-KNEN 122
+GEG +G+V G+ + A+K L D++ + + ++++ M+ + K++N
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 123 VVELVGYYV-DGPLRVLAYEHASKGSLHDILHGKK--GVKGA-----KPGPVLSWAQRVK 174
++ L+G DGPL VL E+ASKG+L + L ++ G+ + P L++ V
Sbjct: 80 IINLLGACTQDGPLYVLV-EYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVS 138
Query: 175 IAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTR 234
A ARG+EYL A + IHR++ + NVL+ +D++ KI+DF L+ + +T
Sbjct: 139 CAYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTN 195
Query: 235 VLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT 270
+ APE + +SDV+SFGV+L E+ T
Sbjct: 196 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 81.6 bits (202), Expect = 1e-17
Identities = 54/204 (26%), Positives = 94/204 (46%), Gaps = 18/204 (8%)
Query: 74 IGEGSYGRVYF-GVLRSGRAAAIKKLDSSKQPD---QEFLAQVSMVSRLKNENVVELVGY 129
IGEG++G V+ +G A+KK+ + + L ++ + ++ VV+L+
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67
Query: 130 YVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEK 189
+ G VL E+ L ++L +P L AQ +G+ Y+H
Sbjct: 68 FPHGSGFVLVMEYMP-SDLSEVLR-----DEERP---LPEAQVKSYMRMLLKGVAYMHAN 118
Query: 190 AEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMT 249
I+HR++K +N+L+ D + KI+DF L+ + RL+S +V T Y APE
Sbjct: 119 ---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQV-ATRWYRAPELLYG 174
Query: 250 GQMSSKS-DVYSFGVVLLELLTGR 272
+ D+++ G + ELL G
Sbjct: 175 ARKYDPGVDLWAVGCIFAELLNGS 198
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 2e-17
Identities = 59/205 (28%), Positives = 104/205 (50%), Gaps = 18/205 (8%)
Query: 74 IGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYV-D 132
+G G +G V+ G + A+K L Q FL + +++ L+++ +V L +
Sbjct: 14 LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKE 73
Query: 133 GPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEP 192
P+ ++ E+ +KGSL D L +G K P + + + A G+ Y+ K
Sbjct: 74 EPIYIIT-EYMAKGSLLDFLKSDEGGKVLLP-------KLIDFSAQIAEGMAYIERK--- 122
Query: 193 RIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTF--GYHAPEYAMTG 250
IHR+++++NVL+ + + KI+DF L+ D ++ R F + APE G
Sbjct: 123 NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNE---YTAREGAKFPIKWTAPEAINFG 179
Query: 251 QMSSKSDVYSFGVVLLELLT-GRKP 274
+ KSDV+SFG++L E++T G+ P
Sbjct: 180 SFTIKSDVWSFGILLYEIVTYGKIP 204
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 80.3 bits (198), Expect = 3e-17
Identities = 61/219 (27%), Positives = 111/219 (50%), Gaps = 29/219 (13%)
Query: 72 SLIGEGSYGRVYFGV-LRSGRAAAIKKL---------DSSKQPDQEFLA-QVSMVSRLKN 120
+LIG GS+G VY G+ SG A+K++ K+ + LA +++++ L++
Sbjct: 6 ALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQH 65
Query: 121 ENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGP-VLSWAQRVKIAVGA 179
EN+V+ +G +D + E+ GS+ +L+ GA V ++ +++
Sbjct: 66 ENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNY----GAFEETLVRNFVRQI------ 115
Query: 180 ARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAP----DAAARLHSTRV 235
+GL YLH + IIHR+IK +N+L+ + KISDF +S + +
Sbjct: 116 LKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSL 172
Query: 236 LGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
G+ + APE + K+D++S G +++E+LTG+ P
Sbjct: 173 QGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.2 bits (199), Expect = 3e-17
Identities = 60/211 (28%), Positives = 100/211 (47%), Gaps = 33/211 (15%)
Query: 74 IGEGSYGRVYFGV-LRSGRAAAIKK--LDSSKQ--PDQEFLAQVSMVSRLKNENVVELVG 128
+GEG+YG VY ++G A+KK LD+ ++ P L ++S++ LK+ N+V+L+
Sbjct: 7 LGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIP-STALREISLLKELKHPNIVKLLD 65
Query: 129 YYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHE 188
L +E+ L L + G P + S ++ RGL Y H
Sbjct: 66 VIHTERKLYLVFEYCDM-DLKKYLDKRPG--PLSPNLIKSIMYQL------LRGLAYCHS 116
Query: 189 KAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHS------TRVLGTFGYH 242
RI+HR++K N+L+ D + K++DF L AR T + T Y
Sbjct: 117 H---RILHRDLKPQNILINRDGVLKLADFGL--------ARAFGIPLRTYTHEVVTLWYR 165
Query: 243 APEYAMTGQMSSKS-DVYSFGVVLLELLTGR 272
APE + + S + D++S G + E++TG+
Sbjct: 166 APEILLGSKHYSTAVDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 3e-17
Identities = 63/209 (30%), Positives = 107/209 (51%), Gaps = 21/209 (10%)
Query: 74 IGEGSYGRVYFGVLRSGRA---AAIK--KLDSSKQPDQEFLAQVSMVSRLKNENVVELVG 128
+G G++G V GV + + AIK K ++ K E + + ++ +L N +V ++G
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62
Query: 129 YYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHE 188
+ +L E AS G L+ L GKK ++ + V++ + G++YL
Sbjct: 63 V-CEAEALMLVMEMASGGPLNKFLSGKK--------DEITVSNVVELMHQVSMGMKYLEG 113
Query: 189 KAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTF--GYHAPEY 246
K +HR++ + NVLL + AKISDF LS +A A + R G + ++APE
Sbjct: 114 K---NFVHRDLAARNVLLVNQHYAKISDFGLS-KALGADDSYYKARSAGKWPLKWYAPEC 169
Query: 247 AMTGQMSSKSDVYSFGVVLLELLT-GRKP 274
+ SS+SDV+S+G+ + E + G+KP
Sbjct: 170 INFRKFSSRSDVWSYGITMWEAFSYGQKP 198
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 80.0 bits (198), Expect = 3e-17
Identities = 50/211 (23%), Positives = 92/211 (43%), Gaps = 19/211 (9%)
Query: 74 IGEGSYGRVYFGVLR--SGRAAAIKKLDSSKQPDQE---FLAQVSMVSRLKNENVVELVG 128
IG+GS+G V V R G+ K++D ++E +++V+++ LK+ N+V
Sbjct: 8 IGKGSFGTVR-KVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYD 66
Query: 129 YYVDGPLRVLAY---EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEY 185
+D + L Y E+ G L ++ K + + W +I L
Sbjct: 67 RIIDRSNQTL-YIVMEYCEGGDLAQLIQKCKKERKYIEEEFI-W----RILTQLLLALYE 120
Query: 186 LH--EKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHA 243
H ++HR++K +N+ L ++ K+ DF L+ ++ + +GT Y +
Sbjct: 121 CHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKT--YVGTPYYMS 178
Query: 244 PEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
PE KSD++S G ++ EL P
Sbjct: 179 PEQLNHMSYDEKSDIWSLGCLIYELCALSPP 209
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 4e-17
Identities = 65/216 (30%), Positives = 115/216 (53%), Gaps = 23/216 (10%)
Query: 74 IGEGSYGRVYF----GVLR------SGRAAAIKKLDSSKQPDQEFLAQVSMVSRL-KNEN 122
+GEG +G+V G+ + + A + K D++++ + ++++ M+ + K++N
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85
Query: 123 VVELVGYYV-DGPLRVLAYEHASKGSLHDILHGKK--GVK-----GAKPGPVLSWAQRVK 174
++ L+G DGPL V+ E+ASKG+L + L ++ G++ P LS+ V
Sbjct: 86 IINLLGACTQDGPLYVIV-EYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVS 144
Query: 175 IAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTR 234
A ARG+EYL A + IHR++ + NVL+ +D++ KI+DF L+ +T
Sbjct: 145 CAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 201
Query: 235 VLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT 270
+ APE + +SDV+SFGV+L E+ T
Sbjct: 202 GRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 4e-17
Identities = 57/197 (28%), Positives = 93/197 (47%), Gaps = 14/197 (7%)
Query: 74 IGEGSYGRVYFGVLRSGRA-AAIKKLDSSKQPD--QEFLAQVSMVSRLKNENVVELVGYY 130
IG G++G V+ G LR+ A+K + PD +FL + ++ + + N+V L+G
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62
Query: 131 VDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKA 190
+ E G L + GP L + +++ AA G+EYL K
Sbjct: 63 TQKQPIYIVMELVQGGDFLTFLRTE--------GPRLKVKELIQMVENAAAGMEYLESK- 113
Query: 191 EPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTG 250
IHR++ + N L+ + ++ KISDF +S + D + APE G
Sbjct: 114 --HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYG 171
Query: 251 QMSSKSDVYSFGVVLLE 267
+ SS+SDV+SFG++L E
Sbjct: 172 RYSSESDVWSFGILLWE 188
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 79.6 bits (196), Expect = 4e-17
Identities = 61/214 (28%), Positives = 108/214 (50%), Gaps = 27/214 (12%)
Query: 73 LIGEGSYGRVYFGVLR-SGR---AAAIKKLDS--SKQPDQEFLAQVSMVSRLKNENVVEL 126
+IG G +G V+ G+L+ GR A AIK L +++ Q+FL++ S++ + + N++ L
Sbjct: 12 VIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRL 71
Query: 127 VGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYL 186
G ++ E+ G+L L G S Q V + G A G++YL
Sbjct: 72 EGVVTKFKPAMIITEYMENGALDKYLRDHDGE--------FSSYQLVGMLRGIAAGMKYL 123
Query: 187 HEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFG-----Y 241
++ +HR++ + N+L+ + K+SDF LS D ++T + G +
Sbjct: 124 ---SDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTT----SGGKIPIRW 176
Query: 242 HAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 274
APE + +S SDV+SFG+V+ E+++ G +P
Sbjct: 177 TAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERP 210
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 7e-17
Identities = 51/147 (34%), Positives = 77/147 (52%), Gaps = 16/147 (10%)
Query: 129 YYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHE 188
+Y DG + + EH GSL +L KK G P +L KI++ RGL YL E
Sbjct: 68 FYSDGEISICM-EHMDGGSLDQVL--KKA--GRIPENILG-----KISIAVLRGLTYLRE 117
Query: 189 KAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAM 248
K + I+HR++K SN+L+ K+ DF +S Q D+ A +GT Y +PE
Sbjct: 118 KHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA----NSFVGTRSYMSPERLQ 171
Query: 249 TGQMSSKSDVYSFGVVLLELLTGRKPV 275
+ +SD++S G+ L+E+ GR P+
Sbjct: 172 GTHYTVQSDIWSLGLSLVEMAIGRYPI 198
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 78.8 bits (194), Expect = 8e-17
Identities = 57/213 (26%), Positives = 101/213 (47%), Gaps = 23/213 (10%)
Query: 73 LIGEGSYGRVYFGVLRSGRAAAIKKL-------DSSKQPDQEFLAQVSMVSRLKNENVVE 125
++G+G+YG VY G+ G+ A+K++ ++++ ++ +V ++ LK+ N+V+
Sbjct: 7 VLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQ 66
Query: 126 LVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEY 185
+G +D + E GS+ IL+ G P PV K G+ Y
Sbjct: 67 YLGTCLDDNTISIFMEFVPGGSISSILNRF----GPLPEPVFC-----KYTKQILDGVAY 117
Query: 186 LHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVL----GTFGY 241
LH ++HR+IK +NV+L + I K+ DF + + + +L GT +
Sbjct: 118 LHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYW 174
Query: 242 HAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
APE KSD++S G + E+ TG+ P
Sbjct: 175 MAPEVINESGYGRKSDIWSIGCTVFEMATGKPP 207
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 9e-17
Identities = 63/244 (25%), Positives = 117/244 (47%), Gaps = 25/244 (10%)
Query: 74 IGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDG 133
+G G +G V+ A+K + + FLA+ +++ L+++ +V+L
Sbjct: 14 LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTKE 73
Query: 134 PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPR 193
P+ ++ E +KGSL D L +G K +P P L + + A G+ ++ ++
Sbjct: 74 PIYIIT-EFMAKGSLLDFLKSDEGSK--QPLPKL-----IDFSAQIAEGMAFIEQR---N 122
Query: 194 IIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTF--GYHAPEYAMTGQ 251
IHR+++++N+L+ + KI+DF L+ D ++ R F + APE G
Sbjct: 123 YIHRDLRAANILVSASLVCKIADFGLARVIEDNE---YTAREGAKFPIKWTAPEAINFGS 179
Query: 252 MSSKSDVYSFGVVLLELLT-GRKP--------VDHTLPRGQQSLVTWATPKLSEDKVKQC 302
+ KSDV+SFG++L+E++T GR P V L RG + P+ + + +C
Sbjct: 180 FTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYNIMMRC 239
Query: 303 VDTK 306
+
Sbjct: 240 WKNR 243
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 1e-16
Identities = 78/294 (26%), Positives = 143/294 (48%), Gaps = 43/294 (14%)
Query: 73 LIGEGSYGRVYFGVLRSG---RAAAIKKLD--SSKQPDQEFLAQVSMVSRL-KNENVVEL 126
+IGEG++G+V +++ AAIK L +S+ ++F ++ ++ +L + N++ L
Sbjct: 9 VIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINL 68
Query: 127 VGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPG--------PVLSWAQRVKIAVG 178
+G + +A E+A G+L D L K V P L+ Q ++ A
Sbjct: 69 LGACENRGYLYIAIEYAPYGNLLDFLR-KSRVLETDPAFAKEHGTASTLTSQQLLQFASD 127
Query: 179 AARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGT 238
A G++YL EK + IHR++ + NVL+ ++ +KI+DF LS ++ + +G
Sbjct: 128 VATGMQYLSEK---QFIHRDLAARNVLVGENLASKIADFGLSR-----GEEVYVKKTMGR 179
Query: 239 FG--YHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP--------VDHTLPRGQQSLV 287
+ A E ++KSDV+SFGV+L E+++ G P + LP+G +
Sbjct: 180 LPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR--- 236
Query: 288 TWATPKLSEDKV----KQCVDTKLGGEYPPKAIAKVRKKKFITSECSNISFAEF 337
P+ +D+V +QC + E PP A V+ + + + + ++ A F
Sbjct: 237 -MEKPRNCDDEVYELMRQCWRDR-PYERPPFAQISVQLSRMLEARKAYVNMALF 288
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 2e-16
Identities = 61/203 (30%), Positives = 100/203 (49%), Gaps = 17/203 (8%)
Query: 74 IGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFL-AQVSMVSRLKNENVVELVGYYV 131
IGEGS G V + SGR A+K +D KQ +E L +V ++ +++NVVE+ Y+
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYL 88
Query: 132 DGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAE 191
G + E G+L DI+ + L+ Q + + L YLH +
Sbjct: 89 VGEELWVLMEFLQGGALTDIVSQTR----------LNEEQIATVCESVLQALCYLHSQG- 137
Query: 192 PRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQ 251
+IHR+IKS ++LL D K+SDF Q + S ++GT + APE
Sbjct: 138 --VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS--LVGTPYWMAPEVISRTP 193
Query: 252 MSSKSDVYSFGVVLLELLTGRKP 274
++ D++S G++++E++ G P
Sbjct: 194 YGTEVDIWSLGIMVIEMVDGEPP 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 2e-16
Identities = 58/206 (28%), Positives = 100/206 (48%), Gaps = 17/206 (8%)
Query: 74 IGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDG 133
+G G +G V +G R AIK + + EF+ + ++ +L +E +V+L G
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQ 71
Query: 134 PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPR 193
+ E+ S G L + L ++ K +P +L + V G+ YL K +
Sbjct: 72 RPIYIVTEYMSNGCLLNYL--REHGKRFQPSQLLEMCKDV------CEGMAYLESK---Q 120
Query: 194 IIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTF--GYHAPEYAMTGQ 251
IHR++ + N L+ D K+SDF LS D +++ V F + PE + +
Sbjct: 121 FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDE---YTSSVGSKFPVRWSPPEVLLYSK 177
Query: 252 MSSKSDVYSFGVVLLELLT-GRKPVD 276
SSKSDV++FGV++ E+ + G+ P +
Sbjct: 178 FSSKSDVWAFGVLMWEVYSLGKMPYE 203
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 78.2 bits (193), Expect = 2e-16
Identities = 62/218 (28%), Positives = 100/218 (45%), Gaps = 35/218 (16%)
Query: 73 LIGEGSYGRVYFGVLR-SGRAAAIKKLDSS--KQPDQEFLAQVSMVSRLKNENVVELVGY 129
IG G++G V + + SG A+K++ S+ ++ + L + +V +++ + +V +
Sbjct: 11 EIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVV--MRSSDCPYIVKF 68
Query: 130 YVDGPLRVLAYE----------HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGA 179
Y L E S + ++ K P +L KIAV
Sbjct: 69 Y-----GALFREGDCWICMELMDISLDKFYKYVYEVL--KSVIPEEILG-----KIAVAT 116
Query: 180 ARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTF 239
+ L YL K E +IIHR++K SN+LL + K+ DF +S Q D+ A+ TR G
Sbjct: 117 VKALNYL--KEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAK---TRDAGCR 171
Query: 240 GYHAPEYAMTGQMSS---KSDVYSFGVVLLELLTGRKP 274
Y APE +SDV+S G+ L E+ TG+ P
Sbjct: 172 PYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFP 209
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.6 bits (192), Expect = 2e-16
Identities = 58/219 (26%), Positives = 98/219 (44%), Gaps = 39/219 (17%)
Query: 74 IGEGSYGRVYFGV--LRSGRAAAIKKLD----SSKQPDQEFLAQVSMVSRLKNENVVELV 127
+G+GS+G+V V +G+ A+K L ++ + L + +++SR+ + +V+L
Sbjct: 1 LGKGSFGKVL-LVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLH 59
Query: 128 GYYVDGPLRV-LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAAR----- 181
Y ++ L E+A G L L + + + AR
Sbjct: 60 -YAFQTEEKLYLVLEYAPGGELFSHLS-----------------KEGRFSEERARFYAAE 101
Query: 182 ---GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGT 238
LEYLH II+R++K N+LL D K++DF L+ + +R ++ GT
Sbjct: 102 IVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNT--FCGT 156
Query: 239 FGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDH 277
Y APE + D +S GV+L E+LTG+ P
Sbjct: 157 PEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYA 195
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 2e-16
Identities = 62/216 (28%), Positives = 101/216 (46%), Gaps = 18/216 (8%)
Query: 64 KTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKK---LDSSKQPDQEFLAQVSMVSRLKN 120
+ ++ T S +G G+ G V KK + + ++ L ++ ++ ++
Sbjct: 3 RNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRS 62
Query: 121 ENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAA 180
+V G +++ + E GSL I KKG G P +L KIAV
Sbjct: 63 PYIVSFYGAFLNENNICMCMEFMDCGSLDRIY--KKG--GPIPVEILG-----KIAVAVV 113
Query: 181 RGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFG 240
GL YL+ RI+HR+IK SN+L+ K+ DF +S + ++ A T V GT
Sbjct: 114 EGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIA---DTFV-GTST 167
Query: 241 YHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVD 276
Y +PE G+ + KSDV+S G+ ++EL G+ P
Sbjct: 168 YMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFA 203
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 78.0 bits (192), Expect = 2e-16
Identities = 59/212 (27%), Positives = 105/212 (49%), Gaps = 21/212 (9%)
Query: 73 LIGEGSYGRVYFGVLR-SGRA---AAIKKLDS--SKQPDQEFLAQVSMVSRLKNENVVEL 126
+IG G +G V G L+ G+ AIK L S +++ ++FL++ S++ + + N++ L
Sbjct: 11 VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHL 70
Query: 127 VGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYL 186
G ++ E G+L L G + Q V + G A G++YL
Sbjct: 71 EGVVTKSRPVMIITEFMENGALDSFLRQNDGQ--------FTVIQLVGMLRGIAAGMKYL 122
Query: 187 HEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLG---TFGYHA 243
+E +HR++ + N+L+ + + K+SDF LS D + T LG + A
Sbjct: 123 ---SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTA 179
Query: 244 PEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 274
PE + +S SDV+S+G+V+ E+++ G +P
Sbjct: 180 PEAIAYRKFTSASDVWSYGIVMWEVMSYGERP 211
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 77.4 bits (191), Expect = 2e-16
Identities = 35/93 (37%), Positives = 47/93 (50%), Gaps = 6/93 (6%)
Query: 182 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGY 241
LEYLH K IIHR+IK N+LL + I+DF+++ + +T GT GY
Sbjct: 112 ALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTP---DTLTTSTSGTPGY 165
Query: 242 HAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
APE S D +S GV E L G++P
Sbjct: 166 MAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRP 198
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 2e-16
Identities = 56/216 (25%), Positives = 103/216 (47%), Gaps = 18/216 (8%)
Query: 74 IGEGSYGRVYFG------VLRSGRAAAIKKL-DSSKQPDQEFLAQVSMVSRLKNENVVEL 126
+GEG++G+V+ + A+K L D + ++F + +++ L++E++V+
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72
Query: 127 VGYYVDGPLRVLAYEHASKGSLHDIL--HGKKGVKGAKPGPV-----LSWAQRVKIAVGA 179
G DG ++ +E+ G L+ L HG + P L +Q + IA
Sbjct: 73 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 132
Query: 180 ARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTF 239
A G+ YL A +HR++ + N L+ + + KI DF +S +
Sbjct: 133 ASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 189
Query: 240 GYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 274
+ PE M + +++SDV+SFGV+L E+ T G++P
Sbjct: 190 RWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 225
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 77.2 bits (191), Expect = 4e-16
Identities = 56/211 (26%), Positives = 96/211 (45%), Gaps = 23/211 (10%)
Query: 72 SLIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQP------DQEFLAQVSMVSRLKNENVV 124
+GEG+Y VY +GR AIKK+ ++ + L ++ ++ LK+ N++
Sbjct: 6 KKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNII 65
Query: 125 ELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLE 184
L+ + L +E L ++ K V P + S+ RGLE
Sbjct: 66 GLLDVFGHKSNINLVFEFME-TDLEKVIKDKSIV--LTPADIKSYMLM------TLRGLE 116
Query: 185 YLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAP 244
YLH I+HR++K +N+L+ D + K++DF L+ ++ + +V+ T Y AP
Sbjct: 117 YLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKM-THQVV-TRWYRAP 171
Query: 245 EYAMTGQM-SSKSDVYSFGVVLLELLTGRKP 274
E + D++S G + ELL R P
Sbjct: 172 ELLFGARHYGVGVDMWSVGCIFAELLL-RVP 201
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 5e-16
Identities = 60/216 (27%), Positives = 100/216 (46%), Gaps = 17/216 (7%)
Query: 65 TDNFGTNSLIGEGSYGRVYFGV-LRSGRAAAIKKLD----SSKQPDQEFLAQVSMVSRLK 119
NF IG+G + VY + L GR A+KK+ + Q+ L ++ ++ +L
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 120 NENVVELVGYYVDGPLRVLAYEHASKGSL-HDILHGKKGVKGAKPGPVLSWAQRVKIAVG 178
+ NV++ + +++ + E A G L I H KK K P + W V++
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQ-KRLIPERTI-WKYFVQLC-- 116
Query: 179 AARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGT 238
LE++H K RI+HR+IK +NV + + K+ D L HS ++GT
Sbjct: 117 --SALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGT 169
Query: 239 FGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
Y +PE + KSD++S G +L E+ + P
Sbjct: 170 PYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 5e-16
Identities = 71/235 (30%), Positives = 111/235 (47%), Gaps = 23/235 (9%)
Query: 74 IGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQ-VSMVSRLKNENVVELVGYYV 131
+G G+YG VY L +G AA+K + D + Q + MV K+ N+V G Y+
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYL 76
Query: 132 DGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAE 191
+ E+ GSL DI H GP LS Q + +GL YLH K +
Sbjct: 77 SREKLWICMEYCGGGSLQDIYH--------VTGP-LSELQIAYVCRETLQGLAYLHSKGK 127
Query: 192 PRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAM--- 248
+HR+IK +N+LL D+ K++DF ++ + A+ S +GT + APE A
Sbjct: 128 ---MHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKS--FIGTPYWMAPEVAAVEK 182
Query: 249 TGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVT---WATPKLSEDKVK 300
G + D+++ G+ +EL + P+ P L++ + PKL +DK K
Sbjct: 183 NGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKL-KDKTK 236
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 5e-16
Identities = 55/167 (32%), Positives = 83/167 (49%), Gaps = 28/167 (16%)
Query: 163 PGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222
P +L KIAV + LEYLH K +IHR++K SNVL+ + K+ DF +S
Sbjct: 101 PEDILG-----KIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGY 153
Query: 223 APDAAARLHSTRVLGTFGYHAPEYAMTGQMSS-----KSDVYSFGVVLLELLTGRKPVD- 276
D+ A+ T G Y APE + +++ KSDV+S G+ ++EL TGR P D
Sbjct: 154 LVDSVAK---TIDAGCKPYMAPE-RINPELNQKGYDVKSDVWSLGITMIELATGRFPYDS 209
Query: 277 -HTLPRGQQSLVTWATPKLSEDK--------VKQCV--DTKLGGEYP 312
T + + +V +P+L +K V +C+ + K YP
Sbjct: 210 WKTPFQQLKQVVEEPSPQLPAEKFSPEFQDFVNKCLKKNYKERPNYP 256
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 5e-16
Identities = 57/221 (25%), Positives = 102/221 (46%), Gaps = 39/221 (17%)
Query: 73 LIGEGSYGRVYFGV-LRSGRAAAIKKL-----DSSKQPD--QEFLAQVSMVSRLKNENVV 124
+G G++ Y +++G A+K++ SS+Q + + ++ +++RL + +++
Sbjct: 7 QLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHII 66
Query: 125 ELVGYYV-DGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGL 183
++G D + E + GS+ +L K G A + RGL
Sbjct: 67 RMLGATCEDSHFNLFV-EWMAGGSVSHLLS--------KYGA-FKEAVIINYTEQLLRGL 116
Query: 184 EYLHEKAEPRIIHRNIKSSNVLL-FDDDIAKISDFDLSNQAPDAAARLHST--------- 233
YLHE +IIHR++K +N+L+ +I+DF AAARL +
Sbjct: 117 SYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFG-------AAARLAAKGTGAGEFQG 166
Query: 234 RVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
++LGT + APE Q DV+S G V++E+ T + P
Sbjct: 167 QLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPP 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 6e-16
Identities = 62/231 (26%), Positives = 109/231 (47%), Gaps = 34/231 (14%)
Query: 67 NFGTNSLIGEGSYGRVY--FGVLRSGRAA----AIKKLDSSKQPDQ--EFLAQVSMVSRL 118
N +GEG +G+V GRA A+K L + + + L++ +++ ++
Sbjct: 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQV 60
Query: 119 KNENVVELVGYYV-DGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQR----- 172
+ +V++L G DGPL +L E+A GSL L + V P + S R
Sbjct: 61 NHPHVIKLYGACSQDGPL-LLIVEYAKYGSLRSFLRESRKVG---PSYLGSDGNRNSSYL 116
Query: 173 -------------VKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDL 219
+ A +RG++YL AE +++HR++ + NVL+ + KISDF L
Sbjct: 117 DNPDERALTMGDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGL 173
Query: 220 SNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT 270
S + + + ++ + A E +++SDV+SFGV+L E++T
Sbjct: 174 SRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 7e-16
Identities = 46/186 (24%), Positives = 91/186 (48%), Gaps = 14/186 (7%)
Query: 95 IKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHG 154
+ +L ++ D L ++ ++S L++ N++ +++D ++ E+A+ G+L+D +
Sbjct: 35 LTRLSEKERRDA--LNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVR 92
Query: 155 KKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKI 214
+KG + + + Y+H+ I+HR+IK+ N+ L + K+
Sbjct: 93 QKGQ-------LFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKL 142
Query: 215 SDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
DF +S + V+GT Y +PE + + KSD+++ G VL ELLT ++
Sbjct: 143 GDFGISKILGSE--YSMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRT 200
Query: 275 VDHTLP 280
D T P
Sbjct: 201 FDATNP 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 76.3 bits (187), Expect = 7e-16
Identities = 64/229 (27%), Positives = 109/229 (47%), Gaps = 27/229 (11%)
Query: 61 LKEKTDNFGTNSLIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLK 119
L++ F L+G G+YG+VY G +++G+ AAIK +D + ++E +++M+ +
Sbjct: 1 LRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYS 60
Query: 120 N-ENVVELVGYYV-------DGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQ 171
+ N+ G ++ D L L E GS+ D++ KG L
Sbjct: 61 HHRNIATYYGAFIKKNPPGMDDQLW-LVMEFCGAGSVTDLIKNTKG-------NTLKEEW 112
Query: 172 RVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLH 231
I RGL +LH+ ++IHR+IK NVLL ++ K+ DF +S Q R +
Sbjct: 113 IAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRN 169
Query: 232 STRVLGTFGYHAPEYAMTGQMSS-----KSDVYSFGVVLLELLTGRKPV 275
+ +GT + APE + KSD++S G+ +E+ G P+
Sbjct: 170 T--FIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPL 216
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 8e-16
Identities = 62/216 (28%), Positives = 102/216 (47%), Gaps = 20/216 (9%)
Query: 64 KTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKL---DSSKQPDQEFLAQVSMVSRLKN 120
K D+F S +G G+ G V + +KL + + + ++ ++ +
Sbjct: 3 KDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNS 62
Query: 121 ENVVELVG-YYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGA 179
+V G +Y DG + + EH GSL +L K + P +L K+++
Sbjct: 63 PYIVGFYGAFYSDGEISI-CMEHMDGGSLDQVLKEAKRI----PEEILG-----KVSIAV 112
Query: 180 ARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTF 239
RGL YL EK + I+HR++K SN+L+ K+ DF +S Q D+ A +GT
Sbjct: 113 LRGLAYLREKHQ--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA----NSFVGTR 166
Query: 240 GYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPV 275
Y +PE S +SD++S G+ L+EL GR P+
Sbjct: 167 SYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPI 202
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 1e-15
Identities = 61/211 (28%), Positives = 99/211 (46%), Gaps = 20/211 (9%)
Query: 71 NSLIGEGSYGRVYFGVLRSGR----AAAIK--KLDSSKQPDQEFLAQVSMVSRLKNENVV 124
IGEG +G VY GV S A A+K K +S ++FL + ++ + + ++V
Sbjct: 11 GRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIV 70
Query: 125 ELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLE 184
+L+G + P+ ++ E A G L L K L A + + + L
Sbjct: 71 KLIGVITENPVWIV-MELAPLGELRSYLQVNKYS--------LDLASLILYSYQLSTALA 121
Query: 185 YLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAP 244
YL K R +HR+I + NVL+ D K+ DF LS + + + +++ + AP
Sbjct: 122 YLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLS-RYLEDESYYKASKGKLPIKWMAP 177
Query: 245 EYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 274
E + +S SDV+ FGV + E+L G KP
Sbjct: 178 ESINFRRFTSASDVWMFGVCMWEILMLGVKP 208
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 76.1 bits (187), Expect = 1e-15
Identities = 63/208 (30%), Positives = 96/208 (46%), Gaps = 25/208 (12%)
Query: 74 IGEGSYGRVYFGVLR-----SGRAAAIKKL--DSSKQPDQEFLAQVSMVSRLKNENVVEL 126
+GEG +G+V +G A+K L + +Q + +++++ L +EN+V+
Sbjct: 12 LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71
Query: 127 VGYYVDGPLRV--LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLE 184
G + + L E+ GSL D L P L+ AQ + A G+
Sbjct: 72 KGCCSEQGGKGLQLIMEYVPLGSLRDYL----------PKHKLNLAQLLLFAQQICEGMA 121
Query: 185 YLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAA--RLHSTRVLGTFGYH 242
YLH + IHR++ + NVLL +D + KI DF L+ P+ R+ F Y
Sbjct: 122 YLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY- 177
Query: 243 APEYAMTGQMSSKSDVYSFGVVLLELLT 270
A E + S SDV+SFGV L ELLT
Sbjct: 178 AVECLKENKFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 1e-15
Identities = 57/223 (25%), Positives = 106/223 (47%), Gaps = 25/223 (11%)
Query: 74 IGEGSYGRVY----FGVL--RSGRAAAIKKL--DSSKQPDQEFLAQVSMVSRLKNENVVE 125
IG+G++GRV+ G+L A+K L ++S +F + ++++ + N+V+
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72
Query: 126 LVGYYVDGPLRVLAYEHASKGSLHDILH-------------GKKGVKGAKPGPVLSWAQR 172
L+G G L +E+ + G L++ L K LS ++
Sbjct: 73 LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132
Query: 173 VKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHS 232
+ IA A G+ YL +E + +HR++ + N L+ ++ + KI+DF LS A S
Sbjct: 133 LCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAS 189
Query: 233 TRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 274
+ PE + +++SDV+++GVVL E+ + G +P
Sbjct: 190 ENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQP 232
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 2e-15
Identities = 69/233 (29%), Positives = 114/233 (48%), Gaps = 27/233 (11%)
Query: 74 IGEGSYGRVYF----GVLR---------SGRA--AAIKKL--DSSKQPDQEFLAQVSMVS 116
+GEG +G V+ G+ G+ A+K L D +K +FL ++ ++S
Sbjct: 13 LGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMS 72
Query: 117 RLKNENVVELVGYYV-DGPLRVLAYEHASKGSLHDILHGKK---GVKGAKPGPVLSWAQR 172
RLKN N++ L+G V D PL + E+ G L+ L ++ A P +S A
Sbjct: 73 RLKNPNIIRLLGVCVSDDPL-CMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANL 131
Query: 173 VKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS-NQAPDAAARLH 231
+ +AV A G++YL A +HR++ + N L+ + KI+DF +S N R+
Sbjct: 132 LYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQ 188
Query: 232 STRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQ 284
VL + A E + G+ ++ SDV++FGV L E+ T K ++L +Q
Sbjct: 189 GRAVL-PIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ 240
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 2e-15
Identities = 61/214 (28%), Positives = 110/214 (51%), Gaps = 25/214 (11%)
Query: 73 LIGEGSYGRVYFGVLRSG---RAAAIKKLD--SSKQPDQEFLAQVSMVSRLKNE-NVVEL 126
+IGEG++G+V ++ AAIK++ +SK ++F ++ ++ +L + N++ L
Sbjct: 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 61
Query: 127 VGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPG--------PVLSWAQRVKIAVG 178
+G LA E+A G+L D L K V P LS Q + A
Sbjct: 62 LGACEHRGYLYLAIEYAPHGNLLDFLR-KSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120
Query: 179 AARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGT 238
ARG++YL +K + IHR++ + N+L+ ++ +AKI+DF LS ++ + +G
Sbjct: 121 VARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR-----GQEVYVKKTMGR 172
Query: 239 FG--YHAPEYAMTGQMSSKSDVYSFGVVLLELLT 270
+ A E ++ SDV+S+GV+L E+++
Sbjct: 173 LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 3e-15
Identities = 67/217 (30%), Positives = 107/217 (49%), Gaps = 22/217 (10%)
Query: 64 KTDNFGTNSLIGEGSYGRVYFGVLR--SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLK 119
K D+F S +G G+ G V F V SG A K + +P + + ++ ++
Sbjct: 3 KDDDFEKISELGAGN-GGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECN 61
Query: 120 NENVVELVG-YYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVG 178
+ +V G +Y DG + + EH GSL +L KK G P +L K+++
Sbjct: 62 SPYIVGFYGAFYSDGEISI-CMEHMDGGSLDQVL--KKA--GRIPEQILG-----KVSIA 111
Query: 179 AARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGT 238
+GL YL EK +I+HR++K SN+L+ K+ DF +S Q D+ A +GT
Sbjct: 112 VIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA----NSFVGT 165
Query: 239 FGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPV 275
Y +PE S +SD++S G+ L+E+ GR P+
Sbjct: 166 RSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPI 202
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 3e-15
Identities = 56/209 (26%), Positives = 97/209 (46%), Gaps = 27/209 (12%)
Query: 74 IGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYV-D 132
+G G +G V+ G R+ AIK ++ +++F+ + ++ +L + +V+L G
Sbjct: 12 LGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQ 71
Query: 133 GPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEP 192
PL ++ E G L + L ++G +LS Q V G+EYL +
Sbjct: 72 KPLYIVT-EFMENGCLLNYLRQRQGKLS--KDMLLSMCQDV------CEGMEYLERNS-- 120
Query: 193 RIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFG------YHAPEY 246
IHR++ + N L+ + K+SDF ++ D + G + PE
Sbjct: 121 -FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLD-------DEYTSSSGAKFPVKWSPPEV 172
Query: 247 AMTGQMSSKSDVYSFGVVLLELLT-GRKP 274
+ SSKSDV+SFGV++ E+ T G+ P
Sbjct: 173 FNFSKYSSKSDVWSFGVLMWEVFTEGKMP 201
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 3e-15
Identities = 59/216 (27%), Positives = 110/216 (50%), Gaps = 23/216 (10%)
Query: 74 IGEGSYGRVYFGVL--------RSGRAAAIKKL--DSSKQPDQEFLAQVSMVSRL-KNEN 122
+GEG +G+V + A+K L D++++ + ++++ M+ + K++N
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82
Query: 123 VVELVGYYV-DGPLRVLAYEHASKGSLHDILHGKKGVK-------GAKPGPVLSWAQRVK 174
++ L+G DGPL V+ E+ASKG+L + L ++ P +++ V
Sbjct: 83 IINLLGACTQDGPLYVIV-EYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVS 141
Query: 175 IAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTR 234
ARG+EYL A + IHR++ + NVL+ ++++ KI+DF L+ + +T
Sbjct: 142 CTYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTN 198
Query: 235 VLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT 270
+ APE + +SDV+SFGV++ E+ T
Sbjct: 199 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 4e-15
Identities = 62/234 (26%), Positives = 113/234 (48%), Gaps = 27/234 (11%)
Query: 56 ISVDELKEKTDNFGTNSLIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQVSM 114
I + L++ F ++G G+YG+VY G +++G+ AAIK +D ++ ++E +++M
Sbjct: 6 IDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINM 65
Query: 115 VSRLKNE-NVVELVGYYV-------DGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPV 166
+ + + N+ G ++ D L L E GS+ D++ KG +
Sbjct: 66 LKKYSHHRNIATYYGAFIKKSPPGHDDQLW-LVMEFCGAGSVTDLVKNTKGNALKE---- 120
Query: 167 LSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDA 226
W + + RGL +LH ++IHR+IK NVLL ++ K+ DF +S Q
Sbjct: 121 -DWIAYICREI--LRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRT 174
Query: 227 AARLHSTRVLGTFGYHAPEYAMTGQ-----MSSKSDVYSFGVVLLELLTGRKPV 275
R ++ +GT + APE + +SD++S G+ +E+ G P+
Sbjct: 175 VGRRNT--FIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPL 226
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 5e-15
Identities = 70/223 (31%), Positives = 108/223 (48%), Gaps = 31/223 (13%)
Query: 74 IGEGSYGRVYFGVL------RSGRAAAIKKL-DSSKQP-DQEFLAQVSMVSRLKNENVVE 125
+GE +G+VY G L +A AIK L D ++ P +EF + M SRL++ N+V
Sbjct: 13 LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVC 72
Query: 126 LVGYYV-DGPLRVLAYEHASKGSLHDIL-----HGKKG-------VKGAKPGPVLSWAQR 172
L+G + PL ++ + + S LH+ L H G VK L A
Sbjct: 73 LLGVVTKEQPLSMI-FSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKST-----LEPADF 126
Query: 173 VKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHS 232
V I A G+E+L + ++H+++ + NVL+FD KISD L + A
Sbjct: 127 VHIVTQIAAGMEFL---SSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLM 183
Query: 233 TRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 274
L + +PE M G+ S SD++S+GVVL E+ + G +P
Sbjct: 184 GNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 226
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 6e-15
Identities = 56/206 (27%), Positives = 106/206 (51%), Gaps = 26/206 (12%)
Query: 74 IGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPD---QEFLAQVSMVSRLKNENVVELVGY 129
IGEGS+G+ + G+ IK+++ SK +E +V+++S +K+ N+V+
Sbjct: 8 IGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQES 67
Query: 130 YVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEK 189
+ + + ++ G L+ ++ ++GV + +L W ++ +A L+++H++
Sbjct: 68 FEENGNLYIVMDYCEGGDLYKKINAQRGVLFPED-QILDWFVQICLA------LKHVHDR 120
Query: 190 AEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVL-----GTFGYHAP 244
+I+HR+IKS N+ L D K+ DF + A L+ST L GT Y +P
Sbjct: 121 ---KILHRDIKSQNIFLTKDGTIKLGDFGI-------ARVLNSTVELARTCIGTPYYLSP 170
Query: 245 EYAMTGQMSSKSDVYSFGVVLLELLT 270
E ++KSD+++ G VL E+ T
Sbjct: 171 EICENRPYNNKSDIWALGCVLYEMCT 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 6e-15
Identities = 67/246 (27%), Positives = 113/246 (45%), Gaps = 31/246 (12%)
Query: 74 IGEGSYGRV---YFGVLRSGRAAAIKKL---DSSKQPDQEFLAQVSMVSRLKNENVVELV 127
+G G++G V + + +S + A+K L ++ E L + +++ +L N +V ++
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 128 GYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLH 187
G + +L E A G L+ L K V + +V + G++YL
Sbjct: 63 GI-CEAESWMLVMELAELGPLNKFLQKNKHVTEKN---ITELVHQVSM------GMKYLE 112
Query: 188 EKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTF--GYHAPE 245
E +HR++ + NVLL AKISDF LS +A A + + G + ++APE
Sbjct: 113 ET---NFVHRDLAARNVLLVTQHYAKISDFGLS-KALGADENYYKAKTHGKWPVKWYAPE 168
Query: 246 YAMTGQMSSKSDVYSFGVVLLELLT-GRKP--------VDHTLPRGQQSLVTWATPKLSE 296
+ SSKSDV+SFGV++ E + G+KP V + G++ P
Sbjct: 169 CMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMECPQRCPPEMY 228
Query: 297 DKVKQC 302
D +K C
Sbjct: 229 DLMKLC 234
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.5 bits (181), Expect = 7e-15
Identities = 58/215 (26%), Positives = 97/215 (45%), Gaps = 24/215 (11%)
Query: 66 DNFGTNSLIGEGSYGRVY-FGVLRSGRAAAIKKL---DSSKQPDQEFLAQVSMVSRLKNE 121
+ + ++GEG+YG V +G AIKK + + + L +V ++ +L++E
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHE 60
Query: 122 NVVELVGYY-VDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPV--LSWAQRVKIAVG 178
N+V L + G L L +E+ + +L ++L G G P V W Q ++
Sbjct: 61 NIVNLKEAFRRKGRL-YLVFEYVER-TLLELLEASPG--GLPPDAVRSYIW-QLLQ---- 111
Query: 179 AARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGT 238
+ Y H IIHR+IK N+L+ + + K+ DF + A T + T
Sbjct: 112 ---AIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALR-ARPASPLTDYVAT 164
Query: 239 FGYHAPEYAMTGQMSSKS-DVYSFGVVLLELLTGR 272
Y APE + K DV++ G ++ ELL G
Sbjct: 165 RWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGE 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 8e-15
Identities = 58/213 (27%), Positives = 110/213 (51%), Gaps = 23/213 (10%)
Query: 73 LIGEGSYGRVYFGVLRSG---RAAAIKKLD--SSKQPDQEFLAQVSMVSRL-KNENVVEL 126
+IGEG++G+V ++ AAIK++ +SK ++F ++ ++ +L + N++ L
Sbjct: 14 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 73
Query: 127 VGYYVDGPLRVLAYEHASKGSLHDILHGKKGVK-------GAKPGPVLSWAQRVKIAVGA 179
+G LA E+A G+L D L + ++ LS Q + A
Sbjct: 74 LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 133
Query: 180 ARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTF 239
ARG++YL +K + IHR++ + N+L+ ++ +AKI+DF LS ++ + +G
Sbjct: 134 ARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR-----GQEVYVKKTMGRL 185
Query: 240 G--YHAPEYAMTGQMSSKSDVYSFGVVLLELLT 270
+ A E ++ SDV+S+GV+L E+++
Sbjct: 186 PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 1e-14
Identities = 58/205 (28%), Positives = 99/205 (48%), Gaps = 25/205 (12%)
Query: 74 IGEGSYGRVYFG-VLRSGRAAAIK--KLDSSKQPDQEFLAQVSMVSRLKNENVVELVG-Y 129
+G G+ G VY L + R A+K LD + + ++ ++++ ++ + + ++ G +
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF 68
Query: 130 YVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEK 189
+V+ + + E GSL V P VL +IAV +GL YL
Sbjct: 69 FVENRISICT-EFMDGGSLD--------VYRKIPEHVLG-----RIAVAVVKGLTYLWSL 114
Query: 190 AEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMT 249
+I+HR++K SN+L+ K+ DF +S Q ++ A+ + +GT Y APE
Sbjct: 115 ---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTY----VGTNAYMAPERISG 167
Query: 250 GQMSSKSDVYSFGVVLLELLTGRKP 274
Q SDV+S G+ +EL GR P
Sbjct: 168 EQYGIHSDVWSLGISFMELALGRFP 192
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.4 bits (178), Expect = 2e-14
Identities = 51/207 (24%), Positives = 90/207 (43%), Gaps = 25/207 (12%)
Query: 74 IGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPD---QEFLAQVSMVSRLKNENVVELVGY 129
IGEG+YG VY +G AIKK+ + + + L ++ ++ L + N+++L+
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDV 66
Query: 130 YVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEK 189
+ L +E D+ +K + G L + +GL + H
Sbjct: 67 FRHKGDLYLVFEFM----DTDLYKL---IKDRQRG--LPESLIKSYLYQLLQGLAFCHSH 117
Query: 190 AEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQA-PDAAARLH--STRVLGTFGYHAPEY 246
I+HR++K N+L+ + + K++DF L+ H TR Y APE
Sbjct: 118 ---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTR-----WYRAPEL 169
Query: 247 AMT-GQMSSKSDVYSFGVVLLELLTGR 272
+ S+ D++S G + ELL+ R
Sbjct: 170 LLGDKGYSTPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 2e-14
Identities = 53/206 (25%), Positives = 96/206 (46%), Gaps = 12/206 (5%)
Query: 74 IGEGSYGRVYFGVLRS------GRAAAIKKLDSSKQPDQ--EFLAQVSMVSRLKNENVVE 125
+G+GS+G VY G+ + AIK ++ + + EFL + S++ +VV
Sbjct: 14 LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 126 LVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVL-SWAQRVKIAVGAARGLE 184
L+G G ++ E ++G L L + P S + +++A A G+
Sbjct: 74 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMA 133
Query: 185 YLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAP 244
YL+ + +HR++ + N ++ +D KI DF ++ + + L + +P
Sbjct: 134 YLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 190
Query: 245 EYAMTGQMSSKSDVYSFGVVLLELLT 270
E G ++ SDV+SFGVVL E+ T
Sbjct: 191 ESLKDGVFTTYSDVWSFGVVLWEIAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 3e-14
Identities = 58/212 (27%), Positives = 104/212 (49%), Gaps = 23/212 (10%)
Query: 73 LIGEGSYGRVYFGVLR-SGR---AAAIKKLDSSKQPDQ--EFLAQVSMVSRLKNENVVEL 126
+IG G +G V G L+ G+ AIK L + Q +FL++ S++ + + N++ L
Sbjct: 11 VIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHL 70
Query: 127 VGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYL 186
G ++ E+ GSL L G + Q V + G A G++YL
Sbjct: 71 EGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQ--------FTVIQLVGMLRGIASGMKYL 122
Query: 187 HEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS---NQAPDAAARLHSTRVLGTFGYHA 243
++ +HR++ + N+L+ + + K+SDF LS P+AA ++ + A
Sbjct: 123 ---SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI--PIRWTA 177
Query: 244 PEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 274
PE + +S SDV+S+G+V+ E+++ G +P
Sbjct: 178 PEAIAYRKFTSASDVWSYGIVMWEVMSYGERP 209
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.9 bits (177), Expect = 4e-14
Identities = 59/224 (26%), Positives = 100/224 (44%), Gaps = 47/224 (20%)
Query: 74 IGEGSYGRVYFGVL---RSGRAAAIKKLDSSKQPDQEF----LAQVSMVSRLKNENVVEL 126
IG G+YGRVY + G+ AIKK K+ +++++ LK+ENVV L
Sbjct: 8 IGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSL 67
Query: 127 VGYYV-DGPLRV-LAYEHASKGSLHDILHGKKGVKGAKPGPVLSW---AQRVKIAVGAAR 181
V ++ V L +++A HD+ ++ + A+RV I +
Sbjct: 68 VEVFLEHADKSVYLLFDYAE----HDLWQ------------IIKFHRQAKRVSIPPSMVK 111
Query: 182 --------GLEYLHEKAEPRIIHRNIKSSNVLL----FDDDIAKISDFDLSN--QAPDAA 227
G+ YLH ++HR++K +N+L+ + + KI D L+ AP
Sbjct: 112 SLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAP-LK 167
Query: 228 ARLHSTRVLGTFGYHAPEYAMTGQMSSKS-DVYSFGVVLLELLT 270
V+ T Y APE + + +K+ D+++ G + ELLT
Sbjct: 168 PLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 6e-14
Identities = 59/222 (26%), Positives = 102/222 (45%), Gaps = 35/222 (15%)
Query: 66 DNFGTNSLIGEGSYGRVY----FGVLRSGRA--AAIKKLDSSKQPD--QEFLAQVSMVSR 117
+N +G G++G+V +G+ +S A+K L + + ++++ ++S
Sbjct: 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSH 94
Query: 118 LKN-ENVVELVGY-YVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKI 175
L N EN+V L+G + GP+ V+ E+ G L + L K+ L+ +
Sbjct: 95 LGNHENIVNLLGACTIGGPILVI-TEYCCYGDLLNFLRRKRES-------FLTLEDLLSF 146
Query: 176 AVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDL-------SNQAPDAAA 228
+ A+G+ +L K IHR++ + NVLL I KI DF L SN A
Sbjct: 147 SYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNA 203
Query: 229 RLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT 270
RL + APE + +SDV+S+G++L E+ +
Sbjct: 204 RL-------PVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 6e-14
Identities = 57/224 (25%), Positives = 103/224 (45%), Gaps = 39/224 (17%)
Query: 73 LIGEGSYGRVYFGVLRSG-----RAAAIKKLDSSKQPDQ--EFLAQVSMVSRLKNENVVE 125
L+ EG++GR+++G+L +K + Q L + ++ L ++N++
Sbjct: 13 LLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILP 72
Query: 126 LVGYYVDGPLR-VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLE 184
++ ++ + Y + + G+L L + + P LS Q V +A+ A G+
Sbjct: 73 ILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNP-QALSTQQLVHMAIQIACGMS 131
Query: 185 YLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYH-- 242
YLH++ +IH++I + N ++ ++ KI+D LS R L YH
Sbjct: 132 YLHKR---GVIHKDIAARNCVIDEELQVKITDNALS-------------RDLFPMDYHCL 175
Query: 243 -----------APEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 274
A E + + SS SDV+SFGV+L EL+T G+ P
Sbjct: 176 GDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTP 219
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 7e-14
Identities = 57/206 (27%), Positives = 98/206 (47%), Gaps = 12/206 (5%)
Query: 74 IGEGSYGRVYFGVLR---SGRA---AAIKKLDSSKQPDQ--EFLAQVSMVSRLKNENVVE 125
+G+GS+G VY G R G A A+K ++ S + EFL + S++ +VV
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73
Query: 126 LVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPG-PVLSWAQRVKIAVGAARGLE 184
L+G G ++ E + G L L + PG P + + +++A A G+
Sbjct: 74 LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 133
Query: 185 YLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAP 244
YL+ K + +HR++ + N ++ D KI DF ++ + + L + AP
Sbjct: 134 YLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 190
Query: 245 EYAMTGQMSSKSDVYSFGVVLLELLT 270
E G ++ SD++SFGVVL E+ +
Sbjct: 191 ESLKDGVFTTSSDMWSFGVVLWEITS 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 70.7 bits (174), Expect = 7e-14
Identities = 57/241 (23%), Positives = 88/241 (36%), Gaps = 66/241 (27%)
Query: 73 LIGEGSYGRVYFGVLR-SGRAAAIKKLDSS------KQPD--QE-----FLAQVSMVSRL 118
+IGEGS+ V + + + AIK LD K E L + +L
Sbjct: 8 IIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKL 67
Query: 119 -----KNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSW--AQ 171
EN+ Y+V E+A G L + G+ + A+
Sbjct: 68 YYTFQDEENL-----YFV--------LEYAPNGELLQYIR----KYGSLDEKCTRFYAAE 110
Query: 172 RVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ--------- 222
+ LEYLH K IIHR++K N+LL D KI+DF +
Sbjct: 111 ILLA-------LEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPES 160
Query: 223 ---------APDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRK 273
+ R +GT Y +PE SD+++ G ++ ++LTG+
Sbjct: 161 NKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKP 220
Query: 274 P 274
P
Sbjct: 221 P 221
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 8e-14
Identities = 56/210 (26%), Positives = 103/210 (49%), Gaps = 20/210 (9%)
Query: 73 LIGEGSYGRVYFGV-LRSGRA----AAIKKLD--SSKQPDQEFLAQVSMVSRLKNENVVE 125
L+G G +G V+ G+ + G + AIK + S +Q QE + + L + +V
Sbjct: 14 LLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVR 73
Query: 126 LVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEY 185
L+G G L + + GSL D + + P +L+W ++ A+G+ Y
Sbjct: 74 LLGI-CPGASLQLVTQLSPLGSLLDHVRQHRDSLD--PQRLLNWCVQI------AKGMYY 124
Query: 186 LHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245
L E R++HRN+ + N+LL D I +I+DF +++ + + + A E
Sbjct: 125 LEEH---RMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALE 181
Query: 246 YAMTGQMSSKSDVYSFGVVLLELLT-GRKP 274
+ G+ + +SDV+S+GV + E+++ G +P
Sbjct: 182 SILFGRYTHQSDVWSYGVTVWEMMSYGAEP 211
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 1e-13
Identities = 60/223 (26%), Positives = 100/223 (44%), Gaps = 34/223 (15%)
Query: 67 NFGTNSLIGEGSYGRVYFGV-LRSGRAAAIKKLD---SSKQPDQEFLA---QVSMVSRLK 119
N+ L+G+G++GRVY + +GR A+K++ S + +E A ++ ++ L+
Sbjct: 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQ 62
Query: 120 NENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGA 179
+E +V+ G D + E+ GS+ D L G + R K
Sbjct: 63 HERIVQYYGCLRDDETLSIFMEYMPGGSVKDQL--------KAYGALTETVTR-KYTRQI 113
Query: 180 ARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTR----- 234
G+EYLH I+HR+IK +N+L K+ DF A+ RL +
Sbjct: 114 LEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDF-------GASKRLQTICSSGTG 163
Query: 235 ---VLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
V GT + +PE K+DV+S G ++E+LT + P
Sbjct: 164 MKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPP 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 2e-13
Identities = 62/214 (28%), Positives = 107/214 (50%), Gaps = 29/214 (13%)
Query: 74 IGEGSYGRVYFGVLRS--GRAAAIKK----LDSSKQPDQEFLAQVSMVSRLKNENVVELV 127
+G+G+YG VY VL G A+K+ LD SK + + ++ ++ + + +V+
Sbjct: 9 LGKGNYGSVY-KVLHRPTGVTMAMKEIRLELDESKF--NQIIMELDILHKAVSPYIVDFY 65
Query: 128 G-YYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYL 186
G ++++G + + E+ GSL D L+ P VL +I +GL++L
Sbjct: 66 GAFFIEGAV-YMCMEYMDAGSL-DKLYAGGVATEGIPEDVLR-----RITYAVVKGLKFL 118
Query: 187 HEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEY 246
K E IIHR++K +NVL+ + K+ DF +S + A+ + +G Y APE
Sbjct: 119 --KEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTN----IGCQSYMAPER 172
Query: 247 AMTGQMSS------KSDVYSFGVVLLELLTGRKP 274
+G + +SDV+S G+ +LE+ GR P
Sbjct: 173 IKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYP 206
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 69.7 bits (171), Expect = 2e-13
Identities = 61/211 (28%), Positives = 103/211 (48%), Gaps = 22/211 (10%)
Query: 72 SLIGEGSYGRVY-FGVLRSGRAAAIKKL--DSSKQPDQEFLAQVSMVSRLKN-ENVVELV 127
IG G+ G+VY ++G A+K++ +K+ ++ L + +V + + +V+
Sbjct: 21 GEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCY 80
Query: 128 GYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLH 187
GY++ + E S + D L K ++G P +L K+ V + L YL
Sbjct: 81 GYFITDSDVFICMELMS--TCLDKL--LKRIQGPIPEDILG-----KMTVAIVKALHYLK 131
Query: 188 EKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEY- 246
EK +IHR++K SN+LL K+ DF +S + D+ A+ TR G Y APE
Sbjct: 132 EKHG--VIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAK---TRSAGCAAYMAPERI 186
Query: 247 ---AMTGQMSSKSDVYSFGVVLLELLTGRKP 274
+ ++DV+S G+ L+EL TG+ P
Sbjct: 187 DPPDPNPKYDIRADVWSLGISLVELATGQFP 217
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 3e-13
Identities = 62/210 (29%), Positives = 104/210 (49%), Gaps = 24/210 (11%)
Query: 72 SLIGEGSYGRV---YFGVLR--SGRAAAIKKLD-SSKQPDQEFLAQVSMVSRLKNENVVE 125
+G+G++G V + L+ +G A+KKL S+ + ++F ++ ++ L+++N+V+
Sbjct: 10 QQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVK 69
Query: 126 L--VGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGL 183
V Y L E+ GSL D L + + +L +A ++ +G+
Sbjct: 70 YKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRK--LLLYASQI------CKGM 121
Query: 184 EYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLG---TFG 240
EYL K R +HR++ + N+L+ ++ KI DF L+ P + R G F
Sbjct: 122 EYLGSK---RYVHRDLATRNILVESENRVKIGDFGLTKVLP-QDKEYYKVREPGESPIFW 177
Query: 241 YHAPEYAMTGQMSSKSDVYSFGVVLLELLT 270
Y APE + S SDV+SFGVVL EL T
Sbjct: 178 Y-APESLTESKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 69.2 bits (170), Expect = 3e-13
Identities = 61/221 (27%), Positives = 108/221 (48%), Gaps = 30/221 (13%)
Query: 66 DNFGTNSLIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEF----LAQVSMVSRLKN 120
D + + I EG+YG VY ++G A+KKL K+ + F L +++++ +L++
Sbjct: 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKE-KEGFPITSLREINILLKLQH 63
Query: 121 ENVVEL----VGYYVDGPLRVLAY-EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKI 175
N+V + VG +D V+ Y EH K + P ++ +
Sbjct: 64 PNIVTVKEVVVGSNLDKIYMVMEYVEHDLKSLMET-----------MKQP-FLQSEVKCL 111
Query: 176 AVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRV 235
+ G+ +LH+ I+HR++K+SN+LL + I KI DF L+ + T++
Sbjct: 112 MLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPY--TQL 166
Query: 236 LGTFGYHAPEYAM-TGQMSSKSDVYSFGVVLLELLTGRKPV 275
+ T Y APE + + S+ D++S G + ELLT +KP+
Sbjct: 167 VVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLT-KKPL 206
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 4e-13
Identities = 57/219 (26%), Positives = 104/219 (47%), Gaps = 26/219 (11%)
Query: 74 IGEGSYGRVY--------------FGVLRSGRA---AAIKKL--DSSKQPDQEFLAQVSM 114
+GEG +G V+ F + SG A+K L D++K +FL ++ +
Sbjct: 13 LGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKI 72
Query: 115 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDIL--HGKKGVKGAKPGPVLSWAQR 172
+SRLK+ N++ L+ + + E+ G L+ L H + +S++
Sbjct: 73 MSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTL 132
Query: 173 VKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS-NQAPDAAARLH 231
+ +A A G++YL + +HR++ + N L+ + KI+DF +S N R+
Sbjct: 133 IFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQ 189
Query: 232 STRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT 270
VL + + E + G+ ++ SDV++FGV L E+LT
Sbjct: 190 GRAVL-PIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 7e-13
Identities = 55/220 (25%), Positives = 91/220 (41%), Gaps = 46/220 (20%)
Query: 74 IGEGSYGRVYFGVLR-SGRAAAIKKLDSS----KQPDQEFLAQVSMVSRLKNENVVELVG 128
+G+G +G V ++ +G+ A KKLD ++ +Q L + ++ ++ + +V L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSL-- 58
Query: 129 YYVDGPLRVLAYEHASKGSLHDIL--------------HGKKGVKGAKPGPVLSWAQRVK 174
AY +K L ++ G+ P A+ +
Sbjct: 59 ----------AYAFETKDDLCLVMTLMNGGDLKYHIYNVGE---------PGFPEARAIF 99
Query: 175 IAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTR 234
A GLE+LH++ RI++R++K NVLL D +ISD L A +
Sbjct: 100 YAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGL---AVELKGGKKIKG 153
Query: 235 VLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
GT GY APE D ++ G L E++ GR P
Sbjct: 154 RAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.3 bits (165), Expect = 9e-13
Identities = 68/221 (30%), Positives = 105/221 (47%), Gaps = 39/221 (17%)
Query: 72 SLIGEGSYGRVYFGV-LRSGRAAAIKK----LDSSKQPDQEFLAQVSMVSRLKN---ENV 123
+ IGEG+YG VY L +GR A+KK L P L +++++ +L++ N+
Sbjct: 5 AEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIP-LSTLREIALLKQLESFEHPNI 63
Query: 124 VEL----VGYYVDGPLRV-LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVG 178
V L G D L++ L +EH + L L K KPG L +
Sbjct: 64 VRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLS-----KCPKPG--LPPETIKDLMRQ 115
Query: 179 AARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHS-----T 233
RG+++LH RI+HR++K N+L+ D KI+DF L AR++S T
Sbjct: 116 LLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGL--------ARIYSFEMALT 164
Query: 234 RVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
V+ T Y APE + ++ D++S G + EL R+P
Sbjct: 165 SVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFR-RRP 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 1e-12
Identities = 57/204 (27%), Positives = 106/204 (51%), Gaps = 24/204 (11%)
Query: 74 IGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPD-QEFLAQVSMVSRLKNENVVELVG-YY 130
+G+G++G+VY + +G AA K +++ + + ++++ ++ +++ + +V+L+G +Y
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79
Query: 131 VDGPLRVLAYEHASKGSLHDI-LHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEK 189
DG L ++ E G++ I L +G L+ Q I L+YLH
Sbjct: 80 WDGKLWIMI-EFCPGGAVDAIMLELDRG---------LTEPQIQVICRQMLEALQYLHSM 129
Query: 190 AEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMT 249
+IIHR++K+ NVLL D K++DF +S + R S +GT + APE M
Sbjct: 130 ---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDS--FIGTPYWMAPEVVMC 184
Query: 250 GQMSS-----KSDVYSFGVVLLEL 268
M K+D++S G+ L+E+
Sbjct: 185 ETMKDTPYDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 1e-12
Identities = 54/208 (25%), Positives = 87/208 (41%), Gaps = 26/208 (12%)
Query: 74 IGEGSYGRVYFGVLR-SGRAAAIKKL-----DSSKQPDQEFLAQVSMVSRLKNENVVELV 127
I +G++G VY R +G AIK L + Q + M+ + ++ V +L
Sbjct: 4 ISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLY 63
Query: 128 GYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPV-LSWAQRVKIAVGAARGLEYL 186
+ L E+ + G ++ G + WA+ + G+E L
Sbjct: 64 YSFQSKDYLYLVMEYLNGGDCASLIK--------TLGGLPEDWAK--QYIAEVVLGVEDL 113
Query: 187 HEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEY 246
H++ IIHR+IK N+L+ K++DF LS L + + +GT Y APE
Sbjct: 114 HQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSR------NGLENKKFVGTPDYLAPET 164
Query: 247 AMTGQMSSKSDVYSFGVVLLELLTGRKP 274
+ SD +S G V+ E L G P
Sbjct: 165 ILGVGDDKMSDWWSLGCVIFEFLFGYPP 192
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 2e-12
Identities = 56/210 (26%), Positives = 96/210 (45%), Gaps = 21/210 (10%)
Query: 73 LIGEGSYGRVYFGVL----RSGRAAAIKKLDSSKQPDQE--FLAQVSMVSRLKNENVVEL 126
++G G +G + G L + AI L + Q FLA+ + + + N+V L
Sbjct: 12 ILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRL 71
Query: 127 VGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYL 186
G G ++ E+ S G+L L +G L Q + + G A G++YL
Sbjct: 72 EGVITRGNTMMIVTEYMSNGALDSFLRKHEGQ--------LVAGQLMGMLPGLASGMKYL 123
Query: 187 HEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHST-RVLGTFGYHAPE 245
+E +H+ + + VL+ D + KIS F + D + +++T + APE
Sbjct: 124 ---SEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQE--DKSEAIYTTMSGKSPVLWAAPE 178
Query: 246 YAMTGQMSSKSDVYSFGVVLLELLT-GRKP 274
SS SDV+SFG+V+ E+++ G +P
Sbjct: 179 AIQYHHFSSASDVWSFGIVMWEVMSYGERP 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 2e-12
Identities = 72/243 (29%), Positives = 111/243 (45%), Gaps = 42/243 (17%)
Query: 74 IGEGSYGRVYFGVL--RSGRAAAIKKLD-------SSKQPDQEFLAQVSMVSRLKNENVV 124
IG G++G V + V R G+ A+KK+ S K+ +E + M+ K++NV+
Sbjct: 8 IGYGAFG-VVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRE----LKMLCFFKHDNVL 62
Query: 125 ELVGYYVDGPLRVLAYEHA------SKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAV- 177
+ + P + +E + LH I+ P P LS + VK+ +
Sbjct: 63 SALD--ILQPPHIDPFEEIYVVTELMQSDLHKII--------VSPQP-LS-SDHVKVFLY 110
Query: 178 GAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN-QAPDAAARLHSTRVL 236
RGL+YLH I+HR+IK N+L+ + + KI DF L+ + PD H T+ +
Sbjct: 111 QILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVEEPD--ESKHMTQEV 165
Query: 237 GTFGYHAPEYAMTGQ-MSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVT--WATPK 293
T Y APE M + +S D++S G + ELL R P Q L+T TP
Sbjct: 166 VTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPS 225
Query: 294 LSE 296
L
Sbjct: 226 LEA 228
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 2e-12
Identities = 52/200 (26%), Positives = 92/200 (46%), Gaps = 25/200 (12%)
Query: 89 SGRAAAIKKLDSSKQPDQE----FLAQVSMVSRLKNENVVELVGYYVDGPLRVLA-YEHA 143
+G AIK L + ++ F + ++ +RL + N+V L+ P + A +E+
Sbjct: 2 TGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYV 61
Query: 144 SKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSN 203
+L ++L A G L + ++ + L H + I+HR++K N
Sbjct: 62 PGRTLREVL--------AADGA-LPAGETGRLMLQVLDALACAHNQG---IVHRDLKPQN 109
Query: 204 VLLFDDDI---AKISDFDLSNQAPDA--AARLHSTR---VLGTFGYHAPEYAMTGQMSSK 255
+++ + AK+ DF + P A TR VLGT Y APE ++
Sbjct: 110 IMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPN 169
Query: 256 SDVYSFGVVLLELLTGRKPV 275
SD+Y++G++ LE LTG++ V
Sbjct: 170 SDLYAWGLIFLECLTGQRVV 189
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 2e-12
Identities = 60/222 (27%), Positives = 101/222 (45%), Gaps = 50/222 (22%)
Query: 73 LIGEGSYGRVYFGVL----RSGRAAAIKKLD--SSKQPDQEFLAQVSMVSRLKNENVVEL 126
+IG+G +G VY G L A+K L+ + + ++FL + ++ + NV+ L
Sbjct: 2 VIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSL 61
Query: 127 VGYYVD---GPLRVLAYEHASKGSLHDILHG--KKGVKGAKPGPVLSWAQRVKIAVG--- 178
+G + PL VL Y + HG + ++ P VK +G
Sbjct: 62 LGICLPSEGSPLVVLPY----------MKHGDLRNFIRSETHNPT------VKDLIGFGL 105
Query: 179 -AARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPD---------AAA 228
A+G+EYL A + +HR++ + N +L + K++DF L+ D A
Sbjct: 106 QVAKGMEYL---ASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGA 162
Query: 229 RLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT 270
+L + A E T + ++KSDV+SFGV+L EL+T
Sbjct: 163 KL-------PVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 197
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 2e-12
Identities = 65/207 (31%), Positives = 102/207 (49%), Gaps = 27/207 (13%)
Query: 74 IGEGSYGRVYFGVLRS-GRAAAIKKLD---SSKQPDQEFLAQVSMVSRLKNENVVELVGY 129
+G+GSYG V R+ G+ IKKL+ +S++ + + ++S+LK+ N+V
Sbjct: 8 VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRES 67
Query: 130 YV--DGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLH 187
+ DG L ++ G L+ L +KG +L Q V+ V A L+YLH
Sbjct: 68 WEGEDGLLYIVM-GFCEGGDLYHKLKEQKG-------KLLPENQVVEWFVQIAMALQYLH 119
Query: 188 EKAEPRIIHRNIKSSNVLLFDDDIAKISDFD----LSNQAPDAAARLHSTRVLGTFGYHA 243
EK I+HR++K+ NV L +I K+ D L NQ D A+ L +GT Y +
Sbjct: 120 EK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC-DMASTL-----IGTPYYMS 170
Query: 244 PEYAMTGQMSSKSDVYSFGVVLLELLT 270
PE + KSDV++ G + E+ T
Sbjct: 171 PELFSNKPYNYKSDVWALGCCVYEMAT 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 3e-12
Identities = 63/215 (29%), Positives = 101/215 (46%), Gaps = 24/215 (11%)
Query: 63 EKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKK-LDSSKQPDQEFLA--QVSMVSRL 118
EK +N G L+GEGSYG V + +G+ AIKK L+S + +A ++ M+ +L
Sbjct: 1 EKYENLG---LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQL 57
Query: 119 KNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRV-KIAV 177
++EN+V L+ + L +E L D+ G+ RV K
Sbjct: 58 RHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLD----------ESRVRKYLF 107
Query: 178 GAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLG 237
RG+E+ H IIHR+IK N+L+ + K+ DF + AA T +
Sbjct: 108 QILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTL--AAPGEVYTDYVA 162
Query: 238 TFGYHAPEYAMTGQMSSKS-DVYSFGVVLLELLTG 271
T Y APE + ++ D+++ G ++ E+LTG
Sbjct: 163 TRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 65.7 bits (161), Expect = 3e-12
Identities = 68/216 (31%), Positives = 100/216 (46%), Gaps = 31/216 (14%)
Query: 74 IGEGSYGRVYFGVLRS-GRAAAIKKLDSS----KQPDQEFLAQVSMVSRLKNENVVELVG 128
I +G+YGRV+ +S G AIK + + K + L + ++S+ ++ VV+L
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLY- 59
Query: 129 YYVDGPLRV-LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIA--VGAARGLEY 185
Y G + L E+ G L +L G+ A R+ IA V A LEY
Sbjct: 60 YSFQGKKNLYLVMEYLPGGDLASLLENV----GSLDE---DVA-RIYIAEIVLA---LEY 108
Query: 186 LHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS------NQAPDAAARLHSTRVLGTF 239
LH IIHR++K N+L+ + K++DF LS Q R++GT
Sbjct: 109 LHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTP 165
Query: 240 GYHAPEYAMTGQMSSKS-DVYSFGVVLLELLTGRKP 274
Y APE + GQ SK+ D +S G +L E L G P
Sbjct: 166 DYIAPE-VILGQGHSKTVDWWSLGCILYEFLVGIPP 200
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 65.8 bits (161), Expect = 4e-12
Identities = 58/218 (26%), Positives = 104/218 (47%), Gaps = 28/218 (12%)
Query: 74 IGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEF----LAQVSMVSRLKNENVVELVG 128
+GEG++G VY +++GR A+KK+ + D F L ++ ++ +LK+ NVV L+
Sbjct: 16 LGEGTFGEVYKARQIKTGRVVALKKILMHNEKDG-FPITALREIKILKKLKHPNVVPLID 74
Query: 129 YYVDGPLRVLAYEHASKGSLHDIL----HGKKGVKGAKPGPVLSWAQRVKIAVGAARGLE 184
V+ P + +GS++ + H G+ P L+ +Q + G+
Sbjct: 75 MAVERPDK----SKRKRGSVYMVTPYMDHDLSGLLE-NPSVKLTESQIKCYMLQLLEGIN 129
Query: 185 YLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDL---------SNQAPDAAARLHSTRV 235
YLHE I+HR+IK++N+L+ + I KI+DF L + + T +
Sbjct: 130 YLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNL 186
Query: 236 LGTFGYHAPEYAM-TGQMSSKSDVYSFGVVLLELLTGR 272
+ T Y PE + + ++ D++ G V E+ T R
Sbjct: 187 VVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRR 224
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 65.5 bits (159), Expect = 5e-12
Identities = 58/212 (27%), Positives = 108/212 (50%), Gaps = 20/212 (9%)
Query: 73 LIGEGSYGRVYFGV-LRSGRAA----AIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVE 125
++G G++G VY G+ + G AIK L+ + P + EF+ + +++ + + ++V
Sbjct: 14 VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 73
Query: 126 LVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEY 185
L+G + P L + G L D +H K G++ +L+W ++ A+G+ Y
Sbjct: 74 LLGVCLS-PTIQLVTQLMPHGCLLDYVHEHKDNIGSQL--LLNWCVQI------AKGMMY 124
Query: 186 LHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245
L E+ R++HR++ + NVL+ + KI+DF L+ ++ + A E
Sbjct: 125 LEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALE 181
Query: 246 YAMTGQMSSKSDVYSFGVVLLELLT-GRKPVD 276
+ + +SDV+S+GV + EL+T G KP D
Sbjct: 182 CIHYRKFTHQSDVWSYGVTIWELMTFGGKPYD 213
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 6e-12
Identities = 61/225 (27%), Positives = 99/225 (44%), Gaps = 36/225 (16%)
Query: 67 NFGTNSLIGEGSYGRVYFGV-LRSGRAAAIKKLD---SSKQPDQEFLA---QVSMVSRLK 119
N+ L+G+G++GRVY +GR A+K++ S + +E A ++ ++ L
Sbjct: 3 NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL 62
Query: 120 NENVVELVGYYVDGPLRVLA--YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAV 177
+E +V+ G D R L+ EH GS+ D L K L+ K
Sbjct: 63 HERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQL---------KSYGALTENVTRKYTR 113
Query: 178 GAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHS----- 232
G+ YLH I+HR+IK +N+L K+ DF A+ RL +
Sbjct: 114 QILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFG-------ASKRLQTICLSG 163
Query: 233 ---TRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
V GT + +PE K+D++S G ++E+LT + P
Sbjct: 164 TGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 9e-12
Identities = 59/215 (27%), Positives = 102/215 (47%), Gaps = 40/215 (18%)
Query: 74 IGEGSYGRVYFGVLR-SGRAAAIK--KLDSSKQPDQEFLAQVSMVSRLKNENVVEL---- 126
+GEG+Y VY G R +G A+K LD+ + + ++S++ LK+EN+V L
Sbjct: 8 LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVI 67
Query: 127 --------VGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVG 178
V Y+D L+ H +G+L P V S+ ++
Sbjct: 68 HTENKLMLVFEYMDKDLKKYMDTHGVRGAL-------------DPNTVKSFTYQL----- 109
Query: 179 AARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGT 238
+G+ + HE R++HR++K N+L+ K++DF L+ +A S V+ T
Sbjct: 110 -LKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLA-RAFGIPVNTFSNEVV-T 163
Query: 239 FGYHAPEYAMTGQMSSKS-DVYSFGVVLLELLTGR 272
Y AP+ + + S S D++S G ++ E++TGR
Sbjct: 164 LWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 1e-11
Identities = 58/233 (24%), Positives = 99/233 (42%), Gaps = 46/233 (19%)
Query: 71 NSLIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQP-----DQEFLAQVSM---------- 114
+ +GEG+YG+V +G+ AIKK+ + D++ + +
Sbjct: 14 GAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKI 73
Query: 115 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGK-KGVKGAKPGPVLSWAQRV 173
++ +K+EN++ LV YV+G L + DI+ K V K L+ +Q
Sbjct: 74 MNEIKHENIMGLVDVYVEGDFINL---------VMDIMASDLKKVVDRKI--RLTESQVK 122
Query: 174 KIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDF-------------DLS 220
I + GL LH+ +HR++ +N+ + I KI+DF LS
Sbjct: 123 CILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLS 179
Query: 221 NQAPDAAARLHSTRVLGTFGYHAPEYAM-TGQMSSKSDVYSFGVVLLELLTGR 272
+++V+ T Y APE M + D++S G + ELLTG+
Sbjct: 180 KDETMQRREEMTSKVV-TLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 1e-11
Identities = 57/212 (26%), Positives = 104/212 (49%), Gaps = 29/212 (13%)
Query: 73 LIGEGSYGRVYFGV-LRSGRAAAIK--KLDSSKQPDQEFLAQVSMVSRLKNENVVELV-G 128
++GEGS+GR + S + A+K +L S ++ + +++++K+ N+V
Sbjct: 7 VVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKES 66
Query: 129 YYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHE 188
+ DG L ++ E+ G L + ++G K +L W ++ + V +++HE
Sbjct: 67 FEADGHLYIVM-EYCDGGDLMQKIKLQRG-KLFPEDTILQWFVQMCLGV------QHIHE 118
Query: 189 KAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRV------LGTFGYH 242
K R++HR+IKS N+ L + K+ DF +ARL ++ +GT Y
Sbjct: 119 K---RVLHRDIKSKNIFLTQNGKVKLGDF--------GSARLLTSPGAYACTYVGTPYYV 167
Query: 243 APEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
PE ++KSD++S G +L EL T + P
Sbjct: 168 PPEIWENMPYNNKSDIWSLGCILYELCTLKHP 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 2e-11
Identities = 53/213 (24%), Positives = 93/213 (43%), Gaps = 15/213 (7%)
Query: 67 NFGTNSLIGEGSYGRVYFGV-LRSGRAAAIKKLD----SSKQPDQEFLAQVSMVSRLKNE 121
NF IG G + VY L G A+KK+ + + + ++ ++ +L +
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62
Query: 122 NVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAAR 181
NV++ +++ + E A G L ++ K K P + W K V
Sbjct: 63 NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTV-W----KYFVQLCS 117
Query: 182 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGY 241
LE++H + R++HR+IK +NV + + K+ D L HS ++GT Y
Sbjct: 118 ALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYY 172
Query: 242 HAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
+PE + KSD++S G +L E+ + P
Sbjct: 173 MSPERIHENGYNFKSDIWSLGCLLYEMAALQSP 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 63.7 bits (156), Expect = 2e-11
Identities = 60/222 (27%), Positives = 97/222 (43%), Gaps = 44/222 (19%)
Query: 72 SLIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQ-----VSMVSRLKNENVVE 125
IG G+YG V V R+GR AIKK+ S D A+ + ++ L++EN++
Sbjct: 6 KPIGSGAYGVVCSAVDKRTGRKVAIKKI--SNVFDDLIDAKRILREIKLLRHLRHENIIG 63
Query: 126 LVGYYVDGPLRVLAYEHASKGS------------LHDILHGKKGVKGAKPGPVLSWAQRV 173
L L +L + LH ++ + L+ +
Sbjct: 64 L--------LDILRPPSPEDFNDVYIVTELMETDLHKVIKSPQ---------PLT-DDHI 105
Query: 174 K-IAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQA-PDAAARLH 231
+ RGL+YLH +IHR++K SN+L+ + KI DF L+ PD +
Sbjct: 106 QYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGF 162
Query: 232 STRVLGTFGYHAPEYAMTGQMSSKS-DVYSFGVVLLELLTGR 272
T + T Y APE ++ +K+ D++S G + ELLT +
Sbjct: 163 LTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 2e-11
Identities = 49/209 (23%), Positives = 100/209 (47%), Gaps = 18/209 (8%)
Query: 73 LIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQ--PDQEFLAQ--VSMVSRLKNENVVELVG 128
++G G++G V+ ++ + I K +Q D+ AQ ++ L + N++E
Sbjct: 7 VVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYE 66
Query: 129 YYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHE 188
+++ ++ E+A G+L + + K+ +L + ++ +A L ++H
Sbjct: 67 NFLEDKALMIVMEYAPGGTLAEYIQ-KRCNSLLDEDTILHFFVQILLA------LHHVHT 119
Query: 189 KAEPRIIHRNIKSSNVLL-FDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYA 247
K I+HR++K+ N+LL + KI DF +S + + V+GT Y +PE
Sbjct: 120 K---LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK---AYTVVGTPCYISPELC 173
Query: 248 MTGQMSSKSDVYSFGVVLLELLTGRKPVD 276
+ KSD+++ G VL EL + ++ +
Sbjct: 174 EGKPYNQKSDIWALGCVLYELASLKRAFE 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 2e-11
Identities = 57/210 (27%), Positives = 107/210 (50%), Gaps = 20/210 (9%)
Query: 74 IGEGSYGRVYFGV-LRSGRAAAIKK--LDSSKQ--PDQEFLAQVSMVSRLKNENVVELVG 128
IGEG+YG VY G ++G+ A+KK L+S ++ P + ++S++ L++ N+V L
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTA-IREISLLKELQHPNIVCLQD 66
Query: 129 YYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHE 188
+ L +E S L L + V S+ ++ +G+ + H
Sbjct: 67 VLMQESRLYLIFEFLSM-DLKKYLDSLPKGQYMDAELVKSYLYQI------LQGILFCHS 119
Query: 189 KAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAM 248
+ R++HR++K N+L+ + + K++DF L+ +A R+++ V+ T Y APE +
Sbjct: 120 R---RVLHRDLKPQNLLIDNKGVIKLADFGLA-RAFGIPVRVYTHEVV-TLWYRAPEVLL 174
Query: 249 TGQM-SSKSDVYSFGVVLLELLTGRKPVDH 277
S+ D++S G + E+ T +KP+ H
Sbjct: 175 GSPRYSTPVDIWSIGTIFAEMAT-KKPLFH 203
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 3e-11
Identities = 57/220 (25%), Positives = 101/220 (45%), Gaps = 28/220 (12%)
Query: 73 LIGEGSYGRVYFGVLRSGRAAAIK------KLDSSKQPD-QEFLAQVSMVSRLKNENVVE 125
++GEG +G V G L + +K KLD + +EFL++ + + + NV++
Sbjct: 6 ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65
Query: 126 LVGYYVDG--------PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAV 177
L+G + P+ +L + G LH L + + P+ +K V
Sbjct: 66 LIGVCFEASSLQKIPKPMVILPF--MKHGDLHSFLLYSRLGGLPEKLPL---QTLLKFMV 120
Query: 178 GAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ--APDAAARLHSTRV 235
A G+EYL + IHR++ + N +L +D ++DF LS + + D + ++
Sbjct: 121 DIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKM 177
Query: 236 LGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 274
+ A E +SKSDV++FGV + E+ T G+ P
Sbjct: 178 --PVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTP 215
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 63.1 bits (154), Expect = 3e-11
Identities = 62/235 (26%), Positives = 105/235 (44%), Gaps = 42/235 (17%)
Query: 74 IGEGSYGRVYF-----------------GVLRSGRAAAIKKL--DSSKQPDQEFLAQVSM 114
+GEG +G V+ + A+K L D+S ++FL +V +
Sbjct: 13 LGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKI 72
Query: 115 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDIL--HGKKGVKGAKPGPVLSWAQR 172
+SRL + N+ L+G P + E+ G L+ L H + A LS++
Sbjct: 73 LSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTL 132
Query: 173 VKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHS 232
+ +A A G+ YL +HR++ + N L+ + KI+DF +S + + +
Sbjct: 133 LYMATQIASGMRYLESL---NFVHRDLATRNCLVGKNYTIKIADFGMSR---NLYSSDYY 186
Query: 233 TRVLGTFGYHAP--------EYAMTGQMSSKSDVYSFGVVLLELLT--GRKPVDH 277
RV G AP E + G+ ++KSDV++FGV L E+LT +P +H
Sbjct: 187 -RVQG----RAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEH 236
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 3e-11
Identities = 60/221 (27%), Positives = 108/221 (48%), Gaps = 20/221 (9%)
Query: 64 KTDNFGTNSLIGEGSYGRVYFGV-LRSGR----AAAIKKLDSSKQP--DQEFLAQVSMVS 116
K F ++G G++G VY G+ + G AIK+L + P ++E L + +++
Sbjct: 5 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMA 64
Query: 117 RLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIA 176
+ N +V L+G + ++++ + G L D + K G++ +L+W
Sbjct: 65 SVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQY--LLNWC------ 115
Query: 177 VGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVL 236
V A+G+ YL E+ R++HR++ + NVL+ KI+DF L+ H+
Sbjct: 116 VQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGK 172
Query: 237 GTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVD 276
+ A E + + +SDV+S+GV + EL+T G KP D
Sbjct: 173 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 213
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 3e-11
Identities = 53/213 (24%), Positives = 96/213 (45%), Gaps = 15/213 (7%)
Query: 67 NFGTNSLIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPD----QEFLAQVSMVSRLKNE 121
NF IG G + VY L + A+KK+ + D Q+ + ++ ++ +L +
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62
Query: 122 NVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAAR 181
NV++ + +++ + E A G L ++ K K P + W K V
Sbjct: 63 NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTV-W----KYFVQLCS 117
Query: 182 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGY 241
+E++H + R++HR+IK +NV + + K+ D L HS ++GT Y
Sbjct: 118 AVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYY 172
Query: 242 HAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
+PE + KSD++S G +L E+ + P
Sbjct: 173 MSPERIHENGYNFKSDIWSLGCLLYEMAALQSP 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 4e-11
Identities = 53/212 (25%), Positives = 106/212 (50%), Gaps = 20/212 (9%)
Query: 73 LIGEGSYGRVYFGV-------LRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVE 125
++G G++G VY G+ ++ A + + ++S + ++E L + +++ + + V
Sbjct: 14 VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCR 73
Query: 126 LVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEY 185
L+G + ++ L + G L D + K G++ +L+W ++ A+G+ Y
Sbjct: 74 LLGICLTSTVQ-LVTQLMPYGCLLDYVRENKDRIGSQD--LLNWCVQI------AKGMSY 124
Query: 186 LHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245
L E R++HR++ + NVL+ + KI+DF L+ H+ + A E
Sbjct: 125 LEEV---RLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALE 181
Query: 246 YAMTGQMSSKSDVYSFGVVLLELLT-GRKPVD 276
+ + + +SDV+S+GV + EL+T G KP D
Sbjct: 182 SILHRRFTHQSDVWSYGVTVWELMTFGAKPYD 213
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 4e-11
Identities = 59/210 (28%), Positives = 95/210 (45%), Gaps = 33/210 (15%)
Query: 74 IGEGSYGRVYFGVLR-SGRAAAIKK-LDSSKQPDQEFLA--QVSMVSRLKNENVVELVGY 129
IGEGSYG V+ R +G+ AIKK ++S P + +A ++ M+ +LK+ N+V L+
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEV 68
Query: 130 YVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEK 189
+ L +E+ L+++ +GV KI + + + H+
Sbjct: 69 FRRKRKLHLVFEYCDHTVLNELEKNPRGVPEH---------LIKKIIWQTLQAVNFCHKH 119
Query: 190 AEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHS------TRVLGTFGYHA 243
IHR++K N+L+ K+ DF AR+ + T + T Y A
Sbjct: 120 ---NCIHRDVKPENILITKQGQIKLCDFGF--------ARILTGPGDDYTDYVATRWYRA 168
Query: 244 PEYAMTG--QMSSKSDVYSFGVVLLELLTG 271
PE + G Q DV++ G V ELLTG
Sbjct: 169 PEL-LVGDTQYGPPVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 6e-11
Identities = 56/208 (26%), Positives = 91/208 (43%), Gaps = 23/208 (11%)
Query: 74 IGEGSYGRVYFGVL-----RSGRAAAIKKLDSSKQPDQ--EFLAQVSMVSRLKNENVVEL 126
+GEG +G+V +G A+K L + + ++ ++ L +EN+V+
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71
Query: 127 VGYYVDGPLR--VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLE 184
G + L E GSL + L K K Q++K AV +G++
Sbjct: 72 KGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLK--------QQLKYAVQICKGMD 123
Query: 185 YLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN--QAPDAAARLHSTRVLGTFGYH 242
YL + + +HR++ + NVL+ + KI DF L+ + + F Y
Sbjct: 124 YLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWY- 179
Query: 243 APEYAMTGQMSSKSDVYSFGVVLLELLT 270
APE + + SDV+SFGV L ELLT
Sbjct: 180 APECLIQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 7e-11
Identities = 53/211 (25%), Positives = 98/211 (46%), Gaps = 17/211 (8%)
Query: 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQ---EFLAQVSMVSRLKNE 121
+ F ++GEG+YG V + + AIKK S++ ++ L ++ M+ LK E
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQE 60
Query: 122 NVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAAR 181
N+VEL + L +E+ K L + ++ G P V S+ ++ +
Sbjct: 61 NIVELKEAFRRRGKLYLVFEYVEKNMLELL---EEMPNGVPPEKVRSYIYQL------IK 111
Query: 182 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGY 241
+ + H+ I+HR+IK N+L+ +D+ K+ DF + + + + T + T Y
Sbjct: 112 AIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSE-GSNANYTEYVATRWY 167
Query: 242 HAPEYAMTGQMSSKSDVYSFGVVLLELLTGR 272
+PE + D++S G +L EL G+
Sbjct: 168 RSPELLLGAPYGKAVDMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 7e-11
Identities = 53/203 (26%), Positives = 106/203 (52%), Gaps = 22/203 (10%)
Query: 74 IGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPD-QEFLAQVSMVSRLKNENVVELV-GYY 130
+G+G++G+VY + +G AA K +D+ + + ++++ ++ +++ + N+V+L+ +Y
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72
Query: 131 VDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKA 190
+ L +L E + G++ ++ ++ +P L+ Q + L YLHE
Sbjct: 73 YENNLWILI-EFCAGGAVDAVM-----LELERP---LTEPQIRVVCKQTLEALNYLHEN- 122
Query: 191 EPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTG 250
+IIHR++K+ N+L D K++DF +S + R S +GT + APE M
Sbjct: 123 --KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS--FIGTPYWMAPEVVMCE 178
Query: 251 QMSS-----KSDVYSFGVVLLEL 268
K+DV+S G+ L+E+
Sbjct: 179 TSKDRPYDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 8e-11
Identities = 51/193 (26%), Positives = 85/193 (44%), Gaps = 19/193 (9%)
Query: 77 GSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLR 136
GS GRV F + G+ + L ++ L + ++ + + +V+ + V G +
Sbjct: 77 GSEGRV-FVATKPGQPDPVV-LKIGQKGTT--LIEAMLLQNVNHPSVIRMKDTLVSGAIT 132
Query: 137 VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIH 196
+ H L+ L + L Q + I GL YLH + RIIH
Sbjct: 133 CMVLPH-YSSDLYTYLTKRSRP--------LPIDQALIIEKQILEGLRYLHAQ---RIIH 180
Query: 197 RNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKS 256
R++K+ N+ + D D I D + Q P A + GT +APE + +SK+
Sbjct: 181 RDVKTENIFINDVDQVCIGDLGAA-QFPVVAPAFLG--LAGTVETNAPEVLARDKYNSKA 237
Query: 257 DVYSFGVVLLELL 269
D++S G+VL E+L
Sbjct: 238 DIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 8e-11
Identities = 59/218 (27%), Positives = 98/218 (44%), Gaps = 22/218 (10%)
Query: 67 NFGTNSLIGEGSYGRVYFGV-LRSGRAAAIKKLD---SSKQPDQEFLA---QVSMVSRLK 119
N+ L+G+G++GRVY + +GR A K++ S + +E A ++ ++ L+
Sbjct: 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQ 62
Query: 120 NENVVELVGYYVDGPLRVLA--YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAV 177
+E +V+ G D + L E+ GS+ D L K L+ + K
Sbjct: 63 HERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQL---------KAYGALTESVTRKYTR 113
Query: 178 GAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTR-VL 236
G+ YLH I+HR+IK +N+L K+ DF S + R V
Sbjct: 114 QILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVT 170
Query: 237 GTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
GT + +PE K+DV+S G ++E+LT + P
Sbjct: 171 GTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 8e-11
Identities = 33/91 (36%), Positives = 48/91 (52%)
Query: 186 LHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245
+H +IHR+IKS+N+LL + + K+ DF S + GT Y APE
Sbjct: 156 VHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPE 215
Query: 246 YAMTGQMSSKSDVYSFGVVLLELLTGRKPVD 276
S K+D++S GV+L ELLT ++P D
Sbjct: 216 IWRRKPYSKKADMFSLGVLLYELLTLKRPFD 246
|
Length = 496 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 8e-11
Identities = 34/95 (35%), Positives = 54/95 (56%), Gaps = 5/95 (5%)
Query: 180 ARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTF 239
A L++LH II+R++K N+LL ++ K++DF LS ++ D + +S GT
Sbjct: 108 ALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGTV 162
Query: 240 GYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
Y APE + +D +SFGV++ E+LTG P
Sbjct: 163 EYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLP 197
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 1e-10
Identities = 33/89 (37%), Positives = 51/89 (57%)
Query: 186 LHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245
L E +++HR++KS+N+ L I K+ DF S Q D+ + ++ GT Y APE
Sbjct: 182 LDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPE 241
Query: 246 YAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
+ S K+D++S GV+L ELLT +P
Sbjct: 242 LWERKRYSKKADMWSLGVILYELLTLHRP 270
|
Length = 478 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 61.2 bits (149), Expect = 1e-10
Identities = 62/215 (28%), Positives = 99/215 (46%), Gaps = 36/215 (16%)
Query: 72 SLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFL------AQVSMVSRLKNENVV 124
S +G G+YG+V +GR AIKKL +P Q + ++ ++ + +ENV+
Sbjct: 21 SPVGSGAYGQVCSAFDTKTGRKVAIKKLS---RPFQSAIHAKRTYRELRLLKHMDHENVI 77
Query: 125 ELVGYYV-DGPLR----VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGA 179
L+ + L V H L++I+ +K LS +
Sbjct: 78 GLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKCQK----------LSDDHIQFLVYQI 127
Query: 180 ARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTF 239
RGL+Y+H IIHR++K SN+ + +D KI DF L+ D T + T
Sbjct: 128 LRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFGLARHTDDEM-----TGYVATR 179
Query: 240 GYHAPEYAMTGQMS-SKS-DVYSFGVVLLELLTGR 272
Y APE M M +++ D++S G ++ ELLTG+
Sbjct: 180 WYRAPE-IMLNWMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 3e-10
Identities = 56/210 (26%), Positives = 92/210 (43%), Gaps = 21/210 (10%)
Query: 74 IGEGSYGRVYFGVLRSGRAAA---IKKLDSSKQPDQE--FLAQVSMVSRLKNENVVELVG 128
IG G +G+V G G + A +K+L +S PD++ FL +V L + NV++ +G
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62
Query: 129 YYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHE 188
++ +L E G L + L +G+ + QR +A A GL +LH+
Sbjct: 63 QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDV--LQR--MACEVASGLLWLHQ 118
Query: 189 KAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS-NQAPDAAARLHSTRVLGTFGYHAPEYA 247
IH ++ N L D KI D+ L+ Q P+ + + APE
Sbjct: 119 A---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAV-PLRWLAPELV 174
Query: 248 -------MTGQMSSKSDVYSFGVVLLELLT 270
+ + KS+++S GV + EL T
Sbjct: 175 EIRGQDLLPKDQTKKSNIWSLGVTMWELFT 204
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 4e-10
Identities = 33/92 (35%), Positives = 52/92 (56%), Gaps = 5/92 (5%)
Query: 183 LEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYH 242
L YLH+ E RI+HR++ +N++L +DD I+DF L+ Q + T V+GT Y
Sbjct: 126 LRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPES---KLTSVVGTILYS 180
Query: 243 APEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
PE K+DV++FG +L ++ T + P
Sbjct: 181 CPEIVKNEPYGEKADVWAFGCILYQMCTLQPP 212
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 5e-10
Identities = 65/233 (27%), Positives = 99/233 (42%), Gaps = 29/233 (12%)
Query: 67 NFGTNSLIGEGSYGRVYF----GVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNEN 122
NF ++G G+YG+V+ G +G+ A+K L + + A+ + R
Sbjct: 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTER----Q 56
Query: 123 VVELVGYYVDGPLRV-LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQ-----RVKIA 176
V+E V P V L Y + LH IL V G + L + V++
Sbjct: 57 VLEAVR---RCPFLVTLHYAFQTDTKLHLIL---DYVNGGELFTHLYQREHFTESEVRVY 110
Query: 177 VGA-ARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ-APDAAARLHSTR 234
+ L++LH+ II+R+IK N+LL + ++DF LS + + R +S
Sbjct: 111 IAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYS-- 165
Query: 235 VLGTFGYHAPEYAMTGQ--MSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQS 285
GT Y APE G D +S GV+ ELLTG P + QS
Sbjct: 166 FCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQS 218
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 6e-10
Identities = 61/225 (27%), Positives = 102/225 (45%), Gaps = 38/225 (16%)
Query: 63 EKTDNFGTNSLIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFL------AQVSMV 115
E + + S +G G+YG V ++G A+KKL +P Q + ++ ++
Sbjct: 14 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL---SRPFQSIIHAKRTYRELRLL 70
Query: 116 SRLKNENVVELVGYYVDGPLR-------VLAYEHASKGSLHDILHGKKGVKGAKPGPVLS 168
+K+ENV+ L+ + P R V H L++I+ +K L+
Sbjct: 71 KHMKHENVIGLLDVFT--PARSLEEFNDVYLVTHLMGADLNNIVKCQK----------LT 118
Query: 169 WAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAA 228
+ RGL+Y+H IIHR++K SN+ + +D KI DF L+ D
Sbjct: 119 DDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT 175
Query: 229 RLHSTRVLGTFGYHAPEYAMTGQMSSKS-DVYSFGVVLLELLTGR 272
+TR Y APE + +++ D++S G ++ ELLTGR
Sbjct: 176 GYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.2 bits (144), Expect = 8e-10
Identities = 61/224 (27%), Positives = 100/224 (44%), Gaps = 50/224 (22%)
Query: 72 SLIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPD--QEFLAQVSMVSRLKNENVVELVG 128
S IGEG+YG V +G AIKK+ + Q L ++ ++ R K+EN++ ++
Sbjct: 11 SYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILD 70
Query: 129 YYVDGPLRVLAYEHASKGSLHDI----------LHGKKGVKGAKPGPVLSWAQRVKIAVG 178
+R ++E S +D+ L+ K +K LS
Sbjct: 71 I-----IRPPSFE-----SFNDVYIVQELMETDLY--KLIKTQH----LSNDHIQYFLYQ 114
Query: 179 AARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHS------ 232
RGL+Y+H ++HR++K SN+LL + KI DF L AR+
Sbjct: 115 ILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGL--------ARIADPEHDHT 163
Query: 233 ---TRVLGTFGYHAPEYAMTGQMSSKS-DVYSFGVVLLELLTGR 272
T + T Y APE + + +K+ D++S G +L E+L+ R
Sbjct: 164 GFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 1e-09
Identities = 56/209 (26%), Positives = 96/209 (45%), Gaps = 22/209 (10%)
Query: 73 LIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK----QPDQEFLAQVSMVSRLKNENVVELV 127
++G+G +G V +R +G+ A KKL+ + + + L + ++ ++ + VV L
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLA 66
Query: 128 GYY--VDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEY 185
Y D VL + H G+ G + + V A GLE
Sbjct: 67 YAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRA---------VFYAAEICCGLED 117
Query: 186 LHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245
LH++ RI++R++K N+LL D +ISD L+ P+ + RV GT GY APE
Sbjct: 118 LHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPE--GQTIKGRV-GTVGYMAPE 171
Query: 246 YAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
+ + D ++ G +L E++ G+ P
Sbjct: 172 VVKNERYTFSPDWWALGCLLYEMIAGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 1e-09
Identities = 64/228 (28%), Positives = 109/228 (47%), Gaps = 35/228 (15%)
Query: 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKK--LDSSKQ--PDQEFLAQVSMVSRLKN 120
D F IGEG+YG+VY + +G A+KK LD+ K+ P + ++ ++ +L +
Sbjct: 7 DKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITA-IREIKILRQLNH 65
Query: 121 ENVVELVGYYVDGPLRV----------LAYEHASKGSLHDILHG--KKGVKGAKPGPVLS 168
N+V L D + L +E+ HD L G + G+ + S
Sbjct: 66 RNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMD----HD-LMGLLESGLVHFSEDHIKS 120
Query: 169 WAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAA 228
+ +++ GL Y H+K +HR+IK SN+LL + K++DF L+ +
Sbjct: 121 FMKQL------LEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKLADFGLARLYNSEES 171
Query: 229 RLHSTRVLGTFGYHAPEYAMTGQMSSKS-DVYSFGVVLLELLTGRKPV 275
R ++ +V+ T Y PE + + + DV+S G +L EL T +KP+
Sbjct: 172 RPYTNKVI-TLWYRPPELLLGEERYGPAIDVWSCGCILGELFT-KKPI 217
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 1e-09
Identities = 61/230 (26%), Positives = 99/230 (43%), Gaps = 40/230 (17%)
Query: 74 IGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPD--QEFLAQVSMVSRLKNENVVELVGYY 130
IG G+ G VY + R +GR A+K + + + ++ ++ ++ + + NVV+ +
Sbjct: 82 IGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMF 141
Query: 131 -VDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEK 189
+G ++VL E GSL +G + +A G+ YLH +
Sbjct: 142 DHNGEIQVL-LEFMDGGSL----------EGTH---IADEQFLADVARQILSGIAYLHRR 187
Query: 190 AEPRIIHRNIKSSNVLLFDDDIAKISDFDLS---NQAPDAAARLHSTRVLGTFGYHAPEY 246
I+HR+IK SN+L+ KI+DF +S Q D +GT Y +PE
Sbjct: 188 ---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPC-----NSSVGTIAYMSPER 239
Query: 247 AMTGQMSSK-----SDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWAT 291
T D++S GV +LE GR P G+Q WA+
Sbjct: 240 INTDLNHGAYDGYAGDIWSLGVSILEFYLGRFP----FGVGRQG--DWAS 283
|
Length = 353 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 2e-09
Identities = 63/231 (27%), Positives = 93/231 (40%), Gaps = 61/231 (26%)
Query: 74 IGEGSYGRVY---------FGVLRSGRA---------------AAIKKLDSSKQPDQEFL 109
IG G+YG VY F L+S R A +K+L++ P+ L
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67
Query: 110 AQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSW 169
V SR E V LV +VD LR + K P P L
Sbjct: 68 MDVCATSRTDRETKVTLVFEHVDQDLRT----YLDKV----------------PPPGLPA 107
Query: 170 AQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAAR 229
+ RGL++LH I+HR++K N+L+ K++DF L AR
Sbjct: 108 ETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGL--------AR 156
Query: 230 LHS-----TRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPV 275
++S T V+ T Y APE + ++ D++S G + E+ RKP+
Sbjct: 157 IYSCQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKPL 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 2e-09
Identities = 38/174 (21%), Positives = 80/174 (45%), Gaps = 24/174 (13%)
Query: 111 QVSMVSRLKNENVVELVGYYVDG----PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPV 166
++ + R+ + N++++ G+ +D P L E+ ++G L ++L +K
Sbjct: 68 EIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKEKD--------- 118
Query: 167 LSWAQRVKIAVGAARGLEYLHEK-AEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPD 225
LS+ ++ +A+ +GL L++ +P ++N+ S + L+ ++ KI L
Sbjct: 119 LSFKTKLDMAIDCCKGLYNLYKYTNKP---YKNLTSVSFLVTENYKLKIICHGLEKILSS 175
Query: 226 AAARLHSTRVLGTFGYHAPEYAMT--GQMSSKSDVYSFGVVLLELLTGRKPVDH 277
V Y + + + + K D+YS GVVL E+ TG+ P ++
Sbjct: 176 PP----FKNV-NFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFEN 224
|
Length = 283 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 2e-09
Identities = 56/217 (25%), Positives = 98/217 (45%), Gaps = 46/217 (21%)
Query: 74 IGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLA--QVSMVSRLKNENVVELVGYY 130
+GEGSY VY G+ R +G+ A+K + + F A + S++ LK+ N+V
Sbjct: 13 LGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIV------ 66
Query: 131 VDGPLRVLAYEHASKGSLHDILHGKKGVK--------------GAKPGPVLSWAQRVKIA 176
LHDI+H K+ + PG + + R+
Sbjct: 67 ----------------LLHDIIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRL-FM 109
Query: 177 VGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVL 236
RGL Y+H + I+HR++K N+L+ K++DF L+ +A ++ +S+ V+
Sbjct: 110 FQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLA-RAKSIPSQTYSSEVV 165
Query: 237 GTFGYHAPEYAM-TGQMSSKSDVYSFGVVLLELLTGR 272
T Y P+ + SS D++ G + +E+L G+
Sbjct: 166 -TLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQ 201
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 2e-09
Identities = 33/93 (35%), Positives = 53/93 (56%), Gaps = 5/93 (5%)
Query: 182 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGY 241
GL++LH K I++R++K N+LL D KI+DF + + A+ + GT Y
Sbjct: 108 GLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAK--TCTFCGTPDY 162
Query: 242 HAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
APE + + ++ D +SFGV+L E+L G+ P
Sbjct: 163 IAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 2e-09
Identities = 72/274 (26%), Positives = 117/274 (42%), Gaps = 56/274 (20%)
Query: 74 IGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPD---QEFLAQVSMVSRLKNENVVELVGY 129
+G G+YG V + R+G AIKKL Q + + ++ ++ +K+ENV+ L+
Sbjct: 23 VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDV 82
Query: 130 YV-DGPLR-------VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAV-GAA 180
+ D L V+ + G L + H K R++ V
Sbjct: 83 FTPDLSLDRFHDFYLVMPFMGTDLGKL--MKHEKLS------------EDRIQFLVYQML 128
Query: 181 RGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFG 240
+GL+Y+H IIHR++K N+ + +D KI DF L+ Q TR
Sbjct: 129 KGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMTGYVVTR-----W 180
Query: 241 YHAPEYAMTGQMSSKS-DVYSFGVVLLELLTGR---KPVDHTLPRGQQSLVTWATP---- 292
Y APE + +++ D++S G ++ E+LTG+ K DH L + + + TP
Sbjct: 181 YRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDH-LDQLMEIMKVTGTPSKEF 239
Query: 293 --KLSEDKVKQCVDTKLGGEYPPKAIAKVRKKKF 324
KL + K V K + + RKK F
Sbjct: 240 VQKLQSEDAKNYV----------KKLPRFRKKDF 263
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 2e-09
Identities = 33/93 (35%), Positives = 52/93 (55%), Gaps = 5/93 (5%)
Query: 182 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGY 241
GLE+LH++ RII+R++K NVLL +D +ISD L+ + D ++ + GT G+
Sbjct: 109 GLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK--TKGYAGTPGF 163
Query: 242 HAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
APE + D ++ GV L E++ R P
Sbjct: 164 MAPELLQGEEYDFSVDYFALGVTLYEMIAARGP 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 3e-09
Identities = 62/252 (24%), Positives = 96/252 (38%), Gaps = 58/252 (23%)
Query: 73 LIGEGSYGRVYFGV-LRSGRAAAIKKL--DSSKQP--DQEFLAQVSMVSRLKNENVV--- 124
LIG+G G VY R A+KK+ D S+ P + FL + + + L + +V
Sbjct: 9 LIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVY 68
Query: 125 ------ELVGY---YVDG-PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVK 174
+ V Y Y++G L+ L K SL L K V
Sbjct: 69 SICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLS----------- 117
Query: 175 IAVGAARGLEYLHEKAEPRIIHRNIKSSNVLL--------FDDDIAKI----SDFDLSNQ 222
I +EY+H K ++HR++K N+LL D A + L
Sbjct: 118 IFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDID 174
Query: 223 APDAAARLHST----RVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-------- 270
+ S +++GT Y APE + S +D+Y+ GV+L ++LT
Sbjct: 175 VDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRK 234
Query: 271 -GRK-PVDHTLP 280
GRK +
Sbjct: 235 KGRKISYRDVIL 246
|
Length = 932 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 3e-09
Identities = 56/214 (26%), Positives = 103/214 (48%), Gaps = 22/214 (10%)
Query: 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLA--QVSMVSRLKN 120
K D++ +GEGSY VY G + +G+ A+K + ++ F A + S++ LK+
Sbjct: 3 KADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKH 62
Query: 121 ENVVEL--VGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVG 178
N+V L + + + V Y H D K G P V + ++
Sbjct: 63 ANIVLLHDIIHTKETLTLVFEYVHTDLCQYMD-----KHPGGLHPENVKLFLFQL----- 112
Query: 179 AARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGT 238
RGL Y+H++ I+HR++K N+L+ D K++DF L+ +A + +S V+ T
Sbjct: 113 -LRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLA-RAKSVPSHTYSNEVV-T 166
Query: 239 FGYHAPEYAM-TGQMSSKSDVYSFGVVLLELLTG 271
Y P+ + + + S+ D++ G + +E++ G
Sbjct: 167 LWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 3e-09
Identities = 34/98 (34%), Positives = 55/98 (56%), Gaps = 17/98 (17%)
Query: 180 ARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN---QAPD----AAARLHS 232
ARG+E+L A + IHR++ + N+LL ++++ KI DF L+ + PD ARL
Sbjct: 183 ARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL-- 237
Query: 233 TRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT 270
+ APE +++SDV+SFGV+L E+ +
Sbjct: 238 -----PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 3e-09
Identities = 55/212 (25%), Positives = 98/212 (46%), Gaps = 20/212 (9%)
Query: 67 NFGTNSLIGEGSYGRVYFGV-LRSGRAAAIKKL----DSSKQPDQEFLAQVSMVSRLKNE 121
NF IGEG+YG VY +G A+KK+ ++ P + ++S++ L +
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTA-IREISLLKELNHP 59
Query: 122 NVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAAR 181
N+V+L+ L +E LH L KK + + + +
Sbjct: 60 NIVKLLDVIHTENKLYLVFEF-----LHQDL--KKFMDASPLSG-IPLPLIKSYLFQLLQ 111
Query: 182 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGY 241
GL + H R++HR++K N+L+ + K++DF L+ +A R ++ V+ T Y
Sbjct: 112 GLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA-RAFGVPVRTYTHEVV-TLWY 166
Query: 242 HAPEYAMTGQM-SSKSDVYSFGVVLLELLTGR 272
APE + + S+ D++S G + E++T R
Sbjct: 167 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 3e-09
Identities = 36/99 (36%), Positives = 58/99 (58%), Gaps = 10/99 (10%)
Query: 180 ARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN---QAPDAAARLHSTRVL 236
ARG+E+L A + IHR++ + N+LL ++++ KI DF L+ + PD R S R+
Sbjct: 184 ARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPD-YVRKGSARL- 238
Query: 237 GTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 274
+ APE +++SDV+SFGV+L E+ + G P
Sbjct: 239 -PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASP 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 3e-09
Identities = 54/207 (26%), Positives = 98/207 (47%), Gaps = 28/207 (13%)
Query: 74 IGEGSYGRVYFGVLRSGRAAAIKKLDSSKQ-------PDQEFLAQV--SMVSRLKNENVV 124
+G+GS+G VY +++ +A A ++L K+ P++ A ++S+L + +V
Sbjct: 8 LGKGSFGTVY--LVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIV 65
Query: 125 ELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLE 184
+ +++ + E+ L L K G LS Q + + G+
Sbjct: 66 KFHASFLERDAFCIITEYCEGRDLDCKLEELK-----HTGKTLSENQVCEWFIQLLLGVH 120
Query: 185 YLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN---QAPDAAARLHSTRVLGTFGY 241
Y+H++ RI+HR++K+ N+ L +++ KI DF +S + D A T GT Y
Sbjct: 121 YMHQR---RILHRDLKAKNIFL-KNNLLKIGDFGVSRLLMGSCDLA-----TTFTGTPYY 171
Query: 242 HAPEYAMTGQMSSKSDVYSFGVVLLEL 268
+PE SKSD++S G +L E+
Sbjct: 172 MSPEALKHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 4e-09
Identities = 58/232 (25%), Positives = 94/232 (40%), Gaps = 62/232 (26%)
Query: 74 IGEGSYGRVY----------FGVLRSGRA---------------AAIKKLDSSKQPDQEF 108
IGEG+YG+V+ F L+ R A ++ L++ + P+
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68
Query: 109 LAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLS 168
L V VSR E + LV +VD L + P P +
Sbjct: 69 LFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDK--------------------VPEPGVP 108
Query: 169 WAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAA 228
+ RGL++LH R++HR++K N+L+ K++DF L A
Sbjct: 109 TETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGL--------A 157
Query: 229 RLHS-----TRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPV 275
R++S T V+ T Y APE + ++ D++S G + E+ RKP+
Sbjct: 158 RIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKPL 208
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 4e-09
Identities = 55/216 (25%), Positives = 93/216 (43%), Gaps = 23/216 (10%)
Query: 74 IGEGSYGRVYFGVLRSGRA---AAIKKLD---SSKQPDQEFLAQVSMVSRLKNENVVELV 127
+GEG +G V G L + A+K + ++ ++FL++ + + NV+ L+
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 128 GYYVDG------PLRVLAYEHASKGSLHD-ILHGKKGVKGAKPGPVLSWAQR-VKIAVGA 179
G + P V+ G LH +L+ + G P Q VK
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLG-----DCPQYLPTQMLVKFMTDI 121
Query: 180 ARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTF 239
A G+EYL K IHR++ + N +L ++ ++DF LS + +
Sbjct: 122 ASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPV 178
Query: 240 GYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 274
+ A E ++KSDV+SFGV + E+ T G+ P
Sbjct: 179 KWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTP 214
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 5e-09
Identities = 65/222 (29%), Positives = 98/222 (44%), Gaps = 29/222 (13%)
Query: 67 NFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVV-- 124
NF ++G G+YG+V+ SG DS K + L + ++V + K
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGH-------DSGKLYAMKVLKKATIVQKAKTTEHTRT 53
Query: 125 --ELVGYYVDGPLRV-LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQR-----VKIA 176
+++ + P V L Y + LH IL + G + LS +R V+I
Sbjct: 54 ERQVLEHIRQSPFLVTLHYAFQTDTKLHLIL---DYINGGELFTHLSQRERFKEQEVQIY 110
Query: 177 VGA-ARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ-APDAAARLHSTR 234
G LE+LH+ II+R+IK N+LL + ++DF LS + D R +S
Sbjct: 111 SGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYS-- 165
Query: 235 VLGTFGYHAPEYAMTGQMSSKS--DVYSFGVVLLELLTGRKP 274
GT Y AP+ G D +S GV++ ELLTG P
Sbjct: 166 FCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 56.5 bits (137), Expect = 5e-09
Identities = 57/209 (27%), Positives = 98/209 (46%), Gaps = 33/209 (15%)
Query: 74 IGEGSYGRVYFG-VLRSGRAAAIKKL----DSSKQPDQEFLAQVSMVSRLK-NENVVELV 127
IGEG++ V ++G+ AIK + S +Q + L ++ + RL + N++ L+
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNN--LREIQALRRLSPHPNILRLI 64
Query: 128 GYYVDGPLRVLAYE-HASKGSLHDILHGKKGVKGAKPGP---VLSWA-QRVKIAVGAARG 182
D LA +L++++ G+K +P P V S+ Q +K
Sbjct: 65 EVLFDRKTGRLALVFELMDMNLYELIKGRK-----RPLPEKRVKSYMYQLLK-------S 112
Query: 183 LEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYH 242
L+++H I HR+IK N+L+ DDI K++DF ++ T + T Y
Sbjct: 113 LDHMHRNG---IFHRDIKPENILI-KDDILKLADF---GSCRGIYSKPPYTEYISTRWYR 165
Query: 243 APEYAMT-GQMSSKSDVYSFGVVLLELLT 270
APE +T G K D+++ G V E+L+
Sbjct: 166 APECLLTDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 7e-09
Identities = 63/218 (28%), Positives = 99/218 (45%), Gaps = 39/218 (17%)
Query: 73 LIGEGSYGRVYFGVLR--SGRAAAIKKLDSS----KQPDQEFLAQVSMVSRLKNENVVEL 126
+IG G +G VY G + +G+ A+K LD KQ + L + M+S + + +
Sbjct: 1 IIGRGGFGEVY-GCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 59
Query: 127 V--GYYVDGPLRV-LAYEHASKGSLHDIL--HGKKGVKGAKPGPVLSWAQRVKIAVGAAR 181
V Y P ++ + + G LH L HG V S A+ A
Sbjct: 60 VCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHG-----------VFSEAEMRFYAAEIIL 108
Query: 182 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDF----DLSNQAPDAAARLHSTRVLG 237
GLE++H + +++R++K +N+LL + +ISD D S + P A+ +G
Sbjct: 109 GLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS--------VG 157
Query: 238 TFGYHAPEYAMTG-QMSSKSDVYSFGVVLLELLTGRKP 274
T GY APE G S +D +S G +L +LL G P
Sbjct: 158 THGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 7e-09
Identities = 54/217 (24%), Positives = 102/217 (47%), Gaps = 46/217 (21%)
Query: 74 IGEGSYGRVYFGVLR-SGRAAAIK--KLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYY 130
+GEG+Y V+ G + + A+K +L+ + + +VS++ LK+ N+V
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIV------ 66
Query: 131 VDGPLRVLAYEHASKGSLHDILHGKKGVKGA-------------KPGPVLSWAQRVKIAV 177
+LHDI+H ++ + G ++S VKI +
Sbjct: 67 ----------------TLHDIIHTERCLTLVFEYLDSDLKQYLDNCGNLMS-MHNVKIFM 109
Query: 178 -GAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVL 236
RGL Y H++ +I+HR++K N+L+ + K++DF L+ +A + +S V+
Sbjct: 110 FQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLA-RAKSVPTKTYSNEVV 165
Query: 237 GTFGYHAPEYAM-TGQMSSKSDVYSFGVVLLELLTGR 272
T Y P+ + + + S+ D++ G +L E+ TGR
Sbjct: 166 -TLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 55.8 bits (135), Expect = 8e-09
Identities = 33/102 (32%), Positives = 54/102 (52%), Gaps = 7/102 (6%)
Query: 176 AVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRV 235
A GL++LHE+ II+R++K NVLL + KI+DF + + ++
Sbjct: 102 AAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVT--TSTF 156
Query: 236 LGTFGYHAPEYAMTGQMSSKS-DVYSFGVVLLELLTGRKPVD 276
GT Y APE ++ Q + D ++ GV+L E+L G+ P +
Sbjct: 157 CGTPDYIAPE-ILSYQPYGPAVDWWALGVLLYEMLAGQSPFE 197
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 9e-09
Identities = 34/93 (36%), Positives = 51/93 (54%), Gaps = 5/93 (5%)
Query: 182 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGY 241
GL++LH K II+R++K NV+L D KI+DF + + R ++ GT Y
Sbjct: 108 GLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNR--ASTFCGTPDY 162
Query: 242 HAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
APE + + D +SFGV+L E+L G+ P
Sbjct: 163 IAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.4 bits (134), Expect = 1e-08
Identities = 54/209 (25%), Positives = 98/209 (46%), Gaps = 25/209 (11%)
Query: 74 IGEGSYGRVYFGV-LRSGRAAAIKK--LDSSKQ--PDQEFLAQVSMVSRLKNENVVELVG 128
IGEG+YG VY +G A+KK L++ + P + ++S++ L + N+V L+
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTA-IREISLLKELNHPNIVRLLD 65
Query: 129 YYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRV--KIAVGAARGLEYL 186
L +E D+ KK + + P+ + +G+ Y
Sbjct: 66 VVHSENKLYLVFEFLD----LDL---KKYMDSS---PLTGLDPPLIKSYLYQLLQGIAYC 115
Query: 187 HEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEY 246
H R++HR++K N+L+ + K++DF L+ +A R ++ V+ T Y APE
Sbjct: 116 HSH---RVLHRDLKPQNLLIDREGALKLADFGLA-RAFGVPVRTYTHEVV-TLWYRAPEI 170
Query: 247 AMTG-QMSSKSDVYSFGVVLLELLTGRKP 274
+ Q S+ D++S G + E++ R+P
Sbjct: 171 LLGSRQYSTPVDIWSIGCIFAEMVN-RRP 198
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 1e-08
Identities = 38/101 (37%), Positives = 55/101 (54%), Gaps = 13/101 (12%)
Query: 181 RGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS-----NQAPDAAARLHSTRV 235
GL+Y+H ++HR++K N+L+ D KI DF L+ N +A T
Sbjct: 116 CGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAG---FMTEY 169
Query: 236 LGTFGYHAPEYAMTGQMSSKS-DVYSFGVVLLELLTGRKPV 275
+ T Y APE ++ Q +K+ DV+S G +L ELL GRKPV
Sbjct: 170 VATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELL-GRKPV 209
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 1e-08
Identities = 62/218 (28%), Positives = 98/218 (44%), Gaps = 39/218 (17%)
Query: 73 LIGEGSYGRVYFGVLR--SGRAAAIKKLDSS----KQPDQEFLAQVSMVSRLKNENVVEL 126
+IG G +G VY G + +G+ A+K LD KQ + L + M+S + + +
Sbjct: 1 IIGRGGFGEVY-GCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 59
Query: 127 V--GYYVDGPLRV-LAYEHASKGSLHDIL--HGKKGVKGAKPGPVLSWAQRVKIAVGAAR 181
V Y P ++ + + G LH L HG V S + A
Sbjct: 60 VCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHG-----------VFSEKEMRFYATEIIL 108
Query: 182 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDF----DLSNQAPDAAARLHSTRVLG 237
GLE++H + +++R++K +N+LL + +ISD D S + P A+ +G
Sbjct: 109 GLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS--------VG 157
Query: 238 TFGYHAPEYAMTGQM-SSKSDVYSFGVVLLELLTGRKP 274
T GY APE G S +D +S G +L +LL G P
Sbjct: 158 THGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 1e-08
Identities = 45/153 (29%), Positives = 70/153 (45%), Gaps = 33/153 (21%)
Query: 181 RGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN-QAPDAAARLHSTRVLGTF 239
RGL+Y+H ++HR++K SN+L+ ++ KI DF L+ Q P T + T
Sbjct: 119 RGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARIQDP------QMTGYVSTR 169
Query: 240 GYHAPEYAMTGQ-MSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDK 298
Y APE +T Q + D++S G + E+L G KP+ P +D
Sbjct: 170 YYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEG-KPL---FP--------------GKDH 211
Query: 299 VKQ-CVDTKLGGEYPPKAIAKVRKK---KFITS 327
V Q + T L G P I + + +F+ S
Sbjct: 212 VNQFSIITDLLGTPPDDVINTICSENTLRFVQS 244
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 2e-08
Identities = 59/216 (27%), Positives = 96/216 (44%), Gaps = 38/216 (17%)
Query: 74 IGEGSYGRV-YFGVLRSGRAAAIKKLDSS--KQPDQEFLAQVSMVSRLKNENVVELVGYY 130
+G+G +G V V +G+ A KKLD K+ E +A L + ++E V
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMA-------LLEKEILEKV--- 50
Query: 131 VDGPLRV-LAYEHASKGSL---HDILHGKK--------GVKGAKPGPVLSWAQRVKIAVG 178
+ P V LAY SK L +++G G +G + V+ ++ ++
Sbjct: 51 -NSPFIVNLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQI----- 104
Query: 179 AARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGT 238
G+ +LH I++R++K NVLL D ++SD L+ + D T+ GT
Sbjct: 105 -TCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT---ITQRAGT 157
Query: 239 FGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
GY APE S D ++ G + E++ GR P
Sbjct: 158 NGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 2e-08
Identities = 53/215 (24%), Positives = 91/215 (42%), Gaps = 38/215 (17%)
Query: 74 IGEGSYGRVYFGVLRSGRAAAI-----------KKLDSSKQPDQEFLAQVSMVSRLKNEN 122
+G+G++ +Y GVLR I K L S + F S++S+L +++
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 123 VVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARG 182
+V+L G V ++ E+ G L LH +K L W ++ +A A
Sbjct: 63 LVKLYGVCVRDE-NIMVEEYVKFGPLDVFLHREKN------NVSLHW--KLDVAKQLASA 113
Query: 183 LEYLHEKAEPRIIHRNIKSSNVLLFDDDI-------AKISDFDLSNQAPDAAARLHSTRV 235
L YL +K +++H N+ N+L+ + K+SD + R+
Sbjct: 114 LHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVERIPW 170
Query: 236 LGTFGYHAPEYAMTGQ--MSSKSDVYSFGVVLLEL 268
+ APE GQ ++ +D +SFG LLE+
Sbjct: 171 I------APECIRNGQASLTIAADKWSFGTTLLEI 199
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 3e-08
Identities = 53/214 (24%), Positives = 95/214 (44%), Gaps = 22/214 (10%)
Query: 68 FGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK----QPDQEFLAQVSMVSRLKNEN 122
F ++G+G +G V +R +G+ A K+L+ + + + L + ++ ++ ++
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61
Query: 123 VVELVGYY--VDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAA 180
VV L Y D VL + H G G + + L +A +
Sbjct: 62 VVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEER---ALFYAAEILC----- 113
Query: 181 RGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFG 240
GLE LH + ++R++K N+LL D +ISD L+ + P+ RV GT G
Sbjct: 114 -GLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPE--GESIRGRV-GTVG 166
Query: 241 YHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
Y APE + + D + G ++ E++ G+ P
Sbjct: 167 YMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 3e-08
Identities = 37/94 (39%), Positives = 57/94 (60%), Gaps = 7/94 (7%)
Query: 182 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGY 241
GL++LH+K II+R++K NVLL D KI+DF + + + + ++ GT Y
Sbjct: 108 GLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGK--ASTFCGTPDY 162
Query: 242 HAPEYAMTGQMSSKS-DVYSFGVVLLELLTGRKP 274
APE + GQ ++S D +SFGV+L E+L G+ P
Sbjct: 163 IAPE-ILKGQKYNESVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 3e-08
Identities = 60/218 (27%), Positives = 91/218 (41%), Gaps = 26/218 (11%)
Query: 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSS-----KQPDQEFLAQVSMVSR 117
K +F +G GS+GRV + +G AIK L KQ Q + S++
Sbjct: 16 KLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQV-QHVAQEKSILME 74
Query: 118 LKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLS-WAQRVKIA 176
L + +V ++ + D E G L H +K G P V + + +A
Sbjct: 75 LSHPFIVNMMCSFQDENRVYFLLEFVVGGEL--FTHLRKA--GRFPNDVAKFYHAELVLA 130
Query: 177 VGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVL 236
EYLH K II+R++K N+LL + K++DF + + PD L
Sbjct: 131 ------FEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTFTL-----C 176
Query: 237 GTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
GT Y APE + D ++ GV+L E + G P
Sbjct: 177 GTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPP 214
|
Length = 329 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 4e-08
Identities = 58/215 (26%), Positives = 96/215 (44%), Gaps = 39/215 (18%)
Query: 73 LIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLA-----QVSMVSRLKNENVVEL 126
+G G+YG V + R+G AIKKL Q E A +++++ +++ENV+ L
Sbjct: 22 QVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQ--SEIFAKRAYRELTLLKHMQHENVIGL 79
Query: 127 VGYYVDGPL--------RVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVG 178
+ + V+ Y L I+ G LS + +
Sbjct: 80 LDVFTSAVSGDEFQDFYLVMPYMQTD---LQKIM-----------GHPLSEDKVQYLVYQ 125
Query: 179 AARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGT 238
GL+Y+H IIHR++K N+ + +D KI DF L+ A DA T + T
Sbjct: 126 MLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLARHA-DA----EMTGYVVT 177
Query: 239 FGYHAPEYAMTGQMSSKS-DVYSFGVVLLELLTGR 272
Y APE + +++ D++S G ++ E+LTG+
Sbjct: 178 RWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 4e-08
Identities = 35/99 (35%), Positives = 48/99 (48%), Gaps = 9/99 (9%)
Query: 180 ARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDL--SNQAPDAAARLHSTRVLG 237
A GL +LH K II+R++K NV+L + KI+DF + N R G
Sbjct: 111 AIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTR----TFCG 163
Query: 238 TFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVD 276
T Y APE D ++FGV+L E+L G+ P D
Sbjct: 164 TPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 4e-08
Identities = 34/93 (36%), Positives = 52/93 (55%), Gaps = 9/93 (9%)
Query: 181 RGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFG 240
RGL+Y+H IIHR++K SNV + +D +I DF L+ QA D +TR
Sbjct: 129 RGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTGYVATR-----W 180
Query: 241 YHAPEYAMTGQMSSKS-DVYSFGVVLLELLTGR 272
Y APE + +++ D++S G ++ ELL G+
Sbjct: 181 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 5e-08
Identities = 32/93 (34%), Positives = 50/93 (53%), Gaps = 6/93 (6%)
Query: 182 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGY 241
GLE LH + RI++R++K N+LL D +ISD L+ + P+ RV GT GY
Sbjct: 114 GLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPE--GETIRGRV-GTVGY 167
Query: 242 HAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
APE + + D + G ++ E++ G+ P
Sbjct: 168 MAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 53.0 bits (128), Expect = 5e-08
Identities = 54/207 (26%), Positives = 85/207 (41%), Gaps = 22/207 (10%)
Query: 74 IGEGSYGRVYF-GVLRSGRAAAIKKLDSS-----KQPDQEFLAQVSMVSRLKNENVVELV 127
+G G +GRV V R A+K + Q + F + ++ + +V+L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEK-EILEECNHPFIVKLY 59
Query: 128 GYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLH 187
+ D + E+ G L IL + G + R IA EYLH
Sbjct: 60 RTFKDKKYIYMLMEYCLGGELWTILRDR--------GLFDEYTARFYIA-CVVLAFEYLH 110
Query: 188 EKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYA 247
+ II+R++K N+LL + K+ DF + + + + GT Y APE
Sbjct: 111 NRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ-KTWT--FCGTPEYVAPEII 164
Query: 248 MTGQMSSKSDVYSFGVVLLELLTGRKP 274
+ D +S G++L ELLTGR P
Sbjct: 165 LNKGYDFSVDYWSLGILLYELLTGRPP 191
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 5e-08
Identities = 68/241 (28%), Positives = 104/241 (43%), Gaps = 40/241 (16%)
Query: 67 NFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNE----- 121
NF ++G G+YG+V+ +G D+ K + L + ++V + K
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGH-------DTGKLYAMKVLQKAALVQKAKTVEHTRT 53
Query: 122 --NVVELVGYYVDGPLRV-LAYEHASKGSLHDILHGKKGVKGAKPGPVLS-WAQR----- 172
NV+E V P V L Y ++ LH IL G G + + QR
Sbjct: 54 ERNVLEHVR---QSPFLVTLHYAFQTEAKLHLILDYVSG------GEMFTHLYQRDNFSE 104
Query: 173 --VKIAVGAA-RGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ-APDAAA 228
V+ G LE+LH+ I++R+IK N+LL + ++DF LS + +
Sbjct: 105 DEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKE 161
Query: 229 RLHSTRVLGTFGYHAPEYAMTGQMSSKS-DVYSFGVVLLELLTGRKPVDHTLPRGQQSLV 287
R +S GT Y APE K+ D +S G+++ ELLTG P R QS V
Sbjct: 162 RTYS--FCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEV 219
Query: 288 T 288
+
Sbjct: 220 S 220
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 6e-08
Identities = 60/227 (26%), Positives = 95/227 (41%), Gaps = 35/227 (15%)
Query: 60 ELKEKTDNFGTNSLIGEGSYGRVYFGVLRSGR--AAAIKKLDSSK-----QPDQEFLAQV 112
+ K K ++F +G GS+GRV ++ AIK+ + SK Q D F ++
Sbjct: 24 KNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVF-SER 82
Query: 113 SMVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSW--A 170
+++ + + V L G + D L E G L K P V + A
Sbjct: 83 KILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRF----PNDVGCFYAA 138
Query: 171 QRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARL 230
Q V I EYL I++R++K N+LL D K++DF A++
Sbjct: 139 QIVLI-------FEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGF--------AKV 180
Query: 231 HSTR---VLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
TR + GT Y APE + +D ++ G+ + E+L G P
Sbjct: 181 VDTRTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPP 227
|
Length = 340 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 7e-08
Identities = 59/245 (24%), Positives = 117/245 (47%), Gaps = 21/245 (8%)
Query: 74 IGEGSYGRVYFGV-LRSGRAAAIKKLD-SSKQPDQEFLAQVSMVSRLKNENVVELVGYYV 131
+G GS G V+ V + A+KK+ + Q + L ++ ++ RL ++N+V++ Y V
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKV--YEV 70
Query: 132 DGPL-RVLAYEHASKGSLHDILHGKKGV-----KGAKPGPVLSWAQRVKIAVGAARGLEY 185
GP L + S L+ + ++ + + GP+ R+ RGL+Y
Sbjct: 71 LGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARL-FMYQLLRGLKY 129
Query: 186 LHEKAEPRIIHRNIKSSNVLLFDDDIA-KISDFDLSN-QAPDAAARLHSTRVLGTFGYHA 243
+H ++HR++K +NV + +D+ KI DF L+ P + + + + L T Y +
Sbjct: 130 IHSA---NVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRS 186
Query: 244 PEYAMTGQMSSKS-DVYSFGVVLLELLTGRK--PVDHTLPRGQQSLVTWATPKLSEDKVK 300
P ++ +K+ D+++ G + E+LTG+ H L Q L+ + P + E+
Sbjct: 187 PRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELE--QMQLILESVPVVREEDRN 244
Query: 301 QCVDT 305
+ ++
Sbjct: 245 ELLNV 249
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 7e-08
Identities = 54/221 (24%), Positives = 97/221 (43%), Gaps = 20/221 (9%)
Query: 68 FGTNSLIGEGSYGRVYFGVLR----SGRAAAIKKLDS---SKQPDQEFLAQVSMVSRLKN 120
F ++G+G +G V L+ S + A+K L + S +EFL + + + +
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60
Query: 121 ENVVELVGYYVDG------PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVK 174
NV++L+G + P+ ++ G LH L + G +P L V+
Sbjct: 61 PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSR--IGEEPF-TLPLQTLVR 117
Query: 175 IAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTR 234
+ A G+EYL K IHR++ + N +L ++ ++DF LS +
Sbjct: 118 FMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCA 174
Query: 235 VLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 274
+ A E ++ SDV++FGV + E++T G+ P
Sbjct: 175 SKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTP 215
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 7e-08
Identities = 54/217 (24%), Positives = 102/217 (47%), Gaps = 46/217 (21%)
Query: 74 IGEGSYGRVYFGVLR-SGRAAAIK--KLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYY 130
+GEG+Y V+ G + + A+K +L+ + + +VS++ LK+ N+V
Sbjct: 14 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIV------ 67
Query: 131 VDGPLRVLAYEHASKGSLHDILHGKKGV--------KGAKP-----GPVLSWAQRVKIAV 177
+LHDI+H K + K K G ++S VKI +
Sbjct: 68 ----------------TLHDIVHTDKSLTLVFEYLDKDLKQYMDDCGNIMS-MHNVKIFL 110
Query: 178 -GAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVL 236
RGL Y H + +++HR++K N+L+ + K++DF L+ +A + +S V+
Sbjct: 111 YQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLA-RAKSVPTKTYSNEVV 166
Query: 237 GTFGYHAPEYAM-TGQMSSKSDVYSFGVVLLELLTGR 272
T Y P+ + + + S++ D++ G + E+ +GR
Sbjct: 167 -TLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 8e-08
Identities = 31/106 (29%), Positives = 52/106 (49%), Gaps = 3/106 (2%)
Query: 165 PVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAP 224
P LS+ V + A G+E+L K +HR++ + NVL+ + + KI DF L+
Sbjct: 234 PALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAARNVLICEGKLVKICDFGLARDIM 290
Query: 225 DAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT 270
+ + + APE ++ SDV+SFG++L E+ T
Sbjct: 291 RDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 53.1 bits (128), Expect = 8e-08
Identities = 34/96 (35%), Positives = 52/96 (54%), Gaps = 7/96 (7%)
Query: 181 RGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFG 240
RGL+Y+H ++HR++K SN+LL + KI DF L+ + + T + T
Sbjct: 119 RGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFM--TEYVVTRW 173
Query: 241 YHAPEYAMTGQMSSKS-DVYSFGVVLLELLTGRKPV 275
Y APE + + + DV+S G + ELL GRKP+
Sbjct: 174 YRAPELLLNCSEYTTAIDVWSVGCIFAELL-GRKPL 208
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 9e-08
Identities = 52/216 (24%), Positives = 97/216 (44%), Gaps = 44/216 (20%)
Query: 74 IGEGSYGRVYFGVLR-SGRAAAIK--KLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYY 130
+GEG+Y VY G + + A+K +L+ + + +VS++ LK+ N+V
Sbjct: 14 LGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIV------ 67
Query: 131 VDGPLRVLAYEHASKGSLHDILHGKKGV--------KGAKP-----GPVLSWAQRVKIAV 177
+LHDI+H +K + K K G ++
Sbjct: 68 ----------------TLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNSINMHNVKLFLF 111
Query: 178 GAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLG 237
RGL Y H + +++HR++K N+L+ + K++DF L+ +A + +S V+
Sbjct: 112 QLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLA-RAKSIPTKTYSNEVV- 166
Query: 238 TFGYHAPEYAM-TGQMSSKSDVYSFGVVLLELLTGR 272
T Y P+ + + S++ D++ G + E+ TGR
Sbjct: 167 TLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 9e-08
Identities = 35/103 (33%), Positives = 56/103 (54%), Gaps = 18/103 (17%)
Query: 180 ARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN---QAPD----AAARLHS 232
A+G+E+L A + IHR++ + N+LL ++++ KI DF L+ + PD ARL
Sbjct: 189 AKGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL-- 243
Query: 233 TRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 274
+ APE + +SDV+SFGV+L E+ + G P
Sbjct: 244 -----PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 281
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.4 bits (126), Expect = 9e-08
Identities = 55/221 (24%), Positives = 101/221 (45%), Gaps = 54/221 (24%)
Query: 74 IGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLA--QVSMVSRLKNENVVELVGYY 130
+GEGSY VY G + +G+ A+K++ + F A + S++ LK+ N+V
Sbjct: 13 LGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIV------ 66
Query: 131 VDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQR-----------------V 173
+LHDI+H KK + V + V
Sbjct: 67 ----------------TLHDIIHTKKTLT-----LVFEYLDTDLKQYMDDCGGGLSMHNV 105
Query: 174 KIAV-GAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHS 232
++ + RGL Y H++ R++HR++K N+L+ + K++DF L+ +A ++ +S
Sbjct: 106 RLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLA-RAKSVPSKTYS 161
Query: 233 TRVLGTFGYHAPEYAM-TGQMSSKSDVYSFGVVLLELLTGR 272
V+ T Y P+ + + + S+ D++ G + E+ TGR
Sbjct: 162 NEVV-TLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.3 bits (126), Expect = 1e-07
Identities = 60/241 (24%), Positives = 98/241 (40%), Gaps = 56/241 (23%)
Query: 73 LIGEGSYGRVYFGVLR-SGRAAAIKKLD-SSKQPDQEF---LAQVSMVSRLKNENVVELV 127
L+G+G GRV+ L+ +G+ A+K LD + L + +++ L + + L
Sbjct: 8 LLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLY 67
Query: 128 GYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLS------WAQRVKIAVGAAR 181
+ L ++ G L +L +PG LS +A V +A
Sbjct: 68 ASFQTETYLCLVMDYCPGGELFRLLQ-------RQPGKCLSEEVARFYAAEVLLA----- 115
Query: 182 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQA-----------------P 224
LEYLH I++R++K N+LL + +SDFDLS Q+
Sbjct: 116 -LEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRS 171
Query: 225 DAAARLHSTRV----------LGTFGYHAPEYAMTGQ-MSSKSDVYSFGVVLLELLTGRK 273
+ T +GT Y APE ++G S D ++ G++L E+L G
Sbjct: 172 SVNSIPSETFSEEPSFRSNSFVGTEEYIAPE-VISGDGHGSAVDWWTLGILLYEMLYGTT 230
Query: 274 P 274
P
Sbjct: 231 P 231
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 2e-07
Identities = 43/147 (29%), Positives = 67/147 (45%), Gaps = 25/147 (17%)
Query: 181 RGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQA-PDAAARLHSTRVLGTF 239
R L+Y+H + HR++K N+L D KI DF L+ A D + T + T
Sbjct: 114 RALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR 170
Query: 240 GYHAPEY--AMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSED 297
Y APE + + + D++S G + E+LTG KP+ P ++
Sbjct: 171 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTG-KPL---FP--------------GKN 212
Query: 298 KVKQC-VDTKLGGEYPPKAIAKVRKKK 323
V Q + T L G P+ I++VR +K
Sbjct: 213 VVHQLDLITDLLGTPSPETISRVRNEK 239
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 2e-07
Identities = 56/217 (25%), Positives = 92/217 (42%), Gaps = 20/217 (9%)
Query: 74 IGEGSYGRVYFGVLRSGRAAA---IKKLDSSKQPDQE--FLAQVSMVSRLKNENVVELVG 128
IG G +G+V G + SG A +K+L S ++ FL + L++ N+++ +G
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62
Query: 129 YYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHE 188
+ +L E G L L + + P P QR +A A GL +LH+
Sbjct: 63 QCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTT--LQR--MACEIALGLLHLHK 118
Query: 189 KAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYA- 247
IH ++ N LL D KI D+ LS+ + ++ + APE
Sbjct: 119 N---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVD 175
Query: 248 ------MTGQMSSKSDVYSFGVVLLELLT-GRKPVDH 277
+ + +S+V+S GV + EL G +P H
Sbjct: 176 EVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRH 212
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 2e-07
Identities = 52/209 (24%), Positives = 95/209 (45%), Gaps = 23/209 (11%)
Query: 74 IGEGSYGRVYFGVLR-SGRAAAIKK--LDSSKQPDQEF-LAQVSMVSRLKNENVVELVGY 129
IGEG+YG V+ R + A+K+ LD + L ++ ++ LK++N+V L
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDV 67
Query: 130 YVDGPLRVLAYEHASKG--SLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLH 187
L +E+ + D +G P V S+ ++ +GL + H
Sbjct: 68 LHSDKKLTLVFEYCDQDLKKYFDSCNGD-----IDPEIVKSFMFQL------LKGLAFCH 116
Query: 188 EKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYA 247
++HR++K N+L+ + K++DF L+ +A R +S V+ T Y P+
Sbjct: 117 SH---NVLHRDLKPQNLLINKNGELKLADFGLA-RAFGIPVRCYSAEVV-TLWYRPPDVL 171
Query: 248 MTGQMSSKS-DVYSFGVVLLELLTGRKPV 275
++ S S D++S G + EL +P+
Sbjct: 172 FGAKLYSTSIDMWSAGCIFAELANAGRPL 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 2e-07
Identities = 32/93 (34%), Positives = 49/93 (52%), Gaps = 6/93 (6%)
Query: 182 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGY 241
GLE L + RI++R++K N+LL D +ISD L+ Q P+ RV GT GY
Sbjct: 114 GLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETV--RGRV-GTVGY 167
Query: 242 HAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
APE + + D + G ++ E++ G+ P
Sbjct: 168 MAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 51.6 bits (124), Expect = 2e-07
Identities = 30/99 (30%), Positives = 54/99 (54%), Gaps = 9/99 (9%)
Query: 181 RGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN---QAPDAAARLHSTRVLG 237
RGL+Y+H +IHR++K SN+L+ +D +I DF ++ +P T +
Sbjct: 118 RGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKY-FMTEYVA 173
Query: 238 TFGYHAPEYAMT-GQMSSKSDVYSFGVVLLELLTGRKPV 275
T Y APE ++ + ++ D++S G + E+L GR+ +
Sbjct: 174 TRWYRAPELLLSLPEYTTAIDMWSVGCIFAEML-GRRQL 211
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.4 bits (124), Expect = 2e-07
Identities = 54/218 (24%), Positives = 100/218 (45%), Gaps = 47/218 (21%)
Query: 74 IGEGSYGRVYFGVLRS-GRAAAIKKLDSSKQPDQEF-----LAQVSMVSRLK-NENVVEL 126
+G+G++G VY + G AIKK+ K+ + L +V + +L + N+V+L
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKKM---KKKFYSWEECMNLREVKSLRKLNEHPNIVKL 63
Query: 127 VGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYL 186
+ + +E+ +G+L+ ++ +KG + + S ++ +GL ++
Sbjct: 64 KEVFRENDELYFVFEYM-EGNLYQLMKDRKGKPFS-ESVIRSIIYQI------LQGLAHI 115
Query: 187 HEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAAR-LHS----TRVLGTFGY 241
H+ HR++K N+L+ ++ KI+DF L AR + S T + T Y
Sbjct: 116 HKHG---FFHRDLKPENLLVSGPEVVKIADFGL--------AREIRSRPPYTDYVSTRWY 164
Query: 242 HAPE-------YAMTGQMSSKSDVYSFGVVLLELLTGR 272
APE Y SS D+++ G ++ EL T R
Sbjct: 165 RAPEILLRSTSY------SSPVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 2e-07
Identities = 49/209 (23%), Positives = 89/209 (42%), Gaps = 22/209 (10%)
Query: 62 KEKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNE 121
K+ D FG N E + V G +K+ D+++ V M+ +
Sbjct: 148 KKDLDIFGINP-ADESTRSYVILSFENKGDYMDMKQADTTQY--------VPMLEIKEAS 198
Query: 122 NVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAAR 181
++ D P +Y+ ++ + ++L G +G +LS+ +V AR
Sbjct: 199 KYSDIQRSNYDRPA---SYKGSNDSEVKNLL-SDDGSEGLTTLDLLSFTYQV------AR 248
Query: 182 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGY 241
G+E+L K +HR++ + NVLL I KI DF L+ + + +
Sbjct: 249 GMEFLASK---NCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKW 305
Query: 242 HAPEYAMTGQMSSKSDVYSFGVVLLELLT 270
APE ++ SDV+S+G++L E+ +
Sbjct: 306 MAPESIFDNLYTTLSDVWSYGILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 2e-07
Identities = 44/154 (28%), Positives = 75/154 (48%), Gaps = 20/154 (12%)
Query: 183 LEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYH 242
LE+LH++ II+R++K N+LL K++DF L ++ H+ GT Y
Sbjct: 113 LEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHT--FCGTIEYM 167
Query: 243 APEYAMTGQMSSKSDVYSFGVVLLELLTG---------RKPVDHTLPRGQQSLVTWATPK 293
APE M D +S G ++ ++LTG +K +D L +G+ +L + TP+
Sbjct: 168 APEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKIL-KGKLNLPPYLTPE 226
Query: 294 ---LSEDKVKQCVDTKLGGEYPPKAIAKVRKKKF 324
L + +K+ ++LG P A+V+ F
Sbjct: 227 ARDLLKKLLKRNPSSRLGAG--PGDAAEVQSHPF 258
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 51.2 bits (123), Expect = 3e-07
Identities = 56/223 (25%), Positives = 106/223 (47%), Gaps = 40/223 (17%)
Query: 74 IGEGSYGRVYFGVLR-SGRAAAIKK--LDSSKQPDQEF----LAQVSMVSRLKNENVVEL 126
IG+G++G V+ + + + A+KK +++ K+ F L ++ ++ LK+ENVV L
Sbjct: 20 IGQGTFGEVFKARHKKTKQIVALKKVLMENEKE---GFPITALREIKILQLLKHENVVNL 76
Query: 127 VGYYVDGPLRVLAYEHASKGSL--------HDI--LHGKKGVKGAKPGPVLSWAQRVKIA 176
+ + KGS HD+ L K VK + ++ K+
Sbjct: 77 IEICRTKATP----YNRYKGSFYLVFEFCEHDLAGLLSNKNVK-------FTLSEIKKVM 125
Query: 177 VGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS---NQAPDAAARLHST 233
GL Y+H +I+HR++K++N+L+ D I K++DF L+ + + ++ ++
Sbjct: 126 KMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTN 182
Query: 234 RVLGTFGYHAPEYAMTG-QMSSKSDVYSFGVVLLELLTGRKPV 275
RV+ T Y PE + D++ G ++ E+ T R P+
Sbjct: 183 RVV-TLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWT-RSPI 223
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 3e-07
Identities = 59/220 (26%), Positives = 98/220 (44%), Gaps = 28/220 (12%)
Query: 67 NFGTNSLIGEGSYGRVYFGVLR-SGRAAAIK--KLDSSKQPDQEFLAQVSMVSRL----- 118
+F ++G+GS+G+V + + AIK K D Q D + +MV +
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDD---VECTMVEKRVLALQ 57
Query: 119 -KNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAV 177
K + +L + E+ + G L + H ++ K +P V A+ I+V
Sbjct: 58 DKPPFLTQLHSCFQTVDRLYFVMEYVNGGDL--MYHIQQVGKFKEPQAVFYAAE---ISV 112
Query: 178 GAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVL- 236
G L +LH + II+R++K NV+L + KI+DF + + +TR
Sbjct: 113 G----LFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGV---TTRTFC 162
Query: 237 GTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVD 276
GT Y APE D +++GV+L E+L G+ P D
Sbjct: 163 GTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 3e-07
Identities = 56/218 (25%), Positives = 98/218 (44%), Gaps = 22/218 (10%)
Query: 67 NFGTNSLIGEGSYGRVYFGV-LRSGRAAAIKKLD---SSKQPDQEFLA---QVSMVSRLK 119
N+ L+G G++G VY +GR A+K++ S++ +E A ++ ++ L+
Sbjct: 3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR 62
Query: 120 NENVVELVGYYVDGPLRVLA--YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAV 177
++ +V+ G D + L+ E+ GS+ D L GA V R +
Sbjct: 63 HDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAY----GALTENVTRRYTRQIL-- 116
Query: 178 GAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTR-VL 236
+G+ YLH I+HR+IK +N+L K+ DF S + + V
Sbjct: 117 ---QGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVT 170
Query: 237 GTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
GT + +PE K+DV+S ++E+LT + P
Sbjct: 171 GTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 4e-07
Identities = 41/201 (20%), Positives = 76/201 (37%), Gaps = 20/201 (9%)
Query: 77 GSYGRVYFGVLR---SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDG 133
GS G V+ + +K + K P +E + ++ + + ++ L+ Y
Sbjct: 103 GSEGEVFVCTKHGDEQRKKVIVKAVTGGKTPGRE----IDILKTISHRAIINLIHAYRWK 158
Query: 134 PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPR 193
+ D+ V + P L Q + I L YLH +
Sbjct: 159 STVCMVMPKYK----CDLF---TYVDRSGP---LPLEQAITIQRRLLEALAYLHGRG--- 205
Query: 194 IIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMS 253
IIHR++K+ N+ L + + A + DF + + GT ++PE
Sbjct: 206 IIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYC 265
Query: 254 SKSDVYSFGVVLLELLTGRKP 274
+K+D++S G+VL E+
Sbjct: 266 AKTDIWSAGLVLFEMSVKNVT 286
|
Length = 392 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 4e-07
Identities = 41/120 (34%), Positives = 54/120 (45%), Gaps = 13/120 (10%)
Query: 175 IAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISD----FDLSNQAPDAAARL 230
I GA RGL YLH+ IHRNIK+S++L+ D + +S + L A
Sbjct: 106 ILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVY 162
Query: 231 H----STRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSL 286
ST VL + G + KSD+YS G+ EL TGR P + R Q L
Sbjct: 163 DFPQFSTSVLPWLSPELLRQDLYG-YNVKSDIYSVGITACELATGRVPF-QDMLRTQMLL 220
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 5e-07
Identities = 35/103 (33%), Positives = 53/103 (51%), Gaps = 18/103 (17%)
Query: 180 ARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDL-------SNQAPDAAARLHS 232
A+G+++L K IHR++ + NVLL D +AKI DF L SN ARL
Sbjct: 222 AQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARL-- 276
Query: 233 TRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 274
+ APE + +SDV+S+G++L E+ + G+ P
Sbjct: 277 -----PVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSP 314
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 5e-07
Identities = 31/92 (33%), Positives = 46/92 (50%), Gaps = 5/92 (5%)
Query: 183 LEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYH 242
LEYLH + +++R+IK N++L D KI+DF L + A + + GT Y
Sbjct: 108 LEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT--FCGTPEYL 162
Query: 243 APEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
APE D + GVV+ E++ GR P
Sbjct: 163 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 7e-07
Identities = 30/93 (32%), Positives = 47/93 (50%), Gaps = 4/93 (4%)
Query: 182 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGY 241
L+YLH +E +++R++K N++L D KI+DF L + A + + GT Y
Sbjct: 107 ALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT--FCGTPEY 162
Query: 242 HAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
APE D + GVV+ E++ GR P
Sbjct: 163 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 49.7 bits (118), Expect = 9e-07
Identities = 57/220 (25%), Positives = 103/220 (46%), Gaps = 27/220 (12%)
Query: 74 IGEGSYGRVYFGVLRSGRAA---AIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYY 130
+G G+YG VY + G+ A+K+++ + +++++ LK+ NV+ L +
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG-ISMSACREIALLRELKHPNVISLQKVF 67
Query: 131 VDGPLRV--LAYEHASKGSLHDILHGKKGVKGAKPG--PVLSWAQRVK-IAVGAARGLEY 185
+ R L +++A HD+ H K + +K PV VK + G+ Y
Sbjct: 68 LSHADRKVWLLFDYAE----HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHY 123
Query: 186 LHEKAEPRIIHRNIKSSNVLLFDD-------DIAKISDFDLSNQAPDAAARLHSTRVLGT 238
LH ++HR++K +N+L+ + IA + L N A L V+ T
Sbjct: 124 LHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDP--VVVT 178
Query: 239 FGYHAPEYAMTGQMSSKS-DVYSFGVVLLELLTGRKPVDH 277
F Y APE + + +K+ D+++ G + ELLT +P+ H
Sbjct: 179 FWYRAPELLLGARHYTKAIDIWAIGCIFAELLTS-EPIFH 217
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 1e-06
Identities = 29/95 (30%), Positives = 48/95 (50%), Gaps = 5/95 (5%)
Query: 182 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGY 241
L +LHE+ II+R++K NVLL D K++D+ + + ++ GT Y
Sbjct: 108 ALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDT--TSTFCGTPNY 162
Query: 242 HAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVD 276
APE + D ++ GV++ E++ GR P D
Sbjct: 163 IAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 49.7 bits (118), Expect = 1e-06
Identities = 31/93 (33%), Positives = 47/93 (50%), Gaps = 5/93 (5%)
Query: 182 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGY 241
L+YLH +I++R++K N++L D KI+DF L + AA + + GT Y
Sbjct: 107 ALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKT--FCGTPEY 161
Query: 242 HAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
APE D + GVV+ E++ GR P
Sbjct: 162 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 1e-06
Identities = 53/217 (24%), Positives = 99/217 (45%), Gaps = 21/217 (9%)
Query: 74 IGEGSYGRVYFGVLRSGRAA---AIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYY 130
+G G+YG VY + G+ A+K+++ + +++++ LK+ NV+ L +
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG-ISMSACREIALLRELKHPNVIALQKVF 67
Query: 131 VDGPLRV--LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHE 188
+ R L +++A H I+ + K K L + + G+ YLH
Sbjct: 68 LSHSDRKVWLLFDYAEHDLWH-IIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHA 126
Query: 189 KAEPRIIHRNIKSSNVLLFDD-------DIAKISDFDLSNQAPDAAARLHSTRVLGTFGY 241
++HR++K +N+L+ + IA + L N A L V+ TF Y
Sbjct: 127 NW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDP--VVVTFWY 181
Query: 242 HAPEYAMTGQMSSKS-DVYSFGVVLLELLTGRKPVDH 277
APE + + +K+ D+++ G + ELLT +P+ H
Sbjct: 182 RAPELLLGARHYTKAIDIWAIGCIFAELLTS-EPIFH 217
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 48.9 bits (117), Expect = 1e-06
Identities = 49/222 (22%), Positives = 91/222 (40%), Gaps = 35/222 (15%)
Query: 72 SLIGEGSYGRVYFGVLR---SGRAAAIKKLDSSKQPDQEFL---AQVSMVSRLKNENVVE 125
+LIG+ + + + + A+KK++ ++ ++ +L++ N++
Sbjct: 4 TLIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILP 63
Query: 126 LVGYYVDGPLRVLAYEHASKGSLHDIL--HGKKGVKGAKPGPVLSWAQRVKIAVGAARGL 183
V ++ + + GS D+L H +G+ P L+ A +K L
Sbjct: 64 YVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGL------PELAIAFILK---DVLNAL 114
Query: 184 EYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS--------NQAPDAAARLHSTRV 235
+Y+H K IHR++K+S++LL D +S S Q S +
Sbjct: 115 DYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKN 171
Query: 236 LGTFGYHAPEY---AMTGQMSSKSDVYSFGVVLLELLTGRKP 274
L + +PE + G + KSD+YS G+ EL G P
Sbjct: 172 L---PWLSPEVLQQNLQG-YNEKSDIYSVGITACELANGHVP 209
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 2e-06
Identities = 29/95 (30%), Positives = 47/95 (49%), Gaps = 5/95 (5%)
Query: 182 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGY 241
L YLHE+ II+R++K NVLL + K++D+ + + ++ GT Y
Sbjct: 108 ALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT--TSTFCGTPNY 162
Query: 242 HAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVD 276
APE D ++ GV++ E++ GR P D
Sbjct: 163 IAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 2e-06
Identities = 50/215 (23%), Positives = 87/215 (40%), Gaps = 24/215 (11%)
Query: 66 DNFGTNSLIGEGSYGRVYFGVLRSGRA-AAIKKLD-----SSKQPDQEFLAQVSMVSRLK 119
D+ +G G++GRV+ R A+K + KQ +Q + ++ +
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQ-EQHVHNEKRVLKEVS 59
Query: 120 NENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGA 179
+ ++ L D + E+ G L L L +A + A
Sbjct: 60 HPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSN---STGLFYASEIVCA--- 113
Query: 180 ARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTF 239
LEYLH K I++R++K N+LL + K++DF + + D L GT
Sbjct: 114 ---LEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTWTL-----CGTP 162
Query: 240 GYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
Y APE + + D ++ G+++ E+L G P
Sbjct: 163 EYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 2e-06
Identities = 55/229 (24%), Positives = 94/229 (41%), Gaps = 23/229 (10%)
Query: 55 VISVDELKEKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSS----KQPDQEFLA 110
V + +L+ K +++ +IG G++G V +S + KL S K+ D F
Sbjct: 32 VRKIRKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFW 91
Query: 111 QVSMVSRLKNEN-VVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSW 169
+ + N VV+L + D + E+ G L +++ + W
Sbjct: 92 EERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPE--------KW 143
Query: 170 AQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAAR 229
A+ V A L+ +H +IHR++K N+LL K++DF + D
Sbjct: 144 AKFYTAEVVLA--LDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMKM-DETGM 197
Query: 230 LHSTRVLGTFGYHAPEYAMT----GQMSSKSDVYSFGVVLLELLTGRKP 274
+ +GT Y +PE + G + D +S GV L E+L G P
Sbjct: 198 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 3e-06
Identities = 58/233 (24%), Positives = 92/233 (39%), Gaps = 42/233 (18%)
Query: 66 DNFGTNSLIGEGSYGRVYFGVLRSGRAA-AIKKLDSS-----KQPDQEFLAQVSMVSRLK 119
++F T LI G+YG VY + R A+KK++ Q Q F + +++ +
Sbjct: 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVF-VERDILTFAE 59
Query: 120 NENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPV----LSWAQRVKI 175
N VV + + + E+ G +L K PV + +A+ V
Sbjct: 60 NPFVVSMFCSFETKRHLCMVMEYVEGGDCATLL------KNIGALPVDMARMYFAETV-- 111
Query: 176 AVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS--------------N 221
LEYLH I+HR++K N+L+ K++DF LS +
Sbjct: 112 -----LALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGH 163
Query: 222 QAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
D +V GT Y APE + D ++ G++L E L G P
Sbjct: 164 IEKD-TREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVP 215
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 3e-06
Identities = 31/98 (31%), Positives = 46/98 (46%), Gaps = 8/98 (8%)
Query: 183 LEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYH 242
L YLH +++R++K N++L D KI+DF L + A + + GT Y
Sbjct: 108 LGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKT--FCGTPEYL 162
Query: 243 APEYAMTGQMSSKSDVYSFGVVLLELLTGRKPV---DH 277
APE D + GVV+ E++ GR P DH
Sbjct: 163 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH 200
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 47.5 bits (114), Expect = 4e-06
Identities = 61/222 (27%), Positives = 97/222 (43%), Gaps = 38/222 (17%)
Query: 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLD-----SSKQPDQEFLAQVSMVSRLK 119
D+F +G GS+GRV + SG+ A+K L KQ + L + ++ ++
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEH-VLNEKRILQSIR 59
Query: 120 NENVVELVGYYVDGPLRVLAYEHASKGSLHDILH--GKKGVKGAKPGPVLSWAQRVKIAV 177
+ +V L G + D L E+ G L L G+ A+ +A +V +A
Sbjct: 60 HPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVAR-----FYAAQVVLA- 113
Query: 178 GAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLG 237
LEYLH I++R++K N+LL D KI+DF + + L G
Sbjct: 114 -----LEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTYTL-----CG 160
Query: 238 TFGYHAPEYAMTGQMSSK-----SDVYSFGVVLLELLTGRKP 274
T Y APE + SK D ++ G+++ E+L G P
Sbjct: 161 TPEYLAPEI-----ILSKGYGKAVDWWALGILIYEMLAGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 4e-06
Identities = 32/93 (34%), Positives = 48/93 (51%), Gaps = 5/93 (5%)
Query: 182 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGY 241
GL+YLHE +I++R++K N+LL + KI+DF L + R ST GT +
Sbjct: 113 GLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRT-ST-FCGTPEF 167
Query: 242 HAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
APE + D + GV++ E+L G P
Sbjct: 168 LAPEVLTETSYTRAVDWWGLGVLIYEMLVGESP 200
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 5e-06
Identities = 56/215 (26%), Positives = 86/215 (40%), Gaps = 36/215 (16%)
Query: 74 IGEGSYGRVYFGVLRS-GRAAAIKKLDSS----KQPDQEFLAQVSMVSRLKNENVVELVG 128
IG+GS+G+V ++ G+ A+K L K+ + +A+ +++ LKN LVG
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVL--LKNVKHPFLVG 60
Query: 129 YYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVK---------IAVGA 179
L Y + L+ +L G G + QR + A
Sbjct: 61 ---------LHYSFQTADKLYFVLDYVNG------GELFFHLQRERSFPEPRARFYAAEI 105
Query: 180 ARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTF 239
A L YLH II+R++K N+LL ++DF L + ++ GT
Sbjct: 106 ASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKE--GIEHSKTTSTFCGTP 160
Query: 240 GYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
Y APE D + G VL E+L G P
Sbjct: 161 EYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 5e-06
Identities = 52/225 (23%), Positives = 95/225 (42%), Gaps = 36/225 (16%)
Query: 66 DNFGTNSLIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQE-----FLAQVS---MVS 116
D + IGEG+YG+VY +G+ A+KK D+E L ++S M+S
Sbjct: 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEM--DEEGIPPTALREISLLQMLS 58
Query: 117 R-------LKNENVVELVGYYVDGPLRVLAYEH-ASKGSLHDILHGKKGVKGAKPGPVLS 168
L E+V E G P L +E+ S +G+ + + S
Sbjct: 59 ESIYIVRLLDVEHVEEKNG----KPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKS 114
Query: 169 WAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDD-DIAKISDFDLSNQAPDAA 227
+ ++ G+ + H+ ++HR++K N+L+ + KI+D L +A
Sbjct: 115 FMYQLLK------GVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLGLG-RAFSIP 164
Query: 228 ARLHSTRVLGTFGYHAPEYAMTG-QMSSKSDVYSFGVVLLELLTG 271
+ ++ ++ T Y APE + S+ D++S G + E+
Sbjct: 165 VKSYTHEIV-TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRK 208
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 47.2 bits (113), Expect = 5e-06
Identities = 30/96 (31%), Positives = 51/96 (53%), Gaps = 7/96 (7%)
Query: 181 RGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS---NQAPDAAARLHSTRVLG 237
+ L+Y+H +IHR++K SN+LL D K++DF L+ ++ + T +
Sbjct: 118 KALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVA 174
Query: 238 TFGYHAPEYAMTGQMSSKS-DVYSFGVVLLELLTGR 272
T Y APE + +K D++S G +L E+L G+
Sbjct: 175 TRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 8e-06
Identities = 33/101 (32%), Positives = 51/101 (50%), Gaps = 5/101 (4%)
Query: 176 AVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRV 235
A A GL +LH K II+R++K NV+L + KI+DF + + + + +
Sbjct: 107 AAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKE--NMWDGVTTKTF 161
Query: 236 LGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVD 276
GT Y APE D ++FGV+L E+L G+ P +
Sbjct: 162 CGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 9e-06
Identities = 54/221 (24%), Positives = 97/221 (43%), Gaps = 51/221 (23%)
Query: 74 IGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEF----LAQVSMVSRLKNENVVELVG 128
IGEG+YG VY R + A+KK+ +Q D+ + ++S++ +++ N+V L
Sbjct: 10 IGEGTYGVVYKARDRVTNETIALKKI-RLEQEDEGVPSTAIREISLLKEMQHGNIVRL-- 66
Query: 129 YYVDGPLRVLAYEHASKGSLHDILHGKKGV------------KGAKPGPVLSWAQR-VKI 175
D++H +K + K P + R +K
Sbjct: 67 --------------------QDVVHSEKRLYLVFEYLDLDLKKHMDSSPDFAKNPRLIKT 106
Query: 176 AV-GAARGLEYLHEKAEPRIIHRNIKSSNVLLFD--DDIAKISDFDLSNQAPDAAARLHS 232
+ RG+ Y H R++HR++K N LL D + K++DF L+ +A R +
Sbjct: 107 YLYQILRGIAYCHSH---RVLHRDLKPQN-LLIDRRTNALKLADFGLA-RAFGIPVRTFT 161
Query: 233 TRVLGTFGYHAPEYAM-TGQMSSKSDVYSFGVVLLELLTGR 272
V+ T Y APE + + S+ D++S G + E++ +
Sbjct: 162 HEVV-TLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 9e-06
Identities = 30/94 (31%), Positives = 47/94 (50%), Gaps = 5/94 (5%)
Query: 183 LEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYH 242
L +LHE+ II+R++K NVLL + K++D+ + + ST GT Y
Sbjct: 109 LNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGI-RPGDTTST-FCGTPNYI 163
Query: 243 APEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVD 276
APE D ++ GV++ E++ GR P D
Sbjct: 164 APEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 1e-05
Identities = 30/90 (33%), Positives = 45/90 (50%), Gaps = 6/90 (6%)
Query: 182 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGY 241
G+++LH IIHR++K SN+++ D KI DF L A A T + T Y
Sbjct: 135 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL---ARTACTNFMMTPYVVTRYY 188
Query: 242 HAPEYAMTGQMSSKSDVYSFGVVLLELLTG 271
APE + D++S G ++ EL+ G
Sbjct: 189 RAPEVILGMGYKENVDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 1e-05
Identities = 33/103 (32%), Positives = 49/103 (47%), Gaps = 18/103 (17%)
Query: 180 ARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDL-------SNQAPDAAARLHS 232
A+G+ +L K IHR++ + N+LL I KI DF L SN ARL
Sbjct: 224 AKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARL-- 278
Query: 233 TRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 274
+ APE + +SDV+S+G++L E+ + G P
Sbjct: 279 -----PVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSP 316
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 2e-05
Identities = 29/92 (31%), Positives = 43/92 (46%), Gaps = 4/92 (4%)
Query: 181 RGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFG 240
R ++YLHE RIIHR+IK+ N+ + + DF + D A + GT
Sbjct: 193 RAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWA-GTIA 248
Query: 241 YHAPEYAMTGQMSSKSDVYSFGVVLLELLTGR 272
+APE D++S G+VL E+ T
Sbjct: 249 TNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 2e-05
Identities = 29/91 (31%), Positives = 45/91 (49%), Gaps = 6/91 (6%)
Query: 182 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGY 241
G+++LH IIHR++K SN+++ D KI DF L A A T + T Y
Sbjct: 130 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL---ARTAGTSFMMTPYVVTRYY 183
Query: 242 HAPEYAMTGQMSSKSDVYSFGVVLLELLTGR 272
APE + D++S G ++ E++ G
Sbjct: 184 RAPEVILGMGYKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 2e-05
Identities = 29/98 (29%), Positives = 47/98 (47%), Gaps = 13/98 (13%)
Query: 183 LEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTF--- 239
L +LH+K II+R++K NVLL + K++DF + + + + + TF
Sbjct: 109 LMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEG------IFNGKTTSTFCGT 159
Query: 240 -GYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVD 276
Y APE D ++ GV+L E+L G P +
Sbjct: 160 PDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFE 197
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 3e-05
Identities = 55/226 (24%), Positives = 92/226 (40%), Gaps = 23/226 (10%)
Query: 58 VDELKEKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSS----KQPDQEFLAQVS 113
+ +L+ K +++ +IG G++G V +S R KL S K+ D F +
Sbjct: 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEER 94
Query: 114 MVSRLKNEN-VVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQR 172
+ N VV+L + D + E+ G L +++ P WA+
Sbjct: 95 DIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD-----VPE---KWARF 146
Query: 173 VKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHS 232
V A L+ +H IHR++K N+LL K++DF + + +
Sbjct: 147 YTAEVVLA--LDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKM-NKEGMVRC 200
Query: 233 TRVLGTFGYHAPEYAMT----GQMSSKSDVYSFGVVLLELLTGRKP 274
+GT Y +PE + G + D +S GV L E+L G P
Sbjct: 201 DTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 3e-05
Identities = 56/231 (24%), Positives = 100/231 (43%), Gaps = 27/231 (11%)
Query: 55 VISVDELKEKTDNFGTNSLIGEGSYGRVYFGVLR---SGRAAAIK---KLDSSKQPDQEF 108
+ +L+ K ++F +IG G++G V ++R S + A+K K + K+ D F
Sbjct: 32 AEKITKLRMKAEDFDVIKVIGRGAFGEVQ--LVRHKSSKQVYAMKLLSKFEMIKRSDSAF 89
Query: 109 L-AQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVL 167
+ +++ +E +V+L + D + E+ G L +++ +
Sbjct: 90 FWEERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPE-------- 141
Query: 168 SWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAA 227
WA+ V A L+ +H IHR++K N+LL K++DF + DA
Sbjct: 142 KWARFYTAEVVLA--LDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKM-DAN 195
Query: 228 ARLHSTRVLGTFGYHAPEYAMT----GQMSSKSDVYSFGVVLLELLTGRKP 274
+ +GT Y +PE + G + D +S GV L E+L G P
Sbjct: 196 GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 4e-05
Identities = 28/93 (30%), Positives = 45/93 (48%), Gaps = 6/93 (6%)
Query: 183 LEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYH 242
LE+LH+ I++R++K N+LL + DF LS + + GT Y
Sbjct: 109 LEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSK--ANLTDNKTTNTFCGTTEYL 163
Query: 243 APEYAMTGQMSSKS-DVYSFGVVLLELLTGRKP 274
APE + + +K D +S GV++ E+ G P
Sbjct: 164 APEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSP 196
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 5e-05
Identities = 49/197 (24%), Positives = 80/197 (40%), Gaps = 26/197 (13%)
Query: 109 LAQVSMVSRLKNE-------NVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGA 161
L + S SR + N+V L Y V L +HA G L + +
Sbjct: 26 LRKSSEYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIP-- 83
Query: 162 KPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221
V WA + +A L+ LH + I+ R++ +N+LL D +++ F +
Sbjct: 84 -EECVKRWAAEMVVA------LDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWS 133
Query: 222 QAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPR 281
+ D+ + Y APE + + D +S G +L ELLTG K + P
Sbjct: 134 EVEDSCDGEAVENM-----YCAPEVGGISEETEACDWWSLGAILFELLTG-KTLVECHPS 187
Query: 282 GQQSLVTWATPK-LSED 297
G + T P+ +SE+
Sbjct: 188 GINTHTTLNIPEWVSEE 204
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.9 bits (104), Expect = 6e-05
Identities = 55/214 (25%), Positives = 91/214 (42%), Gaps = 34/214 (15%)
Query: 74 IGEGSYGRVYFGVLR-SGRAAAIKKLDSS--KQPDQ--EFLAQVSMVSRLKNENVVELVG 128
+G+G YG+V+ + +G A+K++ S + ++ L + +++ K+E +V+L+
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLY 68
Query: 129 YYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLS------WAQRVKIAVGAARG 182
+ D LA E+ G +L+ VLS + + AV A
Sbjct: 69 AFQDDEYLYLAMEYVPGGDFRTLLNNLG---------VLSEDHARFYMAEMFEAVDA--- 116
Query: 183 LEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYH 242
LHE IHR++K N L+ K++DF LS +S V+G+ Y
Sbjct: 117 ---LHELG---YIHRDLKPENFLIDASGHIKLTDFGLSK---GIVTYANS--VVGSPDYM 165
Query: 243 APEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVD 276
APE D +S G +L E L G P
Sbjct: 166 APEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFS 199
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 7e-05
Identities = 54/220 (24%), Positives = 88/220 (40%), Gaps = 23/220 (10%)
Query: 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQV----SMVSRLKN 120
+F SL+G G +G V + +G A+K + S QE ++ ++S +
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNS 60
Query: 121 ENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAA 180
+ +L + D L E+ G L +L+ + AQ A
Sbjct: 61 PWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDE------DMAQ-----FYLA 109
Query: 181 RGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFG 240
+ +H + +HR+IK NVL+ K++DF S A ++S +GT
Sbjct: 110 ELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFG-SAARLTANKMVNSKLPVGTPD 168
Query: 241 YHAPEYAMTGQMSSKS------DVYSFGVVLLELLTGRKP 274
Y APE T K D +S GV+ E++ GR P
Sbjct: 169 YIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSP 208
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 8e-05
Identities = 38/143 (26%), Positives = 55/143 (38%), Gaps = 46/143 (32%)
Query: 195 IHRNIKSSNVLLFDDDIAKISDF--------------------------DLSNQAPDA-- 226
IHR+IK N+L+ D K++DF D SN+ D
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPAN 182
Query: 227 -------------AARLH----STRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELL 269
AAR H + ++GT Y APE + + D +S GV+L E+L
Sbjct: 183 CRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML 242
Query: 270 TGRKPVDHTLP-RGQQSLVTWAT 291
G+ P P Q ++ W T
Sbjct: 243 VGQPPFLAQTPLETQMKVINWQT 265
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 1e-04
Identities = 29/91 (31%), Positives = 45/91 (49%), Gaps = 6/91 (6%)
Query: 182 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGY 241
G+++LH IIHR++K SN+++ D KI DF L A A T + T Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL---ARTAGTSFMMTPYVVTRYY 191
Query: 242 HAPEYAMTGQMSSKSDVYSFGVVLLELLTGR 272
APE + D++S G ++ E++ G
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 42.8 bits (100), Expect = 2e-04
Identities = 32/102 (31%), Positives = 47/102 (46%), Gaps = 12/102 (11%)
Query: 182 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGY 241
G+++LH IIHR++K SN+++ D KI DF L A A T + T Y
Sbjct: 131 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL---ARTAGTSFMMTPYVVTRYY 184
Query: 242 HAPEYAMTGQMSSKSDVYSFGVVLLE------LLTGRKPVDH 277
APE + D++S G ++ E L GR +D
Sbjct: 185 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ 226
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 2e-04
Identities = 54/215 (25%), Positives = 97/215 (45%), Gaps = 24/215 (11%)
Query: 74 IGEGSYGRVYFGVLRS----GRA----AAIKKLDSS-KQPDQEFLAQVSMVSRLKNENVV 124
+G+G++ +++ G+ R G +K LD S + + F SM+S+L ++++V
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 125 ELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLE 184
G V G ++ E+ GSL L K + SW ++++A A L
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINI------SW--KLEVAKQLAWALH 114
Query: 185 YLHEKAEPRIIHRNIKSSNVLLFDDDIAKISD--FDLSNQAPDAAARLHSTRVLGTFGYH 242
+L +K + H N+ + NVLL ++ K + F + + L +L +
Sbjct: 115 FLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLERIPWV 171
Query: 243 APEYAMTGQ-MSSKSDVYSFGVVLLELLTG-RKPV 275
PE Q +S +D +SFG L E+ +G KP+
Sbjct: 172 PPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPL 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.7 bits (101), Expect = 2e-04
Identities = 31/119 (26%), Positives = 46/119 (38%), Gaps = 30/119 (25%)
Query: 183 LEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARL------------ 230
L+ +H+ IHR+IK N+L+ D K++DF L + A R
Sbjct: 114 LDSVHKL---GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFR 170
Query: 231 ---------------HSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
+ +GT Y APE + D +S GV+L E+L G P
Sbjct: 171 DNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPP 229
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 4e-04
Identities = 25/92 (27%), Positives = 46/92 (50%), Gaps = 5/92 (5%)
Query: 183 LEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYH 242
L +LH +I+R++K N+LL + K++DF + + + +T GT Y
Sbjct: 109 LMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEG--ILNGVTTTTFCGTPDYI 163
Query: 243 APEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
APE + D ++ GV++ E++ G+ P
Sbjct: 164 APEILQELEYGPSVDWWALGVLMYEMMAGQPP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 6e-04
Identities = 55/216 (25%), Positives = 88/216 (40%), Gaps = 36/216 (16%)
Query: 73 LIGEGSYGRVYFGVL-RSGRAAAIKKLDS----SKQPDQEFLAQVSMVSRLKNENVVELV 127
+IG+GS+G+V G+ A+K L +++ + +A+ +++ LKN LV
Sbjct: 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVL--LKNVKHPFLV 59
Query: 128 GYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVK---------IAVG 178
G L Y + L+ +L G G + QR + A
Sbjct: 60 G---------LHYSFQTTEKLYFVLDFVNG------GELFFHLQRERSFPEPRARFYAAE 104
Query: 179 AARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGT 238
A L YLH I++R++K N+LL ++DF L + + +T GT
Sbjct: 105 IASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDT--TTTFCGT 159
Query: 239 FGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
Y APE + D + G VL E+L G P
Sbjct: 160 PEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 7e-04
Identities = 35/151 (23%), Positives = 53/151 (35%), Gaps = 45/151 (29%)
Query: 183 LEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDF------------------------- 217
+E +H+ IHR+IK N+L+ D K++DF
Sbjct: 114 IESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDS 170
Query: 218 --------DLSNQAPDAAARLH---STRVL-----GTFGYHAPEYAMTGQMSSKSDVYSF 261
++ R R L GT Y APE + + D +S
Sbjct: 171 MEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSV 230
Query: 262 GVVLLELLTGRKPVDHTLPRG-QQSLVTWAT 291
GV+L E+L G+ P P Q ++ W T
Sbjct: 231 GVILYEMLVGQPPFLADTPAETQLKVINWET 261
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.001
Identities = 28/94 (29%), Positives = 46/94 (48%), Gaps = 6/94 (6%)
Query: 186 LHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245
+H + +HR+IK NVLL + +++DF + + S+ +GT Y +PE
Sbjct: 115 IHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGT-VQSSVAVGTPDYISPE 173
Query: 246 Y--AM---TGQMSSKSDVYSFGVVLLELLTGRKP 274
AM G+ + D +S GV + E+L G P
Sbjct: 174 ILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 39.5 bits (92), Expect = 0.001
Identities = 45/212 (21%), Positives = 89/212 (41%), Gaps = 28/212 (13%)
Query: 74 IGEGSYGRVYFGVLRSGRAAA---IKKLDSSKQPDQ--EFLAQVSMVSRLKNENVVELVG 128
IG G +G+V + + A +K+L ++ + EFL Q L++ N+++ +G
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62
Query: 129 YYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHE 188
V+ +L +E+ G L L ++ + +L ++A A G+ ++H+
Sbjct: 63 QCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQ-----RMACEIAAGVTHMHK 117
Query: 189 KAEPRIIHRNIKSSNVLLFDDDIAKISDFDL--SNQAPD---------AAARLHSTRVLG 237
+H ++ N L D K+ D+ + S D R + ++G
Sbjct: 118 H---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVG 174
Query: 238 TFGYHAPEYAMTGQMSSKSDVYSFGVVLLELL 269
F +T + + S+V++ GV L EL
Sbjct: 175 EF----HGGLITAEQTKPSNVWALGVTLWELF 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 38.8 bits (90), Expect = 0.002
Identities = 57/216 (26%), Positives = 93/216 (43%), Gaps = 39/216 (18%)
Query: 74 IGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVV--ELVGYYV 131
IG+GS+G+V ++K D+ + + + + +VSR + + + V V
Sbjct: 1 IGKGSFGKV----------MQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQV 50
Query: 132 DGPLRV-LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRV-KIAVGAAR-------- 181
+ P V L + S L+ +L G G + QR + + AR
Sbjct: 51 NCPFIVPLKFSFQSPEKLYLVLAFING------GELFHHLQREGRFDLSRARFYTAELLC 104
Query: 182 GLEYLHEKAEPRIIHRNIKSSNVLL-FDDDIAKISDFDLS--NQAPDAAARLHSTRVLGT 238
LE LH+ +I+R++K N+LL + IA + DF L N D + GT
Sbjct: 105 ALENLHKF---NVIYRDLKPENILLDYQGHIA-LCDFGLCKLNMKDDDK----TNTFCGT 156
Query: 239 FGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
Y APE + + D ++ GV+L E+LTG P
Sbjct: 157 PEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPP 192
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 39.3 bits (91), Expect = 0.003
Identities = 30/115 (26%), Positives = 53/115 (46%), Gaps = 18/115 (15%)
Query: 162 KPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221
K P+L + + + A +EY+H+K ++IHR+IK N+ L D + DF
Sbjct: 261 KDRPLLKQTRAIMKQLLCA--VEYIHDK---KLIHRDIKLENIFLNCDGKIVLGDFG--- 312
Query: 222 QAPDAAARLHSTRV------LGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT 270
A R +GT ++PE +D++S G++LL++L+
Sbjct: 313 ----TAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 38.9 bits (90), Expect = 0.003
Identities = 68/308 (22%), Positives = 117/308 (37%), Gaps = 73/308 (23%)
Query: 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVV 124
D+F + +IG G++G V + +G A+K L + ++E +A + R + + +V
Sbjct: 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHI----RAERDILV 56
Query: 125 ELVGYYV--------DGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIA 176
E G +V D L E G + +L K + ++ +A
Sbjct: 57 EADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIA---ETVLA 113
Query: 177 VGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDF----------------DLS 220
+ A L + IHR+IK N+LL K+SDF +L+
Sbjct: 114 IDAIHQLGF---------IHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLT 164
Query: 221 NQAPD--AAARLHSTR---------------VLGTFGYHAPEYAMTGQMSSKSDVYSFGV 263
+ P + ++S R +GT Y APE M + D +S GV
Sbjct: 165 HNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGV 224
Query: 264 VLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKVRKKK 323
++ E+L G P TP+ + KV +T + +PP+ + K
Sbjct: 225 IMYEMLIGYPP------------FCSETPQETYRKVMNWKETLV---FPPEVPISEKAKD 269
Query: 324 FITSECSN 331
I C++
Sbjct: 270 LILRFCTD 277
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 38.7 bits (90), Expect = 0.004
Identities = 31/108 (28%), Positives = 52/108 (48%), Gaps = 4/108 (3%)
Query: 160 GAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDL 219
GA+ P L AQ +A ++Y+H + IIHR+IK+ NVL+ + + DF
Sbjct: 251 GARLRP-LGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGA 306
Query: 220 SNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLE 267
+ A + + + GT +APE + D++S G+V+ E
Sbjct: 307 ACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 38.7 bits (90), Expect = 0.004
Identities = 40/164 (24%), Positives = 69/164 (42%), Gaps = 41/164 (25%)
Query: 74 IGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQ----------------VSMVS 116
I G++G+VY G + + + A+K + + ++ + Q V +
Sbjct: 12 ISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYY 71
Query: 117 RLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIA 176
L++ N V LV Y+ G G + +LH + G + VK
Sbjct: 72 SLQSANNVYLVMEYLIG------------GDVKSLLH----IYGYFDEEM-----AVKYI 110
Query: 177 VGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220
A L+YLH IIHR++K N+L+ ++ K++DF LS
Sbjct: 111 SEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLS 151
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 38.2 bits (89), Expect = 0.004
Identities = 29/87 (33%), Positives = 43/87 (49%), Gaps = 6/87 (6%)
Query: 193 RIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEY--AM-- 248
+HR+IK NVLL + +++DF S A + S +GT Y +PE AM
Sbjct: 122 GYVHRDIKPDNVLLDKNGHIRLADFG-SCLRLLADGTVQSNVAVGTPDYISPEILQAMED 180
Query: 249 -TGQMSSKSDVYSFGVVLLELLTGRKP 274
G+ + D +S GV + E+L G P
Sbjct: 181 GKGRYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 351 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.98 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.98 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.97 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.97 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.97 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.97 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.97 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.97 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.97 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.96 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.96 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.96 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.96 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.95 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.95 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.94 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.93 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.91 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.91 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.91 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.91 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.9 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.89 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.89 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.89 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.89 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.86 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.86 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.86 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.85 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.84 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.83 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.83 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.82 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.81 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.81 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.79 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.77 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.75 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.73 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.73 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.72 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.67 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.59 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.53 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.53 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.51 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.47 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.45 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.38 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.36 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.36 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.36 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.26 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.22 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.19 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.15 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 99.05 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.05 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.0 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.94 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.93 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.9 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.89 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.78 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.7 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.62 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.62 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.59 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.54 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.48 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.42 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.4 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.38 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 98.38 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 98.34 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 98.32 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.27 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 98.21 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 98.13 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 98.11 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 98.05 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 98.04 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.03 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 98.03 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.95 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.82 | |
| PLN02236 | 344 | choline kinase | 97.74 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.58 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 97.56 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 97.55 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 97.55 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 97.53 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 97.49 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 97.49 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 97.36 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 97.27 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 97.2 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 97.16 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 97.16 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.03 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.93 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 96.87 | |
| PF04655 | 253 | APH_6_hur: Aminoglycoside/hydroxyurea antibiotic r | 96.76 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 96.71 | |
| PTZ00384 | 383 | choline kinase; Provisional | 96.41 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 96.27 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 96.24 | |
| PTZ00296 | 442 | choline kinase; Provisional | 96.12 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-50 Score=370.76 Aligned_cols=270 Identities=51% Similarity=0.861 Sum_probs=241.3
Q ss_pred cccccCHHHHHHHhcCCCCCceeccCCcEEEEEEEECCCCEEEEEEcCCCCCc-hHHHHHHHHHHHhccCCceeeeEEEE
Q 018712 52 AVPVISVDELKEKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQP-DQEFLAQVSMVSRLKNENVVELVGYY 130 (351)
Q Consensus 52 ~~~~~~~~~~~~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~e~~~l~~l~h~niv~~~~~~ 130 (351)
....++++++...+++|...+.||+|+||.||+|...++..||||++...... ..+|.+|+.++.+++|||+|+++|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 56779999999999999999999999999999999998899999988776654 66799999999999999999999999
Q ss_pred ecCC-ceEEEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccC
Q 018712 131 VDGP-LRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDD 209 (351)
Q Consensus 131 ~~~~-~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~ 209 (351)
.+.+ ..+||+||+++|+|.++|...... .++|..+++|+.+++.||+|||....++|||||||+.|||+|++
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~-------~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~ 213 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE-------PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDED 213 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCC-------CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCC
Confidence 9998 499999999999999999876531 38999999999999999999999887789999999999999999
Q ss_pred CceEEecccccCCCcc-cccccccccc-ccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccch
Q 018712 210 DIAKISDFDLSNQAPD-AAARLHSTRV-LGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLV 287 (351)
Q Consensus 210 ~~vkl~Dfg~a~~~~~-~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~ 287 (351)
+++||+|||+|+..+. .... ... .||.+|+|||++..+..+.++||||||+++.||+||+.|.+...+.....+.
T Consensus 214 ~~aKlsDFGLa~~~~~~~~~~---~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~ 290 (361)
T KOG1187|consen 214 FNAKLSDFGLAKLGPEGDTSV---STTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLV 290 (361)
T ss_pred CCEEccCccCcccCCccccce---eeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHH
Confidence 9999999999976654 2211 122 7999999999999999999999999999999999999998877666677789
Q ss_pred hhcccCCCccchhhhcccccC-CCCCH-HHHHHHHHHHHHhhhhcc
Q 018712 288 TWATPKLSEDKVKQCVDTKLG-GEYPP-KAIAKVRKKKFITSECSN 331 (351)
Q Consensus 288 ~~~~~~~~~~~~~~~ld~~~~-~~~~~-~~~~~~~~~~~~~~~~~~ 331 (351)
.|..+.+.+..+.+++|+.+. ..+.. +++.++..+++.|++...
T Consensus 291 ~w~~~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~ 336 (361)
T KOG1187|consen 291 EWAKPLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDP 336 (361)
T ss_pred HHHHHHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCC
Confidence 999888888899999999987 66665 799999999999988773
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-51 Score=374.87 Aligned_cols=243 Identities=23% Similarity=0.405 Sum_probs=211.1
Q ss_pred cCCCCCceeccCCcEEEEEEEE-CCCCEEEEEEcCC----CCCchHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEE
Q 018712 66 DNFGTNSLIGEGSYGRVYFGVL-RSGRAAAIKKLDS----SKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAY 140 (351)
Q Consensus 66 ~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~----~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 140 (351)
.+|...+.||+|||+.||.+++ .+|..||+|++.+ .....+.+.+|+++.+.|+|||||+++++|++.++.|+|+
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 5799999999999999999997 7899999999976 4445678999999999999999999999999999999999
Q ss_pred EeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEeccccc
Q 018712 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (351)
Q Consensus 141 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a 220 (351)
|+|..++|..+++..+. +++.+++.+++||+.||.|||+++ |+|||||.+|+|++++.+|||+|||+|
T Consensus 98 ELC~~~sL~el~Krrk~---------ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLA 165 (592)
T KOG0575|consen 98 ELCHRGSLMELLKRRKP---------LTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLA 165 (592)
T ss_pred EecCCccHHHHHHhcCC---------CCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEeccccee
Confidence 99999999999996553 999999999999999999999999 999999999999999999999999999
Q ss_pred CCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccchhhcccCC------
Q 018712 221 NQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKL------ 294 (351)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~------ 294 (351)
......... ..+.+|||.|.|||++.+...+..+||||+||++|.|+.|++||+...-.+....+....-.+
T Consensus 166 t~le~~~Er--k~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~~P~~ls~ 243 (592)
T KOG0575|consen 166 TQLEYDGER--KKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYSMPSHLSA 243 (592)
T ss_pred eeecCcccc--cceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCcccccccCH
Confidence 988755333 267899999999999999999999999999999999999999999764433333332221111
Q ss_pred -CccchhhhcccccCCCCCHHHHHHHHHHHHH
Q 018712 295 -SEDKVKQCVDTKLGGEYPPKAIAKVRKKKFI 325 (351)
Q Consensus 295 -~~~~~~~~ld~~~~~~~~~~~~~~~~~~~~~ 325 (351)
..+++.++|+++|.+|++.+++ +.+.|+
T Consensus 244 ~A~dLI~~lL~~~P~~Rpsl~~v---L~h~Ff 272 (592)
T KOG0575|consen 244 EAKDLIRKLLRPNPSERPSLDEV---LDHPFF 272 (592)
T ss_pred HHHHHHHHHhcCCcccCCCHHHH---hcCHhh
Confidence 2378999999999999988776 444444
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-50 Score=351.77 Aligned_cols=204 Identities=30% Similarity=0.490 Sum_probs=183.7
Q ss_pred HhcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCC---CchHHHHHHHHHHHhccCCceeeeEEEEecCCceEEE
Q 018712 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK---QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLA 139 (351)
Q Consensus 64 ~~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 139 (351)
...+|...+.||.|+||+||+|+++ ++..||||.+.+.. ...+.+..|+++|+.++|||||.+++++...+.+|+|
T Consensus 8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lV 87 (429)
T KOG0595|consen 8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLV 87 (429)
T ss_pred ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEE
Confidence 4568999999999999999999975 78999999997654 2345578999999999999999999999999999999
Q ss_pred EEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccC------CceE
Q 018712 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDD------DIAK 213 (351)
Q Consensus 140 ~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~------~~vk 213 (351)
||||.||+|.+|++..+. +++.+++.++.||+.||++||+++ ||||||||.|||++.. -.+|
T Consensus 88 MEyC~gGDLs~yi~~~~~---------l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LK 155 (429)
T KOG0595|consen 88 MEYCNGGDLSDYIRRRGR---------LPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLK 155 (429)
T ss_pred EEeCCCCCHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEE
Confidence 999999999999998864 999999999999999999999999 9999999999999765 4689
Q ss_pred EecccccCCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCC
Q 018712 214 ISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRG 282 (351)
Q Consensus 214 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~ 282 (351)
|+|||+|+....... ..+.+|++.|||||++..+.|+.|+|+||+|+++|+|++|+.||...+..+
T Consensus 156 IADFGfAR~L~~~~~---a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~e 221 (429)
T KOG0595|consen 156 IADFGFARFLQPGSM---AETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKE 221 (429)
T ss_pred ecccchhhhCCchhH---HHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHH
Confidence 999999998875433 367899999999999999999999999999999999999999999665543
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-50 Score=352.88 Aligned_cols=249 Identities=24% Similarity=0.359 Sum_probs=208.2
Q ss_pred HhcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCC----chHHHHHHHHHHHhccCCceeeeEEEEecCCceEE
Q 018712 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ----PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVL 138 (351)
Q Consensus 64 ~~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 138 (351)
..++|++.+.||+|+||+||.++.+ +++.||+|++++... ......+|..+|.+++||+||+++..|++.+.+|+
T Consensus 23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLyl 102 (357)
T KOG0598|consen 23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYL 102 (357)
T ss_pred ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEE
Confidence 4578999999999999999999954 789999999976532 34567899999999999999999999999999999
Q ss_pred EEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEeccc
Q 018712 139 AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFD 218 (351)
Q Consensus 139 v~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg 218 (351)
|+||+.||.|...|++.+. +++..+..++.+|+.||.|||++| ||||||||+|||+|.+|+++|+|||
T Consensus 103 Vld~~~GGeLf~hL~~eg~---------F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFg 170 (357)
T KOG0598|consen 103 VLDYLNGGELFYHLQREGR---------FSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFG 170 (357)
T ss_pred EEeccCCccHHHHHHhcCC---------cchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccc
Confidence 9999999999999997764 999999999999999999999999 9999999999999999999999999
Q ss_pred ccCCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccchhhcc----cC-
Q 018712 219 LSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWAT----PK- 293 (351)
Q Consensus 219 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~~~~~----~~- 293 (351)
+|+........ +.+++||+.|||||++.+..|+..+|+||||+++|||++|.+||...+.......+...+ |.
T Consensus 171 L~k~~~~~~~~--t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~~p~~ 248 (357)
T KOG0598|consen 171 LCKEDLKDGDA--TRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPLPPGY 248 (357)
T ss_pred cchhcccCCCc--cccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCCCCcc
Confidence 99875444322 356899999999999999999999999999999999999999999876554443333322 11
Q ss_pred CC---ccchhhhcccccCCCCC-HHHHHHHHHHHHHh
Q 018712 294 LS---EDKVKQCVDTKLGGEYP-PKAIAKVRKKKFIT 326 (351)
Q Consensus 294 ~~---~~~~~~~ld~~~~~~~~-~~~~~~~~~~~~~~ 326 (351)
+. .+.++.++..++.+|.. ......+..|.+++
T Consensus 249 ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF~ 285 (357)
T KOG0598|consen 249 LSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFK 285 (357)
T ss_pred CCHHHHHHHHHHhccCHHHhcCCCCChHHhhcCcccc
Confidence 11 25677777777777763 23344466666544
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-49 Score=341.17 Aligned_cols=238 Identities=29% Similarity=0.411 Sum_probs=201.4
Q ss_pred hcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCC--CCCchHHHHHHHHHHHhccCCceeeeEEEEecCCc-eEEEE
Q 018712 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDS--SKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPL-RVLAY 140 (351)
Q Consensus 65 ~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-~~lv~ 140 (351)
.++.+..+.||+|..|+||++.++ +++.+|+|.+.. +....+++.+|+++++..+||+||++++.|..... .+++|
T Consensus 78 ~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~m 157 (364)
T KOG0581|consen 78 LSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICM 157 (364)
T ss_pred HHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeeh
Confidence 346777889999999999999986 789999999943 34446789999999999999999999999998884 99999
Q ss_pred EeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhh-CCCCCeeeccccCCcEEEccCCceEEecccc
Q 018712 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHE-KAEPRIIHRNIKSSNVLLFDDDIAKISDFDL 219 (351)
Q Consensus 141 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~-~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~ 219 (351)
|||++|||.+++...+. +++...-.++.++++||.|||+ .+ ||||||||+|||++..|.|||||||.
T Consensus 158 EYMDgGSLd~~~k~~g~---------i~E~~L~~ia~~VL~GL~YLh~~~~---IIHRDIKPsNlLvNskGeVKicDFGV 225 (364)
T KOG0581|consen 158 EYMDGGSLDDILKRVGR---------IPEPVLGKIARAVLRGLSYLHEERK---IIHRDIKPSNLLVNSKGEVKICDFGV 225 (364)
T ss_pred hhcCCCCHHHHHhhcCC---------CCHHHHHHHHHHHHHHHHHHhhccC---eeeccCCHHHeeeccCCCEEeccccc
Confidence 99999999999987653 8999999999999999999996 66 99999999999999999999999999
Q ss_pred cCCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCC--CCccc----hhhcccC
Q 018712 220 SNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPR--GQQSL----VTWATPK 293 (351)
Q Consensus 220 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~--~~~~~----~~~~~~~ 293 (351)
+..+-+.. ..+++||..|||||.+.+..|+.++||||||++++|+++|++||....+. ....+ .....|.
T Consensus 226 S~~lvnS~----a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~ 301 (364)
T KOG0581|consen 226 SGILVNSI----ANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPR 301 (364)
T ss_pred cHHhhhhh----cccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCC
Confidence 98876552 36788999999999999999999999999999999999999999875221 11111 1122333
Q ss_pred CCc--------cchhhhcccccCCCCCHHHHHH
Q 018712 294 LSE--------DKVKQCVDTKLGGEYPPKAIAK 318 (351)
Q Consensus 294 ~~~--------~~~~~~ld~~~~~~~~~~~~~~ 318 (351)
++. ..+..|+.+++..|+++.++..
T Consensus 302 lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~ 334 (364)
T KOG0581|consen 302 LPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQ 334 (364)
T ss_pred CCcccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 333 4677899999999998877644
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-48 Score=349.92 Aligned_cols=245 Identities=24% Similarity=0.336 Sum_probs=207.2
Q ss_pred HHHhcCCCCCceeccCCcEEEEEEEE-CCCCEEEEEEcCCCCCc----hHHHHHHHHHHHhc-cCCceeeeEEEEecCCc
Q 018712 62 KEKTDNFGTNSLIGEGSYGRVYFGVL-RSGRAAAIKKLDSSKQP----DQEFLAQVSMVSRL-KNENVVELVGYYVDGPL 135 (351)
Q Consensus 62 ~~~~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~----~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~ 135 (351)
.....+|...+.||.|+|++|++|.. .+++.||||++.+.... .+.+..|-.+|.+| .||.|++++..|+++..
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s 148 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES 148 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence 45567999999999999999999995 48999999999765322 23466788889999 89999999999999999
Q ss_pred eEEEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEe
Q 018712 136 RVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKIS 215 (351)
Q Consensus 136 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~ 215 (351)
+|+|+||+++|+|.++|++.+. +.+..++.++.+|+.||+|||++| ||||||||+|||+|++|++||+
T Consensus 149 LYFvLe~A~nGdll~~i~K~Gs---------fde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikIT 216 (604)
T KOG0592|consen 149 LYFVLEYAPNGDLLDLIKKYGS---------FDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKIT 216 (604)
T ss_pred eEEEEEecCCCcHHHHHHHhCc---------chHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEe
Confidence 9999999999999999998865 999999999999999999999999 9999999999999999999999
Q ss_pred cccccCCCcccccc---------ccc--cccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCc
Q 018712 216 DFDLSNQAPDAAAR---------LHS--TRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQ 284 (351)
Q Consensus 216 Dfg~a~~~~~~~~~---------~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~ 284 (351)
|||.|+.+...... ... ..++||..|.+||++.....++.+|||+||||+|+|+.|++||.+.++--..
T Consensus 217 DFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliF 296 (604)
T KOG0592|consen 217 DFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIF 296 (604)
T ss_pred eccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHH
Confidence 99999887543322 112 4589999999999999999999999999999999999999999987653322
Q ss_pred cchh-------hcccCCCccchhhhcccccCCCCCHHHHHH
Q 018712 285 SLVT-------WATPKLSEDKVKQCVDTKLGGEYPPKAIAK 318 (351)
Q Consensus 285 ~~~~-------~~~~~~~~~~~~~~ld~~~~~~~~~~~~~~ 318 (351)
..|. ...+....++++.+|..++..|++.+++.+
T Consensus 297 qkI~~l~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~ 337 (604)
T KOG0592|consen 297 QKIQALDYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKA 337 (604)
T ss_pred HHHHHhcccCCCCCCHHHHHHHHHHHccCccccccHHHHhh
Confidence 2221 222333357889999999999998866543
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-49 Score=344.82 Aligned_cols=241 Identities=23% Similarity=0.370 Sum_probs=199.2
Q ss_pred HHhcCCCCCceeccCCcEEEEEEEE-CCCCEEEEEEcCCCCC--------chHHHHHHHHHHHhccCCceeeeEEEEecC
Q 018712 63 EKTDNFGTNSLIGEGSYGRVYFGVL-RSGRAAAIKKLDSSKQ--------PDQEFLAQVSMVSRLKNENVVELVGYYVDG 133 (351)
Q Consensus 63 ~~~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~ 133 (351)
...+.|.+.+.||+|+||.|-+|.. ++|+.||||++.+... ......+|+++|++|+|||||+++++|...
T Consensus 169 s~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ 248 (475)
T KOG0615|consen 169 SFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVP 248 (475)
T ss_pred hhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecC
Confidence 3567788999999999999999995 5899999999975432 223467999999999999999999999999
Q ss_pred CceEEEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccC---C
Q 018712 134 PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDD---D 210 (351)
Q Consensus 134 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~---~ 210 (351)
+..|+||||+.||+|.+.+-..+. +.+.....+++|++.|+.|||++| |+||||||+|||+..+ .
T Consensus 249 ds~YmVlE~v~GGeLfd~vv~nk~---------l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~ 316 (475)
T KOG0615|consen 249 DSSYMVLEYVEGGELFDKVVANKY---------LREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDC 316 (475)
T ss_pred CceEEEEEEecCccHHHHHHhccc---------cccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcce
Confidence 999999999999999999987764 777788999999999999999999 9999999999999766 6
Q ss_pred ceEEecccccCCCccccccccccccccccCccCcccccCCCC---CccchhHhHHHHHHHHHcCCCCCCCCCCCC-Cccc
Q 018712 211 IAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQM---SSKSDVYSFGVVLLELLTGRKPVDHTLPRG-QQSL 286 (351)
Q Consensus 211 ~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~DvwslG~il~el~tg~~Pf~~~~~~~-~~~~ 286 (351)
.+||+|||+|+...... ...+++|||.|.|||++.+..+ ..+.|+||+||+||-+++|.+||.+..... ....
T Consensus 317 llKItDFGlAK~~g~~s---fm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQ 393 (475)
T KOG0615|consen 317 LLKITDFGLAKVSGEGS---FMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQ 393 (475)
T ss_pred EEEecccchhhccccce---ehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHH
Confidence 89999999999876433 2367899999999999986643 347899999999999999999999765433 1111
Q ss_pred h--------hhcccCCCc---cchhhhcccccCCCCCHHHHHH
Q 018712 287 V--------TWATPKLSE---DKVKQCVDTKLGGEYPPKAIAK 318 (351)
Q Consensus 287 ~--------~~~~~~~~~---~~~~~~ld~~~~~~~~~~~~~~ 318 (351)
+ ...+..+.+ +++..+|--+|..|++.+++..
T Consensus 394 I~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~ 436 (475)
T KOG0615|consen 394 ILKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALN 436 (475)
T ss_pred HhcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence 1 111112222 6788899999999998887643
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-48 Score=327.64 Aligned_cols=207 Identities=26% Similarity=0.353 Sum_probs=187.4
Q ss_pred HhcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCCc----hHHHHHHHHHHHhccCCceeeeEEEEecCCceEE
Q 018712 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP----DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVL 138 (351)
Q Consensus 64 ~~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 138 (351)
..++|++.+.||.|+||+|.+++.+ +|..||+|++++...- .+...+|..+|+.+.||+++++.+.+.+.+.+|+
T Consensus 42 ~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lym 121 (355)
T KOG0616|consen 42 SLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYM 121 (355)
T ss_pred chhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEE
Confidence 4578999999999999999999965 7889999999876432 2456789999999999999999999999999999
Q ss_pred EEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEeccc
Q 018712 139 AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFD 218 (351)
Q Consensus 139 v~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg 218 (351)
||||.+||.|..++++.+. +++..++.++.||+.||+|||+.+ |++|||||+|||+|.+|++||+|||
T Consensus 122 vmeyv~GGElFS~Lrk~~r---------F~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFG 189 (355)
T KOG0616|consen 122 VMEYVPGGELFSYLRKSGR---------FSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFG 189 (355)
T ss_pred EEeccCCccHHHHHHhcCC---------CCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEecc
Confidence 9999999999999998765 999999999999999999999999 9999999999999999999999999
Q ss_pred ccCCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccch
Q 018712 219 LSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLV 287 (351)
Q Consensus 219 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~ 287 (351)
+|+..... +-+.+|||.|+|||.++...|+.++|.|||||++|||+.|.+||...++......|
T Consensus 190 FAK~v~~r-----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI 253 (355)
T KOG0616|consen 190 FAKRVSGR-----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKI 253 (355)
T ss_pred ceEEecCc-----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHH
Confidence 99887654 25689999999999999999999999999999999999999999988774443333
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-46 Score=340.34 Aligned_cols=247 Identities=32% Similarity=0.468 Sum_probs=204.2
Q ss_pred CCCCceeccCCcEEEEEEEECCCCEEEEEEcCCCCCc---hHHHHHHHHHHHhccCCceeeeEEEEecCC-ceEEEEEeC
Q 018712 68 FGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVDGP-LRVLAYEHA 143 (351)
Q Consensus 68 y~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-~~~lv~e~~ 143 (351)
..+.+.||+|+||+||+|.++....||+|++...... ...+.+|+.+|++++|||||++++++.+.. .+++||||+
T Consensus 43 l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~ 122 (362)
T KOG0192|consen 43 LPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYM 122 (362)
T ss_pred hhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeC
Confidence 3444559999999999999986556999999865433 347999999999999999999999999887 799999999
Q ss_pred CCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCC-ceEEecccccCC
Q 018712 144 SKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD-IAKISDFDLSNQ 222 (351)
Q Consensus 144 ~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~-~vkl~Dfg~a~~ 222 (351)
++|+|.+++..... ..+++..++.++.||+.||.|||++++ ||||||||+|||++.++ ++||+|||+++.
T Consensus 123 ~~GsL~~~l~~~~~-------~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~ 193 (362)
T KOG0192|consen 123 PGGSLSVLLHKKRK-------RKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSRE 193 (362)
T ss_pred CCCcHHHHHhhccc-------CCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCcccee
Confidence 99999999987411 129999999999999999999999973 89999999999999998 999999999987
Q ss_pred CccccccccccccccccCccCccccc--CCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCC---------ccchhhcc
Q 018712 223 APDAAARLHSTRVLGTFGYHAPEYAM--TGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQ---------QSLVTWAT 291 (351)
Q Consensus 223 ~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~---------~~~~~~~~ 291 (351)
..... ...+...||+.|||||++. ...|+.++||||||+++|||+||+.||....+... ...+....
T Consensus 194 ~~~~~--~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~p~~~ 271 (362)
T KOG0192|consen 194 KVISK--TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPIPKEC 271 (362)
T ss_pred ecccc--ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCccC
Confidence 65432 1124467999999999999 66999999999999999999999999998775221 11122222
Q ss_pred cCCCccchhhhcccccCCCCCHHHHHHHHHHHHH
Q 018712 292 PKLSEDKVKQCVDTKLGGEYPPKAIAKVRKKKFI 325 (351)
Q Consensus 292 ~~~~~~~~~~~ld~~~~~~~~~~~~~~~~~~~~~ 325 (351)
+......+..|++.++..|++..++...++....
T Consensus 272 ~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~ 305 (362)
T KOG0192|consen 272 PPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMS 305 (362)
T ss_pred CHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHH
Confidence 3333478889999999999999988777765544
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-49 Score=328.88 Aligned_cols=243 Identities=22% Similarity=0.331 Sum_probs=199.2
Q ss_pred HhcCCCCCceeccCCcEEEEEEEE-CCCCEEEEEEcCCCCC---chHHHHHHHHHHHhccCCceeeeEE-EEecCCc-eE
Q 018712 64 KTDNFGTNSLIGEGSYGRVYFGVL-RSGRAAAIKKLDSSKQ---PDQEFLAQVSMVSRLKNENVVELVG-YYVDGPL-RV 137 (351)
Q Consensus 64 ~~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~h~niv~~~~-~~~~~~~-~~ 137 (351)
...+|++++.||.|+||.||++.. .+|..+|.|.+.-... ..+.+..|+.+|++|+|||||++++ .|.+++. ++
T Consensus 17 ~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evln 96 (375)
T KOG0591|consen 17 TLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLN 96 (375)
T ss_pred cHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhH
Confidence 345789999999999999999994 5899999999874433 3567889999999999999999998 5555555 89
Q ss_pred EEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCC-CCCeeeccccCCcEEEccCCceEEec
Q 018712 138 LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKA-EPRIIHRNIKSSNVLLFDDDIAKISD 216 (351)
Q Consensus 138 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~-~~~ivH~Dlkp~Nill~~~~~vkl~D 216 (351)
||||+|.+|+|.++++..+..+ ..+++..+++++.|++.||..+|.+- +..|+||||||.||+++.+|.|||+|
T Consensus 97 ivmE~c~~GDLsqmIk~~K~qk-----r~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGD 171 (375)
T KOG0591|consen 97 IVMELCDAGDLSQMIKHFKKQK-----RLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGD 171 (375)
T ss_pred HHHHhhcccCHHHHHHHHHhcc-----ccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeecc
Confidence 9999999999999997654332 23899999999999999999999931 11289999999999999999999999
Q ss_pred ccccCCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccchh-hcccCCC
Q 018712 217 FDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVT-WATPKLS 295 (351)
Q Consensus 217 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~~-~~~~~~~ 295 (351)
||+++.+...... ..+.+|||.||+||.+....|+.+|||||+||++|||+.-++||.+.+--.....|. -..|.++
T Consensus 172 fGL~r~l~s~~tf--A~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~~p 249 (375)
T KOG0591|consen 172 FGLGRFLSSKTTF--AHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPPLP 249 (375)
T ss_pred chhHhHhcchhHH--HHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCCCCc
Confidence 9999988765433 356789999999999999999999999999999999999999999873322222222 1222222
Q ss_pred --------ccchhhhcccccCCCCCH
Q 018712 296 --------EDKVKQCVDTKLGGEYPP 313 (351)
Q Consensus 296 --------~~~~~~~ld~~~~~~~~~ 313 (351)
...+..|++.++..||+.
T Consensus 250 ~~~YS~~l~~li~~ci~vd~~~RP~t 275 (375)
T KOG0591|consen 250 DEHYSTDLRELINMCIAVDPEQRPDT 275 (375)
T ss_pred HHHhhhHHHHHHHHHccCCcccCCCc
Confidence 256788999999999974
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-47 Score=322.33 Aligned_cols=238 Identities=25% Similarity=0.369 Sum_probs=197.9
Q ss_pred cCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCCc---hHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEEE
Q 018712 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYE 141 (351)
Q Consensus 66 ~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 141 (351)
+.|+.+.++|+|+||+||+++++ +|+.||||++..+..+ .+-.++|+++|++++|+|+|.+++.|.....++||+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 56888999999999999999976 7999999998655443 4567899999999999999999999999999999999
Q ss_pred eCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccccC
Q 018712 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (351)
Q Consensus 142 ~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~ 221 (351)
||+. ++.+-|..... .++...+..++.|++.|+.|+|+++ +|||||||+||||+.+|.+||||||+|+
T Consensus 82 ~~dh-TvL~eLe~~p~--------G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR 149 (396)
T KOG0593|consen 82 YCDH-TVLHELERYPN--------GVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFAR 149 (396)
T ss_pred ecch-HHHHHHHhccC--------CCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhH
Confidence 9988 66566655443 2888999999999999999999999 9999999999999999999999999999
Q ss_pred CCccccccccccccccccCccCcccccC-CCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccchhhcc---------
Q 018712 222 QAPDAAARLHSTRVLGTFGYHAPEYAMT-GQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWAT--------- 291 (351)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~~~~~--------- 291 (351)
.+...... .+..+.|..|.|||.+.| ..|+...||||+||++.||++|.+-|.+....++...|....
T Consensus 150 ~L~~pgd~--YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~ 227 (396)
T KOG0593|consen 150 TLSAPGDN--YTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQS 227 (396)
T ss_pred hhcCCcch--hhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHH
Confidence 88642222 255678999999999998 689999999999999999999999999876654433222111
Q ss_pred --------------------------cCCCc---cchhhhcccccCCCCCHHHHH
Q 018712 292 --------------------------PKLSE---DKVKQCVDTKLGGEYPPKAIA 317 (351)
Q Consensus 292 --------------------------~~~~~---~~~~~~ld~~~~~~~~~~~~~ 317 (351)
|.... +.++.|++-+|.+|++.+++.
T Consensus 228 iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll 282 (396)
T KOG0593|consen 228 IFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLL 282 (396)
T ss_pred HhccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHh
Confidence 11111 677889999999998877654
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-46 Score=339.68 Aligned_cols=210 Identities=25% Similarity=0.336 Sum_probs=182.4
Q ss_pred HhcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCCc----hHHHHHHHHHHHhccCCceeeeEEEEecCCceEE
Q 018712 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP----DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVL 138 (351)
Q Consensus 64 ~~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 138 (351)
..++|+++..||+|+||.||+|+-+ +|..+|+|+++++... -..++.|-.+|....++.||+++..|++.+++||
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL 218 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL 218 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence 4568999999999999999999954 8999999999876432 2456778888989999999999999999999999
Q ss_pred EEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEeccc
Q 018712 139 AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFD 218 (351)
Q Consensus 139 v~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg 218 (351)
||||++||++..+|...+. +++..+..++.+++.||..||+.| +|||||||+|+|||..|++||+|||
T Consensus 219 iMEylPGGD~mTLL~~~~~---------L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFG 286 (550)
T KOG0605|consen 219 IMEYLPGGDMMTLLMRKDT---------LTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFG 286 (550)
T ss_pred EEEecCCccHHHHHHhcCc---------CchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeecccc
Confidence 9999999999999987764 999999999999999999999999 9999999999999999999999999
Q ss_pred ccCCCccc----------------------ccc-----c------------------cccccccccCccCcccccCCCCC
Q 018712 219 LSNQAPDA----------------------AAR-----L------------------HSTRVLGTFGYHAPEYAMTGQMS 253 (351)
Q Consensus 219 ~a~~~~~~----------------------~~~-----~------------------~~~~~~gt~~y~aPE~~~~~~~~ 253 (351)
+|.-+... ... . .....+|||.|+|||++.+..|+
T Consensus 287 Ls~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~ 366 (550)
T KOG0605|consen 287 LSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYG 366 (550)
T ss_pred ccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCC
Confidence 98532110 000 0 00135799999999999999999
Q ss_pred ccchhHhHHHHHHHHHcCCCCCCCCCCCCCcc
Q 018712 254 SKSDVYSFGVVLLELLTGRKPVDHTLPRGQQS 285 (351)
Q Consensus 254 ~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~ 285 (351)
..+|+||||||+|||+.|.+||...++.....
T Consensus 367 ~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~r 398 (550)
T KOG0605|consen 367 KECDWWSLGCIMYEMLVGYPPFCSETPQETYR 398 (550)
T ss_pred ccccHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 99999999999999999999999987765543
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-46 Score=346.11 Aligned_cols=238 Identities=21% Similarity=0.310 Sum_probs=200.2
Q ss_pred HHHHhcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCC----chHHHHHHHHHHHhc-cCCceeeeEEEEecCC
Q 018712 61 LKEKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ----PDQEFLAQVSMVSRL-KNENVVELVGYYVDGP 134 (351)
Q Consensus 61 ~~~~~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~ 134 (351)
.....++|.++++||+|+||+|+++..+ +++.||||.+++... .-+..+.|..++... +||++++++..|++.+
T Consensus 363 ~~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~ 442 (694)
T KOG0694|consen 363 GPLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKE 442 (694)
T ss_pred CcccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCC
Confidence 4556789999999999999999999976 688999999987643 234567777777766 5999999999999999
Q ss_pred ceEEEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEE
Q 018712 135 LRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKI 214 (351)
Q Consensus 135 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl 214 (351)
++|.||||+.||++..+.+... +++..++.+++.++.||+|||++| ||+||||.+|||+|.+|++||
T Consensus 443 ~l~fvmey~~Ggdm~~~~~~~~----------F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~ki 509 (694)
T KOG0694|consen 443 HLFFVMEYVAGGDLMHHIHTDV----------FSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKI 509 (694)
T ss_pred eEEEEEEecCCCcEEEEEeccc----------ccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEe
Confidence 9999999999999665555443 999999999999999999999999 999999999999999999999
Q ss_pred ecccccCCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccchhhcccCC
Q 018712 215 SDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKL 294 (351)
Q Consensus 215 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~ 294 (351)
+|||+++....... .+++++|||.|||||++.+..|+...|+|||||+||||+.|..||.+.++++.-.-|....+.+
T Consensus 510 ADFGlcKe~m~~g~--~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~~y 587 (694)
T KOG0694|consen 510 ADFGLCKEGMGQGD--RTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEVRY 587 (694)
T ss_pred cccccccccCCCCC--ccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCC
Confidence 99999998653322 3478999999999999999999999999999999999999999999887765444443332222
Q ss_pred Cc-------cchhhhcccccCCCCCH
Q 018712 295 SE-------DKVKQCVDTKLGGEYPP 313 (351)
Q Consensus 295 ~~-------~~~~~~ld~~~~~~~~~ 313 (351)
+. +.++.++..+|.+|.-.
T Consensus 588 P~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 588 PRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred CCcccHHHHHHHHHHhccCcccccCC
Confidence 22 56677788888777644
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-45 Score=334.15 Aligned_cols=245 Identities=29% Similarity=0.420 Sum_probs=206.7
Q ss_pred CCCCceeccCCcEEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEEEeCCCCC
Q 018712 68 FGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASKGS 147 (351)
Q Consensus 68 y~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gs 147 (351)
+..++.||+|-||.|+.|.++....||+|.+.......+.+.+|+++|++|+|+|||++++++..++.+||||||++.|+
T Consensus 208 l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~Gs 287 (468)
T KOG0197|consen 208 LKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGS 287 (468)
T ss_pred HHHHHHhcCCccceEEEEEEcCCCcccceEEeccccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCc
Confidence 34456799999999999999888899999998877777889999999999999999999999999889999999999999
Q ss_pred HHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccccCCCcccc
Q 018712 148 LHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAA 227 (351)
Q Consensus 148 L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~ 227 (351)
|.++|...... .+...+.+.++.||++|++||++++ +|||||...||||+++..+||+|||+|+...+..
T Consensus 288 Ll~yLr~~~~~-------~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~ 357 (468)
T KOG0197|consen 288 LLDYLRTREGG-------LLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARLIGDDE 357 (468)
T ss_pred HHHHhhhcCCC-------ccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccccccCCCc
Confidence 99999973332 3889999999999999999999999 9999999999999999999999999999655443
Q ss_pred ccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCCccchhh--------cccCCCccc
Q 018712 228 ARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTW--------ATPKLSEDK 298 (351)
Q Consensus 228 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~Pf~~~~~~~~~~~~~~--------~~~~~~~~~ 298 (351)
... .....-...|.|||.+....++.+||||||||+||||+| |+.||......+....+.. ..|...-+.
T Consensus 358 Y~~-~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp~P~~CP~~vY~l 436 (468)
T KOG0197|consen 358 YTA-SEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLPRPEGCPDEVYEL 436 (468)
T ss_pred eee-cCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCCCCCCCCHHHHHH
Confidence 322 122234678999999999999999999999999999999 9999998766544333332 222222368
Q ss_pred hhhhcccccCCCCCHHHHHHHHHHH
Q 018712 299 VKQCVDTKLGGEYPPKAIAKVRKKK 323 (351)
Q Consensus 299 ~~~~ld~~~~~~~~~~~~~~~~~~~ 323 (351)
+..|+..+|.+||+.+.+...++-.
T Consensus 437 M~~CW~~~P~~RPtF~~L~~~l~~~ 461 (468)
T KOG0197|consen 437 MKSCWHEDPEDRPTFETLREVLEDF 461 (468)
T ss_pred HHHHhhCCcccCCCHHHHHHHHHHh
Confidence 8999999999999999776655543
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=331.94 Aligned_cols=241 Identities=25% Similarity=0.380 Sum_probs=202.7
Q ss_pred HHhcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCC----C--CchHHHHHHHHHHHhcc-CCceeeeEEEEecCC
Q 018712 63 EKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSS----K--QPDQEFLAQVSMVSRLK-NENVVELVGYYVDGP 134 (351)
Q Consensus 63 ~~~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~----~--~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~ 134 (351)
...++|.+.+.||+|+||+|+.|.+. ++..||+|++.+. . ...+.+.+|+.++++++ ||||+++++++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 45678999999999999999999854 7899999987654 1 22455678999999998 999999999999999
Q ss_pred ceEEEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccC-CceE
Q 018712 135 LRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDD-DIAK 213 (351)
Q Consensus 135 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~-~~vk 213 (351)
..|+||||+.||+|.+++..... +.+..+..++.||+.|++|||++| |+||||||+|||++.+ +++|
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~~g~---------l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~K 161 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVNKGR---------LKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLK 161 (370)
T ss_pred eEEEEEEecCCccHHHHHHHcCC---------CChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEE
Confidence 99999999999999999998443 888999999999999999999999 9999999999999999 9999
Q ss_pred EecccccCCCccccccccccccccccCccCcccccCCC-C-CccchhHhHHHHHHHHHcCCCCCCCCCCCCCccchh---
Q 018712 214 ISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQ-M-SSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVT--- 288 (351)
Q Consensus 214 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~-~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~~--- 288 (351)
|+|||++..... ........+||+.|+|||++.+.. | +.++||||+||+||.|++|+.||...........+.
T Consensus 162 l~DFG~s~~~~~--~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~ 239 (370)
T KOG0583|consen 162 LSDFGLSAISPG--EDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGE 239 (370)
T ss_pred EeccccccccCC--CCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCC
Confidence 999999987741 112236679999999999999887 8 478999999999999999999999855332222221
Q ss_pred hcccCCC-----ccchhhhcccccCCCCCHHHHH
Q 018712 289 WATPKLS-----EDKVKQCVDTKLGGEYPPKAIA 317 (351)
Q Consensus 289 ~~~~~~~-----~~~~~~~ld~~~~~~~~~~~~~ 317 (351)
...|.+. ..++..|++++|..|++..++.
T Consensus 240 ~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~ 273 (370)
T KOG0583|consen 240 FKIPSYLLSPEARSLIEKMLVPDPSTRITLLEIL 273 (370)
T ss_pred ccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHh
Confidence 1223322 4688999999999999888875
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-46 Score=336.72 Aligned_cols=243 Identities=26% Similarity=0.346 Sum_probs=204.5
Q ss_pred cCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCCch---HHHHHHHHHHHhccCCceeeeEEEEecCCceEEEEE
Q 018712 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPD---QEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYE 141 (351)
Q Consensus 66 ~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~---~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 141 (351)
++|.+.+.||+|+||+||+|+.+ +.+.||+|.+.+..+.+ +.+.+|+++++.++||||+.++++|....++++|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 57999999999999999999965 78899999998776655 447889999999999999999999999999999999
Q ss_pred eCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccccC
Q 018712 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (351)
Q Consensus 142 ~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~ 221 (351)
|+.| +|..+|..... +++..+..++.+++.||.|||+++ |+|||+||.|||++.+|++|+||||+|+
T Consensus 82 ~a~g-~L~~il~~d~~---------lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar 148 (808)
T KOG0597|consen 82 YAVG-DLFTILEQDGK---------LPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLAR 148 (808)
T ss_pred hhhh-hHHHHHHhccC---------CCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhh
Confidence 9988 99999988765 999999999999999999999999 9999999999999999999999999998
Q ss_pred CCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccchhhcccCCC------
Q 018712 222 QAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLS------ 295 (351)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~------ 295 (351)
....... ..+...|||.|||||+..++.|+..+|+||+||++|||++|++||....-......|......++
T Consensus 149 ~m~~~t~--vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~~p~~~S~~ 226 (808)
T KOG0597|consen 149 AMSTNTS--VLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPVKPPSTASSS 226 (808)
T ss_pred hcccCce--eeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCCCcccccHH
Confidence 8765432 23667899999999999999999999999999999999999999986533222222322222222
Q ss_pred -ccchhhhcccccCCCCCHHHHHHHHHHHHHh
Q 018712 296 -EDKVKQCVDTKLGGEYPPKAIAKVRKKKFIT 326 (351)
Q Consensus 296 -~~~~~~~ld~~~~~~~~~~~~~~~~~~~~~~ 326 (351)
...+..++.++|.+|++=. .++.++|+-
T Consensus 227 f~nfl~gLL~kdP~~RltW~---~Ll~HpF~k 255 (808)
T KOG0597|consen 227 FVNFLQGLLIKDPAQRLTWT---DLLGHPFWK 255 (808)
T ss_pred HHHHHHHHhhcChhhcccHH---HHhcChHHh
Confidence 2466777788888887543 345566554
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-45 Score=326.12 Aligned_cols=211 Identities=25% Similarity=0.390 Sum_probs=182.8
Q ss_pred HhcCCCCCceeccCCcEEEEEEEE-CCCCEEEEEEcCCCCC---chHHHHHHHHHHHhccCCceeeeEEEEecC--CceE
Q 018712 64 KTDNFGTNSLIGEGSYGRVYFGVL-RSGRAAAIKKLDSSKQ---PDQEFLAQVSMVSRLKNENVVELVGYYVDG--PLRV 137 (351)
Q Consensus 64 ~~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~ 137 (351)
..+.|+.+++||+|.||.||+|++ .+|+.||+|++..+.. ...-..+|+.+|++|+||||+++.+...+. ..+|
T Consensus 115 ~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siY 194 (560)
T KOG0600|consen 115 RADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIY 194 (560)
T ss_pred chHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEE
Confidence 445688899999999999999995 5899999999876542 245678999999999999999999988766 6899
Q ss_pred EEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecc
Q 018712 138 LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDF 217 (351)
Q Consensus 138 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Df 217 (351)
||+|||+. +|.-++..... .++..++..++.||+.||.|||.+| |+|||||..|||||.+|.+||+||
T Consensus 195 lVFeYMdh-DL~GLl~~p~v--------kft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDF 262 (560)
T KOG0600|consen 195 LVFEYMDH-DLSGLLSSPGV--------KFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADF 262 (560)
T ss_pred EEEecccc-hhhhhhcCCCc--------ccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccc
Confidence 99999988 99999886543 2999999999999999999999999 999999999999999999999999
Q ss_pred cccCCCccccccccccccccccCccCcccccCC-CCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccch
Q 018712 218 DLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTG-QMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLV 287 (351)
Q Consensus 218 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~ 287 (351)
|+|+......... .+..+-|..|.|||++.|. .|+...|+||.||||.||++|++.|++.++..+...|
T Consensus 263 GLAr~y~~~~~~~-~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kI 332 (560)
T KOG0600|consen 263 GLARFYTPSGSAP-YTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKI 332 (560)
T ss_pred cceeeccCCCCcc-cccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHH
Confidence 9999765443322 3556679999999999875 7999999999999999999999999998766555444
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-44 Score=298.34 Aligned_cols=208 Identities=27% Similarity=0.395 Sum_probs=183.4
Q ss_pred cCCCCCceeccCCcEEEEEEEE-CCCCEEEEEEcCCCCCc---hHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEEE
Q 018712 66 DNFGTNSLIGEGSYGRVYFGVL-RSGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYE 141 (351)
Q Consensus 66 ~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 141 (351)
++|...+.||+|.||.||+|.+ ++|+.||||+++..... .....+|++.|+.++|+||+.+++.|...+.+.||+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 4688899999999999999995 58999999999865433 4668999999999999999999999999999999999
Q ss_pred eCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccccC
Q 018712 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (351)
Q Consensus 142 ~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~ 221 (351)
|++. +|...++.... .++...+..++.++++||+|||.+. |+||||||.|+|++++|.+||+|||+|+
T Consensus 82 fm~t-dLe~vIkd~~i--------~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr 149 (318)
T KOG0659|consen 82 FMPT-DLEVVIKDKNI--------ILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLAR 149 (318)
T ss_pred eccc-cHHHHhccccc--------ccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchh
Confidence 9987 99999987754 3899999999999999999999999 9999999999999999999999999999
Q ss_pred CCccccccccccccccccCccCcccccCC-CCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccch
Q 018712 222 QAPDAAARLHSTRVLGTFGYHAPEYAMTG-QMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLV 287 (351)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~ 287 (351)
......... +..+-|..|.|||.+.|. .|+...|+||.|||+.||+.|.+-|.+.+.-++...+
T Consensus 150 ~f~~p~~~~--~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~I 214 (318)
T KOG0659|consen 150 FFGSPNRIQ--THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKI 214 (318)
T ss_pred ccCCCCccc--ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHH
Confidence 887654433 333679999999988764 7899999999999999999999988887665554443
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-44 Score=332.35 Aligned_cols=243 Identities=25% Similarity=0.325 Sum_probs=207.4
Q ss_pred hcCCCCCceeccCCcEEEEEEEE-CCCCEEEEEEcCCCC----CchHHHHHHHHHHHhccCCceeeeEEEEecCCceEEE
Q 018712 65 TDNFGTNSLIGEGSYGRVYFGVL-RSGRAAAIKKLDSSK----QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLA 139 (351)
Q Consensus 65 ~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 139 (351)
.+-|.+++.||+|+.|.|-+|++ .+|+.+|||++.+.. .....+.+|+.+|+-+.||||+++++.+.+..++|+|
T Consensus 11 iGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylv 90 (786)
T KOG0588|consen 11 IGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLV 90 (786)
T ss_pred ccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEE
Confidence 45689999999999999999996 589999999997652 2246688999999999999999999999999999999
Q ss_pred EEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccc
Q 018712 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDL 219 (351)
Q Consensus 140 ~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~ 219 (351)
+||+++|.|.+++-..+. +++.++..++.||+.|+.|+|..+ |+||||||+|+|+|..+++||+|||+
T Consensus 91 lEyv~gGELFdylv~kG~---------l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGM 158 (786)
T KOG0588|consen 91 LEYVPGGELFDYLVRKGP---------LPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGM 158 (786)
T ss_pred EEecCCchhHHHHHhhCC---------CCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccce
Confidence 999999999999988764 899999999999999999999999 99999999999999999999999999
Q ss_pred cCCCccccccccccccccccCccCcccccCCCC-CccchhHhHHHHHHHHHcCCCCCCCCCCCCCccchhhcc-------
Q 018712 220 SNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQM-SSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWAT------- 291 (351)
Q Consensus 220 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~~~~~------- 291 (351)
|.....+.- -.+-||+|.|.|||++.|..| +.++||||.|||||.|+||+.||++++-+.....+....
T Consensus 159 AsLe~~gkl---LeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f~MPs~I 235 (786)
T KOG0588|consen 159 ASLEVPGKL---LETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVFEMPSNI 235 (786)
T ss_pred eecccCCcc---ccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcccCCCcC
Confidence 977654432 255689999999999999998 689999999999999999999999765543333332221
Q ss_pred cCCCccchhhhcccccCCCCCHHHHHHHHHHHHH
Q 018712 292 PKLSEDKVKQCVDTKLGGEYPPKAIAKVRKKKFI 325 (351)
Q Consensus 292 ~~~~~~~~~~~ld~~~~~~~~~~~~~~~~~~~~~ 325 (351)
+.-.++++..|+|-++..|++.+++ ++|.|+
T Consensus 236 s~eaQdLLr~ml~VDp~~RiT~~eI---~kHP~l 266 (786)
T KOG0588|consen 236 SSEAQDLLRRMLDVDPSTRITTEEI---LKHPFL 266 (786)
T ss_pred CHHHHHHHHHHhccCccccccHHHH---hhCchh
Confidence 1222478999999999999987765 555553
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-44 Score=316.57 Aligned_cols=248 Identities=26% Similarity=0.427 Sum_probs=196.7
Q ss_pred hcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCCc-hHHHHHHHHHHHhccCCceeeeEEEEecCC--ceEEEE
Q 018712 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP-DQEFLAQVSMVSRLKNENVVELVGYYVDGP--LRVLAY 140 (351)
Q Consensus 65 ~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~e~~~l~~l~h~niv~~~~~~~~~~--~~~lv~ 140 (351)
..+|...+.||+|+||.||++.+. +|...|||.+...... .+.+.+|+.+|++++|||||++++...... .++++|
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~m 95 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFM 95 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeee
Confidence 456888899999999999999975 5899999998765322 355889999999999999999999754444 689999
Q ss_pred EeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEcc-CCceEEecccc
Q 018712 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFD-DDIAKISDFDL 219 (351)
Q Consensus 141 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~-~~~vkl~Dfg~ 219 (351)
||+++|+|.+++...+. . +++..++.+++||++||.|||++| ++||||||+|||++. ++.+||+|||+
T Consensus 96 Ey~~~GsL~~~~~~~g~-~-------l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~ 164 (313)
T KOG0198|consen 96 EYAPGGSLSDLIKRYGG-K-------LPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGL 164 (313)
T ss_pred eccCCCcHHHHHHHcCC-C-------CCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCcc
Confidence 99999999999998763 2 899999999999999999999999 999999999999999 79999999999
Q ss_pred cCCCcc-ccccccccccccccCccCcccccCC-CCCccchhHhHHHHHHHHHcCCCCCCCC-CCCCCc---------cch
Q 018712 220 SNQAPD-AAARLHSTRVLGTFGYHAPEYAMTG-QMSSKSDVYSFGVVLLELLTGRKPVDHT-LPRGQQ---------SLV 287 (351)
Q Consensus 220 a~~~~~-~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~Pf~~~-~~~~~~---------~~~ 287 (351)
++.... ...........||+.|||||++..+ ....++|||||||++.||+||+.||... ...... ..+
T Consensus 165 a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P~i 244 (313)
T KOG0198|consen 165 AKKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLPEI 244 (313)
T ss_pred ccccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCCCC
Confidence 887653 1111122457899999999999853 3345999999999999999999999873 111100 011
Q ss_pred hhcccCCCccchhhhcccccCCCCCHHHHHHHHHHHHHh
Q 018712 288 TWATPKLSEDKVKQCVDTKLGGEYPPKAIAKVRKKKFIT 326 (351)
Q Consensus 288 ~~~~~~~~~~~~~~~ld~~~~~~~~~~~~~~~~~~~~~~ 326 (351)
....+....+.+..|+..++..|++++++. .+.|.+
T Consensus 245 p~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL---~hpf~~ 280 (313)
T KOG0198|consen 245 PDSLSDEAKDFLRKCFKRDPEKRPTAEELL---EHPFLK 280 (313)
T ss_pred CcccCHHHHHHHHHHhhcCcccCcCHHHHh---hChhhh
Confidence 111112223678899999999999887764 444443
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=313.56 Aligned_cols=245 Identities=24% Similarity=0.328 Sum_probs=203.6
Q ss_pred HhcCCCCCceeccCCcEEEEEEEE-CCCCEEEEEEcCCCCCc--hHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEE
Q 018712 64 KTDNFGTNSLIGEGSYGRVYFGVL-RSGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAY 140 (351)
Q Consensus 64 ~~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 140 (351)
..++|++.+.||.|..+.||+|.. ..+..||||++..+.-. -..+.+|+..|+.++||||++++..|..+..+|+||
T Consensus 24 n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVm 103 (516)
T KOG0582|consen 24 NAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVM 103 (516)
T ss_pred CccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEee
Confidence 457899999999999999999995 47899999999765433 367899999999999999999999999999999999
Q ss_pred EeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEeccccc
Q 018712 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (351)
Q Consensus 141 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a 220 (351)
.||.+||+.+++...-.. .+.+..+..+++++++||.|||.+| .||||||++||||+.+|.|||+|||.+
T Consensus 104 pfMa~GS~ldIik~~~~~-------Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvs 173 (516)
T KOG0582|consen 104 PFMAGGSLLDIIKTYYPD-------GLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVS 173 (516)
T ss_pred hhhcCCcHHHHHHHHccc-------cccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceee
Confidence 999999999999876433 2899999999999999999999999 999999999999999999999999987
Q ss_pred CCCcccccc-c-cccccccccCccCccccc--CCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccc-hhhcc----
Q 018712 221 NQAPDAAAR-L-HSTRVLGTFGYHAPEYAM--TGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSL-VTWAT---- 291 (351)
Q Consensus 221 ~~~~~~~~~-~-~~~~~~gt~~y~aPE~~~--~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~-~~~~~---- 291 (351)
..+.....+ . ....++||+.|||||++. ...|+.|+||||||++..||++|..||....+.....+ +....
T Consensus 174 a~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~ 253 (516)
T KOG0582|consen 174 ASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLL 253 (516)
T ss_pred eeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcc
Confidence 665433221 1 125678999999999954 35899999999999999999999999998765432211 11111
Q ss_pred ------------cCCCccchhhhcccccCCCCCHHHHHH
Q 018712 292 ------------PKLSEDKVKQCVDTKLGGEYPPKAIAK 318 (351)
Q Consensus 292 ------------~~~~~~~~~~~ld~~~~~~~~~~~~~~ 318 (351)
.+-..+.+..|+..+|.+|++++.+.+
T Consensus 254 t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 254 TSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred cccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 111236788999999999999887654
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-44 Score=326.08 Aligned_cols=244 Identities=27% Similarity=0.478 Sum_probs=207.0
Q ss_pred hcCCCCCceeccCCcEEEEEEEE-CCCCEEEEEEcCCCCCc-hHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEEEe
Q 018712 65 TDNFGTNSLIGEGSYGRVYFGVL-RSGRAAAIKKLDSSKQP-DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEH 142 (351)
Q Consensus 65 ~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 142 (351)
...|....+||+|+.|.||.|.. .+++.||||++...... .+-+.+|+.+|+..+|+|||++++.|...+.+++||||
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEy 351 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEY 351 (550)
T ss_pred hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEee
Confidence 34688889999999999999994 57899999999876655 45578999999999999999999999988999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccccCC
Q 018712 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222 (351)
Q Consensus 143 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~ 222 (351)
++||+|.+++.... +++.++..++++++.||+|||.+| |+|||||.+|||++.+|.+||+|||+|..
T Consensus 352 m~ggsLTDvVt~~~----------~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaq 418 (550)
T KOG0578|consen 352 MEGGSLTDVVTKTR----------MTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQ 418 (550)
T ss_pred cCCCchhhhhhccc----------ccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeec
Confidence 99999999998765 899999999999999999999999 99999999999999999999999999988
Q ss_pred CccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccchh-hcccCCC------
Q 018712 223 APDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVT-WATPKLS------ 295 (351)
Q Consensus 223 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~~-~~~~~~~------ 295 (351)
+...... ..+.+|||.|||||+.....|+++.||||||++++||+-|.+||-...+-....++. ...|.+.
T Consensus 419 i~~~~~K--R~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~~~klS 496 (550)
T KOG0578|consen 419 ISEEQSK--RSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKNPEKLS 496 (550)
T ss_pred cccccCc--cccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCCccccC
Confidence 7655432 367889999999999999999999999999999999999999998655433333332 2222222
Q ss_pred ---ccchhhhcccccCCCCCHHHHHHHHHHHHHh
Q 018712 296 ---EDKVKQCVDTKLGGEYPPKAIAKVRKKKFIT 326 (351)
Q Consensus 296 ---~~~~~~~ld~~~~~~~~~~~~~~~~~~~~~~ 326 (351)
.+.+..||..++.+|.++.++. ++.|+-
T Consensus 497 ~~~kdFL~~cL~~dv~~RasA~eLL---~HpFl~ 527 (550)
T KOG0578|consen 497 PELKDFLDRCLVVDVEQRASAKELL---EHPFLK 527 (550)
T ss_pred HHHHHHHHHHhhcchhcCCCHHHHh---cChhhh
Confidence 2667788888888888877764 455544
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-44 Score=315.82 Aligned_cols=241 Identities=24% Similarity=0.350 Sum_probs=205.4
Q ss_pred HhcCCCCCceeccCCcEEEEEEE-ECCCCEEEEEEcCCCCCch----HHHHHHHHHHHhccCCceeeeEEEEecCCceEE
Q 018712 64 KTDNFGTNSLIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPD----QEFLAQVSMVSRLKNENVVELVGYYVDGPLRVL 138 (351)
Q Consensus 64 ~~~~y~~~~~Lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 138 (351)
...+|++.+.||+|.||+|-+|. +..|+.||||.++++...+ -.+.+|+++|+.|+||||+++++.|.+.+...|
T Consensus 51 lkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvi 130 (668)
T KOG0611|consen 51 LKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVI 130 (668)
T ss_pred hhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEE
Confidence 44679999999999999999998 4789999999998765432 347899999999999999999999999999999
Q ss_pred EEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEeccc
Q 018712 139 AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFD 218 (351)
Q Consensus 139 v~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg 218 (351)
||||..+|.|++|+...+. +++.+++.+++||+.|+.|+|.++ ++|||||.+|||+|.++++||+|||
T Consensus 131 vMEYaS~GeLYDYiSer~~---------LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFG 198 (668)
T KOG0611|consen 131 VMEYASGGELYDYISERGS---------LSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFG 198 (668)
T ss_pred EEEecCCccHHHHHHHhcc---------ccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccc
Confidence 9999999999999998875 999999999999999999999999 9999999999999999999999999
Q ss_pred ccCCCccccccccccccccccCccCcccccCCCC-CccchhHhHHHHHHHHHcCCCCCCCCCCCCCccchh------hcc
Q 018712 219 LSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQM-SSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVT------WAT 291 (351)
Q Consensus 219 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~~------~~~ 291 (351)
++-.+..... .++++|++.|.+||++.|..| ++..|-||||++||.|+.|..||++.+.......|. -..
T Consensus 199 LSNly~~~kf---LqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrEP~~ 275 (668)
T KOG0611|consen 199 LSNLYADKKF---LQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYREPET 275 (668)
T ss_pred hhhhhccccH---HHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccCCCC
Confidence 9877654433 367899999999999999998 688999999999999999999999865433222221 111
Q ss_pred cCCCccchhhhcccccCCCCCHHHHHHH
Q 018712 292 PKLSEDKVKQCVDTKLGGEYPPKAIAKV 319 (351)
Q Consensus 292 ~~~~~~~~~~~ld~~~~~~~~~~~~~~~ 319 (351)
|.-...+++.++--+|..|.+.+.+..-
T Consensus 276 PSdA~gLIRwmLmVNP~RRATieDiAsH 303 (668)
T KOG0611|consen 276 PSDASGLIRWMLMVNPERRATIEDIASH 303 (668)
T ss_pred CchHHHHHHHHHhcCcccchhHHHHhhh
Confidence 2222368888888888888877776554
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=316.03 Aligned_cols=245 Identities=29% Similarity=0.392 Sum_probs=193.4
Q ss_pred HHHHHhcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCCc---------------hHHHHHHHHHHHhccCCce
Q 018712 60 ELKEKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP---------------DQEFLAQVSMVSRLKNENV 123 (351)
Q Consensus 60 ~~~~~~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---------------~~~~~~e~~~l~~l~h~ni 123 (351)
+-....+.|++++.||+|.||.|-+|.+. +++.||||++.+.... .+...+|+.+|+++.||||
T Consensus 91 ~~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nV 170 (576)
T KOG0585|consen 91 QDRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNV 170 (576)
T ss_pred ccceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCe
Confidence 33456688999999999999999999965 7899999999653221 2468899999999999999
Q ss_pred eeeEEEEec--CCceEEEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccC
Q 018712 124 VELVGYYVD--GPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKS 201 (351)
Q Consensus 124 v~~~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp 201 (351)
|++++...+ .+.+|||+|||..|.+...-... +.+++.+++.++++++.||.|||.+| ||||||||
T Consensus 171 V~LiEvLDDP~s~~~YlVley~s~G~v~w~p~d~---------~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKP 238 (576)
T KOG0585|consen 171 VKLIEVLDDPESDKLYLVLEYCSKGEVKWCPPDK---------PELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKP 238 (576)
T ss_pred eEEEEeecCcccCceEEEEEeccCCccccCCCCc---------ccccHHHHHHHHHHHHHHHHHHHhcC---eeccccch
Confidence 999998865 45789999999988876543222 22899999999999999999999999 99999999
Q ss_pred CcEEEccCCceEEecccccCCCcccc---ccccccccccccCccCcccccCCC----CCccchhHhHHHHHHHHHcCCCC
Q 018712 202 SNVLLFDDDIAKISDFDLSNQAPDAA---ARLHSTRVLGTFGYHAPEYAMTGQ----MSSKSDVYSFGVVLLELLTGRKP 274 (351)
Q Consensus 202 ~Nill~~~~~vkl~Dfg~a~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwslG~il~el~tg~~P 274 (351)
.|+|++++|+|||+|||.+....... ........+|||.|+|||...++. .+.+.||||+||+||.|+.|+.|
T Consensus 239 sNLLl~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~P 318 (576)
T KOG0585|consen 239 SNLLLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLP 318 (576)
T ss_pred hheEEcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCC
Confidence 99999999999999999988663221 111123468999999999987632 36688999999999999999999
Q ss_pred CCCCCCCCCccchhh---ccc------CCCccchhhhcccccCCCCCHHHH
Q 018712 275 VDHTLPRGQQSLVTW---ATP------KLSEDKVKQCVDTKLGGEYPPKAI 316 (351)
Q Consensus 275 f~~~~~~~~~~~~~~---~~~------~~~~~~~~~~ld~~~~~~~~~~~~ 316 (351)
|-+.........|.. ..| ...+++++.+|+++|..|+...++
T Consensus 319 F~~~~~~~l~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~i 369 (576)
T KOG0585|consen 319 FFDDFELELFDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDI 369 (576)
T ss_pred cccchHHHHHHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhh
Confidence 987654332222221 111 222478899999999999876554
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=323.27 Aligned_cols=241 Identities=22% Similarity=0.352 Sum_probs=200.4
Q ss_pred HHhcCCCCCceeccCCcEEEEEEEE-CCCCEEEEEEcCCCCCchHH--HHHHHHHHHhcc-CCceeeeEEEEecCC-ceE
Q 018712 63 EKTDNFGTNSLIGEGSYGRVYFGVL-RSGRAAAIKKLDSSKQPDQE--FLAQVSMVSRLK-NENVVELVGYYVDGP-LRV 137 (351)
Q Consensus 63 ~~~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~--~~~e~~~l~~l~-h~niv~~~~~~~~~~-~~~ 137 (351)
...++|.++++||.|+||.||+|+. .++..||||++++....-++ -++|++.|++++ ||||+++.+.+.+.+ .+|
T Consensus 7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~ 86 (538)
T KOG0661|consen 7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILY 86 (538)
T ss_pred hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEe
Confidence 4668899999999999999999995 47899999999876555443 468999999998 999999999998888 899
Q ss_pred EEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecc
Q 018712 138 LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDF 217 (351)
Q Consensus 138 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Df 217 (351)
+|||||+. +|+++++.+.. .+++..++.|+.||++||+|+|++| +.||||||+|||+.....+||+||
T Consensus 87 fVfE~Md~-NLYqLmK~R~r--------~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDF 154 (538)
T KOG0661|consen 87 FVFEFMDC-NLYQLMKDRNR--------LFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADF 154 (538)
T ss_pred eeHHhhhh-hHHHHHhhcCC--------cCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEeccc
Confidence 99999976 99999998743 3999999999999999999999999 999999999999998999999999
Q ss_pred cccCCCccccccccccccccccCccCccccc-CCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccch---------
Q 018712 218 DLSNQAPDAAARLHSTRVLGTFGYHAPEYAM-TGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLV--------- 287 (351)
Q Consensus 218 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~--------- 287 (351)
|+|+........ +..+.|..|+|||++. ...|+.+.|+||+|||++|+.+-++-|.+.++.++...+
T Consensus 155 GLARev~SkpPY---TeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~ 231 (538)
T KOG0661|consen 155 GLAREVRSKPPY---TEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDK 231 (538)
T ss_pred ccccccccCCCc---chhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCcc
Confidence 999998655432 5667899999999886 457899999999999999999999999886553322111
Q ss_pred -------------hhcccCCCc---------------cchhhhcccccCCCCCHHHHHH
Q 018712 288 -------------TWATPKLSE---------------DKVKQCVDTKLGGEYPPKAIAK 318 (351)
Q Consensus 288 -------------~~~~~~~~~---------------~~~~~~ld~~~~~~~~~~~~~~ 318 (351)
....|.... +++.+|+..+|.+|++++++.+
T Consensus 232 ~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~ 290 (538)
T KOG0661|consen 232 DSWPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQ 290 (538)
T ss_pred ccchhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhc
Confidence 111111111 5677888888888888877644
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-44 Score=294.61 Aligned_cols=241 Identities=25% Similarity=0.349 Sum_probs=205.2
Q ss_pred HHhcCCCCCceeccCCcEEEEEEEE-CCCCEEEEEEcCCCC----CchHHHHHHHHHHHhccCCceeeeEEEEecCCceE
Q 018712 63 EKTDNFGTNSLIGEGSYGRVYFGVL-RSGRAAAIKKLDSSK----QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRV 137 (351)
Q Consensus 63 ~~~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 137 (351)
...++|++.+.||+|.||.||+|+. +++..||+|++.++. ...+++.+|+++-+.|+||||++++++|.+....|
T Consensus 19 ~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riy 98 (281)
T KOG0580|consen 19 WTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIY 98 (281)
T ss_pred cchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeE
Confidence 4568899999999999999999995 578899999987653 23567899999999999999999999999999999
Q ss_pred EEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecc
Q 018712 138 LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDF 217 (351)
Q Consensus 138 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Df 217 (351)
|++||...|+|...|......+ +++.....++.|++.||.|+|.++ ++||||||+|+|++..+.+||+||
T Consensus 99 LilEya~~gel~k~L~~~~~~~-------f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdf 168 (281)
T KOG0580|consen 99 LILEYAPRGELYKDLQEGRMKR-------FDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADF 168 (281)
T ss_pred EEEEecCCchHHHHHHhccccc-------ccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCC
Confidence 9999999999999999665433 888889999999999999999999 999999999999999999999999
Q ss_pred cccCCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccchhhccc----C
Q 018712 218 DLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATP----K 293 (351)
Q Consensus 218 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~----~ 293 (351)
|.+...+... ..+.+||..|.+||+..+..++...|+|++|++.||++.|.+||...........+....- .
T Consensus 169 GwsV~~p~~k----R~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~~p~~ 244 (281)
T KOG0580|consen 169 GWSVHAPSNK----RKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLKFPST 244 (281)
T ss_pred CceeecCCCC----ceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccccCCcc
Confidence 9987765322 2678999999999999999999999999999999999999999998764433333332221 1
Q ss_pred C---CccchhhhcccccCCCCCHHHHH
Q 018712 294 L---SEDKVKQCVDTKLGGEYPPKAIA 317 (351)
Q Consensus 294 ~---~~~~~~~~ld~~~~~~~~~~~~~ 317 (351)
+ ..+.+..|+-.++.+|....++.
T Consensus 245 is~~a~dlI~~ll~~~p~~r~~l~~v~ 271 (281)
T KOG0580|consen 245 ISGGAADLISRLLVKNPIERLALTEVM 271 (281)
T ss_pred cChhHHHHHHHHhccCccccccHHHHh
Confidence 1 23678888888888888766654
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-43 Score=307.87 Aligned_cols=262 Identities=23% Similarity=0.331 Sum_probs=212.9
Q ss_pred HHhcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCCc----hHHHHHHHHHHHhccCCceeeeEEEEecCCceE
Q 018712 63 EKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP----DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRV 137 (351)
Q Consensus 63 ~~~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 137 (351)
...+.|++++.||+|.-|+||++..+ ++..+|+|++.+.... -.+...|-++|+.++||.++.++..|..+...|
T Consensus 74 l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~c 153 (459)
T KOG0610|consen 74 LGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSC 153 (459)
T ss_pred cCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeE
Confidence 34466888889999999999999976 5689999999865432 245677889999999999999999999999999
Q ss_pred EEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecc
Q 018712 138 LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDF 217 (351)
Q Consensus 138 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Df 217 (351)
++||||+||+|..+++++.... +++..++.++.+++.||+|||..| ||+|||||+||||.++|+|.|+||
T Consensus 154 l~meyCpGGdL~~LrqkQp~~~-------fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDF 223 (459)
T KOG0610|consen 154 LVMEYCPGGDLHSLRQKQPGKR-------FSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDF 223 (459)
T ss_pred EEEecCCCccHHHHHhhCCCCc-------cchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeec
Confidence 9999999999999999876544 999999999999999999999999 999999999999999999999999
Q ss_pred cccCCCccc----------------------------------c--------------------ccccccccccccCccC
Q 018712 218 DLSNQAPDA----------------------------------A--------------------ARLHSTRVLGTFGYHA 243 (351)
Q Consensus 218 g~a~~~~~~----------------------------------~--------------------~~~~~~~~~gt~~y~a 243 (351)
.++...... . ....+..++||-.|+|
T Consensus 224 DLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlA 303 (459)
T KOG0610|consen 224 DLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLA 303 (459)
T ss_pred cccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCcccccccccccccc
Confidence 987432110 0 0012234689999999
Q ss_pred cccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccchhhcccCCC---------ccchhhhcccccCCCCC-H
Q 018712 244 PEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLS---------EDKVKQCVDTKLGGEYP-P 313 (351)
Q Consensus 244 PE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~---------~~~~~~~ld~~~~~~~~-~ 313 (351)
||++.|...+.++|+|+|||++|||+.|..||.+.+.+.....+......++ .++++.+|-++|.+|+. .
T Consensus 304 PEvI~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~ 383 (459)
T KOG0610|consen 304 PEVIRGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGSK 383 (459)
T ss_pred ceeeecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCCcchhHHHHHHHHHhccChhhhhccc
Confidence 9999999999999999999999999999999999877654433332222222 37889999999999986 3
Q ss_pred HHHHHHHHHHHHh------hhhccccc
Q 018712 314 KAIAKVRKKKFIT------SECSNISF 334 (351)
Q Consensus 314 ~~~~~~~~~~~~~------~~~~~~~~ 334 (351)
.-+..+-+|+|+- ++|.++.+
T Consensus 384 rGA~eIK~HpFF~gVnWaLir~~~PP~ 410 (459)
T KOG0610|consen 384 RGAAEIKRHPFFEGVNWALIRCARPPE 410 (459)
T ss_pred cchHHhhcCccccCCChhheeccCCCc
Confidence 3455566666643 56666555
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-43 Score=316.01 Aligned_cols=243 Identities=21% Similarity=0.308 Sum_probs=197.9
Q ss_pred cCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCC----CchHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEE
Q 018712 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK----QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAY 140 (351)
Q Consensus 66 ~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 140 (351)
++|++.+.||+|+||.||+|... +++.||+|++.... ...+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 47899999999999999999975 78999999986432 22356788999999999999999999999999999999
Q ss_pred EeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEeccccc
Q 018712 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (351)
Q Consensus 141 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a 220 (351)
||+++|+|.+++..... +++..+..++.||+.||.|||++| ++||||||+|||++.++.+||+|||++
T Consensus 81 e~~~~~~L~~~~~~~~~---------~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~ 148 (291)
T cd05612 81 EYVPGGELFSYLRNSGR---------FSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFA 148 (291)
T ss_pred eCCCCCCHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcc
Confidence 99999999999976542 888999999999999999999999 999999999999999999999999998
Q ss_pred CCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccchhhcc-------cC
Q 018712 221 NQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWAT-------PK 293 (351)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~~~~~-------~~ 293 (351)
....... ....||+.|+|||++.+..++.++||||||+++|+|++|+.||...........+.... +.
T Consensus 149 ~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 223 (291)
T cd05612 149 KKLRDRT-----WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPRHLDL 223 (291)
T ss_pred hhccCCc-----ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcCCCccCCH
Confidence 7654321 34568999999999999999999999999999999999999998754432211111111 11
Q ss_pred CCccchhhhcccccCCCCCHH--HHHHHHHHHHH
Q 018712 294 LSEDKVKQCVDTKLGGEYPPK--AIAKVRKKKFI 325 (351)
Q Consensus 294 ~~~~~~~~~ld~~~~~~~~~~--~~~~~~~~~~~ 325 (351)
...+.++.|+..++.+|++.. .+..+.++.++
T Consensus 224 ~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~ 257 (291)
T cd05612 224 YAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWF 257 (291)
T ss_pred HHHHHHHHHcCCCHHHccCCccCCHHHHhcCccc
Confidence 224688889999999998521 23334455544
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-44 Score=315.46 Aligned_cols=240 Identities=27% Similarity=0.418 Sum_probs=209.0
Q ss_pred cCCCCCceeccCCcEEEEEEEE-CCCCEEEEEEcCCCCCc--hHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEEEe
Q 018712 66 DNFGTNSLIGEGSYGRVYFGVL-RSGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEH 142 (351)
Q Consensus 66 ~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 142 (351)
..|...+.||+|+||.||+|.+ .+++.||+|++..+... ..++.+|+.+|..++++||.++++.+..+..++++|||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey 92 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY 92 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence 3577778999999999999995 58999999999765443 46788999999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccccCC
Q 018712 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222 (351)
Q Consensus 143 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~ 222 (351)
|.||++.+.++.... +.+..+..++++++.|+.|||.++ .+|||||+.|||+..+|.|||+|||++..
T Consensus 93 ~~gGsv~~lL~~~~~---------~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~q 160 (467)
T KOG0201|consen 93 CGGGSVLDLLKSGNI---------LDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQ 160 (467)
T ss_pred hcCcchhhhhccCCC---------CccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeee
Confidence 999999999987652 467777889999999999999999 99999999999999999999999999987
Q ss_pred CccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccchhhcccCCCc------
Q 018712 223 APDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSE------ 296 (351)
Q Consensus 223 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~------ 296 (351)
........ .+++||+.|||||++++..|+.++||||||++.+||++|.+|+....+.....+|....|...+
T Consensus 161 l~~~~~rr--~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~~PP~L~~~~S~~ 238 (467)
T KOG0201|consen 161 LTNTVKRR--KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKSAPPRLDGDFSPP 238 (467)
T ss_pred eechhhcc--ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCCCCCccccccCHH
Confidence 76554332 6789999999999999999999999999999999999999999998886666666655443332
Q ss_pred --cchhhhcccccCCCCCHHHHHHH
Q 018712 297 --DKVKQCVDTKLGGEYPPKAIAKV 319 (351)
Q Consensus 297 --~~~~~~ld~~~~~~~~~~~~~~~ 319 (351)
+.+..|++.+|..|+++.++.+-
T Consensus 239 ~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 239 FKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred HHHHHHHHhhcCcccCcCHHHHhhh
Confidence 67788999999999988876553
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-43 Score=322.60 Aligned_cols=245 Identities=24% Similarity=0.334 Sum_probs=200.7
Q ss_pred HhcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCC----CchHHHHHHHHHHHhccCCceeeeEEEEecCCceEE
Q 018712 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK----QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVL 138 (351)
Q Consensus 64 ~~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 138 (351)
..++|.+.+.||+|+||.||+|.++ +++.||+|++.... ...+.+.+|+.++++++||||+++++.+.+++..|+
T Consensus 16 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 95 (329)
T PTZ00263 16 KLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYF 95 (329)
T ss_pred CchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEE
Confidence 3468999999999999999999975 68899999986432 223567899999999999999999999999999999
Q ss_pred EEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEeccc
Q 018712 139 AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFD 218 (351)
Q Consensus 139 v~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg 218 (351)
||||+.+|+|.+++..... ++...+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||
T Consensus 96 v~e~~~~~~L~~~l~~~~~---------~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg 163 (329)
T PTZ00263 96 LLEFVVGGELFTHLRKAGR---------FPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFG 163 (329)
T ss_pred EEcCCCCChHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeecc
Confidence 9999999999999976542 788899999999999999999999 9999999999999999999999999
Q ss_pred ccCCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccchhhc-------c
Q 018712 219 LSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWA-------T 291 (351)
Q Consensus 219 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~~~~-------~ 291 (351)
++....... ....||+.|+|||++.+..++.++|||||||++|+|++|+.||...........+... .
T Consensus 164 ~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~p~~~ 238 (329)
T PTZ00263 164 FAKKVPDRT-----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPNWF 238 (329)
T ss_pred CceEcCCCc-----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCcCCCCCC
Confidence 987654322 3357899999999999999999999999999999999999999765432211111111 1
Q ss_pred cCCCccchhhhcccccCCCCCH--HHHHHHHHHHHH
Q 018712 292 PKLSEDKVKQCVDTKLGGEYPP--KAIAKVRKKKFI 325 (351)
Q Consensus 292 ~~~~~~~~~~~ld~~~~~~~~~--~~~~~~~~~~~~ 325 (351)
+....+.+..|+..+|.+|++. ..+..++.+.++
T Consensus 239 ~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f 274 (329)
T PTZ00263 239 DGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYF 274 (329)
T ss_pred CHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCcc
Confidence 1112368889999999999863 234556666554
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-43 Score=299.58 Aligned_cols=206 Identities=26% Similarity=0.374 Sum_probs=180.0
Q ss_pred hcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCCc---hHHHHHHHHHHHhccCCceeeeEEEEe--cCCceEE
Q 018712 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYV--DGPLRVL 138 (351)
Q Consensus 65 ~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~--~~~~~~l 138 (351)
.+.|+.++.|++|+||.||+|+++ +++.||+|+++.+... .-..++|+.+|.+++|||||.+..+.. +-+.+|+
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~ 154 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYI 154 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeee
Confidence 457999999999999999999975 7899999999865532 235789999999999999999998765 3456899
Q ss_pred EEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEeccc
Q 018712 139 AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFD 218 (351)
Q Consensus 139 v~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg 218 (351)
|||||+. +|..++...+. .+...++..++.|++.|++|||.+. |+||||||+|+|+++.|.+||+|||
T Consensus 155 VMe~~Eh-DLksl~d~m~q--------~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFG 222 (419)
T KOG0663|consen 155 VMEYVEH-DLKSLMETMKQ--------PFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFG 222 (419)
T ss_pred eHHHHHh-hHHHHHHhccC--------CCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccc
Confidence 9999987 99999987652 3889999999999999999999999 9999999999999999999999999
Q ss_pred ccCCCccccccccccccccccCccCcccccCC-CCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCc
Q 018712 219 LSNQAPDAAARLHSTRVLGTFGYHAPEYAMTG-QMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQ 284 (351)
Q Consensus 219 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~ 284 (351)
+|+..+..... .+..+-|..|.|||++.+. .|+...|+||+|||+.||+++++-|.+....++.
T Consensus 223 LAR~ygsp~k~--~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl 287 (419)
T KOG0663|consen 223 LAREYGSPLKP--YTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQL 287 (419)
T ss_pred hhhhhcCCccc--CcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHH
Confidence 99998776433 3667789999999999875 6899999999999999999999999987655443
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=315.92 Aligned_cols=227 Identities=21% Similarity=0.269 Sum_probs=186.5
Q ss_pred ceeccCCcEEEEEEEEC-CCCEEEEEEcCCCC----CchHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEEEeCCCC
Q 018712 72 SLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK----QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASKG 146 (351)
Q Consensus 72 ~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 146 (351)
+.||+|+||.||++... +++.||+|++.... .....+.+|+.++++++||||+++++.+...+..|+||||+.++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999965 78999999987532 22345778999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccccCCCccc
Q 018712 147 SLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDA 226 (351)
Q Consensus 147 sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~ 226 (351)
+|.+++..... +++..+..++.||+.||.|||++| |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 ~L~~~l~~~~~---------~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~ 148 (323)
T cd05571 81 ELFFHLSRERV---------FSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISD 148 (323)
T ss_pred cHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccccC
Confidence 99999976542 889999999999999999999999 999999999999999999999999998754322
Q ss_pred cccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccchhh-------cccCCCccch
Q 018712 227 AARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTW-------ATPKLSEDKV 299 (351)
Q Consensus 227 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~~~-------~~~~~~~~~~ 299 (351)
.. ......||+.|+|||++.+..++.++|||||||++|||++|+.||...........+.. ..+....+.+
T Consensus 149 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li 226 (323)
T cd05571 149 GA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLL 226 (323)
T ss_pred CC--cccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 11 12345799999999999999999999999999999999999999976533221111111 1111123678
Q ss_pred hhhcccccCCCCC
Q 018712 300 KQCVDTKLGGEYP 312 (351)
Q Consensus 300 ~~~ld~~~~~~~~ 312 (351)
..|+..+|.+|+.
T Consensus 227 ~~~L~~dP~~R~~ 239 (323)
T cd05571 227 AGLLKKDPKQRLG 239 (323)
T ss_pred HHHccCCHHHcCC
Confidence 8999999999983
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=316.08 Aligned_cols=239 Identities=20% Similarity=0.258 Sum_probs=194.7
Q ss_pred eccCCcEEEEEEEEC-CCCEEEEEEcCCC----CCchHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEEEeCCCCCH
Q 018712 74 IGEGSYGRVYFGVLR-SGRAAAIKKLDSS----KQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSL 148 (351)
Q Consensus 74 Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL 148 (351)
||+|+||.||++... +++.||+|++... ......+.+|+.++++++||||+++++.+.+.+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 699999999999975 6889999998643 22234577899999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccccCCCccccc
Q 018712 149 HDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAA 228 (351)
Q Consensus 149 ~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~ 228 (351)
.+++..... +++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.......
T Consensus 81 ~~~l~~~~~---------~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 148 (312)
T cd05585 81 FHHLQREGR---------FDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD 148 (312)
T ss_pred HHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccCCC
Confidence 999976542 888999999999999999999999 99999999999999999999999999876432221
Q ss_pred cccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccchhh-------cccCCCccchhh
Q 018712 229 RLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTW-------ATPKLSEDKVKQ 301 (351)
Q Consensus 229 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~~~-------~~~~~~~~~~~~ 301 (351)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||...........+.. ..+....+.+..
T Consensus 149 --~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 226 (312)
T cd05585 149 --KTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPDGFDRDAKDLLIG 226 (312)
T ss_pred --ccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCCCCCcCCHHHHHHHHH
Confidence 12445799999999999999999999999999999999999999976533221111111 111122368899
Q ss_pred hcccccCCCCCHHHHHHHHHHHHHh
Q 018712 302 CVDTKLGGEYPPKAIAKVRKKKFIT 326 (351)
Q Consensus 302 ~ld~~~~~~~~~~~~~~~~~~~~~~ 326 (351)
|+..+|.+|++...+..++.+.++.
T Consensus 227 ~L~~dp~~R~~~~~~~e~l~hp~~~ 251 (312)
T cd05585 227 LLSRDPTRRLGYNGAQEIKNHPFFS 251 (312)
T ss_pred HcCCCHHHcCCCCCHHHHHcCCCcC
Confidence 9999999998766666677766543
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=313.17 Aligned_cols=257 Identities=20% Similarity=0.320 Sum_probs=198.5
Q ss_pred hcCCCCCceeccCCcEEEEEEEE------CCCCEEEEEEcCCCCC--chHHHHHHHHHHHhc-cCCceeeeEEEEecC-C
Q 018712 65 TDNFGTNSLIGEGSYGRVYFGVL------RSGRAAAIKKLDSSKQ--PDQEFLAQVSMVSRL-KNENVVELVGYYVDG-P 134 (351)
Q Consensus 65 ~~~y~~~~~Lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~-~ 134 (351)
.++|++.+.||+|+||.||+|.+ .+++.||+|++..... ....+.+|+.+++.+ +||||+++++++... .
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG 85 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence 46799999999999999999974 2356899999875432 235688999999999 899999999987754 4
Q ss_pred ceEEEEEeCCCCCHHHHhccCCCCCC-----------------------------------------------------C
Q 018712 135 LRVLAYEHASKGSLHDILHGKKGVKG-----------------------------------------------------A 161 (351)
Q Consensus 135 ~~~lv~e~~~~gsL~~~l~~~~~~~~-----------------------------------------------------~ 161 (351)
..+++|||+++|+|.+++........ .
T Consensus 86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (338)
T cd05102 86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD 165 (338)
T ss_pred ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence 68999999999999999975421100 0
Q ss_pred CCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccccCCCccccccccccccccccCc
Q 018712 162 KPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGY 241 (351)
Q Consensus 162 ~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y 241 (351)
.....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++...............++..|
T Consensus 166 ~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y 242 (338)
T cd05102 166 LWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKW 242 (338)
T ss_pred cccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccc
Confidence 00123778889999999999999999999 999999999999999999999999999765433222222334467889
Q ss_pred cCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCCc-cchh--------hcccCCCccchhhhcccccCCCC
Q 018712 242 HAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQ-SLVT--------WATPKLSEDKVKQCVDTKLGGEY 311 (351)
Q Consensus 242 ~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~Pf~~~~~~~~~-~~~~--------~~~~~~~~~~~~~~ld~~~~~~~ 311 (351)
+|||++.+..++.++||||||+++|||++ |..||......... ..+. ...+....+.+..|+..+|.+|+
T Consensus 243 ~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RP 322 (338)
T cd05102 243 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAPENATPEIYRIMLACWQGDPKERP 322 (338)
T ss_pred cCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHccCChhhCc
Confidence 99999999999999999999999999997 99999865332110 0000 01111123688899999999999
Q ss_pred CHHHHHHHHHHHH
Q 018712 312 PPKAIAKVRKKKF 324 (351)
Q Consensus 312 ~~~~~~~~~~~~~ 324 (351)
+..++...++-.+
T Consensus 323 s~~el~~~l~~~~ 335 (338)
T cd05102 323 TFSALVEILGDLL 335 (338)
T ss_pred CHHHHHHHHHHHH
Confidence 9999888776543
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-42 Score=306.88 Aligned_cols=246 Identities=21% Similarity=0.305 Sum_probs=195.7
Q ss_pred CCCCCceeccCCcEEEEEEEE-CCCCEEEEEEcCCCCC----chHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEEE
Q 018712 67 NFGTNSLIGEGSYGRVYFGVL-RSGRAAAIKKLDSSKQ----PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYE 141 (351)
Q Consensus 67 ~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 141 (351)
.|+..+.||+|+||.||++.. .+++.||+|.+..... ....+.+|+.++++++|+||+++++.+.+.+..++|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 377788999999999999996 4789999999864321 22457789999999999999999999999999999999
Q ss_pred eCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccccC
Q 018712 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (351)
Q Consensus 142 ~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~ 221 (351)
|+++|+|.+++...... .+++..+..++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||++.
T Consensus 81 ~~~~g~L~~~~~~~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~ 150 (285)
T cd05631 81 IMNGGDLKFHIYNMGNP-------GFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAV 150 (285)
T ss_pred ecCCCcHHHHHHhhCCC-------CCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcE
Confidence 99999999888643321 2888999999999999999999999 9999999999999999999999999987
Q ss_pred CCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccchh----h-------c
Q 018712 222 QAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVT----W-------A 290 (351)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~~----~-------~ 290 (351)
....... .....||..|+|||++.+..++.++|||||||++|+|++|+.||...........+. . .
T Consensus 151 ~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (285)
T cd05631 151 QIPEGET---VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEK 227 (285)
T ss_pred EcCCCCe---ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCcc
Confidence 6533221 134568999999999999999999999999999999999999998754432111110 0 0
Q ss_pred ccCCCccchhhhcccccCCCCCHH--HHHHHHHHHHH
Q 018712 291 TPKLSEDKVKQCVDTKLGGEYPPK--AIAKVRKKKFI 325 (351)
Q Consensus 291 ~~~~~~~~~~~~ld~~~~~~~~~~--~~~~~~~~~~~ 325 (351)
.+....+.+..|+..+|.+|++.. .+..++++.++
T Consensus 228 ~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~ 264 (285)
T cd05631 228 FSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIF 264 (285)
T ss_pred CCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhh
Confidence 111123577888888998888632 24445555554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=317.23 Aligned_cols=231 Identities=23% Similarity=0.337 Sum_probs=191.5
Q ss_pred HhcCCCCCceeccCCcEEEEEEEECC--CCEEEEEEcCCCC----CchHHHHHHHHHHHhccCCceeeeEEEEecCCceE
Q 018712 64 KTDNFGTNSLIGEGSYGRVYFGVLRS--GRAAAIKKLDSSK----QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRV 137 (351)
Q Consensus 64 ~~~~y~~~~~Lg~G~~g~Vy~~~~~~--~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 137 (351)
..++|.+.+.||+|+||.||+|.+.. +..||+|++.... .....+.+|+.+++.++||||+++++++.+.+..+
T Consensus 28 ~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~ 107 (340)
T PTZ00426 28 KYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLY 107 (340)
T ss_pred ChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEE
Confidence 45679999999999999999998543 3689999886432 22356788999999999999999999999999999
Q ss_pred EEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecc
Q 018712 138 LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDF 217 (351)
Q Consensus 138 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Df 217 (351)
+||||+.+|+|.+++..... +++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+||
T Consensus 108 lv~Ey~~~g~L~~~i~~~~~---------~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DF 175 (340)
T PTZ00426 108 LVLEFVIGGEFFTFLRRNKR---------FPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDF 175 (340)
T ss_pred EEEeCCCCCcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecC
Confidence 99999999999999976543 888999999999999999999999 999999999999999999999999
Q ss_pred cccCCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccchhhc-------
Q 018712 218 DLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWA------- 290 (351)
Q Consensus 218 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~~~~------- 290 (351)
|++...... .....||+.|+|||++.+..++.++|||||||++|||++|+.||....+......+...
T Consensus 176 G~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~ 250 (340)
T PTZ00426 176 GFAKVVDTR-----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFPKF 250 (340)
T ss_pred CCCeecCCC-----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCC
Confidence 998765322 13457999999999999988999999999999999999999999875442211111111
Q ss_pred ccCCCccchhhhcccccCCCC
Q 018712 291 TPKLSEDKVKQCVDTKLGGEY 311 (351)
Q Consensus 291 ~~~~~~~~~~~~ld~~~~~~~ 311 (351)
.+....+.+++|+..+|.+|+
T Consensus 251 ~~~~~~~li~~~l~~dp~~R~ 271 (340)
T PTZ00426 251 LDNNCKHLMKKLLSHDLTKRY 271 (340)
T ss_pred CCHHHHHHHHHHcccCHHHcC
Confidence 111123678889999998887
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=311.55 Aligned_cols=226 Identities=22% Similarity=0.277 Sum_probs=185.9
Q ss_pred ceeccCCcEEEEEEEEC-CCCEEEEEEcCCCC----CchHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEEEeCCCC
Q 018712 72 SLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK----QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASKG 146 (351)
Q Consensus 72 ~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 146 (351)
+.||+|+||.||++... +++.||+|++.... .....+.+|+++++.++||||+++++.+...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 36999999999999965 78999999986532 22356778999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccccCCCccc
Q 018712 147 SLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDA 226 (351)
Q Consensus 147 sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~ 226 (351)
+|.+++..... +++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 ~L~~~l~~~~~---------l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~ 148 (328)
T cd05593 81 ELFFHLSRERV---------FSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITD 148 (328)
T ss_pred CHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCc
Confidence 99999876542 889999999999999999999999 999999999999999999999999998754322
Q ss_pred cccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccchhhc-------ccCCCccch
Q 018712 227 AARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWA-------TPKLSEDKV 299 (351)
Q Consensus 227 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~~~~-------~~~~~~~~~ 299 (351)
.. ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...........+... .+....+.+
T Consensus 149 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li 226 (328)
T cd05593 149 AA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPRTLSADAKSLL 226 (328)
T ss_pred cc--ccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCCccCCCCCCHHHHHHH
Confidence 11 123457999999999999999999999999999999999999999765432221111111 111123678
Q ss_pred hhhcccccCCCC
Q 018712 300 KQCVDTKLGGEY 311 (351)
Q Consensus 300 ~~~ld~~~~~~~ 311 (351)
..|+..+|.+|+
T Consensus 227 ~~~L~~dP~~R~ 238 (328)
T cd05593 227 SGLLIKDPNKRL 238 (328)
T ss_pred HHHcCCCHHHcC
Confidence 889999999997
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=310.76 Aligned_cols=226 Identities=21% Similarity=0.287 Sum_probs=185.0
Q ss_pred ceeccCCcEEEEEEEEC-CCCEEEEEEcCCCC----CchHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEEEeCCCC
Q 018712 72 SLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK----QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASKG 146 (351)
Q Consensus 72 ~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 146 (351)
+.||+|+||.||++... +|..||+|++.... .....+.+|+++++.++||||+++++.+...+..|+||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 46999999999999965 78999999986532 22345678999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccccCCCccc
Q 018712 147 SLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDA 226 (351)
Q Consensus 147 sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~ 226 (351)
+|..++..... +++..++.++.||+.||.|||++| ++||||||+|||+++++.+||+|||++......
T Consensus 81 ~L~~~l~~~~~---------~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~ 148 (323)
T cd05595 81 ELFFHLSRERV---------FTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD 148 (323)
T ss_pred cHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCC
Confidence 99999876542 889999999999999999999999 999999999999999999999999998754222
Q ss_pred cccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccchhh-------cccCCCccch
Q 018712 227 AARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTW-------ATPKLSEDKV 299 (351)
Q Consensus 227 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~~~-------~~~~~~~~~~ 299 (351)
... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||...........+.. ..+....+.+
T Consensus 149 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li 226 (323)
T cd05595 149 GAT--MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLL 226 (323)
T ss_pred CCc--cccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHH
Confidence 111 1345689999999999999999999999999999999999999976543321111111 1111223677
Q ss_pred hhhcccccCCCC
Q 018712 300 KQCVDTKLGGEY 311 (351)
Q Consensus 300 ~~~ld~~~~~~~ 311 (351)
..|+..+|.+|+
T Consensus 227 ~~~L~~dP~~R~ 238 (323)
T cd05595 227 AGLLKKDPKQRL 238 (323)
T ss_pred HHHccCCHHHhC
Confidence 888888888887
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-42 Score=313.98 Aligned_cols=236 Identities=24% Similarity=0.354 Sum_probs=194.3
Q ss_pred cCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCC----CchHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEE
Q 018712 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK----QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAY 140 (351)
Q Consensus 66 ~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 140 (351)
++|++.+.||+|+||.||+|.+. +++.||+|++.... .....+.+|+.+++.++||||+++++.+.+.+..|+||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 47899999999999999999976 68899999986432 22356788999999999999999999999999999999
Q ss_pred EeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEeccccc
Q 018712 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (351)
Q Consensus 141 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a 220 (351)
||+++++|.+++..... +++..+..++.||+.||.|||+++ ++||||||+|||++.++.+||+|||++
T Consensus 81 e~~~g~~L~~~l~~~~~---------l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a 148 (333)
T cd05600 81 EYVPGGDFRTLLNNLGV---------LSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLS 148 (333)
T ss_pred eCCCCCCHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCC
Confidence 99999999999976542 888999999999999999999999 999999999999999999999999998
Q ss_pred CCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccchh-h----cccC--
Q 018712 221 NQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVT-W----ATPK-- 293 (351)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~~-~----~~~~-- 293 (351)
..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...........+. + ..+.
T Consensus 149 ~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 223 (333)
T cd05600 149 KGIVT-----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYD 223 (333)
T ss_pred ccccc-----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCC
Confidence 76543 1244579999999999999999999999999999999999999998654432111110 0 0111
Q ss_pred --------CCccchhhhcccccCCCCCHHHHHH
Q 018712 294 --------LSEDKVKQCVDTKLGGEYPPKAIAK 318 (351)
Q Consensus 294 --------~~~~~~~~~ld~~~~~~~~~~~~~~ 318 (351)
...+.+..|+...+..|++.+++.+
T Consensus 224 ~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~ 256 (333)
T cd05600 224 DPRFNLSDEAWDLITKLINDPSRRFGSLEDIKN 256 (333)
T ss_pred ccccccCHHHHHHHHHHhhChhhhcCCHHHHHh
Confidence 1125677788877777887665543
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=313.76 Aligned_cols=231 Identities=30% Similarity=0.452 Sum_probs=197.0
Q ss_pred CceeccCCcEEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEEEeCCCCCHHH
Q 018712 71 NSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHD 150 (351)
Q Consensus 71 ~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~ 150 (351)
++-||+|+.|.||+|+++ ++.||||+++.- -..+++.|++|+|+||+.+.+.|....-+|||||||..|.|..
T Consensus 129 LeWlGSGaQGAVF~Grl~-netVAVKKV~el------kETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~~ 201 (904)
T KOG4721|consen 129 LEWLGSGAQGAVFLGRLH-NETVAVKKVREL------KETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLYE 201 (904)
T ss_pred hhhhccCcccceeeeecc-CceehhHHHhhh------hhhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHHH
Confidence 456999999999999986 678999987533 2356889999999999999999999999999999999999999
Q ss_pred HhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccccCCCccccccc
Q 018712 151 ILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARL 230 (351)
Q Consensus 151 ~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~ 230 (351)
+|+.... +.......|..+|+.|+.|||.+. |||||||.-||||..+..|||+|||.++...+..+.
T Consensus 202 VLka~~~---------itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~STk- 268 (904)
T KOG4721|consen 202 VLKAGRP---------ITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSKELSDKSTK- 268 (904)
T ss_pred HHhccCc---------cCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchHhhhhhhhh-
Confidence 9998764 788899999999999999999998 999999999999999999999999999887665332
Q ss_pred cccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCC------cc---chhhcccCCCccchhh
Q 018712 231 HSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQ------QS---LVTWATPKLSEDKVKQ 301 (351)
Q Consensus 231 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~------~~---~~~~~~~~~~~~~~~~ 301 (351)
-.++||..|||||++.+.+.+.|+|||||||+||||+||..||.+...... .. .+....|.-..-++++
T Consensus 269 --MSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~LpvPstcP~GfklL~Kq 346 (904)
T KOG4721|consen 269 --MSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLHLPVPSTCPDGFKLLLKQ 346 (904)
T ss_pred --hhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEeccCCcccccCcccCchHHHHHHHH
Confidence 457899999999999999999999999999999999999999986543211 11 1122223333358899
Q ss_pred hcccccCCCCCHHHHHHHHHHH
Q 018712 302 CVDTKLGGEYPPKAIAKVRKKK 323 (351)
Q Consensus 302 ~ld~~~~~~~~~~~~~~~~~~~ 323 (351)
|+...+..|++..++..-++++
T Consensus 347 cw~sKpRNRPSFrqil~HldIa 368 (904)
T KOG4721|consen 347 CWNSKPRNRPSFRQILLHLDIA 368 (904)
T ss_pred HHhcCCCCCccHHHHHHHHhhc
Confidence 9999999999999988777665
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=305.52 Aligned_cols=253 Identities=23% Similarity=0.329 Sum_probs=198.2
Q ss_pred hcCCCCCceeccCCcEEEEEEEECC-----------------CCEEEEEEcCCCCCc--hHHHHHHHHHHHhccCCceee
Q 018712 65 TDNFGTNSLIGEGSYGRVYFGVLRS-----------------GRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVE 125 (351)
Q Consensus 65 ~~~y~~~~~Lg~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~niv~ 125 (351)
.++|.+.+.||+|+||.||+|.+.+ +..||+|.+...... ...+.+|+.++++++||||++
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 3579999999999999999997532 336999998764332 356889999999999999999
Q ss_pred eEEEEecCCceEEEEEeCCCCCHHHHhccCCCCCC----------CCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCee
Q 018712 126 LVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKG----------AKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRII 195 (351)
Q Consensus 126 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~----------~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~iv 195 (351)
+++++.+.+..++||||+.+++|.+++........ ......+++..+..++.||+.||.|||+.+ ++
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---iv 160 (304)
T cd05096 84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FV 160 (304)
T ss_pred EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---cc
Confidence 99999999999999999999999999965432111 111234788899999999999999999999 99
Q ss_pred eccccCCcEEEccCCceEEecccccCCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHc--CCC
Q 018712 196 HRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT--GRK 273 (351)
Q Consensus 196 H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t--g~~ 273 (351)
||||||+|||++.++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|+|++ +..
T Consensus 161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~ 240 (304)
T cd05096 161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQ 240 (304)
T ss_pred ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCC
Confidence 999999999999999999999999876543322222233456788999999988899999999999999999986 667
Q ss_pred CCCCCCCCCCccch---------------hhcccCCCccchhhhcccccCCCCCHHHHHHHH
Q 018712 274 PVDHTLPRGQQSLV---------------TWATPKLSEDKVKQCVDTKLGGEYPPKAIAKVR 320 (351)
Q Consensus 274 Pf~~~~~~~~~~~~---------------~~~~~~~~~~~~~~~ld~~~~~~~~~~~~~~~~ 320 (351)
||............ ....+....+.+..|+..+|.+|++.+++..++
T Consensus 241 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l 302 (304)
T cd05096 241 PYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFL 302 (304)
T ss_pred CCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHH
Confidence 88765332211000 001112223788999999999999999987664
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=316.27 Aligned_cols=202 Identities=24% Similarity=0.307 Sum_probs=173.6
Q ss_pred CCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCC----CchHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEEE
Q 018712 67 NFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK----QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYE 141 (351)
Q Consensus 67 ~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 141 (351)
.|.+++.||+|+||.||+|... +++.||+|++.... .....+.+|+.+++.++|+||+++++.+.+.+..|+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 5888999999999999999964 78899999986532 123457889999999999999999999999999999999
Q ss_pred eCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccccC
Q 018712 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (351)
Q Consensus 142 ~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~ 221 (351)
|+++|+|.+++..... +++..+..++.||+.||.|||+.+ |+||||||+|||++.++++||+|||++.
T Consensus 82 ~~~gg~L~~~l~~~~~---------~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~ 149 (381)
T cd05626 82 YIPGGDMMSLLIRMEV---------FPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCT 149 (381)
T ss_pred cCCCCcHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCc
Confidence 9999999999976542 788899999999999999999999 9999999999999999999999999975
Q ss_pred CCccccc---------------------------------------------cccccccccccCccCcccccCCCCCccc
Q 018712 222 QAPDAAA---------------------------------------------RLHSTRVLGTFGYHAPEYAMTGQMSSKS 256 (351)
Q Consensus 222 ~~~~~~~---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 256 (351)
....... ........||+.|+|||++.+..++.++
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~ 229 (381)
T cd05626 150 GFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLC 229 (381)
T ss_pred ccccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCcc
Confidence 4311000 0001235799999999999999999999
Q ss_pred hhHhHHHHHHHHHcCCCCCCCCCC
Q 018712 257 DVYSFGVVLLELLTGRKPVDHTLP 280 (351)
Q Consensus 257 DvwslG~il~el~tg~~Pf~~~~~ 280 (351)
|||||||++|||++|+.||....+
T Consensus 230 DiwSlG~il~elltG~~Pf~~~~~ 253 (381)
T cd05626 230 DWWSVGVILFEMLVGQPPFLAPTP 253 (381)
T ss_pred ceeehhhHHHHHHhCCCCCcCCCH
Confidence 999999999999999999987554
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-42 Score=327.30 Aligned_cols=259 Identities=24% Similarity=0.382 Sum_probs=214.8
Q ss_pred hcCCCCCceeccCCcEEEEEEEEC------CCCEEEEEEcCCCCCc--hHHHHHHHHHHHhccCCceeeeEEEEecCCce
Q 018712 65 TDNFGTNSLIGEGSYGRVYFGVLR------SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPLR 136 (351)
Q Consensus 65 ~~~y~~~~~Lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 136 (351)
..+....+.||+|+||+||+|... +...||||.++..... .++|++|++++..++|||||+++|.|.+++.+
T Consensus 485 r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~ 564 (774)
T KOG1026|consen 485 RSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPL 564 (774)
T ss_pred hhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCee
Confidence 445566778999999999999843 3568999999866544 57899999999999999999999999999999
Q ss_pred EEEEEeCCCCCHHHHhccCCCCCCCC-C----CCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCc
Q 018712 137 VLAYEHASKGSLHDILHGKKGVKGAK-P----GPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDI 211 (351)
Q Consensus 137 ~lv~e~~~~gsL~~~l~~~~~~~~~~-~----~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~ 211 (351)
++|+|||..|+|.+||.......... . .+.++..+.+.|+.||+.|+.||-++. +|||||..+|+||.++..
T Consensus 565 ~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge~l~ 641 (774)
T KOG1026|consen 565 CMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGENLV 641 (774)
T ss_pred EEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceeccceE
Confidence 99999999999999998654322111 1 334899999999999999999999998 999999999999999999
Q ss_pred eEEecccccCCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCCccchh--
Q 018712 212 AKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVT-- 288 (351)
Q Consensus 212 vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~Pf~~~~~~~~~~~~~-- 288 (351)
|||+|||+++.....+.......-.-..+|||||.+..+.+|.+||||||||+|||+++ |+.||.+...++....+.
T Consensus 642 VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~~g 721 (774)
T KOG1026|consen 642 VKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIRAG 721 (774)
T ss_pred EEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHHHHcC
Confidence 99999999998876554433323345779999999999999999999999999999999 999999876654333322
Q ss_pred ------hcccCCCccchhhhcccccCCCCCHHHHHHHHHHHHHh
Q 018712 289 ------WATPKLSEDKVKQCVDTKLGGEYPPKAIAKVRKKKFIT 326 (351)
Q Consensus 289 ------~~~~~~~~~~~~~~ld~~~~~~~~~~~~~~~~~~~~~~ 326 (351)
...|...-.++.+|+...|.+|++..++...++..-.-
T Consensus 722 ~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~ 765 (774)
T KOG1026|consen 722 QLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQA 765 (774)
T ss_pred CcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhc
Confidence 23333334789999999999999999998887765443
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=313.39 Aligned_cols=203 Identities=25% Similarity=0.354 Sum_probs=175.8
Q ss_pred cCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCC----CchHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEE
Q 018712 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK----QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAY 140 (351)
Q Consensus 66 ~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 140 (351)
++|++.+.||+|+||.||++... +++.||+|++.... .....+.+|+.++++++|+||+++++.+.+....|+||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 47899999999999999999865 68999999986532 12345778999999999999999999999999999999
Q ss_pred EeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEeccccc
Q 018712 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (351)
Q Consensus 141 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a 220 (351)
||+++|+|.+++..... +++..+..++.|++.||.|||++| |+||||||+|||++.++.+||+|||++
T Consensus 81 E~~~gg~L~~~l~~~~~---------l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla 148 (363)
T cd05628 81 EFLPGGDMMTLLMKKDT---------LTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLC 148 (363)
T ss_pred cCCCCCcHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCc
Confidence 99999999999976542 889999999999999999999999 999999999999999999999999998
Q ss_pred CCCcccccc---------------------------------ccccccccccCccCcccccCCCCCccchhHhHHHHHHH
Q 018712 221 NQAPDAAAR---------------------------------LHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLE 267 (351)
Q Consensus 221 ~~~~~~~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~e 267 (351)
+........ ......+||+.|+|||++.+..++.++|||||||++||
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~e 228 (363)
T cd05628 149 TGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYE 228 (363)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHH
Confidence 754321100 00123579999999999999999999999999999999
Q ss_pred HHcCCCCCCCCCC
Q 018712 268 LLTGRKPVDHTLP 280 (351)
Q Consensus 268 l~tg~~Pf~~~~~ 280 (351)
|++|+.||.....
T Consensus 229 ll~G~~Pf~~~~~ 241 (363)
T cd05628 229 MLIGYPPFCSETP 241 (363)
T ss_pred HHhCCCCCCCCCH
Confidence 9999999986544
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-42 Score=318.66 Aligned_cols=203 Identities=26% Similarity=0.372 Sum_probs=175.2
Q ss_pred cCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCC----CchHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEE
Q 018712 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK----QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAY 140 (351)
Q Consensus 66 ~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 140 (351)
++|++.+.||+|+||.||+|... +++.||+|++.... .....+.+|+.+++.++|+||+++++.+.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 47999999999999999999975 68999999986432 22345778999999999999999999999999999999
Q ss_pred EeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEeccccc
Q 018712 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (351)
Q Consensus 141 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a 220 (351)
||+.+|+|.+++..... +++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 81 E~~~~g~L~~~l~~~~~---------l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~ 148 (364)
T cd05599 81 EYLPGGDMMTLLMKKDT---------FTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLC 148 (364)
T ss_pred CCCCCcHHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccc
Confidence 99999999999976542 899999999999999999999999 999999999999999999999999998
Q ss_pred CCCcccccc------------------------------------ccccccccccCccCcccccCCCCCccchhHhHHHH
Q 018712 221 NQAPDAAAR------------------------------------LHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVV 264 (351)
Q Consensus 221 ~~~~~~~~~------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~i 264 (351)
......... ......+||+.|+|||++.+..++.++|||||||+
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~i 228 (364)
T cd05599 149 TGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVI 228 (364)
T ss_pred eeccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhH
Confidence 654321100 00112469999999999999999999999999999
Q ss_pred HHHHHcCCCCCCCCCC
Q 018712 265 LLELLTGRKPVDHTLP 280 (351)
Q Consensus 265 l~el~tg~~Pf~~~~~ 280 (351)
+|||++|..||.....
T Consensus 229 l~el~~G~~Pf~~~~~ 244 (364)
T cd05599 229 MYEMLVGYPPFCSDNP 244 (364)
T ss_pred HHHhhcCCCCCCCCCH
Confidence 9999999999986543
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=302.59 Aligned_cols=201 Identities=24% Similarity=0.369 Sum_probs=172.9
Q ss_pred cCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCC---chHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEEE
Q 018712 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ---PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYE 141 (351)
Q Consensus 66 ~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 141 (351)
++|++.+.||+|+||.||++.++ +++.||+|++..... ..+.+.+|+++++.++|+||+++++.+...+..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 47999999999999999999976 688999999875432 24567889999999999999999999999999999999
Q ss_pred eCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccccC
Q 018712 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (351)
Q Consensus 142 ~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~ 221 (351)
|+.++++..+..... .+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++.
T Consensus 81 ~~~~~~l~~~~~~~~---------~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~ 148 (287)
T cd07848 81 YVEKNMLELLEEMPN---------GVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFAR 148 (287)
T ss_pred cCCCCHHHHHHhcCC---------CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCcc
Confidence 999877766554322 2888999999999999999999999 9999999999999999999999999998
Q ss_pred CCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCC
Q 018712 222 QAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTL 279 (351)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~ 279 (351)
........ ......||+.|+|||++.+..++.++|||||||++|+|++|+.||....
T Consensus 149 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~ 205 (287)
T cd07848 149 NLSEGSNA-NYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGES 205 (287)
T ss_pred cccccccc-cccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCC
Confidence 76432211 1234568999999999998899999999999999999999999998643
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=308.08 Aligned_cols=226 Identities=23% Similarity=0.321 Sum_probs=184.6
Q ss_pred ceeccCCcEEEEEEEE----CCCCEEEEEEcCCCC-----CchHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEEEe
Q 018712 72 SLIGEGSYGRVYFGVL----RSGRAAAIKKLDSSK-----QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEH 142 (351)
Q Consensus 72 ~~Lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~-----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 142 (351)
+.||+|+||.||++.. .+++.||+|++.... .....+.+|+.+++.++||||+++++.+..++..|+||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 5799999999999985 257899999986431 2234567899999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccccCC
Q 018712 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222 (351)
Q Consensus 143 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~ 222 (351)
+.+++|.+++..... +....+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 82 ~~~~~L~~~~~~~~~---------~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 149 (323)
T cd05584 82 LSGGELFMHLEREGI---------FMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKE 149 (323)
T ss_pred CCCchHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCee
Confidence 999999999976542 778888999999999999999999 99999999999999999999999999875
Q ss_pred CccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccchhhc----c---cCCC
Q 018712 223 APDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWA----T---PKLS 295 (351)
Q Consensus 223 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~~~~----~---~~~~ 295 (351)
...... ......||+.|+|||++.+..++.++||||||+++|||++|+.||...........+... . +...
T Consensus 150 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (323)
T cd05584 150 SIHEGT--VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPPYLTPEA 227 (323)
T ss_pred cccCCC--cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHH
Confidence 432221 123456999999999999888999999999999999999999999865432211111111 1 1112
Q ss_pred ccchhhhcccccCCCC
Q 018712 296 EDKVKQCVDTKLGGEY 311 (351)
Q Consensus 296 ~~~~~~~ld~~~~~~~ 311 (351)
.+.+..|+..+|.+|+
T Consensus 228 ~~li~~~l~~~p~~R~ 243 (323)
T cd05584 228 RDLLKKLLKRNPSSRL 243 (323)
T ss_pred HHHHHHHcccCHhHcC
Confidence 3778899999999998
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-42 Score=319.10 Aligned_cols=203 Identities=26% Similarity=0.336 Sum_probs=173.8
Q ss_pred cCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCC----CchHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEE
Q 018712 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK----QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAY 140 (351)
Q Consensus 66 ~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 140 (351)
++|.+.+.||+|+||.||++... +++.||+|++.... .....+.+|+++++.++||||+++++++.+.+..|+||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 47899999999999999999865 78999999986432 12345778999999999999999999999999999999
Q ss_pred EeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEeccccc
Q 018712 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (351)
Q Consensus 141 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a 220 (351)
||+++|+|.+++..... +++..+..++.|++.||.|||+.| |+||||||+|||++.++.+||+|||++
T Consensus 81 E~~~gg~L~~~l~~~~~---------~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla 148 (377)
T cd05629 81 EFLPGGDLMTMLIKYDT---------FSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLS 148 (377)
T ss_pred eCCCCCcHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeecccc
Confidence 99999999999976542 888999999999999999999999 999999999999999999999999998
Q ss_pred CCCcccccc---------------------------------------------ccccccccccCccCcccccCCCCCcc
Q 018712 221 NQAPDAAAR---------------------------------------------LHSTRVLGTFGYHAPEYAMTGQMSSK 255 (351)
Q Consensus 221 ~~~~~~~~~---------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~ 255 (351)
+........ .......||+.|+|||++.+..++.+
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 228 (377)
T cd05629 149 TGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQE 228 (377)
T ss_pred cccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCc
Confidence 643211000 00012469999999999999999999
Q ss_pred chhHhHHHHHHHHHcCCCCCCCCCC
Q 018712 256 SDVYSFGVVLLELLTGRKPVDHTLP 280 (351)
Q Consensus 256 ~DvwslG~il~el~tg~~Pf~~~~~ 280 (351)
+|||||||++|||++|+.||.....
T Consensus 229 ~DiwSlGvil~elltG~~Pf~~~~~ 253 (377)
T cd05629 229 CDWWSLGAIMFECLIGWPPFCSENS 253 (377)
T ss_pred eeeEecchhhhhhhcCCCCCCCCCH
Confidence 9999999999999999999986544
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=307.89 Aligned_cols=242 Identities=21% Similarity=0.339 Sum_probs=191.4
Q ss_pred CCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCC----CchHHHHHHHHHH---HhccCCceeeeEEEEecCCceEEE
Q 018712 68 FGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK----QPDQEFLAQVSMV---SRLKNENVVELVGYYVDGPLRVLA 139 (351)
Q Consensus 68 y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l---~~l~h~niv~~~~~~~~~~~~~lv 139 (351)
|.+.+.||+|+||.||+|.+. +++.||+|++.... ...+.+.+|.+++ +.++||||+++++++.+.+..|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 677889999999999999965 78999999986432 2234456665554 567899999999999999999999
Q ss_pred EEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccc
Q 018712 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDL 219 (351)
Q Consensus 140 ~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~ 219 (351)
|||+++++|..++.... +++..+..++.||+.||.|||+++ ++||||||+||++++++.+||+|||+
T Consensus 81 ~E~~~~~~L~~~~~~~~----------l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~ 147 (324)
T cd05589 81 MEYAAGGDLMMHIHTDV----------FSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGL 147 (324)
T ss_pred EcCCCCCcHHHHhhcCC----------CCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccC
Confidence 99999999999886542 899999999999999999999999 99999999999999999999999999
Q ss_pred cCCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccchhhc-------cc
Q 018712 220 SNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWA-------TP 292 (351)
Q Consensus 220 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~~~~-------~~ 292 (351)
++....... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||...........+... .+
T Consensus 148 ~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~p~~~~ 225 (324)
T cd05589 148 CKEGMGFGD--RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLS 225 (324)
T ss_pred CccCCCCCC--cccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCC
Confidence 875432211 124467999999999999999999999999999999999999999865433221111111 11
Q ss_pred CCCccchhhhcccccCCCCCHH--HHHHHHHHHH
Q 018712 293 KLSEDKVKQCVDTKLGGEYPPK--AIAKVRKKKF 324 (351)
Q Consensus 293 ~~~~~~~~~~ld~~~~~~~~~~--~~~~~~~~~~ 324 (351)
....+.+.+|+..+|.+|+... .+..+.++.+
T Consensus 226 ~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~ 259 (324)
T cd05589 226 REAISIMRRLLRRNPERRLGSGEKDAEDVKKQPF 259 (324)
T ss_pred HHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCCC
Confidence 1123688999999999998532 2344444443
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=308.09 Aligned_cols=233 Identities=22% Similarity=0.262 Sum_probs=189.0
Q ss_pred CCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCC----CchHHHHHHHHHHHhccC-CceeeeEEEEecCCceEEEE
Q 018712 67 NFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK----QPDQEFLAQVSMVSRLKN-ENVVELVGYYVDGPLRVLAY 140 (351)
Q Consensus 67 ~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~h-~niv~~~~~~~~~~~~~lv~ 140 (351)
+|++.+.||+|+||.||+|... +++.||+|++.... ...+.+..|.+++..+.| ++|+++++++.+.+..|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 5888999999999999999965 67899999987532 223557788899999976 56888999999999999999
Q ss_pred EeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEeccccc
Q 018712 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (351)
Q Consensus 141 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a 220 (351)
||+++|+|.+++..... +++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 81 E~~~~g~L~~~~~~~~~---------~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~ 148 (324)
T cd05587 81 EYVNGGDLMYHIQQVGK---------FKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMC 148 (324)
T ss_pred cCCCCCcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcc
Confidence 99999999999976542 788999999999999999999999 999999999999999999999999998
Q ss_pred CCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccchhhccc----CCC-
Q 018712 221 NQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATP----KLS- 295 (351)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~----~~~- 295 (351)
........ ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...........+..... ...
T Consensus 149 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 226 (324)
T cd05587 149 KENIFGGK--TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSK 226 (324)
T ss_pred eecCCCCC--ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCH
Confidence 65322111 12345699999999999999999999999999999999999999986543322111111111 111
Q ss_pred --ccchhhhcccccCCCCCH
Q 018712 296 --EDKVKQCVDTKLGGEYPP 313 (351)
Q Consensus 296 --~~~~~~~ld~~~~~~~~~ 313 (351)
.+.+..|+..+|.+|++.
T Consensus 227 ~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 227 EAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred HHHHHHHHHhhcCHHHcCCC
Confidence 257889999999999865
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=294.43 Aligned_cols=206 Identities=24% Similarity=0.360 Sum_probs=177.4
Q ss_pred hcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCC---chHHHHHHHHHHHhccCCc-eeeeEEEEecCC-----
Q 018712 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ---PDQEFLAQVSMVSRLKNEN-VVELVGYYVDGP----- 134 (351)
Q Consensus 65 ~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~h~n-iv~~~~~~~~~~----- 134 (351)
...|...++||+|+||+||+|+.+ +|+.||+|++..... ......+|+.+|+.++|+| |+.+++++...+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 455777788999999999999964 789999999976544 3566789999999999999 999999998877
Q ss_pred -ceEEEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceE
Q 018712 135 -LRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAK 213 (351)
Q Consensus 135 -~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vk 213 (351)
.+++|+||+.. +|..++....... ..++...+..+++||+.||+|||+++ |+||||||.||||++.|.+|
T Consensus 90 ~~l~lvfe~~d~-DL~~ymd~~~~~~-----~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lK 160 (323)
T KOG0594|consen 90 GKLYLVFEFLDR-DLKKYMDSLPKKP-----QGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLK 160 (323)
T ss_pred ceEEEEEEeecc-cHHHHHHhccccc-----cCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEe
Confidence 78999999976 9999998765321 12666889999999999999999999 99999999999999999999
Q ss_pred EecccccCCCccccccccccccccccCccCcccccCC-CCCccchhHhHHHHHHHHHcCCCCCCCCCCC
Q 018712 214 ISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTG-QMSSKSDVYSFGVVLLELLTGRKPVDHTLPR 281 (351)
Q Consensus 214 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~Pf~~~~~~ 281 (351)
|+|||+|+...-.... .+..++|..|.|||++.+. .|+...||||+|||+.||++++.-|.+....
T Consensus 161 laDFGlAra~~ip~~~--yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~ 227 (323)
T KOG0594|consen 161 LADFGLARAFSIPMRT--YTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEI 227 (323)
T ss_pred eeccchHHHhcCCccc--ccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHH
Confidence 9999999866533322 2556789999999999887 7899999999999999999999999986653
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-41 Score=301.28 Aligned_cols=201 Identities=23% Similarity=0.378 Sum_probs=172.4
Q ss_pred hcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCC--CchHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEEE
Q 018712 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK--QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYE 141 (351)
Q Consensus 65 ~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 141 (351)
.++|.+.+.||.|+||.||+|..+ ++..||+|++.... .....+.+|+.++++++||||+++++++.+++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFE 83 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEe
Confidence 467999999999999999999975 78999999986443 224567899999999999999999999999999999999
Q ss_pred eCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccccC
Q 018712 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (351)
Q Consensus 142 ~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~ 221 (351)
|+.+ +|.+++..... .++...+..++.||+.||+|||++| |+||||||+|||++.++.+||+|||+++
T Consensus 84 ~~~~-~l~~~l~~~~~--------~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~ 151 (288)
T cd07871 84 YLDS-DLKQYLDNCGN--------LMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLAR 151 (288)
T ss_pred CCCc-CHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCccee
Confidence 9975 99998865432 2788899999999999999999999 9999999999999999999999999987
Q ss_pred CCccccccccccccccccCccCcccccC-CCCCccchhHhHHHHHHHHHcCCCCCCCCC
Q 018712 222 QAPDAAARLHSTRVLGTFGYHAPEYAMT-GQMSSKSDVYSFGVVLLELLTGRKPVDHTL 279 (351)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~Pf~~~~ 279 (351)
........ .....+|+.|+|||++.+ ..++.++||||+|+++|+|++|+.||....
T Consensus 152 ~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~ 208 (288)
T cd07871 152 AKSVPTKT--YSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGST 208 (288)
T ss_pred eccCCCcc--ccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 64332211 133467999999998875 568999999999999999999999997654
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-42 Score=309.96 Aligned_cols=245 Identities=21% Similarity=0.334 Sum_probs=208.5
Q ss_pred hcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCCc---hHHHHHHHHHHHhccCCceeeeEEEEecCCc-eEEE
Q 018712 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVDGPL-RVLA 139 (351)
Q Consensus 65 ~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-~~lv 139 (351)
.++|..++.+|+|+||.+++.+++ +++.+++|++...... .+...+|+.+++++.|||||.+.+.|.+++. .+||
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv 82 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV 82 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence 468999999999999999999965 6789999998754433 3467899999999999999999999998888 9999
Q ss_pred EEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccc
Q 018712 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDL 219 (351)
Q Consensus 140 ~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~ 219 (351)
|+||+||+|.+.+.+.+.. .+++..+..|+.|++.|+.|||++. |+|||||+.|||+++++.|||+|||+
T Consensus 83 m~Y~eGg~l~~~i~~~k~~-------~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGl 152 (426)
T KOG0589|consen 83 MEYCEGGDLAQLIKEQKGV-------LFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGL 152 (426)
T ss_pred EeecCCCCHHHHHHHHhhc-------cccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhh
Confidence 9999999999999987733 3899999999999999999999888 99999999999999999999999999
Q ss_pred cCCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccchhhcc-cCCC---
Q 018712 220 SNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWAT-PKLS--- 295 (351)
Q Consensus 220 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~~~~~-~~~~--- 295 (351)
|+....... ...+..||+.|++||++.+.+|+.++|||||||++|||++=+.+|...+-......+.... ..++
T Consensus 153 aK~l~~~~~--~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Plp~~y 230 (426)
T KOG0589|consen 153 AKILNPEDS--LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPLPSMY 230 (426)
T ss_pred hhhcCCchh--hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCCCCccc
Confidence 999876542 2366789999999999999999999999999999999999999999875543322222111 1111
Q ss_pred ----ccchhhhcccccCCCCCHHHHHHHHH
Q 018712 296 ----EDKVKQCVDTKLGGEYPPKAIAKVRK 321 (351)
Q Consensus 296 ----~~~~~~~ld~~~~~~~~~~~~~~~~~ 321 (351)
..+++.|+..+|..|+++.++.+.-.
T Consensus 231 s~el~~lv~~~l~~~P~~RPsa~~LL~~P~ 260 (426)
T KOG0589|consen 231 SSELRSLVKSMLRKNPEHRPSALELLRRPH 260 (426)
T ss_pred cHHHHHHHHHHhhcCCccCCCHHHHhhChh
Confidence 25789999999999999988877633
|
|
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=309.80 Aligned_cols=226 Identities=22% Similarity=0.287 Sum_probs=184.6
Q ss_pred ceeccCCcEEEEEEEEC-CCCEEEEEEcCCCC----CchHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEEEeCCCC
Q 018712 72 SLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK----QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASKG 146 (351)
Q Consensus 72 ~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 146 (351)
+.||+|+||.||++... +++.||+|++.... .....+.+|+++++.++||||+++++.+...+..|+||||+.+|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999964 78999999986532 22345678899999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhh-CCCCCeeeccccCCcEEEccCCceEEecccccCCCcc
Q 018712 147 SLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHE-KAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPD 225 (351)
Q Consensus 147 sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~-~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~ 225 (351)
+|..++..... +++..+..++.||+.||.|||+ .+ |+||||||+|||++.++.+||+|||+++....
T Consensus 81 ~L~~~l~~~~~---------l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~ 148 (325)
T cd05594 81 ELFFHLSRERV---------FSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIK 148 (325)
T ss_pred cHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecCC
Confidence 99999876542 8899999999999999999997 68 99999999999999999999999999875332
Q ss_pred ccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccchhhc-------ccCCCccc
Q 018712 226 AAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWA-------TPKLSEDK 298 (351)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~~~~-------~~~~~~~~ 298 (351)
.... .....||+.|+|||++.+..++.++||||||+++|+|++|+.||...........+... .+....+.
T Consensus 149 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~l 226 (325)
T cd05594 149 DGAT--MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSL 226 (325)
T ss_pred CCcc--cccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHH
Confidence 2111 23456999999999999999999999999999999999999999765433221111111 11112367
Q ss_pred hhhhcccccCCCC
Q 018712 299 VKQCVDTKLGGEY 311 (351)
Q Consensus 299 ~~~~ld~~~~~~~ 311 (351)
+..|+..+|.+|+
T Consensus 227 i~~~L~~dP~~R~ 239 (325)
T cd05594 227 LSGLLKKDPKQRL 239 (325)
T ss_pred HHHHhhcCHHHhC
Confidence 8889999999997
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-42 Score=318.40 Aligned_cols=202 Identities=24% Similarity=0.294 Sum_probs=173.2
Q ss_pred CCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCC----chHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEEE
Q 018712 67 NFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ----PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYE 141 (351)
Q Consensus 67 ~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 141 (351)
.|.+++.||+|+||.||+|... +++.||+|++..... ....+.+|+.++++++|+||+++++.+.+.+..|+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 5888999999999999999965 688999999865321 23467889999999999999999999999999999999
Q ss_pred eCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccccC
Q 018712 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (351)
Q Consensus 142 ~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~ 221 (351)
|+++|+|.+++..... ++...+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.
T Consensus 82 ~~~gg~L~~~l~~~~~---------~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~ 149 (382)
T cd05625 82 YIPGGDMMSLLIRMGI---------FPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCT 149 (382)
T ss_pred CCCCCcHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCc
Confidence 9999999999976532 788899999999999999999999 9999999999999999999999999975
Q ss_pred CCcccc---------------------------------------------ccccccccccccCccCcccccCCCCCccc
Q 018712 222 QAPDAA---------------------------------------------ARLHSTRVLGTFGYHAPEYAMTGQMSSKS 256 (351)
Q Consensus 222 ~~~~~~---------------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 256 (351)
...... .........||+.|+|||++.+..++.++
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~ 229 (382)
T cd05625 150 GFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLC 229 (382)
T ss_pred cccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCee
Confidence 321000 00001234699999999999999999999
Q ss_pred hhHhHHHHHHHHHcCCCCCCCCCC
Q 018712 257 DVYSFGVVLLELLTGRKPVDHTLP 280 (351)
Q Consensus 257 DvwslG~il~el~tg~~Pf~~~~~ 280 (351)
|||||||++|||++|+.||....+
T Consensus 230 DiwSlGvil~elltG~~Pf~~~~~ 253 (382)
T cd05625 230 DWWSVGVILYEMLVGQPPFLAQTP 253 (382)
T ss_pred eEEechHHHHHHHhCCCCCCCCCH
Confidence 999999999999999999987544
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=316.13 Aligned_cols=203 Identities=24% Similarity=0.303 Sum_probs=174.4
Q ss_pred cCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCC----CchHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEE
Q 018712 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK----QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAY 140 (351)
Q Consensus 66 ~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 140 (351)
++|++.+.||+|+||.||++... +++.||+|++.... .....+.+|+.++++++|+||+++++.+.+++..|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 47999999999999999999965 68999999986432 22355788999999999999999999999999999999
Q ss_pred EeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEeccccc
Q 018712 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (351)
Q Consensus 141 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a 220 (351)
||+++|+|.+++..... ++...+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|
T Consensus 81 E~~~~g~L~~~i~~~~~---------~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a 148 (376)
T cd05598 81 DYIPGGDMMSLLIRLGI---------FEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLC 148 (376)
T ss_pred eCCCCCcHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCC
Confidence 99999999999976542 788889999999999999999999 999999999999999999999999997
Q ss_pred CCCcccc-----------------------------------------ccccccccccccCccCcccccCCCCCccchhH
Q 018712 221 NQAPDAA-----------------------------------------ARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVY 259 (351)
Q Consensus 221 ~~~~~~~-----------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvw 259 (351)
....... .........||+.|+|||++.+..++.++|||
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diw 228 (376)
T cd05598 149 TGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWW 228 (376)
T ss_pred ccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeee
Confidence 5321000 00001235799999999999999999999999
Q ss_pred hHHHHHHHHHcCCCCCCCCCC
Q 018712 260 SFGVVLLELLTGRKPVDHTLP 280 (351)
Q Consensus 260 slG~il~el~tg~~Pf~~~~~ 280 (351)
||||++|||++|+.||....+
T Consensus 229 SlGvilyell~G~~Pf~~~~~ 249 (376)
T cd05598 229 SVGVILYEMLVGQPPFLADTP 249 (376)
T ss_pred eccceeeehhhCCCCCCCCCH
Confidence 999999999999999987654
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-41 Score=305.12 Aligned_cols=229 Identities=23% Similarity=0.307 Sum_probs=184.2
Q ss_pred ceeccCCcEEEEEEEEC-CCCEEEEEEcCCCC----CchHHHHHHHHHHHhc-cCCceeeeEEEEecCCceEEEEEeCCC
Q 018712 72 SLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK----QPDQEFLAQVSMVSRL-KNENVVELVGYYVDGPLRVLAYEHASK 145 (351)
Q Consensus 72 ~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 145 (351)
+.||+|+||.||+|... +++.||+|.+.... ...+....|..++..+ +||||+++++.+...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999965 68899999986532 2223455566666654 899999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccccCCCcc
Q 018712 146 GSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPD 225 (351)
Q Consensus 146 gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~ 225 (351)
|+|.+++..... ++...+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 81 g~L~~~~~~~~~---------~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~ 148 (316)
T cd05592 81 GDLMFHIQSSGR---------FDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMN 148 (316)
T ss_pred CcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCC
Confidence 999999976542 888999999999999999999999 99999999999999999999999999875432
Q ss_pred ccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccchhhcc-------cCCCccc
Q 018712 226 AAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWAT-------PKLSEDK 298 (351)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~~~~~-------~~~~~~~ 298 (351)
... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...........+.... +....+.
T Consensus 149 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~l 226 (316)
T cd05592 149 GEG--KASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPRWISKEAKDC 226 (316)
T ss_pred CCC--ccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 221 1244579999999999999999999999999999999999999998654322111111111 1112367
Q ss_pred hhhhcccccCCCCCHH
Q 018712 299 VKQCVDTKLGGEYPPK 314 (351)
Q Consensus 299 ~~~~ld~~~~~~~~~~ 314 (351)
+..|++.+|.+|++..
T Consensus 227 l~~~l~~~P~~R~~~~ 242 (316)
T cd05592 227 LSKLFERDPTKRLGVD 242 (316)
T ss_pred HHHHccCCHHHcCCCh
Confidence 8899999999999763
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=298.25 Aligned_cols=234 Identities=21% Similarity=0.311 Sum_probs=192.0
Q ss_pred ceeccCCcEEEEEEEECCCCEEEEEEcCCCCCch----HHHHHHHHHHHhccCCceeeeEEEEec----CCceEEEEEeC
Q 018712 72 SLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPD----QEFLAQVSMVSRLKNENVVELVGYYVD----GPLRVLAYEHA 143 (351)
Q Consensus 72 ~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~----~~~~~e~~~l~~l~h~niv~~~~~~~~----~~~~~lv~e~~ 143 (351)
..||+|+++.||+|.+ +|+.||+|.+....... +.+.+|+.+|++++||||+++++++.+ ....++||||+
T Consensus 26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~ 104 (283)
T PHA02988 26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC 104 (283)
T ss_pred eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence 5799999999999998 68899999997654433 456799999999999999999999876 45789999999
Q ss_pred CCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhC-CCCCeeeccccCCcEEEccCCceEEecccccCC
Q 018712 144 SKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEK-AEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222 (351)
Q Consensus 144 ~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~-~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~ 222 (351)
.+|+|.+++..... +++.....++.|++.||.|||+. + ++||||||+||++++++.+||+|||+++.
T Consensus 105 ~~g~L~~~l~~~~~---------~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~nill~~~~~~kl~dfg~~~~ 172 (283)
T PHA02988 105 TRGYLREVLDKEKD---------LSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSFLVTENYKLKIICHGLEKI 172 (283)
T ss_pred CCCcHHHHHhhCCC---------CChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhEEECCCCcEEEcccchHhh
Confidence 99999999986542 78899999999999999999985 6 88999999999999999999999999876
Q ss_pred CccccccccccccccccCccCcccccC--CCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccchh--h-------cc
Q 018712 223 APDAAARLHSTRVLGTFGYHAPEYAMT--GQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVT--W-------AT 291 (351)
Q Consensus 223 ~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~~--~-------~~ 291 (351)
..... ....||..|+|||++.+ ..++.++||||||+++|||++|+.||...........+. . ..
T Consensus 173 ~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 247 (283)
T PHA02988 173 LSSPP-----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPLDC 247 (283)
T ss_pred hcccc-----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCCcC
Confidence 54321 23468899999999876 688999999999999999999999998764332211110 0 11
Q ss_pred cCCCccchhhhcccccCCCCCHHHHHHHHHHH
Q 018712 292 PKLSEDKVKQCVDTKLGGEYPPKAIAKVRKKK 323 (351)
Q Consensus 292 ~~~~~~~~~~~ld~~~~~~~~~~~~~~~~~~~ 323 (351)
+....+.+.+|+..+|.+|++.+++...++.-
T Consensus 248 ~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~ 279 (283)
T PHA02988 248 PLEIKCIVEACTSHDSIKRPNIKEILYNLSLY 279 (283)
T ss_pred cHHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence 22223788999999999999999887766543
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=305.28 Aligned_cols=198 Identities=29% Similarity=0.434 Sum_probs=175.0
Q ss_pred hcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCC--chHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEEE
Q 018712 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ--PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYE 141 (351)
Q Consensus 65 ~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 141 (351)
.++|++.+.||+|+||.||++.+. ++..+|+|.+..... ....+.+|++++++++||||+++++++...+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 478999999999999999999976 688999999875432 23568899999999999999999999999999999999
Q ss_pred eCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccccC
Q 018712 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (351)
Q Consensus 142 ~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~ 221 (351)
|+++++|.+++..... +++..+..++.|++.||.|||+.+ +|+||||||+|||++.++.+||+|||++.
T Consensus 84 ~~~~~~L~~~l~~~~~---------~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~ 152 (331)
T cd06649 84 HMDGGSLDQVLKEAKR---------IPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSG 152 (331)
T ss_pred cCCCCcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCcccc
Confidence 9999999999976542 788999999999999999999852 29999999999999999999999999987
Q ss_pred CCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCC
Q 018712 222 QAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDH 277 (351)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~ 277 (351)
...... .....||+.|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus 153 ~~~~~~----~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~ 204 (331)
T cd06649 153 QLIDSM----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPP 204 (331)
T ss_pred cccccc----cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence 654322 1345689999999999999999999999999999999999999964
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=293.97 Aligned_cols=246 Identities=24% Similarity=0.304 Sum_probs=197.8
Q ss_pred HhcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCC---CCchHHHHHHHHHHHhccCCceeeeEEEEec-----CC
Q 018712 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSS---KQPDQEFLAQVSMVSRLKNENVVELVGYYVD-----GP 134 (351)
Q Consensus 64 ~~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-----~~ 134 (351)
....|...+.||+|+||.|..+.++ +|+.||||++... ....++..+|+++|+.++|+||+.+.+.+.. -+
T Consensus 20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~ 99 (359)
T KOG0660|consen 20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN 99 (359)
T ss_pred ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence 4456777889999999999999965 8999999998733 2345778899999999999999999998865 34
Q ss_pred ceEEEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEE
Q 018712 135 LRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKI 214 (351)
Q Consensus 135 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl 214 (351)
.+|+|+|+|+. +|.++++..+. ++...+..++.||+.||.|+|+.+ |+||||||.|+|++.+..+||
T Consensus 100 DvYiV~elMet-DL~~iik~~~~---------L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI 166 (359)
T KOG0660|consen 100 DVYLVFELMET-DLHQIIKSQQD---------LTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKI 166 (359)
T ss_pred eeEEehhHHhh-HHHHHHHcCcc---------ccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEe
Confidence 68999999954 99999998764 899999999999999999999999 999999999999999999999
Q ss_pred ecccccCCCccccccccccccccccCccCccccc-CCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccchhhcccC
Q 018712 215 SDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAM-TGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPK 293 (351)
Q Consensus 215 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~ 293 (351)
+|||+|+...........+..+.|..|.|||++. ...|+...||||+|||+.||++|++-|.+.....+..++....+.
T Consensus 167 ~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGt 246 (359)
T KOG0660|consen 167 CDFGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGT 246 (359)
T ss_pred ccccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCC
Confidence 9999999875432222335567899999999875 568999999999999999999999999987654333322211111
Q ss_pred CCc--------------------------------------cchhhhcccccCCCCCHHHHHHHHHH
Q 018712 294 LSE--------------------------------------DKVKQCVDTKLGGEYPPKAIAKVRKK 322 (351)
Q Consensus 294 ~~~--------------------------------------~~~~~~ld~~~~~~~~~~~~~~~~~~ 322 (351)
..+ +++.++|.-+|.+|++++++..--.+
T Consensus 247 P~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl 313 (359)
T KOG0660|consen 247 PSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYL 313 (359)
T ss_pred CCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhh
Confidence 111 56677777778888887776544333
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=301.14 Aligned_cols=200 Identities=24% Similarity=0.390 Sum_probs=171.0
Q ss_pred hcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCC--chHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEEE
Q 018712 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ--PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYE 141 (351)
Q Consensus 65 ~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 141 (351)
.++|.+.+.||+|+||.||+|... +++.||+|++..... ....+.+|+.+++.++||||+++++++.+....++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 478999999999999999999976 788999999875432 23457789999999999999999999999999999999
Q ss_pred eCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccccC
Q 018712 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (351)
Q Consensus 142 ~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~ 221 (351)
|+. ++|.+++..... .++...+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.
T Consensus 84 ~~~-~~l~~~~~~~~~--------~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~ 151 (303)
T cd07869 84 YVH-TDLCQYMDKHPG--------GLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLAR 151 (303)
T ss_pred CCC-cCHHHHHHhCCC--------CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcce
Confidence 996 588888865432 2788899999999999999999999 9999999999999999999999999986
Q ss_pred CCccccccccccccccccCccCcccccC-CCCCccchhHhHHHHHHHHHcCCCCCCCC
Q 018712 222 QAPDAAARLHSTRVLGTFGYHAPEYAMT-GQMSSKSDVYSFGVVLLELLTGRKPVDHT 278 (351)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~Pf~~~ 278 (351)
........ .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...
T Consensus 152 ~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~ 207 (303)
T cd07869 152 AKSVPSHT--YSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGM 207 (303)
T ss_pred eccCCCcc--CCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 54322211 133568999999998865 45788999999999999999999999864
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-41 Score=305.96 Aligned_cols=226 Identities=19% Similarity=0.279 Sum_probs=184.4
Q ss_pred ceeccCCcEEEEEEEEC-CCCEEEEEEcCCCC----CchHHHHHHHHHHHhc-cCCceeeeEEEEecCCceEEEEEeCCC
Q 018712 72 SLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK----QPDQEFLAQVSMVSRL-KNENVVELVGYYVDGPLRVLAYEHASK 145 (351)
Q Consensus 72 ~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 145 (351)
+.||+|+||.||+|... +++.||+|++.... .....+..|.++++.+ +||||+++++++.+.+..|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 36999999999999975 67899999987532 2234567788888866 799999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccccCCCcc
Q 018712 146 GSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPD 225 (351)
Q Consensus 146 gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~ 225 (351)
++|..++..... +++..+..++.||+.||.|||++| |+||||||+|||++.++.+||+|||++.....
T Consensus 81 ~~L~~~l~~~~~---------~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~ 148 (321)
T cd05591 81 GDLMFQIQRSRK---------FDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGIL 148 (321)
T ss_pred CcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceeccc
Confidence 999999876543 888999999999999999999999 99999999999999999999999999875432
Q ss_pred ccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccchhhc---c----cCCCccc
Q 018712 226 AAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWA---T----PKLSEDK 298 (351)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~~~~---~----~~~~~~~ 298 (351)
... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||...........+... . +....+.
T Consensus 149 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~l 226 (321)
T cd05591 149 NGV--TTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPVWLSKEAVSI 226 (321)
T ss_pred CCc--cccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 221 123456899999999999999999999999999999999999999876543222111111 1 1112367
Q ss_pred hhhhcccccCCCC
Q 018712 299 VKQCVDTKLGGEY 311 (351)
Q Consensus 299 ~~~~ld~~~~~~~ 311 (351)
+..|+..+|.+|+
T Consensus 227 l~~~L~~dp~~R~ 239 (321)
T cd05591 227 LKAFMTKNPNKRL 239 (321)
T ss_pred HHHHhccCHHHcC
Confidence 8899999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-41 Score=307.97 Aligned_cols=250 Identities=27% Similarity=0.396 Sum_probs=201.6
Q ss_pred HHHHHHhcCCCCCceeccCCcEEEEEEEECCCCEEEEEEcCCCCCc---hHHHHHHHHHHHhccCCceeeeEEEEecCCc
Q 018712 59 DELKEKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVDGPL 135 (351)
Q Consensus 59 ~~~~~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 135 (351)
.+.....+...+...||+|.||+||+|.+. ..||||++....-. .+.|++|+..+++.+|.||+-++|++...+.
T Consensus 385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~ 462 (678)
T KOG0193|consen 385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL 462 (678)
T ss_pred cccccCHHHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce
Confidence 334444556777889999999999999986 36999999765433 4679999999999999999999999988877
Q ss_pred eEEEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEe
Q 018712 136 RVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKIS 215 (351)
Q Consensus 136 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~ 215 (351)
.||..+|+|.+|+.+|+.... .+...+.+.|+.||++|+.|||.++ |||||||..||++.+++.|||+
T Consensus 463 -AIiTqwCeGsSLY~hlHv~et--------kfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIg 530 (678)
T KOG0193|consen 463 -AIITQWCEGSSLYTHLHVQET--------KFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIG 530 (678)
T ss_pred -eeeehhccCchhhhhccchhh--------hhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEe
Confidence 999999999999999987653 2888999999999999999999999 9999999999999999999999
Q ss_pred cccccCCCccccccccccccccccCccCcccccC---CCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccc------
Q 018712 216 DFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMT---GQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSL------ 286 (351)
Q Consensus 216 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~------ 286 (351)
|||++..-.............|...|||||++.. .+|+..+||||||+++|||+||..||.....+.....
T Consensus 531 DFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l 610 (678)
T KOG0193|consen 531 DFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYL 610 (678)
T ss_pred cccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEeccccc
Confidence 9999876554433333345568889999999864 4789999999999999999999999994333221111
Q ss_pred ------hhhcccCCCccchhhhcccccCCCCCHHHHHHHHHH
Q 018712 287 ------VTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKVRKK 322 (351)
Q Consensus 287 ------~~~~~~~~~~~~~~~~ld~~~~~~~~~~~~~~~~~~ 322 (351)
+....++-..+++..|+...+.+|+...++...+..
T Consensus 611 ~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~ 652 (678)
T KOG0193|consen 611 MPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEE 652 (678)
T ss_pred CccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHH
Confidence 112222233478889999999999988877664433
|
|
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-41 Score=304.69 Aligned_cols=229 Identities=24% Similarity=0.321 Sum_probs=185.6
Q ss_pred ceeccCCcEEEEEEEEC-CCCEEEEEEcCCCC----CchHHHHHHHHHHHhc-cCCceeeeEEEEecCCceEEEEEeCCC
Q 018712 72 SLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK----QPDQEFLAQVSMVSRL-KNENVVELVGYYVDGPLRVLAYEHASK 145 (351)
Q Consensus 72 ~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 145 (351)
+.||+|+||.||+|.++ ++..||+|.+.... ........|..++... +||||+++++++.+.+..|+||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 46999999999999976 68899999987532 2234566677777654 899999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccccCCCcc
Q 018712 146 GSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPD 225 (351)
Q Consensus 146 gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~ 225 (351)
|+|.+++..... +++..+..++.|++.||.|||++| |+||||||+|||++.++.+||+|||+++....
T Consensus 81 g~L~~~i~~~~~---------~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 148 (316)
T cd05620 81 GDLMFHIQDKGR---------FDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVF 148 (316)
T ss_pred CcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeeccc
Confidence 999999876532 888999999999999999999999 99999999999999999999999999865322
Q ss_pred ccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccchhhcccCC-------Cccc
Q 018712 226 AAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKL-------SEDK 298 (351)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~-------~~~~ 298 (351)
... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||...........+....+.. ..+.
T Consensus 149 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 226 (316)
T cd05620 149 GDN--RASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRWITKESKDI 226 (316)
T ss_pred CCC--ceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 211 1244679999999999999999999999999999999999999998654332221111111111 1367
Q ss_pred hhhhcccccCCCCCHH
Q 018712 299 VKQCVDTKLGGEYPPK 314 (351)
Q Consensus 299 ~~~~ld~~~~~~~~~~ 314 (351)
+..|++.+|.+|++..
T Consensus 227 i~~~l~~dP~~R~~~~ 242 (316)
T cd05620 227 LEKLFERDPTRRLGVV 242 (316)
T ss_pred HHHHccCCHHHcCCCh
Confidence 8899999999999763
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-41 Score=305.75 Aligned_cols=233 Identities=22% Similarity=0.264 Sum_probs=188.2
Q ss_pred CCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCC----chHHHHHHHHHHHhc-cCCceeeeEEEEecCCceEEEE
Q 018712 67 NFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ----PDQEFLAQVSMVSRL-KNENVVELVGYYVDGPLRVLAY 140 (351)
Q Consensus 67 ~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~ 140 (351)
+|.+.+.||+|+||.||+|... +++.||+|++.+... .......|..++..+ .|++|+++++++.+.+..|+||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 5888999999999999999976 678999999875421 223456677777777 5799999999999999999999
Q ss_pred EeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEeccccc
Q 018712 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (351)
Q Consensus 141 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a 220 (351)
||+++|+|.+++..... +++..+..++.||+.||.|||+++ |+||||||+|||+++++.+||+|||++
T Consensus 81 E~~~~g~L~~~~~~~~~---------~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~ 148 (323)
T cd05616 81 EYVNGGDLMYQIQQVGR---------FKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMC 148 (323)
T ss_pred cCCCCCCHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCc
Confidence 99999999999976542 888999999999999999999999 999999999999999999999999998
Q ss_pred CCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccchhhcc-------cC
Q 018712 221 NQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWAT-------PK 293 (351)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~~~~~-------~~ 293 (351)
+....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...........+.... ..
T Consensus 149 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~ 226 (323)
T cd05616 149 KENMWDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSK 226 (323)
T ss_pred eecCCCCC--ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcCCH
Confidence 75432211 1234679999999999999999999999999999999999999998754432221111111 11
Q ss_pred CCccchhhhcccccCCCCCH
Q 018712 294 LSEDKVKQCVDTKLGGEYPP 313 (351)
Q Consensus 294 ~~~~~~~~~ld~~~~~~~~~ 313 (351)
...+.+..|+..+|.+|++.
T Consensus 227 ~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 227 EAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred HHHHHHHHHcccCHHhcCCC
Confidence 11256788888899888864
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-41 Score=312.36 Aligned_cols=205 Identities=21% Similarity=0.332 Sum_probs=175.8
Q ss_pred HHHhcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCC----CchHHHHHHHHHHHhccCCceeeeEEEEecCCce
Q 018712 62 KEKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK----QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLR 136 (351)
Q Consensus 62 ~~~~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 136 (351)
....++|++.+.||+|+||.||++... +++.+|+|++.+.. .....+.+|+.+++.++||||+++++.+.+++..
T Consensus 39 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~ 118 (370)
T cd05621 39 QMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYL 118 (370)
T ss_pred CCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEE
Confidence 344578999999999999999999975 68899999986421 2234577899999999999999999999999999
Q ss_pred EEEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEec
Q 018712 137 VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISD 216 (351)
Q Consensus 137 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~D 216 (351)
|+||||+++|+|.+++.... ++...+..++.||+.||.|||+++ |+||||||+|||+++++.+||+|
T Consensus 119 ~lv~Ey~~gg~L~~~l~~~~----------~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~D 185 (370)
T cd05621 119 YMVMEYMPGGDLVNLMSNYD----------VPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLAD 185 (370)
T ss_pred EEEEcCCCCCcHHHHHHhcC----------CCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEe
Confidence 99999999999999997543 788899999999999999999999 99999999999999999999999
Q ss_pred ccccCCCccccccccccccccccCccCcccccCCC----CCccchhHhHHHHHHHHHcCCCCCCCCCC
Q 018712 217 FDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQ----MSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (351)
Q Consensus 217 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwslG~il~el~tg~~Pf~~~~~ 280 (351)
||++........ .......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.....
T Consensus 186 FG~a~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~ 252 (370)
T cd05621 186 FGTCMKMDETGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSL 252 (370)
T ss_pred cccceecccCCc-eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCH
Confidence 999876532211 1123457999999999987543 78899999999999999999999986543
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-41 Score=305.40 Aligned_cols=240 Identities=21% Similarity=0.290 Sum_probs=191.5
Q ss_pred ceeccCCcEEEEEEEEC-CCCEEEEEEcCCCC----CchHHHHHHHHHHHhc-cCCceeeeEEEEecCCceEEEEEeCCC
Q 018712 72 SLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK----QPDQEFLAQVSMVSRL-KNENVVELVGYYVDGPLRVLAYEHASK 145 (351)
Q Consensus 72 ~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 145 (351)
+.||+|+||.||+|.++ +++.||+|++.... .....+..|..++..+ +||||+++++++.+.+..|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999975 68899999986432 2234567788888776 699999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccccCCCcc
Q 018712 146 GSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPD 225 (351)
Q Consensus 146 gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~ 225 (351)
|+|.+++..... +++..+..++.|++.||.|||+++ ++||||||+|||++.++.+||+|||++.....
T Consensus 81 g~L~~~i~~~~~---------l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~ 148 (320)
T cd05590 81 GDLMFHIQKSRR---------FDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIF 148 (320)
T ss_pred chHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCc
Confidence 999999876543 889999999999999999999999 99999999999999999999999999875422
Q ss_pred ccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccchhhc-------ccCCCccc
Q 018712 226 AAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWA-------TPKLSEDK 298 (351)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~~~~-------~~~~~~~~ 298 (351)
... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||...........+... .+....+.
T Consensus 149 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~l 226 (320)
T cd05590 149 NGK--TTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLSQDAVDI 226 (320)
T ss_pred CCC--cccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHH
Confidence 211 123457999999999999999999999999999999999999999865433221111111 11112367
Q ss_pred hhhhcccccCCCCCHHH---HHHHHHHHHH
Q 018712 299 VKQCVDTKLGGEYPPKA---IAKVRKKKFI 325 (351)
Q Consensus 299 ~~~~ld~~~~~~~~~~~---~~~~~~~~~~ 325 (351)
+..|+..+|.+|++... ...+..+.++
T Consensus 227 i~~~L~~dP~~R~~~~~~~~~~~~~~h~~f 256 (320)
T cd05590 227 LKAFMTKNPTMRLGSLTLGGEEAILRHPFF 256 (320)
T ss_pred HHHHcccCHHHCCCCCCCCCHHHHHcCCCc
Confidence 88999999999998632 2445555554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=308.75 Aligned_cols=255 Identities=22% Similarity=0.346 Sum_probs=199.3
Q ss_pred hcCCCCCceeccCCcEEEEEEEE------CCCCEEEEEEcCCCCC--chHHHHHHHHHHHhc-cCCceeeeEEEEecCCc
Q 018712 65 TDNFGTNSLIGEGSYGRVYFGVL------RSGRAAAIKKLDSSKQ--PDQEFLAQVSMVSRL-KNENVVELVGYYVDGPL 135 (351)
Q Consensus 65 ~~~y~~~~~Lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~ 135 (351)
.++|++.+.||+|+||.||+|.. .++..||+|++..... ..+.+.+|+.+++.+ +||||+++++++.+.+.
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~ 113 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP 113 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence 45799999999999999999973 2466899999875432 235688999999999 89999999999999999
Q ss_pred eEEEEEeCCCCCHHHHhccCCCCCC-------------------------------------------------------
Q 018712 136 RVLAYEHASKGSLHDILHGKKGVKG------------------------------------------------------- 160 (351)
Q Consensus 136 ~~lv~e~~~~gsL~~~l~~~~~~~~------------------------------------------------------- 160 (351)
.++||||+++|+|.+++........
T Consensus 114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (375)
T cd05104 114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS 193 (375)
T ss_pred ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence 9999999999999999975431100
Q ss_pred -----------CCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccccCCCcccccc
Q 018712 161 -----------AKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAAR 229 (351)
Q Consensus 161 -----------~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~ 229 (351)
......+++..+..++.||+.||.|||+++ ++||||||+|||++.++.+||+|||++.........
T Consensus 194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 270 (375)
T cd05104 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY 270 (375)
T ss_pred ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence 001124788899999999999999999999 999999999999999999999999998765433221
Q ss_pred ccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCC-ccchh--------hcccCCCccch
Q 018712 230 LHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQ-QSLVT--------WATPKLSEDKV 299 (351)
Q Consensus 230 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~Pf~~~~~~~~-~~~~~--------~~~~~~~~~~~ 299 (351)
.......++..|+|||.+.+..++.++||||||+++|||++ |..||........ ...+. ...+....+.+
T Consensus 271 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 350 (375)
T cd05104 271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLSPECAPSEMYDIM 350 (375)
T ss_pred cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCCCCCCCCHHHHHHH
Confidence 11222345678999999999999999999999999999998 8999976533211 00111 01111223788
Q ss_pred hhhcccccCCCCCHHHHHHHHHH
Q 018712 300 KQCVDTKLGGEYPPKAIAKVRKK 322 (351)
Q Consensus 300 ~~~ld~~~~~~~~~~~~~~~~~~ 322 (351)
..|++++|.+|++..++...++.
T Consensus 351 ~~cl~~dP~~RPs~~eil~~l~~ 373 (375)
T cd05104 351 KSCWDADPLKRPTFKQIVQLIEQ 373 (375)
T ss_pred HHHccCChhHCcCHHHHHHHHHh
Confidence 99999999999999998877653
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=306.62 Aligned_cols=236 Identities=23% Similarity=0.340 Sum_probs=186.8
Q ss_pred hcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCCc--hHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEEE
Q 018712 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYE 141 (351)
Q Consensus 65 ~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 141 (351)
.++|+..+.||+|+||.||+|.+. +++.||+|++...... ...+.+|+++++.++|+||+++++++.+.+..++|||
T Consensus 73 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 152 (353)
T PLN00034 73 LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLE 152 (353)
T ss_pred HHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEe
Confidence 456788899999999999999965 7899999998654322 4568899999999999999999999999999999999
Q ss_pred eCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccccC
Q 018712 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (351)
Q Consensus 142 ~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~ 221 (351)
|+.+++|.+... .....+..++.||+.||.|||+++ |+||||||+|||+++++.+||+|||++.
T Consensus 153 ~~~~~~L~~~~~-------------~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~ 216 (353)
T PLN00034 153 FMDGGSLEGTHI-------------ADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSR 216 (353)
T ss_pred cCCCCccccccc-------------CCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccce
Confidence 999999865321 566778889999999999999999 9999999999999999999999999987
Q ss_pred CCccccccccccccccccCccCcccccC-----CCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccchh--------
Q 018712 222 QAPDAAARLHSTRVLGTFGYHAPEYAMT-----GQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVT-------- 288 (351)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~~-------- 288 (351)
........ .....||..|+|||++.. ...+.++|||||||++|||++|+.||..........+..
T Consensus 217 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 294 (353)
T PLN00034 217 ILAQTMDP--CNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPP 294 (353)
T ss_pred eccccccc--ccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCCC
Confidence 65432211 134568999999998743 234568999999999999999999998432221111110
Q ss_pred ---hcccCCCccchhhhcccccCCCCCHHHHHH
Q 018712 289 ---WATPKLSEDKVKQCVDTKLGGEYPPKAIAK 318 (351)
Q Consensus 289 ---~~~~~~~~~~~~~~ld~~~~~~~~~~~~~~ 318 (351)
...+....+.+..|+..++.+|++..++..
T Consensus 295 ~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~ 327 (353)
T PLN00034 295 EAPATASREFRHFISCCLQREPAKRWSAMQLLQ 327 (353)
T ss_pred CCCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 011111236788999999999998776543
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=309.38 Aligned_cols=257 Identities=23% Similarity=0.376 Sum_probs=200.5
Q ss_pred HhcCCCCCceeccCCcEEEEEEEEC------CCCEEEEEEcCCCCCc--hHHHHHHHHHHHhc-cCCceeeeEEEEecCC
Q 018712 64 KTDNFGTNSLIGEGSYGRVYFGVLR------SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRL-KNENVVELVGYYVDGP 134 (351)
Q Consensus 64 ~~~~y~~~~~Lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~ 134 (351)
..++|++.+.||+|+||.||+|... ++..||+|++...... ...+.+|+.+++.+ +|+||+++++.+...+
T Consensus 36 ~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~ 115 (374)
T cd05106 36 PRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGG 115 (374)
T ss_pred cHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCC
Confidence 3457999999999999999998842 3457999999754332 34578899999999 8999999999999999
Q ss_pred ceEEEEEeCCCCCHHHHhccCCCC--------------------------------------------------------
Q 018712 135 LRVLAYEHASKGSLHDILHGKKGV-------------------------------------------------------- 158 (351)
Q Consensus 135 ~~~lv~e~~~~gsL~~~l~~~~~~-------------------------------------------------------- 158 (351)
..++||||+++|+|.+++......
T Consensus 116 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (374)
T cd05106 116 PVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSS 195 (374)
T ss_pred CeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccc
Confidence 999999999999999998653210
Q ss_pred -----CCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccccCCCcccccccccc
Q 018712 159 -----KGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHST 233 (351)
Q Consensus 159 -----~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~ 233 (351)
........+++..++.++.||+.||.|||+++ ++||||||+|||+++++.+||+|||+++............
T Consensus 196 ~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~ 272 (374)
T cd05106 196 DSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKG 272 (374)
T ss_pred cccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeecc
Confidence 00011124788899999999999999999999 9999999999999999999999999987654332211122
Q ss_pred ccccccCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCCc-cchhh--------cccCCCccchhhhc
Q 018712 234 RVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQ-SLVTW--------ATPKLSEDKVKQCV 303 (351)
Q Consensus 234 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~Pf~~~~~~~~~-~~~~~--------~~~~~~~~~~~~~l 303 (351)
...++..|+|||++.+..++.++||||||+++|+|++ |+.||......... ..+.. ..+....+.+..|+
T Consensus 273 ~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl 352 (374)
T cd05106 273 NARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSRPDFAPPEIYSIMKMCW 352 (374)
T ss_pred CCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCccCCCCCCHHHHHHHHHHc
Confidence 2345678999999998999999999999999999997 99999865432211 11110 01112236788999
Q ss_pred ccccCCCCCHHHHHHHHHHH
Q 018712 304 DTKLGGEYPPKAIAKVRKKK 323 (351)
Q Consensus 304 d~~~~~~~~~~~~~~~~~~~ 323 (351)
..+|.+|++.+++.++++-.
T Consensus 353 ~~dp~~RPs~~~l~~~l~~~ 372 (374)
T cd05106 353 NLEPTERPTFSQISQLIQRQ 372 (374)
T ss_pred CCChhhCcCHHHHHHHHHHH
Confidence 99999999999998887654
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=303.65 Aligned_cols=229 Identities=23% Similarity=0.323 Sum_probs=185.4
Q ss_pred ceeccCCcEEEEEEEEC-CCCEEEEEEcCCCC----CchHHHHHHHHHHHh-ccCCceeeeEEEEecCCceEEEEEeCCC
Q 018712 72 SLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK----QPDQEFLAQVSMVSR-LKNENVVELVGYYVDGPLRVLAYEHASK 145 (351)
Q Consensus 72 ~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~-l~h~niv~~~~~~~~~~~~~lv~e~~~~ 145 (351)
+.||+|+||.||+|.+. +++.||+|++.... ........|..+++. ++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999975 67899999987532 223445667777776 4899999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccccCCCcc
Q 018712 146 GSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPD 225 (351)
Q Consensus 146 gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~ 225 (351)
|+|.+++..... +++..+..++.|++.||.|||+++ ++||||||+|||++.++.+||+|||++.....
T Consensus 81 g~L~~~l~~~~~---------~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~ 148 (316)
T cd05619 81 GDLMFHIQSCHK---------FDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENML 148 (316)
T ss_pred CcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCC
Confidence 999999976432 788999999999999999999999 99999999999999999999999999865322
Q ss_pred ccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccchhhcccCC-------Cccc
Q 018712 226 AAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKL-------SEDK 298 (351)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~-------~~~~ 298 (351)
... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...........+....+.. ..+.
T Consensus 149 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~l 226 (316)
T cd05619 149 GDA--KTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPRWLTREAKDI 226 (316)
T ss_pred CCC--ceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHH
Confidence 211 1234568999999999999999999999999999999999999998654332222222111111 1367
Q ss_pred hhhhcccccCCCCCHH
Q 018712 299 VKQCVDTKLGGEYPPK 314 (351)
Q Consensus 299 ~~~~ld~~~~~~~~~~ 314 (351)
+..|+..+|.+|++..
T Consensus 227 i~~~l~~~P~~R~~~~ 242 (316)
T cd05619 227 LVKLFVREPERRLGVK 242 (316)
T ss_pred HHHHhccCHhhcCCCh
Confidence 8899999999998875
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-42 Score=297.89 Aligned_cols=207 Identities=26% Similarity=0.379 Sum_probs=170.9
Q ss_pred cCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCCchHHHHHHHHHHHhccCCceeeeEEEEecC---C--ceEEE
Q 018712 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDG---P--LRVLA 139 (351)
Q Consensus 66 ~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~---~--~~~lv 139 (351)
-.|...+++|.|+||.||+|... ++..||||++-.+.... -+|+++|+.+.|||||++.-+|... + ...+|
T Consensus 24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~k---nrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV 100 (364)
T KOG0658|consen 24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYK---NRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV 100 (364)
T ss_pred EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcC---cHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence 35777889999999999999964 67999999987665432 3689999999999999999887532 1 45689
Q ss_pred EEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccC-CceEEeccc
Q 018712 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDD-DIAKISDFD 218 (351)
Q Consensus 140 ~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~-~~vkl~Dfg 218 (351)
|||++. +|.++++.....+ ..++...+.-+..||++||.|||+.| |+||||||.|+|+|.+ |.+||||||
T Consensus 101 leymP~-tL~~~~r~~~~~~-----~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFG 171 (364)
T KOG0658|consen 101 LEYMPE-TLYRVIRHYTRAN-----QRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFG 171 (364)
T ss_pred HHhchH-HHHHHHHHHhhcC-----CCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCC
Confidence 999987 9999998532111 12777888999999999999999999 9999999999999987 899999999
Q ss_pred ccCCCccccccccccccccccCccCcccccCC-CCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccch
Q 018712 219 LSNQAPDAAARLHSTRVLGTFGYHAPEYAMTG-QMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLV 287 (351)
Q Consensus 219 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~ 287 (351)
.|+.+..+... .....|..|+|||.+.|. .|+.+.||||.||++.||+-|++-|.+.+..++...+
T Consensus 172 SAK~L~~~epn---iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eI 238 (364)
T KOG0658|consen 172 SAKVLVKGEPN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEI 238 (364)
T ss_pred cceeeccCCCc---eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHH
Confidence 99988655443 334568899999998865 7999999999999999999999999997665444333
|
|
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=310.38 Aligned_cols=239 Identities=21% Similarity=0.326 Sum_probs=193.8
Q ss_pred ceeccCCcEEEEEEEE----CCCCEEEEEEcCCCC---CchHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEEEeCC
Q 018712 72 SLIGEGSYGRVYFGVL----RSGRAAAIKKLDSSK---QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHAS 144 (351)
Q Consensus 72 ~~Lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 144 (351)
+.||+|+||.||++.. .+++.||+|++.... .....+.+|++++++++||||+++++.+.+.+..|+||||+.
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999875 367899999987532 223456789999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccccCCCc
Q 018712 145 KGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAP 224 (351)
Q Consensus 145 ~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~ 224 (351)
+|+|.+++..... +++..+..++.||+.||.|||+++ ++||||||+|||++.++.+||+|||++....
T Consensus 82 ~~~L~~~l~~~~~---------l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~ 149 (318)
T cd05582 82 GGDLFTRLSKEVM---------FTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESI 149 (318)
T ss_pred CCcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccC
Confidence 9999999976432 889999999999999999999999 9999999999999999999999999987654
Q ss_pred cccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccchhhc-------ccCCCcc
Q 018712 225 DAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWA-------TPKLSED 297 (351)
Q Consensus 225 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~~~~-------~~~~~~~ 297 (351)
..... .....||+.|+|||.+.+..++.++||||||+++|+|++|+.||...........+... .+....+
T Consensus 150 ~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ 227 (318)
T cd05582 150 DHEKK--AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQFLSPEAQS 227 (318)
T ss_pred CCCCc--eecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence 33211 23457899999999999888999999999999999999999999865432211111111 1112246
Q ss_pred chhhhcccccCCCCCHHH--HHHHHHHHH
Q 018712 298 KVKQCVDTKLGGEYPPKA--IAKVRKKKF 324 (351)
Q Consensus 298 ~~~~~ld~~~~~~~~~~~--~~~~~~~~~ 324 (351)
.+..|++.+|.+|+++.+ +..++.+.+
T Consensus 228 li~~~l~~~P~~R~~a~~~~~~~~~~~~~ 256 (318)
T cd05582 228 LLRALFKRNPANRLGAGPDGVEEIKRHPF 256 (318)
T ss_pred HHHHHhhcCHhHcCCCCCCCHHHHhCCCC
Confidence 889999999999998655 555555544
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=292.71 Aligned_cols=246 Identities=25% Similarity=0.388 Sum_probs=202.4
Q ss_pred hcCCCCCceeccCCcEEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEEEeCC
Q 018712 65 TDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHAS 144 (351)
Q Consensus 65 ~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 144 (351)
.++|++.++||+|+||.||+|...++..||+|.+.......+.+.+|+.++++++|+||+++++.+.+.+..+++|||++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 84 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMA 84 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCchhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCC
Confidence 46789999999999999999998888899999987665556788999999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccccCCCc
Q 018712 145 KGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAP 224 (351)
Q Consensus 145 ~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~ 224 (351)
+++|.+++...... .+++..++.++.|++.||+|||+.+ ++||||||+||++++++.++|+|||++....
T Consensus 85 ~~~L~~~l~~~~~~-------~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~ 154 (261)
T cd05072 85 KGSLLDFLKSDEGG-------KVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIE 154 (261)
T ss_pred CCcHHHHHHHhcCC-------CCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecC
Confidence 99999999754321 2788899999999999999999999 9999999999999999999999999997764
Q ss_pred cccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCCccchhh--------cccCCC
Q 018712 225 DAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTW--------ATPKLS 295 (351)
Q Consensus 225 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~Pf~~~~~~~~~~~~~~--------~~~~~~ 295 (351)
..... ......++..|+|||.+.+..++.++||||||+++|+|++ |+.||...........+.. ..+...
T Consensus 155 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (261)
T cd05072 155 DNEYT-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRMENCPDEL 233 (261)
T ss_pred CCcee-ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHH
Confidence 32211 1122345678999999988889999999999999999998 9999976543221111110 111122
Q ss_pred ccchhhhcccccCCCCCHHHHHHHHH
Q 018712 296 EDKVKQCVDTKLGGEYPPKAIAKVRK 321 (351)
Q Consensus 296 ~~~~~~~ld~~~~~~~~~~~~~~~~~ 321 (351)
.+.+.+|+..+|.+|++.+++..+++
T Consensus 234 ~~li~~~l~~~p~~Rp~~~~i~~~l~ 259 (261)
T cd05072 234 YDIMKTCWKEKAEERPTFDYLQSVLD 259 (261)
T ss_pred HHHHHHHccCCcccCcCHHHHHHHHh
Confidence 36788999999999999999877764
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=291.04 Aligned_cols=243 Identities=23% Similarity=0.397 Sum_probs=199.2
Q ss_pred cCCCCCceeccCCcEEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEEEeCCC
Q 018712 66 DNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASK 145 (351)
Q Consensus 66 ~~y~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 145 (351)
++|++.+.||+|+||.||++..+++..+|+|.+.........+.+|+.++++++||||+++++++.+.+..+++|||+++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~ 83 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMEN 83 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCC
Confidence 46888899999999999999988888999999876666667889999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccccCCCcc
Q 018712 146 GSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPD 225 (351)
Q Consensus 146 gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~ 225 (351)
|+|.+++..... .+++..+..++.|++.||.|||+++ ++||||||+||++++++.+||+|||.+.....
T Consensus 84 ~~L~~~~~~~~~--------~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~ 152 (256)
T cd05114 84 GCLLNYLRQRQG--------KLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLD 152 (256)
T ss_pred CcHHHHHHhCcc--------CCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCC
Confidence 999999975432 2788999999999999999999999 99999999999999999999999999876543
Q ss_pred ccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCCccchhhc----ccC----CCc
Q 018712 226 AAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWA----TPK----LSE 296 (351)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~Pf~~~~~~~~~~~~~~~----~~~----~~~ 296 (351)
.... ......++..|+|||.+.+..++.++|+||||+++|+|++ |+.||...........+... .+. ...
T Consensus 153 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 231 (256)
T cd05114 153 DEYT-SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRPKLASMTVY 231 (256)
T ss_pred Ccee-ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHH
Confidence 2211 1122235668999999998889999999999999999999 99999765433211111110 111 123
Q ss_pred cchhhhcccccCCCCCHHHHHHHH
Q 018712 297 DKVKQCVDTKLGGEYPPKAIAKVR 320 (351)
Q Consensus 297 ~~~~~~ld~~~~~~~~~~~~~~~~ 320 (351)
+.+..|+.++|.+|++.+++...+
T Consensus 232 ~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 232 EVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred HHHHHHccCCcccCcCHHHHHHhh
Confidence 677899999999999998886643
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-41 Score=306.03 Aligned_cols=245 Identities=22% Similarity=0.291 Sum_probs=194.0
Q ss_pred CCCCCceeccCCcEEEEEEEEC----CCCEEEEEEcCCCC-----CchHHHHHHHHHHHhc-cCCceeeeEEEEecCCce
Q 018712 67 NFGTNSLIGEGSYGRVYFGVLR----SGRAAAIKKLDSSK-----QPDQEFLAQVSMVSRL-KNENVVELVGYYVDGPLR 136 (351)
Q Consensus 67 ~y~~~~~Lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~-----~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~ 136 (351)
+|++.+.||+|+||.||++... +++.||+|++.+.. .....+.+|+.+++.+ +|+||+++++++...+..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 5888999999999999998853 68899999986421 2234577899999999 589999999999999999
Q ss_pred EEEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEec
Q 018712 137 VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISD 216 (351)
Q Consensus 137 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~D 216 (351)
++||||+.+|+|.+++..... +++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~~---------~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~D 148 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRDN---------FSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTD 148 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEee
Confidence 999999999999999976542 889999999999999999999999 99999999999999999999999
Q ss_pred ccccCCCccccccccccccccccCccCcccccCC-CCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccch----hh--
Q 018712 217 FDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTG-QMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLV----TW-- 289 (351)
Q Consensus 217 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~----~~-- 289 (351)
||+++........ ......||+.|+|||++.+. .++.++||||||+++|||++|+.||...........+ ..
T Consensus 149 fG~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 227 (332)
T cd05614 149 FGLSKEFLSEEKE-RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCD 227 (332)
T ss_pred CcCCccccccCCC-ccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCC
Confidence 9998765332211 12345799999999998865 4788999999999999999999999754332221111 01
Q ss_pred -----cccCCCccchhhhcccccCCCCCHH--HHHHHHHHHH
Q 018712 290 -----ATPKLSEDKVKQCVDTKLGGEYPPK--AIAKVRKKKF 324 (351)
Q Consensus 290 -----~~~~~~~~~~~~~ld~~~~~~~~~~--~~~~~~~~~~ 324 (351)
..+....+.+..|+..+|.+|++.. .+..++++.+
T Consensus 228 ~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~ 269 (332)
T cd05614 228 PPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPF 269 (332)
T ss_pred CCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCC
Confidence 1111124788899999999999543 4444555544
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=311.56 Aligned_cols=239 Identities=23% Similarity=0.293 Sum_probs=194.1
Q ss_pred cCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCC----CchHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEE
Q 018712 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK----QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAY 140 (351)
Q Consensus 66 ~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 140 (351)
++|.+.+.||+|+||.||+|... +++.||+|++.... .....+.+|+++++.++|+||+++++.+.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 47899999999999999999975 78999999986432 23456788999999999999999999999999999999
Q ss_pred EeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEeccccc
Q 018712 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (351)
Q Consensus 141 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a 220 (351)
||+++++|.+++..... ++...+..++.||+.||.|||+.| ++||||||+|||++.++.+||+|||++
T Consensus 81 e~~~~~~L~~~l~~~~~---------l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~ 148 (350)
T cd05573 81 EYMPGGDLMNLLIRKDV---------FPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLC 148 (350)
T ss_pred cCCCCCCHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCC
Confidence 99999999999986532 889999999999999999999999 999999999999999999999999998
Q ss_pred CCCcccc---------------------------ccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCC
Q 018712 221 NQAPDAA---------------------------ARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRK 273 (351)
Q Consensus 221 ~~~~~~~---------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~ 273 (351)
....... .........||+.|+|||++.+..++.++|||||||++|+|++|+.
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~ 228 (350)
T cd05573 149 KKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFP 228 (350)
T ss_pred ccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCC
Confidence 7654332 0011234568999999999999999999999999999999999999
Q ss_pred CCCCCCCCCCccchhh-----cc------cCCCccchhhhcccccCCCCC-HHHHH
Q 018712 274 PVDHTLPRGQQSLVTW-----AT------PKLSEDKVKQCVDTKLGGEYP-PKAIA 317 (351)
Q Consensus 274 Pf~~~~~~~~~~~~~~-----~~------~~~~~~~~~~~ld~~~~~~~~-~~~~~ 317 (351)
||...........+.. .. +....+.+..|+. ++.+|++ .+++.
T Consensus 229 Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll 283 (350)
T cd05573 229 PFYSDTLQETYNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIK 283 (350)
T ss_pred CCCCCCHHHHHHHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHh
Confidence 9987653221111111 11 1111356677775 7778887 55554
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=313.49 Aligned_cols=204 Identities=26% Similarity=0.365 Sum_probs=175.8
Q ss_pred cCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCC----CCchHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEE
Q 018712 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSS----KQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAY 140 (351)
Q Consensus 66 ~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 140 (351)
++|++.+.||+|+||.||++... +++.||+|++... ......+.+|+.++..++|+||+++++.+.+.+..|+||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47889999999999999999975 6899999998642 222356778999999999999999999999999999999
Q ss_pred EeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEeccccc
Q 018712 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (351)
Q Consensus 141 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a 220 (351)
||+++|+|.+++..... ++...+..++.|++.||.|||+.| |+||||||+|||++.++.+||+|||++
T Consensus 81 E~~~gg~L~~~l~~~~~---------l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~ 148 (360)
T cd05627 81 EFLPGGDMMTLLMKKDT---------LSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLC 148 (360)
T ss_pred eCCCCccHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCC
Confidence 99999999999976542 889999999999999999999999 999999999999999999999999998
Q ss_pred CCCcccccc---------------------------------ccccccccccCccCcccccCCCCCccchhHhHHHHHHH
Q 018712 221 NQAPDAAAR---------------------------------LHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLE 267 (351)
Q Consensus 221 ~~~~~~~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~e 267 (351)
......... ......+||+.|+|||++.+..++.++|||||||++||
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilye 228 (360)
T cd05627 149 TGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYE 228 (360)
T ss_pred cccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeee
Confidence 754321100 00123469999999999999999999999999999999
Q ss_pred HHcCCCCCCCCCCC
Q 018712 268 LLTGRKPVDHTLPR 281 (351)
Q Consensus 268 l~tg~~Pf~~~~~~ 281 (351)
|++|+.||....+.
T Consensus 229 l~tG~~Pf~~~~~~ 242 (360)
T cd05627 229 MLIGYPPFCSETPQ 242 (360)
T ss_pred cccCCCCCCCCCHH
Confidence 99999999876543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-41 Score=311.42 Aligned_cols=240 Identities=21% Similarity=0.289 Sum_probs=189.8
Q ss_pred HHhcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCC----CchHHHHHHHHHHHhccCCceeeeEEEEecCCceE
Q 018712 63 EKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK----QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRV 137 (351)
Q Consensus 63 ~~~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 137 (351)
...++|++.+.||+|+||.||++... +++.||+|++.... .....+.+|+.+++.++||||+++++++.+++..+
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~ 119 (370)
T cd05596 40 MKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLY 119 (370)
T ss_pred CCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence 34568999999999999999999975 68899999986421 22345678999999999999999999999999999
Q ss_pred EEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecc
Q 018712 138 LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDF 217 (351)
Q Consensus 138 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Df 217 (351)
+||||+++|+|.+++.... ++...+..++.||+.||.|||+++ |+||||||+|||+++++.+||+||
T Consensus 120 lv~Ey~~gg~L~~~l~~~~----------l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~Df 186 (370)
T cd05596 120 MVMEYMPGGDLVNLMSNYD----------IPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADF 186 (370)
T ss_pred EEEcCCCCCcHHHHHHhcC----------CCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEec
Confidence 9999999999999997543 778889999999999999999999 999999999999999999999999
Q ss_pred cccCCCccccccccccccccccCccCcccccCC----CCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccchhh----
Q 018712 218 DLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTG----QMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTW---- 289 (351)
Q Consensus 218 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~~~---- 289 (351)
|++........ .......||+.|+|||++.+. .++.++|||||||++|||++|+.||...........+..
T Consensus 187 G~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~ 265 (370)
T cd05596 187 GTCMKMDANGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNS 265 (370)
T ss_pred cceeeccCCCc-ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCc
Confidence 99876543211 112345799999999988653 478899999999999999999999987543221111110
Q ss_pred -ccc------CCCccchhhhcccccCC--CCCHHHH
Q 018712 290 -ATP------KLSEDKVKQCVDTKLGG--EYPPKAI 316 (351)
Q Consensus 290 -~~~------~~~~~~~~~~ld~~~~~--~~~~~~~ 316 (351)
..+ ....+.+..|+..++.. |++.+++
T Consensus 266 ~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~el 301 (370)
T cd05596 266 LTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEI 301 (370)
T ss_pred CCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHH
Confidence 011 11124567777766654 6665554
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-41 Score=312.10 Aligned_cols=209 Identities=21% Similarity=0.324 Sum_probs=177.8
Q ss_pred HHHHHHHhcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCC----CchHHHHHHHHHHHhccCCceeeeEEEEec
Q 018712 58 VDELKEKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK----QPDQEFLAQVSMVSRLKNENVVELVGYYVD 132 (351)
Q Consensus 58 ~~~~~~~~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~ 132 (351)
...+....++|++.+.||+|+||.||++.+. +++.+|+|++.... .....+.+|..+++.++||||+++++.+.+
T Consensus 35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~ 114 (371)
T cd05622 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 114 (371)
T ss_pred HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence 3344556689999999999999999999976 68899999986422 223456789999999999999999999999
Q ss_pred CCceEEEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCce
Q 018712 133 GPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIA 212 (351)
Q Consensus 133 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~v 212 (351)
++..++||||+++|+|.+++.... ++...+..++.||+.||.|||+++ |+||||||+|||++.++.+
T Consensus 115 ~~~~~lv~Ey~~gg~L~~~~~~~~----------~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~i 181 (371)
T cd05622 115 DRYLYMVMEYMPGGDLVNLMSNYD----------VPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHL 181 (371)
T ss_pred CCEEEEEEcCCCCCcHHHHHHhcC----------CCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCE
Confidence 999999999999999999997543 788889999999999999999999 9999999999999999999
Q ss_pred EEecccccCCCccccccccccccccccCccCcccccCC----CCCccchhHhHHHHHHHHHcCCCCCCCCCC
Q 018712 213 KISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTG----QMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (351)
Q Consensus 213 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwslG~il~el~tg~~Pf~~~~~ 280 (351)
||+|||++........ .......||+.|+|||++.+. .++.++|||||||++|||++|+.||.....
T Consensus 182 kL~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~ 252 (371)
T cd05622 182 KLADFGTCMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL 252 (371)
T ss_pred EEEeCCceeEcCcCCc-ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCH
Confidence 9999999876543211 112345799999999998754 378899999999999999999999986543
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=315.47 Aligned_cols=202 Identities=20% Similarity=0.334 Sum_probs=167.3
Q ss_pred HHHHHhcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCCchHHHHHHHHHHHhccC------CceeeeEEEEec
Q 018712 60 ELKEKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKN------ENVVELVGYYVD 132 (351)
Q Consensus 60 ~~~~~~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h------~niv~~~~~~~~ 132 (351)
++....++|++.+.||+|+||+||+|.+. +++.||||+++...........|+++++.+.| .+++++++++..
T Consensus 123 ~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~ 202 (467)
T PTZ00284 123 DIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQN 202 (467)
T ss_pred ccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEc
Confidence 33445678999999999999999999965 67899999997544444556678888777754 458888888875
Q ss_pred C-CceEEEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhh-CCCCCeeeccccCCcEEEccCC
Q 018712 133 G-PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHE-KAEPRIIHRNIKSSNVLLFDDD 210 (351)
Q Consensus 133 ~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~-~~~~~ivH~Dlkp~Nill~~~~ 210 (351)
. ...++||+++ +++|.+++..... +++..+..++.||+.||.|||+ .| |+||||||+|||++.++
T Consensus 203 ~~~~~~iv~~~~-g~~l~~~l~~~~~---------l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~ 269 (467)
T PTZ00284 203 ETGHMCIVMPKY-GPCLLDWIMKHGP---------FSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSD 269 (467)
T ss_pred CCceEEEEEecc-CCCHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCC
Confidence 4 5688999988 6689988876532 8899999999999999999998 48 99999999999998765
Q ss_pred ----------------ceEEecccccCCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCC
Q 018712 211 ----------------IAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274 (351)
Q Consensus 211 ----------------~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P 274 (351)
.+||+|||.+...... .....||+.|+|||++.+..++.++|||||||++|||++|+.|
T Consensus 270 ~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~~~-----~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~p 344 (467)
T PTZ00284 270 TVVDPVTNRALPPDPCRVRICDLGGCCDERHS-----RTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLL 344 (467)
T ss_pred cccccccccccCCCCceEEECCCCccccCccc-----cccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence 4999999987643221 2456799999999999999999999999999999999999999
Q ss_pred CCCCC
Q 018712 275 VDHTL 279 (351)
Q Consensus 275 f~~~~ 279 (351)
|....
T Consensus 345 f~~~~ 349 (467)
T PTZ00284 345 YDTHD 349 (467)
T ss_pred CCCCC
Confidence 98654
|
|
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-41 Score=305.82 Aligned_cols=239 Identities=21% Similarity=0.302 Sum_probs=188.3
Q ss_pred ceeccCCcEEEEEEEEC-CCCEEEEEEcCCCC----CchHHHHHHHH-HHHhccCCceeeeEEEEecCCceEEEEEeCCC
Q 018712 72 SLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK----QPDQEFLAQVS-MVSRLKNENVVELVGYYVDGPLRVLAYEHASK 145 (351)
Q Consensus 72 ~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~-~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 145 (351)
+.||+|+||.||+|.+. +++.||+|++.... .....+..|.. +++.++||||+++++.+.+.+..++||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 46999999999999975 78999999986432 12233445544 56789999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccccCCCcc
Q 018712 146 GSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPD 225 (351)
Q Consensus 146 gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~ 225 (351)
|+|..++..... +++..+..++.||+.||.|||++| |+||||||+|||++.++.+||+|||++.....
T Consensus 81 g~L~~~l~~~~~---------~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~ 148 (323)
T cd05575 81 GELFFHLQRERS---------FPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIE 148 (323)
T ss_pred CCHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCccccc
Confidence 999999976542 888999999999999999999999 99999999999999999999999999875432
Q ss_pred ccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccchh----hcc---cCCCccc
Q 018712 226 AAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVT----WAT---PKLSEDK 298 (351)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~~----~~~---~~~~~~~ 298 (351)
... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||...........+. ... +....+.
T Consensus 149 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~l 226 (323)
T cd05575 149 HSK--TTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLKPNISVSARHL 226 (323)
T ss_pred CCC--ccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 221 1244579999999999999999999999999999999999999998654322111111 011 1122367
Q ss_pred hhhhcccccCCCCCHH-HHHHHHHHHH
Q 018712 299 VKQCVDTKLGGEYPPK-AIAKVRKKKF 324 (351)
Q Consensus 299 ~~~~ld~~~~~~~~~~-~~~~~~~~~~ 324 (351)
+..|+..++.+|++.. ....++.+.+
T Consensus 227 i~~~l~~~p~~R~~~~~~~~~il~~~~ 253 (323)
T cd05575 227 LEGLLQKDRTKRLGAKDDFLEIKNHVF 253 (323)
T ss_pred HHHHhhcCHHhCCCCCCCHHHHHcCCC
Confidence 8889999999998764 3334455444
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=302.41 Aligned_cols=240 Identities=23% Similarity=0.322 Sum_probs=203.9
Q ss_pred HHhcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCC----chHHHHHHHHHHHhcc-CCceeeeEEEEecCCce
Q 018712 63 EKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ----PDQEFLAQVSMVSRLK-NENVVELVGYYVDGPLR 136 (351)
Q Consensus 63 ~~~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~ 136 (351)
.....|.+.+.||+|.||.||++..+ +|+.+|+|.+.+... ....+.+|+.+|+++. ||||+++++.|.+...+
T Consensus 32 ~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~ 111 (382)
T KOG0032|consen 32 DIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSV 111 (382)
T ss_pred cccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeE
Confidence 34567999999999999999999976 599999999976543 2357899999999998 99999999999999999
Q ss_pred EEEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccC----Cce
Q 018712 137 VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDD----DIA 212 (351)
Q Consensus 137 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~----~~v 212 (351)
++|||++.||.|.+.+... . +++..+..++.|++.++.|||+.| ++||||||+|+|+... +.+
T Consensus 112 ~lvmEL~~GGeLfd~i~~~-~---------~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~i 178 (382)
T KOG0032|consen 112 YLVMELCEGGELFDRIVKK-H---------YSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRI 178 (382)
T ss_pred EEEEEecCCchHHHHHHHc-c---------CCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcE
Confidence 9999999999999999876 1 899999999999999999999999 9999999999999643 479
Q ss_pred EEecccccCCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccchhhc--
Q 018712 213 KISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWA-- 290 (351)
Q Consensus 213 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~~~~-- 290 (351)
|++|||++...... ......+||+.|+|||++....|+..+||||+|+++|.|++|.+||...........+...
T Consensus 179 k~~DFGla~~~~~~---~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~ 255 (382)
T KOG0032|consen 179 KLIDFGLAKFIKPG---ERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDF 255 (382)
T ss_pred EEeeCCCceEccCC---ceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCC
Confidence 99999999887662 2236789999999999999999999999999999999999999999987654332222211
Q ss_pred ------ccCCC---ccchhhhcccccCCCCCHHHHHH
Q 018712 291 ------TPKLS---EDKVKQCVDTKLGGEYPPKAIAK 318 (351)
Q Consensus 291 ------~~~~~---~~~~~~~ld~~~~~~~~~~~~~~ 318 (351)
++.+. .+.+..++..++..|++..++..
T Consensus 256 ~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~ 292 (382)
T KOG0032|consen 256 DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQ 292 (382)
T ss_pred CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhc
Confidence 11111 26788889999999998877655
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=303.86 Aligned_cols=200 Identities=25% Similarity=0.402 Sum_probs=168.2
Q ss_pred CCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCC---CchHHHHHHHHHHHhccCCceeeeEEEEecC-----CceE
Q 018712 67 NFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK---QPDQEFLAQVSMVSRLKNENVVELVGYYVDG-----PLRV 137 (351)
Q Consensus 67 ~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~~~ 137 (351)
+|++.+.||+|+||.||+|... ++..||+|++.... .....+.+|+.+++.++||||+++++++... ...|
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 5888999999999999999965 78999999986432 2234678999999999999999999987543 2479
Q ss_pred EEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecc
Q 018712 138 LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDF 217 (351)
Q Consensus 138 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Df 217 (351)
+||||+. ++|.+++..... +++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+||
T Consensus 81 lv~e~~~-~~L~~~l~~~~~---------~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Df 147 (338)
T cd07859 81 VVFELME-SDLHQVIKANDD---------LTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDF 147 (338)
T ss_pred EEEecCC-CCHHHHHHhccc---------CCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccC
Confidence 9999996 599999876542 889999999999999999999999 999999999999999999999999
Q ss_pred cccCCCccccc-cccccccccccCccCcccccC--CCCCccchhHhHHHHHHHHHcCCCCCCCCC
Q 018712 218 DLSNQAPDAAA-RLHSTRVLGTFGYHAPEYAMT--GQMSSKSDVYSFGVVLLELLTGRKPVDHTL 279 (351)
Q Consensus 218 g~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~el~tg~~Pf~~~~ 279 (351)
|+++....... ........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||....
T Consensus 148 g~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~ 212 (338)
T cd07859 148 GLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKN 212 (338)
T ss_pred ccccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCC
Confidence 99876532211 111234568999999998875 678999999999999999999999997643
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-40 Score=300.55 Aligned_cols=198 Identities=28% Similarity=0.449 Sum_probs=174.3
Q ss_pred hcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCCc--hHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEEE
Q 018712 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYE 141 (351)
Q Consensus 65 ~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 141 (351)
.++|++.+.||+|+||.||++.+. ++..+|+|.+...... ...+.+|+++++.++|+||+++++++.+.+..++|||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 478999999999999999999976 6888999988754322 3568899999999999999999999999999999999
Q ss_pred eCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhC-CCCCeeeccccCCcEEEccCCceEEeccccc
Q 018712 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEK-AEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (351)
Q Consensus 142 ~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~-~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a 220 (351)
|+.+++|.+++..... ++...+..++.|++.||.|||+. + ++||||||+|||+++++.+||+|||++
T Consensus 84 ~~~~~~L~~~l~~~~~---------~~~~~~~~~~~~l~~~l~~lH~~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~ 151 (333)
T cd06650 84 HMDGGSLDQVLKKAGR---------IPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVS 151 (333)
T ss_pred cCCCCcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChhhEEEcCCCCEEEeeCCcc
Confidence 9999999999976542 78889999999999999999975 6 999999999999999999999999998
Q ss_pred CCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCC
Q 018712 221 NQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHT 278 (351)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~ 278 (351)
....... .....||..|+|||++.+..++.++|||||||++|+|++|+.||...
T Consensus 152 ~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~ 205 (333)
T cd06650 152 GQLIDSM----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPP 205 (333)
T ss_pred hhhhhhc----cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 7653321 13456899999999999989999999999999999999999999753
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=316.32 Aligned_cols=244 Identities=18% Similarity=0.220 Sum_probs=196.1
Q ss_pred CCCCCceeccCCcEEEEEEEEC-C-CCEEEEEEcCCCCCc-hHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEEEeC
Q 018712 67 NFGTNSLIGEGSYGRVYFGVLR-S-GRAAAIKKLDSSKQP-DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHA 143 (351)
Q Consensus 67 ~y~~~~~Lg~G~~g~Vy~~~~~-~-~~~vavK~~~~~~~~-~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 143 (351)
.|.+.+.||+|++|.||+|... + +..||+|.+...... ...+.+|+.+++.++||||+++++++...+..|+||||+
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~ 147 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence 4889999999999999999854 4 678888877544332 345778999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccccCCC
Q 018712 144 SKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQA 223 (351)
Q Consensus 144 ~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~ 223 (351)
++|+|.+++...... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 148 ~gg~L~~~l~~~~~~-----~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~ 219 (478)
T PTZ00267 148 SGGDLNKQIKQRLKE-----HLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQY 219 (478)
T ss_pred CCCCHHHHHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceec
Confidence 999999988643211 113788899999999999999999999 999999999999999999999999999876
Q ss_pred ccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccchhh--------cccCCC
Q 018712 224 PDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTW--------ATPKLS 295 (351)
Q Consensus 224 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~~~--------~~~~~~ 295 (351)
............+||+.|+|||++.+..++.++|||||||++|+|++|+.||...........+.. ..+...
T Consensus 220 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~s~~~ 299 (478)
T PTZ00267 220 SDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPFPCPVSSGM 299 (478)
T ss_pred CCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCccCCHHH
Confidence 443222223456799999999999999999999999999999999999999976543221111100 011112
Q ss_pred ccchhhhcccccCCCCCHHHHHH
Q 018712 296 EDKVKQCVDTKLGGEYPPKAIAK 318 (351)
Q Consensus 296 ~~~~~~~ld~~~~~~~~~~~~~~ 318 (351)
.+.+..|+..+|..|++.+++..
T Consensus 300 ~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 300 KALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred HHHHHHHhccChhhCcCHHHHHh
Confidence 36788999999999999887643
|
|
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=302.29 Aligned_cols=233 Identities=21% Similarity=0.259 Sum_probs=187.9
Q ss_pred CCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCC----CchHHHHHHHHHHHhcc-CCceeeeEEEEecCCceEEEE
Q 018712 67 NFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK----QPDQEFLAQVSMVSRLK-NENVVELVGYYVDGPLRVLAY 140 (351)
Q Consensus 67 ~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~ 140 (351)
+|+..+.||+|+||.||+|... +++.||+|++.... .....+..|..+++.+. |++|+++++++.+.+..|+||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 4777889999999999999965 78999999987532 22345677888888885 577888999999999999999
Q ss_pred EeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEeccccc
Q 018712 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (351)
Q Consensus 141 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a 220 (351)
||+++|+|.+++..... +++..+..++.||+.||.|||++| ++||||||+|||+++++.+||+|||++
T Consensus 81 Ey~~~g~L~~~i~~~~~---------l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~ 148 (323)
T cd05615 81 EYVNGGDLMYHIQQVGK---------FKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMC 148 (323)
T ss_pred cCCCCCcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccc
Confidence 99999999999976542 889999999999999999999999 999999999999999999999999998
Q ss_pred CCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccchhhcc-------cC
Q 018712 221 NQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWAT-------PK 293 (351)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~~~~~-------~~ 293 (351)
+....... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||...........+.... +.
T Consensus 149 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~ 226 (323)
T cd05615 149 KEHMVDGV--TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSK 226 (323)
T ss_pred cccCCCCc--cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCH
Confidence 75432211 1234568999999999999999999999999999999999999998764332211111111 11
Q ss_pred CCccchhhhcccccCCCCCH
Q 018712 294 LSEDKVKQCVDTKLGGEYPP 313 (351)
Q Consensus 294 ~~~~~~~~~ld~~~~~~~~~ 313 (351)
...+.+..|+..+|.+|++.
T Consensus 227 ~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 227 EAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred HHHHHHHHHcccCHhhCCCC
Confidence 11256788889999999864
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=300.26 Aligned_cols=240 Identities=20% Similarity=0.331 Sum_probs=202.5
Q ss_pred HhcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCCc---hHHHHHHHHHHHhccCCceeeeEEEEecCCceEEE
Q 018712 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLA 139 (351)
Q Consensus 64 ~~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 139 (351)
+..-|.+.+.||+|.|++|-+|++- +|..||||++.+.+.. ...+.+|++.|+-++|||||++|+.......+|||
T Consensus 16 IAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLi 95 (864)
T KOG4717|consen 16 IAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLI 95 (864)
T ss_pred eeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEE
Confidence 4456899999999999999999864 8999999999876644 46789999999999999999999999999999999
Q ss_pred EEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEc-cCCceEEeccc
Q 018712 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLF-DDDIAKISDFD 218 (351)
Q Consensus 140 ~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~-~~~~vkl~Dfg 218 (351)
+|+-.+|+|++||-+... .+.+..+.+++.||+.||.|+|+.. +|||||||+||.+. +-|.|||.|||
T Consensus 96 LELGD~GDl~DyImKHe~--------Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFG 164 (864)
T KOG4717|consen 96 LELGDGGDLFDYIMKHEE--------GLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFG 164 (864)
T ss_pred EEecCCchHHHHHHhhhc--------cccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeecc
Confidence 999999999999977654 2899999999999999999999998 99999999998775 56899999999
Q ss_pred ccCCCccccccccccccccccCccCcccccCCCCC-ccchhHhHHHHHHHHHcCCCCCCCCCCCCCccchhh---cccCC
Q 018712 219 LSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMS-SKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTW---ATPKL 294 (351)
Q Consensus 219 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~~~---~~~~~ 294 (351)
++-.+..+... ++.+|+..|-|||++.|..|. ++.||||||||||.|++|+.||+..+..+...+|.. ..|..
T Consensus 165 FSNkf~PG~kL---~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYtvPsh 241 (864)
T KOG4717|consen 165 FSNKFQPGKKL---TTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYTVPSH 241 (864)
T ss_pred ccccCCCcchh---hcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccccCchh
Confidence 99877655433 678999999999999999996 578999999999999999999998766554443321 11111
Q ss_pred C----ccchhhhcccccCCCCCHHHHH
Q 018712 295 S----EDKVKQCVDTKLGGEYPPKAIA 317 (351)
Q Consensus 295 ~----~~~~~~~ld~~~~~~~~~~~~~ 317 (351)
. .+++..|+-.+|.+|.+.+++.
T Consensus 242 vS~eCrdLI~sMLvRdPkkRAslEeI~ 268 (864)
T KOG4717|consen 242 VSKECRDLIQSMLVRDPKKRASLEEIV 268 (864)
T ss_pred hhHHHHHHHHHHHhcCchhhccHHHHh
Confidence 1 2677788888888887776653
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=292.36 Aligned_cols=253 Identities=26% Similarity=0.396 Sum_probs=200.6
Q ss_pred cCCCCCceeccCCcEEEEEEEECC------CCEEEEEEcCCCCCc--hHHHHHHHHHHHhccCCceeeeEEEEecCCceE
Q 018712 66 DNFGTNSLIGEGSYGRVYFGVLRS------GRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRV 137 (351)
Q Consensus 66 ~~y~~~~~Lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 137 (351)
++|++.+.||+|+||.||+|.... ...+|+|.+...... ...+.+|+.++++++||||+++++++.+....+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 578899999999999999998642 257999988654332 356889999999999999999999999999999
Q ss_pred EEEEeCCCCCHHHHhccCCCCCC-------CCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCC
Q 018712 138 LAYEHASKGSLHDILHGKKGVKG-------AKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD 210 (351)
Q Consensus 138 lv~e~~~~gsL~~~l~~~~~~~~-------~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~ 210 (351)
++|||+++++|.+++........ ......+++..++.++.|++.||.|||+++ ++|+||||+||++++++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCCC
Confidence 99999999999999976432111 001134788999999999999999999999 99999999999999999
Q ss_pred ceEEecccccCCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCCccchhh
Q 018712 211 IAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTW 289 (351)
Q Consensus 211 ~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~Pf~~~~~~~~~~~~~~ 289 (351)
.+||+|||++................+++.|+|||.+.+..++.++||||||+++|||++ |..||...........+..
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i~~ 241 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIRS 241 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence 999999999876543322222234456889999999988899999999999999999998 9999987554332222111
Q ss_pred --------cccCCCccchhhhcccccCCCCCHHHHHHHHH
Q 018712 290 --------ATPKLSEDKVKQCVDTKLGGEYPPKAIAKVRK 321 (351)
Q Consensus 290 --------~~~~~~~~~~~~~ld~~~~~~~~~~~~~~~~~ 321 (351)
..+....+.+..|++.+|.+|++..++...++
T Consensus 242 ~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~ 281 (283)
T cd05048 242 RQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLR 281 (283)
T ss_pred CCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHh
Confidence 11112237889999999999999998876553
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-40 Score=293.25 Aligned_cols=253 Identities=25% Similarity=0.391 Sum_probs=201.6
Q ss_pred hcCCCCCceeccCCcEEEEEEEEC------CCCEEEEEEcCCCCCc--hHHHHHHHHHHHhccCCceeeeEEEEecCCce
Q 018712 65 TDNFGTNSLIGEGSYGRVYFGVLR------SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPLR 136 (351)
Q Consensus 65 ~~~y~~~~~Lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 136 (351)
.++|.+.+.||+|+||.||+|... ++..||+|.+...... .+.+.+|++++++++|+||+++++++......
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 83 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP 83 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence 456888999999999999999863 3478999998765443 46788999999999999999999999999999
Q ss_pred EEEEEeCCCCCHHHHhccCCCCCC-----CCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCc
Q 018712 137 VLAYEHASKGSLHDILHGKKGVKG-----AKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDI 211 (351)
Q Consensus 137 ~lv~e~~~~gsL~~~l~~~~~~~~-----~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~ 211 (351)
+++|||+++++|.+++........ ......+++..+..++.|++.||.|||+++ ++||||||+||+++.++.
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLV 160 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCe
Confidence 999999999999999976532110 112234788999999999999999999999 999999999999999999
Q ss_pred eEEecccccCCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCCccchh--
Q 018712 212 AKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVT-- 288 (351)
Q Consensus 212 vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~Pf~~~~~~~~~~~~~-- 288 (351)
+||+|||++................+++.|+|||++.+..++.++||||||+++|||++ |+.||...........+.
T Consensus 161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~~~ 240 (280)
T cd05049 161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQG 240 (280)
T ss_pred EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC
Confidence 99999999876433221111223345788999999999999999999999999999998 999997654332211111
Q ss_pred ------hcccCCCccchhhhcccccCCCCCHHHHHHHH
Q 018712 289 ------WATPKLSEDKVKQCVDTKLGGEYPPKAIAKVR 320 (351)
Q Consensus 289 ------~~~~~~~~~~~~~~ld~~~~~~~~~~~~~~~~ 320 (351)
...+....+.+.+|+..+|.+|++.+++...+
T Consensus 241 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l 278 (280)
T cd05049 241 RLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERL 278 (280)
T ss_pred CcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHh
Confidence 11112224788999999999999998887654
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=288.86 Aligned_cols=246 Identities=25% Similarity=0.381 Sum_probs=200.5
Q ss_pred hcCCCCCceeccCCcEEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEEEeCC
Q 018712 65 TDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHAS 144 (351)
Q Consensus 65 ~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 144 (351)
.++|++.+.||+|++|.||+|...+++.||+|.+.......+.+.+|+.++++++|+||+++++++...+..+++|||++
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 84 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMK 84 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeeccc
Confidence 45689999999999999999998778899999998766556778999999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccccCCCc
Q 018712 145 KGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAP 224 (351)
Q Consensus 145 ~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~ 224 (351)
+++|.+++..... ..+++..+..++.|++.||.+||+++ ++||||||+||++++++.+||+|||++....
T Consensus 85 ~~~L~~~~~~~~~-------~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~ 154 (261)
T cd05068 85 YGSLLEYLQGGAG-------RALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIK 154 (261)
T ss_pred CCcHHHHHhccCC-------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEcc
Confidence 9999999976431 13889999999999999999999999 9999999999999999999999999987664
Q ss_pred cccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCCccchhh--------cccCCC
Q 018712 225 DAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTW--------ATPKLS 295 (351)
Q Consensus 225 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~Pf~~~~~~~~~~~~~~--------~~~~~~ 295 (351)
...... ......+..|+|||.+.+..++.++||||||+++|+|++ |+.||...........+.. ..+...
T Consensus 155 ~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (261)
T cd05068 155 EDIYEA-REGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMPCPPGCPKEL 233 (261)
T ss_pred CCcccc-cCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHH
Confidence 321111 111223457999999998899999999999999999999 9999986543221111111 111122
Q ss_pred ccchhhhcccccCCCCCHHHHHHHHH
Q 018712 296 EDKVKQCVDTKLGGEYPPKAIAKVRK 321 (351)
Q Consensus 296 ~~~~~~~ld~~~~~~~~~~~~~~~~~ 321 (351)
.+.+.+|+..+|.+|++.+++...++
T Consensus 234 ~~li~~~l~~~P~~Rp~~~~l~~~l~ 259 (261)
T cd05068 234 YDIMLDCWKEDPDDRPTFETLQWKLE 259 (261)
T ss_pred HHHHHHHhhcCcccCCCHHHHHHHHh
Confidence 36778899999999999988877654
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-40 Score=290.57 Aligned_cols=245 Identities=24% Similarity=0.380 Sum_probs=197.0
Q ss_pred hcCCCCCceeccCCcEEEEEEEEC----CCCEEEEEEcCCCCCc--hHHHHHHHHHHHhccCCceeeeEEEEecCCceEE
Q 018712 65 TDNFGTNSLIGEGSYGRVYFGVLR----SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVL 138 (351)
Q Consensus 65 ~~~y~~~~~Lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 138 (351)
.++|++.+.||+|+||.||+|.++ .+..||+|.+...... ...+.+|+..+++++||||+++++++..++..++
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 83 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI 83 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence 356889999999999999999853 4568999998765432 3468899999999999999999999999999999
Q ss_pred EEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEeccc
Q 018712 139 AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFD 218 (351)
Q Consensus 139 v~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg 218 (351)
||||+++|+|.+++..... .+++..++.++.|++.||+|||+++ ++||||||+||+++.++.+|++|||
T Consensus 84 v~e~~~~~~L~~~l~~~~~--------~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg 152 (266)
T cd05064 84 VTEYMSNGALDSFLRKHEG--------QLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFR 152 (266)
T ss_pred EEEeCCCCcHHHHHHhCCC--------CCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCc
Confidence 9999999999999976432 2889999999999999999999999 9999999999999999999999999
Q ss_pred ccCCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCCccch--------hh
Q 018712 219 LSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLV--------TW 289 (351)
Q Consensus 219 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~Pf~~~~~~~~~~~~--------~~ 289 (351)
.+........ .......++..|+|||.+.+..++.++||||||+++||+++ |+.||...........+ ..
T Consensus 153 ~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 231 (266)
T cd05064 153 RLQEDKSEAI-YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRLPAPR 231 (266)
T ss_pred ccccccccch-hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCC
Confidence 8765432211 11112335678999999999999999999999999999775 99999865433211111 11
Q ss_pred cccCCCccchhhhcccccCCCCCHHHHHHHHH
Q 018712 290 ATPKLSEDKVKQCVDTKLGGEYPPKAIAKVRK 321 (351)
Q Consensus 290 ~~~~~~~~~~~~~ld~~~~~~~~~~~~~~~~~ 321 (351)
..+....+.+..|+.++|.+|++.+++.+.+.
T Consensus 232 ~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~ 263 (266)
T cd05064 232 NCPNLLHQLMLDCWQKERGERPRFSQIHSILS 263 (266)
T ss_pred CCCHHHHHHHHHHcCCCchhCCCHHHHHHHHH
Confidence 11222236788899999999999998877654
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=286.58 Aligned_cols=240 Identities=21% Similarity=0.318 Sum_probs=199.4
Q ss_pred HHhcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCC---CCchHHHHHHHHHHHhccCCceeeeEEEEecCCceEE
Q 018712 63 EKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSS---KQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVL 138 (351)
Q Consensus 63 ~~~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 138 (351)
...+.|++.+.||+|.|+.|+++.+. +|+.+|+|++... ....+++.+|+.+-+.|+||||+++.+.+.+....|+
T Consensus 8 ~f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~yl 87 (355)
T KOG0033|consen 8 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL 87 (355)
T ss_pred ccchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEE
Confidence 34577899999999999999999864 8999999987533 3356789999999999999999999999999999999
Q ss_pred EEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccC---CceEEe
Q 018712 139 AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDD---DIAKIS 215 (351)
Q Consensus 139 v~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~---~~vkl~ 215 (351)
|+|++.|++|..-+-... ..++..+-..+.||+++|.|+|.++ |||||+||.|+++.+. .-+||+
T Consensus 88 vFe~m~G~dl~~eIV~R~---------~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~ 155 (355)
T KOG0033|consen 88 VFDLVTGGELFEDIVARE---------FYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLA 155 (355)
T ss_pred EEecccchHHHHHHHHHH---------HHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeec
Confidence 999999999976665442 3788889999999999999999999 9999999999999643 469999
Q ss_pred cccccCCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCc--------cch
Q 018712 216 DFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQ--------SLV 287 (351)
Q Consensus 216 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~--------~~~ 287 (351)
|||+|....+... ...++|||.|||||++...+|+..+|||+-||+||-|+.|.+||.+.+..... ..-
T Consensus 156 ~FGvAi~l~~g~~---~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~ 232 (355)
T KOG0033|consen 156 DFGLAIEVNDGEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYP 232 (355)
T ss_pred ccceEEEeCCccc---cccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCC
Confidence 9999988873322 25578999999999999999999999999999999999999999984432211 111
Q ss_pred hhcccCCC---ccchhhhcccccCCCCCHHHHH
Q 018712 288 TWATPKLS---EDKVKQCVDTKLGGEYPPKAIA 317 (351)
Q Consensus 288 ~~~~~~~~---~~~~~~~ld~~~~~~~~~~~~~ 317 (351)
...++.++ .+++++|+..+|.+|+++.++.
T Consensus 233 ~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL 265 (355)
T KOG0033|consen 233 SPEWDTVTPEAKSLIRRMLTVNPKKRITADEAL 265 (355)
T ss_pred CcccCcCCHHHHHHHHHHhccChhhhccHHHHh
Confidence 11222222 3789999999999999887763
|
|
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=301.03 Aligned_cols=240 Identities=20% Similarity=0.312 Sum_probs=189.7
Q ss_pred ceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCC----chHHHHHHHHHHHhc-cCCceeeeEEEEecCCceEEEEEeCCC
Q 018712 72 SLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ----PDQEFLAQVSMVSRL-KNENVVELVGYYVDGPLRVLAYEHASK 145 (351)
Q Consensus 72 ~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 145 (351)
+.||+|+||.||++.+. +++.||+|++..... ....+..|..+++.+ +||||+++++++.+.+..|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 36999999999999965 688999999875322 234577888999888 799999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccccCCCcc
Q 018712 146 GSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPD 225 (351)
Q Consensus 146 gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~ 225 (351)
|+|.+++..... +++..+..++.||+.||.|||++| ++||||||+|||++.++.+||+|||+++....
T Consensus 81 g~L~~~~~~~~~---------l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~ 148 (329)
T cd05588 81 GDLMFHMQRQRK---------LPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIR 148 (329)
T ss_pred CCHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCcccccccc
Confidence 999998875542 899999999999999999999999 99999999999999999999999999875322
Q ss_pred ccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCC--C---c----cchhhc---cc-
Q 018712 226 AAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRG--Q---Q----SLVTWA---TP- 292 (351)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~--~---~----~~~~~~---~~- 292 (351)
... ......||+.|+|||++.+..++.++|+||||+++|+|++|+.||....... . . ..+... .|
T Consensus 149 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~ 226 (329)
T cd05588 149 PGD--TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPR 226 (329)
T ss_pred CCC--ccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCCCC
Confidence 111 1234579999999999999999999999999999999999999997432111 0 0 001111 11
Q ss_pred CC---CccchhhhcccccCCCCCHH---HHHHHHHHHHH
Q 018712 293 KL---SEDKVKQCVDTKLGGEYPPK---AIAKVRKKKFI 325 (351)
Q Consensus 293 ~~---~~~~~~~~ld~~~~~~~~~~---~~~~~~~~~~~ 325 (351)
.+ ..+.+..|+..+|.+|++.. .+..++.+.++
T Consensus 227 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~ 265 (329)
T cd05588 227 SLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFF 265 (329)
T ss_pred CCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCC
Confidence 11 12688899999999998742 24445555554
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-40 Score=294.01 Aligned_cols=242 Identities=21% Similarity=0.295 Sum_probs=190.0
Q ss_pred eccCCcEEEEEEEEC-CCCEEEEEEcCCCCCc----hHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEEEeCCCCCH
Q 018712 74 IGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP----DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSL 148 (351)
Q Consensus 74 Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL 148 (351)
||+|+||+||++.+. +++.||+|.+...... ...+..|+.+++.++|+||+++.+.+......++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 699999999999965 7889999998654321 24567899999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccccCCCccccc
Q 018712 149 HDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAA 228 (351)
Q Consensus 149 ~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~ 228 (351)
.+++...... ...+++..+..++.||+.||.|||+++ |+||||||+||++++++.+||+|||++........
T Consensus 81 ~~~~~~~~~~-----~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~ 152 (280)
T cd05608 81 RYHIYNVDEE-----NPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS 152 (280)
T ss_pred HHHHHhcccc-----CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCCc
Confidence 9887542211 123889999999999999999999999 99999999999999999999999999876543322
Q ss_pred cccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCcc-chh----------hcccCCCcc
Q 018712 229 RLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQS-LVT----------WATPKLSED 297 (351)
Q Consensus 229 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~-~~~----------~~~~~~~~~ 297 (351)
. .....||+.|+|||++.+..++.++||||||+++|+|++|+.||.......... ... ...+....+
T Consensus 153 ~--~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (280)
T cd05608 153 K--TKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKS 230 (280)
T ss_pred c--ccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCCCCcccCCHHHHH
Confidence 1 234568999999999999999999999999999999999999998643321110 000 011112236
Q ss_pred chhhhcccccCCCCCHH--HHHHHHHHHHH
Q 018712 298 KVKQCVDTKLGGEYPPK--AIAKVRKKKFI 325 (351)
Q Consensus 298 ~~~~~ld~~~~~~~~~~--~~~~~~~~~~~ 325 (351)
.+..|++.+|.+|++.+ .+..++.+.++
T Consensus 231 li~~~l~~~P~~R~~~~~~~~~~~l~h~~~ 260 (280)
T cd05608 231 FCEALLAKDPEKRLGFRDGNCDGLRTHPLF 260 (280)
T ss_pred HHHHHhcCCHHHhcCCCCCCHHHHhcChhh
Confidence 78889999999998442 23445555554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-40 Score=294.96 Aligned_cols=248 Identities=22% Similarity=0.333 Sum_probs=196.8
Q ss_pred CCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCC----chHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEEE
Q 018712 67 NFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ----PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYE 141 (351)
Q Consensus 67 ~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 141 (351)
+|++.+.||+|+||.||++... +++.||+|++..... ....+.+|+.++++++|+||+++++.+.+++..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 4788899999999999999964 789999999865322 12446789999999999999999999999999999999
Q ss_pred eCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccccC
Q 018712 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (351)
Q Consensus 142 ~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~ 221 (351)
|+.+|+|.+++...... .+++..+..++.|++.||.|||+++ ++||||||+||++++++.++|+|||++.
T Consensus 81 ~~~~~~L~~~~~~~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~ 150 (285)
T cd05605 81 LMNGGDLKFHIYNMGNP-------GFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAV 150 (285)
T ss_pred ccCCCcHHHHHHhcCcC-------CCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCce
Confidence 99999999888654321 2889999999999999999999999 9999999999999999999999999987
Q ss_pred CCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccc----hhh-------c
Q 018712 222 QAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSL----VTW-------A 290 (351)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~----~~~-------~ 290 (351)
....... .....|++.|+|||++.+..++.++||||+|+++|+|++|+.||........... +.. .
T Consensus 151 ~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (285)
T cd05605 151 EIPEGET---IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEK 227 (285)
T ss_pred ecCCCCc---cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCcc
Confidence 6533221 1334689999999999988999999999999999999999999986543221110 110 1
Q ss_pred ccCCCccchhhhcccccCCCCCHH--HHHHHHHHHHHhh
Q 018712 291 TPKLSEDKVKQCVDTKLGGEYPPK--AIAKVRKKKFITS 327 (351)
Q Consensus 291 ~~~~~~~~~~~~ld~~~~~~~~~~--~~~~~~~~~~~~~ 327 (351)
.+....+.+..|+..+|.+|++.. .+..++.+.+++.
T Consensus 228 ~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~ 266 (285)
T cd05605 228 FSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRT 266 (285)
T ss_pred cCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcCccC
Confidence 111123678889999999999433 3444555555543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=300.65 Aligned_cols=228 Identities=21% Similarity=0.287 Sum_probs=186.2
Q ss_pred ceeccCCcEEEEEEEEC-CCCEEEEEEcCCCC----CchHHHHHHHHHHHhc-cCCceeeeEEEEecCCceEEEEEeCCC
Q 018712 72 SLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK----QPDQEFLAQVSMVSRL-KNENVVELVGYYVDGPLRVLAYEHASK 145 (351)
Q Consensus 72 ~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 145 (351)
+.||+|+||.||++.+. ++..||+|++.... .....+.+|..+++.+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999975 67899999987532 2234567788888887 699999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccccCCCcc
Q 018712 146 GSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPD 225 (351)
Q Consensus 146 gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~ 225 (351)
|+|..++..... +++..+..++.||+.||.|||+++ ++||||||+||++++++.+||+|||++.....
T Consensus 81 ~~L~~~~~~~~~---------l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 148 (318)
T cd05570 81 GDLMFHIQRSGR---------FDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGIL 148 (318)
T ss_pred CCHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCc
Confidence 999999876542 899999999999999999999999 99999999999999999999999999865322
Q ss_pred ccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccchh-------hcccCCCccc
Q 018712 226 AAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVT-------WATPKLSEDK 298 (351)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~~-------~~~~~~~~~~ 298 (351)
... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...........+. ...+....+.
T Consensus 149 ~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~l 226 (318)
T cd05570 149 GGV--TTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPRWLSKEAKSI 226 (318)
T ss_pred CCC--cccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCcCCHHHHHH
Confidence 211 1234568999999999999999999999999999999999999997654322111111 1111222378
Q ss_pred hhhhcccccCCCCCH
Q 018712 299 VKQCVDTKLGGEYPP 313 (351)
Q Consensus 299 ~~~~ld~~~~~~~~~ 313 (351)
+..|+..+|.+|++.
T Consensus 227 i~~~l~~dP~~R~s~ 241 (318)
T cd05570 227 LKSFLTKNPEKRLGC 241 (318)
T ss_pred HHHHccCCHHHcCCC
Confidence 889999999999987
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-41 Score=306.74 Aligned_cols=239 Identities=21% Similarity=0.269 Sum_probs=190.9
Q ss_pred cCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCC----chHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEE
Q 018712 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ----PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAY 140 (351)
Q Consensus 66 ~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 140 (351)
++|.+.+.||+|+||.||++... +++.||+|++..... ....+.+|+.+++.++|+||+++++.+.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 47899999999999999999965 789999999875422 3355788999999999999999999999999999999
Q ss_pred EeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEeccccc
Q 018712 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (351)
Q Consensus 141 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a 220 (351)
||+++|+|.+++..... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 81 e~~~~~~L~~~l~~~~~--------~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a 149 (330)
T cd05601 81 EYQPGGDLLSLLNRYED--------QFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSA 149 (330)
T ss_pred CCCCCCCHHHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCC
Confidence 99999999999986532 2889999999999999999999999 999999999999999999999999998
Q ss_pred CCCccccccccccccccccCccCccccc------CCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccchhh-----
Q 018712 221 NQAPDAAARLHSTRVLGTFGYHAPEYAM------TGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTW----- 289 (351)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~~~----- 289 (351)
......... ......||+.|+|||++. +..++.++||||||+++|+|++|+.||...........+..
T Consensus 150 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~ 228 (330)
T cd05601 150 ARLTANKMV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFL 228 (330)
T ss_pred eECCCCCce-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCcc
Confidence 765433221 123346899999999986 45678899999999999999999999986543221111100
Q ss_pred ccc---CCC---ccchhhhcccccCCCCCHHHHH
Q 018712 290 ATP---KLS---EDKVKQCVDTKLGGEYPPKAIA 317 (351)
Q Consensus 290 ~~~---~~~---~~~~~~~ld~~~~~~~~~~~~~ 317 (351)
..+ ... .+.+..|+. ++.+|++.+++.
T Consensus 229 ~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~ 261 (330)
T cd05601 229 KFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLC 261 (330)
T ss_pred CCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHh
Confidence 001 111 245666775 788888776553
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=301.97 Aligned_cols=239 Identities=19% Similarity=0.280 Sum_probs=186.6
Q ss_pred ceeccCCcEEEEEEEEC-CCCEEEEEEcCCCC----CchHHHHHHH-HHHHhccCCceeeeEEEEecCCceEEEEEeCCC
Q 018712 72 SLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK----QPDQEFLAQV-SMVSRLKNENVVELVGYYVDGPLRVLAYEHASK 145 (351)
Q Consensus 72 ~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~-~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 145 (351)
+.||+|+||.||+|.+. +++.||+|++.... .....+..|. .+++.++|+||+++++.+.+.+..|+||||+.+
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 46999999999999976 67889999986432 1123344444 356788999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccccCCCcc
Q 018712 146 GSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPD 225 (351)
Q Consensus 146 gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~ 225 (351)
++|.+++..... ++...+..++.||+.||.|||++| |+||||||+|||++.++.+||+|||+++....
T Consensus 81 ~~L~~~~~~~~~---------~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~ 148 (325)
T cd05602 81 GELFYHLQRERC---------FLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIE 148 (325)
T ss_pred CcHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCccccc
Confidence 999999976542 778888999999999999999999 99999999999999999999999999875432
Q ss_pred ccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccchhh-------cccCCCccc
Q 018712 226 AAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTW-------ATPKLSEDK 298 (351)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~~~-------~~~~~~~~~ 298 (351)
... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...........+.. ..+....+.
T Consensus 149 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~l 226 (325)
T cd05602 149 HNG--TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHL 226 (325)
T ss_pred CCC--CcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCCcCCCCCCCHHHHHH
Confidence 211 12445799999999999999999999999999999999999999986543221111110 111122367
Q ss_pred hhhhcccccCCCCCHH-HHHHHHHHHH
Q 018712 299 VKQCVDTKLGGEYPPK-AIAKVRKKKF 324 (351)
Q Consensus 299 ~~~~ld~~~~~~~~~~-~~~~~~~~~~ 324 (351)
+..|+..++.+|++.. .+..+.++.+
T Consensus 227 i~~~l~~~p~~R~~~~~~~~~i~~~~~ 253 (325)
T cd05602 227 LEGLLQKDRTKRLGAKDDFMEIKNHIF 253 (325)
T ss_pred HHHHcccCHHHCCCCCCCHHHHhcCcc
Confidence 8889999999998764 3334444443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=316.16 Aligned_cols=250 Identities=21% Similarity=0.271 Sum_probs=198.8
Q ss_pred HHHhcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCCc---hHHHHHHHHHHHhccCCceeeeEEEEecCC---
Q 018712 62 KEKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVDGP--- 134 (351)
Q Consensus 62 ~~~~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~--- 134 (351)
....++|.+.+.||+|+||.||+|... +++.||+|++...... ...+.+|+.++..++|+||++++..+....
T Consensus 28 ~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~ 107 (496)
T PTZ00283 28 KEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRN 107 (496)
T ss_pred cccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccC
Confidence 345579999999999999999999864 7899999998754332 345778999999999999999988765332
Q ss_pred -----ceEEEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccC
Q 018712 135 -----LRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDD 209 (351)
Q Consensus 135 -----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~ 209 (351)
.+++||||+.+|+|.+++...... ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.+
T Consensus 108 ~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~-----~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~ 179 (496)
T PTZ00283 108 PENVLMIALVLDYANAGDLRQEIKSRAKT-----NRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSN 179 (496)
T ss_pred cccceEEEEEEeCCCCCcHHHHHHHhhcc-----CCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCC
Confidence 368999999999999999754321 123889999999999999999999999 9999999999999999
Q ss_pred CceEEecccccCCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccch--
Q 018712 210 DIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLV-- 287 (351)
Q Consensus 210 ~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~-- 287 (351)
+.+||+|||+++...............||+.|+|||++.+..++.++||||||+++|||++|+.||...........+
T Consensus 180 ~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~ 259 (496)
T PTZ00283 180 GLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLA 259 (496)
T ss_pred CCEEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc
Confidence 999999999987654332222234567999999999999999999999999999999999999999865432111110
Q ss_pred ------hhcccCCCccchhhhcccccCCCCCHHHHHHH
Q 018712 288 ------TWATPKLSEDKVKQCVDTKLGGEYPPKAIAKV 319 (351)
Q Consensus 288 ------~~~~~~~~~~~~~~~ld~~~~~~~~~~~~~~~ 319 (351)
....+....+.+..|+..+|.+|++..++...
T Consensus 260 ~~~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 260 GRYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred CCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 01111122367889999999999999887653
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-41 Score=287.98 Aligned_cols=250 Identities=21% Similarity=0.293 Sum_probs=209.7
Q ss_pred HHhcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCCch----HHHHHHHHHHHhccCCceeeeEEEEecCCceE
Q 018712 63 EKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPD----QEFLAQVSMVSRLKNENVVELVGYYVDGPLRV 137 (351)
Q Consensus 63 ~~~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 137 (351)
...++|..+++||+|.||+|.+++-+ +++.||+|++++.-.-. ..-+.|-++|+..+||++..+.-.|+..+++|
T Consensus 165 vTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlC 244 (516)
T KOG0690|consen 165 VTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLC 244 (516)
T ss_pred eccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEE
Confidence 45688999999999999999999954 89999999998764322 22356778999999999999999999999999
Q ss_pred EEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecc
Q 018712 138 LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDF 217 (351)
Q Consensus 138 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Df 217 (351)
.||||..||.|.-+|+..+. +++...+.+...|+.||.|||+++ ||.||||.+|+|+|++|++||+||
T Consensus 245 FVMeyanGGeLf~HLsrer~---------FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDF 312 (516)
T KOG0690|consen 245 FVMEYANGGELFFHLSRERV---------FSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDF 312 (516)
T ss_pred EEEEEccCceEeeehhhhhc---------ccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeec
Confidence 99999999999999887653 899999999999999999999999 999999999999999999999999
Q ss_pred cccCCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccchhh----cccC
Q 018712 218 DLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTW----ATPK 293 (351)
Q Consensus 218 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~~~----~~~~ 293 (351)
|+|+....... ...+++|||.|+|||++....|+...|+|.+||++|||++|+.||..........+|.. ....
T Consensus 313 GLCKE~I~~g~--t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~kFPr~ 390 (516)
T KOG0690|consen 313 GLCKEEIKYGD--TTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDLKFPRT 390 (516)
T ss_pred ccchhcccccc--eeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhccCCcc
Confidence 99987543322 23678999999999999999999999999999999999999999997766544443321 1112
Q ss_pred CC---ccchhhhcccccCCCC--CHHHHHHHHHHHHHh
Q 018712 294 LS---EDKVKQCVDTKLGGEY--PPKAIAKVRKKKFIT 326 (351)
Q Consensus 294 ~~---~~~~~~~ld~~~~~~~--~~~~~~~~~~~~~~~ 326 (351)
+. ..++..++..+|.+|. .++.+..+.++.|+.
T Consensus 391 ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~ 428 (516)
T KOG0690|consen 391 LSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFA 428 (516)
T ss_pred CCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhc
Confidence 22 2567778888888886 467888888888764
|
|
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-41 Score=305.19 Aligned_cols=240 Identities=21% Similarity=0.314 Sum_probs=188.8
Q ss_pred ceeccCCcEEEEEEEEC-CCCEEEEEEcCCCC----CchHHHHHHHH-HHHhccCCceeeeEEEEecCCceEEEEEeCCC
Q 018712 72 SLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK----QPDQEFLAQVS-MVSRLKNENVVELVGYYVDGPLRVLAYEHASK 145 (351)
Q Consensus 72 ~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~-~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 145 (351)
+.||+|+||.||+|... +|+.+|+|++.... .....+..|.. +++.++||||+++++.+...+..|+||||+.+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46999999999999965 78999999986432 22234455544 57778999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccccCCCcc
Q 018712 146 GSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPD 225 (351)
Q Consensus 146 gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~ 225 (351)
|+|..++..... +++..+..++.||+.||.|||++| ++||||||+|||+++++.+||+|||+++....
T Consensus 81 ~~L~~~l~~~~~---------~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~ 148 (325)
T cd05604 81 GELFFHLQRERS---------FPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIA 148 (325)
T ss_pred CCHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCC
Confidence 999998876542 889999999999999999999999 99999999999999999999999999875422
Q ss_pred ccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccchhh----cccCCC---ccc
Q 018712 226 AAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTW----ATPKLS---EDK 298 (351)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~~~----~~~~~~---~~~ 298 (351)
... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...........+.. ..+... .+.
T Consensus 149 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 226 (325)
T cd05604 149 QSD--TTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRPGASLTAWSI 226 (325)
T ss_pred CCC--CcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCCccCCCCCCHHHHHH
Confidence 211 12445799999999999999999999999999999999999999986543221111111 111111 267
Q ss_pred hhhhcccccCCCCCHH-HHHHHHHHHHH
Q 018712 299 VKQCVDTKLGGEYPPK-AIAKVRKKKFI 325 (351)
Q Consensus 299 ~~~~ld~~~~~~~~~~-~~~~~~~~~~~ 325 (351)
+.+|+..++.+|++.. ....++++.++
T Consensus 227 l~~ll~~~p~~R~~~~~~~~~i~~h~~f 254 (325)
T cd05604 227 LEELLEKDRQRRLGAKEDFLEIQEHPFF 254 (325)
T ss_pred HHHHhccCHHhcCCCCCCHHHHhcCCCc
Confidence 8899999999998764 34445555443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=287.76 Aligned_cols=242 Identities=24% Similarity=0.354 Sum_probs=197.4
Q ss_pred cCCCCCceeccCCcEEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEEEeCCC
Q 018712 66 DNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASK 145 (351)
Q Consensus 66 ~~y~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 145 (351)
++|.+.+.||+|+||.||.+...++..+|+|.+.........+.+|+.++++++||||+++++++.+.+..+++|||+.+
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSN 83 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCC
Confidence 46888899999999999999987777899999886655567799999999999999999999999988899999999999
Q ss_pred CCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccccCCCcc
Q 018712 146 GSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPD 225 (351)
Q Consensus 146 gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~ 225 (351)
++|.+++..... .+++..++.++.||+.||.|||+.+ ++|+||||+||+++.++.+||+|||.++....
T Consensus 84 ~~l~~~i~~~~~--------~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~ 152 (256)
T cd05113 84 GCLLNYLREHGK--------RFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLD 152 (256)
T ss_pred CcHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCC
Confidence 999999976432 2889999999999999999999999 99999999999999999999999999876543
Q ss_pred ccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCCccchhhc--------ccCCCc
Q 018712 226 AAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWA--------TPKLSE 296 (351)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~Pf~~~~~~~~~~~~~~~--------~~~~~~ 296 (351)
.... ......++..|+|||.+.+..++.++||||||+++|+|++ |+.||...........+... .+....
T Consensus 153 ~~~~-~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (256)
T cd05113 153 DEYT-SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRPHLASEKVY 231 (256)
T ss_pred Ccee-ecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCCCCCCCCCHHHH
Confidence 2211 1122335678999999988889999999999999999998 99999765432211111110 111123
Q ss_pred cchhhhcccccCCCCCHHHHHHH
Q 018712 297 DKVKQCVDTKLGGEYPPKAIAKV 319 (351)
Q Consensus 297 ~~~~~~ld~~~~~~~~~~~~~~~ 319 (351)
+.+..|+.++|.+|++..++...
T Consensus 232 ~li~~cl~~~p~~Rp~~~~ll~~ 254 (256)
T cd05113 232 AIMYSCWHEKAEERPTFQQLLSS 254 (256)
T ss_pred HHHHHHcCCCcccCCCHHHHHHh
Confidence 67788999999999998887654
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=300.34 Aligned_cols=238 Identities=21% Similarity=0.285 Sum_probs=185.3
Q ss_pred ceeccCCcEEEEEEEEC-CCCEEEEEEcCCCC----CchHHHHHHHH-HHHhccCCceeeeEEEEecCCceEEEEEeCCC
Q 018712 72 SLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK----QPDQEFLAQVS-MVSRLKNENVVELVGYYVDGPLRVLAYEHASK 145 (351)
Q Consensus 72 ~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~-~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 145 (351)
+.||+|+||.||+|.+. +++.||+|++.... .....+..|.. +++.++||||+++++.+.+.+..|+||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999975 68899999986432 12233445544 57889999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccccCCCcc
Q 018712 146 GSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPD 225 (351)
Q Consensus 146 gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~ 225 (351)
++|...+..... ++...+..++.||+.||.|||+++ |+||||||+||+++.++.+||+|||+++....
T Consensus 81 ~~L~~~l~~~~~---------~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 148 (321)
T cd05603 81 GELFFHLQRERC---------FLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVE 148 (321)
T ss_pred CCHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCC
Confidence 999998875432 788889999999999999999999 99999999999999999999999999875322
Q ss_pred ccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccchhhcc-------cCCCccc
Q 018712 226 AAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWAT-------PKLSEDK 298 (351)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~~~~~-------~~~~~~~ 298 (351)
... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...........+.... .....+.
T Consensus 149 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~l 226 (321)
T cd05603 149 PEE--TTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLPGGKTVAACDL 226 (321)
T ss_pred CCC--ccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHH
Confidence 211 1244578999999999998899999999999999999999999998654321111111111 1111267
Q ss_pred hhhhcccccCCCCCHH-HHHHHHHHH
Q 018712 299 VKQCVDTKLGGEYPPK-AIAKVRKKK 323 (351)
Q Consensus 299 ~~~~ld~~~~~~~~~~-~~~~~~~~~ 323 (351)
+..|+..++.+|++.. ....+.++.
T Consensus 227 i~~~l~~~p~~R~~~~~~~~~~~~~~ 252 (321)
T cd05603 227 LVGLLHKDQRRRLGAKADFLEIKNHV 252 (321)
T ss_pred HHHHccCCHhhcCCCCCCHHHHhCCC
Confidence 8888999998998653 333344333
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-40 Score=293.77 Aligned_cols=200 Identities=24% Similarity=0.377 Sum_probs=166.9
Q ss_pred cCCCCCceeccCCcEEEEEEEEC--CCCEEEEEEcCCCCC---chHHHHHHHHHHHhc---cCCceeeeEEEEe-----c
Q 018712 66 DNFGTNSLIGEGSYGRVYFGVLR--SGRAAAIKKLDSSKQ---PDQEFLAQVSMVSRL---KNENVVELVGYYV-----D 132 (351)
Q Consensus 66 ~~y~~~~~Lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l---~h~niv~~~~~~~-----~ 132 (351)
++|++.+.||+|+||.||+|.+. +++.||+|.+..... ....+.+|+.+++.+ +||||+++++++. .
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 47999999999999999999863 467899998864332 223466777777665 6999999999875 3
Q ss_pred CCceEEEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCce
Q 018712 133 GPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIA 212 (351)
Q Consensus 133 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~v 212 (351)
....++||||+. ++|.+++...... .+++..+..++.|++.||.|||+++ ++||||||+|||++.++.+
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~~~-------~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~ 149 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVPEP-------GVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQI 149 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCCCC-------CCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCE
Confidence 456899999997 5999998754321 2788999999999999999999999 9999999999999999999
Q ss_pred EEecccccCCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCC
Q 018712 213 KISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTL 279 (351)
Q Consensus 213 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~ 279 (351)
||+|||++....... ......||+.|+|||++.+..++.++||||||+++|||++|+.||....
T Consensus 150 kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~ 213 (290)
T cd07862 150 KLADFGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSS 213 (290)
T ss_pred EEccccceEeccCCc---ccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCC
Confidence 999999987654321 1244568999999999998899999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-41 Score=281.22 Aligned_cols=245 Identities=24% Similarity=0.381 Sum_probs=201.5
Q ss_pred HHHHHHhcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCC-----ch----HHHHHHHHHHHhc-cCCceeeeE
Q 018712 59 DELKEKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ-----PD----QEFLAQVSMVSRL-KNENVVELV 127 (351)
Q Consensus 59 ~~~~~~~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-----~~----~~~~~e~~~l~~l-~h~niv~~~ 127 (351)
..-......|.-.+.||.|..++|-++.++ +|..+|+|++..... .. +.-.+|+.+|+++ .||+|+++.
T Consensus 10 ~aa~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~ 89 (411)
T KOG0599|consen 10 DAAKGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQ 89 (411)
T ss_pred hhHhhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEee
Confidence 344566778899999999999999998865 789999999853321 11 2345788999998 699999999
Q ss_pred EEEecCCceEEEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEc
Q 018712 128 GYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLF 207 (351)
Q Consensus 128 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~ 207 (351)
++|......++|+|.|+.|.|.++|...-. ++++..+.|++|+++|+.|||..+ ||||||||+|||++
T Consensus 90 D~yes~sF~FlVFdl~prGELFDyLts~Vt---------lSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILld 157 (411)
T KOG0599|consen 90 DVYESDAFVFLVFDLMPRGELFDYLTSKVT---------LSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLD 157 (411)
T ss_pred eeccCcchhhhhhhhcccchHHHHhhhhee---------ecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeec
Confidence 999999999999999999999999987754 999999999999999999999999 99999999999999
Q ss_pred cCCceEEecccccCCCccccccccccccccccCccCccccc------CCCCCccchhHhHHHHHHHHHcCCCCCCCCCCC
Q 018712 208 DDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAM------TGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPR 281 (351)
Q Consensus 208 ~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~ 281 (351)
++.++||+|||+++.+..+... ...+|||+|+|||.+. ...|+...|+||.|+|+|.|+.|.+||-.....
T Consensus 158 dn~~i~isDFGFa~~l~~GekL---relCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQm 234 (411)
T KOG0599|consen 158 DNMNIKISDFGFACQLEPGEKL---RELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQM 234 (411)
T ss_pred cccceEEeccceeeccCCchhH---HHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHH
Confidence 9999999999999998776543 5679999999999885 346888999999999999999999999754221
Q ss_pred CCccch-----hhcccCCC------ccchhhhcccccCCCCCHHHHHH
Q 018712 282 GQQSLV-----TWATPKLS------EDKVKQCVDTKLGGEYPPKAIAK 318 (351)
Q Consensus 282 ~~~~~~-----~~~~~~~~------~~~~~~~ld~~~~~~~~~~~~~~ 318 (351)
-...++ ....|.|. .+++.+|+.-++.+|++.++...
T Consensus 235 lMLR~ImeGkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~La 282 (411)
T KOG0599|consen 235 LMLRMIMEGKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALA 282 (411)
T ss_pred HHHHHHHhcccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence 111111 11222222 37889999999999998887644
|
|
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=286.26 Aligned_cols=242 Identities=24% Similarity=0.358 Sum_probs=196.5
Q ss_pred cCCCCCceeccCCcEEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEEEeCCC
Q 018712 66 DNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASK 145 (351)
Q Consensus 66 ~~y~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 145 (351)
.+|++.+.||+|+||.||++.++++..+|+|.+.........+.+|+.+++.++|+||+++++++.+.+..++||||+++
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMAN 83 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCC
Confidence 45888999999999999999988788999999876655566788999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccccCCCcc
Q 018712 146 GSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPD 225 (351)
Q Consensus 146 gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~ 225 (351)
++|.+++..... .+++..++.++.|++.||.|||+.+ ++||||||+||++++++.+||+|||+++....
T Consensus 84 ~~L~~~l~~~~~--------~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~ 152 (256)
T cd05059 84 GCLLNYLRERKG--------KLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLD 152 (256)
T ss_pred CCHHHHHHhccc--------CCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceeccc
Confidence 999999975432 2889999999999999999999999 99999999999999999999999999876543
Q ss_pred ccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCCccchhh--------cccCCCc
Q 018712 226 AAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTW--------ATPKLSE 296 (351)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~Pf~~~~~~~~~~~~~~--------~~~~~~~ 296 (351)
..... .....++..|+|||.+.+..++.++||||||+++|+|++ |+.||...........+.. ..+....
T Consensus 153 ~~~~~-~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (256)
T cd05059 153 DQYTS-SQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYRPKLAPTEVY 231 (256)
T ss_pred ccccc-cCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHH
Confidence 22111 111223457999999998999999999999999999999 8999976543221111110 1112223
Q ss_pred cchhhhcccccCCCCCHHHHHHH
Q 018712 297 DKVKQCVDTKLGGEYPPKAIAKV 319 (351)
Q Consensus 297 ~~~~~~ld~~~~~~~~~~~~~~~ 319 (351)
+.+..|+...+.+|++.+++.+.
T Consensus 232 ~li~~cl~~~p~~Rpt~~~~l~~ 254 (256)
T cd05059 232 TIMYSCWHEKPEDRPAFKKLLSQ 254 (256)
T ss_pred HHHHHHhcCChhhCcCHHHHHHH
Confidence 67788888888999988887654
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=287.32 Aligned_cols=246 Identities=24% Similarity=0.355 Sum_probs=200.6
Q ss_pred cCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCCchHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEEEeCC
Q 018712 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHAS 144 (351)
Q Consensus 66 ~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 144 (351)
.+|.+.+.||+|+||.||+|... +++.+|+|.+.........+.+|++++++++|+||+++++++...+..+++|||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMT 85 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCC
Confidence 45788889999999999999965 68899999988665556678999999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccccCCCc
Q 018712 145 KGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAP 224 (351)
Q Consensus 145 ~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~ 224 (351)
+++|.+++...... .+++..++.++.|++.||.|||+++ ++||||||+||++++++.+||+|||++....
T Consensus 86 ~~~L~~~~~~~~~~-------~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~ 155 (263)
T cd05052 86 YGNLLDYLRECNRQ-------EVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMT 155 (263)
T ss_pred CCcHHHHHHhCCCC-------CCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCccccccc
Confidence 99999999754321 2788999999999999999999999 9999999999999999999999999987764
Q ss_pred cccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCCccchhh--------cccCCC
Q 018712 225 DAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTW--------ATPKLS 295 (351)
Q Consensus 225 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~Pf~~~~~~~~~~~~~~--------~~~~~~ 295 (351)
...... .....++..|+|||.+.+..++.++||||||+++|||++ |..||...........+.. ..+...
T Consensus 156 ~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (263)
T cd05052 156 GDTYTA-HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRMERPEGCPPKV 234 (263)
T ss_pred cceeec-cCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHH
Confidence 432211 112234668999999998999999999999999999998 9999976443221111111 111122
Q ss_pred ccchhhhcccccCCCCCHHHHHHHHHH
Q 018712 296 EDKVKQCVDTKLGGEYPPKAIAKVRKK 322 (351)
Q Consensus 296 ~~~~~~~ld~~~~~~~~~~~~~~~~~~ 322 (351)
.+.+.+|++.+|.+|++..++.+.++.
T Consensus 235 ~~li~~cl~~~p~~Rp~~~~l~~~l~~ 261 (263)
T cd05052 235 YELMRACWQWNPSDRPSFAEIHQAFET 261 (263)
T ss_pred HHHHHHHccCCcccCCCHHHHHHHHHh
Confidence 368899999999999999998776553
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=304.20 Aligned_cols=195 Identities=21% Similarity=0.299 Sum_probs=169.3
Q ss_pred HhcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCCchHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEEEe
Q 018712 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEH 142 (351)
Q Consensus 64 ~~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 142 (351)
...+|.+.+.||+|+||.||++.+. +++.||+|.... ..+.+|++++++++||||+++++++......++|+|+
T Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~-----~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~ 164 (391)
T PHA03212 90 EKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR-----GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR 164 (391)
T ss_pred ccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh-----hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence 3467999999999999999999964 789999997542 3467899999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccccCC
Q 018712 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222 (351)
Q Consensus 143 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~ 222 (351)
+. ++|..++..... +++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++..
T Consensus 165 ~~-~~L~~~l~~~~~---------l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~ 231 (391)
T PHA03212 165 YK-TDLYCYLAAKRN---------IAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACF 231 (391)
T ss_pred CC-CCHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCcccc
Confidence 95 589888866532 888999999999999999999999 99999999999999999999999999865
Q ss_pred CccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCC
Q 018712 223 APDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDH 277 (351)
Q Consensus 223 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~ 277 (351)
...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 232 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~ 285 (391)
T PHA03212 232 PVDINA-NKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFE 285 (391)
T ss_pred cccccc-cccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCC
Confidence 432211 112345799999999999999999999999999999999999988653
|
|
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=286.76 Aligned_cols=246 Identities=27% Similarity=0.419 Sum_probs=199.6
Q ss_pred cCCCCCceeccCCcEEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEEEeCCC
Q 018712 66 DNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASK 145 (351)
Q Consensus 66 ~~y~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 145 (351)
++|++.+.||+|+||.||+|.+.++..||+|++.........+.+|++++++++|+||+++++.+. ....++||||+++
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~~ 84 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMSK 84 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCccCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcCCC
Confidence 569999999999999999999877678999999876655677899999999999999999998774 4568999999999
Q ss_pred CCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccccCCCcc
Q 018712 146 GSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPD 225 (351)
Q Consensus 146 gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~ 225 (351)
++|.+++..... ..+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.+||+|||.+.....
T Consensus 85 ~~L~~~~~~~~~-------~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~ 154 (262)
T cd05071 85 GSLLDFLKGEMG-------KYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIED 154 (262)
T ss_pred CcHHHHHhhccc-------cCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeeccc
Confidence 999999975432 12788999999999999999999999 99999999999999999999999999876543
Q ss_pred ccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCCccchh--------hcccCCCc
Q 018712 226 AAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVT--------WATPKLSE 296 (351)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~Pf~~~~~~~~~~~~~--------~~~~~~~~ 296 (351)
..... .....++..|+|||+..+..++.++||||||+++|+|++ |+.||...........+. ...+....
T Consensus 155 ~~~~~-~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 233 (262)
T cd05071 155 NEYTA-RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLH 233 (262)
T ss_pred ccccc-ccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCCCCCccccCHHHH
Confidence 32111 122346678999999988899999999999999999999 889997654332111111 11122223
Q ss_pred cchhhhcccccCCCCCHHHHHHHHHHH
Q 018712 297 DKVKQCVDTKLGGEYPPKAIAKVRKKK 323 (351)
Q Consensus 297 ~~~~~~ld~~~~~~~~~~~~~~~~~~~ 323 (351)
+.+.+|+.+++.+|++..++..+++-.
T Consensus 234 ~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 234 DLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred HHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 688899999999999999988876643
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-40 Score=299.41 Aligned_cols=228 Identities=21% Similarity=0.317 Sum_probs=182.9
Q ss_pred ceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCC----chHHHHHHHHHHHhc-cCCceeeeEEEEecCCceEEEEEeCCC
Q 018712 72 SLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ----PDQEFLAQVSMVSRL-KNENVVELVGYYVDGPLRVLAYEHASK 145 (351)
Q Consensus 72 ~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 145 (351)
+.||+|+||.||++... +++.||+|++.+... ....+.+|..++.++ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 36999999999999965 688999999875421 234467788888776 899999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccccCCCcc
Q 018712 146 GSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPD 225 (351)
Q Consensus 146 gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~ 225 (351)
|+|..++..... +++..+..++.||+.||.|||+++ |+||||||+||+++.++.+||+|||+++....
T Consensus 81 ~~L~~~~~~~~~---------l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~ 148 (329)
T cd05618 81 GDLMFHMQRQRK---------LPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 148 (329)
T ss_pred CCHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccC
Confidence 999998876542 889999999999999999999999 99999999999999999999999999875422
Q ss_pred ccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCC--c-------cchhhc---ccC
Q 018712 226 AAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQ--Q-------SLVTWA---TPK 293 (351)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~--~-------~~~~~~---~~~ 293 (351)
... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||........ . ..+... .|.
T Consensus 149 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~ 226 (329)
T cd05618 149 PGD--TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR 226 (329)
T ss_pred CCC--ccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCCCC
Confidence 211 12345789999999999999999999999999999999999999963211110 0 000000 111
Q ss_pred -C---CccchhhhcccccCCCCCH
Q 018712 294 -L---SEDKVKQCVDTKLGGEYPP 313 (351)
Q Consensus 294 -~---~~~~~~~~ld~~~~~~~~~ 313 (351)
. ..+.+..|+..+|.+|++.
T Consensus 227 ~~~~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 227 SLSVKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred CCCHHHHHHHHHHhcCCHHHcCCC
Confidence 1 1267788999999999874
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=286.81 Aligned_cols=245 Identities=27% Similarity=0.412 Sum_probs=198.5
Q ss_pred hcCCCCCceeccCCcEEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEEEeCC
Q 018712 65 TDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHAS 144 (351)
Q Consensus 65 ~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 144 (351)
.++|++.+.||+|+||.||+|...++..+|+|.+.......+.+.+|+.++++++|+|++++++++. ....+++|||+.
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~ 83 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMS 83 (260)
T ss_pred hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCCCHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecC
Confidence 3578999999999999999999888889999999876666677999999999999999999999875 456899999999
Q ss_pred CCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccccCCCc
Q 018712 145 KGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAP 224 (351)
Q Consensus 145 ~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~ 224 (351)
+++|.+++..... ..+++..+..++.|++.||.|||+++ ++||||||+||++++++.++|+|||++....
T Consensus 84 ~~~L~~~~~~~~~-------~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~ 153 (260)
T cd05070 84 KGSLLDFLKDGEG-------RALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIE 153 (260)
T ss_pred CCcHHHHHHhcCC-------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeecc
Confidence 9999999976432 12789999999999999999999999 9999999999999999999999999987654
Q ss_pred cccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCCccchhh--------cccCCC
Q 018712 225 DAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTW--------ATPKLS 295 (351)
Q Consensus 225 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~Pf~~~~~~~~~~~~~~--------~~~~~~ 295 (351)
...... .....++..|+|||.+.+..++.++|+||||+++|+|++ |..||...........+.. ..+...
T Consensus 154 ~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (260)
T cd05070 154 DNEYTA-RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQDCPISL 232 (260)
T ss_pred Cccccc-ccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHH
Confidence 322111 122235668999999988889999999999999999999 9999976543321111111 111122
Q ss_pred ccchhhhcccccCCCCCHHHHHHHHH
Q 018712 296 EDKVKQCVDTKLGGEYPPKAIAKVRK 321 (351)
Q Consensus 296 ~~~~~~~ld~~~~~~~~~~~~~~~~~ 321 (351)
.+.+.+|+..+|.+|++..++..+++
T Consensus 233 ~~li~~~l~~~p~~Rpt~~~l~~~l~ 258 (260)
T cd05070 233 HELMLQCWKKDPEERPTFEYLQSFLE 258 (260)
T ss_pred HHHHHHHcccCcccCcCHHHHHHHHh
Confidence 36788999999999999888876653
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=304.71 Aligned_cols=254 Identities=30% Similarity=0.412 Sum_probs=207.5
Q ss_pred HHHhcCCCCCceeccCCcEEEEEEEECC--C--CE-EEEEEcCCCC----CchHHHHHHHHHHHhccCCceeeeEEEEec
Q 018712 62 KEKTDNFGTNSLIGEGSYGRVYFGVLRS--G--RA-AAIKKLDSSK----QPDQEFLAQVSMVSRLKNENVVELVGYYVD 132 (351)
Q Consensus 62 ~~~~~~y~~~~~Lg~G~~g~Vy~~~~~~--~--~~-vavK~~~~~~----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~ 132 (351)
....++-.+.++||+|+||.||+|..+. + .. ||+|...... ....++++|.++|+.++|||||+++|+...
T Consensus 153 el~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~ 232 (474)
T KOG0194|consen 153 ELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVL 232 (474)
T ss_pred EEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcC
Confidence 3445566677899999999999999652 2 23 8999887522 224679999999999999999999999999
Q ss_pred CCceEEEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCce
Q 018712 133 GPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIA 212 (351)
Q Consensus 133 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~v 212 (351)
+..+++|||+|.||+|.++|.+.+. .++..+...++.+.+.||+|||+++ ++||||..+|+|+..++.+
T Consensus 233 ~~Pl~ivmEl~~gGsL~~~L~k~~~--------~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~v 301 (474)
T KOG0194|consen 233 EEPLMLVMELCNGGSLDDYLKKNKK--------SLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVV 301 (474)
T ss_pred CCccEEEEEecCCCcHHHHHHhCCC--------CCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeE
Confidence 9999999999999999999998764 2899999999999999999999999 9999999999999999999
Q ss_pred EEecccccCCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCCccch----
Q 018712 213 KISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLV---- 287 (351)
Q Consensus 213 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~Pf~~~~~~~~~~~~---- 287 (351)
||+|||+++....-... .....-...|+|||.+....|+.++|||||||++||+++ |..||.+.........+
T Consensus 302 KISDFGLs~~~~~~~~~--~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~ 379 (474)
T KOG0194|consen 302 KISDFGLSRAGSQYVMK--KFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNG 379 (474)
T ss_pred EeCccccccCCcceeec--cccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcC
Confidence 99999998765411111 111234678999999999999999999999999999999 89999987644322222
Q ss_pred -----hhcccCCCccchhhhcccccCCCCCHHHHHHHHHHHHHhhh
Q 018712 288 -----TWATPKLSEDKVKQCVDTKLGGEYPPKAIAKVRKKKFITSE 328 (351)
Q Consensus 288 -----~~~~~~~~~~~~~~~ld~~~~~~~~~~~~~~~~~~~~~~~~ 328 (351)
....|......+.+|+...+..|++..++.+.++....+.+
T Consensus 380 ~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~ 425 (474)
T KOG0194|consen 380 YRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKE 425 (474)
T ss_pred ccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccc
Confidence 22333333467789999999999999999888887766644
|
|
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=285.39 Aligned_cols=245 Identities=24% Similarity=0.373 Sum_probs=200.5
Q ss_pred hcCCCCCceeccCCcEEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEEEeCC
Q 018712 65 TDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHAS 144 (351)
Q Consensus 65 ~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 144 (351)
.++|++.+.||+|+||.||+|..++++.||+|.+.........+.+|+.++++++|+||+++++++. .+..+++|||+.
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~ 83 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYME 83 (260)
T ss_pred hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCCcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcCC
Confidence 4679999999999999999999888999999999877666778999999999999999999999864 557899999999
Q ss_pred CCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccccCCCc
Q 018712 145 KGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAP 224 (351)
Q Consensus 145 ~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~ 224 (351)
+++|.+++...... .+++..+..++.|++.||.|||+.+ ++||||||+||++++++.++|+|||++....
T Consensus 84 ~~~L~~~~~~~~~~-------~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~ 153 (260)
T cd05067 84 NGSLVDFLKTPEGI-------KLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIE 153 (260)
T ss_pred CCCHHHHHHhcCCC-------CCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecC
Confidence 99999998754322 2888999999999999999999999 9999999999999999999999999987654
Q ss_pred cccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCCccchh--------hcccCCC
Q 018712 225 DAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVT--------WATPKLS 295 (351)
Q Consensus 225 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~Pf~~~~~~~~~~~~~--------~~~~~~~ 295 (351)
..... ......++..|+|||.+.+..++.++||||||+++|+|++ |+.||............. ...+...
T Consensus 154 ~~~~~-~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (260)
T cd05067 154 DNEYT-AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMPRPDNCPEEL 232 (260)
T ss_pred CCCcc-cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCCCCCCHHH
Confidence 22211 1122345678999999998889999999999999999999 999997654322111111 1111223
Q ss_pred ccchhhhcccccCCCCCHHHHHHHHH
Q 018712 296 EDKVKQCVDTKLGGEYPPKAIAKVRK 321 (351)
Q Consensus 296 ~~~~~~~ld~~~~~~~~~~~~~~~~~ 321 (351)
.+.+.+|+..+|.+|++.+++..+++
T Consensus 233 ~~li~~~l~~~p~~Rp~~~~l~~~l~ 258 (260)
T cd05067 233 YELMRLCWKEKPEERPTFEYLRSVLE 258 (260)
T ss_pred HHHHHHHccCChhhCCCHHHHHHHhh
Confidence 46788999999999999998887664
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=300.03 Aligned_cols=199 Identities=24% Similarity=0.302 Sum_probs=169.6
Q ss_pred HHhcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCC---CchHHHHHHHHHHHhccCCceeeeEEEEecCC----
Q 018712 63 EKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK---QPDQEFLAQVSMVSRLKNENVVELVGYYVDGP---- 134 (351)
Q Consensus 63 ~~~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~---- 134 (351)
...++|++.+.||+|+||.||++.+. ++..||+|++.... .....+.+|+.+++.++||||+++++++....
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 97 (359)
T cd07876 18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEE 97 (359)
T ss_pred hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccc
Confidence 35688999999999999999999965 68999999986542 22456778999999999999999999886443
Q ss_pred --ceEEEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCce
Q 018712 135 --LRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIA 212 (351)
Q Consensus 135 --~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~v 212 (351)
..|+||||+.+ +|.+.+... ++...+..++.|++.||.|||++| |+||||||+|||++.++.+
T Consensus 98 ~~~~~lv~e~~~~-~l~~~~~~~-----------~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~ 162 (359)
T cd07876 98 FQDVYLVMELMDA-NLCQVIHME-----------LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTL 162 (359)
T ss_pred cceeEEEEeCCCc-CHHHHHhcc-----------CCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCE
Confidence 47999999976 677766432 778889999999999999999999 9999999999999999999
Q ss_pred EEecccccCCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCC
Q 018712 213 KISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTL 279 (351)
Q Consensus 213 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~ 279 (351)
||+|||+++....... .....||+.|+|||++.+..++.++||||||+++|+|++|+.||....
T Consensus 163 kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~ 226 (359)
T cd07876 163 KILDFGLARTACTNFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTD 226 (359)
T ss_pred EEecCCCccccccCcc---CCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC
Confidence 9999999876433211 234568999999999999999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-42 Score=289.46 Aligned_cols=241 Identities=30% Similarity=0.480 Sum_probs=202.3
Q ss_pred CCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCCchHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEEEeCCCC
Q 018712 68 FGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASKG 146 (351)
Q Consensus 68 y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 146 (351)
|.++++||+|+||.||+|.++ +|..+|||.+..+. .-+++..|+.+|+++..|++|++++.|.....+++|||||..|
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s-DLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGAG 113 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT-DLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGAG 113 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccc-hHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCCC
Confidence 666778999999999999975 79999999987654 4577999999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccccCCCccc
Q 018712 147 SLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDA 226 (351)
Q Consensus 147 sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~ 226 (351)
++.++++.+.. .+++.++..+++..++||+|||... -+|||||.+|||++.+|++||+|||.|..+.+.
T Consensus 114 SiSDI~R~R~K--------~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDT 182 (502)
T KOG0574|consen 114 SISDIMRARRK--------PLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLTDT 182 (502)
T ss_pred cHHHHHHHhcC--------CccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhhhh
Confidence 99999987654 3999999999999999999999998 899999999999999999999999999887654
Q ss_pred cccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccchhhccc-CCC---------c
Q 018712 227 AARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATP-KLS---------E 296 (351)
Q Consensus 227 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~-~~~---------~ 296 (351)
... ..++.|||-|||||++..-.|+.++||||||++..||..|++||.+..+......+.-..| .+. .
T Consensus 183 MAK--RNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~PPPTF~KPE~WS~~F~ 260 (502)
T KOG0574|consen 183 MAK--RNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTKPPPTFKKPEEWSSEFN 260 (502)
T ss_pred HHh--hCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEeccCCCCCCCCChHhhhhHHH
Confidence 433 2667899999999999999999999999999999999999999998766554444432222 111 1
Q ss_pred cchhhhcccccCCCCCHHHHHHHHHHHHH
Q 018712 297 DKVKQCVDTKLGGEYPPKAIAKVRKKKFI 325 (351)
Q Consensus 297 ~~~~~~ld~~~~~~~~~~~~~~~~~~~~~ 325 (351)
+.++.|+-..|.+|-+ +.+++++.|.
T Consensus 261 DFi~~CLiK~PE~R~T---A~~L~~H~Fi 286 (502)
T KOG0574|consen 261 DFIRSCLIKKPEERKT---ALRLCEHTFI 286 (502)
T ss_pred HHHHHHhcCCHHHHHH---HHHHhhhhhh
Confidence 5667777777766653 3445556554
|
|
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=301.33 Aligned_cols=256 Identities=21% Similarity=0.325 Sum_probs=199.8
Q ss_pred HhcCCCCCceeccCCcEEEEEEEEC------CCCEEEEEEcCCCCCc--hHHHHHHHHHHHhcc-CCceeeeEEEEecCC
Q 018712 64 KTDNFGTNSLIGEGSYGRVYFGVLR------SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLK-NENVVELVGYYVDGP 134 (351)
Q Consensus 64 ~~~~y~~~~~Lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~ 134 (351)
..++|.+.+.||+|+||.||+|.+. .+..||+|++...... .+.+.+|+++++++. ||||+++++++.+.+
T Consensus 35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~ 114 (400)
T cd05105 35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSG 114 (400)
T ss_pred cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCC
Confidence 3568999999999999999999853 2347999999754332 456889999999996 999999999999999
Q ss_pred ceEEEEEeCCCCCHHHHhccCCCCCC------------------------------------------------------
Q 018712 135 LRVLAYEHASKGSLHDILHGKKGVKG------------------------------------------------------ 160 (351)
Q Consensus 135 ~~~lv~e~~~~gsL~~~l~~~~~~~~------------------------------------------------------ 160 (351)
..|+||||+++|+|.+++........
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (400)
T cd05105 115 PIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEI 194 (400)
T ss_pred ceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhh
Confidence 99999999999999999875421000
Q ss_pred ---------------------------------CCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEc
Q 018712 161 ---------------------------------AKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLF 207 (351)
Q Consensus 161 ---------------------------------~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~ 207 (351)
......+++..+..++.|++.||.|||+.+ ++||||||+|||++
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nill~ 271 (400)
T cd05105 195 KEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVLLA 271 (400)
T ss_pred hhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEEEe
Confidence 001123778888999999999999999999 99999999999999
Q ss_pred cCCceEEecccccCCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCCc-c
Q 018712 208 DDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQ-S 285 (351)
Q Consensus 208 ~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~Pf~~~~~~~~~-~ 285 (351)
+++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|+|++ |..||......... .
T Consensus 272 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~ 351 (400)
T cd05105 272 QGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYN 351 (400)
T ss_pred CCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHHH
Confidence 999999999999876543322222233456788999999998899999999999999999997 99999764332111 0
Q ss_pred chh--------hcccCCCccchhhhcccccCCCCCHHHHHHHHHH
Q 018712 286 LVT--------WATPKLSEDKVKQCVDTKLGGEYPPKAIAKVRKK 322 (351)
Q Consensus 286 ~~~--------~~~~~~~~~~~~~~ld~~~~~~~~~~~~~~~~~~ 322 (351)
.+. ...+....+.+.+|+..+|.+|++..++.++++.
T Consensus 352 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~ 396 (400)
T cd05105 352 KIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVES 396 (400)
T ss_pred HHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHH
Confidence 000 0111122367889999999999999888887664
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=298.01 Aligned_cols=239 Identities=21% Similarity=0.300 Sum_probs=188.7
Q ss_pred ceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCC----chHHHHHHHHHHHhc-cCCceeeeEEEEecCCceEEEEEeCCC
Q 018712 72 SLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ----PDQEFLAQVSMVSRL-KNENVVELVGYYVDGPLRVLAYEHASK 145 (351)
Q Consensus 72 ~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 145 (351)
+.||+|+||.||++... +++.||+|++..... ....+.+|..++.++ +|+||+++++++.+.+..|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 36999999999999965 678999999975432 234577888888888 699999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccccCCCcc
Q 018712 146 GSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPD 225 (351)
Q Consensus 146 gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~ 225 (351)
|+|..++..... +++..+..++.||+.||.|||+++ ++||||||+|||++.++.+||+|||+++....
T Consensus 81 ~~L~~~~~~~~~---------l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~ 148 (327)
T cd05617 81 GDLMFHMQRQRK---------LPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLG 148 (327)
T ss_pred CcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccC
Confidence 999998875542 899999999999999999999999 99999999999999999999999999875322
Q ss_pred ccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCcc-------chh-------hcc
Q 018712 226 AAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQS-------LVT-------WAT 291 (351)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~-------~~~-------~~~ 291 (351)
... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||.......... .+. ...
T Consensus 149 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~ 226 (327)
T cd05617 149 PGD--TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFL 226 (327)
T ss_pred CCC--ceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCCCCCCC
Confidence 111 1234679999999999999999999999999999999999999997533221110 000 011
Q ss_pred cCCCccchhhhcccccCCCCCHH---HHHHHHHHHH
Q 018712 292 PKLSEDKVKQCVDTKLGGEYPPK---AIAKVRKKKF 324 (351)
Q Consensus 292 ~~~~~~~~~~~ld~~~~~~~~~~---~~~~~~~~~~ 324 (351)
+....+.+..|+..+|.+|++.. ....+..+.+
T Consensus 227 ~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~ 262 (327)
T cd05617 227 SVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTF 262 (327)
T ss_pred CHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcCCC
Confidence 11123678888999999998642 2334444444
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=287.98 Aligned_cols=253 Identities=26% Similarity=0.365 Sum_probs=197.6
Q ss_pred cCCCCCceeccCCcEEEEEEEE-----CCCCEEEEEEcCCCCCc--hHHHHHHHHHHHhccCCceeeeEEEEecCCceEE
Q 018712 66 DNFGTNSLIGEGSYGRVYFGVL-----RSGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVL 138 (351)
Q Consensus 66 ~~y~~~~~Lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 138 (351)
++|++.+.||+|+||.||+|.. .++..+++|.+...... ...+.+|+.++++++|+||+++++++......++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 5788889999999999999984 24678999998754332 2467889999999999999999999999999999
Q ss_pred EEEeCCCCCHHHHhccCCCCC--------CCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCC
Q 018712 139 AYEHASKGSLHDILHGKKGVK--------GAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD 210 (351)
Q Consensus 139 v~e~~~~gsL~~~l~~~~~~~--------~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~ 210 (351)
+|||+.+++|.+++....... .......+++...+.++.|++.||.|||+++ ++||||||+|||+++++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCC
Confidence 999999999999986432100 0001123788899999999999999999999 99999999999999999
Q ss_pred ceEEecccccCCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCCccchh-
Q 018712 211 IAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVT- 288 (351)
Q Consensus 211 ~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~Pf~~~~~~~~~~~~~- 288 (351)
.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..||...........+.
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~~~ 241 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRK 241 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence 999999999977543322222233446778999999988889999999999999999998 999997654321111111
Q ss_pred -------hcccCCCccchhhhcccccCCCCCHHHHHHHHH
Q 018712 289 -------WATPKLSEDKVKQCVDTKLGGEYPPKAIAKVRK 321 (351)
Q Consensus 289 -------~~~~~~~~~~~~~~ld~~~~~~~~~~~~~~~~~ 321 (351)
...+....+.+..|++++|.+|++..++.+.++
T Consensus 242 ~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 281 (283)
T cd05090 242 RQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLR 281 (283)
T ss_pred CCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhh
Confidence 111112235778999999999999988876543
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=289.51 Aligned_cols=240 Identities=23% Similarity=0.320 Sum_probs=191.0
Q ss_pred eccCCcEEEEEEEEC-CCCEEEEEEcCCCCC----chHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEEEeCCCCCH
Q 018712 74 IGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ----PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSL 148 (351)
Q Consensus 74 Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL 148 (351)
||+|+||.||++..+ +|+.||+|.+..... .......|++++++++||||+++++.+.+....++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 699999999999965 689999999864321 233456799999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccccCCCccccc
Q 018712 149 HDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAA 228 (351)
Q Consensus 149 ~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~ 228 (351)
.+++...... .+++..+..++.|++.||+|||+.+ ++||||||+||++++++.++|+|||++........
T Consensus 81 ~~~~~~~~~~-------~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~ 150 (277)
T cd05607 81 KYHIYNVGER-------GLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT 150 (277)
T ss_pred HHHHHhcccc-------CCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCCce
Confidence 9888654321 2788899999999999999999999 99999999999999999999999999876543221
Q ss_pred cccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCc-cchh-----------hcccCCCc
Q 018712 229 RLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQ-SLVT-----------WATPKLSE 296 (351)
Q Consensus 229 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~-~~~~-----------~~~~~~~~ 296 (351)
.....||..|+|||++.+..++.++|||||||++|+|++|+.||......... .... ...+....
T Consensus 151 ---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (277)
T cd05607 151 ---ITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQNFTEESK 227 (277)
T ss_pred ---eeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccccccccCCHHHH
Confidence 13346899999999999888999999999999999999999999764322111 0000 01112224
Q ss_pred cchhhhcccccCCCCCHHH-HHHHHHHHHHh
Q 018712 297 DKVKQCVDTKLGGEYPPKA-IAKVRKKKFIT 326 (351)
Q Consensus 297 ~~~~~~ld~~~~~~~~~~~-~~~~~~~~~~~ 326 (351)
+.+..|+..+|.+|++.++ +..+..+.+..
T Consensus 228 ~li~~~L~~~P~~R~~~~~~~~~~~~h~~f~ 258 (277)
T cd05607 228 DICRLFLAKKPEDRLGSREKNDDPRKHEFFK 258 (277)
T ss_pred HHHHHHhccCHhhCCCCccchhhhhcChhhc
Confidence 7889999999999998754 33455565553
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-39 Score=283.22 Aligned_cols=239 Identities=24% Similarity=0.391 Sum_probs=190.4
Q ss_pred ceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCC--chHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEEEeCCCCCH
Q 018712 72 SLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ--PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSL 148 (351)
Q Consensus 72 ~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL 148 (351)
+.||+|+||.||+|... +++.+|+|.+..... ....+.+|++++++++|+||+++++++......++||||+.+++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 36999999999999965 789999998764432 245688999999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccccCCCccccc
Q 018712 149 HDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAA 228 (351)
Q Consensus 149 ~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~ 228 (351)
.+++..... .+++..++.++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++........
T Consensus 81 ~~~~~~~~~--------~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~ 149 (252)
T cd05084 81 LTFLRTEGP--------RLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVY 149 (252)
T ss_pred HHHHHhCCC--------CCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccccccc
Confidence 999965431 2788999999999999999999999 99999999999999999999999999876543211
Q ss_pred cccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCCccchhh--------cccCCCccch
Q 018712 229 RLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTW--------ATPKLSEDKV 299 (351)
Q Consensus 229 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~Pf~~~~~~~~~~~~~~--------~~~~~~~~~~ 299 (351)
........++..|+|||.+.+..++.++||||||+++|+|++ |..||...........+.. ..+....+.+
T Consensus 150 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 229 (252)
T cd05084 150 ASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLPCPELCPDAVYRLM 229 (252)
T ss_pred cccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCcccCCHHHHHHH
Confidence 111111123457999999998899999999999999999998 9999976543221111111 1111223578
Q ss_pred hhhcccccCCCCCHHHHHHHHH
Q 018712 300 KQCVDTKLGGEYPPKAIAKVRK 321 (351)
Q Consensus 300 ~~~ld~~~~~~~~~~~~~~~~~ 321 (351)
.+|+..+|.+|++..++...++
T Consensus 230 ~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 230 ERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred HHHcCCChhhCcCHHHHHHHHh
Confidence 8999999999999998876643
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=293.45 Aligned_cols=245 Identities=23% Similarity=0.347 Sum_probs=194.3
Q ss_pred hcCCCCCceeccCCcEEEEEEEEC-CCC----EEEEEEcCCCC--CchHHHHHHHHHHHhccCCceeeeEEEEecCCceE
Q 018712 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGR----AAAIKKLDSSK--QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRV 137 (351)
Q Consensus 65 ~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 137 (351)
..+|++.+.||+|+||.||+|.+. ++. .||+|.+.... ...+.+.+|+.+++.++||||+++++++... ..+
T Consensus 6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~ 84 (316)
T cd05108 6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ 84 (316)
T ss_pred hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cce
Confidence 457999999999999999999854 333 48999986443 2346788999999999999999999988765 567
Q ss_pred EEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecc
Q 018712 138 LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDF 217 (351)
Q Consensus 138 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Df 217 (351)
+++||+.+|+|.+++..... .+++..++.++.||+.||+|||+++ ++||||||+|||+++++.+||+||
T Consensus 85 ~v~e~~~~g~l~~~l~~~~~--------~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~Df 153 (316)
T cd05108 85 LITQLMPFGCLLDYVREHKD--------NIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDF 153 (316)
T ss_pred eeeecCCCCCHHHHHHhccc--------cCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEccc
Confidence 99999999999999986532 2788899999999999999999999 999999999999999999999999
Q ss_pred cccCCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCCccchhhc------
Q 018712 218 DLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWA------ 290 (351)
Q Consensus 218 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~Pf~~~~~~~~~~~~~~~------ 290 (351)
|+++...............++..|+|||++.+..++.++||||||+++|||++ |+.||...............
T Consensus 154 G~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~ 233 (316)
T cd05108 154 GLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQP 233 (316)
T ss_pred cccccccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhCCCCCCCC
Confidence 99987654332222222334678999999999999999999999999999998 99999865432211111110
Q ss_pred --ccCCCccchhhhcccccCCCCCHHHHHHHHH
Q 018712 291 --TPKLSEDKVKQCVDTKLGGEYPPKAIAKVRK 321 (351)
Q Consensus 291 --~~~~~~~~~~~~ld~~~~~~~~~~~~~~~~~ 321 (351)
.+.-....+..|+..+|.+|++..++...+.
T Consensus 234 ~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~ 266 (316)
T cd05108 234 PICTIDVYMIMVKCWMIDADSRPKFRELIIEFS 266 (316)
T ss_pred CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 0111135778999999999999988876543
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-39 Score=283.79 Aligned_cols=246 Identities=27% Similarity=0.417 Sum_probs=202.0
Q ss_pred hcCCCCCceeccCCcEEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEEEeCC
Q 018712 65 TDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHAS 144 (351)
Q Consensus 65 ~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 144 (351)
.++|.+.+.||+|+||.||+|...++..+|+|.+.........+.+|+.++++++|+||+++++++......+++|||++
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 84 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMS 84 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCccCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEeccC
Confidence 46899999999999999999998888899999998776667789999999999999999999999998889999999999
Q ss_pred CCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccccCCCc
Q 018712 145 KGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAP 224 (351)
Q Consensus 145 ~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~ 224 (351)
+++|.+++...... .+++..+..++.|++.||.|||+++ ++|+||||+||++++++.+||+|||++....
T Consensus 85 ~~~L~~~i~~~~~~-------~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~ 154 (261)
T cd05034 85 KGSLLDFLKSGEGK-------KLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIE 154 (261)
T ss_pred CCCHHHHHhccccC-------CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceecc
Confidence 99999999764321 3889999999999999999999999 9999999999999999999999999987664
Q ss_pred cccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCCccchhh--------cccCCC
Q 018712 225 DAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTW--------ATPKLS 295 (351)
Q Consensus 225 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~Pf~~~~~~~~~~~~~~--------~~~~~~ 295 (351)
..... ......++..|+|||.+.+..++.++|+||||+++|+|++ |+.||...........+.. ..+...
T Consensus 155 ~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (261)
T cd05034 155 DDEYT-AREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMPRPPNCPEEL 233 (261)
T ss_pred chhhh-hhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHH
Confidence 32111 1122234668999999998889999999999999999998 9999976543221111111 111222
Q ss_pred ccchhhhcccccCCCCCHHHHHHHHH
Q 018712 296 EDKVKQCVDTKLGGEYPPKAIAKVRK 321 (351)
Q Consensus 296 ~~~~~~~ld~~~~~~~~~~~~~~~~~ 321 (351)
.+.+.+|+..+|.+|++.+++..+++
T Consensus 234 ~~~i~~~l~~~p~~Rp~~~~l~~~l~ 259 (261)
T cd05034 234 YDLMLQCWDKDPEERPTFEYLQSFLE 259 (261)
T ss_pred HHHHHHHcccCcccCCCHHHHHHHHh
Confidence 35778889999999999888876654
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=298.76 Aligned_cols=202 Identities=22% Similarity=0.315 Sum_probs=172.3
Q ss_pred cCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCC----CCchHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEE
Q 018712 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSS----KQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAY 140 (351)
Q Consensus 66 ~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 140 (351)
++|++.+.||+|+||.||++... +++.||+|++.+. ....+.+.+|..+++.++|+||+++++.+.+.+..|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 47999999999999999999965 6899999998642 122345778999999999999999999999999999999
Q ss_pred EeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEeccccc
Q 018712 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (351)
Q Consensus 141 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a 220 (351)
||+.+|+|.+++..... .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 81 e~~~g~~L~~~l~~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~ 149 (331)
T cd05597 81 DYYVGGDLLTLLSKFED--------RLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSC 149 (331)
T ss_pred ecCCCCcHHHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCce
Confidence 99999999999975322 2888999999999999999999999 999999999999999999999999998
Q ss_pred CCCccccccccccccccccCccCcccccC-----CCCCccchhHhHHHHHHHHHcCCCCCCCCC
Q 018712 221 NQAPDAAARLHSTRVLGTFGYHAPEYAMT-----GQMSSKSDVYSFGVVLLELLTGRKPVDHTL 279 (351)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~il~el~tg~~Pf~~~~ 279 (351)
......... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||....
T Consensus 150 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~ 212 (331)
T cd05597 150 LRLLADGTV-QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAES 212 (331)
T ss_pred eecCCCCCc-cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCC
Confidence 665432211 1123468999999999863 457889999999999999999999997643
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=295.42 Aligned_cols=257 Identities=21% Similarity=0.324 Sum_probs=199.0
Q ss_pred cCCCCCceeccCCcEEEEEEEEC------CCCEEEEEEcCCCCCc--hHHHHHHHHHHHhc-cCCceeeeEEEEec-CCc
Q 018712 66 DNFGTNSLIGEGSYGRVYFGVLR------SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRL-KNENVVELVGYYVD-GPL 135 (351)
Q Consensus 66 ~~y~~~~~Lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l-~h~niv~~~~~~~~-~~~ 135 (351)
++|++.+.||+|+||.||+|... +++.||+|++...... .+.+..|+.+++++ +|+||+++++++.. +..
T Consensus 7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~ 86 (337)
T cd05054 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGP 86 (337)
T ss_pred HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCC
Confidence 47999999999999999999632 3578999998754322 34577899999999 89999999998764 457
Q ss_pred eEEEEEeCCCCCHHHHhccCCCCCC----------------------------------------------------CCC
Q 018712 136 RVLAYEHASKGSLHDILHGKKGVKG----------------------------------------------------AKP 163 (351)
Q Consensus 136 ~~lv~e~~~~gsL~~~l~~~~~~~~----------------------------------------------------~~~ 163 (351)
.+++|||+++++|.+++........ ...
T Consensus 87 ~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (337)
T cd05054 87 LMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELY 166 (337)
T ss_pred EEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHh
Confidence 8899999999999999865322100 000
Q ss_pred CCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccccCCCccccccccccccccccCccC
Q 018712 164 GPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHA 243 (351)
Q Consensus 164 ~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~a 243 (351)
...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++................++..|+|
T Consensus 167 ~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~a 243 (337)
T cd05054 167 KEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMA 243 (337)
T ss_pred hcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccC
Confidence 124789999999999999999999999 99999999999999999999999999987644332222234456778999
Q ss_pred cccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCCc-cchh-hcc-------cCCCccchhhhcccccCCCCCH
Q 018712 244 PEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQ-SLVT-WAT-------PKLSEDKVKQCVDTKLGGEYPP 313 (351)
Q Consensus 244 PE~~~~~~~~~~~DvwslG~il~el~t-g~~Pf~~~~~~~~~-~~~~-~~~-------~~~~~~~~~~~ld~~~~~~~~~ 313 (351)
||++.+..++.++|||||||++|||++ |..||......... ..+. ... .....+.+..|+..+|.+|++.
T Consensus 244 PE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~ 323 (337)
T cd05054 244 PESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPEYATPEIYSIMLDCWHNNPEDRPTF 323 (337)
T ss_pred cHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCCCccCCHHHHHHHHHHccCChhhCcCH
Confidence 999999999999999999999999997 99999764322110 0000 000 1111356788999999999999
Q ss_pred HHHHHHHHHHHH
Q 018712 314 KAIAKVRKKKFI 325 (351)
Q Consensus 314 ~~~~~~~~~~~~ 325 (351)
+++.+.++-.+.
T Consensus 324 ~ell~~l~~~~~ 335 (337)
T cd05054 324 SELVEILGDLLQ 335 (337)
T ss_pred HHHHHHHHHHHh
Confidence 999888877664
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=305.89 Aligned_cols=205 Identities=25% Similarity=0.342 Sum_probs=181.0
Q ss_pred CCCCCceeccCCcEEEEEEEE-CCCCEEEEEEcCCCCCchHHHHHHHHHHHhcc-C-----CceeeeEEEEecCCceEEE
Q 018712 67 NFGTNSLIGEGSYGRVYFGVL-RSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLK-N-----ENVVELVGYYVDGPLRVLA 139 (351)
Q Consensus 67 ~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~-h-----~niv~~~~~~~~~~~~~lv 139 (351)
+|.+.+.||+|+||.|.+|.+ ++++.||||++++.+....+...|+.+|..|+ | -|+|+++++|...+++|||
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~HlciV 266 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCIV 266 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceeee
Confidence 578899999999999999996 47999999999998888888899999999997 4 5899999999999999999
Q ss_pred EEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCC--ceEEecc
Q 018712 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD--IAKISDF 217 (351)
Q Consensus 140 ~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~--~vkl~Df 217 (351)
+|.+.. +|+++++...-.. ++...++.++.||+.||.+||..+ |||+||||+|||+.+.+ .|||+||
T Consensus 267 fELL~~-NLYellK~n~f~G-------lsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDF 335 (586)
T KOG0667|consen 267 FELLST-NLYELLKNNKFRG-------LSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDF 335 (586)
T ss_pred ehhhhh-hHHHHHHhcCCCC-------CCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEec
Confidence 999976 9999999876533 899999999999999999999999 99999999999997644 7999999
Q ss_pred cccCCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccch
Q 018712 218 DLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLV 287 (351)
Q Consensus 218 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~ 287 (351)
|.|+....... ...-+..|+|||++.|.+|+.+.||||||||+.||++|.+-|.+.++.++...|
T Consensus 336 GSSc~~~q~vy-----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I 400 (586)
T KOG0667|consen 336 GSSCFESQRVY-----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARI 400 (586)
T ss_pred ccccccCCcce-----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHH
Confidence 99987765433 233467899999999999999999999999999999999999988765554433
|
|
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-39 Score=283.58 Aligned_cols=247 Identities=25% Similarity=0.392 Sum_probs=199.3
Q ss_pred hcCCCCCceeccCCcEEEEEEEEC----CCCEEEEEEcCCCCCc--hHHHHHHHHHHHhccCCceeeeEEEEecCCceEE
Q 018712 65 TDNFGTNSLIGEGSYGRVYFGVLR----SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVL 138 (351)
Q Consensus 65 ~~~y~~~~~Lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 138 (351)
.++|++.+.||+|+||.||+|.+. +...+|+|.+...... ...+.+|+.++++++|+||+++++.+.+.+..++
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i 82 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI 82 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence 357899999999999999999874 2457999988754332 3568889999999999999999999999999999
Q ss_pred EEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEeccc
Q 018712 139 AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFD 218 (351)
Q Consensus 139 v~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg 218 (351)
+|||+++++|.+++..... .+++..++.++.|++.||.|||+++ ++|+||||+||++++++.++|+|||
T Consensus 83 v~e~~~~~~L~~~~~~~~~--------~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg 151 (266)
T cd05033 83 ITEYMENGSLDKFLRENDG--------KFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFG 151 (266)
T ss_pred EEEcCCCCCHHHHHHhccC--------CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccc
Confidence 9999999999999976432 2889999999999999999999999 9999999999999999999999999
Q ss_pred ccCCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCCccchh--------h
Q 018712 219 LSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVT--------W 289 (351)
Q Consensus 219 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~Pf~~~~~~~~~~~~~--------~ 289 (351)
++................++..|+|||.+.+..++.++||||||+++|+|++ |..||...........+. .
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 231 (266)
T cd05033 152 LSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRLPPPM 231 (266)
T ss_pred hhhcccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCC
Confidence 9987752222221222345678999999998899999999999999999998 999997543322111111 0
Q ss_pred cccCCCccchhhhcccccCCCCCHHHHHHHHHH
Q 018712 290 ATPKLSEDKVKQCVDTKLGGEYPPKAIAKVRKK 322 (351)
Q Consensus 290 ~~~~~~~~~~~~~ld~~~~~~~~~~~~~~~~~~ 322 (351)
..+....+.+..|+..+|.+|++.+++...+..
T Consensus 232 ~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~ 264 (266)
T cd05033 232 DCPSALYQLMLDCWQKDRNERPTFSQIVSTLDK 264 (266)
T ss_pred CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence 111222367889999999999999988776653
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=293.45 Aligned_cols=240 Identities=19% Similarity=0.331 Sum_probs=191.6
Q ss_pred hcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCC--chHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEEE
Q 018712 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ--PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYE 141 (351)
Q Consensus 65 ~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 141 (351)
.++|.+.+.||+|+||.||+|..+ +++.+|+|.+..... ....+.+|+.++++++|+||+++++++..++..++|||
T Consensus 5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 84 (309)
T cd07872 5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFE 84 (309)
T ss_pred CCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEe
Confidence 467999999999999999999975 678999999864432 23457789999999999999999999999999999999
Q ss_pred eCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccccC
Q 018712 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (351)
Q Consensus 142 ~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~ 221 (351)
|+.+ +|.+++..... .++...+..++.||+.||.|||++| |+||||||+||+++.++.+||+|||++.
T Consensus 85 ~~~~-~l~~~~~~~~~--------~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~ 152 (309)
T cd07872 85 YLDK-DLKQYMDDCGN--------IMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLAR 152 (309)
T ss_pred CCCC-CHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccce
Confidence 9976 88888865432 2788899999999999999999999 9999999999999999999999999987
Q ss_pred CCccccccccccccccccCccCcccccC-CCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccch-------------
Q 018712 222 QAPDAAARLHSTRVLGTFGYHAPEYAMT-GQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLV------------- 287 (351)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~------------- 287 (351)
........ .....+|+.|+|||++.+ ..++.++||||||+++|+|++|+.||...........+
T Consensus 153 ~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (309)
T cd07872 153 AKSVPTKT--YSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWP 230 (309)
T ss_pred ecCCCccc--cccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Confidence 64332211 123457899999998865 46789999999999999999999999765432111000
Q ss_pred ---------hhc---------------ccCCCccchhhhcccccCCCCCHHHHHH
Q 018712 288 ---------TWA---------------TPKLSEDKVKQCVDTKLGGEYPPKAIAK 318 (351)
Q Consensus 288 ---------~~~---------------~~~~~~~~~~~~ld~~~~~~~~~~~~~~ 318 (351)
... .+....+.+.+|+..+|.+|++.+++..
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 231 GISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred hhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 000 0111136788999999999998776643
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-39 Score=288.44 Aligned_cols=256 Identities=23% Similarity=0.369 Sum_probs=201.6
Q ss_pred hcCCCCCceeccCCcEEEEEEEEC------CCCEEEEEEcCCCCC-chHHHHHHHHHHHhccCCceeeeEEEEecCCceE
Q 018712 65 TDNFGTNSLIGEGSYGRVYFGVLR------SGRAAAIKKLDSSKQ-PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRV 137 (351)
Q Consensus 65 ~~~y~~~~~Lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 137 (351)
.++|.+.+.||+|+||.||++... ++..+|+|.+..... ....+.+|++++++++|+||+++++++...+..+
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 83 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence 457899999999999999999842 345689998865432 2456889999999999999999999999999999
Q ss_pred EEEEeCCCCCHHHHhccCCCCCC----CCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceE
Q 018712 138 LAYEHASKGSLHDILHGKKGVKG----AKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAK 213 (351)
Q Consensus 138 lv~e~~~~gsL~~~l~~~~~~~~----~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vk 213 (351)
++|||+++++|.+++........ ......+++..++.++.|++.||.|||++| ++||||||+||++++++.+|
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~k 160 (288)
T cd05093 84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVK 160 (288)
T ss_pred EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEE
Confidence 99999999999999975432111 011123899999999999999999999999 99999999999999999999
Q ss_pred EecccccCCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCCccchh----
Q 018712 214 ISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVT---- 288 (351)
Q Consensus 214 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~Pf~~~~~~~~~~~~~---- 288 (351)
|+|||++................++..|+|||++.+..++.++||||||+++|+|++ |..||...........+.
T Consensus 161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~~~~ 240 (288)
T cd05093 161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRV 240 (288)
T ss_pred eccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCc
Confidence 999999876543322212233345778999999998899999999999999999998 999997654322111111
Q ss_pred ----hcccCCCccchhhhcccccCCCCCHHHHHHHHHHH
Q 018712 289 ----WATPKLSEDKVKQCVDTKLGGEYPPKAIAKVRKKK 323 (351)
Q Consensus 289 ----~~~~~~~~~~~~~~ld~~~~~~~~~~~~~~~~~~~ 323 (351)
...+....+.+.+|+.++|.+|++.+++...++-.
T Consensus 241 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~ 279 (288)
T cd05093 241 LQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNL 279 (288)
T ss_pred CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHH
Confidence 01111223688999999999999999987766544
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-39 Score=284.29 Aligned_cols=246 Identities=20% Similarity=0.306 Sum_probs=198.4
Q ss_pred cCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCC----CchHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEE
Q 018712 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK----QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAY 140 (351)
Q Consensus 66 ~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 140 (351)
++|++.+.||+|+||.||+|... +++.||+|.+.... .....+.+|+++++.++||||+++++++.+.+..++++
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 57999999999999999999965 78999999875422 22345788999999999999999999999999999999
Q ss_pred EeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEeccccc
Q 018712 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (351)
Q Consensus 141 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a 220 (351)
||+++++|.+++...... ...++...+..++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++
T Consensus 82 e~~~~~~L~~~~~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~ 153 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQ-----KRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLG 153 (267)
T ss_pred EecCCCcHHHHHHHhhhc-----cCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccc
Confidence 999999999988643211 113788899999999999999999999 999999999999999999999999998
Q ss_pred CCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCc--cch---------hh
Q 018712 221 NQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQ--SLV---------TW 289 (351)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~--~~~---------~~ 289 (351)
......... .....|++.|+|||.+.+..++.++|+||||+++|+|++|+.||......... ..+ ..
T Consensus 154 ~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (267)
T cd08228 154 RFFSSKTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTE 231 (267)
T ss_pred eeccchhHH--HhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCCChh
Confidence 765433221 12346888999999999888999999999999999999999999754321100 000 01
Q ss_pred cccCCCccchhhhcccccCCCCCHHHHHHHHH
Q 018712 290 ATPKLSEDKVKQCVDTKLGGEYPPKAIAKVRK 321 (351)
Q Consensus 290 ~~~~~~~~~~~~~ld~~~~~~~~~~~~~~~~~ 321 (351)
..+....+.+.+|++.+|.+|++.+++.+.++
T Consensus 232 ~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~ 263 (267)
T cd08228 232 HYSEKLRELVSMCIYPDPDQRPDIGYVHQIAK 263 (267)
T ss_pred hcCHHHHHHHHHHCCCCcccCcCHHHHHHHHH
Confidence 11122246788999999999999999887654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-39 Score=286.11 Aligned_cols=254 Identities=22% Similarity=0.343 Sum_probs=197.5
Q ss_pred HhcCCCCCceeccCCcEEEEEEEEC------CCCEEEEEEcCCCCC--chHHHHHHHHHHHhccCCceeeeEEEEecCCc
Q 018712 64 KTDNFGTNSLIGEGSYGRVYFGVLR------SGRAAAIKKLDSSKQ--PDQEFLAQVSMVSRLKNENVVELVGYYVDGPL 135 (351)
Q Consensus 64 ~~~~y~~~~~Lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 135 (351)
..++|++.+.||+|+||.||+|.+. ++..||+|++..... ....+.+|+.+++.++|+||+++++++.++..
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 3567999999999999999998753 356799998864332 23467889999999999999999999999999
Q ss_pred eEEEEEeCCCCCHHHHhccCCCCCCC-CCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEE
Q 018712 136 RVLAYEHASKGSLHDILHGKKGVKGA-KPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKI 214 (351)
Q Consensus 136 ~~lv~e~~~~gsL~~~l~~~~~~~~~-~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl 214 (351)
.++||||+++++|.+++......... .....+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.++|
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEEE
Confidence 99999999999999999764321111 11123678889999999999999999999 999999999999999999999
Q ss_pred ecccccCCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCCccchh-----
Q 018712 215 SDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVT----- 288 (351)
Q Consensus 215 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~Pf~~~~~~~~~~~~~----- 288 (351)
+|||++................+++.|+|||++.+..++.++||||||+++|||++ |..||...........+.
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~ 240 (277)
T cd05062 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGGLL 240 (277)
T ss_pred CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcC
Confidence 99999876543322211222345778999999998899999999999999999999 789997654332111111
Q ss_pred ---hcccCCCccchhhhcccccCCCCCHHHHHHHH
Q 018712 289 ---WATPKLSEDKVKQCVDTKLGGEYPPKAIAKVR 320 (351)
Q Consensus 289 ---~~~~~~~~~~~~~~ld~~~~~~~~~~~~~~~~ 320 (351)
...+....+.+.+|+..+|.+|++..++...+
T Consensus 241 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l 275 (277)
T cd05062 241 DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSI 275 (277)
T ss_pred CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHh
Confidence 01111123578899999999999988876654
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=288.40 Aligned_cols=246 Identities=22% Similarity=0.327 Sum_probs=193.8
Q ss_pred CCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCCc----hHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEEE
Q 018712 67 NFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP----DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYE 141 (351)
Q Consensus 67 ~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 141 (351)
.|+..+.||+|+||.||++... +++.||+|.+...... ...+.+|+.++++++|+||+.+++.+.+.+..++|||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 3677889999999999999965 7899999998654321 2346789999999999999999999999999999999
Q ss_pred eCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccccC
Q 018712 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (351)
Q Consensus 142 ~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~ 221 (351)
|+.+++|.+++...... .++...+..++.|++.||.|||+.+ ++||||||+||++++++.++|+|||++.
T Consensus 81 ~~~g~~L~~~l~~~~~~-------~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~ 150 (285)
T cd05630 81 LMNGGDLKFHIYHMGEA-------GFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAV 150 (285)
T ss_pred ecCCCcHHHHHHHhccc-------CCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeecccee
Confidence 99999999998654321 2888999999999999999999999 9999999999999999999999999986
Q ss_pred CCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCcc----chh----h---c
Q 018712 222 QAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQS----LVT----W---A 290 (351)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~----~~~----~---~ 290 (351)
....... .....||..|+|||++.+..++.++||||||+++|+|++|+.||.......... ... . .
T Consensus 151 ~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (285)
T cd05630 151 HVPEGQT---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEK 227 (285)
T ss_pred ecCCCcc---ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhhhhcCcc
Confidence 6543221 123468999999999999999999999999999999999999998643321110 000 0 0
Q ss_pred ccCCCccchhhhcccccCCCCCHH--HHHHHHHHHHH
Q 018712 291 TPKLSEDKVKQCVDTKLGGEYPPK--AIAKVRKKKFI 325 (351)
Q Consensus 291 ~~~~~~~~~~~~ld~~~~~~~~~~--~~~~~~~~~~~ 325 (351)
.+....+.+..|+..+|.+|++.+ .+..+..+.+.
T Consensus 228 ~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~ 264 (285)
T cd05630 228 FSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLF 264 (285)
T ss_pred CCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChhh
Confidence 111123678889999999998732 13334444443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-39 Score=283.87 Aligned_cols=244 Identities=27% Similarity=0.428 Sum_probs=198.0
Q ss_pred cCCCCCceeccCCcEEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEEEeCCC
Q 018712 66 DNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASK 145 (351)
Q Consensus 66 ~~y~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 145 (351)
++|.+.+.||+|++|.||++.+..+..+|+|.+.......+.+.+|+.++++++|+|++++++++. .+..+++|||+.+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~ 84 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMGK 84 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCCC
Confidence 568889999999999999999877778999998766555677889999999999999999998875 4568999999999
Q ss_pred CCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccccCCCcc
Q 018712 146 GSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPD 225 (351)
Q Consensus 146 gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~ 225 (351)
++|.+++..... ..+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.++|+|||++.....
T Consensus 85 ~~L~~~~~~~~~-------~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~ 154 (260)
T cd05069 85 GSLLDFLKEGDG-------KYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIED 154 (260)
T ss_pred CCHHHHHhhCCC-------CCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccC
Confidence 999999976432 12788999999999999999999999 99999999999999999999999999876533
Q ss_pred ccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCCccchh--------hcccCCCc
Q 018712 226 AAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVT--------WATPKLSE 296 (351)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~Pf~~~~~~~~~~~~~--------~~~~~~~~ 296 (351)
.... ......++..|+|||...+..++.++||||||+++|+|++ |+.||...........+. ...+....
T Consensus 155 ~~~~-~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (260)
T cd05069 155 NEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPCPQGCPESLH 233 (260)
T ss_pred Cccc-ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHH
Confidence 2211 1122345678999999988889999999999999999999 999998654332111111 11122234
Q ss_pred cchhhhcccccCCCCCHHHHHHHHH
Q 018712 297 DKVKQCVDTKLGGEYPPKAIAKVRK 321 (351)
Q Consensus 297 ~~~~~~ld~~~~~~~~~~~~~~~~~ 321 (351)
+.+.+|+..+|.+|++.+++.++++
T Consensus 234 ~li~~~l~~~p~~Rp~~~~i~~~l~ 258 (260)
T cd05069 234 ELMKLCWKKDPDERPTFEYIQSFLE 258 (260)
T ss_pred HHHHHHccCCcccCcCHHHHHHHHh
Confidence 6888999999999999998877654
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=285.05 Aligned_cols=245 Identities=28% Similarity=0.420 Sum_probs=201.3
Q ss_pred hcCCCCCceeccCCcEEEEEEEECCCCEEEEEEcCCCCC-chHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEEEeC
Q 018712 65 TDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQ-PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHA 143 (351)
Q Consensus 65 ~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 143 (351)
..+|++.+.||.|+||.||+|...++..+++|.+..... ....+.+|+.+++.++|+||+++++++.+.+..++||||+
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 84 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELM 84 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeec
Confidence 356899999999999999999988899999999876654 4567889999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccccCCC
Q 018712 144 SKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQA 223 (351)
Q Consensus 144 ~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~ 223 (351)
++++|.+++...... .+++..+..++.||+.||.|||+++ ++|+||||+||++++++.+||+|||++...
T Consensus 85 ~~~~L~~~~~~~~~~-------~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~ 154 (261)
T cd05148 85 EKGSLLAFLRSPEGQ-------VLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLI 154 (261)
T ss_pred ccCCHHHHHhcCCCC-------CCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhc
Confidence 999999999764322 2789999999999999999999999 999999999999999999999999998766
Q ss_pred ccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCCccchhh--------cccCC
Q 018712 224 PDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTW--------ATPKL 294 (351)
Q Consensus 224 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~Pf~~~~~~~~~~~~~~--------~~~~~ 294 (351)
...... .....++..|+|||.+.+..++.++||||||+++|+|++ |+.||...........+.. ..+..
T Consensus 155 ~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (261)
T cd05148 155 KEDVYL--SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMPCPAKCPQE 232 (261)
T ss_pred CCcccc--ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCcCCCCCCCCHH
Confidence 433221 123345778999999988899999999999999999998 8999976543221111111 11111
Q ss_pred CccchhhhcccccCCCCCHHHHHHHHH
Q 018712 295 SEDKVKQCVDTKLGGEYPPKAIAKVRK 321 (351)
Q Consensus 295 ~~~~~~~~ld~~~~~~~~~~~~~~~~~ 321 (351)
..+.+.+|+..+|.+|++..++...++
T Consensus 233 ~~~~i~~~l~~~p~~Rpt~~~l~~~L~ 259 (261)
T cd05148 233 IYKIMLECWAAEPEDRPSFKALREELD 259 (261)
T ss_pred HHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 236778899999999999988877654
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-41 Score=324.48 Aligned_cols=268 Identities=21% Similarity=0.274 Sum_probs=208.8
Q ss_pred HHHHHHHhcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCC----CCchHHHHHHHHHHHhccCCceeeeEEEEec
Q 018712 58 VDELKEKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSS----KQPDQEFLAQVSMVSRLKNENVVELVGYYVD 132 (351)
Q Consensus 58 ~~~~~~~~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~ 132 (351)
..+++...++|.+++.||+|+||.|.+++.+ +++.||+|++.+. .....-|..|-.+|...+.+=|++++-.|++
T Consensus 67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD 146 (1317)
T KOG0612|consen 67 VKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQD 146 (1317)
T ss_pred HHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC
Confidence 4566677889999999999999999999975 7899999999763 2234567788889988899999999999999
Q ss_pred CCceEEEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCce
Q 018712 133 GPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIA 212 (351)
Q Consensus 133 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~v 212 (351)
++++|+||||++||+|-.++.+... +++.-++.++..|+.||.-||+.| +|||||||+|||+|..|++
T Consensus 147 ~~~LYlVMdY~pGGDlltLlSk~~~---------~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHi 214 (1317)
T KOG0612|consen 147 ERYLYLVMDYMPGGDLLTLLSKFDR---------LPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHI 214 (1317)
T ss_pred ccceEEEEecccCchHHHHHhhcCC---------ChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcE
Confidence 9999999999999999999988763 899999999999999999999999 9999999999999999999
Q ss_pred EEecccccCCCccccccccccccccccCccCccccc----C-CCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccch
Q 018712 213 KISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAM----T-GQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLV 287 (351)
Q Consensus 213 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~ 287 (351)
||+|||.|-..... ........+|||.|++||+++ + +.|+..+|+||+||++|||++|..||....-.+....|
T Consensus 215 kLADFGsClkm~~d-G~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KI 293 (1317)
T KOG0612|consen 215 KLADFGSCLKMDAD-GTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKI 293 (1317)
T ss_pred eeccchhHHhcCCC-CcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHH
Confidence 99999998776533 334456778999999999986 3 57899999999999999999999999876433333333
Q ss_pred hhcccCCCccchhhhcccccCCCCCHHHHHHHHHHHHHhhhhcccc---chhhhh-cccCCccccc
Q 018712 288 TWATPKLSEDKVKQCVDTKLGGEYPPKAIAKVRKKKFITSECSNIS---FAEFNI-NWHCPLEWSV 349 (351)
Q Consensus 288 ~~~~~~~~~~~~~~~ld~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~-~~~~~~~w~~ 349 (351)
.... +++.= | ......+-.+-+--+|+|..-.+.. .+++.- +++..+||++
T Consensus 294 m~hk---------~~l~F-P-~~~~VSeeakdLI~~ll~~~e~RLgrngiedik~HpFF~g~~W~~ 348 (1317)
T KOG0612|consen 294 MNHK---------ESLSF-P-DETDVSEEAKDLIEALLCDREVRLGRNGIEDIKNHPFFEGIDWDN 348 (1317)
T ss_pred hchh---------hhcCC-C-cccccCHHHHHHHHHHhcChhhhcccccHHHHHhCccccCCChhh
Confidence 2221 11110 0 1222333344444566665555433 333332 2667778864
|
|
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=285.13 Aligned_cols=246 Identities=23% Similarity=0.338 Sum_probs=193.5
Q ss_pred hcCCCCCceeccCCcEEEEEEEEC-CCC----EEEEEEcCCCCC--chHHHHHHHHHHHhccCCceeeeEEEEecCCceE
Q 018712 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGR----AAAIKKLDSSKQ--PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRV 137 (351)
Q Consensus 65 ~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 137 (351)
.++|++.+.||+|+||.||+|.+. ++. .+++|.+..... ...++..|+..++++.||||+++++++. ....+
T Consensus 6 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~ 84 (279)
T cd05111 6 ETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQ 84 (279)
T ss_pred HhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccE
Confidence 357888999999999999999964 444 477887754322 2345677888899999999999999875 45678
Q ss_pred EEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecc
Q 018712 138 LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDF 217 (351)
Q Consensus 138 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Df 217 (351)
+++||+++|+|.+++..... .+++..+..++.||+.||.|||+++ ++||||||+||+++.++.+||+||
T Consensus 85 ~i~e~~~~gsL~~~l~~~~~--------~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Df 153 (279)
T cd05111 85 LVTQLSPLGSLLDHVRQHRD--------SLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADF 153 (279)
T ss_pred EEEEeCCCCcHHHHHHhccc--------CCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCC
Confidence 99999999999999976432 2889999999999999999999999 999999999999999999999999
Q ss_pred cccCCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCCccchhhc------
Q 018712 218 DLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWA------ 290 (351)
Q Consensus 218 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~Pf~~~~~~~~~~~~~~~------ 290 (351)
|+++...............++..|+|||.+.+..++.++||||||+++|||++ |+.||.+.........+...
T Consensus 154 g~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~ 233 (279)
T cd05111 154 GVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGERLAQP 233 (279)
T ss_pred ccceeccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCC
Confidence 99976543332222234557788999999998899999999999999999998 99999875433221111110
Q ss_pred --ccCCCccchhhhcccccCCCCCHHHHHHHHHH
Q 018712 291 --TPKLSEDKVKQCVDTKLGGEYPPKAIAKVRKK 322 (351)
Q Consensus 291 --~~~~~~~~~~~~ld~~~~~~~~~~~~~~~~~~ 322 (351)
.+......+..|++.+|..|++..++...+..
T Consensus 234 ~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~ 267 (279)
T cd05111 234 QICTIDVYMVMVKCWMIDENVRPTFKELANEFTR 267 (279)
T ss_pred CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHH
Confidence 01111246778999999999999998775544
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=307.64 Aligned_cols=239 Identities=21% Similarity=0.289 Sum_probs=185.2
Q ss_pred HhcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCCchHHHHHHHHHHHhccCCceeeeEEEEecC--------C
Q 018712 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDG--------P 134 (351)
Q Consensus 64 ~~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--------~ 134 (351)
..++|.+.+.||+|+||.||+|... +++.||||++.... ....+|+.+++.++|+||+++++++... .
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~---~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 140 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP---QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNI 140 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc---chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCce
Confidence 3467999999999999999999975 68899999886543 2345799999999999999998876432 2
Q ss_pred ceEEEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCC-ceE
Q 018712 135 LRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD-IAK 213 (351)
Q Consensus 135 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~-~vk 213 (351)
.+++||||+++ +|.+++...... ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++ .+|
T Consensus 141 ~l~lvmE~~~~-~l~~~~~~~~~~-----~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vk 211 (440)
T PTZ00036 141 FLNVVMEFIPQ-TVHKYMKHYARN-----NHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLK 211 (440)
T ss_pred EEEEEEecCCc-cHHHHHHHHhhc-----CCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCcee
Confidence 46799999975 787776532111 123889999999999999999999999 99999999999998665 799
Q ss_pred EecccccCCCccccccccccccccccCccCcccccCC-CCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccchh----
Q 018712 214 ISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTG-QMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVT---- 288 (351)
Q Consensus 214 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~~---- 288 (351)
|+|||+++....... .....||+.|+|||++.+. .++.++|||||||++|||++|++||.+.........+.
T Consensus 212 L~DFGla~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~ 288 (440)
T PTZ00036 212 LCDFGSAKNLLAGQR---SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLG 288 (440)
T ss_pred eeccccchhccCCCC---cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Confidence 999999986643322 1345689999999988764 68999999999999999999999998754321100000
Q ss_pred ----------------------------h----cccCCCccchhhhcccccCCCCCHHHHH
Q 018712 289 ----------------------------W----ATPKLSEDKVKQCVDTKLGGEYPPKAIA 317 (351)
Q Consensus 289 ----------------------------~----~~~~~~~~~~~~~ld~~~~~~~~~~~~~ 317 (351)
. ..+....+.+..|+..+|.+|+++.++.
T Consensus 289 ~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l 349 (440)
T PTZ00036 289 TPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEAL 349 (440)
T ss_pred CCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHh
Confidence 0 0011123688899999999999887764
|
|
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=285.59 Aligned_cols=255 Identities=24% Similarity=0.338 Sum_probs=200.2
Q ss_pred CCCCCceeccCCcEEEEEEEEC------CCCEEEEEEcCCCCCc--hHHHHHHHHHHHhccCCceeeeEEEEecCCceEE
Q 018712 67 NFGTNSLIGEGSYGRVYFGVLR------SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVL 138 (351)
Q Consensus 67 ~y~~~~~Lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 138 (351)
+|++.+.||+|+||.||+|... ....+++|.+...... ...+.+|+.+++.++||||+++++.+...+..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 4788899999999999999853 2357889888654432 3568889999999999999999999999999999
Q ss_pred EEEeCCCCCHHHHhccCCCCC---------------CCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCc
Q 018712 139 AYEHASKGSLHDILHGKKGVK---------------GAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSN 203 (351)
Q Consensus 139 v~e~~~~gsL~~~l~~~~~~~---------------~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~N 203 (351)
++||+.+++|.+++....... .......+++..++.++.|++.||.|||+.+ ++||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhhe
Confidence 999999999999987543211 0111234789999999999999999999999 9999999999
Q ss_pred EEEccCCceEEecccccCCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCC
Q 018712 204 VLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRG 282 (351)
Q Consensus 204 ill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~Pf~~~~~~~ 282 (351)
||+++++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|+|++ |..||....+..
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~ 237 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER 237 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence 9999999999999999876543322211233345778999999988889999999999999999998 999997654432
Q ss_pred Cccchhh--------cccCCCccchhhhcccccCCCCCHHHHHHHHHHHH
Q 018712 283 QQSLVTW--------ATPKLSEDKVKQCVDTKLGGEYPPKAIAKVRKKKF 324 (351)
Q Consensus 283 ~~~~~~~--------~~~~~~~~~~~~~ld~~~~~~~~~~~~~~~~~~~~ 324 (351)
....... ..+.-..+.+..|++.+|.+|++..++...++-.+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~ 287 (290)
T cd05045 238 LFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMM 287 (290)
T ss_pred HHHHHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHH
Confidence 2111111 01111226788999999999999999988776554
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=281.05 Aligned_cols=241 Identities=22% Similarity=0.324 Sum_probs=194.5
Q ss_pred cCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCC------chHHHHHHHHHHHhccCCceeeeEEEEecCCceEE
Q 018712 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ------PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVL 138 (351)
Q Consensus 66 ~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 138 (351)
++|.+.+.||+|++|.||.+... ++..+|+|.+..... ....+.+|++++++++||||+++++++.+.+..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 57999999999999999999964 689999998864322 12457889999999999999999999999999999
Q ss_pred EEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEeccc
Q 018712 139 AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFD 218 (351)
Q Consensus 139 v~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg 218 (351)
++||+++++|.+++..... ++...+..++.|++.||.|||+.+ ++||||+|+||++++++.++|+|||
T Consensus 82 v~e~~~~~~l~~~~~~~~~---------~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg 149 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYGA---------LTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFG 149 (263)
T ss_pred EEEECCCCcHHHHHHHhCC---------CCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecc
Confidence 9999999999999976542 788899999999999999999999 9999999999999999999999999
Q ss_pred ccCCCcccccccc-ccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccc---------hh
Q 018712 219 LSNQAPDAAARLH-STRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSL---------VT 288 (351)
Q Consensus 219 ~a~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~---------~~ 288 (351)
++........... .....|+..|+|||++.+..++.++||||||+++|+|++|+.||........... +.
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 229 (263)
T cd06625 150 ASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLP 229 (263)
T ss_pred cceeccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCCCCCC
Confidence 9876533211110 1234578899999999998899999999999999999999999976433211100 01
Q ss_pred hcccCCCccchhhhcccccCCCCCHHHHHH
Q 018712 289 WATPKLSEDKVKQCVDTKLGGEYPPKAIAK 318 (351)
Q Consensus 289 ~~~~~~~~~~~~~~ld~~~~~~~~~~~~~~ 318 (351)
...+....+.+..|+...|.+|++..++..
T Consensus 230 ~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 259 (263)
T cd06625 230 SHVSPDARNFLRRTFVENAKKRPSAEELLR 259 (263)
T ss_pred ccCCHHHHHHHHHHhhcCcccCCCHHHHhh
Confidence 111112236778888889999998777643
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=297.11 Aligned_cols=202 Identities=21% Similarity=0.309 Sum_probs=171.9
Q ss_pred cCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCC----CchHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEE
Q 018712 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK----QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAY 140 (351)
Q Consensus 66 ~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 140 (351)
++|.+.+.||+|+||.||++..+ +++.+|+|++.+.. .....+.+|..++..++|+||+++++.+.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 47899999999999999999975 57889999986421 12344778899999999999999999999999999999
Q ss_pred EeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEeccccc
Q 018712 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (351)
Q Consensus 141 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a 220 (351)
||+.+|+|.+++..... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 81 ey~~~g~L~~~l~~~~~--------~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a 149 (332)
T cd05623 81 DYYVGGDLLTLLSKFED--------RLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSC 149 (332)
T ss_pred eccCCCcHHHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchh
Confidence 99999999999976432 2788899999999999999999999 999999999999999999999999998
Q ss_pred CCCccccccccccccccccCccCccccc-----CCCCCccchhHhHHHHHHHHHcCCCCCCCCC
Q 018712 221 NQAPDAAARLHSTRVLGTFGYHAPEYAM-----TGQMSSKSDVYSFGVVLLELLTGRKPVDHTL 279 (351)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~el~tg~~Pf~~~~ 279 (351)
........ .......||+.|+|||++. ...++.++|||||||++|||++|+.||....
T Consensus 150 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~ 212 (332)
T cd05623 150 LKLMEDGT-VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAES 212 (332)
T ss_pred eecccCCc-ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCC
Confidence 76432221 1123456999999999886 3467889999999999999999999998654
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=310.32 Aligned_cols=248 Identities=19% Similarity=0.268 Sum_probs=194.8
Q ss_pred cCCCCCceeccCCcEEEEEEEECCC-CEEEEEEcCCC-CCchHHHHHHHHHHHhcc-CCceeeeEEE-Eec------CCc
Q 018712 66 DNFGTNSLIGEGSYGRVYFGVLRSG-RAAAIKKLDSS-KQPDQEFLAQVSMVSRLK-NENVVELVGY-YVD------GPL 135 (351)
Q Consensus 66 ~~y~~~~~Lg~G~~g~Vy~~~~~~~-~~vavK~~~~~-~~~~~~~~~e~~~l~~l~-h~niv~~~~~-~~~------~~~ 135 (351)
.++++.+.|.+|||+.||+|.+..+ ..||+|++-.. ...-+.+.+|+.+|+.|+ |+|||.+++. ... .-.
T Consensus 37 ~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~E 116 (738)
T KOG1989|consen 37 HRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWE 116 (738)
T ss_pred EEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeE
Confidence 4567888999999999999998755 99999987544 334567899999999996 9999999993 221 124
Q ss_pred eEEEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEe
Q 018712 136 RVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKIS 215 (351)
Q Consensus 136 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~ 215 (351)
++|.||||.||+|-++++.+...+ |++.++++|+.++++|+.+||...+ +|||||||-+||||..+|+.|||
T Consensus 117 vllLmEyC~gg~Lvd~mn~Rlq~~-------lte~eVLkIf~dv~~AVa~mH~~~p-PiIHRDLKiENvLls~~g~~KLC 188 (738)
T KOG1989|consen 117 VLLLMEYCKGGSLVDFMNTRLQTR-------LTEDEVLKIFYDVCEAVAAMHYLKP-PIIHRDLKIENVLLSADGNYKLC 188 (738)
T ss_pred EEeehhhccCCcHHHHHHHHHhcc-------CChHHHHHHHHHHHHHHHHHhcCCC-ccchhhhhhhheEEcCCCCEEeC
Confidence 689999999999999998665432 9999999999999999999999964 49999999999999999999999
Q ss_pred cccccCCCcccccccc-------ccccccccCccCcccc---cCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCcc
Q 018712 216 DFDLSNQAPDAAARLH-------STRVLGTFGYHAPEYA---MTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQS 285 (351)
Q Consensus 216 Dfg~a~~~~~~~~~~~-------~~~~~gt~~y~aPE~~---~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~ 285 (351)
|||.|........... .-...-|+.|+|||++ .+..+++|+|||||||+||-|+....||+....-....
T Consensus 189 DFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~laIln 268 (738)
T KOG1989|consen 189 DFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLAILN 268 (738)
T ss_pred cccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcceeEEe
Confidence 9999876433221110 0012358999999987 47789999999999999999999999998652211110
Q ss_pred chhhcccCC---C---ccchhhhcccccCCCCCHHHHHHHHHH
Q 018712 286 LVTWATPKL---S---EDKVKQCVDTKLGGEYPPKAIAKVRKK 322 (351)
Q Consensus 286 ~~~~~~~~~---~---~~~~~~~ld~~~~~~~~~~~~~~~~~~ 322 (351)
-....|.. . .++++.||.++|.+|++..++...+..
T Consensus 269 -g~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~ 310 (738)
T KOG1989|consen 269 -GNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFE 310 (738)
T ss_pred -ccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHH
Confidence 11122222 1 378999999999999998887665443
|
|
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-40 Score=299.14 Aligned_cols=238 Identities=21% Similarity=0.264 Sum_probs=185.5
Q ss_pred eccCCcEEEEEEEEC-CCCEEEEEEcCCCCC----chHHHHHHHHHHHhc---cCCceeeeEEEEecCCceEEEEEeCCC
Q 018712 74 IGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ----PDQEFLAQVSMVSRL---KNENVVELVGYYVDGPLRVLAYEHASK 145 (351)
Q Consensus 74 Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l---~h~niv~~~~~~~~~~~~~lv~e~~~~ 145 (351)
||+|+||.||+|... +++.||+|++..... .......|..++... .||||+++++.+.+.+..|+||||+.+
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 799999999999965 689999999864321 122344566666655 699999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccccCCCcc
Q 018712 146 GSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPD 225 (351)
Q Consensus 146 gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~ 225 (351)
|+|.+++..... +++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 81 g~L~~~l~~~~~---------~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~ 148 (330)
T cd05586 81 GELFWHLQKEGR---------FSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLT 148 (330)
T ss_pred ChHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCC
Confidence 999999876543 889999999999999999999999 99999999999999999999999999876432
Q ss_pred ccccccccccccccCccCcccccCC-CCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccchhh--------cccCCCc
Q 018712 226 AAARLHSTRVLGTFGYHAPEYAMTG-QMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTW--------ATPKLSE 296 (351)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~~~--------~~~~~~~ 296 (351)
.... .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||...........+.. ..+....
T Consensus 149 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 226 (330)
T cd05586 149 DNKT--TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKNVLSDEGR 226 (330)
T ss_pred CCCC--ccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHH
Confidence 2211 2346799999999998754 579999999999999999999999986543221111111 1111223
Q ss_pred cchhhhcccccCCCCCHH-HHHHHHHHHHH
Q 018712 297 DKVKQCVDTKLGGEYPPK-AIAKVRKKKFI 325 (351)
Q Consensus 297 ~~~~~~ld~~~~~~~~~~-~~~~~~~~~~~ 325 (351)
+.+..|+..+|.+|++.. .+..++++.++
T Consensus 227 ~li~~~L~~~P~~R~~~~~~~~~ll~h~~~ 256 (330)
T cd05586 227 QFVKGLLNRNPQHRLGAHRDAVELKEHPFF 256 (330)
T ss_pred HHHHHHcCCCHHHCCCCCCCHHHHhcCccc
Confidence 678999999999998532 34445555554
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-39 Score=286.97 Aligned_cols=247 Identities=21% Similarity=0.327 Sum_probs=195.1
Q ss_pred CCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCC----chHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEEEe
Q 018712 68 FGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ----PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEH 142 (351)
Q Consensus 68 y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 142 (351)
|+..+.||+|+||.||++.+. +++.+|+|.+..... ....+.+|++++++++|+||+.+.+.+..++..+++|||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 667788999999999999965 788999999865432 123467899999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccccCC
Q 018712 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222 (351)
Q Consensus 143 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~ 222 (351)
+.+++|.+++...... .+++..+..++.|++.||.|||+.+ |+||||||+||++++++.+||+|||++..
T Consensus 82 ~~~~~L~~~~~~~~~~-------~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~ 151 (285)
T cd05632 82 MNGGDLKFHIYNMGNP-------GFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVK 151 (285)
T ss_pred ccCccHHHHHHHhcCC-------CCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCccee
Confidence 9999999988654321 2899999999999999999999999 99999999999999999999999998865
Q ss_pred CccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccchh--------hcccCC
Q 018712 223 APDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVT--------WATPKL 294 (351)
Q Consensus 223 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~~--------~~~~~~ 294 (351)
...... .....|+..|+|||.+.+..++.++|+||||+++|+|++|+.||...........+. ...+..
T Consensus 152 ~~~~~~---~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (285)
T cd05632 152 IPEGES---IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKF 228 (285)
T ss_pred cCCCCc---ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCccC
Confidence 432211 133468999999999998899999999999999999999999998653321110000 011112
Q ss_pred ---CccchhhhcccccCCCCCHH--HHHHHHHHHHHhh
Q 018712 295 ---SEDKVKQCVDTKLGGEYPPK--AIAKVRKKKFITS 327 (351)
Q Consensus 295 ---~~~~~~~~ld~~~~~~~~~~--~~~~~~~~~~~~~ 327 (351)
..+.+..|+..+|.+|++.. .+..+..+.+++.
T Consensus 229 ~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~ 266 (285)
T cd05632 229 SEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRN 266 (285)
T ss_pred CHHHHHHHHHHccCCHhHcCCCcccChHHHHcChhhhc
Confidence 23577888999999998743 2344555555443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=286.65 Aligned_cols=255 Identities=23% Similarity=0.362 Sum_probs=201.8
Q ss_pred cCCCCCceeccCCcEEEEEEEEC------CCCEEEEEEcCCCCCc-hHHHHHHHHHHHhccCCceeeeEEEEecCCceEE
Q 018712 66 DNFGTNSLIGEGSYGRVYFGVLR------SGRAAAIKKLDSSKQP-DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVL 138 (351)
Q Consensus 66 ~~y~~~~~Lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 138 (351)
.+|.+.+.||+|+||.||++... ++..+++|.+...... .+.+.+|+.++++++|+||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 56888899999999999999842 3557899988654432 3568899999999999999999999999999999
Q ss_pred EEEeCCCCCHHHHhccCCCCC-------CCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCc
Q 018712 139 AYEHASKGSLHDILHGKKGVK-------GAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDI 211 (351)
Q Consensus 139 v~e~~~~gsL~~~l~~~~~~~-------~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~ 211 (351)
||||+++++|.+++....... .......+++..++.++.||+.||.|||+++ ++||||||+||++++++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCc
Confidence 999999999999997643210 0011123789999999999999999999999 999999999999999999
Q ss_pred eEEecccccCCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCCccch---
Q 018712 212 AKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLV--- 287 (351)
Q Consensus 212 vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~Pf~~~~~~~~~~~~--- 287 (351)
++|+|||++................++..|+|||++.+..++.++||||||+++|+|++ |+.||...........+
T Consensus 162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~ 241 (291)
T cd05094 162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQG 241 (291)
T ss_pred EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhCC
Confidence 99999999876544322222233456788999999999999999999999999999998 99999765432111100
Q ss_pred -----hhcccCCCccchhhhcccccCCCCCHHHHHHHHHHH
Q 018712 288 -----TWATPKLSEDKVKQCVDTKLGGEYPPKAIAKVRKKK 323 (351)
Q Consensus 288 -----~~~~~~~~~~~~~~~ld~~~~~~~~~~~~~~~~~~~ 323 (351)
....+....+.+.+|+.++|.+|++.+++.+.++-.
T Consensus 242 ~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~ 282 (291)
T cd05094 242 RVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHAL 282 (291)
T ss_pred CCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHH
Confidence 111122234688999999999999999988776554
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=281.66 Aligned_cols=245 Identities=22% Similarity=0.377 Sum_probs=199.1
Q ss_pred hcCCCCCceeccCCcEEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEEEeCC
Q 018712 65 TDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHAS 144 (351)
Q Consensus 65 ~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 144 (351)
.++|.+.+.||+|+||.||++....+..+|+|.+.........+.+|++++++++|+||+++++.+.+ ...+++|||++
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~~ 83 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMA 83 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecCCccEEEEecCCChhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeCC
Confidence 46799999999999999999998777889999987665555678899999999999999999999877 77899999999
Q ss_pred CCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccccCCCc
Q 018712 145 KGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAP 224 (351)
Q Consensus 145 ~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~ 224 (351)
+++|.+++...... .+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||.+....
T Consensus 84 ~~~L~~~~~~~~~~-------~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~ 153 (260)
T cd05073 84 KGSLLDFLKSDEGS-------KQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIE 153 (260)
T ss_pred CCcHHHHHHhCCcc-------ccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeecc
Confidence 99999999764321 2788889999999999999999999 9999999999999999999999999987654
Q ss_pred cccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCCccchhh--------cccCCC
Q 018712 225 DAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTW--------ATPKLS 295 (351)
Q Consensus 225 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~Pf~~~~~~~~~~~~~~--------~~~~~~ 295 (351)
..... ......++..|+|||++.+..++.++|+||||+++|++++ |+.||...........+.. ..+...
T Consensus 154 ~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (260)
T cd05073 154 DNEYT-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEEL 232 (260)
T ss_pred CCCcc-cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCCCCcccCCHHH
Confidence 32211 1122345677999999998889999999999999999998 9999986543221111111 111112
Q ss_pred ccchhhhcccccCCCCCHHHHHHHHH
Q 018712 296 EDKVKQCVDTKLGGEYPPKAIAKVRK 321 (351)
Q Consensus 296 ~~~~~~~ld~~~~~~~~~~~~~~~~~ 321 (351)
.+.+.+|++.+|.+|++..++..+++
T Consensus 233 ~~~i~~~l~~~p~~Rp~~~~l~~~L~ 258 (260)
T cd05073 233 YNIMMRCWKNRPEERPTFEYIQSVLD 258 (260)
T ss_pred HHHHHHHcccCcccCcCHHHHHHHHh
Confidence 36788999999999999988877654
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=300.44 Aligned_cols=238 Identities=24% Similarity=0.318 Sum_probs=190.2
Q ss_pred CCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCC---chHHHHHHHHHHHhccCCceeeeEEEEecCC-----ceE
Q 018712 67 NFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ---PDQEFLAQVSMVSRLKNENVVELVGYYVDGP-----LRV 137 (351)
Q Consensus 67 ~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-----~~~ 137 (351)
+|++.+.||+|+||.||++.+. +++.||+|++..... ....+.+|+.+++.++|+||+++++++...+ ..|
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 5788999999999999999964 789999999865322 2356789999999999999999999988776 789
Q ss_pred EEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecc
Q 018712 138 LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDF 217 (351)
Q Consensus 138 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Df 217 (351)
+||||+. ++|.+++..... ++...+..++.||+.||.|||+++ ++||||||+|||++.++.+||+||
T Consensus 81 lv~e~~~-~~l~~~~~~~~~---------l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Df 147 (372)
T cd07853 81 VVTELMQ-SDLHKIIVSPQP---------LSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDF 147 (372)
T ss_pred EEeeccc-cCHHHHHhcCCC---------CCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccc
Confidence 9999997 488888865432 889999999999999999999999 999999999999999999999999
Q ss_pred cccCCCccccccccccccccccCccCcccccCC-CCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccchhh-------
Q 018712 218 DLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTG-QMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTW------- 289 (351)
Q Consensus 218 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~~~------- 289 (351)
|++......... ......+|+.|+|||.+.+. .++.++|||||||++|||++|+.||....+......+..
T Consensus 148 g~a~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~ 226 (372)
T cd07853 148 GLARVEEPDESK-HMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSL 226 (372)
T ss_pred cceeecccCccc-cCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCH
Confidence 998765332211 12334578999999998874 578999999999999999999999986543221111000
Q ss_pred --------------------------------cccCCCccchhhhcccccCCCCCHHHHHH
Q 018712 290 --------------------------------ATPKLSEDKVKQCVDTKLGGEYPPKAIAK 318 (351)
Q Consensus 290 --------------------------------~~~~~~~~~~~~~ld~~~~~~~~~~~~~~ 318 (351)
..+....+.+..|+..+|.+|++.+++..
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 287 (372)
T cd07853 227 EAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALA 287 (372)
T ss_pred HHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhc
Confidence 00011125788999999999999877644
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=298.16 Aligned_cols=199 Identities=23% Similarity=0.286 Sum_probs=170.2
Q ss_pred HHhcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCC---chHHHHHHHHHHHhccCCceeeeEEEEecC-----
Q 018712 63 EKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ---PDQEFLAQVSMVSRLKNENVVELVGYYVDG----- 133 (351)
Q Consensus 63 ~~~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~h~niv~~~~~~~~~----- 133 (351)
...++|++.+.||+|+||.||++.+. +++.||+|++..... ....+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 93 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE 93 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence 45689999999999999999999864 688999999875432 235677899999999999999999987643
Q ss_pred -CceEEEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCce
Q 018712 134 -PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIA 212 (351)
Q Consensus 134 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~v 212 (351)
...|+||||+.+ +|.+.+... ++...+..++.|++.||.|||++| |+||||||+|||++.++.+
T Consensus 94 ~~~~~lv~e~~~~-~l~~~~~~~-----------l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~ 158 (355)
T cd07874 94 FQDVYLVMELMDA-NLCQVIQME-----------LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTL 158 (355)
T ss_pred cceeEEEhhhhcc-cHHHHHhhc-----------CCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCE
Confidence 357999999976 777777532 788889999999999999999999 9999999999999999999
Q ss_pred EEecccccCCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCC
Q 018712 213 KISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTL 279 (351)
Q Consensus 213 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~ 279 (351)
||+|||+++....... .....||+.|+|||++.+..++.++||||||+++|+|++|+.||....
T Consensus 159 kl~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 222 (355)
T cd07874 159 KILDFGLARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRD 222 (355)
T ss_pred EEeeCcccccCCCccc---cCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999999976543221 234568999999999999999999999999999999999999997643
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=288.37 Aligned_cols=258 Identities=25% Similarity=0.350 Sum_probs=200.9
Q ss_pred cCCCCCceeccCCcEEEEEEEEC--------CCCEEEEEEcCCCCC--chHHHHHHHHHHHhc-cCCceeeeEEEEecCC
Q 018712 66 DNFGTNSLIGEGSYGRVYFGVLR--------SGRAAAIKKLDSSKQ--PDQEFLAQVSMVSRL-KNENVVELVGYYVDGP 134 (351)
Q Consensus 66 ~~y~~~~~Lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~ 134 (351)
++|.+.+.||+|+||.||++... +...+|+|.+..... ....+.+|+.+++.+ +|+||+++++++...+
T Consensus 18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 97 (307)
T cd05098 18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 97 (307)
T ss_pred HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence 57999999999999999999753 235799999875432 235678899999999 7999999999999999
Q ss_pred ceEEEEEeCCCCCHHHHhccCCCCC-------CCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEc
Q 018712 135 LRVLAYEHASKGSLHDILHGKKGVK-------GAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLF 207 (351)
Q Consensus 135 ~~~lv~e~~~~gsL~~~l~~~~~~~-------~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~ 207 (351)
..++||||+++|+|.+++....... ...+...+++.+++.++.|++.||+|||++| ++||||||+||+++
T Consensus 98 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill~ 174 (307)
T cd05098 98 PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLVT 174 (307)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHheEEc
Confidence 9999999999999999997653211 0112234889999999999999999999999 99999999999999
Q ss_pred cCCceEEecccccCCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCCccc
Q 018712 208 DDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSL 286 (351)
Q Consensus 208 ~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~Pf~~~~~~~~~~~ 286 (351)
.++.+||+|||++................++..|+|||.+.+..++.++||||||+++|+|++ |..||...........
T Consensus 175 ~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~~~~ 254 (307)
T cd05098 175 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL 254 (307)
T ss_pred CCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHH
Confidence 999999999999876543221111122234568999999998889999999999999999998 8999976543221111
Q ss_pred hhhc--------ccCCCccchhhhcccccCCCCCHHHHHHHHHHHHHh
Q 018712 287 VTWA--------TPKLSEDKVKQCVDTKLGGEYPPKAIAKVRKKKFIT 326 (351)
Q Consensus 287 ~~~~--------~~~~~~~~~~~~ld~~~~~~~~~~~~~~~~~~~~~~ 326 (351)
+... .+....+.+.+|+..+|.+|++..++...++-.+..
T Consensus 255 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~ 302 (307)
T cd05098 255 LKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILAL 302 (307)
T ss_pred HHcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHH
Confidence 1111 111112577899999999999999998877765543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-39 Score=316.32 Aligned_cols=246 Identities=21% Similarity=0.271 Sum_probs=193.6
Q ss_pred cCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCC----chHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEE
Q 018712 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ----PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAY 140 (351)
Q Consensus 66 ~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 140 (351)
++|++.+.||+|+||.||+|.+. +++.||+|++..... ..+.+.+|++++++++||||+++++++.+.+..+++|
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 57999999999999999999975 689999999875432 2356889999999999999999999999999999999
Q ss_pred EeCCCCCHHHHhccCCCCCCC--CCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEeccc
Q 018712 141 EHASKGSLHDILHGKKGVKGA--KPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFD 218 (351)
Q Consensus 141 e~~~~gsL~~~l~~~~~~~~~--~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg 218 (351)
||++|++|.+++......... .....+++..++.++.||+.||+|||++| |+||||||+||+++.++.+||+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecC
Confidence 999999999998753211111 01123567788999999999999999999 9999999999999999999999999
Q ss_pred ccCCCccccc----------------cccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCC
Q 018712 219 LSNQAPDAAA----------------RLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRG 282 (351)
Q Consensus 219 ~a~~~~~~~~----------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~ 282 (351)
+++....... ........||+.|+|||++.+..++.++|||||||++|||+||+.||.......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 9976521100 001123569999999999999999999999999999999999999998643322
Q ss_pred Cccchh----------hcccCCCccchhhhcccccCCCCCHH
Q 018712 283 QQSLVT----------WATPKLSEDKVKQCVDTKLGGEYPPK 314 (351)
Q Consensus 283 ~~~~~~----------~~~~~~~~~~~~~~ld~~~~~~~~~~ 314 (351)
...... ...+....+.+.+|+..+|.+|++..
T Consensus 239 i~~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~ 280 (932)
T PRK13184 239 ISYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSV 280 (932)
T ss_pred hhhhhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHH
Confidence 110000 01111223677899999999998653
|
|
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=288.08 Aligned_cols=197 Identities=28% Similarity=0.443 Sum_probs=172.6
Q ss_pred cCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCCc--hHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEEEe
Q 018712 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEH 142 (351)
Q Consensus 66 ~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 142 (351)
++|++.+.||+|+||.||++.+. ++..+|+|.+...... ...+.+|++++++++||||+++++.+.+++..+++|||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 46899999999999999999965 6888999988654322 34578899999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhh-CCCCCeeeccccCCcEEEccCCceEEecccccC
Q 018712 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHE-KAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (351)
Q Consensus 143 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~-~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~ 221 (351)
+++++|.+++..... +++..+..++.|++.||.|||+ .+ ++|+||||+|||+++++.+||+|||++.
T Consensus 81 ~~~~~L~~~l~~~~~---------~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~ 148 (308)
T cd06615 81 MDGGSLDQVLKKAGR---------IPENILGKISIAVLRGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSG 148 (308)
T ss_pred cCCCcHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHhhCC---EEECCCChHHEEEecCCcEEEccCCCcc
Confidence 999999999976532 7889999999999999999997 47 9999999999999999999999999987
Q ss_pred CCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCC
Q 018712 222 QAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHT 278 (351)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~ 278 (351)
...... .....|+..|+|||.+.+..++.++|+||||+++|+|++|+.||...
T Consensus 149 ~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~ 201 (308)
T cd06615 149 QLIDSM----ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPP 201 (308)
T ss_pred cccccc----cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCc
Confidence 653322 13456899999999998888999999999999999999999998643
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=282.14 Aligned_cols=240 Identities=25% Similarity=0.358 Sum_probs=193.0
Q ss_pred hcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCC-chHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEEEe
Q 018712 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ-PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEH 142 (351)
Q Consensus 65 ~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 142 (351)
.++|++.+.||+|+||.||+|... +++.||+|++..... ....+.+|+.++++++|+||+++++.+...+..++||||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~ 87 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY 87 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence 457999999999999999999964 788999999865432 334577899999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccccCC
Q 018712 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222 (351)
Q Consensus 143 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~ 222 (351)
+++++|.+++..... +++..+..++.|++.||.|||+.+ ++||||+|+||++++++.+||+|||++..
T Consensus 88 ~~~~~L~~~~~~~~~---------~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~ 155 (267)
T cd06646 88 CGGGSLQDIYHVTGP---------LSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAK 155 (267)
T ss_pred CCCCcHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCcccee
Confidence 999999999875432 788999999999999999999999 99999999999999999999999999876
Q ss_pred CccccccccccccccccCccCccccc---CCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccch---hhcc-----
Q 018712 223 APDAAARLHSTRVLGTFGYHAPEYAM---TGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLV---TWAT----- 291 (351)
Q Consensus 223 ~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~---~~~~----- 291 (351)
....... .....|+..|+|||.+. ...++.++|+||||+++|+|++|+.||....+......+ ....
T Consensus 156 ~~~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (267)
T cd06646 156 ITATIAK--RKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKD 233 (267)
T ss_pred ecccccc--cCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCcc
Confidence 5332211 13346889999999874 345788999999999999999999999654332211110 0011
Q ss_pred ----cCCCccchhhhcccccCCCCCHHHHHH
Q 018712 292 ----PKLSEDKVKQCVDTKLGGEYPPKAIAK 318 (351)
Q Consensus 292 ----~~~~~~~~~~~ld~~~~~~~~~~~~~~ 318 (351)
+....+.+..|+..+|.+|++.+++..
T Consensus 234 ~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 264 (267)
T cd06646 234 KTKWSSTFHNFVKISLTKNPKKRPTAERLLT 264 (267)
T ss_pred ccccCHHHHHHHHHHhhCChhhCcCHHHHhc
Confidence 111236788888899999998877643
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=297.41 Aligned_cols=198 Identities=19% Similarity=0.287 Sum_probs=171.9
Q ss_pred hcCCCCCceeccCCcEEEEEEEEC---CCCEEEEEEcCCCCCchHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEEE
Q 018712 65 TDNFGTNSLIGEGSYGRVYFGVLR---SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYE 141 (351)
Q Consensus 65 ~~~y~~~~~Lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 141 (351)
..+|.+.+.||+|+||.||++... ++..||+|.+.... ...+|++++++++|+||+++++.+......+++||
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~----~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e 166 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK----TPGREIDILKTISHRAIINLIHAYRWKSTVCMVMP 166 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccc----cHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEeh
Confidence 457999999999999999999753 46789999886542 35689999999999999999999999999999999
Q ss_pred eCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccccC
Q 018712 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (351)
Q Consensus 142 ~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~ 221 (351)
++. ++|.+++.... .+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||++.
T Consensus 167 ~~~-~~l~~~l~~~~---------~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~ 233 (392)
T PHA03207 167 KYK-CDLFTYVDRSG---------PLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAAC 233 (392)
T ss_pred hcC-CCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCcccc
Confidence 996 58988885433 2899999999999999999999999 9999999999999999999999999997
Q ss_pred CCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCC
Q 018712 222 QAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTL 279 (351)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~ 279 (351)
...............||+.|+|||++.+..++.++|||||||++|||++|+.||.+..
T Consensus 234 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~ 291 (392)
T PHA03207 234 KLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQ 291 (392)
T ss_pred ccCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCC
Confidence 6654333222334679999999999999999999999999999999999999997654
|
|
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=286.60 Aligned_cols=240 Identities=24% Similarity=0.407 Sum_probs=197.2
Q ss_pred HhcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCC-chHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEEE
Q 018712 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ-PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYE 141 (351)
Q Consensus 64 ~~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 141 (351)
...+|.+.+.||+|+||.||+|... ++..+++|.+..... ....+.+|+.+++.++|+||+++++.+......++|||
T Consensus 18 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e 97 (296)
T cd06654 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (296)
T ss_pred cccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeec
Confidence 3468999999999999999999964 788999998875443 34568889999999999999999999999999999999
Q ss_pred eCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccccC
Q 018712 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (351)
Q Consensus 142 ~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~ 221 (351)
|+++++|.+++.... +++.++..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++.
T Consensus 98 ~~~~~~L~~~~~~~~----------~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~ 164 (296)
T cd06654 98 YLAGGSLTDVVTETC----------MDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCA 164 (296)
T ss_pred ccCCCCHHHHHHhcC----------CCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccch
Confidence 999999999996542 788899999999999999999999 9999999999999999999999999987
Q ss_pred CCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccchh----------hcc
Q 018712 222 QAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVT----------WAT 291 (351)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~~----------~~~ 291 (351)
........ .....|++.|+|||.+.+..++.++||||||+++|+|++|+.||....+........ ...
T Consensus 165 ~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (296)
T cd06654 165 QITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKL 242 (296)
T ss_pred hccccccc--cCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCCCCCcccc
Confidence 65332211 133468899999999998889999999999999999999999998655422111110 011
Q ss_pred cCCCccchhhhcccccCCCCCHHHHHH
Q 018712 292 PKLSEDKVKQCVDTKLGGEYPPKAIAK 318 (351)
Q Consensus 292 ~~~~~~~~~~~ld~~~~~~~~~~~~~~ 318 (351)
+....+.+.+|+++++..|++.+++..
T Consensus 243 ~~~l~~li~~~l~~~p~~Rpt~~eil~ 269 (296)
T cd06654 243 SAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (296)
T ss_pred CHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence 111235788999999999998777654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-39 Score=297.27 Aligned_cols=199 Identities=23% Similarity=0.291 Sum_probs=170.0
Q ss_pred HHhcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCC---CchHHHHHHHHHHHhccCCceeeeEEEEecC-----
Q 018712 63 EKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK---QPDQEFLAQVSMVSRLKNENVVELVGYYVDG----- 133 (351)
Q Consensus 63 ~~~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~----- 133 (351)
...++|.+.+.||+|+||.||++.+. +++.||||++.... .....+.+|+.+++.++||||+++++.+...
T Consensus 21 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~ 100 (364)
T cd07875 21 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEE 100 (364)
T ss_pred chhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccc
Confidence 34678999999999999999999965 68899999987542 2245678899999999999999999887543
Q ss_pred -CceEEEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCce
Q 018712 134 -PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIA 212 (351)
Q Consensus 134 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~v 212 (351)
...|+||||+.+ +|.+++... ++...+..++.|++.||.|||+++ |+||||||+|||++.++.+
T Consensus 101 ~~~~~lv~e~~~~-~l~~~~~~~-----------~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~ 165 (364)
T cd07875 101 FQDVYIVMELMDA-NLCQVIQME-----------LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTL 165 (364)
T ss_pred cCeEEEEEeCCCC-CHHHHHHhc-----------CCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcE
Confidence 357999999976 788877532 778889999999999999999999 9999999999999999999
Q ss_pred EEecccccCCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCC
Q 018712 213 KISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTL 279 (351)
Q Consensus 213 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~ 279 (351)
||+|||+++....... .....||..|+|||++.+..++.++|||||||++|+|++|+.||....
T Consensus 166 kL~DfG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~ 229 (364)
T cd07875 166 KILDFGLARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTD 229 (364)
T ss_pred EEEeCCCccccCCCCc---ccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCC
Confidence 9999999976543221 234568999999999999999999999999999999999999997643
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=269.37 Aligned_cols=252 Identities=25% Similarity=0.329 Sum_probs=202.1
Q ss_pred HhcCCCCCceeccCCcEEEEEEE-ECCCCEEEEEEcCCCC-CchHHHHHHHHHHHhccCCceeeeEEEEecCC-----ce
Q 018712 64 KTDNFGTNSLIGEGSYGRVYFGV-LRSGRAAAIKKLDSSK-QPDQEFLAQVSMVSRLKNENVVELVGYYVDGP-----LR 136 (351)
Q Consensus 64 ~~~~y~~~~~Lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-----~~ 136 (351)
..++|.+.+.||.|||+-||+++ ..++..||+|++.... ...+..++|++..++++|||+++++++...+. ..
T Consensus 19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~ 98 (302)
T KOG2345|consen 19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEA 98 (302)
T ss_pred cCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeE
Confidence 45789999999999999999999 4588999999987655 45677899999999999999999998765333 48
Q ss_pred EEEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEec
Q 018712 137 VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISD 216 (351)
Q Consensus 137 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~D 216 (351)
|++++|...|||.+.+....... ..+++.+.+.|+.++++||.+||+..+ ++.||||||.|||+.+.+.++|.|
T Consensus 99 yll~Pyy~~Gsl~d~i~~~k~kg-----~~~sE~~iL~if~gic~gL~~lH~~~~-~yAH~DiKP~NILls~~~~~vl~D 172 (302)
T KOG2345|consen 99 YLLLPYYKRGSLLDEIERLKIKG-----NFVSEAQILWIFLGICRGLEALHEKEP-PYAHRDIKPANILLSDSGLPVLMD 172 (302)
T ss_pred EEEeehhccccHHHHHHHHhhcC-----CccCHHHHHHHHHHHHHHHHHHhccCC-cccccCCCcceeEecCCCceEEEe
Confidence 99999999999999998765432 348999999999999999999999975 499999999999999999999999
Q ss_pred ccccCCCccccccc-------cccccccccCccCccccc---CCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCc--
Q 018712 217 FDLSNQAPDAAARL-------HSTRVLGTFGYHAPEYAM---TGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQ-- 284 (351)
Q Consensus 217 fg~a~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~-- 284 (351)
||.+....-..... .......|..|.|||.+. +...+.++|||||||++|.|+.|..||+.....+..
T Consensus 173 ~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSla 252 (302)
T KOG2345|consen 173 LGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLA 252 (302)
T ss_pred ccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEE
Confidence 99987764332211 112345799999999885 446789999999999999999999999975544322
Q ss_pred ------cchhhcccCCCc---cchhhhcccccCCCCCHHHHHHHHH
Q 018712 285 ------SLVTWATPKLSE---DKVKQCVDTKLGGEYPPKAIAKVRK 321 (351)
Q Consensus 285 ------~~~~~~~~~~~~---~~~~~~ld~~~~~~~~~~~~~~~~~ 321 (351)
.+.-+....+++ +.++.|+..+|.+||+..++...++
T Consensus 253 LAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d 298 (302)
T KOG2345|consen 253 LAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLD 298 (302)
T ss_pred EeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHH
Confidence 111122222332 6788999999999999888765443
|
|
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-39 Score=286.07 Aligned_cols=253 Identities=26% Similarity=0.344 Sum_probs=198.1
Q ss_pred cCCCCCceeccCCcEEEEEEEEC------CCCEEEEEEcCCCCCc--hHHHHHHHHHHHhccCCceeeeEEEEecCCceE
Q 018712 66 DNFGTNSLIGEGSYGRVYFGVLR------SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRV 137 (351)
Q Consensus 66 ~~y~~~~~Lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 137 (351)
.+|.+.+.||+|+||.||+|... .+..||+|++...... ...+.+|+.+++.++||||+++++++.+....+
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~ 84 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS 84 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence 45777889999999999999853 2578999998755432 355788999999999999999999999999999
Q ss_pred EEEEeCCCCCHHHHhccCCCCC-------CCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCC
Q 018712 138 LAYEHASKGSLHDILHGKKGVK-------GAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD 210 (351)
Q Consensus 138 lv~e~~~~gsL~~~l~~~~~~~-------~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~ 210 (351)
+++||+.+++|.+++....... .......+++..+..++.|++.||.|||+++ ++||||||+||++++++
T Consensus 85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~ 161 (283)
T cd05091 85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKL 161 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCC
Confidence 9999999999999986432110 0111224788889999999999999999999 99999999999999999
Q ss_pred ceEEecccccCCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCCccchhh
Q 018712 211 IAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTW 289 (351)
Q Consensus 211 ~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~Pf~~~~~~~~~~~~~~ 289 (351)
.+||+|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ |..||...........+..
T Consensus 162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i~~ 241 (283)
T cd05091 162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRN 241 (283)
T ss_pred ceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence 999999999887644332222233446789999999988889999999999999999998 8899976544322211111
Q ss_pred --------cccCCCccchhhhcccccCCCCCHHHHHHHHH
Q 018712 290 --------ATPKLSEDKVKQCVDTKLGGEYPPKAIAKVRK 321 (351)
Q Consensus 290 --------~~~~~~~~~~~~~ld~~~~~~~~~~~~~~~~~ 321 (351)
..+....+.+.+|++..|.+||+..++...++
T Consensus 242 ~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~ 281 (283)
T cd05091 242 RQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLR 281 (283)
T ss_pred CCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhh
Confidence 11122236788999999999999988876543
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-39 Score=287.26 Aligned_cols=199 Identities=25% Similarity=0.382 Sum_probs=165.9
Q ss_pred CCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCC---chHHHHHHHHHHHhc---cCCceeeeEEEEec-----CC
Q 018712 67 NFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ---PDQEFLAQVSMVSRL---KNENVVELVGYYVD-----GP 134 (351)
Q Consensus 67 ~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l---~h~niv~~~~~~~~-----~~ 134 (351)
+|++.+.||+|+||.||+|.+. +++.||+|.+..... ......+|+.+++++ +||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 5888999999999999999975 789999998865322 223456777776665 79999999998764 34
Q ss_pred ceEEEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEE
Q 018712 135 LRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKI 214 (351)
Q Consensus 135 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl 214 (351)
..+++||++.+ +|.+++...... .+++..+..++.|++.||.|||++| ++||||||+||+++.++.+||
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~~~~-------~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl 149 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKVPPP-------GLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKL 149 (288)
T ss_pred eEEEEEccccc-CHHHHHHhcCCC-------CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEE
Confidence 57999999975 899988754321 2889999999999999999999999 999999999999999999999
Q ss_pred ecccccCCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCC
Q 018712 215 SDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTL 279 (351)
Q Consensus 215 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~ 279 (351)
+|||++........ .....||..|+|||++.+..++.++|||||||++|+|++|++||....
T Consensus 150 ~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~ 211 (288)
T cd07863 150 ADFGLARIYSCQMA---LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNS 211 (288)
T ss_pred CccCccccccCccc---CCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCC
Confidence 99999876543221 134568999999999998899999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-39 Score=295.59 Aligned_cols=241 Identities=24% Similarity=0.316 Sum_probs=204.0
Q ss_pred HHhcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCCc---hHHHHHHHHHHHhccCCceeeeEEEEecCCceEE
Q 018712 63 EKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVL 138 (351)
Q Consensus 63 ~~~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 138 (351)
.....|.+...||+|.|+.|.+|.+. ++..||||.+.+...+ .+.+.+|+++|+.++|||||+++.+......+|+
T Consensus 53 ~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lyl 132 (596)
T KOG0586|consen 53 NSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYL 132 (596)
T ss_pred ccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEE
Confidence 44568999999999999999999965 8999999999876543 3558899999999999999999999999999999
Q ss_pred EEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEeccc
Q 018712 139 AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFD 218 (351)
Q Consensus 139 v~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg 218 (351)
||||+.+|.+.+++.+... +....+..++.|++.|++|||+++ |+|||||++|+|++.+.++||+|||
T Consensus 133 V~eya~~ge~~~yl~~~gr---------~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfg 200 (596)
T KOG0586|consen 133 VMEYASGGELFDYLVKHGR---------MKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFG 200 (596)
T ss_pred EEEeccCchhHHHHHhccc---------chhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccc
Confidence 9999999999999998875 666889999999999999999999 9999999999999999999999999
Q ss_pred ccCCCccccccccccccccccCccCcccccCCCC-CccchhHhHHHHHHHHHcCCCCCCCCCCCCCccc-------hhhc
Q 018712 219 LSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQM-SSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSL-------VTWA 290 (351)
Q Consensus 219 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~-------~~~~ 290 (351)
++..+..... ..+++|++.|.|||++.+..| ++.+|+||+|+++|-|++|..||++.+-...... +...
T Consensus 201 fS~~~~~~~~---lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~rIp~~ 277 (596)
T KOG0586|consen 201 FSTFFDYGLM---LQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKYRIPFY 277 (596)
T ss_pred cceeeccccc---ccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeeeecccce
Confidence 9988764332 367899999999999998877 7899999999999999999999997654332211 1111
Q ss_pred ccCCCccchhhhcccccCCCCCHHHHHH
Q 018712 291 TPKLSEDKVKQCVDTKLGGEYPPKAIAK 318 (351)
Q Consensus 291 ~~~~~~~~~~~~ld~~~~~~~~~~~~~~ 318 (351)
...--++++.++|-..+..|++.+++.+
T Consensus 278 ms~dce~lLrk~lvl~Pskr~~~dqim~ 305 (596)
T KOG0586|consen 278 MSCDCEDLLRKFLVLNPSKRGPCDQIMK 305 (596)
T ss_pred eechhHHHHHHhhccCccccCCHHHhhh
Confidence 1122246777887788889998777654
|
|
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=295.26 Aligned_cols=202 Identities=22% Similarity=0.311 Sum_probs=172.9
Q ss_pred cCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCC----CchHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEE
Q 018712 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK----QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAY 140 (351)
Q Consensus 66 ~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 140 (351)
++|.+.+.||+|+||.||++... +++.||+|++.... .....+.+|..++..++|+||+++++.+.+.+..|+||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47999999999999999999975 68899999986422 22344778899999999999999999999999999999
Q ss_pred EeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEeccccc
Q 018712 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (351)
Q Consensus 141 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a 220 (351)
||+.+|+|.+++..... .+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 81 Ey~~gg~L~~~l~~~~~--------~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a 149 (331)
T cd05624 81 DYYVGGDLLTLLSKFED--------RLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSC 149 (331)
T ss_pred eCCCCCcHHHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccce
Confidence 99999999999976322 2788999999999999999999999 999999999999999999999999998
Q ss_pred CCCccccccccccccccccCccCcccccC-----CCCCccchhHhHHHHHHHHHcCCCCCCCCC
Q 018712 221 NQAPDAAARLHSTRVLGTFGYHAPEYAMT-----GQMSSKSDVYSFGVVLLELLTGRKPVDHTL 279 (351)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~il~el~tg~~Pf~~~~ 279 (351)
........ .......||+.|+|||++.+ ..++.++||||||+++|+|++|+.||....
T Consensus 150 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~ 212 (331)
T cd05624 150 LKMNQDGT-VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAES 212 (331)
T ss_pred eeccCCCc-eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCC
Confidence 76543221 11233569999999998875 467889999999999999999999997653
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=285.66 Aligned_cols=257 Identities=23% Similarity=0.352 Sum_probs=200.0
Q ss_pred HhcCCCCCceeccCCcEEEEEEEEC------CCCEEEEEEcCCCCCc--hHHHHHHHHHHHhccCCceeeeEEEEecCCc
Q 018712 64 KTDNFGTNSLIGEGSYGRVYFGVLR------SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPL 135 (351)
Q Consensus 64 ~~~~y~~~~~Lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 135 (351)
..++|++.+.||+|+||.||+|..+ .+..||+|.+...... ...+.+|+.++++++|+||+++++.+.+...
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 3568999999999999999999753 2458999988654432 3457789999999999999999999999999
Q ss_pred eEEEEEeCCCCCHHHHhccCCCCCCC-CCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEE
Q 018712 136 RVLAYEHASKGSLHDILHGKKGVKGA-KPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKI 214 (351)
Q Consensus 136 ~~lv~e~~~~gsL~~~l~~~~~~~~~-~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl 214 (351)
.++||||+++|+|.+++......... ...+.++...+..++.|++.||.|||+++ ++||||||+||++++++.++|
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEEE
Confidence 99999999999999999754321110 11133577788999999999999999999 999999999999999999999
Q ss_pred ecccccCCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCCccchh-----
Q 018712 215 SDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVT----- 288 (351)
Q Consensus 215 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~Pf~~~~~~~~~~~~~----- 288 (351)
+|||+++...............++..|+|||.+.+..++.++|+||||+++|||++ |..||......+....+.
T Consensus 161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~ 240 (288)
T cd05061 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYL 240 (288)
T ss_pred CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC
Confidence 99999876543322211223345678999999998899999999999999999998 789997654332111110
Q ss_pred ---hcccCCCccchhhhcccccCCCCCHHHHHHHHHHH
Q 018712 289 ---WATPKLSEDKVKQCVDTKLGGEYPPKAIAKVRKKK 323 (351)
Q Consensus 289 ---~~~~~~~~~~~~~~ld~~~~~~~~~~~~~~~~~~~ 323 (351)
...+....+.+..|++.+|.+|++..++...++..
T Consensus 241 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~ 278 (288)
T cd05061 241 DQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD 278 (288)
T ss_pred CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence 01112224788999999999999998887766554
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=283.77 Aligned_cols=253 Identities=24% Similarity=0.344 Sum_probs=198.9
Q ss_pred hcCCCCCceeccCCcEEEEEEEEC------CCCEEEEEEcCCCCCc--hHHHHHHHHHHHhccCCceeeeEEEEecCCce
Q 018712 65 TDNFGTNSLIGEGSYGRVYFGVLR------SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPLR 136 (351)
Q Consensus 65 ~~~y~~~~~Lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 136 (351)
.++|.+.+.||+|+||.||+|... ++..||+|.+...... ...+.+|+.+++.++|+||+++++++......
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 467899999999999999999864 2468999998655432 34678899999999999999999999999999
Q ss_pred EEEEEeCCCCCHHHHhccCCCCCCC-CCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEe
Q 018712 137 VLAYEHASKGSLHDILHGKKGVKGA-KPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKIS 215 (351)
Q Consensus 137 ~lv~e~~~~gsL~~~l~~~~~~~~~-~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~ 215 (351)
++||||+++++|.+++......... .....+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEEC
Confidence 9999999999999999764322111 11223788899999999999999999999 9999999999999999999999
Q ss_pred cccccCCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCCccchh------
Q 018712 216 DFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVT------ 288 (351)
Q Consensus 216 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~Pf~~~~~~~~~~~~~------ 288 (351)
|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |+.||...........+.
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~ 241 (277)
T cd05032 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDGGHLD 241 (277)
T ss_pred CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhcCCCCC
Confidence 9999876543322222233456789999999988889999999999999999998 999997654332111111
Q ss_pred --hcccCCCccchhhhcccccCCCCCHHHHHHHH
Q 018712 289 --WATPKLSEDKVKQCVDTKLGGEYPPKAIAKVR 320 (351)
Q Consensus 289 --~~~~~~~~~~~~~~ld~~~~~~~~~~~~~~~~ 320 (351)
...+....+.+.+|+..+|.+|++..++...+
T Consensus 242 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l 275 (277)
T cd05032 242 LPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSL 275 (277)
T ss_pred CCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHh
Confidence 11111223677889999999999888876654
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=283.83 Aligned_cols=233 Identities=23% Similarity=0.361 Sum_probs=189.8
Q ss_pred cCCCCCceeccCCcEEEEEEEE-CCCCEEEEEEcCCCCC--chHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEEEe
Q 018712 66 DNFGTNSLIGEGSYGRVYFGVL-RSGRAAAIKKLDSSKQ--PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEH 142 (351)
Q Consensus 66 ~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 142 (351)
++|++.+.||+|+||.||+|.+ .++..||+|.+..... ....+.+|++++++++||||+++++.+...+..++||||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 4688899999999999999996 4788999999865432 235688999999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccccCC
Q 018712 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222 (351)
Q Consensus 143 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~ 222 (351)
+++++|..+.. +++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++..
T Consensus 81 ~~~~~l~~~~~-------------~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~ 144 (279)
T cd06619 81 MDGGSLDVYRK-------------IPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQ 144 (279)
T ss_pred CCCCChHHhhc-------------CCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCccee
Confidence 99999976531 678888999999999999999999 99999999999999999999999999876
Q ss_pred CccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCc----cch----hhcccC-
Q 018712 223 APDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQ----SLV----TWATPK- 293 (351)
Q Consensus 223 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~----~~~----~~~~~~- 293 (351)
..... .....||..|+|||.+.+..++.++|+||||+++|+|++|+.||......... ... ....+.
T Consensus 145 ~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 220 (279)
T cd06619 145 LVNSI----AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVL 220 (279)
T ss_pred ccccc----ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCC
Confidence 54322 23457899999999999999999999999999999999999999753321111 000 000111
Q ss_pred ----C---CccchhhhcccccCCCCCHHHHHH
Q 018712 294 ----L---SEDKVKQCVDTKLGGEYPPKAIAK 318 (351)
Q Consensus 294 ----~---~~~~~~~~ld~~~~~~~~~~~~~~ 318 (351)
. ..+.+.+|+..+|.+|++.+++..
T Consensus 221 ~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~ 252 (279)
T cd06619 221 PVGQFSEKFVHFITQCMRKQPKERPAPENLMD 252 (279)
T ss_pred CCCcCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 1 125678899999999998776543
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=295.70 Aligned_cols=242 Identities=21% Similarity=0.316 Sum_probs=196.5
Q ss_pred HHhcCCCCCceeccCCcEEEEEEEECCCCEEEEEEcCCCC---CchHHHHHHHHHHHhc-cCCceeeeEEEEecCCceEE
Q 018712 63 EKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSK---QPDQEFLAQVSMVSRL-KNENVVELVGYYVDGPLRVL 138 (351)
Q Consensus 63 ~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~l 138 (351)
.+...|+++++||+||.+.||++...+.+.||+|++.... .....+.+|+..|.+| .|.+||++++|-..++++|+
T Consensus 358 Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYm 437 (677)
T KOG0596|consen 358 VKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYM 437 (677)
T ss_pred ECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEE
Confidence 3445799999999999999999998888899999875433 3346799999999999 58999999999999999999
Q ss_pred EEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEeccc
Q 018712 139 AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFD 218 (351)
Q Consensus 139 v~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg 218 (351)
|||+-+. +|..+|++.... .+...++.+..||+.++.++|.+| |||.||||.|+|+ -.|.+||+|||
T Consensus 438 vmE~Gd~-DL~kiL~k~~~~--------~~~~~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLl-VkG~LKLIDFG 504 (677)
T KOG0596|consen 438 VMECGDI-DLNKILKKKKSI--------DPDWFLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLL-VKGRLKLIDFG 504 (677)
T ss_pred Eeecccc-cHHHHHHhccCC--------CchHHHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEE-EeeeEEeeeec
Confidence 9999755 999999987643 343478889999999999999999 9999999999999 45789999999
Q ss_pred ccCCCccccccccccccccccCccCcccccCCC-----------CCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccch
Q 018712 219 LSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQ-----------MSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLV 287 (351)
Q Consensus 219 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-----------~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~ 287 (351)
+|..+............+||+.||+||.+.... .+.++||||||||||+|+.|+.||..-...- ..+.
T Consensus 505 IA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~-aKl~ 583 (677)
T KOG0596|consen 505 IANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQI-AKLH 583 (677)
T ss_pred hhcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHH-HHHH
Confidence 999988777666667788999999999885332 4578999999999999999999998643110 0000
Q ss_pred h-------hcccCC-----CccchhhhcccccCCCCCHHHHHH
Q 018712 288 T-------WATPKL-----SEDKVKQCVDTKLGGEYPPKAIAK 318 (351)
Q Consensus 288 ~-------~~~~~~-----~~~~~~~~ld~~~~~~~~~~~~~~ 318 (351)
. .-.|.. .-+.++.||..+|.+|++..++..
T Consensus 584 aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLq 626 (677)
T KOG0596|consen 584 AITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQ 626 (677)
T ss_pred hhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhc
Confidence 0 011122 236789999999999998766544
|
|
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=291.19 Aligned_cols=193 Identities=25% Similarity=0.362 Sum_probs=165.0
Q ss_pred HHhcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCCchHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEEE
Q 018712 63 EKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYE 141 (351)
Q Consensus 63 ~~~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 141 (351)
....+|.+.+.||+|+||.||+|... ++..||+|+..... ...|+.++++++|+||+++++++...+..++|||
T Consensus 63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~~-----~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 137 (357)
T PHA03209 63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGT-----TLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLP 137 (357)
T ss_pred hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCccc-----cHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEE
Confidence 34467999999999999999999975 57889999754332 3568999999999999999999999999999999
Q ss_pred eCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccccC
Q 018712 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (351)
Q Consensus 142 ~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~ 221 (351)
++. ++|.+++..... .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 138 ~~~-~~l~~~l~~~~~--------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~ 205 (357)
T PHA03209 138 HYS-SDLYTYLTKRSR--------PLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQ 205 (357)
T ss_pred ccC-CcHHHHHHhccC--------CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCcccc
Confidence 996 588888865432 2889999999999999999999999 9999999999999999999999999987
Q ss_pred CCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCC
Q 018712 222 QAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPV 275 (351)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf 275 (351)
....... .....||+.|+|||++.+..++.++|||||||++|||+++..|+
T Consensus 206 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 206 FPVVAPA---FLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred ccccCcc---cccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 5432211 13456899999999999999999999999999999999855444
|
|
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=279.89 Aligned_cols=239 Identities=26% Similarity=0.383 Sum_probs=195.0
Q ss_pred CCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCC---CCchHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEEEe
Q 018712 67 NFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSS---KQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEH 142 (351)
Q Consensus 67 ~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 142 (351)
+|.+.+.||+|++|.||++... ++..|++|.+... ......+.+|++++++++||||+++++.+.+.+..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 4788899999999999999975 7899999988643 23356688899999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccccCC
Q 018712 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222 (351)
Q Consensus 143 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~ 222 (351)
+++++|.+++..... ..+++..++.++.|++.||.|||+.+ ++|+||||+||++++++.++|+|||++..
T Consensus 81 ~~~~~L~~~l~~~~~-------~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~ 150 (256)
T cd08529 81 AENGDLHKLLKMQRG-------RPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKL 150 (256)
T ss_pred CCCCcHHHHHHHhcC-------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEccccccee
Confidence 999999999976422 12888999999999999999999999 99999999999999999999999999876
Q ss_pred CccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccc-hhh-------cccCC
Q 018712 223 APDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSL-VTW-------ATPKL 294 (351)
Q Consensus 223 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~-~~~-------~~~~~ 294 (351)
....... .....|++.|+|||++.+..++.++|+||||+++|+|++|+.||........... ... ..+..
T Consensus 151 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (256)
T cd08529 151 LSDNTNF--ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQMYSQQ 228 (256)
T ss_pred ccCccch--hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccccCHH
Confidence 5433221 2344688999999999998899999999999999999999999986543211111 111 11111
Q ss_pred CccchhhhcccccCCCCCHHHHH
Q 018712 295 SEDKVKQCVDTKLGGEYPPKAIA 317 (351)
Q Consensus 295 ~~~~~~~~ld~~~~~~~~~~~~~ 317 (351)
..+.+..|+...|.+|++..++.
T Consensus 229 ~~~~i~~~l~~~p~~Rp~~~~ll 251 (256)
T cd08529 229 LAQLIDQCLTKDYRQRPDTFQLL 251 (256)
T ss_pred HHHHHHHHccCCcccCcCHHHHh
Confidence 23577888888899999877664
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=285.18 Aligned_cols=240 Identities=32% Similarity=0.476 Sum_probs=186.5
Q ss_pred CCceeccCCcEEEEEEEEC-----CCCEEEEEEcCCCCCc--hHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEEEe
Q 018712 70 TNSLIGEGSYGRVYFGVLR-----SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEH 142 (351)
Q Consensus 70 ~~~~Lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 142 (351)
+.+.||.|.||.||+|.+. .+..|+||.+...... ...+.+|++.+++++||||+++++++...+..++|+||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 3568999999999999976 3578999999654332 47799999999999999999999999988889999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccccCC
Q 018712 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222 (351)
Q Consensus 143 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~ 222 (351)
+++|+|.++|..... ..+++..+..++.||+.||.|||+++ ++|+||+++||++++++.+||+|||++..
T Consensus 83 ~~~g~L~~~L~~~~~-------~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~ 152 (259)
T PF07714_consen 83 CPGGSLDDYLKSKNK-------EPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRP 152 (259)
T ss_dssp -TTEBHHHHHHHTCT-------TTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEE
T ss_pred ccccccccccccccc-------cccccccccccccccccccccccccc---ccccccccccccccccccccccccccccc
Confidence 999999999998722 12899999999999999999999999 99999999999999999999999999877
Q ss_pred CccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCCccchh-h-------cccC
Q 018712 223 APDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVT-W-------ATPK 293 (351)
Q Consensus 223 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~Pf~~~~~~~~~~~~~-~-------~~~~ 293 (351)
..............+...|+|||.+....++.++||||||+++|||++ |+.||...........+. . ..+.
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (259)
T PF07714_consen 153 ISEKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQRLPIPDNCPK 232 (259)
T ss_dssp TTTSSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEETTSBTTSBH
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccceeccchhH
Confidence 632222122233456778999999998889999999999999999999 789987653322111111 1 1111
Q ss_pred CCccchhhhcccccCCCCCHHHHHHH
Q 018712 294 LSEDKVKQCVDTKLGGEYPPKAIAKV 319 (351)
Q Consensus 294 ~~~~~~~~~ld~~~~~~~~~~~~~~~ 319 (351)
...+.+.+|++.+|.+||+.+++...
T Consensus 233 ~~~~li~~C~~~~p~~RPs~~~i~~~ 258 (259)
T PF07714_consen 233 DIYSLIQQCWSHDPEKRPSFQEILQE 258 (259)
T ss_dssp HHHHHHHHHT-SSGGGS--HHHHHHH
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHhc
Confidence 12368899999999999998887653
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=286.11 Aligned_cols=249 Identities=24% Similarity=0.372 Sum_probs=199.3
Q ss_pred HhcCCCCCceeccCCcEEEEEEEEC------CCCEEEEEEcCCCCCc--hHHHHHHHHHHHhc-cCCceeeeEEEEecCC
Q 018712 64 KTDNFGTNSLIGEGSYGRVYFGVLR------SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRL-KNENVVELVGYYVDGP 134 (351)
Q Consensus 64 ~~~~y~~~~~Lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~ 134 (351)
..++|.+.+.||+|+||.||++... ++..+|+|.+...... .+.+.+|+.+++++ +|+||+++++.+...+
T Consensus 33 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 112 (302)
T cd05055 33 PRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGG 112 (302)
T ss_pred cHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCC
Confidence 3457999999999999999999742 3458999988754332 35688999999999 7999999999999999
Q ss_pred ceEEEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEE
Q 018712 135 LRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKI 214 (351)
Q Consensus 135 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl 214 (351)
..+++|||+.+|+|.+++...... .+++.++..++.|++.||.|||+++ ++|+||||+|||++.++.++|
T Consensus 113 ~~~lv~e~~~~~~L~~~i~~~~~~-------~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l 182 (302)
T cd05055 113 PILVITEYCCYGDLLNFLRRKRES-------FLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKI 182 (302)
T ss_pred ceEEEEEcCCCCcHHHHHHhCCCC-------CCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEE
Confidence 999999999999999999754321 2789999999999999999999999 999999999999999999999
Q ss_pred ecccccCCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCCc-cchh----
Q 018712 215 SDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQ-SLVT---- 288 (351)
Q Consensus 215 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~Pf~~~~~~~~~-~~~~---- 288 (351)
+|||++................++..|+|||.+.+..++.++||||||+++|+|++ |..||......... ..+.
T Consensus 183 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~ 262 (302)
T cd05055 183 CDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYR 262 (302)
T ss_pred CCCcccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCc
Confidence 99999876643322111223346778999999999999999999999999999998 99999765432111 0110
Q ss_pred ----hcccCCCccchhhhcccccCCCCCHHHHHHHHHH
Q 018712 289 ----WATPKLSEDKVKQCVDTKLGGEYPPKAIAKVRKK 322 (351)
Q Consensus 289 ----~~~~~~~~~~~~~~ld~~~~~~~~~~~~~~~~~~ 322 (351)
...+....+.+..|++++|.+|++..++...++-
T Consensus 263 ~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~ 300 (302)
T cd05055 263 MAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGK 300 (302)
T ss_pred CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHh
Confidence 0111122368889999999999999998776654
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=298.27 Aligned_cols=195 Identities=23% Similarity=0.271 Sum_probs=167.4
Q ss_pred hcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCCchHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEEEeC
Q 018712 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHA 143 (351)
Q Consensus 65 ~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 143 (351)
..+|.+.+.||+|+||.||++.+. +++.||+|.... ..+.+|++++++++|+||+++++++..++..++|||++
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~-----~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~ 242 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY-----ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKY 242 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc-----cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEcc
Confidence 457999999999999999999975 578899996432 23578999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccccCCC
Q 018712 144 SKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQA 223 (351)
Q Consensus 144 ~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~ 223 (351)
. ++|.+++..... .+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||+++..
T Consensus 243 ~-~~L~~~l~~~~~--------~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~ 310 (461)
T PHA03211 243 R-SDLYTYLGARLR--------PLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFA 310 (461)
T ss_pred C-CCHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceec
Confidence 5 589888865432 2899999999999999999999999 999999999999999999999999998765
Q ss_pred ccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCC
Q 018712 224 PDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVD 276 (351)
Q Consensus 224 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~ 276 (351)
.............||+.|+|||++.+..++.++|||||||++|||++|..|+-
T Consensus 311 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf 363 (461)
T PHA03211 311 RGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLF 363 (461)
T ss_pred ccccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcc
Confidence 43322211234569999999999999999999999999999999999876543
|
|
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=282.99 Aligned_cols=241 Identities=27% Similarity=0.420 Sum_probs=190.6
Q ss_pred HhcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCCchHHHHHHHHHHHhc-cCCceeeeEEEEecC------Cc
Q 018712 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRL-KNENVVELVGYYVDG------PL 135 (351)
Q Consensus 64 ~~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~------~~ 135 (351)
..+.|++.+.||+|+||.||+|... +++.+|+|.+.........+.+|+.+++++ +|+||+++++++... ..
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~ 83 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQ 83 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcE
Confidence 3456888899999999999999965 688999999877666667788999999998 699999999988643 46
Q ss_pred eEEEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEe
Q 018712 136 RVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKIS 215 (351)
Q Consensus 136 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~ 215 (351)
.+++|||+.+++|.+++...... .+++..+..++.|++.||.|||+++ ++|+||||+||++++++.+||+
T Consensus 84 ~~iv~e~~~~~~L~~~l~~~~~~-------~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~ 153 (272)
T cd06637 84 LWLVMEFCGAGSVTDLIKNTKGN-------TLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLV 153 (272)
T ss_pred EEEEEEcCCCCcHHHHHHhccCC-------CCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEc
Confidence 89999999999999999864321 2888999999999999999999999 9999999999999999999999
Q ss_pred cccccCCCccccccccccccccccCccCccccc-----CCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccchh--
Q 018712 216 DFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAM-----TGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVT-- 288 (351)
Q Consensus 216 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~~-- 288 (351)
|||++........ ......|+..|+|||++. +..++.++||||||+++|+|++|+.||....+........
T Consensus 154 Dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~ 231 (272)
T cd06637 154 DFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN 231 (272)
T ss_pred cCCCceecccccc--cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcC
Confidence 9999876543221 124456899999999886 3457889999999999999999999997543222111111
Q ss_pred -------hcccCCCccchhhhcccccCCCCCHHHH
Q 018712 289 -------WATPKLSEDKVKQCVDTKLGGEYPPKAI 316 (351)
Q Consensus 289 -------~~~~~~~~~~~~~~ld~~~~~~~~~~~~ 316 (351)
...+....+.+..|+..++.+|++.+++
T Consensus 232 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i 266 (272)
T cd06637 232 PAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQL 266 (272)
T ss_pred CCCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHH
Confidence 0111122356677777777778776655
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=286.97 Aligned_cols=203 Identities=23% Similarity=0.383 Sum_probs=163.6
Q ss_pred CceeccCCcEEEEEEEEC---CCCEEEEEEcCCCCCchHHHHHHHHHHHhccCCceeeeEEEEec--CCceEEEEEeCCC
Q 018712 71 NSLIGEGSYGRVYFGVLR---SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVD--GPLRVLAYEHASK 145 (351)
Q Consensus 71 ~~~Lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e~~~~ 145 (351)
.++||+|+||.||+|... +++.||+|.+..... .....+|+.++++++||||+++++.+.. ....+++|||+.+
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~ 84 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI-SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH 84 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC-cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccCC
Confidence 357999999999999864 568899999875543 3457889999999999999999998854 4567999999865
Q ss_pred CCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEE----ccCCceEEecccccC
Q 018712 146 GSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLL----FDDDIAKISDFDLSN 221 (351)
Q Consensus 146 gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill----~~~~~vkl~Dfg~a~ 221 (351)
+|.+++..............++...+..++.||+.||.|||+++ |+||||||+|||+ +..+.+||+|||+++
T Consensus 85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07868 85 -DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred -CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCcee
Confidence 89888865432222222234888999999999999999999999 9999999999999 455789999999997
Q ss_pred CCcccccc-ccccccccccCccCcccccCC-CCCccchhHhHHHHHHHHHcCCCCCCCC
Q 018712 222 QAPDAAAR-LHSTRVLGTFGYHAPEYAMTG-QMSSKSDVYSFGVVLLELLTGRKPVDHT 278 (351)
Q Consensus 222 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~Pf~~~ 278 (351)
........ .......||+.|+|||++.+. .++.++||||+||++|+|++|+.||...
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~ 219 (317)
T cd07868 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred ccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence 65432211 112345789999999998764 5899999999999999999999999754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=293.73 Aligned_cols=197 Identities=28% Similarity=0.417 Sum_probs=168.9
Q ss_pred HHhcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCC---chHHHHHHHHHHHhccCCceeeeEEEEecC-----
Q 018712 63 EKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ---PDQEFLAQVSMVSRLKNENVVELVGYYVDG----- 133 (351)
Q Consensus 63 ~~~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~h~niv~~~~~~~~~----- 133 (351)
...++|.+.+.||+|+||.||+|.+. +++.||+|++..... ....+.+|+.++++++|+||+++++++...
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN 91 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence 45678999999999999999999964 788999999875432 234577899999999999999999877533
Q ss_pred -CceEEEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCce
Q 018712 134 -PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIA 212 (351)
Q Consensus 134 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~v 212 (351)
...|++++++ +++|.+++.... ++...+..++.||+.||.|||+++ |+||||||+|||+++++.+
T Consensus 92 ~~~~~~~~~~~-~~~l~~~~~~~~----------l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~ 157 (343)
T cd07878 92 FNEVYLVTNLM-GADLNNIVKCQK----------LSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCEL 157 (343)
T ss_pred cCcEEEEeecC-CCCHHHHHhcCC----------CCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCE
Confidence 3568999988 679999886543 889999999999999999999999 9999999999999999999
Q ss_pred EEecccccCCCccccccccccccccccCccCcccccC-CCCCccchhHhHHHHHHHHHcCCCCCCCC
Q 018712 213 KISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMT-GQMSSKSDVYSFGVVLLELLTGRKPVDHT 278 (351)
Q Consensus 213 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~Pf~~~ 278 (351)
||+|||++...... .....||+.|+|||++.+ ..++.++||||||+++|+|++|+.||...
T Consensus 158 kl~Dfg~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 219 (343)
T cd07878 158 RILDFGLARQADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGN 219 (343)
T ss_pred EEcCCccceecCCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCC
Confidence 99999998765432 134568999999999876 56899999999999999999999999754
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=281.71 Aligned_cols=251 Identities=26% Similarity=0.390 Sum_probs=196.4
Q ss_pred hcCCCCCceeccCCcEEEEEEEEC------CCCEEEEEEcCCCCCc--hHHHHHHHHHHHhccCCceeeeEEEEecCCce
Q 018712 65 TDNFGTNSLIGEGSYGRVYFGVLR------SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPLR 136 (351)
Q Consensus 65 ~~~y~~~~~Lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 136 (351)
.++|.+.+.||+|++|.||+|.+. ++..|++|.+...... ...+.+|+.++++++|+||+++++++.+....
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR 84 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence 467899999999999999999975 3568899988644332 34688899999999999999999999988899
Q ss_pred EEEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCC---ceE
Q 018712 137 VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD---IAK 213 (351)
Q Consensus 137 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~---~vk 213 (351)
+++|||+.+++|.+++....... .....+++..++.++.||+.||.|||+++ ++||||||+||+++.++ .+|
T Consensus 85 ~lv~e~~~g~~L~~~i~~~~~~~--~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~k 159 (277)
T cd05036 85 FILLELMAGGDLKSFLRENRPRP--ERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAK 159 (277)
T ss_pred EEEEecCCCCCHHHHHHHhCCCC--CCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceE
Confidence 99999999999999997654211 11224899999999999999999999999 99999999999998765 699
Q ss_pred EecccccCCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCCccchhh---
Q 018712 214 ISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTW--- 289 (351)
Q Consensus 214 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~Pf~~~~~~~~~~~~~~--- 289 (351)
|+|||+++................+..|+|||++.+..++.++|||||||++|+|++ |+.||...........+..
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~ 239 (277)
T cd05036 160 IADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGGR 239 (277)
T ss_pred eccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCc
Confidence 999999987633221111122234568999999998999999999999999999997 9999986543322211111
Q ss_pred -----cccCCCccchhhhcccccCCCCCHHHHHHHH
Q 018712 290 -----ATPKLSEDKVKQCVDTKLGGEYPPKAIAKVR 320 (351)
Q Consensus 290 -----~~~~~~~~~~~~~ld~~~~~~~~~~~~~~~~ 320 (351)
..+....+.+.+|+..+|.+|++..++...+
T Consensus 240 ~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l 275 (277)
T cd05036 240 LDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERI 275 (277)
T ss_pred CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHh
Confidence 0111123677899999999999988876543
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=317.25 Aligned_cols=247 Identities=26% Similarity=0.387 Sum_probs=201.6
Q ss_pred CCCCCceeccCCcEEEEEEEEC--CCC----EEEEEEcCCCCC--chHHHHHHHHHHHhccCCceeeeEEEEecCCceEE
Q 018712 67 NFGTNSLIGEGSYGRVYFGVLR--SGR----AAAIKKLDSSKQ--PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVL 138 (351)
Q Consensus 67 ~y~~~~~Lg~G~~g~Vy~~~~~--~~~----~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 138 (351)
..+....||+|.||.||.|... .+. .||+|.+..... ...+|++|..+|+.++||||+++++.+.+....+|
T Consensus 693 ~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i 772 (1025)
T KOG1095|consen 693 NVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLI 772 (1025)
T ss_pred heEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEE
Confidence 4455678999999999999965 233 489999876643 35679999999999999999999999999999999
Q ss_pred EEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEeccc
Q 018712 139 AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFD 218 (351)
Q Consensus 139 v~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg 218 (351)
++|||.+|+|..||++.+..... ...++....+.++.+|++|+.||++++ +|||||..+|+|++....|||+|||
T Consensus 773 ~leyM~gGDL~sflr~~r~~~~~--~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDFG 847 (1025)
T KOG1095|consen 773 LLEYMEGGDLLSFLRESRPAPFQ--PSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADFG 847 (1025)
T ss_pred EehhcccCcHHHHHHhcccccCC--CCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcccc
Confidence 99999999999999987544333 234899999999999999999999999 9999999999999999999999999
Q ss_pred ccCCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCCccch--------hh
Q 018712 219 LSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLV--------TW 289 (351)
Q Consensus 219 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~Pf~~~~~~~~~~~~--------~~ 289 (351)
+|+.+.............-...|||||.+..+.++.++|||||||++||++| |..||....+.+..... ..
T Consensus 848 lArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~ggRL~~P~ 927 (1025)
T KOG1095|consen 848 LARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGGRLDPPS 927 (1025)
T ss_pred hhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCCccCCCC
Confidence 9996654433222222234568999999999999999999999999999999 99999987654332211 11
Q ss_pred cccCCCccchhhhcccccCCCCCHHHHHH
Q 018712 290 ATPKLSEDKVKQCVDTKLGGEYPPKAIAK 318 (351)
Q Consensus 290 ~~~~~~~~~~~~~ld~~~~~~~~~~~~~~ 318 (351)
..|...-+.+.+|+...|..|++...+..
T Consensus 928 ~CP~~ly~lM~~CW~~~pe~RP~F~~i~~ 956 (1025)
T KOG1095|consen 928 YCPEKLYQLMLQCWKHDPEDRPSFRTIVE 956 (1025)
T ss_pred CCChHHHHHHHHHccCChhhCccHHHHHh
Confidence 22222227889999999999999887766
|
|
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=279.82 Aligned_cols=240 Identities=22% Similarity=0.297 Sum_probs=195.3
Q ss_pred CCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCC--CchHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEEEeC
Q 018712 67 NFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK--QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHA 143 (351)
Q Consensus 67 ~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 143 (351)
+|++.+.||.|+||.||++... ++..+|+|.+.... ...+.+.+|+.+++.++|+||+++++.+.+.+..+++|||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 5788999999999999999965 78899999885432 23456788999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccccCCC
Q 018712 144 SKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQA 223 (351)
Q Consensus 144 ~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~ 223 (351)
++++|.+++...... .++...++.++.|++.||.|||+++ ++|+||||+||++++++.++|+|||.+...
T Consensus 81 ~~~~l~~~~~~~~~~-------~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~ 150 (255)
T cd08219 81 DGGDLMQKIKLQRGK-------LFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLL 150 (255)
T ss_pred CCCcHHHHHHhccCC-------CCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceee
Confidence 999999998654321 2788899999999999999999999 999999999999999999999999998765
Q ss_pred ccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccch--------hhcccCCC
Q 018712 224 PDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLV--------TWATPKLS 295 (351)
Q Consensus 224 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~--------~~~~~~~~ 295 (351)
..... ......|++.|+|||++.+..++.++|+||||+++|+|++|+.||...........+ ....+...
T Consensus 151 ~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (255)
T cd08219 151 TSPGA--YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLPSHYSYEL 228 (255)
T ss_pred ccccc--ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCCCCCcccCHHH
Confidence 43221 123456889999999999888999999999999999999999999865432111111 01111112
Q ss_pred ccchhhhcccccCCCCCHHHHHH
Q 018712 296 EDKVKQCVDTKLGGEYPPKAIAK 318 (351)
Q Consensus 296 ~~~~~~~ld~~~~~~~~~~~~~~ 318 (351)
.+.+.+|++.+|.+|++..++..
T Consensus 229 ~~li~~~l~~~P~~Rp~~~~il~ 251 (255)
T cd08219 229 RSLIKQMFKRNPRSRPSATTILS 251 (255)
T ss_pred HHHHHHHHhCCcccCCCHHHHhh
Confidence 36788999999999998887643
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=279.62 Aligned_cols=239 Identities=23% Similarity=0.376 Sum_probs=192.8
Q ss_pred CCCCCceeccCCcEEEEEEEECCCCEEEEEEcCCCCCc-------hHHHHHHHHHHHhccCCceeeeEEEEecCCceEEE
Q 018712 67 NFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQP-------DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLA 139 (351)
Q Consensus 67 ~y~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 139 (351)
+|.+.+.||+|+||.||+|...+++.+|+|.+...... ...+.+|++++++++|+||+++++++.+.+..+++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 58889999999999999999888999999988654321 24578899999999999999999999999999999
Q ss_pred EEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccc
Q 018712 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDL 219 (351)
Q Consensus 140 ~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~ 219 (351)
+||+++++|.+++..... +++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||+
T Consensus 81 ~e~~~~~~L~~~l~~~~~---------~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~ 148 (265)
T cd06631 81 MEFVPGGSISSILNRFGP---------LPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGC 148 (265)
T ss_pred EecCCCCcHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchh
Confidence 999999999999976432 788899999999999999999999 99999999999999999999999999
Q ss_pred cCCCccccc----cccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccchh-------
Q 018712 220 SNQAPDAAA----RLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVT------- 288 (351)
Q Consensus 220 a~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~~------- 288 (351)
+........ ........|+..|+|||.+.+..++.++|+||||+++|+|++|+.||...........+.
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 228 (265)
T cd06631 149 ARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMP 228 (265)
T ss_pred hHhhhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCC
Confidence 875432110 111123468899999999998889999999999999999999999997643322111110
Q ss_pred hcc---cCCCccchhhhcccccCCCCCHHHHH
Q 018712 289 WAT---PKLSEDKVKQCVDTKLGGEYPPKAIA 317 (351)
Q Consensus 289 ~~~---~~~~~~~~~~~ld~~~~~~~~~~~~~ 317 (351)
... +....+.+.+|+.+++.+|++..++.
T Consensus 229 ~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l 260 (265)
T cd06631 229 RLPDSFSAAAIDFVTSCLTRDQHERPSALQLL 260 (265)
T ss_pred CCCCCCCHHHHHHHHHHhcCCcccCCCHHHHh
Confidence 011 11112567888888899998877654
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=285.33 Aligned_cols=259 Identities=22% Similarity=0.344 Sum_probs=202.5
Q ss_pred HhcCCCCCceeccCCcEEEEEEEEC--------CCCEEEEEEcCCCC--CchHHHHHHHHHHHhc-cCCceeeeEEEEec
Q 018712 64 KTDNFGTNSLIGEGSYGRVYFGVLR--------SGRAAAIKKLDSSK--QPDQEFLAQVSMVSRL-KNENVVELVGYYVD 132 (351)
Q Consensus 64 ~~~~y~~~~~Lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~ 132 (351)
..++|.+.+.||+|+||.||+|... ++..+|+|.+.... ...+.+.+|+.+++.+ +||||+++++.+..
T Consensus 13 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 92 (304)
T cd05101 13 SRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 92 (304)
T ss_pred cHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEec
Confidence 4567889999999999999999741 24579999886543 2245688999999999 89999999999999
Q ss_pred CCceEEEEEeCCCCCHHHHhccCCCCCC-------CCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEE
Q 018712 133 GPLRVLAYEHASKGSLHDILHGKKGVKG-------AKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVL 205 (351)
Q Consensus 133 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~-------~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nil 205 (351)
....+++|||+.+++|.+++........ ..+...+++..+..++.||+.||.|||++| ++||||||+||+
T Consensus 93 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nil 169 (304)
T cd05101 93 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNVL 169 (304)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceEE
Confidence 9999999999999999999976532110 012234788999999999999999999999 999999999999
Q ss_pred EccCCceEEecccccCCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCCc
Q 018712 206 LFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQ 284 (351)
Q Consensus 206 l~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~Pf~~~~~~~~~ 284 (351)
++.++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|+|++ |..||.........
T Consensus 170 i~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~ 249 (304)
T cd05101 170 VTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF 249 (304)
T ss_pred EcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHH
Confidence 99999999999999987644332222233345678999999998889999999999999999998 88898765432221
Q ss_pred cchhh--------cccCCCccchhhhcccccCCCCCHHHHHHHHHHHHH
Q 018712 285 SLVTW--------ATPKLSEDKVKQCVDTKLGGEYPPKAIAKVRKKKFI 325 (351)
Q Consensus 285 ~~~~~--------~~~~~~~~~~~~~ld~~~~~~~~~~~~~~~~~~~~~ 325 (351)
..+.. ..+......+.+|+.+.|.+|++..++.+.++-.+.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~ 298 (304)
T cd05101 250 KLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILT 298 (304)
T ss_pred HHHHcCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHH
Confidence 11111 111222368889999999999999988777655443
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=281.57 Aligned_cols=244 Identities=27% Similarity=0.365 Sum_probs=191.5
Q ss_pred cCC-CCCceeccCCcEEEEEEEE-----CCCCEEEEEEcCCCCC--chHHHHHHHHHHHhccCCceeeeEEEEecC--Cc
Q 018712 66 DNF-GTNSLIGEGSYGRVYFGVL-----RSGRAAAIKKLDSSKQ--PDQEFLAQVSMVSRLKNENVVELVGYYVDG--PL 135 (351)
Q Consensus 66 ~~y-~~~~~Lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~ 135 (351)
++| .+.+.||+|+||+||++.. .++..||+|.+..... ....+.+|++++++++||||+++++++... ..
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (283)
T cd05080 3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKG 82 (283)
T ss_pred hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCce
Confidence 344 8889999999999988653 3578899999875433 345678999999999999999999987653 45
Q ss_pred eEEEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEe
Q 018712 136 RVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKIS 215 (351)
Q Consensus 136 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~ 215 (351)
.+++|||+.+++|.+++.... +++..++.++.|++.||.|||+++ ++||||||+||++++++.+||+
T Consensus 83 ~~lv~e~~~~~~l~~~~~~~~----------l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~ 149 (283)
T cd05080 83 LQLIMEYVPLGSLRDYLPKHK----------LNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIG 149 (283)
T ss_pred EEEEecCCCCCCHHHHHHHcC----------CCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEe
Confidence 799999999999999997643 899999999999999999999999 9999999999999999999999
Q ss_pred cccccCCCcccccccc-ccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCC-----------
Q 018712 216 DFDLSNQAPDAAARLH-STRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQ----------- 283 (351)
Q Consensus 216 Dfg~a~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~----------- 283 (351)
|||++........... .....++..|+|||.+.+..++.++||||||+++|+|++|..||......-.
T Consensus 150 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 229 (283)
T cd05080 150 DFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMT 229 (283)
T ss_pred ecccccccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccc
Confidence 9999887644322111 1222356679999999888899999999999999999999999875432100
Q ss_pred -ccch-----------hhcccCCCccchhhhcccccCCCCCHHHHHHHHHH
Q 018712 284 -QSLV-----------TWATPKLSEDKVKQCVDTKLGGEYPPKAIAKVRKK 322 (351)
Q Consensus 284 -~~~~-----------~~~~~~~~~~~~~~~ld~~~~~~~~~~~~~~~~~~ 322 (351)
.... ....+....+.+..|+.++|.+|++.+++...++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~ 280 (283)
T cd05080 230 VVRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKE 280 (283)
T ss_pred hhhhhhhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHH
Confidence 0000 00011122357888898899999998888776543
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=281.71 Aligned_cols=244 Identities=23% Similarity=0.338 Sum_probs=192.7
Q ss_pred hcCCCCCceeccCCcEEEEEEEEC-CCC----EEEEEEcCCCCC--chHHHHHHHHHHHhccCCceeeeEEEEecCCceE
Q 018712 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGR----AAAIKKLDSSKQ--PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRV 137 (351)
Q Consensus 65 ~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 137 (351)
.++|++.+.||+|+||.||+|.+. ++. .||+|.+..... ....+.+|..+++.++|+||+++++++.. ...+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~ 84 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQ 84 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcE
Confidence 467899999999999999999853 444 489998865433 24567889999999999999999998875 4578
Q ss_pred EEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecc
Q 018712 138 LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDF 217 (351)
Q Consensus 138 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Df 217 (351)
+++||+++|+|.+++..... .+++..++.++.|++.||.|||+++ ++||||||+|||+++++.+||+||
T Consensus 85 l~~~~~~~g~l~~~l~~~~~--------~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~df 153 (279)
T cd05109 85 LVTQLMPYGCLLDYVRENKD--------RIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDF 153 (279)
T ss_pred EEEEcCCCCCHHHHHhhccC--------CCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCC
Confidence 99999999999999976432 2889999999999999999999999 999999999999999999999999
Q ss_pred cccCCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCCccchhhc------
Q 018712 218 DLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWA------ 290 (351)
Q Consensus 218 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~Pf~~~~~~~~~~~~~~~------ 290 (351)
|+++...............+++.|+|||.+.+..++.++||||||+++|||++ |..||...........+...
T Consensus 154 G~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~ 233 (279)
T cd05109 154 GLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLPQP 233 (279)
T ss_pred CceeecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCC
Confidence 99877643322221222335678999999998899999999999999999998 99999765432211111110
Q ss_pred --ccCCCccchhhhcccccCCCCCHHHHHHHH
Q 018712 291 --TPKLSEDKVKQCVDTKLGGEYPPKAIAKVR 320 (351)
Q Consensus 291 --~~~~~~~~~~~~ld~~~~~~~~~~~~~~~~ 320 (351)
.+....+.+.+|+..+|.+|++..++...+
T Consensus 234 ~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l 265 (279)
T cd05109 234 PICTIDVYMIMVKCWMIDSECRPRFRELVDEF 265 (279)
T ss_pred ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 011112578899999999999998887544
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=280.59 Aligned_cols=249 Identities=22% Similarity=0.279 Sum_probs=190.8
Q ss_pred CCCCceeccCCcEEEEEEEECC-CC--EEEEEEcCCCCC---chHHHHHHHHHHHhccCCceeeeEEEEecC------Cc
Q 018712 68 FGTNSLIGEGSYGRVYFGVLRS-GR--AAAIKKLDSSKQ---PDQEFLAQVSMVSRLKNENVVELVGYYVDG------PL 135 (351)
Q Consensus 68 y~~~~~Lg~G~~g~Vy~~~~~~-~~--~vavK~~~~~~~---~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------~~ 135 (351)
|.+.+.||+|+||.||+|.+.. +. .+|+|.++.... ..+.+.+|+++++.++|+||+++++.+... ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 4567889999999999999753 32 689998875432 235678899999999999999999976422 24
Q ss_pred eEEEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEe
Q 018712 136 RVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKIS 215 (351)
Q Consensus 136 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~ 215 (351)
.+++|||+.+|+|.+++...... .....+++..+..++.|++.||+|||+++ |+||||||+|||+++++.+||+
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~---~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~ 154 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLG---DCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVA 154 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhccc---CCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEEC
Confidence 68999999999999988533211 01123789999999999999999999999 9999999999999999999999
Q ss_pred cccccCCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCCccchh------
Q 018712 216 DFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVT------ 288 (351)
Q Consensus 216 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~Pf~~~~~~~~~~~~~------ 288 (351)
|||+++...............+++.|+|||.+.+..++.++||||||+++|+|++ |+.||...........+.
T Consensus 155 Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~ 234 (272)
T cd05075 155 DFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLK 234 (272)
T ss_pred CCCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCC
Confidence 9999987643322111123345778999999999999999999999999999999 899997643322111111
Q ss_pred --hcccCCCccchhhhcccccCCCCCHHHHHHHHHH
Q 018712 289 --WATPKLSEDKVKQCVDTKLGGEYPPKAIAKVRKK 322 (351)
Q Consensus 289 --~~~~~~~~~~~~~~ld~~~~~~~~~~~~~~~~~~ 322 (351)
...+....+.+..|+.++|.+|++.+++...++.
T Consensus 235 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~ 270 (272)
T cd05075 235 QPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEK 270 (272)
T ss_pred CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence 1111112367889999999999999988776553
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=284.30 Aligned_cols=256 Identities=25% Similarity=0.346 Sum_probs=198.6
Q ss_pred cCCCCCceeccCCcEEEEEEEEC-CC--CEEEEEEcCCCCC--chHHHHHHHHHHHhc-cCCceeeeEEEEecCCceEEE
Q 018712 66 DNFGTNSLIGEGSYGRVYFGVLR-SG--RAAAIKKLDSSKQ--PDQEFLAQVSMVSRL-KNENVVELVGYYVDGPLRVLA 139 (351)
Q Consensus 66 ~~y~~~~~Lg~G~~g~Vy~~~~~-~~--~~vavK~~~~~~~--~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv 139 (351)
++|++.+.||+|+||.||+|..+ ++ ..+++|.+..... ..+.+.+|+.+++++ +||||+++++++.+.+..+++
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 57999999999999999999865 33 3478888764322 235688899999999 799999999999999999999
Q ss_pred EEeCCCCCHHHHhccCCCCCC-------CCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCce
Q 018712 140 YEHASKGSLHDILHGKKGVKG-------AKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIA 212 (351)
Q Consensus 140 ~e~~~~gsL~~~l~~~~~~~~-------~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~v 212 (351)
+||+++++|.+++........ ......+++..++.++.|++.||+|||+.+ ++||||||+|||++.++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeE
Confidence 999999999999976432110 011124888999999999999999999999 9999999999999999999
Q ss_pred EEecccccCCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCCccchhh--
Q 018712 213 KISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTW-- 289 (351)
Q Consensus 213 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~Pf~~~~~~~~~~~~~~-- 289 (351)
||+|||++........ ......+..|+|||++.+..++.++||||||+++|||++ |..||...........+..
T Consensus 159 kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~~ 235 (297)
T cd05089 159 KIADFGLSRGEEVYVK---KTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY 235 (297)
T ss_pred EECCcCCCccccceec---cCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCC
Confidence 9999999864322111 111223557999999998899999999999999999997 9999986544321111111
Q ss_pred ------cccCCCccchhhhcccccCCCCCHHHHHHHHHHHHHhh
Q 018712 290 ------ATPKLSEDKVKQCVDTKLGGEYPPKAIAKVRKKKFITS 327 (351)
Q Consensus 290 ------~~~~~~~~~~~~~ld~~~~~~~~~~~~~~~~~~~~~~~ 327 (351)
..+....+.+..|+..+|.+|++.+++.+.+.-++...
T Consensus 236 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~ 279 (297)
T cd05089 236 RMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEAR 279 (297)
T ss_pred CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 11112237889999999999999999977766655443
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=278.41 Aligned_cols=241 Identities=30% Similarity=0.478 Sum_probs=199.3
Q ss_pred hcCCCCCceeccCCcEEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEEEeCC
Q 018712 65 TDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHAS 144 (351)
Q Consensus 65 ~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 144 (351)
.++|++.+.||+|+||.||+|... ++.||+|.+.......+.+.+|+.++++++|+||+++++++.+.+..++||||++
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 83 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMA 83 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchhHHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecC
Confidence 457899999999999999999875 7899999998765556778999999999999999999999998999999999999
Q ss_pred CCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccccCCCc
Q 018712 145 KGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAP 224 (351)
Q Consensus 145 ~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~ 224 (351)
+++|.+++...... .+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.+||+|||.++...
T Consensus 84 ~~~L~~~~~~~~~~-------~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~ 153 (256)
T cd05039 84 KGSLVDYLRSRGRA-------VITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEAS 153 (256)
T ss_pred CCcHHHHHHhcCCC-------CCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEcccccccccc
Confidence 99999999765421 2899999999999999999999999 9999999999999999999999999988763
Q ss_pred cccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCCccchh--------hcccCCC
Q 018712 225 DAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVT--------WATPKLS 295 (351)
Q Consensus 225 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~Pf~~~~~~~~~~~~~--------~~~~~~~ 295 (351)
... ....++..|+|||.+.+..++.++||||||+++|+|++ |..||...........+. ...+...
T Consensus 154 ~~~-----~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (256)
T cd05039 154 QGQ-----DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYRMEAPEGCPPEV 228 (256)
T ss_pred ccc-----ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCccCCCHHH
Confidence 322 12234667999999988889999999999999999997 999997654322111110 1111222
Q ss_pred ccchhhhcccccCCCCCHHHHHHHHH
Q 018712 296 EDKVKQCVDTKLGGEYPPKAIAKVRK 321 (351)
Q Consensus 296 ~~~~~~~ld~~~~~~~~~~~~~~~~~ 321 (351)
.+.+.+|+..+|.+|++.+++...++
T Consensus 229 ~~li~~~l~~~p~~Rp~~~~l~~~l~ 254 (256)
T cd05039 229 YKVMKDCWELDPAKRPTFKQLREQLA 254 (256)
T ss_pred HHHHHHHhccChhhCcCHHHHHHHHh
Confidence 36788899999999999988877653
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=301.12 Aligned_cols=201 Identities=27% Similarity=0.439 Sum_probs=174.8
Q ss_pred CCCCCceeccCCcEEEEEEEE-CCCCEEEEEEcCCC--CCchHHHHHHHHHHHhccCCceeeeEEEEecC------CceE
Q 018712 67 NFGTNSLIGEGSYGRVYFGVL-RSGRAAAIKKLDSS--KQPDQEFLAQVSMVSRLKNENVVELVGYYVDG------PLRV 137 (351)
Q Consensus 67 ~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------~~~~ 137 (351)
.|...+.||+|+||.||++++ .+|+.||||.+... ....+...+|+++|++++|+|||++++.-.+. ....
T Consensus 14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~v 93 (732)
T KOG4250|consen 14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPV 93 (732)
T ss_pred ceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccce
Confidence 466678899999999999995 48999999998763 34457788999999999999999999875443 3468
Q ss_pred EEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccC--C--ceE
Q 018712 138 LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDD--D--IAK 213 (351)
Q Consensus 138 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~--~--~vk 213 (351)
+|||||.+|||..+|++..+.. .+++.+.+.++..+..||.|||++| |+||||||+||++-.+ | ..|
T Consensus 94 lvmEyC~gGsL~~~L~~PEN~~------GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyK 164 (732)
T KOG4250|consen 94 LVMEYCSGGSLRKVLNSPENAY------GLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYK 164 (732)
T ss_pred EEEeecCCCcHHHHhcCccccc------CCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEe
Confidence 9999999999999998876543 4899999999999999999999999 9999999999998543 3 579
Q ss_pred EecccccCCCccccccccccccccccCccCcccccC-CCCCccchhHhHHHHHHHHHcCCCCCCCCC
Q 018712 214 ISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMT-GQMSSKSDVYSFGVVLLELLTGRKPVDHTL 279 (351)
Q Consensus 214 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~Pf~~~~ 279 (351)
|+|||.|+...++. ....++||..|++||+... +.|+..+|.|||||++|+.+||..||....
T Consensus 165 LtDfG~Arel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~ 228 (732)
T KOG4250|consen 165 LTDFGAARELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFG 228 (732)
T ss_pred eecccccccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCC
Confidence 99999999987765 2477899999999999984 889999999999999999999999998643
|
|
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=284.44 Aligned_cols=253 Identities=26% Similarity=0.403 Sum_probs=197.7
Q ss_pred cCHHHHHHHhcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCCchHHHHHHHHHHHhc-cCCceeeeEEEEe--
Q 018712 56 ISVDELKEKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRL-KNENVVELVGYYV-- 131 (351)
Q Consensus 56 ~~~~~~~~~~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~-- 131 (351)
+..+.+....++|++.+.||+|+||.||++... +++.+|+|++.........+.+|+.+++++ +|+||+++++++.
T Consensus 8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 87 (286)
T cd06638 8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKK 87 (286)
T ss_pred EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCeeeeeeeeeec
Confidence 344556677889999999999999999999965 688999999876555556788899999999 6999999999874
Q ss_pred ---cCCceEEEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEcc
Q 018712 132 ---DGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFD 208 (351)
Q Consensus 132 ---~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~ 208 (351)
.++..++||||+++++|.+++...... ...+++..+..++.|++.||.|||+.+ ++||||||+||++++
T Consensus 88 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~ 159 (286)
T cd06638 88 DVKNGDQLWLVLELCNGGSVTDLVKGFLKR-----GERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTT 159 (286)
T ss_pred ccCCCCeEEEEEeecCCCCHHHHHHHhhcc-----CccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECC
Confidence 445789999999999999988642111 123788899999999999999999999 999999999999999
Q ss_pred CCceEEecccccCCCccccccccccccccccCccCccccc-----CCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCC
Q 018712 209 DDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAM-----TGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQ 283 (351)
Q Consensus 209 ~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~ 283 (351)
++.+||+|||++........ ......|++.|+|||++. +..++.++||||||+++|+|++|+.||....+...
T Consensus 160 ~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~ 237 (286)
T cd06638 160 EGGVKLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRA 237 (286)
T ss_pred CCCEEEccCCceeecccCCC--ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHH
Confidence 99999999999876543221 123346899999999875 34578899999999999999999999986543221
Q ss_pred ccchh-h-----ccc----CCCccchhhhcccccCCCCCHHHHHH
Q 018712 284 QSLVT-W-----ATP----KLSEDKVKQCVDTKLGGEYPPKAIAK 318 (351)
Q Consensus 284 ~~~~~-~-----~~~----~~~~~~~~~~ld~~~~~~~~~~~~~~ 318 (351)
..... . ..+ ....+.+..|+..+|.+|++..++..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~ 282 (286)
T cd06638 238 LFKIPRNPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQ 282 (286)
T ss_pred HhhccccCCCcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 11110 0 011 11235678888899999998777643
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=286.30 Aligned_cols=236 Identities=28% Similarity=0.462 Sum_probs=192.3
Q ss_pred CCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCCchHH---HHHHHHHHHhccCCceeeeEEEEecCCceEEEEEeC
Q 018712 68 FGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQE---FLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHA 143 (351)
Q Consensus 68 y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~---~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 143 (351)
|++.+.||+|+||+||++... +++.||+|++......... ..+|+.++++++|+||+++++++.+....+++||++
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 567889999999999999976 5678999999877544332 345899999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccccCCC
Q 018712 144 SKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQA 223 (351)
Q Consensus 144 ~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~ 223 (351)
.+++|.+++..... ++...+..++.||+.||.+||+++ ++|+||||+||+++.++.++|+|||.+...
T Consensus 81 ~~~~L~~~l~~~~~---------~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~ 148 (260)
T PF00069_consen 81 PGGSLQDYLQKNKP---------LSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKL 148 (260)
T ss_dssp TTEBHHHHHHHHSS---------BBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEES
T ss_pred cccccccccccccc---------cccccccccccccccccccccccc---cccccccccccccccccccccccccccccc
Confidence 99999999983332 899999999999999999999999 999999999999999999999999998653
Q ss_pred ccccccccccccccccCccCccccc-CCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccchh--------hcc---
Q 018712 224 PDAAARLHSTRVLGTFGYHAPEYAM-TGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVT--------WAT--- 291 (351)
Q Consensus 224 ~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~~--------~~~--- 291 (351)
.... .......+|..|+|||++. +..++.++||||+|+++|+|++|..||...........+. ...
T Consensus 149 ~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (260)
T PF00069_consen 149 SENN--ENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQS 226 (260)
T ss_dssp TSTT--SEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSH
T ss_pred cccc--cccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhccccccccccccc
Confidence 1111 1124556899999999998 8889999999999999999999999998762111111110 011
Q ss_pred ---cCCCccchhhhcccccCCCCCHHHHH
Q 018712 292 ---PKLSEDKVKQCVDTKLGGEYPPKAIA 317 (351)
Q Consensus 292 ---~~~~~~~~~~~ld~~~~~~~~~~~~~ 317 (351)
+....+.+..|++.+|.+|++..++.
T Consensus 227 ~~~~~~l~~li~~~l~~~p~~R~~~~~l~ 255 (260)
T PF00069_consen 227 REKSEELRDLIKKMLSKDPEQRPSAEELL 255 (260)
T ss_dssp TTSHHHHHHHHHHHSSSSGGGSTTHHHHH
T ss_pred chhHHHHHHHHHHHccCChhHCcCHHHHh
Confidence 12234678899999999999877654
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=283.55 Aligned_cols=241 Identities=24% Similarity=0.409 Sum_probs=197.6
Q ss_pred HHhcCCCCCceeccCCcEEEEEEEE-CCCCEEEEEEcCCCCC-chHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEE
Q 018712 63 EKTDNFGTNSLIGEGSYGRVYFGVL-RSGRAAAIKKLDSSKQ-PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAY 140 (351)
Q Consensus 63 ~~~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 140 (351)
...++|.+.+.||+|+||.||++.. .+++.||+|.+..... ..+.+.+|+.+++.++|+||+++++.+...+..++||
T Consensus 16 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 95 (297)
T cd06656 16 DPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 95 (297)
T ss_pred ChhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEee
Confidence 3447899999999999999999996 4789999999875433 3456788999999999999999999999999999999
Q ss_pred EeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEeccccc
Q 018712 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (351)
Q Consensus 141 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a 220 (351)
||+++++|.+++.... +++..+..++.|++.||.|||+.+ ++||||||+|||++.++.++|+|||++
T Consensus 96 e~~~~~~L~~~~~~~~----------~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~ 162 (297)
T cd06656 96 EYLAGGSLTDVVTETC----------MDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFC 162 (297)
T ss_pred cccCCCCHHHHHHhCC----------CCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccc
Confidence 9999999999997543 788899999999999999999999 999999999999999999999999998
Q ss_pred CCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccchhh----------c
Q 018712 221 NQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTW----------A 290 (351)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~~~----------~ 290 (351)
......... .....+++.|+|||.+.+..++.++|+||||+++|+|++|+.||....+......+.. .
T Consensus 163 ~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (297)
T cd06656 163 AQITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPER 240 (297)
T ss_pred eEccCCccC--cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCCCCCCccc
Confidence 765332211 1334688899999999988899999999999999999999999976544222111110 1
Q ss_pred ccCCCccchhhhcccccCCCCCHHHHHH
Q 018712 291 TPKLSEDKVKQCVDTKLGGEYPPKAIAK 318 (351)
Q Consensus 291 ~~~~~~~~~~~~ld~~~~~~~~~~~~~~ 318 (351)
.+....+.+..|+..+|..|++.+++..
T Consensus 241 ~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 241 LSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred cCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1111236778999999999998776543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-38 Score=278.43 Aligned_cols=239 Identities=23% Similarity=0.381 Sum_probs=192.5
Q ss_pred CCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCCc----------hHHHHHHHHHHHhccCCceeeeEEEEecCCc
Q 018712 67 NFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP----------DQEFLAQVSMVSRLKNENVVELVGYYVDGPL 135 (351)
Q Consensus 67 ~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~----------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 135 (351)
+|.+.+.||+|++|.||+|... +++.+|+|.+...... .+.+.+|+.++++++||||+++++++.+.+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 4788899999999999999964 6889999988644321 1357789999999999999999999999999
Q ss_pred eEEEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEe
Q 018712 136 RVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKIS 215 (351)
Q Consensus 136 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~ 215 (351)
.+++|||+++++|.+++..... ++...+..++.|++.||.|||+++ ++||||+|+||++++++.++|+
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~---------l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~ 148 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNYGA---------FEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKIS 148 (267)
T ss_pred cEEEEEecCCCCHHHHHHhccC---------ccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEec
Confidence 9999999999999999976542 788899999999999999999999 9999999999999999999999
Q ss_pred cccccCCCcccccc----ccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCcc-chhh-
Q 018712 216 DFDLSNQAPDAAAR----LHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQS-LVTW- 289 (351)
Q Consensus 216 Dfg~a~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~-~~~~- 289 (351)
|||.++........ .......|+..|+|||.+.+..++.++|+||||+++|+|++|+.||.......... ....
T Consensus 149 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~ 228 (267)
T cd06628 149 DFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENA 228 (267)
T ss_pred ccCCCcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhccC
Confidence 99998876532111 11123457889999999998889999999999999999999999998643321110 0011
Q ss_pred ------cccCCCccchhhhcccccCCCCCHHHHH
Q 018712 290 ------ATPKLSEDKVKQCVDTKLGGEYPPKAIA 317 (351)
Q Consensus 290 ------~~~~~~~~~~~~~ld~~~~~~~~~~~~~ 317 (351)
..+....+.+..|+.+++.+|++..++.
T Consensus 229 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il 262 (267)
T cd06628 229 SPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELL 262 (267)
T ss_pred CCcCCcccCHHHHHHHHHHccCCchhCcCHHHHh
Confidence 1112223678888999999999876654
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=277.86 Aligned_cols=243 Identities=22% Similarity=0.402 Sum_probs=197.4
Q ss_pred cCCCCCceeccCCcEEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEEEeCCC
Q 018712 66 DNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASK 145 (351)
Q Consensus 66 ~~y~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 145 (351)
.+|++.+.||+|+||.||++.+.++..+|+|.+.........+.+|++++++++||||+++++++......+++|||+.+
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~ 83 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEH 83 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCC
Confidence 46888899999999999999987788999999887666667899999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccccCCCcc
Q 018712 146 GSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPD 225 (351)
Q Consensus 146 gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~ 225 (351)
++|.+++..... .+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++.....
T Consensus 84 ~~L~~~~~~~~~--------~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~ 152 (256)
T cd05112 84 GCLSDYLRAQRG--------KFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLD 152 (256)
T ss_pred CcHHHHHHhCcc--------CCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeeccc
Confidence 999999975432 2788999999999999999999999 99999999999999999999999999876533
Q ss_pred ccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCCccchh--------hcccCCCc
Q 018712 226 AAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVT--------WATPKLSE 296 (351)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~Pf~~~~~~~~~~~~~--------~~~~~~~~ 296 (351)
..... .....++..|+|||.+.+..++.++||||||+++|||++ |+.||...........+. ...+....
T Consensus 153 ~~~~~-~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (256)
T cd05112 153 DQYTS-STGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKPRLASQSVY 231 (256)
T ss_pred Ccccc-cCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCCCCCCCCCHHHH
Confidence 22111 112234678999999998899999999999999999998 999997654322111111 01111223
Q ss_pred cchhhhcccccCCCCCHHHHHHHH
Q 018712 297 DKVKQCVDTKLGGEYPPKAIAKVR 320 (351)
Q Consensus 297 ~~~~~~ld~~~~~~~~~~~~~~~~ 320 (351)
+.+..|+..+|.+|++.+++.+.+
T Consensus 232 ~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 232 ELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred HHHHHHcccChhhCCCHHHHHHhh
Confidence 678888988999999888876543
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=284.46 Aligned_cols=230 Identities=24% Similarity=0.350 Sum_probs=191.4
Q ss_pred cCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCC----CchHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEE
Q 018712 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK----QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAY 140 (351)
Q Consensus 66 ~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 140 (351)
++|++.+.||+|+||.||++.+. +++.+|+|.+.... .....+.+|++++++++||||+++++.+.+++..++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 47899999999999999999965 68999999986432 22356788999999999999999999999999999999
Q ss_pred EeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEeccccc
Q 018712 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (351)
Q Consensus 141 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a 220 (351)
||+++++|.+++..... ++...+..++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||++
T Consensus 81 e~~~~~~L~~~~~~~~~---------l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~ 148 (290)
T cd05580 81 EYVPGGELFSHLRKSGR---------FPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFA 148 (290)
T ss_pred ecCCCCCHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCc
Confidence 99999999999976542 889999999999999999999999 999999999999999999999999998
Q ss_pred CCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccchhh-------cccC
Q 018712 221 NQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTW-------ATPK 293 (351)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~~~-------~~~~ 293 (351)
...... .....|++.|+|||.+.+...+.++||||||+++|+|++|+.||...........+.. ..+.
T Consensus 149 ~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (290)
T cd05580 149 KRVKGR-----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFPSFFSP 223 (290)
T ss_pred cccCCC-----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCccCCccCCH
Confidence 776443 1345689999999999888889999999999999999999999976543211111111 1111
Q ss_pred CCccchhhhcccccCCCCC
Q 018712 294 LSEDKVKQCVDTKLGGEYP 312 (351)
Q Consensus 294 ~~~~~~~~~ld~~~~~~~~ 312 (351)
...+.+..|+..+|.+|++
T Consensus 224 ~l~~li~~~l~~~p~~R~~ 242 (290)
T cd05580 224 DAKDLIRNLLQVDLTKRLG 242 (290)
T ss_pred HHHHHHHHHccCCHHHccC
Confidence 2236788889888988884
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-38 Score=278.75 Aligned_cols=248 Identities=23% Similarity=0.303 Sum_probs=193.1
Q ss_pred CCCCceeccCCcEEEEEEEEC----CCCEEEEEEcCCCCCc---hHHHHHHHHHHHhccCCceeeeEEEEecCCc-----
Q 018712 68 FGTNSLIGEGSYGRVYFGVLR----SGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVDGPL----- 135 (351)
Q Consensus 68 y~~~~~Lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~----- 135 (351)
|.+.+.||+|+||.||+|... .+..||+|++...... ...+.+|+..++.++|+||+++++.+...+.
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 567889999999999999864 2468999998754332 3467889999999999999999998765544
Q ss_pred -eEEEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEE
Q 018712 136 -RVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKI 214 (351)
Q Consensus 136 -~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl 214 (351)
.++++||+++++|..++....... ....+++..+..++.|++.||.|||+.+ ++||||||+||++++++.+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~---~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl 154 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGG---LPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCV 154 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccC---CcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEE
Confidence 799999999999999986543211 1123889999999999999999999999 999999999999999999999
Q ss_pred ecccccCCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCCccch------
Q 018712 215 SDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLV------ 287 (351)
Q Consensus 215 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~Pf~~~~~~~~~~~~------ 287 (351)
+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..||...........+
T Consensus 155 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~ 234 (273)
T cd05035 155 ADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRL 234 (273)
T ss_pred CCccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC
Confidence 99999886644332211222335678999999988899999999999999999999 99999765432211111
Q ss_pred --hhcccCCCccchhhhcccccCCCCCHHHHHHHHH
Q 018712 288 --TWATPKLSEDKVKQCVDTKLGGEYPPKAIAKVRK 321 (351)
Q Consensus 288 --~~~~~~~~~~~~~~~ld~~~~~~~~~~~~~~~~~ 321 (351)
....+....+.+.+|+..+|.+|++..++.+.++
T Consensus 235 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~ 270 (273)
T cd05035 235 KQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLE 270 (273)
T ss_pred CCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 1111112236788899999999999888877654
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=282.60 Aligned_cols=254 Identities=22% Similarity=0.348 Sum_probs=199.0
Q ss_pred hcCCCCCceeccCCcEEEEEEEEC------CCCEEEEEEcCCCCC-chHHHHHHHHHHHhccCCceeeeEEEEecCCceE
Q 018712 65 TDNFGTNSLIGEGSYGRVYFGVLR------SGRAAAIKKLDSSKQ-PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRV 137 (351)
Q Consensus 65 ~~~y~~~~~Lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 137 (351)
.++|...++||+|+||.||++... ++..+|+|.+..... ....+.+|++++++++|+||+++++++.+....+
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (280)
T cd05092 4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLL 83 (280)
T ss_pred hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceE
Confidence 457888999999999999999742 456889998764432 2457889999999999999999999999999999
Q ss_pred EEEEeCCCCCHHHHhccCCCCC------CCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCc
Q 018712 138 LAYEHASKGSLHDILHGKKGVK------GAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDI 211 (351)
Q Consensus 138 lv~e~~~~gsL~~~l~~~~~~~------~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~ 211 (351)
++|||+++++|.+++....... .......+++..++.++.|++.||+|||+.+ ++||||||+|||+++++.
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~ 160 (280)
T cd05092 84 MVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLV 160 (280)
T ss_pred EEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCC
Confidence 9999999999999997643210 0111134789999999999999999999999 999999999999999999
Q ss_pred eEEecccccCCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCCccchh--
Q 018712 212 AKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVT-- 288 (351)
Q Consensus 212 vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~Pf~~~~~~~~~~~~~-- 288 (351)
+||+|||++................+++.|+|||.+.+..++.++||||||+++|+|++ |+.||...........+.
T Consensus 161 ~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~ 240 (280)
T cd05092 161 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQG 240 (280)
T ss_pred EEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHHcC
Confidence 99999999875533221111223345778999999999999999999999999999998 999997654322111111
Q ss_pred ------hcccCCCccchhhhcccccCCCCCHHHHHHHHH
Q 018712 289 ------WATPKLSEDKVKQCVDTKLGGEYPPKAIAKVRK 321 (351)
Q Consensus 289 ------~~~~~~~~~~~~~~ld~~~~~~~~~~~~~~~~~ 321 (351)
...+....+.+..|+..+|.+|++.+++...++
T Consensus 241 ~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 241 RELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred ccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 111222237889999999999999998876653
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=285.58 Aligned_cols=202 Identities=23% Similarity=0.377 Sum_probs=171.7
Q ss_pred HhcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCC--CchHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEE
Q 018712 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK--QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAY 140 (351)
Q Consensus 64 ~~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 140 (351)
..++|.+.+.||+|+||.||+|... ++..||+|.+.... .....+.+|+.++++++|+||+++++++...+..++||
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~ 83 (301)
T cd07873 4 KLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVF 83 (301)
T ss_pred cccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEE
Confidence 3568999999999999999999975 68899999986443 22346778999999999999999999999999999999
Q ss_pred EeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEeccccc
Q 018712 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (351)
Q Consensus 141 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a 220 (351)
||+.+ +|.+++..... .+++..+..++.||+.||.|||+.+ ++|+||||+||++++++.+||+|||++
T Consensus 84 e~~~~-~l~~~l~~~~~--------~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~ 151 (301)
T cd07873 84 EYLDK-DLKQYLDDCGN--------SINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLA 151 (301)
T ss_pred ecccc-CHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcch
Confidence 99974 99998875432 2788999999999999999999999 999999999999999999999999998
Q ss_pred CCCccccccccccccccccCccCcccccCC-CCCccchhHhHHHHHHHHHcCCCCCCCCC
Q 018712 221 NQAPDAAARLHSTRVLGTFGYHAPEYAMTG-QMSSKSDVYSFGVVLLELLTGRKPVDHTL 279 (351)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~Pf~~~~ 279 (351)
......... .....+++.|+|||.+.+. .++.++||||||+++|+|++|+.||....
T Consensus 152 ~~~~~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~ 209 (301)
T cd07873 152 RAKSIPTKT--YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGST 209 (301)
T ss_pred hccCCCCCc--ccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 764332211 1234578899999988654 57889999999999999999999998654
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-38 Score=276.91 Aligned_cols=247 Identities=23% Similarity=0.340 Sum_probs=199.5
Q ss_pred cCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCC----CchHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEE
Q 018712 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK----QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAY 140 (351)
Q Consensus 66 ~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 140 (351)
++|++.+.||+|+||.||+|... +++.||+|.+.... .....+.+|++++++++|+||+++++.+.+.+..+++|
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57999999999999999999976 88999999886422 22456889999999999999999999999999999999
Q ss_pred EeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEeccccc
Q 018712 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (351)
Q Consensus 141 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a 220 (351)
||+++++|.+++...... ...++...+..++.|++.||.|||+.| ++||||+|+||+++.++.++|+|||++
T Consensus 82 e~~~~~~L~~~l~~~~~~-----~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~ 153 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQ-----KRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLG 153 (267)
T ss_pred ecCCCCCHHHHHHHhccc-----CCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEecccee
Confidence 999999999998653211 123788999999999999999999999 999999999999999999999999998
Q ss_pred CCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCc---cchh--------h
Q 018712 221 NQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQ---SLVT--------W 289 (351)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~---~~~~--------~ 289 (351)
......... .....++..|+|||.+.+..++.++|+||||+++|+|++|+.||......... .... .
T Consensus 154 ~~~~~~~~~--~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (267)
T cd08224 154 RFFSSKTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPAD 231 (267)
T ss_pred eeccCCCcc--cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCCCCChh
Confidence 765432211 13346888999999999888999999999999999999999999654321000 0000 0
Q ss_pred cccCCCccchhhhcccccCCCCCHHHHHHHHHH
Q 018712 290 ATPKLSEDKVKQCVDTKLGGEYPPKAIAKVRKK 322 (351)
Q Consensus 290 ~~~~~~~~~~~~~ld~~~~~~~~~~~~~~~~~~ 322 (351)
..+....+.+..|+++.|.+|++..++...++.
T Consensus 232 ~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~ 264 (267)
T cd08224 232 HYSEELRDLVSRCINPDPEKRPDISYVLQVAKE 264 (267)
T ss_pred hcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHH
Confidence 111122367889999999999999988776553
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=285.21 Aligned_cols=255 Identities=25% Similarity=0.352 Sum_probs=197.2
Q ss_pred HhcCCCCCceeccCCcEEEEEEEEC-CCC--EEEEEEcCCCCC--chHHHHHHHHHHHhc-cCCceeeeEEEEecCCceE
Q 018712 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGR--AAAIKKLDSSKQ--PDQEFLAQVSMVSRL-KNENVVELVGYYVDGPLRV 137 (351)
Q Consensus 64 ~~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~--~vavK~~~~~~~--~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~ 137 (351)
..++|++.+.||+|+||.||+|.++ ++. .+++|.+..... ....+.+|+.++.++ +|+||+++++++.+++..+
T Consensus 5 ~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~ 84 (303)
T cd05088 5 EWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY 84 (303)
T ss_pred chhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCce
Confidence 3468899999999999999999965 444 457777654322 235678899999999 8999999999999999999
Q ss_pred EEEEeCCCCCHHHHhccCCCCCC-------CCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCC
Q 018712 138 LAYEHASKGSLHDILHGKKGVKG-------AKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD 210 (351)
Q Consensus 138 lv~e~~~~gsL~~~l~~~~~~~~-------~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~ 210 (351)
+||||+++++|.+++........ ......+++..++.++.|++.||+|||++| ++||||||+|||+++++
T Consensus 85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~ 161 (303)
T cd05088 85 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENY 161 (303)
T ss_pred EEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCC
Confidence 99999999999999976532110 011234889999999999999999999999 99999999999999999
Q ss_pred ceEEecccccCCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCCccchhh
Q 018712 211 IAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTW 289 (351)
Q Consensus 211 ~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~Pf~~~~~~~~~~~~~~ 289 (351)
.+||+|||++........ .....++..|+|||++.+..++.++||||||+++|||+| |..||...........+..
T Consensus 162 ~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~ 238 (303)
T cd05088 162 VAKIADFGLSRGQEVYVK---KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ 238 (303)
T ss_pred cEEeCccccCcccchhhh---cccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHhc
Confidence 999999999864321111 122234667999999988889999999999999999998 9999976543221111110
Q ss_pred --------cccCCCccchhhhcccccCCCCCHHHHHHHHHHHH
Q 018712 290 --------ATPKLSEDKVKQCVDTKLGGEYPPKAIAKVRKKKF 324 (351)
Q Consensus 290 --------~~~~~~~~~~~~~ld~~~~~~~~~~~~~~~~~~~~ 324 (351)
..+....+.+.+|+..+|.+|++.+++...+.-.+
T Consensus 239 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~ 281 (303)
T cd05088 239 GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 281 (303)
T ss_pred CCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 01112236888999999999999998877665443
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=276.79 Aligned_cols=238 Identities=28% Similarity=0.436 Sum_probs=196.4
Q ss_pred cCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCCchHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEEEeCC
Q 018712 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHAS 144 (351)
Q Consensus 66 ~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 144 (351)
++|++.+.||+|+||.||+|... ++..+++|.+..... .+.+.+|++++++++|+||+++++.+.+....|+++||+.
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 81 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED-LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCG 81 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH-HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCC
Confidence 67999999999999999999976 478999999875543 5678999999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccccCCCc
Q 018712 145 KGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAP 224 (351)
Q Consensus 145 ~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~ 224 (351)
+++|.+++..... .+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||++....
T Consensus 82 ~~~L~~~l~~~~~--------~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~ 150 (256)
T cd06612 82 AGSVSDIMKITNK--------TLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLT 150 (256)
T ss_pred CCcHHHHHHhCcc--------CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcc
Confidence 9999999975432 2899999999999999999999999 9999999999999999999999999988765
Q ss_pred cccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccchhh-cc---------cCC
Q 018712 225 DAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTW-AT---------PKL 294 (351)
Q Consensus 225 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~~~-~~---------~~~ 294 (351)
..... .....++..|+|||++.+..++.++||||||+++|+|++|+.||....+......+.. .. +..
T Consensus 151 ~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (256)
T cd06612 151 DTMAK--RNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPE 228 (256)
T ss_pred cCccc--cccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCCCCCchhhcCHH
Confidence 43211 2334578899999999988999999999999999999999999986543322111110 00 111
Q ss_pred CccchhhhcccccCCCCCHHHHH
Q 018712 295 SEDKVKQCVDTKLGGEYPPKAIA 317 (351)
Q Consensus 295 ~~~~~~~~ld~~~~~~~~~~~~~ 317 (351)
..+.+..|+..+|.+|++.+++.
T Consensus 229 ~~~~i~~~l~~~P~~Rps~~~il 251 (256)
T cd06612 229 FNDFVKKCLVKDPEERPSAIQLL 251 (256)
T ss_pred HHHHHHHHHhcChhhCcCHHHHh
Confidence 13567788888888888877654
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=283.20 Aligned_cols=256 Identities=24% Similarity=0.341 Sum_probs=199.6
Q ss_pred HHhcCCCCCceeccCCcEEEEEEEEC------CCCEEEEEEcCCCCCc--hHHHHHHHHHHHhc-cCCceeeeEEEEecC
Q 018712 63 EKTDNFGTNSLIGEGSYGRVYFGVLR------SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRL-KNENVVELVGYYVDG 133 (351)
Q Consensus 63 ~~~~~y~~~~~Lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l-~h~niv~~~~~~~~~ 133 (351)
...++|++.+.||+|+||.||++... ....+|+|.+...... ...+.+|+.+++++ +|+||+++++++...
T Consensus 9 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 88 (293)
T cd05053 9 LPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQE 88 (293)
T ss_pred cCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCC
Confidence 34567899999999999999999864 2368999998754332 24578899999999 899999999999999
Q ss_pred CceEEEEEeCCCCCHHHHhccCCCCC-------CCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEE
Q 018712 134 PLRVLAYEHASKGSLHDILHGKKGVK-------GAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLL 206 (351)
Q Consensus 134 ~~~~lv~e~~~~gsL~~~l~~~~~~~-------~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill 206 (351)
+..+++|||+++|+|.+++....... .......+++..++.++.|++.||.|||+++ ++||||||+||++
T Consensus 89 ~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Nil~ 165 (293)
T cd05053 89 GPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNVLV 165 (293)
T ss_pred CCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeEEE
Confidence 99999999999999999997542110 0012234889999999999999999999999 9999999999999
Q ss_pred ccCCceEEecccccCCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCCcc
Q 018712 207 FDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQS 285 (351)
Q Consensus 207 ~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~Pf~~~~~~~~~~ 285 (351)
++++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..||..........
T Consensus 166 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~ 245 (293)
T cd05053 166 TEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFK 245 (293)
T ss_pred cCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHHH
Confidence 9999999999999987644322111222335678999999988899999999999999999998 999997654322111
Q ss_pred chhh--------cccCCCccchhhhcccccCCCCCHHHHHHHHH
Q 018712 286 LVTW--------ATPKLSEDKVKQCVDTKLGGEYPPKAIAKVRK 321 (351)
Q Consensus 286 ~~~~--------~~~~~~~~~~~~~ld~~~~~~~~~~~~~~~~~ 321 (351)
.+.. ..+....+.+.+|++++|.+|++..++...++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~ 289 (293)
T cd05053 246 LLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLD 289 (293)
T ss_pred HHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHH
Confidence 1110 11111236788999999999999988876554
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=281.76 Aligned_cols=249 Identities=26% Similarity=0.419 Sum_probs=195.6
Q ss_pred CHHHHHHHhcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCCchHHHHHHHHHHHhc-cCCceeeeEEEEec--
Q 018712 57 SVDELKEKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRL-KNENVVELVGYYVD-- 132 (351)
Q Consensus 57 ~~~~~~~~~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~-- 132 (351)
++.++....+.|++.+.||.|+||.||+|.+. +++.+|+|.+.........+..|+.+++++ +|+||+++++++..
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~ 86 (282)
T cd06636 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKS 86 (282)
T ss_pred hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhccc
Confidence 33444455678999999999999999999974 688999999876655556788899999998 79999999998853
Q ss_pred ----CCceEEEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEcc
Q 018712 133 ----GPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFD 208 (351)
Q Consensus 133 ----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~ 208 (351)
....+++|||+.+|+|.+++...... .+++..+..++.||+.||.|||+.+ ++|+||+|+||++++
T Consensus 87 ~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~-------~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~ 156 (282)
T cd06636 87 PPGHDDQLWLVMEFCGAGSVTDLVKNTKGN-------ALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTE 156 (282)
T ss_pred ccCCCCEEEEEEEeCCCCcHHHHHHHccCC-------CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECC
Confidence 45789999999999999999764422 2778888999999999999999999 999999999999999
Q ss_pred CCceEEecccccCCCccccccccccccccccCccCccccc-----CCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCC
Q 018712 209 DDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAM-----TGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQ 283 (351)
Q Consensus 209 ~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~ 283 (351)
++.++|+|||++........ ......|+..|+|||.+. +..++.++|+||||+++|+|++|+.||....+...
T Consensus 157 ~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~ 234 (282)
T cd06636 157 NAEVKLVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRA 234 (282)
T ss_pred CCCEEEeeCcchhhhhcccc--CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhh
Confidence 99999999999876532221 123456899999999875 34678899999999999999999999976543222
Q ss_pred ccchhhc---------ccCCCccchhhhcccccCCCCCHHHHH
Q 018712 284 QSLVTWA---------TPKLSEDKVKQCVDTKLGGEYPPKAIA 317 (351)
Q Consensus 284 ~~~~~~~---------~~~~~~~~~~~~ld~~~~~~~~~~~~~ 317 (351)
...+... .+....+.+..|+..++.+|++..++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell 277 (282)
T cd06636 235 LFLIPRNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLL 277 (282)
T ss_pred hhhHhhCCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHh
Confidence 1111111 111123677788888888888877653
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=284.24 Aligned_cols=252 Identities=24% Similarity=0.327 Sum_probs=195.8
Q ss_pred cCCCCCceeccCCcEEEEEEEECC---------------CCEEEEEEcCCCCCc--hHHHHHHHHHHHhccCCceeeeEE
Q 018712 66 DNFGTNSLIGEGSYGRVYFGVLRS---------------GRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVG 128 (351)
Q Consensus 66 ~~y~~~~~Lg~G~~g~Vy~~~~~~---------------~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~ 128 (351)
++|++.+.||+|+||.||++.... ...||+|.+...... ...+.+|++++++++|+||+++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 579999999999999999987532 235899998754322 346889999999999999999999
Q ss_pred EEecCCceEEEEEeCCCCCHHHHhccCCCCC---CCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEE
Q 018712 129 YYVDGPLRVLAYEHASKGSLHDILHGKKGVK---GAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVL 205 (351)
Q Consensus 129 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~---~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nil 205 (351)
++...+..++||||+.+++|.+++....... .....+.+++..+..++.|++.||.|||+++ ++||||||+||+
T Consensus 85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil 161 (295)
T cd05097 85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNCL 161 (295)
T ss_pred EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhEE
Confidence 9999999999999999999999996542111 1111223688899999999999999999999 999999999999
Q ss_pred EccCCceEEecccccCCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHc--CCCCCCCCCCCCC
Q 018712 206 LFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT--GRKPVDHTLPRGQ 283 (351)
Q Consensus 206 l~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t--g~~Pf~~~~~~~~ 283 (351)
+++++.+||+|||++................++..|+|||.+.+..++.++||||||+++|+|++ |..||........
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~ 241 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQV 241 (295)
T ss_pred EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHHH
Confidence 99999999999999876543322111223345778999999998889999999999999999988 6778876433211
Q ss_pred ccch---------------hhcccCCCccchhhhcccccCCCCCHHHHHHHH
Q 018712 284 QSLV---------------TWATPKLSEDKVKQCVDTKLGGEYPPKAIAKVR 320 (351)
Q Consensus 284 ~~~~---------------~~~~~~~~~~~~~~~ld~~~~~~~~~~~~~~~~ 320 (351)
...+ ....+....+.+..|++.+|.+|++.+++...+
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l 293 (295)
T cd05097 242 IENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFL 293 (295)
T ss_pred HHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHH
Confidence 1000 001111223678899999999999999887655
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=293.32 Aligned_cols=257 Identities=25% Similarity=0.376 Sum_probs=200.5
Q ss_pred HhcCCCCCceeccCCcEEEEEEEEC------CCCEEEEEEcCCCCCc--hHHHHHHHHHHHhcc-CCceeeeEEEEecCC
Q 018712 64 KTDNFGTNSLIGEGSYGRVYFGVLR------SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLK-NENVVELVGYYVDGP 134 (351)
Q Consensus 64 ~~~~y~~~~~Lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~ 134 (351)
..++|.+.+.||+|+||.||+|.+. ++..||+|++...... .+.+.+|+++|.++. ||||+++++.+...+
T Consensus 35 ~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~ 114 (401)
T cd05107 35 PRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGG 114 (401)
T ss_pred cHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCC
Confidence 4456888999999999999999853 3468999999754332 346889999999997 999999999999999
Q ss_pred ceEEEEEeCCCCCHHHHhccCCCCC-------------------------------------------------------
Q 018712 135 LRVLAYEHASKGSLHDILHGKKGVK------------------------------------------------------- 159 (351)
Q Consensus 135 ~~~lv~e~~~~gsL~~~l~~~~~~~------------------------------------------------------- 159 (351)
..++||||+.+|+|.++++......
T Consensus 115 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (401)
T cd05107 115 PIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQD 194 (401)
T ss_pred CcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhc
Confidence 9999999999999999997543200
Q ss_pred ----------------------------------CCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEE
Q 018712 160 ----------------------------------GAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVL 205 (351)
Q Consensus 160 ----------------------------------~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nil 205 (351)
.....+.+++..++.++.||+.||.|||+.+ ++||||||+|||
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~NiL 271 (401)
T cd05107 195 MKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAARNVL 271 (401)
T ss_pred chhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcceEE
Confidence 0011234788889999999999999999998 999999999999
Q ss_pred EccCCceEEecccccCCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCCc
Q 018712 206 LFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQ 284 (351)
Q Consensus 206 l~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~Pf~~~~~~~~~ 284 (351)
+++++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..||.........
T Consensus 272 l~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~ 351 (401)
T cd05107 272 ICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQF 351 (401)
T ss_pred EeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHH
Confidence 99999999999999876533221111223456788999999998889999999999999999998 89999764332211
Q ss_pred -cchhh--------cccCCCccchhhhcccccCCCCCHHHHHHHHHHH
Q 018712 285 -SLVTW--------ATPKLSEDKVKQCVDTKLGGEYPPKAIAKVRKKK 323 (351)
Q Consensus 285 -~~~~~--------~~~~~~~~~~~~~ld~~~~~~~~~~~~~~~~~~~ 323 (351)
..+.. ..+....+.+.+|+..+|..|++.+++...++-.
T Consensus 352 ~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~ 399 (401)
T cd05107 352 YNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDL 399 (401)
T ss_pred HHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 11110 0111123678999999999999999988876654
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=290.28 Aligned_cols=206 Identities=26% Similarity=0.396 Sum_probs=181.9
Q ss_pred cCCCCCceeccCCcEEEEEEEECCCCEEEEEEcCCCCCc--hHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEEEeC
Q 018712 66 DNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHA 143 (351)
Q Consensus 66 ~~y~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 143 (351)
+...+.++||+|-||.|.++....+..||+|+++..... ..+|.+|+++|.+|+||||+++++.|..++.+++++||+
T Consensus 538 s~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYm 617 (807)
T KOG1094|consen 538 SRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYM 617 (807)
T ss_pred hheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHH
Confidence 457788899999999999999988899999999876543 468999999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccccCCC
Q 018712 144 SKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQA 223 (351)
Q Consensus 144 ~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~ 223 (351)
++|+|.+|+.+..... +.......++.||+.|++||.+.+ +|||||.+.|+|++.++++||+|||+++.+
T Consensus 618 EnGDLnqFl~aheapt-------~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~l 687 (807)
T KOG1094|consen 618 ENGDLNQFLSAHELPT-------AETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRNL 687 (807)
T ss_pred hcCcHHHHHHhccCcc-------cccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCccccccc
Confidence 9999999999875321 344566779999999999999999 999999999999999999999999999987
Q ss_pred ccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHc--CCCCCCCCCCC
Q 018712 224 PDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT--GRKPVDHTLPR 281 (351)
Q Consensus 224 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t--g~~Pf~~~~~~ 281 (351)
..........+.+-..+|||||.+..+.++.++|+|+||+++||+++ ...||.....+
T Consensus 688 ysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e 747 (807)
T KOG1094|consen 688 YSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDE 747 (807)
T ss_pred ccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHH
Confidence 76665544556677889999999999999999999999999999765 88999876543
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=289.07 Aligned_cols=205 Identities=25% Similarity=0.398 Sum_probs=183.0
Q ss_pred HhcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCC----CchHHHHHHHHHHHhccCCceeeeEEEEecCCceEE
Q 018712 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK----QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVL 138 (351)
Q Consensus 64 ~~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 138 (351)
..+.|.....||+||||.|+-+..+ +|+-||.|++.+.. ......++|-++|.+++.++||.+--.|.+.+.+++
T Consensus 183 t~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LCl 262 (591)
T KOG0986|consen 183 TKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCL 262 (591)
T ss_pred cccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEE
Confidence 4467888899999999999999854 89999999886432 234557899999999999999999999999999999
Q ss_pred EEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEeccc
Q 018712 139 AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFD 218 (351)
Q Consensus 139 v~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg 218 (351)
||..|.||+|.-+|...+. +.+++..++.++.+|+.||.+||+.+ ||+|||||+|||+|+.|+|+|+|+|
T Consensus 263 VLtlMNGGDLkfHiyn~g~-------~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLG 332 (591)
T KOG0986|consen 263 VLTLMNGGDLKFHIYNHGN-------PGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLG 332 (591)
T ss_pred EEEeecCCceeEEeeccCC-------CCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccc
Confidence 9999999999999987763 34999999999999999999999999 9999999999999999999999999
Q ss_pred ccCCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCC
Q 018712 219 LSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPR 281 (351)
Q Consensus 219 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~ 281 (351)
+|..++..... ...+||.+|||||++.+..|+...|+|||||++|||+.|+.||......
T Consensus 333 LAvei~~g~~~---~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeK 392 (591)
T KOG0986|consen 333 LAVEIPEGKPI---RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEK 392 (591)
T ss_pred eEEecCCCCcc---ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhh
Confidence 99988776543 4458999999999999999999999999999999999999999875443
|
|
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=279.85 Aligned_cols=239 Identities=28% Similarity=0.377 Sum_probs=191.6
Q ss_pred hcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCC-chHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEEEe
Q 018712 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ-PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEH 142 (351)
Q Consensus 65 ~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 142 (351)
.++|.+.+.||+|+||.||+|... +++.||+|.+..... ....+.+|+.+++.++||||+++++.+...+..+++|||
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~ 87 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEF 87 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Confidence 357888899999999999999864 688999999875432 234577899999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccccCC
Q 018712 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222 (351)
Q Consensus 143 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~ 222 (351)
+++++|.+++..... +++.++..++.|++.||.|||+.| ++|+||||+||+++.++.+||+|||++..
T Consensus 88 ~~~~~L~~~~~~~~~---------~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~ 155 (267)
T cd06645 88 CGGGSLQDIYHVTGP---------LSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQ 155 (267)
T ss_pred cCCCcHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeE
Confidence 999999999876542 889999999999999999999999 99999999999999999999999999865
Q ss_pred CccccccccccccccccCccCccccc---CCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccchh---hcc-----
Q 018712 223 APDAAARLHSTRVLGTFGYHAPEYAM---TGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVT---WAT----- 291 (351)
Q Consensus 223 ~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~~---~~~----- 291 (351)
...... ......|+..|+|||++. ...++.++|+||||+++|+|++|+.||....+........ ...
T Consensus 156 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (267)
T cd06645 156 ITATIA--KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKD 233 (267)
T ss_pred ccCccc--ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccc
Confidence 532211 123456899999999874 4568889999999999999999999987544322111100 000
Q ss_pred ----cCCCccchhhhcccccCCCCCHHHHH
Q 018712 292 ----PKLSEDKVKQCVDTKLGGEYPPKAIA 317 (351)
Q Consensus 292 ----~~~~~~~~~~~ld~~~~~~~~~~~~~ 317 (351)
+....+.+..|+..+|.+|++.+++.
T Consensus 234 ~~~~~~~~~~li~~~l~~~P~~R~~~~~ll 263 (267)
T cd06645 234 KMKWSNSFHHFVKMALTKNPKKRPTAEKLL 263 (267)
T ss_pred cCCCCHHHHHHHHHHccCCchhCcCHHHHh
Confidence 11112577888888888888876653
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-38 Score=276.64 Aligned_cols=246 Identities=28% Similarity=0.392 Sum_probs=197.1
Q ss_pred ceeccCCcEEEEEEEECC----CCEEEEEEcCCCCCc--hHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEEEeCCC
Q 018712 72 SLIGEGSYGRVYFGVLRS----GRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASK 145 (351)
Q Consensus 72 ~~Lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 145 (351)
+.||+|+||.||+|.... +..+++|.+...... ...+.+|++.++.++|+||+++++++.+....+++|||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 469999999999999753 789999998766544 46788999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccccCCCcc
Q 018712 146 GSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPD 225 (351)
Q Consensus 146 gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~ 225 (351)
++|.+++..............+++..+..++.|++.||.|||+++ ++|+||+|+||+++.++.+||+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccccccccc
Confidence 999999987521110111123899999999999999999999999 99999999999999999999999999987654
Q ss_pred ccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCCccchh--------hcccCCCc
Q 018712 226 AAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVT--------WATPKLSE 296 (351)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~Pf~~~~~~~~~~~~~--------~~~~~~~~ 296 (351)
...........++..|+|||.+....++.++||||||+++|+|++ |..||...........+. ...+....
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRLPKPEYCPDELY 237 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCccCChHHH
Confidence 432222234567889999999988889999999999999999999 699998764322111111 11112223
Q ss_pred cchhhhcccccCCCCCHHHHHHHH
Q 018712 297 DKVKQCVDTKLGGEYPPKAIAKVR 320 (351)
Q Consensus 297 ~~~~~~ld~~~~~~~~~~~~~~~~ 320 (351)
+.+..|+..++.+|++.+++...+
T Consensus 238 ~li~~~l~~~p~~Rps~~~l~~~l 261 (262)
T cd00192 238 ELMLSCWQLDPEDRPTFSELVERL 261 (262)
T ss_pred HHHHHHccCCcccCcCHHHHHHhh
Confidence 567889999999999998887654
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=285.87 Aligned_cols=250 Identities=23% Similarity=0.324 Sum_probs=202.3
Q ss_pred cCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCC----chHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEE
Q 018712 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ----PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAY 140 (351)
Q Consensus 66 ~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 140 (351)
++|++.+.||+|+||.||++... +++.|++|.+..... ....+.+|+.+++.++||||+++++.+..++..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 47889999999999999999975 678999998865432 2345778999999999999999999999999999999
Q ss_pred EeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEeccccc
Q 018712 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (351)
Q Consensus 141 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a 220 (351)
||+++++|.+++..... +++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++
T Consensus 81 e~~~g~~L~~~l~~~~~---------~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~ 148 (305)
T cd05609 81 EYVEGGDCATLLKNIGA---------LPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLS 148 (305)
T ss_pred ecCCCCcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCc
Confidence 99999999999976532 788999999999999999999999 999999999999999999999999988
Q ss_pred CCCcccc-------------ccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccch
Q 018712 221 NQAPDAA-------------ARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLV 287 (351)
Q Consensus 221 ~~~~~~~-------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~ 287 (351)
+...... .........++..|+|||.+.+..++.++|+||||+++|+|++|..||.+..........
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~ 228 (305)
T cd05609 149 KIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQV 228 (305)
T ss_pred cccCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 6421100 000112245788999999998888999999999999999999999999865432211111
Q ss_pred hh----------cccCCCccchhhhcccccCCCCCHHHHHHHHHHHHHhh
Q 018712 288 TW----------ATPKLSEDKVKQCVDTKLGGEYPPKAIAKVRKKKFITS 327 (351)
Q Consensus 288 ~~----------~~~~~~~~~~~~~ld~~~~~~~~~~~~~~~~~~~~~~~ 327 (351)
.. ..+....+.+..|+..+|.+|++...+..++++++++.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~ 278 (305)
T cd05609 229 ISDDIEWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLG 278 (305)
T ss_pred HhcccCCCCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccC
Confidence 10 11122246889999999999999888888888887643
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=283.41 Aligned_cols=253 Identities=23% Similarity=0.325 Sum_probs=197.0
Q ss_pred hcCCCCCceeccCCcEEEEEEEECC-----------------CCEEEEEEcCCCCCc--hHHHHHHHHHHHhccCCceee
Q 018712 65 TDNFGTNSLIGEGSYGRVYFGVLRS-----------------GRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVE 125 (351)
Q Consensus 65 ~~~y~~~~~Lg~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~niv~ 125 (351)
.++|++.+.||+|+||.||++.... +..||+|.+...... ...+.+|++++++++|+||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 4679999999999999999988542 246899998755432 456788999999999999999
Q ss_pred eEEEEecCCceEEEEEeCCCCCHHHHhccCCCCCCC--CCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCc
Q 018712 126 LVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGA--KPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSN 203 (351)
Q Consensus 126 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~--~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~N 203 (351)
+++++..++..+++||++.+++|.+++......... .....+++..++.++.|++.||.|||+++ ++|+||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhc
Confidence 999999999999999999999999999765421100 11123889999999999999999999999 9999999999
Q ss_pred EEEccCCceEEecccccCCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHc--CCCCCCCCCCC
Q 018712 204 VLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT--GRKPVDHTLPR 281 (351)
Q Consensus 204 ill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t--g~~Pf~~~~~~ 281 (351)
|++++++.++|+|||++................++..|+|||++.+..++.++||||||+++|||++ |..||......
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQ 240 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChH
Confidence 9999999999999999876543322222234456788999999988889999999999999999998 77888764332
Q ss_pred CCccchh---------------hcccCCCccchhhhcccccCCCCCHHHHHHHH
Q 018712 282 GQQSLVT---------------WATPKLSEDKVKQCVDTKLGGEYPPKAIAKVR 320 (351)
Q Consensus 282 ~~~~~~~---------------~~~~~~~~~~~~~~ld~~~~~~~~~~~~~~~~ 320 (351)
....... ...+....+.+..|+..+|.+|++..++...+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L 294 (296)
T cd05051 241 QVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFL 294 (296)
T ss_pred HHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHh
Confidence 1100000 00011224677888999999999988886554
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=279.37 Aligned_cols=246 Identities=20% Similarity=0.309 Sum_probs=197.6
Q ss_pred cCCCCCceeccCCcEEEEEEEE-CCCCEEEEEEcCCCCC----chHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEE
Q 018712 66 DNFGTNSLIGEGSYGRVYFGVL-RSGRAAAIKKLDSSKQ----PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAY 140 (351)
Q Consensus 66 ~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 140 (351)
++|++.+.||+|+||.||++.. .++..+++|.+..... ....+.+|+.+++.++|+||+++++++.+++..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 5788999999999999999996 4889999998764322 2356788999999999999999999999999999999
Q ss_pred EeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEeccccc
Q 018712 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (351)
Q Consensus 141 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a 220 (351)
||+++++|.+++...... ...+++..++.++.||+.||.|||+++ ++|+||||+||+++.++.++|+|||++
T Consensus 82 e~~~~~~L~~~~~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~ 153 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQ-----KRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLG 153 (267)
T ss_pred EecCCCCHHHHHHHhhcc-----CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhh
Confidence 999999999998742211 123889999999999999999999999 999999999999999999999999998
Q ss_pred CCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCc--cch-hhc-------
Q 018712 221 NQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQ--SLV-TWA------- 290 (351)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~--~~~-~~~------- 290 (351)
......... .....|+..|+|||.+.+..++.++|+||||+++|+|++|..||......... ..+ ...
T Consensus 154 ~~~~~~~~~--~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (267)
T cd08229 154 RFFSSKTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSD 231 (267)
T ss_pred hccccCCcc--cccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCCCCcc
Confidence 765433221 12346889999999998888999999999999999999999999754322110 000 001
Q ss_pred -ccCCCccchhhhcccccCCCCCHHHHHHHHH
Q 018712 291 -TPKLSEDKVKQCVDTKLGGEYPPKAIAKVRK 321 (351)
Q Consensus 291 -~~~~~~~~~~~~ld~~~~~~~~~~~~~~~~~ 321 (351)
.+....+.+.+|++.+|.+|++..++...++
T Consensus 232 ~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~ 263 (267)
T cd08229 232 HYSEELRQLVNMCINPDPEKRPDITYVYDVAK 263 (267)
T ss_pred cccHHHHHHHHHhcCCCcccCCCHHHHHHHHh
Confidence 1112236778899999999999987766554
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-38 Score=276.58 Aligned_cols=240 Identities=28% Similarity=0.437 Sum_probs=193.6
Q ss_pred hcCCCCCceeccCCcEEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHHhccCCceeeeEEEE-ecCCceEEEEEeC
Q 018712 65 TDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYY-VDGPLRVLAYEHA 143 (351)
Q Consensus 65 ~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~-~~~~~~~lv~e~~ 143 (351)
.++|.+.+.||+|+||.||++... +..+|+|.+.... ..+.+.+|+.++++++|+|++++++++ .+.+..+++|||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~ 82 (256)
T cd05082 5 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 82 (256)
T ss_pred HHhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc-hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence 457899999999999999999765 7789999886543 345688999999999999999999875 4556789999999
Q ss_pred CCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccccCCC
Q 018712 144 SKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQA 223 (351)
Q Consensus 144 ~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~ 223 (351)
++++|.+++..... ..+++..++.++.|++.||+|||+++ ++||||||+||++++++.+||+|||++...
T Consensus 83 ~~~~L~~~~~~~~~-------~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~ 152 (256)
T cd05082 83 AKGSLVDYLRSRGR-------SVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEA 152 (256)
T ss_pred CCCcHHHHHHhcCC-------CCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceec
Confidence 99999999976542 12788999999999999999999999 999999999999999999999999998754
Q ss_pred ccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCCccchh--------hcccCC
Q 018712 224 PDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVT--------WATPKL 294 (351)
Q Consensus 224 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~Pf~~~~~~~~~~~~~--------~~~~~~ 294 (351)
.... ....++..|+|||++.+..++.++||||||+++|+|++ |+.||...........+. ...+..
T Consensus 153 ~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (256)
T cd05082 153 SSTQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPV 227 (256)
T ss_pred cccC-----CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCHH
Confidence 3322 22334668999999998899999999999999999997 999997543322111111 011222
Q ss_pred CccchhhhcccccCCCCCHHHHHHHHH
Q 018712 295 SEDKVKQCVDTKLGGEYPPKAIAKVRK 321 (351)
Q Consensus 295 ~~~~~~~~ld~~~~~~~~~~~~~~~~~ 321 (351)
..+.+.+|+..+|.+|++..++.+.++
T Consensus 228 ~~~li~~~l~~~p~~Rpt~~~l~~~l~ 254 (256)
T cd05082 228 VYDVMKQCWHLDAATRPSFLQLREQLE 254 (256)
T ss_pred HHHHHHHHhcCChhhCcCHHHHHHHHh
Confidence 246788999999999999988876554
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=280.15 Aligned_cols=244 Identities=27% Similarity=0.417 Sum_probs=199.8
Q ss_pred cCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCC--CchHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEEEe
Q 018712 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK--QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEH 142 (351)
Q Consensus 66 ~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 142 (351)
++|++.+.||.|++|.||+|... ++..+|+|.+.... .....+.+|+++++.++|+||+++++.+.++...++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 46888999999999999999965 68899999987543 2235678899999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccccCC
Q 018712 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222 (351)
Q Consensus 143 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~ 222 (351)
+++++|.+++.... +++..+..++.|++.||.|||+++ ++|+||+|+||++++++.++|+|||++..
T Consensus 81 ~~~~~L~~~~~~~~----------~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~ 147 (274)
T cd06609 81 CGGGSCLDLLKPGK----------LDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQ 147 (274)
T ss_pred eCCCcHHHHHhhcC----------CCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccccccee
Confidence 99999999998652 889999999999999999999999 99999999999999999999999999877
Q ss_pred CccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccchhhc---------ccC
Q 018712 223 APDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWA---------TPK 293 (351)
Q Consensus 223 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~~~~---------~~~ 293 (351)
...... ......+++.|+|||.+.+..++.++||||||+++|+|++|+.||....+......+... .+.
T Consensus 148 ~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (274)
T cd06609 148 LTSTMS--KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLEGNKFSK 225 (274)
T ss_pred eccccc--ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCCCCCcccccCH
Confidence 654321 123456888999999999888999999999999999999999999765432211111111 112
Q ss_pred CCccchhhhcccccCCCCCHHHHHHHHHHHHHhh
Q 018712 294 LSEDKVKQCVDTKLGGEYPPKAIAKVRKKKFITS 327 (351)
Q Consensus 294 ~~~~~~~~~ld~~~~~~~~~~~~~~~~~~~~~~~ 327 (351)
...+.+..|+..+|.+|++.+++ +.+.++..
T Consensus 226 ~~~~~l~~~l~~~p~~Rpt~~~i---l~~~~~~~ 256 (274)
T cd06609 226 PFKDFVSLCLNKDPKERPSAKEL---LKHKFIKK 256 (274)
T ss_pred HHHHHHHHHhhCChhhCcCHHHH---hhChhhcC
Confidence 23467788999999999987665 44555443
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=282.34 Aligned_cols=260 Identities=23% Similarity=0.344 Sum_probs=201.4
Q ss_pred hcCCCCCceeccCCcEEEEEEEEC--------CCCEEEEEEcCCCCCc--hHHHHHHHHHHHhc-cCCceeeeEEEEecC
Q 018712 65 TDNFGTNSLIGEGSYGRVYFGVLR--------SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRL-KNENVVELVGYYVDG 133 (351)
Q Consensus 65 ~~~y~~~~~Lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l-~h~niv~~~~~~~~~ 133 (351)
.++|.+.+.||+|+||.||++... ....+|+|.+...... ...+.+|+.+++++ .||||+++++++.+.
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE 90 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence 357889999999999999999742 2457899988754332 34678899999999 699999999999999
Q ss_pred CceEEEEEeCCCCCHHHHhccCCCCC-------CCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEE
Q 018712 134 PLRVLAYEHASKGSLHDILHGKKGVK-------GAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLL 206 (351)
Q Consensus 134 ~~~~lv~e~~~~gsL~~~l~~~~~~~-------~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill 206 (351)
+..+++|||+++|+|.+++....... .......+++.++..++.||+.||.|||++| ++||||||+|||+
T Consensus 91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill 167 (314)
T cd05099 91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVLV 167 (314)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEEE
Confidence 99999999999999999997643210 0111234889999999999999999999999 9999999999999
Q ss_pred ccCCceEEecccccCCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCCcc
Q 018712 207 FDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQS 285 (351)
Q Consensus 207 ~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~Pf~~~~~~~~~~ 285 (351)
+.++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|+|++ |..||..........
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~ 247 (314)
T cd05099 168 TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFK 247 (314)
T ss_pred cCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 9999999999999986643222111122234567999999998899999999999999999999 899997654322111
Q ss_pred chhh--------cccCCCccchhhhcccccCCCCCHHHHHHHHHHHHHhh
Q 018712 286 LVTW--------ATPKLSEDKVKQCVDTKLGGEYPPKAIAKVRKKKFITS 327 (351)
Q Consensus 286 ~~~~--------~~~~~~~~~~~~~ld~~~~~~~~~~~~~~~~~~~~~~~ 327 (351)
.+.. ..+....+.+.+|+..++.+|++..++...++......
T Consensus 248 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~ 297 (314)
T cd05099 248 LLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAV 297 (314)
T ss_pred HHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHHh
Confidence 1111 11111236888999999999999999888776654433
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-38 Score=281.61 Aligned_cols=252 Identities=21% Similarity=0.306 Sum_probs=195.8
Q ss_pred cCCCCCceeccCCcEEEEEEEEC-----------------CCCEEEEEEcCCCCC--chHHHHHHHHHHHhccCCceeee
Q 018712 66 DNFGTNSLIGEGSYGRVYFGVLR-----------------SGRAAAIKKLDSSKQ--PDQEFLAQVSMVSRLKNENVVEL 126 (351)
Q Consensus 66 ~~y~~~~~Lg~G~~g~Vy~~~~~-----------------~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~ 126 (351)
++|++.+.||+|+||.||++... ++..+|+|.+..... ....+.+|+.+++.++|+||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 56999999999999999998532 234689999875432 23568899999999999999999
Q ss_pred EEEEecCCceEEEEEeCCCCCHHHHhccCCCCCC--CCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcE
Q 018712 127 VGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKG--AKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNV 204 (351)
Q Consensus 127 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~--~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Ni 204 (351)
++++...+..+++|||+.+++|.+++........ ......+++.++..++.|++.||+|||+.+ ++|+||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~Ni 161 (296)
T cd05095 85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRNC 161 (296)
T ss_pred EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChheE
Confidence 9999999999999999999999999976542211 112234788899999999999999999999 99999999999
Q ss_pred EEccCCceEEecccccCCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHc--CCCCCCCCCCCC
Q 018712 205 LLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT--GRKPVDHTLPRG 282 (351)
Q Consensus 205 ll~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t--g~~Pf~~~~~~~ 282 (351)
|+++++.++|+|||++................++..|+|||...+..++.++||||||+++|||++ |..||.......
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~ 241 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ 241 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHH
Confidence 999999999999999876543322111223345678999999888889999999999999999998 778987543322
Q ss_pred Cccch---------------hhcccCCCccchhhhcccccCCCCCHHHHHHHH
Q 018712 283 QQSLV---------------TWATPKLSEDKVKQCVDTKLGGEYPPKAIAKVR 320 (351)
Q Consensus 283 ~~~~~---------------~~~~~~~~~~~~~~~ld~~~~~~~~~~~~~~~~ 320 (351)
..... ....+....+.+..|+..+|.+|++..++...+
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l 294 (296)
T cd05095 242 VIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATL 294 (296)
T ss_pred HHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHH
Confidence 11000 000111223678899999999999988886654
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-38 Score=278.71 Aligned_cols=246 Identities=24% Similarity=0.384 Sum_probs=196.8
Q ss_pred cCCCCCceeccCCcEEEEEEEEC-C---CCEEEEEEcCCCCCc--hHHHHHHHHHHHhccCCceeeeEEEEecCCceEEE
Q 018712 66 DNFGTNSLIGEGSYGRVYFGVLR-S---GRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLA 139 (351)
Q Consensus 66 ~~y~~~~~Lg~G~~g~Vy~~~~~-~---~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 139 (351)
.+|++.+.||+|+||.||+|... + +..+|+|.+...... ...+.+|+.++++++||||+++++++.+++..+++
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 57889999999999999999864 2 337999988754332 35688999999999999999999999999999999
Q ss_pred EEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccc
Q 018712 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDL 219 (351)
Q Consensus 140 ~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~ 219 (351)
|||+++++|.+++..... .+++.++..++.|++.||.|||+++ ++||||||+||+++.++.++|+|||+
T Consensus 84 ~e~~~~~~L~~~~~~~~~--------~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~ 152 (267)
T cd05066 84 TEYMENGSLDAFLRKHDG--------QFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGL 152 (267)
T ss_pred EEcCCCCCHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCc
Confidence 999999999999976432 2788999999999999999999999 99999999999999999999999999
Q ss_pred cCCCcccccccc-ccccccccCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCCccchhh--------
Q 018712 220 SNQAPDAAARLH-STRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTW-------- 289 (351)
Q Consensus 220 a~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~Pf~~~~~~~~~~~~~~-------- 289 (351)
+........... .....++..|+|||.+.+..++.++|+||||+++|++++ |+.||...........+..
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 232 (267)
T cd05066 153 SRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRLPAPM 232 (267)
T ss_pred ccccccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCcCCCCC
Confidence 887644322111 112223568999999998899999999999999999886 9999976543221111110
Q ss_pred cccCCCccchhhhcccccCCCCCHHHHHHHHHH
Q 018712 290 ATPKLSEDKVKQCVDTKLGGEYPPKAIAKVRKK 322 (351)
Q Consensus 290 ~~~~~~~~~~~~~ld~~~~~~~~~~~~~~~~~~ 322 (351)
..+....+.+.+|+..++.+|++..++...++-
T Consensus 233 ~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 265 (267)
T cd05066 233 DCPAALHQLMLDCWQKDRNERPKFEQIVSILDK 265 (267)
T ss_pred CCCHHHHHHHHHHcccCchhCCCHHHHHHHHHh
Confidence 111122467889999999999999888777653
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-38 Score=276.00 Aligned_cols=239 Identities=26% Similarity=0.395 Sum_probs=188.1
Q ss_pred eeccCCcEEEEEEEEC---CCCEEEEEEcCCCCCc--hHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEEEeCCCCC
Q 018712 73 LIGEGSYGRVYFGVLR---SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASKGS 147 (351)
Q Consensus 73 ~Lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gs 147 (351)
.||+|+||.||+|.+. .+..||+|++...... .+.+.+|+.++++++|+||+++++.+. ....++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 4899999999999864 3557999988754322 356889999999999999999999875 457899999999999
Q ss_pred HHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccccCCCcccc
Q 018712 148 LHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAA 227 (351)
Q Consensus 148 L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~ 227 (351)
|.+++..... .+++..++.++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++.......
T Consensus 81 L~~~l~~~~~--------~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~ 149 (257)
T cd05115 81 LNKFLSGKKD--------EITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADD 149 (257)
T ss_pred HHHHHHhCCC--------CCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCc
Confidence 9999975432 2889999999999999999999999 9999999999999999999999999987654332
Q ss_pred cccc-ccccccccCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCCccchhhc--------ccCCCcc
Q 018712 228 ARLH-STRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWA--------TPKLSED 297 (351)
Q Consensus 228 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~Pf~~~~~~~~~~~~~~~--------~~~~~~~ 297 (351)
.... .....++..|+|||.+.+..++.++||||||+++|+|++ |..||...........+... .+.-..+
T Consensus 150 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 229 (257)
T cd05115 150 SYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRLDCPAECPPEMYA 229 (257)
T ss_pred cceeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCCCCCHHHHH
Confidence 2111 111223578999999988889999999999999999996 99999865443221111110 0111136
Q ss_pred chhhhcccccCCCCCHHHHHHHHHHH
Q 018712 298 KVKQCVDTKLGGEYPPKAIAKVRKKK 323 (351)
Q Consensus 298 ~~~~~ld~~~~~~~~~~~~~~~~~~~ 323 (351)
.+.+|+..++.+|++..++.+.++..
T Consensus 230 li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 230 LMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred HHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 78899999999999999887766543
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-38 Score=282.41 Aligned_cols=244 Identities=25% Similarity=0.430 Sum_probs=198.7
Q ss_pred hcCCCCCceeccCCcEEEEEEEE-CCCCEEEEEEcCCCCC-chHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEEEe
Q 018712 65 TDNFGTNSLIGEGSYGRVYFGVL-RSGRAAAIKKLDSSKQ-PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEH 142 (351)
Q Consensus 65 ~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 142 (351)
..+|++.+.||.|++|.||+|.. .+++.|++|.+..... ....+.+|+.+++.++|+||+++++.+...+..++|+||
T Consensus 18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 97 (296)
T cd06655 18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEY 97 (296)
T ss_pred cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEe
Confidence 35699999999999999999986 4789999998865432 345678899999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccccCC
Q 018712 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222 (351)
Q Consensus 143 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~ 222 (351)
+.+++|.+++.... +++.++..++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++..
T Consensus 98 ~~~~~L~~~~~~~~----------l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~ 164 (296)
T cd06655 98 LAGGSLTDVVTETC----------MDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQ 164 (296)
T ss_pred cCCCcHHHHHHhcC----------CCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchh
Confidence 99999999987543 889999999999999999999999 99999999999999999999999999876
Q ss_pred CccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccchh----------hccc
Q 018712 223 APDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVT----------WATP 292 (351)
Q Consensus 223 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~~----------~~~~ 292 (351)
....... .....++..|+|||.+.+..++.++||||||+++|+|++|+.||....+......+. ...+
T Consensus 165 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (296)
T cd06655 165 ITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLS 242 (296)
T ss_pred ccccccc--CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcccCCcccCC
Confidence 5433221 133468899999999998889999999999999999999999998654322111111 0111
Q ss_pred CCCccchhhhcccccCCCCCHHHHHHHHHHHHHh
Q 018712 293 KLSEDKVKQCVDTKLGGEYPPKAIAKVRKKKFIT 326 (351)
Q Consensus 293 ~~~~~~~~~~ld~~~~~~~~~~~~~~~~~~~~~~ 326 (351)
....+.+.+|+..+|.+|++.+++ +.+.++.
T Consensus 243 ~~~~~li~~~l~~dp~~Rpt~~~i---l~~~~~~ 273 (296)
T cd06655 243 PIFRDFLNRCLEMDVEKRGSAKEL---LQHPFLK 273 (296)
T ss_pred HHHHHHHHHHhhcChhhCCCHHHH---hhChHhh
Confidence 112356789999999999977655 4455443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-38 Score=280.08 Aligned_cols=200 Identities=28% Similarity=0.403 Sum_probs=172.2
Q ss_pred cCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCC---chHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEEE
Q 018712 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ---PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYE 141 (351)
Q Consensus 66 ~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 141 (351)
++|++.+.||+|++|.||+|..+ +++.||+|++..... ..+.+.+|+.++++++|+||+++++++...+..++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 47899999999999999999976 689999998864322 23557899999999999999999999999999999999
Q ss_pred eCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccccC
Q 018712 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (351)
Q Consensus 142 ~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~ 221 (351)
|+++++|..++..... +++..+..++.|++.||.|||+.+ ++||||||+||++++++.+||+|||++.
T Consensus 81 ~~~~~~l~~~~~~~~~---------~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~ 148 (286)
T cd07847 81 YCDHTVLNELEKNPRG---------VPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFAR 148 (286)
T ss_pred ccCccHHHHHHhCCCC---------CCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccce
Confidence 9999888888765432 889999999999999999999999 9999999999999999999999999987
Q ss_pred CCccccccccccccccccCccCcccccC-CCCCccchhHhHHHHHHHHHcCCCCCCCCC
Q 018712 222 QAPDAAARLHSTRVLGTFGYHAPEYAMT-GQMSSKSDVYSFGVVLLELLTGRKPVDHTL 279 (351)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~Pf~~~~ 279 (351)
........ .....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||.+..
T Consensus 149 ~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~ 205 (286)
T cd07847 149 ILTGPGDD--YTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKS 205 (286)
T ss_pred ecCCCccc--ccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCC
Confidence 76443211 123457889999998876 457899999999999999999999998654
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=299.51 Aligned_cols=232 Identities=27% Similarity=0.428 Sum_probs=189.7
Q ss_pred eeccCCcEEEEEEEEC-CCCEEEEEEcCCC-CCchHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEEEeCCCCCHHH
Q 018712 73 LIGEGSYGRVYFGVLR-SGRAAAIKKLDSS-KQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHD 150 (351)
Q Consensus 73 ~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~ 150 (351)
+||+|.||+||.|++. +...+|||.+... ....+-+..|+.+-++|+|.|||++++.+.+++++-+.||-.+||||.+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 6999999999999975 5678999988643 3445668899999999999999999999999999999999999999999
Q ss_pred HhccCCCCCCCCCCCCC--CHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEcc-CCceEEecccccCCCcccc
Q 018712 151 ILHGKKGVKGAKPGPVL--SWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFD-DDIAKISDFDLSNQAPDAA 227 (351)
Q Consensus 151 ~l~~~~~~~~~~~~~~l--~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~-~~~vkl~Dfg~a~~~~~~~ 227 (351)
+|....+. + .+.+.-.+..||++||.|||++. |||||||-+||||+. .|.+||+|||.++.+..-.
T Consensus 662 LLrskWGP--------lKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgin 730 (1226)
T KOG4279|consen 662 LLRSKWGP--------LKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGIN 730 (1226)
T ss_pred HHHhccCC--------CccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhccCC
Confidence 99876532 4 66778889999999999999998 999999999999975 6899999999998875433
Q ss_pred ccccccccccccCccCcccccCC--CCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccchh---hcccCCCc------
Q 018712 228 ARLHSTRVLGTFGYHAPEYAMTG--QMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVT---WATPKLSE------ 296 (351)
Q Consensus 228 ~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~~---~~~~~~~~------ 296 (351)
.. +.++.||..|||||++..+ .|+.++|||||||++.||.||++||-.........+.. +.-|.+++
T Consensus 731 P~--TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPeelsaea 808 (1226)
T KOG4279|consen 731 PC--TETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPEELSAEA 808 (1226)
T ss_pred cc--ccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcHHHHHHH
Confidence 22 3567899999999999754 68999999999999999999999998653322111111 12233332
Q ss_pred -cchhhhcccccCCCCCHHHHH
Q 018712 297 -DKVKQCVDTKLGGEYPPKAIA 317 (351)
Q Consensus 297 -~~~~~~ld~~~~~~~~~~~~~ 317 (351)
..+..|+.+++..|+++..+.
T Consensus 809 k~FilrcFepd~~~R~sA~~LL 830 (1226)
T KOG4279|consen 809 KNFILRCFEPDPCDRPSAKDLL 830 (1226)
T ss_pred HHHHHHHcCCCcccCccHHHhc
Confidence 467888999999998877653
|
|
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=274.81 Aligned_cols=235 Identities=26% Similarity=0.384 Sum_probs=185.5
Q ss_pred eeccCCcEEEEEEEEC---CCCEEEEEEcCCCCCc---hHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEEEeCCCC
Q 018712 73 LIGEGSYGRVYFGVLR---SGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASKG 146 (351)
Q Consensus 73 ~Lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 146 (351)
.||+|+||.||+|.++ ++..+|+|++...... .+.+.+|+.+++.+.|+||+++++++. .+..++||||++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 5899999999999753 5789999998654332 356888999999999999999999875 45678999999999
Q ss_pred CHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccccCCCccc
Q 018712 147 SLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDA 226 (351)
Q Consensus 147 sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~ 226 (351)
+|.+++..... +++..+..++.|++.||.|||+++ ++||||||.||++++++.+||+|||++......
T Consensus 81 ~L~~~l~~~~~---------~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~ 148 (257)
T cd05116 81 PLNKFLQKNKH---------VTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGAD 148 (257)
T ss_pred cHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCC
Confidence 99999975432 788999999999999999999999 999999999999999999999999998766433
Q ss_pred ccccc-ccccccccCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCCccchhh--------cccCCCc
Q 018712 227 AARLH-STRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTW--------ATPKLSE 296 (351)
Q Consensus 227 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~Pf~~~~~~~~~~~~~~--------~~~~~~~ 296 (351)
..... .....++..|+|||.+....++.++|+||||+++|||++ |+.||...........+.. ..+....
T Consensus 149 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~ 228 (257)
T cd05116 149 ENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMECPQRCPPEMY 228 (257)
T ss_pred CCeeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHH
Confidence 22111 122234578999999988889999999999999999998 9999986543221111111 1111123
Q ss_pred cchhhhcccccCCCCCHHHHHHHH
Q 018712 297 DKVKQCVDTKLGGEYPPKAIAKVR 320 (351)
Q Consensus 297 ~~~~~~ld~~~~~~~~~~~~~~~~ 320 (351)
+.+..|+..++..||+.+.+...+
T Consensus 229 ~li~~~~~~~p~~Rp~~~~i~~~l 252 (257)
T cd05116 229 DLMKLCWTYGVDERPGFAVVELRL 252 (257)
T ss_pred HHHHHHhccCchhCcCHHHHHHHH
Confidence 678888888899999887775543
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=274.06 Aligned_cols=238 Identities=27% Similarity=0.393 Sum_probs=190.0
Q ss_pred ceeccCCcEEEEEEEEC-C---CCEEEEEEcCCCCC--chHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEEEeCCC
Q 018712 72 SLIGEGSYGRVYFGVLR-S---GRAAAIKKLDSSKQ--PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASK 145 (351)
Q Consensus 72 ~~Lg~G~~g~Vy~~~~~-~---~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 145 (351)
+.||+|+||.||+|.+. . +..+|+|.+..... ..+.+.+|+++++++.|+||+++++++. .+..++||||+.+
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 46999999999999853 2 36899999876654 4567889999999999999999999875 4568999999999
Q ss_pred CCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccccCCCcc
Q 018712 146 GSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPD 225 (351)
Q Consensus 146 gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~ 225 (351)
++|.+++..... +++..+..++.|++.||.|||+.+ ++|+||||+|||++.++.+||+|||+++....
T Consensus 80 ~~L~~~l~~~~~---------~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~ 147 (257)
T cd05060 80 GPLLKYLKKRRE---------IPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGA 147 (257)
T ss_pred CcHHHHHHhCCC---------CCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeec
Confidence 999999986542 889999999999999999999999 99999999999999999999999999876643
Q ss_pred cccccc-ccccccccCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCCccchh--------hcccCCC
Q 018712 226 AAARLH-STRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVT--------WATPKLS 295 (351)
Q Consensus 226 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~Pf~~~~~~~~~~~~~--------~~~~~~~ 295 (351)
...... .....++..|+|||.+.+..++.++||||||+++|+|++ |..||...........+. ...+...
T Consensus 148 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 227 (257)
T cd05060 148 GSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLPRPEECPQEI 227 (257)
T ss_pred CCcccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCcCCCCCCCCHHH
Confidence 322111 111223567999999998899999999999999999998 999997654322111111 0111122
Q ss_pred ccchhhhcccccCCCCCHHHHHHHHHH
Q 018712 296 EDKVKQCVDTKLGGEYPPKAIAKVRKK 322 (351)
Q Consensus 296 ~~~~~~~ld~~~~~~~~~~~~~~~~~~ 322 (351)
.+.+.+|+..+|.+|++..++...++-
T Consensus 228 ~~li~~cl~~~p~~Rp~~~~l~~~l~~ 254 (257)
T cd05060 228 YSIMLSCWKYRPEDRPTFSELESTFRR 254 (257)
T ss_pred HHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence 368889999999999999988877653
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=313.51 Aligned_cols=248 Identities=20% Similarity=0.300 Sum_probs=192.2
Q ss_pred HHhcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCC---chHHHHHHHHHHHhccCCceeeeEEEEec--CCce
Q 018712 63 EKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ---PDQEFLAQVSMVSRLKNENVVELVGYYVD--GPLR 136 (351)
Q Consensus 63 ~~~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~ 136 (351)
...++|.+.+.||+|+||.||++.+. ++..+|+|.+..... ....+..|+.+++.++||||++++++|.+ ...+
T Consensus 10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~l 89 (1021)
T PTZ00266 10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKL 89 (1021)
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEE
Confidence 45678999999999999999999975 677899998865432 24568889999999999999999998854 4568
Q ss_pred EEEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCC----CCeeeccccCCcEEEccC---
Q 018712 137 VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAE----PRIIHRNIKSSNVLLFDD--- 209 (351)
Q Consensus 137 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~----~~ivH~Dlkp~Nill~~~--- 209 (351)
|+||||+.+++|.++|....... ..+++..++.|+.||+.||.|||+.+. .+|+||||||+||||+.+
T Consensus 90 yIVMEY~~gGSL~~lL~k~~~~~-----g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~ 164 (1021)
T PTZ00266 90 YILMEFCDAGDLSRNIQKCYKMF-----GKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRH 164 (1021)
T ss_pred EEEEeCCCCCcHHHHHHHHhhcc-----CCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccc
Confidence 99999999999999997532110 128999999999999999999998431 239999999999999642
Q ss_pred --------------CceEEecccccCCCccccccccccccccccCccCcccccC--CCCCccchhHhHHHHHHHHHcCCC
Q 018712 210 --------------DIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMT--GQMSSKSDVYSFGVVLLELLTGRK 273 (351)
Q Consensus 210 --------------~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~el~tg~~ 273 (351)
+.+||+|||++........ .....||+.|+|||++.+ ..++.++||||||||+|+|++|+.
T Consensus 165 lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~---~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~ 241 (1021)
T PTZ00266 165 IGKITAQANNLNGRPIAKIGDFGLSKNIGIESM---AHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKT 241 (1021)
T ss_pred cccccccccccCCCCceEEccCCcccccccccc---ccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCC
Confidence 3589999999976543221 234568999999999864 458899999999999999999999
Q ss_pred CCCCCCCCCCccchhhc--------ccCCCccchhhhcccccCCCCCHHHHHH
Q 018712 274 PVDHTLPRGQQSLVTWA--------TPKLSEDKVKQCVDTKLGGEYPPKAIAK 318 (351)
Q Consensus 274 Pf~~~~~~~~~~~~~~~--------~~~~~~~~~~~~ld~~~~~~~~~~~~~~ 318 (351)
||............... .+....+.+..||..+|..|+++.++..
T Consensus 242 PF~~~~~~~qli~~lk~~p~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 242 PFHKANNFSQLISELKRGPDLPIKGKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred CCCcCCcHHHHHHHHhcCCCCCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 99754322111101011 1111236789999999999999887754
|
|
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=272.50 Aligned_cols=237 Identities=28% Similarity=0.410 Sum_probs=190.1
Q ss_pred ceeccCCcEEEEEEEECCCCEEEEEEcCCCCCc--hHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEEEeCCCCCHH
Q 018712 72 SLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLH 149 (351)
Q Consensus 72 ~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~ 149 (351)
+.||+|+||.||+|...++..+|+|.+...... ...+.+|+.++++++|+||+++++++...+..++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 368999999999999888899999998755432 346888999999999999999999999999999999999999999
Q ss_pred HHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccccCCCcccccc
Q 018712 150 DILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAAR 229 (351)
Q Consensus 150 ~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~ 229 (351)
+++..... .+.+..+..++.|++.||.|+|+++ ++||||||+||++++++.+||+|||++.........
T Consensus 81 ~~~~~~~~--------~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~ 149 (250)
T cd05085 81 SFLRKKKD--------ELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYS 149 (250)
T ss_pred HHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceeccccccc
Confidence 99865432 2788999999999999999999999 999999999999999999999999998654332211
Q ss_pred ccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCCccchh--------hcccCCCccchh
Q 018712 230 LHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVT--------WATPKLSEDKVK 300 (351)
Q Consensus 230 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~Pf~~~~~~~~~~~~~--------~~~~~~~~~~~~ 300 (351)
. .....++..|+|||++.+..++.++||||||+++|+|++ |..||...........+. ...+....+.+.
T Consensus 150 ~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 228 (250)
T cd05085 150 S-SGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSCPQKCPDDVYKVMQ 228 (250)
T ss_pred c-CCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHH
Confidence 1 112234667999999998889999999999999999998 999997654322111111 011122236788
Q ss_pred hhcccccCCCCCHHHHHHHH
Q 018712 301 QCVDTKLGGEYPPKAIAKVR 320 (351)
Q Consensus 301 ~~ld~~~~~~~~~~~~~~~~ 320 (351)
+|+..+|.+|++..++.+.+
T Consensus 229 ~~l~~~p~~Rp~~~~l~~~l 248 (250)
T cd05085 229 RCWDYKPENRPKFSELQKEL 248 (250)
T ss_pred HHcccCcccCCCHHHHHHHh
Confidence 99999999999988886653
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-38 Score=287.60 Aligned_cols=259 Identities=21% Similarity=0.334 Sum_probs=197.4
Q ss_pred hcCCCCCceeccCCcEEEEEEEE------CCCCEEEEEEcCCCCCc--hHHHHHHHHHHHhc-cCCceeeeEEEEec-CC
Q 018712 65 TDNFGTNSLIGEGSYGRVYFGVL------RSGRAAAIKKLDSSKQP--DQEFLAQVSMVSRL-KNENVVELVGYYVD-GP 134 (351)
Q Consensus 65 ~~~y~~~~~Lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l-~h~niv~~~~~~~~-~~ 134 (351)
.++|++.+.||+|+||.||+|.+ .+++.||+|++...... ...+.+|+.++.++ +|+||+++++++.. +.
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 85 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence 46799999999999999999973 35789999998754322 34678899999999 68999999998764 45
Q ss_pred ceEEEEEeCCCCCHHHHhccCCCCCCC-----------------------------------------------------
Q 018712 135 LRVLAYEHASKGSLHDILHGKKGVKGA----------------------------------------------------- 161 (351)
Q Consensus 135 ~~~lv~e~~~~gsL~~~l~~~~~~~~~----------------------------------------------------- 161 (351)
..+++|||+.+|+|.+++.........
T Consensus 86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (343)
T cd05103 86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 165 (343)
T ss_pred ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence 678999999999999999754210000
Q ss_pred -----CCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccccCCCccccccccccccc
Q 018712 162 -----KPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVL 236 (351)
Q Consensus 162 -----~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~ 236 (351)
.....+++..+..++.||+.||.|||+++ ++||||||+||+++.++.+||+|||++................
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 242 (343)
T cd05103 166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR 242 (343)
T ss_pred hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence 00123678888999999999999999999 9999999999999999999999999987653322211122334
Q ss_pred cccCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCCc-cchh----hcccC----CCccchhhhcccc
Q 018712 237 GTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQ-SLVT----WATPK----LSEDKVKQCVDTK 306 (351)
Q Consensus 237 gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~Pf~~~~~~~~~-~~~~----~~~~~----~~~~~~~~~ld~~ 306 (351)
++..|+|||.+.+..++.++||||||+++|+|++ |..||......... ..+. ...+. ...+.+..|+.++
T Consensus 243 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~~ 322 (343)
T cd05103 243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGE 322 (343)
T ss_pred CCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCCCCCCCHHHHHHHHHHccCC
Confidence 5678999999998899999999999999999997 99999764322110 0000 00011 1125677889999
Q ss_pred cCCCCCHHHHHHHHHHHHHh
Q 018712 307 LGGEYPPKAIAKVRKKKFIT 326 (351)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~ 326 (351)
|.+|++..++...++..+.+
T Consensus 323 p~~Rps~~eil~~l~~~~~~ 342 (343)
T cd05103 323 PSQRPTFSELVEHLGNLLQA 342 (343)
T ss_pred hhhCcCHHHHHHHHHHHHhc
Confidence 99999999998887776654
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-40 Score=298.04 Aligned_cols=232 Identities=30% Similarity=0.441 Sum_probs=190.9
Q ss_pred CCCCceeccCCcEEEEEEEE-CCCCEEEEEEcCCCCCc----hHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEEEe
Q 018712 68 FGTNSLIGEGSYGRVYFGVL-RSGRAAAIKKLDSSKQP----DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEH 142 (351)
Q Consensus 68 y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 142 (351)
|.-+..||-|+||.||.|.+ ++...||||++..+... -+++..|+..|++++|||++.+.++|..+...||||||
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY 107 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY 107 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence 56667899999999999996 47889999998754322 36789999999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccccCC
Q 018712 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222 (351)
Q Consensus 143 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~ 222 (351)
|-| |-.+++.-.+. .+.+.++..|+.+.+.||+|||+.+ .||||||.+|||+++.|.|||+|||.|..
T Consensus 108 ClG-SAsDlleVhkK--------plqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi 175 (948)
T KOG0577|consen 108 CLG-SASDLLEVHKK--------PLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASI 175 (948)
T ss_pred Hhc-cHHHHHHHHhc--------cchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhh
Confidence 965 88888876553 2888899999999999999999999 99999999999999999999999999876
Q ss_pred CccccccccccccccccCccCccccc---CCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccch-hhccc-----C
Q 018712 223 APDAAARLHSTRVLGTFGYHAPEYAM---TGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLV-TWATP-----K 293 (351)
Q Consensus 223 ~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~-~~~~~-----~ 293 (351)
.... ..++|||.|||||++. .+.|+-++||||||++..||...++|+-..+......-| ....| .
T Consensus 176 ~~PA------nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLqs~e 249 (948)
T KOG0577|consen 176 MAPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNE 249 (948)
T ss_pred cCch------hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCCCch
Confidence 6443 5678999999999886 568999999999999999999999998765443211111 11122 2
Q ss_pred CC---ccchhhhcccccCCCCCHHHHH
Q 018712 294 LS---EDKVKQCVDTKLGGEYPPKAIA 317 (351)
Q Consensus 294 ~~---~~~~~~~ld~~~~~~~~~~~~~ 317 (351)
|+ ...+..|+...|.+|++.+++.
T Consensus 250 WS~~F~~Fvd~CLqKipqeRptse~ll 276 (948)
T KOG0577|consen 250 WSDYFRNFVDSCLQKIPQERPTSEELL 276 (948)
T ss_pred hHHHHHHHHHHHHhhCcccCCcHHHHh
Confidence 22 2456778888888888877654
|
|
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=277.74 Aligned_cols=237 Identities=26% Similarity=0.401 Sum_probs=195.3
Q ss_pred cCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCC--chHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEEEe
Q 018712 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ--PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEH 142 (351)
Q Consensus 66 ~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 142 (351)
..|+..+.||.|+||.||+|.+. ++..+|+|.+..... ....+.+|+++++++.|+||+++++.+.+....++||||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence 45778889999999999999975 688999998875432 245688899999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccccCC
Q 018712 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222 (351)
Q Consensus 143 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~ 222 (351)
+++++|.+++.... ++...+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++..
T Consensus 84 ~~~~~L~~~i~~~~----------l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~ 150 (277)
T cd06640 84 LGGGSALDLLRAGP----------FDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQ 150 (277)
T ss_pred CCCCcHHHHHhcCC----------CCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEccccccee
Confidence 99999999997543 788889999999999999999999 99999999999999999999999999876
Q ss_pred CccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccchhhc-c-------cCC
Q 018712 223 APDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWA-T-------PKL 294 (351)
Q Consensus 223 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~~~~-~-------~~~ 294 (351)
...... ......++..|+|||.+.+..++.++|+||||+++|+|++|+.||....+......+... . +..
T Consensus 151 ~~~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (277)
T cd06640 151 LTDTQI--KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLTGEFSKP 228 (277)
T ss_pred ccCCcc--ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcCCCCCCchhhhHH
Confidence 543221 123346788999999998888999999999999999999999999865443322221111 1 111
Q ss_pred CccchhhhcccccCCCCCHHHHH
Q 018712 295 SEDKVKQCVDTKLGGEYPPKAIA 317 (351)
Q Consensus 295 ~~~~~~~~ld~~~~~~~~~~~~~ 317 (351)
..+.+..|+..+|.+|++.+++.
T Consensus 229 ~~~li~~~l~~~p~~Rp~~~~il 251 (277)
T cd06640 229 FKEFIDACLNKDPSFRPTAKELL 251 (277)
T ss_pred HHHHHHHHcccCcccCcCHHHHH
Confidence 23678899999999999886663
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=279.76 Aligned_cols=240 Identities=23% Similarity=0.349 Sum_probs=191.6
Q ss_pred hcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCC-chHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEEEe
Q 018712 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ-PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEH 142 (351)
Q Consensus 65 ~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 142 (351)
.+.|++.+.||.|+||.||+|... ++..+++|.+..... ..+.+.+|+.+++.++|+||+++++.+..++..++||||
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 90 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEF 90 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEec
Confidence 367999999999999999999975 588999999875432 245678899999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccccCC
Q 018712 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222 (351)
Q Consensus 143 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~ 222 (351)
+++++|..++.+... .+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++..
T Consensus 91 ~~~~~l~~~~~~~~~--------~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~ 159 (292)
T cd06644 91 CPGGAVDAIMLELDR--------GLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAK 159 (292)
T ss_pred CCCCcHHHHHHhhcC--------CCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCcccee
Confidence 999999988865432 2889999999999999999999999 99999999999999999999999998865
Q ss_pred CccccccccccccccccCccCccccc-----CCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccchh-hccc----
Q 018712 223 APDAAARLHSTRVLGTFGYHAPEYAM-----TGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVT-WATP---- 292 (351)
Q Consensus 223 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~~-~~~~---- 292 (351)
...... ......+++.|+|||++. ...++.++|+||||+++|+|++|+.||............. ...+
T Consensus 160 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 237 (292)
T cd06644 160 NVKTLQ--RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQ 237 (292)
T ss_pred cccccc--ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCccCCC
Confidence 432211 113446788999999885 3456789999999999999999999997643221110000 0000
Q ss_pred --C---CCccchhhhcccccCCCCCHHHHH
Q 018712 293 --K---LSEDKVKQCVDTKLGGEYPPKAIA 317 (351)
Q Consensus 293 --~---~~~~~~~~~ld~~~~~~~~~~~~~ 317 (351)
. -..+.+..|+..+|.+|++.+++.
T Consensus 238 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~il 267 (292)
T cd06644 238 PSKWSMEFRDFLKTALDKHPETRPSAAQLL 267 (292)
T ss_pred CcccCHHHHHHHHHHhcCCcccCcCHHHHh
Confidence 1 113578899999999999877653
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=278.98 Aligned_cols=201 Identities=23% Similarity=0.377 Sum_probs=169.6
Q ss_pred CCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCC---chHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEEEe
Q 018712 67 NFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ---PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEH 142 (351)
Q Consensus 67 ~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 142 (351)
+|++.+.||+|++|.||+|... ++..||+|++..... ....+.+|+.++++++||||+++++++.+++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 5888899999999999999975 789999999864422 235678899999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccccCC
Q 018712 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222 (351)
Q Consensus 143 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~ 222 (351)
+. ++|.+++..... +..+++..+..++.||+.||.|||+++ ++|+||||+||++++++.+||+|||++..
T Consensus 81 ~~-~~l~~~~~~~~~------~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 150 (285)
T cd07861 81 LS-MDLKKYLDSLPK------GQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARA 150 (285)
T ss_pred CC-CCHHHHHhcCCC------CCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceee
Confidence 97 589888865332 123889999999999999999999999 99999999999999999999999999875
Q ss_pred CccccccccccccccccCccCcccccCC-CCCccchhHhHHHHHHHHHcCCCCCCCCC
Q 018712 223 APDAAARLHSTRVLGTFGYHAPEYAMTG-QMSSKSDVYSFGVVLLELLTGRKPVDHTL 279 (351)
Q Consensus 223 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~Pf~~~~ 279 (351)
....... .....+++.|+|||.+.+. .++.++||||||+++|+|++|+.||....
T Consensus 151 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~ 206 (285)
T cd07861 151 FGIPVRV--YTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDS 206 (285)
T ss_pred cCCCccc--ccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence 5322111 1233578899999988654 57889999999999999999999998643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=278.57 Aligned_cols=256 Identities=22% Similarity=0.313 Sum_probs=200.0
Q ss_pred HhcCCCCCceeccCCcEEEEEEEECC-----CCEEEEEEcCCCCCc--hHHHHHHHHHHHhccCCceeeeEEEEec-CCc
Q 018712 64 KTDNFGTNSLIGEGSYGRVYFGVLRS-----GRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVD-GPL 135 (351)
Q Consensus 64 ~~~~y~~~~~Lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~ 135 (351)
..++|.+.+.||+|+||.||+|.+.. +..|++|.+...... ...+.+|+.++++++|+||+++++++.. ...
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 83 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP 83 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 35689999999999999999999765 688999988654322 3557889999999999999999998665 567
Q ss_pred eEEEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEe
Q 018712 136 RVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKIS 215 (351)
Q Consensus 136 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~ 215 (351)
.+++++|+++++|.+++....... ......+++..+..++.|++.||.|||+++ ++||||||+||++++++.+||+
T Consensus 84 ~~~~~~~~~~~~L~~~l~~~~~~~-~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~ 159 (280)
T cd05043 84 PFVLYPYMNWGNLKLFLQQCRLGE-ANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKIT 159 (280)
T ss_pred CEEEEEcCCCCcHHHHHHhccccc-cccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEEC
Confidence 899999999999999997653221 111234889999999999999999999999 9999999999999999999999
Q ss_pred cccccCCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCCccchhh-----
Q 018712 216 DFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTW----- 289 (351)
Q Consensus 216 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~Pf~~~~~~~~~~~~~~----- 289 (351)
|||+++...............++..|+|||++.+..++.++||||||+++|++++ |+.||....+......+..
T Consensus 160 d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~ 239 (280)
T cd05043 160 DNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGYRLA 239 (280)
T ss_pred CCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcCCCCC
Confidence 9999986543322211223345778999999998889999999999999999999 9999986543221111100
Q ss_pred ---cccCCCccchhhhcccccCCCCCHHHHHHHHHHH
Q 018712 290 ---ATPKLSEDKVKQCVDTKLGGEYPPKAIAKVRKKK 323 (351)
Q Consensus 290 ---~~~~~~~~~~~~~ld~~~~~~~~~~~~~~~~~~~ 323 (351)
..+....+.+..|+..+|.+|++..++...+.-.
T Consensus 240 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~ 276 (280)
T cd05043 240 QPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDF 276 (280)
T ss_pred CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 0011123678889999999999998887766543
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-38 Score=278.26 Aligned_cols=245 Identities=24% Similarity=0.393 Sum_probs=193.8
Q ss_pred cCCCCCceeccCCcEEEEEEEEC-CC---CEEEEEEcCCCCC--chHHHHHHHHHHHhccCCceeeeEEEEecCCceEEE
Q 018712 66 DNFGTNSLIGEGSYGRVYFGVLR-SG---RAAAIKKLDSSKQ--PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLA 139 (351)
Q Consensus 66 ~~y~~~~~Lg~G~~g~Vy~~~~~-~~---~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 139 (351)
.+|++.+.||+|+||.||+|... ++ ..||+|.+..... ....+..|+.+++.++||||+++++++.++...++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 45788999999999999999965 33 3699999875432 245788999999999999999999999999999999
Q ss_pred EEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccc
Q 018712 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDL 219 (351)
Q Consensus 140 ~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~ 219 (351)
|||+++++|.+++..... .+++.+++.++.|++.||.|||++| ++|+||||+||+++.++.+||+|||+
T Consensus 84 ~e~~~~~~L~~~l~~~~~--------~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~ 152 (269)
T cd05065 84 TEFMENGALDSFLRQNDG--------QFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGL 152 (269)
T ss_pred EecCCCCcHHHHHhhCCC--------CCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCcc
Confidence 999999999999976432 2789999999999999999999999 99999999999999999999999999
Q ss_pred cCCCcccccccccc-ccc--cccCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCCccchhh------
Q 018712 220 SNQAPDAAARLHST-RVL--GTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTW------ 289 (351)
Q Consensus 220 a~~~~~~~~~~~~~-~~~--gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~Pf~~~~~~~~~~~~~~------ 289 (351)
+............. ... .+..|+|||.+.+..++.++||||||+++|||++ |..||...........+..
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~~~~~ 232 (269)
T cd05065 153 SRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRLPP 232 (269)
T ss_pred ccccccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCcCCC
Confidence 87654322111111 111 2457999999998999999999999999999886 9999976543221111110
Q ss_pred --cccCCCccchhhhcccccCCCCCHHHHHHHHH
Q 018712 290 --ATPKLSEDKVKQCVDTKLGGEYPPKAIAKVRK 321 (351)
Q Consensus 290 --~~~~~~~~~~~~~ld~~~~~~~~~~~~~~~~~ 321 (351)
..+....+.+..|+.+++.+|++.+++...++
T Consensus 233 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 266 (269)
T cd05065 233 PMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLD 266 (269)
T ss_pred cccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 01112236778899999999999988876544
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=280.88 Aligned_cols=247 Identities=23% Similarity=0.345 Sum_probs=197.3
Q ss_pred hcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCC-chHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEEEe
Q 018712 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ-PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEH 142 (351)
Q Consensus 65 ~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 142 (351)
.++|++.+.||.|+||.||++.+. ++..+|+|.+..... ..+.+.+|++++++++|+||+++++.+.+....++||||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF 83 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence 356999999999999999999975 688999999865432 235688899999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccccCC
Q 018712 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222 (351)
Q Consensus 143 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~ 222 (351)
+++++|.+++..... .+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++..
T Consensus 84 ~~~~~L~~~~~~~~~--------~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~ 152 (280)
T cd06611 84 CDGGALDSIMLELER--------GLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAK 152 (280)
T ss_pred cCCCcHHHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchh
Confidence 999999999876432 2889999999999999999999999 99999999999999999999999998766
Q ss_pred CccccccccccccccccCccCccccc-----CCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccchhh--------
Q 018712 223 APDAAARLHSTRVLGTFGYHAPEYAM-----TGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTW-------- 289 (351)
Q Consensus 223 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~~~-------- 289 (351)
...... ......+++.|+|||.+. ...++.++|+||||+++|+|++|+.||...........+..
T Consensus 153 ~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 230 (280)
T cd06611 153 NKSTLQ--KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQ 230 (280)
T ss_pred hccccc--ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCCcCC
Confidence 533221 123456899999999875 34567899999999999999999999986543221111110
Q ss_pred --cccCCCccchhhhcccccCCCCCHHHHHHHHHHHHHhh
Q 018712 290 --ATPKLSEDKVKQCVDTKLGGEYPPKAIAKVRKKKFITS 327 (351)
Q Consensus 290 --~~~~~~~~~~~~~ld~~~~~~~~~~~~~~~~~~~~~~~ 327 (351)
..+....+.+..|++.+|.+|++.+++ +++.++..
T Consensus 231 ~~~~~~~~~~li~~~l~~~p~~Rps~~~i---l~~~~~~~ 267 (280)
T cd06611 231 PSKWSSSFNDFLKSCLVKDPDDRPTAAEL---LKHPFVSD 267 (280)
T ss_pred cccCCHHHHHHHHHHhccChhhCcCHHHH---hcChhhcc
Confidence 111122367889999999999987765 44555443
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=272.04 Aligned_cols=238 Identities=27% Similarity=0.420 Sum_probs=192.0
Q ss_pred ceeccCCcEEEEEEEECCCCEEEEEEcCCCCCc--hHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEEEeCCCCCHH
Q 018712 72 SLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLH 149 (351)
Q Consensus 72 ~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~ 149 (351)
++||.|+||.||++.+..++.|++|.+...... ...+.+|++++++++|+||+++++++.+....++||||+.+++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 369999999999999776999999998765432 456889999999999999999999999999999999999999999
Q ss_pred HHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccccCCCcccccc
Q 018712 150 DILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAAR 229 (351)
Q Consensus 150 ~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~ 229 (351)
+++..... .++...+..++.+++.||.|||+++ ++||||||+||+++.++.+||+|||++.........
T Consensus 81 ~~l~~~~~--------~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~ 149 (251)
T cd05041 81 TFLRKKKN--------RLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYT 149 (251)
T ss_pred HHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCcce
Confidence 99965432 2788899999999999999999999 999999999999999999999999998765422211
Q ss_pred ccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCCccchh--------hcccCCCccchh
Q 018712 230 LHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVT--------WATPKLSEDKVK 300 (351)
Q Consensus 230 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~Pf~~~~~~~~~~~~~--------~~~~~~~~~~~~ 300 (351)
.......++..|+|||.+.+..++.++|+||||+++|+|++ |..||...........+. ...+....+.+.
T Consensus 150 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 229 (251)
T cd05041 150 VSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMPAPQLCPEEIYRLML 229 (251)
T ss_pred eccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCCCCCCCccCCHHHHHHHH
Confidence 11112234667999999988899999999999999999999 899997654322211111 111222346778
Q ss_pred hhcccccCCCCCHHHHHHHH
Q 018712 301 QCVDTKLGGEYPPKAIAKVR 320 (351)
Q Consensus 301 ~~ld~~~~~~~~~~~~~~~~ 320 (351)
+|+..+|.+|++.+++...+
T Consensus 230 ~~l~~~p~~Rp~~~ell~~l 249 (251)
T cd05041 230 QCWAYDPENRPSFSEIYNEL 249 (251)
T ss_pred HHhccChhhCcCHHHHHHHh
Confidence 89999999999988887654
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=275.94 Aligned_cols=251 Identities=23% Similarity=0.351 Sum_probs=199.0
Q ss_pred cCCCCCceeccCCcEEEEEEEEC------CCCEEEEEEcCCCCCc--hHHHHHHHHHHHhccCCceeeeEEEEecCCceE
Q 018712 66 DNFGTNSLIGEGSYGRVYFGVLR------SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRV 137 (351)
Q Consensus 66 ~~y~~~~~Lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 137 (351)
++|++...||+|+||.||+|..+ +.+.+++|.+...... ...+.+|++++++++|+||+++++++.+.+..+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 57889999999999999999964 3467999988654432 457899999999999999999999999989999
Q ss_pred EEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecc
Q 018712 138 LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDF 217 (351)
Q Consensus 138 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Df 217 (351)
+||||+++++|.+++..............+++..+..++.|++.||+|||+++ ++||||||+||+++.++.++|+||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEccc
Confidence 99999999999999976553222222234899999999999999999999999 999999999999999999999999
Q ss_pred cccCCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCCccchh-----h--
Q 018712 218 DLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVT-----W-- 289 (351)
Q Consensus 218 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~Pf~~~~~~~~~~~~~-----~-- 289 (351)
|++........ .......++..|+|||.+.+..++.++||||||+++|+|++ |..||............. +
T Consensus 162 ~~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~~~ 240 (275)
T cd05046 162 SLSKDVYNSEY-YKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELPV 240 (275)
T ss_pred ccccccCcccc-cccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCCcCCCC
Confidence 99865432211 11223356778999999988888999999999999999999 889997543322111111 1
Q ss_pred --cccCCCccchhhhcccccCCCCCHHHHHHHH
Q 018712 290 --ATPKLSEDKVKQCVDTKLGGEYPPKAIAKVR 320 (351)
Q Consensus 290 --~~~~~~~~~~~~~ld~~~~~~~~~~~~~~~~ 320 (351)
..+....+.+.+|+..+|.+|++..++...+
T Consensus 241 ~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l 273 (275)
T cd05046 241 PEGCPSRLYKLMTRCWAVNPKDRPSFSELVSAL 273 (275)
T ss_pred CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHh
Confidence 1122224678899999999999998876654
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=283.11 Aligned_cols=250 Identities=24% Similarity=0.366 Sum_probs=197.4
Q ss_pred cCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCCc----hHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEE
Q 018712 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP----DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAY 140 (351)
Q Consensus 66 ~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 140 (351)
++|++.+.||+|++|.||++... +++.+|+|.+...... .+.+.+|+++++.++|+||+++++.+.+....+++|
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 46888999999999999999975 5899999998765422 346788999999999999999999999999999999
Q ss_pred EeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEeccccc
Q 018712 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (351)
Q Consensus 141 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a 220 (351)
||+.+++|.+++...... .+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++
T Consensus 81 e~~~~~~L~~~~~~~~~~-------~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~ 150 (316)
T cd05574 81 DYCPGGELFRLLQRQPGK-------CLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLS 150 (316)
T ss_pred EecCCCCHHHHHHhCCCC-------ccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchh
Confidence 999999999999754321 2888999999999999999999999 999999999999999999999999998
Q ss_pred CCCcccccc---------------------------ccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCC
Q 018712 221 NQAPDAAAR---------------------------LHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRK 273 (351)
Q Consensus 221 ~~~~~~~~~---------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~ 273 (351)
......... .......||..|+|||++.+..++.++||||||+++|+|++|+.
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~ 230 (316)
T cd05574 151 KQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTT 230 (316)
T ss_pred hcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCC
Confidence 654322110 01123468899999999998889999999999999999999999
Q ss_pred CCCCCCCCCCccchhh---c------ccCCCccchhhhcccccCCCCCH-HHHHHHHHHHHH
Q 018712 274 PVDHTLPRGQQSLVTW---A------TPKLSEDKVKQCVDTKLGGEYPP-KAIAKVRKKKFI 325 (351)
Q Consensus 274 Pf~~~~~~~~~~~~~~---~------~~~~~~~~~~~~ld~~~~~~~~~-~~~~~~~~~~~~ 325 (351)
||...........+.. . .+....+.+..|+..++..|++. +.+..++.+.++
T Consensus 231 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~ 292 (316)
T cd05574 231 PFKGSNRDETFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFF 292 (316)
T ss_pred CCCCCchHHHHHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchh
Confidence 9976543221111000 0 12223478889999999999982 223334444443
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=279.31 Aligned_cols=254 Identities=23% Similarity=0.338 Sum_probs=198.3
Q ss_pred hcCCCCCceeccCCcEEEEEEEEC------CCCEEEEEEcCCCCCc--hHHHHHHHHHHHhccCCceeeeEEEEecCCce
Q 018712 65 TDNFGTNSLIGEGSYGRVYFGVLR------SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPLR 136 (351)
Q Consensus 65 ~~~y~~~~~Lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 136 (351)
.++|++.+.||+|+||.||++... ++..+|+|.+...... ...+.+|+.++++++||||+++++++.++...
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 467999999999999999999863 4678999998754332 35688899999999999999999999999999
Q ss_pred EEEEEeCCCCCHHHHhccCCCCCC-------------CCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCc
Q 018712 137 VLAYEHASKGSLHDILHGKKGVKG-------------AKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSN 203 (351)
Q Consensus 137 ~lv~e~~~~gsL~~~l~~~~~~~~-------------~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~N 203 (351)
+++|||+++++|.+++........ ......+++..++.++.|++.||.|||+++ ++||||||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHhh
Confidence 999999999999999975432100 111134788899999999999999999999 9999999999
Q ss_pred EEEccCCceEEecccccCCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCC
Q 018712 204 VLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRG 282 (351)
Q Consensus 204 ill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~Pf~~~~~~~ 282 (351)
|+++.++.++|+|||++................++..|+|||.+.+..++.++||||||+++|+|++ |..||.......
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~ 240 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEE 240 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 9999999999999999875533221111122334667999999998899999999999999999997 888987543322
Q ss_pred Cccchh--------hcccCCCccchhhhcccccCCCCCHHHHHHHHH
Q 018712 283 QQSLVT--------WATPKLSEDKVKQCVDTKLGGEYPPKAIAKVRK 321 (351)
Q Consensus 283 ~~~~~~--------~~~~~~~~~~~~~~ld~~~~~~~~~~~~~~~~~ 321 (351)
....+. ...+....+.+.+|+..+|.+|++.+++...++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~ 287 (288)
T cd05050 241 VIYYVRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQ 287 (288)
T ss_pred HHHHHhcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhh
Confidence 111111 011112236888999999999999998877654
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=281.70 Aligned_cols=202 Identities=22% Similarity=0.379 Sum_probs=162.6
Q ss_pred ceeccCCcEEEEEEEEC---CCCEEEEEEcCCCCCchHHHHHHHHHHHhccCCceeeeEEEEe--cCCceEEEEEeCCCC
Q 018712 72 SLIGEGSYGRVYFGVLR---SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYV--DGPLRVLAYEHASKG 146 (351)
Q Consensus 72 ~~Lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~--~~~~~~lv~e~~~~g 146 (351)
..||+|+||.||+|... ++..||+|.+..... ...+.+|++++++++||||+++++++. .+...+++|||+.+
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~-~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~- 84 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI-SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH- 84 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCCC-cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC-
Confidence 57999999999999965 457899999875443 345788999999999999999999885 35578999999875
Q ss_pred CHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEE----ccCCceEEecccccCC
Q 018712 147 SLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLL----FDDDIAKISDFDLSNQ 222 (351)
Q Consensus 147 sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill----~~~~~vkl~Dfg~a~~ 222 (351)
+|.+++..............+++..+..++.||+.||.|||+.+ ++||||||+|||+ +.++.+||+|||+++.
T Consensus 85 ~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~ 161 (317)
T cd07867 85 DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARL 161 (317)
T ss_pred cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeeccceec
Confidence 88888764332221122234888999999999999999999999 9999999999999 4567999999999976
Q ss_pred Ccccccc-ccccccccccCccCcccccCC-CCCccchhHhHHHHHHHHHcCCCCCCCC
Q 018712 223 APDAAAR-LHSTRVLGTFGYHAPEYAMTG-QMSSKSDVYSFGVVLLELLTGRKPVDHT 278 (351)
Q Consensus 223 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~Pf~~~ 278 (351)
....... .......||+.|+|||++.+. .++.++||||||+++|||+||+.||...
T Consensus 162 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~ 219 (317)
T cd07867 162 FNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred cCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence 5433211 112345689999999998764 5799999999999999999999999754
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=279.88 Aligned_cols=252 Identities=28% Similarity=0.407 Sum_probs=196.0
Q ss_pred cCHHHHHHHhcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCCchHHHHHHHHHHHhc-cCCceeeeEEEEecC
Q 018712 56 ISVDELKEKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRL-KNENVVELVGYYVDG 133 (351)
Q Consensus 56 ~~~~~~~~~~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~ 133 (351)
+....+....++|.+.+.||+|+||.||++... +++.+|+|.+.........+.+|+.+++++ +|+|++++++++...
T Consensus 12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~ 91 (291)
T cd06639 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKA 91 (291)
T ss_pred hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEec
Confidence 334455566789999999999999999999974 788999999876555566788899999999 899999999988643
Q ss_pred -----CceEEEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEcc
Q 018712 134 -----PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFD 208 (351)
Q Consensus 134 -----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~ 208 (351)
+..++||||+++++|.++++..... ...+++..++.++.|++.||.|||+.+ ++||||||+||++++
T Consensus 92 ~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~-----~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~ 163 (291)
T cd06639 92 DKLVGGQLWLVLELCNGGSVTELVKGLLIC-----GQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTT 163 (291)
T ss_pred cccCCCeeEEEEEECCCCcHHHHHHHhhhc-----CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcC
Confidence 3589999999999999988642111 112788999999999999999999999 999999999999999
Q ss_pred CCceEEecccccCCCccccccccccccccccCccCcccccCC-----CCCccchhHhHHHHHHHHHcCCCCCCCCCCCCC
Q 018712 209 DDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTG-----QMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQ 283 (351)
Q Consensus 209 ~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~ 283 (351)
++.+||+|||++......... .....|+..|+|||.+... .++.++||||||+++|+|++|+.||....+...
T Consensus 164 ~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~ 241 (291)
T cd06639 164 EGGVKLVDFGVSAQLTSTRLR--RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKT 241 (291)
T ss_pred CCCEEEeecccchhccccccc--ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHH
Confidence 999999999998765432211 1334688899999987543 368899999999999999999999976543211
Q ss_pred ccchh-hcccC---------CCccchhhhcccccCCCCCHHHHH
Q 018712 284 QSLVT-WATPK---------LSEDKVKQCVDTKLGGEYPPKAIA 317 (351)
Q Consensus 284 ~~~~~-~~~~~---------~~~~~~~~~ld~~~~~~~~~~~~~ 317 (351)
...+. ...+. ...+.+.+|++.+|.+|++..++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il 285 (291)
T cd06639 242 LFKIPRNPPPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLL 285 (291)
T ss_pred HHHHhcCCCCCCCcccccCHHHHHHHHHHhhcChhhCcCHHHHh
Confidence 11110 10111 112567888888888888876654
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=278.27 Aligned_cols=236 Identities=22% Similarity=0.379 Sum_probs=189.6
Q ss_pred CCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCC-CchHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEEEeCCC
Q 018712 68 FGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK-QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASK 145 (351)
Q Consensus 68 y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 145 (351)
|++.+.||+|+||.||++... ++..+++|.+.... .....+.+|+++++.++|+||+++++.+...+..++|+||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 677889999999999999975 57788999886543 2245678899999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccccCCCcc
Q 018712 146 GSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPD 225 (351)
Q Consensus 146 gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~ 225 (351)
++|..++..... .+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++.....
T Consensus 87 ~~l~~~~~~~~~--------~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~ 155 (282)
T cd06643 87 GAVDAVMLELER--------PLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTR 155 (282)
T ss_pred CcHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEccccccccccc
Confidence 999998865321 2889999999999999999999999 99999999999999999999999999876533
Q ss_pred ccccccccccccccCccCccccc-----CCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccch----------hhc
Q 018712 226 AAARLHSTRVLGTFGYHAPEYAM-----TGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLV----------TWA 290 (351)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~----------~~~ 290 (351)
... ......++..|+|||++. +..++.++|||||||++|+|++|+.||....+......+ ...
T Consensus 156 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (282)
T cd06643 156 TIQ--RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSR 233 (282)
T ss_pred ccc--ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCCCCccc
Confidence 221 123456899999999874 445778999999999999999999999765432111111 011
Q ss_pred ccCCCccchhhhcccccCCCCCHHHH
Q 018712 291 TPKLSEDKVKQCVDTKLGGEYPPKAI 316 (351)
Q Consensus 291 ~~~~~~~~~~~~ld~~~~~~~~~~~~ 316 (351)
.+....+.+..|+..+|.+|++.+++
T Consensus 234 ~~~~~~~li~~~l~~~p~~Rp~~~~i 259 (282)
T cd06643 234 WSSEFKDFLKKCLEKNVDARWTTTQL 259 (282)
T ss_pred cCHHHHHHHHHHccCChhhCcCHHHH
Confidence 11223468889999999999987654
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-38 Score=279.26 Aligned_cols=237 Identities=27% Similarity=0.392 Sum_probs=194.1
Q ss_pred CCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCC--chHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEEEeC
Q 018712 67 NFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ--PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHA 143 (351)
Q Consensus 67 ~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 143 (351)
.|+..+.||+|+||.||+|.+. ++..||+|.+..... ..+.+.+|++++++++|+||+++++.+...+..++||||+
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence 4666778999999999999865 678999998874432 2356889999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccccCCC
Q 018712 144 SKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQA 223 (351)
Q Consensus 144 ~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~ 223 (351)
++++|.+++.... +++..+..++.|++.||.|||+++ ++|+||+|+||++++++.++|+|||++...
T Consensus 85 ~~~~L~~~~~~~~----------~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~ 151 (277)
T cd06642 85 GGGSALDLLKPGP----------LEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQL 151 (277)
T ss_pred CCCcHHHHhhcCC----------CCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccc
Confidence 9999999986532 788999999999999999999999 999999999999999999999999998765
Q ss_pred ccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccchhhc-c-------cCCC
Q 018712 224 PDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWA-T-------PKLS 295 (351)
Q Consensus 224 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~~~~-~-------~~~~ 295 (351)
..... ......|+..|+|||++.+..++.++|+||||+++|+|++|+.||....+......+... . +...
T Consensus 152 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (277)
T cd06642 152 TDTQI--KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGQYSKPF 229 (277)
T ss_pred cCcch--hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcCCCCCCCcccCHHH
Confidence 43221 123346788999999999889999999999999999999999999765433211111110 1 1112
Q ss_pred ccchhhhcccccCCCCCHHHHHH
Q 018712 296 EDKVKQCVDTKLGGEYPPKAIAK 318 (351)
Q Consensus 296 ~~~~~~~ld~~~~~~~~~~~~~~ 318 (351)
.+.+..|+..+|.+|++..++..
T Consensus 230 ~~li~~~l~~~p~~Rp~~~~il~ 252 (277)
T cd06642 230 KEFVEACLNKDPRFRPTAKELLK 252 (277)
T ss_pred HHHHHHHccCCcccCcCHHHHHH
Confidence 35788899999999999887765
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=273.92 Aligned_cols=239 Identities=24% Similarity=0.335 Sum_probs=191.1
Q ss_pred CCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCC---chHHHHHHHHHHHhccCCceeeeEEEEec-CCceEEEEE
Q 018712 67 NFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ---PDQEFLAQVSMVSRLKNENVVELVGYYVD-GPLRVLAYE 141 (351)
Q Consensus 67 ~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e 141 (351)
+|++.+.||+|++|.||++..+ +++.+|+|++..... ..+.+.+|++++++++|+|++++++.+.. ....+++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 5889999999999999999965 678999999865432 23567889999999999999999988764 446799999
Q ss_pred eCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccccC
Q 018712 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (351)
Q Consensus 142 ~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~ 221 (351)
|+++++|.+++..... ..+++.++..++.|++.||.+||++| ++||||||+||+++.++.++|+|||++.
T Consensus 81 ~~~~~~l~~~l~~~~~-------~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~ 150 (257)
T cd08223 81 FCEGGDLYHKLKEQKG-------KLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIAR 150 (257)
T ss_pred ccCCCcHHHHHHHhcC-------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceE
Confidence 9999999999976432 12789999999999999999999999 9999999999999999999999999987
Q ss_pred CCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccch-hh-------cccC
Q 018712 222 QAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLV-TW-------ATPK 293 (351)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~-~~-------~~~~ 293 (351)
....... ......+++.|+|||++.+..++.++|+||||+++|+|++|+.||...........+ .. ..+.
T Consensus 151 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (257)
T cd08223 151 VLENQCD--MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMPKDYSP 228 (257)
T ss_pred EecccCC--ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCccccCH
Confidence 6533221 123456889999999999999999999999999999999999999764332211111 10 1111
Q ss_pred CCccchhhhcccccCCCCCHHHHH
Q 018712 294 LSEDKVKQCVDTKLGGEYPPKAIA 317 (351)
Q Consensus 294 ~~~~~~~~~ld~~~~~~~~~~~~~ 317 (351)
...+.+..|++++|.+|++..++.
T Consensus 229 ~~~~li~~~l~~~p~~Rp~~~~~l 252 (257)
T cd08223 229 ELGELIATMLSKRPEKRPSVKSIL 252 (257)
T ss_pred HHHHHHHHHhccCcccCCCHHHHh
Confidence 123677888999999998876654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=274.43 Aligned_cols=239 Identities=27% Similarity=0.398 Sum_probs=193.1
Q ss_pred cCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCC-chHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEEEeC
Q 018712 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ-PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHA 143 (351)
Q Consensus 66 ~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 143 (351)
++|++.+.||+|+||.||+|... +++.+++|.+..... ..+.+.+|++++++++||||+++++.+.+....+++|||+
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~ 82 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC 82 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence 57899999999999999999965 678999999875432 3467889999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccccCCC
Q 018712 144 SKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQA 223 (351)
Q Consensus 144 ~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~ 223 (351)
.+++|.+++..... .++...+..++.|++.||.|||+++ ++|+||+|+||++++++.+||+|||++...
T Consensus 83 ~~~~l~~~~~~~~~--------~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~ 151 (262)
T cd06613 83 GGGSLQDIYQVTRG--------PLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQL 151 (262)
T ss_pred CCCcHHHHHHhhcc--------CCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhh
Confidence 99999999876521 2889999999999999999999999 999999999999999999999999998765
Q ss_pred ccccccccccccccccCccCcccccCC---CCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccchhhc----------
Q 018712 224 PDAAARLHSTRVLGTFGYHAPEYAMTG---QMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWA---------- 290 (351)
Q Consensus 224 ~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~~~~---------- 290 (351)
...... .....++..|+|||.+.+. .++.++|+||||+++|+|++|+.||....+..........
T Consensus 152 ~~~~~~--~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (262)
T cd06613 152 TATIAK--RKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDK 229 (262)
T ss_pred hhhhhc--cccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccch
Confidence 432211 1335688899999998776 7889999999999999999999999765432211111000
Q ss_pred --ccCCCccchhhhcccccCCCCCHHHHH
Q 018712 291 --TPKLSEDKVKQCVDTKLGGEYPPKAIA 317 (351)
Q Consensus 291 --~~~~~~~~~~~~ld~~~~~~~~~~~~~ 317 (351)
.+....+.+..|+..+|..|++.+++.
T Consensus 230 ~~~~~~~~~li~~~l~~~p~~Rpt~~~il 258 (262)
T cd06613 230 EKWSPVFHDFIKKCLTKDPKKRPTATKLL 258 (262)
T ss_pred hhhhHHHHHHHHHHcCCChhhCCCHHHHh
Confidence 011113567778888888888776653
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=279.64 Aligned_cols=239 Identities=25% Similarity=0.365 Sum_probs=195.2
Q ss_pred hcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCC--chHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEEE
Q 018712 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ--PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYE 141 (351)
Q Consensus 65 ~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 141 (351)
.++|++.+.||+|+||.||++... +++.||+|++..... ....+.+|+++++.++||||+++++.+...+..++|||
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCME 83 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEe
Confidence 467888999999999999999965 688999998764432 34678899999999999999999999999999999999
Q ss_pred eCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhh-CCCCCeeeccccCCcEEEccCCceEEeccccc
Q 018712 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHE-KAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (351)
Q Consensus 142 ~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~-~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a 220 (351)
|+++++|.+++...+. +++..+..++.+++.||.|||+ .+ ++||||+|+||++++++.++|+|||++
T Consensus 84 ~~~~~~L~~~~~~~~~---------~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~d~gl~ 151 (284)
T cd06620 84 FMDCGSLDRIYKKGGP---------IPVEILGKIAVAVVEGLTYLYNVHR---IMHRDIKPSNILVNSRGQIKLCDFGVS 151 (284)
T ss_pred cCCCCCHHHHHHhccC---------CCHHHHHHHHHHHHHHHHHHHHhcC---eeccCCCHHHEEECCCCcEEEccCCcc
Confidence 9999999999876432 8899999999999999999997 57 999999999999999999999999998
Q ss_pred CCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCc--------c----chh
Q 018712 221 NQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQ--------S----LVT 288 (351)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~--------~----~~~ 288 (351)
....... .....|+..|+|||++.+..++.++|+||||+++|+|++|..||......... . .+.
T Consensus 152 ~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (284)
T cd06620 152 GELINSI----ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQ 227 (284)
T ss_pred cchhhhc----cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhh
Confidence 6543221 13456899999999998888999999999999999999999999865432100 0 000
Q ss_pred hc--------ccCCCccchhhhcccccCCCCCHHHHHHH
Q 018712 289 WA--------TPKLSEDKVKQCVDTKLGGEYPPKAIAKV 319 (351)
Q Consensus 289 ~~--------~~~~~~~~~~~~ld~~~~~~~~~~~~~~~ 319 (351)
.. .+....+.+..|+..+|.+|++.+++.+.
T Consensus 228 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~ 266 (284)
T cd06620 228 EPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAM 266 (284)
T ss_pred ccCCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 00 11122357888999999999988776543
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=267.90 Aligned_cols=245 Identities=19% Similarity=0.288 Sum_probs=194.0
Q ss_pred HHHhcCCCCC-ceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCCchHHHHHHHHHHHhc-cCCceeeeEEEEe----cCC
Q 018712 62 KEKTDNFGTN-SLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRL-KNENVVELVGYYV----DGP 134 (351)
Q Consensus 62 ~~~~~~y~~~-~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~----~~~ 134 (351)
..++++|.+. ++||-|-.|.|..+.++ +++.+|+|++... +...+|+++--.. .|+|||.+++.|. ...
T Consensus 57 ~~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rk 132 (400)
T KOG0604|consen 57 YSITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS----PKARREVELHWMASGHPHIVSIIDVYENSYQGRK 132 (400)
T ss_pred ccchhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCce
Confidence 3467788875 57999999999999865 8999999998654 3466788774444 7999999999865 445
Q ss_pred ceEEEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEcc---CCc
Q 018712 135 LRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFD---DDI 211 (351)
Q Consensus 135 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~---~~~ 211 (351)
.+.+|||.++||.|.+.++.++.. .+++.++..|+.||..|++|||+.+ |.||||||+|+|... +..
T Consensus 133 cLLiVmE~meGGeLfsriq~~g~~-------afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~ 202 (400)
T KOG0604|consen 133 CLLIVMECMEGGELFSRIQDRGDQ-------AFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAP 202 (400)
T ss_pred eeEeeeecccchHHHHHHHHcccc-------cchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcc
Confidence 678999999999999999987653 3999999999999999999999999 999999999999965 457
Q ss_pred eEEecccccCCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCC----Cccch
Q 018712 212 AKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRG----QQSLV 287 (351)
Q Consensus 212 vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~----~~~~~ 287 (351)
+||+|||+|+....... ..+.+-||.|.|||++....|+...|+||+||++|-|++|.+||....... ....|
T Consensus 203 lKLtDfGFAK~t~~~~~---L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI 279 (400)
T KOG0604|consen 203 LKLTDFGFAKETQEPGD---LMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRI 279 (400)
T ss_pred eEecccccccccCCCcc---ccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHh
Confidence 99999999988654222 255678999999999999999999999999999999999999999764321 11222
Q ss_pred hhc-----ccCCC------ccchhhhcccccCCCCCHHHHHHHHHHHHHh
Q 018712 288 TWA-----TPKLS------EDKVKQCVDTKLGGEYPPKAIAKVRKKKFIT 326 (351)
Q Consensus 288 ~~~-----~~~~~------~~~~~~~ld~~~~~~~~~~~~~~~~~~~~~~ 326 (351)
... .++|. .++++.+|...|.+|.+.++. +.+.++.
T Consensus 280 ~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~---m~hpwi~ 326 (400)
T KOG0604|consen 280 RTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEV---MDHPWIN 326 (400)
T ss_pred hccCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHh---hcCchhc
Confidence 211 11222 267888888888888876654 4444443
|
|
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=273.02 Aligned_cols=241 Identities=22% Similarity=0.309 Sum_probs=182.2
Q ss_pred ceeccCCcEEEEEEEEC---CCCEEEEEEcCCCCCc--hHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEEEeCCCC
Q 018712 72 SLIGEGSYGRVYFGVLR---SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASKG 146 (351)
Q Consensus 72 ~~Lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 146 (351)
+.||+|+||.||+|... ++..+|+|.+...... ...+.+|+.++++++||||+++++.+.+....++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 35899999999999854 3467999988755432 346888999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccccCCCccc
Q 018712 147 SLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDA 226 (351)
Q Consensus 147 sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~ 226 (351)
+|.+++....... ....++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++......
T Consensus 81 ~L~~~l~~~~~~~----~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~ 153 (269)
T cd05087 81 DLKGYLRSCRKAE----LMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKE 153 (269)
T ss_pred cHHHHHHHhhhcc----cccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCc
Confidence 9999997543211 112567778889999999999999999 999999999999999999999999998754433
Q ss_pred cccccccccccccCccCcccccCC-------CCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCCccc-hh-----hccc
Q 018712 227 AARLHSTRVLGTFGYHAPEYAMTG-------QMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSL-VT-----WATP 292 (351)
Q Consensus 227 ~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~~DvwslG~il~el~t-g~~Pf~~~~~~~~~~~-~~-----~~~~ 292 (351)
..........++..|+|||++.+. .++.++|+||||+++|||++ |+.||....+...... +. ...+
T Consensus 154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 233 (269)
T cd05087 154 DYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKP 233 (269)
T ss_pred ceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCC
Confidence 222222334578889999988642 35789999999999999996 9999976433221100 00 0011
Q ss_pred C-------CCccchhhhcccccCCCCCHHHHHHHH
Q 018712 293 K-------LSEDKVKQCVDTKLGGEYPPKAIAKVR 320 (351)
Q Consensus 293 ~-------~~~~~~~~~ld~~~~~~~~~~~~~~~~ 320 (351)
. ...+.+..|+ .+|.+|++.+++.+.+
T Consensus 234 ~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l 267 (269)
T cd05087 234 RLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLL 267 (269)
T ss_pred ccCCCCChHHHHHHHHHh-cCcccCCCHHHHHHHh
Confidence 1 1113556666 4688888888877553
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=278.73 Aligned_cols=240 Identities=23% Similarity=0.377 Sum_probs=191.9
Q ss_pred cCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCCc--hHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEEEe
Q 018712 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEH 142 (351)
Q Consensus 66 ~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 142 (351)
++|++.+.||+|+||.||++... ++..||+|.+...... ...+.+|+.++++++|+||+++++.+...+..++||||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 46889999999999999999975 7899999988654322 35688899999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhh-CCCCCeeeccccCCcEEEccCCceEEecccccC
Q 018712 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHE-KAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (351)
Q Consensus 143 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~-~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~ 221 (351)
+++++|.+++..... ...+++..+..++.|++.||.|||+ .+ ++|+||||+||+++.++.+||+|||++.
T Consensus 81 ~~~~~l~~~~~~~~~------~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~ 151 (286)
T cd06622 81 MDAGSLDKLYAGGVA------TEGIPEDVLRRITYAVVKGLKFLKEEHN---IIHRDVKPTNVLVNGNGQVKLCDFGVSG 151 (286)
T ss_pred cCCCCHHHHHHhccc------cCCCCHHHHHHHHHHHHHHHHHHHhcCC---EeeCCCCHHHEEECCCCCEEEeecCCcc
Confidence 999999999876421 1138999999999999999999997 47 9999999999999999999999999987
Q ss_pred CCccccccccccccccccCccCcccccCC------CCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccc----hhhcc
Q 018712 222 QAPDAAARLHSTRVLGTFGYHAPEYAMTG------QMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSL----VTWAT 291 (351)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~----~~~~~ 291 (351)
...... .....++..|+|||.+.+. .++.++|+||||+++|+|++|+.||........... .....
T Consensus 152 ~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 227 (286)
T cd06622 152 NLVASL----AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDP 227 (286)
T ss_pred cccCCc----cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCC
Confidence 653322 1334578899999988544 347899999999999999999999976433221111 11111
Q ss_pred cC-------CCccchhhhcccccCCCCCHHHHHH
Q 018712 292 PK-------LSEDKVKQCVDTKLGGEYPPKAIAK 318 (351)
Q Consensus 292 ~~-------~~~~~~~~~ld~~~~~~~~~~~~~~ 318 (351)
+. ...+.+.+|+..+|.+|++.+++..
T Consensus 228 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 261 (286)
T cd06622 228 PTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE 261 (286)
T ss_pred CCCCcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence 11 1125778999999999999876543
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=279.82 Aligned_cols=250 Identities=24% Similarity=0.359 Sum_probs=195.8
Q ss_pred hcCCCCCceeccCCcEEEEEEEEC-CCC----EEEEEEcCCCCCc--hHHHHHHHHHHHhccCCceeeeEEEEecCCceE
Q 018712 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGR----AAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRV 137 (351)
Q Consensus 65 ~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 137 (351)
.++|++.+.||+|+||.||+|.+. ++. .+|+|.+...... ...+.+|+.+++.++|+||+++++++... ..+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~ 84 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQ 84 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cce
Confidence 457888999999999999999864 443 5788988654332 34678899999999999999999988654 467
Q ss_pred EEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecc
Q 018712 138 LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDF 217 (351)
Q Consensus 138 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Df 217 (351)
+++||+++|+|.+++..... .+++..+..++.|++.||.|||+++ ++||||||+||++++++.+||+||
T Consensus 85 ~v~e~~~~g~l~~~~~~~~~--------~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Df 153 (303)
T cd05110 85 LVTQLMPHGCLLDYVHEHKD--------NIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDF 153 (303)
T ss_pred eeehhcCCCCHHHHHHhccc--------CCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEccc
Confidence 99999999999999976532 2788899999999999999999999 999999999999999999999999
Q ss_pred cccCCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCCccchhhcc-----
Q 018712 218 DLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWAT----- 291 (351)
Q Consensus 218 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~----- 291 (351)
|+++...............++..|+|||.+.+..++.++||||||+++|||++ |+.||...........+....
T Consensus 154 g~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~ 233 (303)
T cd05110 154 GLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLPQP 233 (303)
T ss_pred cccccccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCC
Confidence 99987643332222223345778999999998999999999999999999997 999997653322111111110
Q ss_pred ---cCCCccchhhhcccccCCCCCHHHHHHHHHHHHHh
Q 018712 292 ---PKLSEDKVKQCVDTKLGGEYPPKAIAKVRKKKFIT 326 (351)
Q Consensus 292 ---~~~~~~~~~~~ld~~~~~~~~~~~~~~~~~~~~~~ 326 (351)
+.-..+.+..|+..++.+|++.+++...+......
T Consensus 234 ~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~ 271 (303)
T cd05110 234 PICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARD 271 (303)
T ss_pred CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 11113567899999999999999987766654433
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=275.05 Aligned_cols=247 Identities=25% Similarity=0.351 Sum_probs=196.0
Q ss_pred hcCCCCCceeccCCcEEEEEEEEC-CCC----EEEEEEcCCCCC--chHHHHHHHHHHHhccCCceeeeEEEEecCCceE
Q 018712 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGR----AAAIKKLDSSKQ--PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRV 137 (351)
Q Consensus 65 ~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 137 (351)
..+|++.+.||+|+||.||+|..+ ++. .+|+|.+..... ....+.+|+.++++++|+||+++++++.. ...+
T Consensus 6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~ 84 (279)
T cd05057 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQ 84 (279)
T ss_pred HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceE
Confidence 367889999999999999999864 333 689998875543 23568889999999999999999999877 7889
Q ss_pred EEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecc
Q 018712 138 LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDF 217 (351)
Q Consensus 138 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Df 217 (351)
++|||+.+|+|.+++..... .+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+||
T Consensus 85 ~v~e~~~~g~L~~~l~~~~~--------~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~df 153 (279)
T cd05057 85 LITQLMPLGCLLDYVRNHKD--------NIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDF 153 (279)
T ss_pred EEEecCCCCcHHHHHHhccC--------CCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCC
Confidence 99999999999999976532 2889999999999999999999999 999999999999999999999999
Q ss_pred cccCCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCCccchhhc----cc
Q 018712 218 DLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWA----TP 292 (351)
Q Consensus 218 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~Pf~~~~~~~~~~~~~~~----~~ 292 (351)
|+++...............++..|+|||.+....++.++|+||||+++||+++ |+.||...........+... .+
T Consensus 154 g~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 233 (279)
T cd05057 154 GLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERLPQP 233 (279)
T ss_pred cccccccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCCCCCC
Confidence 99987653322221122234568999999988889999999999999999998 99999876443222211111 01
Q ss_pred C----CCccchhhhcccccCCCCCHHHHHHHHHHH
Q 018712 293 K----LSEDKVKQCVDTKLGGEYPPKAIAKVRKKK 323 (351)
Q Consensus 293 ~----~~~~~~~~~ld~~~~~~~~~~~~~~~~~~~ 323 (351)
. ...+.+.+|+..++..|++..++...+.-.
T Consensus 234 ~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~ 268 (279)
T cd05057 234 PICTIDVYMVLVKCWMIDAESRPTFKELINEFSKM 268 (279)
T ss_pred CCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 1 112567889999999999988886665544
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=298.35 Aligned_cols=245 Identities=23% Similarity=0.382 Sum_probs=200.0
Q ss_pred cCCCCCceeccCCcEEEEEEEECC-CCEEEEEEcCCCC-CchHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEEEeC
Q 018712 66 DNFGTNSLIGEGSYGRVYFGVLRS-GRAAAIKKLDSSK-QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHA 143 (351)
Q Consensus 66 ~~y~~~~~Lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 143 (351)
+-|.|+..||.|+||.||+|..+. +-..|.|++.... ..-.+++-|+++|..+.||+||++++.|..++.++++.|||
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC 111 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFC 111 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeec
Confidence 458888899999999999999774 4556777776443 33467899999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccccCCC
Q 018712 144 SKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQA 223 (351)
Q Consensus 144 ~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~ 223 (351)
.||-+..++-.-.. .+.+.++..+++|++.||.|||++. |||||||.+|||++-+|.++|+|||.+...
T Consensus 112 ~GGAVDaimlEL~r--------~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn 180 (1187)
T KOG0579|consen 112 GGGAVDAIMLELGR--------VLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKN 180 (1187)
T ss_pred CCchHhHHHHHhcc--------ccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccc
Confidence 99999999876553 4999999999999999999999999 999999999999999999999999997654
Q ss_pred ccccccccccccccccCccCccccc-----CCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccchhhcc-cCC---
Q 018712 224 PDAAARLHSTRVLGTFGYHAPEYAM-----TGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWAT-PKL--- 294 (351)
Q Consensus 224 ~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~~~~~-~~~--- 294 (351)
.... .....+.|||+|||||+.. ..+|+.++||||||++|.||..+.+|....++......+.... |.+
T Consensus 181 ~~t~--qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLlqP 258 (1187)
T KOG0579|consen 181 KSTR--QKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLLQP 258 (1187)
T ss_pred hhHH--hhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCcccCc
Confidence 3322 2235688999999999764 5689999999999999999999999988766543333332221 111
Q ss_pred ------CccchhhhcccccCCCCCHHHHHHHHHHHHHh
Q 018712 295 ------SEDKVKQCVDTKLGGEYPPKAIAKVRKKKFIT 326 (351)
Q Consensus 295 ------~~~~~~~~ld~~~~~~~~~~~~~~~~~~~~~~ 326 (351)
..+.++.|++.++..|+++.++ +++.|..
T Consensus 259 S~Ws~~F~DfLk~cL~Knp~~Rp~aaql---l~Hpfv~ 293 (1187)
T KOG0579|consen 259 SHWSRSFSDFLKRCLVKNPRNRPPAAQL---LKHPFVQ 293 (1187)
T ss_pred chhhhHHHHHHHHHHhcCCccCCCHHHH---hhCcccc
Confidence 1378899999999999987765 4444433
|
|
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-38 Score=282.16 Aligned_cols=236 Identities=25% Similarity=0.401 Sum_probs=190.4
Q ss_pred CCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCC-chHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEEEeCCC
Q 018712 68 FGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ-PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASK 145 (351)
Q Consensus 68 y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 145 (351)
|.....||+|+||.||++... ++..||+|.+..... ....+.+|+.+++.++|+||+++++.+...+..++||||+++
T Consensus 24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~ 103 (292)
T cd06658 24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEG 103 (292)
T ss_pred HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCC
Confidence 444456999999999999964 688999999865432 245678999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccccCCCcc
Q 018712 146 GSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPD 225 (351)
Q Consensus 146 gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~ 225 (351)
++|.+++.... +++..+..++.||+.||.|||+++ ++||||||+||++++++.++|+|||++.....
T Consensus 104 ~~L~~~~~~~~----------l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~ 170 (292)
T cd06658 104 GALTDIVTHTR----------MNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSK 170 (292)
T ss_pred CcHHHHHhcCC----------CCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhccc
Confidence 99999986532 788999999999999999999999 99999999999999999999999999875433
Q ss_pred ccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccchhhc----------ccCCC
Q 018712 226 AAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWA----------TPKLS 295 (351)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~~~~----------~~~~~ 295 (351)
.... .....|+..|+|||.+.+..++.++||||||+++|||++|+.||...........+... .+...
T Consensus 171 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (292)
T cd06658 171 EVPK--RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHKVSSVL 248 (292)
T ss_pred cccc--CceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCccccccccCHHH
Confidence 2211 13346889999999998888999999999999999999999999765432211111110 11112
Q ss_pred ccchhhhcccccCCCCCHHHHHH
Q 018712 296 EDKVKQCVDTKLGGEYPPKAIAK 318 (351)
Q Consensus 296 ~~~~~~~ld~~~~~~~~~~~~~~ 318 (351)
.+.+..|+..+|.+|++.+++..
T Consensus 249 ~~li~~~l~~~P~~Rpt~~~il~ 271 (292)
T cd06658 249 RGFLDLMLVREPSQRATAQELLQ 271 (292)
T ss_pred HHHHHHHccCChhHCcCHHHHhh
Confidence 35678888899999998876654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=282.22 Aligned_cols=257 Identities=24% Similarity=0.343 Sum_probs=199.8
Q ss_pred hcCCCCCceeccCCcEEEEEEEEC--------CCCEEEEEEcCCCCC--chHHHHHHHHHHHhc-cCCceeeeEEEEecC
Q 018712 65 TDNFGTNSLIGEGSYGRVYFGVLR--------SGRAAAIKKLDSSKQ--PDQEFLAQVSMVSRL-KNENVVELVGYYVDG 133 (351)
Q Consensus 65 ~~~y~~~~~Lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~ 133 (351)
..+|.+.+.||+|+||.||++... .+..+|+|.+..... ..+.+.+|+++++++ +|+||+++++.+...
T Consensus 11 ~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (334)
T cd05100 11 RTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 90 (334)
T ss_pred HhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccC
Confidence 357899999999999999999742 123689998875432 235688999999999 799999999999999
Q ss_pred CceEEEEEeCCCCCHHHHhccCCCCCC-------CCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEE
Q 018712 134 PLRVLAYEHASKGSLHDILHGKKGVKG-------AKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLL 206 (351)
Q Consensus 134 ~~~~lv~e~~~~gsL~~~l~~~~~~~~-------~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill 206 (351)
+..++++||+++|+|.+++........ ..+...+++.+++.++.|++.||.|||++| ++||||||+||++
T Consensus 91 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nill 167 (334)
T cd05100 91 GPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARNVLV 167 (334)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEE
Confidence 999999999999999999976432100 112234888999999999999999999999 9999999999999
Q ss_pred ccCCceEEecccccCCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCCcc
Q 018712 207 FDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQS 285 (351)
Q Consensus 207 ~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~Pf~~~~~~~~~~ 285 (351)
+.++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..||..........
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~ 247 (334)
T cd05100 168 TEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFK 247 (334)
T ss_pred cCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Confidence 9999999999999876543322211222334567999999999999999999999999999998 899997654332211
Q ss_pred chhh-c-------ccCCCccchhhhcccccCCCCCHHHHHHHHHHHH
Q 018712 286 LVTW-A-------TPKLSEDKVKQCVDTKLGGEYPPKAIAKVRKKKF 324 (351)
Q Consensus 286 ~~~~-~-------~~~~~~~~~~~~ld~~~~~~~~~~~~~~~~~~~~ 324 (351)
.+.. . .+....+.+.+|+...+.+|++..++...++..+
T Consensus 248 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~ 294 (334)
T cd05100 248 LLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVL 294 (334)
T ss_pred HHHcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHh
Confidence 1111 0 0111225789999999999999998887765554
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=276.28 Aligned_cols=201 Identities=23% Similarity=0.395 Sum_probs=170.7
Q ss_pred hcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCC--chHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEEE
Q 018712 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ--PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYE 141 (351)
Q Consensus 65 ~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 141 (351)
.++|++.+.||+|++|.||+|..+ +++.||+|.+..... ....+.+|++++++++|+||+++++++.+.+..++|||
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFE 83 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEe
Confidence 468999999999999999999976 689999999865432 23456789999999999999999999999999999999
Q ss_pred eCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccccC
Q 018712 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (351)
Q Consensus 142 ~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~ 221 (351)
|+.+ +|.+++..... .+++..+..++.|++.||.|||+.+ ++||||||+||++++++.+||+|||+++
T Consensus 84 ~~~~-~L~~~~~~~~~--------~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~ 151 (291)
T cd07844 84 YLDT-DLKQYMDDCGG--------GLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLAR 151 (291)
T ss_pred cCCC-CHHHHHHhCCC--------CCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECcccccc
Confidence 9985 99998875432 2788999999999999999999999 9999999999999999999999999986
Q ss_pred CCccccccccccccccccCccCcccccC-CCCCccchhHhHHHHHHHHHcCCCCCCCCC
Q 018712 222 QAPDAAARLHSTRVLGTFGYHAPEYAMT-GQMSSKSDVYSFGVVLLELLTGRKPVDHTL 279 (351)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~Pf~~~~ 279 (351)
........ .....++..|+|||.+.+ ..++.++||||+|+++|+|++|+.||....
T Consensus 152 ~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~ 208 (291)
T cd07844 152 AKSVPSKT--YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGST 208 (291)
T ss_pred ccCCCCcc--ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCc
Confidence 54322111 122346888999998875 457899999999999999999999997543
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=272.83 Aligned_cols=246 Identities=26% Similarity=0.363 Sum_probs=189.4
Q ss_pred ceeccCCcEEEEEEEEC-CCC--EEEEEEcCCCC--CchHHHHHHHHHHHhc-cCCceeeeEEEEecCCceEEEEEeCCC
Q 018712 72 SLIGEGSYGRVYFGVLR-SGR--AAAIKKLDSSK--QPDQEFLAQVSMVSRL-KNENVVELVGYYVDGPLRVLAYEHASK 145 (351)
Q Consensus 72 ~~Lg~G~~g~Vy~~~~~-~~~--~vavK~~~~~~--~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 145 (351)
+.||+|+||.||+|... ++. .+++|.+.... ...+.+.+|+++++++ +||||+++++++...+..+++|||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 36899999999999975 443 46888876432 2345688899999999 799999999999999999999999999
Q ss_pred CCHHHHhccCCCCCC-------CCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEeccc
Q 018712 146 GSLHDILHGKKGVKG-------AKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFD 218 (351)
Q Consensus 146 gsL~~~l~~~~~~~~-------~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg 218 (351)
++|.+++........ ......+++..++.++.|++.||+|||+.+ ++||||||+||++++++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCC
Confidence 999999976532110 111234789999999999999999999999 9999999999999999999999999
Q ss_pred ccCCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCCccchhh--------
Q 018712 219 LSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTW-------- 289 (351)
Q Consensus 219 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~Pf~~~~~~~~~~~~~~-------- 289 (351)
++........ ......+..|+|||++....++.++||||||+++|||++ |..||...........+..
T Consensus 158 l~~~~~~~~~---~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 234 (270)
T cd05047 158 LSRGQEVYVK---KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPL 234 (270)
T ss_pred Cccccchhhh---ccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCCCCCCCC
Confidence 9854321111 112234567999999988889999999999999999997 9999976543221111110
Q ss_pred cccCCCccchhhhcccccCCCCCHHHHHHHHHHH
Q 018712 290 ATPKLSEDKVKQCVDTKLGGEYPPKAIAKVRKKK 323 (351)
Q Consensus 290 ~~~~~~~~~~~~~ld~~~~~~~~~~~~~~~~~~~ 323 (351)
..+....+.+.+|+..+|.+|++.+++...+.-.
T Consensus 235 ~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~ 268 (270)
T cd05047 235 NCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 268 (270)
T ss_pred cCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHh
Confidence 0111123678899999999999999887765543
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=272.25 Aligned_cols=238 Identities=29% Similarity=0.385 Sum_probs=190.4
Q ss_pred ceeccCCcEEEEEEEECC--C--CEEEEEEcCCCCC--chHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEEEeCCC
Q 018712 72 SLIGEGSYGRVYFGVLRS--G--RAAAIKKLDSSKQ--PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASK 145 (351)
Q Consensus 72 ~~Lg~G~~g~Vy~~~~~~--~--~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 145 (351)
+.||+|++|.||+|.+.+ + ..+|+|.+..... ..+.+.+|+.++++++|+||+++++.+.+ ...+++|||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 368999999999998643 3 3689999876654 34578899999999999999999999888 889999999999
Q ss_pred CCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccccCCCcc
Q 018712 146 GSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPD 225 (351)
Q Consensus 146 gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~ 225 (351)
++|.+++..... ..+++..++.++.|++.||.|||+++ ++|+||||+||+++.++.+||+|||++.....
T Consensus 80 ~~L~~~l~~~~~-------~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~ 149 (257)
T cd05040 80 GSLLDRLRKDAL-------GHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQ 149 (257)
T ss_pred CcHHHHHHhccc-------ccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEeccccccccccc
Confidence 999999976542 12889999999999999999999999 99999999999999999999999999887644
Q ss_pred ccccc-cccccccccCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCCccchh---------hcccCC
Q 018712 226 AAARL-HSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVT---------WATPKL 294 (351)
Q Consensus 226 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~Pf~~~~~~~~~~~~~---------~~~~~~ 294 (351)
..... ......++..|+|||.+.+..++.++||||||+++|+|++ |+.||...........+. ...+..
T Consensus 150 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (257)
T cd05040 150 NEDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQD 229 (257)
T ss_pred cccceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCCCCccCCHH
Confidence 22211 1123456788999999998899999999999999999998 999997543322111111 111222
Q ss_pred CccchhhhcccccCCCCCHHHHHHHH
Q 018712 295 SEDKVKQCVDTKLGGEYPPKAIAKVR 320 (351)
Q Consensus 295 ~~~~~~~~ld~~~~~~~~~~~~~~~~ 320 (351)
..+.+.+|+..+|.+|++..++...+
T Consensus 230 ~~~li~~~l~~~p~~Rps~~~~~~~l 255 (257)
T cd05040 230 IYNVMLQCWAHNPADRPTFAALREFL 255 (257)
T ss_pred HHHHHHHHCCCCcccCCCHHHHHHHh
Confidence 23678888999999999888876543
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=271.62 Aligned_cols=240 Identities=20% Similarity=0.322 Sum_probs=193.9
Q ss_pred CCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCC---CchHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEEEe
Q 018712 67 NFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK---QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEH 142 (351)
Q Consensus 67 ~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 142 (351)
+|+..+.||.|+||.||.+... ++..+++|.+.... .....+.+|++++++++|+||+++++++.+.+..+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 5888999999999999999854 68899999876432 2345688999999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccccCC
Q 018712 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222 (351)
Q Consensus 143 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~ 222 (351)
+++++|.+++..... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||++..
T Consensus 81 ~~~~~L~~~~~~~~~-------~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~ 150 (256)
T cd08221 81 ANGGTLYDKIVRQKG-------QLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKI 150 (256)
T ss_pred cCCCcHHHHHHhccc-------cCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEE
Confidence 999999999976532 23888999999999999999999999 99999999999999999999999999876
Q ss_pred CccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccchhh--------cccCC
Q 018712 223 APDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTW--------ATPKL 294 (351)
Q Consensus 223 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~~~--------~~~~~ 294 (351)
...... ......|++.|+|||.+.+..++.++|+||||+++|+|++|..||...........+.. ..+..
T Consensus 151 ~~~~~~--~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (256)
T cd08221 151 LGSEYS--MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVYSSE 228 (256)
T ss_pred cccccc--cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccCHH
Confidence 543321 12345689999999999888889999999999999999999999976543221111110 01111
Q ss_pred CccchhhhcccccCCCCCHHHHHH
Q 018712 295 SEDKVKQCVDTKLGGEYPPKAIAK 318 (351)
Q Consensus 295 ~~~~~~~~ld~~~~~~~~~~~~~~ 318 (351)
..+.+..|+..+|.+|++.+++.+
T Consensus 229 ~~~~i~~~l~~~p~~R~s~~~ll~ 252 (256)
T cd08221 229 LISLVHSLLQQDPEKRPTADEVLD 252 (256)
T ss_pred HHHHHHHHcccCcccCCCHHHHhh
Confidence 235667888888888887776643
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=273.07 Aligned_cols=238 Identities=27% Similarity=0.447 Sum_probs=191.1
Q ss_pred cCCCCCceeccCCcEEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEEEeCCC
Q 018712 66 DNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASK 145 (351)
Q Consensus 66 ~~y~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 145 (351)
++|.+.+.||+|+||.||++.. +++.+|+|.+.... ....+.+|+.++++++|+||+++++++... ..+++|||+.+
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~~ 82 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV-TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMSK 82 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc-hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCCC
Confidence 5689999999999999999875 57889999986543 346788999999999999999999988655 47999999999
Q ss_pred CCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccccCCCcc
Q 018712 146 GSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPD 225 (351)
Q Consensus 146 gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~ 225 (351)
++|.+++...... .+++..+..++.|++.||.|||+.| ++||||||+||+++.++.+||+|||++.....
T Consensus 83 ~~L~~~l~~~~~~-------~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~ 152 (254)
T cd05083 83 GNLVNFLRTRGRA-------LVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSM 152 (254)
T ss_pred CCHHHHHHhcCcC-------CCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceeccc
Confidence 9999999765321 2788899999999999999999999 99999999999999999999999999865432
Q ss_pred ccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCCccchhhc--------ccCCCc
Q 018712 226 AAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWA--------TPKLSE 296 (351)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~Pf~~~~~~~~~~~~~~~--------~~~~~~ 296 (351)
.. .....+..|+|||.+.+..++.++|+||||+++|+|++ |+.||...........+... .+....
T Consensus 153 ~~-----~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (254)
T cd05083 153 GV-----DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRMEPPEGCPADVY 227 (254)
T ss_pred cC-----CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCCCCCCCCcCCHHHH
Confidence 21 22234567999999988899999999999999999997 99999765433211111111 111123
Q ss_pred cchhhhcccccCCCCCHHHHHHHHH
Q 018712 297 DKVKQCVDTKLGGEYPPKAIAKVRK 321 (351)
Q Consensus 297 ~~~~~~ld~~~~~~~~~~~~~~~~~ 321 (351)
+.+..|+...+..|++.+++...++
T Consensus 228 ~li~~~l~~~p~~Rp~~~~l~~~l~ 252 (254)
T cd05083 228 VLMTSCWETEPKKRPSFHKLREKLE 252 (254)
T ss_pred HHHHHHcCCChhhCcCHHHHHHHHc
Confidence 5778888888888988887766543
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-39 Score=288.76 Aligned_cols=204 Identities=26% Similarity=0.413 Sum_probs=175.8
Q ss_pred HHhcCCCC--CceeccCCcEEEEEEEEC-CCCEEEEEEcCCCC---CchHHHHHHHHHHHhccCCceeeeEEEEecCCce
Q 018712 63 EKTDNFGT--NSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK---QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLR 136 (351)
Q Consensus 63 ~~~~~y~~--~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 136 (351)
++..-|++ .+.||+|-||+||-|+++ +|+.||||++.+.. .....+.+|+.+|+.+.||.||.+...|...++.
T Consensus 559 d~stvYQif~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~erv 638 (888)
T KOG4236|consen 559 DISTVYQIFADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERV 638 (888)
T ss_pred hHHHHHHhhhHhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceE
Confidence 33344555 478999999999999964 89999999987543 3356789999999999999999999999999999
Q ss_pred EEEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccC---CceE
Q 018712 137 VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDD---DIAK 213 (351)
Q Consensus 137 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~---~~vk 213 (351)
++|||.+.|.-|.-+|...+. .+++.....++.||+.||+|||.++ |+|+||||+|||+.+. -.+|
T Consensus 639 FVVMEKl~GDMLEMILSsEkg--------RL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvK 707 (888)
T KOG4236|consen 639 FVVMEKLHGDMLEMILSSEKG--------RLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVK 707 (888)
T ss_pred EEEehhhcchHHHHHHHhhcc--------cchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCcee
Confidence 999999977555555554443 2899999999999999999999999 9999999999999754 3799
Q ss_pred EecccccCCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCC
Q 018712 214 ISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (351)
Q Consensus 214 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~ 280 (351)
|||||+|+.++....+ ...+|||.|+|||+++++.|+..-|+||+|||+|--++|..||..+..
T Consensus 708 lCDFGfARiIgEksFR---rsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEd 771 (888)
T KOG4236|consen 708 LCDFGFARIIGEKSFR---RSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDED 771 (888)
T ss_pred eccccceeecchhhhh---hhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccc
Confidence 9999999998765543 567899999999999999999999999999999999999999987643
|
|
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=273.58 Aligned_cols=246 Identities=25% Similarity=0.391 Sum_probs=194.5
Q ss_pred hcCCCCCceeccCCcEEEEEEEEC-CC---CEEEEEEcCCCCC--chHHHHHHHHHHHhccCCceeeeEEEEecCCceEE
Q 018712 65 TDNFGTNSLIGEGSYGRVYFGVLR-SG---RAAAIKKLDSSKQ--PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVL 138 (351)
Q Consensus 65 ~~~y~~~~~Lg~G~~g~Vy~~~~~-~~---~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 138 (351)
.++|+..+.||+|+||.||+|... ++ ..+|+|.+..... ..+.+.+|++++++++|+||+++.+++.+.+..++
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 357888899999999999999975 33 3799999875432 24568899999999999999999999999999999
Q ss_pred EEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEeccc
Q 018712 139 AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFD 218 (351)
Q Consensus 139 v~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg 218 (351)
||||+++++|.+++..... .+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.+||+|||
T Consensus 84 v~e~~~~~~L~~~~~~~~~--------~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg 152 (268)
T cd05063 84 ITEYMENGALDKYLRDHDG--------EFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFG 152 (268)
T ss_pred EEEcCCCCCHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCc
Confidence 9999999999999975432 2788999999999999999999999 9999999999999999999999999
Q ss_pred ccCCCcccccccc-ccccccccCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCCccchhh--c----
Q 018712 219 LSNQAPDAAARLH-STRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTW--A---- 290 (351)
Q Consensus 219 ~a~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~Pf~~~~~~~~~~~~~~--~---- 290 (351)
++........... ......+..|+|||++.+..++.++||||||+++|||++ |+.||...........+.. .
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~~~~~ 232 (268)
T cd05063 153 LSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLPAP 232 (268)
T ss_pred cceecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCCCCCC
Confidence 9876543222111 111223457999999988889999999999999999997 9999976543221111110 0
Q ss_pred --ccCCCccchhhhcccccCCCCCHHHHHHHHH
Q 018712 291 --TPKLSEDKVKQCVDTKLGGEYPPKAIAKVRK 321 (351)
Q Consensus 291 --~~~~~~~~~~~~ld~~~~~~~~~~~~~~~~~ 321 (351)
.+....+.+..|+...|.+|++..++...++
T Consensus 233 ~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~ 265 (268)
T cd05063 233 MDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLD 265 (268)
T ss_pred CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence 1111126778889889999999888876654
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=275.30 Aligned_cols=243 Identities=25% Similarity=0.399 Sum_probs=190.8
Q ss_pred eeccCCcEEEEEEEECC-------CCEEEEEEcCCCC--CchHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEEEeC
Q 018712 73 LIGEGSYGRVYFGVLRS-------GRAAAIKKLDSSK--QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHA 143 (351)
Q Consensus 73 ~Lg~G~~g~Vy~~~~~~-------~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 143 (351)
.||+|+||.||+|...+ +..+|+|.+.... .....+.+|+.+++.++||||+++++++...+..+++|||+
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELM 81 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEecc
Confidence 58999999999998642 2579999876543 23467889999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCC-----ceEEeccc
Q 018712 144 SKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD-----IAKISDFD 218 (351)
Q Consensus 144 ~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~-----~vkl~Dfg 218 (351)
++++|.+++........ ....+++.+++.++.|++.||.|||+.+ ++|+||||+||++++++ .++|+|||
T Consensus 82 ~~~~L~~~l~~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg 156 (269)
T cd05044 82 EGGDLLSYLRDARVERF--GPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFG 156 (269)
T ss_pred CCCcHHHHHHHhhhccc--CCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCcc
Confidence 99999999975432110 1223788999999999999999999999 99999999999999887 89999999
Q ss_pred ccCCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCCccch--------hh
Q 018712 219 LSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLV--------TW 289 (351)
Q Consensus 219 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~Pf~~~~~~~~~~~~--------~~ 289 (351)
++................++..|+|||.+.+..++.++||||||+++|+|++ |+.||...........+ ..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 236 (269)
T cd05044 157 LARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGRLQKPE 236 (269)
T ss_pred cccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcCCccCCcc
Confidence 9876543322111223345778999999999999999999999999999998 99999754322111111 11
Q ss_pred cccCCCccchhhhcccccCCCCCHHHHHHHH
Q 018712 290 ATPKLSEDKVKQCVDTKLGGEYPPKAIAKVR 320 (351)
Q Consensus 290 ~~~~~~~~~~~~~ld~~~~~~~~~~~~~~~~ 320 (351)
..+....+.+.+|+..+|.+|++.+++...+
T Consensus 237 ~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l 267 (269)
T cd05044 237 NCPDKIYQLMTNCWAQDPSERPTFDRIQEIL 267 (269)
T ss_pred cchHHHHHHHHHHcCCCcccCCCHHHHHHHH
Confidence 1122224688899999999999999887655
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=277.28 Aligned_cols=244 Identities=27% Similarity=0.421 Sum_probs=193.8
Q ss_pred HhcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCCchHHHHHHHHHHHhc-cCCceeeeEEEEecCC------c
Q 018712 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRL-KNENVVELVGYYVDGP------L 135 (351)
Q Consensus 64 ~~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~------~ 135 (351)
..++|++.+.||+|++|.||+|..+ +++.+++|++.........+.+|+.+++++ .|+||+++++++.+.. .
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~ 83 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQ 83 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceE
Confidence 4578999999999999999999975 678999999887666667789999999999 7999999999987544 4
Q ss_pred eEEEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEe
Q 018712 136 RVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKIS 215 (351)
Q Consensus 136 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~ 215 (351)
.++||||+++++|.+++...... ...+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~-----~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~ 155 (275)
T cd06608 84 LWLVMELCGGGSVTDLVKGLRKK-----GKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLV 155 (275)
T ss_pred EEEEEEcCCCCcHHHHHHHHhhc-----CCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEEC
Confidence 89999999999999998753310 112889999999999999999999999 9999999999999999999999
Q ss_pred cccccCCCccccccccccccccccCccCcccccC-----CCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccchhhc
Q 018712 216 DFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMT-----GQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWA 290 (351)
Q Consensus 216 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~~~~ 290 (351)
|||++......... .....|+..|+|||.+.. ..++.++||||||+++|+|++|+.||...........+...
T Consensus 156 d~~~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~ 233 (275)
T cd06608 156 DFGVSAQLDSTLGR--RNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRN 233 (275)
T ss_pred CCccceecccchhh--hcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhcc
Confidence 99998765432221 234568899999998753 34678899999999999999999999754322111111100
Q ss_pred ----------ccCCCccchhhhcccccCCCCCHHHHH
Q 018712 291 ----------TPKLSEDKVKQCVDTKLGGEYPPKAIA 317 (351)
Q Consensus 291 ----------~~~~~~~~~~~~ld~~~~~~~~~~~~~ 317 (351)
.+....+.+.+|+..+|.+|++.+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll 270 (275)
T cd06608 234 PPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELL 270 (275)
T ss_pred CCCCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHh
Confidence 111223677888889999999877764
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-37 Score=271.29 Aligned_cols=240 Identities=23% Similarity=0.342 Sum_probs=177.8
Q ss_pred eeccCCcEEEEEEEEC---CCCEEEEEEcCCCCCc--hHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEEEeCCCCC
Q 018712 73 LIGEGSYGRVYFGVLR---SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASKGS 147 (351)
Q Consensus 73 ~Lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gs 147 (351)
.||+|+||.||+|... ....+++|.+...... ...+.+|+..++.++|+||+++++.+.+....++||||+++|+
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD 81 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence 5899999999999754 3457888877644322 3457889999999999999999999999999999999999999
Q ss_pred HHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccccCCCcccc
Q 018712 148 LHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAA 227 (351)
Q Consensus 148 L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~ 227 (351)
|.+++....... ....++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++.......
T Consensus 82 L~~~l~~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~ 154 (269)
T cd05042 82 LKNYLRSNRGMV----AQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPED 154 (269)
T ss_pred HHHHHHhccccc----cccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccch
Confidence 999997654211 112467788899999999999999999 9999999999999999999999999986543322
Q ss_pred ccccccccccccCccCcccccC-------CCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCCcc-chhhc-----ccC
Q 018712 228 ARLHSTRVLGTFGYHAPEYAMT-------GQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQS-LVTWA-----TPK 293 (351)
Q Consensus 228 ~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwslG~il~el~t-g~~Pf~~~~~~~~~~-~~~~~-----~~~ 293 (351)
.........++..|+|||++.. ..++.++||||||+++|||++ |..||....+..... .+... .+.
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (269)
T cd05042 155 YYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQ 234 (269)
T ss_pred heeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCCc
Confidence 1111233345778999998743 356789999999999999999 888987654321100 00000 011
Q ss_pred ----CC---ccchhhhcccccCCCCCHHHHHHHH
Q 018712 294 ----LS---EDKVKQCVDTKLGGEYPPKAIAKVR 320 (351)
Q Consensus 294 ----~~---~~~~~~~ld~~~~~~~~~~~~~~~~ 320 (351)
.. ...+..|+ .+|.+|++.+++..++
T Consensus 235 ~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l 267 (269)
T cd05042 235 LDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELL 267 (269)
T ss_pred ccccCCHHHHHHHHHHh-cCcccccCHHHHHHHh
Confidence 11 12334444 4677888888777654
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=273.63 Aligned_cols=239 Identities=24% Similarity=0.398 Sum_probs=189.4
Q ss_pred CCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCCc-----------hHHHHHHHHHHHhccCCceeeeEEEEecCC
Q 018712 67 NFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP-----------DQEFLAQVSMVSRLKNENVVELVGYYVDGP 134 (351)
Q Consensus 67 ~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-----------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~ 134 (351)
+|.+.+.||.|+||.||+|... +++.+|+|.+...... .+.+.+|+.+++.++|+||+++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 5788899999999999999864 6889999987532111 134678999999999999999999999999
Q ss_pred ceEEEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEE
Q 018712 135 LRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKI 214 (351)
Q Consensus 135 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl 214 (351)
..++||||+++++|.+++..... ++...+..++.|++.||.|||+++ ++||||+|+||+++.++.++|
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~---------l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l 149 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTYGR---------FEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKI 149 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhccC---------CCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEE
Confidence 99999999999999999976532 888899999999999999999999 999999999999999999999
Q ss_pred ecccccCCCccccccccccccccccCccCcccccCCC--CCccchhHhHHHHHHHHHcCCCCCCCCCCCCCc--------
Q 018712 215 SDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQ--MSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQ-------- 284 (351)
Q Consensus 215 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~-------- 284 (351)
+|||++................|+..|+|||.+.... ++.++|+||||+++|+|++|..||.........
T Consensus 150 ~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~ 229 (272)
T cd06629 150 SDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRS 229 (272)
T ss_pred eeccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhcccc
Confidence 9999987654322222223456889999999887654 789999999999999999999999754321100
Q ss_pred --cchhhc---ccCCCccchhhhcccccCCCCCHHHHH
Q 018712 285 --SLVTWA---TPKLSEDKVKQCVDTKLGGEYPPKAIA 317 (351)
Q Consensus 285 --~~~~~~---~~~~~~~~~~~~ld~~~~~~~~~~~~~ 317 (351)
...... .+....+.+.+|+.++|..|++.+++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il 267 (272)
T cd06629 230 APPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELL 267 (272)
T ss_pred CCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHh
Confidence 000001 112223567788888999998866643
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=274.86 Aligned_cols=245 Identities=25% Similarity=0.340 Sum_probs=190.5
Q ss_pred cCCCCCceeccCCcEEEEEEEEC-----CCCEEEEEEcCCCCCc-hHHHHHHHHHHHhccCCceeeeEEEEec--CCceE
Q 018712 66 DNFGTNSLIGEGSYGRVYFGVLR-----SGRAAAIKKLDSSKQP-DQEFLAQVSMVSRLKNENVVELVGYYVD--GPLRV 137 (351)
Q Consensus 66 ~~y~~~~~Lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~-~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~ 137 (351)
.+|++.+.||+|+||.||++... ++..||+|++...... .+.+.+|++++++++||||+++++++.. ....+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 57889999999999999999742 5789999998754332 4568899999999999999999997643 34689
Q ss_pred EEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecc
Q 018712 138 LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDF 217 (351)
Q Consensus 138 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Df 217 (351)
+||||+++++|.+++..... .+++..+..++.|++.||.|||++| ++||||||+||++++++.+||+||
T Consensus 84 lv~e~~~~~~L~~~l~~~~~--------~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~df 152 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKHRE--------RLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDF 152 (284)
T ss_pred EEEEecCCCCHHHHHHhcCc--------CCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCC
Confidence 99999999999999975432 2788999999999999999999999 999999999999999999999999
Q ss_pred cccCCCcccccccc-ccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCC-------Cc--c--
Q 018712 218 DLSNQAPDAAARLH-STRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRG-------QQ--S-- 285 (351)
Q Consensus 218 g~a~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~-------~~--~-- 285 (351)
|++........... .....++..|+|||++.+..++.++||||||+++|||++|..|+......- .. .
T Consensus 153 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (284)
T cd05081 153 GLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIV 232 (284)
T ss_pred cccccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccch
Confidence 99987643322111 111223456999999998899999999999999999999887764332110 00 0
Q ss_pred --chh-----------hcccCCCccchhhhcccccCCCCCHHHHHHHHH
Q 018712 286 --LVT-----------WATPKLSEDKVKQCVDTKLGGEYPPKAIAKVRK 321 (351)
Q Consensus 286 --~~~-----------~~~~~~~~~~~~~~ld~~~~~~~~~~~~~~~~~ 321 (351)
+.. ...+....+.+.+|+.++|.+|++..++...++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~ 281 (284)
T cd05081 233 YHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVE 281 (284)
T ss_pred HHHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHH
Confidence 000 001112236788999999999999988877654
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=272.98 Aligned_cols=201 Identities=26% Similarity=0.407 Sum_probs=170.2
Q ss_pred cCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCC------chHHHHHHHHHHHhccCCceeeeEEEEecC--Cce
Q 018712 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ------PDQEFLAQVSMVSRLKNENVVELVGYYVDG--PLR 136 (351)
Q Consensus 66 ~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~ 136 (351)
.+|.+.+.||+|+||.||.+... ++..||+|.+..... ....+.+|+.++++++|+||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 57899999999999999999965 689999998753321 124577899999999999999999988763 467
Q ss_pred EEEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEec
Q 018712 137 VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISD 216 (351)
Q Consensus 137 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~D 216 (351)
+++|||+++++|.+++..... +++.....++.|++.||.|||+++ ++|+||||+||+++.++.++|+|
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~~---------~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~D 149 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYGA---------LTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGD 149 (265)
T ss_pred EEEEEecCCCcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECc
Confidence 899999999999999976532 788889999999999999999999 99999999999999999999999
Q ss_pred ccccCCCcccccc-ccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCC
Q 018712 217 FDLSNQAPDAAAR-LHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHT 278 (351)
Q Consensus 217 fg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~ 278 (351)
||++......... .......|+..|+|||++.+..++.++||||||+++|+|++|+.||...
T Consensus 150 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~ 212 (265)
T cd06652 150 FGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEF 212 (265)
T ss_pred CccccccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCcc
Confidence 9998765322111 1113345888999999998888999999999999999999999999754
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=271.64 Aligned_cols=230 Identities=25% Similarity=0.375 Sum_probs=180.1
Q ss_pred ceeccCCcEEEEEEEECC-------------CCEEEEEEcCCCCCc-hHHHHHHHHHHHhccCCceeeeEEEEecCCceE
Q 018712 72 SLIGEGSYGRVYFGVLRS-------------GRAAAIKKLDSSKQP-DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRV 137 (351)
Q Consensus 72 ~~Lg~G~~g~Vy~~~~~~-------------~~~vavK~~~~~~~~-~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 137 (351)
+.||+|+||.||+|...+ ...+++|.+...... ...+.+|+.+++.++||||+++++++......+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 368999999999998532 235888987654332 346778899999999999999999999999999
Q ss_pred EEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCc------
Q 018712 138 LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDI------ 211 (351)
Q Consensus 138 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~------ 211 (351)
++|||+.+++|..++..... .+++..++.++.||+.||+|||+++ ++||||||+|||++.++.
T Consensus 81 lv~e~~~~~~l~~~~~~~~~--------~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~ 149 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRKSD--------VLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGP 149 (262)
T ss_pred EEEecccCCCHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCc
Confidence 99999999999999875432 2788999999999999999999999 999999999999987664
Q ss_pred -eEEecccccCCCccccccccccccccccCccCccccc-CCCCCccchhHhHHHHHHHHH-cCCCCCCCCCCCCCccchh
Q 018712 212 -AKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAM-TGQMSSKSDVYSFGVVLLELL-TGRKPVDHTLPRGQQSLVT 288 (351)
Q Consensus 212 -vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~il~el~-tg~~Pf~~~~~~~~~~~~~ 288 (351)
++++|||++...... ....++..|+|||.+. +..++.++||||||+++|||+ +|..||.............
T Consensus 150 ~~~l~d~g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~ 223 (262)
T cd05077 150 FIKLSDPGIPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERFYE 223 (262)
T ss_pred eeEeCCCCCCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHHHHh
Confidence 899999988655322 2345788899999886 567899999999999999997 5889987543221111111
Q ss_pred hc----c--cCCCccchhhhcccccCCCCCHHHHHH
Q 018712 289 WA----T--PKLSEDKVKQCVDTKLGGEYPPKAIAK 318 (351)
Q Consensus 289 ~~----~--~~~~~~~~~~~ld~~~~~~~~~~~~~~ 318 (351)
.. . +....+.+..|+..+|.+|++..++..
T Consensus 224 ~~~~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~ 259 (262)
T cd05077 224 GQCMLVTPSCKELADLMTHCMNYDPNQRPFFRAIMR 259 (262)
T ss_pred cCccCCCCChHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 00 0 111136788899999999998887754
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-37 Score=272.81 Aligned_cols=248 Identities=27% Similarity=0.400 Sum_probs=198.8
Q ss_pred CCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCC--chHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEEEeC
Q 018712 67 NFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ--PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHA 143 (351)
Q Consensus 67 ~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 143 (351)
-|+..+.||+|+||.||+|... ++..+|+|.+..... ....+.+|+.++++++|+||+++++.+.+++..++||||+
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 84 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence 4778889999999999999864 788999998764432 2356888999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccccCCC
Q 018712 144 SKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQA 223 (351)
Q Consensus 144 ~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~ 223 (351)
++++|.+++.... +++..+..++.|++.|+.+||+.+ ++|+||+|+||+++.++.++|+|||++...
T Consensus 85 ~~~~l~~~i~~~~----------~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~ 151 (277)
T cd06641 85 GGGSALDLLEPGP----------LDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQL 151 (277)
T ss_pred CCCcHHHHHhcCC----------CCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceec
Confidence 9999999997532 789999999999999999999999 999999999999999999999999998765
Q ss_pred ccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccchhh--------cccCCC
Q 018712 224 PDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTW--------ATPKLS 295 (351)
Q Consensus 224 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~~~--------~~~~~~ 295 (351)
...... .....++..|+|||.+.+...+.++|+||||+++|+|++|..||....+......+.. ..+...
T Consensus 152 ~~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (277)
T cd06641 152 TDTQIK--RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPL 229 (277)
T ss_pred ccchhh--hccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcCCCCCCCcccCHHH
Confidence 432211 2334678899999999888889999999999999999999999976543221111111 111122
Q ss_pred ccchhhhcccccCCCCCHHHHHHHHHHHHHhhhhccc
Q 018712 296 EDKVKQCVDTKLGGEYPPKAIAKVRKKKFITSECSNI 332 (351)
Q Consensus 296 ~~~~~~~ld~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 332 (351)
.+.+..|+..+|.+|++..++.. +.++...+.+.
T Consensus 230 ~~~i~~~l~~~p~~Rp~~~~~l~---~~~~~~~~~~~ 263 (277)
T cd06641 230 KEFVEACLNKEPSFRPTAKELLK---HKFIVRFAKKT 263 (277)
T ss_pred HHHHHHHccCChhhCcCHHHHHh---CHHHhhhhhcc
Confidence 36788899999999998776544 55555444443
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=270.83 Aligned_cols=230 Identities=24% Similarity=0.388 Sum_probs=183.6
Q ss_pred ceeccCCcEEEEEEEECC-C----------CEEEEEEcCCCCCchHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEE
Q 018712 72 SLIGEGSYGRVYFGVLRS-G----------RAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAY 140 (351)
Q Consensus 72 ~~Lg~G~~g~Vy~~~~~~-~----------~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 140 (351)
+.||+|+||.||+|.+.+ + ..+++|.+.........+.+|+.+++.++|+||+++++++.. ...++||
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~ 79 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMVE 79 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEEE
Confidence 368999999999999763 3 257888776554446778899999999999999999999887 7789999
Q ss_pred EeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCC-------ceE
Q 018712 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD-------IAK 213 (351)
Q Consensus 141 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~-------~vk 213 (351)
||+++|+|.+++..... .+++..+..++.||+.||+|||+++ ++||||||+|||++.++ .+|
T Consensus 80 e~~~~~~L~~~l~~~~~--------~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~k 148 (259)
T cd05037 80 EYVKFGPLDVFLHREKN--------NVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIK 148 (259)
T ss_pred EcCCCCcHHHHHHhhcc--------CCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEE
Confidence 99999999999986542 2888999999999999999999999 99999999999999887 799
Q ss_pred EecccccCCCccccccccccccccccCccCcccccCC--CCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCCccchhhc
Q 018712 214 ISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTG--QMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWA 290 (351)
Q Consensus 214 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~el~t-g~~Pf~~~~~~~~~~~~~~~ 290 (351)
|+|||++...... ....++..|+|||++.+. .++.++||||||+++|+|++ |..||...............
T Consensus 149 l~Dfg~a~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~~~ 222 (259)
T cd05037 149 LSDPGIPITVLSR------EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQ 222 (259)
T ss_pred eCCCCcccccccc------cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHhcC
Confidence 9999998765431 234567789999998876 78999999999999999999 68888765432221111110
Q ss_pred --cc----CCCccchhhhcccccCCCCCHHHHHHH
Q 018712 291 --TP----KLSEDKVKQCVDTKLGGEYPPKAIAKV 319 (351)
Q Consensus 291 --~~----~~~~~~~~~~ld~~~~~~~~~~~~~~~ 319 (351)
.+ ....+.+.+|++.+|.+|++..++.+.
T Consensus 223 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 257 (259)
T cd05037 223 HRLPMPDCAELANLINQCWTYDPTKRPSFRAILRD 257 (259)
T ss_pred CCCCCCCchHHHHHHHHHhccChhhCCCHHHHHHh
Confidence 00 111266788888888899888776543
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-39 Score=294.65 Aligned_cols=239 Identities=23% Similarity=0.392 Sum_probs=187.5
Q ss_pred CceeccCCcEEEEEEEEC-CCCEEEEEEcC-----CCCCchHHHHHHHHHHHhccCCceeeeEEEEecCCc--eEEEEEe
Q 018712 71 NSLIGEGSYGRVYFGVLR-SGRAAAIKKLD-----SSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPL--RVLAYEH 142 (351)
Q Consensus 71 ~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~-----~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~--~~lv~e~ 142 (351)
...||+|+|-+||+|.+. +|..||--.++ ......+.+..|+.+|+.|+|+||+++++++.+... ..+|.|+
T Consensus 45 ~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL 124 (632)
T KOG0584|consen 45 DEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITEL 124 (632)
T ss_pred hhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeec
Confidence 457999999999999975 67778744332 223334789999999999999999999999987665 7789999
Q ss_pred CCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccC-CceEEecccccC
Q 018712 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDD-DIAKISDFDLSN 221 (351)
Q Consensus 143 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~-~~vkl~Dfg~a~ 221 (351)
+..|+|..|+++.+. .....+..|++||++||.|||++.+ +|+|||||.+||||+.+ |.|||+|+|+|.
T Consensus 125 ~TSGtLr~Y~kk~~~---------vn~kaik~W~RQILkGL~yLHs~~P-PIIHRDLKCDNIFinG~~G~VKIGDLGLAt 194 (632)
T KOG0584|consen 125 FTSGTLREYRKKHRR---------VNIKAIKSWCRQILKGLVYLHSQDP-PIIHRDLKCDNIFVNGNLGEVKIGDLGLAT 194 (632)
T ss_pred ccCCcHHHHHHHhcc---------CCHHHHHHHHHHHHHHhhhhhcCCC-CccccccccceEEEcCCcCceeecchhHHH
Confidence 999999999998875 7888999999999999999999975 59999999999999754 899999999998
Q ss_pred CCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCc-c-----chhhcccCCC
Q 018712 222 QAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQ-S-----LVTWATPKLS 295 (351)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~-~-----~~~~~~~~~~ 295 (351)
....... ....|||.|||||+.. ..|+...||||||+.++||+|+.+||.......+. . +.+....+..
T Consensus 195 l~r~s~a----ksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV~ 269 (632)
T KOG0584|consen 195 LLRKSHA----KSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKVK 269 (632)
T ss_pred Hhhcccc----ceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhccC
Confidence 7654432 4578999999999887 88999999999999999999999999976443221 1 1112222232
Q ss_pred c----cchhhhcccccCCCCCHHHHHHHHHHHHHhhh
Q 018712 296 E----DKVKQCVDTKLGGEYPPKAIAKVRKKKFITSE 328 (351)
Q Consensus 296 ~----~~~~~~ld~~~~~~~~~~~~~~~~~~~~~~~~ 328 (351)
+ +.+..||-+ ...|++..+ ++...|+...
T Consensus 270 dPevr~fIekCl~~-~~~R~sa~e---LL~d~Ff~~d 302 (632)
T KOG0584|consen 270 DPEVREFIEKCLAT-KSERLSAKE---LLKDPFFDED 302 (632)
T ss_pred CHHHHHHHHHHhcC-chhccCHHH---HhhChhhccc
Confidence 3 445555555 455665544 4556666543
|
|
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=273.07 Aligned_cols=239 Identities=22% Similarity=0.397 Sum_probs=192.4
Q ss_pred CCCCCceeccCCcEEEEEEEE-CCCCEEEEEEcCCCCC-------chHHHHHHHHHHHhccCCceeeeEEEEecCCceEE
Q 018712 67 NFGTNSLIGEGSYGRVYFGVL-RSGRAAAIKKLDSSKQ-------PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVL 138 (351)
Q Consensus 67 ~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 138 (351)
+|+..+.||+|++|.||++.. .++..+|+|.+..... ..+.+.+|++++++++|+||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 588889999999999999996 5789999999864331 13568889999999999999999999999999999
Q ss_pred EEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCC-ceEEecc
Q 018712 139 AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD-IAKISDF 217 (351)
Q Consensus 139 v~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~-~vkl~Df 217 (351)
|+||+.+++|.+++..... +++..+..++.|++.||.|||++| ++|+||+|+||+++.++ .+||+||
T Consensus 81 v~e~~~~~~L~~~l~~~~~---------~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~df 148 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYGA---------FKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADF 148 (268)
T ss_pred EEeccCCCcHHHHHHHhCC---------CCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccc
Confidence 9999999999999976432 788999999999999999999999 99999999999998776 6999999
Q ss_pred cccCCCccccccc--cccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccchhh-----c
Q 018712 218 DLSNQAPDAAARL--HSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTW-----A 290 (351)
Q Consensus 218 g~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~~~-----~ 290 (351)
|.+.......... ......|+..|+|||.+.+..++.++|+||+|+++|+|++|..||...........+.. .
T Consensus 149 g~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 228 (268)
T cd06630 149 GAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATT 228 (268)
T ss_pred ccccccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCC
Confidence 9987764332111 11234688899999999888899999999999999999999999975443222111110 0
Q ss_pred ccC----C---CccchhhhcccccCCCCCHHHHH
Q 018712 291 TPK----L---SEDKVKQCVDTKLGGEYPPKAIA 317 (351)
Q Consensus 291 ~~~----~---~~~~~~~~ld~~~~~~~~~~~~~ 317 (351)
.+. . ..+.+..|++.+|.+|++..++.
T Consensus 229 ~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll 262 (268)
T cd06630 229 APSIPEHLSPGLRDVTLRCLELQPEDRPPSRELL 262 (268)
T ss_pred CCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHh
Confidence 111 1 12466788889999999887764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=298.40 Aligned_cols=205 Identities=19% Similarity=0.274 Sum_probs=161.7
Q ss_pred HHHhcCCCCCceeccCCcEEEEEEEEC--CCCEEEEE------------------EcCCCCCchHHHHHHHHHHHhccCC
Q 018712 62 KEKTDNFGTNSLIGEGSYGRVYFGVLR--SGRAAAIK------------------KLDSSKQPDQEFLAQVSMVSRLKNE 121 (351)
Q Consensus 62 ~~~~~~y~~~~~Lg~G~~g~Vy~~~~~--~~~~vavK------------------~~~~~~~~~~~~~~e~~~l~~l~h~ 121 (351)
....++|++++.||+|+||.||++..+ ++...++| .+.........+.+|+.+|++++|+
T Consensus 144 ~~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~Hp 223 (501)
T PHA03210 144 DEFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHE 223 (501)
T ss_pred hhhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCC
Confidence 345678999999999999999998753 22222222 2222222335678999999999999
Q ss_pred ceeeeEEEEecCCceEEEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccC
Q 018712 122 NVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKS 201 (351)
Q Consensus 122 niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp 201 (351)
||+++++++...+..|++++++.+ +|.+++....... ........+..++.||+.||.|||+++ |+||||||
T Consensus 224 nIv~l~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~----~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP 295 (501)
T PHA03210 224 NILKIEEILRSEANTYMITQKYDF-DLYSFMYDEAFDW----KDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKL 295 (501)
T ss_pred CcCcEeEEEEECCeeEEEEecccc-CHHHHHhhccccc----cccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCH
Confidence 999999999999999999999954 7888775433110 011345677889999999999999999 99999999
Q ss_pred CcEEEccCCceEEecccccCCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCC
Q 018712 202 SNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPV 275 (351)
Q Consensus 202 ~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf 275 (351)
+|||++.++.+||+|||+++........ ......||..|+|||++.+..++.++|||||||++|||++|..++
T Consensus 296 ~NILl~~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p 368 (501)
T PHA03210 296 ENIFLNCDGKIVLGDFGTAMPFEKEREA-FDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCP 368 (501)
T ss_pred HHEEECCCCCEEEEeCCCceecCccccc-ccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCC
Confidence 9999999999999999999776433211 123457999999999999999999999999999999999987543
|
|
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=275.69 Aligned_cols=238 Identities=24% Similarity=0.408 Sum_probs=195.5
Q ss_pred hcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCC-CchHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEEEe
Q 018712 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK-QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEH 142 (351)
Q Consensus 65 ~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 142 (351)
.++|.+.+.||+|+||.||++... ++..+++|.+.... ...+.+.+|+.+++.++||||+++++.+...+..++|+||
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~ 97 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEY 97 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEec
Confidence 468999999999999999999864 68899999986433 3345688899999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccccCC
Q 018712 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222 (351)
Q Consensus 143 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~ 222 (351)
+++++|.+++.... +++..+..++.|++.||.|||+++ ++|+||+|+||+++.++.+||+|||++..
T Consensus 98 ~~~~~L~~~~~~~~----------l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~ 164 (293)
T cd06647 98 LAGGSLTDVVTETC----------MDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQ 164 (293)
T ss_pred CCCCcHHHHHhhcC----------CCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceec
Confidence 99999999997643 788899999999999999999999 99999999999999999999999998865
Q ss_pred CccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccchh-hcc---------c
Q 018712 223 APDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVT-WAT---------P 292 (351)
Q Consensus 223 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~~-~~~---------~ 292 (351)
....... .....|++.|+|||.+.+..++.++|+||||+++|+|++|+.||...........+. ... +
T Consensus 165 ~~~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (293)
T cd06647 165 ITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLS 242 (293)
T ss_pred ccccccc--cccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCCCCCCCccccC
Confidence 5433221 233468889999999988889999999999999999999999998654432211111 111 1
Q ss_pred CCCccchhhhcccccCCCCCHHHHH
Q 018712 293 KLSEDKVKQCVDTKLGGEYPPKAIA 317 (351)
Q Consensus 293 ~~~~~~~~~~ld~~~~~~~~~~~~~ 317 (351)
....+.+.+|++.++.+|++.+++.
T Consensus 243 ~~l~~li~~~l~~~p~~Rp~~~~il 267 (293)
T cd06647 243 AIFRDFLNRCLEMDVEKRGSAKELL 267 (293)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHh
Confidence 1123678899999999999776543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-37 Score=274.02 Aligned_cols=245 Identities=23% Similarity=0.344 Sum_probs=191.1
Q ss_pred cCCCCCceeccCCcEEEEEEEE-----CCCCEEEEEEcCCCCC--chHHHHHHHHHHHhccCCceeeeEEEEecC--Cce
Q 018712 66 DNFGTNSLIGEGSYGRVYFGVL-----RSGRAAAIKKLDSSKQ--PDQEFLAQVSMVSRLKNENVVELVGYYVDG--PLR 136 (351)
Q Consensus 66 ~~y~~~~~Lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~ 136 (351)
..|++.+.||+|+||.||++.. .++..||+|.+..... ....+.+|+.++++++|+||+++++++.+. ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 3478899999999999999974 2578999999875432 235688999999999999999999988765 568
Q ss_pred EEEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEec
Q 018712 137 VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISD 216 (351)
Q Consensus 137 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~D 216 (351)
++||||+++++|.+++..... .+++..+..++.|++.||.|||++| ++||||||+||+++.++.++|+|
T Consensus 84 ~lv~e~~~g~~L~~~l~~~~~--------~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~d 152 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRNKN--------KINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGD 152 (284)
T ss_pred EEEEEccCCCCHHHHHHhccC--------CCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECC
Confidence 999999999999999965432 2789999999999999999999999 99999999999999999999999
Q ss_pred ccccCCCccccccc-cccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCC---------CCccc
Q 018712 217 FDLSNQAPDAAARL-HSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPR---------GQQSL 286 (351)
Q Consensus 217 fg~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~---------~~~~~ 286 (351)
||++.......... ......++..|+|||.+.+..++.++||||||+++|+|+++..|+...... .....
T Consensus 153 fg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (284)
T cd05079 153 FGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTV 232 (284)
T ss_pred CccccccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccH
Confidence 99988764332111 112345677899999998888999999999999999999987765332110 00000
Q ss_pred --------------hhhcccCCCccchhhhcccccCCCCCHHHHHHHHH
Q 018712 287 --------------VTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKVRK 321 (351)
Q Consensus 287 --------------~~~~~~~~~~~~~~~~ld~~~~~~~~~~~~~~~~~ 321 (351)
.....+....+.+.+|+..+|.+|++.+++...++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 281 (284)
T cd05079 233 TRLVRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFE 281 (284)
T ss_pred HHHHHHHHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHH
Confidence 00001111226788999999999999888866554
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=281.15 Aligned_cols=199 Identities=18% Similarity=0.272 Sum_probs=164.7
Q ss_pred CCceeccC--CcEEEEEEEEC-CCCEEEEEEcCCCCCc---hHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEEEeC
Q 018712 70 TNSLIGEG--SYGRVYFGVLR-SGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHA 143 (351)
Q Consensus 70 ~~~~Lg~G--~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 143 (351)
++++||+| +|++||++..+ +|+.||+|++...... ...+.+|+.+++.++||||+++++++..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 45689999 78999999864 7899999998754322 345778999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccccCCC
Q 018712 144 SKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQA 223 (351)
Q Consensus 144 ~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~ 223 (351)
++|+|.+++...... .+++..+..++.|++.||.|||+++ ++||||||+|||++.++.++++||+.+...
T Consensus 82 ~~~~l~~~~~~~~~~-------~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~ 151 (327)
T cd08227 82 AYGSAKDLICTHFMD-------GMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSM 151 (327)
T ss_pred CCCcHHHHHHhhccC-------CCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhcc
Confidence 999999999654321 2788999999999999999999999 999999999999999999999999865443
Q ss_pred cccccc-----ccccccccccCccCcccccC--CCCCccchhHhHHHHHHHHHcCCCCCCCC
Q 018712 224 PDAAAR-----LHSTRVLGTFGYHAPEYAMT--GQMSSKSDVYSFGVVLLELLTGRKPVDHT 278 (351)
Q Consensus 224 ~~~~~~-----~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~el~tg~~Pf~~~ 278 (351)
...... .......++..|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 213 (327)
T cd08227 152 INHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDM 213 (327)
T ss_pred ccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCc
Confidence 211110 00122346778999999876 46899999999999999999999999753
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-37 Score=270.10 Aligned_cols=239 Identities=24% Similarity=0.344 Sum_probs=197.8
Q ss_pred cCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCC--chHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEEEe
Q 018712 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ--PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEH 142 (351)
Q Consensus 66 ~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 142 (351)
++|++.+.||+|++|.||+|... +++.+++|++..... ....+.+|+..+++++|+||+++++.+...+..+++|||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 36888999999999999999976 589999999876543 356788999999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhh-CCCCCeeeccccCCcEEEccCCceEEecccccC
Q 018712 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHE-KAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (351)
Q Consensus 143 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~-~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~ 221 (351)
+++++|.+++.... .++......++.|++.||.|||+ .+ ++|+||+|+||+++.++.++|+|||.+.
T Consensus 81 ~~~~~L~~~l~~~~---------~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~ 148 (264)
T cd06623 81 MDGGSLADLLKKVG---------KIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISK 148 (264)
T ss_pred cCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccce
Confidence 99999999997653 28999999999999999999999 98 9999999999999999999999999987
Q ss_pred CCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccch-----------hhc
Q 018712 222 QAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLV-----------TWA 290 (351)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~-----------~~~ 290 (351)
........ .....++..|+|||.+.+..++.++|+||||+++|+|++|+.||............ ...
T Consensus 149 ~~~~~~~~--~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (264)
T cd06623 149 VLENTLDQ--CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAE 226 (264)
T ss_pred ecccCCCc--ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCCCCCcc
Confidence 66433222 12456788999999999888999999999999999999999999876421111111 001
Q ss_pred -ccCCCccchhhhcccccCCCCCHHHHHH
Q 018712 291 -TPKLSEDKVKQCVDTKLGGEYPPKAIAK 318 (351)
Q Consensus 291 -~~~~~~~~~~~~ld~~~~~~~~~~~~~~ 318 (351)
.+....+.+..|+.+.+.+|++.+++..
T Consensus 227 ~~~~~l~~li~~~l~~~p~~R~~~~~ll~ 255 (264)
T cd06623 227 EFSPEFRDFISACLQKDPKKRPSAAELLQ 255 (264)
T ss_pred cCCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 1222346778889899999998777654
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-37 Score=271.33 Aligned_cols=202 Identities=26% Similarity=0.392 Sum_probs=170.9
Q ss_pred cCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCC------chHHHHHHHHHHHhccCCceeeeEEEEec--CCce
Q 018712 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ------PDQEFLAQVSMVSRLKNENVVELVGYYVD--GPLR 136 (351)
Q Consensus 66 ~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~ 136 (351)
.+|...+.||+|+||.||+|... ++..|++|++..... ....+.+|+.++++++|+||+++++++.+ ....
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 47899999999999999999964 689999998864321 12457889999999999999999998865 3578
Q ss_pred EEEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEec
Q 018712 137 VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISD 216 (351)
Q Consensus 137 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~D 216 (351)
++++||+++++|.+++..... +++.....++.|++.||.|||+.+ ++||||+|+||+++.++.+||+|
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~~---------l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~d 149 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYGA---------LTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGD 149 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEcc
Confidence 899999999999999976532 788889999999999999999999 99999999999999999999999
Q ss_pred ccccCCCccccc-cccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCC
Q 018712 217 FDLSNQAPDAAA-RLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTL 279 (351)
Q Consensus 217 fg~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~ 279 (351)
||++........ ........++..|+|||.+.+..++.++||||||+++|+|++|+.||....
T Consensus 150 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~ 213 (266)
T cd06651 150 FGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYE 213 (266)
T ss_pred CCCccccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccc
Confidence 999876532111 111123457889999999998889999999999999999999999998653
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=270.63 Aligned_cols=239 Identities=22% Similarity=0.329 Sum_probs=192.9
Q ss_pred CCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCC---CchHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEEEe
Q 018712 67 NFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK---QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEH 142 (351)
Q Consensus 67 ~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 142 (351)
+|++.+.||+|+||.||.+... +++.||+|.+.... .....+.+|+.++++++|+||+++++++.+.+..++|+||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 5888999999999999999964 78899999886432 2345788999999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccccCC
Q 018712 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222 (351)
Q Consensus 143 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~ 222 (351)
+.+++|.+++...... .+++..+..++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||++..
T Consensus 81 ~~~~~l~~~~~~~~~~-------~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~ 150 (256)
T cd08218 81 CEGGDLYKKINAQRGV-------LFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARV 150 (256)
T ss_pred CCCCcHHHHHHhccCC-------CCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceee
Confidence 9999999999764321 2788899999999999999999999 99999999999999999999999999876
Q ss_pred CccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccch-h-------hcccCC
Q 018712 223 APDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLV-T-------WATPKL 294 (351)
Q Consensus 223 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~-~-------~~~~~~ 294 (351)
....... .....|++.|+|||++.+..++.++|+||||+++|+|++|+.||...........+ . ...+..
T Consensus 151 ~~~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (256)
T cd08218 151 LNSTVEL--ARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPVSSHYSYD 228 (256)
T ss_pred cCcchhh--hhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCCCCCcccCCHH
Confidence 5433211 12345788999999999888999999999999999999999999754322111110 0 011111
Q ss_pred CccchhhhcccccCCCCCHHHHH
Q 018712 295 SEDKVKQCVDTKLGGEYPPKAIA 317 (351)
Q Consensus 295 ~~~~~~~~ld~~~~~~~~~~~~~ 317 (351)
..+.+..|+..+|.+|++..++.
T Consensus 229 ~~~li~~~l~~~p~~Rp~~~~vl 251 (256)
T cd08218 229 LRNLVSQLFKRNPRDRPSVNSIL 251 (256)
T ss_pred HHHHHHHHhhCChhhCcCHHHHh
Confidence 23577788888888888877664
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=278.55 Aligned_cols=237 Identities=25% Similarity=0.383 Sum_probs=192.1
Q ss_pred CCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCC-CchHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEEEeCC
Q 018712 67 NFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK-QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHAS 144 (351)
Q Consensus 67 ~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 144 (351)
.|.....||+|+||.||++... ++..||+|.+.... .....+.+|+.+++.++||||+++++.+..++..++++||++
T Consensus 22 ~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~ 101 (297)
T cd06659 22 LLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQ 101 (297)
T ss_pred hHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCC
Confidence 3444557999999999999965 78999999986432 234568899999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccccCCCc
Q 018712 145 KGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAP 224 (351)
Q Consensus 145 ~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~ 224 (351)
+++|.+++.... +++..+..++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++....
T Consensus 102 ~~~L~~~~~~~~----------~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~ 168 (297)
T cd06659 102 GGALTDIVSQTR----------LNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQIS 168 (297)
T ss_pred CCCHHHHHhhcC----------CCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhcc
Confidence 999999886532 789999999999999999999999 9999999999999999999999999986543
Q ss_pred cccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccchh----------hcccCC
Q 018712 225 DAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVT----------WATPKL 294 (351)
Q Consensus 225 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~~----------~~~~~~ 294 (351)
..... .....|+..|+|||++.+..++.++||||||+++|+|++|+.||....+......+. ...+..
T Consensus 169 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (297)
T cd06659 169 KDVPK--RKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPV 246 (297)
T ss_pred ccccc--ccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCccccCCCCHH
Confidence 32211 133568999999999998889999999999999999999999997543321111110 011112
Q ss_pred CccchhhhcccccCCCCCHHHHHH
Q 018712 295 SEDKVKQCVDTKLGGEYPPKAIAK 318 (351)
Q Consensus 295 ~~~~~~~~ld~~~~~~~~~~~~~~ 318 (351)
..+.+.+|+..+|.+|++.+++..
T Consensus 247 l~~~i~~~l~~~P~~Rps~~~ll~ 270 (297)
T cd06659 247 LRDFLERMLTREPQERATAQELLD 270 (297)
T ss_pred HHHHHHHHhcCCcccCcCHHHHhh
Confidence 246788999999999998776655
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=269.20 Aligned_cols=242 Identities=23% Similarity=0.333 Sum_probs=186.0
Q ss_pred ceeccCCcEEEEEEEEC----CCCEEEEEEcCCCCC--chHHHHHHHHHHHhccCCceeeeEEEEe-cCCceEEEEEeCC
Q 018712 72 SLIGEGSYGRVYFGVLR----SGRAAAIKKLDSSKQ--PDQEFLAQVSMVSRLKNENVVELVGYYV-DGPLRVLAYEHAS 144 (351)
Q Consensus 72 ~~Lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~-~~~~~~lv~e~~~ 144 (351)
+.||+|+||.||+|.+. ++..+|+|.+..... ....+.+|+.+++.++||||+++++++. .++..+++|||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 36899999999999853 245799998854322 2356788999999999999999999765 4556899999999
Q ss_pred CCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccccCCCc
Q 018712 145 KGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAP 224 (351)
Q Consensus 145 ~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~ 224 (351)
+++|.+++..... .+++..+..++.|++.||.|||+.+ ++||||||+|||+++++.+||+|||+++...
T Consensus 81 ~~~L~~~~~~~~~--------~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~ 149 (262)
T cd05058 81 HGDLRNFIRSETH--------NPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIY 149 (262)
T ss_pred CCCHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCcccccccc
Confidence 9999999975432 1577788899999999999999999 9999999999999999999999999987653
Q ss_pred ccccc--ccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcC-CCCCCCCCCCCCccch--------hhcccC
Q 018712 225 DAAAR--LHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTG-RKPVDHTLPRGQQSLV--------TWATPK 293 (351)
Q Consensus 225 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg-~~Pf~~~~~~~~~~~~--------~~~~~~ 293 (351)
..... .......++..|+|||.+.+..++.++||||||+++|||++| .+||...........+ ....+.
T Consensus 150 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (262)
T cd05058 150 DKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQPEYCPD 229 (262)
T ss_pred CCcceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCCCCCcCCH
Confidence 32110 111233457789999999888999999999999999999995 5666643321111111 011112
Q ss_pred CCccchhhhcccccCCCCCHHHHHHHHHHHH
Q 018712 294 LSEDKVKQCVDTKLGGEYPPKAIAKVRKKKF 324 (351)
Q Consensus 294 ~~~~~~~~~ld~~~~~~~~~~~~~~~~~~~~ 324 (351)
...+.+..|+.++|.+|++..++...++..+
T Consensus 230 ~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~ 260 (262)
T cd05058 230 PLYEVMLSCWHPKPEMRPTFSELVSRIEQIF 260 (262)
T ss_pred HHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence 2236788999999999999999888776553
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=272.55 Aligned_cols=245 Identities=24% Similarity=0.343 Sum_probs=193.6
Q ss_pred hcCCCCCceeccCCcEEEEEEEECC----CCEEEEEEcCCCCC--chHHHHHHHHHHHhccCCceeeeEEEEecCCceEE
Q 018712 65 TDNFGTNSLIGEGSYGRVYFGVLRS----GRAAAIKKLDSSKQ--PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVL 138 (351)
Q Consensus 65 ~~~y~~~~~Lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 138 (351)
.++|.+.+.||+|+||.||+|.+.+ ...+++|....... ..+.+.+|+.++++++|+||+++++++.+ +..++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~l 83 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWI 83 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEE
Confidence 3568889999999999999998643 34789998865542 24578899999999999999999998865 45789
Q ss_pred EEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEeccc
Q 018712 139 AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFD 218 (351)
Q Consensus 139 v~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg 218 (351)
||||+++++|.+++..... .+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||
T Consensus 84 v~e~~~~~~L~~~l~~~~~--------~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g 152 (270)
T cd05056 84 VMELAPLGELRSYLQVNKY--------SLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFG 152 (270)
T ss_pred EEEcCCCCcHHHHHHhCCC--------CCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCc
Confidence 9999999999999976432 2789999999999999999999999 9999999999999999999999999
Q ss_pred ccCCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCCccchh--------h
Q 018712 219 LSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVT--------W 289 (351)
Q Consensus 219 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~Pf~~~~~~~~~~~~~--------~ 289 (351)
+++........ ......++..|+|||.+.+..++.++||||||+++|+|++ |..||...........+. .
T Consensus 153 ~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 231 (270)
T cd05056 153 LSRYLEDESYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLPMPP 231 (270)
T ss_pred eeeecccccce-ecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCcCCCCC
Confidence 98765433211 1122234568999999988889999999999999999986 999997664332111111 1
Q ss_pred cccCCCccchhhhcccccCCCCCHHHHHHHHHH
Q 018712 290 ATPKLSEDKVKQCVDTKLGGEYPPKAIAKVRKK 322 (351)
Q Consensus 290 ~~~~~~~~~~~~~ld~~~~~~~~~~~~~~~~~~ 322 (351)
..+....+.+.+|+..+|.+|++..++...++-
T Consensus 232 ~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~ 264 (270)
T cd05056 232 NCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSD 264 (270)
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 112222367889999999999998887665543
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=276.80 Aligned_cols=197 Identities=21% Similarity=0.358 Sum_probs=166.9
Q ss_pred CCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCC---chHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEEEe
Q 018712 67 NFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ---PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEH 142 (351)
Q Consensus 67 ~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 142 (351)
+|++.+.||+|+||.||+|.+. +|..+|+|.+..... ....+.+|+.++++++|+||+++++++.+....++++||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 4788899999999999999975 789999999865322 234577899999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccccCC
Q 018712 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222 (351)
Q Consensus 143 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~ 222 (351)
+.+ +|.+++..... .+++..++.++.||++||.|||+++ ++||||||+||+++.++.+||+|||++..
T Consensus 81 ~~~-~l~~~~~~~~~--------~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~ 148 (284)
T cd07839 81 CDQ-DLKKYFDSCNG--------DIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARA 148 (284)
T ss_pred CCC-CHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhc
Confidence 975 88888765332 2889999999999999999999999 99999999999999999999999999876
Q ss_pred CccccccccccccccccCccCcccccCC-CCCccchhHhHHHHHHHHHcCCCCCCC
Q 018712 223 APDAAARLHSTRVLGTFGYHAPEYAMTG-QMSSKSDVYSFGVVLLELLTGRKPVDH 277 (351)
Q Consensus 223 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~Pf~~ 277 (351)
....... .....++..|+|||++.+. .++.++||||||+++|+|++|..||..
T Consensus 149 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~ 202 (284)
T cd07839 149 FGIPVRC--YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFP 202 (284)
T ss_pred cCCCCCC--cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcC
Confidence 5432211 1234578899999988765 468999999999999999999988643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-37 Score=271.06 Aligned_cols=243 Identities=28% Similarity=0.370 Sum_probs=195.0
Q ss_pred cCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCC--chHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEEEe
Q 018712 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ--PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEH 142 (351)
Q Consensus 66 ~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 142 (351)
++|++.+.||.|+||.||+|... ++..+++|++..... ..+.+.+|+++++.++|+||+++++.+...+..+++||+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 47999999999999999999965 678999999865432 346788999999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccccCC
Q 018712 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222 (351)
Q Consensus 143 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~ 222 (351)
+++++|.+++..... ...+++..+..++.|++.||.|||+.+ ++||||+|+||++++++.++|+|||++..
T Consensus 81 ~~~~~l~~~~~~~~~------~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~ 151 (267)
T cd06610 81 LSGGSLLDIMKSSYP------RGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSAS 151 (267)
T ss_pred cCCCcHHHHHHHhcc------cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHH
Confidence 999999999975422 012788999999999999999999999 99999999999999999999999999876
Q ss_pred Cccccccc--cccccccccCccCcccccCC-CCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccc-hhhc--------
Q 018712 223 APDAAARL--HSTRVLGTFGYHAPEYAMTG-QMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSL-VTWA-------- 290 (351)
Q Consensus 223 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~-~~~~-------- 290 (351)
........ ......|+..|+|||++... .++.++|+||||+++|+|++|+.||........... ....
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (267)
T cd06610 152 LADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGA 231 (267)
T ss_pred hccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCCCcCCcc
Confidence 65432221 12344688999999998876 789999999999999999999999986543221110 0000
Q ss_pred ----ccCCCccchhhhcccccCCCCCHHHHH
Q 018712 291 ----TPKLSEDKVKQCVDTKLGGEYPPKAIA 317 (351)
Q Consensus 291 ----~~~~~~~~~~~~ld~~~~~~~~~~~~~ 317 (351)
.+....+.+..|+..+|..|++.+++.
T Consensus 232 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll 262 (267)
T cd06610 232 DYKKYSKSFRKMISLCLQKDPSKRPTAEELL 262 (267)
T ss_pred ccccccHHHHHHHHHHcCCChhhCcCHHHHh
Confidence 011113677888888888888866654
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=271.36 Aligned_cols=236 Identities=22% Similarity=0.376 Sum_probs=191.3
Q ss_pred CCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCC------chHHHHHHHHHHHhccCCceeeeEEEEecCCceEEE
Q 018712 67 NFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ------PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLA 139 (351)
Q Consensus 67 ~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 139 (351)
+|+..+.||+|++|.||+|... ++..|++|.+..... ..+.+.+|+.+++.++|+||+++++++.+....+++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 4778889999999999999976 789999998764331 235688899999999999999999999999999999
Q ss_pred EEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccc
Q 018712 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDL 219 (351)
Q Consensus 140 ~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~ 219 (351)
+||+++++|.+++..... +++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||+
T Consensus 81 ~e~~~~~~L~~~~~~~~~---------~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~ 148 (258)
T cd06632 81 LELVPGGSLAKLLKKYGS---------FPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGM 148 (258)
T ss_pred EEecCCCcHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCcc
Confidence 999999999999976532 788899999999999999999999 99999999999999999999999999
Q ss_pred cCCCccccccccccccccccCccCcccccCCC-CCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccchhh--cccC---
Q 018712 220 SNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQ-MSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTW--ATPK--- 293 (351)
Q Consensus 220 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~~~--~~~~--- 293 (351)
+....... ......|+..|+|||.+.... ++.++|+||||+++|+|++|+.||....+......+.. ..+.
T Consensus 149 ~~~~~~~~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 225 (258)
T cd06632 149 AKQVVEFS---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPD 225 (258)
T ss_pred ceeccccc---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcccCCCcCC
Confidence 87654332 123456889999999988776 89999999999999999999999976542211111111 0111
Q ss_pred -C---CccchhhhcccccCCCCCHHHHH
Q 018712 294 -L---SEDKVKQCVDTKLGGEYPPKAIA 317 (351)
Q Consensus 294 -~---~~~~~~~~ld~~~~~~~~~~~~~ 317 (351)
. ..+.+..|+..+|.+|++.+++.
T Consensus 226 ~~~~~~~~li~~~l~~~p~~Rp~~~~~l 253 (258)
T cd06632 226 HLSDEAKDFILKCLQRDPSLRPTAAELL 253 (258)
T ss_pred CcCHHHHHHHHHHhhcCcccCcCHHHHh
Confidence 1 12457788888888888776654
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=273.38 Aligned_cols=229 Identities=25% Similarity=0.386 Sum_probs=179.1
Q ss_pred eeccCCcEEEEEEEECC-------------------------CCEEEEEEcCCCCCc-hHHHHHHHHHHHhccCCceeee
Q 018712 73 LIGEGSYGRVYFGVLRS-------------------------GRAAAIKKLDSSKQP-DQEFLAQVSMVSRLKNENVVEL 126 (351)
Q Consensus 73 ~Lg~G~~g~Vy~~~~~~-------------------------~~~vavK~~~~~~~~-~~~~~~e~~~l~~l~h~niv~~ 126 (351)
.||+|+||.||+|.... ...|++|++...... ...+.+|+.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 69999999999997421 135889988654332 3467788999999999999999
Q ss_pred EEEEecCCceEEEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEE
Q 018712 127 VGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLL 206 (351)
Q Consensus 127 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill 206 (351)
++++.+....++||||+++|+|..++..... .+++..+..++.||+.||.|||+++ ++||||||+|||+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~--------~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill 150 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEKG--------RVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILL 150 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEE
Confidence 9999999999999999999999999975432 2788999999999999999999999 9999999999999
Q ss_pred ccCC-------ceEEecccccCCCccccccccccccccccCccCcccccC-CCCCccchhHhHHHHHHHHH-cCCCCCCC
Q 018712 207 FDDD-------IAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMT-GQMSSKSDVYSFGVVLLELL-TGRKPVDH 277 (351)
Q Consensus 207 ~~~~-------~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~-tg~~Pf~~ 277 (351)
++.+ .+|++|||++...... ....++..|+|||.+.+ ..++.++||||||+++|||+ +|+.||..
T Consensus 151 ~~~~~~~~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~ 224 (274)
T cd05076 151 ARLGLAEGTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKE 224 (274)
T ss_pred eccCcccCccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccc
Confidence 7654 3899999987654322 22347788999998875 56899999999999999984 79999986
Q ss_pred CCCCCCccchhhc--cc----CCCccchhhhcccccCCCCCHHHHHH
Q 018712 278 TLPRGQQSLVTWA--TP----KLSEDKVKQCVDTKLGGEYPPKAIAK 318 (351)
Q Consensus 278 ~~~~~~~~~~~~~--~~----~~~~~~~~~~ld~~~~~~~~~~~~~~ 318 (351)
..+.......... .+ ....+.+..|+..+|.+|++..++.+
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~ 271 (274)
T cd05076 225 RTPSEKERFYEKKHRLPEPSCKELATLISQCLTYEPTQRPSFRTILR 271 (274)
T ss_pred cChHHHHHHHHhccCCCCCCChHHHHHHHHHcccChhhCcCHHHHHH
Confidence 5443221111111 11 11235778899999999998877754
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=265.64 Aligned_cols=197 Identities=25% Similarity=0.423 Sum_probs=170.1
Q ss_pred ceeccCCcEEEEEEE-ECCCCEEEEEEcCCCCC-chHHHHHHHHHHHhc-cCCceeeeEEEEecCCceEEEEEeCCCCCH
Q 018712 72 SLIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQ-PDQEFLAQVSMVSRL-KNENVVELVGYYVDGPLRVLAYEHASKGSL 148 (351)
Q Consensus 72 ~~Lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~gsL 148 (351)
+.||+|+|+.|--+. ..+|..||||++.+... ...+..+|++++..+ .|+||++++++|.++..+|||||-+.||+|
T Consensus 84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGpl 163 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPL 163 (463)
T ss_pred HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCchH
Confidence 479999999999888 56899999999987754 356789999999999 699999999999999999999999999999
Q ss_pred HHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCC---ceEEecccccCCCcc
Q 018712 149 HDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD---IAKISDFDLSNQAPD 225 (351)
Q Consensus 149 ~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~---~vkl~Dfg~a~~~~~ 225 (351)
.+.|.+... +++.++..+..+|+.||.+||++| |.||||||+|||..+-. -||||||.+..-...
T Consensus 164 LshI~~~~~---------F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~ 231 (463)
T KOG0607|consen 164 LSHIQKRKH---------FNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICDFDLGSGIKL 231 (463)
T ss_pred HHHHHHhhh---------ccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeecccccccccc
Confidence 999998775 999999999999999999999999 99999999999996654 589999998755432
Q ss_pred ccc-----cccccccccccCccCccccc-----CCCCCccchhHhHHHHHHHHHcCCCCCCCCCC
Q 018712 226 AAA-----RLHSTRVLGTFGYHAPEYAM-----TGQMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (351)
Q Consensus 226 ~~~-----~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~ 280 (351)
... ...-.+.+|+..|||||+.. ...|+.+.|+||||||+|-|++|++||.+...
T Consensus 232 ~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg 296 (463)
T KOG0607|consen 232 NNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCG 296 (463)
T ss_pred CCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccC
Confidence 211 11124568999999999763 34689999999999999999999999998654
|
|
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=271.73 Aligned_cols=237 Identities=25% Similarity=0.426 Sum_probs=193.3
Q ss_pred CCCCCceeccCCcEEEEEEEE-CCCCEEEEEEcCCCC--CchHHHHHHHHHHHhcc---CCceeeeEEEEecCCceEEEE
Q 018712 67 NFGTNSLIGEGSYGRVYFGVL-RSGRAAAIKKLDSSK--QPDQEFLAQVSMVSRLK---NENVVELVGYYVDGPLRVLAY 140 (351)
Q Consensus 67 ~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~lv~ 140 (351)
.|+..+.||+|+||.||+|.+ .+++.+|+|.+.... .....+.+|+.++++++ |+|++++++++.++...+++|
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 478888999999999999996 478999999986542 23456788999999986 999999999999999999999
Q ss_pred EeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEeccccc
Q 018712 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (351)
Q Consensus 141 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a 220 (351)
||+++++|.+++.... +++..++.++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++
T Consensus 82 e~~~~~~L~~~~~~~~----------l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~ 148 (277)
T cd06917 82 EYAEGGSVRTLMKAGP----------IAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVA 148 (277)
T ss_pred ecCCCCcHHHHHHccC----------CCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCce
Confidence 9999999999986542 889999999999999999999999 999999999999999999999999998
Q ss_pred CCCccccccccccccccccCccCcccccC-CCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccchhh-c--------
Q 018712 221 NQAPDAAARLHSTRVLGTFGYHAPEYAMT-GQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTW-A-------- 290 (351)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~~~-~-------- 290 (351)
......... .....|+..|+|||.+.+ ..++.++|+||||+++|+|++|..||...........+.. .
T Consensus 149 ~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (277)
T cd06917 149 ALLNQNSSK--RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLEDNG 226 (277)
T ss_pred eecCCCccc--cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccCCCCCCCccc
Confidence 766543321 234468899999998865 4568999999999999999999999986544322211111 0
Q ss_pred ccCCCccchhhhcccccCCCCCHHHHHH
Q 018712 291 TPKLSEDKVKQCVDTKLGGEYPPKAIAK 318 (351)
Q Consensus 291 ~~~~~~~~~~~~ld~~~~~~~~~~~~~~ 318 (351)
.+....+.+..|+..+|.+|++..++.+
T Consensus 227 ~~~~~~~~i~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 227 YSKLLREFVAACLDEEPKERLSAEELLK 254 (277)
T ss_pred CCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence 1112235778999999999998877754
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=268.53 Aligned_cols=238 Identities=19% Similarity=0.282 Sum_probs=192.7
Q ss_pred CCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCC---chHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEEEe
Q 018712 67 NFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ---PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEH 142 (351)
Q Consensus 67 ~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 142 (351)
+|++.+.||+|+||.||++... ++..+|+|.+..... ....+.+|++++++++|+||+++++.+..++..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 5888999999999999999964 788999999865432 245688899999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccC-CceEEecccccC
Q 018712 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDD-DIAKISDFDLSN 221 (351)
Q Consensus 143 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~-~~vkl~Dfg~a~ 221 (351)
+++++|.+++..... ..+++..+..++.|++.||.|||+++ ++|+||+|+||+++++ +.+||+|||.+.
T Consensus 81 ~~~~~L~~~~~~~~~-------~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~ 150 (256)
T cd08220 81 APGGTLAEYIQKRCN-------SLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISK 150 (256)
T ss_pred CCCCCHHHHHHHhcc-------cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCce
Confidence 999999999976432 12788999999999999999999999 9999999999999865 468999999987
Q ss_pred CCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccchhh--------cccC
Q 018712 222 QAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTW--------ATPK 293 (351)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~~~--------~~~~ 293 (351)
....... .....|+..|+|||.+.+..++.++||||||+++|+|++|+.||...........+.. ..+.
T Consensus 151 ~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (256)
T cd08220 151 ILSSKSK---AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPISDRYSP 227 (256)
T ss_pred ecCCCcc---ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCCCCCCCcCH
Confidence 7643321 1335688899999999988899999999999999999999999976543221111110 0111
Q ss_pred CCccchhhhcccccCCCCCHHHHH
Q 018712 294 LSEDKVKQCVDTKLGGEYPPKAIA 317 (351)
Q Consensus 294 ~~~~~~~~~ld~~~~~~~~~~~~~ 317 (351)
...+.+..|+.++|.+|++.+++.
T Consensus 228 ~l~~li~~~l~~~p~~Rpt~~~ll 251 (256)
T cd08220 228 DLRQLILSMLNLDPSKRPQLSQIM 251 (256)
T ss_pred HHHHHHHHHccCChhhCCCHHHHh
Confidence 123577888888888999888764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-37 Score=273.73 Aligned_cols=200 Identities=25% Similarity=0.378 Sum_probs=171.9
Q ss_pred CCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCC---chHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEEEe
Q 018712 67 NFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ---PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEH 142 (351)
Q Consensus 67 ~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 142 (351)
+|++.+.||+|++|.||+|.+. ++..||+|++..... ....+.+|+.++++++|+||+++++++......++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 5888999999999999999975 789999999875432 245788999999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccccCC
Q 018712 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222 (351)
Q Consensus 143 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~ 222 (351)
+ +++|.+++..... .+++..++.++.||+.||.|||+.+ ++|+||||+||++++++.++|+|||++..
T Consensus 81 ~-~~~L~~~~~~~~~--------~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~ 148 (286)
T cd07832 81 M-PSDLSEVLRDEER--------PLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARL 148 (286)
T ss_pred c-CCCHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeeccc
Confidence 9 9999999875432 2889999999999999999999999 99999999999999999999999999877
Q ss_pred CccccccccccccccccCccCcccccCC-CCCccchhHhHHHHHHHHHcCCCCCCCCC
Q 018712 223 APDAAARLHSTRVLGTFGYHAPEYAMTG-QMSSKSDVYSFGVVLLELLTGRKPVDHTL 279 (351)
Q Consensus 223 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~Pf~~~~ 279 (351)
...... .......|+..|+|||.+.+. .++.++||||+|+++|+|++|.+||....
T Consensus 149 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~ 205 (286)
T cd07832 149 FSEEEP-RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGEN 205 (286)
T ss_pred ccCCCC-CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCC
Confidence 654321 112334689999999988654 46899999999999999999988886543
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=274.93 Aligned_cols=232 Identities=25% Similarity=0.321 Sum_probs=191.6
Q ss_pred CCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCC----CchHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEEE
Q 018712 67 NFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK----QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYE 141 (351)
Q Consensus 67 ~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 141 (351)
+|++.+.||.|+||.||++.+. ++..||+|.+.... ...+.+.+|++++++++||||+++++.+.+....++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 5888999999999999999975 68999999986543 234678899999999999999999999999999999999
Q ss_pred eCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccccC
Q 018712 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (351)
Q Consensus 142 ~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~ 221 (351)
|+.+++|.+++..... ++...+..++.||++||.|||+++ ++|+||+|+||++++++.++|+|||++.
T Consensus 81 ~~~~~~L~~~l~~~~~---------l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~ 148 (258)
T cd05578 81 LLLGGDLRYHLSQKVK---------FSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIAT 148 (258)
T ss_pred CCCCCCHHHHHHhcCC---------cCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeeccccc
Confidence 9999999999976522 888999999999999999999999 9999999999999999999999999987
Q ss_pred CCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccch----------hhcc
Q 018712 222 QAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLV----------TWAT 291 (351)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~----------~~~~ 291 (351)
....... .....|+..|+|||.+.+..++.++|+||||+++|+|++|+.||............ ....
T Consensus 149 ~~~~~~~---~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (258)
T cd05578 149 KVTPDTL---TTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATW 225 (258)
T ss_pred ccCCCcc---ccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhccccccCcccC
Confidence 7644321 13456888999999998888999999999999999999999999876532111111 0111
Q ss_pred cCCCccchhhhcccccCCCCCH
Q 018712 292 PKLSEDKVKQCVDTKLGGEYPP 313 (351)
Q Consensus 292 ~~~~~~~~~~~ld~~~~~~~~~ 313 (351)
+....+.+..|+..+|.+|++.
T Consensus 226 ~~~~~~~i~~~l~~~p~~R~~~ 247 (258)
T cd05578 226 STEAIDAINKLLERDPQKRLGD 247 (258)
T ss_pred cHHHHHHHHHHccCChhHcCCc
Confidence 1222356778888888888877
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-37 Score=274.20 Aligned_cols=200 Identities=24% Similarity=0.380 Sum_probs=169.6
Q ss_pred CCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCCc---hHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEEEe
Q 018712 67 NFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEH 142 (351)
Q Consensus 67 ~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 142 (351)
+|++.+.||.|++|.||+|... ++..||+|++...... ...+.+|++++++++||||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 5888999999999999999975 7899999988654322 35688999999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccccCC
Q 018712 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222 (351)
Q Consensus 143 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~ 222 (351)
+. ++|.+++...... .+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.+||+|||++..
T Consensus 81 ~~-~~l~~~~~~~~~~-------~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~ 149 (284)
T cd07860 81 LH-QDLKKFMDASPLS-------GIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARA 149 (284)
T ss_pred cc-cCHHHHHHhCCCC-------CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhh
Confidence 96 5899988754322 2889999999999999999999999 99999999999999999999999999876
Q ss_pred CccccccccccccccccCccCcccccCCC-CCccchhHhHHHHHHHHHcCCCCCCCCC
Q 018712 223 APDAAARLHSTRVLGTFGYHAPEYAMTGQ-MSSKSDVYSFGVVLLELLTGRKPVDHTL 279 (351)
Q Consensus 223 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~el~tg~~Pf~~~~ 279 (351)
....... .....++..|+|||.+.+.. ++.++||||||+++|+|+||+.||....
T Consensus 150 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~ 205 (284)
T cd07860 150 FGVPVRT--YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 205 (284)
T ss_pred cccCccc--cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence 5432211 12334688999999887654 5889999999999999999999997643
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=274.08 Aligned_cols=201 Identities=23% Similarity=0.360 Sum_probs=168.6
Q ss_pred hcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCCc--hHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEEE
Q 018712 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYE 141 (351)
Q Consensus 65 ~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 141 (351)
+++|.+.+.||+|+||.||+|... ++..||+|.+...... ...+.+|+.+++.++|+||+++++++.+++..++|||
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e 83 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFE 83 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEe
Confidence 478999999999999999999864 6889999998654322 3457789999999999999999999999999999999
Q ss_pred eCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccccC
Q 018712 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (351)
Q Consensus 142 ~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~ 221 (351)
|+. ++|.+++..... .+.+..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||+++
T Consensus 84 ~~~-~~l~~~~~~~~~--------~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~ 151 (291)
T cd07870 84 YMH-TDLAQYMIQHPG--------GLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLAR 151 (291)
T ss_pred ccc-CCHHHHHHhCCC--------CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEecccccc
Confidence 996 577777654321 2677888899999999999999999 9999999999999999999999999987
Q ss_pred CCccccccccccccccccCccCcccccCC-CCCccchhHhHHHHHHHHHcCCCCCCCCC
Q 018712 222 QAPDAAARLHSTRVLGTFGYHAPEYAMTG-QMSSKSDVYSFGVVLLELLTGRKPVDHTL 279 (351)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~Pf~~~~ 279 (351)
........ .....+++.|+|||.+.+. .++.++||||||+++|+|++|+.||....
T Consensus 152 ~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~ 208 (291)
T cd07870 152 AKSIPSQT--YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVS 208 (291)
T ss_pred ccCCCCCC--CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCch
Confidence 64332111 1234578899999988764 57889999999999999999999997543
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=270.08 Aligned_cols=243 Identities=25% Similarity=0.373 Sum_probs=188.1
Q ss_pred HhcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCC-chHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEEE
Q 018712 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ-PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYE 141 (351)
Q Consensus 64 ~~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 141 (351)
.++++.....||+|+||.||+|.+. ++..|++|.+..... ..+.+.+|+.++++++|+||+++++++..++..++++|
T Consensus 6 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 85 (268)
T cd06624 6 EYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFME 85 (268)
T ss_pred ccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEe
Confidence 3445555668999999999999965 678899998865443 34578899999999999999999999999999999999
Q ss_pred eCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEcc-CCceEEeccccc
Q 018712 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFD-DDIAKISDFDLS 220 (351)
Q Consensus 142 ~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~-~~~vkl~Dfg~a 220 (351)
|+++++|.+++...... ...+...+..++.||+.||.|||+++ ++||||||+||+++. ++.++|+|||++
T Consensus 86 ~~~~~~L~~~l~~~~~~------~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~ 156 (268)
T cd06624 86 QVPGGSLSALLRSKWGP------LKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTS 156 (268)
T ss_pred cCCCCCHHHHHHHhccc------CCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhh
Confidence 99999999999764211 00277888899999999999999999 999999999999976 679999999998
Q ss_pred CCCccccccccccccccccCccCcccccCC--CCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCcc-ch--hhcccC--
Q 018712 221 NQAPDAAARLHSTRVLGTFGYHAPEYAMTG--QMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQS-LV--TWATPK-- 293 (351)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~-~~--~~~~~~-- 293 (351)
......... .....|++.|+|||.+.+. .++.++|+||||+++|+|++|+.||.......... .. ....+.
T Consensus 157 ~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 234 (268)
T cd06624 157 KRLAGINPC--TETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIP 234 (268)
T ss_pred eecccCCCc--cccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCCCC
Confidence 765332211 1234578999999998654 37889999999999999999999997543211110 00 001111
Q ss_pred -----CCccchhhhcccccCCCCCHHHHH
Q 018712 294 -----LSEDKVKQCVDTKLGGEYPPKAIA 317 (351)
Q Consensus 294 -----~~~~~~~~~ld~~~~~~~~~~~~~ 317 (351)
...+.+.+|++..|.+|++.+++.
T Consensus 235 ~~~~~~~~~li~~~l~~~p~~Rpt~~~ll 263 (268)
T cd06624 235 ESLSAEAKNFILRCFEPDPDKRASAHDLL 263 (268)
T ss_pred cccCHHHHHHHHHHcCCCchhCCCHHHHH
Confidence 112568888999999998877653
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-37 Score=275.78 Aligned_cols=199 Identities=27% Similarity=0.422 Sum_probs=169.8
Q ss_pred CCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCCc------hHHHHHHHHHHHhccCCceeeeEEEEecCCceEEE
Q 018712 67 NFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP------DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLA 139 (351)
Q Consensus 67 ~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 139 (351)
+|.+.+.||+|++|.||+|... +++.||+|.+...... ...+.+|++++++++|+||+++++++.+.+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 4788899999999999999965 6899999998754322 34567899999999999999999999999999999
Q ss_pred EEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccc
Q 018712 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDL 219 (351)
Q Consensus 140 ~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~ 219 (351)
|||+ +++|.+++..... .+++..++.++.||++||.|||+++ ++|+||+|+||+++.++.++|+|||+
T Consensus 81 ~e~~-~~~L~~~i~~~~~--------~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~ 148 (298)
T cd07841 81 FEFM-ETDLEKVIKDKSI--------VLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGL 148 (298)
T ss_pred Eccc-CCCHHHHHhccCC--------CCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEcccee
Confidence 9999 8899999976531 2889999999999999999999999 99999999999999999999999999
Q ss_pred cCCCccccccccccccccccCccCcccccC-CCCCccchhHhHHHHHHHHHcCCCCCCCCC
Q 018712 220 SNQAPDAAARLHSTRVLGTFGYHAPEYAMT-GQMSSKSDVYSFGVVLLELLTGRKPVDHTL 279 (351)
Q Consensus 220 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~Pf~~~~ 279 (351)
+......... .....+++.|+|||.+.+ ..++.++|+||||+++|+|++|.+||....
T Consensus 149 ~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~ 207 (298)
T cd07841 149 ARSFGSPNRK--MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDS 207 (298)
T ss_pred eeeccCCCcc--ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCc
Confidence 8766443211 122346788999998864 467899999999999999999988887544
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=267.89 Aligned_cols=241 Identities=28% Similarity=0.419 Sum_probs=193.5
Q ss_pred CCCCceeccCCcEEEEEEEECC-----CCEEEEEEcCCCCC--chHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEE
Q 018712 68 FGTNSLIGEGSYGRVYFGVLRS-----GRAAAIKKLDSSKQ--PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAY 140 (351)
Q Consensus 68 y~~~~~Lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 140 (351)
+++.+.||.|+||.||++.... +..+|+|.+..... ....+.+|+.+++.++|+||+++++.+.+.+..+++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 4567899999999999999753 38899999976554 3567889999999999999999999999999999999
Q ss_pred EeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEeccccc
Q 018712 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (351)
Q Consensus 141 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a 220 (351)
||+++++|.+++...... .+++..+..++.|++.||.+||+.+ ++|+||||+||++++++.++|+|||++
T Consensus 81 e~~~~~~l~~~~~~~~~~-------~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~ 150 (258)
T smart00219 81 EYMEGGDLLDYLRKNRPK-------ELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLS 150 (258)
T ss_pred eccCCCCHHHHHHhhhhc-------cCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCc
Confidence 999999999999765421 1789999999999999999999999 999999999999999999999999998
Q ss_pred CCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCCccchh--------hcc
Q 018712 221 NQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVT--------WAT 291 (351)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~Pf~~~~~~~~~~~~~--------~~~ 291 (351)
........... ....++..|+|||.+.+..++.++|+||||+++|+|++ |..||...........+. ...
T Consensus 151 ~~~~~~~~~~~-~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (258)
T smart00219 151 RDLYDDDYYKK-KGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYRLPKPENC 229 (258)
T ss_pred eeccccccccc-ccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCcC
Confidence 77654322111 12236789999999988889999999999999999998 889987643321111110 011
Q ss_pred cCCCccchhhhcccccCCCCCHHHHHHH
Q 018712 292 PKLSEDKVKQCVDTKLGGEYPPKAIAKV 319 (351)
Q Consensus 292 ~~~~~~~~~~~ld~~~~~~~~~~~~~~~ 319 (351)
+....+.+..|+..++.+|++..++...
T Consensus 230 ~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 257 (258)
T smart00219 230 PPEIYKLMLQCWAEDPEDRPTFSELVEI 257 (258)
T ss_pred CHHHHHHHHHHCcCChhhCcCHHHHHhh
Confidence 1112357788999999999988877543
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=276.77 Aligned_cols=199 Identities=27% Similarity=0.442 Sum_probs=170.7
Q ss_pred cCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCC---chHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEEE
Q 018712 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ---PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYE 141 (351)
Q Consensus 66 ~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 141 (351)
++|++.+.||+|+||.||+|.+. +++.||+|++..... ..+.+.+|+++++.++|+||+++++++.+.+..++|+|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 46889999999999999999975 689999998764332 23567889999999999999999999999999999999
Q ss_pred eCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccccC
Q 018712 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (351)
Q Consensus 142 ~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~ 221 (351)
|+.+++|.++...... +++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++.
T Consensus 81 ~~~~~~l~~~~~~~~~---------~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~ 148 (286)
T cd07846 81 FVDHTVLDDLEKYPNG---------LDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFAR 148 (286)
T ss_pred cCCccHHHHHHhccCC---------CCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeee
Confidence 9999999887765432 889999999999999999999999 9999999999999999999999999987
Q ss_pred CCccccccccccccccccCccCcccccC-CCCCccchhHhHHHHHHHHHcCCCCCCCC
Q 018712 222 QAPDAAARLHSTRVLGTFGYHAPEYAMT-GQMSSKSDVYSFGVVLLELLTGRKPVDHT 278 (351)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~Pf~~~ 278 (351)
........ .....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||...
T Consensus 149 ~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~ 204 (286)
T cd07846 149 TLAAPGEV--YTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGD 204 (286)
T ss_pred eccCCccc--cCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCC
Confidence 65433221 133457889999998875 34688999999999999999999999754
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=272.98 Aligned_cols=255 Identities=26% Similarity=0.408 Sum_probs=205.0
Q ss_pred HHhcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCCchHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEEE
Q 018712 63 EKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYE 141 (351)
Q Consensus 63 ~~~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 141 (351)
...+.|...+.||+|++|.||++.+. ++..+++|++.........+.+|+++++.++|+||+++++.+...+..++++|
T Consensus 16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 95 (286)
T cd06614 16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME 95 (286)
T ss_pred CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence 45567889999999999999999976 78899999987655455678899999999999999999999999999999999
Q ss_pred eCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccccC
Q 018712 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (351)
Q Consensus 142 ~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~ 221 (351)
|+++++|.+++..... .+++..+..++.|++.||.|||+.| ++|+||+|+||+++.++.++|+|||++.
T Consensus 96 ~~~~~~L~~~l~~~~~--------~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~ 164 (286)
T cd06614 96 YMDGGSLTDIITQNFV--------RMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAA 164 (286)
T ss_pred ccCCCcHHHHHHHhcc--------CCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhh
Confidence 9999999999987641 2889999999999999999999999 9999999999999999999999999876
Q ss_pred CCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccchh-hc---------c
Q 018712 222 QAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVT-WA---------T 291 (351)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~~-~~---------~ 291 (351)
........ .....++..|+|||.+.+..++.++|+||||+++|+|++|+.||....+......+. .. .
T Consensus 165 ~~~~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (286)
T cd06614 165 QLTKEKSK--RNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKW 242 (286)
T ss_pred hhccchhh--hccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCcchhhC
Confidence 55432211 133457889999999988889999999999999999999999998654321111110 00 1
Q ss_pred cCCCccchhhhcccccCCCCCHHHHHHHHHHHHHhhhhcccc
Q 018712 292 PKLSEDKVKQCVDTKLGGEYPPKAIAKVRKKKFITSECSNIS 333 (351)
Q Consensus 292 ~~~~~~~~~~~ld~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 333 (351)
+....+.+..|+..++.+|++.+++.. +.++.-.|-+..
T Consensus 243 ~~~l~~li~~~l~~~p~~Rpt~~~il~---~~~~~~~~~~~~ 281 (286)
T cd06614 243 SPEFKDFLNKCLVKDPEKRPSAEELLQ---HPFLKKACPKEE 281 (286)
T ss_pred CHHHHHHHHHHhccChhhCcCHHHHhh---ChHhhccCchHh
Confidence 122236788899999999998876644 444444454433
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=272.16 Aligned_cols=245 Identities=26% Similarity=0.394 Sum_probs=193.8
Q ss_pred cCCCCCceeccCCcEEEEEEEEC-----CCCEEEEEEcCCCCCc--hHHHHHHHHHHHhccCCceeeeEEEEec--CCce
Q 018712 66 DNFGTNSLIGEGSYGRVYFGVLR-----SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVD--GPLR 136 (351)
Q Consensus 66 ~~y~~~~~Lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~ 136 (351)
++|.+.+.||+|+||.||++... ++..+|+|.+...... ...+.+|+++++.++|+||+++++++.. ....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 46788899999999999999853 4689999999866553 5678999999999999999999998876 5678
Q ss_pred EEEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEec
Q 018712 137 VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISD 216 (351)
Q Consensus 137 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~D 216 (351)
+++|||+++++|.+++..... .+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.++|+|
T Consensus 84 ~lv~e~~~~~~l~~~l~~~~~--------~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~d 152 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRHRD--------QINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISD 152 (284)
T ss_pred EEEEecCCCCCHHHHHHhCcc--------ccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcc
Confidence 999999999999999976542 2889999999999999999999999 99999999999999999999999
Q ss_pred ccccCCCcccccccc-ccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCc-----------
Q 018712 217 FDLSNQAPDAAARLH-STRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQ----------- 284 (351)
Q Consensus 217 fg~a~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~----------- 284 (351)
||.+........... .....++..|+|||.+.+..++.++||||||+++|+|++|..|+.........
T Consensus 153 fg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 232 (284)
T cd05038 153 FGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIV 232 (284)
T ss_pred cccccccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccH
Confidence 999987653222111 11223456799999998888999999999999999999999998754322110
Q ss_pred -cchhh-----------cccCCCccchhhhcccccCCCCCHHHHHHHHH
Q 018712 285 -SLVTW-----------ATPKLSEDKVKQCVDTKLGGEYPPKAIAKVRK 321 (351)
Q Consensus 285 -~~~~~-----------~~~~~~~~~~~~~ld~~~~~~~~~~~~~~~~~ 321 (351)
.+... ..+....+.+.+|+.++|.+|++..++...++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~ 281 (284)
T cd05038 233 TRLLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVD 281 (284)
T ss_pred HHHHHHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHh
Confidence 00000 00111125667888888888888877766654
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=271.87 Aligned_cols=241 Identities=27% Similarity=0.346 Sum_probs=186.5
Q ss_pred cCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCC--chHHHHHHHHH-HHhccCCceeeeEEEEecCCceEEEEE
Q 018712 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ--PDQEFLAQVSM-VSRLKNENVVELVGYYVDGPLRVLAYE 141 (351)
Q Consensus 66 ~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~e~~~-l~~l~h~niv~~~~~~~~~~~~~lv~e 141 (351)
++|++.+.||+|+||.||++.+. +|+.||+|++..... ....+..|+.. ++.++|+||+++++++...+..+++||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 47899999999999999999975 799999999876532 23445566665 666789999999999999999999999
Q ss_pred eCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhC-CCCCeeeccccCCcEEEccCCceEEeccccc
Q 018712 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEK-AEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (351)
Q Consensus 142 ~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~-~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a 220 (351)
|++ ++|.+++...... ...+++..++.++.|++.||.|||++ + ++||||||+||+++.++.+||+|||++
T Consensus 81 ~~~-~~l~~~l~~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~dfg~~ 151 (283)
T cd06617 81 VMD-TSLDKFYKKVYDK-----GLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCDFGIS 151 (283)
T ss_pred hhc-ccHHHHHHHhccC-----CCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecccc
Confidence 997 5898888653211 12389999999999999999999997 7 999999999999999999999999998
Q ss_pred CCCccccccccccccccccCccCcccccC----CCCCccchhHhHHHHHHHHHcCCCCCCCCCCC-CC-ccchhhc----
Q 018712 221 NQAPDAAARLHSTRVLGTFGYHAPEYAMT----GQMSSKSDVYSFGVVLLELLTGRKPVDHTLPR-GQ-QSLVTWA---- 290 (351)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~-~~-~~~~~~~---- 290 (351)
........ .....|+..|+|||.+.+ ..++.++|+||||+++|+|++|+.||...... .. .......
T Consensus 152 ~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 228 (283)
T cd06617 152 GYLVDSVA---KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQL 228 (283)
T ss_pred cccccccc---cccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCCCCC
Confidence 76543221 133468889999998865 45688999999999999999999999753221 00 0001111
Q ss_pred ----ccCCCccchhhhcccccCCCCCHHHHHH
Q 018712 291 ----TPKLSEDKVKQCVDTKLGGEYPPKAIAK 318 (351)
Q Consensus 291 ----~~~~~~~~~~~~ld~~~~~~~~~~~~~~ 318 (351)
.+....+.+..|+..+|.+|++.+++..
T Consensus 229 ~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 229 PAEKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred CccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1111235678899999999998866643
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=289.82 Aligned_cols=209 Identities=23% Similarity=0.363 Sum_probs=185.5
Q ss_pred HhcCCCCCceeccCCcEEEEEEEECCCC-EEEEEEcCCCCC----chHHHHHHHHHHHhccCCceeeeEEEEecCCceEE
Q 018712 64 KTDNFGTNSLIGEGSYGRVYFGVLRSGR-AAAIKKLDSSKQ----PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVL 138 (351)
Q Consensus 64 ~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~-~vavK~~~~~~~----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 138 (351)
...++.++..||-|+||+|-++..++.. .+|+|++++... ..+.+..|-.+|..+++|.||++|..|.+..++|+
T Consensus 418 ~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYm 497 (732)
T KOG0614|consen 418 KLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYM 497 (732)
T ss_pred chhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhh
Confidence 3457788889999999999999866443 489998876432 23457788899999999999999999999999999
Q ss_pred EEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEeccc
Q 018712 139 AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFD 218 (351)
Q Consensus 139 v~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg 218 (351)
+||-|-||.|..+|+..+. +...++..++..+++|++|||++| ||+|||||+|++++.+|-+||.|||
T Consensus 498 LmEaClGGElWTiLrdRg~---------Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFG 565 (732)
T KOG0614|consen 498 LMEACLGGELWTILRDRGS---------FDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFG 565 (732)
T ss_pred hHHhhcCchhhhhhhhcCC---------cccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehh
Confidence 9999999999999998764 888899999999999999999999 9999999999999999999999999
Q ss_pred ccCCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccch
Q 018712 219 LSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLV 287 (351)
Q Consensus 219 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~ 287 (351)
+|+.+..+... .+++|||.|.|||++.+...+.++|.||||+++|||++|.+||.+.++.....+|
T Consensus 566 FAKki~~g~KT---wTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~I 631 (732)
T KOG0614|consen 566 FAKKIGSGRKT---WTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLI 631 (732)
T ss_pred hHHHhccCCce---eeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHH
Confidence 99998766543 6789999999999999999999999999999999999999999998876555444
|
|
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=270.32 Aligned_cols=237 Identities=22% Similarity=0.309 Sum_probs=180.4
Q ss_pred eeccCCcEEEEEEEEC-CCCEEEEEEcCCCCCc----hHHHHHHHHHHH---hccCCceeeeEEEEecCCceEEEEEeCC
Q 018712 73 LIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP----DQEFLAQVSMVS---RLKNENVVELVGYYVDGPLRVLAYEHAS 144 (351)
Q Consensus 73 ~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~----~~~~~~e~~~l~---~l~h~niv~~~~~~~~~~~~~lv~e~~~ 144 (351)
.||+|+||.||++... +++.+|+|.+...... .....+|..+++ ...|+||+.+++.+...+..++||||+.
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999975 6889999988654321 223344444433 3479999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccccCCCc
Q 018712 145 KGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAP 224 (351)
Q Consensus 145 ~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~ 224 (351)
+++|.+++..... +++..+..++.|++.||.|||+.+ ++||||||+|||+++++.++|+|||++....
T Consensus 81 ~~~L~~~i~~~~~---------l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~ 148 (279)
T cd05633 81 GGDLHYHLSQHGV---------FSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFS 148 (279)
T ss_pred CCCHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceecc
Confidence 9999999876542 899999999999999999999999 9999999999999999999999999986553
Q ss_pred cccccccccccccccCccCccccc-CCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccchh------h----cccC
Q 018712 225 DAAARLHSTRVLGTFGYHAPEYAM-TGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVT------W----ATPK 293 (351)
Q Consensus 225 ~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~~------~----~~~~ 293 (351)
.... ....||..|+|||.+. +..++.++||||+|+++|+|++|+.||............. . ..+.
T Consensus 149 ~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (279)
T cd05633 149 KKKP----HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFSP 224 (279)
T ss_pred ccCc----cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhhcCCcCCccccCH
Confidence 3221 2346899999999886 4568899999999999999999999997653322111110 0 0111
Q ss_pred CCccchhhhcccccCCCCCH--HHHHHHHHHHHH
Q 018712 294 LSEDKVKQCVDTKLGGEYPP--KAIAKVRKKKFI 325 (351)
Q Consensus 294 ~~~~~~~~~ld~~~~~~~~~--~~~~~~~~~~~~ 325 (351)
...+.+.+|+..+|.+|++. +.+..+.++.++
T Consensus 225 ~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~ 258 (279)
T cd05633 225 ELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFF 258 (279)
T ss_pred HHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCccc
Confidence 11367788899999888841 123344555543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-37 Score=270.79 Aligned_cols=237 Identities=29% Similarity=0.408 Sum_probs=192.8
Q ss_pred cCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCC--chHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEEEe
Q 018712 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ--PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEH 142 (351)
Q Consensus 66 ~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 142 (351)
++|+..+.||+|++|.||++.++ +++.+++|.+..... ....+.+|++++++++||||+++++.+...+..++++||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 46788889999999999999976 688999999876533 345688999999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhh-CCCCCeeeccccCCcEEEccCCceEEecccccC
Q 018712 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHE-KAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (351)
Q Consensus 143 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~-~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~ 221 (351)
+.+++|.+++..... .++...+..++.|++.||.|||+ .+ ++|+||||+||++++++.++|+|||.+.
T Consensus 81 ~~~~~L~~~~~~~~~--------~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~ 149 (265)
T cd06605 81 MDGGSLDKILKEVQG--------RIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSG 149 (265)
T ss_pred cCCCcHHHHHHHccC--------CCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccch
Confidence 999999999986531 28889999999999999999999 88 9999999999999999999999999987
Q ss_pred CCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCC--CCccch----hhcccC--
Q 018712 222 QAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPR--GQQSLV----TWATPK-- 293 (351)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~--~~~~~~----~~~~~~-- 293 (351)
....... ....++..|+|||.+.+..++.++||||||+++|+|++|+.||...... ...... ....+.
T Consensus 150 ~~~~~~~----~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (265)
T cd06605 150 QLVNSLA----KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLP 225 (265)
T ss_pred hhHHHHh----hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCCCC
Confidence 6543221 1256888999999999999999999999999999999999999754211 101111 111111
Q ss_pred ------CCccchhhhcccccCCCCCHHHHH
Q 018712 294 ------LSEDKVKQCVDTKLGGEYPPKAIA 317 (351)
Q Consensus 294 ------~~~~~~~~~ld~~~~~~~~~~~~~ 317 (351)
...+.+..|+..+|.+|++..++.
T Consensus 226 ~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll 255 (265)
T cd06605 226 SGKFSPDFQDFVNLCLIKDPRERPSYKELL 255 (265)
T ss_pred hhhcCHHHHHHHHHHcCCCchhCcCHHHHh
Confidence 123567788888888898876653
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=267.24 Aligned_cols=239 Identities=25% Similarity=0.400 Sum_probs=193.6
Q ss_pred CCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCC---chHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEEEe
Q 018712 67 NFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ---PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEH 142 (351)
Q Consensus 67 ~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 142 (351)
+|.+.+.||+|+||.||++... +++.+++|.+..... ....+.+|+.++++++|+||+++++.+.+.+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 5888999999999999999964 789999999876544 346788999999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccccCC
Q 018712 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222 (351)
Q Consensus 143 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~ 222 (351)
+++++|.+++..... +++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||++..
T Consensus 81 ~~~~~L~~~~~~~~~---------~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~ 148 (264)
T cd06626 81 CSGGTLEELLEHGRI---------LDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVK 148 (264)
T ss_pred CCCCcHHHHHhhcCC---------CChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccc
Confidence 999999999976532 778889999999999999999999 99999999999999999999999999877
Q ss_pred Ccccccccc--ccccccccCccCcccccCCC---CCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccc-h----hhccc
Q 018712 223 APDAAARLH--STRVLGTFGYHAPEYAMTGQ---MSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSL-V----TWATP 292 (351)
Q Consensus 223 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~---~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~-~----~~~~~ 292 (351)
......... .....++..|+|||++.+.. ++.++||||||+++|+|++|+.||........... + ....+
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 228 (264)
T cd06626 149 LKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIP 228 (264)
T ss_pred cCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCCCCCC
Confidence 654322111 11345788999999998766 88999999999999999999999975432111100 0 00111
Q ss_pred ------CCCccchhhhcccccCCCCCHHHHH
Q 018712 293 ------KLSEDKVKQCVDTKLGGEYPPKAIA 317 (351)
Q Consensus 293 ------~~~~~~~~~~ld~~~~~~~~~~~~~ 317 (351)
....+.+..|+..+|.+|++.+++.
T Consensus 229 ~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~ 259 (264)
T cd06626 229 DSLQLSPEGKDFLDRCLESDPKKRPTASELL 259 (264)
T ss_pred cccccCHHHHHHHHHHccCCcccCCCHHHHh
Confidence 1113678888888898998877653
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=268.24 Aligned_cols=242 Identities=19% Similarity=0.284 Sum_probs=192.3
Q ss_pred CCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCC---chHHHHHHHHHHHhccCCceeeeEEEEec--CCceEEEE
Q 018712 67 NFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ---PDQEFLAQVSMVSRLKNENVVELVGYYVD--GPLRVLAY 140 (351)
Q Consensus 67 ~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~lv~ 140 (351)
+|++.+.||.|+||.||++... ++..+|+|.+..... ..+.+.+|++++++++|+||+++++++.. +...+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 5888999999999999999864 788999999865432 23457789999999999999999997753 45679999
Q ss_pred EeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhh-----hCCCCCeeeccccCCcEEEccCCceEEe
Q 018712 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLH-----EKAEPRIIHRNIKSSNVLLFDDDIAKIS 215 (351)
Q Consensus 141 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH-----~~~~~~ivH~Dlkp~Nill~~~~~vkl~ 215 (351)
||+++++|.+++...... ...+++..++.++.||+.||.||| +.+ ++|+||+|+||++++++.+||+
T Consensus 81 e~~~~~~L~~~l~~~~~~-----~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~---i~h~dl~p~nili~~~~~~kl~ 152 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKE-----RKYIEEEFIWRILTQLLLALYECHNRSDPGNT---VLHRDLKPANIFLDANNNVKLG 152 (265)
T ss_pred hhccCCCHHHHHHHHhhc-----ccCCCHHHHHHHHHHHHHHHHHHhcCccccCc---ceecCCCHHHEEEecCCCEEEe
Confidence 999999999999754211 123889999999999999999999 777 9999999999999999999999
Q ss_pred cccccCCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccchh-------
Q 018712 216 DFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVT------- 288 (351)
Q Consensus 216 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~~------- 288 (351)
|||++......... .....+++.|+|||.+.+..++.++|+||||+++|+|++|+.||...........+.
T Consensus 153 d~g~~~~~~~~~~~--~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 230 (265)
T cd08217 153 DFGLAKILGHDSSF--AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRRI 230 (265)
T ss_pred cccccccccCCccc--ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCCCCCC
Confidence 99998876543321 133468999999999998889999999999999999999999998654221111111
Q ss_pred -hcccCCCccchhhhcccccCCCCCHHHHHH
Q 018712 289 -WATPKLSEDKVKQCVDTKLGGEYPPKAIAK 318 (351)
Q Consensus 289 -~~~~~~~~~~~~~~ld~~~~~~~~~~~~~~ 318 (351)
...+....+.+..|+...|.+|++.+++..
T Consensus 231 ~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~ 261 (265)
T cd08217 231 PYRYSSELNEVIKSMLNVDPDKRPSTEELLQ 261 (265)
T ss_pred ccccCHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 111111236778889889999998877643
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=269.71 Aligned_cols=239 Identities=22% Similarity=0.300 Sum_probs=188.8
Q ss_pred eccCCcEEEEEEEEC-CCCEEEEEEcCCCC----CchHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEEEeCCCCCH
Q 018712 74 IGEGSYGRVYFGVLR-SGRAAAIKKLDSSK----QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSL 148 (351)
Q Consensus 74 Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL 148 (351)
||+|+||.||++... +++.||+|.+.... .....+.+|++++++++||||+++++.+...+..|+||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 699999999999865 68899999886432 1234567899999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccccCCCccccc
Q 018712 149 HDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAA 228 (351)
Q Consensus 149 ~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~ 228 (351)
.+++...... .+++..+..++.|++.||.|||+.+ ++||||+|+||++++++.++|+|||.+........
T Consensus 81 ~~~l~~~~~~-------~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 150 (277)
T cd05577 81 KYHIYNVGEP-------GFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK 150 (277)
T ss_pred HHHHHHcCcC-------CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhccCCc
Confidence 9999765421 2889999999999999999999999 99999999999999999999999999876543211
Q ss_pred cccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccchh-----------hcccCCCcc
Q 018712 229 RLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVT-----------WATPKLSED 297 (351)
Q Consensus 229 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~~-----------~~~~~~~~~ 297 (351)
.....++..|+|||.+.+..++.++|+||||+++|+|++|+.||...........+. ...+....+
T Consensus 151 ---~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (277)
T cd05577 151 ---IKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKD 227 (277)
T ss_pred ---cccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCCccCCHHHHH
Confidence 133457889999999988889999999999999999999999997654321111110 011112246
Q ss_pred chhhhcccccCCCCCHHH--HHHHHHHHHH
Q 018712 298 KVKQCVDTKLGGEYPPKA--IAKVRKKKFI 325 (351)
Q Consensus 298 ~~~~~ld~~~~~~~~~~~--~~~~~~~~~~ 325 (351)
.+.+|+..+|.+|++.++ +..++.+.++
T Consensus 228 li~~~l~~~p~~R~~~~~~~~~~ll~h~~~ 257 (277)
T cd05577 228 LCEALLQKDPEKRLGCRGGSADEVREHPLF 257 (277)
T ss_pred HHHHHccCChhHccCCCcccHHHHHhChhh
Confidence 888999999999994333 3334445554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-37 Score=273.66 Aligned_cols=200 Identities=26% Similarity=0.387 Sum_probs=172.3
Q ss_pred cCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCC---CchHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEEE
Q 018712 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK---QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYE 141 (351)
Q Consensus 66 ~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 141 (351)
++|++.+.||+|+||.||+|.+. +++.||+|++.... .....+.+|++++++++|+||+++++.+.+.+..+++||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 46889999999999999999976 68899999886532 234678899999999999999999999999999999999
Q ss_pred eCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccccC
Q 018712 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (351)
Q Consensus 142 ~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~ 221 (351)
|+.++.+..+...... ++...+..++.|++.||.|||+++ ++|+||+|+||++++++.+||+|||++.
T Consensus 81 ~~~~~~l~~~~~~~~~---------~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~ 148 (288)
T cd07833 81 YVERTLLELLEASPGG---------LPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFAR 148 (288)
T ss_pred cCCCCHHHHHHhcCCC---------CCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeeccc
Confidence 9998777766654332 788999999999999999999999 9999999999999999999999999987
Q ss_pred CCccccccccccccccccCccCcccccCC-CCCccchhHhHHHHHHHHHcCCCCCCCC
Q 018712 222 QAPDAAARLHSTRVLGTFGYHAPEYAMTG-QMSSKSDVYSFGVVLLELLTGRKPVDHT 278 (351)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~Pf~~~ 278 (351)
........ ......++..|+|||++.+. .++.++||||||+++|+|++|+.||...
T Consensus 149 ~~~~~~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~ 205 (288)
T cd07833 149 ALRARPAS-PLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGD 205 (288)
T ss_pred ccCCCccc-cccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 76543321 12335678899999999888 8899999999999999999999999754
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=270.82 Aligned_cols=236 Identities=24% Similarity=0.384 Sum_probs=190.7
Q ss_pred CCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCC-chHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEEEeCC
Q 018712 67 NFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ-PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHAS 144 (351)
Q Consensus 67 ~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 144 (351)
.|...+.||+|++|.||++... +++.+++|++..... ..+.+.+|+.+++.++|+||+++++++...+..++++||+.
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~ 99 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE 99 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence 4555678999999999999964 788999998864332 24557889999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccccCCCc
Q 018712 145 KGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAP 224 (351)
Q Consensus 145 ~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~ 224 (351)
+++|.+++.... ++...+..++.|++.||.|||+++ ++||||+|+||+++.++.++|+|||.+....
T Consensus 100 ~~~L~~~~~~~~----------~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~ 166 (285)
T cd06648 100 GGALTDIVTHTR----------MNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVS 166 (285)
T ss_pred CCCHHHHHHhCC----------CCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhc
Confidence 999999997632 788999999999999999999999 9999999999999999999999999876554
Q ss_pred cccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccchhhc----------ccCC
Q 018712 225 DAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWA----------TPKL 294 (351)
Q Consensus 225 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~~~~----------~~~~ 294 (351)
..... .....|+..|+|||.+.+..++.++||||||+++|+|++|+.||....+......+... .+..
T Consensus 167 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (285)
T cd06648 167 KEVPR--RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHKVSPR 244 (285)
T ss_pred cCCcc--cccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCCCCCcccccCCHH
Confidence 32211 12345889999999998888999999999999999999999999764332111111100 1112
Q ss_pred CccchhhhcccccCCCCCHHHHH
Q 018712 295 SEDKVKQCVDTKLGGEYPPKAIA 317 (351)
Q Consensus 295 ~~~~~~~~ld~~~~~~~~~~~~~ 317 (351)
..+.+..|+..+|.+|++.+++.
T Consensus 245 l~~li~~~l~~~p~~Rpt~~~il 267 (285)
T cd06648 245 LRSFLDRMLVRDPAQRATAAELL 267 (285)
T ss_pred HHHHHHHHcccChhhCcCHHHHc
Confidence 23678888999999998776554
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=277.15 Aligned_cols=209 Identities=25% Similarity=0.311 Sum_probs=179.5
Q ss_pred HHHhcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCCc----hHHHHHHHHHHHhc-cCCceeeeEEEEecCCc
Q 018712 62 KEKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP----DQEFLAQVSMVSRL-KNENVVELVGYYVDGPL 135 (351)
Q Consensus 62 ~~~~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~----~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~ 135 (351)
.....+|..+.+||+|+||.|.+|..+ +.+.||||+++++-.- -+--+.|-++|... +.|.+++++..|+.-++
T Consensus 345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDR 424 (683)
T KOG0696|consen 345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDR 424 (683)
T ss_pred ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhh
Confidence 345568999999999999999999976 5778999999875322 12234566666655 56899999999999999
Q ss_pred eEEEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEe
Q 018712 136 RVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKIS 215 (351)
Q Consensus 136 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~ 215 (351)
+|.||||+.||+|.-.+++.+. +.+..+..++..|+-||-+||++| |++||||.+|||++.+|++||+
T Consensus 425 LyFVMEyvnGGDLMyhiQQ~Gk---------FKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~ 492 (683)
T KOG0696|consen 425 LYFVMEYVNGGDLMYHIQQVGK---------FKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIA 492 (683)
T ss_pred eeeEEEEecCchhhhHHHHhcc---------cCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEee
Confidence 9999999999999999988765 778889999999999999999999 9999999999999999999999
Q ss_pred cccccCCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCc
Q 018712 216 DFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQ 284 (351)
Q Consensus 216 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~ 284 (351)
|||+++..-... ..+.+++|||.|+|||++..++|+..+|+||+||+||||+.|++||++.++....
T Consensus 493 DFGmcKEni~~~--~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF 559 (683)
T KOG0696|consen 493 DFGMCKENIFDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELF 559 (683)
T ss_pred ecccccccccCC--cceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHH
Confidence 999998754332 2346789999999999999999999999999999999999999999987665443
|
|
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=271.06 Aligned_cols=245 Identities=29% Similarity=0.405 Sum_probs=192.9
Q ss_pred cCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCC--chHHHHHHHHHHHhccCCceeeeEEEEecC--CceEEEE
Q 018712 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ--PDQEFLAQVSMVSRLKNENVVELVGYYVDG--PLRVLAY 140 (351)
Q Consensus 66 ~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~lv~ 140 (351)
++|...+.||.|++|.||++.+. +++.+|+|.+..... ....+.+|++++++++||||+++++++.+. +..++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 46788899999999999999975 688999999875433 346688999999999999999999988653 4689999
Q ss_pred EeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEeccccc
Q 018712 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (351)
Q Consensus 141 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a 220 (351)
||+++++|.+++...... ...++...+..++.||+.||.|||+.+ ++|+||+|+||+++.++.++|+|||++
T Consensus 81 e~~~~~~L~~~l~~~~~~-----~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~ 152 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKR-----GGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVS 152 (287)
T ss_pred EecCCCCHHHHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeecccc
Confidence 999999999987643211 123788899999999999999999999 999999999999999999999999998
Q ss_pred CCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCC--CCccchhh----cccC-
Q 018712 221 NQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPR--GQQSLVTW----ATPK- 293 (351)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~--~~~~~~~~----~~~~- 293 (351)
........ ....++..|+|||.+.+..++.++||||||+++|+|++|+.||...... .......+ ..+.
T Consensus 153 ~~~~~~~~----~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (287)
T cd06621 153 GELVNSLA----GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPEL 228 (287)
T ss_pred cccccccc----ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhh
Confidence 66533221 2345788999999999889999999999999999999999999865221 11111111 0000
Q ss_pred ------------CCccchhhhcccccCCCCCHHHHHHHHHHHHH
Q 018712 294 ------------LSEDKVKQCVDTKLGGEYPPKAIAKVRKKKFI 325 (351)
Q Consensus 294 ------------~~~~~~~~~ld~~~~~~~~~~~~~~~~~~~~~ 325 (351)
...+.+..|+..+|.+|++..++ +++.++
T Consensus 229 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~ei---l~~~~~ 269 (287)
T cd06621 229 KDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDM---LEHPWI 269 (287)
T ss_pred ccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHH---HhCccc
Confidence 11367788999999999987654 444444
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=281.26 Aligned_cols=198 Identities=24% Similarity=0.319 Sum_probs=169.4
Q ss_pred HHhcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCC---chHHHHHHHHHHHhccCCceeeeEEEEecC-----
Q 018712 63 EKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ---PDQEFLAQVSMVSRLKNENVVELVGYYVDG----- 133 (351)
Q Consensus 63 ~~~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~h~niv~~~~~~~~~----- 133 (351)
...++|++.+.||+|+||.||+|... +++.||+|.+..... ....+.+|+.++++++|+||+++++++...
T Consensus 13 ~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 92 (353)
T cd07850 13 TVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEE 92 (353)
T ss_pred hhhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccc
Confidence 35678999999999999999999965 789999999865322 234577899999999999999999987643
Q ss_pred -CceEEEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCce
Q 018712 134 -PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIA 212 (351)
Q Consensus 134 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~v 212 (351)
...|+||||+.+ +|.+.+... ++...+..++.|++.||.|||++| ++||||||+||+++.++.+
T Consensus 93 ~~~~~lv~e~~~~-~l~~~~~~~-----------l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~ 157 (353)
T cd07850 93 FQDVYLVMELMDA-NLCQVIQMD-----------LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTL 157 (353)
T ss_pred cCcEEEEEeccCC-CHHHHHhhc-----------CCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCE
Confidence 357999999965 888888642 778889999999999999999999 9999999999999999999
Q ss_pred EEecccccCCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCC
Q 018712 213 KISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHT 278 (351)
Q Consensus 213 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~ 278 (351)
||+|||++........ .....++..|+|||++.+..++.++||||||+++|+|++|+.||...
T Consensus 158 kL~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~ 220 (353)
T cd07850 158 KILDFGLARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGT 220 (353)
T ss_pred EEccCccceeCCCCCC---CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCC
Confidence 9999999976543221 23345788999999999999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=268.65 Aligned_cols=223 Identities=24% Similarity=0.339 Sum_probs=174.4
Q ss_pred eeccCCcEEEEEEEEC-CCCEEEEEEcCCCCCc----hHHHHHHH---HHHHhccCCceeeeEEEEecCCceEEEEEeCC
Q 018712 73 LIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP----DQEFLAQV---SMVSRLKNENVVELVGYYVDGPLRVLAYEHAS 144 (351)
Q Consensus 73 ~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~----~~~~~~e~---~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 144 (351)
.||+|+||.||++... +++.||+|.+...... ......|. +.++...||+|+++++.+.+.+..++||||+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999864 6889999998654321 12233343 34455679999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccccCCCc
Q 018712 145 KGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAP 224 (351)
Q Consensus 145 ~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~ 224 (351)
+++|.+++.... .+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++....
T Consensus 81 g~~L~~~l~~~~---------~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~ 148 (278)
T cd05606 81 GGDLHYHLSQHG---------VFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFS 148 (278)
T ss_pred CCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccC
Confidence 999999987543 2899999999999999999999999 9999999999999999999999999987653
Q ss_pred cccccccccccccccCccCcccccCC-CCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccc---hh---hc----ccC
Q 018712 225 DAAARLHSTRVLGTFGYHAPEYAMTG-QMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSL---VT---WA----TPK 293 (351)
Q Consensus 225 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~---~~---~~----~~~ 293 (351)
.... ....|+..|+|||.+.++ .++.++||||+|+++|+|++|+.||........... .. .. .+.
T Consensus 149 ~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 224 (278)
T cd05606 149 KKKP----HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSP 224 (278)
T ss_pred ccCC----cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhccCCCCCCcCCH
Confidence 3221 234689999999998754 689999999999999999999999986533221111 10 00 111
Q ss_pred CCccchhhhcccccCCCC
Q 018712 294 LSEDKVKQCVDTKLGGEY 311 (351)
Q Consensus 294 ~~~~~~~~~ld~~~~~~~ 311 (351)
...+.+.+|+..++.+|+
T Consensus 225 ~~~~li~~~l~~~p~~R~ 242 (278)
T cd05606 225 ELRSLLEGLLQRDVNRRL 242 (278)
T ss_pred HHHHHHHHHhhcCHHhcc
Confidence 123677788888888887
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=266.65 Aligned_cols=224 Identities=23% Similarity=0.327 Sum_probs=183.0
Q ss_pred eccCCcEEEEEEEEC-CCCEEEEEEcCCCC----CchHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEEEeCCCCCH
Q 018712 74 IGEGSYGRVYFGVLR-SGRAAAIKKLDSSK----QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSL 148 (351)
Q Consensus 74 Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL 148 (351)
||.|++|.||++... ++..+|+|.+.... ...+.+.+|++++++++|+||+++++.+.+++..++++||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 699999999999975 58999999986543 2345688999999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccccCCCccccc
Q 018712 149 HDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAA 228 (351)
Q Consensus 149 ~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~ 228 (351)
.+++..... ++...+..++.||+.||.|||+++ ++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~l~~~~~---------l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~ 148 (262)
T cd05572 81 WTILRDRGL---------FDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQK 148 (262)
T ss_pred HHHHhhcCC---------CCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCcccc
Confidence 999976542 788999999999999999999999 99999999999999999999999999887654321
Q ss_pred cccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCC--Cccchh-----hc----ccCCCcc
Q 018712 229 RLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRG--QQSLVT-----WA----TPKLSED 297 (351)
Q Consensus 229 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~--~~~~~~-----~~----~~~~~~~ 297 (351)
.....|+..|+|||.+.+..++.++|+||||+++|+|++|+.||....... ....+. .. .+....+
T Consensus 149 ---~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (262)
T cd05572 149 ---TWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKD 225 (262)
T ss_pred ---cccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCcccCHHHHH
Confidence 133468899999999988889999999999999999999999998664211 000000 00 0111235
Q ss_pred chhhhcccccCCCCC
Q 018712 298 KVKQCVDTKLGGEYP 312 (351)
Q Consensus 298 ~~~~~ld~~~~~~~~ 312 (351)
.+.+|+..++.+|++
T Consensus 226 ~i~~~l~~~p~~R~~ 240 (262)
T cd05572 226 LIKQLLRRNPEERLG 240 (262)
T ss_pred HHHHHccCChhhCcC
Confidence 667777777777776
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=268.46 Aligned_cols=236 Identities=24% Similarity=0.341 Sum_probs=187.1
Q ss_pred ceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCCc----hHHHHHHHHH-HHhccCCceeeeEEEEecCCceEEEEEeCCC
Q 018712 72 SLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP----DQEFLAQVSM-VSRLKNENVVELVGYYVDGPLRVLAYEHASK 145 (351)
Q Consensus 72 ~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~----~~~~~~e~~~-l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 145 (351)
+.||+|+||.||+|... +++.||+|.+...... ...+..|..+ ....+|+|++++++.+..++..|+++||+.+
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 56999999999999964 6889999998654321 1223444444 4455899999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccccCCCcc
Q 018712 146 GSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPD 225 (351)
Q Consensus 146 gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~ 225 (351)
++|.+++..... ++...+..++.|++.||.|||+.+ ++||||+|+||++++++.+||+|||++.....
T Consensus 82 ~~L~~~l~~~~~---------~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 149 (260)
T cd05611 82 GDCASLIKTLGG---------LPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE 149 (260)
T ss_pred CCHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceeccc
Confidence 999999976542 788999999999999999999999 99999999999999999999999998875433
Q ss_pred ccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccchh-----h------cccCC
Q 018712 226 AAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVT-----W------ATPKL 294 (351)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~~-----~------~~~~~ 294 (351)
.....++..|+|||.+.+..++.++||||||+++|+|++|..||...........+. + ..+..
T Consensus 150 ------~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (260)
T cd05611 150 ------NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPE 223 (260)
T ss_pred ------cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHH
Confidence 134468889999999988889999999999999999999999997654322111110 0 11222
Q ss_pred CccchhhhcccccCCCCCHHHHHHHHHHHHH
Q 018712 295 SEDKVKQCVDTKLGGEYPPKAIAKVRKKKFI 325 (351)
Q Consensus 295 ~~~~~~~~ld~~~~~~~~~~~~~~~~~~~~~ 325 (351)
..+.+.+|+..+|..|++...+..++.+.++
T Consensus 224 ~~~~i~~~l~~~p~~R~~~~~~~~~l~~~~~ 254 (260)
T cd05611 224 AVDLINRLLCMDPAKRLGANGYQEIKSHPFF 254 (260)
T ss_pred HHHHHHHHccCCHHHccCCCcHHHHHcChHh
Confidence 2367888899999999987766666666554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=266.96 Aligned_cols=238 Identities=20% Similarity=0.304 Sum_probs=176.0
Q ss_pred eeccCCcEEEEEEEECCC---CEEEEEEcCCCC--CchHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEEEeCCCCC
Q 018712 73 LIGEGSYGRVYFGVLRSG---RAAAIKKLDSSK--QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASKGS 147 (351)
Q Consensus 73 ~Lg~G~~g~Vy~~~~~~~---~~vavK~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gs 147 (351)
.||+|+||.||++...++ ..+++|.+.... .....+.+|+.+++.++||||+++++.+.+....++||||+++|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 599999999999975433 356677765443 234678899999999999999999999999999999999999999
Q ss_pred HHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccccCCCcccc
Q 018712 148 LHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAA 227 (351)
Q Consensus 148 L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~ 227 (351)
|.+++...... ....+...+..++.||+.||.|||+.+ ++||||||+|||++.++.+||+|||++.......
T Consensus 82 L~~~l~~~~~~-----~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~ 153 (268)
T cd05086 82 LKSYLSQEQWH-----RRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKED 153 (268)
T ss_pred HHHHHHhhhcc-----cccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcch
Confidence 99999764321 112566778899999999999999999 9999999999999999999999999876432221
Q ss_pred ccccccccccccCccCcccccC-------CCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCCccc-hhh-----cccC
Q 018712 228 ARLHSTRVLGTFGYHAPEYAMT-------GQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSL-VTW-----ATPK 293 (351)
Q Consensus 228 ~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwslG~il~el~t-g~~Pf~~~~~~~~~~~-~~~-----~~~~ 293 (351)
.........++..|+|||++.. ..++.++||||||+++|||++ |..||........... +.. ..+.
T Consensus 154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (268)
T cd05086 154 YIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQ 233 (268)
T ss_pred hhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCc
Confidence 1111234567889999998753 245788999999999999997 6778865433211110 000 0111
Q ss_pred C----C---ccchhhhcccccCCCCCHHHHHHH
Q 018712 294 L----S---EDKVKQCVDTKLGGEYPPKAIAKV 319 (351)
Q Consensus 294 ~----~---~~~~~~~ld~~~~~~~~~~~~~~~ 319 (351)
+ . .+.+..|+ .+|.+|++.+++.+.
T Consensus 234 ~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~ 265 (268)
T cd05086 234 LELPYSERWYEVLQFCW-LSPEKRATAEEVHRL 265 (268)
T ss_pred cCCCCcHHHHHHHHHHh-hCcccCCCHHHHHHH
Confidence 1 1 13455566 458888888887554
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=270.59 Aligned_cols=231 Identities=25% Similarity=0.380 Sum_probs=181.5
Q ss_pred ceeccCCcEEEEEEEECC--------CCEEEEEEcCCCCC-chHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEEEe
Q 018712 72 SLIGEGSYGRVYFGVLRS--------GRAAAIKKLDSSKQ-PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEH 142 (351)
Q Consensus 72 ~~Lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 142 (351)
+.||+|+||.||+|.... ...+++|.+..... ..+.+.+|..+++.++||||+++++++......++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 369999999999998642 23588888765432 245678899999999999999999999998999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCc--------eEE
Q 018712 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDI--------AKI 214 (351)
Q Consensus 143 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~--------vkl 214 (351)
+.+|+|.+++..... .+++..++.++.||+.||.|||+++ ++||||||+||+++.++. +++
T Consensus 81 ~~~g~L~~~l~~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l 149 (258)
T cd05078 81 VKFGSLDTYLKKNKN--------LINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKL 149 (258)
T ss_pred CCCCcHHHHHhcCCC--------CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEe
Confidence 999999999976542 2788899999999999999999999 999999999999987764 699
Q ss_pred ecccccCCCccccccccccccccccCccCcccccC-CCCCccchhHhHHHHHHHHHcCC-CCCCCCCCCCCccchhh--c
Q 018712 215 SDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMT-GQMSSKSDVYSFGVVLLELLTGR-KPVDHTLPRGQQSLVTW--A 290 (351)
Q Consensus 215 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~-~Pf~~~~~~~~~~~~~~--~ 290 (351)
+|||++...... ....++..|+|||.+.+ ..++.++||||||+++|+|++|. .||....+......... .
T Consensus 150 ~d~g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~ 223 (258)
T cd05078 150 SDPGISITVLPK------EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFYEDRHQ 223 (258)
T ss_pred cccccccccCCc------hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHHHHcccc
Confidence 999988654322 23457889999999986 45799999999999999999984 66655433221111111 0
Q ss_pred cc----CCCccchhhhcccccCCCCCHHHHHHH
Q 018712 291 TP----KLSEDKVKQCVDTKLGGEYPPKAIAKV 319 (351)
Q Consensus 291 ~~----~~~~~~~~~~ld~~~~~~~~~~~~~~~ 319 (351)
.+ ....+.+.+|+..+|.+|++.+++.+.
T Consensus 224 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 256 (258)
T cd05078 224 LPAPKWTELANLINQCMDYEPDFRPSFRAIIRD 256 (258)
T ss_pred CCCCCcHHHHHHHHHHhccChhhCCCHHHHHHh
Confidence 11 111367888999999999998887553
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=272.13 Aligned_cols=233 Identities=26% Similarity=0.399 Sum_probs=189.7
Q ss_pred CceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCC-chHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEEEeCCCCCH
Q 018712 71 NSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ-PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSL 148 (351)
Q Consensus 71 ~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL 148 (351)
...||+|+||.||++... ++..+|+|++..... ....+.+|+.+++.++|+||+++++.+...+..+++|||+++++|
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 104 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL 104 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence 356999999999999874 789999998864332 345688899999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccccCCCccccc
Q 018712 149 HDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAA 228 (351)
Q Consensus 149 ~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~ 228 (351)
.+++.... +++..+..++.|++.||.|||+.| ++||||+|+||++++++.++|+|||++........
T Consensus 105 ~~~~~~~~----------~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~ 171 (292)
T cd06657 105 TDIVTHTR----------MNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP 171 (292)
T ss_pred HHHHhcCC----------CCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceecccccc
Confidence 99886532 788999999999999999999999 99999999999999999999999998876543221
Q ss_pred cccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccchhhc----------ccCCCccc
Q 018712 229 RLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWA----------TPKLSEDK 298 (351)
Q Consensus 229 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~~~~----------~~~~~~~~ 298 (351)
. .....|++.|+|||.+.+..++.++|+||+|+++|+|++|+.||...........+... .+....+.
T Consensus 172 ~--~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 249 (292)
T cd06657 172 R--RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGF 249 (292)
T ss_pred c--ccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCcccCCcccCCHHHHHH
Confidence 1 13346889999999998888899999999999999999999999764332111111110 11112356
Q ss_pred hhhhcccccCCCCCHHHHHH
Q 018712 299 VKQCVDTKLGGEYPPKAIAK 318 (351)
Q Consensus 299 ~~~~ld~~~~~~~~~~~~~~ 318 (351)
+.+|++.+|.+|++.+++..
T Consensus 250 i~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 250 LDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred HHHHHhCCcccCcCHHHHhc
Confidence 88999999999998887544
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=266.96 Aligned_cols=248 Identities=21% Similarity=0.299 Sum_probs=190.6
Q ss_pred CCCCceeccCCcEEEEEEEEC----CCCEEEEEEcCCCCCc---hHHHHHHHHHHHhccCCceeeeEEEEecCC------
Q 018712 68 FGTNSLIGEGSYGRVYFGVLR----SGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVDGP------ 134 (351)
Q Consensus 68 y~~~~~Lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------ 134 (351)
|.+.+.||+|+||.||+|... ++..+|+|++...... .+.+.+|++++++++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 667889999999999999853 4688999998764332 345788999999999999999999876432
Q ss_pred ceEEEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEE
Q 018712 135 LRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKI 214 (351)
Q Consensus 135 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl 214 (351)
..+++++|+.+|+|.+++....... ....++...+..++.|++.||+|||+.+ ++||||||+||++++++.+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~---~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl 154 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGE---EPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCV 154 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccC---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEE
Confidence 2478899999999998875432110 0123788899999999999999999999 999999999999999999999
Q ss_pred ecccccCCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCCccchhh----
Q 018712 215 SDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTW---- 289 (351)
Q Consensus 215 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~Pf~~~~~~~~~~~~~~---- 289 (351)
+|||+++...............+++.|++||.+.+..++.++||||||+++|+|++ |+.||...........+..
T Consensus 155 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~ 234 (273)
T cd05074 155 ADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRL 234 (273)
T ss_pred CcccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCcC
Confidence 99999886643322111223345678999999998889999999999999999999 8999976543221111110
Q ss_pred ----cccCCCccchhhhcccccCCCCCHHHHHHHHH
Q 018712 290 ----ATPKLSEDKVKQCVDTKLGGEYPPKAIAKVRK 321 (351)
Q Consensus 290 ----~~~~~~~~~~~~~ld~~~~~~~~~~~~~~~~~ 321 (351)
..+....+.+.+|+...|..|++..++...++
T Consensus 235 ~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~ 270 (273)
T cd05074 235 KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLE 270 (273)
T ss_pred CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 01112236788899999999999888877654
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-36 Score=265.57 Aligned_cols=236 Identities=23% Similarity=0.250 Sum_probs=183.8
Q ss_pred HHHHHHhcCCCCCcee--ccCCcEEEEEEEEC-CCCEEEEEEcCCCCCchHHHHHHHHHHHhc-cCCceeeeEEEEecCC
Q 018712 59 DELKEKTDNFGTNSLI--GEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRL-KNENVVELVGYYVDGP 134 (351)
Q Consensus 59 ~~~~~~~~~y~~~~~L--g~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~ 134 (351)
.+.....++|.+.+.+ |+|+||.||++..+ ++..+|+|.+........ |+.....+ +|+||+++++.+...+
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~----e~~~~~~~~~h~~iv~~~~~~~~~~ 82 (267)
T PHA03390 7 SELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI----EPMVHQLMKDNPNFIKLYYSVTTLK 82 (267)
T ss_pred HHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh----hHHHHHHhhcCCCEEEEEEEEecCC
Confidence 4455566788887776 99999999999964 788999999865432221 22222222 7999999999999999
Q ss_pred ceEEEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCC-ceE
Q 018712 135 LRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD-IAK 213 (351)
Q Consensus 135 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~-~vk 213 (351)
..++||||+++++|.+++..... +++..+..++.|++.||.|||+.+ ++||||||+||+++.++ .++
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~~~~---------l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~ 150 (267)
T PHA03390 83 GHVLIMDYIKDGDLFDLLKKEGK---------LSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIY 150 (267)
T ss_pred eeEEEEEcCCCCcHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEE
Confidence 99999999999999999976542 899999999999999999999999 99999999999999998 999
Q ss_pred EecccccCCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCc--cch---h
Q 018712 214 ISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQ--SLV---T 288 (351)
Q Consensus 214 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~--~~~---~ 288 (351)
|+|||++...... ....++..|+|||++.+..++.++||||||+++|+|++|+.||......... ... .
T Consensus 151 l~dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 224 (267)
T PHA03390 151 LCDYGLCKIIGTP------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQ 224 (267)
T ss_pred EecCccceecCCC------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhc
Confidence 9999998765322 2345889999999999989999999999999999999999999854332210 000 0
Q ss_pred ---hc---ccCCCccchhhhcccccCCCCCH-HHH
Q 018712 289 ---WA---TPKLSEDKVKQCVDTKLGGEYPP-KAI 316 (351)
Q Consensus 289 ---~~---~~~~~~~~~~~~ld~~~~~~~~~-~~~ 316 (351)
.. .+....+.+..|++.+|.+|++. +++
T Consensus 225 ~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~ 259 (267)
T PHA03390 225 KKLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEI 259 (267)
T ss_pred ccCCcccccCHHHHHHHHHHhccChhhCCchHHHH
Confidence 00 11111256778888888888743 443
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=284.08 Aligned_cols=271 Identities=25% Similarity=0.345 Sum_probs=226.0
Q ss_pred HHHHHhcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCCchHHHHHHHHHHHhccCCceeeeEEEEecCCceEE
Q 018712 60 ELKEKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVL 138 (351)
Q Consensus 60 ~~~~~~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 138 (351)
.......+.....+||-|-||.||.|.++ -.-.||||.++.+...-++|+.|..+|+.++|||+|++++.|..+..+||
T Consensus 261 kWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYI 340 (1157)
T KOG4278|consen 261 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYI 340 (1157)
T ss_pred hhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEE
Confidence 33334445666778999999999999986 46789999998888788899999999999999999999999999999999
Q ss_pred EEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEeccc
Q 018712 139 AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFD 218 (351)
Q Consensus 139 v~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg 218 (351)
|.|||..|+|.+||++..... ++....+.++.||..|+.||..++ +|||||...|+|+.++..||++|||
T Consensus 341 iTEfM~yGNLLdYLRecnr~e-------v~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFG 410 (1157)
T KOG4278|consen 341 ITEFMCYGNLLDYLRECNRSE-------VPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFG 410 (1157)
T ss_pred EEecccCccHHHHHHHhchhh-------cchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccc
Confidence 999999999999999876533 667778899999999999999999 9999999999999999999999999
Q ss_pred ccCCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCCccchhhc-------
Q 018712 219 LSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWA------- 290 (351)
Q Consensus 219 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~Pf~~~~~~~~~~~~~~~------- 290 (351)
+++.........+ ....-.+.|.|||.+....++.++|||+|||+|||+.| |..||.+..-.....++...
T Consensus 411 LsRlMtgDTYTAH-AGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgyRM~~Pe 489 (1157)
T KOG4278|consen 411 LSRLMTGDTYTAH-AGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGYRMDGPE 489 (1157)
T ss_pred hhhhhcCCceecc-cCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhccccccCCC
Confidence 9988765443222 11223678999999999999999999999999999998 99999876543333333322
Q ss_pred -ccCCCccchhhhcccccCCCCCHHHHHHHHHHHHHhhhhccccchhhhhcc
Q 018712 291 -TPKLSEDKVKQCVDTKLGGEYPPKAIAKVRKKKFITSECSNISFAEFNINW 341 (351)
Q Consensus 291 -~~~~~~~~~~~~ld~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 341 (351)
.|...-++++.|+...|..|+...++...++.+|......+.--++++.+.
T Consensus 490 GCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~sSisdEV~keLgk~~ 541 (1157)
T KOG4278|consen 490 GCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSSSSISDEVQKELGKNN 541 (1157)
T ss_pred CCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhccccccHHHHHHHhhcc
Confidence 222223789999999999999999999999999988777766666776653
|
|
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-36 Score=269.03 Aligned_cols=200 Identities=22% Similarity=0.346 Sum_probs=167.2
Q ss_pred cCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCC---chHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEEE
Q 018712 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ---PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYE 141 (351)
Q Consensus 66 ~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 141 (351)
++|++.+.||+|++|.||+|... +++.||+|.+..... ....+.+|++++++++|+||+++++++.+.+..++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 57899999999999999999975 788999999865432 23567889999999999999999999999999999999
Q ss_pred eCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEcc-CCceEEeccccc
Q 018712 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFD-DDIAKISDFDLS 220 (351)
Q Consensus 142 ~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~-~~~vkl~Dfg~a 220 (351)
|+.+ +|.+++...... .++...+..++.||+.||.|||+++ ++|+||+|+||+++. ++.+||+|||++
T Consensus 82 ~~~~-~l~~~~~~~~~~-------~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~ 150 (294)
T PLN00009 82 YLDL-DLKKHMDSSPDF-------AKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLA 150 (294)
T ss_pred cccc-cHHHHHHhCCCC-------CcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccc
Confidence 9964 888887654321 2577888899999999999999999 999999999999985 557999999998
Q ss_pred CCCccccccccccccccccCccCcccccCC-CCCccchhHhHHHHHHHHHcCCCCCCCC
Q 018712 221 NQAPDAAARLHSTRVLGTFGYHAPEYAMTG-QMSSKSDVYSFGVVLLELLTGRKPVDHT 278 (351)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~Pf~~~ 278 (351)
......... .....+++.|+|||.+.+. .++.++||||||+++|+|++|+.||...
T Consensus 151 ~~~~~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~ 207 (294)
T PLN00009 151 RAFGIPVRT--FTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGD 207 (294)
T ss_pred cccCCCccc--cccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 765432111 1234578899999988664 5789999999999999999999999754
|
|
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=272.52 Aligned_cols=205 Identities=23% Similarity=0.372 Sum_probs=168.5
Q ss_pred HHhcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCC---chHHHHHHHHHHHhccCCceeeeEEEEecCC----
Q 018712 63 EKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ---PDQEFLAQVSMVSRLKNENVVELVGYYVDGP---- 134 (351)
Q Consensus 63 ~~~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~---- 134 (351)
...++|++.+.||+|+||.||+|... +++.||+|.+..... ....+.+|++++++++||||+++++++...+
T Consensus 9 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (310)
T cd07865 9 DEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYN 88 (310)
T ss_pred chhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEeccccccc
Confidence 34568999999999999999999975 689999998864322 2334678999999999999999999876543
Q ss_pred ----ceEEEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCC
Q 018712 135 ----LRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD 210 (351)
Q Consensus 135 ----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~ 210 (351)
..++||||+.+ +|.+++..... .+++.+++.++.||+.||.|||+++ ++|+||||+||+++.++
T Consensus 89 ~~~~~~~lv~e~~~~-~l~~~l~~~~~--------~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~ 156 (310)
T cd07865 89 RYKGSFYLVFEFCEH-DLAGLLSNKNV--------KFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDG 156 (310)
T ss_pred CCCceEEEEEcCCCc-CHHHHHHhccc--------CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCC
Confidence 45999999975 88888865431 2889999999999999999999999 99999999999999999
Q ss_pred ceEEecccccCCCcccccc--ccccccccccCccCcccccCC-CCCccchhHhHHHHHHHHHcCCCCCCCCC
Q 018712 211 IAKISDFDLSNQAPDAAAR--LHSTRVLGTFGYHAPEYAMTG-QMSSKSDVYSFGVVLLELLTGRKPVDHTL 279 (351)
Q Consensus 211 ~vkl~Dfg~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~Pf~~~~ 279 (351)
.+||+|||++......... .......++..|+|||.+.+. .++.++||||||+++|+|++|+.||....
T Consensus 157 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~ 228 (310)
T cd07865 157 ILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNT 228 (310)
T ss_pred cEEECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCC
Confidence 9999999998765432211 111234578899999988664 46889999999999999999999997654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=268.52 Aligned_cols=201 Identities=25% Similarity=0.395 Sum_probs=170.5
Q ss_pred CCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCC--chHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEEEeC
Q 018712 67 NFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ--PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHA 143 (351)
Q Consensus 67 ~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 143 (351)
+|++.+.||.|++|.||+|.+. ++..||+|.+..... ....+.+|+.++++++|+||+++++++.+.+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 5888999999999999999975 688999999875432 2456778999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccccCCC
Q 018712 144 SKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQA 223 (351)
Q Consensus 144 ~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~ 223 (351)
.+ +|.+++...... ..+++..+..++.|++.||.|||+.+ ++||||||+||++++++.++|+|||++...
T Consensus 81 ~~-~l~~~~~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~ 150 (284)
T cd07836 81 DK-DLKKYMDTHGVR------GALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAF 150 (284)
T ss_pred Cc-cHHHHHHhcCCC------CCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhh
Confidence 86 898888654321 13889999999999999999999999 999999999999999999999999998755
Q ss_pred ccccccccccccccccCccCcccccCC-CCCccchhHhHHHHHHHHHcCCCCCCCCC
Q 018712 224 PDAAARLHSTRVLGTFGYHAPEYAMTG-QMSSKSDVYSFGVVLLELLTGRKPVDHTL 279 (351)
Q Consensus 224 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~Pf~~~~ 279 (351)
...... .....++..|+|||.+.+. .++.++||||||+++|+|++|+.||....
T Consensus 151 ~~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~ 205 (284)
T cd07836 151 GIPVNT--FSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTN 205 (284)
T ss_pred cCCccc--cccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 332111 1234578899999988654 56889999999999999999999998654
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=243.80 Aligned_cols=211 Identities=22% Similarity=0.338 Sum_probs=177.6
Q ss_pred cCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCCc---hHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEEE
Q 018712 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYE 141 (351)
Q Consensus 66 ~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 141 (351)
.+|.-.++||+|.||+||+|+.+ +++.||+|.++.+... .....+|+-+++.++|.|||++++....++.+.+|+|
T Consensus 2 ~~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe 81 (292)
T KOG0662|consen 2 QKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_pred cchHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHH
Confidence 35666788999999999999965 7899999998755433 4678999999999999999999999999999999999
Q ss_pred eCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccccC
Q 018712 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (351)
Q Consensus 142 ~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~ 221 (351)
||.. +|..+...... .+....++.++.|++.||.++|+++ +.||||||.|+||+.+|.+||+|||+++
T Consensus 82 ~cdq-dlkkyfdslng--------~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglar 149 (292)
T KOG0662|consen 82 FCDQ-DLKKYFDSLNG--------DLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLAR 149 (292)
T ss_pred HhhH-HHHHHHHhcCC--------cCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhh
Confidence 9966 99999877654 2888999999999999999999999 9999999999999999999999999998
Q ss_pred CCccccccccccccccccCccCcccccCC-CCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCCccchhhc
Q 018712 222 QAPDAAARLHSTRVLGTFGYHAPEYAMTG-QMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWA 290 (351)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~t-g~~Pf~~~~~~~~~~~~~~~ 290 (351)
...-..... +..+-|..|.+|.++.+. -|+...|+||.|||+.|+.. |++-|.+.+-.++...+-+.
T Consensus 150 afgipvrcy--saevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~ 218 (292)
T KOG0662|consen 150 AFGIPVRCY--SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRL 218 (292)
T ss_pred hcCCceEee--eceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHH
Confidence 876544332 233568999999998875 57999999999999999997 77777776544444444333
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=274.22 Aligned_cols=202 Identities=31% Similarity=0.413 Sum_probs=169.0
Q ss_pred HhcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCCc---hHHHHHHHHHHHhccCCceeeeEEEEecC--CceE
Q 018712 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVDG--PLRV 137 (351)
Q Consensus 64 ~~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~ 137 (351)
..++|++.+.||.|+||.||+|.+. ++..||+|.+...... ...+.+|+.++++++|+||+++++++.+. +..+
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIF 84 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEE
Confidence 3468999999999999999999975 6899999998643221 23466899999999999999999998755 4689
Q ss_pred EEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecc
Q 018712 138 LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDF 217 (351)
Q Consensus 138 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Df 217 (351)
+||||+.+ +|.+++..... .+++..+..++.||+.||.|||+.+ ++||||||+||++++++.+||+||
T Consensus 85 lv~e~~~~-~l~~~l~~~~~--------~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~df 152 (309)
T cd07845 85 LVMEYCEQ-DLASLLDNMPT--------PFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADF 152 (309)
T ss_pred EEEecCCC-CHHHHHHhccc--------CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcc
Confidence 99999975 89888875431 2889999999999999999999999 999999999999999999999999
Q ss_pred cccCCCccccccccccccccccCccCcccccC-CCCCccchhHhHHHHHHHHHcCCCCCCCCC
Q 018712 218 DLSNQAPDAAARLHSTRVLGTFGYHAPEYAMT-GQMSSKSDVYSFGVVLLELLTGRKPVDHTL 279 (351)
Q Consensus 218 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~Pf~~~~ 279 (351)
|++......... .....+++.|+|||.+.+ ..++.++||||||+++|+|++|+.||....
T Consensus 153 g~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~ 213 (309)
T cd07845 153 GLARTYGLPAKP--MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKS 213 (309)
T ss_pred ceeeecCCccCC--CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 998776433211 122345788999998865 457899999999999999999999997554
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-36 Score=264.21 Aligned_cols=201 Identities=24% Similarity=0.377 Sum_probs=170.5
Q ss_pred cCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCC------CchHHHHHHHHHHHhccCCceeeeEEEEecC--Cce
Q 018712 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK------QPDQEFLAQVSMVSRLKNENVVELVGYYVDG--PLR 136 (351)
Q Consensus 66 ~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~------~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~ 136 (351)
.+|.+.+.||+|+||.||+|.+. ++..+|+|.+.... .....+.+|++++++++|+||+++++.+.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 47899999999999999999964 68999999875321 1224678899999999999999999988654 468
Q ss_pred EEEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEec
Q 018712 137 VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISD 216 (351)
Q Consensus 137 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~D 216 (351)
++++||+++++|.+++..... +++..+..++.|++.||.|||+++ ++|+||||+||+++.++.++|+|
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~~---------l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~d 149 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYGA---------LTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGD 149 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECc
Confidence 899999999999999975432 788889999999999999999999 99999999999999999999999
Q ss_pred ccccCCCccccc-cccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCC
Q 018712 217 FDLSNQAPDAAA-RLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHT 278 (351)
Q Consensus 217 fg~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~ 278 (351)
||+++....... ........|+..|+|||++.+..++.++|+||||+++|+|++|+.||...
T Consensus 150 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 212 (264)
T cd06653 150 FGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEY 212 (264)
T ss_pred cccccccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCcc
Confidence 999876532111 11112346889999999999888999999999999999999999999754
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-36 Score=262.20 Aligned_cols=239 Identities=24% Similarity=0.364 Sum_probs=195.5
Q ss_pred CCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCC---chHHHHHHHHHHHhccCCceeeeEEEEecC--CceEEEE
Q 018712 67 NFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ---PDQEFLAQVSMVSRLKNENVVELVGYYVDG--PLRVLAY 140 (351)
Q Consensus 67 ~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~lv~ 140 (351)
+|...+.||+|++|.||+|... +++.+++|++..... ..+.+.+|+.++++++|+||+++++.+.+. ...++++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4778899999999999999976 789999999876542 356788999999999999999999999888 8899999
Q ss_pred EeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEeccccc
Q 018712 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (351)
Q Consensus 141 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a 220 (351)
|++.+++|.+++..... +++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||.+
T Consensus 81 e~~~~~~L~~~~~~~~~---------~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~ 148 (260)
T cd06606 81 EYVSGGSLSSLLKKFGK---------LPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCA 148 (260)
T ss_pred EecCCCcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccE
Confidence 99999999999986542 899999999999999999999999 999999999999999999999999998
Q ss_pred CCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCC----------ccchhhc
Q 018712 221 NQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQ----------QSLVTWA 290 (351)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~----------~~~~~~~ 290 (351)
................++..|+|||.+.+...+.++||||||+++|+|++|..||........ ...+...
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (260)
T cd06606 149 KRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEH 228 (260)
T ss_pred EecccccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCCcCCCcc
Confidence 776544321112345688899999999888899999999999999999999999986541100 0001111
Q ss_pred ccCCCccchhhhcccccCCCCCHHHHH
Q 018712 291 TPKLSEDKVKQCVDTKLGGEYPPKAIA 317 (351)
Q Consensus 291 ~~~~~~~~~~~~ld~~~~~~~~~~~~~ 317 (351)
.+....+.+..|+..++.+|++..++.
T Consensus 229 ~~~~l~~~i~~~l~~~p~~Rp~~~~ll 255 (260)
T cd06606 229 LSEEAKDFLRKCLRRDPKKRPTADELL 255 (260)
T ss_pred cCHHHHHHHHHhCcCChhhCCCHHHHh
Confidence 122233667788888888888777654
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=269.75 Aligned_cols=200 Identities=27% Similarity=0.397 Sum_probs=170.0
Q ss_pred hcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCCc---hHHHHHHHHHHHhccCCceeeeEEEEecC--CceEE
Q 018712 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVDG--PLRVL 138 (351)
Q Consensus 65 ~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~l 138 (351)
.++|++.+.||+|+||.||+|... +++.+++|.++..... ...+.+|+.++++++||||+++++++... +..|+
T Consensus 4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~l 83 (293)
T cd07843 4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYM 83 (293)
T ss_pred hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEE
Confidence 357999999999999999999976 6889999998654322 23467899999999999999999998777 88999
Q ss_pred EEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEeccc
Q 018712 139 AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFD 218 (351)
Q Consensus 139 v~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg 218 (351)
||||+.+ +|.+++..... .+++..++.++.|++.||.|||+++ ++|+||||+||++++++.+||+|||
T Consensus 84 v~e~~~~-~L~~~~~~~~~--------~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g 151 (293)
T cd07843 84 VMEYVEH-DLKSLMETMKQ--------PFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFG 151 (293)
T ss_pred EehhcCc-CHHHHHHhccC--------CCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecC
Confidence 9999975 99999876432 2899999999999999999999999 9999999999999999999999999
Q ss_pred ccCCCccccccccccccccccCccCcccccCC-CCCccchhHhHHHHHHHHHcCCCCCCCC
Q 018712 219 LSNQAPDAAARLHSTRVLGTFGYHAPEYAMTG-QMSSKSDVYSFGVVLLELLTGRKPVDHT 278 (351)
Q Consensus 219 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~Pf~~~ 278 (351)
++......... .....+++.|+|||.+.+. .++.++|+||||+++|+|++|+.||...
T Consensus 152 ~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~ 210 (293)
T cd07843 152 LAREYGSPLKP--YTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGK 210 (293)
T ss_pred ceeeccCCccc--cccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 98876543211 1334578899999988754 4688999999999999999999999754
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=265.99 Aligned_cols=243 Identities=21% Similarity=0.343 Sum_probs=191.2
Q ss_pred CCCCCceeccCCcEEEEEEEECC--CCEEEEEEcCCCC-----------CchHHHHHHHHHHHh-ccCCceeeeEEEEec
Q 018712 67 NFGTNSLIGEGSYGRVYFGVLRS--GRAAAIKKLDSSK-----------QPDQEFLAQVSMVSR-LKNENVVELVGYYVD 132 (351)
Q Consensus 67 ~y~~~~~Lg~G~~g~Vy~~~~~~--~~~vavK~~~~~~-----------~~~~~~~~e~~~l~~-l~h~niv~~~~~~~~ 132 (351)
+|++.+.||+|+||.||++.... ++.+|+|.+.... .....+.+|+.++.+ ++|+||+++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 48888999999999999999754 7889999875321 112346678887765 799999999999999
Q ss_pred CCceEEEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhh-CCCCCeeeccccCCcEEEccCCc
Q 018712 133 GPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHE-KAEPRIIHRNIKSSNVLLFDDDI 211 (351)
Q Consensus 133 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~-~~~~~ivH~Dlkp~Nill~~~~~ 211 (351)
.+..+++|||+++++|.+++...... ...++...++.++.|++.||.|||+ .+ ++|+||+|+||++++++.
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~-----~~~~~~~~~~~~~~~l~~~l~~lh~~~~---i~H~dl~~~nil~~~~~~ 152 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEK-----KQRFTEERIWNIFVQMVLALRYLHKEKR---IVHRDLTPNNIMLGEDDK 152 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHhccCCc---eeecCCCHHHEEECCCCc
Confidence 99999999999999999988542211 1238889999999999999999996 66 999999999999999999
Q ss_pred eEEecccccCCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccchh-h-
Q 018712 212 AKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVT-W- 289 (351)
Q Consensus 212 vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~~-~- 289 (351)
+||+|||.+....... ......|+..|+|||.+.+..++.++|+||||+++|+|++|+.||...........+. .
T Consensus 153 ~~l~dfg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~ 229 (269)
T cd08528 153 VTITDFGLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAV 229 (269)
T ss_pred EEEecccceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhcc
Confidence 9999999987654432 1234568899999999998889999999999999999999999997643221110000 0
Q ss_pred -------cccCCCccchhhhcccccCCCCCHHHHHHHH
Q 018712 290 -------ATPKLSEDKVKQCVDTKLGGEYPPKAIAKVR 320 (351)
Q Consensus 290 -------~~~~~~~~~~~~~ld~~~~~~~~~~~~~~~~ 320 (351)
..+....+.+.+|+..+|.+|++..++...+
T Consensus 230 ~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~ 267 (269)
T cd08528 230 YEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMI 267 (269)
T ss_pred CCcCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHh
Confidence 1111223577889999999999988876654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=260.37 Aligned_cols=237 Identities=28% Similarity=0.447 Sum_probs=195.8
Q ss_pred CCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCC-chHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEEEeCC
Q 018712 67 NFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ-PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHAS 144 (351)
Q Consensus 67 ~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 144 (351)
+|...+.||+|++|.||++... ++..+++|++..... ....+.+|+.++++++|+|++++++.+......++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 4788899999999999999975 788999999876553 45678899999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccccCCCc
Q 018712 145 KGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAP 224 (351)
Q Consensus 145 ~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~ 224 (351)
+++|.+++..... .+++..+..++.|++.||.+||+.+ ++||||+|+||++++++.++|+|||.+....
T Consensus 81 ~~~L~~~~~~~~~--------~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~ 149 (253)
T cd05122 81 GGSLKDLLKSTNQ--------TLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLS 149 (253)
T ss_pred CCcHHHHHhhcCC--------CCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccc
Confidence 9999999977531 2899999999999999999999998 9999999999999999999999999987765
Q ss_pred cccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccch--------hhcc--cCC
Q 018712 225 DAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLV--------TWAT--PKL 294 (351)
Q Consensus 225 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~--------~~~~--~~~ 294 (351)
.... .....++..|+|||.+.+..++.++|+||||+++|+|++|+.||............ .... +..
T Consensus 150 ~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (253)
T cd05122 150 DTKA---RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDE 226 (253)
T ss_pred cccc---ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcCCCCcCcccccCHH
Confidence 4322 23456889999999998888999999999999999999999999765321111000 0000 122
Q ss_pred CccchhhhcccccCCCCCHHHHH
Q 018712 295 SEDKVKQCVDTKLGGEYPPKAIA 317 (351)
Q Consensus 295 ~~~~~~~~ld~~~~~~~~~~~~~ 317 (351)
..+.+..|++.++.+|++..++.
T Consensus 227 ~~~~i~~~l~~~p~~R~t~~~~l 249 (253)
T cd05122 227 FKDFLKKCLQKNPEKRPTAEQLL 249 (253)
T ss_pred HHHHHHHHccCChhhCCCHHHHh
Confidence 24677888888888888877654
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-36 Score=269.85 Aligned_cols=235 Identities=29% Similarity=0.401 Sum_probs=188.9
Q ss_pred cCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCC----chHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEE
Q 018712 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ----PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAY 140 (351)
Q Consensus 66 ~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 140 (351)
+.|.+.+.||+|+||.||+|... +++.||+|.+..... ..+.+.+|+++++.++||||+++++++.+.+..++|+
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 56899999999999999999965 689999998864322 1245788999999999999999999999999999999
Q ss_pred EeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEeccccc
Q 018712 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (351)
Q Consensus 141 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a 220 (351)
||+.+ +|.+++..... .+++..+..++.|++.||.|||+.+ ++||||+|+||++++++.++|+|||++
T Consensus 95 e~~~g-~l~~~~~~~~~--------~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~ 162 (307)
T cd06607 95 EYCLG-SASDILEVHKK--------PLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSA 162 (307)
T ss_pred HhhCC-CHHHHHHHccc--------CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcc
Confidence 99974 88777754332 2889999999999999999999999 999999999999999999999999988
Q ss_pred CCCccccccccccccccccCccCccccc---CCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccchh---------
Q 018712 221 NQAPDAAARLHSTRVLGTFGYHAPEYAM---TGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVT--------- 288 (351)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~~--------- 288 (351)
...... ....++..|+|||++. ...++.++||||||+++|+|++|+.||...........+.
T Consensus 163 ~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 236 (307)
T cd06607 163 SLVSPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSS 236 (307)
T ss_pred eecCCC------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCc
Confidence 654322 2345788999999874 4567889999999999999999999997643221110000
Q ss_pred hcccCCCccchhhhcccccCCCCCHHHHHH
Q 018712 289 WATPKLSEDKVKQCVDTKLGGEYPPKAIAK 318 (351)
Q Consensus 289 ~~~~~~~~~~~~~~ld~~~~~~~~~~~~~~ 318 (351)
...+....+.+.+|+..+|.+|++.+++..
T Consensus 237 ~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 266 (307)
T cd06607 237 NDWSDYFRNFVDSCLQKIPQDRPSSEELLK 266 (307)
T ss_pred hhhCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 011112246788999999999998777754
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-36 Score=267.62 Aligned_cols=199 Identities=23% Similarity=0.351 Sum_probs=168.9
Q ss_pred CCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCC---chHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEEEeC
Q 018712 68 FGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ---PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHA 143 (351)
Q Consensus 68 y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 143 (351)
|++.+.||.|++|.||+|... +|..||+|++..... ....+.+|+++++.++|+|++++++++.+.+..+++|||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 677889999999999999965 799999999865432 2356788999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccccCCC
Q 018712 144 SKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQA 223 (351)
Q Consensus 144 ~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~ 223 (351)
. ++|.+++..... ..+++..+..++.|++.||.|||+++ ++||||+|+||++++++.++|+|||++...
T Consensus 81 ~-~~l~~~~~~~~~-------~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~ 149 (283)
T cd07835 81 D-LDLKKYMDSSPL-------TGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAF 149 (283)
T ss_pred C-cCHHHHHhhCCC-------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeeccccccc
Confidence 5 599999876542 12889999999999999999999998 999999999999999999999999998765
Q ss_pred ccccccccccccccccCccCcccccCC-CCCccchhHhHHHHHHHHHcCCCCCCCCC
Q 018712 224 PDAAARLHSTRVLGTFGYHAPEYAMTG-QMSSKSDVYSFGVVLLELLTGRKPVDHTL 279 (351)
Q Consensus 224 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~Pf~~~~ 279 (351)
...... .....++..|+|||++.+. .++.++|+||||+++|+|++|+.||....
T Consensus 150 ~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 204 (283)
T cd07835 150 GVPVRT--YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDS 204 (283)
T ss_pred CCCccc--cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 322211 1223568899999987654 56889999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-36 Score=266.80 Aligned_cols=196 Identities=26% Similarity=0.388 Sum_probs=163.9
Q ss_pred CCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCC--chHHHHHHHHHHHhcc-CCceeeeEEEEecC--CceEEEEE
Q 018712 68 FGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ--PDQEFLAQVSMVSRLK-NENVVELVGYYVDG--PLRVLAYE 141 (351)
Q Consensus 68 y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~--~~~~lv~e 141 (351)
|++.+.||+|+||.||+|... ++..+|+|++..... ......+|+.+++++. |+||+++++++.+. +..++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 677889999999999999965 688999999875432 2234557888888885 99999999999877 88999999
Q ss_pred eCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccccC
Q 018712 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (351)
Q Consensus 142 ~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~ 221 (351)
|+.+ +|.+++..... .+++..+..++.|++.||.|||+.+ ++||||+|+||++++ +.+||+|||++.
T Consensus 81 ~~~~-~l~~~l~~~~~--------~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~ 147 (282)
T cd07831 81 LMDM-NLYELIKGRKR--------PLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCR 147 (282)
T ss_pred cCCc-cHHHHHHhccC--------CCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEeccccc
Confidence 9975 88888865432 2899999999999999999999999 999999999999999 999999999987
Q ss_pred CCccccccccccccccccCccCccccc-CCCCCccchhHhHHHHHHHHHcCCCCCCCCC
Q 018712 222 QAPDAAARLHSTRVLGTFGYHAPEYAM-TGQMSSKSDVYSFGVVLLELLTGRKPVDHTL 279 (351)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~il~el~tg~~Pf~~~~ 279 (351)
........ ....++..|+|||.+. +..++.++|||||||++|||++|+.||...+
T Consensus 148 ~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~ 203 (282)
T cd07831 148 GIYSKPPY---TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTN 203 (282)
T ss_pred ccccCCCc---CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCC
Confidence 66433221 2345788999999765 4557889999999999999999999997643
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-36 Score=268.67 Aligned_cols=203 Identities=23% Similarity=0.333 Sum_probs=167.1
Q ss_pred cCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCC---chHHHHHHHHHHHhcc-CCceeeeEEEEecCCc-----
Q 018712 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ---PDQEFLAQVSMVSRLK-NENVVELVGYYVDGPL----- 135 (351)
Q Consensus 66 ~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~----- 135 (351)
++|++.+.||+|+||.||+|.+. +++.||+|.+..... ....+.+|+.+++.+. |+||+++++.+...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 46899999999999999999965 689999998765432 2356788999999995 6999999998876655
Q ss_pred eEEEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEcc-CCceEE
Q 018712 136 RVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFD-DDIAKI 214 (351)
Q Consensus 136 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~-~~~vkl 214 (351)
.|++|||+.+ +|.+++...... ....+++..++.++.||+.||.|||+++ ++||||+|+||+++. ++.+||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~----~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl 152 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRG----PGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKI 152 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhccc----CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEE
Confidence 8999999986 898888654321 1123789999999999999999999999 999999999999998 889999
Q ss_pred ecccccCCCccccccccccccccccCccCcccccC-CCCCccchhHhHHHHHHHHHcCCCCCCCC
Q 018712 215 SDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMT-GQMSSKSDVYSFGVVLLELLTGRKPVDHT 278 (351)
Q Consensus 215 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~Pf~~~ 278 (351)
+|||++......... .....+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||...
T Consensus 153 ~dfg~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~ 215 (295)
T cd07837 153 ADLGLGRAFSIPVKS--YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGD 215 (295)
T ss_pred eecccceecCCCccc--cCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Confidence 999998765332111 122346888999998865 45789999999999999999999999754
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=265.21 Aligned_cols=239 Identities=23% Similarity=0.382 Sum_probs=190.5
Q ss_pred CCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCC---CchHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEEEe
Q 018712 67 NFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK---QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEH 142 (351)
Q Consensus 67 ~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 142 (351)
+|.+.+.||+|+||.||++..+ ++..+|+|.+.... .....+.+|+++++.++|+||+++++.+...+..++++||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 5788899999999999999975 68899999986532 2345678999999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCC-ceEEecccccC
Q 018712 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD-IAKISDFDLSN 221 (351)
Q Consensus 143 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~-~vkl~Dfg~a~ 221 (351)
+++++|.+++..... ..+++..+..++.|++.||.|||+.+ ++|+||||+||++++++ .+||+|||.+.
T Consensus 81 ~~~~~L~~~~~~~~~-------~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~ 150 (257)
T cd08225 81 CDGGDLMKRINRQRG-------VLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIAR 150 (257)
T ss_pred CCCCcHHHHHHhccC-------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccch
Confidence 999999999976432 12789999999999999999999999 99999999999998886 56999999987
Q ss_pred CCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccch-h----hcc---cC
Q 018712 222 QAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLV-T----WAT---PK 293 (351)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~-~----~~~---~~ 293 (351)
........ .....|++.|+|||++.+..++.++|+||||+++|+|++|..||...........+ . ... +.
T Consensus 151 ~~~~~~~~--~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (257)
T cd08225 151 QLNDSMEL--AYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISPNFSR 228 (257)
T ss_pred hccCCccc--ccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcccCCCCCCCCCH
Confidence 66433211 12345888999999998888999999999999999999999999754322111100 0 011 11
Q ss_pred CCccchhhhcccccCCCCCHHHHH
Q 018712 294 LSEDKVKQCVDTKLGGEYPPKAIA 317 (351)
Q Consensus 294 ~~~~~~~~~ld~~~~~~~~~~~~~ 317 (351)
...+.+.+|+..+|.+|++..++.
T Consensus 229 ~~~~~i~~~l~~~p~~Rpt~~~ll 252 (257)
T cd08225 229 DLRSLISQLFKVSPRDRPSITSIL 252 (257)
T ss_pred HHHHHHHHHhccChhhCcCHHHHh
Confidence 123556778888888888776654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=268.45 Aligned_cols=239 Identities=25% Similarity=0.350 Sum_probs=188.5
Q ss_pred eccCCcEEEEEEEEC-CCCEEEEEEcCCCCC----chHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEEEeCCCCCH
Q 018712 74 IGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ----PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSL 148 (351)
Q Consensus 74 Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL 148 (351)
||.|+||.||++... +++.+++|.+..... ....+.+|++++++++|+||+++++.+..+...|+++||+.+++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999976 589999999865432 245688899999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccccCCCccccc
Q 018712 149 HDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAA 228 (351)
Q Consensus 149 ~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~ 228 (351)
.+++..... +++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++........
T Consensus 81 ~~~l~~~~~---------~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 148 (265)
T cd05579 81 ASLLENVGS---------LDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQ 148 (265)
T ss_pred HHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCcc
Confidence 999976542 889999999999999999999999 99999999999999999999999999876533211
Q ss_pred ------cccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccchhh---cc------cC
Q 018712 229 ------RLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTW---AT------PK 293 (351)
Q Consensus 229 ------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~~~---~~------~~ 293 (351)
........++..|+|||...+...+.++||||||+++|+|++|+.||...........+.. .. +.
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (265)
T cd05579 149 INLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDVEVSD 228 (265)
T ss_pred cccccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcCCCccccCCH
Confidence 1112345678899999999888899999999999999999999999976543221111100 00 11
Q ss_pred CCccchhhhcccccCCCCCHHHHHHHHHHHH
Q 018712 294 LSEDKVKQCVDTKLGGEYPPKAIAKVRKKKF 324 (351)
Q Consensus 294 ~~~~~~~~~ld~~~~~~~~~~~~~~~~~~~~ 324 (351)
...+.+.+|+..++.+|++...+..++.+.+
T Consensus 229 ~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~ 259 (265)
T cd05579 229 EAIDLISKLLVPDPEKRLGAKSIEEIKNHPF 259 (265)
T ss_pred HHHHHHHHHhcCCHhhcCCCccHHHHhcCcc
Confidence 2235667777777777777655555554443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=269.54 Aligned_cols=202 Identities=18% Similarity=0.200 Sum_probs=155.3
Q ss_pred hcCCCCCceeccCCcEEEEEEEECC----CCEEEEEEcCCCCCch------------HHHHHHHHHHHhccCCceeeeEE
Q 018712 65 TDNFGTNSLIGEGSYGRVYFGVLRS----GRAAAIKKLDSSKQPD------------QEFLAQVSMVSRLKNENVVELVG 128 (351)
Q Consensus 65 ~~~y~~~~~Lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~------------~~~~~e~~~l~~l~h~niv~~~~ 128 (351)
.++|.+.+.||+|+||.||+|...+ +..+|+|+........ .....++..+..+.|++++++++
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~ 90 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG 90 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence 3689999999999999999999653 4566777543222110 11122334455678999999998
Q ss_pred EEecCC----ceEEEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcE
Q 018712 129 YYVDGP----LRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNV 204 (351)
Q Consensus 129 ~~~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Ni 204 (351)
.+.... ..+++++++.. ++.+.+..... .++..+..++.|++.||.|||+.+ ++||||||+||
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~---------~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Ni 157 (294)
T PHA02882 91 CGSFKRCRMYYRFILLEKLVE-NTKEIFKRIKC---------KNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENI 157 (294)
T ss_pred eeeEecCCceEEEEEEehhcc-CHHHHHHhhcc---------CCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHE
Confidence 765433 34778887754 77777764321 567788899999999999999999 99999999999
Q ss_pred EEccCCceEEecccccCCCcccccc-----ccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCC
Q 018712 205 LLFDDDIAKISDFDLSNQAPDAAAR-----LHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTL 279 (351)
Q Consensus 205 ll~~~~~vkl~Dfg~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~ 279 (351)
|++.++.++|+|||+|+........ .......||+.|+|||+..+..++.++||||||+++|||++|+.||....
T Consensus 158 ll~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~ 237 (294)
T PHA02882 158 MVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFG 237 (294)
T ss_pred EEcCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccc
Confidence 9999999999999999765322111 11123469999999999999999999999999999999999999998763
|
|
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=276.62 Aligned_cols=200 Identities=27% Similarity=0.383 Sum_probs=167.3
Q ss_pred hcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCC--CchHHHHHHHHHHHhccCCceeeeEEEEecC-----Cce
Q 018712 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK--QPDQEFLAQVSMVSRLKNENVVELVGYYVDG-----PLR 136 (351)
Q Consensus 65 ~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~~ 136 (351)
.++|.+.+.||+|+||.||+|.+. ++..||+|.+.... .....+.+|+.++++++|+||+++++++... ...
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 468999999999999999999864 78999999986432 2345678899999999999999999876544 357
Q ss_pred EEEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEec
Q 018712 137 VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISD 216 (351)
Q Consensus 137 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~D 216 (351)
++++||+.+ +|.+++.... +++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|
T Consensus 84 ~lv~e~~~~-~l~~~~~~~~----------l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~d 149 (336)
T cd07849 84 YIVQELMET-DLYKLIKTQH----------LSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICD 149 (336)
T ss_pred EEEehhccc-CHHHHHhcCC----------CCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECc
Confidence 999999975 8888886543 889999999999999999999999 99999999999999999999999
Q ss_pred ccccCCCccccccc-cccccccccCccCcccccC-CCCCccchhHhHHHHHHHHHcCCCCCCCC
Q 018712 217 FDLSNQAPDAAARL-HSTRVLGTFGYHAPEYAMT-GQMSSKSDVYSFGVVLLELLTGRKPVDHT 278 (351)
Q Consensus 217 fg~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~Pf~~~ 278 (351)
||++.......... ......||+.|+|||.+.+ ..++.++||||||+++|+|++|+.||...
T Consensus 150 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~ 213 (336)
T cd07849 150 FGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGK 213 (336)
T ss_pred ccceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 99987654322111 1123468899999998754 56899999999999999999999999653
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=260.56 Aligned_cols=237 Identities=27% Similarity=0.428 Sum_probs=194.4
Q ss_pred CCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCC---chHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEEEe
Q 018712 67 NFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ---PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEH 142 (351)
Q Consensus 67 ~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 142 (351)
+|++.+.||+|++|.||++... +++.|++|.+..... ....+.+|++++++++|+|++++++++.+.+..+++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 5788899999999999999865 678999999876543 345688999999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccccCC
Q 018712 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222 (351)
Q Consensus 143 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~ 222 (351)
+.+++|.+++..... +++..+..++.|++.||.+||+.| ++||||+|+||+++.++.++|+|||++..
T Consensus 81 ~~~~~L~~~~~~~~~---------l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~ 148 (254)
T cd06627 81 AENGSLRQIIKKFGP---------FPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATK 148 (254)
T ss_pred CCCCcHHHHHHhccC---------CCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEecccccee
Confidence 999999999976532 889999999999999999999999 99999999999999999999999999887
Q ss_pred CccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCcc-c-------hhhcccCC
Q 018712 223 APDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQS-L-------VTWATPKL 294 (351)
Q Consensus 223 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~-~-------~~~~~~~~ 294 (351)
....... .....++..|+|||...+..++.++||||+|+++|+|++|..||....+..... . .....+..
T Consensus 149 ~~~~~~~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (254)
T cd06627 149 LNDVSKD--DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPPLPEGISPE 226 (254)
T ss_pred cCCCccc--ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccCCCCCCCCCCHH
Confidence 6543321 133568889999999988888999999999999999999999997543211110 0 00111122
Q ss_pred CccchhhhcccccCCCCCHHHHH
Q 018712 295 SEDKVKQCVDTKLGGEYPPKAIA 317 (351)
Q Consensus 295 ~~~~~~~~ld~~~~~~~~~~~~~ 317 (351)
..+.+..|+.+++.+|++..++.
T Consensus 227 ~~~~i~~~l~~~p~~R~~~~~~l 249 (254)
T cd06627 227 LKDFLMQCFQKDPNLRPTAKQLL 249 (254)
T ss_pred HHHHHHHHHhCChhhCcCHHHHh
Confidence 23567888888888888876654
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=269.48 Aligned_cols=206 Identities=26% Similarity=0.410 Sum_probs=169.9
Q ss_pred CCCCCceeccCCcEEEEEEEEC---CCCEEEEEEcCCCC----CchHHHHHHHHHHHhccCCceeeeEEEEecC--CceE
Q 018712 67 NFGTNSLIGEGSYGRVYFGVLR---SGRAAAIKKLDSSK----QPDQEFLAQVSMVSRLKNENVVELVGYYVDG--PLRV 137 (351)
Q Consensus 67 ~y~~~~~Lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~ 137 (351)
+|.+.+.||+|+||.||+|... ++..||+|.+.... .....+.+|+.+++.++||||+++++++.+. ...+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 4788899999999999999975 47899999987632 2235678899999999999999999999988 7899
Q ss_pred EEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEcc----CCceE
Q 018712 138 LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFD----DDIAK 213 (351)
Q Consensus 138 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~----~~~vk 213 (351)
+||||+.+ +|.+++....... ...++...+..++.|++.||.|||+.+ ++||||||+||+++. ++.+|
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~k 152 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAK----RVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVK 152 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCC----CcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEE
Confidence 99999975 7777775433211 123788999999999999999999999 999999999999999 89999
Q ss_pred EecccccCCCccccc-cccccccccccCccCcccccCC-CCCccchhHhHHHHHHHHHcCCCCCCCCCC
Q 018712 214 ISDFDLSNQAPDAAA-RLHSTRVLGTFGYHAPEYAMTG-QMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (351)
Q Consensus 214 l~Dfg~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~Pf~~~~~ 280 (351)
|+|||++........ ........+++.|+|||.+.+. .++.++||||||+++|+|++|+.||.....
T Consensus 153 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~ 221 (316)
T cd07842 153 IGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREA 221 (316)
T ss_pred ECCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcc
Confidence 999999886543322 1112345678899999988764 578999999999999999999999986543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=301.49 Aligned_cols=242 Identities=26% Similarity=0.387 Sum_probs=185.3
Q ss_pred HHhcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCC--CchHHHHHHHHHHHhccCCceeeeEEEEec-------
Q 018712 63 EKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK--QPDQEFLAQVSMVSRLKNENVVELVGYYVD------- 132 (351)
Q Consensus 63 ~~~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~------- 132 (351)
.-..+|+.++.||+||||.||+++++ +|+.||||++.... .....+.+|+++|++|+|||||+++..+.+
T Consensus 476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~ 555 (1351)
T KOG1035|consen 476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV 555 (1351)
T ss_pred hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence 44567888999999999999999987 89999999998664 334568899999999999999999832210
Q ss_pred --------------------------------------------------------------------------------
Q 018712 133 -------------------------------------------------------------------------------- 132 (351)
Q Consensus 133 -------------------------------------------------------------------------------- 132 (351)
T Consensus 556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~ 635 (1351)
T KOG1035|consen 556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD 635 (1351)
T ss_pred ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence
Q ss_pred ------------------------C--------CceEEEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHH
Q 018712 133 ------------------------G--------PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAA 180 (351)
Q Consensus 133 ------------------------~--------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~ 180 (351)
+ -.+||-||||+..+|.++++..... -.....++++++|+
T Consensus 636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~--------~~~d~~wrLFreIl 707 (1351)
T KOG1035|consen 636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFN--------SQRDEAWRLFREIL 707 (1351)
T ss_pred cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccc--------hhhHHHHHHHHHHH
Confidence 0 1358889999998888888766421 13678899999999
Q ss_pred HHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccccCCCc---c-------------ccccccccccccccCccCc
Q 018712 181 RGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAP---D-------------AAARLHSTRVLGTFGYHAP 244 (351)
Q Consensus 181 ~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~---~-------------~~~~~~~~~~~gt~~y~aP 244 (351)
+||.|+|++| ||||||||.||++++++.|||+|||+|.... . .......+..+||..|+||
T Consensus 708 EGLaYIH~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAP 784 (1351)
T KOG1035|consen 708 EGLAYIHDQG---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAP 784 (1351)
T ss_pred HHHHHHHhCc---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecH
Confidence 9999999999 9999999999999999999999999998721 0 1111234667899999999
Q ss_pred ccccCCC---CCccchhHhHHHHHHHHHcCCCCCCCCCCCCC--ccchhh--------cccCCC--ccchhhhcccccCC
Q 018712 245 EYAMTGQ---MSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQ--QSLVTW--------ATPKLS--EDKVKQCVDTKLGG 309 (351)
Q Consensus 245 E~~~~~~---~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~--~~~~~~--------~~~~~~--~~~~~~~ld~~~~~ 309 (351)
|++.+.. |+.|+|+||||+|++||+. ||....++.. ..+..- ..+... ...++.+++++|.+
T Consensus 785 Ell~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~k 861 (1351)
T KOG1035|consen 785 ELLSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSK 861 (1351)
T ss_pred HHhcccccccccchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCcc
Confidence 9997654 9999999999999999996 3543222110 000000 111111 25778899999999
Q ss_pred CCCHHHHHH
Q 018712 310 EYPPKAIAK 318 (351)
Q Consensus 310 ~~~~~~~~~ 318 (351)
||++.++..
T Consensus 862 RPtA~eLL~ 870 (1351)
T KOG1035|consen 862 RPTATELLN 870 (1351)
T ss_pred CCCHHHHhh
Confidence 999877654
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=269.01 Aligned_cols=236 Identities=24% Similarity=0.333 Sum_probs=193.0
Q ss_pred cCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCC----CchHHHHHHHHHHHhcc-CCceeeeEEEEecCCceEEE
Q 018712 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK----QPDQEFLAQVSMVSRLK-NENVVELVGYYVDGPLRVLA 139 (351)
Q Consensus 66 ~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv 139 (351)
++|.+.+.||+|+||.||++... ++..+|+|++.... .....+.+|.++++++. |+||+++++.+.+.+..+++
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 47899999999999999999975 78999999987532 22356788999999998 99999999999999999999
Q ss_pred EEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccc
Q 018712 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDL 219 (351)
Q Consensus 140 ~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~ 219 (351)
||++.+++|.+++.... .+++..+..++.|++.||.+||+.+ ++|+||+|+||+++.++.++|+|||+
T Consensus 81 ~e~~~~~~L~~~l~~~~---------~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~ 148 (280)
T cd05581 81 LEYAPNGELLQYIRKYG---------SLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGT 148 (280)
T ss_pred EcCCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCcc
Confidence 99999999999998654 2899999999999999999999999 99999999999999999999999999
Q ss_pred cCCCcccccc------------------ccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCC
Q 018712 220 SNQAPDAAAR------------------LHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPR 281 (351)
Q Consensus 220 a~~~~~~~~~------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~ 281 (351)
+......... .......++..|+|||...+..++.++|+||||++++++++|+.||......
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~ 228 (280)
T cd05581 149 AKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEY 228 (280)
T ss_pred ccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHH
Confidence 8765433211 1123346788999999998888999999999999999999999999865421
Q ss_pred CCccch---hh----cccCCCccchhhhcccccCCCCCH
Q 018712 282 GQQSLV---TW----ATPKLSEDKVKQCVDTKLGGEYPP 313 (351)
Q Consensus 282 ~~~~~~---~~----~~~~~~~~~~~~~ld~~~~~~~~~ 313 (351)
.....+ .+ ..+....+.+..|++.+|.+|++.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~ 267 (280)
T cd05581 229 LTFQKILKLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGV 267 (280)
T ss_pred HHHHHHHhcCCCCCCccCHHHHHHHHHHhcCCHhhCCCc
Confidence 111111 11 111222367788888888889887
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=266.49 Aligned_cols=232 Identities=23% Similarity=0.325 Sum_probs=183.7
Q ss_pred CCCCCceeccCCcEEEEEEEEC----CCCEEEEEEcCCCC-----CchHHHHHHHHHHHhc-cCCceeeeEEEEecCCce
Q 018712 67 NFGTNSLIGEGSYGRVYFGVLR----SGRAAAIKKLDSSK-----QPDQEFLAQVSMVSRL-KNENVVELVGYYVDGPLR 136 (351)
Q Consensus 67 ~y~~~~~Lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~-----~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~ 136 (351)
+|++.+.||+|+||.||.+... +|..||+|++.... ...+.+.+|+++++++ +|+||+++++.+..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 4788899999999999999863 68899999986432 2235678899999999 589999999999999999
Q ss_pred EEEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEec
Q 018712 137 VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISD 216 (351)
Q Consensus 137 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~D 216 (351)
++||||+++++|.+++..... ++...+..++.|++.||.|||+.+ ++||||+|+|||++.++.+||+|
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~---------l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~d 148 (290)
T cd05613 81 HLILDYINGGELFTHLSQRER---------FKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTD 148 (290)
T ss_pred EEEEecCCCCcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEee
Confidence 999999999999999976542 788899999999999999999999 99999999999999999999999
Q ss_pred ccccCCCccccccccccccccccCccCcccccCC--CCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccchh----hc
Q 018712 217 FDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTG--QMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVT----WA 290 (351)
Q Consensus 217 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~~----~~ 290 (351)
||++......... ......|+..|+|||.+.+. .++.++||||||+++|+|++|..||...........+. ..
T Consensus 149 fg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~ 227 (290)
T cd05613 149 FGLSKEFHEDEVE-RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKS 227 (290)
T ss_pred Cccceeccccccc-ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhcc
Confidence 9998765432211 11234688999999988753 46789999999999999999999997533221111110 00
Q ss_pred -------ccCCCccchhhhcccccCCCC
Q 018712 291 -------TPKLSEDKVKQCVDTKLGGEY 311 (351)
Q Consensus 291 -------~~~~~~~~~~~~ld~~~~~~~ 311 (351)
.+....+.+.+|+..+|.+|+
T Consensus 228 ~~~~~~~~~~~~~~ll~~~l~~~p~~R~ 255 (290)
T cd05613 228 EPPYPQEMSALAKDIIQRLLMKDPKKRL 255 (290)
T ss_pred CCCCCccCCHHHHHHHHHHhcCCHHHhc
Confidence 111123567778888887786
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=308.34 Aligned_cols=240 Identities=24% Similarity=0.363 Sum_probs=193.6
Q ss_pred HHhcCCCCCceeccCCcEEEEEEEE-CCCCEEEEEEcCCCCCc---hHHHHHHHHHHHhccCCceeeeEEEEecCCceEE
Q 018712 63 EKTDNFGTNSLIGEGSYGRVYFGVL-RSGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVL 138 (351)
Q Consensus 63 ~~~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 138 (351)
..+-+|+...+||.|.||.||-|.+ .+|...|+|.+...... -....+|..++..++|||+|+++++-..++..+|
T Consensus 1232 nV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~I 1311 (1509)
T KOG4645|consen 1232 NVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYI 1311 (1509)
T ss_pred cceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHH
Confidence 3445788889999999999999995 57999999987644332 3457789999999999999999999999999999
Q ss_pred EEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEeccc
Q 018712 139 AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFD 218 (351)
Q Consensus 139 v~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg 218 (351)
.||||.+|+|.+.+...+. ..+.....+..|++.|+.|||++| ||||||||.||+++.+|.+|++|||
T Consensus 1312 FMEyC~~GsLa~ll~~gri---------~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFG 1379 (1509)
T KOG4645|consen 1312 FMEYCEGGSLASLLEHGRI---------EDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFG 1379 (1509)
T ss_pred HHHHhccCcHHHHHHhcch---------hhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeeccc
Confidence 9999999999999987653 677778889999999999999999 9999999999999999999999999
Q ss_pred ccCCCccccccc--cccccccccCccCcccccCC---CCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCc--cchhhcc
Q 018712 219 LSNQAPDAAARL--HSTRVLGTFGYHAPEYAMTG---QMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQ--SLVTWAT 291 (351)
Q Consensus 219 ~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~--~~~~~~~ 291 (351)
.|..+....... ......||+.|||||++.+. +...++|||||||++.||+||+.||...+..=.. ..-....
T Consensus 1380 sa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~ 1459 (1509)
T KOG4645|consen 1380 SAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHK 1459 (1509)
T ss_pred ceeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCC
Confidence 998876543111 12356799999999999753 4567899999999999999999999876443111 1111223
Q ss_pred cCCC-------ccchhhhcccccCCCCCHH
Q 018712 292 PKLS-------EDKVKQCVDTKLGGEYPPK 314 (351)
Q Consensus 292 ~~~~-------~~~~~~~ld~~~~~~~~~~ 314 (351)
|.++ .+.+..|+..+|..|..+.
T Consensus 1460 Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~ 1489 (1509)
T KOG4645|consen 1460 PQIPERLSSEGRDFLEHCLEQDPKMRWTAS 1489 (1509)
T ss_pred CCCchhhhHhHHHHHHHHHhcCchhhhHHH
Confidence 3333 2567788888888775444
|
|
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=267.55 Aligned_cols=234 Identities=29% Similarity=0.411 Sum_probs=188.4
Q ss_pred CCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCCc----hHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEEE
Q 018712 67 NFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP----DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYE 141 (351)
Q Consensus 67 ~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 141 (351)
.|...+.||+|+||.||++... ++..+|+|++...... ...+.+|++++++++|+|++++++++.+....++|||
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 105 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME 105 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence 3778889999999999999964 6889999998654221 2457889999999999999999999999999999999
Q ss_pred eCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccccC
Q 018712 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (351)
Q Consensus 142 ~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~ 221 (351)
|+.+ +|.+++..... .+++..+..++.|++.||.|||+.+ ++||||+|+||+++.++.+||+|||++.
T Consensus 106 ~~~g-~l~~~~~~~~~--------~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~ 173 (317)
T cd06635 106 YCLG-SASDLLEVHKK--------PLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSAS 173 (317)
T ss_pred CCCC-CHHHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCcc
Confidence 9975 88887754332 2889999999999999999999999 9999999999999999999999999886
Q ss_pred CCccccccccccccccccCccCccccc---CCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccchh---------h
Q 018712 222 QAPDAAARLHSTRVLGTFGYHAPEYAM---TGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVT---------W 289 (351)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~~---------~ 289 (351)
..... ....|+..|+|||++. ...++.++||||||+++|+|++|+.||...........+. .
T Consensus 174 ~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 247 (317)
T cd06635 174 IASPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSN 247 (317)
T ss_pred ccCCc------ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCCCCc
Confidence 54322 3346888999999874 4568899999999999999999999987653321111110 0
Q ss_pred cccCCCccchhhhcccccCCCCCHHHHHH
Q 018712 290 ATPKLSEDKVKQCVDTKLGGEYPPKAIAK 318 (351)
Q Consensus 290 ~~~~~~~~~~~~~ld~~~~~~~~~~~~~~ 318 (351)
..+....+.+.+|+..+|.+|++.+++..
T Consensus 248 ~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 276 (317)
T cd06635 248 EWSDYFRNFVDSCLQKIPQDRPTSEELLK 276 (317)
T ss_pred cccHHHHHHHHHHccCCcccCcCHHHHHh
Confidence 11112236788899999999999887765
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=268.65 Aligned_cols=239 Identities=26% Similarity=0.336 Sum_probs=183.7
Q ss_pred cCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCC--chHHHHHHHHHHHhcc-CCceeeeEEEEecCCceEEEEE
Q 018712 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ--PDQEFLAQVSMVSRLK-NENVVELVGYYVDGPLRVLAYE 141 (351)
Q Consensus 66 ~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e 141 (351)
++|...+.||+|+||.||++.+. ++..+|+|.+..... ....+.+|+.++.++. |+||+++++++..++..+++||
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e 83 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICME 83 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEe
Confidence 35666778999999999999965 689999999875432 2456788999999996 9999999999999999999999
Q ss_pred eCCCCCHHHHhc---cCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhC-CCCCeeeccccCCcEEEccCCceEEecc
Q 018712 142 HASKGSLHDILH---GKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEK-AEPRIIHRNIKSSNVLLFDDDIAKISDF 217 (351)
Q Consensus 142 ~~~~gsL~~~l~---~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~-~~~~ivH~Dlkp~Nill~~~~~vkl~Df 217 (351)
|+.. +|.++.. .... ..+++..+..++.|++.||+|||+. + ++||||||+||+++.++.+||+||
T Consensus 84 ~~~~-~l~~l~~~~~~~~~-------~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~df 152 (288)
T cd06616 84 LMDI-SLDKFYKYVYEVLK-------SVIPEEILGKIAVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKLCDF 152 (288)
T ss_pred cccC-CHHHHHHHHHHhhc-------CCCCHHHHHHHHHHHHHHHHHHhhcCC---eeccCCCHHHEEEccCCcEEEeec
Confidence 9865 6655432 1111 1288999999999999999999975 7 999999999999999999999999
Q ss_pred cccCCCccccccccccccccccCccCcccccCC---CCCccchhHhHHHHHHHHHcCCCCCCCCCCCCC--ccchhhcc-
Q 018712 218 DLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTG---QMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQ--QSLVTWAT- 291 (351)
Q Consensus 218 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~--~~~~~~~~- 291 (351)
|++......... ....|+..|+|||++.+. .++.++||||||+++|+|++|+.||........ ........
T Consensus 153 g~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~ 229 (288)
T cd06616 153 GISGQLVDSIAK---TRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPP 229 (288)
T ss_pred chhHHhccCCcc---ccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCC
Confidence 998765432211 334588899999998766 689999999999999999999999975431100 00000000
Q ss_pred ----------cCCCccchhhhcccccCCCCCHHHHHH
Q 018712 292 ----------PKLSEDKVKQCVDTKLGGEYPPKAIAK 318 (351)
Q Consensus 292 ----------~~~~~~~~~~~ld~~~~~~~~~~~~~~ 318 (351)
+....+.+..|+..+|.+|++.+++..
T Consensus 230 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~ 266 (288)
T cd06616 230 ILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLE 266 (288)
T ss_pred cCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 111136788999999999998776543
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=273.22 Aligned_cols=201 Identities=29% Similarity=0.428 Sum_probs=169.8
Q ss_pred HHHHHHhcCCCCCceeccCCcEEEEEEEE-CCCCEEEEEEcCCCCC---chHHHHHHHHHHHhccCCceeeeEEEEecC-
Q 018712 59 DELKEKTDNFGTNSLIGEGSYGRVYFGVL-RSGRAAAIKKLDSSKQ---PDQEFLAQVSMVSRLKNENVVELVGYYVDG- 133 (351)
Q Consensus 59 ~~~~~~~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~h~niv~~~~~~~~~- 133 (351)
..+....++|.+.+.||+|+||.||++.. .++..||+|++..... ....+.+|+.++++++|+||+++++++...
T Consensus 10 ~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~ 89 (345)
T cd07877 10 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPAR 89 (345)
T ss_pred HHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecc
Confidence 45556779999999999999999999985 4789999999875432 235577899999999999999999987533
Q ss_pred -----CceEEEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEcc
Q 018712 134 -----PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFD 208 (351)
Q Consensus 134 -----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~ 208 (351)
...+++++++ +++|.+++.... +++..+..++.|++.||.|||+.+ ++||||||+||++++
T Consensus 90 ~~~~~~~~~lv~~~~-~~~L~~~~~~~~----------l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~ 155 (345)
T cd07877 90 SLEEFNDVYLVTHLM-GADLNNIVKCQK----------LTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNE 155 (345)
T ss_pred cccccccEEEEehhc-ccCHHHHHhcCC----------CCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcC
Confidence 3467888876 679999886543 889999999999999999999999 999999999999999
Q ss_pred CCceEEecccccCCCccccccccccccccccCccCcccccC-CCCCccchhHhHHHHHHHHHcCCCCCCCC
Q 018712 209 DDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMT-GQMSSKSDVYSFGVVLLELLTGRKPVDHT 278 (351)
Q Consensus 209 ~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~Pf~~~ 278 (351)
++.+||+|||++...... .....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||...
T Consensus 156 ~~~~kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~ 221 (345)
T cd07877 156 DCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 221 (345)
T ss_pred CCCEEEeccccccccccc-----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 999999999998765322 133467889999998876 56788999999999999999999999754
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=258.19 Aligned_cols=209 Identities=26% Similarity=0.399 Sum_probs=177.1
Q ss_pred HHhcCCCCCceeccCCcEEEEEEEEC---C--CCEEEEEEcCCCCCc---hHHHHHHHHHHHhccCCceeeeEEEEec-C
Q 018712 63 EKTDNFGTNSLIGEGSYGRVYFGVLR---S--GRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVD-G 133 (351)
Q Consensus 63 ~~~~~y~~~~~Lg~G~~g~Vy~~~~~---~--~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~-~ 133 (351)
+....|+..+.||+|.||.||+|..+ + .+.+|||+++.++.. .....+|+.+++.++|+||+.+...|.. +
T Consensus 21 e~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d 100 (438)
T KOG0666|consen 21 EDLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHD 100 (438)
T ss_pred HHHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccC
Confidence 45678999999999999999999743 2 347999999765332 3568899999999999999999998877 7
Q ss_pred CceEEEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccC----
Q 018712 134 PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDD---- 209 (351)
Q Consensus 134 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~---- 209 (351)
..+++++||.+. +|.++|+-....+. ..++...+..|+.||+.|+.|||++- |+||||||.|||+..+
T Consensus 101 ~~v~l~fdYAEh-DL~~II~fHr~~~~----~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgper 172 (438)
T KOG0666|consen 101 KKVWLLFDYAEH-DLWHIIKFHRASKA----KQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPER 172 (438)
T ss_pred ceEEEEehhhhh-hHHHHHHHhccchh----ccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCcc
Confidence 789999999987 99999986654332 24888999999999999999999998 9999999999999877
Q ss_pred CceEEecccccCCCccccccc-cccccccccCccCcccccCC-CCCccchhHhHHHHHHHHHcCCCCCCCCC
Q 018712 210 DIAKISDFDLSNQAPDAAARL-HSTRVLGTFGYHAPEYAMTG-QMSSKSDVYSFGVVLLELLTGRKPVDHTL 279 (351)
Q Consensus 210 ~~vkl~Dfg~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~Pf~~~~ 279 (351)
|.|||+|||+++...+.-... ....++-|..|.|||.+.|. .||.+.||||+|||+.||+|-++-|.+..
T Consensus 173 G~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E 244 (438)
T KOG0666|consen 173 GRVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGRE 244 (438)
T ss_pred CeeEeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchh
Confidence 899999999999876543332 33456789999999999875 78999999999999999999999998653
|
|
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-36 Score=268.04 Aligned_cols=245 Identities=22% Similarity=0.310 Sum_probs=193.0
Q ss_pred CCCCCceeccCCcEEEEEEEEC----CCCEEEEEEcCCCC-----CchHHHHHHHHHHHhc-cCCceeeeEEEEecCCce
Q 018712 67 NFGTNSLIGEGSYGRVYFGVLR----SGRAAAIKKLDSSK-----QPDQEFLAQVSMVSRL-KNENVVELVGYYVDGPLR 136 (351)
Q Consensus 67 ~y~~~~~Lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~-----~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~ 136 (351)
+|++.+.||+|++|.||++... +++.||+|.+.... .....+.+|++++.++ +|+||+++++.+..+...
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 4788899999999999998843 57889999886432 2235577899999999 599999999999999999
Q ss_pred EEEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEec
Q 018712 137 VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISD 216 (351)
Q Consensus 137 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~D 216 (351)
++||||+.+++|.+++..... +++..+..++.|++.||.|||+.+ ++||||+|+||+++.++.++|+|
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~~---------~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~d 148 (288)
T cd05583 81 HLILDYVNGGELFTHLYQREH---------FTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTD 148 (288)
T ss_pred EEEEecCCCCcHHHHHhhcCC---------cCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEE
Confidence 999999999999999875432 788899999999999999999999 99999999999999999999999
Q ss_pred ccccCCCccccccccccccccccCccCcccccCCC--CCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccch-----h-
Q 018712 217 FDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQ--MSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLV-----T- 288 (351)
Q Consensus 217 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~-----~- 288 (351)
||++......... ......|+..|+|||.+.+.. .+.++|+||||+++|+|++|..||...........+ .
T Consensus 149 fg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 227 (288)
T cd05583 149 FGLSKEFLAEEEE-RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKS 227 (288)
T ss_pred Ccccccccccccc-ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHcc
Confidence 9998765433211 112345889999999987654 688999999999999999999999643222111000 0
Q ss_pred -----hcccCCCccchhhhcccccCCCCCHHHHHHHHHHHH
Q 018712 289 -----WATPKLSEDKVKQCVDTKLGGEYPPKAIAKVRKKKF 324 (351)
Q Consensus 289 -----~~~~~~~~~~~~~~ld~~~~~~~~~~~~~~~~~~~~ 324 (351)
...+....+.+.+|+..++..|++...+..++.+.+
T Consensus 228 ~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~ 268 (288)
T cd05583 228 KPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPF 268 (288)
T ss_pred CCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcc
Confidence 011112235677888888888888777777766654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=259.72 Aligned_cols=241 Identities=24% Similarity=0.358 Sum_probs=196.3
Q ss_pred CCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCC---chHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEEEe
Q 018712 67 NFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ---PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEH 142 (351)
Q Consensus 67 ~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 142 (351)
+|.+.+.||.|+||.||++.+. ++..+++|++..... ....+.+|+++++.++|+|++++.+.+...+..++++|+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 5788899999999999999975 689999999876533 345688999999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccccCC
Q 018712 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222 (351)
Q Consensus 143 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~ 222 (351)
+++++|.+++..... ....+++..+..++.+++.||.|||+++ ++|+||+|+||++++++.++|+|||.+..
T Consensus 81 ~~~~~L~~~l~~~~~-----~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~ 152 (258)
T cd08215 81 ADGGDLSQKIKKQKK-----EGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKV 152 (258)
T ss_pred cCCCcHHHHHHHhhc-----cCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceee
Confidence 999999999986531 1123899999999999999999999999 99999999999999999999999999876
Q ss_pred CccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccc-h-------hhcccCC
Q 018712 223 APDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSL-V-------TWATPKL 294 (351)
Q Consensus 223 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~-~-------~~~~~~~ 294 (351)
...... ......|++.|+|||.+.+..++.++|+||+|+++|+|++|+.||........... . ....+..
T Consensus 153 ~~~~~~--~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (258)
T cd08215 153 LSSTVD--LAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPIPSQYSSE 230 (258)
T ss_pred cccCcc--eecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCCCCCCCCCCHH
Confidence 644321 12334688999999999888899999999999999999999999976532211110 0 0111122
Q ss_pred CccchhhhcccccCCCCCHHHHH
Q 018712 295 SEDKVKQCVDTKLGGEYPPKAIA 317 (351)
Q Consensus 295 ~~~~~~~~ld~~~~~~~~~~~~~ 317 (351)
..+.+..|+..+|.+|++.+++.
T Consensus 231 ~~~~i~~~l~~~p~~Rp~~~~ll 253 (258)
T cd08215 231 LRNLVSSLLQKDPEERPSIAQIL 253 (258)
T ss_pred HHHHHHHHcCCChhhCcCHHHHh
Confidence 23577788999999999888764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=271.92 Aligned_cols=202 Identities=25% Similarity=0.374 Sum_probs=168.7
Q ss_pred HhcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCC---CchHHHHHHHHHHHhc-cCCceeeeEEEEecC--Cce
Q 018712 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK---QPDQEFLAQVSMVSRL-KNENVVELVGYYVDG--PLR 136 (351)
Q Consensus 64 ~~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~--~~~ 136 (351)
..++|++.+.||+|+||.||+|.+. ++..+|+|++.... .....+.+|+.+++++ +|+||+++++++... ...
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 4578999999999999999999975 68899999885432 2234577899999999 999999999987643 368
Q ss_pred EEEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEec
Q 018712 137 VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISD 216 (351)
Q Consensus 137 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~D 216 (351)
++||||+.+ +|.+++.... +.+..+..++.||+.||.|||++| ++||||||+||+++.++.+||+|
T Consensus 85 ~lv~e~~~~-~L~~~~~~~~----------~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d 150 (337)
T cd07852 85 YLVFEYMET-DLHAVIRANI----------LEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLAD 150 (337)
T ss_pred EEEeccccc-CHHHHHhcCC----------CCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEee
Confidence 999999975 9999987642 788889999999999999999999 99999999999999999999999
Q ss_pred ccccCCCcccccc---ccccccccccCccCcccccC-CCCCccchhHhHHHHHHHHHcCCCCCCCCC
Q 018712 217 FDLSNQAPDAAAR---LHSTRVLGTFGYHAPEYAMT-GQMSSKSDVYSFGVVLLELLTGRKPVDHTL 279 (351)
Q Consensus 217 fg~a~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~Pf~~~~ 279 (351)
||++......... .......||..|+|||.+.+ ..++.++|+||||+++|+|++|+.||....
T Consensus 151 ~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~ 217 (337)
T cd07852 151 FGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTS 217 (337)
T ss_pred ccchhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCC
Confidence 9998765433211 11233568999999998765 457889999999999999999999997543
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=271.80 Aligned_cols=199 Identities=26% Similarity=0.389 Sum_probs=167.8
Q ss_pred hcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCC---CCchHHHHHHHHHHHhccCCceeeeEEEEecC-----Cc
Q 018712 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSS---KQPDQEFLAQVSMVSRLKNENVVELVGYYVDG-----PL 135 (351)
Q Consensus 65 ~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~ 135 (351)
.++|.+.+.||+|+||.||++... +++.||+|.+... ......+.+|+.+++.++|+||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 457999999999999999999964 7899999998643 22234577899999999999999999987644 34
Q ss_pred eEEEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEe
Q 018712 136 RVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKIS 215 (351)
Q Consensus 136 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~ 215 (351)
.|+++||+. ++|.+++..... ++...+..++.|++.||.|||+++ ++||||||+||+++.++.+||+
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~~~---------l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~ 150 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRSSQT---------LSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKIC 150 (337)
T ss_pred EEEEEeCCC-CCHHHHHhcCCC---------CCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEC
Confidence 799999996 589998876532 889999999999999999999999 9999999999999999999999
Q ss_pred cccccCCCccccccccccccccccCccCcccccC-CCCCccchhHhHHHHHHHHHcCCCCCCCC
Q 018712 216 DFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMT-GQMSSKSDVYSFGVVLLELLTGRKPVDHT 278 (351)
Q Consensus 216 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~Pf~~~ 278 (351)
|||++........ ......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||...
T Consensus 151 Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~ 212 (337)
T cd07858 151 DFGLARTTSEKGD--FMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGK 212 (337)
T ss_pred cCccccccCCCcc--cccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCC
Confidence 9999876643321 1233457889999998765 46889999999999999999999999754
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=271.42 Aligned_cols=203 Identities=27% Similarity=0.418 Sum_probs=168.3
Q ss_pred HhcCCCC-CceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCCch---------------HHHHHHHHHHHhccCCceeee
Q 018712 64 KTDNFGT-NSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPD---------------QEFLAQVSMVSRLKNENVVEL 126 (351)
Q Consensus 64 ~~~~y~~-~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~---------------~~~~~e~~~l~~l~h~niv~~ 126 (351)
..++|.. .+.||.|+||.||+|.+. +++.||+|++....... ..+.+|+++++.++|+||+++
T Consensus 6 ~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~ 85 (335)
T PTZ00024 6 ISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGL 85 (335)
T ss_pred cccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeee
Confidence 3456764 567999999999999965 78999999886443221 246789999999999999999
Q ss_pred EEEEecCCceEEEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEE
Q 018712 127 VGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLL 206 (351)
Q Consensus 127 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill 206 (351)
++++..++..+++|||+. ++|.+++..... ++......++.|++.||.|||+.+ ++|+||+|+||++
T Consensus 86 ~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~---------~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill 152 (335)
T PTZ00024 86 VDVYVEGDFINLVMDIMA-SDLKKVVDRKIR---------LTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFI 152 (335)
T ss_pred eEEEecCCcEEEEEeccc-cCHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEE
Confidence 999999999999999997 599999875432 888999999999999999999999 9999999999999
Q ss_pred ccCCceEEecccccCCCcccc------------ccccccccccccCccCcccccCC-CCCccchhHhHHHHHHHHHcCCC
Q 018712 207 FDDDIAKISDFDLSNQAPDAA------------ARLHSTRVLGTFGYHAPEYAMTG-QMSSKSDVYSFGVVLLELLTGRK 273 (351)
Q Consensus 207 ~~~~~vkl~Dfg~a~~~~~~~------------~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~ 273 (351)
+.++.++|+|||++....... .........+++.|+|||.+.+. .++.++||||||+++|+|++|+.
T Consensus 153 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~ 232 (335)
T PTZ00024 153 NSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKP 232 (335)
T ss_pred CCCCCEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCC
Confidence 999999999999987654111 01111223468889999998764 46899999999999999999999
Q ss_pred CCCCCC
Q 018712 274 PVDHTL 279 (351)
Q Consensus 274 Pf~~~~ 279 (351)
||....
T Consensus 233 p~~~~~ 238 (335)
T PTZ00024 233 LFPGEN 238 (335)
T ss_pred CCCCCC
Confidence 997654
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-35 Score=264.81 Aligned_cols=233 Identities=28% Similarity=0.408 Sum_probs=187.1
Q ss_pred CCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCC----chHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEEEe
Q 018712 68 FGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ----PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEH 142 (351)
Q Consensus 68 y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 142 (351)
|...+.||+|+||.||+|... ++..+++|++..... ....+.+|+++++.++|+|++++++++.+....|+||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 677788999999999999964 688999999864322 124578899999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccccCC
Q 018712 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222 (351)
Q Consensus 143 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~ 222 (351)
+.+ +|.+++..... .+++..+..++.||+.||.|||++| ++|+||+|+||+++.++.+||+|||++..
T Consensus 103 ~~~-~l~~~l~~~~~--------~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~ 170 (313)
T cd06633 103 CLG-SASDLLEVHKK--------PLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASK 170 (313)
T ss_pred CCC-CHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCcc
Confidence 964 88887764332 2788999999999999999999999 99999999999999999999999998864
Q ss_pred CccccccccccccccccCccCccccc---CCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccch---------hhc
Q 018712 223 APDAAARLHSTRVLGTFGYHAPEYAM---TGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLV---------TWA 290 (351)
Q Consensus 223 ~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~---------~~~ 290 (351)
.... ....|+..|+|||++. ...++.++||||||+++|+|++|..||...........+ ...
T Consensus 171 ~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (313)
T cd06633 171 SSPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNE 244 (313)
T ss_pred cCCC------CCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccc
Confidence 3221 3456889999999874 456788999999999999999999999765432211100 011
Q ss_pred ccCCCccchhhhcccccCCCCCHHHHHH
Q 018712 291 TPKLSEDKVKQCVDTKLGGEYPPKAIAK 318 (351)
Q Consensus 291 ~~~~~~~~~~~~ld~~~~~~~~~~~~~~ 318 (351)
.+....+.+..|+...|.+|++.+++..
T Consensus 245 ~~~~l~~li~~~l~~~P~~Rp~~~~~l~ 272 (313)
T cd06633 245 WTDSFRGFVDYCLQKIPQERPASAELLR 272 (313)
T ss_pred cCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1112246788899999999999877654
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=270.30 Aligned_cols=245 Identities=25% Similarity=0.372 Sum_probs=204.0
Q ss_pred CCCCceeccCCcEEEEEEEECC---C--CEEEEEEcCCCC--CchHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEE
Q 018712 68 FGTNSLIGEGSYGRVYFGVLRS---G--RAAAIKKLDSSK--QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAY 140 (351)
Q Consensus 68 y~~~~~Lg~G~~g~Vy~~~~~~---~--~~vavK~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 140 (351)
....+.||.|-||.||.|.+.+ | -.||||..+.+. ...+.|+.|..+|+.++||||++++|.+.+. ..++||
T Consensus 391 Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~Wivm 469 (974)
T KOG4257|consen 391 ITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PMWIVM 469 (974)
T ss_pred ccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-ceeEEE
Confidence 4445679999999999999642 2 368999988654 3467899999999999999999999998765 579999
Q ss_pred EeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEeccccc
Q 018712 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (351)
Q Consensus 141 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a 220 (351)
|.++-|.|..||+..+.. ++......++.||..||.|||+.. +|||||..+|||+.+..-|||+|||++
T Consensus 470 EL~~~GELr~yLq~nk~s--------L~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFGLS 538 (974)
T KOG4257|consen 470 ELAPLGELREYLQQNKDS--------LPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFGLS 538 (974)
T ss_pred ecccchhHHHHHHhcccc--------chHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccchh
Confidence 999999999999987653 899999999999999999999998 999999999999999999999999999
Q ss_pred CCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCCccchhhc--------c
Q 018712 221 NQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWA--------T 291 (351)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~Pf~~~~~~~~~~~~~~~--------~ 291 (351)
+...+..... .+...-...|||||.+.-..++.++|||-|||.+||+++ |..||.+..+.+....+... .
T Consensus 539 R~~ed~~yYk-aS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeRlP~P~nC 617 (974)
T KOG4257|consen 539 RYLEDDAYYK-ASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGERLPCPPNC 617 (974)
T ss_pred hhccccchhh-ccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCCCCCCCCC
Confidence 9887654332 233445778999999999999999999999999999988 99999997766544443321 1
Q ss_pred cCCCccchhhhcccccCCCCCHHHHHHHHHHHHH
Q 018712 292 PKLSEDKVKQCVDTKLGGEYPPKAIAKVRKKKFI 325 (351)
Q Consensus 292 ~~~~~~~~~~~ld~~~~~~~~~~~~~~~~~~~~~ 325 (351)
|...-.++.+|++..|.+|+...++...+.-.++
T Consensus 618 Pp~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 618 PPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred ChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 1111268899999999999999888877666655
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=272.33 Aligned_cols=198 Identities=28% Similarity=0.405 Sum_probs=168.9
Q ss_pred HHHhcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCCc---hHHHHHHHHHHHhccCCceeeeEEEEecCC---
Q 018712 62 KEKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVDGP--- 134 (351)
Q Consensus 62 ~~~~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~--- 134 (351)
-...++|++.+.||+|+||.||++... ++..||+|++...... ...+.+|+.++++++|+||+++++.+....
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07880 11 WEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLD 90 (343)
T ss_pred hccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccc
Confidence 345678999999999999999999854 7899999998643222 345788999999999999999999887554
Q ss_pred ---ceEEEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCc
Q 018712 135 ---LRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDI 211 (351)
Q Consensus 135 ---~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~ 211 (351)
..++||||+ +++|.+++.... +++..+..++.|++.||.|||+.| ++||||||+||++++++.
T Consensus 91 ~~~~~~lv~e~~-~~~l~~~~~~~~----------l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~ 156 (343)
T cd07880 91 RFHDFYLVMPFM-GTDLGKLMKHEK----------LSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCE 156 (343)
T ss_pred ccceEEEEEecC-CCCHHHHHhcCC----------CCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCC
Confidence 358999998 679999886532 889999999999999999999999 999999999999999999
Q ss_pred eEEecccccCCCccccccccccccccccCccCcccccC-CCCCccchhHhHHHHHHHHHcCCCCCCCC
Q 018712 212 AKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMT-GQMSSKSDVYSFGVVLLELLTGRKPVDHT 278 (351)
Q Consensus 212 vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~Pf~~~ 278 (351)
+||+|||++....... ....+++.|+|||.+.+ ..++.++|+||||+++|+|++|+.||...
T Consensus 157 ~kl~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~ 219 (343)
T cd07880 157 LKILDFGLARQTDSEM-----TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGH 219 (343)
T ss_pred EEEeecccccccccCc-----cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 9999999987654321 23457889999998876 45789999999999999999999999754
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=266.33 Aligned_cols=202 Identities=27% Similarity=0.387 Sum_probs=168.4
Q ss_pred HhcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCC---CchHHHHHHHHHHHhccCCceeeeEEEEecCC-----
Q 018712 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK---QPDQEFLAQVSMVSRLKNENVVELVGYYVDGP----- 134 (351)
Q Consensus 64 ~~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----- 134 (351)
..++|++.+.||+|+||.||+|..+ +++.||+|++.... .....+.+|++++++++||||+++++++.+..
T Consensus 5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~ 84 (302)
T cd07864 5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDF 84 (302)
T ss_pred hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhc
Confidence 4578999999999999999999975 68899999986432 22356778999999999999999999887654
Q ss_pred -----ceEEEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccC
Q 018712 135 -----LRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDD 209 (351)
Q Consensus 135 -----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~ 209 (351)
..++++||+.+ +|.+++..... .+++..++.++.|++.||.|||+.+ ++|+||||+||+++++
T Consensus 85 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~--------~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~ 152 (302)
T cd07864 85 KKDKGAFYLVFEYMDH-DLMGLLESGLV--------HFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNK 152 (302)
T ss_pred cccCCcEEEEEcccCc-cHHHHHhcCCC--------CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCC
Confidence 78999999986 77777765421 2889999999999999999999999 9999999999999999
Q ss_pred CceEEecccccCCCccccccccccccccccCccCcccccCC-CCCccchhHhHHHHHHHHHcCCCCCCCC
Q 018712 210 DIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTG-QMSSKSDVYSFGVVLLELLTGRKPVDHT 278 (351)
Q Consensus 210 ~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~Pf~~~ 278 (351)
+.+||+|||++......... ......++..|+|||.+.+. .++.++||||||+++|+|++|+.||...
T Consensus 153 ~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~ 221 (302)
T cd07864 153 GQIKLADFGLARLYNSEESR-PYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQAN 221 (302)
T ss_pred CcEEeCcccccccccCCccc-ccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence 99999999998765433211 11223467789999988653 5688999999999999999999999754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-36 Score=273.98 Aligned_cols=233 Identities=23% Similarity=0.323 Sum_probs=188.3
Q ss_pred CCCCceeccCCcEEEEEEE-ECCCCEEEEEEcCCCCCc----hHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEEEe
Q 018712 68 FGTNSLIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQP----DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEH 142 (351)
Q Consensus 68 y~~~~~Lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 142 (351)
|..++.||-|+||.|-++. ..+...||.|.+++.... -.....|-.||....++-||+++-.|++.+.+|+||+|
T Consensus 631 Fvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdY 710 (1034)
T KOG0608|consen 631 FVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDY 710 (1034)
T ss_pred eEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEec
Confidence 5667889999999999998 446788999998765322 12356778889999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccccCC
Q 018712 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222 (351)
Q Consensus 143 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~ 222 (351)
++||++..+|-+.+. +.+..++.++.++..|+++.|+.| +|||||||+|||||.+|++||.|||+|.-
T Consensus 711 IPGGDmMSLLIrmgI---------FeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTG 778 (1034)
T KOG0608|consen 711 IPGGDMMSLLIRMGI---------FEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTG 778 (1034)
T ss_pred cCCccHHHHHHHhcc---------CHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeecccccc
Confidence 999999999977653 889999999999999999999999 99999999999999999999999999853
Q ss_pred Ccc---------cc-------------------------------ccccccccccccCccCcccccCCCCCccchhHhHH
Q 018712 223 APD---------AA-------------------------------ARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFG 262 (351)
Q Consensus 223 ~~~---------~~-------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG 262 (351)
+.= +. .....-..+||+.|+|||++....|+..+|+||.|
T Consensus 779 fRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~g 858 (1034)
T KOG0608|consen 779 FRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVG 858 (1034)
T ss_pred ceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhh
Confidence 210 00 00001135799999999999999999999999999
Q ss_pred HHHHHHHcCCCCCCCCCCCCCc-cchhhcccCCCccchhhhcccccCCCCCHHHHHHHHHH
Q 018712 263 VVLLELLTGRKPVDHTLPRGQQ-SLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKVRKK 322 (351)
Q Consensus 263 ~il~el~tg~~Pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~ld~~~~~~~~~~~~~~~~~~ 322 (351)
||||||+.|+.||-...+.+.+ .++.| +..|+--.....+.+.+.-+.++
T Consensus 859 vil~em~~g~~pf~~~tp~~tq~kv~nw----------~~~l~~~~~~~ls~e~~~li~kL 909 (1034)
T KOG0608|consen 859 VILYEMLVGQPPFLADTPGETQYKVINW----------RNFLHIPYQGNLSKEALDLIQKL 909 (1034)
T ss_pred HHHHHHhhCCCCccCCCCCcceeeeeeh----------hhccccccccccCHHHHHHHHHH
Confidence 9999999999999988776644 34444 33344445556666655544443
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=271.46 Aligned_cols=201 Identities=24% Similarity=0.398 Sum_probs=168.9
Q ss_pred hcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCC---CchHHHHHHHHHHHhccCCceeeeEEEEe----cCCce
Q 018712 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK---QPDQEFLAQVSMVSRLKNENVVELVGYYV----DGPLR 136 (351)
Q Consensus 65 ~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~----~~~~~ 136 (351)
.++|++.+.||.|+||.||+|... ++..||+|++.... .....+.+|+.++++++|+||+++++++. .....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 368999999999999999999965 78999999987542 23456778999999999999999998775 33568
Q ss_pred EEEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEec
Q 018712 137 VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISD 216 (351)
Q Consensus 137 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~D 216 (351)
++||||+. ++|.+++..... +++..+..++.||+.||.|||+++ ++||||||+||++++++.+||+|
T Consensus 84 ~lv~e~~~-~~l~~~~~~~~~---------~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~d 150 (334)
T cd07855 84 YVVMDLME-SDLHHIIHSDQP---------LTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGD 150 (334)
T ss_pred EEEEehhh-hhHHHHhccCCC---------CCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEecc
Confidence 99999996 599999875542 889999999999999999999999 99999999999999999999999
Q ss_pred ccccCCCcccccc--ccccccccccCccCcccccC-CCCCccchhHhHHHHHHHHHcCCCCCCCC
Q 018712 217 FDLSNQAPDAAAR--LHSTRVLGTFGYHAPEYAMT-GQMSSKSDVYSFGVVLLELLTGRKPVDHT 278 (351)
Q Consensus 217 fg~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~Pf~~~ 278 (351)
||++......... .......|+..|+|||.+.+ ..++.++||||||+++|+|++|+.||...
T Consensus 151 fg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 215 (334)
T cd07855 151 FGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGK 215 (334)
T ss_pred cccceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCC
Confidence 9998765432211 11123468899999998765 46889999999999999999999999764
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=263.84 Aligned_cols=199 Identities=25% Similarity=0.419 Sum_probs=169.1
Q ss_pred CCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCC---CchHHHHHHHHHHHhccCCceeeeEEEEecC--CceEEEEE
Q 018712 68 FGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK---QPDQEFLAQVSMVSRLKNENVVELVGYYVDG--PLRVLAYE 141 (351)
Q Consensus 68 y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~lv~e 141 (351)
|++.+.||+|++|.||+|... ++..+|+|++.... .....+.+|++++++++|+|++++++.+.+. +..++|+|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 677889999999999999976 58899999987653 2245678899999999999999999999887 88999999
Q ss_pred eCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccccC
Q 018712 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (351)
Q Consensus 142 ~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~ 221 (351)
|+++ +|.+++..... .+++..++.++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||++.
T Consensus 81 ~~~~-~l~~~~~~~~~--------~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~ 148 (287)
T cd07840 81 YMDH-DLTGLLDSPEV--------KFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLAR 148 (287)
T ss_pred cccc-cHHHHHhccCC--------CCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEcccccee
Confidence 9975 89998875421 2889999999999999999999999 9999999999999999999999999987
Q ss_pred CCccccccccccccccccCccCcccccC-CCCCccchhHhHHHHHHHHHcCCCCCCCCC
Q 018712 222 QAPDAAARLHSTRVLGTFGYHAPEYAMT-GQMSSKSDVYSFGVVLLELLTGRKPVDHTL 279 (351)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~Pf~~~~ 279 (351)
........ ......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||....
T Consensus 149 ~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~ 206 (287)
T cd07840 149 PYTKRNSA-DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGST 206 (287)
T ss_pred eccCCCcc-cccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 76543211 1123456888999998765 457899999999999999999999997654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=268.31 Aligned_cols=199 Identities=25% Similarity=0.360 Sum_probs=169.1
Q ss_pred HHHhcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCC---CchHHHHHHHHHHHhccCCceeeeEEEEec-CCce
Q 018712 62 KEKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK---QPDQEFLAQVSMVSRLKNENVVELVGYYVD-GPLR 136 (351)
Q Consensus 62 ~~~~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~~ 136 (351)
-.+.++|++.+.||.|+||.||++... +++.||+|++.... ...+.+.+|+++++.++||||+++.+++.. ....
T Consensus 6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 85 (328)
T cd07856 6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDI 85 (328)
T ss_pred eccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcE
Confidence 346788999999999999999999965 78999999876432 224567889999999999999999998865 5678
Q ss_pred EEEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEec
Q 018712 137 VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISD 216 (351)
Q Consensus 137 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~D 216 (351)
++++||+ +++|.+++.... ++...+..++.|+++||.|||+.+ ++||||+|+||++++++.++|+|
T Consensus 86 ~lv~e~~-~~~L~~~~~~~~----------~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~d 151 (328)
T cd07856 86 YFVTELL-GTDLHRLLTSRP----------LEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICD 151 (328)
T ss_pred EEEeehh-ccCHHHHHhcCC----------CCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCc
Confidence 9999998 559999887543 777888899999999999999999 99999999999999999999999
Q ss_pred ccccCCCccccccccccccccccCccCcccccC-CCCCccchhHhHHHHHHHHHcCCCCCCCCC
Q 018712 217 FDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMT-GQMSSKSDVYSFGVVLLELLTGRKPVDHTL 279 (351)
Q Consensus 217 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~Pf~~~~ 279 (351)
||.+....... ....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||....
T Consensus 152 fg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~ 210 (328)
T cd07856 152 FGLARIQDPQM-----TGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKD 210 (328)
T ss_pred cccccccCCCc-----CCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 99987543221 23457889999998765 568999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=269.85 Aligned_cols=195 Identities=26% Similarity=0.397 Sum_probs=165.1
Q ss_pred hcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCC---chHHHHHHHHHHHhccCCceeeeEEEEecCC------
Q 018712 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ---PDQEFLAQVSMVSRLKNENVVELVGYYVDGP------ 134 (351)
Q Consensus 65 ~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------ 134 (351)
.++|.+.+.||+|+||.||+|... ++..||+|++..... ....+.+|+.+++.++|+||+++++++....
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 478999999999999999999965 789999999865322 2345788999999999999999999886543
Q ss_pred ceEEEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEE
Q 018712 135 LRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKI 214 (351)
Q Consensus 135 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl 214 (351)
..++|+||+.. +|.+++.. .+++..+..++.|++.||.|||+++ ++||||||+||+++.++.+||
T Consensus 94 ~~~lv~e~~~~-~l~~~~~~-----------~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL 158 (342)
T cd07879 94 DFYLVMPYMQT-DLQKIMGH-----------PLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKI 158 (342)
T ss_pred eEEEEeccccc-CHHHHHcC-----------CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEE
Confidence 46899999965 78777632 1788999999999999999999999 999999999999999999999
Q ss_pred ecccccCCCccccccccccccccccCccCcccccC-CCCCccchhHhHHHHHHHHHcCCCCCCCCC
Q 018712 215 SDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMT-GQMSSKSDVYSFGVVLLELLTGRKPVDHTL 279 (351)
Q Consensus 215 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~Pf~~~~ 279 (351)
+|||+++...... ....++..|+|||.+.+ ..++.++||||||+++|||++|+.||....
T Consensus 159 ~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~ 219 (342)
T cd07879 159 LDFGLARHADAEM-----TGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD 219 (342)
T ss_pred eeCCCCcCCCCCC-----CCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999987653221 33457889999998876 468899999999999999999999998653
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-37 Score=287.41 Aligned_cols=248 Identities=24% Similarity=0.386 Sum_probs=209.9
Q ss_pred CCCCCceeccCCcEEEEEEEEC----CCCEEEEEEcCCCCCc--hHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEE
Q 018712 67 NFGTNSLIGEGSYGRVYFGVLR----SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAY 140 (351)
Q Consensus 67 ~y~~~~~Lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 140 (351)
...|.++||.|.||.|++|.++ ....||||.++..... ..+|+.|..+|.+++||||+++.+.........||.
T Consensus 630 ~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiT 709 (996)
T KOG0196|consen 630 CVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIIT 709 (996)
T ss_pred heEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEh
Confidence 4567889999999999999976 2457999999866543 467999999999999999999999999999999999
Q ss_pred EeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEeccccc
Q 018712 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (351)
Q Consensus 141 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a 220 (351)
|||++|+|..||+..... +.+.+...+++.|+.|++||-+.+ +|||||...|||++.+-..|++|||++
T Consensus 710 EyMENGsLDsFLR~~DGq--------ftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLS 778 (996)
T KOG0196|consen 710 EYMENGSLDSFLRQNDGQ--------FTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLS 778 (996)
T ss_pred hhhhCCcHHHHHhhcCCc--------eEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccce
Confidence 999999999999987653 899999999999999999999999 999999999999999999999999999
Q ss_pred CCCcccccccccccccc--ccCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCCccchhhcc------
Q 018712 221 NQAPDAAARLHSTRVLG--TFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWAT------ 291 (351)
Q Consensus 221 ~~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~------ 291 (351)
+.++++..... +..-| ..+|.|||.+....+|.++||||+|+++||.++ |..||=+..+++....+....
T Consensus 779 Rvledd~~~~y-tt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPpPm 857 (996)
T KOG0196|consen 779 RVLEDDPEAAY-TTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPPPM 857 (996)
T ss_pred eecccCCCccc-cccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhccCCCCCC
Confidence 98866653222 22222 568999999999999999999999999999877 999998877665544443322
Q ss_pred --cCCCccchhhhcccccCCCCCHHHHHHHHHHHHHh
Q 018712 292 --PKLSEDKVKQCVDTKLGGEYPPKAIAKVRKKKFIT 326 (351)
Q Consensus 292 --~~~~~~~~~~~ld~~~~~~~~~~~~~~~~~~~~~~ 326 (351)
|.-...++.+|+..+=..|+...++-..++..+..
T Consensus 858 DCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrn 894 (996)
T KOG0196|consen 858 DCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRN 894 (996)
T ss_pred CCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcC
Confidence 22223788899999999999999998888877765
|
|
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=263.32 Aligned_cols=198 Identities=24% Similarity=0.393 Sum_probs=170.1
Q ss_pred CCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCCc---hHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEEEeC
Q 018712 68 FGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHA 143 (351)
Q Consensus 68 y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 143 (351)
|.+.+.||+|++|.||++... +++.+++|.+...... ...+.+|++++++++|+||+++++++..++..++++||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 677889999999999999965 7889999998654332 456788999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccccCCC
Q 018712 144 SKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQA 223 (351)
Q Consensus 144 ~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~ 223 (351)
.+ +|.+++..... .+++..+..++.|++.||.|||+++ ++|+||||+||++++++.++|+|||.+...
T Consensus 81 ~~-~l~~~l~~~~~--------~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~ 148 (283)
T cd05118 81 DT-DLYKLIKDRQR--------GLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSF 148 (283)
T ss_pred CC-CHHHHHHhhcc--------cCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEec
Confidence 76 88888876431 2889999999999999999999999 999999999999999999999999998766
Q ss_pred ccccccccccccccccCccCcccccCC-CCCccchhHhHHHHHHHHHcCCCCCCCCC
Q 018712 224 PDAAARLHSTRVLGTFGYHAPEYAMTG-QMSSKSDVYSFGVVLLELLTGRKPVDHTL 279 (351)
Q Consensus 224 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~Pf~~~~ 279 (351)
...... .....++..|+|||.+.+. .++.++|+||||+++|+|++|+.||....
T Consensus 149 ~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~ 203 (283)
T cd05118 149 GSPVRP--YTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKS 203 (283)
T ss_pred CCCccc--ccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence 543311 1234578899999998876 78999999999999999999999997544
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=259.90 Aligned_cols=239 Identities=25% Similarity=0.360 Sum_probs=193.4
Q ss_pred CCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCC---CchHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEEEe
Q 018712 67 NFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK---QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEH 142 (351)
Q Consensus 67 ~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 142 (351)
+|++.+.||.|+||.||++... ++..+++|.+.... .....+.+|+++++.++|+||+++++.+.+....++|+||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 5888899999999999999865 78899999987543 2234677899999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccccCC
Q 018712 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222 (351)
Q Consensus 143 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~ 222 (351)
+++++|.+++...... ...+++..+..++.|++.||.|||+.| ++|+||+|+||++++++.+||+|||++..
T Consensus 81 ~~~~~L~~~~~~~~~~-----~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~ 152 (256)
T cd08530 81 APFGDLSKAISKRKKK-----RKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKV 152 (256)
T ss_pred cCCCCHHHHHHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhh
Confidence 9999999998763211 123888999999999999999999999 99999999999999999999999999877
Q ss_pred CccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccch-hhccc-------CC
Q 018712 223 APDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLV-TWATP-------KL 294 (351)
Q Consensus 223 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~-~~~~~-------~~ 294 (351)
..... .....++..|+|||.+.+..++.++|+||||+++|+|++|+.||...........+ ....+ ..
T Consensus 153 ~~~~~----~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (256)
T cd08530 153 LKKNM----AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIPPIYSQD 228 (256)
T ss_pred hccCC----cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCchhhCHH
Confidence 65431 12345788999999999989999999999999999999999999865432111111 01111 11
Q ss_pred CccchhhhcccccCCCCCHHHHH
Q 018712 295 SEDKVKQCVDTKLGGEYPPKAIA 317 (351)
Q Consensus 295 ~~~~~~~~ld~~~~~~~~~~~~~ 317 (351)
..+.+..|+..++.+|++..++.
T Consensus 229 ~~~li~~~l~~~p~~Rp~~~~~l 251 (256)
T cd08530 229 LQNFIRSMLQVKPKLRPNCDKIL 251 (256)
T ss_pred HHHHHHHHcCCCcccCCCHHHHh
Confidence 23677788888888888887664
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=262.55 Aligned_cols=198 Identities=28% Similarity=0.404 Sum_probs=166.3
Q ss_pred CCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCCc---hHHHHHHHHHHHhc---cCCceeeeEEEEecCCc-----
Q 018712 68 FGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP---DQEFLAQVSMVSRL---KNENVVELVGYYVDGPL----- 135 (351)
Q Consensus 68 y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l---~h~niv~~~~~~~~~~~----- 135 (351)
|++.+.||+|+||.||+|..+ ++..||+|++...... ...+.+|+.+++++ +|+||+++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 667889999999999999976 5899999998743322 23466777776665 69999999999987776
Q ss_pred eEEEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEe
Q 018712 136 RVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKIS 215 (351)
Q Consensus 136 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~ 215 (351)
.+++|||+.+ +|.+++...... .+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~~~~-------~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~ 149 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKCPKP-------GLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIA 149 (287)
T ss_pred eEEEehhccc-CHHHHHHHccCC-------CCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEe
Confidence 8999999975 899988764321 2889999999999999999999999 9999999999999999999999
Q ss_pred cccccCCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCC
Q 018712 216 DFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTL 279 (351)
Q Consensus 216 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~ 279 (351)
|||.+......... ....++..|+|||.+.+..++.++|+||||+++|+|++|+.||....
T Consensus 150 dfg~~~~~~~~~~~---~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~ 210 (287)
T cd07838 150 DFGLARIYSFEMAL---TSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTS 210 (287)
T ss_pred ccCcceeccCCccc---ccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCC
Confidence 99998775433211 23357889999999998899999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=267.47 Aligned_cols=203 Identities=26% Similarity=0.410 Sum_probs=166.4
Q ss_pred hcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCC---chHHHHHHHHHHHhccCCceeeeEEEEecCC------
Q 018712 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ---PDQEFLAQVSMVSRLKNENVVELVGYYVDGP------ 134 (351)
Q Consensus 65 ~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------ 134 (351)
.++|.+.+.||+|+||.||+|... +++.+|+|++..... ....+.+|++++++++|+||+++++.+.+..
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 578999999999999999999965 688999998854322 2345678999999999999999998775433
Q ss_pred --ceEEEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCce
Q 018712 135 --LRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIA 212 (351)
Q Consensus 135 --~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~v 212 (351)
..++|+||+.+ +|...+..... .+++..+..++.|+++||.|||++| ++|+||||+||++++++.+
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~~~~--------~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~ 154 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLENPSV--------KLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGIL 154 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhcccc--------CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCE
Confidence 46999999975 77777764321 2899999999999999999999999 9999999999999999999
Q ss_pred EEecccccCCCccccccc---------cccccccccCccCcccccCC-CCCccchhHhHHHHHHHHHcCCCCCCCCC
Q 018712 213 KISDFDLSNQAPDAAARL---------HSTRVLGTFGYHAPEYAMTG-QMSSKSDVYSFGVVLLELLTGRKPVDHTL 279 (351)
Q Consensus 213 kl~Dfg~a~~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~Pf~~~~ 279 (351)
||+|||++.......... ..+...+++.|+|||.+.+. .++.++||||||+++|+|++|+.||....
T Consensus 155 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~ 231 (311)
T cd07866 155 KIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKS 231 (311)
T ss_pred EECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCC
Confidence 999999987654322111 11234578889999987654 57899999999999999999999997543
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=252.95 Aligned_cols=237 Identities=26% Similarity=0.406 Sum_probs=182.0
Q ss_pred cCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCCc--hHHHHHHHHHHHhc-cCCceeeeEEEEecCCceEEEEE
Q 018712 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRL-KNENVVELVGYYVDGPLRVLAYE 141 (351)
Q Consensus 66 ~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e 141 (351)
++.+.+..||.|+.|.|+++..+ +|...|||.+...... .++++..+.++... ..|+||+.+++|..+...++.||
T Consensus 92 ndl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMe 171 (391)
T KOG0983|consen 92 NDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICME 171 (391)
T ss_pred HHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHH
Confidence 34556678999999999999975 6899999998765432 34566666665554 47999999999999999999999
Q ss_pred eCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccccC
Q 018712 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (351)
Q Consensus 142 ~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~ 221 (351)
.|.. -+..++..... .+++..+-++...+++||.||.++. +|+|||+||+|||+|+.|++||||||++.
T Consensus 172 lMs~-C~ekLlkrik~--------piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsG 240 (391)
T KOG0983|consen 172 LMST-CAEKLLKRIKG--------PIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISG 240 (391)
T ss_pred HHHH-HHHHHHHHhcC--------CchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccc
Confidence 9854 55555554432 2788888899999999999999875 49999999999999999999999999998
Q ss_pred CCccccccccccccccccCccCccccc---CCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCC-ccch-hhcccCCC-
Q 018712 222 QAPDAAARLHSTRVLGTFGYHAPEYAM---TGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQ-QSLV-TWATPKLS- 295 (351)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~-~~~~-~~~~~~~~- 295 (351)
.+-+.... +...|.+.|||||.+. ...|+.++||||||++++||+||++||.....+-. ...+ ....|.+.
T Consensus 241 rlvdSkAh---trsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ePP~L~~ 317 (391)
T KOG0983|consen 241 RLVDSKAH---TRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEPPLLPG 317 (391)
T ss_pred eeeccccc---ccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCCCCCCc
Confidence 87655443 5567999999999886 34688999999999999999999999998543311 1111 11112222
Q ss_pred --------ccchhhhcccccCCCCCHHHH
Q 018712 296 --------EDKVKQCVDTKLGGEYPPKAI 316 (351)
Q Consensus 296 --------~~~~~~~ld~~~~~~~~~~~~ 316 (351)
.+.+..|+..+...|+.-.++
T Consensus 318 ~~gFSp~F~~fv~~CL~kd~r~RP~Y~~L 346 (391)
T KOG0983|consen 318 HMGFSPDFQSFVKDCLTKDHRKRPKYNKL 346 (391)
T ss_pred ccCcCHHHHHHHHHHhhcCcccCcchHHH
Confidence 246678888888888754433
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=258.39 Aligned_cols=228 Identities=25% Similarity=0.328 Sum_probs=185.8
Q ss_pred eccCCcEEEEEEEEC-CCCEEEEEEcCCCCC----chHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEEEeCCCCCH
Q 018712 74 IGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ----PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSL 148 (351)
Q Consensus 74 Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL 148 (351)
||.|+||.||++... +++.+|+|.+..... ....+.+|+.++++++|+||+++++.+..++..+++||++++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 699999999999975 588999999875432 234688899999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccccCCCccccc
Q 018712 149 HDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAA 228 (351)
Q Consensus 149 ~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~ 228 (351)
.+++..... +++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~l~~~~~---------l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~ 148 (250)
T cd05123 81 FSHLSKEGR---------FSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS 148 (250)
T ss_pred HHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCCC
Confidence 999976542 889999999999999999999999 99999999999999999999999999876543321
Q ss_pred cccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccch-------hhcccCCCccchhh
Q 018712 229 RLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLV-------TWATPKLSEDKVKQ 301 (351)
Q Consensus 229 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~-------~~~~~~~~~~~~~~ 301 (351)
......++..|+|||...+...+.++|+||||+++|+|++|+.||...........+ ....+....+.+..
T Consensus 149 --~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~ 226 (250)
T cd05123 149 --RTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFPEFLSPEARDLISG 226 (250)
T ss_pred --cccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHH
Confidence 123456788999999998888899999999999999999999999765421111111 11112222367788
Q ss_pred hcccccCCCCCHHH
Q 018712 302 CVDTKLGGEYPPKA 315 (351)
Q Consensus 302 ~ld~~~~~~~~~~~ 315 (351)
|+..++..|++...
T Consensus 227 ~l~~~p~~R~~~~~ 240 (250)
T cd05123 227 LLQKDPTKRLGSGG 240 (250)
T ss_pred HhcCCHhhCCCccc
Confidence 88888888887743
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=265.56 Aligned_cols=197 Identities=24% Similarity=0.341 Sum_probs=161.2
Q ss_pred ceeccC--CcEEEEEEEEC-CCCEEEEEEcCCCCCc---hHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEEEeCCC
Q 018712 72 SLIGEG--SYGRVYFGVLR-SGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASK 145 (351)
Q Consensus 72 ~~Lg~G--~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 145 (351)
..||+| +||+||++.+. +++.||+|++...... .+.+.+|+.+++.++||||+++++++..++..++|+||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 356666 99999999975 7999999998754432 25578899999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccccCCCcc
Q 018712 146 GSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPD 225 (351)
Q Consensus 146 gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~ 225 (351)
++|.+++...... .+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++++||+.+.....
T Consensus 84 ~~l~~~l~~~~~~-------~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~ 153 (328)
T cd08226 84 GSANSLLKTYFPE-------GMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVR 153 (328)
T ss_pred CCHHHHHHhhccc-------CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhc
Confidence 9999998865321 2788899999999999999999999 99999999999999999999999986533221
Q ss_pred ccccc-----cccccccccCccCcccccCC--CCCccchhHhHHHHHHHHHcCCCCCCCC
Q 018712 226 AAARL-----HSTRVLGTFGYHAPEYAMTG--QMSSKSDVYSFGVVLLELLTGRKPVDHT 278 (351)
Q Consensus 226 ~~~~~-----~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~el~tg~~Pf~~~ 278 (351)
..... ......++..|+|||++.+. .++.++||||||+++|+|++|+.||...
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~ 213 (328)
T cd08226 154 NGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDM 213 (328)
T ss_pred cCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCc
Confidence 11000 00112345679999998764 4789999999999999999999999764
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=268.63 Aligned_cols=239 Identities=23% Similarity=0.314 Sum_probs=192.0
Q ss_pred CCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCC---CchHHHHHHHHHHHhccCCceeeeEEEEecCC-----ceE
Q 018712 67 NFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK---QPDQEFLAQVSMVSRLKNENVVELVGYYVDGP-----LRV 137 (351)
Q Consensus 67 ~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-----~~~ 137 (351)
+|.+.+.||.|++|.||+|... ++..+|+|++.... ...+.+.+|+.+++.++|+||+++++++.... ..|
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 5888999999999999999975 58999999887543 23467889999999999999999999887765 789
Q ss_pred EEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecc
Q 018712 138 LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDF 217 (351)
Q Consensus 138 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Df 217 (351)
++|||+.+ +|.+++.... .+++..+..++.||+.||.|||+.| ++||||||+|||++.++.++|+||
T Consensus 81 lv~e~~~~-~l~~~l~~~~---------~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~df 147 (330)
T cd07834 81 IVTELMET-DLHKVIKSPQ---------PLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDF 147 (330)
T ss_pred EEecchhh-hHHHHHhCCC---------CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEccc
Confidence 99999975 8999987653 2899999999999999999999999 999999999999999999999999
Q ss_pred cccCCCcccccc-ccccccccccCccCcccccCC-CCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccc---------
Q 018712 218 DLSNQAPDAAAR-LHSTRVLGTFGYHAPEYAMTG-QMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSL--------- 286 (351)
Q Consensus 218 g~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~--------- 286 (351)
|++......... .......++..|+|||.+.+. .++.++|+||||+++|+|++|+.||...........
T Consensus 148 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~ 227 (330)
T cd07834 148 GLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPS 227 (330)
T ss_pred CceEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCC
Confidence 998876543210 112334578899999999887 789999999999999999999999976542110000
Q ss_pred ---------------hh---------h--c---ccCCCccchhhhcccccCCCCCHHHHHH
Q 018712 287 ---------------VT---------W--A---TPKLSEDKVKQCVDTKLGGEYPPKAIAK 318 (351)
Q Consensus 287 ---------------~~---------~--~---~~~~~~~~~~~~ld~~~~~~~~~~~~~~ 318 (351)
+. + . .+....+.+..|+..+|.+|++.+++..
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~ 288 (330)
T cd07834 228 EEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALA 288 (330)
T ss_pred hhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 00 0 0 0111136788999999999999877654
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=270.25 Aligned_cols=240 Identities=21% Similarity=0.285 Sum_probs=185.0
Q ss_pred hcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCC-chHHHHHHHHHHHhccCCceeeeEEEEecC---------
Q 018712 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ-PDQEFLAQVSMVSRLKNENVVELVGYYVDG--------- 133 (351)
Q Consensus 65 ~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--------- 133 (351)
..+|.+.+.||.|+||.||+|... ++..||+|++..... ....+.+|++++++++||||+++++.+...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 368999999999999999999965 689999998865433 345688899999999999999998765543
Q ss_pred -----CceEEEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEcc
Q 018712 134 -----PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFD 208 (351)
Q Consensus 134 -----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~ 208 (351)
...++||||+.+ +|.+++.... +++..++.++.||+.||.|||+.| ++||||||+||+++.
T Consensus 84 ~~~~~~~~~lv~e~~~~-~L~~~~~~~~----------l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~ 149 (342)
T cd07854 84 SLTELNSVYIVQEYMET-DLANVLEQGP----------LSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINT 149 (342)
T ss_pred cccccceEEEEeecccc-cHHHHHHcCC----------CCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcC
Confidence 357899999974 9998886532 888999999999999999999999 999999999999974
Q ss_pred -CCceEEecccccCCCccccccc-cccccccccCccCcccccC-CCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCcc
Q 018712 209 -DDIAKISDFDLSNQAPDAAARL-HSTRVLGTFGYHAPEYAMT-GQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQS 285 (351)
Q Consensus 209 -~~~vkl~Dfg~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~ 285 (351)
++.+||+|||++.......... ......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||....+.....
T Consensus 150 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~ 229 (342)
T cd07854 150 EDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQ 229 (342)
T ss_pred CCceEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 5578999999987653221111 1122357889999997654 567889999999999999999999997543211100
Q ss_pred ch----------------------------------hhcccCCC---ccchhhhcccccCCCCCHHHHHH
Q 018712 286 LV----------------------------------TWATPKLS---EDKVKQCVDTKLGGEYPPKAIAK 318 (351)
Q Consensus 286 ~~----------------------------------~~~~~~~~---~~~~~~~ld~~~~~~~~~~~~~~ 318 (351)
.. ....+... .+.+..|+.++|.+|++.+++..
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 230 LILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred HHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence 00 00011111 25788999999999998887643
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-35 Score=261.88 Aligned_cols=240 Identities=24% Similarity=0.381 Sum_probs=185.8
Q ss_pred HhcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCC--chHHHHHHHHHHHhc-cCCceeeeEEEEecCCceEEE
Q 018712 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ--PDQEFLAQVSMVSRL-KNENVVELVGYYVDGPLRVLA 139 (351)
Q Consensus 64 ~~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv 139 (351)
..++|++.+.||+|+||.||+|.+. +++.||+|.+..... ....+..|+.++.+. .|+||+++++++.+....+++
T Consensus 13 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v 92 (296)
T cd06618 13 DLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFIC 92 (296)
T ss_pred CcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEE
Confidence 4467899999999999999999976 489999999875432 234566677766666 599999999999999999999
Q ss_pred EEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhh-CCCCCeeeccccCCcEEEccCCceEEeccc
Q 018712 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHE-KAEPRIIHRNIKSSNVLLFDDDIAKISDFD 218 (351)
Q Consensus 140 ~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~-~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg 218 (351)
|||+.+ +|.+++..... .+++..+..++.|++.||.|||+ .+ ++||||+|+||++++++.+||+|||
T Consensus 93 ~e~~~~-~l~~l~~~~~~--------~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~~~~~~kL~dfg 160 (296)
T cd06618 93 MELMST-CLDKLLKRIQG--------PIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDFG 160 (296)
T ss_pred eeccCc-CHHHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEcCCCCEEECccc
Confidence 999854 78777765332 28889999999999999999997 57 9999999999999999999999999
Q ss_pred ccCCCccccccccccccccccCccCcccccCCC----CCccchhHhHHHHHHHHHcCCCCCCCCCCCCC-c-cchhhc--
Q 018712 219 LSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQ----MSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQ-Q-SLVTWA-- 290 (351)
Q Consensus 219 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~-~-~~~~~~-- 290 (351)
++......... ....++..|+|||.+.+.. ++.++||||||+++|+|++|+.||........ . ......
T Consensus 161 ~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~ 237 (296)
T cd06618 161 ISGRLVDSKAK---TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPP 237 (296)
T ss_pred cchhccCCCcc---cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCC
Confidence 98765432221 2335788999999987554 78899999999999999999999975322100 0 000000
Q ss_pred -------ccCCCccchhhhcccccCCCCCHHHHHH
Q 018712 291 -------TPKLSEDKVKQCVDTKLGGEYPPKAIAK 318 (351)
Q Consensus 291 -------~~~~~~~~~~~~ld~~~~~~~~~~~~~~ 318 (351)
.+....+.+..|+..+|.+|++.+++..
T Consensus 238 ~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 272 (296)
T cd06618 238 SLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQ 272 (296)
T ss_pred CCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 1111236778899999999998766643
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-35 Score=263.93 Aligned_cols=235 Identities=27% Similarity=0.411 Sum_probs=187.3
Q ss_pred CCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCC----chHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEEE
Q 018712 67 NFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ----PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYE 141 (351)
Q Consensus 67 ~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 141 (351)
.|...+.||+|+||.||+|... ++..+|+|.+..... ....+.+|+++++.++|+|++++++++......++|||
T Consensus 16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 95 (308)
T cd06634 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (308)
T ss_pred HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEE
Confidence 4777788999999999999965 678899998864321 23457789999999999999999999999999999999
Q ss_pred eCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccccC
Q 018712 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (351)
Q Consensus 142 ~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~ 221 (351)
|+. |+|.+++..... .++...+..++.|++.||.|||+.+ ++||||+|+||+++.++.++|+|||++.
T Consensus 96 ~~~-~~l~~~~~~~~~--------~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~ 163 (308)
T cd06634 96 YCL-GSASDLLEVHKK--------PLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSAS 163 (308)
T ss_pred ccC-CCHHHHHHHcCC--------CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccce
Confidence 997 588887754332 2788999999999999999999999 9999999999999999999999999886
Q ss_pred CCccccccccccccccccCccCccccc---CCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccch-h--------h
Q 018712 222 QAPDAAARLHSTRVLGTFGYHAPEYAM---TGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLV-T--------W 289 (351)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~-~--------~ 289 (351)
..... ....++..|+|||.+. ...++.++||||||+++|+|++|+.||...........+ . .
T Consensus 164 ~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 237 (308)
T cd06634 164 IMAPA------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSG 237 (308)
T ss_pred eecCc------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCCCcCcc
Confidence 54322 3345788999999874 346788999999999999999999998764332111111 0 1
Q ss_pred cccCCCccchhhhcccccCCCCCHHHHHHH
Q 018712 290 ATPKLSEDKVKQCVDTKLGGEYPPKAIAKV 319 (351)
Q Consensus 290 ~~~~~~~~~~~~~ld~~~~~~~~~~~~~~~ 319 (351)
..+....+.+.+|+...|.+|++.+++...
T Consensus 238 ~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~ 267 (308)
T cd06634 238 HWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 267 (308)
T ss_pred cccHHHHHHHHHHhhCCcccCCCHHHHhhC
Confidence 111122367889999999999998776543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=277.87 Aligned_cols=256 Identities=25% Similarity=0.347 Sum_probs=204.0
Q ss_pred CCCCceeccCCcEEEEEEEEC--CCC--EEEEEEcCCCCCc--hHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEEE
Q 018712 68 FGTNSLIGEGSYGRVYFGVLR--SGR--AAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYE 141 (351)
Q Consensus 68 y~~~~~Lg~G~~g~Vy~~~~~--~~~--~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 141 (351)
..+.++||+|+||.|++|.+. +|+ .||||.+...... ..+|++|+.+|.+|+|+|++++|+...+ ....+|+|
T Consensus 112 i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~E 190 (1039)
T KOG0199|consen 112 IKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFE 190 (1039)
T ss_pred HHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhh
Confidence 345668999999999999975 343 6899999866543 5789999999999999999999999887 56789999
Q ss_pred eCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccccC
Q 018712 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (351)
Q Consensus 142 ~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~ 221 (351)
+++.|||.+.|++... ..|.....-.++.||+.|+.||..++ +|||||...|+|+.....|||+|||+.+
T Consensus 191 LaplGSLldrLrka~~-------~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmR 260 (1039)
T KOG0199|consen 191 LAPLGSLLDRLRKAKK-------AILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMR 260 (1039)
T ss_pred hcccchHHHHHhhccc-------cceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeeccccee
Confidence 9999999999987322 23788889999999999999999999 9999999999999999999999999999
Q ss_pred CCccccccccc-cccccccCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCCccchhh----cccCCC
Q 018712 222 QAPDAAARLHS-TRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTW----ATPKLS 295 (351)
Q Consensus 222 ~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~Pf~~~~~~~~~~~~~~----~~~~~~ 295 (351)
.+......+.. ....-...|.|||.+....++.++|||+|||++|||+| |..||-+.........++. -+|+..
T Consensus 261 aLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~erLpRPk~c 340 (1039)
T KOG0199|consen 261 ALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGERLPRPKYC 340 (1039)
T ss_pred ccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccccccCCCCCCC
Confidence 88765543322 22234568999999999999999999999999999999 9999998765544444431 111111
Q ss_pred ----ccchhhhcccccCCCCCHHHHH--HHHHHHHHhhhhccccc
Q 018712 296 ----EDKVKQCVDTKLGGEYPPKAIA--KVRKKKFITSECSNISF 334 (351)
Q Consensus 296 ----~~~~~~~ld~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~ 334 (351)
-+.+++|+...+.+|++...+. -+...+.-...|..-++
T Consensus 341 sedIY~imk~cWah~paDRptFsair~~~~l~eaqp~~a~~~~d~ 385 (1039)
T KOG0199|consen 341 SEDIYQIMKNCWAHNPADRPTFSAIREDLVLAEAQPAVARETYDS 385 (1039)
T ss_pred hHHHHHHHHHhccCCccccccHHHHHHhHHHHhcCCceeeeeccc
Confidence 1678999999999999998885 33444433344443333
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-35 Score=260.20 Aligned_cols=198 Identities=25% Similarity=0.423 Sum_probs=167.7
Q ss_pred CCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCC--chHHHHHHHHHHHhcc-CCceeeeEEEEecCCceEEEEEeC
Q 018712 68 FGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ--PDQEFLAQVSMVSRLK-NENVVELVGYYVDGPLRVLAYEHA 143 (351)
Q Consensus 68 y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~ 143 (351)
|.+.+.||+|++|.||+|... +++.|++|++..... ......+|+..+++++ |+||+++++.+.+++..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 677889999999999999975 578999999865433 2234567899999998 999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccccCCC
Q 018712 144 SKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQA 223 (351)
Q Consensus 144 ~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~ 223 (351)
+++|.+++..... ..+++..+..++.|++.+|.|||+++ ++|+||+|+||++++++.++|+|||++...
T Consensus 81 -~~~l~~~~~~~~~-------~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~ 149 (283)
T cd07830 81 -EGNLYQLMKDRKG-------KPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREI 149 (283)
T ss_pred -CCCHHHHHHhccc-------ccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceec
Confidence 7799999876541 12899999999999999999999999 999999999999999999999999998765
Q ss_pred ccccccccccccccccCccCccccc-CCCCCccchhHhHHHHHHHHHcCCCCCCCCC
Q 018712 224 PDAAARLHSTRVLGTFGYHAPEYAM-TGQMSSKSDVYSFGVVLLELLTGRKPVDHTL 279 (351)
Q Consensus 224 ~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~il~el~tg~~Pf~~~~ 279 (351)
..... .....++..|+|||.+. +..++.++|+||||+++++|++|+.||....
T Consensus 150 ~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~ 203 (283)
T cd07830 150 RSRPP---YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSS 203 (283)
T ss_pred cCCCC---cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCC
Confidence 43221 13345788999999875 4457899999999999999999999996543
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=264.87 Aligned_cols=199 Identities=24% Similarity=0.322 Sum_probs=164.0
Q ss_pred CCCCCceeccCCcEEEEEEEEC-C--CCEEEEEEcCCCCC---chHHHHHHHHHHHhc-cCCceeeeEEEEec----CCc
Q 018712 67 NFGTNSLIGEGSYGRVYFGVLR-S--GRAAAIKKLDSSKQ---PDQEFLAQVSMVSRL-KNENVVELVGYYVD----GPL 135 (351)
Q Consensus 67 ~y~~~~~Lg~G~~g~Vy~~~~~-~--~~~vavK~~~~~~~---~~~~~~~e~~~l~~l-~h~niv~~~~~~~~----~~~ 135 (351)
+|.+.+.||+|+||.||++... + +..||+|++..... ..+.+.+|+.+++++ +|+||+++++.+.. ...
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 4788899999999999999965 4 78999999864322 245678899999999 59999999986432 245
Q ss_pred eEEEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEe
Q 018712 136 RVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKIS 215 (351)
Q Consensus 136 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~ 215 (351)
.+++++++. ++|.+++..... +++..++.++.||+.||.|||++| ++||||||+|||++.++.+||+
T Consensus 81 ~~~~~e~~~-~~L~~~l~~~~~---------~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~ 147 (332)
T cd07857 81 LYLYEELME-ADLHQIIRSGQP---------LTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKIC 147 (332)
T ss_pred EEEEEeccc-CCHHHHHhcCCC---------CCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeC
Confidence 788899886 599999865432 889999999999999999999999 9999999999999999999999
Q ss_pred cccccCCCcccccc--ccccccccccCccCcccccC-CCCCccchhHhHHHHHHHHHcCCCCCCCC
Q 018712 216 DFDLSNQAPDAAAR--LHSTRVLGTFGYHAPEYAMT-GQMSSKSDVYSFGVVLLELLTGRKPVDHT 278 (351)
Q Consensus 216 Dfg~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~Pf~~~ 278 (351)
|||++......... .......||..|+|||.+.+ ..++.++|+||||+++|+|++|+.||...
T Consensus 148 Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~ 213 (332)
T cd07857 148 DFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGK 213 (332)
T ss_pred cCCCceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCC
Confidence 99999765432211 11233568999999998765 46899999999999999999999999754
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=278.72 Aligned_cols=254 Identities=28% Similarity=0.454 Sum_probs=207.6
Q ss_pred HHHHHHHhcCCCCCceeccCCcEEEEEEEE-CCCCEEEEEEcCCCCCchHHHHHHHHHHHhc-cCCceeeeEEEEe----
Q 018712 58 VDELKEKTDNFGTNSLIGEGSYGRVYFGVL-RSGRAAAIKKLDSSKQPDQEFLAQVSMVSRL-KNENVVELVGYYV---- 131 (351)
Q Consensus 58 ~~~~~~~~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~---- 131 (351)
++.+..-++-|++.+.||.|.+|.||+++. ++++..|+|+.......+.++..|..+++.+ .|||++.++++|.
T Consensus 11 ~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~ 90 (953)
T KOG0587|consen 11 LSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDP 90 (953)
T ss_pred hhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEecC
Confidence 344455667899999999999999999995 5889999999998888888899999999988 6899999999886
Q ss_pred -cCCceEEEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCC
Q 018712 132 -DGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD 210 (351)
Q Consensus 132 -~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~ 210 (351)
.++.++||||||.+||..++++..... .+.+..+..|++.++.|+.+||++. ++|||||-.|||++.++
T Consensus 91 ~~~DqLWLVMEfC~gGSVTDLVKn~~g~-------rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~ 160 (953)
T KOG0587|consen 91 GNGDQLWLVMEFCGGGSVTDLVKNTKGN-------RLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENA 160 (953)
T ss_pred CCCCeEEEEeeccCCccHHHHHhhhccc-------chhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccC
Confidence 456899999999999999999876633 3899999999999999999999998 99999999999999999
Q ss_pred ceEEecccccCCCccccccccccccccccCccCcccccC-----CCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCcc
Q 018712 211 IAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMT-----GQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQS 285 (351)
Q Consensus 211 ~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~ 285 (351)
.|||+|||++....... ....+..|||.|||||++.. ..|+..+|+||||++..||.-|.+|+.+..+..-..
T Consensus 161 ~VKLvDFGvSaQldsT~--grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF 238 (953)
T KOG0587|consen 161 EVKLVDFGVSAQLDSTV--GRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALF 238 (953)
T ss_pred cEEEeeeeeeeeeeccc--ccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhc
Confidence 99999999987764432 23366789999999999863 357789999999999999999999999887765555
Q ss_pred chhhcccCCC----------ccchhhhcccccCCCCCHHHHHHHHHHHHHh
Q 018712 286 LVTWATPKLS----------EDKVKQCVDTKLGGEYPPKAIAKVRKKKFIT 326 (351)
Q Consensus 286 ~~~~~~~~~~----------~~~~~~~ld~~~~~~~~~~~~~~~~~~~~~~ 326 (351)
.|....|.-. .+.+..|+..+-..|+...++ +++.|+.
T Consensus 239 ~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~l---l~hpFi~ 286 (953)
T KOG0587|consen 239 LIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEEL---LKHPFIT 286 (953)
T ss_pred cCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhh---ccCCccc
Confidence 5544433222 156677777777777755443 4444443
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=272.85 Aligned_cols=232 Identities=21% Similarity=0.316 Sum_probs=190.0
Q ss_pred HhcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCCchHHHHHHHHHHHhc-cCCceeeeEEEEecCCceEEEEE
Q 018712 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRL-KNENVVELVGYYVDGPLRVLAYE 141 (351)
Q Consensus 64 ~~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e 141 (351)
.++.|.....+|.|+|+.|-.+.+. +++..++|++.+... +..+|+.++... +|+||+++.+.+.+....|+|||
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~---~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e 396 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD---DNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVME 396 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheecccccc---ccccccchhhhhcCCCcceeecceecCCceeeeeeh
Confidence 4678999999999999999999864 788999999987732 234567665555 89999999999999999999999
Q ss_pred eCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEE-ccCCceEEeccccc
Q 018712 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLL-FDDDIAKISDFDLS 220 (351)
Q Consensus 142 ~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill-~~~~~vkl~Dfg~a 220 (351)
.+.|+-|.+.+...+. +. .++..|+++|+.|+.|||.+| +|||||||+|||+ ++.++++|+|||.+
T Consensus 397 ~l~g~ell~ri~~~~~---------~~-~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a 463 (612)
T KOG0603|consen 397 LLDGGELLRRIRSKPE---------FC-SEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFW 463 (612)
T ss_pred hccccHHHHHHHhcch---------hH-HHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechh
Confidence 9999888877766542 33 778889999999999999999 9999999999999 58899999999999
Q ss_pred CCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccchhhccc-------C
Q 018712 221 NQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATP-------K 293 (351)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~-------~ 293 (351)
+..... ..+.+-|..|.|||++....|++++|+||||++||+|++|+.||....... ...-....+ .
T Consensus 464 ~~~~~~-----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~-ei~~~i~~~~~s~~vS~ 537 (612)
T KOG0603|consen 464 SELERS-----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGI-EIHTRIQMPKFSECVSD 537 (612)
T ss_pred hhCchh-----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchH-HHHHhhcCCccccccCH
Confidence 887654 123456889999999999999999999999999999999999999765441 111111122 1
Q ss_pred CCccchhhhcccccCCCCCHHHHH
Q 018712 294 LSEDKVKQCVDTKLGGEYPPKAIA 317 (351)
Q Consensus 294 ~~~~~~~~~ld~~~~~~~~~~~~~ 317 (351)
...+++.+||..+|..|++..++.
T Consensus 538 ~AKdLl~~LL~~dP~~Rl~~~~i~ 561 (612)
T KOG0603|consen 538 EAKDLLQQLLQVDPALRLGADEIG 561 (612)
T ss_pred HHHHHHHHhccCChhhCcChhhhc
Confidence 123788999999999999877654
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=262.95 Aligned_cols=198 Identities=19% Similarity=0.232 Sum_probs=160.8
Q ss_pred CCceeccCCcEEEEEEEECCCCEEEEEEcCCCC---CchHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEEEeCCCC
Q 018712 70 TNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSK---QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASKG 146 (351)
Q Consensus 70 ~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 146 (351)
+.+.+|.|+++.|+++.. +++.||+|++.... .....+.+|+++++.++|+||+++++.+.+.+..+++|||++++
T Consensus 6 i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~ 84 (314)
T cd08216 6 IGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYG 84 (314)
T ss_pred hhHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCC
Confidence 344455555555555444 68999999987542 23356889999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccccCCCccc
Q 018712 147 SLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDA 226 (351)
Q Consensus 147 sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~ 226 (351)
+|.+++...... .++...+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||.+......
T Consensus 85 ~l~~~l~~~~~~-------~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~ 154 (314)
T cd08216 85 SCEDLLKTHFPE-------GLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKH 154 (314)
T ss_pred CHHHHHHHhccc-------CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeeccc
Confidence 999999864322 2788899999999999999999999 999999999999999999999999988654322
Q ss_pred cc-----cccccccccccCccCcccccC--CCCCccchhHhHHHHHHHHHcCCCCCCCC
Q 018712 227 AA-----RLHSTRVLGTFGYHAPEYAMT--GQMSSKSDVYSFGVVLLELLTGRKPVDHT 278 (351)
Q Consensus 227 ~~-----~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~el~tg~~Pf~~~ 278 (351)
.. ........++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~ 213 (314)
T cd08216 155 GKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDM 213 (314)
T ss_pred cccccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Confidence 11 011123456788999999875 35889999999999999999999999854
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=269.44 Aligned_cols=198 Identities=30% Similarity=0.443 Sum_probs=168.6
Q ss_pred HHhcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCC---chHHHHHHHHHHHhccCCceeeeEEEEecCCc---
Q 018712 63 EKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ---PDQEFLAQVSMVSRLKNENVVELVGYYVDGPL--- 135 (351)
Q Consensus 63 ~~~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~--- 135 (351)
...++|.+...||+|++|.||+|... ++..||+|++..... ....+.+|+.+++++.|+||+++++++...+.
T Consensus 12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07851 12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED 91 (343)
T ss_pred cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence 35678999999999999999999975 688999999865322 23457789999999999999999987765554
Q ss_pred ---eEEEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCce
Q 018712 136 ---RVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIA 212 (351)
Q Consensus 136 ---~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~v 212 (351)
.++|+||+ +++|.+++.... +++..+..++.|++.||.|||+.| ++||||||+||++++++.+
T Consensus 92 ~~~~~lv~e~~-~~~L~~~~~~~~----------l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~ 157 (343)
T cd07851 92 FQDVYLVTHLM-GADLNNIVKCQK----------LSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCEL 157 (343)
T ss_pred cccEEEEEecC-CCCHHHHHhcCC----------CCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCE
Confidence 89999998 569999997532 899999999999999999999999 9999999999999999999
Q ss_pred EEecccccCCCccccccccccccccccCccCcccccC-CCCCccchhHhHHHHHHHHHcCCCCCCCCC
Q 018712 213 KISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMT-GQMSSKSDVYSFGVVLLELLTGRKPVDHTL 279 (351)
Q Consensus 213 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~Pf~~~~ 279 (351)
+|+|||++...... .....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||....
T Consensus 158 kL~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~ 220 (343)
T cd07851 158 KILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSD 220 (343)
T ss_pred EEcccccccccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999998765432 133457889999998865 367899999999999999999999997543
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=254.54 Aligned_cols=216 Identities=19% Similarity=0.212 Sum_probs=171.0
Q ss_pred CCcEEEEEEEEC-CCCEEEEEEcCCCCCchHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEEEeCCCCCHHHHhccC
Q 018712 77 GSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGK 155 (351)
Q Consensus 77 G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~ 155 (351)
|.+|.||++.+. +++.||+|.+..... ..+|...+....||||+++++++.+.+..+++|||+++|+|.+++...
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~----~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 79 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSSE----YSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKF 79 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchhh----hhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHHh
Confidence 889999999975 789999999876532 334445555567999999999999999999999999999999998765
Q ss_pred CCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccccCCCcccccccccccc
Q 018712 156 KGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRV 235 (351)
Q Consensus 156 ~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~ 235 (351)
.. +++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||.+....... ...
T Consensus 80 ~~---------l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~-----~~~ 142 (237)
T cd05576 80 LN---------IPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC-----DGE 142 (237)
T ss_pred cC---------CCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhcccccc-----ccC
Confidence 32 889999999999999999999999 9999999999999999999999999876554321 223
Q ss_pred ccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccc---hhhcccCCCccchhhhcccccCCCCC
Q 018712 236 LGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSL---VTWATPKLSEDKVKQCVDTKLGGEYP 312 (351)
Q Consensus 236 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~---~~~~~~~~~~~~~~~~ld~~~~~~~~ 312 (351)
.++..|+|||.+.+..++.++|+||+|+++|+|++|+.|+........... +....+....+.+..|++.+|.+|++
T Consensus 143 ~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~ 222 (237)
T cd05576 143 AVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGINTHTTLNIPEWVSEEARSLLQQLLQFNPTERLG 222 (237)
T ss_pred CcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhcccccccCCcccCCHHHHHHHHHHccCCHHHhcC
Confidence 457789999999888899999999999999999999998764322111100 11111111235778888888888886
Q ss_pred H
Q 018712 313 P 313 (351)
Q Consensus 313 ~ 313 (351)
.
T Consensus 223 ~ 223 (237)
T cd05576 223 A 223 (237)
T ss_pred C
Confidence 4
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=262.66 Aligned_cols=246 Identities=29% Similarity=0.462 Sum_probs=188.5
Q ss_pred hcCCCCCceeccCCcEEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHHh--ccCCceeeeEEEEecCC----ceEE
Q 018712 65 TDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSR--LKNENVVELVGYYVDGP----LRVL 138 (351)
Q Consensus 65 ~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~--l~h~niv~~~~~~~~~~----~~~l 138 (351)
....+..++||+|.||.||+|.+. ++.||||++.... .+.+.+|-.+++. +.|+||+++++.-.... .++|
T Consensus 209 l~pl~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~~~--kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywL 285 (534)
T KOG3653|consen 209 LDPLQLLELIGRGRFGCVWKAQLD-NRLVAVKIFPEQE--KQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWL 285 (534)
T ss_pred CCchhhHHHhhcCccceeehhhcc-CceeEEEecCHHH--HHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeE
Confidence 345566778999999999999985 5899999986543 4667788777664 58999999998865444 7899
Q ss_pred EEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCC------CCCeeeccccCCcEEEccCCce
Q 018712 139 AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKA------EPRIIHRNIKSSNVLLFDDDIA 212 (351)
Q Consensus 139 v~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~------~~~ivH~Dlkp~Nill~~~~~v 212 (351)
|++|.+.|+|.+||+... ++|....+++..+++||+|||+.- .+.|+|||||..||||.+|++.
T Consensus 286 Vt~fh~kGsL~dyL~~nt----------isw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTc 355 (534)
T KOG3653|consen 286 VTEFHPKGSLCDYLKANT----------ISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTC 355 (534)
T ss_pred EeeeccCCcHHHHHHhcc----------ccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcE
Confidence 999999999999999875 999999999999999999999863 3459999999999999999999
Q ss_pred EEecccccCCCccccccccccccccccCccCcccccCCC-CC-----ccchhHhHHHHHHHHHcCCCCCC-CCCCC----
Q 018712 213 KISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQ-MS-----SKSDVYSFGVVLLELLTGRKPVD-HTLPR---- 281 (351)
Q Consensus 213 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-----~~~DvwslG~il~el~tg~~Pf~-~~~~~---- 281 (351)
.|+|||+|..+............+||.+|||||++.+.. .. .+.||||+|.++|||+++-.-+. +..+.
T Consensus 356 cIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlp 435 (534)
T KOG3653|consen 356 CIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLP 435 (534)
T ss_pred EeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCc
Confidence 999999998887555444444578999999999997652 22 36899999999999998543332 11111
Q ss_pred ------------CCcc--chhhcccCCCc------------cchhhhcccccCCCCCHHHH-HHHHHHH
Q 018712 282 ------------GQQS--LVTWATPKLSE------------DKVKQCVDTKLGGEYPPKAI-AKVRKKK 323 (351)
Q Consensus 282 ------------~~~~--~~~~~~~~~~~------------~~~~~~ld~~~~~~~~~~~~-~~~~~~~ 323 (351)
..+. ...+.+|.+.+ +.+.+|+|.++.-|.++.-+ .++.++.
T Consensus 436 fe~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~ 504 (534)
T KOG3653|consen 436 FEAEVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELM 504 (534)
T ss_pred hhHHhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHh
Confidence 0011 12244555543 67889999988888776533 3344443
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=255.46 Aligned_cols=240 Identities=20% Similarity=0.268 Sum_probs=182.7
Q ss_pred CCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCC------CCchHHHHHHHHHHHhccCCceeeeEEEEecCCceEEE
Q 018712 67 NFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSS------KQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLA 139 (351)
Q Consensus 67 ~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~------~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 139 (351)
+|.+.+.||+|+||.||++.+. .+..+++|.++.. ......+..|+.+++.++||||+++++++.+.+..+++
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 5888999999999999999865 3445656655421 12233566788999999999999999999999999999
Q ss_pred EEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccc
Q 018712 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDL 219 (351)
Q Consensus 140 ~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~ 219 (351)
+||+++++|.+++...... ...+++..++.++.|++.||.|||+.+ ++|+||+|+||++++ +.++|+|||+
T Consensus 81 ~e~~~~~~l~~~~~~~~~~-----~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~ 151 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHT-----GKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGV 151 (260)
T ss_pred EEeCCCCCHHHHHHHHhhc-----ccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCc
Confidence 9999999999988643211 123889999999999999999999999 999999999999975 5699999999
Q ss_pred cCCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccch--------hhcc
Q 018712 220 SNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLV--------TWAT 291 (351)
Q Consensus 220 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~--------~~~~ 291 (351)
+......... .....|+..|+|||.+.+..++.++|+||||+++|+|++|..||...........+ ....
T Consensus 152 ~~~~~~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (260)
T cd08222 152 SRLLMGSCDL--ATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSLPETY 229 (260)
T ss_pred eeecCCCccc--ccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCCcchh
Confidence 8765432211 13345788999999998888899999999999999999999999643221110000 0011
Q ss_pred cCCCccchhhhcccccCCCCCHHHHH
Q 018712 292 PKLSEDKVKQCVDTKLGGEYPPKAIA 317 (351)
Q Consensus 292 ~~~~~~~~~~~ld~~~~~~~~~~~~~ 317 (351)
+....+.+..|+..+|.+|++..++.
T Consensus 230 ~~~~~~li~~~l~~~p~~Rp~~~~il 255 (260)
T cd08222 230 SRQLNSIMQSMLNKDPSLRPSAAEIL 255 (260)
T ss_pred cHHHHHHHHHHhcCChhhCcCHHHHh
Confidence 11112467778888888888776654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=283.99 Aligned_cols=145 Identities=26% Similarity=0.359 Sum_probs=130.5
Q ss_pred hcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCCc----hHHHHHHHHHHHhccCCceeeeEEEEecCCceEEE
Q 018712 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP----DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLA 139 (351)
Q Consensus 65 ~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 139 (351)
.++|.+.+.||+|+||.||+|.+. +++.||+|++...... ...+..|+.+++.++|+||++++..+......|+|
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence 468999999999999999999976 7899999998754321 25678899999999999999999999999999999
Q ss_pred EEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccc
Q 018712 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDL 219 (351)
Q Consensus 140 ~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~ 219 (351)
|||+.+++|.+++..... +++..++.++.||+.||.|||.++ |+||||||+|||++.++.+||+|||+
T Consensus 83 mEy~~g~~L~~li~~~~~---------l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGl 150 (669)
T cd05610 83 MEYLIGGDVKSLLHIYGY---------FDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGL 150 (669)
T ss_pred EeCCCCCCHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCC
Confidence 999999999999976432 788889999999999999999999 99999999999999999999999998
Q ss_pred cC
Q 018712 220 SN 221 (351)
Q Consensus 220 a~ 221 (351)
++
T Consensus 151 s~ 152 (669)
T cd05610 151 SK 152 (669)
T ss_pred Cc
Confidence 75
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-34 Score=293.64 Aligned_cols=240 Identities=25% Similarity=0.445 Sum_probs=184.6
Q ss_pred HHhcCCCCCceeccCCcEEEEEEEE-CCCCEEEEEEcCCCCCchHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEEE
Q 018712 63 EKTDNFGTNSLIGEGSYGRVYFGVL-RSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYE 141 (351)
Q Consensus 63 ~~~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 141 (351)
.....|...+.||+|+||.||+|.. .++..||+|++...... ...|++.+++++||||+++++++.+.+..++|||
T Consensus 687 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~E 763 (968)
T PLN00113 687 DILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI---PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHE 763 (968)
T ss_pred HHHhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc---cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEe
Confidence 3345677888999999999999997 47899999998654332 2356889999999999999999999999999999
Q ss_pred eCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccccC
Q 018712 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (351)
Q Consensus 142 ~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~ 221 (351)
|+++|+|.++++. +++..+..++.|++.||+|||.....+++||||||+||+++.++..++. ||...
T Consensus 764 y~~~g~L~~~l~~------------l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~ 830 (968)
T PLN00113 764 YIEGKNLSEVLRN------------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPG 830 (968)
T ss_pred CCCCCcHHHHHhc------------CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccc
Confidence 9999999999952 7889999999999999999995422339999999999999998887775 66543
Q ss_pred CCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccchhhcc----------
Q 018712 222 QAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWAT---------- 291 (351)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~~~~~---------- 291 (351)
..... ....||+.|+|||++.+..++.++|||||||++|||+||+.||....... .....|..
T Consensus 831 ~~~~~------~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~ 903 (968)
T PLN00113 831 LLCTD------TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVH-GSIVEWARYCYSDCHLDM 903 (968)
T ss_pred ccccC------CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCC-CcHHHHHHHhcCccchhh
Confidence 32211 22367899999999999999999999999999999999999996432211 11111111
Q ss_pred ---cCCC-------------ccchhhhcccccCCCCCHHHHHHHHHHHHH
Q 018712 292 ---PKLS-------------EDKVKQCVDTKLGGEYPPKAIAKVRKKKFI 325 (351)
Q Consensus 292 ---~~~~-------------~~~~~~~ld~~~~~~~~~~~~~~~~~~~~~ 325 (351)
+... .+.+.+|+..+|.+|++.+++.+.++....
T Consensus 904 ~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~ 953 (968)
T PLN00113 904 WIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR 953 (968)
T ss_pred eeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence 1110 123456777777888877777666555443
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=254.96 Aligned_cols=198 Identities=28% Similarity=0.422 Sum_probs=170.0
Q ss_pred CCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCC---CchHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEEEeC
Q 018712 68 FGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK---QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHA 143 (351)
Q Consensus 68 y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 143 (351)
|+..+.||+|++|.||+|... +++.+|+|.+.... ...+.+.+|+.++++++|+||+++++++.+.+..++|+||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 566788999999999999975 68999999987642 23456788999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccccCCC
Q 018712 144 SKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQA 223 (351)
Q Consensus 144 ~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~ 223 (351)
.+ +|.+++..... .+++..+..++.|++.||.|||+++ ++||||+|+||++++++.++|+|||.+...
T Consensus 81 ~~-~l~~~i~~~~~--------~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~ 148 (282)
T cd07829 81 DM-DLKKYLDKRPG--------PLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAF 148 (282)
T ss_pred Cc-CHHHHHHhhcc--------CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCccccc
Confidence 85 99999986531 2889999999999999999999999 999999999999999999999999998765
Q ss_pred ccccccccccccccccCccCcccccCC-CCCccchhHhHHHHHHHHHcCCCCCCCCC
Q 018712 224 PDAAARLHSTRVLGTFGYHAPEYAMTG-QMSSKSDVYSFGVVLLELLTGRKPVDHTL 279 (351)
Q Consensus 224 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~Pf~~~~ 279 (351)
...... .....++..|+|||.+.+. .++.++||||||+++|||++|+.||....
T Consensus 149 ~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~ 203 (282)
T cd07829 149 GIPLRT--YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDS 203 (282)
T ss_pred CCCccc--cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCcc
Confidence 433221 1233457789999998766 78999999999999999999999997643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=251.19 Aligned_cols=200 Identities=23% Similarity=0.356 Sum_probs=174.1
Q ss_pred HhcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCCch----HHHHHHHHHHHhc-cCCceeeeEEEEecCCceE
Q 018712 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPD----QEFLAQVSMVSRL-KNENVVELVGYYVDGPLRV 137 (351)
Q Consensus 64 ~~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~----~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~ 137 (351)
..++|.++.+||+|+|++|.++.++ +.+.||+|++++.-.++ .=...|-.+..+. +||++|.++..|+.+.+++
T Consensus 248 ~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlf 327 (593)
T KOG0695|consen 248 GLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLF 327 (593)
T ss_pred ccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEE
Confidence 4568999999999999999999964 78899999987643322 2234454455544 7999999999999999999
Q ss_pred EEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecc
Q 018712 138 LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDF 217 (351)
Q Consensus 138 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Df 217 (351)
.|.||.+||+|.-.++..+. ++++.++.+...|.-||.|||+.| |+.||||.+|+|+|..|++||.|+
T Consensus 328 fvieyv~ggdlmfhmqrqrk---------lpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdy 395 (593)
T KOG0695|consen 328 FVIEYVNGGDLMFHMQRQRK---------LPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDY 395 (593)
T ss_pred EEEEEecCcceeeehhhhhc---------CcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeeccc
Confidence 99999999999888877764 999999999999999999999999 999999999999999999999999
Q ss_pred cccCCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCC
Q 018712 218 DLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDH 277 (351)
Q Consensus 218 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~ 277 (351)
|+++....... .+++++|||.|.|||++.+..|+...|+|+||++++||+.|+.||+-
T Consensus 396 gmcke~l~~gd--~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdi 453 (593)
T KOG0695|consen 396 GMCKEGLGPGD--TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDI 453 (593)
T ss_pred chhhcCCCCCc--ccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcce
Confidence 99987543322 23678999999999999999999999999999999999999999984
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=262.26 Aligned_cols=241 Identities=25% Similarity=0.374 Sum_probs=187.4
Q ss_pred cCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCCc--------hHHHHHHHHHHHhccCCceeeeEEEEe-cCCc
Q 018712 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP--------DQEFLAQVSMVSRLKNENVVELVGYYV-DGPL 135 (351)
Q Consensus 66 ~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--------~~~~~~e~~~l~~l~h~niv~~~~~~~-~~~~ 135 (351)
++|-.+.+||+|||+.||+|.+- ..+-||+|+-...+.+ .+...+|..+-+.|.||.||+++++|. +.+.
T Consensus 463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtds 542 (775)
T KOG1151|consen 463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDS 542 (775)
T ss_pred HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecccc
Confidence 45777889999999999999854 5788899986544333 234678999999999999999999986 6677
Q ss_pred eEEEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccC---Cce
Q 018712 136 RVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDD---DIA 212 (351)
Q Consensus 136 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~---~~v 212 (351)
+|.|+|||+|.+|.-||+..+. +++.+++.|+.||+.||.||....+ +|||-||||.|||+.++ |.+
T Consensus 543 FCTVLEYceGNDLDFYLKQhkl---------mSEKEARSIiMQiVnAL~YLNEikp-PIIHYDLKPgNILLv~GtacGeI 612 (775)
T KOG1151|consen 543 FCTVLEYCEGNDLDFYLKQHKL---------MSEKEARSIIMQIVNALKYLNEIKP-PIIHYDLKPGNILLVNGTACGEI 612 (775)
T ss_pred ceeeeeecCCCchhHHHHhhhh---------hhHHHHHHHHHHHHHHHHHHhccCC-CeeeeccCCccEEEecCccccee
Confidence 8999999999999999998875 8999999999999999999999864 49999999999999654 689
Q ss_pred EEecccccCCCcccccc-----ccccccccccCccCcccccCC----CCCccchhHhHHHHHHHHHcCCCCCCCCCCCCC
Q 018712 213 KISDFDLSNQAPDAAAR-----LHSTRVLGTFGYHAPEYAMTG----QMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQ 283 (351)
Q Consensus 213 kl~Dfg~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~ 283 (351)
||.|||+++...+.... ..+....||..|++||.+.-+ .++.+.||||+|||+|+.++|+.||........
T Consensus 613 KITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQd 692 (775)
T KOG1151|consen 613 KITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQD 692 (775)
T ss_pred EeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHH
Confidence 99999999887554322 123456899999999988633 468899999999999999999999997543211
Q ss_pred c---cchhh-------cccCCC---ccchhhhcccccCCCCCHHHH
Q 018712 284 Q---SLVTW-------ATPKLS---EDKVKQCVDTKLGGEYPPKAI 316 (351)
Q Consensus 284 ~---~~~~~-------~~~~~~---~~~~~~~ld~~~~~~~~~~~~ 316 (351)
. ..|.. ..|... ...++.|+..+-..|++..++
T Consensus 693 ILqeNTIlkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qL 738 (775)
T KOG1151|consen 693 ILQENTILKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQL 738 (775)
T ss_pred HHhhhchhcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHH
Confidence 0 11111 111111 245667777666666655544
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=235.27 Aligned_cols=203 Identities=29% Similarity=0.364 Sum_probs=165.9
Q ss_pred hcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCC--CchHHHHHHHHHHHhc-cCCceeeeEEEEecCCceEEEE
Q 018712 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK--QPDQEFLAQVSMVSRL-KNENVVELVGYYVDGPLRVLAY 140 (351)
Q Consensus 65 ~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~ 140 (351)
.++...+..||+|++|.|-+-++. +|...|+|.+...- +...++++|+.+..+. ..|++|.+++.+.+....++.|
T Consensus 45 ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcM 124 (282)
T KOG0984|consen 45 ADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICM 124 (282)
T ss_pred hhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeH
Confidence 345555667999999999887754 89999999987543 3356677888876665 6799999999998999999999
Q ss_pred EeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEeccccc
Q 018712 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (351)
Q Consensus 141 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a 220 (351)
|.|.- ||..+-.+--.. +..+++..+-+|+..++.||.|||++- .++|||+||+|||++.+|.||+||||++
T Consensus 125 E~M~t-Sldkfy~~v~~~-----g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIs 196 (282)
T KOG0984|consen 125 ELMDT-SLDKFYRKVLKK-----GGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGIS 196 (282)
T ss_pred HHhhh-hHHHHHHHHHhc-----CCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccccc
Confidence 99976 887765443211 123788888999999999999999985 4999999999999999999999999998
Q ss_pred CCCccccccccccccccccCccCccccc----CCCCCccchhHhHHHHHHHHHcCCCCCCCC
Q 018712 221 NQAPDAAARLHSTRVLGTFGYHAPEYAM----TGQMSSKSDVYSFGVVLLELLTGRKPVDHT 278 (351)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~~DvwslG~il~el~tg~~Pf~~~ 278 (351)
..+.+.... +...|...|||||.+. ...|+-++||||||+++.||.++++||...
T Consensus 197 G~L~dSiAk---t~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w 255 (282)
T KOG0984|consen 197 GYLVDSIAK---TMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESW 255 (282)
T ss_pred eeehhhhHH---HHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccccc
Confidence 777654432 3346888999999875 347899999999999999999999999854
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=263.73 Aligned_cols=198 Identities=22% Similarity=0.392 Sum_probs=173.6
Q ss_pred HHhcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCCch---------HHHHHHHHHHHhcc---CCceeeeEEE
Q 018712 63 EKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPD---------QEFLAQVSMVSRLK---NENVVELVGY 129 (351)
Q Consensus 63 ~~~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~---------~~~~~e~~~l~~l~---h~niv~~~~~ 129 (351)
....+|..++.||.|+||.|++|.++ +...|+||.+.+++.-. ...-.|+++|..++ |+||++++++
T Consensus 558 ~k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdf 637 (772)
T KOG1152|consen 558 KKFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDF 637 (772)
T ss_pred cccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhe
Confidence 34567999999999999999999976 56789999987654321 22446899999997 9999999999
Q ss_pred EecCCceEEEEEeCC-CCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEcc
Q 018712 130 YVDGPLRVLAYEHAS-KGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFD 208 (351)
Q Consensus 130 ~~~~~~~~lv~e~~~-~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~ 208 (351)
|.+++++||+||-.. +-+|.+++..... +.+.++..|++|++.|+++||++| |||||||-+|+.++.
T Consensus 638 FEddd~yyl~te~hg~gIDLFd~IE~kp~---------m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~ 705 (772)
T KOG1152|consen 638 FEDDDYYYLETEVHGEGIDLFDFIEFKPR---------MDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDS 705 (772)
T ss_pred eecCCeeEEEecCCCCCcchhhhhhccCc---------cchHHHHHHHHHHHhccccccccC---ceecccccccEEEec
Confidence 999999999999764 5689999987754 899999999999999999999999 999999999999999
Q ss_pred CCceEEecccccCCCccccccccccccccccCccCcccccCCCC-CccchhHhHHHHHHHHHcCCCCCC
Q 018712 209 DDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQM-SSKSDVYSFGVVLLELLTGRKPVD 276 (351)
Q Consensus 209 ~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~el~tg~~Pf~ 276 (351)
+|-+||+|||.+.....+.. ..++||..|.|||++.|..| +..-|||++|++||.++....||.
T Consensus 706 ~g~~klidfgsaa~~ksgpf----d~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 706 NGFVKLIDFGSAAYTKSGPF----DVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred CCeEEEeeccchhhhcCCCc----ceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 99999999999877665543 56789999999999999888 677899999999999999999986
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=249.69 Aligned_cols=201 Identities=28% Similarity=0.387 Sum_probs=163.7
Q ss_pred cCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCC--CchHHHHHHHHHHHh-ccCCceeeeEEEEecCCceEEEEE
Q 018712 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK--QPDQEFLAQVSMVSR-LKNENVVELVGYYVDGPLRVLAYE 141 (351)
Q Consensus 66 ~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~e~~~l~~-l~h~niv~~~~~~~~~~~~~lv~e 141 (351)
++.+-+..||.|+||+|++-.++ +|+..|||+++... ...++++.|++...+ -+.||||++++....++..++.||
T Consensus 64 ~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCME 143 (361)
T KOG1006|consen 64 DNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICME 143 (361)
T ss_pred chHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHH
Confidence 34455567999999999998865 89999999997554 345678888876544 467999999999888999999999
Q ss_pred eCCCCCHHHHhc---cCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEeccc
Q 018712 142 HASKGSLHDILH---GKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFD 218 (351)
Q Consensus 142 ~~~~gsL~~~l~---~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg 218 (351)
.|.- ||..+.+ ..+.. .+++..+-.++...+.||.||-..- +|||||+||+|||++..|.|||||||
T Consensus 144 LMd~-SlDklYk~vy~vq~~-------~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFG 213 (361)
T KOG1006|consen 144 LMDI-SLDKLYKRVYSVQKS-------RIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFG 213 (361)
T ss_pred HHhh-hHHHHHHHHHHHHhc-------cCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeeccc
Confidence 9965 6654432 22221 2778888888889999999998875 59999999999999999999999999
Q ss_pred ccCCCccccccccccccccccCccCccccc--CCCCCccchhHhHHHHHHHHHcCCCCCCCCC
Q 018712 219 LSNQAPDAAARLHSTRVLGTFGYHAPEYAM--TGQMSSKSDVYSFGVVLLELLTGRKPVDHTL 279 (351)
Q Consensus 219 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DvwslG~il~el~tg~~Pf~~~~ 279 (351)
++..+.+.... +.-.|...|||||.+. +..|+.+|||||||++|||+.||+.||....
T Consensus 214 IcGqLv~SiAk---T~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~ 273 (361)
T KOG1006|consen 214 ICGQLVDSIAK---TVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWD 273 (361)
T ss_pred chHhHHHHHHh---hhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHH
Confidence 99877654433 4557888999999885 3468999999999999999999999998653
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-33 Score=247.09 Aligned_cols=209 Identities=25% Similarity=0.435 Sum_probs=169.3
Q ss_pred HHHHhcCCCCCceeccCCcEEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHHh--ccCCceeeeEEEEecC----C
Q 018712 61 LKEKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSR--LKNENVVELVGYYVDG----P 134 (351)
Q Consensus 61 ~~~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~--l~h~niv~~~~~~~~~----~ 134 (351)
.+.......+.+.||+|.||.||+|.++ |..||||++.... ++...+|.++++. |+|+||+.+++.=..+ .
T Consensus 206 QRTiarqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~srd--E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~T 282 (513)
T KOG2052|consen 206 QRTIARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSRD--ERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWT 282 (513)
T ss_pred HHhhhheeEEEEEecCccccceeecccc-CCceEEEEecccc--hhhhhhHHHHHHHHHhccchhhhhhhccccCCCceE
Confidence 3445567788999999999999999997 7899999987543 4567788888775 4999999998864322 2
Q ss_pred ceEEEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhC-----CCCCeeeccccCCcEEEccC
Q 018712 135 LRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEK-----AEPRIIHRNIKSSNVLLFDD 209 (351)
Q Consensus 135 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~-----~~~~ivH~Dlkp~Nill~~~ 209 (351)
.++||.+|.+.|||+|||.... ++....++++..++.||++||.. |.+.|.|||||..|||+.++
T Consensus 283 QLwLvTdYHe~GSL~DyL~r~t----------v~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn 352 (513)
T KOG2052|consen 283 QLWLVTDYHEHGSLYDYLNRNT----------VTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKN 352 (513)
T ss_pred EEEEeeecccCCcHHHHHhhcc----------CCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccC
Confidence 5799999999999999999865 89999999999999999999974 66779999999999999999
Q ss_pred CceEEecccccCCCccccc--cccccccccccCccCcccccCCC----C--CccchhHhHHHHHHHHHcC----------
Q 018712 210 DIAKISDFDLSNQAPDAAA--RLHSTRVLGTFGYHAPEYAMTGQ----M--SSKSDVYSFGVVLLELLTG---------- 271 (351)
Q Consensus 210 ~~vkl~Dfg~a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~----~--~~~~DvwslG~il~el~tg---------- 271 (351)
+...|+|+|+|........ ....+..+||.+|||||++...- + -..+||||||.++||++..
T Consensus 353 ~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey 432 (513)
T KOG2052|consen 353 GTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEY 432 (513)
T ss_pred CcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhh
Confidence 9999999999976544322 22345678999999999886431 2 2358999999999999752
Q ss_pred CCCCCCCCCCC
Q 018712 272 RKPVDHTLPRG 282 (351)
Q Consensus 272 ~~Pf~~~~~~~ 282 (351)
+.||.+..+.+
T Consensus 433 ~~Pyyd~Vp~D 443 (513)
T KOG2052|consen 433 QLPYYDVVPSD 443 (513)
T ss_pred cCCcccCCCCC
Confidence 36777665543
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-34 Score=267.34 Aligned_cols=243 Identities=23% Similarity=0.340 Sum_probs=200.7
Q ss_pred CCCCceeccCCcEEEEEEEEC-C----CCEEEEEEcCCCCC--chHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEE
Q 018712 68 FGTNSLIGEGSYGRVYFGVLR-S----GRAAAIKKLDSSKQ--PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAY 140 (351)
Q Consensus 68 y~~~~~Lg~G~~g~Vy~~~~~-~----~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 140 (351)
....++||+|+||+||+|.+- . +-+||||++..... ...+++.|...|.++.|||++++++++.... +-||+
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvt 776 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVT 776 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHH
Confidence 344678999999999999963 3 35789998865443 3678999999999999999999999987665 78999
Q ss_pred EeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEeccccc
Q 018712 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (351)
Q Consensus 141 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a 220 (351)
+|++.|+|.++++..+.. +.....+.|..||++|+.|||.+. +|||||..+|||+.+-.+|||.|||++
T Consensus 777 q~mP~G~LlDyvr~hr~~--------igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla 845 (1177)
T KOG1025|consen 777 QLMPLGCLLDYVREHRDN--------IGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLA 845 (1177)
T ss_pred HhcccchHHHHHHHhhcc--------ccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchh
Confidence 999999999999987643 788899999999999999999998 999999999999999999999999999
Q ss_pred CCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCCccchhhcccCCCc---
Q 018712 221 NQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSE--- 296 (351)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~--- 296 (351)
+...............-.+.|||-|.+....|+.++|||||||++||++| |..|+.+...++...++..... ++.
T Consensus 846 ~ll~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geR-LsqPpi 924 (1177)
T KOG1025|consen 846 KLLAPDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGER-LSQPPI 924 (1177)
T ss_pred hccCcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhcccc-CCCCCC
Confidence 98876665554444455778999999999999999999999999999999 9999998876665555443222 211
Q ss_pred ------cchhhhcccccCCCCCHHHHHHHHHHH
Q 018712 297 ------DKVKQCVDTKLGGEYPPKAIAKVRKKK 323 (351)
Q Consensus 297 ------~~~~~~ld~~~~~~~~~~~~~~~~~~~ 323 (351)
-.+.+|+..+...|+..+++..-+.-+
T Consensus 925 CtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ 957 (1177)
T KOG1025|consen 925 CTIDVYMVMVKCWMIDADSRPTFKELAEEFSRM 957 (1177)
T ss_pred ccHHHHHHHHHHhccCcccCccHHHHHHHHHHH
Confidence 356788888888888887776554443
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=245.26 Aligned_cols=211 Identities=25% Similarity=0.419 Sum_probs=173.6
Q ss_pred cCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCC---CCchHHHHHHHHHHHhccCCceeeeEEEEe--------cC
Q 018712 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSS---KQPDQEFLAQVSMVSRLKNENVVELVGYYV--------DG 133 (351)
Q Consensus 66 ~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~--------~~ 133 (351)
+.|....+||+|.||.||+|+.+ +|+.||+|++..+ ........+|+++|..++|+|++.+++.|. +.
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r 96 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR 96 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence 34666778999999999999965 6888999876432 223456789999999999999999988764 23
Q ss_pred CceEEEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceE
Q 018712 134 PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAK 213 (351)
Q Consensus 134 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vk 213 (351)
..+|+||.+|+. +|.-+|..... .++..++..++.+++.||.|+|++. |+|||+|+.|+||+.+|.+|
T Consensus 97 ~t~ylVf~~ceh-DLaGlLsn~~v--------r~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilk 164 (376)
T KOG0669|consen 97 ATFYLVFDFCEH-DLAGLLSNRKV--------RFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILK 164 (376)
T ss_pred ceeeeeHHHhhh-hHHHHhcCccc--------cccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEE
Confidence 458999999987 99999976642 2899999999999999999999998 99999999999999999999
Q ss_pred EecccccCCCcccccc--ccccccccccCccCcccccCC-CCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccchh
Q 018712 214 ISDFDLSNQAPDAAAR--LHSTRVLGTFGYHAPEYAMTG-QMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVT 288 (351)
Q Consensus 214 l~Dfg~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~~ 288 (351)
|+|||+++.+...... ...+..+-|..|.+||.+.|. .|+++.|||..|||+.||++|.+-+++.+...+..+|.
T Consensus 165 lADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is 242 (376)
T KOG0669|consen 165 LADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLIS 242 (376)
T ss_pred eeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHH
Confidence 9999999876543322 123445669999999998865 78999999999999999999999999877665555444
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=249.79 Aligned_cols=201 Identities=20% Similarity=0.334 Sum_probs=174.3
Q ss_pred hcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCCchHHHHHHHHHHHhccC--C----ceeeeEEEEecCCceE
Q 018712 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKN--E----NVVELVGYYVDGPLRV 137 (351)
Q Consensus 65 ~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h--~----niv~~~~~~~~~~~~~ 137 (351)
..+|.+..+||+|.||.|-.+.+. ++..||+|+++.-....+..+-|+++|.++.+ | -++++.++|.-.++.|
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghiC 167 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHIC 167 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCceE
Confidence 678999999999999999999964 67899999998777777778889999999942 2 3778888999999999
Q ss_pred EEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEcc---------
Q 018712 138 LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFD--------- 208 (351)
Q Consensus 138 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~--------- 208 (351)
+|+|.+ |-|+.++|..+.-. .++...++.++.|+++++++||+.+ ++|.||||+|||+.+
T Consensus 168 ivfell-G~S~~dFlk~N~y~-------~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~~~~ 236 (415)
T KOG0671|consen 168 IVFELL-GLSTFDFLKENNYI-------PFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKTYNP 236 (415)
T ss_pred EEEecc-ChhHHHHhccCCcc-------ccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEEecc
Confidence 999999 45999999876543 3889999999999999999999999 999999999999842
Q ss_pred -----------CCceEEecccccCCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCC
Q 018712 209 -----------DDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDH 277 (351)
Q Consensus 209 -----------~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~ 277 (351)
+..|||+|||.|....... ...+.|..|.|||++.+-+++.++||||+||||+|+.+|...|+.
T Consensus 237 k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h-----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqt 311 (415)
T KOG0671|consen 237 KKKVCFIRPLKSTAIKVIDFGSATFDHEHH-----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQT 311 (415)
T ss_pred CCccceeccCCCcceEEEecCCcceeccCc-----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceeccc
Confidence 2358999999987654332 567789999999999999999999999999999999999999987
Q ss_pred CCCC
Q 018712 278 TLPR 281 (351)
Q Consensus 278 ~~~~ 281 (351)
....
T Consensus 312 Hen~ 315 (415)
T KOG0671|consen 312 HENL 315 (415)
T ss_pred CCcH
Confidence 6543
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-35 Score=243.39 Aligned_cols=208 Identities=26% Similarity=0.387 Sum_probs=173.8
Q ss_pred CCCCCceeccCCcEEEEEEEE-CCCCEEEEEEcCCCC---CchHHHHHHHHHHHhccCCceeeeEEEEecCC-----ceE
Q 018712 67 NFGTNSLIGEGSYGRVYFGVL-RSGRAAAIKKLDSSK---QPDQEFLAQVSMVSRLKNENVVELVGYYVDGP-----LRV 137 (351)
Q Consensus 67 ~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-----~~~ 137 (351)
+.+-.+.||.|+||.||.+.+ ++|+.||+|++..-. ...+.+.+|+++|..++|.|++..+++.+... .+|
T Consensus 54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY 133 (449)
T KOG0664|consen 54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY 133 (449)
T ss_pred cCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence 445667899999999999986 489999999986533 23577899999999999999999988765432 467
Q ss_pred EEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecc
Q 018712 138 LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDF 217 (351)
Q Consensus 138 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Df 217 (351)
++.|.+.. +|..++-.... ++...+.-+.+||+.||+|||+.+ |.||||||+|+|++++..+|||||
T Consensus 134 V~TELmQS-DLHKIIVSPQ~---------Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDF 200 (449)
T KOG0664|consen 134 VLTELMQS-DLHKIIVSPQA---------LTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDF 200 (449)
T ss_pred HHHHHHHh-hhhheeccCCC---------CCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEeccc
Confidence 88888865 89888876553 888889999999999999999999 999999999999999999999999
Q ss_pred cccCCCccccccccccccccccCccCcccccCC-CCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccchh
Q 018712 218 DLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTG-QMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVT 288 (351)
Q Consensus 218 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~~ 288 (351)
|+++........ +.+..+-|..|.|||++.|. .|+.+.||||.|||+.||+..+.-|+...+..+..+|.
T Consensus 201 GLARvee~d~~~-hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lIt 271 (449)
T KOG0664|consen 201 GLARTWDQRDRL-NMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMII 271 (449)
T ss_pred ccccccchhhhh-hhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHH
Confidence 999877554332 33445678899999999875 68999999999999999999999999887766555543
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-32 Score=265.08 Aligned_cols=256 Identities=24% Similarity=0.373 Sum_probs=200.1
Q ss_pred cCCCCCceeccCCcEEEEEEEEC----C----CCEEEEEEcCCCCCc--hHHHHHHHHHHHhc-cCCceeeeEEEEecCC
Q 018712 66 DNFGTNSLIGEGSYGRVYFGVLR----S----GRAAAIKKLDSSKQP--DQEFLAQVSMVSRL-KNENVVELVGYYVDGP 134 (351)
Q Consensus 66 ~~y~~~~~Lg~G~~g~Vy~~~~~----~----~~~vavK~~~~~~~~--~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~ 134 (351)
++..+.+.||+|.||.|++|... . ...||||.++..... .+.+..|+++|+.+ .|+||+.+++.+...+
T Consensus 296 ~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~ 375 (609)
T KOG0200|consen 296 ENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDG 375 (609)
T ss_pred hhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCC
Confidence 34456669999999999999843 1 457999998755433 56789999999999 6999999999999999
Q ss_pred ceEEEEEeCCCCCHHHHhccCC-CCCCCC----CC--CCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEc
Q 018712 135 LRVLAYEHASKGSLHDILHGKK-GVKGAK----PG--PVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLF 207 (351)
Q Consensus 135 ~~~lv~e~~~~gsL~~~l~~~~-~~~~~~----~~--~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~ 207 (351)
..++|+||+..|+|.++++..+ ...... +. ..++....+.++.||+.|++||++.. ++||||..+|||+.
T Consensus 376 ~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAaRNVLi~ 452 (609)
T KOG0200|consen 376 PLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAARNVLIT 452 (609)
T ss_pred ceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhhhhEEec
Confidence 9999999999999999999877 111111 11 23899999999999999999999998 99999999999999
Q ss_pred cCCceEEecccccCCCccccccccccccc--cccCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCC-CCCC
Q 018712 208 DDDIAKISDFDLSNQAPDAAARLHSTRVL--GTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTL-PRGQ 283 (351)
Q Consensus 208 ~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~--gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~Pf~~~~-~~~~ 283 (351)
++..+||+|||+|+.......... ..-. -...|||||.+....|+.++||||||++|||++| |..||.+.. ..+.
T Consensus 453 ~~~~~kIaDFGlar~~~~~~~y~~-~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l 531 (609)
T KOG0200|consen 453 KNKVIKIADFGLARDHYNKDYYRT-KSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEEL 531 (609)
T ss_pred CCCEEEEccccceeccCCCCceEe-cCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcHHHH
Confidence 999999999999986544332211 1111 2446999999999999999999999999999999 999998733 1111
Q ss_pred ccchhh----cccCCCc----cchhhhcccccCCCCCHHHHHHHHHHHHH
Q 018712 284 QSLVTW----ATPKLSE----DKVKQCVDTKLGGEYPPKAIAKVRKKKFI 325 (351)
Q Consensus 284 ~~~~~~----~~~~~~~----~~~~~~ld~~~~~~~~~~~~~~~~~~~~~ 325 (351)
...+.. ..|..-. +.++.|+...|..|++..+....+...+.
T Consensus 532 ~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~ 581 (609)
T KOG0200|consen 532 LEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHLQ 581 (609)
T ss_pred HHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHHH
Confidence 111111 1222211 45799999999999999999888877543
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.3e-32 Score=262.87 Aligned_cols=252 Identities=21% Similarity=0.271 Sum_probs=167.1
Q ss_pred HhcCCCCCceeccCCcEEEEEEEEC-C----CCEEEEEEcCCCCCchHHHHHHHHHHHhccCCceeeeEEE------Eec
Q 018712 64 KTDNFGTNSLIGEGSYGRVYFGVLR-S----GRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGY------YVD 132 (351)
Q Consensus 64 ~~~~y~~~~~Lg~G~~g~Vy~~~~~-~----~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~------~~~ 132 (351)
..++|.+.+.||+|+||.||+|.+. + +..||+|++...... +...++ .++...+.++..++.. ...
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~-e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~~ 206 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV-EIWMNE--RVRRACPNSCADFVYGFLEPVSSKK 206 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh-HHHHHH--HHHhhchhhHHHHHHhhhccccccc
Confidence 5678999999999999999999975 4 689999987643221 111111 1222222222222211 235
Q ss_pred CCceEEEEEeCCCCCHHHHhccCCCCC-----------CCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccC
Q 018712 133 GPLRVLAYEHASKGSLHDILHGKKGVK-----------GAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKS 201 (351)
Q Consensus 133 ~~~~~lv~e~~~~gsL~~~l~~~~~~~-----------~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp 201 (351)
+...++|+||+.+++|.+++....... ............+..++.||+.||.|||+++ |+||||||
T Consensus 207 ~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLKP 283 (566)
T PLN03225 207 EDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVKP 283 (566)
T ss_pred CCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCCH
Confidence 667899999999999999997543100 0001111223456679999999999999999 99999999
Q ss_pred CcEEEcc-CCceEEecccccCCCccccccccccccccccCccCcccccCC----------------------CCCccchh
Q 018712 202 SNVLLFD-DDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTG----------------------QMSSKSDV 258 (351)
Q Consensus 202 ~Nill~~-~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~~~Dv 258 (351)
+|||++. ++.+||+|||+++....... .......+|+.|+|||.+... .++.++||
T Consensus 284 ~NILl~~~~~~~KL~DFGlA~~l~~~~~-~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DV 362 (566)
T PLN03225 284 QNIIFSEGSGSFKIIDLGAAADLRVGIN-YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDI 362 (566)
T ss_pred HHEEEeCCCCcEEEEeCCCccccccccc-cCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCccc
Confidence 9999986 57999999999976543221 122456789999999966432 23445699
Q ss_pred HhHHHHHHHHHcCCCCCCCCCC-------CCCccchhhc---ccCCC-----------------ccchhhhcccccCCCC
Q 018712 259 YSFGVVLLELLTGRKPVDHTLP-------RGQQSLVTWA---TPKLS-----------------EDKVKQCVDTKLGGEY 311 (351)
Q Consensus 259 wslG~il~el~tg~~Pf~~~~~-------~~~~~~~~~~---~~~~~-----------------~~~~~~~ld~~~~~~~ 311 (351)
|||||++|||+++..|+..... ........|. .+... -+++..|+..+|.+|+
T Consensus 363 wSlGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR~ 442 (566)
T PLN03225 363 YSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQRI 442 (566)
T ss_pred HHHHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcccCC
Confidence 9999999999998777553210 0000111110 00000 1588899999999999
Q ss_pred CHHHHHHHHHHHHH
Q 018712 312 PPKAIAKVRKKKFI 325 (351)
Q Consensus 312 ~~~~~~~~~~~~~~ 325 (351)
+++++.. +.++
T Consensus 443 ta~e~L~---Hpff 453 (566)
T PLN03225 443 SAKAALA---HPYF 453 (566)
T ss_pred CHHHHhC---CcCc
Confidence 8776644 5554
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.7e-33 Score=264.25 Aligned_cols=237 Identities=26% Similarity=0.375 Sum_probs=188.2
Q ss_pred CCCCceeccCCcEE-EEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHHhc-cCCceeeeEEEEecCCceEEEEEeCCC
Q 018712 68 FGTNSLIGEGSYGR-VYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRL-KNENVVELVGYYVDGPLRVLAYEHASK 145 (351)
Q Consensus 68 y~~~~~Lg~G~~g~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 145 (351)
|...+.+|.|+.|+ ||+|... ++.||||++-.+. ..-..+|+..|+.- .|||||++++.-.++...||..|.|..
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~e~--~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~~ 587 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVYE-GREVAVKRLLEEF--FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCAC 587 (903)
T ss_pred eccHHHcccCCCCcEEEEEeeC-CceehHHHHhhHh--HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhhh
Confidence 45556788998876 7899884 7899999986543 24567899999988 699999999999999999999999976
Q ss_pred CCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEcc---C--CceEEeccccc
Q 018712 146 GSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFD---D--DIAKISDFDLS 220 (351)
Q Consensus 146 gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~---~--~~vkl~Dfg~a 220 (351)
+|.+++...... .. .......+.+..|+++||++||+.+ ||||||||.||||+. + ..++|+|||++
T Consensus 588 -sL~dlie~~~~d--~~---~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfgls 658 (903)
T KOG1027|consen 588 -SLQDLIESSGLD--VE---MQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLS 658 (903)
T ss_pred -hHHHHHhccccc--hh---hcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEecccccc
Confidence 999999885111 00 0222456788999999999999998 999999999999976 3 37899999999
Q ss_pred CCCccccccc-cccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcC-CCCCCCCCCC------CCccchhhccc
Q 018712 221 NQAPDAAARL-HSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTG-RKPVDHTLPR------GQQSLVTWATP 292 (351)
Q Consensus 221 ~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg-~~Pf~~~~~~------~~~~~~~~~~~ 292 (351)
+....+.... +.....||-+|+|||++....-+.++||||+||++|+.++| +.||.....+ +...+......
T Consensus 659 Kkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl~~~~~L~~L~~~ 738 (903)
T KOG1027|consen 659 KKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANILTGNYTLVHLEPL 738 (903)
T ss_pred cccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhhhcCccceeeeccC
Confidence 9986554332 23556799999999999998888899999999999999985 9999987655 22222222222
Q ss_pred C--CCccchhhhcccccCCCCCHHHH
Q 018712 293 K--LSEDKVKQCVDTKLGGEYPPKAI 316 (351)
Q Consensus 293 ~--~~~~~~~~~ld~~~~~~~~~~~~ 316 (351)
. ...+++.+|+++.|..|+++..+
T Consensus 739 ~d~eA~dLI~~ml~~dP~~RPsa~~V 764 (903)
T KOG1027|consen 739 PDCEAKDLISRMLNPDPQLRPSATDV 764 (903)
T ss_pred chHHHHHHHHHhcCCCcccCCCHHHH
Confidence 2 45689999999999999987665
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-31 Score=229.86 Aligned_cols=226 Identities=29% Similarity=0.416 Sum_probs=184.1
Q ss_pred CcEEEEEEEEC-CCCEEEEEEcCCCCCc--hHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEEEeCCCCCHHHHhcc
Q 018712 78 SYGRVYFGVLR-SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHG 154 (351)
Q Consensus 78 ~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~ 154 (351)
+||.||+|... +++.+++|++...... .+.+.+|++.+++++|+||+++++.+......++++|++.+++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999976 5899999998765433 47789999999999999999999999998999999999999999999976
Q ss_pred CCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccccCCCccccccccccc
Q 018712 155 KKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTR 234 (351)
Q Consensus 155 ~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~ 234 (351)
... ++...+..++.+++.++.+||+.+ ++|+||+|+||++++++.++|+|||.+....... ....
T Consensus 81 ~~~---------~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~ 145 (244)
T smart00220 81 RGR---------LSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTT 145 (244)
T ss_pred ccC---------CCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc---cccc
Confidence 542 788999999999999999999999 9999999999999999999999999987765432 1234
Q ss_pred cccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCC-CCCCCccchhhc----------ccCCCccchhhhc
Q 018712 235 VLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHT-LPRGQQSLVTWA----------TPKLSEDKVKQCV 303 (351)
Q Consensus 235 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~-~~~~~~~~~~~~----------~~~~~~~~~~~~l 303 (351)
..++..|++||.+.+..++.++|+||||+++++|++|..||... ............ .+....+.+.+|+
T Consensus 146 ~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l 225 (244)
T smart00220 146 FVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWKISPEAKDLIRKLL 225 (244)
T ss_pred ccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccccccCCHHHHHHHHHHc
Confidence 56788999999998888899999999999999999999999763 211111111100 1111235778888
Q ss_pred ccccCCCCCHHHHHH
Q 018712 304 DTKLGGEYPPKAIAK 318 (351)
Q Consensus 304 d~~~~~~~~~~~~~~ 318 (351)
..+|.+|++..++..
T Consensus 226 ~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 226 VKDPEKRLTAEEALQ 240 (244)
T ss_pred cCCchhccCHHHHhh
Confidence 888888888777643
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.2e-31 Score=249.68 Aligned_cols=211 Identities=24% Similarity=0.360 Sum_probs=154.4
Q ss_pred HHhcCCCCCceeccCCcEEEEEEEE-----------------CCCCEEEEEEcCCCCCc-h--------------HHHHH
Q 018712 63 EKTDNFGTNSLIGEGSYGRVYFGVL-----------------RSGRAAAIKKLDSSKQP-D--------------QEFLA 110 (351)
Q Consensus 63 ~~~~~y~~~~~Lg~G~~g~Vy~~~~-----------------~~~~~vavK~~~~~~~~-~--------------~~~~~ 110 (351)
...++|.+.++||+|+||.||+|.. ..++.||||++...... . +....
T Consensus 142 ~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~v 221 (507)
T PLN03224 142 WSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMV 221 (507)
T ss_pred ccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHH
Confidence 4567899999999999999999964 23568999998643221 1 22334
Q ss_pred HHHHHHhccCCce-----eeeEEEEec--------CCceEEEEEeCCCCCHHHHhccCCCCC---------------CCC
Q 018712 111 QVSMVSRLKNENV-----VELVGYYVD--------GPLRVLAYEHASKGSLHDILHGKKGVK---------------GAK 162 (351)
Q Consensus 111 e~~~l~~l~h~ni-----v~~~~~~~~--------~~~~~lv~e~~~~gsL~~~l~~~~~~~---------------~~~ 162 (351)
|+.++.+++|.++ +++++++.. .+..++||||+++++|.++++...... ...
T Consensus 222 E~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~ 301 (507)
T PLN03224 222 EAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNM 301 (507)
T ss_pred HHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhc
Confidence 6667777766554 566666542 356899999999999999997532110 011
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccccCCCccccccccccccccccCcc
Q 018712 163 PGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYH 242 (351)
Q Consensus 163 ~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~ 242 (351)
....+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++......... ......+|+.|+
T Consensus 302 ~~~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~-~~~~g~~tp~Y~ 377 (507)
T PLN03224 302 PQDKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINF-NPLYGMLDPRYS 377 (507)
T ss_pred ccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCcc-CccccCCCccee
Confidence 1123567788999999999999999999 999999999999999999999999998765332211 111223578999
Q ss_pred CcccccCCC--------------------C--CccchhHhHHHHHHHHHcCCC-CCCC
Q 018712 243 APEYAMTGQ--------------------M--SSKSDVYSFGVVLLELLTGRK-PVDH 277 (351)
Q Consensus 243 aPE~~~~~~--------------------~--~~~~DvwslG~il~el~tg~~-Pf~~ 277 (351)
|||.+.... + ..+.|+||+||++|+|++|.. ||..
T Consensus 378 aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~ 435 (507)
T PLN03224 378 PPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVAN 435 (507)
T ss_pred ChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccc
Confidence 999875432 1 124699999999999999886 7653
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-32 Score=247.37 Aligned_cols=206 Identities=21% Similarity=0.265 Sum_probs=177.2
Q ss_pred hcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCCchHHHHHHHHHHHhccC------CceeeeEEEEecCCceE
Q 018712 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKN------ENVVELVGYYVDGPLRV 137 (351)
Q Consensus 65 ~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h------~niv~~~~~~~~~~~~~ 137 (351)
..+|.+....|+|-|++|.+|.+. -|..||||++.......+.=+.|+++|++|+. -|+++++..|...+++|
T Consensus 431 D~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknHLC 510 (752)
T KOG0670|consen 431 DSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNHLC 510 (752)
T ss_pred cceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcceeE
Confidence 457888889999999999999965 47799999999887777777899999999953 58999999999999999
Q ss_pred EEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccC-CceEEec
Q 018712 138 LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDD-DIAKISD 216 (351)
Q Consensus 138 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~-~~vkl~D 216 (351)
||+|.+.- +|.++|++.+.. ..+....+..++.|++-||..|-..| |+|.||||+|||+++. ..+||||
T Consensus 511 lVFE~Lsl-NLRevLKKyG~n------vGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k~iLKLCD 580 (752)
T KOG0670|consen 511 LVFEPLSL-NLREVLKKYGRN------VGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESKNILKLCD 580 (752)
T ss_pred EEehhhhc-hHHHHHHHhCcc------cceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCcceeeecc
Confidence 99999965 999999887643 23788899999999999999999999 9999999999999876 4789999
Q ss_pred ccccCCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCc
Q 018712 217 FDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQ 284 (351)
Q Consensus 217 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~ 284 (351)
||.|........ +...-+.-|.|||++.|..|+...|+||+||+||||.||+..|.+.+.....
T Consensus 581 fGSA~~~~enei----tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~ML 644 (752)
T KOG0670|consen 581 FGSASFASENEI----TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQML 644 (752)
T ss_pred Cccccccccccc----cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHH
Confidence 999987765432 2223355699999999999999999999999999999999999987664433
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-30 Score=222.07 Aligned_cols=198 Identities=33% Similarity=0.494 Sum_probs=171.3
Q ss_pred CCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCC--chHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEEEeCC
Q 018712 68 FGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ--PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHAS 144 (351)
Q Consensus 68 y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 144 (351)
|.+.+.||+|++|.||++... ++..+++|.+..... ....+.+|++.+++++|+|++++++++......++++|++.
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 567788999999999999976 488999999876543 35678899999999999999999999999899999999999
Q ss_pred CCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccccCCCc
Q 018712 145 KGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAP 224 (351)
Q Consensus 145 ~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~ 224 (351)
+++|.+++...... +++.....++.+++.++.+||+.+ ++|+||+|.||+++.++.++|+|||.+....
T Consensus 81 ~~~L~~~~~~~~~~--------~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~ 149 (225)
T smart00221 81 GGDLFDYLRKKGGK--------LSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIH 149 (225)
T ss_pred CCCHHHHHHhcccC--------CCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEec
Confidence 99999999865421 678899999999999999999998 9999999999999999999999999987765
Q ss_pred cccccccccccccccCccCcccc-cCCCCCccchhHhHHHHHHHHHcCCCCCCC
Q 018712 225 DAAARLHSTRVLGTFGYHAPEYA-MTGQMSSKSDVYSFGVVLLELLTGRKPVDH 277 (351)
Q Consensus 225 ~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwslG~il~el~tg~~Pf~~ 277 (351)
..... ......++..|++||.+ ....++.++|+|+||+++++|++|+.||..
T Consensus 150 ~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 150 RDLAA-LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred Ccccc-cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 43210 12334678889999998 667778899999999999999999999965
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-31 Score=221.71 Aligned_cols=197 Identities=23% Similarity=0.432 Sum_probs=164.6
Q ss_pred HhcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCCchHHHHHHHHHHHhc-cCCceeeeEE-EEecCCceEEEE
Q 018712 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRL-KNENVVELVG-YYVDGPLRVLAY 140 (351)
Q Consensus 64 ~~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~-~~~~~~~~~lv~ 140 (351)
..+.|.+.+.||+|.||.+-++.++ ++..+++|.+........+|.+|.----.| .|.||+.-++ .|+..+.++.++
T Consensus 22 l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~q 101 (378)
T KOG1345|consen 22 LEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQ 101 (378)
T ss_pred hhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEee
Confidence 4467999999999999999999976 678999999988888888999998664445 5899998776 477888889999
Q ss_pred EeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEcc--CCceEEeccc
Q 018712 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFD--DDIAKISDFD 218 (351)
Q Consensus 141 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~--~~~vkl~Dfg 218 (351)
||++.|+|.+-+...+ +.+.....++.|+++||.|+|+++ +||||||.+||||-+ .-.|||||||
T Consensus 102 E~aP~gdL~snv~~~G----------igE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG 168 (378)
T KOG1345|consen 102 EFAPRGDLRSNVEAAG----------IGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFG 168 (378)
T ss_pred ccCccchhhhhcCccc----------ccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeecc
Confidence 9999999999887654 788889999999999999999999 999999999999954 3489999999
Q ss_pred ccCCCccccccccccccccccCccCcccccCC-----CCCccchhHhHHHHHHHHHcCCCCCCCC
Q 018712 219 LSNQAPDAAARLHSTRVLGTFGYHAPEYAMTG-----QMSSKSDVYSFGVVLLELLTGRKPVDHT 278 (351)
Q Consensus 219 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwslG~il~el~tg~~Pf~~~ 278 (351)
..+..+..- ....-+..|.+||..... ...+.+|+|.||+++|.++||++||+..
T Consensus 169 ~t~k~g~tV-----~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka 228 (378)
T KOG1345|consen 169 LTRKVGTTV-----KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKA 228 (378)
T ss_pred cccccCcee-----hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhh
Confidence 987654322 223346679999976422 3467899999999999999999999954
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.6e-30 Score=218.66 Aligned_cols=265 Identities=19% Similarity=0.286 Sum_probs=201.8
Q ss_pred cCCCCCceeccCCcEEEEEEEE-CCCCEEEEEEcCCCCCchHHHHHHHHHHHhcc-CCceeeeEEEEecCCceEEEEEeC
Q 018712 66 DNFGTNSLIGEGSYGRVYFGVL-RSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLK-NENVVELVGYYVDGPLRVLAYEHA 143 (351)
Q Consensus 66 ~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~ 143 (351)
-.|.+.++||+|+||.++.|.. -++..||||.- ..+....++..|.+..+.|. .+.|.+++-+..++.+-.||+|++
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfE-PrkS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL 106 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFE-PRKSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL 106 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEec-cccCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh
Confidence 3799999999999999999994 58999999964 34445567899999999995 599999999989999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccC-----CceEEeccc
Q 018712 144 SKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDD-----DIAKISDFD 218 (351)
Q Consensus 144 ~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~-----~~vkl~Dfg 218 (351)
|.||.+++.-.+.. ++.+++..+|.|++.-++|+|++. +|.|||||+|+||..- ..+-|+|||
T Consensus 107 -GPSLEDLFD~CgR~--------FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFG 174 (449)
T KOG1165|consen 107 -GPSLEDLFDLCGRR--------FSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFG 174 (449)
T ss_pred -CcCHHHHHHHhcCc--------ccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEecc
Confidence 56999999877643 999999999999999999999999 9999999999999654 368999999
Q ss_pred ccCCCcccccccc-----ccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccchhhcccC
Q 018712 219 LSNQAPDAAARLH-----STRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPK 293 (351)
Q Consensus 219 ~a~~~~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~ 293 (351)
+|+...+..+..+ .....||.+||+-....|.+.+.+.|+-|||.++++.+.|..||++.........-.+....
T Consensus 175 mAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~ 254 (449)
T KOG1165|consen 175 MAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGET 254 (449)
T ss_pred chhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccc
Confidence 9999876654432 24567999999999999999999999999999999999999999987655443322222211
Q ss_pred CCccchhhhcccccCCCCCHHHHHHHH---HHHHHh-------hhhccccchhhhhcccCCcccc
Q 018712 294 LSEDKVKQCVDTKLGGEYPPKAIAKVR---KKKFIT-------SECSNISFAEFNINWHCPLEWS 348 (351)
Q Consensus 294 ~~~~~~~~~ld~~~~~~~~~~~~~~~~---~~~~~~-------~~~~~~~~~~~~~~~~~~~~w~ 348 (351)
.-...+..+.+ .++.+....+. .+.|.- -.....-|..++.-.|.-|||-
T Consensus 255 Kr~T~i~~Lc~-----g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~g~t~Dg~yDW~ 314 (449)
T KOG1165|consen 255 KRSTPIEVLCE-----GFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRLGETDDGEYDWM 314 (449)
T ss_pred cccCCHHHHHh-----cCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhcCCccccccccc
Confidence 11122222222 23222222222 222211 1222334677888889999994
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.9e-31 Score=225.02 Aligned_cols=201 Identities=23% Similarity=0.290 Sum_probs=168.7
Q ss_pred hcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCC---CchHHHHHHHHHHHhccCCceeeeEEEEecC------C
Q 018712 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK---QPDQEFLAQVSMVSRLKNENVVELVGYYVDG------P 134 (351)
Q Consensus 65 ~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------~ 134 (351)
..+|...+.+|.|.- .|-.+-+. .++.||+|++.... ...+...+|+.++..++|+||++++.+|.-. .
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~ 94 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ 94 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence 457888889999988 55555543 78999999886442 2246678999999999999999999998643 3
Q ss_pred ceEEEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEE
Q 018712 135 LRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKI 214 (351)
Q Consensus 135 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl 214 (351)
..|+|||++.. +|.+.+... +.-.++..++.|++.|++|||+.| |+||||||+||++..++.+||
T Consensus 95 e~y~v~e~m~~-nl~~vi~~e-----------lDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi 159 (369)
T KOG0665|consen 95 EVYLVMELMDA-NLCQVILME-----------LDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKI 159 (369)
T ss_pred hHHHHHHhhhh-HHHHHHHHh-----------cchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheee
Confidence 57999999976 999998733 777889999999999999999999 999999999999999999999
Q ss_pred ecccccCCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCc
Q 018712 215 SDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQ 284 (351)
Q Consensus 215 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~ 284 (351)
.|||+|+..... ...+..+.|..|.|||++.+..+.+.+||||+||++.||++|+.-|.+....++.
T Consensus 160 ~dfg~ar~e~~~---~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~ 226 (369)
T KOG0665|consen 160 LDFGLARTEDTD---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQW 226 (369)
T ss_pred ccchhhcccCcc---cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHH
Confidence 999999876543 2235567899999999999999999999999999999999999999876544433
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=246.97 Aligned_cols=240 Identities=28% Similarity=0.398 Sum_probs=197.0
Q ss_pred HhcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCCc-hHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEEE
Q 018712 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP-DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYE 141 (351)
Q Consensus 64 ~~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 141 (351)
-.++|.....+|+|.||.||++++. +++..|+|+++..... -.....|+-+++..+|+||+.+++.+.....+++.||
T Consensus 13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicME 92 (829)
T KOG0576|consen 13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICME 92 (829)
T ss_pred CccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEE
Confidence 3468999999999999999999964 8999999999876544 3556788999999999999999999999999999999
Q ss_pred eCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccccC
Q 018712 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (351)
Q Consensus 142 ~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~ 221 (351)
||.+|+|.+.-+.... +++.++....+..+.|+.|||++| -+|||||-.||++++.|.||++|||.+.
T Consensus 93 ycgggslQdiy~~Tgp---------lselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsa 160 (829)
T KOG0576|consen 93 YCGGGSLQDIYHVTGP---------LSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSA 160 (829)
T ss_pred ecCCCcccceeeeccc---------chhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchh
Confidence 9999999998876653 889999999999999999999999 8999999999999999999999999987
Q ss_pred CCccccccccccccccccCccCcccc---cCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccchh---hcccCC-
Q 018712 222 QAPDAAARLHSTRVLGTFGYHAPEYA---MTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVT---WATPKL- 294 (351)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~aPE~~---~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~~---~~~~~~- 294 (351)
.+...... ...+.||+.|||||+. ..+.|...+|||++|++..|+..-+.|--...+.....+.. ...|.+
T Consensus 161 qitati~K--rksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lk 238 (829)
T KOG0576|consen 161 QITATIAK--RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLK 238 (829)
T ss_pred hhhhhhhh--hhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCccc
Confidence 76543322 3567899999999976 46789999999999999999988877755443322221111 111111
Q ss_pred --------CccchhhhcccccCCCCCHHHHH
Q 018712 295 --------SEDKVKQCVDTKLGGEYPPKAIA 317 (351)
Q Consensus 295 --------~~~~~~~~ld~~~~~~~~~~~~~ 317 (351)
..+.++.++-.++.+|++++.+.
T Consensus 239 Dk~kws~~fh~fvK~altknpKkRptaeklL 269 (829)
T KOG0576|consen 239 DKTKWSEFFHNFVKGALTKNPKKRPTAEKLL 269 (829)
T ss_pred CCccchHHHHHHHHHHhcCCCccCCChhhhe
Confidence 12677888999999999876554
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.9e-30 Score=224.09 Aligned_cols=255 Identities=22% Similarity=0.276 Sum_probs=196.0
Q ss_pred HHHHHhcCCCCCceeccCCcEEEEEEEEC------CCCEEEEEEcCCCCCch--HHHHHHHHHHHhccCCceeeeEEEEe
Q 018712 60 ELKEKTDNFGTNSLIGEGSYGRVYFGVLR------SGRAAAIKKLDSSKQPD--QEFLAQVSMVSRLKNENVVELVGYYV 131 (351)
Q Consensus 60 ~~~~~~~~y~~~~~Lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~--~~~~~e~~~l~~l~h~niv~~~~~~~ 131 (351)
++.....+++...++-+|.||+||+|.++ +.+.|.+|.++...... ..++.|.-++..+.|||+..+.+...
T Consensus 278 ~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~i 357 (563)
T KOG1024|consen 278 ELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSI 357 (563)
T ss_pred hhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEe
Confidence 44445567888889999999999999765 24566677776544332 34677888888899999999999865
Q ss_pred -cCCceEEEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCC
Q 018712 132 -DGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD 210 (351)
Q Consensus 132 -~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~ 210 (351)
+....++++.+..-|+|..+|...+..... ....++..+...++.|++.|++|||+++ +||.||..+|++||+.-
T Consensus 358 e~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~-~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd~L 433 (563)
T KOG1024|consen 358 EDYATPFVLYPATGVGNLKSFLQICRGDDPS-YAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDDQL 433 (563)
T ss_pred eccCcceEEEeccCcchHHHHHHHhccCCCc-cccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehhhe
Confidence 445678889999999999999866533222 2234777888999999999999999999 99999999999999999
Q ss_pred ceEEecccccCCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCCccchhh
Q 018712 211 IAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTW 289 (351)
Q Consensus 211 ~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~Pf~~~~~~~~~~~~~~ 289 (351)
.|||+|=.+++.+-..+.............||+||.+.+..|+.++|+||||+++|||+| |+.|+...++.+....+..
T Consensus 434 qVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkd 513 (563)
T KOG1024|consen 434 QVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKD 513 (563)
T ss_pred eEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhc
Confidence 999999999998876665554445556789999999999999999999999999999999 9999988776554333321
Q ss_pred --------cccCCCccchhhhcccccCCCCCHHHHHH
Q 018712 290 --------ATPKLSEDKVKQCVDTKLGGEYPPKAIAK 318 (351)
Q Consensus 290 --------~~~~~~~~~~~~~ld~~~~~~~~~~~~~~ 318 (351)
..|.-.-..+.=|+.-.+.+|++.+++-.
T Consensus 514 GyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~ 550 (563)
T KOG1024|consen 514 GYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVI 550 (563)
T ss_pred cceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence 11111113344556666777777766643
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.4e-31 Score=214.45 Aligned_cols=195 Identities=18% Similarity=0.338 Sum_probs=165.7
Q ss_pred HhcCCCCCceeccCCcEEEEEEEE-CCCCEEEEEEcCCCCCchHHHHHHHHHHHhcc-CCceeeeEEEEecC--CceEEE
Q 018712 64 KTDNFGTNSLIGEGSYGRVYFGVL-RSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLK-NENVVELVGYYVDG--PLRVLA 139 (351)
Q Consensus 64 ~~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~--~~~~lv 139 (351)
..++|++.+++|+|.|+.||.|.. .++..++||+++.-+ .+.+.+|+++|+.|. ||||+++++...+. ....|+
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk--kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi 113 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK--KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI 113 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH--HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence 457899999999999999999994 578899999987543 466899999999996 99999999988755 356899
Q ss_pred EEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCC-ceEEeccc
Q 018712 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD-IAKISDFD 218 (351)
Q Consensus 140 ~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~-~vkl~Dfg 218 (351)
+||..+.+...+... ++...++.++.+++.||.|+|+.| |+|||+||.|++||... .++|+|+|
T Consensus 114 FE~v~n~Dfk~ly~t------------l~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWG 178 (338)
T KOG0668|consen 114 FEYVNNTDFKQLYPT------------LTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWG 178 (338)
T ss_pred hhhhccccHHHHhhh------------hchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecc
Confidence 999999888777642 778889999999999999999999 99999999999998754 69999999
Q ss_pred ccCCCccccccccccccccccCccCcccccC-CCCCccchhHhHHHHHHHHHcCCCCCCCC
Q 018712 219 LSNQAPDAAARLHSTRVLGTFGYHAPEYAMT-GQMSSKSDVYSFGVVLLELLTGRKPVDHT 278 (351)
Q Consensus 219 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~Pf~~~ 278 (351)
+|......... ...+.+..|--||.+.. ..|+..-|+|||||++..|+..+.||-..
T Consensus 179 LAEFYHp~~eY---nVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG 236 (338)
T KOG0668|consen 179 LAEFYHPGKEY---NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHG 236 (338)
T ss_pred hHhhcCCCcee---eeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCC
Confidence 99876544322 34456778999998875 46788999999999999999999998753
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-28 Score=207.93 Aligned_cols=208 Identities=32% Similarity=0.518 Sum_probs=177.9
Q ss_pred eccCCcEEEEEEEEC-CCCEEEEEEcCCCCCc--hHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEEEeCCCCCHHH
Q 018712 74 IGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHD 150 (351)
Q Consensus 74 Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~ 150 (351)
||+|++|.||++... +++.+++|++...... ...+.+|++.++.++|++|+++++++......++++|++.+++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 689999999999975 4899999998766542 4678999999999999999999999999899999999999999999
Q ss_pred HhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEcc-CCceEEecccccCCCcccccc
Q 018712 151 ILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFD-DDIAKISDFDLSNQAPDAAAR 229 (351)
Q Consensus 151 ~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~-~~~vkl~Dfg~a~~~~~~~~~ 229 (351)
++.... ..++...+..++.+++.++.+||+.+ ++|+||+|.||+++. ++.++|+|||.+........
T Consensus 81 ~~~~~~--------~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~- 148 (215)
T cd00180 81 LLKENE--------GKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS- 148 (215)
T ss_pred HHHhcc--------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-
Confidence 998652 12788999999999999999999999 999999999999999 89999999999876544321
Q ss_pred ccccccccccCccCcccccCC-CCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccchhhcccCCCccchhhhcccccC
Q 018712 230 LHSTRVLGTFGYHAPEYAMTG-QMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLG 308 (351)
Q Consensus 230 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ld~~~~ 308 (351)
......+...|++||.+... .++.++|+|++|+++++| ....+.+..|++.++.
T Consensus 149 -~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l------------------------~~~~~~l~~~l~~~p~ 203 (215)
T cd00180 149 -LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL------------------------PELKDLIRKMLQKDPE 203 (215)
T ss_pred -hhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH------------------------HHHHHHHHHHhhCCcc
Confidence 11334578889999998877 888999999999999999 1224678889999999
Q ss_pred CCCCHHHHHH
Q 018712 309 GEYPPKAIAK 318 (351)
Q Consensus 309 ~~~~~~~~~~ 318 (351)
.|++.+++.+
T Consensus 204 ~R~~~~~l~~ 213 (215)
T cd00180 204 KRPSAKEILE 213 (215)
T ss_pred cCcCHHHHhh
Confidence 9999877654
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.1e-30 Score=210.18 Aligned_cols=210 Identities=23% Similarity=0.326 Sum_probs=176.5
Q ss_pred HhcCCCCCceeccCCcEEEEEEE-ECCCCEEEEEEcCCCCCchHHHHHHHHHHHhccC-CceeeeEEEEecCCceEEEEE
Q 018712 64 KTDNFGTNSLIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKN-ENVVELVGYYVDGPLRVLAYE 141 (351)
Q Consensus 64 ~~~~y~~~~~Lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h-~niv~~~~~~~~~~~~~lv~e 141 (351)
...+|.++++||+|+||.+|.|. ..+|..||||.-+... ....+.-|.++.+.|++ ..|..+..++.+..+-.+||+
T Consensus 13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a-~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMd 91 (341)
T KOG1163|consen 13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA-KHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMD 91 (341)
T ss_pred eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccC-CCcchhHHHHHHHHhccCCCCchhhhhccccccceeeee
Confidence 45689999999999999999999 4689999999765543 34567889999999976 678888888888999999999
Q ss_pred eCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccC---CceEEeccc
Q 018712 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDD---DIAKISDFD 218 (351)
Q Consensus 142 ~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~---~~vkl~Dfg 218 (351)
.+ |.||.++++-.... ++..+++-++-|++.-++|+|.++ ++||||||+|+|+.-+ ..+-|+|||
T Consensus 92 LL-GPsLEdLfnfC~R~--------ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFG 159 (341)
T KOG1163|consen 92 LL-GPSLEDLFNFCSRR--------FTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFG 159 (341)
T ss_pred cc-CccHHHHHHHHhhh--------hhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEecc
Confidence 99 56999988766542 899999999999999999999999 9999999999999543 468999999
Q ss_pred ccCCCcccccccc-----ccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccc
Q 018712 219 LSNQAPDAAARLH-----STRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSL 286 (351)
Q Consensus 219 ~a~~~~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~ 286 (351)
+|+...+..+..+ .....||..|.+--...+...+.+.|+-|+|.++.++-.|..||++..+....+.
T Consensus 160 LaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QK 232 (341)
T KOG1163|consen 160 LAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQK 232 (341)
T ss_pred chhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHH
Confidence 9998765543322 3456799999998888888889999999999999999999999999876654443
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.5e-28 Score=217.61 Aligned_cols=132 Identities=22% Similarity=0.389 Sum_probs=114.8
Q ss_pred cCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCCchHHHHHHHHHHHhcc-----C---CceeeeEEEEe----c
Q 018712 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLK-----N---ENVVELVGYYV----D 132 (351)
Q Consensus 66 ~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~-----h---~niv~~~~~~~----~ 132 (351)
.+|.+.++||=|-|++||++.+. +.+.||+|+.+......+..+.|+++|++++ | .+||++++.|. .
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGpN 157 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGPN 157 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCCC
Confidence 68999999999999999999964 6789999999877777788899999999983 2 47999999986 4
Q ss_pred CCceEEEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEc
Q 018712 133 GPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLF 207 (351)
Q Consensus 133 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~ 207 (351)
+.++|+|+|++ |.+|..+|....-.. ++...+..|++|++.||.|||+.. +|||.||||+|||+.
T Consensus 158 G~HVCMVfEvL-GdnLLklI~~s~YrG-------lpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~ 222 (590)
T KOG1290|consen 158 GQHVCMVFEVL-GDNLLKLIKYSNYRG-------LPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLC 222 (590)
T ss_pred CcEEEEEehhh-hhHHHHHHHHhCCCC-------CcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeee
Confidence 56899999999 558888887665432 899999999999999999999986 599999999999984
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2e-27 Score=216.36 Aligned_cols=263 Identities=21% Similarity=0.263 Sum_probs=192.5
Q ss_pred CCCCCceeccCCcEEEEEEEECCC--CEEEEEEcCCCCCc-hHHHHHHHHHHHhccC----CceeeeEEEE-ecCCceEE
Q 018712 67 NFGTNSLIGEGSYGRVYFGVLRSG--RAAAIKKLDSSKQP-DQEFLAQVSMVSRLKN----ENVVELVGYY-VDGPLRVL 138 (351)
Q Consensus 67 ~y~~~~~Lg~G~~g~Vy~~~~~~~--~~vavK~~~~~~~~-~~~~~~e~~~l~~l~h----~niv~~~~~~-~~~~~~~l 138 (351)
+|.+.+.||+|+||.||.+...+. ..+|+|........ ...+..|..++..+.. .++..+++.+ ......++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 899999999999999999997653 47888877654322 2267888888888863 6899999998 47778899
Q ss_pred EEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccC-----CceE
Q 018712 139 AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDD-----DIAK 213 (351)
Q Consensus 139 v~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~-----~~vk 213 (351)
||+.+ |.+|.++....... .++..++..++.|++.+|.+||+.| ++||||||+|+++... ..+.
T Consensus 99 VM~l~-G~sL~dl~~~~~~~-------~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~ 167 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNPPG-------RFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLY 167 (322)
T ss_pred EEecc-CccHHHHHHhCCCC-------CcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEE
Confidence 99998 66999988655422 3999999999999999999999999 9999999999999765 3699
Q ss_pred EecccccC--CCcccccc----c-c-ccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCcc
Q 018712 214 ISDFDLSN--QAPDAAAR----L-H-STRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQS 285 (351)
Q Consensus 214 l~Dfg~a~--~~~~~~~~----~-~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~ 285 (351)
|.|||+++ ........ . . ...+.||..|.++....+...+.+.|+||++.++.+++.|..||..........
T Consensus 168 llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~ 247 (322)
T KOG1164|consen 168 LLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKS 247 (322)
T ss_pred EEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHH
Confidence 99999998 32222111 1 1 234569999999999999999999999999999999999999997655332211
Q ss_pred chhh-----ccc---CCCc---cchhhhcc-cccCCCCCHHHHHHHHHHHHHhhhhccccchhhhhcccCCcccccC
Q 018712 286 LVTW-----ATP---KLSE---DKVKQCVD-TKLGGEYPPKAIAKVRKKKFITSECSNISFAEFNINWHCPLEWSVG 350 (351)
Q Consensus 286 ~~~~-----~~~---~~~~---~~~~~~ld-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~~ 350 (351)
.... ... .... ..+...++ .....+++-..+..+++-. +.+.+...+.|+||...
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~----------~~~~~~~~~~~~dw~~~ 314 (322)
T KOG1164|consen 248 KFEKDPRKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDV----------FDSEGSKEDSPFDWEVK 314 (322)
T ss_pred HHHHHhhhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHH----------HHhcCCCCCCCCccccc
Confidence 1110 000 0011 12222222 4555566666655553333 33336667799999864
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.1e-28 Score=216.64 Aligned_cols=204 Identities=25% Similarity=0.381 Sum_probs=170.4
Q ss_pred HHHHHhcCCCCCceeccCCcEEEEEEEEC----CCCEEEEEEcCCCCCchHHHHHHHHHHHhc-cCCceeeeEEEEecCC
Q 018712 60 ELKEKTDNFGTNSLIGEGSYGRVYFGVLR----SGRAAAIKKLDSSKQPDQEFLAQVSMVSRL-KNENVVELVGYYVDGP 134 (351)
Q Consensus 60 ~~~~~~~~y~~~~~Lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~ 134 (351)
.+....+.|..+++||.|+|++||++.+. ..+.||+|.+..... ...+.+|+++|.++ .+.||+++.+.+..++
T Consensus 30 ~~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~-p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd 108 (418)
T KOG1167|consen 30 DIPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS-PSRILNELEMLYRLGGSDNIIKLNGCFRNND 108 (418)
T ss_pred hhhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC-chHHHHHHHHHHHhccchhhhcchhhhccCC
Confidence 34556778999999999999999999853 467899999876544 35589999999999 6899999999999999
Q ss_pred ceEEEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccC-CceE
Q 018712 135 LRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDD-DIAK 213 (351)
Q Consensus 135 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~-~~vk 213 (351)
...+|+||++.....++... ++...+..+++.++.||.++|.+| ||||||||+|+|.+.. +.-.
T Consensus 109 ~v~ivlp~~~H~~f~~l~~~------------l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~ 173 (418)
T KOG1167|consen 109 QVAIVLPYFEHDRFRDLYRS------------LSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGV 173 (418)
T ss_pred eeEEEecccCccCHHHHHhc------------CCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCce
Confidence 99999999999999999875 778899999999999999999999 9999999999999864 5778
Q ss_pred EecccccCCCcc-c------c-----------c------------------------cccccccccccCccCcccccCC-
Q 018712 214 ISDFDLSNQAPD-A------A-----------A------------------------RLHSTRVLGTFGYHAPEYAMTG- 250 (351)
Q Consensus 214 l~Dfg~a~~~~~-~------~-----------~------------------------~~~~~~~~gt~~y~aPE~~~~~- 250 (351)
|+|||+|..... . . . ........||++|.|||++.+.
T Consensus 174 LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~ 253 (418)
T KOG1167|consen 174 LVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCP 253 (418)
T ss_pred EEechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhcc
Confidence 999999872100 0 0 0 0001124699999999998765
Q ss_pred CCCccchhHhHHHHHHHHHcCCCCCCCCC
Q 018712 251 QMSSKSDVYSFGVVLLELLTGRKPVDHTL 279 (351)
Q Consensus 251 ~~~~~~DvwslG~il~el~tg~~Pf~~~~ 279 (351)
..++++||||.|+|+.-++++++||-...
T Consensus 254 ~QttaiDiws~GVI~Lslls~~~PFf~a~ 282 (418)
T KOG1167|consen 254 RQTTAIDIWSAGVILLSLLSRRYPFFKAK 282 (418)
T ss_pred CcCCccceeeccceeehhhccccccccCc
Confidence 56889999999999999999999987643
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.8e-26 Score=208.91 Aligned_cols=166 Identities=19% Similarity=0.191 Sum_probs=129.5
Q ss_pred HHHHhcCCCCCceeccCCcEEEEEEEEC--CCCEEEEEEcCCCC------CchHHHHHHHHHHHhccCCceee-eEEEEe
Q 018712 61 LKEKTDNFGTNSLIGEGSYGRVYFGVLR--SGRAAAIKKLDSSK------QPDQEFLAQVSMVSRLKNENVVE-LVGYYV 131 (351)
Q Consensus 61 ~~~~~~~y~~~~~Lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~------~~~~~~~~e~~~l~~l~h~niv~-~~~~~~ 131 (351)
.....++|.+.+.||+|+||+||+|.+. +++.+|||++.... .....+.+|+++|++++|+|++. ++.
T Consensus 13 ~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~--- 89 (365)
T PRK09188 13 IPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA--- 89 (365)
T ss_pred cccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---
Confidence 3445678999999999999999999864 57778999865331 12356889999999999999985 443
Q ss_pred cCCceEEEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccc-cCCcEEEccCC
Q 018712 132 DGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNI-KSSNVLLFDDD 210 (351)
Q Consensus 132 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dl-kp~Nill~~~~ 210 (351)
.+..|+||||++|++|... .. .. ...++.|++++|.|||++| |+|||| ||+|||++.++
T Consensus 90 -~~~~~LVmE~~~G~~L~~~-~~------------~~---~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~ 149 (365)
T PRK09188 90 -TGKDGLVRGWTEGVPLHLA-RP------------HG---DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDG 149 (365)
T ss_pred -cCCcEEEEEccCCCCHHHh-Cc------------cc---hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCC
Confidence 2457999999999999732 11 11 1357889999999999999 999999 99999999999
Q ss_pred ceEEecccccCCCcccccccc------ccccccccCccCcccccC
Q 018712 211 IAKISDFDLSNQAPDAAARLH------STRVLGTFGYHAPEYAMT 249 (351)
Q Consensus 211 ~vkl~Dfg~a~~~~~~~~~~~------~~~~~gt~~y~aPE~~~~ 249 (351)
.+||+|||+|+.......... .....+++.|+|||.+..
T Consensus 150 ~ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 150 EAAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred CEEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 999999999987644321111 134668889999998864
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.7e-27 Score=237.56 Aligned_cols=189 Identities=17% Similarity=0.160 Sum_probs=132.0
Q ss_pred hccC-CceeeeEEEE-------ecCCceEEEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhh
Q 018712 117 RLKN-ENVVELVGYY-------VDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHE 188 (351)
Q Consensus 117 ~l~h-~niv~~~~~~-------~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~ 188 (351)
.++| +||.+++++| .....++.++|++ +++|.++|..... .++..+++.++.||+.||.|||+
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~--------~~~~~~~~~i~~qi~~al~~lH~ 98 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDR--------SVDAFECFHVFRQIVEIVNAAHS 98 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccc--------cccHHHHHHHHHHHHHHHHHHHh
Confidence 3455 5777777776 2334567788887 5599999975321 28899999999999999999999
Q ss_pred CCCCCeeeccccCCcEEEccCC-------------------ceEEecccccCCCccccc--------------ccccccc
Q 018712 189 KAEPRIIHRNIKSSNVLLFDDD-------------------IAKISDFDLSNQAPDAAA--------------RLHSTRV 235 (351)
Q Consensus 189 ~~~~~ivH~Dlkp~Nill~~~~-------------------~vkl~Dfg~a~~~~~~~~--------------~~~~~~~ 235 (351)
+| |+||||||+||||+..+ .+|++|||+++....... .......
T Consensus 99 ~g---IvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 175 (793)
T PLN00181 99 QG---IVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILA 175 (793)
T ss_pred CC---eeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCccccccc
Confidence 99 99999999999996544 455666666543211000 0001123
Q ss_pred ccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccchhhcc-c----CCC--ccchhhhcccccC
Q 018712 236 LGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWAT-P----KLS--EDKVKQCVDTKLG 308 (351)
Q Consensus 236 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~~~~~-~----~~~--~~~~~~~ld~~~~ 308 (351)
.||+.|+|||++.+..++.++|||||||++|||++|..|+....... ..+..... + ... ...+..|+.++|.
T Consensus 176 ~gt~~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~L~~~P~ 254 (793)
T PLN00181 176 MEMSWYTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSRTM-SSLRHRVLPPQILLNWPKEASFCLWLLHPEPS 254 (793)
T ss_pred CCCcceEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHHHH-HHHHHhhcChhhhhcCHHHHHHHHHhCCCChh
Confidence 57889999999999999999999999999999999999876431100 00000000 0 111 2455678899999
Q ss_pred CCCCHHHHHH
Q 018712 309 GEYPPKAIAK 318 (351)
Q Consensus 309 ~~~~~~~~~~ 318 (351)
.|++..++..
T Consensus 255 ~Rps~~eil~ 264 (793)
T PLN00181 255 CRPSMSELLQ 264 (793)
T ss_pred hCcChHHHhh
Confidence 9998887643
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.3e-24 Score=184.57 Aligned_cols=169 Identities=14% Similarity=0.187 Sum_probs=133.3
Q ss_pred hcCCCCCceeccCCcEEEEEEEECCCCEEEEEEcCCCCCchHH----------HHHHHHHHHhccCCceeeeEEEEecC-
Q 018712 65 TDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQE----------FLAQVSMVSRLKNENVVELVGYYVDG- 133 (351)
Q Consensus 65 ~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~----------~~~e~~~l~~l~h~niv~~~~~~~~~- 133 (351)
.++|.+.+.||.|+||.||++.. ++..+|+|.+.......+. +.+|+..+.++.|++|..+.+++...
T Consensus 30 ~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~ 108 (232)
T PRK10359 30 SYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAE 108 (232)
T ss_pred hCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeecc
Confidence 57899999999999999999766 5778999999755433332 57889999999999999999886633
Q ss_pred -------CceEEEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEE
Q 018712 134 -------PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLL 206 (351)
Q Consensus 134 -------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill 206 (351)
+..+++|||++|.+|.++.. ++. ....+++.+|..+|+.| ++|||+||+||++
T Consensus 109 ~~~~~~~~~~~lvmEyi~G~tL~~~~~-------------~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili 168 (232)
T PRK10359 109 RKTLRYAHTYIMLIEYIEGVELNDMPE-------------ISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIV 168 (232)
T ss_pred cccccccCCeEEEEEEECCccHHHhhh-------------ccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEE
Confidence 35789999999999988742 322 24569999999999999 9999999999999
Q ss_pred ccCCceEEecccccCCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHH
Q 018712 207 FDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELL 269 (351)
Q Consensus 207 ~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~ 269 (351)
+++| ++|+|||........... . .+.....+..++|+||||+++..+.
T Consensus 169 ~~~g-i~liDfg~~~~~~e~~a~---d-----------~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 169 SKNG-LRIIDLSGKRCTAQRKAK---D-----------RIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred eCCC-EEEEECCCcccccchhhH---H-----------HHHHHhHhcccccccceeEeehHHH
Confidence 9998 999999987655322111 0 0234455677999999999987654
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.1e-23 Score=187.93 Aligned_cols=201 Identities=35% Similarity=0.535 Sum_probs=170.8
Q ss_pred CCCCceeccCCcEEEEEEEECCCCEEEEEEcCCCCC----chHHHHHHHHHHHhccCC-ceeeeEEEEecCCceEEEEEe
Q 018712 68 FGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQ----PDQEFLAQVSMVSRLKNE-NVVELVGYYVDGPLRVLAYEH 142 (351)
Q Consensus 68 y~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~h~-niv~~~~~~~~~~~~~lv~e~ 142 (351)
|.+.+.||.|+|+.||++... ..+++|.+..... ....+.+|..+++.+.|+ +++++.+.+......++++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 677889999999999999976 7899999875543 256788999999999988 799999999877778999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCC-ceEEecccccC
Q 018712 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD-IAKISDFDLSN 221 (351)
Q Consensus 143 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~-~vkl~Dfg~a~ 221 (351)
+.++++.+++...... ..+.......++.|++.++.|+|..+ ++|||+||+||+++..+ .++++|||.+.
T Consensus 80 ~~~~~l~~~~~~~~~~------~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~ 150 (384)
T COG0515 80 VDGGSLEDLLKKIGRK------GPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAK 150 (384)
T ss_pred CCCCcHHHHHHhcccc------cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcce
Confidence 9999999887765321 12888999999999999999999999 99999999999999988 79999999987
Q ss_pred CCccccccc----cccccccccCccCcccccC---CCCCccchhHhHHHHHHHHHcCCCCCCCCC
Q 018712 222 QAPDAAARL----HSTRVLGTFGYHAPEYAMT---GQMSSKSDVYSFGVVLLELLTGRKPVDHTL 279 (351)
Q Consensus 222 ~~~~~~~~~----~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~il~el~tg~~Pf~~~~ 279 (351)
......... ......||..|+|||.+.+ ..++...|+||+|++++++++|..||....
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~ 215 (384)
T COG0515 151 LLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEK 215 (384)
T ss_pred ecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 554433221 2356679999999999987 578899999999999999999999977654
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.3e-24 Score=179.19 Aligned_cols=152 Identities=22% Similarity=0.190 Sum_probs=118.0
Q ss_pred CCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccccCCCcc
Q 018712 146 GSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPD 225 (351)
Q Consensus 146 gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~ 225 (351)
|+|.+++...+. .+++..++.++.|++.||.|||+++ ||+|||++.++.+|+ ||++.....
T Consensus 1 GsL~~~l~~~~~--------~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~ 61 (176)
T smart00750 1 VSLADILEVRGR--------PLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTP 61 (176)
T ss_pred CcHHHHHHHhCC--------CCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeecc
Confidence 689999976432 2899999999999999999999985 999999999999999 998876533
Q ss_pred ccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCc--cchhhccc-----------
Q 018712 226 AAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQ--SLVTWATP----------- 292 (351)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~--~~~~~~~~----------- 292 (351)
. ...||+.|+|||++.+..++.++||||||+++|||++|+.||......... .+.....+
T Consensus 62 ~-------~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 134 (176)
T smart00750 62 E-------QSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLES 134 (176)
T ss_pred c-------cCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHH
Confidence 2 125899999999999999999999999999999999999999754322110 01100000
Q ss_pred --C--CCccchhhhcccccCCCCCHHHHHHHHHHH
Q 018712 293 --K--LSEDKVKQCVDTKLGGEYPPKAIAKVRKKK 323 (351)
Q Consensus 293 --~--~~~~~~~~~ld~~~~~~~~~~~~~~~~~~~ 323 (351)
. ...+.+..|+..+|.+|++..++.......
T Consensus 135 ~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~ 169 (176)
T smart00750 135 VSAARSFADFMRVCASRLPQRREAANHYLAHCRAL 169 (176)
T ss_pred HHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHH
Confidence 0 234678889999999999888876654433
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.91 E-value=8.8e-24 Score=177.28 Aligned_cols=138 Identities=18% Similarity=0.170 Sum_probs=107.5
Q ss_pred CceeccCCcEEEEEEEECCCCEEEEEEcCCCCCc----------h-----------------HHHHHHHHHHHhccCCce
Q 018712 71 NSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQP----------D-----------------QEFLAQVSMVSRLKNENV 123 (351)
Q Consensus 71 ~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~----------~-----------------~~~~~e~~~l~~l~h~ni 123 (351)
.+.||+|+||.||+|...+|+.||+|+++..... . ....+|++++.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 4679999999999999888999999998654211 0 112348999999988776
Q ss_pred eeeEEEEecCCceEEEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhh-hhCCCCCeeeccccCC
Q 018712 124 VELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYL-HEKAEPRIIHRNIKSS 202 (351)
Q Consensus 124 v~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~l-H~~~~~~ivH~Dlkp~ 202 (351)
.....+... ..++||||++++++...+.... .++...+..++.|++.+|.++ |+.| |+||||||+
T Consensus 82 ~~p~~~~~~--~~~iVmE~i~g~~l~~~~~~~~---------~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~ 147 (190)
T cd05147 82 PCPEPILLK--SHVLVMEFIGDDGWAAPRLKDA---------PLSESKARELYLQVIQIMRILYQDCR---LVHADLSEY 147 (190)
T ss_pred CCCcEEEec--CCEEEEEEeCCCCCcchhhhcC---------CCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHH
Confidence 443333222 2389999999887765432222 278889999999999999999 7888 999999999
Q ss_pred cEEEccCCceEEecccccCCC
Q 018712 203 NVLLFDDDIAKISDFDLSNQA 223 (351)
Q Consensus 203 Nill~~~~~vkl~Dfg~a~~~ 223 (351)
|||++ ++.++|+|||+|...
T Consensus 148 NIli~-~~~v~LiDFG~a~~~ 167 (190)
T cd05147 148 NLLYH-DGKLYIIDVSQSVEH 167 (190)
T ss_pred HEEEE-CCcEEEEEccccccC
Confidence 99998 478999999998754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.90 E-value=7.5e-23 Score=172.16 Aligned_cols=139 Identities=17% Similarity=0.160 Sum_probs=110.3
Q ss_pred CceeccCCcEEEEEEEECCCCEEEEEEcCCCCCc---------------------------hHHHHHHHHHHHhccCCce
Q 018712 71 NSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQP---------------------------DQEFLAQVSMVSRLKNENV 123 (351)
Q Consensus 71 ~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---------------------------~~~~~~e~~~l~~l~h~ni 123 (351)
...||+|++|.||+|.+.+|+.||||++...... ......|.+.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 5689999999999999878999999998754211 1123578899999999887
Q ss_pred eeeEEEEecCCceEEEEEeCCCCCHHHH-hccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhh-CCCCCeeeccccC
Q 018712 124 VELVGYYVDGPLRVLAYEHASKGSLHDI-LHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHE-KAEPRIIHRNIKS 201 (351)
Q Consensus 124 v~~~~~~~~~~~~~lv~e~~~~gsL~~~-l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~-~~~~~ivH~Dlkp 201 (351)
.....+.... .++||||++|+++... +.... ++......++.|++.++.++|. .| |+||||||
T Consensus 82 ~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~~~----------~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP 146 (190)
T cd05145 82 PVPEPILLKK--NVLVMEFIGDDGSPAPRLKDVP----------LEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSE 146 (190)
T ss_pred CCceEEEecC--CEEEEEEecCCCchhhhhhhcc----------CCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCh
Confidence 5544433332 4899999998755433 43221 6778899999999999999999 98 99999999
Q ss_pred CcEEEccCCceEEecccccCCCcc
Q 018712 202 SNVLLFDDDIAKISDFDLSNQAPD 225 (351)
Q Consensus 202 ~Nill~~~~~vkl~Dfg~a~~~~~ 225 (351)
+|||++ ++.++|+|||++.....
T Consensus 147 ~NIll~-~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 147 YNILYH-DGKPYIIDVSQAVELDH 169 (190)
T ss_pred hhEEEE-CCCEEEEEcccceecCC
Confidence 999998 88999999999877643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.3e-24 Score=210.36 Aligned_cols=237 Identities=19% Similarity=0.261 Sum_probs=181.8
Q ss_pred CCCceeccCCcEEEEEEEEC-CCCEEEEEEcC----CCCCc---hHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEE
Q 018712 69 GTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLD----SSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAY 140 (351)
Q Consensus 69 ~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~----~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 140 (351)
.....+|.|++|.|+.+... ....++.|... ..... ...+..|+.+-..++|+|++..+..+.+....+-.|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 35668999999988777643 34445555433 11111 112555677777889999988777766666666669
Q ss_pred EeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEeccccc
Q 018712 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (351)
Q Consensus 141 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a 220 (351)
|||++ +|..++..... +...++-.++.|++.|++|+|..| +.|||||++|+++..+|.+||+|||.+
T Consensus 401 E~~~~-Dlf~~~~~~~~---------~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~ 467 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSNGK---------LTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAA 467 (601)
T ss_pred hcccH-HHHHHHhcccc---------cchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcc
Confidence 99999 99999987632 788899999999999999999999 999999999999999999999999998
Q ss_pred CCCcccccc--ccccccccccCccCcccccCCCCCc-cchhHhHHHHHHHHHcCCCCCCCCCCCCCcc------------
Q 018712 221 NQAPDAAAR--LHSTRVLGTFGYHAPEYAMTGQMSS-KSDVYSFGVVLLELLTGRKPVDHTLPRGQQS------------ 285 (351)
Q Consensus 221 ~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~-~~DvwslG~il~el~tg~~Pf~~~~~~~~~~------------ 285 (351)
......... ......+|+..|+|||.+.+..|.+ ..||||.|++++.|.+|+.||......++..
T Consensus 468 ~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~ 547 (601)
T KOG0590|consen 468 SVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIF 547 (601)
T ss_pred eeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccc
Confidence 776544333 3345678999999999999999965 5899999999999999999998765443321
Q ss_pred ----chhhcccCCCccchhhhcccccCCCCCHHHHHH
Q 018712 286 ----LVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAK 318 (351)
Q Consensus 286 ----~~~~~~~~~~~~~~~~~ld~~~~~~~~~~~~~~ 318 (351)
.+....|......+-.+|+.+|.+|++.+++..
T Consensus 548 ~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 548 EGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred cChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 111223333346788999999999999888755
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.2e-22 Score=169.21 Aligned_cols=187 Identities=15% Similarity=0.099 Sum_probs=141.7
Q ss_pred CCCceeccCCcEEEEEEEECCCCEEEEEEcCCCCCchH-----HHHHHHHHHHhcc-CCceeeeEEEEecCCceEEEEEe
Q 018712 69 GTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQ-----EFLAQVSMVSRLK-NENVVELVGYYVDGPLRVLAYEH 142 (351)
Q Consensus 69 ~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~-----~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~ 142 (351)
.+...|++|+||+||.+.. .+.+++.+.+........ .+.+|+++|+++. |+++++++++ +..+++|||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey 79 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY 79 (218)
T ss_pred ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence 3456799999999997765 678898888876654333 5789999999995 5889999886 347999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccc-cCCcEEEccCCceEEecccccC
Q 018712 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNI-KSSNVLLFDDDIAKISDFDLSN 221 (351)
Q Consensus 143 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dl-kp~Nill~~~~~vkl~Dfg~a~ 221 (351)
+.|.+|.+.+.. ....++.|++.+|.++|++| |+|||| ||+|||++.++.++|+|||++.
T Consensus 80 I~G~~L~~~~~~----------------~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~ 140 (218)
T PRK12274 80 LAGAAMYQRPPR----------------GDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAV 140 (218)
T ss_pred ecCccHHhhhhh----------------hhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCce
Confidence 999998754321 11347789999999999999 999999 7999999999999999999998
Q ss_pred CCcccccc----c-------cccccccccCccCcccccCC-CCC-ccchhHhHHHHHHHHHcCCCCCCCCC
Q 018712 222 QAPDAAAR----L-------HSTRVLGTFGYHAPEYAMTG-QMS-SKSDVYSFGVVLLELLTGRKPVDHTL 279 (351)
Q Consensus 222 ~~~~~~~~----~-------~~~~~~gt~~y~aPE~~~~~-~~~-~~~DvwslG~il~el~tg~~Pf~~~~ 279 (351)
........ . .......++.|++|+...-. ..+ ...+.++.|.-+|.++|+..|+-.+.
T Consensus 141 ~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~ 211 (218)
T PRK12274 141 RGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN 211 (218)
T ss_pred ecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence 65432210 0 01112357788888754432 233 46788899999999999998876543
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=3e-23 Score=182.74 Aligned_cols=195 Identities=19% Similarity=0.258 Sum_probs=148.3
Q ss_pred cCCceeeeEEEEec---------------------------CCceEEEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHH
Q 018712 119 KNENVVELVGYYVD---------------------------GPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQ 171 (351)
Q Consensus 119 ~h~niv~~~~~~~~---------------------------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~ 171 (351)
+|||||++.+.|.+ ...+|+||..+.. +|.+++.... .+...
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~----------~s~r~ 342 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRH----------RSYRT 342 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCC----------CchHH
Confidence 69999999987753 2457999998866 9999998765 77788
Q ss_pred HHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEc--cCC--ceEEecccccCCCccccc----cccccccccccCccC
Q 018712 172 RVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLF--DDD--IAKISDFDLSNQAPDAAA----RLHSTRVLGTFGYHA 243 (351)
Q Consensus 172 ~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~--~~~--~vkl~Dfg~a~~~~~~~~----~~~~~~~~gt~~y~a 243 (351)
..-++.|+++|+.|||++| |.|||+|.+|||+. +|+ .+.|+|||.+-......- ....-..-|...-||
T Consensus 343 ~~~~laQlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmA 419 (598)
T KOG4158|consen 343 GRVILAQLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMA 419 (598)
T ss_pred HHHHHHHHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecc
Confidence 8899999999999999999 99999999999993 444 578999998754332111 111122347778999
Q ss_pred cccccCCC------CCccchhHhHHHHHHHHHcCCCCCCCCCC---------CCCccchhhcccCCCccchhhhcccccC
Q 018712 244 PEYAMTGQ------MSSKSDVYSFGVVLLELLTGRKPVDHTLP---------RGQQSLVTWATPKLSEDKVKQCVDTKLG 308 (351)
Q Consensus 244 PE~~~~~~------~~~~~DvwslG~il~el~tg~~Pf~~~~~---------~~~~~~~~~~~~~~~~~~~~~~ld~~~~ 308 (351)
||+....+ --.++|.|+.|.+.||+++...||..... +.+..-.....|....+++..++.+++.
T Consensus 420 PEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~qLPalp~~vpp~~rqlV~~lL~r~ps 499 (598)
T KOG4158|consen 420 PEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQLPALPSRVPPVARQLVFDLLKRDPS 499 (598)
T ss_pred hhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhhhCCCCcccCChHHHHHHHHHhcCCcc
Confidence 99876432 12479999999999999999999987321 1111222333444455788999999999
Q ss_pred CCCCHHHHHHHHHHHHHhh
Q 018712 309 GEYPPKAIAKVRKKKFITS 327 (351)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~ 327 (351)
+|.++.-+..++.+.+|--
T Consensus 500 kRvsp~iAANvl~LsLw~~ 518 (598)
T KOG4158|consen 500 KRVSPNIAANVLNLSLWRM 518 (598)
T ss_pred ccCCccHHHhHHHHHHhcC
Confidence 9999999999999988763
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.8e-23 Score=203.76 Aligned_cols=198 Identities=24% Similarity=0.260 Sum_probs=160.6
Q ss_pred HHhcCCCCCceeccCCcEEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHHhcc---CCceeeeEEEEecCCceEEE
Q 018712 63 EKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLK---NENVVELVGYYVDGPLRVLA 139 (351)
Q Consensus 63 ~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~lv 139 (351)
.....|.|.+.||+|+||.||+|...+|+.||+|+-+...... |.--.+++.||+ -+-|..+...+.-.+..+||
T Consensus 695 ~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE--fYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv 772 (974)
T KOG1166|consen 695 VGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE--FYICLQVMERLKPQMLPSIMHISSAHVFQNASVLV 772 (974)
T ss_pred ecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCcee--eeehHHHHHhhchhhhcchHHHHHHHccCCcceee
Confidence 3456788999999999999999998889999999876554332 222244555665 24455555555666778899
Q ss_pred EEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEcc-------CCce
Q 018712 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFD-------DDIA 212 (351)
Q Consensus 140 ~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~-------~~~v 212 (351)
+||.+.|+|.++++..+ .+.+..++.++.|++..+..||..+ ||||||||+|+||.. ...+
T Consensus 773 ~ey~~~Gtlld~~N~~~---------~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l 840 (974)
T KOG1166|consen 773 SEYSPYGTLLDLINTNK---------VMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGL 840 (974)
T ss_pred eeccccccHHHhhccCC---------CCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccce
Confidence 99999999999999544 3889999999999999999999999 999999999999953 2368
Q ss_pred EEecccccCCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCC
Q 018712 213 KISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274 (351)
Q Consensus 213 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P 274 (351)
+|+|||.+....--.........++|-.+-.+|+..|+.++..+|.|.|+.+++-|+.|++-
T Consensus 841 ~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~ 902 (974)
T KOG1166|consen 841 YLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM 902 (974)
T ss_pred EEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence 99999998765443333344667789999999999999999999999999999999999865
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.3e-23 Score=193.55 Aligned_cols=185 Identities=28% Similarity=0.354 Sum_probs=156.9
Q ss_pred eeccCCcEEEEEEEE----CCCCEEEEEEcCCCCC---chHHHHHHHHHHHhcc-CCceeeeEEEEecCCceEEEEEeCC
Q 018712 73 LIGEGSYGRVYFGVL----RSGRAAAIKKLDSSKQ---PDQEFLAQVSMVSRLK-NENVVELVGYYVDGPLRVLAYEHAS 144 (351)
Q Consensus 73 ~Lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~ 144 (351)
.+|.|+||.|+++.. ..+..||+|++.+... .......|-.++...+ ||.++++...++.+...++++++..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 379999999998762 3577889888764321 1123445667777776 9999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccccCCCc
Q 018712 145 KGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAP 224 (351)
Q Consensus 145 ~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~ 224 (351)
||.|...+..... +.+.....+...++-+++++|+.+ ++|||+|++||+++.+|++++.|||+++..-
T Consensus 81 gg~lft~l~~~~~---------f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v 148 (612)
T KOG0603|consen 81 GGDLFTRLSKEVM---------FDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAV 148 (612)
T ss_pred cchhhhccccCCc---------hHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhH
Confidence 9999988887654 777888889999999999999999 9999999999999999999999999988764
Q ss_pred cccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCC
Q 018712 225 DAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDH 277 (351)
Q Consensus 225 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~ 277 (351)
.... .+||..|||||++. .....+|.||||++++||+||..||..
T Consensus 149 ~~~~------~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~ 193 (612)
T KOG0603|consen 149 KEKI------ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG 193 (612)
T ss_pred hhhh------cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch
Confidence 4322 28999999999888 667789999999999999999999987
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=7.2e-23 Score=199.72 Aligned_cols=237 Identities=16% Similarity=0.174 Sum_probs=178.6
Q ss_pred CCCCCceeccCCcEEEEEEEECCCCEEEEEEcCCCC--CchH---HHHHHHHHHHhccCCceeeeEEEEecCCceEEEEE
Q 018712 67 NFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSK--QPDQ---EFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYE 141 (351)
Q Consensus 67 ~y~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~---~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 141 (351)
+|...+.||++.|=+|.+|+++.|. |+||++-+.. ..-. +...|++ ...+++||++.+.-+.......|||-+
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRq 101 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQ 101 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHH
Confidence 6778889999999999999998886 8899875443 1222 3334444 555689999999888777888899999
Q ss_pred eCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccccC
Q 018712 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (351)
Q Consensus 142 ~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~ 221 (351)
|..+ +|+|.+..+. .+...+.+.|+.|++.||..+|+.| |+|||||.+||||++-+.+.|+||...+
T Consensus 102 yvkh-nLyDRlSTRP---------FL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFK 168 (1431)
T KOG1240|consen 102 YVKH-NLYDRLSTRP---------FLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFK 168 (1431)
T ss_pred HHhh-hhhhhhccch---------HHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccC
Confidence 9976 9999998664 4888889999999999999999999 9999999999999999999999998776
Q ss_pred CCcc---cc--ccccccccccccCccCcccccCC----------C-CCccchhHhHHHHHHHHHc-CCCCCCCC------
Q 018712 222 QAPD---AA--ARLHSTRVLGTFGYHAPEYAMTG----------Q-MSSKSDVYSFGVVLLELLT-GRKPVDHT------ 278 (351)
Q Consensus 222 ~~~~---~~--~~~~~~~~~gt~~y~aPE~~~~~----------~-~~~~~DvwslG~il~el~t-g~~Pf~~~------ 278 (351)
...- .. ......+...-..|+|||.+... . .+++-||||+||++.||++ |++||.-.
T Consensus 169 PtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aYr 248 (1431)
T KOG1240|consen 169 PTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAYR 248 (1431)
T ss_pred CccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhHh
Confidence 5321 11 11111112223369999987531 1 5678999999999999998 89998742
Q ss_pred --CCCCCccchhhcccCCCccchhhhcccccCCCCCHHHHHH
Q 018712 279 --LPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAK 318 (351)
Q Consensus 279 --~~~~~~~~~~~~~~~~~~~~~~~~ld~~~~~~~~~~~~~~ 318 (351)
.......+.......-..+++..|++.+|..|.++++...
T Consensus 249 ~~~~~~~e~~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~ 290 (1431)
T KOG1240|consen 249 SGNADDPEQLLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQ 290 (1431)
T ss_pred ccCccCHHHHHHhCcCccHHHHHHHHHccCchhccCHHHHHH
Confidence 1112223344444445567889999999999999887654
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=1e-20 Score=160.25 Aligned_cols=137 Identities=15% Similarity=0.137 Sum_probs=105.1
Q ss_pred CCCCceeccCCcEEEEEEEECCCCEEEEEEcCCCC-CchHHHHHHHHHHHhc-----cCCceeeeEEEEecCC---ceE-
Q 018712 68 FGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSK-QPDQEFLAQVSMVSRL-----KNENVVELVGYYVDGP---LRV- 137 (351)
Q Consensus 68 y~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l-----~h~niv~~~~~~~~~~---~~~- 137 (351)
+.-.+.||+|+||.||. +......+||++.... .....+.+|+.+++.+ .||||+++++++.++. ..+
T Consensus 4 L~~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~ 81 (210)
T PRK10345 4 LSEQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYD 81 (210)
T ss_pred cCCcceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEE
Confidence 34456899999999995 4433334799876542 2356789999999999 5799999999998763 333
Q ss_pred EEEEe--CCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHH-HhhhhCCCCCeeeccccCCcEEEccC----C
Q 018712 138 LAYEH--ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGL-EYLHEKAEPRIIHRNIKSSNVLLFDD----D 210 (351)
Q Consensus 138 lv~e~--~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l-~~lH~~~~~~ivH~Dlkp~Nill~~~----~ 210 (351)
+|+|| +.+++|.+++.+.. +++. ..++.|++.++ +|||+++ |+||||||+|||++.. +
T Consensus 82 ~I~e~~G~~~~tL~~~l~~~~----------~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~ 146 (210)
T PRK10345 82 VIADFDGKPSITLTEFAEQCR----------YEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEV 146 (210)
T ss_pred EEecCCCCcchhHHHHHHccc----------ccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCC
Confidence 78999 55799999997642 4444 35678888777 9999999 9999999999999743 3
Q ss_pred ceEEecccccC
Q 018712 211 IAKISDFDLSN 221 (351)
Q Consensus 211 ~vkl~Dfg~a~ 221 (351)
.++|+||+.+.
T Consensus 147 ~~~LiDg~G~~ 157 (210)
T PRK10345 147 IPVVCDNIGES 157 (210)
T ss_pred cEEEEECCCCc
Confidence 79999955443
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=4.3e-22 Score=167.49 Aligned_cols=235 Identities=22% Similarity=0.306 Sum_probs=177.6
Q ss_pred CCceeccCCcEEEEEEEECCCCEEEEEEcCCC---CCchHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEEEeCCCC
Q 018712 70 TNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSS---KQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASKG 146 (351)
Q Consensus 70 ~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 146 (351)
+.-+|.....|..|+|+++.+ .++.|++... ....++|..|+-.|+.+.||||+.+++.+.....+.++..|++.|
T Consensus 194 l~tkl~e~hsgelwrgrwqgn-divakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~g 272 (448)
T KOG0195|consen 194 LITKLAESHSGELWRGRWQGN-DIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFG 272 (448)
T ss_pred hhhhhccCCCcccccccccCc-chhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccch
Confidence 344688889999999999744 4556666433 233467888999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEe--cccccCCCc
Q 018712 147 SLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKIS--DFDLSNQAP 224 (351)
Q Consensus 147 sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~--Dfg~a~~~~ 224 (351)
||+..|++.... +....++.+++.+++.|++|||+..+. |.---|....+++|++.+.+|+ |--++.
T Consensus 273 slynvlhe~t~v-------vvd~sqav~faldiargmaflhslep~-ipr~~lns~hvmidedltarismad~kfsf--- 341 (448)
T KOG0195|consen 273 SLYNVLHEQTSV-------VVDHSQAVRFALDIARGMAFLHSLEPM-IPRFYLNSKHVMIDEDLTARISMADTKFSF--- 341 (448)
T ss_pred HHHHHHhcCccE-------EEecchHHHHHHHHHhhHHHHhhcchh-hhhhhcccceEEecchhhhheecccceeee---
Confidence 999999987642 367788999999999999999998632 4455788999999999887764 321111
Q ss_pred cccccccccccccccCccCcccccCCCC---CccchhHhHHHHHHHHHcCCCCCCCCCCCCCccch------hhcccCCC
Q 018712 225 DAAARLHSTRVLGTFGYHAPEYAMTGQM---SSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLV------TWATPKLS 295 (351)
Q Consensus 225 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~------~~~~~~~~ 295 (351)
......-.|.||+||.++..+. -..+|+|||++++|||.|...||....+.+-...+ ....|...
T Consensus 342 ------qe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv~ippgis 415 (448)
T KOG0195|consen 342 ------QEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRVHIPPGIS 415 (448)
T ss_pred ------eccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccccCCCCcc
Confidence 1122234788999999987654 34789999999999999999999987765433222 12222222
Q ss_pred c---cchhhhcccccCCCCCHHHHHHHHHH
Q 018712 296 E---DKVKQCVDTKLGGEYPPKAIAKVRKK 322 (351)
Q Consensus 296 ~---~~~~~~ld~~~~~~~~~~~~~~~~~~ 322 (351)
. .++.-|++.+|.+|+..+.+--+++.
T Consensus 416 ~hm~klm~icmnedpgkrpkfdmivpilek 445 (448)
T KOG0195|consen 416 RHMNKLMNICMNEDPGKRPKFDMIVPILEK 445 (448)
T ss_pred HHHHHHHHHHhcCCCCcCCCcceehhhHHH
Confidence 2 56778899999999988776555543
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.84 E-value=5e-21 Score=167.56 Aligned_cols=203 Identities=20% Similarity=0.270 Sum_probs=127.6
Q ss_pred CCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCC----chHHHHHHHHHHHhcc----------CCceeeeEEEE--
Q 018712 68 FGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ----PDQEFLAQVSMVSRLK----------NENVVELVGYY-- 130 (351)
Q Consensus 68 y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~----------h~niv~~~~~~-- 130 (351)
+.....||.|+++.||.+.+. +++.+|+|+...... .-+.+.+|.-....+. |-.++..++..
T Consensus 14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i 93 (288)
T PF14531_consen 14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI 93 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence 345678999999999999986 689999998743322 1234555543333321 21222222221
Q ss_pred -------ecC---C-----ceEEEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCee
Q 018712 131 -------VDG---P-----LRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRII 195 (351)
Q Consensus 131 -------~~~---~-----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~iv 195 (351)
... + ..+++|+-+.+ +|.+++..-...... ...+.......+..|+++.+++||..| ++
T Consensus 94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~-dL~~~~~~l~~~~~~--~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lV 167 (288)
T PF14531_consen 94 PGKPPFFERGPGQSIYWVLNRFLLMPRAQG-DLQDLVEALFSRAQT--HSPLAFAARLSLTVQMIRLVANLHSYG---LV 167 (288)
T ss_dssp TTS-SEEEECETTEEEEEESEEEEEE--SE-EHHHHHHHHHHHTTT--SHHHHHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred cCCCcceecCCCCccceeehhhhccchhhh-cHHHHHHHHhhcccc--cchhHHHHHHHHHHHHHHHHHHHhhcc---eE
Confidence 111 1 23677777754 888886531110000 111445556677899999999999999 99
Q ss_pred eccccCCcEEEccCCceEEecccccCCCccccccccccccccccCccCcccccC--------CCCCccchhHhHHHHHHH
Q 018712 196 HRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMT--------GQMSSKSDVYSFGVVLLE 267 (351)
Q Consensus 196 H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DvwslG~il~e 267 (351)
|+||+|+|++++.+|.+.|+||+........... ...+..|.+||.... -.++.+.|.|+||+++|.
T Consensus 168 Hgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~-----~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~ 242 (288)
T PF14531_consen 168 HGDIKPENFLLDQDGGVFLGDFSSLVRAGTRYRC-----SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYS 242 (288)
T ss_dssp EST-SGGGEEE-TTS-EEE--GGGEEETTEEEEG-----GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHH
T ss_pred ecccceeeEEEcCCCCEEEcChHHHeecCceeec-----cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHH
Confidence 9999999999999999999999977665443221 234577999997643 246889999999999999
Q ss_pred HHcCCCCCCCCCCC
Q 018712 268 LLTGRKPVDHTLPR 281 (351)
Q Consensus 268 l~tg~~Pf~~~~~~ 281 (351)
|++|..||....+.
T Consensus 243 lWC~~lPf~~~~~~ 256 (288)
T PF14531_consen 243 LWCGRLPFGLSSPE 256 (288)
T ss_dssp HHHSS-STCCCGGG
T ss_pred HHHccCCCCCCCcc
Confidence 99999999976443
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.1e-21 Score=189.30 Aligned_cols=213 Identities=27% Similarity=0.420 Sum_probs=147.4
Q ss_pred HhcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCCchHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEEEe
Q 018712 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEH 142 (351)
Q Consensus 64 ~~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 142 (351)
...+|..+++|..|+||.||..+++ +.+.+|+| +.++.. +.+. ++....+|++|
T Consensus 81 ~e~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~l----ilRn--ilt~a~npfvv------------------ 135 (1205)
T KOG0606|consen 81 SESDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNL----ILRN--ILTFAGNPFVV------------------ 135 (1205)
T ss_pred CccccceeEeeccCCCCceeeeeccccccchhhc-ccccch----hhhc--cccccCCccee------------------
Confidence 4568999999999999999999976 46678884 332211 1111 23333444444
Q ss_pred CCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccccCC
Q 018712 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222 (351)
Q Consensus 143 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~ 222 (351)
|+-...++..+. ++. +++.+++|||+.| |+|||+||+|++|+.-|++|+.|||+++.
T Consensus 136 ---gDc~tllk~~g~---------lPv--------dmvla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~ 192 (1205)
T KOG0606|consen 136 ---GDCATLLKNIGP---------LPV--------DMVLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKK 192 (1205)
T ss_pred ---chhhhhcccCCC---------Ccc--------hhhHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhh
Confidence 455555554332 332 2377899999999 99999999999999999999999999876
Q ss_pred Cccccc-------------cccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccch--
Q 018712 223 APDAAA-------------RLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLV-- 287 (351)
Q Consensus 223 ~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~-- 287 (351)
...... .......+||+.|.|||++..+.|+..+|+|++|+|+||.+.|..||.+++++.....+
T Consensus 193 GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~vis 272 (1205)
T KOG0606|consen 193 GLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVIS 272 (1205)
T ss_pred hhhhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhh
Confidence 432211 11234568999999999999999999999999999999999999999998766433221
Q ss_pred ---hh-----cccCCCccchhhhcccccCCCCCHHHHHHHHHHHH
Q 018712 288 ---TW-----ATPKLSEDKVKQCVDTKLGGEYPPKAIAKVRKKKF 324 (351)
Q Consensus 288 ---~~-----~~~~~~~~~~~~~ld~~~~~~~~~~~~~~~~~~~~ 324 (351)
.| ..+.-..+.+.++++..+..|.-......+.++.+
T Consensus 273 d~i~wpE~dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~f 317 (1205)
T KOG0606|consen 273 DDIEWPEEDEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGF 317 (1205)
T ss_pred hhccccccCcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccc
Confidence 11 12222235566666666666654444444444443
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.83 E-value=5e-20 Score=159.74 Aligned_cols=144 Identities=16% Similarity=0.138 Sum_probs=111.7
Q ss_pred hcCCCCCceeccCCcEEEEEEE--ECCCCEEEEEEcCCCCCc-------------------------hHHHHHHHHHHHh
Q 018712 65 TDNFGTNSLIGEGSYGRVYFGV--LRSGRAAAIKKLDSSKQP-------------------------DQEFLAQVSMVSR 117 (351)
Q Consensus 65 ~~~y~~~~~Lg~G~~g~Vy~~~--~~~~~~vavK~~~~~~~~-------------------------~~~~~~e~~~l~~ 117 (351)
...|.+.+.||+|++|.||+|. ..+|+.||+|++...... ...+.+|+..+++
T Consensus 27 ~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~ 106 (237)
T smart00090 27 GILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQR 106 (237)
T ss_pred CchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHH
Confidence 3358899999999999999998 458999999998643210 1225679999999
Q ss_pred ccCC--ceeeeEEEEecCCceEEEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCee
Q 018712 118 LKNE--NVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRII 195 (351)
Q Consensus 118 l~h~--niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~iv 195 (351)
+.+. .+.+++.+ ...++||||+.+++|........ .+.......++.|++.++.+||++| .++
T Consensus 107 L~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~---------~~~~~~~~~i~~qi~~~l~~LH~~g--~ii 171 (237)
T smart00090 107 LYEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDV---------EPEEEEEFELYDDILEEMRKLYKEG--ELV 171 (237)
T ss_pred HHhcCCCCCeeeEe----cCceEEEEEecCCcccccccccC---------CcchHHHHHHHHHHHHHHHHHHhcC--CEE
Confidence 9753 34444442 23589999999988876653222 1555667889999999999999996 499
Q ss_pred eccccCCcEEEccCCceEEecccccCCCc
Q 018712 196 HRNIKSSNVLLFDDDIAKISDFDLSNQAP 224 (351)
Q Consensus 196 H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~ 224 (351)
||||||+||+++ ++.++|+|||.+....
T Consensus 172 H~Dikp~NIli~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 172 HGDLSEYNILVH-DGKVVIIDVSQSVELD 199 (237)
T ss_pred eCCCChhhEEEE-CCCEEEEEChhhhccC
Confidence 999999999998 8899999999886543
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=2.3e-19 Score=153.57 Aligned_cols=134 Identities=22% Similarity=0.331 Sum_probs=112.9
Q ss_pred ceeccCCcEEEEEEEECCCCEEEEEEcCCCCCc---------hHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEEEe
Q 018712 72 SLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQP---------DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEH 142 (351)
Q Consensus 72 ~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 142 (351)
+.||+|++|.||+|.. .+..+++|+....... ...+.+|+.++..+.|+++.....++.+.+..+++|||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5799999999999987 6778999976533211 13467899999999999988777777777888999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccccCC
Q 018712 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222 (351)
Q Consensus 143 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~ 222 (351)
++|++|.+++.... . ....++.+++.+|.++|+.+ ++|+|++|.|||++ ++.++|+|||.+..
T Consensus 81 ~~G~~L~~~~~~~~------------~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSNG------------M-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhcc------------H-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 99999999986431 2 77889999999999999999 99999999999998 78899999998865
Q ss_pred C
Q 018712 223 A 223 (351)
Q Consensus 223 ~ 223 (351)
.
T Consensus 144 ~ 144 (211)
T PRK14879 144 S 144 (211)
T ss_pred C
Confidence 3
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.81 E-value=3.6e-19 Score=151.02 Aligned_cols=130 Identities=24% Similarity=0.340 Sum_probs=106.0
Q ss_pred eeccCCcEEEEEEEECCCCEEEEEEcCCCCC-c--------hHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEEEeC
Q 018712 73 LIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQ-P--------DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHA 143 (351)
Q Consensus 73 ~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~--------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 143 (351)
.||+|+||.||+|.. ++..+++|....... . ...+.+|+++++.+.|+++.....++...+..+++|||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 489999999999985 578899998543221 1 144678999999998887665555555667789999999
Q ss_pred CCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccccCCC
Q 018712 144 SKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQA 223 (351)
Q Consensus 144 ~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~ 223 (351)
+|++|.+++.... . .++.+++.+|.+||+.+ ++|||++|+||+++ ++.++++|||++...
T Consensus 80 ~g~~l~~~~~~~~----------~------~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 80 EGKPLKDVIEEGN----------D------ELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKYS 139 (199)
T ss_pred CCccHHHHHhhcH----------H------HHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence 9999999875431 1 78899999999999999 99999999999998 889999999988664
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.81 E-value=5.6e-19 Score=149.69 Aligned_cols=138 Identities=16% Similarity=0.120 Sum_probs=109.4
Q ss_pred cCCCCCceeccCCcEEEEEEEECCCCEEEEEEcCCCCCc-----------------------hHHHHHHHHHHHhccCC-
Q 018712 66 DNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQP-----------------------DQEFLAQVSMVSRLKNE- 121 (351)
Q Consensus 66 ~~y~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-----------------------~~~~~~e~~~l~~l~h~- 121 (351)
.-|.+.+.||+|+||.||++...+|+.+|||++...... ......|+.++..+.|+
T Consensus 15 ~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 94 (198)
T cd05144 15 VVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEG 94 (198)
T ss_pred chhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcC
Confidence 348888999999999999999888999999986543210 11356788888888776
Q ss_pred -ceeeeEEEEecCCceEEEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeecccc
Q 018712 122 -NVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIK 200 (351)
Q Consensus 122 -niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlk 200 (351)
.++..++ ....+++|||++|++|..+... .....++.+++.++.++|..| ++|||||
T Consensus 95 i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~---------------~~~~~~~~~i~~~l~~lh~~g---i~H~Dl~ 152 (198)
T cd05144 95 FPVPKPID----WNRHAVVMEYIDGVELYRVRVL---------------EDPEEVLDEILEEIVKAYKHG---IIHGDLS 152 (198)
T ss_pred CCCCceee----cCCceEEEEEeCCcchhhcccc---------------ccHHHHHHHHHHHHHHHHHCC---CCcCCCC
Confidence 4444443 2345899999999999765431 234578899999999999999 9999999
Q ss_pred CCcEEEccCCceEEecccccCCCcc
Q 018712 201 SSNVLLFDDDIAKISDFDLSNQAPD 225 (351)
Q Consensus 201 p~Nill~~~~~vkl~Dfg~a~~~~~ 225 (351)
|+||++++++.++|+|||.+.....
T Consensus 153 p~Nill~~~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 153 EFNILVDDDEKIYIIDWPQMVSTDH 177 (198)
T ss_pred cccEEEcCCCcEEEEECCccccCCC
Confidence 9999999999999999999866543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.5e-18 Score=168.46 Aligned_cols=137 Identities=22% Similarity=0.295 Sum_probs=111.0
Q ss_pred hcCCCCCceeccCCcEEEEEEEECCCCEEEEEE-cCCCCC--------chHHHHHHHHHHHhccCCceeeeEEEEecCCc
Q 018712 65 TDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKK-LDSSKQ--------PDQEFLAQVSMVSRLKNENVVELVGYYVDGPL 135 (351)
Q Consensus 65 ~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~-~~~~~~--------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 135 (351)
...|...+.||+|+||.||++.+.... +++|+ +.+... ....+.+|+++++.++|++++....++.+...
T Consensus 332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~ 410 (535)
T PRK09605 332 KRRKIPDHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEE 410 (535)
T ss_pred ccccCccceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCC
Confidence 345667889999999999999875443 44443 222111 12457889999999999999888777777778
Q ss_pred eEEEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEe
Q 018712 136 RVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKIS 215 (351)
Q Consensus 136 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~ 215 (351)
.++||||+++++|.+++. ....++.+++.+|.+||+.+ ++||||||+|||+ +++.++|+
T Consensus 411 ~~lv~E~~~g~~L~~~l~-----------------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~li 469 (535)
T PRK09605 411 KTIVMEYIGGKDLKDVLE-----------------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLI 469 (535)
T ss_pred CEEEEEecCCCcHHHHHH-----------------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEE
Confidence 899999999999999875 24568999999999999999 9999999999999 67899999
Q ss_pred cccccCCC
Q 018712 216 DFDLSNQA 223 (351)
Q Consensus 216 Dfg~a~~~ 223 (351)
|||+++..
T Consensus 470 DFGla~~~ 477 (535)
T PRK09605 470 DFGLGKYS 477 (535)
T ss_pred eCcccccC
Confidence 99998764
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.6e-18 Score=161.15 Aligned_cols=200 Identities=25% Similarity=0.365 Sum_probs=152.6
Q ss_pred HHhccCCceeeeEEEEecCCceEEEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCe
Q 018712 115 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 194 (351)
Q Consensus 115 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~i 194 (351)
|+.+.|.|+.++++.+.+++..++|.+||..|+|.+.+..... .+++.-...+.++|+.||.|||+.. |
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~--------~~d~~F~~s~~rdi~~Gl~ylh~s~---i 69 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDI--------KLDYFFILSFIRDISKGLAYLHNSP---I 69 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhcccc--------CccHHHHHHHHHHHHHHHHHHhcCc---c
Confidence 4568999999999999999999999999999999999987432 2788888899999999999999986 5
Q ss_pred -eeccccCCcEEEccCCceEEecccccCCCccccccccccccccccCccCcccccCC-------CCCccchhHhHHHHHH
Q 018712 195 -IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTG-------QMSSKSDVYSFGVVLL 266 (351)
Q Consensus 195 -vH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~~DvwslG~il~ 266 (351)
.|+.|+..|++++....+||+|||+.................-...|.|||.+.+. ..+.+.|+||||++++
T Consensus 70 ~~hg~l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ 149 (484)
T KOG1023|consen 70 GYHGALKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMY 149 (484)
T ss_pred eeeeeeccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHH
Confidence 89999999999999999999999998766431111111222235579999988753 1467799999999999
Q ss_pred HHHcCCCCCCCCCCCCC-ccchhh--------cccCC---------CccchhhhcccccCCCCCHHHHHHHHHHHHH
Q 018712 267 ELLTGRKPVDHTLPRGQ-QSLVTW--------ATPKL---------SEDKVKQCVDTKLGGEYPPKAIAKVRKKKFI 325 (351)
Q Consensus 267 el~tg~~Pf~~~~~~~~-~~~~~~--------~~~~~---------~~~~~~~~ld~~~~~~~~~~~~~~~~~~~~~ 325 (351)
|+++.+.||........ ..++.. ..|.. .-..+.+|+...|..|++.+.+...++....
T Consensus 150 ei~~r~~~~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~ 226 (484)
T KOG1023|consen 150 EILFRSGPFDLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINK 226 (484)
T ss_pred HHHhccCccccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcc
Confidence 99999999987432221 111111 11111 1246788899999999988888777666543
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.75 E-value=2.1e-19 Score=164.30 Aligned_cols=165 Identities=26% Similarity=0.311 Sum_probs=126.4
Q ss_pred ceEEEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEE
Q 018712 135 LRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKI 214 (351)
Q Consensus 135 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl 214 (351)
++|+.|++|.-.+|.++|...... ...++.....++.|++.|+.| ++ .+|+|+||.||++..+..+||
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~------e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kI 397 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTG------EERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKI 397 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcc------cccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhh
Confidence 578999999999999999754432 126778889999999999999 77 999999999999999999999
Q ss_pred ecccccCCCcccc----ccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCC-----CCCCc
Q 018712 215 SDFDLSNQAPDAA----ARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTL-----PRGQQ 284 (351)
Q Consensus 215 ~Dfg~a~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~Pf~~~~-----~~~~~ 284 (351)
+|||+........ .....+...||..||+||++.+..|+.++||||||++|+|++. =..+|...- ..+..
T Consensus 398 gDFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~~t~~d~r~g~i 477 (516)
T KOG1033|consen 398 GDFGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERIATLTDIRDGII 477 (516)
T ss_pred hhhhheeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHHHhhhhhhcCCC
Confidence 9999987765443 2223356789999999999999999999999999999999998 333333211 11111
Q ss_pred cchhhcccCCCccchhhhcccccCCCC
Q 018712 285 SLVTWATPKLSEDKVKQCVDTKLGGEY 311 (351)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~ld~~~~~~~ 311 (351)
.-..+......-+.+.+++.+.+..||
T Consensus 478 p~~~~~d~p~e~~ll~~lls~~p~~RP 504 (516)
T KOG1033|consen 478 PPEFLQDYPEEYTLLQQLLSPSPEERP 504 (516)
T ss_pred ChHHhhcCcHHHHHHHHhcCCCcccCc
Confidence 111122222223688899999999999
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.1e-17 Score=140.40 Aligned_cols=135 Identities=17% Similarity=0.201 Sum_probs=98.0
Q ss_pred CceeccCCcEEEEEEEECCCCEEEEEEcCCCCCch---HH----------------------HHHHHHHHHhccCC--ce
Q 018712 71 NSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPD---QE----------------------FLAQVSMVSRLKNE--NV 123 (351)
Q Consensus 71 ~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~---~~----------------------~~~e~~~l~~l~h~--ni 123 (351)
.+.||+|+||.||+|...+++.||||++....... .. ...|...+.++.+. .+
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 46799999999999998889999999886543211 11 13455666666443 24
Q ss_pred eeeEEEEecCCceEEEEEeCCCCCHHH-HhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhh-CCCCCeeeccccC
Q 018712 124 VELVGYYVDGPLRVLAYEHASKGSLHD-ILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHE-KAEPRIIHRNIKS 201 (351)
Q Consensus 124 v~~~~~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~-~~~~~ivH~Dlkp 201 (351)
.+.++. ...+++|||++++++.. .+.... .. .....++.+++.++.++|. .+ ++|+||||
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~----------~~-~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p 143 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR----------LL-EDPEELYDQILELMRKLYREAG---LVHGDLSE 143 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh----------hc-ccHHHHHHHHHHHHHHHhhccC---cCcCCCCh
Confidence 444443 24589999999854321 111110 11 5577899999999999999 88 99999999
Q ss_pred CcEEEccCCceEEecccccCCCc
Q 018712 202 SNVLLFDDDIAKISDFDLSNQAP 224 (351)
Q Consensus 202 ~Nill~~~~~vkl~Dfg~a~~~~ 224 (351)
+||+++ ++.++|+|||.+....
T Consensus 144 ~Nili~-~~~~~liDfg~a~~~~ 165 (187)
T cd05119 144 YNILVD-DGKVYIIDVPQAVEID 165 (187)
T ss_pred hhEEEE-CCcEEEEECccccccc
Confidence 999999 8999999999986553
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.73 E-value=4.7e-17 Score=131.11 Aligned_cols=136 Identities=20% Similarity=0.211 Sum_probs=112.7
Q ss_pred CCceeccCCcEEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHHhccC--CceeeeEEEEecCCceEEEEEeCCCCC
Q 018712 70 TNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKN--ENVVELVGYYVDGPLRVLAYEHASKGS 147 (351)
Q Consensus 70 ~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h--~niv~~~~~~~~~~~~~lv~e~~~~gs 147 (351)
+.+.||+|.++.||++...+ ..+++|....... ...+.+|+.+++.+.+ .++++++.+....+..+++|||+.+++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~-~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~ 79 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK-GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGET 79 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc-hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCee
Confidence 45679999999999999754 7899999866544 4578899999999976 589999988888788999999999877
Q ss_pred HHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccccCCC
Q 018712 148 LHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQA 223 (351)
Q Consensus 148 L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~ 223 (351)
+..+ +......++.+++.++.++|.....+++|+|++|+||++++.+.++++|||.+...
T Consensus 80 ~~~~----------------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~ 139 (155)
T cd05120 80 LDEV----------------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYG 139 (155)
T ss_pred cccC----------------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCC
Confidence 7543 23456678899999999999963223999999999999999899999999987643
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.72 E-value=1.1e-16 Score=139.14 Aligned_cols=135 Identities=16% Similarity=0.208 Sum_probs=103.4
Q ss_pred ceec-cCCcEEEEEEEECCCCEEEEEEcCCCC--------------CchHHHHHHHHHHHhccCCce--eeeEEEEecC-
Q 018712 72 SLIG-EGSYGRVYFGVLRSGRAAAIKKLDSSK--------------QPDQEFLAQVSMVSRLKNENV--VELVGYYVDG- 133 (351)
Q Consensus 72 ~~Lg-~G~~g~Vy~~~~~~~~~vavK~~~~~~--------------~~~~~~~~e~~~l~~l~h~ni--v~~~~~~~~~- 133 (351)
..|| .||.|+||.+... +..+++|.+.... .....+.+|+.++.++.|++| +..+++....
T Consensus 37 ~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~ 115 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH 115 (239)
T ss_pred ceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence 3577 7888899988774 6789998774311 123457889999999988774 6666654332
Q ss_pred Cc---eEEEEEeCCC-CCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccC
Q 018712 134 PL---RVLAYEHASK-GSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDD 209 (351)
Q Consensus 134 ~~---~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~ 209 (351)
.. .++|||+++| .+|.+++.... ++.. .+.+|+.+|.+||++| |+||||||+|||++.+
T Consensus 116 ~~~~~~~lV~e~l~G~~~L~~~l~~~~----------l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~ 178 (239)
T PRK01723 116 GLFYRADILIERIEGARDLVALLQEAP----------LSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDPD 178 (239)
T ss_pred CcceeeeEEEEecCCCCCHHHHHhcCC----------CCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCC
Confidence 22 2599999997 69999986532 4433 3578999999999999 9999999999999999
Q ss_pred CceEEecccccCCCc
Q 018712 210 DIAKISDFDLSNQAP 224 (351)
Q Consensus 210 ~~vkl~Dfg~a~~~~ 224 (351)
+.++|+|||.+....
T Consensus 179 ~~v~LIDfg~~~~~~ 193 (239)
T PRK01723 179 GKFWLIDFDRGELRT 193 (239)
T ss_pred CCEEEEECCCcccCC
Confidence 999999999876643
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.67 E-value=9.3e-18 Score=162.90 Aligned_cols=206 Identities=24% Similarity=0.334 Sum_probs=164.1
Q ss_pred cCCCCCceeccCCcEEEEEEEEC--CCCEEEEEEcCCCCCc---hHHHHHHHHHHHhcc-CCceeeeEEEEecCCceEEE
Q 018712 66 DNFGTNSLIGEGSYGRVYFGVLR--SGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLK-NENVVELVGYYVDGPLRVLA 139 (351)
Q Consensus 66 ~~y~~~~~Lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv 139 (351)
..|.+.+.||+|+|+.|-..... ....+|.|.+...... ......|..+-+.+. |.|++.+++...+.+..+++
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~ 99 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS 99 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence 34667777999999999888753 3456677766544322 233344666766776 99999999999999999999
Q ss_pred EEeCCCCCHHHHhc-cCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhh-hCCCCCeeeccccCCcEEEccCC-ceEEec
Q 018712 140 YEHASKGSLHDILH-GKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLH-EKAEPRIIHRNIKSSNVLLFDDD-IAKISD 216 (351)
Q Consensus 140 ~e~~~~gsL~~~l~-~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH-~~~~~~ivH~Dlkp~Nill~~~~-~vkl~D 216 (351)
+++..++++.+.+. .... ..+....-.++.|+..++.|+| ..+ +.|+||||+|.+++..+ .++++|
T Consensus 100 ~~~s~g~~~f~~i~~~~~~--------~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~d 168 (601)
T KOG0590|consen 100 LSYSDGGSLFSKISHPDST--------GTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIAD 168 (601)
T ss_pred cCcccccccccccccCCcc--------CCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCC
Confidence 99999999998883 3221 2555667789999999999999 888 99999999999999999 999999
Q ss_pred ccccCCCcc-cccccccccccc-ccCccCcccccCC-CCCccchhHhHHHHHHHHHcCCCCCCCCCCCC
Q 018712 217 FDLSNQAPD-AAARLHSTRVLG-TFGYHAPEYAMTG-QMSSKSDVYSFGVVLLELLTGRKPVDHTLPRG 282 (351)
Q Consensus 217 fg~a~~~~~-~~~~~~~~~~~g-t~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~ 282 (351)
||+|..... ..........+| ++.|+|||...+. ...+..|+||.|+++.-+++|..||.......
T Consensus 169 f~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~ 237 (601)
T KOG0590|consen 169 FGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKD 237 (601)
T ss_pred chhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccc
Confidence 999988766 333333445678 9999999999885 55788999999999999999999998765443
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.59 E-value=7.9e-15 Score=138.22 Aligned_cols=141 Identities=21% Similarity=0.253 Sum_probs=98.5
Q ss_pred CceeccCCcEEEEEEEECCCCEEEEEEcCCCCCch-----------------------------------------HHHH
Q 018712 71 NSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPD-----------------------------------------QEFL 109 (351)
Q Consensus 71 ~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-----------------------------------------~~~~ 109 (351)
.+.||+|++|.||+|..++|+.||||+........ -++.
T Consensus 122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 36799999999999999999999999986542110 0133
Q ss_pred HHHHHHHhcc----CCceeeeEEEE-ecCCceEEEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHH-HH
Q 018712 110 AQVSMVSRLK----NENVVELVGYY-VDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAAR-GL 183 (351)
Q Consensus 110 ~e~~~l~~l~----h~niv~~~~~~-~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~-~l 183 (351)
+|...+.++. |.+-+.+-..+ ...+..++||||++|++|.++....... . ....++.+++. .+
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~--------~---~~~~ia~~~~~~~l 270 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAG--------L---DRKALAENLARSFL 270 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcC--------C---CHHHHHHHHHHHHH
Confidence 4444444442 22222222222 2234568999999999998886532110 2 12345566655 46
Q ss_pred HhhhhCCCCCeeeccccCCcEEEccCCceEEecccccCCCcc
Q 018712 184 EYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPD 225 (351)
Q Consensus 184 ~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~ 225 (351)
..+|..| ++|+|+||+||++++++.++|+|||++.....
T Consensus 271 ~ql~~~g---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 271 NQVLRDG---FFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred HHHHhCC---ceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 7889999 99999999999999999999999999987754
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.53 E-value=9.7e-14 Score=114.42 Aligned_cols=131 Identities=15% Similarity=0.077 Sum_probs=97.1
Q ss_pred CceeccCCcEEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHHhccCCce-eeeEEEEecCCceEEEEEeCCCCCHH
Q 018712 71 NSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENV-VELVGYYVDGPLRVLAYEHASKGSLH 149 (351)
Q Consensus 71 ~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~~~gsL~ 149 (351)
.+.|+.|.++.||++... +..+++|...........+.+|+.+++.+.+.++ .+++... ....++||||++|.++.
T Consensus 3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l~ 79 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTELLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSELL 79 (170)
T ss_pred eeecCCcccCceEEEEEC-CeEEEEEeCCCCcccccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCccc
Confidence 356899999999999875 7789999876554333446789999998865444 4555443 33458999999998875
Q ss_pred HHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCC--CCCeeeccccCCcEEEccCCceEEecccccCC
Q 018712 150 DILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKA--EPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222 (351)
Q Consensus 150 ~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~--~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~ 222 (351)
+. . .. ...++.+++.+|..||..+ ...++|+|++|+||+++ ++.++++|||.+..
T Consensus 80 ~~----~----------~~---~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 80 TE----D----------FS---DPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred cc----c----------cc---CHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 43 0 11 1235678999999999987 12249999999999998 67899999998754
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.53 E-value=1.5e-14 Score=138.14 Aligned_cols=145 Identities=17% Similarity=0.252 Sum_probs=94.3
Q ss_pred cCCCCCceeccCCcEEEEEEEECC-CCEEEEEEcCCCCCc-----------------------------------hH---
Q 018712 66 DNFGTNSLIGEGSYGRVYFGVLRS-GRAAAIKKLDSSKQP-----------------------------------DQ--- 106 (351)
Q Consensus 66 ~~y~~~~~Lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~-----------------------------------~~--- 106 (351)
..|.. +.||+|++|.||+|..++ |+.||||+..+.... .+
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 45666 789999999999999876 999999998754210 01
Q ss_pred ---HHHHHHHHHHhc----cCCceeeeEEEEec-CCceEEEEEeCCCCCHHHHh--ccCCCCCCCCCCCCCCHHHHHHHH
Q 018712 107 ---EFLAQVSMVSRL----KNENVVELVGYYVD-GPLRVLAYEHASKGSLHDIL--HGKKGVKGAKPGPVLSWAQRVKIA 176 (351)
Q Consensus 107 ---~~~~e~~~l~~l----~h~niv~~~~~~~~-~~~~~lv~e~~~~gsL~~~l--~~~~~~~~~~~~~~l~~~~~~~i~ 176 (351)
++.+|...+.++ .+.+.+.+-..+.+ ....+|||||+.|+.+.++- ...+.. ...+....+..++
T Consensus 199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d-----~~~la~~~v~~~~ 273 (537)
T PRK04750 199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTD-----MKLLAERGVEVFF 273 (537)
T ss_pred HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCC-----HHHHHHHHHHHHH
Confidence 133344444443 23333333333222 34568999999999998753 222100 0013333333444
Q ss_pred HHHHHHHHhhhhCCCCCeeeccccCCcEEEccCC----ceEEecccccCCCccc
Q 018712 177 VGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD----IAKISDFDLSNQAPDA 226 (351)
Q Consensus 177 ~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~----~vkl~Dfg~a~~~~~~ 226 (351)
.|+ ...| ++|+|+||+||+++.++ .++++|||++......
T Consensus 274 ~Qi-------f~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~~ 317 (537)
T PRK04750 274 TQV-------FRDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNKE 317 (537)
T ss_pred HHH-------HhCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECCHH
Confidence 444 3577 99999999999999988 9999999998877543
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.51 E-value=3.9e-14 Score=122.82 Aligned_cols=199 Identities=21% Similarity=0.334 Sum_probs=143.3
Q ss_pred HHHHhccCCceeeeEEEEecC-----CceEEEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhh
Q 018712 113 SMVSRLKNENVVELVGYYVDG-----PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLH 187 (351)
Q Consensus 113 ~~l~~l~h~niv~~~~~~~~~-----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH 187 (351)
..+-.+.|.||++++.|+.+. .+..++.||+..|+|.++|++..... ..+......+|+.||+.||.|||
T Consensus 119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~-----~a~~~~~wkkw~tqIlsal~yLh 193 (458)
T KOG1266|consen 119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQ-----KALFQKAWKKWCTQILSALSYLH 193 (458)
T ss_pred HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhh-----hhhhHHHHHHHHHHHHhhhhhhh
Confidence 345566899999999987643 45788899999999999998765432 23778888999999999999999
Q ss_pred hCCCCCeeeccccCCcEEEccCCceEEecccccCCCc--cccccccccccccccCccCcccccCCCCCccchhHhHHHHH
Q 018712 188 EKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAP--DAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVL 265 (351)
Q Consensus 188 ~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~--~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il 265 (351)
+..++ |+|+++..+.|++..+|.+|++----..... ............+-++|.|||.-.....+..+|||+||+..
T Consensus 194 s~~Pp-iihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcA 272 (458)
T KOG1266|consen 194 SCDPP-IIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCA 272 (458)
T ss_pred ccCCc-cccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHH
Confidence 99654 9999999999999999988875321111110 01111112233467899999987777788899999999999
Q ss_pred HHHHcCCCCC-CCCCCC----CCccchhhcccCCCccchhhhcccccCCCCCHHHHH
Q 018712 266 LELLTGRKPV-DHTLPR----GQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIA 317 (351)
Q Consensus 266 ~el~tg~~Pf-~~~~~~----~~~~~~~~~~~~~~~~~~~~~ld~~~~~~~~~~~~~ 317 (351)
.+|.-+..-- ...... .....+......+..+.+..|+...|.+|+++..+.
T Consensus 273 lemailEiq~tnseS~~~~ee~ia~~i~~len~lqr~~i~kcl~~eP~~rp~ar~ll 329 (458)
T KOG1266|consen 273 LEMAILEIQSTNSESKVEVEENIANVIIGLENGLQRGSITKCLEGEPNGRPDARLLL 329 (458)
T ss_pred HHHHHheeccCCCcceeehhhhhhhheeeccCccccCcCcccccCCCCCCcchhhhh
Confidence 9998877542 222111 112223333344556789999999999999887654
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.47 E-value=6.3e-13 Score=125.57 Aligned_cols=167 Identities=16% Similarity=0.208 Sum_probs=127.9
Q ss_pred ECCCCEEEEEEcCCCCC-chHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEEEeCCCCCHHHHhccCCCCCCCCCCC
Q 018712 87 LRSGRAAAIKKLDSSKQ-PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGP 165 (351)
Q Consensus 87 ~~~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~ 165 (351)
..++.+|.|...+.... ......+.++.|+.++||||+++++.+..++..|+|+|-+. .|..++++
T Consensus 34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~----------- 100 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE----------- 100 (690)
T ss_pred eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH-----------
Confidence 34677888887765544 23446778899999999999999999999999999999985 58888876
Q ss_pred CCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccccCCCccccccccccccccccCccCcc
Q 018712 166 VLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245 (351)
Q Consensus 166 ~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE 245 (351)
+........+.||+.||.+||+.+ +++|++|.-+.|+|+..|..||++|.++.......... .....-..|..|+
T Consensus 101 -l~~~~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~--~~~~~~~s~~~P~ 175 (690)
T KOG1243|consen 101 -LGKEEVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPA--KSLYLIESFDDPE 175 (690)
T ss_pred -hHHHHHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCccc--ccchhhhcccChh
Confidence 445566678899999999998665 49999999999999999999999999886654332111 1111223466676
Q ss_pred cccCCCCCccchhHhHHHHHHHHHcCCC
Q 018712 246 YAMTGQMSSKSDVYSFGVVLLELLTGRK 273 (351)
Q Consensus 246 ~~~~~~~~~~~DvwslG~il~el~tg~~ 273 (351)
.+.... ...|.|-||+++++++.|..
T Consensus 176 ~~~~s~--~s~D~~~Lg~li~el~ng~~ 201 (690)
T KOG1243|consen 176 EIDPSE--WSIDSWGLGCLIEELFNGSL 201 (690)
T ss_pred hcCccc--cchhhhhHHHHHHHHhCccc
Confidence 544322 45799999999999999933
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.45 E-value=1.6e-12 Score=108.41 Aligned_cols=135 Identities=17% Similarity=0.142 Sum_probs=97.8
Q ss_pred CceeccCCcEEEEEEEECC-------CCEEEEEEcCCCCC----------------------c-hHHH----HHHHHHHH
Q 018712 71 NSLIGEGSYGRVYFGVLRS-------GRAAAIKKLDSSKQ----------------------P-DQEF----LAQVSMVS 116 (351)
Q Consensus 71 ~~~Lg~G~~g~Vy~~~~~~-------~~~vavK~~~~~~~----------------------~-~~~~----~~e~~~l~ 116 (351)
...||.|.-+.||.|...+ +..+|||+.+.... + ...+ .+|++.|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 3568999999999998543 47999998742110 0 1122 37889999
Q ss_pred hccC--CceeeeEEEEecCCceEEEEEeCCCCCHH-HHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhh-hhCCCC
Q 018712 117 RLKN--ENVVELVGYYVDGPLRVLAYEHASKGSLH-DILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYL-HEKAEP 192 (351)
Q Consensus 117 ~l~h--~niv~~~~~~~~~~~~~lv~e~~~~gsL~-~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~l-H~~~~~ 192 (351)
++.. -++.+++.+ ...++||||+.+..+. ..++.. .++..+...+..+++.+|..+ |+.|
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~----------~~~~~~~~~i~~~i~~~l~~l~H~~g-- 145 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDA----------KLNDEEMKNAYYQVLSMMKQLYKECN-- 145 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhcc----------ccCHHHHHHHHHHHHHHHHHHHHhCC--
Confidence 9853 466666654 4568999999765332 122221 144556677889999999998 8998
Q ss_pred CeeeccccCCcEEEccCCceEEecccccCCC
Q 018712 193 RIIHRNIKSSNVLLFDDDIAKISDFDLSNQA 223 (351)
Q Consensus 193 ~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~ 223 (351)
++||||++.|||++ ++.+.|+|||.+...
T Consensus 146 -lVHGDLs~~NIL~~-~~~v~iIDF~qav~~ 174 (197)
T cd05146 146 -LVHADLSEYNMLWH-DGKVWFIDVSQSVEP 174 (197)
T ss_pred -eecCCCCHHHEEEE-CCcEEEEECCCceeC
Confidence 99999999999996 567999999987654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.38 E-value=7e-12 Score=107.85 Aligned_cols=141 Identities=18% Similarity=0.256 Sum_probs=106.1
Q ss_pred ceeccCCcEEEEEEEECCCCEEEEEEcCCCCC--chHHHHHHHHHHHhccC--CceeeeEEEEecC---CceEEEEEeCC
Q 018712 72 SLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQ--PDQEFLAQVSMVSRLKN--ENVVELVGYYVDG---PLRVLAYEHAS 144 (351)
Q Consensus 72 ~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h--~niv~~~~~~~~~---~~~~lv~e~~~ 144 (351)
+.|+.|.++.||++...+|..+++|....... ....+.+|.++++.+.+ .++.+++.+.... +..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 46899999999999887678999999765443 34568899999999965 4467777766543 25689999999
Q ss_pred CCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCC----------------------------------
Q 018712 145 KGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKA---------------------------------- 190 (351)
Q Consensus 145 ~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~---------------------------------- 190 (351)
|.++.+.+... .++......++.+++.+|..||+..
T Consensus 84 G~~l~~~~~~~----------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (223)
T cd05154 84 GRVLRDRLLRP----------ELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDE 153 (223)
T ss_pred CEecCCCCCCC----------CCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccc
Confidence 98887765321 1555666667777777777777531
Q ss_pred -------------------CCCeeeccccCCcEEEcc--CCceEEecccccCC
Q 018712 191 -------------------EPRIIHRNIKSSNVLLFD--DDIAKISDFDLSNQ 222 (351)
Q Consensus 191 -------------------~~~ivH~Dlkp~Nill~~--~~~vkl~Dfg~a~~ 222 (351)
...++|+|++|+||+++. ++.+.|+||+.+..
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 154 PPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred cHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 123799999999999998 66789999997754
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.36 E-value=2.1e-11 Score=98.50 Aligned_cols=131 Identities=20% Similarity=0.300 Sum_probs=98.3
Q ss_pred ceeccCCcEEEEEEEECCCCEEEEEE-cCCCCCc--------hHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEEEe
Q 018712 72 SLIGEGSYGRVYFGVLRSGRAAAIKK-LDSSKQP--------DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEH 142 (351)
Q Consensus 72 ~~Lg~G~~g~Vy~~~~~~~~~vavK~-~~~~~~~--------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 142 (351)
..+++|+-+.+|.+.+. |..+++|. +.+.... ...-.+|..+++++.--.|...+-+..+.+...|+|||
T Consensus 2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 35789999999999764 44466664 3332221 13456789999988765555555556678888999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccccCC
Q 018712 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222 (351)
Q Consensus 143 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~ 222 (351)
++|..|.+++.... ..++..+-.-+.-||..| |+|+||+++||++..++ +.++|||++..
T Consensus 81 I~G~~lkd~l~~~~----------------~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 81 IEGELLKDALEEAR----------------PDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred eCChhHHHHHHhcc----------------hHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCcccc
Confidence 99999999987541 245666777788899999 99999999999996665 89999999864
Q ss_pred C
Q 018712 223 A 223 (351)
Q Consensus 223 ~ 223 (351)
.
T Consensus 141 s 141 (204)
T COG3642 141 S 141 (204)
T ss_pred c
Confidence 3
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.36 E-value=1.6e-11 Score=98.84 Aligned_cols=142 Identities=20% Similarity=0.237 Sum_probs=106.7
Q ss_pred CCceeccCCcEEEEEEEECCCCEEEEEEcC-CCCC--------chHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEE
Q 018712 70 TNSLIGEGSYGRVYFGVLRSGRAAAIKKLD-SSKQ--------PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAY 140 (351)
Q Consensus 70 ~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~-~~~~--------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 140 (351)
....|-+|+-+.|+++.+. |+.+.||.-. +... ..++..+|.++|.++.--.|.-..-++.+...-.|+|
T Consensus 11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 5678999999999999885 7777777532 2211 1345778999999886555555555566777788999
Q ss_pred EeCCC-CCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCC---ceEEec
Q 018712 141 EHASK-GSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD---IAKISD 216 (351)
Q Consensus 141 e~~~~-gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~---~vkl~D 216 (351)
||++| .++.+++....... ........++.+|-+.+.-||.++ ++||||..+||++.+++ .+.|+|
T Consensus 90 E~~~g~~~vk~~i~~~~~~~-------~~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lId 159 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDE-------SEDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILID 159 (229)
T ss_pred EeccchhHHHHHHHHHccCc-------ccchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEe
Confidence 99987 47888887654321 222333678899999999999999 99999999999998766 458999
Q ss_pred ccccCC
Q 018712 217 FDLSNQ 222 (351)
Q Consensus 217 fg~a~~ 222 (351)
||++..
T Consensus 160 fgls~~ 165 (229)
T KOG3087|consen 160 FGLSSV 165 (229)
T ss_pred ecchhc
Confidence 998754
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.36 E-value=1.3e-12 Score=122.18 Aligned_cols=241 Identities=21% Similarity=0.202 Sum_probs=172.3
Q ss_pred hcCCCCCceecc--CCcEEEEEEEE--C-CCCEEEEEEcCCCC---CchHHHHHHHHHHHhc-cCCceeeeEEEEecCCc
Q 018712 65 TDNFGTNSLIGE--GSYGRVYFGVL--R-SGRAAAIKKLDSSK---QPDQEFLAQVSMVSRL-KNENVVELVGYYVDGPL 135 (351)
Q Consensus 65 ~~~y~~~~~Lg~--G~~g~Vy~~~~--~-~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~ 135 (351)
...+.+.+.+|. |.+|.||.+.. . ++..+|+|+-+... .....-.+|+...+++ .|+|.++.+..+...+.
T Consensus 113 ~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~ 192 (524)
T KOG0601|consen 113 DQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGI 192 (524)
T ss_pred hhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCc
Confidence 345777888999 99999999986 3 68889999743222 1222334566666666 58999998888999999
Q ss_pred eEEEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHH----HHHhhhhCCCCCeeeccccCCcEEEccC-C
Q 018712 136 RVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAAR----GLEYLHEKAEPRIIHRNIKSSNVLLFDD-D 210 (351)
Q Consensus 136 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~----~l~~lH~~~~~~ivH~Dlkp~Nill~~~-~ 210 (351)
.++-+|++. .+|.++...... .++...++....+... ||.++|..+ ++|-|+||.||++..+ .
T Consensus 193 lfiqtE~~~-~sl~~~~~~~~~--------~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~ 260 (524)
T KOG0601|consen 193 LFIQTELCG-ESLQSYCHTPCN--------FLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWT 260 (524)
T ss_pred ceeeecccc-chhHHhhhcccc--------cCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccc
Confidence 999999996 588888876543 2677778888888888 999999999 9999999999999999 8
Q ss_pred ceEEecccccCCCcccccccc---ccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccch
Q 018712 211 IAKISDFDLSNQAPDAAARLH---STRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLV 287 (351)
Q Consensus 211 ~vkl~Dfg~a~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~ 287 (351)
..+++|||+...+........ .....|...|++||.. ...++..+|+||+|.++.+..+|..++.......-..+.
T Consensus 261 s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~-~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r 339 (524)
T KOG0601|consen 261 SCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELL-NGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLR 339 (524)
T ss_pred eeecCCcceeEEccCCccccceeeeecCCCCceEeChhhh-ccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccc
Confidence 899999999988765542211 1222577889999955 567788999999999999998877665433111111111
Q ss_pred hhc-----c-c--CCCccchhhhcccccCCCCCHHHHHH
Q 018712 288 TWA-----T-P--KLSEDKVKQCVDTKLGGEYPPKAIAK 318 (351)
Q Consensus 288 ~~~-----~-~--~~~~~~~~~~ld~~~~~~~~~~~~~~ 318 (351)
.+. . + .-....+.+++|++..-++..+.+..
T Consensus 340 ~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 340 QGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred cccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 000 0 0 00012556777777766666555544
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.26 E-value=1.3e-12 Score=128.54 Aligned_cols=209 Identities=22% Similarity=0.238 Sum_probs=147.9
Q ss_pred HhcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCCc----hHHHHHHHHHHHhccCCceeeeEEEEecCCceEE
Q 018712 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP----DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVL 138 (351)
Q Consensus 64 ~~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 138 (351)
..+++.+.+.+-+|+++.++.+.-. +|...++|.......- .+....+-.++-...+|.++.....+......+|
T Consensus 802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L 881 (1205)
T KOG0606|consen 802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPL 881 (1205)
T ss_pred CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcch
Confidence 4456777778889999999887633 4544454443222111 1111111112212234666655555556778899
Q ss_pred EEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEeccc
Q 018712 139 AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFD 218 (351)
Q Consensus 139 v~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg 218 (351)
+++|..+++|...|+.... .+..-.+.....+..++++||... +.|+|++|.|+++..+++.++.|||
T Consensus 882 ~~~~~~~~~~~Skl~~~~~---------~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~ 949 (1205)
T KOG0606|consen 882 VGHYLNGGDLPSKLHNSGC---------LSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFG 949 (1205)
T ss_pred hhHHhccCCchhhhhcCCC---------cccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCccc
Confidence 9999999999999987653 344445566777889999999997 8999999999999999999999998
Q ss_pred ccCCCccc--------cc-----------------c----ccccccccccCccCcccccCCCCCccchhHhHHHHHHHHH
Q 018712 219 LSNQAPDA--------AA-----------------R----LHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELL 269 (351)
Q Consensus 219 ~a~~~~~~--------~~-----------------~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~ 269 (351)
........ .. . .......||+.|.+||...+......+|+|++|++++|.+
T Consensus 950 t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l 1029 (1205)
T KOG0606|consen 950 TLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVL 1029 (1205)
T ss_pred cccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhh
Confidence 43322110 00 0 0112356899999999999999999999999999999999
Q ss_pred cCCCCCCCCCCCCCc
Q 018712 270 TGRKPVDHTLPRGQQ 284 (351)
Q Consensus 270 tg~~Pf~~~~~~~~~ 284 (351)
+|..||....+....
T Consensus 1030 ~g~pp~na~tpq~~f 1044 (1205)
T KOG0606|consen 1030 TGIPPFNAETPQQIF 1044 (1205)
T ss_pred cCCCCCCCcchhhhh
Confidence 999999987765543
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.22 E-value=6.3e-12 Score=117.62 Aligned_cols=196 Identities=21% Similarity=0.206 Sum_probs=148.5
Q ss_pred HHHhcCCCCCceeccCCcEEEEEEEEC--CCCEEEEEEcCCCCCc---hHHHHHHHHHHHhc-cCCceeeeEEEEecCCc
Q 018712 62 KEKTDNFGTNSLIGEGSYGRVYFGVLR--SGRAAAIKKLDSSKQP---DQEFLAQVSMVSRL-KNENVVELVGYYVDGPL 135 (351)
Q Consensus 62 ~~~~~~y~~~~~Lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~ 135 (351)
.....+|..+..||.|.|+.|+....+ ++..|++|.+.+.... +..-..|+.+...+ .|.+++.....+.....
T Consensus 261 s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~ 340 (524)
T KOG0601|consen 261 SCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQ 340 (524)
T ss_pred eeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccc
Confidence 344567888999999999999988743 6889999987654322 22234566666666 58888888887777778
Q ss_pred eEEEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccC-CceEE
Q 018712 136 RVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDD-DIAKI 214 (351)
Q Consensus 136 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~-~~vkl 214 (351)
.|+-.|||.++++...+.-.. .+.....+.+..|++.++.++|+.. ++|+|+||.||++..+ +.-++
T Consensus 341 ~~ip~e~~~~~s~~l~~~~~~---------~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~ 408 (524)
T KOG0601|consen 341 GYIPLEFCEGGSSSLRSVTSQ---------MLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKL 408 (524)
T ss_pred ccCchhhhcCcchhhhhHHHH---------hcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhc
Confidence 889999999988776663222 1667778899999999999999999 9999999999999886 78899
Q ss_pred ecccccCCCccccccccccccccccCcc--CcccccCCCCCccchhHhHHHHHHHHHcCCCC
Q 018712 215 SDFDLSNQAPDAAARLHSTRVLGTFGYH--APEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274 (351)
Q Consensus 215 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~~~~~DvwslG~il~el~tg~~P 274 (351)
+|||......... .....+-+++ ++.......+..+.|++|||..+.+.++|..-
T Consensus 409 ~~~~~~t~~~~~~-----~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~l 465 (524)
T KOG0601|consen 409 GDFGCWTRLAFSS-----GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPL 465 (524)
T ss_pred cccccccccceec-----ccccccccccccchhhccccccccccccccccccccccccCccc
Confidence 9999876532211 1122233344 55555667788999999999999999998753
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.19 E-value=1.3e-10 Score=96.65 Aligned_cols=124 Identities=19% Similarity=0.221 Sum_probs=81.8
Q ss_pred EEEEEEECCCCEEEEEEcCCCCC----------------------c-----hHHHHHHHHHHHhccCC--ceeeeEEEEe
Q 018712 81 RVYFGVLRSGRAAAIKKLDSSKQ----------------------P-----DQEFLAQVSMVSRLKNE--NVVELVGYYV 131 (351)
Q Consensus 81 ~Vy~~~~~~~~~vavK~~~~~~~----------------------~-----~~~~~~e~~~l~~l~h~--niv~~~~~~~ 131 (351)
.||.|...+|..+|+|+.+.... . .....+|.+.|.++..- ++.+++.+.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 48999998899999998743210 0 12357899999999764 566776542
Q ss_pred cCCceEEEEEeCC--CCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHh-hhhCCCCCeeeccccCCcEEEcc
Q 018712 132 DGPLRVLAYEHAS--KGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEY-LHEKAEPRIIHRNIKSSNVLLFD 208 (351)
Q Consensus 132 ~~~~~~lv~e~~~--~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~-lH~~~~~~ivH~Dlkp~Nill~~ 208 (351)
..++||||+. |..+..+.... ++......++.+++..+.. +|..| ++||||.+.|||+++
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~~~-----------~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~ 142 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKDVD-----------LSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDD 142 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHHCG-----------GGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEET
T ss_pred ---CCEEEEEecCCCccchhhHHhcc-----------ccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeec
Confidence 3479999998 65555444322 2223455677778875555 57998 999999999999987
Q ss_pred CCceEEecccccCCC
Q 018712 209 DDIAKISDFDLSNQA 223 (351)
Q Consensus 209 ~~~vkl~Dfg~a~~~ 223 (351)
+ .+.|+|||.+...
T Consensus 143 ~-~~~iIDf~qav~~ 156 (188)
T PF01163_consen 143 G-KVYIIDFGQAVDS 156 (188)
T ss_dssp T-CEEE--GTTEEET
T ss_pred c-eEEEEecCcceec
Confidence 7 8999999977544
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.15 E-value=1.7e-09 Score=95.21 Aligned_cols=138 Identities=16% Similarity=0.046 Sum_probs=96.8
Q ss_pred eccCCcEEEEEEEECCCCEEEEEEcCCCC------------CchHHHHHHHHHHHhccCCc--eeeeEEEEec-----CC
Q 018712 74 IGEGSYGRVYFGVLRSGRAAAIKKLDSSK------------QPDQEFLAQVSMVSRLKNEN--VVELVGYYVD-----GP 134 (351)
Q Consensus 74 Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~------------~~~~~~~~e~~~l~~l~h~n--iv~~~~~~~~-----~~ 134 (351)
+-......|++... +|+.|.||...... .....+.+|+..+.++...+ +++++.++.. ..
T Consensus 30 v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~ 108 (268)
T PRK15123 30 FRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATR 108 (268)
T ss_pred EecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccc
Confidence 33333344666655 57789999764322 11124778998888884333 3344445432 23
Q ss_pred ceEEEEEeCCCC-CHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEcc-----
Q 018712 135 LRVLAYEHASKG-SLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFD----- 208 (351)
Q Consensus 135 ~~~lv~e~~~~g-sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~----- 208 (351)
..++|+|++++. +|.+++...... .........++.+++..+.-||..| |+|+|+++.|||++.
T Consensus 109 ~s~LVte~l~~~~sL~~~~~~~~~~-------~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~ 178 (268)
T PRK15123 109 TSFIITEDLAPTISLEDYCADWATN-------PPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGR 178 (268)
T ss_pred eeEEEEeeCCCCccHHHHHHhhccc-------CCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCC
Confidence 468999999985 899998642211 1455677789999999999999999 999999999999975
Q ss_pred --CCceEEecccccCC
Q 018712 209 --DDIAKISDFDLSNQ 222 (351)
Q Consensus 209 --~~~vkl~Dfg~a~~ 222 (351)
+..+.|+||+.+..
T Consensus 179 ~~~~~~~LIDl~r~~~ 194 (268)
T PRK15123 179 EEDLKLSVIDLHRAQI 194 (268)
T ss_pred CCCceEEEEECCcccc
Confidence 46799999998753
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.05 E-value=1.2e-09 Score=93.70 Aligned_cols=136 Identities=16% Similarity=0.165 Sum_probs=100.3
Q ss_pred CCCCCceeccCCcEEEEEEEECCCCEEEEEEcCCCCC-----------------------chHHHHHHHHHHHhccCC--
Q 018712 67 NFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQ-----------------------PDQEFLAQVSMVSRLKNE-- 121 (351)
Q Consensus 67 ~y~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-----------------------~~~~~~~e~~~l~~l~h~-- 121 (351)
-+.+...||-|.-|.||.|....|.++|+|.=+.... +.....+|+++|.+|...
T Consensus 92 ve~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 92 VEAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HHhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 3567789999999999999999999999996432110 113367899999999654
Q ss_pred ceeeeEEEEecCCceEEEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccC
Q 018712 122 NVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKS 201 (351)
Q Consensus 122 niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp 201 (351)
.|.+.+++ ++..+|||++.|-.|...-- .....-.++..|++-+..+-..| +||+|+.+
T Consensus 172 ~VP~P~~~----nRHaVvMe~ieG~eL~~~r~--------------~~en~~~il~~il~~~~~~~~~G---iVHGDlSe 230 (304)
T COG0478 172 KVPKPIAW----NRHAVVMEYIEGVELYRLRL--------------DVENPDEILDKILEEVRKAYRRG---IVHGDLSE 230 (304)
T ss_pred CCCCcccc----ccceeeeehcccceeecccC--------------cccCHHHHHHHHHHHHHHHHHcC---ccccCCch
Confidence 77777754 56789999999966654431 12333344555555555555677 99999999
Q ss_pred CcEEEccCCceEEecccccCCC
Q 018712 202 SNVLLFDDDIAKISDFDLSNQA 223 (351)
Q Consensus 202 ~Nill~~~~~vkl~Dfg~a~~~ 223 (351)
-||+++++|.+.++||--+...
T Consensus 231 fNIlV~~dg~~~vIDwPQ~v~~ 252 (304)
T COG0478 231 FNILVTEDGDIVVIDWPQAVPI 252 (304)
T ss_pred heEEEecCCCEEEEeCcccccC
Confidence 9999999999999999765443
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.05 E-value=4.1e-09 Score=97.37 Aligned_cols=173 Identities=16% Similarity=0.187 Sum_probs=127.7
Q ss_pred cEEEEEEEE-CCCCEEEEEEcCCCCC-chHHHHHHHHHHHhccCCceeeeEEEEe----cCCceEEEEEeCCC-CCHHHH
Q 018712 79 YGRVYFGVL-RSGRAAAIKKLDSSKQ-PDQEFLAQVSMVSRLKNENVVELVGYYV----DGPLRVLAYEHASK-GSLHDI 151 (351)
Q Consensus 79 ~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~----~~~~~~lv~e~~~~-gsL~~~ 151 (351)
-.+.|++.. .+|..|++|++..... .......-+++++++.|.|||++.+.|. .+..+++|++|+++ ++|.++
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~ 368 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL 368 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence 356788884 4899999999943221 1223345578899999999999998876 34467999999986 578776
Q ss_pred hccCCCCC------CCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccccCCCcc
Q 018712 152 LHGKKGVK------GAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPD 225 (351)
Q Consensus 152 l~~~~~~~------~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~ 225 (351)
.-...... ....+...++..+|.++.|+..||.++|+.| +.-+-|.|.+|+++.+.+++|+..|.......
T Consensus 369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQE 445 (655)
T ss_pred HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeecC
Confidence 54332221 1333455788999999999999999999999 99999999999999988999988886544332
Q ss_pred ccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCC
Q 018712 226 AAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRK 273 (351)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~ 273 (351)
.. + |.+.+ ..+-|.=.||.++..|.||..
T Consensus 446 d~---------~-------~~le~---~Qq~D~~~lG~ll~aLAt~~~ 474 (655)
T KOG3741|consen 446 DP---------T-------EPLES---QQQNDLRDLGLLLLALATGTE 474 (655)
T ss_pred CC---------C-------cchhH---HhhhhHHHHHHHHHHHhhccc
Confidence 21 0 00111 236799999999999999953
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.00 E-value=8.6e-09 Score=93.13 Aligned_cols=196 Identities=17% Similarity=0.203 Sum_probs=128.6
Q ss_pred CceeccCCcEEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHHhc-cCCceeeeEEE------EecCC-ceEEEEEe
Q 018712 71 NSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRL-KNENVVELVGY------YVDGP-LRVLAYEH 142 (351)
Q Consensus 71 ~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~------~~~~~-~~~lv~e~ 142 (351)
...||+|+-+.+|-.-- -...+.|++....-..+. ..+..|... .||-+-.-+.| .-++. ..-+.|..
T Consensus 16 gr~LgqGgea~ly~l~e--~~d~VAKIYh~Pppa~~a--qk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflmP~ 91 (637)
T COG4248 16 GRPLGQGGEADLYTLGE--VRDQVAKIYHAPPPAAQA--QKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLMPK 91 (637)
T ss_pred CccccCCccceeeecch--hhchhheeecCCCchHHH--HHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEeccc
Confidence 45699999999995431 122355666544322221 122333333 45433221111 11222 35677887
Q ss_pred CCCC-CHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccccC
Q 018712 143 ASKG-SLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (351)
Q Consensus 143 ~~~g-sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~ 221 (351)
+.+. ....+++.....+. -+...|.-.++.++.++.+.+.||..| .+-+|+.++|+|+.+++.|.|.|=..-.
T Consensus 92 v~g~~pI~~~y~p~tRRqs---~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVdsDsfq 165 (637)
T COG4248 92 VSGKEPIHMIYSPATRRQS---YPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDSDSFQ 165 (637)
T ss_pred CCCccchhhhcCchhhccc---CCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEccccee
Confidence 7763 34444443332221 234789999999999999999999999 9999999999999999999999855432
Q ss_pred CCccccccccccccccccCccCccccc-----CCCCCccchhHhHHHHHHHHHcC-CCCCCCCC
Q 018712 222 QAPDAAARLHSTRVLGTFGYHAPEYAM-----TGQMSSKSDVYSFGVVLLELLTG-RKPVDHTL 279 (351)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~el~tg-~~Pf~~~~ 279 (351)
....+ ......+|...|.+||... +...+...|.|.||+++++++.| +.||.+..
T Consensus 166 i~~ng---~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~ 226 (637)
T COG4248 166 INANG---TLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIP 226 (637)
T ss_pred eccCC---ceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCccc
Confidence 22111 1124457899999999654 44567789999999999999885 99998753
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.94 E-value=1.3e-08 Score=86.58 Aligned_cols=123 Identities=24% Similarity=0.206 Sum_probs=90.1
Q ss_pred CCCEEEEEEcCCC--------CCchHHHHHHHHHHHhccC--CceeeeEEEEecC----CceEEEEEeCCC-CCHHHHhc
Q 018712 89 SGRAAAIKKLDSS--------KQPDQEFLAQVSMVSRLKN--ENVVELVGYYVDG----PLRVLAYEHASK-GSLHDILH 153 (351)
Q Consensus 89 ~~~~vavK~~~~~--------~~~~~~~~~e~~~l~~l~h--~niv~~~~~~~~~----~~~~lv~e~~~~-gsL~~~l~ 153 (351)
.++.+.+|..... ........+|...+.+|.. -.+++.+.+.... ...++|+|++++ .+|.+++.
T Consensus 31 ~~~~y~~k~~~~~~~~~~~~~~~~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~ 110 (206)
T PF06293_consen 31 VGRRYYRKRLWNKLRRDRLRFPLRRSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQ 110 (206)
T ss_pred cceEEEECCeechhccchhhhcccchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHH
Confidence 4566666653211 1234567888888887743 3344555554432 235899999988 48999998
Q ss_pred cCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCC---ceEEecccccCCC
Q 018712 154 GKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD---IAKISDFDLSNQA 223 (351)
Q Consensus 154 ~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~---~vkl~Dfg~a~~~ 223 (351)
.... .+......++.+++..+.-||.+| |+|+|+++.|||++.++ .+.|+||+.++..
T Consensus 111 ~~~~---------~~~~~~~~ll~~l~~~i~~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 111 QWEQ---------LDPSQRRELLRALARLIAKLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred hhcc---------cchhhHHHHHHHHHHHHHHHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 6432 455667889999999999999999 99999999999999887 8999999987654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.93 E-value=5.2e-08 Score=81.66 Aligned_cols=139 Identities=14% Similarity=0.056 Sum_probs=102.6
Q ss_pred eccCCcEEEEEEEECCCCEEEEEEcCCC-------CCchHHHHHHHHHHHhccC--CceeeeEEEEec----CCceEEEE
Q 018712 74 IGEGSYGRVYFGVLRSGRAAAIKKLDSS-------KQPDQEFLAQVSMVSRLKN--ENVVELVGYYVD----GPLRVLAY 140 (351)
Q Consensus 74 Lg~G~~g~Vy~~~~~~~~~vavK~~~~~-------~~~~~~~~~e~~~l~~l~h--~niv~~~~~~~~----~~~~~lv~ 140 (351)
-|+||.+-|++.... |..+-+|.-... +.....+.+|+..+.+|.. -.+.++...... .-..+||+
T Consensus 26 ~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 26 YRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT 104 (216)
T ss_pred cCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence 467999999987764 447889976511 2245779999999998853 224455422111 12357999
Q ss_pred EeCCC-CCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCc--eEEecc
Q 018712 141 EHASK-GSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDI--AKISDF 217 (351)
Q Consensus 141 e~~~~-gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~--vkl~Df 217 (351)
|-+.+ .+|.+++...... ..+......+..+++..|.-||+.| +.|+|+.+.||+++.++. |+++||
T Consensus 105 e~L~g~~~L~~~l~~~~~~-------~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDl 174 (216)
T PRK09902 105 EDMAGFISIADWYAQHAVS-------PYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDL 174 (216)
T ss_pred EeCCCCccHHHHHhcCCcC-------CcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEh
Confidence 98764 5899998664321 1566777889999999999999999 999999999999987776 999999
Q ss_pred cccCCC
Q 018712 218 DLSNQA 223 (351)
Q Consensus 218 g~a~~~ 223 (351)
.-++..
T Consensus 175 Ek~r~~ 180 (216)
T PRK09902 175 EKSRRR 180 (216)
T ss_pred hccchh
Confidence 876553
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.90 E-value=5e-08 Score=84.09 Aligned_cols=145 Identities=12% Similarity=0.077 Sum_probs=86.0
Q ss_pred ceeccCCcEEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHHhccCC--ceeeeEEEEecCCceEEEEEeCCCCC-H
Q 018712 72 SLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNE--NVVELVGYYVDGPLRVLAYEHASKGS-L 148 (351)
Q Consensus 72 ~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~--niv~~~~~~~~~~~~~lv~e~~~~gs-L 148 (351)
..||+|..+.||+. .+..+++|...... ......+|.++++.+..- .+.+++.+....+...+|||+++|.+ +
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~-~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~~ 82 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF-DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRSF 82 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC-CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccch
Confidence 46899999999984 35568888876533 345678999999998643 35677777777777889999999963 2
Q ss_pred HHHhccCC----------------CCCCCCCCCCCCHHHHHHHHHH----------HHHH-HHhhhh-CCCCCeeecccc
Q 018712 149 HDILHGKK----------------GVKGAKPGPVLSWAQRVKIAVG----------AARG-LEYLHE-KAEPRIIHRNIK 200 (351)
Q Consensus 149 ~~~l~~~~----------------~~~~~~~~~~l~~~~~~~i~~q----------i~~~-l~~lH~-~~~~~ivH~Dlk 200 (351)
...+.... -.....+...+... ...+..+ +... ..+|.. .....++|+|+.
T Consensus 83 ~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~-~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~ 161 (226)
T TIGR02172 83 SRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSY-KEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQ 161 (226)
T ss_pred hhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHH-HHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCC
Confidence 22221100 00000000001100 0000000 0000 111111 112347899999
Q ss_pred CCcEEEccCCceEEecccccCC
Q 018712 201 SSNVLLFDDDIAKISDFDLSNQ 222 (351)
Q Consensus 201 p~Nill~~~~~vkl~Dfg~a~~ 222 (351)
|.||++++++ +.++||+.+..
T Consensus 162 ~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 162 IGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred CCcEEEcCCC-cEEEechhcCc
Confidence 9999999888 99999998754
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.89 E-value=1.3e-08 Score=97.03 Aligned_cols=140 Identities=20% Similarity=0.263 Sum_probs=92.4
Q ss_pred ceeccCCcEEEEEEEECCCCEEEEEEcCCCCCch-----------------------------------H------HHHH
Q 018712 72 SLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPD-----------------------------------Q------EFLA 110 (351)
Q Consensus 72 ~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-----------------------------------~------~~~~ 110 (351)
..|+.++-|.||+|+.++|+.||||+..+.-... + ++.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 5789999999999999999999999986532110 0 1334
Q ss_pred HHHHHHhcc-----CCceeeeEEEEecCCceEEEEEeCCCCCHHHHh--ccCCCCCCCCCCCCCCHHHHHHHHHHHHHHH
Q 018712 111 QVSMVSRLK-----NENVVELVGYYVDGPLRVLAYEHASKGSLHDIL--HGKKGVKGAKPGPVLSWAQRVKIAVGAARGL 183 (351)
Q Consensus 111 e~~~l~~l~-----h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l--~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l 183 (351)
|...+.++. .+++.-..-+..-.+...|+|||++|-.+.++. +..+ .+...+.....++. +
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g----------~d~k~ia~~~~~~f--~ 278 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAG----------IDRKELAELLVRAF--L 278 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcC----------CCHHHHHHHHHHHH--H
Confidence 444444442 233332222233345678999999998888884 3322 44333322222222 2
Q ss_pred HhhhhCCCCCeeeccccCCcEEEccCCceEEecccccCCCccc
Q 018712 184 EYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDA 226 (351)
Q Consensus 184 ~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~ 226 (351)
..+=..| ++|.|.+|+||+++.+|.+.+.|||+.......
T Consensus 279 ~q~~~dg---ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~~ 318 (517)
T COG0661 279 RQLLRDG---FFHADPHPGNILVRSDGRIVLLDFGIVGRLDPK 318 (517)
T ss_pred HHHHhcC---ccccCCCccceEEecCCcEEEEcCcceecCCHH
Confidence 2233356 999999999999999999999999998877654
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.78 E-value=7.6e-08 Score=80.97 Aligned_cols=136 Identities=14% Similarity=0.183 Sum_probs=90.3
Q ss_pred hcCCCCCceeccCCcEEEEEEEECCCCEEEEEEcCCCCCchHH----------HHHHHHHHHhccC---CceeeeEE---
Q 018712 65 TDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQE----------FLAQVSMVSRLKN---ENVVELVG--- 128 (351)
Q Consensus 65 ~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~----------~~~e~~~l~~l~h---~niv~~~~--- 128 (351)
..+|.+.+.+-......|.+-.. +|..+++|..+......++ ..+.+..+.++.. .....++-
T Consensus 30 ~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~e 108 (229)
T PF06176_consen 30 DNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAE 108 (229)
T ss_pred hCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeee
Confidence 46788888888888777777665 4789999987654332221 2233333334322 12222111
Q ss_pred --EEecCCceEEEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEE
Q 018712 129 --YYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLL 206 (351)
Q Consensus 129 --~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill 206 (351)
.+.-....+++|||++|..|.++.. +.. .++..+.+++.-||+.| ++|+|.+|+|+++
T Consensus 109 kk~~~~~~~~~ll~EYIeG~~l~d~~~-------------i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv 168 (229)
T PF06176_consen 109 KKIFRYTSSYVLLMEYIEGVELNDIED-------------IDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLV 168 (229)
T ss_pred eeeccceeEEEEEEEEecCeecccchh-------------cCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEEE
Confidence 1212234568999999988877643 222 24456778899999999 9999999999999
Q ss_pred ccCCceEEecccccCC
Q 018712 207 FDDDIAKISDFDLSNQ 222 (351)
Q Consensus 207 ~~~~~vkl~Dfg~a~~ 222 (351)
++++ ++++||+..+.
T Consensus 169 ~~~~-i~iID~~~k~~ 183 (229)
T PF06176_consen 169 SNNG-IRIIDTQGKRM 183 (229)
T ss_pred ECCc-EEEEECccccc
Confidence 8655 89999986543
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.70 E-value=2.8e-09 Score=101.62 Aligned_cols=162 Identities=16% Similarity=0.224 Sum_probs=103.9
Q ss_pred HHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccccCCCcccccccc-------ccccccccCccCcccccCC
Q 018712 178 GAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLH-------STRVLGTFGYHAPEYAMTG 250 (351)
Q Consensus 178 qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~-------~~~~~gt~~y~aPE~~~~~ 250 (351)
+.+.|+.|+|+.- ++||++|.|++|.++..+.+||+.|+.+........... ..-..-...|.|||++.+.
T Consensus 107 ~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~ 184 (700)
T KOG2137|consen 107 NVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGT 184 (700)
T ss_pred cccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccc
Confidence 4458999999985 599999999999999999999999998866544211000 0011235679999999998
Q ss_pred CCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCCc-----------cchhhcccCCCccchhhhcccccCCCCCHHHHHH
Q 018712 251 QMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQ-----------SLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAK 318 (351)
Q Consensus 251 ~~~~~~DvwslG~il~el~t-g~~Pf~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~ld~~~~~~~~~~~~~~ 318 (351)
..+.++|+||+|+++|.+.. |+.-+......... .......|.-..+.+..++......|++. ..
T Consensus 185 ~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~---~~ 261 (700)
T KOG2137|consen 185 TNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTL---DL 261 (700)
T ss_pred cccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcch---hh
Confidence 88999999999999999994 55544433111100 01111222222345666667766666633 33
Q ss_pred HHHHHHHhhhhccccchhhhhcccCCccccc
Q 018712 319 VRKKKFITSECSNISFAEFNINWHCPLEWSV 349 (351)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~ 349 (351)
+....++..-| ...++. +|..++|||
T Consensus 262 l~~~~ff~D~~----~~aLrf-LD~l~~kdn 287 (700)
T KOG2137|consen 262 LLSIPFFSDPG----LKALRF-LDDLPQKDN 287 (700)
T ss_pred hhcccccCCch----hhhhhh-cccccccCc
Confidence 34444444443 345555 666666765
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.62 E-value=5.1e-07 Score=76.93 Aligned_cols=150 Identities=17% Similarity=0.199 Sum_probs=101.4
Q ss_pred CHHHHHHHhcCCCCCce---eccCCcEEEEEEEECCCCEEEEEEcCCCCCc--------------------hHH-----H
Q 018712 57 SVDELKEKTDNFGTNSL---IGEGSYGRVYFGVLRSGRAAAIKKLDSSKQP--------------------DQE-----F 108 (351)
Q Consensus 57 ~~~~~~~~~~~y~~~~~---Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--------------------~~~-----~ 108 (351)
+...+....++..+... |..|.-+.||+|...++..+|+|++...... ... .
T Consensus 36 t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~ 115 (268)
T COG1718 36 TLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWA 115 (268)
T ss_pred HHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHH
Confidence 34555566666666554 5567778899999888999999998543211 111 2
Q ss_pred HHHHHHHHhcc--CCceeeeEEEEecCCceEEEEEeCCCCC-HHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHh
Q 018712 109 LAQVSMVSRLK--NENVVELVGYYVDGPLRVLAYEHASKGS-LHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEY 185 (351)
Q Consensus 109 ~~e~~~l~~l~--h~niv~~~~~~~~~~~~~lv~e~~~~gs-L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~ 185 (351)
..|+..|+++. +-.+.+.+.+. .-.|||||+.... -.-.|+. ..+...+...+..++++.+.-
T Consensus 116 ~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~LkD----------v~~e~~e~~~~~~~~v~~~~~ 181 (268)
T COG1718 116 RKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRLKD----------VPLELEEAEGLYEDVVEYMRR 181 (268)
T ss_pred HHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCccc----------CCcCchhHHHHHHHHHHHHHH
Confidence 45777788873 44555655543 3469999996531 0011111 113333677788888888888
Q ss_pred hhh-CCCCCeeeccccCCcEEEccCCceEEecccccCCCc
Q 018712 186 LHE-KAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAP 224 (351)
Q Consensus 186 lH~-~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~ 224 (351)
|-. .+ +||+||..=|||+. ++.+.|+|||-|....
T Consensus 182 l~~~a~---LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~ 217 (268)
T COG1718 182 LYKEAG---LVHGDLSEYNILVH-DGEPYIIDVSQAVTID 217 (268)
T ss_pred HHHhcC---cccccchhhheEEE-CCeEEEEECccccccC
Confidence 777 66 99999999999998 8889999999876654
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.62 E-value=5.3e-07 Score=77.93 Aligned_cols=77 Identities=14% Similarity=0.164 Sum_probs=56.7
Q ss_pred ceeccCCcEEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHHhccCC--ceeeeEEEEe---cCCceEEEEEeCCCC
Q 018712 72 SLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNE--NVVELVGYYV---DGPLRVLAYEHASKG 146 (351)
Q Consensus 72 ~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~--niv~~~~~~~---~~~~~~lv~e~~~~g 146 (351)
+.|+.|..+.||+....+ ..+++|..... .....+.+|..+++.+... .+.+++.... .....+++|++++|.
T Consensus 3 ~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~-~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g~ 80 (239)
T PF01636_consen 3 RPLSGGFSNRVYRVTTDD-GRYVLKFYRPP-DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPGR 80 (239)
T ss_dssp EEEEESSSSEEEEEEETT-SEEEEEEESSH-HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESSE
T ss_pred ccCCCCCeeeEEEEEECC-cEEEEEEeCCC-CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEeccc
Confidence 568999999999999877 69999997655 4456788888888888432 3556665432 233468999999998
Q ss_pred CHHH
Q 018712 147 SLHD 150 (351)
Q Consensus 147 sL~~ 150 (351)
++..
T Consensus 81 ~~~~ 84 (239)
T PF01636_consen 81 PLDD 84 (239)
T ss_dssp EHHH
T ss_pred cccc
Confidence 8777
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.59 E-value=3.8e-09 Score=99.83 Aligned_cols=195 Identities=19% Similarity=0.153 Sum_probs=139.4
Q ss_pred HHHHHhcCCCCCceeccCCcEEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHHhccCCc-eeeeEEEEecCCceEE
Q 018712 60 ELKEKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNEN-VVELVGYYVDGPLRVL 138 (351)
Q Consensus 60 ~~~~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~~~~~~~~~~~~~l 138 (351)
.+..++..|....-+++++++++++.+..-.+....+.+... ....-++++|.+++||| .+..++.+..+...++
T Consensus 236 ~lkDk~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i 311 (829)
T KOG0576|consen 236 TLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWI 311 (829)
T ss_pred cccCCccchHHHHHHHHHHhcCCCccCCChhhheeceeeccc----hhhHHHHHHHHHccCCCCcccccccCCcccccch
Confidence 344555566666678999999999887543334446655433 33456788999999999 7777777778888999
Q ss_pred EEEeCCCC-CHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecc
Q 018712 139 AYEHASKG-SLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDF 217 (351)
Q Consensus 139 v~e~~~~g-sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Df 217 (351)
.++++.++ +......... ..+...+...+.+.-.++++++|+.. -+|+| ||+..+ +.+|..||
T Consensus 312 ~~~i~s~~rs~~~~~~~se--------~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~ 375 (829)
T KOG0576|consen 312 PMRICSTGRSSALEMTVSE--------IALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDF 375 (829)
T ss_pred hhhhhcCCccccccCChhh--------Hhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-cccccccc
Confidence 99999876 2222111111 01333344455666678899999875 58888 777654 67899999
Q ss_pred cccCCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCC
Q 018712 218 DLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDH 277 (351)
Q Consensus 218 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~ 277 (351)
+....+.... ......+|+.++|||......+....|.|++|+-..+|.-|-+|-..
T Consensus 376 ~v~~~L~~~~---~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~ 432 (829)
T KOG0576|consen 376 AVPPQLTRTM---KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSS 432 (829)
T ss_pred cCCcccCccc---ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCCC
Confidence 9887765543 23556799999999999999999999999999887888877776544
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.54 E-value=2.5e-06 Score=74.59 Aligned_cols=75 Identities=17% Similarity=0.091 Sum_probs=53.5
Q ss_pred eccCCc-EEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHHhcc-CCceeeeEEEEecCCceEEEEEeCCCCCHHHH
Q 018712 74 IGEGSY-GRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLK-NENVVELVGYYVDGPLRVLAYEHASKGSLHDI 151 (351)
Q Consensus 74 Lg~G~~-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~ 151 (351)
|..|.+ +.||+.... +..+.+|+..... ...+.+|+++++.+. +--+.+++.+....+..++|||+++|.+|...
T Consensus 6 ~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~--~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~ 82 (244)
T cd05150 6 VTEGQSGATVYRLDGK-NPGLYLKIAPSGP--TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAAL 82 (244)
T ss_pred cCCCCCcCeEEEEcCC-CCcEEEEecCCCc--ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhHh
Confidence 344444 788988754 4688888876543 335678888888873 34466778777766678999999999877644
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.48 E-value=9.3e-07 Score=84.25 Aligned_cols=164 Identities=16% Similarity=0.167 Sum_probs=100.9
Q ss_pred ceeccccccccCHHHHHHHhcC---------CC--CCceeccCCcEEEEEEEECCCCEEEEEEcCCCCCch---------
Q 018712 46 VTVQPIAVPVISVDELKEKTDN---------FG--TNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPD--------- 105 (351)
Q Consensus 46 ~~~~~~~~~~~~~~~~~~~~~~---------y~--~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~--------- 105 (351)
...-...+|.++.+++....+. |. ..+.||..+.|.||+|+.++|+.||||+-.+.-...
T Consensus 130 L~~LqD~~Pp~~~ee~~~i~e~ElG~~ie~if~~f~~~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~ 209 (538)
T KOG1235|consen 130 LSELQDQAPPFPWEEAFKIFEEELGAPIEDIFSEFDEEPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLR 209 (538)
T ss_pred HHHHhccCCCCCHHHHHHHHHHHhCCCHHHHHHhcCcchhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHH
Confidence 3333455666666665443221 22 235799999999999999999999999875432110
Q ss_pred -----------------------------HHHHHHHHHHH----hccCCc------eeeeEEEEecCCceEEEEEeCCCC
Q 018712 106 -----------------------------QEFLAQVSMVS----RLKNEN------VVELVGYYVDGPLRVLAYEHASKG 146 (351)
Q Consensus 106 -----------------------------~~~~~e~~~l~----~l~h~n------iv~~~~~~~~~~~~~lv~e~~~~g 146 (351)
-+|.+|.+... .+.|-+ |.+++-. -.....|+|||++|.
T Consensus 210 ~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~Nae~~~~~f~~~~~~~~V~VP~Vy~~--~st~RVLtME~~~G~ 287 (538)
T KOG1235|consen 210 LLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAKNAERFRENFKDFSLLTYVLVPKVYWD--LSTKRVLTMEYVDGI 287 (538)
T ss_pred HHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHHhHHHHHHHHHhcccccceeCCeehhh--cCcceEEEEEecCCc
Confidence 01334443332 234444 4444432 234578999999997
Q ss_pred CHHHH--hccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEcc----CCceEEeccccc
Q 018712 147 SLHDI--LHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFD----DDIAKISDFDLS 220 (351)
Q Consensus 147 sL~~~--l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~----~~~vkl~Dfg~a 220 (351)
.+.+. |.+.+ ++...+..-+.+...- -+=..| ++|+|=+|+||++.+ ++.+.+.|||+.
T Consensus 288 ~i~Dl~~i~~~g----------i~~~~i~~~l~~~~~~--qIf~~G---ffHaDPHPGNilv~~~~~~~~~ivllDhGl~ 352 (538)
T KOG1235|consen 288 KINDLDAIDKRG----------ISPHDILNKLVEAYLE--QIFKTG---FFHADPHPGNILVRPNPEGDEEIVLLDHGLY 352 (538)
T ss_pred cCCCHHHHHHcC----------CCHHHHHHHHHHHHHH--HHHhcC---CccCCCCCCcEEEecCCCCCccEEEEccccc
Confidence 66554 33332 4444443333332222 222346 999999999999984 568999999998
Q ss_pred CCCccc
Q 018712 221 NQAPDA 226 (351)
Q Consensus 221 ~~~~~~ 226 (351)
..+...
T Consensus 353 ~~is~~ 358 (538)
T KOG1235|consen 353 AVISHK 358 (538)
T ss_pred ccccHH
Confidence 877544
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.42 E-value=1.1e-05 Score=67.68 Aligned_cols=133 Identities=16% Similarity=0.179 Sum_probs=94.9
Q ss_pred CceeccCCcEEEEEEEECCCCEEEEEEcCCCC-----------------CchHHHHHHHHHHHhcc------CCceeeeE
Q 018712 71 NSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSK-----------------QPDQEFLAQVSMVSRLK------NENVVELV 127 (351)
Q Consensus 71 ~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-----------------~~~~~~~~e~~~l~~l~------h~niv~~~ 127 (351)
...||+|+.-.||. +.+.....||+..... ....+..+|+.....+. +.+|.+++
T Consensus 6 ~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 6 SDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred CcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 45799999999984 5566678888876554 12355667776666555 78899999
Q ss_pred EEEecCCceEEEEEeCCC------CCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccC
Q 018712 128 GYYVDGPLRVLAYEHASK------GSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKS 201 (351)
Q Consensus 128 ~~~~~~~~~~lv~e~~~~------gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp 201 (351)
|+..++--.-+|+|.+.+ .+|.+++.... ++. ..... +-+-.+||-+++ |+.+||+|
T Consensus 84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~----------~~~-~~~~~---L~~f~~~l~~~~---Iv~~dl~~ 146 (199)
T PF10707_consen 84 GFVETNLGLGLVVELIRDADGNISPTLEDYLKEGG----------LTE-ELRQA---LDEFKRYLLDHH---IVIRDLNP 146 (199)
T ss_pred EEEecCCceEEEEEEEECCCCCcCccHHHHHHcCC----------ccH-HHHHH---HHHHHHHHHHcC---CeecCCCc
Confidence 999999888999998753 37889986553 444 33333 334456667777 99999999
Q ss_pred CcEEEccCC----ceEEec-ccccCC
Q 018712 202 SNVLLFDDD----IAKISD-FDLSNQ 222 (351)
Q Consensus 202 ~Nill~~~~----~vkl~D-fg~a~~ 222 (351)
.||++.... .+.|+| ||-...
T Consensus 147 ~NIv~~~~~~~~~~lvlIDG~G~~~~ 172 (199)
T PF10707_consen 147 HNIVVQRRDSGEFRLVLIDGLGEKEL 172 (199)
T ss_pred ccEEEEecCCCceEEEEEeCCCCccc
Confidence 999996432 577777 775443
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.40 E-value=2.6e-06 Score=68.80 Aligned_cols=129 Identities=21% Similarity=0.244 Sum_probs=91.0
Q ss_pred CCCceeccCCcEEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHHhccCCcee-eeEEEEecCCceEEEEEeCCCCC
Q 018712 69 GTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVV-ELVGYYVDGPLRVLAYEHASKGS 147 (351)
Q Consensus 69 ~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv-~~~~~~~~~~~~~lv~e~~~~gs 147 (351)
...+.|++|.+|.||++.+. |..+|+|+-+.+ .....+..|.++|..+..-++- +++.+.. .++.|||+.|-+
T Consensus 25 ~v~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~d-s~r~~l~kEakiLeil~g~~~~p~vy~yg~----~~i~me~i~G~~ 98 (201)
T COG2112 25 RVEKELAKGTTSVVYLGEWR-GGEVALKVRRRD-SPRRNLEKEAKILEILAGEGVTPEVYFYGE----DFIRMEYIDGRP 98 (201)
T ss_pred hhhhhhhcccccEEEEeecc-CceEEEEEecCC-cchhhHHHHHHHHHHhhhcCCCceEEEech----hhhhhhhhcCcc
Confidence 34567999999999999986 458888875543 3456788999999999765544 4554422 235599999988
Q ss_pred HHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeecccc-CCcEEEccCCceEEecccccCC
Q 018712 148 LHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIK-SSNVLLFDDDIAKISDFDLSNQ 222 (351)
Q Consensus 148 L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlk-p~Nill~~~~~vkl~Dfg~a~~ 222 (351)
|.+.-... . .+....+++.---|-..| |-|+.|. |...++..++.+.|+||..|+.
T Consensus 99 L~~~~~~~------------~----rk~l~~vlE~a~~LD~~G---I~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 99 LGKLEIGG------------D----RKHLLRVLEKAYKLDRLG---IEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred hhhhhhcc------------c----HHHHHHHHHHHHHHHHhc---cchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 87765431 1 123344555555566677 9999986 5666666666999999998864
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.38 E-value=6.6e-06 Score=84.30 Aligned_cols=78 Identities=14% Similarity=0.175 Sum_probs=56.9
Q ss_pred CceeccCCcEEEEEEEECCC---CEEEEEEcCCCC--CchHHHHHHHHHHHhcc-CCce--eeeEEEEecC---CceEEE
Q 018712 71 NSLIGEGSYGRVYFGVLRSG---RAAAIKKLDSSK--QPDQEFLAQVSMVSRLK-NENV--VELVGYYVDG---PLRVLA 139 (351)
Q Consensus 71 ~~~Lg~G~~g~Vy~~~~~~~---~~vavK~~~~~~--~~~~~~~~e~~~l~~l~-h~ni--v~~~~~~~~~---~~~~lv 139 (351)
...|+.|.++.+|+....++ ..+++|+..... .....+.+|+++|+.+. |.++ .+++.++.+. +..|+|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 45689999999999876543 468888765432 22356889999999995 6554 7777776654 467899
Q ss_pred EEeCCCCCH
Q 018712 140 YEHASKGSL 148 (351)
Q Consensus 140 ~e~~~~gsL 148 (351)
|||++|..+
T Consensus 123 ME~v~G~~~ 131 (822)
T PLN02876 123 MEYLEGRIF 131 (822)
T ss_pred EEecCCccc
Confidence 999998643
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=98.38 E-value=4.1e-06 Score=72.82 Aligned_cols=73 Identities=14% Similarity=0.136 Sum_probs=46.8
Q ss_pred ceeccCCcE-EEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHHhccCC---ceeeeEEEEecC---CceEEEEEeCC
Q 018712 72 SLIGEGSYG-RVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNE---NVVELVGYYVDG---PLRVLAYEHAS 144 (351)
Q Consensus 72 ~~Lg~G~~g-~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~---niv~~~~~~~~~---~~~~lv~e~~~ 144 (351)
+.|+.|+.. .||+. +..+++|.... ......+.+|.++++.+... .+.+++...... ...+++|++++
T Consensus 3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~-~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i~ 77 (235)
T cd05155 3 EPVDSGGTDNATFRL----GDDMSVRLPSA-AGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWLE 77 (235)
T ss_pred eeccCCCcccceEEc----CCceEEEcCCc-cchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEeec
Confidence 457777776 48875 24577886554 22345788999999887532 344555433322 23588999999
Q ss_pred CCCHH
Q 018712 145 KGSLH 149 (351)
Q Consensus 145 ~gsL~ 149 (351)
|.++.
T Consensus 78 G~~l~ 82 (235)
T cd05155 78 GETAT 82 (235)
T ss_pred CCCCC
Confidence 97764
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=98.34 E-value=1.1e-05 Score=70.15 Aligned_cols=73 Identities=11% Similarity=0.062 Sum_probs=48.8
Q ss_pred ceeccCCcEEEEEEEECC--CCEEEEEEcCCCCCchHHHHHHHHHHHhccC-CceeeeEEEEecCCceEEEEEeCCCCCH
Q 018712 72 SLIGEGSYGRVYFGVLRS--GRAAAIKKLDSSKQPDQEFLAQVSMVSRLKN-ENVVELVGYYVDGPLRVLAYEHASKGSL 148 (351)
Q Consensus 72 ~~Lg~G~~g~Vy~~~~~~--~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h-~niv~~~~~~~~~~~~~lv~e~~~~gsL 148 (351)
+.|..|-...+|+....+ +..|++|+............+|+.+++.+.. ...++++..+. -.++|||++|.++
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~~l 79 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTELIIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGRTL 79 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccceecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCCcC
Confidence 467788889999988664 6789999776433222234578888888843 33445544332 2479999998765
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.32 E-value=1.4e-05 Score=71.90 Aligned_cols=77 Identities=16% Similarity=0.028 Sum_probs=56.8
Q ss_pred CCceeccCCcEEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHHhccC---CceeeeEEEEec---CCceEEEEEeC
Q 018712 70 TNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKN---ENVVELVGYYVD---GPLRVLAYEHA 143 (351)
Q Consensus 70 ~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h---~niv~~~~~~~~---~~~~~lv~e~~ 143 (351)
..+.||.|..+.||+....++ .+++|..+ .......+.+|...|+.+.. -.+.++++.+.. .+..++|||++
T Consensus 18 ~~~~i~~G~~~~vy~~~~~~~-~~~~k~~~-~~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i 95 (297)
T PRK10593 18 RVECISEQPYAALWALYDSQG-NPMPLMAR-SFSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERL 95 (297)
T ss_pred eeeecCCccceeEEEEEcCCC-CEEEEEec-ccccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEecc
Confidence 345799999999999876555 46777743 32234578899999998843 467888877654 35689999999
Q ss_pred CCCCH
Q 018712 144 SKGSL 148 (351)
Q Consensus 144 ~~gsL 148 (351)
+++++
T Consensus 96 ~G~~~ 100 (297)
T PRK10593 96 RGVSV 100 (297)
T ss_pred CCEec
Confidence 98765
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.27 E-value=5e-06 Score=69.39 Aligned_cols=102 Identities=25% Similarity=0.217 Sum_probs=80.5
Q ss_pred HHHHHHHHhccC-CceeeeEEEEecCCceEEEEEeCCCCCHHHH---hccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHH
Q 018712 109 LAQVSMVSRLKN-ENVVELVGYYVDGPLRVLAYEHASKGSLHDI---LHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLE 184 (351)
Q Consensus 109 ~~e~~~l~~l~h-~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~---l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~ 184 (351)
.+|.-+++.+.+ +++++++|+|- .+++.|+...+++... +.... ..+|..+.+++.++++.+.
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~~~---------~~~w~~R~~iA~~lL~~l~ 73 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQFL---------QSPWEQRAKIALQLLELLE 73 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCcccccccccccccc---------ccCHHHHHHHHHHHHHHHH
Confidence 357888888866 69999999983 3578899987655422 11110 1789999999999999999
Q ss_pred hhhhCCCCCeeeccccCCcEEEccCCceEEecccccCCC
Q 018712 185 YLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQA 223 (351)
Q Consensus 185 ~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~ 223 (351)
+++......+.-.|++++|+-+++++++|++|.+.+...
T Consensus 74 ~l~~~~~~~~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 74 ELDHGPLGFFYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred HHhcCCCCcEEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 999964445888999999999999999999999976544
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=98.21 E-value=1.8e-05 Score=69.77 Aligned_cols=140 Identities=11% Similarity=0.061 Sum_probs=78.1
Q ss_pred eeccCCcEEEEEEEECCCCEEEEEEcCCCCCch-HHHHHHHHHHHhccCCce-eeeEEEEecCCceEEEEEeCCCCCHHH
Q 018712 73 LIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPD-QEFLAQVSMVSRLKNENV-VELVGYYVDGPLRVLAYEHASKGSLHD 150 (351)
Q Consensus 73 ~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~~~gsL~~ 150 (351)
.+..|-.+.+|+... ++..+++|......... -...+|..+++.+....+ .+++... . -++||||++|..+..
T Consensus 3 ~~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~--~--~~~v~e~i~G~~~~~ 77 (256)
T TIGR02721 3 TLSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN--E--HWLLVEWLEGEVITL 77 (256)
T ss_pred cCCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe--C--CEEEEEeccCccccc
Confidence 356688889998874 56788898765432221 235778888888854323 3444332 2 368999999866532
Q ss_pred H-----------------hccCCCCCCCCCCCCCCHHH-HHHHHHHH---------HHHHHhhhhC-----CCCCeeecc
Q 018712 151 I-----------------LHGKKGVKGAKPGPVLSWAQ-RVKIAVGA---------ARGLEYLHEK-----AEPRIIHRN 198 (351)
Q Consensus 151 ~-----------------l~~~~~~~~~~~~~~l~~~~-~~~i~~qi---------~~~l~~lH~~-----~~~~ivH~D 198 (351)
- ++.... ....+.... ...+..++ ...+..+-.. .+..++|+|
T Consensus 78 ~~~~~~~~~~~la~~l~~lH~~~~-----~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~D 152 (256)
T TIGR02721 78 DQFVALDLLLELAALLHQLHSQPR-----FGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMD 152 (256)
T ss_pred ccccCchhHHHHHHHHHHHhCCCC-----CCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCC
Confidence 1 111110 011122111 11111111 1111111111 122389999
Q ss_pred ccCCcEEEccCCceEEecccccCCC
Q 018712 199 IKSSNVLLFDDDIAKISDFDLSNQA 223 (351)
Q Consensus 199 lkp~Nill~~~~~vkl~Dfg~a~~~ 223 (351)
+.|+||++++++ +.|+||..+...
T Consensus 153 l~~~Nil~~~~~-~~lIDwE~a~~g 176 (256)
T TIGR02721 153 VHAYNLVVTPQG-LKLIDWEYASDG 176 (256)
T ss_pred CCcCcEEEeCCC-CEEEeccccCcC
Confidence 999999999877 789999987543
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=98.13 E-value=3.5e-05 Score=69.36 Aligned_cols=149 Identities=17% Similarity=0.160 Sum_probs=84.6
Q ss_pred CceeccCCcEEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHHhccCC--ceeeeEEE------EecCCceEEEEEe
Q 018712 71 NSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNE--NVVELVGY------YVDGPLRVLAYEH 142 (351)
Q Consensus 71 ~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~--niv~~~~~------~~~~~~~~lv~e~ 142 (351)
.+.|..|....+|+....+ ..+++|+... .....+..|+.++..+.+. .+.+++.. ....+..++++++
T Consensus 19 i~~i~~G~~n~~y~v~~~~-~~~vLr~~~~--~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~~ 95 (296)
T cd05153 19 FEGISAGIENTNYFVTTDS-GRYVLTLFEK--VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVEF 95 (296)
T ss_pred eecccCccccceEEEEeCC-CcEEEEEcCC--CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEEe
Confidence 4567778888999987644 4789998765 3345677788888877432 24444331 1234566899999
Q ss_pred CCCCCHHH----H----------hccCC-CCCCC-CCCCCCCHHHHH----------HHHHHHHHHHHhhhh----CCCC
Q 018712 143 ASKGSLHD----I----------LHGKK-GVKGA-KPGPVLSWAQRV----------KIAVGAARGLEYLHE----KAEP 192 (351)
Q Consensus 143 ~~~gsL~~----~----------l~~~~-~~~~~-~~~~~l~~~~~~----------~i~~qi~~~l~~lH~----~~~~ 192 (351)
++|.++.. . ++... ..... .......+.... .....+..++.++.. ..+.
T Consensus 96 i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~ 175 (296)
T cd05153 96 LAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLPR 175 (296)
T ss_pred CCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCCC
Confidence 99866432 0 01000 00000 000011111110 011122333444443 1122
Q ss_pred CeeeccccCCcEEEccCCceEEecccccCC
Q 018712 193 RIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222 (351)
Q Consensus 193 ~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~ 222 (351)
.++|+|+.|.|+++++++.+.|+||+.+..
T Consensus 176 ~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 176 GVIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred cCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 399999999999999887778999997654
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=98.11 E-value=0.00013 Score=66.10 Aligned_cols=164 Identities=16% Similarity=0.195 Sum_probs=90.2
Q ss_pred CHHHHHHHhcCCCC-----CceeccCCcEEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHHhccCC--ceeeeEEE
Q 018712 57 SVDELKEKTDNFGT-----NSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNE--NVVELVGY 129 (351)
Q Consensus 57 ~~~~~~~~~~~y~~-----~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~--niv~~~~~ 129 (351)
+.+++....+.|.+ .+.++.|....+|+....++ .+++|+..... ....+..|++++..|... .+.+++..
T Consensus 8 ~~~~l~~~l~~y~~~~~~~i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~-~~~~i~~e~~~l~~L~~~g~pvp~~i~t 85 (307)
T TIGR00938 8 SDEEMSSFLDGYDLGELLSLKGIAEGVENSNYLLTTDVG-RYILTLYEKRV-KAEELPFFLALTTHLAARGLPVPKPVKS 85 (307)
T ss_pred CHHHHHHHHHhcCCCCceeccccCCccccceEEEEeCCC-cEEEEEecCCC-CHHHHHHHHHHHHHHHHCCCCCCccccC
Confidence 44566666666655 34567777789999876544 68888765432 234566777777777422 24444432
Q ss_pred ------EecCCceEEEEEeCCCCCHHH-----------H---hccCCCC-CCCCCC--CCCCHHHHH------------H
Q 018712 130 ------YVDGPLRVLAYEHASKGSLHD-----------I---LHGKKGV-KGAKPG--PVLSWAQRV------------K 174 (351)
Q Consensus 130 ------~~~~~~~~lv~e~~~~gsL~~-----------~---l~~~~~~-~~~~~~--~~l~~~~~~------------~ 174 (351)
....+..+++++|++|.++.. . ++..... ...... ....|.... .
T Consensus 86 ~~g~~~~~~~g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~ 165 (307)
T TIGR00938 86 RDGRQLSTLAGKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAH 165 (307)
T ss_pred CCCCeehhcCCeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHH
Confidence 122456789999998854320 0 1111000 000000 001111100 0
Q ss_pred HHHHHHHHHHhhhh----CCCCCeeeccccCCcEEEccCCceEEecccccCC
Q 018712 175 IAVGAARGLEYLHE----KAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222 (351)
Q Consensus 175 i~~qi~~~l~~lH~----~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~ 222 (351)
....+...++++.. .-+..++|+|+++.|+++++++.+.|+||+.+..
T Consensus 166 ~~~~l~~~~~~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~ 217 (307)
T TIGR00938 166 MGAELDKELDYLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFACT 217 (307)
T ss_pred HHHHHHHHHHHHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeecccccC
Confidence 11122334444432 1123499999999999999888778999997643
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=98.05 E-value=0.00018 Score=66.89 Aligned_cols=74 Identities=18% Similarity=0.156 Sum_probs=54.0
Q ss_pred ceeccCCcEEEEEEEECCC-CEEEEEEcCCC--------CCchHHHHHHHHHHHhcc---CCceeeeEEEEecCCceEEE
Q 018712 72 SLIGEGSYGRVYFGVLRSG-RAAAIKKLDSS--------KQPDQEFLAQVSMVSRLK---NENVVELVGYYVDGPLRVLA 139 (351)
Q Consensus 72 ~~Lg~G~~g~Vy~~~~~~~-~~vavK~~~~~--------~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~lv 139 (351)
+.||.|.++.||++...+| +.++||.-... .........|.+.|+.+. ..++++++.+ +.+..++|
T Consensus 32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~lV 109 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVTV 109 (401)
T ss_pred eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEEE
Confidence 5789999999999998776 58999975311 123455677888887763 3567777766 55667899
Q ss_pred EEeCCCCC
Q 018712 140 YEHASKGS 147 (351)
Q Consensus 140 ~e~~~~gs 147 (351)
||++++..
T Consensus 110 ME~L~~~~ 117 (401)
T PRK09550 110 MEDLSDHK 117 (401)
T ss_pred EecCCCcc
Confidence 99998643
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=98.04 E-value=0.0002 Score=65.24 Aligned_cols=165 Identities=17% Similarity=0.195 Sum_probs=86.7
Q ss_pred cCHHHHHHHhcCCCC-----CceeccCCcEEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHHhccCC--ceeeeEE
Q 018712 56 ISVDELKEKTDNFGT-----NSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNE--NVVELVG 128 (351)
Q Consensus 56 ~~~~~~~~~~~~y~~-----~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~--niv~~~~ 128 (351)
.+.+++......|.+ .+.|+.|....+|+....+| .+++|+.. ......+..|..+++.|... .+.+++.
T Consensus 7 ls~~~l~~~l~~y~~~~~~~~~~l~~G~~n~~y~v~t~~g-~~vLK~~~--~~~~~~l~~~~~~l~~L~~~glpvP~~i~ 83 (319)
T PRK05231 7 VSDDELAAFLAPYDLGELLSLKGIAEGIENSNFFLTTTQG-EYVLTLFE--RLTAEDLPFFLGLMQHLAARGVPVPAPVA 83 (319)
T ss_pred CCHHHHHHHHHhcCCchhhccchhccccccceEEEEeCCC-cEEEEEec--cCChHHhHHHHHHHHHHHHCCCCCCccee
Confidence 344555555556655 34566777789999887655 68999876 22334455566666666321 2333332
Q ss_pred ------EEecCCceEEEEEeCCCCCHH-----------HHh---ccCC-CCCCCCCC-CCCCH-HHHHH-----------
Q 018712 129 ------YYVDGPLRVLAYEHASKGSLH-----------DIL---HGKK-GVKGAKPG-PVLSW-AQRVK----------- 174 (351)
Q Consensus 129 ------~~~~~~~~~lv~e~~~~gsL~-----------~~l---~~~~-~~~~~~~~-~~l~~-~~~~~----------- 174 (351)
+....+..+++++|++|..+. +.+ +... ........ ..+.+ .....
T Consensus 84 ~~~G~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (319)
T PRK05231 84 RRDGAALGELAGKPAAIVTFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQA 163 (319)
T ss_pred CCCCCEeeeeCCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHH
Confidence 112345678999999986431 111 1110 00000000 01111 11110
Q ss_pred -HHHH-HHHHHHhhhhC----CCCCeeeccccCCcEEEccCCceEEecccccCCC
Q 018712 175 -IAVG-AARGLEYLHEK----AEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQA 223 (351)
Q Consensus 175 -i~~q-i~~~l~~lH~~----~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~ 223 (351)
...+ +...+..+... -+..++|+|+.|+||+++.+...-|+||+.+...
T Consensus 164 ~~l~~~~~~~~~~~~~~~~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~~ 218 (319)
T PRK05231 164 ALLEAELAAQLAFLASAAWPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFACND 218 (319)
T ss_pred HHHHHHHHHHHHhhhccccccCCcccCCCCCCCCcEEEECCceEEEEecccccCC
Confidence 1111 11122222211 1224999999999999987666689999987543
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.03 E-value=0.00018 Score=60.11 Aligned_cols=124 Identities=27% Similarity=0.411 Sum_probs=87.0
Q ss_pred cCCCCCceeccCCc-EEEEEEEECCCCEEEEEEcCC---C---------C----------CchHHHHHHHHHHHhcc---
Q 018712 66 DNFGTNSLIGEGSY-GRVYFGVLRSGRAAAIKKLDS---S---------K----------QPDQEFLAQVSMVSRLK--- 119 (351)
Q Consensus 66 ~~y~~~~~Lg~G~~-g~Vy~~~~~~~~~vavK~~~~---~---------~----------~~~~~~~~e~~~l~~l~--- 119 (351)
.+++.++.||.|.- |.||++... |+.||+|.+.. . . .....|..|.+...+|+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~-g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~ 115 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEID-GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG 115 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEEC-CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence 67888999999999 999999885 67999999321 0 0 01123677888877774
Q ss_pred CCce--eeeEEEEecC------------------CceEEEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHH
Q 018712 120 NENV--VELVGYYVDG------------------PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGA 179 (351)
Q Consensus 120 h~ni--v~~~~~~~~~------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi 179 (351)
+.++ +++++|..-. ....||.||.+... .+. ..-+.+|
T Consensus 116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~------------------~~~----~~~~~~~ 173 (207)
T PF13095_consen 116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP------------------PLQ----IRDIPQM 173 (207)
T ss_pred ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc------------------ccc----hhHHHHH
Confidence 4556 8999886311 12346666665422 022 2345567
Q ss_pred HHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEeccccc
Q 018712 180 ARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (351)
Q Consensus 180 ~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a 220 (351)
.+-|..+|..| |+-+|+++.|.. + =||+|||.+
T Consensus 174 ~~dl~~~~k~g---I~~~Dv~~~ny~---~--G~lvDfs~~ 206 (207)
T PF13095_consen 174 LRDLKILHKLG---IVPRDVKPRNYR---G--GKLVDFSSS 206 (207)
T ss_pred HHHHHHHHHCC---eeeccCcccccc---C--CEEEecccC
Confidence 77888899999 999999999987 3 389999864
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=98.03 E-value=5.5e-05 Score=68.33 Aligned_cols=74 Identities=20% Similarity=0.169 Sum_probs=49.6
Q ss_pred ceeccCCcEEEEEEEECC-------CCEEEEEEcCCCCCchHHHHHHHHHHHhccCCc-eeeeEEEEecCCceEEEEEeC
Q 018712 72 SLIGEGSYGRVYFGVLRS-------GRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNEN-VVELVGYYVDGPLRVLAYEHA 143 (351)
Q Consensus 72 ~~Lg~G~~g~Vy~~~~~~-------~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~~~~~~~~~~~~~lv~e~~ 143 (351)
+.|..|-...+|+....+ ++.+++|+............+|.++++.+.... ..+++..+.. .+|++|+
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~i 79 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVELLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEFI 79 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCcceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchhhee
Confidence 356677778999988654 578999997655433345678888888885332 3455555432 3588999
Q ss_pred CCCCHH
Q 018712 144 SKGSLH 149 (351)
Q Consensus 144 ~~gsL~ 149 (351)
+|.++.
T Consensus 80 ~G~~l~ 85 (302)
T cd05156 80 PSRTLT 85 (302)
T ss_pred CCCcCC
Confidence 887664
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.95 E-value=1.3e-05 Score=70.93 Aligned_cols=135 Identities=16% Similarity=0.155 Sum_probs=96.9
Q ss_pred CCCCCceeccCCcEEEEEEEECCCCEEEEEEcCCCCCc-----------------------hHHHHHHHHHHHhcc-C-C
Q 018712 67 NFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQP-----------------------DQEFLAQVSMVSRLK-N-E 121 (351)
Q Consensus 67 ~y~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-----------------------~~~~~~e~~~l~~l~-h-~ 121 (351)
-+.+.+.||-|.-+.||.+.+..|++.++|.-+..... .-...+|+..|+.|. | -
T Consensus 93 v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf 172 (465)
T KOG2268|consen 93 VESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF 172 (465)
T ss_pred hhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence 47788999999999999999999999999953211100 112457888888884 3 2
Q ss_pred ceeeeEEEEecCCceEEEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccC
Q 018712 122 NVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKS 201 (351)
Q Consensus 122 niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp 201 (351)
-+.+.+ +.++.++|||++.|..|.+.-+-.. ...+...+..-|--|-++| +||+|..-
T Consensus 173 pVPkpi----D~~RH~Vvmelv~g~Pl~~v~~v~d---------------~~~ly~~lm~~Iv~la~~G---lIHgDFNE 230 (465)
T KOG2268|consen 173 PVPKPI----DHNRHCVVMELVDGYPLRQVRHVED---------------PPTLYDDLMGLIVRLANHG---LIHGDFNE 230 (465)
T ss_pred CCCCcc----cccceeeHHHhhcccceeeeeecCC---------------hHHHHHHHHHHHHHHHHcC---ceecccch
Confidence 344544 4467789999999988876653221 1233344445556677788 99999999
Q ss_pred CcEEEccCCceEEecccccCCC
Q 018712 202 SNVLLFDDDIAKISDFDLSNQA 223 (351)
Q Consensus 202 ~Nill~~~~~vkl~Dfg~a~~~ 223 (351)
=||++++++.++++||--....
T Consensus 231 FNimv~dd~~i~vIDFPQmvS~ 252 (465)
T KOG2268|consen 231 FNIMVKDDDKIVVIDFPQMVST 252 (465)
T ss_pred heeEEecCCCEEEeechHhhcc
Confidence 9999999999999999754433
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.82 E-value=6.7e-05 Score=76.40 Aligned_cols=195 Identities=19% Similarity=0.227 Sum_probs=134.1
Q ss_pred HHHHHHHHHhccCCceeeeEEEEecCCc----eEEEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHH
Q 018712 108 FLAQVSMVSRLKNENVVELVGYYVDGPL----RVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGL 183 (351)
Q Consensus 108 ~~~e~~~l~~l~h~niv~~~~~~~~~~~----~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l 183 (351)
..-|+..+..+.|+|++.++.+..+... ..+..+++...++...+..... .+..+.+.+..++.+|+
T Consensus 229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~---------i~~~~~r~~~~~~~~GL 299 (1351)
T KOG1035|consen 229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGS---------IPLETLRILHQKLLEGL 299 (1351)
T ss_pred HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccc---------cCHHHHHHHHHHHhhhH
Confidence 3445667888899999999988765432 2345578888888888876653 78899999999999999
Q ss_pred HhhhhCCCCCeeeccccCC---cEEEccCCceEEe--cccccCCCccccccccccccccccCccCcccccCCCCCcc--c
Q 018712 184 EYLHEKAEPRIIHRNIKSS---NVLLFDDDIAKIS--DFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSK--S 256 (351)
Q Consensus 184 ~~lH~~~~~~ivH~Dlkp~---Nill~~~~~vkl~--Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~--~ 256 (351)
.|+|+.. ..|.-+... +..++..+.+.++ ||+.++........ ....-+..+.++|......+..+ .
T Consensus 300 ~~~h~~~---l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~---~~~~~~~~~~~~e~~~~~~~~~~r~~ 373 (1351)
T KOG1035|consen 300 AYLHSLS---LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKS---FSDLLAEIRNADEDLKENTAKKSRLT 373 (1351)
T ss_pred HHHHHhc---cceeEEecccccccccCccceeecchhhhcccccCCCcccc---hhhcCccccccccccccccchhhhhh
Confidence 9999996 777666665 4555666777777 99988776554322 22234556888887776665544 7
Q ss_pred hhHhHHHHHHHHHcCCCCCCCCCCCCCccchhhcccCCCccchhhhcccccCCCCCHHHHHHH
Q 018712 257 DVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKV 319 (351)
Q Consensus 257 DvwslG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ld~~~~~~~~~~~~~~~ 319 (351)
|+|.+|..+..+..|..+-... .....+..........+....|++.....|....++...
T Consensus 374 dL~~lgll~~~~~~~~~i~~~~--~~~~~~l~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~ 434 (1351)
T KOG1035|consen 374 DLWCLGLLLLQLSQGEDISEKS--AVPVSLLDVLSTSELLDALPKCLDEDSEERLSALELLTH 434 (1351)
T ss_pred HHHHHHHHHhhhhhcCcccccc--cchhhhhccccchhhhhhhhhhcchhhhhccchhhhhhc
Confidence 9999999999999987653321 111112211111123355677888888888877665443
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.74 E-value=0.00057 Score=62.87 Aligned_cols=144 Identities=14% Similarity=0.197 Sum_probs=80.0
Q ss_pred ceeccCCcEEEEEEEECC-----CCEEEEEEcCCCCCchHHHHHHHHHHHhccCCce-eeeEEEEecCCceEEEEEeCCC
Q 018712 72 SLIGEGSYGRVYFGVLRS-----GRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENV-VELVGYYVDGPLRVLAYEHASK 145 (351)
Q Consensus 72 ~~Lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~~~ 145 (351)
..|..|-...+|+....+ ++.|++|+.......--...+|..+++.+...++ .++++.+..+ .|.+|+++
T Consensus 42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~idR~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~g 117 (344)
T PLN02236 42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFDRDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIHA 117 (344)
T ss_pred EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeechHHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeCC
Confidence 456568888999987532 3689999876543222223678888888854333 3455555332 57899887
Q ss_pred CCHHHH-----------------hccCCCCCCCCCCCCCCHHHHHHHHHHH-----------------HHHHHh----hh
Q 018712 146 GSLHDI-----------------LHGKKGVKGAKPGPVLSWAQRVKIAVGA-----------------ARGLEY----LH 187 (351)
Q Consensus 146 gsL~~~-----------------l~~~~~~~~~~~~~~l~~~~~~~i~~qi-----------------~~~l~~----lH 187 (351)
.+|..- ++.... ........+..+..+..++ ...+.. +.
T Consensus 118 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~---~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~ 194 (344)
T PLN02236 118 RTLSAADLRDPEISALIAAKLREFHSLDM---PGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELS 194 (344)
T ss_pred CCCCHHHcCChHHHHHHHHHHHHHhCCCC---CCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhc
Confidence 665321 111110 0000011222222332211 111111 11
Q ss_pred h-CCCCCeeeccccCCcEEEcc-CCceEEecccccCC
Q 018712 188 E-KAEPRIIHRNIKSSNVLLFD-DDIAKISDFDLSNQ 222 (351)
Q Consensus 188 ~-~~~~~ivH~Dlkp~Nill~~-~~~vkl~Dfg~a~~ 222 (351)
. .....++|+|+++.|||+++ ++.+.|+||..+..
T Consensus 195 ~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 195 GDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred ccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 1 11224899999999999986 46899999997643
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.58 E-value=0.00046 Score=62.43 Aligned_cols=138 Identities=22% Similarity=0.235 Sum_probs=92.9
Q ss_pred CceeccCCcEEEEEEEECCCCEEEEEEcCCCCC----------------------chHH-----HHHHHHHHHhccCCce
Q 018712 71 NSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQ----------------------PDQE-----FLAQVSMVSRLKNENV 123 (351)
Q Consensus 71 ~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~----------------------~~~~-----~~~e~~~l~~l~h~ni 123 (351)
...|..|.-+.||.|...+|..+|||+++.+.. +.+. ...|++.|++++...|
T Consensus 149 nGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aGI 228 (520)
T KOG2270|consen 149 NGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAGI 228 (520)
T ss_pred ccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcCC
Confidence 345677888999999988999999998753210 1111 3457778888876554
Q ss_pred eeeEEEEecCCceEEEEEeCCCCCH-HHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCC
Q 018712 124 VELVGYYVDGPLRVLAYEHASKGSL-HDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSS 202 (351)
Q Consensus 124 v~~~~~~~~~~~~~lv~e~~~~gsL-~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~ 202 (351)
.-.--+... ...|||+|+..... .-.|+. ..++...+..+-.|++.-+.-|-... ++||.||.--
T Consensus 229 P~PePIlLk--~hVLVM~FlGrdgw~aPkLKd----------~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEf 294 (520)
T KOG2270|consen 229 PCPEPILLK--NHVLVMEFLGRDGWAAPKLKD----------ASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEF 294 (520)
T ss_pred CCCCceeee--cceEeeeeccCCCCcCccccc----------ccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhh
Confidence 432222221 24799999964211 111211 12666778888888888887776665 4999999999
Q ss_pred cEEEccCCceEEecccccCCC
Q 018712 203 NVLLFDDDIAKISDFDLSNQA 223 (351)
Q Consensus 203 Nill~~~~~vkl~Dfg~a~~~ 223 (351)
|+|+ .+|.+.|+|.+-+...
T Consensus 295 N~Ly-hdG~lyiIDVSQSVE~ 314 (520)
T KOG2270|consen 295 NLLY-HDGKLYIIDVSQSVEH 314 (520)
T ss_pred hheE-ECCEEEEEEccccccC
Confidence 9998 5678899999876554
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=97.56 E-value=0.0017 Score=59.29 Aligned_cols=79 Identities=20% Similarity=0.167 Sum_probs=52.1
Q ss_pred eeccCCcEEEEEEEECCC-CEEEEEEcCC--------CCCchHHHHHHHHHHHhccC--C-ceeeeEEEEecCCceEEEE
Q 018712 73 LIGEGSYGRVYFGVLRSG-RAAAIKKLDS--------SKQPDQEFLAQVSMVSRLKN--E-NVVELVGYYVDGPLRVLAY 140 (351)
Q Consensus 73 ~Lg~G~~g~Vy~~~~~~~-~~vavK~~~~--------~~~~~~~~~~e~~~l~~l~h--~-niv~~~~~~~~~~~~~lv~ 140 (351)
.||.|....||++...++ +.++||.-.. .+....+..-|...|+.... | .+++++.+ +.+...+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence 579999999999997654 6899996421 12334556677777776532 3 56666544 667778999
Q ss_pred EeCCCC-CHHHHhc
Q 018712 141 EHASKG-SLHDILH 153 (351)
Q Consensus 141 e~~~~g-sL~~~l~ 153 (351)
|+++.. .|...|-
T Consensus 80 EdL~~~~ilR~~Li 93 (370)
T TIGR01767 80 EDLSHHKIARKGLI 93 (370)
T ss_pred hhCccchHHHHHHH
Confidence 999653 3444443
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.55 E-value=0.0054 Score=56.01 Aligned_cols=71 Identities=18% Similarity=0.186 Sum_probs=47.0
Q ss_pred CCcEEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHHhccCC--ceeeeE---E--EEecCCceEEEEEeCCCCC
Q 018712 77 GSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNE--NVVELV---G--YYVDGPLRVLAYEHASKGS 147 (351)
Q Consensus 77 G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~--niv~~~---~--~~~~~~~~~lv~e~~~~gs 147 (351)
+.-..||+....++..+++|+..........+..|++.+..|... .++... + ....++..+.++++++|..
T Consensus 36 s~eN~vy~v~~~~~~~~vlKv~r~~~~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G~~ 113 (325)
T PRK11768 36 SYENRVYQFGDEDGRRVVAKFYRPERWSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGGRA 113 (325)
T ss_pred cccceEEEEecCCCCEEEEEEcCcccCCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCCCC
Confidence 445679999887888999998875555566777888887776321 122211 1 1223456788999998754
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=97.55 E-value=0.001 Score=59.16 Aligned_cols=45 Identities=11% Similarity=0.066 Sum_probs=31.6
Q ss_pred eccCCcEEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHHhcc
Q 018712 74 IGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLK 119 (351)
Q Consensus 74 Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~ 119 (351)
.++|-...|+.....+|..+++|.-... .....+.+|.++|+.+.
T Consensus 19 ~~~g~~~~v~~i~~~~g~~~VlR~p~~~-~~~~~l~rE~~vL~~L~ 63 (276)
T cd05152 19 NESGLDFQVVFAKDTDGVPWVLRIPRRP-DVSERAAAEKRVLALVR 63 (276)
T ss_pred cCCcceeEEEEEEcCCCCeEEEEecCCH-HHHHHHHHHHHHHHHHH
Confidence 4566666777765566889999976432 23456789999998885
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=97.53 E-value=0.0027 Score=59.13 Aligned_cols=79 Identities=14% Similarity=0.145 Sum_probs=52.4
Q ss_pred CceeccCCcEEEEEEEECCCCEEEEEEcCC-----CC---CchHHHHHHHHHHHhcc---CCceeeeEEEEecCCceEEE
Q 018712 71 NSLIGEGSYGRVYFGVLRSGRAAAIKKLDS-----SK---QPDQEFLAQVSMVSRLK---NENVVELVGYYVDGPLRVLA 139 (351)
Q Consensus 71 ~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~-----~~---~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~lv 139 (351)
.+.||.|....||+.... +..++||.-.. .. ....+...|...|+.+. ..++++++.+.. +..+++
T Consensus 37 ~~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlv 113 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIG 113 (418)
T ss_pred EEEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEE
Confidence 457899999999998864 55799997651 11 12334445566666553 357788887754 556889
Q ss_pred EEeCCC--CCHHHHh
Q 018712 140 YEHASK--GSLHDIL 152 (351)
Q Consensus 140 ~e~~~~--gsL~~~l 152 (351)
||++++ ..+.+-+
T Consensus 114 ME~L~~~~~ilr~~L 128 (418)
T PLN02756 114 MRYLEPPHIILRKGL 128 (418)
T ss_pred EeecCCcceehhhhh
Confidence 999977 3454444
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=97.49 E-value=0.0009 Score=59.72 Aligned_cols=73 Identities=14% Similarity=0.095 Sum_probs=47.9
Q ss_pred CceeccCCcEEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHHhc---cCCceeeeEEEEecCCceEEEEEeCCCC
Q 018712 71 NSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRL---KNENVVELVGYYVDGPLRVLAYEHASKG 146 (351)
Q Consensus 71 ~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l---~h~niv~~~~~~~~~~~~~lv~e~~~~g 146 (351)
.+.++.|..+.+|+.. .+++.+.+|.-. ......+..|.+-|+.| ..-.+++++.+....+..+|+|||++.+
T Consensus 22 ~~~v~GG~i~~a~~~~-~~~~~~FvK~~~--~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~~ 97 (288)
T PF03881_consen 22 IEPVSGGDINEAYRLD-TDGGSYFVKVNS--ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEMG 97 (288)
T ss_dssp EEEE--SSSSEEEEEE-TTS-EEEEEEEE--GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE-----
T ss_pred eEecCCCChhheEEEE-CCCccEEEEecC--hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecCC
Confidence 4568889999999877 567899999876 23345678888888877 3456788888887777789999999875
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.49 E-value=0.0017 Score=58.44 Aligned_cols=140 Identities=14% Similarity=0.158 Sum_probs=81.9
Q ss_pred CCCCceeccCCcEEEEEEEECCCCEEEEEEcCC---CCCchHHHHHHHHHHHhccC--CceeeeEEEEecCC--ceEEEE
Q 018712 68 FGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDS---SKQPDQEFLAQVSMVSRLKN--ENVVELVGYYVDGP--LRVLAY 140 (351)
Q Consensus 68 y~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~---~~~~~~~~~~e~~~l~~l~h--~niv~~~~~~~~~~--~~~lv~ 140 (351)
..+.+.+..|-...+|..... ++.+++. ... .........+|+.+++.+.. --+...++.+.++. ..+.||
T Consensus 27 ~~~v~~~~~G~sn~t~~~~~~-~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~ 104 (321)
T COG3173 27 LLIVEEISGGWSNDTFRLGDT-GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVM 104 (321)
T ss_pred CceeeeccCCcccceEEEecC-CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEE
Confidence 334444444444455555543 7788888 321 12224556788888888754 22344555555554 669999
Q ss_pred EeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHH-HHHHHHHHhhhh-------------------------------
Q 018712 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIA-VGAARGLEYLHE------------------------------- 188 (351)
Q Consensus 141 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~-~qi~~~l~~lH~------------------------------- 188 (351)
+|+.|..+.+.+.... .. ..++ ..+...|..||+
T Consensus 105 ~~veGe~~~~~~~~~~----------~~----~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~ 170 (321)
T COG3173 105 EWVEGEVVWSALPPES----------LG----RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAK 170 (321)
T ss_pred EEecceeccCcCCccc----------ch----HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHH
Confidence 9999853322221110 00 0111 133333333333
Q ss_pred -------------------C-----CCCCeeeccccCCcEEEccCCceEEecccccCCC
Q 018712 189 -------------------K-----AEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQA 223 (351)
Q Consensus 189 -------------------~-----~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~ 223 (351)
+ +...++|+|+++.|+++++++.+=+.||+++..-
T Consensus 171 ~~~~~~~p~~~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lG 229 (321)
T COG3173 171 KELGGRIPLADRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLG 229 (321)
T ss_pred HhccCCCchHHHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccC
Confidence 2 2234999999999999999988999999988654
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=97.36 E-value=0.00069 Score=57.74 Aligned_cols=29 Identities=24% Similarity=0.512 Sum_probs=20.6
Q ss_pred eeeccccCCcEEE-ccCCceEEecccccCC
Q 018712 194 IIHRNIKSSNVLL-FDDDIAKISDFDLSNQ 222 (351)
Q Consensus 194 ivH~Dlkp~Nill-~~~~~vkl~Dfg~a~~ 222 (351)
++|.||.+.|||+ +.++.++|+||..|..
T Consensus 145 ~cHnDl~~~Nil~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 145 FCHNDLNPGNILINNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred EeeccCccccEEeccCCCeEEEecHHHHhh
Confidence 7899999999999 8889999999998743
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.27 E-value=0.003 Score=58.49 Aligned_cols=81 Identities=16% Similarity=0.128 Sum_probs=54.5
Q ss_pred CceeccCCcEEEEEEEECC-CCEEEEEEcC----CC---CCchHHHHHHHHHHHhcc---CCceeeeEEEEecCCceEEE
Q 018712 71 NSLIGEGSYGRVYFGVLRS-GRAAAIKKLD----SS---KQPDQEFLAQVSMVSRLK---NENVVELVGYYVDGPLRVLA 139 (351)
Q Consensus 71 ~~~Lg~G~~g~Vy~~~~~~-~~~vavK~~~----~~---~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~lv 139 (351)
.+.||.|.-.-||++.+.+ ++.++||.-. .. +....+..-|.+.|+... ..++++++.+ +.+...+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence 4578999999999999753 5689998642 11 233456677777777663 2356667644 77778899
Q ss_pred EEeCCCC-CHHHHhc
Q 018712 140 YEHASKG-SLHDILH 153 (351)
Q Consensus 140 ~e~~~~g-sL~~~l~ 153 (351)
||+++.. .|.+.|-
T Consensus 112 MEdL~~~~ilR~~Li 126 (409)
T PRK12396 112 MEDLSDHTILRTALI 126 (409)
T ss_pred HHhCcccHHHHHHHH
Confidence 9999642 3444443
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.20 E-value=0.01 Score=54.04 Aligned_cols=147 Identities=20% Similarity=0.254 Sum_probs=85.1
Q ss_pred eeccCCcEEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHHhccCCc------eeeeEE----EEecCCceEEEEEe
Q 018712 73 LIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNEN------VVELVG----YYVDGPLRVLAYEH 142 (351)
Q Consensus 73 ~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~n------iv~~~~----~~~~~~~~~lv~e~ 142 (351)
.|.+ .-..+|+....+|+. ++|+.... ....++..|+..|..|.-.. +...-+ ......+.+-+++|
T Consensus 33 ~l~s-~eN~~f~~~~~~g~~-iLki~~~~-~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~ 109 (331)
T COG2334 33 GLNS-EENSNFRVQTEDGRY-ILKIYRPG-WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEY 109 (331)
T ss_pred cccc-ccCceEEEEecCCCe-EEEEecCC-CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEe
Confidence 3455 567799988876655 99998887 66677888888888773211 121111 12222377889999
Q ss_pred CCCCCHHH-H--------------hccCC-CCCCCCCC--CCCCHHH-------------HHHHHHHHHHHHHhhhhCC-
Q 018712 143 ASKGSLHD-I--------------LHGKK-GVKGAKPG--PVLSWAQ-------------RVKIAVGAARGLEYLHEKA- 190 (351)
Q Consensus 143 ~~~gsL~~-~--------------l~~~~-~~~~~~~~--~~l~~~~-------------~~~i~~qi~~~l~~lH~~~- 190 (351)
++|..+.. . |+... ......++ ....|.. -.....++...+..+.+.-
T Consensus 110 l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~ 189 (331)
T COG2334 110 LPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLP 189 (331)
T ss_pred cCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhch
Confidence 99977763 0 00000 00000111 0122220 0113334444444444431
Q ss_pred ---CCC---eeeccccCCcEEEccCCc-eEEecccccCC
Q 018712 191 ---EPR---IIHRNIKSSNVLLFDDDI-AKISDFDLSNQ 222 (351)
Q Consensus 191 ---~~~---ivH~Dlkp~Nill~~~~~-vkl~Dfg~a~~ 222 (351)
+.. +||+|+.|+||+++.+.. +.++||+-+..
T Consensus 190 ~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~~ 228 (331)
T COG2334 190 AHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAGY 228 (331)
T ss_pred hhCCcccceeeecCCCccceeEcCCCCeeeEEEcccccc
Confidence 222 899999999999998874 88999997654
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=97.16 E-value=0.0049 Score=56.41 Aligned_cols=73 Identities=10% Similarity=0.155 Sum_probs=45.3
Q ss_pred ceeccCCcEEEEEEEECC----CCEEEEEEcCCCCCchHHHHHHHHHHHhccCCce-eeeEEEEecCCceEEEEEeCCCC
Q 018712 72 SLIGEGSYGRVYFGVLRS----GRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENV-VELVGYYVDGPLRVLAYEHASKG 146 (351)
Q Consensus 72 ~~Lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~~~g 146 (351)
+.|..|=...+|+....+ +..|++|+........-...+|..+++.+..-++ .+++.++..+ +|.+|+++.
T Consensus 20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~~IdR~~E~~il~~l~~~gl~P~~l~~~~~G----~i~~fi~g~ 95 (330)
T PLN02421 20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDYVIDRERELQAIKYLSAAGFGAKLLGVFGNG----MIQSFINAR 95 (330)
T ss_pred EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCeEechHHHHHHHHHHHhcCCCCceeEEeCCc----EeehhhcCC
Confidence 345557778899887542 2478999876543322234578888888865444 3555555322 578888776
Q ss_pred CH
Q 018712 147 SL 148 (351)
Q Consensus 147 sL 148 (351)
+|
T Consensus 96 ~l 97 (330)
T PLN02421 96 TL 97 (330)
T ss_pred CC
Confidence 54
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=97.16 E-value=0.0042 Score=56.31 Aligned_cols=31 Identities=16% Similarity=0.223 Sum_probs=27.5
Q ss_pred CeeeccccCCcEEEccCCceEEecccccCCC
Q 018712 193 RIIHRNIKSSNVLLFDDDIAKISDFDLSNQA 223 (351)
Q Consensus 193 ~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~ 223 (351)
.++|+|+.++|+|++.++.+-++||..+...
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~d 227 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKASFA 227 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhcccC
Confidence 4999999999999999999999999977543
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.03 E-value=0.00012 Score=76.63 Aligned_cols=160 Identities=9% Similarity=-0.062 Sum_probs=111.5
Q ss_pred HHHHHHHhccCCceeeeEEEEe--cCCceEEEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhh
Q 018712 110 AQVSMVSRLKNENVVELVGYYV--DGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLH 187 (351)
Q Consensus 110 ~e~~~l~~l~h~niv~~~~~~~--~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH 187 (351)
.|...++...|+++.....-.. +....+.+++++.+|.+.+.+-+..... +.+...-+.....+.+....-+|
T Consensus 1278 ~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~-----~~ld~~~v~~~~kvsvl~~~~~l 1352 (2724)
T KOG1826|consen 1278 SERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEES-----PDLDRSPVHLRHKVSVLNRNVIL 1352 (2724)
T ss_pred hhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccC-----CcchhchHHHHHHHHHhccchhh
Confidence 3444555668888877665443 3345688999999999999987654322 22333333333333355555555
Q ss_pred hCC--CCCeeeccccCCcEEEccCCceEEecccccCCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHH
Q 018712 188 EKA--EPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVL 265 (351)
Q Consensus 188 ~~~--~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il 265 (351)
... ..-.+|++||+-|.+|..+-.+|++++|+.+...... .......+++.|++|++...-.++.++|+|..|+-+
T Consensus 1353 s~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~--sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~l 1430 (2724)
T KOG1826|consen 1353 SLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVL--SFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSL 1430 (2724)
T ss_pred hcccCCccchhhhhhhhccceecCCcccccccccccccCchH--hhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHH
Confidence 442 2236899999999999999999999999988322211 112445678899999998888999999999999999
Q ss_pred HHHHcCCCCCC
Q 018712 266 LELLTGRKPVD 276 (351)
Q Consensus 266 ~el~tg~~Pf~ 276 (351)
|+...|..+|.
T Consensus 1431 y~rs~~n~~fi 1441 (2724)
T KOG1826|consen 1431 YLRSDGNAYFI 1441 (2724)
T ss_pred HHHhcccHHHH
Confidence 99988887764
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.93 E-value=0.026 Score=51.07 Aligned_cols=64 Identities=16% Similarity=0.140 Sum_probs=39.2
Q ss_pred EEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHHhccCC--ceeeeEEE------EecCCceEEEEEeCCCCCH
Q 018712 81 RVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNE--NVVELVGY------YVDGPLRVLAYEHASKGSL 148 (351)
Q Consensus 81 ~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~--niv~~~~~------~~~~~~~~lv~e~~~~gsL 148 (351)
.||+....+| .+++|+.... ...+..++..+..|... .+++++.. ...++..+++++|++|.++
T Consensus 11 ~v~~v~t~~g-~~~LK~~~~~---~~~~~~~~~~~~~L~~~g~~vp~~i~t~~g~~~~~~~~~~~~l~~~i~G~~~ 82 (313)
T TIGR02906 11 NVYKVETDSG-NKCLKKINYP---PERLLFILGAQEHLRKNGFNIPKILKTKDGELYVKYNGDLYVLTEWIEGREC 82 (313)
T ss_pred cEEEEEeCCC-CeEEEEcCCC---HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEehhccCcCC
Confidence 4888876544 6899987532 23455667666666322 33444332 2235568899999998544
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.87 E-value=0.0051 Score=55.75 Aligned_cols=83 Identities=17% Similarity=0.199 Sum_probs=58.6
Q ss_pred CCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccccCCCccccccccccccccccCccCccc
Q 018712 167 LSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEY 246 (351)
Q Consensus 167 l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~ 246 (351)
..++++..++.+.+..+.-+..+- +.-|||+.-+||||+ .|+|.|+||-+++....... ......-.|-.
T Consensus 318 ~~~~e~lsff~s~~sil~~lekkf--~fehrnlt~~niLId-~GnvtLIDfklsRl~~~q~~-------isy~rldhp~l 387 (488)
T COG5072 318 DRSEEELSFFWSCISILDILEKKF--PFEHRNLTLDNILID-EGNVTLIDFKLSRLSYSQGI-------ISYNRLDHPDL 387 (488)
T ss_pred ccHHHHHHHHHHHHHHHhhhhhcC--Ccccccccccceeee-cCceEEEEeeeeecccCCce-------eeccccCchhh
Confidence 567888999999888888887765 488999999999999 99999999999984332211 11122334444
Q ss_pred ccCCCCCccchhHh
Q 018712 247 AMTGQMSSKSDVYS 260 (351)
Q Consensus 247 ~~~~~~~~~~Dvws 260 (351)
+.|.. +.+-|||-
T Consensus 388 F~G~d-d~QFeIYr 400 (488)
T COG5072 388 FNGVD-DYQFEIYR 400 (488)
T ss_pred hcCcc-ceeeeHHH
Confidence 55333 55566665
|
|
| >PF04655 APH_6_hur: Aminoglycoside/hydroxyurea antibiotic resistance kinase; InterPro: IPR006748 The aminoglycosides are a large group of biologically active bacterial secondary metabolites, best known for their antibiotic properties [] | Back alignment and domain information |
|---|
Probab=96.76 E-value=0.014 Score=50.99 Aligned_cols=79 Identities=18% Similarity=0.124 Sum_probs=56.5
Q ss_pred CceeccCCcEEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEEEeC-CCCCHH
Q 018712 71 NSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHA-SKGSLH 149 (351)
Q Consensus 71 ~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~-~~gsL~ 149 (351)
...+..|..+.|+.+...+|...++|+.........+... ...|+..+-...|++++. +.....+++|.+ ++.+|.
T Consensus 7 ~~~~~~g~~s~V~pv~~~dG~~avLKl~~p~~~~~~E~~g-~~~L~~w~G~GaVrll~~--d~~~~AlLLErl~~g~~L~ 83 (253)
T PF04655_consen 7 DGPPAHGSSSLVVPVRRADGTPAVLKLAPPHAEAEHEARG-EAALRWWNGRGAVRLLAA--DPERGALLLERLDPGRSLA 83 (253)
T ss_pred CCCCCCCcceEEEEEEcCCCCeEEEEecCCcccchhhhhH-HhHhheeCCCCceeeecc--ccccchhhhhhccCCCchh
Confidence 3456679999999999999999999987655432222211 245777777888899876 444567888999 555787
Q ss_pred HHh
Q 018712 150 DIL 152 (351)
Q Consensus 150 ~~l 152 (351)
++.
T Consensus 84 ~~~ 86 (253)
T PF04655_consen 84 SLP 86 (253)
T ss_pred hcc
Confidence 766
|
Aminoglycoside phosphotransferases achieve inactivation of these enzymes by phosphorylation, utilising ATP. Likewise, hydroxyurea is inactivated by phosphorylation of the hydroxy group in the hydroxylamine moiety.; GO: 0016773 phosphotransferase activity, alcohol group as acceptor, 0006468 protein phosphorylation, 0019748 secondary metabolic process |
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=96.71 E-value=0.013 Score=49.60 Aligned_cols=149 Identities=13% Similarity=0.157 Sum_probs=83.4
Q ss_pred CcEEEEEEEECCCCEEEEEEcCCCCC--chHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEEEeCCCCCHHHHhccC
Q 018712 78 SYGRVYFGVLRSGRAAAIKKLDSSKQ--PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGK 155 (351)
Q Consensus 78 ~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~ 155 (351)
+.++.-.+..+-| ...+|++...+- ...-+.++..++.++. .|+++..- +.-.+-+++|.|.....
T Consensus 74 gNsTl~~~kt~iG-~L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i------- 141 (308)
T PF07387_consen 74 GNSTLLIGKTKIG-PLFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKI------- 141 (308)
T ss_pred CceEEEEeccccc-hhhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCccc-------
Confidence 3344444433333 344555543332 3455678888887764 35665522 23345688898854111
Q ss_pred CCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccccCCCcccccccccccc
Q 018712 156 KGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRV 235 (351)
Q Consensus 156 ~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~ 235 (351)
... .++.-=+.+|.-.|+... +.+|||-.|+|||-|..|.+||.|-+.--..
T Consensus 142 --------------~~~-N~i~agi~~L~~fH~~~~-~~lHGD~np~NiM~D~~G~lKlVDP~~Ll~~------------ 193 (308)
T PF07387_consen 142 --------------NFS-NFITAGIKDLMDFHSENQ-HCLHGDCNPDNIMCDKFGYLKLVDPVCLLEN------------ 193 (308)
T ss_pred --------------chh-HHHHHhHHHHHHhhccCC-CeecCCCChhheeecCCCCEEecChhhhhhh------------
Confidence 111 111112466788895432 4999999999999999999999998743111
Q ss_pred ccccCccCcccccCCCCCccchhHhHHHHHHHHHcC
Q 018712 236 LGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTG 271 (351)
Q Consensus 236 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg 271 (351)
+..|.- ......|.++.+-+|=.-++++...
T Consensus 194 --~V~~vN---~~Y~~lT~~aE~~~fv~s~l~~v~~ 224 (308)
T PF07387_consen 194 --QVNMVN---IEYESLTQEAEVKVFVKSCLKLVEK 224 (308)
T ss_pred --eeeEEe---eeccccChHHHHHHHHHHHHHHHHH
Confidence 111111 0112345667776666666666653
|
The function of this family is unknown. |
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.41 E-value=0.048 Score=50.86 Aligned_cols=75 Identities=19% Similarity=0.222 Sum_probs=44.7
Q ss_pred CceeccCCcEEEEEEEECCC--CE-----EEEEEcCCCCCchHHHHHHHHHHHhccCCce-eeeEEEEecCCceEEEEEe
Q 018712 71 NSLIGEGSYGRVYFGVLRSG--RA-----AAIKKLDSSKQPDQEFLAQVSMVSRLKNENV-VELVGYYVDGPLRVLAYEH 142 (351)
Q Consensus 71 ~~~Lg~G~~g~Vy~~~~~~~--~~-----vavK~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~ 142 (351)
.+.|..|-.+.+|++...++ .. |.++........--.-.+|+++++.+...++ .++++.+.. +++.||
T Consensus 55 i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~----g~l~ef 130 (383)
T PTZ00384 55 IKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTYNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFGD----FTIQEW 130 (383)
T ss_pred EEEeCCcccceEEEEEecCCCCCccccceEEEEeccCCCceEeccHHHHHHHHHHHhCCCCCeEEEecCC----EEEEEE
Confidence 34566688899999875432 22 4444332221111223578889999865444 455655532 588999
Q ss_pred CCCCCHH
Q 018712 143 ASKGSLH 149 (351)
Q Consensus 143 ~~~gsL~ 149 (351)
++|.+|.
T Consensus 131 IeGr~l~ 137 (383)
T PTZ00384 131 VEGNTMG 137 (383)
T ss_pred eccccCC
Confidence 9987653
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=96.27 E-value=0.069 Score=56.28 Aligned_cols=94 Identities=13% Similarity=0.138 Sum_probs=53.4
Q ss_pred ccCHHHHHH-HhcCCCCC---ceeccCCcEEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHHhcc-------CCce
Q 018712 55 VISVDELKE-KTDNFGTN---SLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLK-------NENV 123 (351)
Q Consensus 55 ~~~~~~~~~-~~~~y~~~---~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~-------h~ni 123 (351)
.++..++.. ..+.|.+. +.|+ |..-.+|+....++..+++|+..... .......|.+.|..|. -|.+
T Consensus 10 ~~s~~~~~~~~~~~ygl~~~~~~L~-s~~d~nf~v~~~~g~~yVLKi~~~~~-~~~~~~~q~~~L~hL~~~~~glpvP~~ 87 (1013)
T PRK06148 10 EFTTKDAEALLAQHFGISATATPLD-GERDLNFRLTTDDGADYILKIVNPSE-PRVESDFQTAALDHLAAVAPDLPVPRL 87 (1013)
T ss_pred CCCHHHHHHHHHHHcCCceEEeecC-CcCCceEEEEeCCCCeEEEEEcCCcc-chhHHHHHHHHHHHHHhhCCCCCcCee
Confidence 344444432 23445443 4564 45688899888788899999987643 3334455566665552 1233
Q ss_pred eeeE-----EEEec-CC--ceEEEEEeCCCCCHHH
Q 018712 124 VELV-----GYYVD-GP--LRVLAYEHASKGSLHD 150 (351)
Q Consensus 124 v~~~-----~~~~~-~~--~~~lv~e~~~~gsL~~ 150 (351)
++-. ..... .+ +.+.+++|++|..|.+
T Consensus 88 i~t~~G~~~~~v~~~~G~~~~vrLl~~l~G~~l~~ 122 (1013)
T PRK06148 88 IPSLSGASLASAQDPDGEPRLLRLLSWLPGTPLAE 122 (1013)
T ss_pred eecCCCCeEEEeecCCCceEEEEEEeccCCCcHHh
Confidence 3221 11111 22 4577899999977765
|
|
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.24 E-value=0.021 Score=52.65 Aligned_cols=61 Identities=20% Similarity=0.093 Sum_probs=42.2
Q ss_pred eEEEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhh-CCCCCeeeccccCCcEEEccC
Q 018712 136 RVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHE-KAEPRIIHRNIKSSNVLLFDD 209 (351)
Q Consensus 136 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~-~~~~~ivH~Dlkp~Nill~~~ 209 (351)
..++=+|..|-++..+++... .++....+++.-.+.|+..+-- .+ ++|.|++|+||++..+
T Consensus 320 ~vl~E~~~~Gl~v~~~v~~~~----------~pe~l~kkva~lg~~AllkMl~vDN---FvHaDlHPGNVlirf~ 381 (565)
T KOG1236|consen 320 LVLVETYERGLSVLRFVKWKS----------QPEALVKKVAKLGVNALLKMLIVDN---FVHADLHPGNVLIRFN 381 (565)
T ss_pred ceeeeeccccccHHhhhhccc----------ChHHHHHHHHHHHHHHHHHHHHhhc---ceecccCCCcEEEEec
Confidence 356667888889999987654 4445555666655666543322 33 9999999999999544
|
|
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.12 E-value=0.076 Score=50.52 Aligned_cols=74 Identities=9% Similarity=0.072 Sum_probs=45.5
Q ss_pred CceeccCCcEEEEEEEECC---------CCEEEEEEcCCCCCchHHHHHHHHHHHhccCCcee-eeEEEEecCCceEEEE
Q 018712 71 NSLIGEGSYGRVYFGVLRS---------GRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVV-ELVGYYVDGPLRVLAY 140 (351)
Q Consensus 71 ~~~Lg~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv-~~~~~~~~~~~~~lv~ 140 (351)
++.|..|=...+|++...+ ++.|.+++.-.....--...+|..+++.+...+|- ++++.+. -..+.
T Consensus 110 i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~te~lIdR~~E~~v~~~ls~~gi~P~l~~~f~----gg~I~ 185 (442)
T PTZ00296 110 VNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDVDELYNPISEFEVYKTMSKYRIAPQLLNTFS----GGRIE 185 (442)
T ss_pred EEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCccceeCHHHHHHHHHHHHHCCCCCceEEEeC----CCEEE
Confidence 4566778788899887542 45788888755433222345677777777543333 4455442 24578
Q ss_pred EeCCCCCH
Q 018712 141 EHASKGSL 148 (351)
Q Consensus 141 e~~~~gsL 148 (351)
+|++|.+|
T Consensus 186 efi~g~~l 193 (442)
T PTZ00296 186 EWLYGDPL 193 (442)
T ss_pred EeeCCccC
Confidence 99987644
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 351 | ||||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 6e-41 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 1e-40 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 4e-38 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 2e-37 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 9e-35 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-34 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 5e-34 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 1e-33 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 8e-23 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 4e-22 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 1e-20 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 1e-20 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 2e-20 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 5e-20 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 1e-19 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 1e-19 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 1e-19 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 1e-19 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 1e-19 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-19 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 2e-19 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-19 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-19 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 2e-19 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 2e-19 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 2e-19 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 3e-19 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 3e-19 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-19 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 3e-19 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-19 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 4e-19 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 4e-19 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 4e-19 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 5e-19 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 5e-19 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 7e-19 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 8e-19 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 8e-19 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 1e-18 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 1e-18 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 2e-18 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 4e-18 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 5e-18 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 8e-18 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 8e-18 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 8e-18 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 1e-17 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 1e-17 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 2e-17 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 2e-17 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 3e-17 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 3e-17 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 3e-17 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 3e-17 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 4e-17 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 5e-17 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 5e-17 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 5e-17 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 5e-17 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 5e-17 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 6e-17 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 6e-17 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 6e-17 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 6e-17 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 7e-17 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 2e-16 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 2e-16 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 2e-16 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 2e-16 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 2e-16 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 3e-16 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 4e-16 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 4e-16 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 4e-16 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 4e-16 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 4e-16 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 4e-16 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 4e-16 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 4e-16 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 4e-16 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-15 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-15 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-15 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 4e-15 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 4e-15 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-15 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 4e-15 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 4e-15 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-15 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 5e-15 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 5e-15 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 5e-15 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 5e-15 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 5e-15 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 6e-15 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 6e-15 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 6e-15 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 6e-15 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 7e-15 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 7e-15 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 7e-15 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 7e-15 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 7e-15 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 7e-15 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 7e-15 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 7e-15 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 7e-15 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 7e-15 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 8e-15 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 8e-15 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 8e-15 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 8e-15 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 8e-15 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 9e-15 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 9e-15 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 1e-14 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 1e-14 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 1e-14 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 1e-14 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 1e-14 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 1e-14 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 1e-14 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 1e-14 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-14 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 1e-14 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-14 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 1e-14 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-14 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 1e-14 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-14 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-14 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 1e-14 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 2e-14 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-14 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-14 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-14 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-14 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-14 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-14 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-14 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-14 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-14 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 2e-14 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-14 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-14 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-14 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 2e-14 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 2e-14 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 2e-14 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-14 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-14 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-14 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-14 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-14 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-14 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-14 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 2e-14 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 2e-14 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-14 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-14 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 3e-14 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 3e-14 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 3e-14 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 3e-14 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 4e-14 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-14 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 4e-14 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 4e-14 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 4e-14 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-14 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 4e-14 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 4e-14 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 4e-14 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 4e-14 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 4e-14 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 5e-14 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 5e-14 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 5e-14 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 5e-14 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 5e-14 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 5e-14 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 5e-14 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 5e-14 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 5e-14 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 5e-14 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 6e-14 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 6e-14 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 6e-14 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 6e-14 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 6e-14 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 6e-14 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 6e-14 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 6e-14 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 6e-14 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 6e-14 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 6e-14 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 7e-14 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 7e-14 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 7e-14 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 7e-14 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 7e-14 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 7e-14 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 7e-14 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-14 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 8e-14 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 8e-14 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 8e-14 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 8e-14 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 8e-14 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 8e-14 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 9e-14 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 9e-14 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 9e-14 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 9e-14 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 9e-14 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 1e-13 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 1e-13 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 1e-13 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 1e-13 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 1e-13 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 1e-13 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-13 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-13 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 1e-13 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 1e-13 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 1e-13 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 1e-13 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 1e-13 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-13 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 1e-13 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 1e-13 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-13 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 1e-13 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 1e-13 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 1e-13 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-13 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-13 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 1e-13 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-13 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 1e-13 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 1e-13 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 1e-13 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 1e-13 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 2e-13 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 2e-13 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-13 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 2e-13 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-13 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-13 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 2e-13 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 2e-13 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 2e-13 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 2e-13 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 2e-13 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 2e-13 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-13 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 2e-13 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 2e-13 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 2e-13 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 2e-13 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 2e-13 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 2e-13 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-13 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-13 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 3e-13 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 3e-13 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 3e-13 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 3e-13 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 3e-13 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 3e-13 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-13 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 3e-13 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 3e-13 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 3e-13 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 3e-13 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 3e-13 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-13 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 3e-13 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 3e-13 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 4e-13 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 4e-13 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 4e-13 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 5e-13 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 5e-13 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 5e-13 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 5e-13 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 5e-13 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 6e-13 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 6e-13 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-13 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 7e-13 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 8e-13 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 1e-12 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 1e-12 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 1e-12 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 1e-12 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 1e-12 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-12 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 1e-12 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 1e-12 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 2e-12 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 2e-12 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 2e-12 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 3e-12 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 3e-12 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 3e-12 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 3e-12 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 3e-12 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 3e-12 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 4e-12 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 4e-12 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 4e-12 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 4e-12 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 6e-12 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 6e-12 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 7e-12 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 8e-12 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 1e-11 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 1e-11 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 1e-11 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-11 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 1e-11 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 1e-11 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 1e-11 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 1e-11 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 1e-11 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 1e-11 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 1e-11 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 1e-11 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 1e-11 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 1e-11 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 1e-11 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 1e-11 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 1e-11 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 1e-11 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 1e-11 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 1e-11 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-11 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 2e-11 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-11 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-11 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-11 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 4e-11 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 4e-11 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 5e-11 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 5e-11 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 5e-11 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-11 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 5e-11 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 5e-11 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 5e-11 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 6e-11 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 6e-11 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 6e-11 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 6e-11 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 6e-11 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 6e-11 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 6e-11 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 6e-11 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 7e-11 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 8e-11 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 8e-11 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 8e-11 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 8e-11 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 8e-11 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 9e-11 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 9e-11 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 1e-10 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-10 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 1e-10 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 1e-10 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 1e-10 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 1e-10 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 1e-10 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 1e-10 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 1e-10 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 1e-10 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 1e-10 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 2e-10 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 2e-10 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 2e-10 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-10 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 2e-10 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-10 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-10 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 2e-10 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 2e-10 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-10 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-10 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-10 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 2e-10 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 2e-10 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 2e-10 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 2e-10 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 2e-10 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 2e-10 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 2e-10 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-10 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 2e-10 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 2e-10 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-10 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 2e-10 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 2e-10 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-10 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 3e-10 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 3e-10 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 3e-10 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 4e-10 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 4e-10 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 4e-10 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 4e-10 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 4e-10 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 4e-10 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 4e-10 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 5e-10 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 5e-10 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 6e-10 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 6e-10 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 6e-10 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 6e-10 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 6e-10 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 6e-10 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 6e-10 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 6e-10 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 6e-10 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 6e-10 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 7e-10 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 7e-10 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 7e-10 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 7e-10 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 7e-10 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 7e-10 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 7e-10 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 7e-10 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 7e-10 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 7e-10 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 8e-10 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 8e-10 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 8e-10 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 8e-10 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 8e-10 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 8e-10 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 8e-10 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 9e-10 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 9e-10 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 9e-10 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 9e-10 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 9e-10 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 1e-09 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-09 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 1e-09 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 1e-09 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 1e-09 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 1e-09 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 1e-09 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 1e-09 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 1e-09 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-09 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 1e-09 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 1e-09 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 1e-09 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 1e-09 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 1e-09 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 1e-09 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 2e-09 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 2e-09 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-09 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 2e-09 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 2e-09 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-09 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 2e-09 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 2e-09 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 2e-09 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-09 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 2e-09 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-09 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 2e-09 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 2e-09 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-09 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 2e-09 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 2e-09 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 2e-09 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 2e-09 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-09 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 2e-09 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 2e-09 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-09 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 2e-09 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 2e-09 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 2e-09 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 2e-09 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 2e-09 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 2e-09 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 2e-09 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-09 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-09 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-09 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-09 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 2e-09 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 3e-09 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 3e-09 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 3e-09 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 3e-09 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-09 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 3e-09 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 3e-09 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 3e-09 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-09 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 3e-09 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 3e-09 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 3e-09 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 3e-09 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-09 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 3e-09 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 3e-09 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 3e-09 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 4e-09 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 4e-09 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 4e-09 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 4e-09 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 4e-09 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 4e-09 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 4e-09 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 4e-09 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 4e-09 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 4e-09 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 4e-09 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 4e-09 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 4e-09 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 4e-09 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 4e-09 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 4e-09 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 4e-09 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 4e-09 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 4e-09 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 4e-09 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 4e-09 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 4e-09 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 4e-09 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 4e-09 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 4e-09 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 4e-09 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 4e-09 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 4e-09 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-09 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 4e-09 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 4e-09 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 5e-09 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 5e-09 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 5e-09 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 5e-09 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 5e-09 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 5e-09 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 6e-09 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 6e-09 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 6e-09 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 6e-09 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 6e-09 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 6e-09 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 7e-09 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 7e-09 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 7e-09 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 7e-09 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 7e-09 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 7e-09 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 7e-09 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 7e-09 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 7e-09 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 7e-09 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 7e-09 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 8e-09 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 8e-09 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 8e-09 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 8e-09 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 8e-09 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 8e-09 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 9e-09 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 9e-09 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 9e-09 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 9e-09 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 9e-09 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 9e-09 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 9e-09 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 1e-08 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 1e-08 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 1e-08 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 1e-08 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-08 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 1e-08 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 1e-08 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 1e-08 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 1e-08 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-08 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 1e-08 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 1e-08 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 1e-08 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 1e-08 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 1e-08 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 1e-08 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-08 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-08 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 1e-08 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-08 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 1e-08 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-08 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 1e-08 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 1e-08 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-08 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-08 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 1e-08 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-08 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 2e-08 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 2e-08 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-08 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 2e-08 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 2e-08 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 2e-08 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 2e-08 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 2e-08 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-08 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-08 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 2e-08 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-08 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-08 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 2e-08 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 2e-08 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-08 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 2e-08 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 2e-08 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-08 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-08 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 2e-08 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 2e-08 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-08 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 2e-08 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-08 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-08 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-08 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 2e-08 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 2e-08 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-08 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-08 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 2e-08 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-08 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-08 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 2e-08 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-08 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 3e-08 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-08 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 3e-08 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 3e-08 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-08 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-08 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 3e-08 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 3e-08 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 4e-08 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 4e-08 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 4e-08 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 4e-08 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 4e-08 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 4e-08 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 4e-08 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 5e-08 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 5e-08 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 5e-08 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 5e-08 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 5e-08 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 5e-08 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-08 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 6e-08 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 6e-08 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 6e-08 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 6e-08 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 6e-08 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 7e-08 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 7e-08 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 7e-08 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 8e-08 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 8e-08 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 8e-08 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 9e-08 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 9e-08 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 9e-08 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 9e-08 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 1e-07 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 1e-07 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 1e-07 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 1e-07 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 1e-07 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 1e-07 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 1e-07 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 1e-07 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 1e-07 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 2e-07 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-07 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-07 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-07 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 2e-07 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 2e-07 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 2e-07 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 2e-07 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 2e-07 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 2e-07 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 2e-07 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-07 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-07 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 2e-07 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-07 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-07 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 3e-07 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 3e-07 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 3e-07 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 3e-07 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 3e-07 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 3e-07 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 4e-07 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 4e-07 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 4e-07 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 4e-07 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 4e-07 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 4e-07 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 4e-07 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 4e-07 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 4e-07 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 4e-07 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 4e-07 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 4e-07 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 4e-07 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 4e-07 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 4e-07 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 4e-07 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 5e-07 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 5e-07 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 5e-07 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 6e-07 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 6e-07 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 7e-07 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 8e-07 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 9e-07 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 9e-07 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 9e-07 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 9e-07 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 9e-07 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 9e-07 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 1e-06 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 1e-06 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 1e-06 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 1e-06 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-06 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-06 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 1e-06 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 1e-06 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 1e-06 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 1e-06 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-06 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-06 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-06 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 1e-06 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 1e-06 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 2e-06 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 2e-06 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 2e-06 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-06 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-06 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-06 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 2e-06 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-06 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 2e-06 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 2e-06 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 2e-06 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 3e-06 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 3e-06 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 3e-06 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 3e-06 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 3e-06 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 3e-06 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 3e-06 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 4e-06 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 4e-06 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 4e-06 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 4e-06 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 4e-06 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 6e-06 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 6e-06 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 6e-06 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 6e-06 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 7e-06 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 1e-05 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 1e-05 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 1e-05 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 1e-05 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 1e-05 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-05 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 1e-05 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 1e-05 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 1e-05 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 1e-05 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-05 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 1e-05 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 2e-05 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 2e-05 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 2e-05 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 2e-05 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 2e-05 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 2e-05 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 2e-05 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 2e-05 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 2e-05 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 2e-05 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 2e-05 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 2e-05 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 2e-05 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 2e-05 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 3e-05 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 3e-05 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 3e-05 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 3e-05 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 3e-05 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 4e-05 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 4e-05 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 4e-05 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 5e-05 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 5e-05 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 5e-05 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 5e-05 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 5e-05 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 5e-05 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 6e-05 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 6e-05 | ||
| 3sv0_A | 483 | Crystal Structure Of Casein Kinase-1 Like Protein I | 6e-05 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 6e-05 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 6e-05 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 6e-05 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 6e-05 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 7e-05 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 7e-05 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 7e-05 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 7e-05 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 7e-05 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 8e-05 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 8e-05 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 8e-05 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 9e-05 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 9e-05 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 9e-05 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 9e-05 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 1e-04 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 1e-04 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 1e-04 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 1e-04 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 1e-04 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 1e-04 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 1e-04 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-04 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 1e-04 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 1e-04 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 1e-04 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-04 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 1e-04 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 1e-04 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 1e-04 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 1e-04 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 1e-04 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 2e-04 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 2e-04 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 2e-04 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 2e-04 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 2e-04 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 2e-04 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-04 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 2e-04 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 2e-04 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 2e-04 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 2e-04 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 2e-04 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 2e-04 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 2e-04 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 2e-04 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 2e-04 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 2e-04 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 2e-04 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 2e-04 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 2e-04 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 2e-04 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 2e-04 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 2e-04 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 2e-04 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 2e-04 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 3e-04 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 3e-04 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 3e-04 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-04 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 3e-04 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 3e-04 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 3e-04 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 3e-04 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 4e-04 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 4e-04 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 4e-04 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 4e-04 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 4e-04 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 5e-04 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 5e-04 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 7e-04 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 7e-04 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 8e-04 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 8e-04 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 8e-04 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 9e-04 |
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 341 bits (878), Expect = e-117
Identities = 101/266 (37%), Positives = 158/266 (59%), Gaps = 11/266 (4%)
Query: 56 ISVDELKEKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLD-SSKQPDQEFLAQVSM 114
+ + +L+E T+NF LIG G +G+VY GVLR G A+K+ S Q +EF ++
Sbjct: 29 VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIET 88
Query: 115 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVK 174
+S ++ ++V L+G+ + +L Y++ G+L L+G P +SW QR++
Sbjct: 89 LSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSD-----LPTMSMSWEQRLE 143
Query: 175 IAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLH-ST 233
I +GAARGL YLH +A IIHR++KS N+LL ++ + KI+DF +S + + + H ST
Sbjct: 144 ICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELD-QTHLST 199
Query: 234 RVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPK 293
V GT GY PEY + G+++ KSDVYSFGVVL E+L R + +LPR +L WA
Sbjct: 200 VVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVES 259
Query: 294 LSEDKVKQCVDTKLGGEYPPKAIAKV 319
+ +++Q VD L + P+++ K
Sbjct: 260 HNNGQLEQIVDPNLADKIRPESLRKF 285
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 334 bits (860), Expect = e-114
Identities = 92/268 (34%), Positives = 153/268 (57%), Gaps = 12/268 (4%)
Query: 57 SVDELKEKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKL--DSSKQPDQEFLAQVSM 114
S+ EL+ +DNF +++G G +G+VY G L G A+K+L + ++ + +F +V M
Sbjct: 21 SLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEM 80
Query: 115 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVK 174
+S + N++ L G+ + R+L Y + + GS+ L + + P L W +R +
Sbjct: 81 ISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQ-----PPLDWPKRQR 135
Query: 175 IAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLH-ST 233
IA+G+ARGL YLH+ +P+IIHR++K++N+LL ++ A + DF L+ H +T
Sbjct: 136 IALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT--HVTT 193
Query: 234 RVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQS--LVTWAT 291
V GT G+ APEY TG+ S K+DV+ +GV+LLEL+TG++ D L+ W
Sbjct: 194 AVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK 253
Query: 292 PKLSEDKVKQCVDTKLGGEYPPKAIAKV 319
L E K++ VD L G Y + + ++
Sbjct: 254 GLLKEKKLEALVDVDLQGNYKDEEVEQL 281
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 316 bits (812), Expect = e-107
Identities = 102/290 (35%), Positives = 157/290 (54%), Gaps = 26/290 (8%)
Query: 42 EMKTVTVQPIAVPVISVDELKEKTDNF------GTNSLIGEGSYGRVYFGVLRSGRAAAI 95
E K++ V S ELK T+NF + +GEG +G VY G + + A+
Sbjct: 1 ENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAV 59
Query: 96 KKLDS-----SKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHD 150
KKL + +++ Q+F ++ ++++ ++EN+VEL+G+ DG L Y + GSL D
Sbjct: 60 KKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLD 119
Query: 151 ILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD 210
L G P LSW R KIA GAA G+ +LHE IHR+IKS+N+LL +
Sbjct: 120 RLSCLDG------TPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAF 170
Query: 211 IAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT 270
AKISDF L+ + A + ++R++GT Y APE + G+++ KSD+YSFGVVLLE++T
Sbjct: 171 TAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIIT 229
Query: 271 GRKPVDHTLPRGQQSLVTWATPKLSEDK-VKQCVDTKLGGEYPPKAIAKV 319
G VD R Q L+ E+K ++ +D K+ ++ +
Sbjct: 230 GLPAVDEH--REPQLLLDIKEEIEDEEKTIEDYIDKKMND-ADSTSVEAM 276
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 217 bits (554), Expect = 1e-68
Identities = 67/279 (24%), Positives = 107/279 (38%), Gaps = 27/279 (9%)
Query: 56 ISVDELKEKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMV 115
+ + L ++ + G +G V+ L A+K + + +V +
Sbjct: 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDKQSWQNEYEVYSL 72
Query: 116 SRLKNENVVELVGYYVDGPLRV----LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQ 171
+K+EN+++ +G G L KGSL D L V+SW +
Sbjct: 73 PGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN----------VVSWNE 122
Query: 172 RVKIAVGAARGLEYLHE-------KAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAP 224
IA ARGL YLHE +P I HR+IKS NVLL ++ A I+DF L+ +
Sbjct: 123 LCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFE 182
Query: 225 DAAARLHSTRVLGTFGYHAPEYAMTG-----QMSSKSDVYSFGVVLLELLTGRKPVDHTL 279
+ + +GT Y APE + D+Y+ G+VL EL + D +
Sbjct: 183 AGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPV 242
Query: 280 PRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAK 318
S + +++ V K K
Sbjct: 243 DEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQK 281
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 186 bits (475), Expect = 5e-57
Identities = 62/202 (30%), Positives = 107/202 (52%), Gaps = 16/202 (7%)
Query: 74 IGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDG 133
+G G++G V R + AIK+++S + + F+ ++ +SR+ + N+V+L G ++
Sbjct: 16 VGRGAFGVVCKAKWR-AKDVAIKQIESESE-RKAFIVELRQLSRVNHPNIVKLYGACLN- 72
Query: 134 PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPR 193
P+ L E+A GSL+++LHG + P P + A + + ++G+ YLH
Sbjct: 73 PVC-LVMEYAEGGSLYNVLHGAE------PLPYYTAAHAMSWCLQCSQGVAYLHSMQPKA 125
Query: 194 IIHRNIKSSNVLLFDDD-IAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQM 252
+IHR++K N+LL + KI DF + H T G+ + APE
Sbjct: 126 LIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT-----HMTNNKGSAAWMAPEVFEGSNY 180
Query: 253 SSKSDVYSFGVVLLELLTGRKP 274
S K DV+S+G++L E++T RKP
Sbjct: 181 SEKCDVFSWGIILWEVITRRKP 202
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 182 bits (465), Expect = 7e-56
Identities = 55/228 (24%), Positives = 94/228 (41%), Gaps = 33/228 (14%)
Query: 56 ISVDELKEKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKL---DSSKQPDQEFLAQV 112
I +L T + E G ++ G + G +K L D S + ++F +
Sbjct: 7 IDFKQLNFLT-------KLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEEC 58
Query: 113 SMVSRLKNENVVELVGYYVDGPLRVLAY--EHASKGSLHDILHGKKGVKGAKPGPVLSWA 170
+ + NV+ ++G P GSL+++LH V+ +
Sbjct: 59 PRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTN-------FVVDQS 111
Query: 171 QRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARL 230
Q VK A+ ARG+ +LH EP I + S +V++ +D A+IS D+
Sbjct: 112 QAVKFALDMARGMAFLHTL-EPLIPRHALNSRSVMIDEDMTARISMADVKFS-------F 163
Query: 231 HSTRVLGTFGYHAPEYAMTGQMSS----KSDVYSFGVVLLELLTGRKP 274
S + + APE A+ + +D++SF V+L EL+T P
Sbjct: 164 QSPGRMYAPAWVAPE-ALQKKPEDTNRRSADMWSFAVLLWELVTREVP 210
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 181 bits (462), Expect = 4e-55
Identities = 70/204 (34%), Positives = 103/204 (50%), Gaps = 13/204 (6%)
Query: 74 IGEGSYGRVYFGVLRSGRAAAIKKL---DSSKQPDQEFLAQVSMVSRLKNENVVELVGYY 130
IG GS+G V+ G A+K L D + EFL +V+++ RL++ N+V +G
Sbjct: 45 IGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV 103
Query: 131 VDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKA 190
P + E+ S+GSL+ +LH L +R+ +A A+G+ YLH +
Sbjct: 104 TQPPNLSIVTEYLSRGSLYRLLHKS------GAREQLDERRRLSMAYDVAKGMNYLHNRN 157
Query: 191 EPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTG 250
P I+HRN+KS N+L+ K+ DF LS S GT + APE
Sbjct: 158 -PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAA--GTPEWMAPEVLRDE 214
Query: 251 QMSSKSDVYSFGVVLLELLTGRKP 274
+ KSDVYSFGV+L EL T ++P
Sbjct: 215 PSNEKSDVYSFGVILWELATLQQP 238
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 179 bits (455), Expect = 2e-54
Identities = 67/214 (31%), Positives = 98/214 (45%), Gaps = 28/214 (13%)
Query: 74 IGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPD-----QEFLAQVSMVSRLKNENVVELVG 128
IG G +G+VY G A+K D + + + + LK+ N++ L G
Sbjct: 15 IGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRG 73
Query: 129 YYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHE 188
+ P L E A G L+ +L GK+ + V AV ARG+ YLH+
Sbjct: 74 VCLKEPNLCLVMEFARGGPLNRVLSGKR----------IPPDILVNWAVQIARGMNYLHD 123
Query: 189 KAEPRIIHRNIKSSNVLL--------FDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFG 240
+A IIHR++KSSN+L+ + I KI+DF L+ + G +
Sbjct: 124 EAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTT----KMSAAGAYA 179
Query: 241 YHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
+ APE S SDV+S+GV+L ELLTG P
Sbjct: 180 WMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVP 213
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 179 bits (456), Expect = 2e-54
Identities = 66/239 (27%), Positives = 114/239 (47%), Gaps = 41/239 (17%)
Query: 53 VPVISVDELKEKTDNFGTNSLIGEGSYGRVYFGVLRS-GRAAAIKKLDSSKQPD------ 105
+P ++ +E++ + IG+G +G V+ G L AIK L
Sbjct: 13 LPTLADNEIEYE-------KQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIE 65
Query: 106 --QEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKP 163
QEF +V ++S L + N+V+L G + P V+ E G L+ L K
Sbjct: 66 KFQEFQREVFIMSNLNHPNIVKLYGLMHNPPRMVM--EFVPCGDLYHRLLDKAHP----- 118
Query: 164 GPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD-----IAKISDFD 218
+ W+ ++++ + A G+EY+ + P I+HR+++S N+ L D AK++DF
Sbjct: 119 ---IKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVADFG 174
Query: 219 LSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQM---SSKSDVYSFGVVLLELLTGRKP 274
LS Q+ + + +LG F + APE + + + K+D YSF ++L +LTG P
Sbjct: 175 LSQQSVHS-----VSGLLGNFQWMAPE-TIGAEEESYTEKADTYSFAMILYTILTGEGP 227
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 169 bits (431), Expect = 2e-50
Identities = 57/228 (25%), Positives = 95/228 (41%), Gaps = 25/228 (10%)
Query: 74 IGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQ-EFLAQVSMVSRLKNENVVELVGYYV 131
+G+G +G+ R +G +K+L + Q FL +V ++ L++ NV++ +G
Sbjct: 18 LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLY 77
Query: 132 DGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAE 191
E+ G+L I+ W+QRV A A G+ YLH
Sbjct: 78 KDKRLNFITEYIKGGTLRGIIK--------SMDSQYPWSQRVSFAKDIASGMAYLHSM-- 127
Query: 192 PRIIHRNIKSSNVLLFDDDIAKISDFDLS------------NQAPDAAARLHSTRVLGTF 239
IIHR++ S N L+ ++ ++DF L+ ++ R V+G
Sbjct: 128 -NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNP 186
Query: 240 GYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLV 287
+ APE K DV+SFG+VL E++ LPR +
Sbjct: 187 YWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGL 234
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 166 bits (423), Expect = 1e-49
Identities = 66/216 (30%), Positives = 106/216 (49%), Gaps = 20/216 (9%)
Query: 74 IGEGSYGRVYFGVLRSGRAAAIKKL---DSSKQPDQEFLAQVSMVSRLKNENVVELVGYY 130
IG GS+G VY G A+K L + Q Q F +V ++ + ++ N++ +GY
Sbjct: 32 IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89
Query: 131 VDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKA 190
L ++ + SL+ LH + + IA ARG++YLH K
Sbjct: 90 TAPQLAIVT-QWCEGSSLYHHLH--------ASETKFEMKKLIDIARQTARGMDYLHAK- 139
Query: 191 EPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE---YA 247
IIHR++KS+N+ L +D+ KI DF L+ + + ++ G+ + APE
Sbjct: 140 --SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQ 197
Query: 248 MTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQ 283
+ S +SDVY+FG+VL EL+TG+ P + R Q
Sbjct: 198 DSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ 233
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 7e-48
Identities = 52/216 (24%), Positives = 85/216 (39%), Gaps = 29/216 (13%)
Query: 74 IGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPD---QEFLAQVSMVSRLKNENVVELVGYY 130
IG+G +G+VY G AI+ +D + + + F +V + ++ENVV +G
Sbjct: 41 IGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGAC 98
Query: 131 VDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKA 190
+ P + +L+ ++ K VL + +IA +G+ YLH K
Sbjct: 99 MSPPHLAIITSLCKGRTLYSVVRDAK--------IVLDVNKTRQIAQEIVKGMGYLHAKG 150
Query: 191 EPRIIHRNIKSSNVLLFDDDIAKISDFDLS---NQAPDAAARLHSTRVLGTFGYHAPE-- 245
I+H+++KS NV D+ I+DF L G + APE
Sbjct: 151 ---ILHKDLKSKNVFY-DNGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEII 206
Query: 246 -------YAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
S SDV++ G + EL P
Sbjct: 207 RQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWP 242
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 2e-47
Identities = 60/248 (24%), Positives = 87/248 (35%), Gaps = 39/248 (15%)
Query: 56 ISVDELKEKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLA--QVS 113
+ E DN LIG G YG VY G L R A+K S Q F+ +
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSLD-ERPVAVKVF--SFANRQNFINEKNIY 59
Query: 114 MVSRLKNENVVELVGYYVDGPLRV-----LAYEHASKGSLHDILHGKKGVKGAKPGPVLS 168
V ++++N+ + L E+ GSL L
Sbjct: 60 RVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT----------SD 109
Query: 169 WAQRVKIAVGAARGLEYLHE------KAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS-- 220
W ++A RGL YLH +P I HR++ S NVL+ +D ISDF LS
Sbjct: 110 WVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMR 169
Query: 221 ----NQAPDAAARLHSTRVLGTFGYHAPEYAM-------TGQMSSKSDVYSFGVVLLELL 269
+ +GT Y APE + D+Y+ G++ E+
Sbjct: 170 LTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIF 229
Query: 270 TGRKPVDH 277
+
Sbjct: 230 MRCTDLFP 237
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 2e-47
Identities = 51/226 (22%), Positives = 91/226 (40%), Gaps = 30/226 (13%)
Query: 73 LIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVD 132
+G+G YG V+ G + G A+K S + ++ L++EN++ + +
Sbjct: 15 CVGKGRYGEVWRGSWQ-GENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMT 73
Query: 133 GPLRVLAY----EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHE 188
+ GSL+D L L ++I + A GL +LH
Sbjct: 74 SRHSSTQLWLITHYHEMGSLYDYLQLTT----------LDTVSCLRIVLSIASGLAHLHI 123
Query: 189 -----KAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS---NQAPDAAARLHSTRVLGTFG 240
+ +P I HR++KS N+L+ + I+D L+ +Q+ + ++ RV GT
Sbjct: 124 EIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRV-GTKR 182
Query: 241 YHAPE------YAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280
Y APE + D+++FG+VL E+
Sbjct: 183 YMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVED 228
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 1e-46
Identities = 56/271 (20%), Positives = 105/271 (38%), Gaps = 36/271 (13%)
Query: 50 PIAVPVISVDELKEKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFL 109
P+ V +++ IG+G YG V+ G R G A+K ++++
Sbjct: 28 PLLVQRTIAKQIQMV-------KQIGKGRYGEVWMGKWR-GEKVAVKVFFTTEEASWFRE 79
Query: 110 AQVSMVSRLKNENVVELVGYYVDGPLRVLAY----EHASKGSLHDILHGKKGVKGAKPGP 165
++ +++EN++ + + G ++ GSL+D L
Sbjct: 80 TEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTT--------- 130
Query: 166 VLSWAQRVKIAVGAARGLEYLHE-----KAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220
L +K+A + GL +LH + +P I HR++KS N+L+ + I+D L+
Sbjct: 131 -LDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 189
Query: 221 --NQAPDAAARLHSTRVLGTFGYHAPE------YAMTGQMSSKSDVYSFGVVLLELLTGR 272
+ + +GT Y PE Q +D+YSFG++L E+ R
Sbjct: 190 VKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVAR-R 248
Query: 273 KPVDHTLPRGQQSLVTWATPKLSEDKVKQCV 303
+ Q S + +++ V
Sbjct: 249 CVSGGIVEEYQLPYHDLVPSDPSYEDMREIV 279
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 158 bits (400), Expect = 1e-45
Identities = 55/226 (24%), Positives = 94/226 (41%), Gaps = 30/226 (13%)
Query: 73 LIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVD 132
IG+G +G V+ G R G A+K S ++ A++ L++EN++ +
Sbjct: 49 SIGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNK 107
Query: 133 GPLRVLAY----EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHE 188
++ GSL D L+ ++ +K+A+ A GL +LH
Sbjct: 108 DNGTWTQLWLVSDYHEHGSLFDYLNRYT----------VTVEGMIKLALSTASGLAHLHM 157
Query: 189 -----KAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS---NQAPDAAARLHSTRVLGTFG 240
+ +P I HR++KS N+L+ + I+D L+ + A D + RV GT
Sbjct: 158 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRV-GTKR 216
Query: 241 YHAPE-----YAMTGQMSS-KSDVYSFGVVLLELLTGRKPVDHTLP 280
Y APE M S ++D+Y+ G+V E+
Sbjct: 217 YMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHED 262
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 7e-36
Identities = 57/218 (26%), Positives = 89/218 (40%), Gaps = 41/218 (18%)
Query: 74 IGEGSYGRVYFGVLRSGRAA-AIKKL--DSSKQPDQEFLAQVSMVSRLKNENVVELVGYY 130
IG G++G V+ G LR+ A+K +FL + ++ + + N+V L+G
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 131 VDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKA 190
+ E G L G L +++ AA G+EYL K
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLR--------TEGARLRVKTLLQMVGDAAAGMEYLESK- 232
Query: 191 EPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYH-------- 242
IHR++ + N L+ + ++ KISDF +S R Y
Sbjct: 233 --CCIHRDLAARNCLVTEKNVLKISDFGMS-------------REEADGVYAASGGLRQV 277
Query: 243 -----APEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 274
APE G+ SS+SDV+SFG++L E + G P
Sbjct: 278 PVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASP 315
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 3e-34
Identities = 53/211 (25%), Positives = 85/211 (40%), Gaps = 24/211 (11%)
Query: 73 LIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQE---FLAQVSMVSRLKNENVVELVG 128
IG GS+ VY G+ + A +L K E F + M+ L++ N+V
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 129 YYVDGPLR----VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLE 184
+ VL E + G+L L + + +GL+
Sbjct: 93 SWESTVKGKKCIVLVTELMTSGTLKTYLK--------RFKV-MKIKVLRSWCRQILKGLQ 143
Query: 185 YLHEKAEPRIIHRNIKSSNVLLFDDD-IAKISDFDLSNQAPDAAARLHSTRVLGTFGYHA 243
+LH + P IIHR++K N+ + KI D L+ + A+ V+GT + A
Sbjct: 144 FLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK----AVIGTPEFMA 198
Query: 244 PEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
PE + DVY+FG+ +LE+ T P
Sbjct: 199 PEM-YEEKYDESVDVYAFGMCMLEMATSEYP 228
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 3e-34
Identities = 53/222 (23%), Positives = 99/222 (44%), Gaps = 46/222 (20%)
Query: 74 IGEGSYGRVYFGVLRSGRAA-----AIKKL--DSSKQPDQEFLAQVSMVSRLKNENVVEL 126
+G G++G VY G+ AIK+L +S + ++E L + +++ + N +V L
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 127 VGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYL 186
+G + ++++ + G L D + K + + V A+G+ YL
Sbjct: 83 LGICLTSTVQLIT-QLMPFGCLLDYVREHKDN--------IGSQYLLNWCVQIAKGMNYL 133
Query: 187 HEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYH---- 242
++ R++HR++ + NVL+ KI+DF L+ ++LG
Sbjct: 134 EDR---RLVHRDLAARNVLVKTPQHVKITDFGLA-------------KLLGAEEKEYHAE 177
Query: 243 ---------APEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 274
A E + + +SDV+S+GV + EL+T G KP
Sbjct: 178 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 219
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 3e-33
Identities = 61/202 (30%), Positives = 104/202 (51%), Gaps = 13/202 (6%)
Query: 74 IGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDG 133
+G+G +G V+ G AIK L + FL + ++ +L++E +V+L +
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE 251
Query: 134 PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPR 193
P+ ++ E+ SKGSL D L G+ G L Q V +A A G+ Y+
Sbjct: 252 PIYIVT-EYMSKGSLLDFLKGET-------GKYLRLPQLVDMAAQIASGMAYVERM---N 300
Query: 194 IIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMS 253
+HR+++++N+L+ ++ + K++DF L+ D + APE A+ G+ +
Sbjct: 301 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFT 359
Query: 254 SKSDVYSFGVVLLELLT-GRKP 274
KSDV+SFG++L EL T GR P
Sbjct: 360 IKSDVWSFGILLTELTTKGRVP 381
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 3e-33
Identities = 53/210 (25%), Positives = 88/210 (41%), Gaps = 22/210 (10%)
Query: 72 SLIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFL------AQVSMVSRLKNENVV 124
+G G VY AIK + + +E L S+L ++N+V
Sbjct: 17 DKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHN--SSQLSHQNIV 74
Query: 125 ELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLE 184
++ + L E+ +L + + GP LS + G++
Sbjct: 75 SMIDVDEEDDCYYLVMEYIEGPTLSEYIESH--------GP-LSVDTAINFTNQILDGIK 125
Query: 185 YLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAP 244
+ H+ RI+HR+IK N+L+ + KI DF ++ +A + + VLGT Y +P
Sbjct: 126 HAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIA-KALSETSLTQTNHVLGTVQYFSP 181
Query: 245 EYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
E A +D+YS G+VL E+L G P
Sbjct: 182 EQAKGEATDECTDIYSIGIVLYEMLVGEPP 211
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 5e-33
Identities = 60/216 (27%), Positives = 101/216 (46%), Gaps = 28/216 (12%)
Query: 72 SLIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFL------AQVSMVSRLKNENVV 124
++G G V+ LR R A+K L + D F AQ + L + +V
Sbjct: 18 EILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQ--NAAALNHPAIV 75
Query: 125 EL--VGYYVDGPLRVLAY---EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGA 179
+ G + P L Y E+ +L DI+H + GP ++ + +++ A
Sbjct: 76 AVYDTGE-AETPAGPLPYIVMEYVDGVTLRDIVHTE--------GP-MTPKRAIEVIADA 125
Query: 180 ARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHST-RVLGT 238
+ L + H+ IIHR++K +N+++ + K+ DF ++ D+ + T V+GT
Sbjct: 126 CQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGT 182
Query: 239 FGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
Y +PE A + ++SDVYS G VL E+LTG P
Sbjct: 183 AQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 9e-33
Identities = 56/204 (27%), Positives = 102/204 (50%), Gaps = 19/204 (9%)
Query: 74 IGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQ-VSMVSRLKNENVVELVG-YY 130
IG+G+ G VY + + +G+ AI++++ +QP +E + + ++ KN N+V + Y
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 131 VDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKA 190
V L V+ E+ + GSL D++ + Q + + LE+LH
Sbjct: 88 VGDELWVVM-EYLAGGSLTDVVTETC----------MDEGQIAAVCRECLQALEFLHSN- 135
Query: 191 EPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTG 250
++IHR+IKS N+LL D K++DF Q ++ + ++GT + APE
Sbjct: 136 --QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVVTRK 191
Query: 251 QMSSKSDVYSFGVVLLELLTGRKP 274
K D++S G++ +E++ G P
Sbjct: 192 AYGPKVDIWSLGIMAIEMIEGEPP 215
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 1e-32
Identities = 50/206 (24%), Positives = 97/206 (47%), Gaps = 16/206 (7%)
Query: 73 LIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQE---FLAQVSMVSRLKNENVVELVG 128
IGEGS+G+ GR IK+++ S+ +E +V++++ +K+ N+V+
Sbjct: 31 KIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRE 90
Query: 129 YYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHE 188
+ + + ++ G L ++ +KGV Q + V L+++H+
Sbjct: 91 SFEENGSLYIVMDYCEGGDLFKRINAQKGVL-------FQEDQILDWFVQICLALKHVHD 143
Query: 189 KAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAM 248
+ +I+HR+IKS N+ L D ++ DF ++ + +GT Y +PE
Sbjct: 144 R---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARA--CIGTPYYLSPEICE 198
Query: 249 TGQMSSKSDVYSFGVVLLELLTGRKP 274
++KSD+++ G VL EL T +
Sbjct: 199 NKPYNNKSDIWALGCVLYELCTLKHA 224
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 121 bits (307), Expect = 1e-32
Identities = 51/204 (25%), Positives = 98/204 (48%), Gaps = 17/204 (8%)
Query: 74 IGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDG 133
IG G +G V+ G + AIK + +++F+ + ++ +L + +V+L G ++
Sbjct: 16 IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ 75
Query: 134 PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPR 193
L E G L D L ++G + + + + + G+ YL E
Sbjct: 76 APICLVTEFMEHGCLSDYLRTQRG--------LFAAETLLGMCLDVCEGMAYLEEA---C 124
Query: 194 IIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYH--APEYAMTGQ 251
+IHR++ + N L+ ++ + K+SDF ++ D +++ F +PE +
Sbjct: 125 VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ---YTSSTGTKFPVKWASPEVFSFSR 181
Query: 252 MSSKSDVYSFGVVLLELLT-GRKP 274
SSKSDV+SFGV++ E+ + G+ P
Sbjct: 182 YSSKSDVWSFGVLMWEVFSEGKIP 205
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 1e-32
Identities = 61/202 (30%), Positives = 104/202 (51%), Gaps = 13/202 (6%)
Query: 74 IGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDG 133
+G+G +G V+ G AIK L + FL + ++ +L++E +V+L +
Sbjct: 275 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE 334
Query: 134 PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPR 193
P+ ++ E+ SKGSL D L G+ G L Q V +A A G+ Y+
Sbjct: 335 PIYIVT-EYMSKGSLLDFLKGET-------GKYLRLPQLVDMAAQIASGMAYVERM---N 383
Query: 194 IIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMS 253
+HR+++++N+L+ ++ + K++DF L+ D + APE A+ G+ +
Sbjct: 384 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFT 442
Query: 254 SKSDVYSFGVVLLELLT-GRKP 274
KSDV+SFG++L EL T GR P
Sbjct: 443 IKSDVWSFGILLTELTTKGRVP 464
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 1e-32
Identities = 53/220 (24%), Positives = 94/220 (42%), Gaps = 35/220 (15%)
Query: 73 LIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQ-PDQEFLAQVSMVSRLKNENVVELVGYY 130
LIG G +G+V+ G+ IK++ + + ++E V +++L + N+V G +
Sbjct: 18 LIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAERE----VKALAKLDHVNIVHYNGCW 73
Query: 131 VDGPLRVLAY----------------EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVK 174
E KG+L + ++G K L ++
Sbjct: 74 DGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEK-------LDKVLALE 126
Query: 175 IAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTR 234
+ +G++Y+H K ++I+R++K SN+ L D KI DF L + R TR
Sbjct: 127 LFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKR---TR 180
Query: 235 VLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
GT Y +PE + + D+Y+ G++L ELL
Sbjct: 181 SKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDT 220
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 2e-32
Identities = 53/204 (25%), Positives = 100/204 (49%), Gaps = 17/204 (8%)
Query: 74 IGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDG 133
+G G +G V+ A+K + + FLA+ +++ L+++ +V+L
Sbjct: 196 LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTKE 255
Query: 134 PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPR 193
P+ ++ E +KGSL D L + G + + + A G+ ++ ++
Sbjct: 256 PIYIIT-EFMAKGSLLDFLKSDE-------GSKQPLPKLIDFSAQIAEGMAFIEQR---N 304
Query: 194 IIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYH--APEYAMTGQ 251
IHR+++++N+L+ + KI+DF L+ D ++ R F APE G
Sbjct: 305 YIHRDLRAANILVSASLVCKIADFGLARVIEDNE---YTAREGAKFPIKWTAPEAINFGS 361
Query: 252 MSSKSDVYSFGVVLLELLT-GRKP 274
+ KSDV+SFG++L+E++T GR P
Sbjct: 362 FTIKSDVWSFGILLMEIVTYGRIP 385
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 2e-32
Identities = 59/220 (26%), Positives = 95/220 (43%), Gaps = 21/220 (9%)
Query: 60 ELKEKTDNFGTNSLIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRL 118
E +E+ +G GS+G V+ ++G A+KK+ +E + + L
Sbjct: 52 EYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVEE----LVACAGL 107
Query: 119 KNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVG 178
+ +V L G +GP + E GSL ++ K L + +
Sbjct: 108 SSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLI---------KQMGCLPEDRALYYLGQ 158
Query: 179 AARGLEYLHEKAEPRIIHRNIKSSNVLLFDD-DIAKISDFDLSNQ-APDAAARLHSTR-- 234
A GLEYLH + RI+H ++K+ NVLL D A + DF + PD + T
Sbjct: 159 ALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDY 215
Query: 235 VLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
+ GT + APE M +K D++S ++L +L G P
Sbjct: 216 IPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHP 255
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 3e-32
Identities = 53/222 (23%), Positives = 99/222 (44%), Gaps = 46/222 (20%)
Query: 74 IGEGSYGRVYFGVLRSGRAA-----AIKKL--DSSKQPDQEFLAQVSMVSRLKNENVVEL 126
+G G++G VY G+ AIK+L +S + ++E L + +++ + N +V L
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 127 VGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYL 186
+G + ++++ + G L D + K + + V A+G+ YL
Sbjct: 83 LGICLTSTVQLIT-QLMPFGCLLDYVREHKDN--------IGSQYLLNWCVQIAKGMNYL 133
Query: 187 HEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYH---- 242
++ R++HR++ + NVL+ KI+DF L+ ++LG
Sbjct: 134 EDR---RLVHRDLAARNVLVKTPQHVKITDFGLA-------------KLLGAEEKEYHAE 177
Query: 243 ---------APEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 274
A E + + +SDV+S+GV + EL+T G KP
Sbjct: 178 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 219
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 3e-32
Identities = 58/204 (28%), Positives = 100/204 (49%), Gaps = 17/204 (8%)
Query: 74 IGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDG 133
+G G +G V+ G A+K L FLA+ +++ +L+++ +V L
Sbjct: 21 LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQE 80
Query: 134 PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPR 193
P+ ++ E+ GSL D L G L+ + + +A A G+ ++ E+
Sbjct: 81 PIYIIT-EYMENGSLVDFLKTPS-------GIKLTINKLLDMAAQIAEGMAFIEER---N 129
Query: 194 IIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYH--APEYAMTGQ 251
IHR+++++N+L+ D KI+DF L+ D ++ R F APE G
Sbjct: 130 YIHRDLRAANILVSDTLSCKIADFGLARLIEDNE---YTAREGAKFPIKWTAPEAINYGT 186
Query: 252 MSSKSDVYSFGVVLLELLT-GRKP 274
+ KSDV+SFG++L E++T GR P
Sbjct: 187 FTIKSDVWSFGILLTEIVTHGRIP 210
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 3e-32
Identities = 65/221 (29%), Positives = 101/221 (45%), Gaps = 45/221 (20%)
Query: 74 IGEGSYGRVYFGVLRSGRAA---AIKKL--DSSKQPDQEFLAQVSMVSRLKNENVVELVG 128
+G G++G V GV R + AIK L + K +E + + ++ +L N +V L+G
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77
Query: 129 YYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHE 188
L ++ E A G LH L GK+ + + ++ + G++YL E
Sbjct: 78 VCQAEALMLVM-EMAGGGPLHKFLVGKREE--------IPVSNVAELLHQVSMGMKYLEE 128
Query: 189 KAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGT--FGYH---- 242
K +HR++ + NVLL + AKISDF LS + LG Y
Sbjct: 129 K---NFVHRDLAARNVLLVNRHYAKISDFGLS-------------KALGADDSYYTARSA 172
Query: 243 --------APEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 274
APE + SS+SDV+S+GV + E L+ G+KP
Sbjct: 173 GKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKP 213
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 3e-32
Identities = 51/210 (24%), Positives = 80/210 (38%), Gaps = 22/210 (10%)
Query: 72 SLIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFL------AQVSMVSRLKNENVV 124
L+G G G VY R A+K + + D F A+ RL+ +VV
Sbjct: 40 RLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREART--AGRLQEPHVV 97
Query: 125 ELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLE 184
+ + + + L +L + GP L+ + V I L+
Sbjct: 98 PIHDFGEIDGQLYVDMRLINGVDLAAMLR--------RQGP-LAPPRAVAIVRQIGSALD 148
Query: 185 YLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAP 244
H HR++K N+L+ DD A + DF ++ A +GT Y AP
Sbjct: 149 AAHAA---GATHRDVKPENILVSADDFAYLVDFGIA-SATTDEKLTQLGNTVGTLYYMAP 204
Query: 245 EYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
E + ++D+Y+ VL E LTG P
Sbjct: 205 ERFSESHATYRADIYALTCVLYECLTGSPP 234
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 6e-32
Identities = 52/222 (23%), Positives = 92/222 (41%), Gaps = 46/222 (20%)
Query: 74 IGEGSYGRVYFGVLRSGRAA-----AIK--KLDSSKQPDQEFLAQVSMVSRLKNENVVEL 126
+G G +G V+ GV + IK + S +Q Q + + L + ++V L
Sbjct: 21 LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRL 80
Query: 127 VGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYL 186
+G L+++ ++ GSL D + +G L + V A+G+ YL
Sbjct: 81 LGLCPGSSLQLVT-QYLPLGSLLDHVRQHRGA--------LGPQLLLNWGVQIAKGMYYL 131
Query: 187 HEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYH---- 242
E ++HRN+ + NVLL +++DF ++ +L
Sbjct: 132 EEH---GMVHRNLAARNVLLKSPSQVQVADFGVA-------------DLLPPDDKQLLYS 175
Query: 243 ---------APEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 274
A E G+ + +SDV+S+GV + EL+T G +P
Sbjct: 176 EAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEP 217
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 6e-32
Identities = 51/207 (24%), Positives = 89/207 (42%), Gaps = 15/207 (7%)
Query: 73 LIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQ----VSMVSRLKNENVVELV 127
IG G + VY L G A+KK+ D + A + ++ +L + NV++
Sbjct: 39 KIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYY 98
Query: 128 GYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLH 187
+++ + E A G L ++ K K ++ K V LE++H
Sbjct: 99 ASFIEDNELNIVLELADAGDLSRMIKHFK-----KQKRLIPERTVWKYFVQLCSALEHMH 153
Query: 188 EKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYA 247
+ R++HR+IK +NV + + K+ D L HS ++GT Y +PE
Sbjct: 154 SR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYMSPERI 208
Query: 248 MTGQMSSKSDVYSFGVVLLELLTGRKP 274
+ KSD++S G +L E+ + P
Sbjct: 209 HENGYNFKSDIWSLGCLLYEMAALQSP 235
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 6e-32
Identities = 54/220 (24%), Positives = 93/220 (42%), Gaps = 39/220 (17%)
Query: 74 IGEGSYGRVYFGVLRSGRAA----AIKKL--DSSKQPDQEFLAQVSMVSRLKNENVVELV 127
IG G +G VY G L A+K L + +FL + ++ + NV+ L+
Sbjct: 33 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 92
Query: 128 G--YYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEY 185
G +G V+ + G L + + + + + A+G++Y
Sbjct: 93 GICLRSEGSPLVV-LPYMKHGDLRNFIR--------NETHNPTVKDLIGFGLQVAKGMKY 143
Query: 186 LHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAAR-LHST---RVLGTFGY 241
L K + +HR++ + N +L + K++DF L+ R ++ V G
Sbjct: 144 LASK---KFVHRDLAARNCMLDEKFTVKVADFGLA--------RDMYDKEYYSVHNKTGA 192
Query: 242 H------APEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 274
A E T + ++KSDV+SFGV+L EL+T G P
Sbjct: 193 KLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 232
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 7e-32
Identities = 48/214 (22%), Positives = 87/214 (40%), Gaps = 37/214 (17%)
Query: 74 IGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDG 133
+G G +G V G + A+K + + EF + + +L + +V+ G
Sbjct: 16 LGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKE 75
Query: 134 PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPR 193
+ E+ S G L + L G L +Q +++ G+ +L +
Sbjct: 76 YPIYIVTEYISNGCLLNYLRSH--------GKGLEPSQLLEMCYDVCEGMAFLESH---Q 124
Query: 194 IIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYH----------- 242
IHR++ + N L+ D K+SDF ++ R + Y
Sbjct: 125 FIHRDLAARNCLVDRDLCVKVSDFGMT-------------RYVLDDQYVSSVGTKFPVKW 171
Query: 243 -APEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 274
APE + SSKSDV++FG+++ E+ + G+ P
Sbjct: 172 SAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMP 205
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 8e-32
Identities = 53/223 (23%), Positives = 95/223 (42%), Gaps = 17/223 (7%)
Query: 61 LKEKTDNFGTNSLIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQE---FLAQVSMVS 116
+ + +++ IG GSYGR G+ K+LD + E +++V+++
Sbjct: 1 MPSRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLR 60
Query: 117 RLKNENVVELVGYYVDGPLRVLAY---EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRV 173
LK+ N+V +D L Y E+ G L ++ KG K L +
Sbjct: 61 ELKHPNIVRYYDRIIDRTNTTL-YIVMEYCEGGDLASVI-----TKGTKERQYLDEEFVL 114
Query: 174 KIAVGAARGLEYLHEKAEP--RIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLH 231
++ L+ H +++ ++HR++K +NV L K+ DF L+ +
Sbjct: 115 RVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAK 174
Query: 232 STRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
+ +GT Y +PE + KSD++S G +L EL P
Sbjct: 175 T--FVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPP 215
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 9e-32
Identities = 53/204 (25%), Positives = 94/204 (46%), Gaps = 17/204 (8%)
Query: 74 IGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDG 133
+G G +G V +G R AIK + + EF+ + ++ L +E +V+L G
Sbjct: 32 LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQ 91
Query: 134 PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPR 193
+ E+ + G L + L + Q +++ +EYL K +
Sbjct: 92 RPIFIITEYMANGCLLNYLR--------EMRHRFQTQQLLEMCKDVCEAMEYLESK---Q 140
Query: 194 IIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYH--APEYAMTGQ 251
+HR++ + N L+ D + K+SDF LS D +++ V F PE M +
Sbjct: 141 FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE---YTSSVGSKFPVRWSPPEVLMYSK 197
Query: 252 MSSKSDVYSFGVVLLELLT-GRKP 274
SSKSD+++FGV++ E+ + G+ P
Sbjct: 198 FSSKSDIWAFGVLMWEIYSLGKMP 221
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 1e-31
Identities = 57/222 (25%), Positives = 94/222 (42%), Gaps = 47/222 (21%)
Query: 74 IGEGSYGRVYFGVLRSGRAA---AIKKL---DSSKQPDQEFLAQVSMVSRLKNENVVELV 127
+G G++G V G + + A+K L + E LA+ +++ +L N +V ++
Sbjct: 25 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 84
Query: 128 GYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLH 187
G ++ E A G L+ L + + +++ + G++YL
Sbjct: 85 GICEAESWMLVM-EMAELGPLNKYLQQNRH---------VKDKNIIELVHQVSMGMKYLE 134
Query: 188 EKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFG--YH--- 242
E +HR++ + NVLL AKISDF LS + L Y
Sbjct: 135 ES---NFVHRDLAARNVLLVTQHYAKISDFGLS-------------KALRADENYYKAQT 178
Query: 243 ---------APEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 274
APE + SSKSDV+SFGV++ E + G+KP
Sbjct: 179 HGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 220
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 1e-31
Identities = 67/210 (31%), Positives = 109/210 (51%), Gaps = 33/210 (15%)
Query: 74 IGEGSYGRVYFGVLRSGRAAAIK--KLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYV 131
IG+G +G V G R G A+K K D++ Q FLA+ S++++L++ N+V+L+G V
Sbjct: 201 IGKGEFGDVMLGDYR-GNKVAVKCIKNDAT---AQAFLAEASVMTQLRHSNLVQLLG--V 254
Query: 132 ---DGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHE 188
+ + E+ +KGSL D L + VL +K ++ +EYL
Sbjct: 255 IVEEKGGLYIVTEYMAKGSLVDYLRSRGR-------SVLGGDCLLKFSLDVCEAMEYLEG 307
Query: 189 KAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAAR-LHSTRVLGTFGYH--APE 245
+HR++ + NVL+ +D++AK+SDF L + ST+ G APE
Sbjct: 308 N---NFVHRDLAARNVLVSEDNVAKVSDFGL--------TKEASSTQDTGKLPVKWTAPE 356
Query: 246 YAMTGQMSSKSDVYSFGVVLLELLT-GRKP 274
+ S+KSDV+SFG++L E+ + GR P
Sbjct: 357 ALREKKFSTKSDVWSFGILLWEIYSFGRVP 386
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 1e-31
Identities = 49/220 (22%), Positives = 93/220 (42%), Gaps = 44/220 (20%)
Query: 74 IGEGSYGRVYFGVLRSGRAA----AIK--KLDSSKQPDQEFLAQVSMVSRLKNENVVELV 127
+GEG +G VY GV + + A+K K D + ++F+++ ++ L + ++V+L+
Sbjct: 20 LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 79
Query: 128 GYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLH 187
G + P ++ E G L L + L V ++ + + YL
Sbjct: 80 GIIEEEPTWIIM-ELYPYGELGHYLE--------RNKNSLKVLTLVLYSLQICKAMAYLE 130
Query: 188 EKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYH----- 242
+HR+I N+L+ + K+ DF LS R + Y+
Sbjct: 131 SI---NCVHRDIAVRNILVASPECVKLGDFGLS-------------RYIEDEDYYKASVT 174
Query: 243 -------APEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 274
+PE + ++ SDV+ F V + E+L+ G++P
Sbjct: 175 RLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQP 214
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 2e-31
Identities = 60/206 (29%), Positives = 99/206 (48%), Gaps = 19/206 (9%)
Query: 74 IGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYV- 131
+G G YG VY GV + A+K L +EFL + +++ +K+ N+V+L+G V
Sbjct: 228 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLG--VC 285
Query: 132 --DGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEK 189
+ P ++ E + G+L D L +S + +A + +EYL +K
Sbjct: 286 TREPPFYIIT-EFMTYGNLLDYLRECNR-------QEVSAVVLLYMATQISSAMEYLEKK 337
Query: 190 AEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMT 249
IHRN+ + N L+ ++ + K++DF LS H+ + APE
Sbjct: 338 ---NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF-PIKWTAPESLAY 393
Query: 250 GQMSSKSDVYSFGVVLLELLT-GRKP 274
+ S KSDV++FGV+L E+ T G P
Sbjct: 394 NKFSIKSDVWAFGVLLWEIATYGMSP 419
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 2e-31
Identities = 44/221 (19%), Positives = 89/221 (40%), Gaps = 30/221 (13%)
Query: 73 LIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQE---FLAQVSMVSRLK--NENVVELV 127
IG G +V+ + + AIK ++ + +Q + +++ +++L+ ++ ++ L
Sbjct: 16 QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 75
Query: 128 GYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLH 187
Y + + E + L+ L KK + +R + +H
Sbjct: 76 DYEITDQYIYMVMECGN-IDLNSWLKKKKS---------IDPWERKSYWKNMLEAVHTIH 125
Query: 188 EKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE-- 245
+ I+H ++K +N L D + K+ DF ++NQ + +GT Y PE
Sbjct: 126 QH---GIVHSDLKPAN-FLIVDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAI 181
Query: 246 ---------YAMTGQMSSKSDVYSFGVVLLELLTGRKPVDH 277
++S KSDV+S G +L + G+ P
Sbjct: 182 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ 222
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 3e-31
Identities = 54/230 (23%), Positives = 91/230 (39%), Gaps = 30/230 (13%)
Query: 73 LIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQ-VSMVSRLKNENVVELVGYY 130
+GEG + V L G A+K++ +Q D+E + M + N++ LV Y
Sbjct: 36 KLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYC 95
Query: 131 VDGPLRVLAY----EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYL 186
+ +G+L + + + G L+ Q + + +G RGLE +
Sbjct: 96 LRERGAKHEAWLLLPFFKRGTLWNEI-----ERLKDKGNFLTEDQILWLLLGICRGLEAI 150
Query: 187 HEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVL-------GTF 239
H HR++K +N+LL D+ + D NQA L T
Sbjct: 151 HA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTI 207
Query: 240 GYHAPE------YAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQ 283
Y APE + + + ++DV+S G VL ++ G P D +G
Sbjct: 208 SYRAPELFSVQSHCVIDE---RTDVWSLGCVLYAMMFGEGPYDMVFQKGD 254
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 3e-31
Identities = 44/221 (19%), Positives = 89/221 (40%), Gaps = 30/221 (13%)
Query: 73 LIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQE---FLAQVSMVSRLK--NENVVELV 127
IG G +V+ + + AIK ++ + +Q + +++ +++L+ ++ ++ L
Sbjct: 35 QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 94
Query: 128 GYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLH 187
Y + + E + L+ L KK + +R + +H
Sbjct: 95 DYEITDQYIYMVMECGN-IDLNSWLKKKKS---------IDPWERKSYWKNMLEAVHTIH 144
Query: 188 EKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE-- 245
+ I+H ++K +N L D + K+ DF ++NQ + +GT Y PE
Sbjct: 145 QH---GIVHSDLKPAN-FLIVDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAI 200
Query: 246 ---------YAMTGQMSSKSDVYSFGVVLLELLTGRKPVDH 277
++S KSDV+S G +L + G+ P
Sbjct: 201 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ 241
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 3e-31
Identities = 52/225 (23%), Positives = 99/225 (44%), Gaps = 38/225 (16%)
Query: 73 LIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPD--QEFLAQVSMVSRLKNENVVELVGY 129
+G G +G V+ AIK++ + ++ + +V +++L++ +V
Sbjct: 12 CLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNA 71
Query: 130 YVDGP---------LRVLAY---EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAV 177
+++ +V Y + K +L D ++G+ ++ + L ++
Sbjct: 72 WLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQI---- 127
Query: 178 GAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS-----------NQAPDA 226
A +E+LH K ++HR++K SN+ DD+ K+ DF L P
Sbjct: 128 --AEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMP 182
Query: 227 AARLHSTRVLGTFGYHAPEYAMTGQM-SSKSDVYSFGVVLLELLT 270
A H+ +V GT Y +PE + G S K D++S G++L ELL
Sbjct: 183 AYARHTGQV-GTKLYMSPE-QIHGNSYSHKVDIFSLGLILFELLY 225
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 3e-31
Identities = 63/224 (28%), Positives = 94/224 (41%), Gaps = 48/224 (21%)
Query: 74 IGEGSYGRVYFGVLRSGRAA----AIKKL----DSSKQPDQEFLAQVSMVSRLKNENVVE 125
+G+GS+G V G + A+K L S + +F+ +V+ + L + N++
Sbjct: 26 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 126 LVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEY 185
L G + P++++ E A GSL D L +G + AV A G+ Y
Sbjct: 86 LYGVVLTPPMKMVT-ELAPLGSLLDRLRKHQGH--------FLLGTLSRYAVQVAEGMGY 136
Query: 186 LHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFG--YH- 242
L K R IHR++ + N+LL D+ KI DF L R L Y
Sbjct: 137 LESK---RFIHRDLAARNLLLATRDLVKIGDFGLM-------------RALPQNDDHYVM 180
Query: 243 -----------APEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 274
APE T S SD + FGV L E+ T G++P
Sbjct: 181 QEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 224
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 4e-31
Identities = 65/208 (31%), Positives = 107/208 (51%), Gaps = 29/208 (13%)
Query: 74 IGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYV-- 131
IG+G +G V G R G A+K + + Q FLA+ S++++L++ N+V+L+G V
Sbjct: 29 IGKGEFGDVMLGDYR-GNKVAVKCIKNDATA-QAFLAEASVMTQLRHSNLVQLLG--VIV 84
Query: 132 -DGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKA 190
+ + E+ +KGSL D L + VL +K ++ +EYL
Sbjct: 85 EEKGGLYIVTEYMAKGSLVDYLRSRGR-------SVLGGDCLLKFSLDVCEAMEYLEGN- 136
Query: 191 EPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAAR-LHSTRVLGTFGYH--APEYA 247
+HR++ + NVL+ +D++AK+SDF L + ST+ G APE
Sbjct: 137 --NFVHRDLAARNVLVSEDNVAKVSDFGL--------TKEASSTQDTGKLPVKWTAPEAL 186
Query: 248 MTGQMSSKSDVYSFGVVLLELLT-GRKP 274
+ S+KSDV+SFG++L E+ + GR P
Sbjct: 187 REKKFSTKSDVWSFGILLWEIYSFGRVP 214
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 5e-31
Identities = 66/221 (29%), Positives = 101/221 (45%), Gaps = 45/221 (20%)
Query: 74 IGEGSYGRVYFGVLRSGRAA---AIKKL--DSSKQPDQEFLAQVSMVSRLKNENVVELVG 128
+G G++G V GV R + AIK L + K +E + + ++ +L N +V L+G
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 403
Query: 129 YYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHE 188
L ++ E A G LH L GK+ + + ++ + G++YL E
Sbjct: 404 VCQAEALMLVM-EMAGGGPLHKFLVGKREE--------IPVSNVAELLHQVSMGMKYLEE 454
Query: 189 KAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGT--FGYH---- 242
K +HRN+ + NVLL + AKISDF LS + LG Y
Sbjct: 455 K---NFVHRNLAARNVLLVNRHYAKISDFGLS-------------KALGADDSYYTARSA 498
Query: 243 --------APEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 274
APE + SS+SDV+S+GV + E L+ G+KP
Sbjct: 499 GKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKP 539
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 5e-31
Identities = 64/204 (31%), Positives = 98/204 (48%), Gaps = 19/204 (9%)
Query: 74 IGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQ-VSMVSRLKNENVVELVG-YY 130
IGEGS G V SGR A+K +D KQ +E L V ++ ++ NVVE+ Y
Sbjct: 53 IGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYL 112
Query: 131 VDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKA 190
V L VL E G+L DI+ L+ Q + + L YLH +
Sbjct: 113 VGEELWVLM-EFLQGGALTDIV---------SQVR-LNEEQIATVCEAVLQALAYLHAQ- 160
Query: 191 EPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTG 250
+IHR+IKS ++LL D K+SDF Q + S ++GT + APE
Sbjct: 161 --GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS--LVGTPYWMAPEVISRS 216
Query: 251 QMSSKSDVYSFGVVLLELLTGRKP 274
+++ D++S G++++E++ G P
Sbjct: 217 LYATEVDIWSLGIMVIEMVDGEPP 240
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 6e-31
Identities = 60/218 (27%), Positives = 100/218 (45%), Gaps = 43/218 (19%)
Query: 74 IGEGSYGRVYFGVLRSGRAA-AIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYV- 131
+G G YG VY GV + A+K L +EFL + +++ +K+ N+V+L+G V
Sbjct: 21 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLG--VC 78
Query: 132 --DGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEK 189
+ P ++ E + G+L D L +S + +A + +EYL +K
Sbjct: 79 TREPPFYIIT-EFMTYGNLLDYLRECNR-------QEVSAVVLLYMATQISSAMEYLEKK 130
Query: 190 AEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYH------- 242
IHR++ + N L+ ++ + K++DF LS R++ Y
Sbjct: 131 ---NFIHRDLAARNCLVGENHLVKVADFGLS-------------RLMTGDTYTAHAGAKF 174
Query: 243 -----APEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 274
APE + S KSDV++FGV+L E+ T G P
Sbjct: 175 PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 212
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 8e-31
Identities = 55/232 (23%), Positives = 105/232 (45%), Gaps = 50/232 (21%)
Query: 74 IGEGSYGRVYFGVLRSGRAA------AIKKL-DSSKQPDQEFLAQVSMVSRLKNENVVEL 126
+GEG++G+V+ + A+K L D + ++F + +++ L++E++V+
Sbjct: 23 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82
Query: 127 VGYYV---DGPLRVLAYEHASKGSLHDIL-------HGKKGVKGAKPGPVLSWAQRVKIA 176
G V PL ++ +E+ G L+ L + + L +Q + IA
Sbjct: 83 YG--VCGDGDPLIMV-FEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 139
Query: 177 VGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVL 236
A G+ YL + +HR++ + N L+ + + KI DF +S R +
Sbjct: 140 SQIASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMS-------------RDV 183
Query: 237 GTFGYH-------------APEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 274
+ Y+ PE M + +++SDV+SFGV+L E+ T G++P
Sbjct: 184 YSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 235
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 9e-31
Identities = 64/233 (27%), Positives = 100/233 (42%), Gaps = 51/233 (21%)
Query: 74 IGEGSYGRVYFGVLRSGRAA------AIKKL--DSSKQPDQEFLAQVSMVSRLKNENVVE 125
+GE +G+VY G L AIK L + +EF + + +RL++ NVV
Sbjct: 17 LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVC 76
Query: 126 LVGYYV---DGPLRVLAYEHASKGSLHDILHGK-------KGVKGAKPGPVLSWAQRVKI 175
L+G V D PL ++ + + S G LH+ L + L V +
Sbjct: 77 LLG--VVTKDQPLSMI-FSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHL 133
Query: 176 AVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRV 235
A G+EYL ++H+++ + NVL++D KISD L R
Sbjct: 134 VAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLNVKISDLGLF-------------RE 177
Query: 236 LGTFGYH-------------APEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 274
+ Y+ APE M G+ S SD++S+GVVL E+ + G +P
Sbjct: 178 VYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 230
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 9e-31
Identities = 60/220 (27%), Positives = 94/220 (42%), Gaps = 44/220 (20%)
Query: 74 IGEGSYGRVYFGVLRSGRAA----AIK--KLDSSKQPDQEFLAQVSMVSRLKNENVVELV 127
IGEG +G V+ G+ S AIK K +S ++FL + + + + ++V+L+
Sbjct: 23 IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 82
Query: 128 GYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLH 187
G + P+ ++ E + G L L L A + A + L YL
Sbjct: 83 GVITENPVWIIM-ELCTLGELRSFLQ--------VRKYSLDLASLILYAYQLSTALAYLE 133
Query: 188 EKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYH----- 242
K R +HR+I + NVL+ +D K+ DF LS R + Y+
Sbjct: 134 SK---RFVHRDIAARNVLVSSNDCVKLGDFGLS-------------RYMEDSTYYKASKG 177
Query: 243 -------APEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 274
APE + +S SDV+ FGV + E+L G KP
Sbjct: 178 KLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKP 217
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 1e-30
Identities = 57/207 (27%), Positives = 99/207 (47%), Gaps = 16/207 (7%)
Query: 73 LIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQ-VSMVSRLKNENVVELVGYY 130
++G+G+YG VY G L + AIK++ + L + +++ LK++N+V+ +G +
Sbjct: 29 VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 88
Query: 131 VDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKA 190
+ + E GSL +L K G + + +++ GL+YLH+
Sbjct: 89 SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQI------LEGLKYLHDN- 141
Query: 191 EPRIIHRNIKSSNVLLFDDD-IAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMT 249
+I+HR+IK NVL+ + KISDF S + + GT Y APE
Sbjct: 142 --QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET--FTGTLQYMAPEIIDK 197
Query: 250 GQM--SSKSDVYSFGVVLLELLTGRKP 274
G +D++S G ++E+ TG+ P
Sbjct: 198 GPRGYGKAADIWSLGCTIIEMATGKPP 224
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 1e-30
Identities = 43/221 (19%), Positives = 87/221 (39%), Gaps = 30/221 (13%)
Query: 73 LIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQE---FLAQVSMVSRLK--NENVVELV 127
IG G +V+ + + AIK ++ + +Q + +++ +++L+ ++ ++ L
Sbjct: 63 QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 122
Query: 128 GYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLH 187
Y + + E L+ L KK + +R + +H
Sbjct: 123 DYEITDQYIYMVMECG-NIDLNSWLKKKKS---------IDPWERKSYWKNMLEAVHTIH 172
Query: 188 EKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE-- 245
+ I+H ++K +N L D + K+ DF ++NQ + +G Y PE
Sbjct: 173 QH---GIVHSDLKPAN-FLIVDGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAI 228
Query: 246 ---------YAMTGQMSSKSDVYSFGVVLLELLTGRKPVDH 277
++S KSDV+S G +L + G+ P
Sbjct: 229 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ 269
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 1e-30
Identities = 59/236 (25%), Positives = 96/236 (40%), Gaps = 28/236 (11%)
Query: 74 IGEGSYGRVYFGVLR-----SGRAAAIKKLDSSKQPDQ--EFLAQVSMVSRLKNENVVEL 126
+GEG +G+V +G A+K L + P + ++ ++ L +E++++
Sbjct: 39 LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKY 98
Query: 127 VG---YYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGL 183
G L+++ E+ GSL D L + AQ + A G+
Sbjct: 99 KGCCEDAGAASLQLVM-EYVPLGSLRDYLPRHS----------IGLAQLLLFAQQICEGM 147
Query: 184 EYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAA--RLHSTRVLGTFGY 241
YLH + IHR++ + NVLL +D + KI DF L+ P+ R+ F Y
Sbjct: 148 AYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY 204
Query: 242 HAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSE 296
APE + SDV+SFGV L ELLT + + +
Sbjct: 205 -APECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLR 259
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 1e-30
Identities = 51/225 (22%), Positives = 91/225 (40%), Gaps = 49/225 (21%)
Query: 74 IGEGSYGRVYFGVLRSGRAA----AIKKL--DSSKQPDQEFLAQVSMVSRLKNENVVELV 127
IG G +G VY G L A+K L + +FL + ++ + NV+ L+
Sbjct: 97 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 156
Query: 128 G--YYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEY 185
G +G V+ + G L + + + + + A+G+++
Sbjct: 157 GICLRSEGSPLVVL-PYMKHGDLRNFIR--------NETHNPTVKDLIGFGLQVAKGMKF 207
Query: 186 LHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYH--- 242
L K + +HR++ + N +L + K++DF L+ R + +
Sbjct: 208 LASK---KFVHRDLAARNCMLDEKFTVKVADFGLA-------------RDMYDKEFDSVH 251
Query: 243 ------------APEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 274
A E T + ++KSDV+SFGV+L EL+T G P
Sbjct: 252 NKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 296
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 2e-30
Identities = 63/259 (24%), Positives = 111/259 (42%), Gaps = 46/259 (17%)
Query: 43 MKTVTVQPIAVPVISVDELKE-KTDNFGTNSLIGEGSYGRVYFGVLRSGRAA------AI 95
M +V + + + V + E + + +G+GS+G VY GV + AI
Sbjct: 1 MASVNPEYFSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAI 60
Query: 96 KKL--DSSKQPDQEFLAQVSMVSRLKNENVVELVGYYV---DGPLRVLAYEHASKGSLHD 150
K + +S + EFL + S++ +VV L+G V P V+ E ++G L
Sbjct: 61 KTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLG--VVSQGQPTLVI-MELMTRGDLKS 117
Query: 151 ILHGKKGVKGAKP-GPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDD 209
L + P S ++ +++A A G+ YL+ + +HR++ + N ++ +D
Sbjct: 118 YLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAED 174
Query: 210 DIAKISDFDLSNQAPDAAARLHSTRVLGTFGYH-------------APEYAMTGQMSSKS 256
KI DF ++ R + Y+ +PE G ++ S
Sbjct: 175 FTVKIGDFGMT-------------RDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYS 221
Query: 257 DVYSFGVVLLELLT-GRKP 274
DV+SFGVVL E+ T +P
Sbjct: 222 DVWSFGVVLWEIATLAEQP 240
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 2e-30
Identities = 54/225 (24%), Positives = 95/225 (42%), Gaps = 49/225 (21%)
Query: 74 IGEGSYGRVYFGVLR-----SGRAAAIKKL-DSSKQPDQEFLAQVSMVSRLKNENVVELV 127
+G+G++G V +G A+K+L S ++F ++ ++ L ++ +V+
Sbjct: 31 LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 90
Query: 128 G---YYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLE 184
G LR++ E+ G L D L + L ++ + + +G+E
Sbjct: 91 GVSYGPGRQSLRLVM-EYLPSGCLRDFLQ--------RHRARLDASRLLLYSSQICKGME 141
Query: 185 YLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFG--YH 242
YL + R +HR++ + N+L+ + KI+DF L+ ++L Y
Sbjct: 142 YLGSR---RCVHRDLAARNILVESEAHVKIADFGLA-------------KLLPLDKDYYV 185
Query: 243 ------------APEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 274
APE S +SDV+SFGVVL EL T K
Sbjct: 186 VREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKS 230
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 2e-30
Identities = 57/224 (25%), Positives = 93/224 (41%), Gaps = 47/224 (20%)
Query: 74 IGEGSYGRVYFGVLRSGRAA----AIK--KLDSSKQPDQEFLAQVSMVSRLKNENVVELV 127
IG+G +G VY G AIK + Q + FL + ++ L + NV+ L+
Sbjct: 29 IGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALI 88
Query: 128 GYYVDG-PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYL 186
G + L + + G L + P + + + ARG+EYL
Sbjct: 89 GIMLPPEGLPHVLLPYMCHGDLLQFIR--------SPQRNPTVKDLISFGLQVARGMEYL 140
Query: 187 HEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYH---- 242
E+ + +HR++ + N +L + K++DF L+ R + Y+
Sbjct: 141 AEQ---KFVHRDLAARNCMLDESFTVKVADFGLA-------------RDILDREYYSVQQ 184
Query: 243 -----------APEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 274
A E T + ++KSDV+SFGV+L ELLT G P
Sbjct: 185 HRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPP 228
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 4e-30
Identities = 62/208 (29%), Positives = 96/208 (46%), Gaps = 20/208 (9%)
Query: 74 IGEGSYGRVYFGVLRSGRAA----AIK--KLDSSKQPDQEFLAQVSMVSRLKNENVVELV 127
IGEG +G V+ G+ S AIK K +S ++FL + + + + ++V+L+
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 128 GYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLH 187
G + P+ ++ E + G L L +K L A + A + L YL
Sbjct: 458 GVITENPVWIIM-ELCTLGELRSFLQVRK--------FSLDLASLILYAYQLSTALAYLE 508
Query: 188 EKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYA 247
K R +HR+I + NVL+ +D K+ DF LS D+ S L APE
Sbjct: 509 SK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM-APESI 564
Query: 248 MTGQMSSKSDVYSFGVVLLELLT-GRKP 274
+ +S SDV+ FGV + E+L G KP
Sbjct: 565 NFRRFTSASDVWMFGVCMWEILMHGVKP 592
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 6e-30
Identities = 53/218 (24%), Positives = 106/218 (48%), Gaps = 22/218 (10%)
Query: 65 TDNFGTNSLIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPD-QEFLAQVSMVSRLKNEN 122
+ + +G+G++G+VY +G AA K +++ + + ++++ ++ +++ +
Sbjct: 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPY 77
Query: 123 VVELVG-YYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAAR 181
+V+L+G YY DG L ++ E G++ I+ L+ Q +
Sbjct: 78 IVKLLGAYYHDGKLWIMI-EFCPGGAVDAIMLELDRG--------LTEPQIQVVCRQMLE 128
Query: 182 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGY 241
L +LH K RIIHR++K+ NVL+ + +++DF +S + + S +GT +
Sbjct: 129 ALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS--FIGTPYW 183
Query: 242 HAPEYAMTGQMS-----SKSDVYSFGVVLLELLTGRKP 274
APE M M K+D++S G+ L+E+ P
Sbjct: 184 MAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPP 221
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 6e-30
Identities = 62/212 (29%), Positives = 110/212 (51%), Gaps = 17/212 (8%)
Query: 65 TDNFGTNSLIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENV 123
+ F +GEGSYG VY + +G+ AIK++ QE + ++S++ + + +V
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDL-QEIIKEISIMQQCDSPHV 86
Query: 124 VELVG-YYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARG 182
V+ G Y+ + L ++ E+ GS+ DI+ + L+ + I +G
Sbjct: 87 VKYYGSYFKNTDLWIVM-EYCGAGSVSDIIRLRNKT--------LTEDEIATILQSTLKG 137
Query: 183 LEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYH 242
LEYLH R IHR+IK+ N+LL + AK++DF ++ Q D A+ ++ V+GT +
Sbjct: 138 LEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNT--VIGTPFWM 192
Query: 243 APEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
APE + +D++S G+ +E+ G+ P
Sbjct: 193 APEVIQEIGYNCVADIWSLGITAIEMAEGKPP 224
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 6e-30
Identities = 63/222 (28%), Positives = 97/222 (43%), Gaps = 45/222 (20%)
Query: 74 IGEGSYGRVYFGVLRSGRAA----AIKKL--DSSKQPDQEFLAQVSMVSRLKNENVVELV 127
IG G G V +G LR AIK L +++ ++FL++ S++ + + N++ L
Sbjct: 57 IGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLE 116
Query: 128 GYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLH 187
G G L ++ E+ GSL L G + Q V + G G+ YL
Sbjct: 117 GVVTRGRLAMIVTEYMENGSLDTFLRTHDGQ--------FTIMQLVGMLRGVGAGMRYLS 168
Query: 188 EKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLG--TFGYH--- 242
+ +HR++ + NVL+ + + K+SDF LS RVL +
Sbjct: 169 DL---GYVHRDLAARNVLVDSNLVCKVSDFGLS-------------RVLEDDPDAAYTTT 212
Query: 243 ---------APEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 274
APE SS SDV+SFGVV+ E+L G +P
Sbjct: 213 GGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERP 254
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 7e-30
Identities = 65/230 (28%), Positives = 114/230 (49%), Gaps = 19/230 (8%)
Query: 49 QPIAVPVISVDELKEK-TDNFGTNSLIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPD- 105
P+ + + LK + F IG+GS+G V+ G+ R+ + AIK +D + D
Sbjct: 4 SPVQSGLPGMQNLKADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDE 63
Query: 106 -QEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPG 164
++ +++++S+ + V + G Y+ + E+ GS D+L +PG
Sbjct: 64 IEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL---------EPG 114
Query: 165 PVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAP 224
P L Q I +GL+YLH + + IHR+IK++NVLL + K++DF ++ Q
Sbjct: 115 P-LDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLT 170
Query: 225 DAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
D + ++ +GT + APE SK+D++S G+ +EL G P
Sbjct: 171 DTQIKRNT--FVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPP 218
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 7e-30
Identities = 69/272 (25%), Positives = 120/272 (44%), Gaps = 40/272 (14%)
Query: 56 ISVDELKEKTDNFGTNSLIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQVSM 114
I + L++ F L+G G+YG+VY G +++G+ AAIK +D + ++E +++M
Sbjct: 14 IDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINM 73
Query: 115 VSRLKN-ENVVELVGYYVDGPLRVLAY------EHASKGSLHDILHGKKGVKGAKPGPVL 167
+ + + N+ G ++ + E GS+ D+ +K K L
Sbjct: 74 LKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDL------IKNTKGNT-L 126
Query: 168 SWAQRVKIAV---GAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAP 224
IA RGL +LH+ ++IHR+IK NVLL ++ K+ DF +S Q
Sbjct: 127 KEEW---IAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD 180
Query: 225 DAAARLHSTRVLGTFGYHAPEYAMTGQMS-----SKSDVYSFGVVLLELLTGRKPVDHTL 279
R ++ +GT + APE + KSD++S G+ +E+ G P+
Sbjct: 181 RTVGRRNT--FIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMH 238
Query: 280 P-RGQQSLVTWATPKLSEDK--------VKQC 302
P R + P+L K ++ C
Sbjct: 239 PMRALFLIPRNPAPRLKSKKWSKKFQSFIESC 270
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 7e-30
Identities = 59/214 (27%), Positives = 101/214 (47%), Gaps = 28/214 (13%)
Query: 74 IGEGSYGRVYFGVLRSGRAA-----AIKKL--DSSKQPDQEFLAQVSMVSRLKNENVVEL 126
IG G +G VY G+L++ AIK L +++ +FL + ++ + + N++ L
Sbjct: 52 IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRL 111
Query: 127 VGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYL 186
G ++ E+ G+L L K G S Q V + G A G++YL
Sbjct: 112 EGVISKYKPMMIITEYMENGALDKFLREKDGE--------FSVLQLVGMLRGIAAGMKYL 163
Query: 187 HEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTR-----VLGTFGY 241
+HR++ + N+L+ + + K+SDF LS D ++T + T
Sbjct: 164 ANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWT--- 217
Query: 242 HAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 274
APE + +S SDV+SFG+V+ E++T G +P
Sbjct: 218 -APEAISYRKFTSASDVWSFGIVMWEVMTYGERP 250
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 9e-30
Identities = 49/234 (20%), Positives = 96/234 (41%), Gaps = 38/234 (16%)
Query: 65 TDNFGTNSLIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENV 123
+F +++G+G++G+V R AIKK+ +++ L++V +++ L ++ V
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYV 64
Query: 124 VELVGYYVDGPLRVLAY-------------EHASKGSLHDILHGKKGVKGAKPGPVLSWA 170
V +++ V E+ G+L+D++ +
Sbjct: 65 VRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLI--HSENLNQQRDEYWRLF 122
Query: 171 QRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARL 230
+++ L Y+H + IIHR++K N+ + + KI DF L+ + L
Sbjct: 123 RQI------LEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDIL 173
Query: 231 HS------------TRVLGTFGYHAPE-YAMTGQMSSKSDVYSFGVVLLELLTG 271
T +GT Y A E TG + K D+YS G++ E++
Sbjct: 174 KLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP 227
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 1e-29
Identities = 54/231 (23%), Positives = 101/231 (43%), Gaps = 49/231 (21%)
Query: 74 IGEGSYGRVYFGVLRSGRAA------AIKKL-DSSKQPDQEFLAQVSMVSRLKNENVVEL 126
+GEG++G+V+ + A+K L ++S+ Q+F + +++ L+++++V
Sbjct: 49 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108
Query: 127 VGYYV---DGPLRVLAYEHASKGSLHDIL------HGKKGVKGAKPGPVLSWAQRVKIAV 177
G V PL ++ +E+ G L+ L L Q + +A
Sbjct: 109 FG--VCTEGRPLLMV-FEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVAS 165
Query: 178 GAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLG 237
A G+ YL +HR++ + N L+ + KI DF +S R +
Sbjct: 166 QVAAGMVYLAGL---HFVHRDLATRNCLVGQGLVVKIGDFGMS-------------RDIY 209
Query: 238 TFGYH-------------APEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 274
+ Y+ PE + + +++SDV+SFGVVL E+ T G++P
Sbjct: 210 STDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP 260
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 2e-29
Identities = 55/213 (25%), Positives = 100/213 (46%), Gaps = 27/213 (12%)
Query: 74 IGEGSYGRVYFGVLRSGRAA----AIKKL--DSSKQPDQEFLAQVSMVSRLKNENVVELV 127
+G G +G V G L+ AIK L +++ ++FL + S++ + + N++ L
Sbjct: 53 VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112
Query: 128 GYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLH 187
G ++ E+ GSL L K + Q V + G A G++YL
Sbjct: 113 GVVTKSKPVMIVTEYMENGSLDSFLR--------KHDAQFTVIQLVGMLRGIASGMKYLS 164
Query: 188 EKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTR-----VLGTFGYH 242
+ +HR++ + N+L+ + + K+SDF L D ++TR + T
Sbjct: 165 DM---GYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWT---- 217
Query: 243 APEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 274
+PE + +S SDV+S+G+VL E+++ G +P
Sbjct: 218 SPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 2e-29
Identities = 62/242 (25%), Positives = 108/242 (44%), Gaps = 25/242 (10%)
Query: 36 KEAPAKEMKTVTVQPIAVPVISVDELKEKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAA 94
E K ++ Q V + D+ ++ S +G G+ G V+ + SG A
Sbjct: 10 DEQQRKRLEAFLTQKQKVGELKDDDFEKI-------SELGAGNGGVVFKVSHKPSGLVMA 62
Query: 95 IKKLDSSKQPD--QEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDIL 152
K + +P + + ++ ++ + +V G + + EH GSL +L
Sbjct: 63 RKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL 122
Query: 153 HGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIA 212
+ P +L K+++ +GL YL EK +I+HR++K SN+L+
Sbjct: 123 KKAGRI----PEQILG-----KVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEI 171
Query: 213 KISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGR 272
K+ DF +S Q D+ A + V GT Y +PE S +SD++S G+ L+E+ GR
Sbjct: 172 KLCDFGVSGQLIDSMAN---SFV-GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 227
Query: 273 KP 274
P
Sbjct: 228 YP 229
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 2e-29
Identities = 56/229 (24%), Positives = 96/229 (41%), Gaps = 49/229 (21%)
Query: 74 IGEGSYGRVYFGVLRSGRAA----AIKKL---DSSKQPDQEFLAQVSMVSRLKNENVVEL 126
+GEG +G V G L+ A+K + +SS++ +EFL++ + + + NV+ L
Sbjct: 42 LGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRL 101
Query: 127 VG-------YYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGA 179
+G + P+ +L G LH L + + +K V
Sbjct: 102 LGVCIEMSSQGIPKPMVIL--PFMKYGDLHTYL---LYSRLETGPKHIPLQTLLKFMVDI 156
Query: 180 ARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTF 239
A G+EYL + +HR++ + N +L DD ++DF LS + + +
Sbjct: 157 ALGMEYLSNR---NFLHRDLAARNCMLRDDMTVCVADFGLS-------------KKIYSG 200
Query: 240 GYH-------------APEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 274
Y+ A E +SKSDV++FGV + E+ T G P
Sbjct: 201 DYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTP 249
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 2e-29
Identities = 58/208 (27%), Positives = 101/208 (48%), Gaps = 24/208 (11%)
Query: 74 IGEGSYGRVYFGVLR-----SGRAAAIKKL-DSSKQPDQEFLAQVSMVSRLKNENVVELV 127
+G+G++G V +G A+KKL S+++ ++F ++ ++ L+++N+V+
Sbjct: 18 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 128 G---YYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLE 184
G L+++ E+ GSL D L K + + ++ +G+E
Sbjct: 78 GVCYSAGRRNLKLIM-EYLPYGSLRDYLQKHKER--------IDHIKLLQYTSQICKGME 128
Query: 185 YLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPD--AAARLHSTRVLGTFGYH 242
YL K R IHR++ + N+L+ +++ KI DF L+ P ++ F Y
Sbjct: 129 YLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWY- 184
Query: 243 APEYAMTGQMSSKSDVYSFGVVLLELLT 270
APE + S SDV+SFGVVL EL T
Sbjct: 185 APESLTESKFSVASDVWSFGVVLYELFT 212
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 2e-29
Identities = 55/226 (24%), Positives = 94/226 (41%), Gaps = 50/226 (22%)
Query: 74 IGEGSYGRVYFGVL-----RSGRAAAIKKL--DSSKQPDQEFLAQVSMVSRLKNENVVEL 126
+GEG +G+V +G A+K L +S + ++ ++ L +EN+V+
Sbjct: 29 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88
Query: 127 VG---YYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGL 183
G ++++ E GSL + L K ++ Q++K AV +G+
Sbjct: 89 KGICTEDGGNGIKLIM-EFLPSGSLKEYLPKNKNK--------INLKQQLKYAVQICKGM 139
Query: 184 EYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVL--GTFGY 241
+YL + + +HR++ + NVL+ + KI DF L+ + + Y
Sbjct: 140 DYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLT-------------KAIETDKEYY 183
Query: 242 H------------APEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 274
APE M + SDV+SFGV L ELLT
Sbjct: 184 TVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSD 229
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 2e-29
Identities = 55/230 (23%), Positives = 93/230 (40%), Gaps = 50/230 (21%)
Query: 74 IGEGSYGRVYFGVLRSGRAA----AIK--KLDSSKQPD-QEFLAQVSMVSRLKNENVVEL 126
+G+G +G V L+ + A+K K D D +EFL + + + + +V +L
Sbjct: 31 LGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKL 90
Query: 127 VG--------YYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVG 178
VG + P+ +L G LH L + + L V+ V
Sbjct: 91 VGVSLRSRAKGRLPIPMVIL--PFMKHGDLHAFL---LASRIGENPFNLPLQTLVRFMVD 145
Query: 179 AARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGT 238
A G+EYL + IHR++ + N +L +D ++DF LS R + +
Sbjct: 146 IACGMEYLSSR---NFIHRDLAARNCMLAEDMTVCVADFGLS-------------RKIYS 189
Query: 239 FGYH-------------APEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 274
Y+ A E + SDV++FGV + E++T G+ P
Sbjct: 190 GDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTP 239
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 3e-29
Identities = 58/208 (27%), Positives = 101/208 (48%), Gaps = 24/208 (11%)
Query: 74 IGEGSYGRVYFGVL-----RSGRAAAIKKL-DSSKQPDQEFLAQVSMVSRLKNENVVELV 127
+G+G++G V +G A+KKL S+++ ++F ++ ++ L+++N+V+
Sbjct: 49 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 108
Query: 128 G---YYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLE 184
G L+++ E+ GSL D L K + + ++ +G+E
Sbjct: 109 GVCYSAGRRNLKLIM-EYLPYGSLRDYLQKHKER--------IDHIKLLQYTSQICKGME 159
Query: 185 YLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPD--AAARLHSTRVLGTFGYH 242
YL K R IHR++ + N+L+ +++ KI DF L+ P ++ F Y
Sbjct: 160 YLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWY- 215
Query: 243 APEYAMTGQMSSKSDVYSFGVVLLELLT 270
APE + S SDV+SFGVVL EL T
Sbjct: 216 APESLTESKFSVASDVWSFGVVLYELFT 243
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 4e-29
Identities = 48/227 (21%), Positives = 89/227 (39%), Gaps = 50/227 (22%)
Query: 74 IGEGSYGRVYFGVLRSGRAA--------AIKKL-DSSKQPDQEFLAQVSMVSRLKNENVV 124
+G+G++ +++ GV R +K L + + + F SM+S+L ++++V
Sbjct: 16 LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75
Query: 125 ELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLE 184
G V G +L E GSL L K ++ ++++A A +
Sbjct: 76 LNYGVCVCGDENILVQEFVKFGSLDTYLK--------KNKNCINILWKLEVAKQLAAAMH 127
Query: 185 YLHEKAEPRIIHRNIKSSNVLLFDDD--------IAKISDFDLSNQAPDAAARLHSTRVL 236
+L E +IH N+ + N+LL ++ K+SD +S +
Sbjct: 128 FLEEN---TLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGIS-------------ITV 171
Query: 237 GTFGYH-------APEYAMTGQM-SSKSDVYSFGVVLLELLT-GRKP 274
PE + + +D +SFG L E+ + G KP
Sbjct: 172 LPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKP 218
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 5e-29
Identities = 52/214 (24%), Positives = 87/214 (40%), Gaps = 21/214 (9%)
Query: 66 DNFGTNSLIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQE---FLAQVSMVSRL-KN 120
+F S +G GSYG V+ GR A+K+ S + ++ LA+V ++ ++
Sbjct: 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQH 116
Query: 121 ENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAA 180
V L + +G + L E SL G L AQ
Sbjct: 117 PCCVRLEQAWEEGGILYLQTELCG-PSLQQHCE--------AWGASLPEAQVWGYLRDTL 167
Query: 181 RGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFG 240
L +LH + ++H ++K +N+ L K+ DF L + A A + G
Sbjct: 168 LALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAG--EVQE-GDPR 221
Query: 241 YHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
Y APE + G + +DV+S G+ +LE+ +
Sbjct: 222 YMAPE-LLQGSYGTAADVFSLGLTILEVACNMEL 254
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 9e-29
Identities = 62/227 (27%), Positives = 99/227 (43%), Gaps = 32/227 (14%)
Query: 60 ELKEKTDNFGTNSLIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRL 118
+ EK ++F +L+G+GS+ VY + +G AIK +D + + MV R+
Sbjct: 5 CIGEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKA------MYKAGMVQRV 58
Query: 119 KNE----------NVVELVGYYVDGPLRV-LAYEHASKGSLHDILHGKKGVKGAKPGPVL 167
+NE +++EL Y+ D V L E G ++ L +
Sbjct: 59 QNEVKIHCQLKHPSILELYNYFED-SNYVYLVLEMCHNGEMNRYLKNRVKP--------F 109
Query: 168 SWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAA 227
S + G+ YLH I+HR++ SN+LL + KI+DF L+ Q
Sbjct: 110 SENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPH 166
Query: 228 ARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
+ ++ GT Y +PE A +SDV+S G + LL GR P
Sbjct: 167 EKHYTL--CGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPP 211
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 1e-28
Identities = 48/240 (20%), Positives = 92/240 (38%), Gaps = 35/240 (14%)
Query: 54 PVISVDELKEKTD-------NFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSS--KQP 104
P + D+ E+T +F ++G G+ G + + + R A+K++
Sbjct: 5 PSLEQDDGDEETSVVIVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFA 64
Query: 105 DQEFLAQVSMVSRLKN-ENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKP 163
D+E V ++ NV+ D + +A E + +L + + +
Sbjct: 65 DRE----VQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA-ATLQEYV--------EQK 111
Query: 164 GPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD-----IAKISDFD 218
+ + + GL +LH I+HR++K N+L+ + A ISDF
Sbjct: 112 DFAHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFG 168
Query: 219 LSNQ-APDAAARLHSTRVLGTFGYHAPEY---AMTGQMSSKSDVYSFGVVLLELLTGRKP 274
L + A + + V GT G+ APE + D++S G V +++
Sbjct: 169 LCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSH 228
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 2e-28
Identities = 66/257 (25%), Positives = 100/257 (38%), Gaps = 29/257 (11%)
Query: 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPD--QEFLAQVSMVSRLKN 120
K D+ +G G+YG V SG+ A+K++ ++ + L + + R +
Sbjct: 5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVD 64
Query: 121 -ENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGA 179
V G + E SL P +L KIAV
Sbjct: 65 CPFTVTFYGALFREGDVWICMELMD-TSLDKFYKQVIDKGQTIPEDILG-----KIAVSI 118
Query: 180 ARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTF 239
+ LE+LH K +IHR++K SNVL+ K+ DF +S D A+ G
Sbjct: 119 VKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAK---DIDAGCK 173
Query: 240 GYHAPE----YAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLP--RGQQSLVTWATPK 293
Y APE S KSD++S G+ ++EL R P D + + +V +P+
Sbjct: 174 PYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQ 233
Query: 294 LSEDK--------VKQC 302
L DK QC
Sbjct: 234 LPADKFSAEFVDFTSQC 250
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 4e-28
Identities = 58/226 (25%), Positives = 95/226 (42%), Gaps = 43/226 (19%)
Query: 74 IGEGSYGRVYFGVLRSGRAA------AIKKL--DSSKQPDQEFLAQVSMVSRLKNENVVE 125
+G G++G VY G + A+K L S+Q + +FL + ++S+ ++N+V
Sbjct: 38 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 126 LVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEY 185
+G + R + E + G L L + L+ + +A A G +Y
Sbjct: 98 CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPS--QPSSLAMLDLLHVARDIACGCQY 155
Query: 186 LHEKAEPRIIHRNIKSSNVLLF---DDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYH 242
L E IHR+I + N LL +AKI DF ++ R + Y+
Sbjct: 156 LEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMA-------------RDIYRASYY 199
Query: 243 -------------APEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 274
PE M G +SK+D +SFGV+L E+ + G P
Sbjct: 200 RKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 245
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 6e-28
Identities = 62/251 (24%), Positives = 103/251 (41%), Gaps = 12/251 (4%)
Query: 66 DNFGTNSLIGEGSYGRVYFGV-LRSGRAAAIKKLD-SSKQPDQEFLAQ-VSMVSRLKNEN 122
D++ +IG G+ V AIK+++ Q + L + + +S+ + N
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74
Query: 123 VVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARG 182
+V +V L + S GS+ DI+ K G L + I G
Sbjct: 75 IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGV-LDESTIATILREVLEG 133
Query: 183 LEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTR---VLGTF 239
LEYLH+ IHR++K+ N+LL +D +I+DF +S + +GT
Sbjct: 134 LEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTP 190
Query: 240 GYHAPEYAMTGQM-SSKSDVYSFGVVLLELLTGRKPVDHTLP-RGQQSLVTWATPKLSED 297
+ APE + K+D++SFG+ +EL TG P P + + P L
Sbjct: 191 CWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETG 250
Query: 298 KVKQCVDTKLG 308
+ + K G
Sbjct: 251 VQDKEMLKKYG 261
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 7e-28
Identities = 59/241 (24%), Positives = 111/241 (46%), Gaps = 59/241 (24%)
Query: 74 IGEGSYGRVYFGVLRSGRAA------AIKKL--DSSKQPDQEFLAQVSMVSRLKNENVVE 125
IGEG++GRV+ A+K L ++S +F + ++++ N N+V+
Sbjct: 55 IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVK 114
Query: 126 LVGYYV---DGPLRVLAYEHASKGSLHDIL---------------HGKKGVKGAKPGPVL 167
L+G V P+ +L +E+ + G L++ L + + P L
Sbjct: 115 LLG--VCAVGKPMCLL-FEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPL 171
Query: 168 SWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAA 227
S A+++ IA A G+ YL E+ + +HR++ + N L+ ++ + KI+DF LS
Sbjct: 172 SCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLS------- 221
Query: 228 ARLHSTRVLGTFGYH-------------APEYAMTGQMSSKSDVYSFGVVLLELLT-GRK 273
R + + Y+ PE + +++SDV+++GVVL E+ + G +
Sbjct: 222 ------RNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ 275
Query: 274 P 274
P
Sbjct: 276 P 276
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 7e-28
Identities = 45/260 (17%), Positives = 94/260 (36%), Gaps = 34/260 (13%)
Query: 39 PAKEMKTVTVQPIAVPVISVDELKEKT--DNFGTNSLIGEGSYGRVYFGVLRSGRAAAIK 96
P MK + + ++ ++ +++ + +G + ++ + + A+K
Sbjct: 2 PLGSMKDILSNYSNLIYLNKYVKEKDKYINDYRIIRTLNQGKFNKIILCE-KDNKFYALK 60
Query: 97 KLD--------SSKQPDQEFLAQVSMVSRLKNE----------NVVELVGYYVDGPLRV- 137
K + + + + ++ S KNE + G + V
Sbjct: 61 KYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIITN-YDEVY 119
Query: 138 LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHR 197
+ YE+ S+ V + I Y+H + I HR
Sbjct: 120 IIYEYMENDSILKFDE-YFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEK--NICHR 176
Query: 198 NIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMS---S 254
++K SN+L+ + K+SDF S D ++ +R GT+ + PE + + S +
Sbjct: 177 DVKPSNILMDKNGRVKLSDFGESEYMVD--KKIKGSR--GTYEFMPPE-FFSNESSYNGA 231
Query: 255 KSDVYSFGVVLLELLTGRKP 274
K D++S G+ L + P
Sbjct: 232 KVDIWSLGICLYVMFYNVVP 251
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 111 bits (278), Expect = 7e-28
Identities = 34/283 (12%), Positives = 64/283 (22%), Gaps = 44/283 (15%)
Query: 36 KEAPAKEMKTVTVQPIAVPVISVDELKEKTDNFGTNSLIGEGSYGRVYFGV-LRSGRAAA 94
+ A E T TV P L + + G V+ + A
Sbjct: 32 EPAAMVEAVTATVWPQNAETTVDSLLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFA 91
Query: 95 IKKLDSSKQPDQEFLAQV----SMVSRLKNENVVELVGYY-------------------- 130
+K + + L ++ +RL E+ E
Sbjct: 92 LKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQL 151
Query: 131 ------VDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLE 184
+L AS L + + R
Sbjct: 152 SPGQDDYAVANYLLLMPAAS-VDLELLFSTLD--FVYVFRGDEGILALHILTAQLIRLAA 208
Query: 185 YLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAP 244
L K ++H + N+ + D + D + Y
Sbjct: 209 NLQSK---GLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGT-----RGPASSVPVTYAPR 260
Query: 245 EYAM--TGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQS 285
E+ T + + + G+ + + P P + S
Sbjct: 261 EFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGS 303
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 8e-28
Identities = 63/222 (28%), Positives = 110/222 (49%), Gaps = 32/222 (14%)
Query: 73 LIGEGSYGRVYFGVLRSG---RAAAIKKL--DSSKQPDQEFLAQVSMVSRL-KNENVVEL 126
+IGEG++G+V ++ AAIK++ +SK ++F ++ ++ +L + N++ L
Sbjct: 32 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 91
Query: 127 VGY-YVDGPLRVLAYEHASKGSLHDILHGKK-------GVKGAKPGPVLSWAQRVKIAVG 178
+G G L + E+A G+L D L + LS Q + A
Sbjct: 92 LGACEHRGYLYLAI-EYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 150
Query: 179 AARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGT 238
ARG++YL +K + IHR++ + N+L+ ++ +AKI+DF LS R V T
Sbjct: 151 VARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLS--------RGQEVYVKKT 199
Query: 239 FG-----YHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 274
G + A E ++ SDV+S+GV+L E+++ G P
Sbjct: 200 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 241
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 8e-28
Identities = 45/227 (19%), Positives = 83/227 (36%), Gaps = 41/227 (18%)
Query: 72 SLIGEGSYGRVYFGV-LR-SGRAAAIKKLDSSKQPDQEFL------AQVSMVSRLKNENV 123
I G G +Y + +GR +K L S D E Q ++ + + ++
Sbjct: 86 GCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSG--DAEAQAMAMAERQF--LAEVVHPSI 141
Query: 124 VEL--VGYYVDGPLRVLAY---EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVG 178
V++ + D + Y E+ SL K L A+ + +
Sbjct: 142 VQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK-----------LPVAEAIAYLLE 190
Query: 179 AARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHST-RVLG 237
L YLH +++ ++K N++L ++ K+ D A +R++S + G
Sbjct: 191 ILPALSYLHSI---GLVYNDLKPENIML-TEEQLKLIDLG-------AVSRINSFGYLYG 239
Query: 238 TFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQ 284
T G+ APE + +D+Y+ G L L + G
Sbjct: 240 TPGFQAPEIV-RTGPTVATDIYTVGRTLAALTLDLPTRNGRYVDGLP 285
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-27
Identities = 30/301 (9%), Positives = 87/301 (28%), Gaps = 48/301 (15%)
Query: 36 KEAPAKEMKTVTVQPIAVPVISVDELKEKTDNFGTNSLIGEGSYGRVYFGV-LRSGRAAA 94
++ A + + ++ P EL E+ +++G+ +G +
Sbjct: 48 MQSAADSLVSTSLWNTGQPFRVESELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFE 107
Query: 95 IKKLDSSKQPDQE-----------------------------FLAQVSMVSRLKNENVVE 125
+ +++P F+ +V + + ++
Sbjct: 108 VHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIR 167
Query: 126 LVG----YYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAAR 181
+ +V + ++ + ++L + L R+++ + R
Sbjct: 168 VRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKS-----LVHHARLQLTLQVIR 222
Query: 182 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGY 241
L LH ++H ++ +++L ++ F+ A+A R
Sbjct: 223 LLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHL-VRDGASAVSPIGRGFAPPET 278
Query: 242 HAPE-----YAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSE 296
A M+ D ++ G+ + + P G + + + +
Sbjct: 279 TAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGSEWIFRSCKNIPQ 338
Query: 297 D 297
Sbjct: 339 P 339
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 2e-27
Identities = 60/216 (27%), Positives = 89/216 (41%), Gaps = 39/216 (18%)
Query: 73 LIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNE---------- 121
+G+G +G VY +S A+K L ++ L + + +L+ E
Sbjct: 16 PLGKGKFGNVYLAREKQSKFILALKVLFKAQ------LEKAGVEHQLRREVEIQSHLRHP 69
Query: 122 NVVELVGYYVDGPLRV-LAYEHASKGSLHDIL--HGKKGVKGAKPGPVLSWAQRVKIAVG 178
N++ L GY+ D RV L E+A G+++ L K +
Sbjct: 70 NILRLYGYFHD-ATRVYLILEYAPLGTVYRELQKLSKFDEQRTA-----------TYITE 117
Query: 179 AARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGT 238
A L Y H K R+IHR+IK N+LL KI+DF S AP + + GT
Sbjct: 118 LANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPS---SRRTD-LCGT 170
Query: 239 FGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
Y PE K D++S GV+ E L G+ P
Sbjct: 171 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 206
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 3e-27
Identities = 67/238 (28%), Positives = 105/238 (44%), Gaps = 20/238 (8%)
Query: 74 IGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPD--QEFLAQVSMVSRLKN-ENVVELVGY 129
IG G+YG V V SG+ A+K++ S+ ++ L + +V R + +V+ G
Sbjct: 30 IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGA 89
Query: 130 YVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEK 189
+ E S + + P +L KI + + L +L E
Sbjct: 90 LFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILG-----KITLATVKALNHLKEN 144
Query: 190 AEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE---- 245
+IIHR+IK SN+LL K+ DF +S Q D+ A+ TR G Y APE
Sbjct: 145 L--KIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAK---TRDAGCRPYMAPERIDP 199
Query: 246 YAMTGQMSSKSDVYSFGVVLLELLTGRKPVD--HTLPRGQQSLVTWATPKLSEDKVKQ 301
A +SDV+S G+ L EL TGR P +++ +V P+LS + ++
Sbjct: 200 SASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSEERE 257
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 5e-27
Identities = 59/226 (26%), Positives = 96/226 (42%), Gaps = 43/226 (19%)
Query: 74 IGEGSYGRVYFGVLRSGRAA------AIKKL--DSSKQPDQEFLAQVSMVSRLKNENVVE 125
+G G++G VY G + A+K L S+Q + +FL + ++S+ ++N+V
Sbjct: 79 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 138
Query: 126 LVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEY 185
+G + R + E + G L L + L+ + +A A G +Y
Sbjct: 139 CIGVSLQSLPRFILLELMAGGDLKSFLRETR--PRPSQPSSLAMLDLLHVARDIACGCQY 196
Query: 186 LHEKAEPRIIHRNIKSSNVLLF---DDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYH 242
L E IHR+I + N LL +AKI DF ++ R + GY+
Sbjct: 197 LEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMA-------------RDIYRAGYY 240
Query: 243 -------------APEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 274
PE M G +SK+D +SFGV+L E+ + G P
Sbjct: 241 RKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 286
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 9e-27
Identities = 58/228 (25%), Positives = 93/228 (40%), Gaps = 24/228 (10%)
Query: 62 KEKTDNFGTNSLIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQP-DQEFLAQ-VSMVSRL 118
+ + +G G +G V + +G AIK+ P ++E + ++ +L
Sbjct: 10 TQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKL 69
Query: 119 KNENVVELV------GYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQR 172
+ NVV L +LA E+ G L L+ + G K GP+ +
Sbjct: 70 NHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSD 129
Query: 173 VKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD---IAKISDFDLSNQAPDAAAR 229
+ + L YLHE RIIHR++K N++L I KI D + +
Sbjct: 130 I------SSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQG--E 178
Query: 230 LHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDH 277
L + V GT Y APE + + D +SFG + E +TG +P
Sbjct: 179 LCTEFV-GTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLP 225
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 1e-26
Identities = 61/234 (26%), Positives = 110/234 (47%), Gaps = 50/234 (21%)
Query: 74 IGEGSYGRVYFGVLRSGRAA--------AIKKL--DSSKQPDQEFLAQVSMVSRL-KNEN 122
+GEG++G+V A+K L D++++ + ++++ M+ + K++N
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 123 VVELVGY-YVDGPLRVLAYEHASKGSLHDIL-------HGKKGVKGAKPGPVLSWAQRVK 174
++ L+G DGPL V+ E+ASKG+L + L P +++ V
Sbjct: 103 IINLLGACTQDGPLYVIV-EYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 161
Query: 175 IAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTR 234
ARG+EYL + + IHR++ + NVL+ ++++ KI+DF L+ R
Sbjct: 162 CTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLA-------------R 205
Query: 235 VLGTFGYH-------------APEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 274
+ Y+ APE + +SDV+SFGV++ E+ T G P
Sbjct: 206 DINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 259
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-26
Identities = 57/261 (21%), Positives = 95/261 (36%), Gaps = 35/261 (13%)
Query: 26 PAGNPGGFYVKEAPAKEMKTVTVQPIAVPVISVDELKEKTDNFGTNSLIGEGSYGRVYFG 85
+PG V A +P + VD + +G+G + + +
Sbjct: 3 APADPGKAGVPGVAAPGAPAAAPPAKEIPEVLVD--PRSRRRYVRGRFLGKGGFAKCFEI 60
Query: 86 V-LRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNE----------NVVELVGYYVDGP 134
+ A K + S L + ++ E +VV G++ D
Sbjct: 61 SDADTKEVFAGKIVPKSL------LLKPHQREKMSMEISIHRSLAHQHVVGFHGFFED-N 113
Query: 135 LRV-LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPR 193
V + E + SL ++ +K + + A+ G +YLH R
Sbjct: 114 DFVFVVLELCRRRSLLELHKRRKALTEPE-------ARY--YLRQIVLGCQYLHRN---R 161
Query: 194 IIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMS 253
+IHR++K N+ L +D KI DF L+ + R GT Y APE S
Sbjct: 162 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVL--CGTPNYIAPEVLSKKGHS 219
Query: 254 SKSDVYSFGVVLLELLTGRKP 274
+ DV+S G ++ LL G+ P
Sbjct: 220 FEVDVWSIGCIMYTLLVGKPP 240
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 2e-26
Identities = 66/236 (27%), Positives = 108/236 (45%), Gaps = 54/236 (22%)
Query: 74 IGEGSYGRVYFGVLRSGRAA--------AIKKL--DSSKQPDQEFLAQVSMVSRLKN-EN 122
+GEG++G+V A+K L D++++ + ++++ M+ + +N
Sbjct: 77 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136
Query: 123 VVELVGYYV---DGPLRVLAYEHASKGSLHDIL-------HGKKGVKGAKPGPVLSWAQR 172
++ L+G DGPL V+ E+ASKG+L + L P LS
Sbjct: 137 IINLLG--ACTQDGPLYVIV-EYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 193
Query: 173 VKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHS 232
V A ARG+EYL K + IHR++ + NVL+ +D++ KI+DF L+
Sbjct: 194 VSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLA------------ 238
Query: 233 TRVLGTFGYH-------------APEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 274
R + Y+ APE + +SDV+SFGV+L E+ T G P
Sbjct: 239 -RDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 293
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 107 bits (267), Expect = 2e-26
Identities = 33/304 (10%), Positives = 89/304 (29%), Gaps = 55/304 (18%)
Query: 37 EAPAKEMKTVTVQPIAVPVISVDELKEKTDNFGTNSLIGEGSYGRVYFGV-LRSGRAAAI 95
++ A + + ++ P EL E+ +++G+ +G + +
Sbjct: 44 QSAADSLVSTSLWNTGQPFRVESELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEV 103
Query: 96 KKLDSSKQPDQE-----------------------------FLAQVSMVSRLKNENVVEL 126
+++P F+ +V + + ++ +
Sbjct: 104 HVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRV 163
Query: 127 VGYYVDG--PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLE 184
D R Y +L G+ + + L R+++ + R L
Sbjct: 164 RLDERDMWVLSRFFLYPRMQ-SNLQTF--GEVLLSHSSTHKSLVHHARLQLTLQVIRLLA 220
Query: 185 YLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAP 244
LH ++H ++ +++L ++ F+ + + G+ P
Sbjct: 221 SLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG------ARVVSSVSRGFEPP 271
Query: 245 EYAMT-----------GQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPK 293
E M+ D ++ G+V+ + P+ G + +
Sbjct: 272 ELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGSEWIFRSCKN 331
Query: 294 LSED 297
+ +
Sbjct: 332 IPQP 335
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 3e-26
Identities = 61/236 (25%), Positives = 109/236 (46%), Gaps = 54/236 (22%)
Query: 74 IGEGSYGRVYFGVLRSGRAA--------AIKKL--DSSKQPDQEFLAQVSMVSRL-KNEN 122
+GEG +G+V A+K L D++++ + ++++ M+ + K++N
Sbjct: 89 LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 148
Query: 123 VVELVGYYV---DGPLRVLAYEHASKGSLHDIL-------HGKKGVKGAKPGPVLSWAQR 172
++ L+G DGPL V+ E+ASKG+L + L P +++
Sbjct: 149 IINLLG--ACTQDGPLYVI-VEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 205
Query: 173 VKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHS 232
V ARG+EYL + + IHR++ + NVL+ ++++ KI+DF L+
Sbjct: 206 VSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLA------------ 250
Query: 233 TRVLGTFGYH-------------APEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 274
R + Y+ APE + +SDV+SFGV++ E+ T G P
Sbjct: 251 -RDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 305
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 104 bits (263), Expect = 3e-26
Identities = 53/236 (22%), Positives = 91/236 (38%), Gaps = 35/236 (14%)
Query: 53 VPVISVDELKEKTDNFGTNSLIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQ 111
+P + VD + +G+G + + + + A K + S L +
Sbjct: 4 IPEVLVD--PRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSL------LLK 55
Query: 112 VSMVSRLKNE----------NVVELVGYYVDGPLRV-LAYEHASKGSLHDILHGKKGVKG 160
++ E +VV G++ D V + E + SL ++ +K +
Sbjct: 56 PHQREKMSMEISIHRSLAHQHVVGFHGFFED-NDFVFVVLELCRRRSLLELHKRRKALTE 114
Query: 161 AKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220
+ A+ G +YLH R+IHR++K N+ L +D KI DF L+
Sbjct: 115 PE-------ARY--YLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLA 162
Query: 221 NQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVD 276
+ R GT Y APE S + DV+S G ++ LL G+ P +
Sbjct: 163 TKVEYDGERKKVL--CGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE 216
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 3e-26
Identities = 53/233 (22%), Positives = 98/233 (42%), Gaps = 49/233 (21%)
Query: 74 IGEGSYGRVYFGVLR------SGRAAAIKKL--DSSKQPDQEFLAQVSMVSRL-KNENVV 124
+G G++G+V + R A+K L ++ + ++++ ++ + + NVV
Sbjct: 35 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 125 ELVG--YYVDGPLRVLAYEHASKGSLHDILHGKKG-------VKGAKPGPVLSWAQRVKI 175
L+G GPL V+ E G+L L K+ L+ +
Sbjct: 95 NLLGACTKPGGPLMVIV-EFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY 153
Query: 176 AVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRV 235
+ A+G+E+L + + IHR++ + N+LL + ++ KI DF L+ R
Sbjct: 154 SFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLA-------------RD 197
Query: 236 LGTFGYH-------------APEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 274
+ + APE + +SDV+SFGV+L E+ + G P
Sbjct: 198 IYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 250
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 4e-26
Identities = 35/214 (16%), Positives = 74/214 (34%), Gaps = 23/214 (10%)
Query: 74 IGEG--SYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEF---LAQVSMVSRLKNENVVELV 127
IG+G V +G +++++ ++ ++ + + N+V
Sbjct: 33 IGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYR 92
Query: 128 GYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLH 187
++ + + GS D++ ++ I G + L+Y+H
Sbjct: 93 ATFIADNELWVVTSFMAYGSAKDLI------CTHFMDG-MNELAIAYILQGVLKALDYIH 145
Query: 188 EKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVL-----GTFGYH 242
+HR++K+S++L+ D +S + R +
Sbjct: 146 HM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWL 202
Query: 243 APEYAMTGQM--SSKSDVYSFGVVLLELLTGRKP 274
+PE +KSD+YS G+ EL G P
Sbjct: 203 SPEVLQQNLQGYDAKSDIYSVGITACELANGHVP 236
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 8e-26
Identities = 57/210 (27%), Positives = 90/210 (42%), Gaps = 27/210 (12%)
Query: 73 LIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQV----SMVSRLKNENVVELV 127
+G+G +G VY ++ A+K L S+ + Q+ + S L++ N++ +
Sbjct: 21 PLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMY 80
Query: 128 GYYVDGPLRV-LAYEHASKGSLHDIL--HGKKGVKGAKPGPVLSWAQRVKIAVGAARGLE 184
Y+ D R+ L E A +G L+ L HG+ + + A L
Sbjct: 81 NYFHD-RKRIYLMLEFAPRGELYKELQKHGRFDEQRSA-----------TFMEELADALH 128
Query: 185 YLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAP 244
Y HE+ ++IHR+IK N+L+ KI+DF S AP R + GT Y P
Sbjct: 129 YCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAPS--LRRRTM--CGTLDYLPP 181
Query: 245 EYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
E K D++ GV+ E L G P
Sbjct: 182 EMIEGKTHDEKVDLWCAGVLCYEFLVGMPP 211
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-25
Identities = 55/241 (22%), Positives = 102/241 (42%), Gaps = 59/241 (24%)
Query: 74 IGEGSYGRVYFGVLRSGRAA------AIKKL--DSSKQPDQEFLAQVSMVSRLKNENVVE 125
+GEG +G+V + A+K L ++S ++ L++ +++ ++ + +V++
Sbjct: 31 LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 126 LVGYYV---DGPLRVLAYEHASKGSLHDIL---------------HGKKGVKGAKPGPVL 167
L G DGPL ++ E+A GSL L L
Sbjct: 91 LYG--ACSQDGPLLLIV-EYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERAL 147
Query: 168 SWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAA 227
+ + A ++G++YL E +++HR++ + N+L+ + KISDF LS
Sbjct: 148 TMGDLISFAWQISQGMQYLAEM---KLVHRDLAARNILVAEGRKMKISDFGLS------- 197
Query: 228 ARLHSTRVLGTFGYH-------------APEYAMTGQMSSKSDVYSFGVVLLELLT-GRK 273
R + + A E +++SDV+SFGV+L E++T G
Sbjct: 198 ------RDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGN 251
Query: 274 P 274
P
Sbjct: 252 P 252
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-25
Identities = 57/231 (24%), Positives = 97/231 (41%), Gaps = 48/231 (20%)
Query: 74 IGEGSYGRVYFGVLR------SGRAAAIKKL--DSSKQPDQEFLAQVSMVSRLKN-ENVV 124
+G G++G+V + A+K L + + ++++ ++S L EN+V
Sbjct: 54 LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 113
Query: 125 ELVGYYV---DGPLRVLAYEHASKGSLHDILHGKKGV-----KGAKPGPVLSWAQRVKIA 176
L+G GP+ V+ E+ G L + L K V A S + +
Sbjct: 114 NLLG--ACTHGGPVLVIT-EYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFS 170
Query: 177 VGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVL 236
A+G+ +L K IHR++ + NVLL + +AKI DF L AR ++
Sbjct: 171 SQVAQGMAFLASK---NCIHRDVAARNVLLTNGHVAKIGDFGL--------ARD----IM 215
Query: 237 GTFGYH------------APEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 274
Y APE + +SDV+S+G++L E+ + G P
Sbjct: 216 NDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNP 266
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 4e-25
Identities = 58/249 (23%), Positives = 102/249 (40%), Gaps = 34/249 (13%)
Query: 74 IGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPD--QEFLAQVSMVSRLKN-ENVVELVGY 129
+G G+ G+V+ ++G A+K++ S + + L + +V + + +V+ G
Sbjct: 33 MGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGT 92
Query: 130 YVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEK 189
++ +A E + + + P +L K+ V + L YL EK
Sbjct: 93 FITNTDVFIAMELMGTCAEKLKKRMQGPI----PERILG-----KMTVAIVKALYYLKEK 143
Query: 190 AEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE---- 245
+IHR++K SN+LL + K+ DF +S + D A+ R G Y APE
Sbjct: 144 H--GVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAK---DRSAGCAAYMAPERIDP 198
Query: 246 -YAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLP--RGQQSLVTWATPKLSEDK---- 298
++DV+S G+ L+EL TG+ P + ++ P L
Sbjct: 199 PDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFSG 258
Query: 299 -----VKQC 302
VK C
Sbjct: 259 DFQSFVKDC 267
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 5e-25
Identities = 63/246 (25%), Positives = 101/246 (41%), Gaps = 35/246 (14%)
Query: 74 IGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQ----VSMVSRLKNENVVELVG 128
IG GS+G VYF +R+ AIKK+ S + E V + +L++ N ++ G
Sbjct: 62 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 121
Query: 129 YYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHE 188
Y+ L E+ GS D+L K L + + GA +GL YLH
Sbjct: 122 CYLREHTAWLVMEYCL-GSASDLLEVHKKP--------LQEVEIAAVTHGALQGLAYLHS 172
Query: 189 KAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAM 248
+IHR++K+ N+LL + + K+ DF ++ A +GT + APE +
Sbjct: 173 H---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA------NSFVGTPYWMAPEVIL 223
Query: 249 TGQMS---SKSDVYSFGVVLLELLTGRKPVDHTLP-RGQQSLVTWATPKLSEDK------ 298
K DV+S G+ +EL + P+ + + +P L
Sbjct: 224 AMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFR 283
Query: 299 --VKQC 302
V C
Sbjct: 284 NFVDSC 289
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 6e-25
Identities = 46/238 (19%), Positives = 89/238 (37%), Gaps = 35/238 (14%)
Query: 62 KEKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLK 119
+ + + ++G GS G V F GR A+K++ E + +++
Sbjct: 11 QSLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALME----IKLLTESD 66
Query: 120 N-ENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVG 178
+ NV+ +A E + +L D++ K + + + +
Sbjct: 67 DHPNVIRYYCSETTDRFLYIALELCN-LNLQDLVESKN--VSDENLKLQKEYNPISLLRQ 123
Query: 179 AARGLEYLHEKAEPRIIHRNIKSSNVLL-------------FDDDIAKISDFDLSNQAPD 225
A G+ +LH +IIHR++K N+L+ ++ ISDF L +
Sbjct: 124 IASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDS 180
Query: 226 AAARLHSTR--VLGTFGYHAPE-------YAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
+ + GT G+ APE +++ D++S G V +L+ K
Sbjct: 181 GQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKH 238
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 7e-25
Identities = 56/227 (24%), Positives = 90/227 (39%), Gaps = 34/227 (14%)
Query: 73 LIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQ-VSMVSRLKN-ENVVELVGY 129
++ EG + VY + SGR A+K+L S+++ + Q V + +L N+V+
Sbjct: 35 VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94
Query: 130 YVDGPLR-------VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARG 182
G L KG L + L K + LS +KI R
Sbjct: 95 ASIGKEESDTGQAEFLLLTELCKGQLVEFL------KKMESRGPLSCDTVLKIFYQTCRA 148
Query: 183 LEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDF----------DLSNQAPDAAARLHS 232
++++H + +P IIHR++K N+LL + K+ DF D S A A
Sbjct: 149 VQHMHRQ-KPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEE 207
Query: 233 TRVLGTFGYHAPEYAMTGQMS-----SKSDVYSFGVVLLELLTGRKP 274
T Y PE + S K D+++ G +L L + P
Sbjct: 208 ITRNTTPMYRTPE--IIDLYSNFPIGEKQDIWALGCILYLLCFRQHP 252
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 7e-25
Identities = 41/221 (18%), Positives = 78/221 (35%), Gaps = 27/221 (12%)
Query: 73 LIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPD---QEFLAQVSMVSRL-KNENVVELV 127
IG G +G V+ V G AIK+ Q L +V + L ++ +VV
Sbjct: 18 KIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYF 77
Query: 128 GYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLH 187
+ + ++ E+ + GSL D + + L + + RGL Y+H
Sbjct: 78 SAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELK-----DLLLQVGRGLRYIH 132
Query: 188 EKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDA------------AARLHSTRV 235
++H +IK SN+ + I + + + R+ S +V
Sbjct: 133 SM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQV 189
Query: 236 L-GTFGYHAPE-YAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
G + A E K+D+++ + ++
Sbjct: 190 EEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPL 230
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 8e-25
Identities = 52/239 (21%), Positives = 96/239 (40%), Gaps = 30/239 (12%)
Query: 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK--QPDQEFLAQVSMVSRLKNEN 122
+ + ++G+G+ V+ G + +G AIK ++ +P + + ++ +L ++N
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68
Query: 123 VVELVGYYVDGPLR--VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAA 180
+V+L + R VL E GSL+ +L G L + V
Sbjct: 69 IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDV------V 122
Query: 181 RGLEYLHEKAEPRIIHRNIKSSNVLLF----DDDIAKISDFDLSNQAPDAAARLHSTRVL 236
G+ +L E I+HRNIK N++ + K++DF + + D + S +
Sbjct: 123 GGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE-QFVS--LY 176
Query: 237 GTFGYHAPE--------YAMTGQMSSKSDVYSFGVVLLELLTGRKP-VDHTLPRGQQSL 286
GT Y P+ + + D++S GV TG P PR + +
Sbjct: 177 GTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEV 235
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-24
Identities = 53/234 (22%), Positives = 92/234 (39%), Gaps = 50/234 (21%)
Query: 74 IGEGSYGRVYFGVLRSGRAA------AIKKL--DSSKQPDQEFLAQVSMVSRLKN-ENVV 124
+G G++G+V + A+K L + + ++++ ++S L N N+V
Sbjct: 31 LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 90
Query: 125 ELVGYY-VDGPLRVLAYEHASKGSLHDILHGKKGVK---------GAKPGPVLSWAQRVK 174
L+G + GP V+ E+ G L + L K+ L +
Sbjct: 91 NLLGACTIGGPTLVIT-EYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLS 149
Query: 175 IAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTR 234
+ A+G+ +L K IHR++ + N+LL I KI DF L+ R
Sbjct: 150 FSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLA-------------R 193
Query: 235 VLGTFGYH-------------APEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 274
+ + APE + +SDV+S+G+ L EL + G P
Sbjct: 194 DIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP 247
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 3e-24
Identities = 52/239 (21%), Positives = 96/239 (40%), Gaps = 30/239 (12%)
Query: 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK--QPDQEFLAQVSMVSRLKNEN 122
+ + ++G+G+ V+ G + +G AIK ++ +P + + ++ +L ++N
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68
Query: 123 VVELVGYYVDGPLR--VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAA 180
+V+L + R VL E GSL+ +L G L + V
Sbjct: 69 IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDV------V 122
Query: 181 RGLEYLHEKAEPRIIHRNIKSSNVLLF----DDDIAKISDFDLSNQAPDAAARLHSTRVL 236
G+ +L E I+HRNIK N++ + K++DF + + D + S +
Sbjct: 123 GGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE-QFVS--LY 176
Query: 237 GTFGYHAPE--------YAMTGQMSSKSDVYSFGVVLLELLTGRKP-VDHTLPRGQQSL 286
GT Y P+ + + D++S GV TG P PR + +
Sbjct: 177 GTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEV 235
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 101 bits (252), Expect = 3e-24
Identities = 44/247 (17%), Positives = 84/247 (34%), Gaps = 32/247 (12%)
Query: 50 PIAVPVISVD-ELKEKTDNFGTNSLIGEGSYGRVYFGVLRSGRAA------AIKKLDSSK 102
+P I E + + + L+GEG++ +VY A +K +
Sbjct: 48 QCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN 107
Query: 103 QPDQEFLAQVSMVSRLKNE---NVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVK 159
EF ++ RLK ++ ++ VL E S G+L + ++ K
Sbjct: 108 P--WEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYK--- 162
Query: 160 GAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIA------- 212
P V+ + A+ +E +H+ IIH +IK N +L + +
Sbjct: 163 -NTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDEDDL 218
Query: 213 ----KISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSS-KSDVYSFGVVLLE 267
+ D S T T G+ E ++ + + + D + +
Sbjct: 219 SAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVE-MLSNKPWNYQIDYFGVAATVYC 277
Query: 268 LLTGRKP 274
+L G
Sbjct: 278 MLFGTYM 284
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 9e-24
Identities = 54/239 (22%), Positives = 104/239 (43%), Gaps = 55/239 (23%)
Query: 74 IGEGSYGRVYFGVLRSGRAA------AIKKL--DSSKQPDQEFLAQVSMVSRL-KNENVV 124
+G G++G+V A+K L + + ++++ M+++L +EN+V
Sbjct: 53 LGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIV 112
Query: 125 ELVGY-YVDGPLRVLAYEHASKGSLHDIL--------------HGKKGVKGAKPGPVLSW 169
L+G + GP+ ++ E+ G L + L +K ++ + VL++
Sbjct: 113 NLLGACTLSGPIYLIF-EYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTF 171
Query: 170 AQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAAR 229
+ A A+G+E+L K +HR++ + NVL+ + KI DF L+
Sbjct: 172 EDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLA--------- 219
Query: 230 LHSTRVLGTFGYH-------------APEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 274
R + + + APE G + KSDV+S+G++L E+ + G P
Sbjct: 220 ----RDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP 274
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 1e-23
Identities = 63/244 (25%), Positives = 96/244 (39%), Gaps = 53/244 (21%)
Query: 73 LIGEGSYGRVYFGV-LRSGRAAAIKKLDSSK-----------------QPDQEFLAQVSM 114
IG+GSYG V A+K L K +
Sbjct: 20 EIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGP 79
Query: 115 VSRLKNE----------NVVELVGYYV-DGPLRVLAY---EHASKGSLHDILHGKKGVKG 160
+ ++ E NVV+L V D P Y E ++G + ++ K
Sbjct: 80 IEQVYQEIAILKKLDHPNVVKL--VEVLDDPNEDHLYMVFELVNQGPVMEVPTLKP---- 133
Query: 161 AKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220
LS Q +G+EYLH + +IIHR+IK SN+L+ +D KI+DF +S
Sbjct: 134 ------LSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVS 184
Query: 221 NQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMS---SKSDVYSFGVVLLELLTGRKP-VD 276
N+ + A L +T GT + APE + DV++ GV L + G+ P +D
Sbjct: 185 NEFKGSDALLSNTV--GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD 242
Query: 277 HTLP 280
+
Sbjct: 243 ERIM 246
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 93.4 bits (232), Expect = 9e-22
Identities = 41/170 (24%), Positives = 71/170 (41%), Gaps = 22/170 (12%)
Query: 115 VSRLKNENVVELVGYYVDGPLRVLAY---EHASKGSLHDILHGKKGVKGAKPGPVLSWAQ 171
+ R+ + VG +V Y + K +L D ++ + ++ + G L
Sbjct: 112 IRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFI 171
Query: 172 RVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDF----------DLSN 221
++ A +E+LH K ++HR++K SN+ DD+ K+ DF +
Sbjct: 172 QI------AEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQT 222
Query: 222 QAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTG 271
A T +GT Y +PE S K D++S G++L ELL
Sbjct: 223 VLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYS 272
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 1e-19
Identities = 60/250 (24%), Positives = 104/250 (41%), Gaps = 39/250 (15%)
Query: 39 PAKEMKTVTVQPIAVPVISVDELKEKTDNFGTN----SLIGEGSYGRVYFGVLR-SGRAA 93
P M + P ++ T F ++G+GS+G V + +G+
Sbjct: 2 PGSMMDHLHATPGMF-------VQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQEC 54
Query: 94 AIKKLD----SSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLH 149
A+K + K + L +V ++ +L + N+++L ++ D L E + G L
Sbjct: 55 AVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELF 114
Query: 150 D--ILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLF 207
D I + A A+ ++ + + Y+H+ +I+HR++K N+LL
Sbjct: 115 DEIISRKRFSEVDA--------ARIIRQVLSG---ITYMHKN---KIVHRDLKPENLLLE 160
Query: 208 DDD---IAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVV 264
+I DF LS + +GT Y APE + G K DV+S GV+
Sbjct: 161 SKSKDANIRIIDFGLSTHFEASKKM---KDKIGTAYYIAPE-VLHGTYDEKCDVWSTGVI 216
Query: 265 LLELLTGRKP 274
L LL+G P
Sbjct: 217 LYILLSGCPP 226
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 1e-19
Identities = 61/227 (26%), Positives = 94/227 (41%), Gaps = 31/227 (13%)
Query: 61 LKEKTDNFGTN----SLIGEGSYGRVYFGVLR-SGRAAAIK---KLDSSKQPDQEFLAQV 112
+ K + +G G+YG V + + AIK K S + + L +V
Sbjct: 28 ITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEV 87
Query: 113 SMVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHD--ILHGKKGVKGAKPGPVLSWA 170
+++ L + N+++L ++ D L E G L D I K A A
Sbjct: 88 AVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDA--------A 139
Query: 171 QRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD---IAKISDFDLSNQAPDAA 227
+K + + YLH+ I+HR++K N+LL + + KI DF LS +
Sbjct: 140 VIIKQVLSG---VTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQK 193
Query: 228 ARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
LGT Y APE + + K DV+S GV+L LL G P
Sbjct: 194 KM---KERLGTAYYIAPE-VLRKKYDEKCDVWSIGVILFILLAGYPP 236
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 2e-19
Identities = 63/222 (28%), Positives = 94/222 (42%), Gaps = 44/222 (19%)
Query: 73 LIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQ--VSMVSRLKNENVVELVGY 129
+GEG+YG V V + A A+K +D + D + + + L +ENVV+ G+
Sbjct: 14 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 130 YVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAAR-------- 181
+G ++ L E+ S G L D + + + A+
Sbjct: 74 RREGNIQYLFLEYCSGGELFDRI-----------------EPDIGMPEPDAQRFFHQLMA 116
Query: 182 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPD-AAARLHSTRVLGTFG 240
G+ YLH I HR+IK N+LL + D KISDF L+ RL + GT
Sbjct: 117 GVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLP 172
Query: 241 YHAPE------YAMTGQMSSKSDVYSFGVVLLELLTGRKPVD 276
Y APE + + DV+S G+VL +L G P D
Sbjct: 173 YVAPELLKRREFH-----AEPVDVWSCGIVLTAMLAGELPWD 209
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 85.6 bits (212), Expect = 3e-19
Identities = 27/208 (12%), Positives = 50/208 (24%), Gaps = 48/208 (23%)
Query: 72 SLIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQVS----MVSRLKNENVVEL 126
G + + + R A+ +D + L + +SR+ V +
Sbjct: 37 IFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARV 96
Query: 127 VGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYL 186
+ ++ E GSL ++ P P ++ A +
Sbjct: 97 LDVVHTRAGGLVVAEWIRGGSLQEVADTS-------PSP----VGAIRAMQSLAAAADAA 145
Query: 187 HEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEY 246
H + S V + D L
Sbjct: 146 HRAG---VALSIDHPSRVRVSIDGDVV----------------------LAYPATMPDA- 179
Query: 247 AMTGQMSSKSDVYSFGVVLLELLTGRKP 274
+ + D+ G L LL R P
Sbjct: 180 ------NPQDDIRGIGASLYALLVNRWP 201
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 8e-19
Identities = 55/233 (23%), Positives = 89/233 (38%), Gaps = 57/233 (24%)
Query: 73 LIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNE---------- 121
L+GEGSYG+V + + A+K L K + + +K E
Sbjct: 12 LLGEGSYGKVKEVLDSETLCRRAVKILKKKK-----LRRIPNGEANVKKEIQLLRRLRHK 66
Query: 122 NVVELVG-YYVDGPLRV-LAYEHASKGS--LHD-ILHGKKGVKGAKPGPVLSWAQRVKIA 176
NV++LV Y + ++ + E+ G + D + +
Sbjct: 67 NVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKR-------------------FP 107
Query: 177 VGAAR--------GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAA 228
V A GLEYLH + I+H++IK N+LL KIS ++ AA
Sbjct: 108 VCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAA 164
Query: 229 --RLHSTRVLGTFGYHAPEYAMTGQM--SSKSDVYSFGVVLLELLTGRKPVDH 277
+++ G+ + PE A K D++S GV L + TG P +
Sbjct: 165 DDTCRTSQ--GSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEG 215
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 1e-18
Identities = 63/222 (28%), Positives = 94/222 (42%), Gaps = 44/222 (19%)
Query: 73 LIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQ--VSMVSRLKNENVVELVGY 129
+GEG+YG V V + A A+K +D + D + + + L +ENVV+ G+
Sbjct: 14 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 130 YVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAAR-------- 181
+G ++ L E+ S G L D + + + A+
Sbjct: 74 RREGNIQYLFLEYCSGGELFDRI-----------------EPDIGMPEPDAQRFFHQLMA 116
Query: 182 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPD-AAARLHSTRVLGTFG 240
G+ YLH I HR+IK N+LL + D KISDF L+ RL + GT
Sbjct: 117 GVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLP 172
Query: 241 YHAPE------YAMTGQMSSKSDVYSFGVVLLELLTGRKPVD 276
Y APE + + DV+S G+VL +L G P D
Sbjct: 173 YVAPELLKRREFH-----AEPVDVWSCGIVLTAMLAGELPWD 209
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 6e-18
Identities = 60/231 (25%), Positives = 96/231 (41%), Gaps = 63/231 (27%)
Query: 73 LIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNE---------- 121
+G G++G+V G +G A+K L+ K + + +V ++K E
Sbjct: 18 TLGVGTFGKVKIGEHQLTGHKVAVKILNRQK------IRSLDVVGKIKREIQNLKLFRHP 71
Query: 122 NVVELVGYYV-DGPLRV-LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGA 179
++++L Y V P + E+ S G L D + + ++
Sbjct: 72 HIIKL--YQVISTPTDFFMVMEYVSGGELFDYI-----------------CKHGRVEEME 112
Query: 180 AR--------GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLH 231
AR ++Y H ++HR++K NVLL AKI+DF LSN D L
Sbjct: 113 ARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD-GEFLR 168
Query: 232 STRVLGTFGYHAPE------YAMTGQMSSKSDVYSFGVVLLELLTGRKPVD 276
++ G+ Y APE YA + D++S GV+L LL G P D
Sbjct: 169 TS--CGSPNYAAPEVISGRLYA-----GPEVDIWSCGVILYALLCGTLPFD 212
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 7e-18
Identities = 64/263 (24%), Positives = 105/263 (39%), Gaps = 44/263 (16%)
Query: 36 KEAPAKEMKTVTVQPIAVPVISVDELKEKTDNFGTN----SLIGEGSYGRVYFGVLR-SG 90
+ + + Q IA+ +++K G + +G G+YG V +
Sbjct: 4 HHHHSSGRENLYFQGIAINPGMY--VRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGH 61
Query: 91 RAAAIKKLDSSK-------------QPDQEFLAQ-VSMVSRLKNENVVELVGYYVDGPLR 136
AIK + S+ + E + +S++ L + N+++L + D
Sbjct: 62 SEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYF 121
Query: 137 VLAYEHASKGSLHD--ILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 194
L E G L + I K A A +K + + YLH+ I
Sbjct: 122 YLVTEFYEGGELFEQIINRHKFDECDA--------ANIMKQILSG---ICYLHKH---NI 167
Query: 195 IHRNIKSSNVLLFDDD---IAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQ 251
+HR+IK N+LL + + KI DF LS+ +L LGT Y APE + +
Sbjct: 168 VHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDY-KLRD--RLGTAYYIAPE-VLKKK 223
Query: 252 MSSKSDVYSFGVVLLELLTGRKP 274
+ K DV+S GV++ LL G P
Sbjct: 224 YNEKCDVWSCGVIMYILLCGYPP 246
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 81.4 bits (201), Expect = 1e-17
Identities = 59/245 (24%), Positives = 80/245 (32%), Gaps = 47/245 (19%)
Query: 74 IGEGSYGRVYFGVLR-SGRAAAIK-----KLDSSKQPDQEFLAQ-VSMVSRLKNENVVEL 126
IG+GSYG V + + AIK K+ D E + V ++ +L + N+ L
Sbjct: 34 IGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARL 93
Query: 127 VGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVG-------- 178
Y D L E G L D L+ K + Q
Sbjct: 94 YEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGS 153
Query: 179 ----------------AAR-------GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIA--K 213
+ L YLH + I HR+IK N L + K
Sbjct: 154 IHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ---GICHRDIKPENFLFSTNKSFEIK 210
Query: 214 ISDFDLSN--QAPDAAARLHSTRVLGTFGYHAPE--YAMTGQMSSKSDVYSFGVVLLELL 269
+ DF LS + T GT + APE K D +S GV+L LL
Sbjct: 211 LVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLL 270
Query: 270 TGRKP 274
G P
Sbjct: 271 MGAVP 275
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 3e-17
Identities = 60/222 (27%), Positives = 99/222 (44%), Gaps = 39/222 (17%)
Query: 74 IGEGSYGRVYFGV-LRSGRAAAIKKLDSSK--QPDQEFLAQ-VSMVSRLKNENVVELVGY 129
IG+G++ +V + +GR AIK +D ++ + L + V ++ L + N+V+L +
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKL--F 80
Query: 130 YV-DGPLRV-LAYEHASKGSLHDIL--HGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEY 185
V + + L E+AS G + D L HG+ + + ++Y
Sbjct: 81 EVIETEKTLYLIMEYASGGEVFDYLVAHGR-----------MKEKEARSKFRQIVSAVQY 129
Query: 186 LHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245
H+K RI+HR++K+ N+LL D KI+DF SN+ G Y APE
Sbjct: 130 CHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTV--GGKLDAFC-GAPPYAAPE 183
Query: 246 ------YAMTGQMSSKSDVYSFGVVLLELLTGRKP-VDHTLP 280
Y + DV+S GV+L L++G P L
Sbjct: 184 LFQGKKYD-----GPEVDVWSLGVILYTLVSGSLPFDGQNLK 220
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 81.3 bits (201), Expect = 3e-17
Identities = 55/210 (26%), Positives = 93/210 (44%), Gaps = 27/210 (12%)
Query: 74 IGEGSYGRVYFGVLR-SGRAAAIKKLDSSK--QPDQEFLAQ-VSMVSRLKNENVVELVGY 129
+G+GS+G V R + + A+K ++ + D + + V ++ +L + N+++L
Sbjct: 30 LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 130 YVDGPLRVLAYEHASKGSLHD--ILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLH 187
D + E + G L D I + A A+ +K + Y+H
Sbjct: 90 LEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDA--------ARIIKQVFSG---ITYMH 138
Query: 188 EKAEPRIIHRNIKSSNVLLFDDD---IAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAP 244
+ I+HR++K N+LL + KI DF LS ++ +GT Y AP
Sbjct: 139 KH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT-KMKD--RIGTAYYIAP 192
Query: 245 EYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
E + G K DV+S GV+L LL+G P
Sbjct: 193 E-VLRGTYDEKCDVWSAGVILYILLSGTPP 221
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 79.9 bits (198), Expect = 4e-17
Identities = 59/219 (26%), Positives = 95/219 (43%), Gaps = 29/219 (13%)
Query: 65 TDNFGTNSLIGEGSYGRVYFGVLRS-GRAAAIKKLDSSKQPDQEFLAQ-VSMVSRLKNEN 122
F ++G G++ V+ R G+ A+K + S L ++++ ++K+EN
Sbjct: 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHEN 67
Query: 123 VVELVGYYVDGPLRVLAYEHASKGSLHD-ILHGKKGV---KGAKPGPVLSWAQRVKIAVG 178
+V L Y L + S G L D IL ++GV K A + ++ +
Sbjct: 68 IVTLEDIYESTTHYYLVMQLVSGGELFDRIL--ERGVYTEKDA--------SLVIQQVLS 117
Query: 179 AARGLEYLHEKAEPRIIHRNIKSSNVLLF---DDDIAKISDFDLSNQAPDAAARLHSTRV 235
A ++YLHE I+HR++K N+L ++ I+DF LS + +
Sbjct: 118 A---VKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIM----STA 167
Query: 236 LGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
GT GY APE S D +S GV+ LL G P
Sbjct: 168 CGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPP 206
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 81.0 bits (200), Expect = 4e-17
Identities = 51/221 (23%), Positives = 94/221 (42%), Gaps = 38/221 (17%)
Query: 74 IGEGSYGRVYFGVLR---SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYY 130
+G G+YG VY + + A+K+++ + +++++ LK+ NV+ L +
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSA-CREIALLRELKHPNVISLQKVF 87
Query: 131 VDGPLR--VLAYEHASKGSLHD---ILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEY 185
+ R L +++A HD I+ + K K L + G+ Y
Sbjct: 88 LSHADRKVWLLFDYAE----HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHY 143
Query: 186 LHEKAEPRIIHRNIKSSNVLLFDDD----IAKISDFDLSNQAPDAAARL---------HS 232
LH ++HR++K +N+L+ + KI+D ARL
Sbjct: 144 LHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGF--------ARLFNSPLKPLADL 192
Query: 233 TRVLGTFGYHAPEYAMTGQMSSKS-DVYSFGVVLLELLTGR 272
V+ TF Y APE + + +K+ D+++ G + ELLT
Sbjct: 193 DPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 233
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 80.2 bits (198), Expect = 7e-17
Identities = 59/231 (25%), Positives = 98/231 (42%), Gaps = 63/231 (27%)
Query: 73 LIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNE---------- 121
+G G++G+V G +G A+K L+ K + + +V +++ E
Sbjct: 23 TLGVGTFGKVKVGKHELTGHKVAVKILNRQK------IRSLDVVGKIRREIQNLKLFRHP 76
Query: 122 NVVELVGYYV-DGPLRV-LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGA 179
++++L Y V P + + E+ S G L D + + ++
Sbjct: 77 HIIKL--YQVISTPSDIFMVMEYVSGGELFDYI-----------------CKNGRLDEKE 117
Query: 180 AR--------GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLH 231
+R G++Y H ++HR++K NVLL AKI+DF LSN D L
Sbjct: 118 SRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD-GEFLR 173
Query: 232 STRVLGTFGYHAPE------YAMTGQMSSKSDVYSFGVVLLELLTGRKPVD 276
++ G+ Y APE YA + D++S GV+L LL G P D
Sbjct: 174 TS--CGSPNYAAPEVISGRLYA-----GPEVDIWSSGVILYALLCGTLPFD 217
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 8e-17
Identities = 45/223 (20%), Positives = 79/223 (35%), Gaps = 39/223 (17%)
Query: 73 LIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNE---------- 121
L+G G +G VY G+ + AIK ++ + D ++ +R+ E
Sbjct: 50 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDW---GELPNGTRVPMEVVLLKKVSSG 106
Query: 122 --NVVELVGYYVDGPLRVLAYEHAS-KGSLHD--ILHGKKGVKGAKPGPVLSWAQRVKIA 176
V+ L+ ++ VL E L D G L
Sbjct: 107 FSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA-----------LQEELARSFF 155
Query: 177 VGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDI-AKISDFDLSNQAPDAAARLHSTRV 235
+ + H ++HR+IK N+L+ + K+ DF D
Sbjct: 156 WQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV--YTDF-- 208
Query: 236 LGTFGYHAPEYAMTGQ-MSSKSDVYSFGVVLLELLTGRKPVDH 277
GT Y PE+ + + V+S G++L +++ G P +H
Sbjct: 209 DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 251
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 9e-17
Identities = 54/224 (24%), Positives = 86/224 (38%), Gaps = 51/224 (22%)
Query: 73 LIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYV 131
IG G++G + A+K ++ D+ ++ L++ N+V V
Sbjct: 27 DIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRF--KEV 84
Query: 132 -DGPLRV-LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAAR-------- 181
P + + E+AS G L++ + + + AR
Sbjct: 85 ILTPTHLAIIMEYASGGELYERI-----------------CNAGRFSEDEARFFFQQLLS 127
Query: 182 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIA---KISDFDLSNQAPDAAARLHSTRVLGT 238
G+ Y H +I HR++K N LL D A KI DF S + + + ST +GT
Sbjct: 128 GVSYCHSM---QICHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVLHS-QPKST--VGT 180
Query: 239 FGYHAPE------YAMTGQMSSKSDVYSFGVVLLELLTGRKPVD 276
Y APE Y +DV+S GV L +L G P +
Sbjct: 181 PAYIAPEVLLRQEYD-----GKIADVWSCGVTLYVMLVGAYPFE 219
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 78.0 bits (193), Expect = 1e-16
Identities = 48/207 (23%), Positives = 85/207 (41%), Gaps = 18/207 (8%)
Query: 74 IGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQE--FLAQVSMVSRLKNENVVELVGYY 130
+G G++G V+ R SG IK ++ + A++ ++ L + N++++ +
Sbjct: 30 LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVF 89
Query: 131 VDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKA 190
D + E G L + + + LS ++ L Y H +
Sbjct: 90 EDYHNMYIVMETCEGGELLERIVSAQARGK-----ALSEGYVAELMKQMMNALAYFHSQ- 143
Query: 191 EPRIIHRNIKSSNVLLFDDDIA---KISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYA 247
++H+++K N+L D KI DF L+ + GT Y APE
Sbjct: 144 --HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKS--DEHSTNAA-GTALYMAPE-V 197
Query: 248 MTGQMSSKSDVYSFGVVLLELLTGRKP 274
++ K D++S GVV+ LLTG P
Sbjct: 198 FKRDVTFKCDIWSAGVVMYFLLTGCLP 224
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 2e-16
Identities = 43/222 (19%), Positives = 79/222 (35%), Gaps = 35/222 (15%)
Query: 73 LIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQVSMVSR-----------LKN 120
L+G+G +G V+ G L AIK + ++ L+ +
Sbjct: 38 LLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGH 97
Query: 121 ENVVELVGYYVDGPLRVLAYEHASKGS-LHD--ILHGKKGVKGAKPGPVLSWAQRVKIAV 177
V+ L+ ++ +L E L D G G ++
Sbjct: 98 PGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSR-----------CFFG 146
Query: 178 GAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD-IAKISDFDLSNQAPDAAARLHSTRVL 236
+++ H + ++HR+IK N+L+ AK+ DF D
Sbjct: 147 QVVAAIQHCHSR---GVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEP--YTDF--D 199
Query: 237 GTFGYHAPEYAMTGQ-MSSKSDVYSFGVVLLELLTGRKPVDH 277
GT Y PE+ Q + + V+S G++L +++ G P +
Sbjct: 200 GTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFER 241
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 77.6 bits (192), Expect = 2e-16
Identities = 51/208 (24%), Positives = 87/208 (41%), Gaps = 25/208 (12%)
Query: 74 IGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQ-VSMVSRLKNENVVELVGYYV 131
IG GS+G V V + + A KK+ D + Q + ++ L + N++ L +
Sbjct: 17 IGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFE 76
Query: 132 DGPLRVLAYEHASKGSLHD--ILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEK 189
D L E + G L + + A A+ +K + A + Y H+
Sbjct: 77 DNTDIYLVMELCTGGELFERVVHKRVFRESDA--------ARIMKDVLSA---VAYCHKL 125
Query: 190 AEPRIIHRNIKSSNVLLFDDDIA---KISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEY 246
+ HR++K N L D K+ DF L+ + ++ T+V GT Y +P+
Sbjct: 126 ---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKP--GKMMRTKV-GTPYYVSPQ- 178
Query: 247 AMTGQMSSKSDVYSFGVVLLELLTGRKP 274
+ G + D +S GV++ LL G P
Sbjct: 179 VLEGLYGPECDEWSAGVMMYVLLCGYPP 206
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 2e-16
Identities = 58/215 (26%), Positives = 88/215 (40%), Gaps = 20/215 (9%)
Query: 74 IGEGSYGRVYFGVLRS-GRAAAIK-----KLDSSKQPDQEFLAQ-VSMVSRLKNENVVEL 126
IG+G + V + R G+ A+K K SS E L + S+ LK+ ++VEL
Sbjct: 32 IGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 91
Query: 127 VGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYL 186
+ Y + + +E L + VK A G V S A L Y
Sbjct: 92 LETYSSDGMLYMVFEFMDGADLCFEI-----VKRADAGFVYSEAVASHYMRQILEALRYC 146
Query: 187 HEKAEPRIIHRNIKSSNVLLFDDDIA---KISDFDLSNQAPDAAARLHSTRVLGTFGYHA 243
H+ IIHR++K VLL + + K+ F ++ Q ++ +GT + A
Sbjct: 147 HDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGG--RVGTPHFMA 201
Query: 244 PEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHT 278
PE DV+ GV+L LL+G P T
Sbjct: 202 PEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGT 236
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 79.1 bits (195), Expect = 2e-16
Identities = 53/266 (19%), Positives = 106/266 (39%), Gaps = 20/266 (7%)
Query: 14 KASKNGPFVPNNPAGNPGGFYVKEAPAKEMKTVTVQPIAVPVISVDELKEKTDNFGTNSL 73
K + G + + + P + D++ +
Sbjct: 105 DERKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEE 164
Query: 74 IGEGSYGRVYFGVLRS-GRAAAIKKLDSSKQPDQEFLAQ-VSMVSRLKNENVVELVGYYV 131
+G G++G V+ R+ G A K + + + D+E + + + +S L++ +V L +
Sbjct: 165 LGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFE 224
Query: 132 DGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAE 191
D V+ YE S G L + + + +S + V+ +GL ++HE
Sbjct: 225 DDNEMVMIYEFMSGGELFEKVADEHN--------KMSEDEAVEYMRQVCKGLCHMHEN-- 274
Query: 192 PRIIHRNIKSSNVLLF--DDDIAKISDFDLSNQ-APDAAARLHSTRVLGTFGYHAPEYAM 248
+H ++K N++ + K+ DF L+ P + ++ GT + APE A
Sbjct: 275 -NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKV----TTGTAEFAAPEVAE 329
Query: 249 TGQMSSKSDVYSFGVVLLELLTGRKP 274
+ +D++S GV+ LL+G P
Sbjct: 330 GKPVGYYTDMWSVGVLSYILLSGLSP 355
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 3e-16
Identities = 60/231 (25%), Positives = 98/231 (42%), Gaps = 64/231 (27%)
Query: 73 LIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNE---------- 121
+GEGS+G+V ++ + A+K + L + M R++ E
Sbjct: 16 TLGEGSFGKVKLATHYKTQQKVALKFISRQL------LKKSDMHMRVEREISYLKLLRHP 69
Query: 122 NVVELVGYYV-DGPLRV-LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGA 179
++++L Y V P + + E+A G L D + ++ ++
Sbjct: 70 HIIKL--YDVITTPTDIVMVIEYAG-GELFDYI-----------------VEKKRMTEDE 109
Query: 180 AR--------GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLH 231
R +EY H +I+HR++K N+LL D+ KI+DF LSN D L
Sbjct: 110 GRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTD-GNFLK 165
Query: 232 STRVLGTFGYHAPE------YAMTGQMSSKSDVYSFGVVLLELLTGRKPVD 276
++ G+ Y APE YA + DV+S G+VL +L GR P D
Sbjct: 166 TS--CGSPNYAAPEVINGKLYA-----GPEVDVWSCGIVLYVMLVGRLPFD 209
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 5e-16
Identities = 66/265 (24%), Positives = 108/265 (40%), Gaps = 35/265 (13%)
Query: 24 NNPAGNPGGFYVKEAPAKEMKTVTVQPIAVPVISVDELKEK-----TDNFGTNSLIGEGS 78
++ +G G + T + P ++ + +D F S +G G+
Sbjct: 6 HHSSGVDLGTENLYFQSMSSVTASAAPGTASLVPDYWIDGSNRDALSDFFEVESELGRGA 65
Query: 79 YGRVYFGVLRS-GRAAAIKKLDSSKQPDQEFLAQ-VSMVSRLKNENVVELVGYYVDGPLR 136
VY + + A+K L K D++ + + ++ RL + N+++L +
Sbjct: 66 TSIVYRCKQKGTQKPYALKVLK--KTVDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEI 123
Query: 137 VLAYEHASKGSLHD-ILHGKKGV---KGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEP 192
L E + G L D I+ +KG + A A VK + A + YLHE
Sbjct: 124 SLVLELVTGGELFDRIV--EKGYYSERDA--------ADAVKQILEA---VAYLHEN--- 167
Query: 193 RIIHRNIKSSNVLLF---DDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMT 249
I+HR++K N+L D KI+DF LS L T GT GY APE
Sbjct: 168 GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEH--QVLMKTVC-GTPGYCAPEILRG 224
Query: 250 GQMSSKSDVYSFGVVLLELLTGRKP 274
+ D++S G++ LL G +P
Sbjct: 225 CAYGPEVDMWSVGIITYILLCGFEP 249
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 7e-16
Identities = 51/229 (22%), Positives = 84/229 (36%), Gaps = 38/229 (16%)
Query: 65 TDNFGTNSLIGEGSYGRVYFGVLRS-GRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNE-- 121
D + + +G G+ G V R + AI+ + K + ++ E
Sbjct: 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGS-AREADPALNVETEIE 192
Query: 122 --------NVVELVGYYVDGPLRVLAYEHASKGSLHD--ILHGKKGVKGAKPGPVLSWAQ 171
++++ ++ D + E G L D + + + K
Sbjct: 193 ILKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEATCK--------- 242
Query: 172 RVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD---IAKISDFDLSNQAPDAAA 228
++YLHE IIHR++K NVLL + + KI+DF S + +
Sbjct: 243 --LYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS- 296
Query: 229 RLHSTRVLGTFGYHAPE---YAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
L T GT Y APE T + D +S GV+L L+G P
Sbjct: 297 -LMRTLC-GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 343
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 9e-16
Identities = 53/222 (23%), Positives = 93/222 (41%), Gaps = 36/222 (16%)
Query: 73 LIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQ-VSMVSRLKN-ENVVELVGY 129
++GEG++ RV + + + A+K ++ + + + V M+ + + NV+EL+ +
Sbjct: 20 VLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEF 79
Query: 130 YVDGPLRVLAYEHASKGSLHDILHGKKGV---KGAKPGPVLSWAQRVKIAVGAARGLEYL 186
+ + L +E GS+ +H K+ A + V+ A L++L
Sbjct: 80 FEEEDRFYLVFEKMRGGSILSHIH-KRRHFNELEA--------SVVVQDVASA---LDFL 127
Query: 187 HEKAEPRIIHRNIKSSNVLLFDDD---IAKISDFDLS------NQAPDAAARLHSTRVLG 237
H K I HR++K N+L + KI DFDL + T G
Sbjct: 128 HNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPC-G 183
Query: 238 TFGYHAPEYAMTGQMSSKS-----DVYSFGVVLLELLTGRKP 274
+ Y APE + D++S GV+L LL+G P
Sbjct: 184 SAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPP 225
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 1e-15
Identities = 52/234 (22%), Positives = 91/234 (38%), Gaps = 41/234 (17%)
Query: 62 KEKTDNFGTNSLIGEGSYGRVYFGV-LRSGRAAAIK-----KLDSSKQPDQEFLAQV--- 112
E + + T S +G G++G V+ V + +K K+ + L +V
Sbjct: 20 GEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLE 79
Query: 113 -SMVSRLKNENVVELVGYYVDGPLRVLAYE-HASKGSLHD--ILHGKKGVKGAKPGPVLS 168
+++SR+++ N+++++ + + L E H S L H + L
Sbjct: 80 IAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPR-----------LD 128
Query: 169 WAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAA 228
I + YL K IIHR+IK N+++ +D K+ DF +
Sbjct: 129 EPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFGSAAYLER--G 183
Query: 229 RLHSTRVLGTFGYHAPE------YAMTGQMSSKSDVYSFGVVLLELLTGRKPVD 276
+L T GT Y APE Y + +++S GV L L+ P
Sbjct: 184 KLFYTFC-GTIEYCAPEVLMGNPYR-----GPELEMWSLGVTLYTLVFEENPFC 231
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 2e-15
Identities = 51/215 (23%), Positives = 97/215 (45%), Gaps = 20/215 (9%)
Query: 65 TDNFGTNSLIGEGSYGRVYFGVLRS-GRAAAIKKLDSSKQPDQEFLAQ-VSMVSRLKNEN 122
D + +G G++G V+ V ++ GR K +++ D+ + +S++++L +
Sbjct: 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPK 109
Query: 123 VVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARG 182
++ L + D VL E S G L D + + +S A+ + A G
Sbjct: 110 LINLHDAFEDKYEMVLILEFLSGGELFDRIAAE--------DYKMSEAEVINYMRQACEG 161
Query: 183 LEYLHEKAEPRIIHRNIKSSNVLLFDDDIA--KISDFDLSNQA-PDAAARLHSTRVLGTF 239
L+++HE I+H +IK N++ + KI DF L+ + PD ++ T
Sbjct: 162 LKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKV----TTATA 214
Query: 240 GYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
+ APE + +D+++ GV+ LL+G P
Sbjct: 215 EFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSP 249
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 2e-15
Identities = 47/224 (20%), Positives = 77/224 (34%), Gaps = 37/224 (16%)
Query: 74 IGEGSYGRVYFGVLRS-GRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNE----------- 121
+G G V + + + A+K +D + + E
Sbjct: 25 LGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHP 84
Query: 122 NVVELVGYYVDGPLRVLAYEHASKGSLHD--ILHGKKGVKGAKPGPVLSWAQRVKIAVGA 179
N+++L Y L ++ KG L D K + ++ +
Sbjct: 85 NIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKET--------RKIMRALLEV 136
Query: 180 ARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTF 239
+ LH+ I+HR++K N+LL DD K++DF S Q GT
Sbjct: 137 ---ICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDP--GEKLREVC-GTP 187
Query: 240 GYHAPE------YAMTGQMSSKSDVYSFGVVLLELLTGRKPVDH 277
Y APE + D++S GV++ LL G P H
Sbjct: 188 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWH 231
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 74.9 bits (185), Expect = 2e-15
Identities = 56/219 (25%), Positives = 92/219 (42%), Gaps = 39/219 (17%)
Query: 74 IGEGSYGRVYFGV-LRSGRAAAIKK--LDSSKQPDQEF----LAQVSMVSRLKN---ENV 123
IG G+YG VY SG A+K + + + +V+++ RL+ NV
Sbjct: 17 IGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNV 76
Query: 124 VEL----VGYYVDGPLRV-LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVG 178
V L D ++V L +EH D+ + P P L +
Sbjct: 77 VRLMDVCATSRTDREIKVTLVFEHVD----QDL----RTYLDKAPPPGLPAETIKDLMRQ 128
Query: 179 AARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHS-----T 233
RGL++LH I+HR++K N+L+ K++DF L AR++S T
Sbjct: 129 FLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGL--------ARIYSYQMALT 177
Query: 234 RVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGR 272
V+ T Y APE + ++ D++S G + E+ +
Sbjct: 178 PVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 3e-15
Identities = 56/219 (25%), Positives = 94/219 (42%), Gaps = 27/219 (12%)
Query: 65 TDNFGTNSLIGEGSYGRVYFGVLRS-GRAAAIKKLDSSK--QPDQEFLAQ-VSMVSRLKN 120
+ + ++G+GS+G V R + A+K ++ + D + + V ++ +L +
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 121 ENVVELVGYYVDGPLRVLAYEHASKGSLHD--ILHGKKGVKGAKPGPVLSWAQRVKIAVG 178
N+++L D + E + G L D I + A A+ +K
Sbjct: 81 PNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDA--------ARIIKQVFS 132
Query: 179 AARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD---IAKISDFDLSNQAPDAAARLHSTRV 235
+ Y+H+ I+HR++K N+LL + KI DF LS R+
Sbjct: 133 G---ITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ--NTKMKDRI 184
Query: 236 LGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
GT Y APE + G K DV+S GV+L LL+G P
Sbjct: 185 -GTAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSGTPP 221
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 3e-15
Identities = 49/214 (22%), Positives = 93/214 (43%), Gaps = 22/214 (10%)
Query: 67 NFGTNSLIGEGSYGRVYFGVLRS-GRAAAIKKLDSSKQPDQEFLAQ-VSMVSRLKNENVV 124
++G G +G+V+ + G A K + + D+E + +S++++L + N++
Sbjct: 90 TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLI 149
Query: 125 ELVGYYVDGPLRVLAYEHASKGSLHD-ILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGL 183
+L + VL E+ G L D I+ + L+ + G+
Sbjct: 150 QLYDAFESKNDIVLVMEYVDGGELFDRII--DESYN-------LTELDTILFMKQICEGI 200
Query: 184 EYLHEKAEPRIIHRNIKSSNVLLF--DDDIAKISDFDLSNQ-APDAAARLHSTRVLGTFG 240
++H+ I+H ++K N+L D KI DF L+ + P ++ GT
Sbjct: 201 RHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKV----NFGTPE 253
Query: 241 YHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
+ APE +S +D++S GV+ LL+G P
Sbjct: 254 FLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSP 287
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 75.3 bits (185), Expect = 5e-15
Identities = 61/224 (27%), Positives = 93/224 (41%), Gaps = 37/224 (16%)
Query: 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSS--KQPDQEFLAQVSMVSRLKNE- 121
++F + +IG G +G VY +G+ A+K LD K E LA NE
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLA--------LNER 240
Query: 122 NVVELVGYYVDGPLRV-LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRV-KIAVGA 179
++ LV D P V ++Y + L IL G G + + +
Sbjct: 241 IMLSLVST-GDCPFIVCMSYAFHTPDKLSFILDLMNG------GDLHYHLSQHGVFSEAD 293
Query: 180 AR--------GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLH 231
R GLE++H + +++R++K +N+LL + +ISD L+
Sbjct: 294 MRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH-- 348
Query: 232 STRVLGTFGYHAPEYAMTGQMSSKS-DVYSFGVVLLELLTGRKP 274
V GT GY APE G S D +S G +L +LL G P
Sbjct: 349 -ASV-GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 6e-15
Identities = 58/261 (22%), Positives = 103/261 (39%), Gaps = 41/261 (15%)
Query: 31 GGFYVKEAPAKEMKTVTVQP----IAVPVISVDELKEKTDNFGTNSLIGEGSYGRVYFGV 86
G F + AP +K + I V +++ + +IG GS+G V+
Sbjct: 1 GSFTMSNAPLNGVKLNPLDDPNKVIKVLASDGKTGEQREIAYTNCKVIGNGSFGVVFQAK 60
Query: 87 LRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGY-YVDGPLRV-----LAY 140
L AIKK+ Q + ++ ++ +K+ NVV+L + Y +G + L
Sbjct: 61 LVESDEVAIKKV---LQDKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVL 117
Query: 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVK-----IAVGAARGLEYLHEKAEPRII 195
E+ + +++ +K P +K + R L Y+H I
Sbjct: 118 EYVPE-TVYRASRHYAKLKQTMP------MLLIKLYMYQLL----RSLAYIHSI---GIC 163
Query: 196 HRNIKSSNVLLF-DDDIAKISDFDLSNQAPDAAARLH--STRVLGTFGYHAPEYAMTGQM 252
HR+IK N+LL + K+ DF + + +R Y APE
Sbjct: 164 HRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSRY-----YRAPELIFGATN 218
Query: 253 SSKS-DVYSFGVVLLELLTGR 272
+ + D++S G V+ EL+ G+
Sbjct: 219 YTTNIDIWSTGCVMAELMQGQ 239
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 7e-15
Identities = 49/210 (23%), Positives = 90/210 (42%), Gaps = 29/210 (13%)
Query: 74 IGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKN-ENVVELVGYYV 131
+GEGS+ V + S +A A+K + + + + +++ + + N+V+L +
Sbjct: 19 LGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQ--KEITALKLCEGHPNIVKLHEVFH 76
Query: 132 DGPLRVLAYEHASKGSLHD-ILHGKKGV---KGAKPGPVLSWAQRVKIAVGAARGLEYLH 187
D L E + G L + I KK A + ++ V A + ++H
Sbjct: 77 DQLHTFLVMELLNGGELFERIK--KKKHFSETEA--------SYIMRKLVSA---VSHMH 123
Query: 188 EKAEPRIIHRNIKSSNVLLFDDD---IAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAP 244
+ ++HR++K N+L D++ KI DF + P L + T Y AP
Sbjct: 124 DV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKT--PCFTLHYAAP 178
Query: 245 EYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
E D++S GV+L +L+G+ P
Sbjct: 179 ELLNQNGYDESCDLWSLGVILYTMLSGQVP 208
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 8e-15
Identities = 46/212 (21%), Positives = 86/212 (40%), Gaps = 29/212 (13%)
Query: 74 IGEGSYGRVYFGVLRS-GRAAAIKKLDSSK--QPDQEFLAQ-VSMVSRLKNENVVELVGY 129
+G+G++ V V G+ A +++ K D + L + + LK+ N+V L
Sbjct: 19 LGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 78
Query: 130 YVDGPLRVLAYEHASKGSLHD-ILHGKKGV---KGAKPGPVLSWAQRVKIAVGAARGLEY 185
+ L ++ + G L + I+ + A + ++ + A + +
Sbjct: 79 ISEEGHHYLIFDLVTGGELFEDIV--AREYYSEADA--------SHCIQQILEA---VLH 125
Query: 186 LHEKAEPRIIHRNIKSSNVLLF---DDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYH 242
H+ ++HRN+K N+LL K++DF L+ + GT GY
Sbjct: 126 CHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFG--FAGTPGYL 180
Query: 243 APEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
+PE D+++ GV+L LL G P
Sbjct: 181 SPEVLRKDPYGKPVDLWACGVILYILLVGYPP 212
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 1e-14
Identities = 53/232 (22%), Positives = 85/232 (36%), Gaps = 38/232 (16%)
Query: 62 KEKTDNFGTNSLIGEGSYGRVYFGVLRS-GRAAAIKKLDSSKQPDQEFLAQVSMVSRLKN 120
K D + + +G G+ G V R + AIK + K + ++
Sbjct: 6 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGS-AREADPALNVET 64
Query: 121 E----------NVVELVGYYVDGPLRVLAYEHASKGSLHD--ILHGKKGVKGAKPGPVLS 168
E ++++ ++ D + E G L D + + +
Sbjct: 65 EIEILKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEATC------- 116
Query: 169 WAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD---IAKISDFDLSNQAPD 225
+ A ++YLHE IIHR++K NVLL + + KI+DF S +
Sbjct: 117 -KLYFYQMLLA---VQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE 169
Query: 226 AAARLHSTRVLGTFGYHAPE---YAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
L T GT Y APE T + D +S GV+L L+G P
Sbjct: 170 --TSLMRTLC-GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 218
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 2e-14
Identities = 55/286 (19%), Positives = 95/286 (33%), Gaps = 42/286 (14%)
Query: 13 RKASKNGPFVPNNPAGNPGGFYVKEAPAKEMKTVTVQPIAVPVISVDELKEKTDNFGTN- 71
R+A + + N K A+ T + ++ F
Sbjct: 37 RRAFIRSLRDDPSQSANLLAEAKKLNDAQPKGTENLYFQSMGPEDELPDWAAAKEFYQKY 96
Query: 72 ---SLIGEGSYGRVYFGVLRS-GRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNE------ 121
+IG G V V R+ G A+K ++ + + + + + E
Sbjct: 97 DPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLE-EVREATRRETHILRQ 155
Query: 122 -----NVVELVGYYVDGPLRVLAYEHASKGSLHD--ILHGKKGVKGAKPGPVLSWAQRVK 174
+++ L+ Y L ++ KG L D K ++
Sbjct: 156 VAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKET--------RSIMR 207
Query: 175 IAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTR 234
+ A + +LH I+HR++K N+LL D+ ++SDF S
Sbjct: 208 SLLEA---VSFLHAN---NIVHRDLKPENILLDDNMQIRLSDFGFSCHLEP--GEKLREL 259
Query: 235 VLGTFGYHAPE------YAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
GT GY APE + D+++ GV+L LL G P
Sbjct: 260 C-GTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPP 304
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 3e-14
Identities = 62/259 (23%), Positives = 103/259 (39%), Gaps = 43/259 (16%)
Query: 43 MKTVTVQPIAVPVISVDELKEKTDNFGTN----SLIGEGSYGRVYFGVLRS-GRAAAIKK 97
M+TV V I +L + F IG GSY + ++ A+K
Sbjct: 1 MQTVGVHSIVQ------QLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKI 54
Query: 98 LDSSKQPDQEFLAQVSMVSRLKN-ENVVELVGYYVDGPLRVLAYEHASKGSLHD-ILHGK 155
+D SK+ E ++ ++ R N++ L Y DG + E G L D IL +
Sbjct: 55 IDKSKRDPTE---EIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKIL--R 109
Query: 156 KGV---KGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD-- 210
+ + A + + +EYLH + ++HR++K SN+L D+
Sbjct: 110 QKFFSEREA--------SAVLFTITKT---VEYLHAQ---GVVHRDLKPSNILYVDESGN 155
Query: 211 --IAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKS-DVYSFGVVLLE 267
+I DF + Q L T T + APE + Q + D++S GV+L
Sbjct: 156 PESIRICDFGFAKQLRAENGLLM-TPC-YTANFVAPE-VLERQGYDAACDIWSLGVLLYT 212
Query: 268 LLTGRKPVDHTLPRGQQSL 286
+LTG P + + +
Sbjct: 213 MLTGYTPFANGPDDTPEEI 231
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 4e-14
Identities = 50/239 (20%), Positives = 89/239 (37%), Gaps = 44/239 (18%)
Query: 56 ISVDELKEKTDNFG-----TNSLIGEGSYGRVYFGVLRS-GRAAAIKKLDSSKQPDQEFL 109
+ + K + ++G G G+V R G+ A+K L S + QE
Sbjct: 14 VLFQGPEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQE-- 71
Query: 110 AQVSMVSRLKN-ENVVELVGYYVDGPLRVLAY----EHASKGSLHD-ILHGKKGVKG--- 160
V + ++V ++ Y + E G L I ++G +
Sbjct: 72 --VDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQ--ERGDQAFTE 127
Query: 161 --AKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD---IAKIS 215
A A+ ++ A +++LH I HR++K N+L + + K++
Sbjct: 128 REA--------AEIMRDIGTA---IQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLT 173
Query: 216 DFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
DF + + A + T T Y APE + D++S GV++ LL G P
Sbjct: 174 DFGFAKETTQNALQ---TPC-YTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPP 228
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 4e-14
Identities = 53/224 (23%), Positives = 103/224 (45%), Gaps = 47/224 (20%)
Query: 74 IGEGSYGRVYFGV-LRSGRAAAIKK--LDSSKQ--PDQEFLA--QVSMVSRLKNENVVEL 126
IG+G++G V+ ++G+ A+KK +++ K+ P A ++ ++ LK+ENVV L
Sbjct: 25 IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFP---ITALREIKILQLLKHENVVNL 81
Query: 127 VGYYVDGPLRVLAYEHASKGSL--------HDILHGKKGVKGAKPGPVLSWAQRVKIAVG 178
+ + KGS+ HD+ G+ + ++ ++
Sbjct: 82 IEICRTKASP----YNRCKGSIYLVFDFCEHDL----AGLLSNVLVK-FTLSEIKRVMQM 132
Query: 179 AARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS---NQAPDAAARLHSTRV 235
GL Y+H +I+HR++K++NVL+ D + K++DF L+ + A ++ ++ RV
Sbjct: 133 LLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRV 189
Query: 236 LGTFGYHAPE-------YAMTGQMSSKSDVYSFGVVLLELLTGR 272
+ T Y PE Y D++ G ++ E+ T
Sbjct: 190 V-TLWYRPPELLLGERDY------GPPIDLWGAGCIMAEMWTRS 226
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 7e-14
Identities = 48/210 (22%), Positives = 89/210 (42%), Gaps = 26/210 (12%)
Query: 74 IGEGSYGRVYFGVLRS-GRAAAIKKLDSSK--QPDQEFLAQ-VSMVSRLKNENVVELVGY 129
+G+G++ V V ++ G A K +++ K D + L + + +L++ N+V L
Sbjct: 37 LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 96
Query: 130 YVDGPLRVLAYEHASKGSLHD--ILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLH 187
+ L ++ + G L + + A + ++ + + + Y H
Sbjct: 97 IQEESFHYLVFDLVTGGELFEDIVAREFYSEADA--------SHCIQQILES---IAYCH 145
Query: 188 EKAEPRIIHRNIKSSNVLLF---DDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAP 244
I+HRN+K N+LL K++DF L+ + D + GT GY +P
Sbjct: 146 SN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND--SEAWHGFA-GTPGYLSP 199
Query: 245 EYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
E S D+++ GV+L LL G P
Sbjct: 200 EVLKKDPYSKPVDIWACGVILYILLVGYPP 229
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 7e-14
Identities = 65/274 (23%), Positives = 109/274 (39%), Gaps = 62/274 (22%)
Query: 24 NNPAGNPGGFYVKEAPAKEMKTVTVQPIAVPVISVDELKEKTDNFGTNSLIGEGSYGRVY 83
P+ ++ ++ TV P P + + ++ +IG GS+G VY
Sbjct: 18 QQPSAFGSMKVSRDKDGSKVTTVVATPGQGP------DRPQEVSYTDTKVIGNGSFGVVY 71
Query: 84 FGVLR-SGRAAAIKKLDSSKQPDQEF-LAQVSMVSRLKNENVVELVGY-YVDGPLRV--- 137
L SG AIKK+ D+ F ++ ++ +L + N+V L + Y G +
Sbjct: 72 QAKLCDSGELVAIKKV----LQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 127
Query: 138 --LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVK-----IAVGAARGLEYLHEKA 190
L ++ + +++ + + + + PV+ VK + R L Y+H
Sbjct: 128 LNLVLDYVPE-TVYRVA--RHYSRAKQTLPVI----YVKLYMYQLF----RSLAYIHSF- 175
Query: 191 EPRIIHRNIKSSNVLLFDD-DIAKISDFDLSNQAPDAAARLHS----------TRVLGTF 239
I HR+IK N+LL D + K+ DF A+ +R
Sbjct: 176 --GICHRDIKPQNLLLDPDTAVLKLCDFGS--------AKQLVRGEPNVSYICSRY---- 221
Query: 240 GYHAPEYAMTGQMSSKS-DVYSFGVVLLELLTGR 272
Y APE + S DV+S G VL ELL G+
Sbjct: 222 -YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 70.3 bits (172), Expect = 9e-14
Identities = 30/113 (26%), Positives = 54/113 (47%), Gaps = 4/113 (3%)
Query: 163 PGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222
L+ + + A+G+E+L + + IHR++ + N+LL + ++ KI DF L+
Sbjct: 186 YKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARD 242
Query: 223 APDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 274
+ + APE + +SDV+SFGV+L E+ + G P
Sbjct: 243 IYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 295
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 1e-13
Identities = 41/205 (20%), Positives = 83/205 (40%), Gaps = 19/205 (9%)
Query: 74 IGEGSYGRVYFGVLRS-GRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVD 132
+G G +G V+ V S + K + ++S+++ ++ N++ L +
Sbjct: 13 LGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFES 72
Query: 133 GPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEP 192
V+ +E S + + ++ L+ + V L++LH
Sbjct: 73 MEELVMIFEFISGLDIFERINTS--------AFELNEREIVSYVHQVCEALQFLHSH--- 121
Query: 193 RIIHRNIKSSNVLLFDDDIA--KISDFDLSNQ-APDAAARLHSTRVLGTFGYHAPEYAMT 249
I H +I+ N++ + KI +F + Q P RL + Y+APE
Sbjct: 122 NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL----LFTAPEYYAPEVHQH 177
Query: 250 GQMSSKSDVYSFGVVLLELLTGRKP 274
+S+ +D++S G ++ LL+G P
Sbjct: 178 DVVSTATDMWSLGTLVYVLLSGINP 202
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 69.5 bits (171), Expect = 1e-13
Identities = 51/222 (22%), Positives = 89/222 (40%), Gaps = 51/222 (22%)
Query: 74 IGEGSYGRVYFGV-LRSGRAAAIKK--LDSSKQ--PDQEFLAQVSMVSRLKNENVVELVG 128
IGEG+YG V+ + A+K+ LD + P L ++ ++ LK++N+V L
Sbjct: 10 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSA-LREICLLKELKHKNIVRL-- 66
Query: 129 YYVDGPLRVLAYEHASKGSLHDILHGKKGV-----------KG--AKPGPVLSWAQRVKI 175
HD+LH K + K L
Sbjct: 67 --------------------HDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSF 106
Query: 176 AVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN--QAPDAAARLHST 233
+GL + H + ++HR++K N+L+ + K+++F L+ P R +S
Sbjct: 107 LFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV---RCYSA 160
Query: 234 RVLGTFGYHAPEYAMTGQMSSKS-DVYSFGVVLLELLTGRKP 274
V+ T Y P+ ++ S S D++S G + EL +P
Sbjct: 161 EVV-TLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRP 201
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 69.1 bits (170), Expect = 1e-13
Identities = 55/206 (26%), Positives = 95/206 (46%), Gaps = 24/206 (11%)
Query: 74 IGEGSYGRVYFGVLRSGRAAAIKK--LDSSKQ--PDQEFLAQVSMVSRLKNENVVELVGY 129
IGEG+YG VY G A+KK L+ + P + ++S++ LK+ N+V+L
Sbjct: 10 IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTT-IREISILKELKHSNIVKLYDV 68
Query: 130 YVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEK 189
VL +EH D+ K + G L + G+ Y H++
Sbjct: 69 IHTKKRLVLVFEHLD----QDL----KKLLDVCEGG-LESVTAKSFLLQLLNGIAYCHDR 119
Query: 190 AEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN--QAPDAAARLHSTRVLGTFGYHAPEYA 247
R++HR++K N+L+ + KI+DF L+ P R ++ ++ T Y AP+
Sbjct: 120 ---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPV---RKYTHEIV-TLWYRAPDVL 172
Query: 248 MTGQMSSKS-DVYSFGVVLLELLTGR 272
M + S + D++S G + E++ G
Sbjct: 173 MGSKKYSTTIDIWSVGCIFAEMVNGT 198
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 69.1 bits (170), Expect = 1e-13
Identities = 51/221 (23%), Positives = 95/221 (42%), Gaps = 30/221 (13%)
Query: 65 TDNFGTNSLIGEGSYGRVYFGVLRS-GRAAAIKKLDSSK--QPDQEFLAQ-VSMVSRLKN 120
+DN+ +G+G++ V V ++ G A K +++ K D + L + + +L++
Sbjct: 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 121 ENVVELVGYYVDGPLRVLAYEHASKGSLHD-ILHGKKGV---KGAKPGPVLSWAQRVKIA 176
N+V L + L ++ + G L + I+ + A + ++
Sbjct: 65 PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIV--AREFYSEADA--------SHCIQQI 114
Query: 177 VGAARGLEYLHEKAEPRIIHRNIKSSNVLLF---DDDIAKISDFDLSNQAPDAAARLHST 233
+ + + Y H I+HRN+K N+LL K++DF L+ + D +
Sbjct: 115 LES---IAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND--SEAWHG 166
Query: 234 RVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
GT GY +PE S D+++ GV+L LL G P
Sbjct: 167 FA-GTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 206
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 69.5 bits (171), Expect = 1e-13
Identities = 57/206 (27%), Positives = 96/206 (46%), Gaps = 24/206 (11%)
Query: 74 IGEGSYGRVYFGVLRSGRAAAIKK--LDSSKQ--PDQEFLAQVSMVSRLKNENVVELVGY 129
+GEG+YG VY GR A+K+ LD+ + P + ++S++ L + N+V L+
Sbjct: 29 VGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTA-IREISLLKELHHPNIVSLIDV 87
Query: 130 YVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEK 189
L +E D+ K V L +Q RG+ + H+
Sbjct: 88 IHSERCLTLVFEFME----KDL----KKVLDENKTG-LQDSQIKIYLYQLLRGVAHCHQH 138
Query: 190 AEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ--APDAAARLHSTRVLGTFGYHAPEYA 247
RI+HR++K N+L+ D K++DF L+ P R ++ V+ T Y AP+
Sbjct: 139 ---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPV---RSYTHEVV-TLWYRAPDVL 191
Query: 248 MTGQMSSKS-DVYSFGVVLLELLTGR 272
M + S S D++S G + E++TG+
Sbjct: 192 MGSKKYSTSVDIWSIGCIFAEMITGK 217
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 68.0 bits (167), Expect = 5e-13
Identities = 54/218 (24%), Positives = 97/218 (44%), Gaps = 39/218 (17%)
Query: 74 IGEGSYGRVYFG--VLRSGRAAAIKK--LDSSKQ--PDQEFLAQVSMVSRLKN---ENVV 124
IGEG+YG+V+ + GR A+K+ + + ++ P + +V+++ L+ NVV
Sbjct: 19 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLST-IREVAVLRHLETFEHPNVV 77
Query: 125 EL----VGYYVDGPLRV-LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGA 179
L D ++ L +EH D+ P P + +
Sbjct: 78 RLFDVCTVSRTDRETKLTLVFEHVD----QDL----TTYLDKVPEPGVPTETIKDMMFQL 129
Query: 180 ARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHS-----TR 234
RGL++LH R++HR++K N+L+ K++DF L AR++S T
Sbjct: 130 LRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGL--------ARIYSFQMALTS 178
Query: 235 VLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGR 272
V+ T Y APE + ++ D++S G + E+ +
Sbjct: 179 VVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 67.2 bits (165), Expect = 9e-13
Identities = 51/236 (21%), Positives = 96/236 (40%), Gaps = 52/236 (22%)
Query: 60 ELKEKTDNFGTNSLIGEGSYGRVYFGV-LRSGRAAAIKK--LDSSKQPDQEF----LAQV 112
++K + + +GEG + VY + + AIKK L + L ++
Sbjct: 4 DVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREI 63
Query: 113 SMVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGV-----------KG- 160
++ L + N++ L D K + +
Sbjct: 64 KLLQELSHPNIIGL----------------------LDAFGHKSNISLVFDFMETDLEVI 101
Query: 161 -AKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDL 219
VL+ + + +GLEYLH+ I+HR++K +N+LL ++ + K++DF L
Sbjct: 102 IKDNSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGL 158
Query: 220 SNQ--APDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKS-DVYSFGVVLLELLTGR 272
+ +P+ R ++ +V+ T Y APE +M D+++ G +L ELL
Sbjct: 159 AKSFGSPN---RAYTHQVV-TRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRV 210
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 1e-12
Identities = 50/219 (22%), Positives = 87/219 (39%), Gaps = 37/219 (16%)
Query: 74 IGEGSYGRVYFGVLRSGRAAAIKKLDSSKQP-------DQEFLAQ-----VSMVSRLKNE 121
I GSYG V GV G AIK++ ++ FL + + +++ +
Sbjct: 30 ISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHP 89
Query: 122 NVVELVGYYVDGPLRV-------LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVK 174
N++ L + L E L ++H ++ V+S
Sbjct: 90 NILGL--RDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQR--------IVISPQHIQY 138
Query: 175 IAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTR 234
GL LHE ++HR++ N+LL D++ I DF+L+ + A + T
Sbjct: 139 FMYHILLGLHVLHEA---GVVHRDLHPGNILLADNNDITICDFNLAREDTADA---NKTH 192
Query: 235 VLGTFGYHAPEYAMTGQMSSKS-DVYSFGVVLLELLTGR 272
+ Y APE M + +K D++S G V+ E+ +
Sbjct: 193 YVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 1e-12
Identities = 41/224 (18%), Positives = 83/224 (37%), Gaps = 38/224 (16%)
Query: 63 EKTDNFGTNSLIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKN- 120
D++ +G G Y V+ + + + +K L K ++ ++ ++ L+
Sbjct: 33 GNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK--KKKIKREIKILENLRGG 90
Query: 121 ENVVELVGYYVDGPLRVLAY--EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVG 178
N++ L D R A EH + + L+
Sbjct: 91 PNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY------------QTLTDYDIRFYMYE 138
Query: 179 AARGLEYLHEKAEPRIIHRNIKSSNVLL-FDDDIAKISDFDLSNQAPDAAARLHST---- 233
+ L+Y H I+HR++K NV++ + ++ D+ L A +
Sbjct: 139 ILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGL--------AEFYHPGQEY 187
Query: 234 --RVLGTFGYHAPEYAMTGQMSSKS-DVYSFGVVLLELLTGRKP 274
RV + + PE + QM S D++S G +L ++ ++P
Sbjct: 188 NVRV-ASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEP 230
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 1e-12
Identities = 52/213 (24%), Positives = 85/213 (39%), Gaps = 27/213 (12%)
Query: 74 IGEGSYGRVYFGVLRS-GRAAAIKKLDSSKQPDQEFLAQVSMVSR-------LKNENVVE 125
+G G + V +S G A K + + + R + + N++
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79
Query: 126 LVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEY 185
L Y + VL E S G L D L K+ LS + G+ Y
Sbjct: 80 LHDVYENRTDVVLILELVSGGELFDFLAQKE---------SLSEEEATSFIKQILDGVNY 130
Query: 186 LHEKAEPRIIHRNIKSSNVLLFDDDIA----KISDFDLSNQAPDAAARLHSTRVLGTFGY 241
LH K +I H ++K N++L D +I K+ DF L+++ D + GT +
Sbjct: 131 LHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF---KNIFGTPEF 184
Query: 242 HAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
APE + ++D++S GV+ LL+G P
Sbjct: 185 VAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 67.5 bits (165), Expect = 2e-12
Identities = 56/220 (25%), Positives = 93/220 (42%), Gaps = 27/220 (12%)
Query: 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNE-NV 123
D F ++G G +G V+ ++ +G+ A KKL+ ++ L + E +
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLN------KKRLKKRKGYQGAMVEKKI 238
Query: 124 VELVGYYVDGPLRV-LAYEHASKGSLHDILHGKKG-------VKGAKPGPVLSWAQRVKI 175
+ V V LAY +K L ++ G + P + +
Sbjct: 239 LAKV----HSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFY 294
Query: 176 AVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRV 235
GLE+LH++ II+R++K NVLL DD +ISD L+ + +
Sbjct: 295 TAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTK-GYA 350
Query: 236 LGTFGYHAPEYAMTGQMSSKS-DVYSFGVVLLELLTGRKP 274
GT G+ APE + G+ S D ++ GV L E++ R P
Sbjct: 351 -GTPGFMAPE-LLLGEEYDFSVDYFALGVTLYEMIAARGP 388
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 67.1 bits (164), Expect = 2e-12
Identities = 60/280 (21%), Positives = 100/280 (35%), Gaps = 41/280 (14%)
Query: 13 RKASKNGPFVPNNPAGNPGGFYVKEAPAKEMKTVTVQPIAVPVISVDELKEKTDN---FG 69
+ S PF P P + PA+ Q V S ++K+
Sbjct: 6 QGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKV 65
Query: 70 TNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKN-ENVVELV 127
T+ ++G G G+V + + A+K L + +E V + R ++V +V
Sbjct: 66 TSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARRE----VELHWRASQCPHIVRIV 121
Query: 128 GYYVDGPLRVLAY----EHASKGSLHD-ILHGKKGVKG-----AKPGPVLSWAQRVKIAV 177
Y + E G L I +G + A ++ +K
Sbjct: 122 DVYENLYAGRKCLLIVMECLDGGELFSRIQ--DRGDQAFTEREA--------SEIMKSIG 171
Query: 178 GAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD---IAKISDFDLSNQAPDAAARLHSTR 234
A ++YLH I HR++K N+L I K++DF + + +T
Sbjct: 172 EA---IQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS--HNSLTTP 223
Query: 235 VLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
T Y APE + D++S GV++ LL G P
Sbjct: 224 C-YTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP 262
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 2e-12
Identities = 49/224 (21%), Positives = 87/224 (38%), Gaps = 31/224 (13%)
Query: 65 TDNFGTNSLIGEGSYGRVYFGVLRS-GRAAAIKKLDSSKQPDQEFLAQVSMVSR------ 117
D + T +G G + V +S G A K + + + R
Sbjct: 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 118 -LKNENVVELVGYYVDGPLRVLAYEHASKGSLHD--ILHGKKGVKGAKPGPVLSWAQRVK 174
+++ NV+ L Y + +L E + G L D + A + +K
Sbjct: 70 EIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEA--------TEFLK 121
Query: 175 IAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIA----KISDFDLSNQAPDAAARL 230
+ + YLH +I H ++K N++L D ++ KI DF L+++ D
Sbjct: 122 QILNG---VYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI-DFGNEF 174
Query: 231 HSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
+ GT + APE + ++D++S GV+ LL+G P
Sbjct: 175 --KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 3e-12
Identities = 45/237 (18%), Positives = 83/237 (35%), Gaps = 50/237 (21%)
Query: 74 IGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEF-LAQVSMVSRLKNENVVELVGYYV 131
+G GS+G V SG+ A+KK+ D + ++ ++ L + N+++LV Y+
Sbjct: 15 LGTGSFGIVCEVFDIESGKRFALKKV----LQDPRYKNRELDIMKVLDHVNIIKLVDYFY 70
Query: 132 DGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWA----------------QRVKI 175
K V + +K
Sbjct: 71 TTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKS 130
Query: 176 AVGAA----------------RGLEYLHEKAEPRIIHRNIKSSNVLLF-DDDIAKISDFD 218
+ + R + ++H I HR+IK N+L+ D+ K+ DF
Sbjct: 131 FIRSGRSIPMNLISIYIYQLFRAVGFIHSL---GICHRDIKPQNLLVNSKDNTLKLCDFG 187
Query: 219 LSNQAPDAAARLH--STRVLGTFGYHAPEYAMTGQMSSKS-DVYSFGVVLLELLTGR 272
+ + + + +R Y APE + + S D++S G V EL+ G+
Sbjct: 188 SAKKLIPSEPSVAYICSRF-----YRAPELMLGATEYTPSIDLWSIGCVFGELILGK 239
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 65.7 bits (161), Expect = 3e-12
Identities = 53/215 (24%), Positives = 95/215 (44%), Gaps = 37/215 (17%)
Query: 74 IGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQE------FLAQVSMVSRLKNENVVEL 126
+G G+Y VY G+ +G A+K++ + D E + ++S++ LK+EN+V L
Sbjct: 13 LGNGTYATVYKGLNKTTGVYVALKEV----KLDSEEGTPSTAIREISLMKELKHENIVRL 68
Query: 127 VGYYVDGPLRVLAYEHASK--GSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLE 184
L +E D +G + V + ++ +GL
Sbjct: 69 YDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQL------LQGLA 122
Query: 185 YLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAP 244
+ HE +I+HR++K N+L+ K+ DF L+ +A S+ V+ T Y AP
Sbjct: 123 FCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLA-RAFGIPVNTFSSEVV-TLWYRAP 177
Query: 245 E-------YAMTGQMSSKSDVYSFGVVLLELLTGR 272
+ Y S+ D++S G +L E++TG+
Sbjct: 178 DVLMGSRTY------STSIDIWSCGCILAEMITGK 206
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 65.3 bits (160), Expect = 3e-12
Identities = 49/217 (22%), Positives = 90/217 (41%), Gaps = 35/217 (16%)
Query: 74 IGEGSYGRVYFGVLRS-GRAAAIKKLDSSKQPDQEFLAQVSMVSR-------LKNENVVE 125
+G G + V + G+ A K + + + R +++ N++
Sbjct: 13 LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72
Query: 126 LVGYYVDGPLRVLAYEHASKGSLHD-ILHGKKGV---KGAKPGPVLSWAQRVKIAVGAAR 181
L + + VL E S G L D + +K A Q +K +
Sbjct: 73 LHDIFENKTDVVLILELVSGGELFDFLA--EKESLTEDEA--------TQFLKQILD--- 119
Query: 182 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIA----KISDFDLSNQAPDAAARLHSTRVLG 237
G+ YLH K RI H ++K N++L D ++ K+ DF ++++ +A + + G
Sbjct: 120 GVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKI-EAGNEFKN--IFG 173
Query: 238 TFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
T + APE + ++D++S GV+ LL+G P
Sbjct: 174 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 210
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 66.4 bits (162), Expect = 4e-12
Identities = 60/224 (26%), Positives = 102/224 (45%), Gaps = 38/224 (16%)
Query: 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNE-NV 123
+ F ++G+G +G V +R +G+ A KKL+ ++ + + + NE +
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLE------KKRIKKRKGEAMALNEKQI 237
Query: 124 VELVGYYVDGPLRV-LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAV---GA 179
+E V + V LAY + +K +L +L G G + + A
Sbjct: 238 LEKV----NSRFVVSLAYAYETKDALCLVLTLMNG------GDLKFHIYHMGQAGFPEAR 287
Query: 180 AR--------GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLH 231
A GLE LH + RI++R++K N+LL D +ISD L+ P+ +
Sbjct: 288 AVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPE--GQTI 342
Query: 232 STRVLGTFGYHAPEYAMTGQMSSKS-DVYSFGVVLLELLTGRKP 274
RV GT GY APE + + + S D ++ G +L E++ G+ P
Sbjct: 343 KGRV-GTVGYMAPE-VVKNERYTFSPDWWALGCLLYEMIAGQSP 384
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 64.9 bits (159), Expect = 5e-12
Identities = 50/224 (22%), Positives = 93/224 (41%), Gaps = 44/224 (19%)
Query: 66 DNFGTNSLIGEGSYGRVYFG-VLRSGRAAAIKK--LDSSKQPDQEFLAQVSMVSRLKNEN 122
+ + +GEG+Y VY G + A+K+ L+ + + +VS++ LK+ N
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHAN 61
Query: 123 VVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGV-----------KG--AKPGPVLSW 169
+V L HDI+H +K + K G +++
Sbjct: 62 IVTL----------------------HDIIHTEKSLTLVFEYLDKDLKQYLDDCGNIINM 99
Query: 170 AQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAAR 229
RGL Y H + +++HR++K N+L+ + K++DF L+ +A +
Sbjct: 100 HNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLA-RAKSIPTK 155
Query: 230 LHSTRVLGTFGYHAPEYAMTGQMSSKS-DVYSFGVVLLELLTGR 272
+ V+ T Y P+ + S D++ G + E+ TGR
Sbjct: 156 TYDNEVV-TLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGR 198
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 5e-12
Identities = 52/214 (24%), Positives = 85/214 (39%), Gaps = 29/214 (13%)
Query: 74 IGEGSYGRVYFGVLRS-GRAAAIKKLDSSKQPDQEFLAQVSMVSR-------LKNENVVE 125
+G G + V +S G A K + + + R + + NV+
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 126 LVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEY 185
L Y + VL E S G L D L K+ LS + G+ Y
Sbjct: 80 LHDVYENRTDVVLILELVSGGELFDFLAQKE---------SLSEEEATSFIKQILDGVNY 130
Query: 186 LHEKAEPRIIHRNIKSSNVLLFDDDIA----KISDFDLSNQ-APDAAARLHSTRVLGTFG 240
LH K +I H ++K N++L D +I K+ DF L+++ + + GT
Sbjct: 131 LHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN----IFGTPE 183
Query: 241 YHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
+ APE + ++D++S GV+ LL+G P
Sbjct: 184 FVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 7e-12
Identities = 51/252 (20%), Positives = 94/252 (37%), Gaps = 42/252 (16%)
Query: 39 PAKEMKTVTVQPIAVPVISVDELKEKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKK 97
P M +++ D F + G+G++G V G + +G + AIKK
Sbjct: 2 PGSMMSLNAAAAADERS------RKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKK 55
Query: 98 LDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLR--------VLAYEHASKGSLH 149
+ + L + ++ L + N+V+L Y + E+ +LH
Sbjct: 56 VIQDPRFRNRELQIMQDLAVLHHPNIVQLQ-SYFYTLGERDRRDIYLNVVMEYVPD-TLH 113
Query: 150 DILHGKKGVKGAKPGPVLSWAQRVK-----IAVGAARGLEYLHEKAEPRIIHRNIKSSNV 204
+ A P +K + R + LH + + HR+IK NV
Sbjct: 114 RCCRNYYRRQVAPP------PILIKVFLFQLI----RSIGCLHLPS-VNVCHRDIKPHNV 162
Query: 205 LLFDDD-IAKISDFDLSNQAPDAAARLH--STRVLGTFGYHAPEYAMTGQMSSKS-DVYS 260
L+ + D K+ DF + + + + +R Y APE Q + + D++S
Sbjct: 163 LVNEADGTLKLCDFGSAKKLSPSEPNVAYICSRY-----YRAPELIFGNQHYTTAVDIWS 217
Query: 261 FGVVLLELLTGR 272
G + E++ G
Sbjct: 218 VGCIFAEMMLGE 229
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 1e-11
Identities = 47/219 (21%), Positives = 94/219 (42%), Gaps = 35/219 (15%)
Query: 74 IGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPD-QEFLAQVSMVSRLKNENVVELVGYYV 131
+G G G V+ V + AIKK+ + + L ++ ++ RL ++N+V++ + +
Sbjct: 19 LGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKV--FEI 76
Query: 132 DGPLRVLAYEHASKGS---------------LHDILHGKKGVKGAKPGPVLSWAQRVKIA 176
GP + + L ++L L
Sbjct: 77 LGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGP----------LLEEHARLFM 126
Query: 177 VGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD-IAKISDFDLS-NQAPDAAARLHSTR 234
RGL+Y+H ++HR++K +N+ + +D + KI DF L+ P + + H +
Sbjct: 127 YQLLRGLKYIHSA---NVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSE 183
Query: 235 VLGTFGYHAPEYAMTGQMSSKS-DVYSFGVVLLELLTGR 272
L T Y +P ++ +K+ D+++ G + E+LTG+
Sbjct: 184 GLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 1e-11
Identities = 35/96 (36%), Positives = 51/96 (53%), Gaps = 9/96 (9%)
Query: 182 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGY 241
L+YL + RIIHR++K N+LL + I+DF+++ P +T + GT Y
Sbjct: 127 ALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPR--ETQITT-MAGTKPY 180
Query: 242 HAPE--YAMTGQMSSKS-DVYSFGVVLLELLTGRKP 274
APE + G S + D +S GV ELL GR+P
Sbjct: 181 MAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRP 216
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 63.7 bits (156), Expect = 1e-11
Identities = 52/205 (25%), Positives = 89/205 (43%), Gaps = 21/205 (10%)
Query: 74 IGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQE---FLAQVSMVSRLKNENVVELVGY 129
IGEGSYG V+ +G+ AIKK S+ L ++ M+ +LK+ N+V L+
Sbjct: 11 IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEV 70
Query: 130 YVDGPLRVLAYEHASKGSLHDILHG-KKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHE 188
+ L +E+ H +LH + +G V S + + + + H+
Sbjct: 71 FRRKRRLHLVFEYCD----HTVLHELDRYQRGVPEHLVKSITWQT------LQAVNFCHK 120
Query: 189 KAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAM 248
IHR++K N+L+ + K+ DF + + + + V T Y +PE +
Sbjct: 121 H---NCIHRDVKPENILITKHSVIKLCDFGFA-RLLTGPSDYYDDEVA-TRWYRSPELLV 175
Query: 249 TGQMSSKS-DVYSFGVVLLELLTGR 272
DV++ G V ELL+G
Sbjct: 176 GDTQYGPPVDVWAIGCVFAELLSGV 200
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 1e-11
Identities = 56/225 (24%), Positives = 101/225 (44%), Gaps = 31/225 (13%)
Query: 62 KEKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKN 120
K++ ++F ++GEGS+ V + R AIK L+ + + + + V +
Sbjct: 26 KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILE------KRHIIKENKVPYVTR 79
Query: 121 ENVVELVGYYVDGPLRV-LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRV-KIAVG 178
E V + +D P V L + L+ L K G +L + +++
Sbjct: 80 ERDV-MS--RLDHPFFVKLYFTFQDDEKLYFGLSYAKN------GELLKYIRKIGSFDET 130
Query: 179 AAR--------GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARL 230
R LEYLH K IIHR++K N+LL +D +I+DF + + +
Sbjct: 131 CTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQA 187
Query: 231 HSTRVLGTFGYHAPEYAMTGQMSSKS-DVYSFGVVLLELLTGRKP 274
+ +GT Y +PE +T + + KS D+++ G ++ +L+ G P
Sbjct: 188 RANSFVGTAQYVSPE-LLTEKSACKSSDLWALGCIIYQLVAGLPP 231
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 1e-11
Identities = 48/214 (22%), Positives = 90/214 (42%), Gaps = 31/214 (14%)
Query: 74 IGEGSYGRVYFGVLRS-GRAAAIKKLDSSK--QPDQEFLAQ-VSMVSRLK-NENVVELVG 128
+G G + V + +S G+ A K L + Q + + ++++ K V+ L
Sbjct: 37 LGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHE 96
Query: 129 YYVDGPLRVLAYEHASKGSLHD-ILHGKKGVKGAKPGPVLSWAQRVKIAVGAAR----GL 183
Y + +L E+A+ G + L + ++S + + G+
Sbjct: 97 VYENTSEIILILEYAAGGEIFSLCL--------PELAEMVS----ENDVIRLIKQILEGV 144
Query: 184 EYLHEKAEPRIIHRNIKSSNVLLFDDDIA---KISDFDLSNQAPDAAARLHSTRVLGTFG 240
YLH+ I+H ++K N+LL KI DF +S + A L ++GT
Sbjct: 145 YYLHQN---NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKI-GHACELRE--IMGTPE 198
Query: 241 YHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
Y APE +++ +D+++ G++ LLT P
Sbjct: 199 YLAPEILNYDPITTATDMWNIGIIAYMLLTHTSP 232
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 2e-11
Identities = 60/213 (28%), Positives = 96/213 (45%), Gaps = 36/213 (16%)
Query: 74 IGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQ-----VSMVSRLKNENVVELV 127
+G G+YG V ++G A+KKL S+ A+ + ++ +K+ENV+ L
Sbjct: 37 VGSGAYGSVCAAFDTKTGLRVAVKKL--SRPFQSIIHAKRTYRELRLLKHMKHENVIGL- 93
Query: 128 GYYVDGPLRVLA-------YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAA 180
V P R L H L++I+ +K L+ +
Sbjct: 94 -LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK----------LTDDHVQFLIYQIL 142
Query: 181 RGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFG 240
RGL+Y+H IIHR++K SN+ + +D KI DF L+ D +TR
Sbjct: 143 RGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVATRW----- 194
Query: 241 YHAPEYAMTGQMSSKS-DVYSFGVVLLELLTGR 272
Y APE + +++ D++S G ++ ELLTGR
Sbjct: 195 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 63.0 bits (154), Expect = 3e-11
Identities = 53/216 (24%), Positives = 93/216 (43%), Gaps = 21/216 (9%)
Query: 63 EKTDNFGTNSLIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEF----LAQVSMVSR 117
+ + + L+GEGSYG V +GR AIKK S D+ + ++ ++ +
Sbjct: 22 QSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDD-DKMVKKIAMREIKLLKQ 80
Query: 118 LKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAV 177
L++EN+V L+ L +E ++ D L G V + ++
Sbjct: 81 LRHENLVNLLEVCKKKKRWYLVFEFVDH-TILDDLELFPN--GLDYQVVQKYLFQI---- 133
Query: 178 GAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLG 237
G+ + H IIHR+IK N+L+ + K+ DF + + A ++ V
Sbjct: 134 --INGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFA-RTLAAPGEVYDDEVA- 186
Query: 238 TFGYHAPEYAMTGQMSSKS-DVYSFGVVLLELLTGR 272
T Y APE + K+ DV++ G ++ E+ G
Sbjct: 187 TRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGE 222
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 5e-11
Identities = 49/213 (23%), Positives = 85/213 (39%), Gaps = 36/213 (16%)
Query: 74 IGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQ-----VSMVSRLKNENVVELV 127
IG G+ G V R AIKKL S+ + A+ + ++ + ++N++ L
Sbjct: 33 IGSGAQGIVCAAYDAILERNVAIKKL--SRPFQNQTHAKRAYRELVLMKCVNHKNIIGL- 89
Query: 128 GYYVDGPLRV--------LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGA 179
V P + + E +L ++ + L + +
Sbjct: 90 -LNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQME-----------LDHERMSYLLYQM 136
Query: 180 ARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTF 239
G+++LH IIHR++K SN+++ D KI DF L A A T + T
Sbjct: 137 LCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL---ARTAGTSFMMTPYVVTR 190
Query: 240 GYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGR 272
Y APE + D++S G ++ E++ G
Sbjct: 191 YYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 62.6 bits (152), Expect = 5e-11
Identities = 48/213 (22%), Positives = 86/213 (40%), Gaps = 36/213 (16%)
Query: 74 IGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQ-----VSMVSRLKNENVVELV 127
IG G+ G V R AIKKL S+ + A+ + ++ + ++N++ L
Sbjct: 70 IGSGAQGIVCAAYDAVLDRNVAIKKL--SRPFQNQTHAKRAYRELVLMKCVNHKNIISL- 126
Query: 128 GYYVDGPLRV--------LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGA 179
V P + L E +L ++ + L + +
Sbjct: 127 -LNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQME-----------LDHERMSYLLYQM 173
Query: 180 ARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTF 239
G+++LH IIHR++K SN+++ D KI DF L+ A + T + T
Sbjct: 174 LCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF---MMTPYVVTR 227
Query: 240 GYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGR 272
Y APE + D++S G ++ E++ +
Sbjct: 228 YYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 7e-11
Identities = 49/225 (21%), Positives = 85/225 (37%), Gaps = 57/225 (25%)
Query: 74 IGEGSYGRVYFGV-LRSGRAAAIKK--LDSSKQ--PDQEFLAQVSMVSRLKNENVVELVG 128
+GEG+YG VY + + AIK+ L+ ++ P + +VS++ L++ N++EL
Sbjct: 42 LGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTA-IREVSLLKELQHRNIIEL-- 98
Query: 129 YYVDGPLRVLAYEHASKGSLHDILHGKKGV------------KGAKPGPVLSWAQRVKIA 176
++H + K P +S
Sbjct: 99 --------------------KSVIHHNHRLHLIFEYAENDLKKYMDKNPDVSMRVIKSFL 138
Query: 177 VGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIA------KISDFDL--SNQAPDAAA 228
G+ + H + R +HR++K N LL A KI DF L + P
Sbjct: 139 YQLINGVNFCHSR---RCLHRDLKPQN-LLLSVSDASETPVLKIGDFGLARAFGIPI--- 191
Query: 229 RLHSTRVLGTFGYHAPEYAMTGQMSSKS-DVYSFGVVLLELLTGR 272
R + ++ T Y PE + + S S D++S + E+L
Sbjct: 192 RQFTHEII-TLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKT 235
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 7e-11
Identities = 55/213 (25%), Positives = 91/213 (42%), Gaps = 36/213 (16%)
Query: 74 IGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQ-----VSMVSRLKNENVVELV 127
+G G+YG V V R+G AIKKL + E A+ + ++ +++ENV+ L
Sbjct: 33 VGSGAYGAVCSAVDGRTGAKVAIKKL--YRPFQSELFAKRAYRELRLLKHMRHENVIGL- 89
Query: 128 GYYVDGPLRVLA-------YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAA 180
V P L L ++ +K L + +
Sbjct: 90 -LDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEK----------LGEDRIQFLVYQML 138
Query: 181 RGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFG 240
+GL Y+H IIHR++K N+ + +D KI DF L+ QA TR
Sbjct: 139 KGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRW----- 190
Query: 241 YHAPEYAMTGQMSSKS-DVYSFGVVLLELLTGR 272
Y APE + +++ D++S G ++ E++TG+
Sbjct: 191 YRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 2e-10
Identities = 55/213 (25%), Positives = 93/213 (43%), Gaps = 37/213 (17%)
Query: 74 IGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQ-----VSMVSRLKNENVVELV 127
+G G+YG V + RSG AIKKL S+ E A+ + ++ +++ENV+ L
Sbjct: 32 VGSGAYGSVCSAIDKRSGEKVAIKKL--SRPFQSEIFAKRAYRELLLLKHMQHENVIGL- 88
Query: 128 GYYVDGPLRVLA-------YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAA 180
V P L + L I+ K S + +
Sbjct: 89 -LDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLK-----------FSEEKIQYLVYQML 136
Query: 181 RGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFG 240
+GL+Y+H ++HR++K N+ + +D KI DF L+ A TR
Sbjct: 137 KGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTRW----- 188
Query: 241 YHAPEYAMTGQMSSKS-DVYSFGVVLLELLTGR 272
Y APE ++ +++ D++S G ++ E+LTG+
Sbjct: 189 YRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 2e-10
Identities = 55/215 (25%), Positives = 92/215 (42%), Gaps = 36/215 (16%)
Query: 74 IGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQP-DQEFLAQ-----VSMVSRLKNENVVEL 126
IGEG+YG V + AIKK+ P + + Q + ++ R ++EN++ +
Sbjct: 35 IGEGAYGMVCSAYDNLNKVRVAIKKIS----PFEHQTYCQRTLREIKILLRFRHENIIGI 90
Query: 127 VGYYVDGPLRV-------LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGA 179
+ + + + L+ +L + LS
Sbjct: 91 --NDIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQH----------LSNDHICYFLYQI 137
Query: 180 ARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS-NQAPDAAARLHSTRVLGT 238
RGL+Y+H A ++HR++K SN+LL KI DF L+ PD T + T
Sbjct: 138 LRGLKYIHS-AN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 194
Query: 239 FGYHAPEYAMTGQMSSKS-DVYSFGVVLLELLTGR 272
Y APE + + +KS D++S G +L E+L+ R
Sbjct: 195 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 4e-10
Identities = 50/237 (21%), Positives = 92/237 (38%), Gaps = 37/237 (15%)
Query: 54 PVISVDELKEKTDNFGTNSLIGEGSYGRVYFGVLR---SGRAAAIKKLDSSKQPDQEFLA 110
+ + +L+ K +++ +IG G++G V ++R + + A+K L + +
Sbjct: 57 TINKIRDLRMKAEDYEVVKVIGRGAFGEVQ--LVRHKSTRKVYAMKLLSKFE------MI 108
Query: 111 QVSMVSRLKNENVVELVGYYVDGPLRV-LAYEHASKGSLHDILHGKKGVKGAKPGPVLSW 169
+ S + E + + + + P V L Y L+ ++ G G +++
Sbjct: 109 KRSDSAFFWEERDI-MA--FANSPWVVQLFYAFQDDRYLYMVMEYMPG------GDLVNL 159
Query: 170 AQRVKIAVGAAR--------GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221
+ AR L+ +H IHR++K N+LL K++DF
Sbjct: 160 MSNYDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCM 216
Query: 222 QAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSK----SDVYSFGVVLLELLTGRKP 274
+ T V GT Y +PE + D +S GV L E+L G P
Sbjct: 217 KMNKEGMVRCDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 272
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 1e-09
Identities = 52/212 (24%), Positives = 81/212 (38%), Gaps = 25/212 (11%)
Query: 74 IGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKN-ENVVELVGYYV 131
IG GS+G +Y G + +G AIK + K + + + ++ + +
Sbjct: 17 IGSGSFGDIYLGTDIAAGEEVAIKL-ECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGA 75
Query: 132 DGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAE 191
+G V+ E SL D L K S + +A +EY+H K
Sbjct: 76 EGDYNVMVMELLGP-SLED-LFNFCSRK-------FSLKTVLLLADQMISRIEYIHSK-- 124
Query: 192 PRIIHRNIKSSNVLLFDDDIAK---ISDFDLSNQAPDAAARLH-----STRVLGTFGYHA 243
IHR++K N L+ I DF L+ + DA H + + GT Y A
Sbjct: 125 -NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARY-A 182
Query: 244 PEYAMTG-QMSSKSDVYSFGVVLLELLTGRKP 274
G + S + D+ S G VL+ G P
Sbjct: 183 SINTHLGIEQSRRDDLESLGYVLMYFNLGSLP 214
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 58.2 bits (141), Expect = 1e-09
Identities = 49/237 (20%), Positives = 96/237 (40%), Gaps = 40/237 (16%)
Query: 57 SVDELKEKTDNFGTNSLIGEGSYGRVYFGVLR---SGRAAAIKKLDSSKQPDQEFLAQVS 113
V +++ ++F +IG G++G V V++ + + A+K L +K + + +
Sbjct: 65 KVKQMRLHREDFEILKVIGRGAFGEVA--VVKLKNADKVFAMKIL--NKW----EMLKRA 116
Query: 114 MVSRLKNENVVELVGYYVDGPLRV-LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQR 172
+ + E V LV D L Y +L+ ++ G G +L+ +
Sbjct: 117 ETACFREERDV-LV--NGDSKWITTLHYAFQDDNNLYLVMDYYVG------GDLLTLLSK 167
Query: 173 V--KIAVGAAR--------GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222
++ AR ++ +H+ +HR+IK N+L+ + +++DF +
Sbjct: 168 FEDRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLK 224
Query: 223 APDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKS-----DVYSFGVVLLELLTGRKP 274
+ S V GT Y +PE + D +S GV + E+L G P
Sbjct: 225 LMEDGTVQSSVAV-GTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETP 280
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 2e-09
Identities = 50/239 (20%), Positives = 95/239 (39%), Gaps = 38/239 (15%)
Query: 55 VISVDELKEKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVS 113
V+ + E++ + D+F +IG G++ V ++ +G+ A+K + +K + +
Sbjct: 50 VVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIM--NKW----DMLKRG 103
Query: 114 MVSRLKNENVVELVGYYVDGPLRV-LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQR 172
VS + E V LV D L + + L+ ++ G G +L+ +
Sbjct: 104 EVSCFREERDV-LV--NGDRRWITQLHFAFQDENYLYLVMEYYVG------GDLLTLLSK 154
Query: 173 V--KIAVGAAR--------GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222
+I AR ++ +H +HR+IK N+LL +++DF +
Sbjct: 155 FGERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADFGSCLK 211
Query: 223 APDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVY-------SFGVVLLELLTGRKP 274
A + S +GT Y +PE + Y + GV E+ G+ P
Sbjct: 212 L-RADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTP 269
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 2e-09
Identities = 29/94 (30%), Positives = 49/94 (52%), Gaps = 6/94 (6%)
Query: 182 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGY 241
L+YLH + +++R++K N++L D KI+DF L + A + + GT Y
Sbjct: 260 ALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT--FCGTPEY 315
Query: 242 HAPEYAMTGQMSSKS-DVYSFGVVLLELLTGRKP 274
APE + ++ D + GVV+ E++ GR P
Sbjct: 316 LAPE-VLEDNDYGRAVDWWGLGVVMYEMMCGRLP 348
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 56.8 bits (138), Expect = 2e-09
Identities = 36/96 (37%), Positives = 58/96 (60%), Gaps = 11/96 (11%)
Query: 182 GLEYLHEKAEPRIIHRNIKSSNVLLFDDD--IAKISDFDLSNQAPDAAARLHSTRVLGTF 239
L++LH II+R++K N+LL D++ I K++DF LS ++ D + +S GT
Sbjct: 138 ALDHLHSLG---IIYRDLKPENILL-DEEGHI-KLTDFGLSKESIDHEKKAYS--FCGTV 190
Query: 240 GYHAPEYAMTGQMSSKS-DVYSFGVVLLELLTGRKP 274
Y APE + + ++S D +SFGV++ E+LTG P
Sbjct: 191 EYMAPE-VVNRRGHTQSADWWSFGVLMFEMLTGTLP 225
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 4e-09
Identities = 30/101 (29%), Positives = 48/101 (47%), Gaps = 12/101 (11%)
Query: 181 RGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFG 240
R ++ LH +IHR++K SN+L+ + K+ DF L+ ++AA +
Sbjct: 123 RAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGM 179
Query: 241 --------YHAPEYAMTGQMSSKS-DVYSFGVVLLELLTGR 272
Y APE +T S++ DV+S G +L EL R
Sbjct: 180 VEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 56.0 bits (136), Expect = 5e-09
Identities = 28/94 (29%), Positives = 49/94 (52%), Gaps = 7/94 (7%)
Query: 182 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGY 241
L +LH+K II+R++K N++L K++DF L ++ H+ GT Y
Sbjct: 133 ALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHT--FCGTIEY 187
Query: 242 HAPEYAMTGQMSSKS-DVYSFGVVLLELLTGRKP 274
APE + +++ D +S G ++ ++LTG P
Sbjct: 188 MAPE-ILMRSGHNRAVDWWSLGALMYDMLTGAPP 220
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 5e-09
Identities = 31/94 (32%), Positives = 49/94 (52%), Gaps = 7/94 (7%)
Query: 182 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGY 241
LEYLH + +++R+IK N++L D KI+DF L + A + + GT Y
Sbjct: 117 ALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT--FCGTPEY 171
Query: 242 HAPEYAMTGQMSSKS-DVYSFGVVLLELLTGRKP 274
APE + ++ D + GVV+ E++ GR P
Sbjct: 172 LAPE-VLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 55.7 bits (135), Expect = 6e-09
Identities = 30/94 (31%), Positives = 49/94 (52%), Gaps = 7/94 (7%)
Query: 182 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGY 241
L YLHE+ II+R++K NVLL + K++D+ + + + GT Y
Sbjct: 122 ALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST--FCGTPNY 176
Query: 242 HAPEYAMTGQMSSKS-DVYSFGVVLLELLTGRKP 274
APE + G+ S D ++ GV++ E++ GR P
Sbjct: 177 IAPE-ILRGEDYGFSVDWWALGVLMFEMMAGRSP 209
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 2e-08
Identities = 43/214 (20%), Positives = 74/214 (34%), Gaps = 55/214 (25%)
Query: 74 IGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRL-KNENVVELVGYYV 131
+G G G+V + + A+K L + +E V + R + ++V +V Y
Sbjct: 26 LGLGINGKVLQIFNKRTQEKFALKMLQDCPKARRE----VELHWRASQCPHIVRIVDVYE 81
Query: 132 DGPLRVLAY----EHASKGSLHDILHGKKGV----KGAKPGPVLSWAQRVKIAVGAARGL 183
+ E G L + + + A ++ +K A +
Sbjct: 82 NLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREA--------SEIMKSIGEA---I 130
Query: 184 EYLHEKAEPRIIHRNIKSSNVLLFDDD---IAKISDFDLSNQAPDAAARLHSTRVLGTFG 240
+YLH I HR++K N+L I K++DF A + G
Sbjct: 131 QYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGF---AKE---------TTGE-K 174
Query: 241 YHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
Y D++S GV++ LL G P
Sbjct: 175 Y-----------DKSCDMWSLGVIMYILLCGYPP 197
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 54.5 bits (132), Expect = 2e-08
Identities = 29/94 (30%), Positives = 47/94 (50%), Gaps = 7/94 (7%)
Query: 182 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGY 241
L +LH+K II+R++K NVLL + K++DF + + + GT Y
Sbjct: 136 ALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTAT--FCGTPDY 190
Query: 242 HAPEYAMTGQMSSKS-DVYSFGVVLLELLTGRKP 274
APE + + + D ++ GV+L E+L G P
Sbjct: 191 IAPE-ILQEMLYGPAVDWWAMGVLLYEMLCGHAP 223
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 2e-08
Identities = 30/94 (31%), Positives = 49/94 (52%), Gaps = 7/94 (7%)
Query: 182 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGY 241
L YLHE+ II+R++K NVLL + K++D+ + + + GT Y
Sbjct: 165 ALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST--FCGTPNY 219
Query: 242 HAPEYAMTGQMSSKS-DVYSFGVVLLELLTGRKP 274
APE + G+ S D ++ GV++ E++ GR P
Sbjct: 220 IAPE-ILRGEDYGFSVDWWALGVLMFEMMAGRSP 252
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 54.1 bits (129), Expect = 2e-08
Identities = 42/248 (16%), Positives = 76/248 (30%), Gaps = 54/248 (21%)
Query: 65 TDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKL---------DSSKQPDQEFLAQVSMV 115
T+ IGEG +G V+ + AIK + S ++ +E L ++ +
Sbjct: 19 TEKLQRCEKIGEGVFGEVFQTIAD-HTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIIS 77
Query: 116 SRLKN---------ENVVELVGYY-VDGP-----LRVLAYEHASKGSLHDILHGKKGVKG 160
L E + L + V G L+ + +++KGS +D K +
Sbjct: 78 KELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQL 137
Query: 161 --------------AKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLL 206
+ S A I L R HR++ NVLL
Sbjct: 138 FIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEAS--LRFEHRDLHWGNVLL 195
Query: 207 FDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAP--EYAMTGQMSSKSDVYSFGVV 264
+ K+ + + + G +Y ++ V+ +
Sbjct: 196 KKTSLKKLHYTLNGK-----------SSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVSM 244
Query: 265 LLELLTGR 272
+L TG
Sbjct: 245 DEDLFTGD 252
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 54.1 bits (131), Expect = 2e-08
Identities = 36/94 (38%), Positives = 55/94 (58%), Gaps = 7/94 (7%)
Query: 182 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGY 241
GL++LH K I++R++K N+LL D KI+DF + + A+ ++ GT Y
Sbjct: 130 GLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT--FCGTPDY 184
Query: 242 HAPEYAMTGQMSSKS-DVYSFGVVLLELLTGRKP 274
APE + GQ + S D +SFGV+L E+L G+ P
Sbjct: 185 IAPE-ILLGQKYNHSVDWWSFGVLLYEMLIGQSP 217
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 3e-08
Identities = 28/94 (29%), Positives = 44/94 (46%), Gaps = 7/94 (7%)
Query: 182 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGY 241
L YLH I++R++K N+LL ++DF L + + + + GT Y
Sbjct: 151 ALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTST--FCGTPEY 205
Query: 242 HAPEYAMTGQMSSKS-DVYSFGVVLLELLTGRKP 274
APE + Q ++ D + G VL E+L G P
Sbjct: 206 LAPE-VLHKQPYDRTVDWWCLGAVLYEMLYGLPP 238
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 53.9 bits (129), Expect = 4e-08
Identities = 33/94 (35%), Positives = 49/94 (52%), Gaps = 7/94 (7%)
Query: 182 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGY 241
GL +L K II+R++K NV+L + KI+DF + + + GT Y
Sbjct: 454 GLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKT--FCGTPDY 508
Query: 242 HAPEYAMTGQMSSKS-DVYSFGVVLLELLTGRKP 274
APE + Q KS D ++FGV+L E+L G+ P
Sbjct: 509 IAPE-IIAYQPYGKSVDWWAFGVLLYEMLAGQAP 541
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 53.7 bits (129), Expect = 4e-08
Identities = 48/249 (19%), Positives = 90/249 (36%), Gaps = 56/249 (22%)
Query: 74 IGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQ-----VSMVSRLKNENVVELV 127
IG GSYG V R AIKK+ + + + +++++RL +++VV++
Sbjct: 61 IGTGSYGHVCEAYDKLEKRVVAIKKI--LRVFEDLIDCKRILREIAILNRLNHDHVVKV- 117
Query: 128 GYYVDGPLRV-------LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAA 180
+ P V + E A + + L+ +
Sbjct: 118 -LDIVIPKDVEKFDELYVVLEIADS-DFKKLF---------RTPVYLTELHIKTLLYNLL 166
Query: 181 RGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS---NQAPDAAARLHSTRVLG 237
G++Y+H I+HR++K +N L+ D K+ DF L+ + + ++L +
Sbjct: 167 VGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPRED 223
Query: 238 TFG----------------------YHAPEYAMTGQMSSKS-DVYSFGVVLLELLTGRKP 274
Y APE + + +++ DV+S G + ELL K
Sbjct: 224 DMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKE 283
Query: 275 VDHTLPRGQ 283
Sbjct: 284 NVAYHADRG 292
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 53.0 bits (128), Expect = 4e-08
Identities = 33/94 (35%), Positives = 49/94 (52%), Gaps = 7/94 (7%)
Query: 182 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGY 241
GL +L K II+R++K NV+L + KI+DF + + + GT Y
Sbjct: 133 GLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKT--FCGTPDY 187
Query: 242 HAPEYAMTGQMSSKS-DVYSFGVVLLELLTGRKP 274
APE + Q KS D ++FGV+L E+L G+ P
Sbjct: 188 IAPE-IIAYQPYGKSVDWWAFGVLLYEMLAGQAP 220
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 54.1 bits (129), Expect = 4e-08
Identities = 50/336 (14%), Positives = 98/336 (29%), Gaps = 96/336 (28%)
Query: 34 YVKEAPAKEMKTVTVQPIAVPVISVDELKEKTDNFGTNSLIGEGS-YGRVY--FGVLRSG 90
+V K+ VQ + ++S +E+ +I F L S
Sbjct: 29 FVDNFDCKD-----VQDMPKSILSKEEIDH---------IIMSKDAVSGTLRLFWTLLSK 74
Query: 91 RAAAIKK-LDSSKQPDQEFLAQ----------------VSMVSRLKNENVVELVGYYVDG 133
+ ++K ++ + + +FL + RL N+N V Y V
Sbjct: 75 QEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQV-FAKYNVSR 133
Query: 134 P-----LRVLAYEHASKGSLHDILHGKKG---------------VKGAKPGPVLSWAQRV 173
LR E ++ ++ G G V+ + W
Sbjct: 134 LQPYLKLRQALLELRPAKNV--LIDGVLGSGKTWVALDVCLSYKVQCKMDFKIF-W---- 186
Query: 174 KIAVGAARG-------LEYLHEKAEPRIIHRNIKSSNV-LLFDDDIAKISDFDLSNQAPD 225
+ + L+ L + +P R+ SSN+ L A++ S +
Sbjct: 187 -LNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYEN 245
Query: 226 AAARL------HSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTL 279
L + + F +T + +D L T +DH
Sbjct: 246 C---LLVLLNVQNAKAWNAFNLSCK-ILLTTRFKQVTD------FLSAATTTHISLDHH- 294
Query: 280 PRGQQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKA 315
+L TP + + + +D + + P +
Sbjct: 295 ---SMTL----TPDEVKSLLLKYLDCRP-QDLPREV 322
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 5e-08
Identities = 47/216 (21%), Positives = 79/216 (36%), Gaps = 31/216 (14%)
Query: 74 IGEGSYGRVYFGV-LRSGRAAAIKK-LDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYV 131
IGEGS+G ++ G L + + AIK S P + + + +
Sbjct: 18 IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRT-YKLLAGCTGIPNVYYFGQ 76
Query: 132 DGPLRVLAYEHASKGSLHDIL--HGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEK 189
+G VL + SL D+L G+K S A ++ +HEK
Sbjct: 77 EGLHNVLVIDLLGP-SLEDLLDLCGRK----------FSVKTVAMAAKQMLARVQSIHEK 125
Query: 190 AEPRIIHRNIKSSNVLLFDDDIAK-----ISDFDLSNQAPDAAARLH-----STRVLGTF 239
+ +++R+IK N L+ + + DF + D + H + GT
Sbjct: 126 S---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTA 182
Query: 240 GYHAPEYAMTG-QMSSKSDVYSFGVVLLELLTGRKP 274
Y G + S + D+ + G V + L G P
Sbjct: 183 RY-MSINTHLGREQSRRDDLEALGHVFMYFLRGSLP 217
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 1e-07
Identities = 36/98 (36%), Positives = 52/98 (53%), Gaps = 12/98 (12%)
Query: 182 GLEYLHEKAEPRIIHRNIKSSNVLLFDDD--IAKISDFDLSNQA-PDAAARLHSTRVLGT 238
LE+LH+ II+R+IK N+LL D + + ++DF LS + D R + GT
Sbjct: 171 ALEHLHKLG---IIYRDIKLENILL-DSNGHV-VLTDFGLSKEFVADETERAYD--FCGT 223
Query: 239 FGYHAPEYAMTGQMS-SKS-DVYSFGVVLLELLTGRKP 274
Y AP+ G K+ D +S GV++ ELLTG P
Sbjct: 224 IEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP 261
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 52.3 bits (125), Expect = 1e-07
Identities = 54/212 (25%), Positives = 89/212 (41%), Gaps = 25/212 (11%)
Query: 74 IGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKN-ENVVELVGYYV 131
IG GS+G +Y G +++ AIK ++ K + L + + L+ + + + V
Sbjct: 15 IGSGSFGEIYLGTNIQTNEEVAIKL-ENVKTKHPQLLYESKIYRILQGGTGIPNVRWFGV 73
Query: 132 DGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAE 191
+G VL + SL D L K LS + +A +E++H K+
Sbjct: 74 EGDYNVLVMDLLGP-SLED-LFNFCSRK-------LSLKTVLMLADQMINRVEFVHSKS- 123
Query: 192 PRIIHRNIKSSNVLL---FDDDIAKISDFDLSNQAPDAAARLH-----STRVLGTFGYHA 243
+HR+IK N L+ + I DF L+ + D + H + + GT Y A
Sbjct: 124 --FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARY-A 180
Query: 244 PEYAMTG-QMSSKSDVYSFGVVLLELLTGRKP 274
G + S + D+ S G VL+ L G P
Sbjct: 181 SVNTHLGIEQSRRDDLESLGYVLMYFLRGSLP 212
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 51.3 bits (123), Expect = 2e-07
Identities = 47/279 (16%), Positives = 89/279 (31%), Gaps = 61/279 (21%)
Query: 35 VKEAPAKEMKTVT---VQPIAVPVISVDELKEKTDNFGTNSLIGEGSYGRVYFGVLRSGR 91
VK A A + + AV I D + IG+G +G +Y + S
Sbjct: 4 VKAAQAGRQSSAKRHLAEQFAVGEIITDMAAAA---WKVGLPIGQGGFGCIYLADMNSSE 60
Query: 92 AAAIK-----KLDSSKQPDQEF-------LAQVSMVSRLKNENVVELVG----------Y 129
+ K++ S A+ + + ++ +G
Sbjct: 61 SVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHD 120
Query: 130 YVDGPLRVLAYEHASKGSLHDIL--HGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLH 187
R + + L I + K+ S +++++ LEY+H
Sbjct: 121 KNGKSYRFMIMDRFGS-DLQKIYEANAKR----------FSRKTVLQLSLRILDILEYIH 169
Query: 188 EKAEPRIIHRNIKSSNVLLFDDDIAKI--SDFDLSNQAPDAAARLH-----STRVLGTFG 240
E +H +IK+SN+LL + ++ D+ L+ + GT
Sbjct: 170 EH---EYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGT-- 224
Query: 241 YHAPEYA-----MTGQMSSKSDVYSFGVVLLELLTGRKP 274
E+ S + D+ G +++ LTG P
Sbjct: 225 ---IEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLP 260
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 2e-07
Identities = 45/215 (20%), Positives = 78/215 (36%), Gaps = 29/215 (13%)
Query: 74 IGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVD 132
IG G++G + G L + AIK + Q L + + ++ +
Sbjct: 17 IGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYFGPC 76
Query: 133 GPLRVLAYEHASKGSLHDI--LHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKA 190
G + E SL D+ L + S + IA+ +EY+H K
Sbjct: 77 GKYNAMVLELLGP-SLEDLFDLCDRT----------FSLKTVLMIAIQLISRMEYVHSKN 125
Query: 191 EPRIIHRNIKSSNVLL-----FDDDIAKISDFDLSNQAPDAAARLH-----STRVLGTFG 240
+I+R++K N L+ + I DF L+ + D + H + GT
Sbjct: 126 ---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTAR 182
Query: 241 YHAPEYAMTG-QMSSKSDVYSFGVVLLELLTGRKP 274
Y G + S + D+ + G + + L G P
Sbjct: 183 Y-MSINTHLGKEQSRRDDLEALGHMFMYFLRGSLP 216
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 3e-07
Identities = 42/223 (18%), Positives = 89/223 (39%), Gaps = 37/223 (16%)
Query: 72 SLIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKN---------- 120
+G G + V+ + + A+K + K + ++ ++ R+ +
Sbjct: 25 RKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMG 84
Query: 121 -ENVVELVGY-YVDGPLR---VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKI 175
++++L+ + GP V+ +E + +L ++ + + +I
Sbjct: 85 ANHILKLLDHFNHKGPNGVHVVMVFEVLGE-NLLALIKKYEHRG-------IPLIYVKQI 136
Query: 176 AVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIA------KISDFDLSNQAPDAAAR 229
+ GL+Y+H + IIH +IK NVL+ D KI+D + +
Sbjct: 137 SKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDE---- 190
Query: 230 LHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGR 272
H T + T Y +PE + +D++S ++ EL+TG
Sbjct: 191 -HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGD 232
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 6e-07
Identities = 48/261 (18%), Positives = 90/261 (34%), Gaps = 47/261 (18%)
Query: 44 KTVTVQPIAVPVISVDELKEKTDNFGTNSLIGEGSYGRVYFGV-LRSGRAAAIK--KLDS 100
+ + Q + P V + E + + IG G +G +Y A K++
Sbjct: 16 ENLYFQSMPFPEGKVLDDMEG-NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEY 74
Query: 101 SKQP--DQEF-----LAQVSMVSRLKNENVVELVG----------YYVDGPLRVLAYEHA 143
+ E +A+ + + ++ +G + R + E
Sbjct: 75 QENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL 134
Query: 144 SKGSLHDIL--HGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKS 201
L I +G VL ++ + LEY+HE +H +IK+
Sbjct: 135 GI-DLQKISGQNGTFKKST-----VL------QLGIRMLDVLEYIHEN---EYVHGDIKA 179
Query: 202 SNVLLFDDDIAKI--SDFDLSNQAPDAAARLH----STRVL-GTFGYHAPEYAMTG-QMS 253
+N+LL + ++ +D+ LS + + GT + A G +S
Sbjct: 180 ANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEF-TSLDAHKGVALS 238
Query: 254 SKSDVYSFGVVLLELLTGRKP 274
+SDV G +L L G+ P
Sbjct: 239 RRSDVEILGYCMLRWLCGKLP 259
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 7e-07
Identities = 25/94 (26%), Positives = 45/94 (47%), Gaps = 12/94 (12%)
Query: 183 LEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVL-GTFGY 241
EYLH +I+R++K N+L+ +++DF + + T L GT
Sbjct: 154 FEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG------RTWTLCGTPEA 204
Query: 242 HAPEYAMTGQMSSKS-DVYSFGVVLLELLTGRKP 274
APE + + +K+ D ++ GV++ E+ G P
Sbjct: 205 LAPE-IILSKGYNKAVDWWALGVLIYEMAAGYPP 237
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 7e-07
Identities = 51/240 (21%), Positives = 92/240 (38%), Gaps = 61/240 (25%)
Query: 74 IGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQ-----VSMVSRLKNENVVELV 127
IG GSYG VY + + AIKK+ ++ + + +++++RLK++ ++ L
Sbjct: 34 IGRGSYGYVYLAYDKNTEKNVAIKKV--NRMFEDLIDCKRILREITILNRLKSDYIIRL- 90
Query: 128 GYYVDGPLRV-------LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVK-----I 175
Y + P + + E A L + L+ + +K +
Sbjct: 91 -YDLIIPDDLLKFDELYIVLEIADS-DLKKLFKTPI---------FLT-EEHIKTILYNL 138
Query: 176 AVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRV 235
+G ++HE + IIHR++K +N LL D K+ DF L+ +
Sbjct: 139 LLG----ENFIHE-SG--IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDL 191
Query: 236 LGTFG--------------------YHAPEYAMTGQMSSKS-DVYSFGVVLLELLTGRKP 274
Y APE + + +KS D++S G + ELL +
Sbjct: 192 EENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQS 251
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 48.7 bits (117), Expect = 1e-06
Identities = 37/95 (38%), Positives = 53/95 (55%), Gaps = 12/95 (12%)
Query: 182 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVL-GTFG 240
LEYLH K II+R++K N+LL + KI+DF + PD T L GT
Sbjct: 118 ALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPD------VTYTLCGTPD 168
Query: 241 YHAPEYAMTGQMSSKS-DVYSFGVVLLELLTGRKP 274
Y APE ++ + +KS D +SFG+++ E+L G P
Sbjct: 169 YIAPE-VVSTKPYNKSIDWWSFGILIYEMLAGYTP 202
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 2e-06
Identities = 27/112 (24%), Positives = 49/112 (43%), Gaps = 23/112 (20%)
Query: 181 RGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFG 240
+ ++YLH ++HR++K SN+LL + K++DF LS + ++ +
Sbjct: 120 KVIKYLHS-GG--LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINEN 176
Query: 241 -------------------YHAPEYAMTGQMSSKS-DVYSFGVVLLELLTGR 272
Y APE + +K D++S G +L E+L G+
Sbjct: 177 TENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 4e-05
Identities = 30/93 (32%), Positives = 43/93 (46%), Gaps = 10/93 (10%)
Query: 182 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIA--KISDFDLSNQAPDAAARLHSTRVLGTF 239
L+ LH+ RIIH ++K N+LL + K+ DF S +R F
Sbjct: 212 CLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYIQSR----F 264
Query: 240 GYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGR 272
Y APE + + D++S G +L ELLTG
Sbjct: 265 -YRAPEVILGARYGMPIDMWSLGCILAELLTGY 296
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 5e-05
Identities = 27/93 (29%), Positives = 41/93 (44%), Gaps = 8/93 (8%)
Query: 182 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIA--KISDFDLSNQAPDAAARLHSTRVLGTF 239
L +L E IIH ++K N+LL + + KI DF S Q + F
Sbjct: 169 ALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQR----IYQYIQSRF 223
Query: 240 GYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGR 272
Y +PE + D++S G +L+E+ TG
Sbjct: 224 -YRSPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 43.4 bits (102), Expect = 7e-05
Identities = 29/135 (21%), Positives = 45/135 (33%), Gaps = 46/135 (34%)
Query: 182 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDI------------------------------ 211
GL+YLH K RIIH +IK N+LL ++
Sbjct: 158 GLDYLHTKC--RIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPA 215
Query: 212 -----------AKISDFDLSNQAPDAAARL---HSTRVLGTFGYHAPEYAMTGQMSSKSD 257
K ++ A A H T + T Y + E + ++ +D
Sbjct: 216 TAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSLEVLIGSGYNTPAD 275
Query: 258 VYSFGVVLLELLTGR 272
++S + EL TG
Sbjct: 276 IWSTACMAFELATGD 290
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 41.3 bits (97), Expect = 3e-04
Identities = 50/258 (19%), Positives = 84/258 (32%), Gaps = 56/258 (21%)
Query: 57 SVDELKEK---TDNFGTN----SLIGEGSYGRVYFGVLRSGRAAAIK--------KLDSS 101
S++ L TD G S + G +Y S KLD+
Sbjct: 26 SLEALPTGTVLTDKSGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAK 85
Query: 102 KQP---DQEFL---AQVSMVSRLKNENVVELVG----YY---VDGPLRVLAYEHASKGSL 148
+Q F A+ V++ K L+ R L + SL
Sbjct: 86 DGRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGR-SL 144
Query: 149 HDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFD 208
L P VLS +++A LE+LHE +H N+ + N+ +
Sbjct: 145 QSALD-------VSPKHVLSERSVLQVACRLLDALEFLHEN---EYVHGNVTAENIFVDP 194
Query: 209 DDIAKI--SDFDLSNQAPDA----AARLHSTRVL-GTFGYHAPEYA-----MTGQMSSKS 256
+D +++ + + + + + A S G E+ S +S
Sbjct: 195 EDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGD-----LEFISMDLHKGCGPSRRS 249
Query: 257 DVYSFGVVLLELLTGRKP 274
D+ S G +L+ L G P
Sbjct: 250 DLQSLGYCMLKWLYGFLP 267
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 351 | |||
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 100.0 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.96 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.93 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.86 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.77 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.54 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.39 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.3 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.21 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.97 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.79 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.76 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.66 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.65 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.63 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.42 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.39 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 98.11 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 98.1 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.05 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 98.03 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 98.02 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 98.01 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.9 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.85 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.79 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.64 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.63 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 97.46 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 97.11 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 97.09 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.2 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.78 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 93.12 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 91.23 | |
| 1cja_A | 342 | Protein (actin-fragmin kinase); transferase; HET: | 82.11 |
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-58 Score=410.52 Aligned_cols=239 Identities=21% Similarity=0.287 Sum_probs=203.1
Q ss_pred cCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCC----CCchHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEE
Q 018712 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSS----KQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAY 140 (351)
Q Consensus 66 ~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 140 (351)
++|++.+.||+|+||+||+|.++ +++.||+|++.+. ....+.+.+|+++|++++|||||+++++|.+++.+|+||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 57999999999999999999975 7999999998643 233467899999999999999999999999999999999
Q ss_pred EeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEeccccc
Q 018712 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (351)
Q Consensus 141 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a 220 (351)
|||+||+|.+++.+.+. +++..+..++.||+.||.|||+++ |+||||||+|||++.++++||+|||+|
T Consensus 112 Ey~~gG~L~~~i~~~~~---------l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla 179 (311)
T 4aw0_A 112 SYAKNGELLKYIRKIGS---------FDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTA 179 (311)
T ss_dssp CCCTTEEHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTC
T ss_pred ecCCCCCHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCc
Confidence 99999999999987643 999999999999999999999999 999999999999999999999999999
Q ss_pred CCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccchhhcccC----CC-
Q 018712 221 NQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPK----LS- 295 (351)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~----~~- 295 (351)
+..............+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+.......+...... ++
T Consensus 180 ~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~p~~~s~ 259 (311)
T 4aw0_A 180 KVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPEKFFP 259 (311)
T ss_dssp EECCTTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTCCH
T ss_pred eecCCCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCcccCH
Confidence 8765443333345678999999999999999999999999999999999999999875433222222211111 11
Q ss_pred --ccchhhhcccccCCCCCHHHH
Q 018712 296 --EDKVKQCVDTKLGGEYPPKAI 316 (351)
Q Consensus 296 --~~~~~~~ld~~~~~~~~~~~~ 316 (351)
.+.+..||..+|.+|++.+++
T Consensus 260 ~~~dli~~lL~~dp~~R~t~~e~ 282 (311)
T 4aw0_A 260 KARDLVEKLLVLDATKRLGCEEM 282 (311)
T ss_dssp HHHHHHHHHSCSSGGGSTTSGGG
T ss_pred HHHHHHHHHccCCHhHCcChHHH
Confidence 257788888888889887765
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-56 Score=407.20 Aligned_cols=247 Identities=23% Similarity=0.354 Sum_probs=200.8
Q ss_pred hcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCCc---hHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEE
Q 018712 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAY 140 (351)
Q Consensus 65 ~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 140 (351)
.++|++++.||+|+||+||+|.+. +|+.||||++...... .+.+.+|+++|++++|||||++++++.+++.+|+||
T Consensus 23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVm 102 (350)
T 4b9d_A 23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVM 102 (350)
T ss_dssp CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence 478999999999999999999975 7999999999765433 356889999999999999999999999999999999
Q ss_pred EeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEeccccc
Q 018712 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (351)
Q Consensus 141 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a 220 (351)
|||+||+|.++|...+.. .+++..++.++.||+.||.|||++| |+||||||+|||++++|++||+|||+|
T Consensus 103 Ey~~gg~L~~~i~~~~~~-------~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla 172 (350)
T 4b9d_A 103 DYCEGGDLFKRINAQKGV-------LFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIA 172 (350)
T ss_dssp ECCTTCBHHHHHHHTTTC-------CCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEE
T ss_pred eCCCCCcHHHHHHHcCCC-------CCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccc
Confidence 999999999999765432 2789999999999999999999999 999999999999999999999999999
Q ss_pred CCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccchh-hccc----CC-
Q 018712 221 NQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVT-WATP----KL- 294 (351)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~~-~~~~----~~- 294 (351)
+........ ....+||+.|||||++.+..|+.++|||||||++|||++|+.||...+.......+. ...+ .+
T Consensus 173 ~~~~~~~~~--~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~s 250 (350)
T 4b9d_A 173 RVLNSTVEL--ARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVSLHYS 250 (350)
T ss_dssp SCCCHHHHH--HHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCCTTSC
T ss_pred eeecCCccc--ccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccCC
Confidence 887543221 245679999999999999999999999999999999999999998764432221111 1111 11
Q ss_pred --CccchhhhcccccCCCCCHHHHHHHHHHHHHh
Q 018712 295 --SEDKVKQCVDTKLGGEYPPKAIAKVRKKKFIT 326 (351)
Q Consensus 295 --~~~~~~~~ld~~~~~~~~~~~~~~~~~~~~~~ 326 (351)
..+.+..||..+|.+|++.+++ +++.++.
T Consensus 251 ~~~~~li~~~L~~dP~~R~s~~e~---l~hp~~~ 281 (350)
T 4b9d_A 251 YDLRSLVSQLFKRNPRDRPSVNSI---LEKGFIA 281 (350)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHH---HTSHHHH
T ss_pred HHHHHHHHHHccCChhHCcCHHHH---hcCHHhh
Confidence 1368899999999999988776 4455543
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-57 Score=410.91 Aligned_cols=244 Identities=26% Similarity=0.410 Sum_probs=205.6
Q ss_pred cCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCC-CchHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEEEeC
Q 018712 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK-QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHA 143 (351)
Q Consensus 66 ~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 143 (351)
+.|++.+.||+|+||+||+|.++ +|+.||||++.... ...+.+.+|+.+|+.++|||||+++++|.+++.+|||||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 56999999999999999999976 79999999986433 23456889999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccccCCC
Q 018712 144 SKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQA 223 (351)
Q Consensus 144 ~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~ 223 (351)
+||+|.+++.... +++..+..++.||+.||.|||++| |+||||||+|||++.+|++||+|||+|+..
T Consensus 154 ~gg~L~~~l~~~~----------l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~ 220 (346)
T 4fih_A 154 EGGALTDIVTHTR----------MNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQV 220 (346)
T ss_dssp TTEEHHHHHHHSC----------CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred CCCcHHHHHHcCC----------CCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceec
Confidence 9999999998643 899999999999999999999999 999999999999999999999999999876
Q ss_pred ccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccchhhcc-------cCCC-
Q 018712 224 PDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWAT-------PKLS- 295 (351)
Q Consensus 224 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~~~~~-------~~~~- 295 (351)
...... ....+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.........+.... +.++
T Consensus 221 ~~~~~~--~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~ 298 (346)
T 4fih_A 221 SKEVPR--RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSP 298 (346)
T ss_dssp CSSSCC--BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCSCGGGSCH
T ss_pred CCCCCc--ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccccCCH
Confidence 543222 256789999999999999999999999999999999999999998764433222222111 1111
Q ss_pred --ccchhhhcccccCCCCCHHHHHHHHHHHHHhh
Q 018712 296 --EDKVKQCVDTKLGGEYPPKAIAKVRKKKFITS 327 (351)
Q Consensus 296 --~~~~~~~ld~~~~~~~~~~~~~~~~~~~~~~~ 327 (351)
.+.+..||..+|.+|++++++ +++.|+..
T Consensus 299 ~~~dli~~~L~~dP~~R~ta~e~---l~Hp~~~~ 329 (346)
T 4fih_A 299 SLKGFLDRLLVRDPAQRATAAEL---LKHPFLAK 329 (346)
T ss_dssp HHHHHHHHHSCSSTTTSCCHHHH---TTCGGGGG
T ss_pred HHHHHHHHHcCCChhHCcCHHHH---hcCHhhcC
Confidence 367899999999999987764 45665543
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-56 Score=401.13 Aligned_cols=254 Identities=21% Similarity=0.260 Sum_probs=210.5
Q ss_pred hcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCCchHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEEEeC
Q 018712 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHA 143 (351)
Q Consensus 65 ~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 143 (351)
.+.|.+.+.||+|+||.||+|.++ +|+.||||+++.... ..+|+.+++.++|||||++++++.+++.+|||||||
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 132 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELL 132 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEecc
Confidence 456888889999999999999975 799999999976543 246999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCC-ceEEecccccCC
Q 018712 144 SKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD-IAKISDFDLSNQ 222 (351)
Q Consensus 144 ~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~-~vkl~Dfg~a~~ 222 (351)
+||+|.++++..+. +++..+..++.||+.||.|||+++ |+||||||+|||++.+| ++||+|||+|+.
T Consensus 133 ~gg~L~~~l~~~~~---------l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~ 200 (336)
T 4g3f_A 133 EGGSLGQLIKQMGC---------LPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALC 200 (336)
T ss_dssp TTCBHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEE
T ss_pred CCCcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeE
Confidence 99999999987543 999999999999999999999999 99999999999999987 699999999987
Q ss_pred Ccccccc---ccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccchhhc-------cc
Q 018712 223 APDAAAR---LHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWA-------TP 292 (351)
Q Consensus 223 ~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~~~~-------~~ 292 (351)
....... ......+||+.|||||++.+..|+.++|||||||++|||+||+.||...........+... .+
T Consensus 201 ~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 280 (336)
T 4g3f_A 201 LQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPP 280 (336)
T ss_dssp C------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGGGGSCT
T ss_pred ccCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCchhcCc
Confidence 6433211 1223467999999999999999999999999999999999999999876554433222211 12
Q ss_pred CCC---ccchhhhcccccCCCCCHHHHHHHHHHHHHhhhhccccc
Q 018712 293 KLS---EDKVKQCVDTKLGGEYPPKAIAKVRKKKFITSECSNISF 334 (351)
Q Consensus 293 ~~~---~~~~~~~ld~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 334 (351)
.++ .+.+..|+..+|.+|++++++.+.+..++.-...+++++
T Consensus 281 ~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw 325 (336)
T 4g3f_A 281 SCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPW 325 (336)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCS
T ss_pred cCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCC
Confidence 222 367899999999999999999888777777666665543
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-56 Score=414.30 Aligned_cols=245 Identities=26% Similarity=0.408 Sum_probs=206.9
Q ss_pred cCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCC-chHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEEEeC
Q 018712 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ-PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHA 143 (351)
Q Consensus 66 ~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 143 (351)
+.|++.+.||+|+||.||+|.++ +|+.||||++..... ..+.+.+|+.+|+.++|||||+++++|.+++.+|||||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~ 230 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 230 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence 56999999999999999999975 799999999865433 3456889999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccccCCC
Q 018712 144 SKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQA 223 (351)
Q Consensus 144 ~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~ 223 (351)
+||+|.+++.... +++..+..++.||+.||.|||++| |+||||||+|||++.+|.+||+|||+|+..
T Consensus 231 ~gG~L~~~i~~~~----------l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~ 297 (423)
T 4fie_A 231 EGGALTDIVTHTR----------MNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQV 297 (423)
T ss_dssp TTEEHHHHHHHSC----------CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEEC
T ss_pred CCCcHHHHHhccC----------CCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceEC
Confidence 9999999997653 899999999999999999999999 999999999999999999999999999876
Q ss_pred ccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccchhhcc-------cCCC-
Q 018712 224 PDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWAT-------PKLS- 295 (351)
Q Consensus 224 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~~~~~-------~~~~- 295 (351)
...... ....+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.........+.... ..++
T Consensus 298 ~~~~~~--~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~ 375 (423)
T 4fie_A 298 SKEVPR--RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSP 375 (423)
T ss_dssp CSSCCC--BCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSSCH
T ss_pred CCCCcc--ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCcccccCCH
Confidence 443222 256789999999999999999999999999999999999999998764433222222111 1111
Q ss_pred --ccchhhhcccccCCCCCHHHHHHHHHHHHHhhh
Q 018712 296 --EDKVKQCVDTKLGGEYPPKAIAKVRKKKFITSE 328 (351)
Q Consensus 296 --~~~~~~~ld~~~~~~~~~~~~~~~~~~~~~~~~ 328 (351)
.+.+..||..++.+|++++++ +++.|+...
T Consensus 376 ~~~dli~~~L~~dP~~R~ta~el---l~Hp~~~~~ 407 (423)
T 4fie_A 376 SLKGFLDRLLVRDPAQRATAAEL---LKHPFLAKA 407 (423)
T ss_dssp HHHHHHHHHSCSSTTTSCCHHHH---TTCGGGGGC
T ss_pred HHHHHHHHHcCCChhHCcCHHHH---hcCHHhcCC
Confidence 368899999999999987764 556665543
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-55 Score=386.79 Aligned_cols=242 Identities=22% Similarity=0.306 Sum_probs=188.8
Q ss_pred hcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCC----chHHHHHHHHHHHhccCCceeeeEEEEecCCceEEE
Q 018712 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ----PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLA 139 (351)
Q Consensus 65 ~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 139 (351)
.++|++.+.||+|+||+||+|.+. +|+.||+|++.+... ....+.+|+++|++++||||+++++++.+.+..|+|
T Consensus 12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv 91 (275)
T 3hyh_A 12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMV 91 (275)
T ss_dssp --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence 478999999999999999999965 799999999865432 245689999999999999999999999999999999
Q ss_pred EEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccc
Q 018712 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDL 219 (351)
Q Consensus 140 ~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~ 219 (351)
|||+ +|+|.+++..... +++..+..++.||+.||+|||++| |+||||||+|||+++++++||+|||+
T Consensus 92 mEy~-~g~L~~~l~~~~~---------l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGl 158 (275)
T 3hyh_A 92 IEYA-GNELFDYIVQRDK---------MSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGL 158 (275)
T ss_dssp EECC-CEEHHHHHHHSCS---------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSC
T ss_pred EeCC-CCCHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCC
Confidence 9999 6799999987643 999999999999999999999999 99999999999999999999999999
Q ss_pred cCCCccccccccccccccccCccCcccccCCCC-CccchhHhHHHHHHHHHcCCCCCCCCCCCCCccchhhcccCC----
Q 018712 220 SNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQM-SSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKL---- 294 (351)
Q Consensus 220 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~---- 294 (351)
|+....... ....+||+.|||||++.+..| +.++||||+||++|+|+||+.||...+.......+......+
T Consensus 159 a~~~~~~~~---~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~~~p~~~ 235 (275)
T 3hyh_A 159 SNIMTDGNF---LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKFL 235 (275)
T ss_dssp C------------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTS
T ss_pred CeecCCCCc---cCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Confidence 987644322 245689999999999998876 579999999999999999999998654322212222111111
Q ss_pred ---CccchhhhcccccCCCCCHHHHHHHHHHHHH
Q 018712 295 ---SEDKVKQCVDTKLGGEYPPKAIAKVRKKKFI 325 (351)
Q Consensus 295 ---~~~~~~~~ld~~~~~~~~~~~~~~~~~~~~~ 325 (351)
..+.+..|+..+|.+|++.+++ +++.++
T Consensus 236 s~~~~~li~~~L~~dP~~R~s~~ei---l~hpw~ 266 (275)
T 3hyh_A 236 SPGAAGLIKRMLIVNPLNRISIHEI---MQDDWF 266 (275)
T ss_dssp CHHHHHHHHHHSCSSGGGSCCHHHH---HHCHHH
T ss_pred CHHHHHHHHHHccCChhHCcCHHHH---HcCccc
Confidence 1368899999999999987765 455654
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-55 Score=393.85 Aligned_cols=254 Identities=23% Similarity=0.379 Sum_probs=204.4
Q ss_pred cCCCCCceeccCCcEEEEEEEEC------CCCEEEEEEcCCCCC-chHHHHHHHHHHHhccCCceeeeEEEEecCCceEE
Q 018712 66 DNFGTNSLIGEGSYGRVYFGVLR------SGRAAAIKKLDSSKQ-PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVL 138 (351)
Q Consensus 66 ~~y~~~~~Lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 138 (351)
++|.+.+.||+|+||.||+|.+. ++..||||+++.... ..+.+.+|+++|++++|||||++++++.+++..|+
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 92 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 92 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 57888999999999999999864 477899999975433 24678999999999999999999999999999999
Q ss_pred EEEeCCCCCHHHHhccCCCC----CCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEE
Q 018712 139 AYEHASKGSLHDILHGKKGV----KGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKI 214 (351)
Q Consensus 139 v~e~~~~gsL~~~l~~~~~~----~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl 214 (351)
|||||++|+|.++|...... ........+++.+++.++.||+.||.|||+++ |+||||||+|||+++++++||
T Consensus 93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~~Ki 169 (299)
T 4asz_A 93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI 169 (299)
T ss_dssp EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCcEEE
Confidence 99999999999999764310 00112234999999999999999999999999 999999999999999999999
Q ss_pred ecccccCCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCCccchhh-c--
Q 018712 215 SDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTW-A-- 290 (351)
Q Consensus 215 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~Pf~~~~~~~~~~~~~~-~-- 290 (351)
+|||+|+...............||+.|||||++.+..|+.++|||||||++|||+| |+.||.+.........+.. .
T Consensus 170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~~~~~ 249 (299)
T 4asz_A 170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRVL 249 (299)
T ss_dssp CCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHHTCCC
T ss_pred CCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCC
Confidence 99999976544433333344579999999999999999999999999999999999 9999987654322221211 1
Q ss_pred -----ccCCCccchhhhcccccCCCCCHHHHHHHHHH
Q 018712 291 -----TPKLSEDKVKQCVDTKLGGEYPPKAIAKVRKK 322 (351)
Q Consensus 291 -----~~~~~~~~~~~~ld~~~~~~~~~~~~~~~~~~ 322 (351)
.+....+.+..|++.+|.+|++.+++...++-
T Consensus 250 ~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~ 286 (299)
T 4asz_A 250 QRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQN 286 (299)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 11112368899999999999999998766554
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-54 Score=386.54 Aligned_cols=243 Identities=30% Similarity=0.423 Sum_probs=192.8
Q ss_pred hcCCCCCceeccCCcEEEEEEEECCCCEEEEEEcCCCCCc---hHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEEE
Q 018712 65 TDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYE 141 (351)
Q Consensus 65 ~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 141 (351)
.+++.+.+.||+|+||+||+|.++ ..||||+++..... .+.+.+|+.+|++++|||||++++++.+ +.++||||
T Consensus 35 ~~~l~l~~~iG~G~fG~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmE 111 (307)
T 3omv_A 35 ASEVMLSTRIGSGSFGTVYKGKWH--GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQ 111 (307)
T ss_dssp TTSCCEEEECCCCSSSEEEEEESS--SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEEC--CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEE
Confidence 357788899999999999999865 36999998754433 3568899999999999999999998754 56899999
Q ss_pred eCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccccC
Q 018712 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (351)
Q Consensus 142 ~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~ 221 (351)
||++|+|.++|..... .+++.+++.++.||+.||.|||+++ ||||||||+|||+++++++||+|||+|+
T Consensus 112 y~~gGsL~~~l~~~~~--------~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~ 180 (307)
T 3omv_A 112 WCEGSSLYKHLHVQET--------KFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLAT 180 (307)
T ss_dssp CCSSCBHHHHHHTSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCB
T ss_pred cCCCCCHHHHHhhcCC--------CCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCce
Confidence 9999999999976532 2899999999999999999999999 9999999999999999999999999998
Q ss_pred CCccccccccccccccccCccCcccccC---CCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCcc-chhh--ccc---
Q 018712 222 QAPDAAARLHSTRVLGTFGYHAPEYAMT---GQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQS-LVTW--ATP--- 292 (351)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~-~~~~--~~~--- 292 (351)
..............+||+.|||||++.+ ..|+.++|||||||++|||+||+.||.+........ .+.. ..|
T Consensus 181 ~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~ 260 (307)
T 3omv_A 181 VKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLS 260 (307)
T ss_dssp C------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCST
T ss_pred ecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCcc
Confidence 7654433333456789999999999864 358999999999999999999999998755432111 1110 111
Q ss_pred -------CCCccchhhhcccccCCCCCHHHHHHHHH
Q 018712 293 -------KLSEDKVKQCVDTKLGGEYPPKAIAKVRK 321 (351)
Q Consensus 293 -------~~~~~~~~~~ld~~~~~~~~~~~~~~~~~ 321 (351)
....+.+..|+..+|.+||+..++...++
T Consensus 261 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le 296 (307)
T 3omv_A 261 KLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIE 296 (307)
T ss_dssp TSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHH
T ss_pred cccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHH
Confidence 11236789999999999999998866543
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-54 Score=391.68 Aligned_cols=255 Identities=21% Similarity=0.339 Sum_probs=198.9
Q ss_pred cCCCCCceeccCCcEEEEEEEEC------CCCEEEEEEcCCCCC-chHHHHHHHHHHHhccCCceeeeEEEEecCCceEE
Q 018712 66 DNFGTNSLIGEGSYGRVYFGVLR------SGRAAAIKKLDSSKQ-PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVL 138 (351)
Q Consensus 66 ~~y~~~~~Lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 138 (351)
++|.+.++||+|+||.||+|.++ +++.||||++..... ..+.+.+|+++|++++|||||++++++.+.+..|+
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 120 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM 120 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 56778889999999999999864 478999999975432 24679999999999999999999999999999999
Q ss_pred EEEeCCCCCHHHHhccCCCCCC------CCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCce
Q 018712 139 AYEHASKGSLHDILHGKKGVKG------AKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIA 212 (351)
Q Consensus 139 v~e~~~~gsL~~~l~~~~~~~~------~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~v 212 (351)
|||||++|+|.++++....... ......+++.+++.++.||+.||.|||+++ |+||||||+|||+++++++
T Consensus 121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~~~ 197 (329)
T 4aoj_A 121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVV 197 (329)
T ss_dssp EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCCcE
Confidence 9999999999999987543211 011234899999999999999999999999 9999999999999999999
Q ss_pred EEecccccCCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCCccchhh-c
Q 018712 213 KISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTW-A 290 (351)
Q Consensus 213 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~Pf~~~~~~~~~~~~~~-~ 290 (351)
||+|||+|+...............||+.|||||++.+..|+.++|||||||++|||+| |+.||...........+.. .
T Consensus 198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~g~ 277 (329)
T 4aoj_A 198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGR 277 (329)
T ss_dssp EECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHHHHTC
T ss_pred EEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC
Confidence 9999999987654443333355679999999999999999999999999999999999 9999987654322222211 1
Q ss_pred c-------cCCCccchhhhcccccCCCCCHHHHHHHHHHH
Q 018712 291 T-------PKLSEDKVKQCVDTKLGGEYPPKAIAKVRKKK 323 (351)
Q Consensus 291 ~-------~~~~~~~~~~~ld~~~~~~~~~~~~~~~~~~~ 323 (351)
. +....+.+..|+..+|.+|++.+++...++..
T Consensus 278 ~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l 317 (329)
T 4aoj_A 278 ELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQAL 317 (329)
T ss_dssp CCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHH
T ss_pred CCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence 1 11123688999999999999999987766543
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-56 Score=398.29 Aligned_cols=246 Identities=20% Similarity=0.308 Sum_probs=197.4
Q ss_pred cCCCCCceeccCCcEEEEEEEEC----CCCEEEEEEcCCCCC---chHHHHHHHHHHHhccCCceeeeEEEEecCCceEE
Q 018712 66 DNFGTNSLIGEGSYGRVYFGVLR----SGRAAAIKKLDSSKQ---PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVL 138 (351)
Q Consensus 66 ~~y~~~~~Lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 138 (351)
++|++.+.||+|+||+||+|+.. +++.||+|++.+... ....+.+|+++|++++|||||++++++.+++.+|+
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 57999999999999999999863 578999999865421 23467889999999999999999999999999999
Q ss_pred EEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEeccc
Q 018712 139 AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFD 218 (351)
Q Consensus 139 v~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg 218 (351)
|||||+||+|.+++.+... +++..+..++.||+.||.|||++| |+||||||+|||++.+|++||+|||
T Consensus 104 vmEy~~gg~L~~~l~~~~~---------l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFG 171 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSKEVM---------FTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFG 171 (304)
T ss_dssp EECCCTTCEEHHHHHHHCC---------CCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSE
T ss_pred EEEcCCCCCHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccc
Confidence 9999999999999987643 899999999999999999999999 9999999999999999999999999
Q ss_pred ccCCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccchhhcccCC----
Q 018712 219 LSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKL---- 294 (351)
Q Consensus 219 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~---- 294 (351)
+|+........ ....+||+.|||||++.+..|+.++|||||||++|||+||+.||.+.+.......+.......
T Consensus 172 la~~~~~~~~~--~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~~~ 249 (304)
T 3ubd_A 172 LSKESIDHEKK--AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFL 249 (304)
T ss_dssp EEEC-----CC--CCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTS
T ss_pred cceeccCCCcc--ccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCCcC
Confidence 99865433222 245789999999999999999999999999999999999999998765433222222221111
Q ss_pred ---CccchhhhcccccCCCCCHH--HHHHHHHHHHH
Q 018712 295 ---SEDKVKQCVDTKLGGEYPPK--AIAKVRKKKFI 325 (351)
Q Consensus 295 ---~~~~~~~~ld~~~~~~~~~~--~~~~~~~~~~~ 325 (351)
..+.+..|+..+|.+|+++. .+..++++.++
T Consensus 250 s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f 285 (304)
T 3ubd_A 250 SPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFF 285 (304)
T ss_dssp CHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGG
T ss_pred CHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCccc
Confidence 13688899999999999753 34555666654
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-54 Score=388.48 Aligned_cols=253 Identities=26% Similarity=0.346 Sum_probs=204.6
Q ss_pred cCCCCCceeccCCcEEEEEEEEC------CCCEEEEEEcCCCCC--chHHHHHHHHHHHhccCCceeeeEEEEecCCceE
Q 018712 66 DNFGTNSLIGEGSYGRVYFGVLR------SGRAAAIKKLDSSKQ--PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRV 137 (351)
Q Consensus 66 ~~y~~~~~Lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 137 (351)
+++++.+.||+|+||.||+|.+. +++.||||++..... ..+.+.+|+.++++++|||||++++++.+.+..+
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~ 105 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS 105 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence 34567789999999999999863 567899999975432 3567999999999999999999999999999999
Q ss_pred EEEEeCCCCCHHHHhccCCCCCC-------CCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCC
Q 018712 138 LAYEHASKGSLHDILHGKKGVKG-------AKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD 210 (351)
Q Consensus 138 lv~e~~~~gsL~~~l~~~~~~~~-------~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~ 210 (351)
+|||||++|+|.++|........ ......+++.+++.++.||+.||.|||+++ ||||||||+|||+++++
T Consensus 106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~~ 182 (308)
T 4gt4_A 106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKL 182 (308)
T ss_dssp EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGG
T ss_pred EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEECCCC
Confidence 99999999999999975432111 011134899999999999999999999999 99999999999999999
Q ss_pred ceEEecccccCCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCCccchhh
Q 018712 211 IAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTW 289 (351)
Q Consensus 211 ~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~Pf~~~~~~~~~~~~~~ 289 (351)
++||+|||+|+...........+...||+.|||||++.+..|+.++|||||||++|||+| |+.||.+.........+..
T Consensus 183 ~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~i~~ 262 (308)
T 4gt4_A 183 NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIRN 262 (308)
T ss_dssp CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHHHHT
T ss_pred CEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Confidence 999999999987655443333455689999999999999999999999999999999998 8999987654322222211
Q ss_pred -c-------ccCCCccchhhhcccccCCCCCHHHHHHHHH
Q 018712 290 -A-------TPKLSEDKVKQCVDTKLGGEYPPKAIAKVRK 321 (351)
Q Consensus 290 -~-------~~~~~~~~~~~~ld~~~~~~~~~~~~~~~~~ 321 (351)
. .+....+.+.+|++.+|.+||+..++...++
T Consensus 263 ~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~ 302 (308)
T 4gt4_A 263 RQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLR 302 (308)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence 1 1111236788999999999999988866543
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-53 Score=380.03 Aligned_cols=233 Identities=25% Similarity=0.364 Sum_probs=189.0
Q ss_pred CCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCCc---hHHHHHHHHHHHhccCCceeeeEEEEec----CCceEEEE
Q 018712 69 GTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVD----GPLRVLAY 140 (351)
Q Consensus 69 ~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~----~~~~~lv~ 140 (351)
++.+.||+|+||+||+|.+. ++..||+|++...... .+.+.+|+++|++++|||||+++++|.+ ++.+|+||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 56678999999999999975 7899999998654322 3568899999999999999999999864 35689999
Q ss_pred EeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEcc-CCceEEecccc
Q 018712 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFD-DDIAKISDFDL 219 (351)
Q Consensus 141 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~-~~~vkl~Dfg~ 219 (351)
|||+||+|.+++..... +++..+..++.||+.||.|||+++. +|+||||||+|||++. ++.+||+|||+
T Consensus 109 Ey~~gg~L~~~l~~~~~---------l~~~~~~~~~~qi~~aL~ylH~~~~-~IiHRDlKp~NILl~~~~g~vKl~DFGl 178 (290)
T 3fpq_A 109 ELMTSGTLKTYLKRFKV---------MKIKVLRSWCRQILKGLQFLHTRTP-PIIHRDLKCDNIFITGPTGSVKIGDLGL 178 (290)
T ss_dssp ECCCSCBHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHTSSS-CCCCCCCCGGGEEESSTTSCEEECCTTG
T ss_pred eCCCCCCHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHCCC-CEEecccChhheeEECCCCCEEEEeCcC
Confidence 99999999999987543 8999999999999999999999853 3999999999999984 78999999999
Q ss_pred cCCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCc-cchh---------h
Q 018712 220 SNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQ-SLVT---------W 289 (351)
Q Consensus 220 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~-~~~~---------~ 289 (351)
|+...... ....+||+.|||||++.+ .|+.++|||||||++|||+||+.||......... ..+. .
T Consensus 179 a~~~~~~~----~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~ 253 (290)
T 3fpq_A 179 ATLKRASF----AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDK 253 (290)
T ss_dssp GGGCCTTS----BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGG
T ss_pred CEeCCCCc----cCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCCCCCCc
Confidence 97543321 245689999999998865 6999999999999999999999999764332111 0010 0
Q ss_pred cccCCCccchhhhcccccCCCCCHHHH
Q 018712 290 ATPKLSEDKVKQCVDTKLGGEYPPKAI 316 (351)
Q Consensus 290 ~~~~~~~~~~~~~ld~~~~~~~~~~~~ 316 (351)
..+....+.+..|+..+|.+|++.+++
T Consensus 254 ~~~~~~~~li~~~L~~dP~~R~s~~e~ 280 (290)
T 3fpq_A 254 VAIPEVKEIIEGCIRQNKDERYSIKDL 280 (290)
T ss_dssp CCCHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred cCCHHHHHHHHHHccCChhHCcCHHHH
Confidence 011112367889999999999987765
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-52 Score=379.56 Aligned_cols=261 Identities=20% Similarity=0.292 Sum_probs=208.2
Q ss_pred HHHhcCCCCCceeccCCcEEEEEEEEC------CCCEEEEEEcCCCCCc--hHHHHHHHHHHHhccC-CceeeeEEEEec
Q 018712 62 KEKTDNFGTNSLIGEGSYGRVYFGVLR------SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKN-ENVVELVGYYVD 132 (351)
Q Consensus 62 ~~~~~~y~~~~~Lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~h-~niv~~~~~~~~ 132 (351)
....++|++.+.||+|+||.||+|.+. +++.||||++...... .+.+.+|+++|++++| ||||+++++|.+
T Consensus 60 Ei~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~ 139 (353)
T 4ase_A 60 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK 139 (353)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECC
T ss_pred EecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEe
Confidence 334578999999999999999999864 2368999999765433 3568899999999965 899999999865
Q ss_pred -CCceEEEEEeCCCCCHHHHhccCCCCCC-------CCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcE
Q 018712 133 -GPLRVLAYEHASKGSLHDILHGKKGVKG-------AKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNV 204 (351)
Q Consensus 133 -~~~~~lv~e~~~~gsL~~~l~~~~~~~~-------~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Ni 204 (351)
++.+++|||||++|+|.++|+....... ......+++..++.++.||+.||.|||+++ ||||||||+||
T Consensus 140 ~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiHRDLK~~NI 216 (353)
T 4ase_A 140 PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNI 216 (353)
T ss_dssp TTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGE
T ss_pred cCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eecCccCccce
Confidence 4568999999999999999976432110 011234899999999999999999999999 99999999999
Q ss_pred EEccCCceEEecccccCCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCC
Q 018712 205 LLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQ 283 (351)
Q Consensus 205 ll~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~Pf~~~~~~~~ 283 (351)
|+++++++||+|||+|+...............||+.|||||++.+..|+.++|||||||++|||+| |+.||.+......
T Consensus 217 Ll~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~ 296 (353)
T 4ase_A 217 LLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE 296 (353)
T ss_dssp EECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH
T ss_pred eeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHH
Confidence 999999999999999987755443333456789999999999999999999999999999999998 9999987543321
Q ss_pred c-cchh-hcccCC-------CccchhhhcccccCCCCCHHHHHHHHHHHHH
Q 018712 284 Q-SLVT-WATPKL-------SEDKVKQCVDTKLGGEYPPKAIAKVRKKKFI 325 (351)
Q Consensus 284 ~-~~~~-~~~~~~-------~~~~~~~~ld~~~~~~~~~~~~~~~~~~~~~ 325 (351)
. ..+. ...+.. ..+.+..|+..+|.+|++.+++...++-.+.
T Consensus 297 ~~~~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq 347 (353)
T 4ase_A 297 FCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 347 (353)
T ss_dssp HHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHH
Confidence 1 1111 111111 1267899999999999999998776654443
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-52 Score=371.47 Aligned_cols=240 Identities=22% Similarity=0.374 Sum_probs=181.3
Q ss_pred hcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCCc--hHHHHHHHHHHHhccCCceeeeEEEEecCC-------
Q 018712 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGP------- 134 (351)
Q Consensus 65 ~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------- 134 (351)
.++|++++.||+|+||.||+|.++ +|+.||||++...... .+.+.+|+++|++++|||||++++++.+.+
T Consensus 4 l~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~ 83 (299)
T 4g31_A 4 LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQP 83 (299)
T ss_dssp HHHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-------
T ss_pred chhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccc
Confidence 356999999999999999999975 7899999998654432 356889999999999999999999986543
Q ss_pred -----ceEEEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccC
Q 018712 135 -----LRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDD 209 (351)
Q Consensus 135 -----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~ 209 (351)
.+|+|||||.+|+|.+++...... ....+..++.++.||+.||.|||++| |+||||||+|||++.+
T Consensus 84 ~~~~~~l~ivmE~~~gg~L~~~l~~~~~~------~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~ 154 (299)
T 4g31_A 84 SSPKVYLYIQMQLCRKENLKDWMNGRCTI------EERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMD 154 (299)
T ss_dssp ---CEEEEEEEECCCSCCHHHHHHTCCSG------GGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTT
T ss_pred cCCCcEEEEEEecCCCCcHHHHHHhcCCC------ChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCC
Confidence 379999999999999999865431 11456778899999999999999999 9999999999999999
Q ss_pred CceEEecccccCCCcccccc----------ccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCC
Q 018712 210 DIAKISDFDLSNQAPDAAAR----------LHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTL 279 (351)
Q Consensus 210 ~~vkl~Dfg~a~~~~~~~~~----------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~ 279 (351)
+.+||+|||+|+........ ...+..+||+.|||||++.+..|+.++|||||||++|||++ ||....
T Consensus 155 ~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~ 231 (299)
T 4g31_A 155 DVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQM 231 (299)
T ss_dssp CCEEECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHH
T ss_pred CcEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCcc
Confidence 99999999999876543211 11234679999999999999999999999999999999996 776432
Q ss_pred CCCCc--cchhhcccCC-------CccchhhhcccccCCCCCHHHH
Q 018712 280 PRGQQ--SLVTWATPKL-------SEDKVKQCVDTKLGGEYPPKAI 316 (351)
Q Consensus 280 ~~~~~--~~~~~~~~~~-------~~~~~~~~ld~~~~~~~~~~~~ 316 (351)
..... .......|.. ..+.+..|+..+|.+|++++++
T Consensus 232 ~~~~~~~~~~~~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~ei 277 (299)
T 4g31_A 232 ERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINI 277 (299)
T ss_dssp HHHHHHHHHHTTCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred HHHHHHHHHhcCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHH
Confidence 11000 0000111110 1257889999999999988765
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-52 Score=371.99 Aligned_cols=245 Identities=22% Similarity=0.312 Sum_probs=186.9
Q ss_pred cCCCCCceeccCCcEEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHHhccCCceeeeEEEEecCC----ceEEEEE
Q 018712 66 DNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGP----LRVLAYE 141 (351)
Q Consensus 66 ~~y~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----~~~lv~e 141 (351)
++|.+.+.||+|+||.||+|.+ +|+.||||++............|+..+.+++|||||++++++.+.+ .+|||||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~E 81 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSD 81 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEec
Confidence 4678889999999999999998 5889999999754433333345666667889999999999987653 5799999
Q ss_pred eCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCC-----CCCeeeccccCCcEEEccCCceEEec
Q 018712 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKA-----EPRIIHRNIKSSNVLLFDDDIAKISD 216 (351)
Q Consensus 142 ~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~-----~~~ivH~Dlkp~Nill~~~~~vkl~D 216 (351)
|+++|+|.++++... +++..+..++.|++.||.|||++. ..+|+||||||+|||++.++++||+|
T Consensus 82 y~~~gsL~~~l~~~~----------l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~D 151 (303)
T 3hmm_A 82 YHEHGSLFDYLNRYT----------VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD 151 (303)
T ss_dssp CCTTCBHHHHHHHCC----------BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECC
T ss_pred CCCCCcHHHHHHhCC----------CCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEe
Confidence 999999999998654 899999999999999999999871 11299999999999999999999999
Q ss_pred ccccCCCcccccc--ccccccccccCccCcccccCC------CCCccchhHhHHHHHHHHHcCCCCCCCCCCCCC-----
Q 018712 217 FDLSNQAPDAAAR--LHSTRVLGTFGYHAPEYAMTG------QMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQ----- 283 (351)
Q Consensus 217 fg~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~----- 283 (351)
||+|+........ ......+||+.|||||++.+. .++.++|||||||++|||+||..||........
T Consensus 152 FGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~ 231 (303)
T 3hmm_A 152 LGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDL 231 (303)
T ss_dssp CTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTT
T ss_pred CCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhc
Confidence 9999765433221 122346799999999998764 367899999999999999999887654322110
Q ss_pred -----c--cch-----hhcccCCC------------ccchhhhcccccCCCCCHHHHHHHHH
Q 018712 284 -----Q--SLV-----TWATPKLS------------EDKVKQCVDTKLGGEYPPKAIAKVRK 321 (351)
Q Consensus 284 -----~--~~~-----~~~~~~~~------------~~~~~~~ld~~~~~~~~~~~~~~~~~ 321 (351)
. .+. ....|.++ .+.+.+|++.+|.+||+..++.+.++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 293 (303)
T 3hmm_A 232 VPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 293 (303)
T ss_dssp SCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHH
T ss_pred ccccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHH
Confidence 0 000 01112211 25678899999999999988877654
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-51 Score=380.26 Aligned_cols=245 Identities=22% Similarity=0.344 Sum_probs=197.7
Q ss_pred cCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCCc---hHHHHHHHHHHHhccCCceeeeEEEEec------CCc
Q 018712 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVD------GPL 135 (351)
Q Consensus 66 ~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~------~~~ 135 (351)
++|++++.||+|+||+||+|.++ +|+.||||++...... .+.+.+|+++|+.++|||||++++++.. .+.
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 57999999999999999999975 7999999999765433 3467899999999999999999998753 367
Q ss_pred eEEEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEe
Q 018712 136 RVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKIS 215 (351)
Q Consensus 136 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~ 215 (351)
+|+|||||. |+|.+++...+. +++..+..++.||+.||.|||++| |+||||||+|||++.++.+||+
T Consensus 134 ~~ivmE~~~-g~L~~~i~~~~~---------l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~ 200 (398)
T 4b99_A 134 VYVVLDLME-SDLHQIIHSSQP---------LTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIG 200 (398)
T ss_dssp EEEEEECCS-EEHHHHHTSSSC---------CCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEEC
T ss_pred EEEEEeCCC-CCHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEe
Confidence 899999996 589999986543 999999999999999999999999 9999999999999999999999
Q ss_pred cccccCCCccccc--cccccccccccCccCcccccCC-CCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccchhh---
Q 018712 216 DFDLSNQAPDAAA--RLHSTRVLGTFGYHAPEYAMTG-QMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTW--- 289 (351)
Q Consensus 216 Dfg~a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~~~--- 289 (351)
|||+|+....... .......+||+.|+|||++.+. .++.++||||+||++|||++|++||.+.+.......+..
T Consensus 201 DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g 280 (398)
T 4b99_A 201 DFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLG 280 (398)
T ss_dssp CCTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHC
T ss_pred ecceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcC
Confidence 9999987643321 2223567899999999998875 569999999999999999999999987543221111100
Q ss_pred --------------------------------cccCCC---ccchhhhcccccCCCCCHHHHHHHHHHHHHh
Q 018712 290 --------------------------------ATPKLS---EDKVKQCVDTKLGGEYPPKAIAKVRKKKFIT 326 (351)
Q Consensus 290 --------------------------------~~~~~~---~~~~~~~ld~~~~~~~~~~~~~~~~~~~~~~ 326 (351)
..+... .+++..||..+|.+|++++++ ++|.|+.
T Consensus 281 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~---L~Hp~f~ 349 (398)
T 4b99_A 281 TPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAA---LRHPFLA 349 (398)
T ss_dssp CCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHH---TTSGGGT
T ss_pred CCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHH---hcCHhhC
Confidence 011111 257899999999999988764 5566654
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-49 Score=365.71 Aligned_cols=200 Identities=26% Similarity=0.397 Sum_probs=171.9
Q ss_pred HHhcCCCCCceeccCCcEEEEEEEEC----CCCEEEEEEcCCCCCchHHHHHHHHHHHhc-cCCceeeeEEEEecCCceE
Q 018712 63 EKTDNFGTNSLIGEGSYGRVYFGVLR----SGRAAAIKKLDSSKQPDQEFLAQVSMVSRL-KNENVVELVGYYVDGPLRV 137 (351)
Q Consensus 63 ~~~~~y~~~~~Lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~ 137 (351)
...++|++.+.||+|+||+||+|.++ +++.||+|++.... ....+.+|+++|+.+ +||||++++++|.+.+.+|
T Consensus 18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~-~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~ 96 (361)
T 4f9c_A 18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS-HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVV 96 (361)
T ss_dssp GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS-CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEE
T ss_pred CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc-CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEE
Confidence 45678999999999999999999863 56889999986654 345688999999998 6999999999999999999
Q ss_pred EEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccC-CceEEec
Q 018712 138 LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDD-DIAKISD 216 (351)
Q Consensus 138 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~-~~vkl~D 216 (351)
+||||+++|+|.+++.. +++.++..++.||+.||.|||++| |+||||||+|||++.+ +.+||+|
T Consensus 97 lvmE~~~g~~L~~~~~~------------l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~D 161 (361)
T 4f9c_A 97 IAMPYLEHESFLDILNS------------LSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVD 161 (361)
T ss_dssp EEEECCCCCCHHHHHTT------------CCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECC
T ss_pred EEEeCCCcccHHHHHcC------------CCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECc
Confidence 99999999999999942 889999999999999999999999 9999999999999877 7999999
Q ss_pred ccccCCCccccc--------------------------cccccccccccCccCcccccCC-CCCccchhHhHHHHHHHHH
Q 018712 217 FDLSNQAPDAAA--------------------------RLHSTRVLGTFGYHAPEYAMTG-QMSSKSDVYSFGVVLLELL 269 (351)
Q Consensus 217 fg~a~~~~~~~~--------------------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~ 269 (351)
||+|+....... ....+..+||+.|+|||++.+. .|+.++||||+||++|||+
T Consensus 162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell 241 (361)
T 4f9c_A 162 FGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLL 241 (361)
T ss_dssp CTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHH
T ss_pred CCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHH
Confidence 999975432211 0112345799999999999875 5899999999999999999
Q ss_pred cCCCCCCCC
Q 018712 270 TGRKPVDHT 278 (351)
Q Consensus 270 tg~~Pf~~~ 278 (351)
+|+.||...
T Consensus 242 ~G~~Pf~~~ 250 (361)
T 4f9c_A 242 SGRYPFYKA 250 (361)
T ss_dssp HTCSSSSCC
T ss_pred HCCCCCCCC
Confidence 999999643
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-50 Score=386.75 Aligned_cols=246 Identities=23% Similarity=0.339 Sum_probs=199.3
Q ss_pred HhcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCC----CchHHHHHH---HHHHHhccCCceeeeEEEEecCCc
Q 018712 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK----QPDQEFLAQ---VSMVSRLKNENVVELVGYYVDGPL 135 (351)
Q Consensus 64 ~~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~e---~~~l~~l~h~niv~~~~~~~~~~~ 135 (351)
..++|++.+.||+|+||.||+|..+ +|+.||+|++.+.. .......+| +.+++.++|||||+++++|.+.+.
T Consensus 187 slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ 266 (689)
T 3v5w_A 187 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDK 266 (689)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSE
T ss_pred chHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCE
Confidence 3578999999999999999999976 79999999986431 222233333 566777899999999999999999
Q ss_pred eEEEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEe
Q 018712 136 RVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKIS 215 (351)
Q Consensus 136 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~ 215 (351)
+|+||||+.||+|.++|..... +++..++.++.||+.||.|||++| ||||||||+|||++.+|++||+
T Consensus 267 lylVmEy~~GGdL~~~l~~~~~---------l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~ 334 (689)
T 3v5w_A 267 LSFILDLMNGGDLHYHLSQHGV---------FSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRIS 334 (689)
T ss_dssp EEEEECCCCSCBHHHHHHHHCC---------CCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEEC
T ss_pred EEEEEecCCCCcHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEec
Confidence 9999999999999999987643 999999999999999999999999 9999999999999999999999
Q ss_pred cccccCCCccccccccccccccccCccCcccccC-CCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccch---hhcc
Q 018712 216 DFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMT-GQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLV---TWAT 291 (351)
Q Consensus 216 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~---~~~~ 291 (351)
|||+|+...... ....+||+.|||||++.+ ..|+.++|||||||++|||++|+.||.+........+. ....
T Consensus 335 DFGlA~~~~~~~----~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~ 410 (689)
T 3v5w_A 335 DLGLACDFSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMA 410 (689)
T ss_dssp CCTTCEECSSCC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCC
T ss_pred ccceeeecCCCC----CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCC
Confidence 999998765432 245689999999999964 57999999999999999999999999865443322111 1111
Q ss_pred ----cCCC---ccchhhhcccccCCCCCH--HHHHHHHHHHHH
Q 018712 292 ----PKLS---EDKVKQCVDTKLGGEYPP--KAIAKVRKKKFI 325 (351)
Q Consensus 292 ----~~~~---~~~~~~~ld~~~~~~~~~--~~~~~~~~~~~~ 325 (351)
..++ .+.+..||..+|.+|++. ..+..+.+|.|+
T Consensus 411 ~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF 453 (689)
T 3v5w_A 411 VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFF 453 (689)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGG
T ss_pred CCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccc
Confidence 1111 368889999999999873 234456666664
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-49 Score=383.14 Aligned_cols=245 Identities=21% Similarity=0.297 Sum_probs=204.4
Q ss_pred HhcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCCc-hHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEEE
Q 018712 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP-DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYE 141 (351)
Q Consensus 64 ~~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 141 (351)
..++|++.+.||+|+||.||+|.++ +|+.||+|++...... .+.+.+|+.+|+.++||||++++++|.+.+.+|+|||
T Consensus 155 il~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E 234 (573)
T 3uto_A 155 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYE 234 (573)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence 3578999999999999999999975 7999999998765433 4568899999999999999999999999999999999
Q ss_pred eCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccC--CceEEecccc
Q 018712 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDD--DIAKISDFDL 219 (351)
Q Consensus 142 ~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~--~~vkl~Dfg~ 219 (351)
||.||+|.++|..... .+++.++..++.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||+
T Consensus 235 ~~~gg~L~~~i~~~~~--------~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~ 303 (573)
T 3uto_A 235 FMSGGELFEKVADEHN--------KMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGL 303 (573)
T ss_dssp CCCCCBHHHHHTCTTS--------CEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSS
T ss_pred ecCCCcHHHHHHHhCC--------CCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccc
Confidence 9999999999965432 2899999999999999999999999 9999999999999854 8999999999
Q ss_pred cCCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccchhh--------cc
Q 018712 220 SNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTW--------AT 291 (351)
Q Consensus 220 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~~~--------~~ 291 (351)
|+....... ....+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.........+.. ..
T Consensus 304 a~~~~~~~~---~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 380 (573)
T 3uto_A 304 TAHLDPKQS---VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAF 380 (573)
T ss_dssp CEECCTTSE---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGG
T ss_pred eeEccCCCc---eeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcccc
Confidence 987654332 2456899999999999999999999999999999999999999987654322222211 11
Q ss_pred cCCC---ccchhhhcccccCCCCCHHHHHHHHHHHHH
Q 018712 292 PKLS---EDKVKQCVDTKLGGEYPPKAIAKVRKKKFI 325 (351)
Q Consensus 292 ~~~~---~~~~~~~ld~~~~~~~~~~~~~~~~~~~~~ 325 (351)
+.++ .+++..||..+|.+|++.+++ ++|.++
T Consensus 381 ~~~s~~~~dli~~~L~~dp~~R~t~~e~---l~Hpw~ 414 (573)
T 3uto_A 381 SGISEDGKDFIRKLLLADPNTRMTIHQA---LEHPWL 414 (573)
T ss_dssp TTSCHHHHHHHHTTSCSSGGGSCCHHHH---HHSTTT
T ss_pred cCCCHHHHHHHHHHccCChhHCcCHHHH---hcCcCc
Confidence 1222 267889999999999988775 345543
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=337.83 Aligned_cols=247 Identities=21% Similarity=0.293 Sum_probs=201.7
Q ss_pred hcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCC----CCchHHHHHHHHHHHhccCCceeeeEEEEecCCceEEE
Q 018712 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSS----KQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLA 139 (351)
Q Consensus 65 ~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 139 (351)
.++|++.+.||+|+||.||+|..+ +++.||+|++.+. ......+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence 468999999999999999999976 7899999998643 23346688999999999999999999999999999999
Q ss_pred EEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccc
Q 018712 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDL 219 (351)
Q Consensus 140 ~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~ 219 (351)
|||+++|+|.+++..... +++..++.++.||+.||.|||++| |+||||||+|||++.+|.+||+|||+
T Consensus 84 ~E~~~gg~L~~~l~~~~~---------~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~ 151 (337)
T 1o6l_A 84 MEYANGGELFFHLSRERV---------FTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGL 151 (337)
T ss_dssp EECCTTCBHHHHHHHHSC---------CCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTT
T ss_pred EeCCCCCcHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccc
Confidence 999999999999986543 899999999999999999999999 99999999999999999999999999
Q ss_pred cCCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccchhhcc-------c
Q 018712 220 SNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWAT-------P 292 (351)
Q Consensus 220 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~~~~~-------~ 292 (351)
++....... .....+||+.|+|||++.+..++.++||||||+++|||++|+.||...........+.... +
T Consensus 152 a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s 229 (337)
T 1o6l_A 152 CKEGISDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLS 229 (337)
T ss_dssp CBCSCCTTC--CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSC
T ss_pred hhhcccCCC--cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCC
Confidence 976432221 1245679999999999999999999999999999999999999998654322221111111 1
Q ss_pred CCCccchhhhcccccCCCCCH--HHHHHHHHHHHH
Q 018712 293 KLSEDKVKQCVDTKLGGEYPP--KAIAKVRKKKFI 325 (351)
Q Consensus 293 ~~~~~~~~~~ld~~~~~~~~~--~~~~~~~~~~~~ 325 (351)
....+.+..|+..+|.+|+.. ..+..++++.++
T Consensus 230 ~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f 264 (337)
T 1o6l_A 230 PEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF 264 (337)
T ss_dssp HHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGG
T ss_pred HHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCc
Confidence 112368899999999999821 123334555543
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-46 Score=338.09 Aligned_cols=240 Identities=25% Similarity=0.319 Sum_probs=201.2
Q ss_pred HHhcCCCCCceeccCCcEEEEEEEE-CCCCEEEEEEcCCCCCc---hHHHHHHHHHHHhccCCceeeeEEEEecCCceEE
Q 018712 63 EKTDNFGTNSLIGEGSYGRVYFGVL-RSGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVL 138 (351)
Q Consensus 63 ~~~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 138 (351)
...++|.+.+.||+|+||.||+|.+ .+|+.||+|++...... .+.+.+|+++++.++||||+++++++.+.+..|+
T Consensus 12 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 91 (328)
T 3fe3_A 12 PHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYL 91 (328)
T ss_dssp CEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred CccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEE
Confidence 3457899999999999999999997 48999999998654322 3567899999999999999999999999999999
Q ss_pred EEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEeccc
Q 018712 139 AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFD 218 (351)
Q Consensus 139 v~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg 218 (351)
||||+++|+|.+++..... +++..+..++.||+.||.|||++| |+||||||+|||++.++.+||+|||
T Consensus 92 v~e~~~~~~L~~~l~~~~~---------l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG 159 (328)
T 3fe3_A 92 IMEYASGGEVFDYLVAHGR---------MKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFG 159 (328)
T ss_dssp EECCCTTCBHHHHHHHHCC---------CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTT
T ss_pred EEECCCCCcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeecc
Confidence 9999999999999976543 899999999999999999999999 9999999999999999999999999
Q ss_pred ccCCCccccccccccccccccCccCcccccCCCCC-ccchhHhHHHHHHHHHcCCCCCCCCCCCCCccchhhcc------
Q 018712 219 LSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMS-SKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWAT------ 291 (351)
Q Consensus 219 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~~~~~------ 291 (351)
++........ ....+||+.|+|||++.+..+. .++||||||+++|+|++|+.||...........+....
T Consensus 160 ~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~~ 236 (328)
T 3fe3_A 160 FSNEFTVGGK---LDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFY 236 (328)
T ss_dssp CCGGGSSSCG---GGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTT
T ss_pred CceecCCCCc---cccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCC
Confidence 9876543322 2456799999999999988774 79999999999999999999998764332222221111
Q ss_pred -cCCCccchhhhcccccCCCCCHHHHH
Q 018712 292 -PKLSEDKVKQCVDTKLGGEYPPKAIA 317 (351)
Q Consensus 292 -~~~~~~~~~~~ld~~~~~~~~~~~~~ 317 (351)
+....+.+..|+..+|.+|++.+++.
T Consensus 237 ~s~~~~~li~~~L~~dP~~R~t~~eil 263 (328)
T 3fe3_A 237 MSTDCENLLKRFLVLNPIKRGTLEQIM 263 (328)
T ss_dssp SCHHHHHHHHHHCCSSTTTSCCHHHHT
T ss_pred CCHHHHHHHHHHCCCChhHCcCHHHHh
Confidence 11123688999999999999987764
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-45 Score=329.85 Aligned_cols=239 Identities=23% Similarity=0.402 Sum_probs=201.0
Q ss_pred HhcCCCCCceeccCCcEEEEEEEE-CCCCEEEEEEcCCCC-CchHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEEE
Q 018712 64 KTDNFGTNSLIGEGSYGRVYFGVL-RSGRAAAIKKLDSSK-QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYE 141 (351)
Q Consensus 64 ~~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 141 (351)
..++|++.+.||+|+||.||+|.+ .+++.||+|++.... ...+.+.+|+.+++.++||||+++++++...+..++|||
T Consensus 18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 97 (297)
T 3fxz_A 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (297)
T ss_dssp GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEE
Confidence 456899999999999999999996 478999999986433 335678899999999999999999999999999999999
Q ss_pred eCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccccC
Q 018712 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (351)
Q Consensus 142 ~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~ 221 (351)
|+.+|+|.+++.... +++..+..++.|++.||.|||++| |+||||||+|||++.++.+||+|||++.
T Consensus 98 ~~~~~~L~~~~~~~~----------~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~ 164 (297)
T 3fxz_A 98 YLAGGSLTDVVTETC----------MDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCA 164 (297)
T ss_dssp CCTTCBHHHHHHHSC----------CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCE
T ss_pred CCCCCCHHHHHhhcC----------CCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCce
Confidence 999999999998653 889999999999999999999999 9999999999999999999999999987
Q ss_pred CCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccchh----------hcc
Q 018712 222 QAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVT----------WAT 291 (351)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~~----------~~~ 291 (351)
........ .....||+.|+|||++.+..++.++||||||+++|+|++|+.||....+......+. ...
T Consensus 165 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (297)
T 3fxz_A 165 QITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKL 242 (297)
T ss_dssp ECCSTTCC--BCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSCGGGS
T ss_pred ecCCcccc--cCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCcccc
Confidence 65433222 245679999999999999999999999999999999999999998654322111110 011
Q ss_pred cCCCccchhhhcccccCCCCCHHHHH
Q 018712 292 PKLSEDKVKQCVDTKLGGEYPPKAIA 317 (351)
Q Consensus 292 ~~~~~~~~~~~ld~~~~~~~~~~~~~ 317 (351)
+....+.+..|+..+|.+|++.+++.
T Consensus 243 ~~~~~~li~~~l~~dp~~Rps~~ell 268 (297)
T 3fxz_A 243 SAIFRDFLNRCLEMDVEKRGSAKELL 268 (297)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCHHHHT
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHh
Confidence 11123678999999999999887764
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-45 Score=333.88 Aligned_cols=261 Identities=18% Similarity=0.228 Sum_probs=214.7
Q ss_pred hcCCCCCceeccCCcEEEEEEEE-CCCCEEEEEEcCCCCCchHHHHHHHHHHHhc-cCCceeeeEEEEecCCceEEEEEe
Q 018712 65 TDNFGTNSLIGEGSYGRVYFGVL-RSGRAAAIKKLDSSKQPDQEFLAQVSMVSRL-KNENVVELVGYYVDGPLRVLAYEH 142 (351)
Q Consensus 65 ~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~ 142 (351)
.++|.+.+.||+|+||.||+|.+ .+++.||+|++..... .+.+.+|+.+++++ +||||+++++++.+.+..++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~ 86 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR-APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLEL 86 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS-SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEEC
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc-hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEe
Confidence 46799999999999999999996 4789999999865433 34588999999999 999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCc-----eEEecc
Q 018712 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDI-----AKISDF 217 (351)
Q Consensus 143 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~-----vkl~Df 217 (351)
+ +++|.+++..... .+++..++.++.||+.||.|||+++ |+||||||+|||++.++. +||+||
T Consensus 87 ~-~~~L~~~~~~~~~--------~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DF 154 (330)
T 2izr_A 87 L-GPSLEDLFDLCDR--------TFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDF 154 (330)
T ss_dssp C-CCBHHHHHHHTTT--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCC
T ss_pred C-CCCHHHHHHHcCC--------CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEc
Confidence 9 8899999986422 2899999999999999999999999 999999999999998887 999999
Q ss_pred cccCCCccccccc-----cccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccchhh---
Q 018712 218 DLSNQAPDAAARL-----HSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTW--- 289 (351)
Q Consensus 218 g~a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~~~--- 289 (351)
|+++......... ......||+.|+|||++.+..++.++||||||+++|||++|+.||..............
T Consensus 155 g~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~ 234 (330)
T 2izr_A 155 ALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGD 234 (330)
T ss_dssp TTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHH
T ss_pred ccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHh
Confidence 9998654332211 12456799999999999999999999999999999999999999997654432211110
Q ss_pred ------------cccCCCccchhhhcccccCCCCCHHHHHHHHHHHHHhhhhccccchhhhhcccCCccccc
Q 018712 290 ------------ATPKLSEDKVKQCVDTKLGGEYPPKAIAKVRKKKFITSECSNISFAEFNINWHCPLEWSV 349 (351)
Q Consensus 290 ------------~~~~~~~~~~~~~ld~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~ 349 (351)
..| ...+.+..|+..++..|++.+++.++++-. +++.+...+..+||..
T Consensus 235 ~~~~~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~----------~~~~~~~~~~~~dw~~ 295 (330)
T 2izr_A 235 TKRATPIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDL----------FDRKGYMFDYEYDWIG 295 (330)
T ss_dssp HHHHSCHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHH----------HHHTTCCCSCCCTTTT
T ss_pred hhccCCHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHH----------HHHcCCCCCCCccCCC
Confidence 012 234678899999999999999998876643 4555666777899974
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-45 Score=335.98 Aligned_cols=239 Identities=23% Similarity=0.331 Sum_probs=200.9
Q ss_pred HhcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCC-------chHHHHHHHHHHHhccCCceeeeEEEEecCCc
Q 018712 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ-------PDQEFLAQVSMVSRLKNENVVELVGYYVDGPL 135 (351)
Q Consensus 64 ~~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 135 (351)
..++|.+.+.||+|+||.||+|... +|+.||+|++..... ..+.+.+|+.+++.++||||+++++++.+.+.
T Consensus 10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 89 (361)
T 2yab_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTD 89 (361)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCE
Confidence 4567999999999999999999976 689999999865432 24678999999999999999999999999999
Q ss_pred eEEEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCC----c
Q 018712 136 RVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD----I 211 (351)
Q Consensus 136 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~----~ 211 (351)
.++||||+.+|+|.+++..... +++..+..++.||+.||.|||++| |+||||||+|||++.++ .
T Consensus 90 ~~lv~e~~~gg~L~~~l~~~~~---------l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~ 157 (361)
T 2yab_A 90 VVLILELVSGGELFDFLAQKES---------LSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPH 157 (361)
T ss_dssp EEEEEECCCSCBHHHHHTTCSC---------CBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCC
T ss_pred EEEEEEcCCCCcHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccC
Confidence 9999999999999999976542 899999999999999999999999 99999999999998877 7
Q ss_pred eEEecccccCCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccchhhc-
Q 018712 212 AKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWA- 290 (351)
Q Consensus 212 vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~~~~- 290 (351)
+||+|||++........ .....||+.|+|||++.+..++.++||||||+++|+|++|..||.+.........+...
T Consensus 158 vkl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~ 234 (361)
T 2yab_A 158 IKLIDFGLAHEIEDGVE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVS 234 (361)
T ss_dssp EEECCCSSCEECCTTCC---CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTC
T ss_pred EEEEecCCceEcCCCCc---cccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC
Confidence 99999999977654322 24567999999999999999999999999999999999999999875432221111111
Q ss_pred -------ccCC---CccchhhhcccccCCCCCHHHHH
Q 018712 291 -------TPKL---SEDKVKQCVDTKLGGEYPPKAIA 317 (351)
Q Consensus 291 -------~~~~---~~~~~~~~ld~~~~~~~~~~~~~ 317 (351)
.+.. ..+.+..|+..+|.+|++.+++.
T Consensus 235 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l 271 (361)
T 2yab_A 235 YDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEAL 271 (361)
T ss_dssp CCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred CCCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHh
Confidence 1111 23688999999999999987764
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-46 Score=340.84 Aligned_cols=250 Identities=20% Similarity=0.269 Sum_probs=199.5
Q ss_pred HHhcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCC----CchHHHHHHHHHHHhc-cCCceeeeEEEEecCCce
Q 018712 63 EKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK----QPDQEFLAQVSMVSRL-KNENVVELVGYYVDGPLR 136 (351)
Q Consensus 63 ~~~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~ 136 (351)
...++|++.+.||+|+||.||+|.++ +++.||+|++.+.. .....+.+|..+++.+ +||||+++++++.+.+..
T Consensus 20 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~ 99 (353)
T 3txo_A 20 LGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRL 99 (353)
T ss_dssp ---CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred CchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEE
Confidence 35678999999999999999999976 68999999986431 2345578899999988 799999999999999999
Q ss_pred EEEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEec
Q 018712 137 VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISD 216 (351)
Q Consensus 137 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~D 216 (351)
|+||||+.+|+|.+++..... +++..++.++.||+.||.|||++| |+||||||+|||++.++++||+|
T Consensus 100 ~lv~E~~~gg~L~~~l~~~~~---------~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~D 167 (353)
T 3txo_A 100 FFVMEFVNGGDLMFHIQKSRR---------FDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLAD 167 (353)
T ss_dssp EEEEECCCSCBHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECC
T ss_pred EEEEeCCCCCcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEcc
Confidence 999999999999999987543 899999999999999999999999 99999999999999999999999
Q ss_pred ccccCCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccchhhccc----
Q 018712 217 FDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATP---- 292 (351)
Q Consensus 217 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~---- 292 (351)
||+++....... .....+||+.|+|||++.+..++.++||||||+++|||++|+.||...........+.....
T Consensus 168 FG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~ 245 (353)
T 3txo_A 168 FGMCKEGICNGV--TTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPT 245 (353)
T ss_dssp CTTCBCSCC-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT
T ss_pred ccceeecccCCc--cccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCC
Confidence 999976433222 22456899999999999998999999999999999999999999987654332222221111
Q ss_pred ---CCCccchhhhcccccCCCCCHH---HHHHHHHHHHHh
Q 018712 293 ---KLSEDKVKQCVDTKLGGEYPPK---AIAKVRKKKFIT 326 (351)
Q Consensus 293 ---~~~~~~~~~~ld~~~~~~~~~~---~~~~~~~~~~~~ 326 (351)
....+.+..|+..+|.+|++.. ....++++.++.
T Consensus 246 ~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~ 285 (353)
T 3txo_A 246 WLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFK 285 (353)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGT
T ss_pred CCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCccc
Confidence 1123688899999999999872 124455666543
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-45 Score=331.07 Aligned_cols=259 Identities=36% Similarity=0.615 Sum_probs=212.3
Q ss_pred HHHHHhcCCCCCceeccCCcEEEEEEEECCCCEEEEEEcCCCCC-chHHHHHHHHHHHhccCCceeeeEEEEecCCceEE
Q 018712 60 ELKEKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQ-PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVL 138 (351)
Q Consensus 60 ~~~~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 138 (351)
++....++|.+.+.||+|+||.||+|.+++++.||+|++..... ..+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 33 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 112 (321)
T 2qkw_B 33 DLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMIL 112 (321)
T ss_dssp CCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEE
T ss_pred HHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEE
Confidence 34456789999999999999999999988899999999875543 34678999999999999999999999999999999
Q ss_pred EEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEeccc
Q 018712 139 AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFD 218 (351)
Q Consensus 139 v~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg 218 (351)
||||+.+|+|.+++...... ...+++..++.++.|++.||.|||+++ ++||||||+||+++.++.+||+|||
T Consensus 113 v~e~~~~~~L~~~l~~~~~~-----~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg 184 (321)
T 2qkw_B 113 IYKYMENGNLKRHLYGSDLP-----TMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFG 184 (321)
T ss_dssp EEECCTTCBTGGGSSSSCCC-----SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEECCCT
T ss_pred EEEcCCCCcHHHHHhccCCC-----ccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEeecc
Confidence 99999999999999765321 123899999999999999999999999 9999999999999999999999999
Q ss_pred ccCCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccchhhcc-------
Q 018712 219 LSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWAT------- 291 (351)
Q Consensus 219 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~~~~~------- 291 (351)
+++...............||+.|+|||++.+..++.++||||||+++|+|++|+.||....+........+..
T Consensus 185 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 264 (321)
T 2qkw_B 185 ISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQ 264 (321)
T ss_dssp TCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTC
T ss_pred cccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhcccccc
Confidence 9876543322222344568999999999998999999999999999999999999998765544333222110
Q ss_pred ------cC----CC-------ccchhhhcccccCCCCCHHHHHHHHHHHHHh
Q 018712 292 ------PK----LS-------EDKVKQCVDTKLGGEYPPKAIAKVRKKKFIT 326 (351)
Q Consensus 292 ------~~----~~-------~~~~~~~ld~~~~~~~~~~~~~~~~~~~~~~ 326 (351)
+. .. .+.+..|+..+|.+|++.+++...++-.+..
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~ 316 (321)
T 2qkw_B 265 LEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRL 316 (321)
T ss_dssp CCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred HHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhc
Confidence 00 11 1456689999999999998888777666543
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-45 Score=331.92 Aligned_cols=246 Identities=17% Similarity=0.208 Sum_probs=205.5
Q ss_pred HhcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCCchHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEEEe
Q 018712 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEH 142 (351)
Q Consensus 64 ~~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 142 (351)
..++|.+.+.||+|+||.||+|.+. +++.||+|.+.........+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 3 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 82 (321)
T 1tki_A 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence 3578999999999999999999976 688999999987665566788999999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEcc--CCceEEeccccc
Q 018712 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFD--DDIAKISDFDLS 220 (351)
Q Consensus 143 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~--~~~vkl~Dfg~a 220 (351)
+++++|.+++..... .+++..+..++.||+.||.|||++| |+||||||+|||++. ++.+||+|||++
T Consensus 83 ~~g~~L~~~l~~~~~--------~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a 151 (321)
T 1tki_A 83 ISGLDIFERINTSAF--------ELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQA 151 (321)
T ss_dssp CCCCBHHHHHTSSSC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTC
T ss_pred CCCCCHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCC
Confidence 999999999976532 2899999999999999999999999 999999999999987 789999999999
Q ss_pred CCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccchhhc--------cc
Q 018712 221 NQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWA--------TP 292 (351)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~~~~--------~~ 292 (351)
........ .....||+.|+|||++.+..++.++||||||+++|+|++|..||...........+... .+
T Consensus 152 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 228 (321)
T 1tki_A 152 RQLKPGDN---FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFK 228 (321)
T ss_dssp EECCTTCE---EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHT
T ss_pred eECCCCCc---cccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhhc
Confidence 77644322 24457899999999999888999999999999999999999999875433211111111 11
Q ss_pred CCC---ccchhhhcccccCCCCCHHHHHHHHHHHHHh
Q 018712 293 KLS---EDKVKQCVDTKLGGEYPPKAIAKVRKKKFIT 326 (351)
Q Consensus 293 ~~~---~~~~~~~ld~~~~~~~~~~~~~~~~~~~~~~ 326 (351)
..+ .+.+..|+..+|.+|++.+++. ++.++.
T Consensus 229 ~~s~~~~~li~~~L~~dp~~Rpt~~e~l---~hp~~~ 262 (321)
T 1tki_A 229 EISIEAMDFVDRLLVKERKSRMTASEAL---QHPWLK 262 (321)
T ss_dssp TSCHHHHHHHHTTSCSSGGGSCCHHHHH---HSHHHH
T ss_pred cCCHHHHHHHHHHcCCChhHCcCHHHHh---cChhhc
Confidence 122 3688999999999999988764 455554
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-45 Score=337.15 Aligned_cols=258 Identities=22% Similarity=0.347 Sum_probs=207.6
Q ss_pred hcCCCCCceeccCCcEEEEEEEEC--------CCCEEEEEEcCCCCCc--hHHHHHHHHHHHhc-cCCceeeeEEEEecC
Q 018712 65 TDNFGTNSLIGEGSYGRVYFGVLR--------SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRL-KNENVVELVGYYVDG 133 (351)
Q Consensus 65 ~~~y~~~~~Lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l-~h~niv~~~~~~~~~ 133 (351)
.++|.+.+.||+|+||.||+|.+. ++..||+|++...... ...+.+|+.+++++ +||||+++++++.+.
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 468999999999999999999852 3457999999765432 35688999999999 899999999999999
Q ss_pred CceEEEEEeCCCCCHHHHhccCCCCC-------CCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEE
Q 018712 134 PLRVLAYEHASKGSLHDILHGKKGVK-------GAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLL 206 (351)
Q Consensus 134 ~~~~lv~e~~~~gsL~~~l~~~~~~~-------~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill 206 (351)
+..|+||||+.+|+|.+++....... ...+...+++..++.++.||+.||.|||+++ |+||||||+|||+
T Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll 236 (370)
T 2psq_A 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLV 236 (370)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhEEE
Confidence 99999999999999999998754210 0111234889999999999999999999999 9999999999999
Q ss_pred ccCCceEEecccccCCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCCcc
Q 018712 207 FDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQS 285 (351)
Q Consensus 207 ~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~Pf~~~~~~~~~~ 285 (351)
+.++.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|||++ |+.||..........
T Consensus 237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~~ 316 (370)
T 2psq_A 237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK 316 (370)
T ss_dssp CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHH
T ss_pred CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 9999999999999986544332222344567889999999999999999999999999999999 999998754432221
Q ss_pred chhhc--------ccCCCccchhhhcccccCCCCCHHHHHHHHHHHHH
Q 018712 286 LVTWA--------TPKLSEDKVKQCVDTKLGGEYPPKAIAKVRKKKFI 325 (351)
Q Consensus 286 ~~~~~--------~~~~~~~~~~~~ld~~~~~~~~~~~~~~~~~~~~~ 325 (351)
.+... .+....+.+..|+..+|.+|++.+++...++..+.
T Consensus 317 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~ 364 (370)
T 2psq_A 317 LLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 364 (370)
T ss_dssp HHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 11111 11112358899999999999999999887776553
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-45 Score=336.00 Aligned_cols=239 Identities=22% Similarity=0.325 Sum_probs=197.5
Q ss_pred HHHhcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCC----CCchHHHHHHHHHHHhc-cCCceeeeEEEEecCCc
Q 018712 62 KEKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSS----KQPDQEFLAQVSMVSRL-KNENVVELVGYYVDGPL 135 (351)
Q Consensus 62 ~~~~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~ 135 (351)
....++|.+.+.||+|+||.||+|.++ +++.||+|++.+. .........|..+++.+ +||||+++++++.+.+.
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~ 92 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN 92 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence 456789999999999999999999976 6899999998653 23345677889998877 99999999999999999
Q ss_pred eEEEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEe
Q 018712 136 RVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKIS 215 (351)
Q Consensus 136 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~ 215 (351)
.|+||||+++|+|.+++..... +++..+..++.||+.||.|||++| |+||||||+|||++.+|++||+
T Consensus 93 ~~lv~E~~~gg~L~~~l~~~~~---------~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~ 160 (345)
T 1xjd_A 93 LFFVMEYLNGGDLMYHIQSCHK---------FDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIA 160 (345)
T ss_dssp EEEEEECCTTCBHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEEC
T ss_pred EEEEEeCCCCCcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEe
Confidence 9999999999999999986542 899999999999999999999999 9999999999999999999999
Q ss_pred cccccCCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccchhhcccCC-
Q 018712 216 DFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKL- 294 (351)
Q Consensus 216 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~- 294 (351)
|||+++....... .....+||+.|+|||++.+..++.++||||||+++|||++|+.||...........+....+.+
T Consensus 161 DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p 238 (345)
T 1xjd_A 161 DFGMCKENMLGDA--KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYP 238 (345)
T ss_dssp CCTTCBCCCCTTC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC
T ss_pred EChhhhhcccCCC--cccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCCCCCC
Confidence 9999976533221 1255689999999999999999999999999999999999999998654332222222111111
Q ss_pred ------CccchhhhcccccCCCCCHH
Q 018712 295 ------SEDKVKQCVDTKLGGEYPPK 314 (351)
Q Consensus 295 ------~~~~~~~~ld~~~~~~~~~~ 314 (351)
..+.+..|+..+|.+|++..
T Consensus 239 ~~~s~~~~~li~~lL~~dp~~R~~~~ 264 (345)
T 1xjd_A 239 RWLEKEAKDLLVKLFVREPEKRLGVR 264 (345)
T ss_dssp TTSCHHHHHHHHHHSCSSGGGSBTTB
T ss_pred cccCHHHHHHHHHHhcCCHhHcCCCh
Confidence 13678888888888888765
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-45 Score=330.55 Aligned_cols=244 Identities=25% Similarity=0.360 Sum_probs=200.7
Q ss_pred hcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCC----CCchHHHHHHHHHHHhccCCceeeeEEEEecCCceEEE
Q 018712 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSS----KQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLA 139 (351)
Q Consensus 65 ~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 139 (351)
.++|++.+.||+|+||.||++... +|+.||+|++.+. ....+.+.+|..+++.++||||+++++++.+.+..|+|
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 84 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 84 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence 468999999999999999999976 7899999998643 22345678899999999999999999999999999999
Q ss_pred EEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccc
Q 018712 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDL 219 (351)
Q Consensus 140 ~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~ 219 (351)
|||+.+|+|.+++..... +++..+..++.||+.||.|||++| |+||||||+|||++.+|.+||+|||+
T Consensus 85 ~e~~~gg~L~~~l~~~~~---------~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~ 152 (318)
T 1fot_A 85 MDYIEGGELFSLLRKSQR---------FPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGF 152 (318)
T ss_dssp ECCCCSCBHHHHHHHTSS---------CCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSS
T ss_pred EeCCCCCCHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCc
Confidence 999999999999987543 899999999999999999999999 99999999999999999999999999
Q ss_pred cCCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccchhhcc----cCC-
Q 018712 220 SNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWAT----PKL- 294 (351)
Q Consensus 220 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~~~~~----~~~- 294 (351)
++..... ....+||+.|+|||++.+..++.++||||||+++|||++|+.||...........+.... +.+
T Consensus 153 a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~ 227 (318)
T 1fot_A 153 AKYVPDV-----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFN 227 (318)
T ss_dssp CEECSSC-----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCTTSC
T ss_pred ceecCCc-----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCC
Confidence 9765432 244679999999999999999999999999999999999999998654322211111111 111
Q ss_pred --CccchhhhcccccCCCCCHH--HHHHHHHHHHH
Q 018712 295 --SEDKVKQCVDTKLGGEYPPK--AIAKVRKKKFI 325 (351)
Q Consensus 295 --~~~~~~~~ld~~~~~~~~~~--~~~~~~~~~~~ 325 (351)
..+.+..|+..++.+|+... .+..+.++.++
T Consensus 228 ~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f 262 (318)
T 1fot_A 228 EDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWF 262 (318)
T ss_dssp HHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGG
T ss_pred HHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCccc
Confidence 23678899999999998321 23334555554
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-44 Score=323.71 Aligned_cols=249 Identities=24% Similarity=0.352 Sum_probs=204.9
Q ss_pred hcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCC-CchHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEEEe
Q 018712 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK-QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEH 142 (351)
Q Consensus 65 ~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 142 (351)
.++|.+.+.||+|+||.||+|.+. +++.||+|++.... ...+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 88 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY 88 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence 467899999999999999999975 68999999886543 2346788999999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccccCC
Q 018712 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222 (351)
Q Consensus 143 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~ 222 (351)
+.+++|.+++..... .+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++..
T Consensus 89 ~~~~~L~~~l~~~~~--------~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 157 (310)
T 3s95_A 89 IKGGTLRGIIKSMDS--------QYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARL 157 (310)
T ss_dssp CTTCBHHHHHHHCCT--------TSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEE
T ss_pred cCCCcHHHHHHhccC--------CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeeccccee
Confidence 999999999987432 2899999999999999999999999 99999999999999999999999999976
Q ss_pred Cccccccc------------cccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccc----
Q 018712 223 APDAAARL------------HSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSL---- 286 (351)
Q Consensus 223 ~~~~~~~~------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~---- 286 (351)
........ ......||+.|+|||++.+..++.++||||||+++|+|++|..||...........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~ 237 (310)
T 3s95_A 158 MVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVR 237 (310)
T ss_dssp CC--------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHH
T ss_pred cccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhh
Confidence 54332211 01145799999999999999999999999999999999999999986544332111
Q ss_pred --h----hhcccCCCccchhhhcccccCCCCCHHHHHHHHHHHH
Q 018712 287 --V----TWATPKLSEDKVKQCVDTKLGGEYPPKAIAKVRKKKF 324 (351)
Q Consensus 287 --~----~~~~~~~~~~~~~~~ld~~~~~~~~~~~~~~~~~~~~ 324 (351)
. ....+....+.+..|++.+|.+|++.+++...++...
T Consensus 238 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~ 281 (310)
T 3s95_A 238 GFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLR 281 (310)
T ss_dssp HHHHHTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ccccccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 0 1112223346889999999999999998887665443
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-45 Score=340.34 Aligned_cols=249 Identities=20% Similarity=0.300 Sum_probs=203.1
Q ss_pred HhcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCC----chHHHHHHHHHHHhc-cCCceeeeEEEEecCCceE
Q 018712 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ----PDQEFLAQVSMVSRL-KNENVVELVGYYVDGPLRV 137 (351)
Q Consensus 64 ~~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~ 137 (351)
..++|++.+.||+|+||.||+|..+ +++.||+|++.+... ....+.+|..+++++ +||||+++++++.+.+..|
T Consensus 50 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 129 (396)
T 4dc2_A 50 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLF 129 (396)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred ChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEE
Confidence 4578999999999999999999976 688999999865322 234578899999887 8999999999999999999
Q ss_pred EEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecc
Q 018712 138 LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDF 217 (351)
Q Consensus 138 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Df 217 (351)
+||||+.+|+|..++..... +++..++.++.||+.||.|||++| |+||||||+|||++.++++||+||
T Consensus 130 lV~E~~~gg~L~~~l~~~~~---------l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DF 197 (396)
T 4dc2_A 130 FVIEYVNGGDLMFHMQRQRK---------LPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDY 197 (396)
T ss_dssp EEEECCTTCBHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCC
T ss_pred EEEEcCCCCcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeec
Confidence 99999999999999987543 899999999999999999999999 999999999999999999999999
Q ss_pred cccCCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCc---------cchh
Q 018712 218 DLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQ---------SLVT 288 (351)
Q Consensus 218 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~---------~~~~ 288 (351)
|+++....... .....+||+.|+|||++.+..++.++||||||+++|||++|+.||......... ..+.
T Consensus 198 Gla~~~~~~~~--~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~ 275 (396)
T 4dc2_A 198 GMCKEGLRPGD--TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVIL 275 (396)
T ss_dssp TTCBCCCCTTC--CBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHH
T ss_pred ceeeecccCCC--ccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHh
Confidence 99976332221 235578999999999999999999999999999999999999999753221110 1111
Q ss_pred hcccC----C---CccchhhhcccccCCCCCH---HHHHHHHHHHHHh
Q 018712 289 WATPK----L---SEDKVKQCVDTKLGGEYPP---KAIAKVRKKKFIT 326 (351)
Q Consensus 289 ~~~~~----~---~~~~~~~~ld~~~~~~~~~---~~~~~~~~~~~~~ 326 (351)
..... + ..+.+..|+..+|.+|++. ..+..+.++.++.
T Consensus 276 ~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~ 323 (396)
T 4dc2_A 276 EKQIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFR 323 (396)
T ss_dssp HCCCCCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTT
T ss_pred ccccCCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCcccc
Confidence 11111 1 1368899999999999985 2456677777753
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-44 Score=322.75 Aligned_cols=262 Identities=17% Similarity=0.202 Sum_probs=215.6
Q ss_pred hcCCCCCceeccCCcEEEEEEEE-CCCCEEEEEEcCCCCCchHHHHHHHHHHHhc-cCCceeeeEEEEecCCceEEEEEe
Q 018712 65 TDNFGTNSLIGEGSYGRVYFGVL-RSGRAAAIKKLDSSKQPDQEFLAQVSMVSRL-KNENVVELVGYYVDGPLRVLAYEH 142 (351)
Q Consensus 65 ~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~ 142 (351)
.++|.+.+.||+|+||.||+|.+ .+++.||+|++.... ....+.+|+.+++.+ +|+|++++++++.+....++||||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~ 87 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDL 87 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT-TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEEC
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC-ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEe
Confidence 46799999999999999999996 478999999986543 234588999999999 799999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCc-----eEEecc
Q 018712 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDI-----AKISDF 217 (351)
Q Consensus 143 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~-----vkl~Df 217 (351)
+ +++|.+++..... .+++..++.++.||+.||.|||+++ |+||||||+|||++.++. +||+||
T Consensus 88 ~-~~~L~~~l~~~~~--------~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Df 155 (298)
T 1csn_A 88 L-GPSLEDLLDLCGR--------KFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDF 155 (298)
T ss_dssp C-CCBHHHHHHHTTT--------CCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCC
T ss_pred c-CCCHHHHHHHhcc--------CCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEEC
Confidence 9 8899999986532 2899999999999999999999999 999999999999987775 999999
Q ss_pred cccCCCcccccc-----ccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccchh----
Q 018712 218 DLSNQAPDAAAR-----LHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVT---- 288 (351)
Q Consensus 218 g~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~~---- 288 (351)
|++......... .......||+.|+|||++.+..++.++||||||+++|+|++|+.||.............
T Consensus 156 g~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~ 235 (298)
T 1csn_A 156 GMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGE 235 (298)
T ss_dssp TTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHH
T ss_pred ccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHh
Confidence 999766443221 11245679999999999999999999999999999999999999998764432221111
Q ss_pred --------h---cccCCCccchhhhcccccCCCCCHHHHHHHHHHHHHhhhhccccchhhhhcccCCccccc
Q 018712 289 --------W---ATPKLSEDKVKQCVDTKLGGEYPPKAIAKVRKKKFITSECSNISFAEFNINWHCPLEWSV 349 (351)
Q Consensus 289 --------~---~~~~~~~~~~~~~ld~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~ 349 (351)
. ..+....+.+..|+..+|.+|++.+++...++-. +++++...+.++||..
T Consensus 236 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~----------~~~~~~~~~~~~dw~~ 297 (298)
T 1csn_A 236 KKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKV----------LERLNTTEDENFDWNL 297 (298)
T ss_dssp HHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHH----------HHHTTCCSCSCCGGGC
T ss_pred hccCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHH----------HHhcCCCCCCccccCC
Confidence 0 1122223688999999999999999998877755 3456667789999974
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=320.02 Aligned_cols=247 Identities=21% Similarity=0.378 Sum_probs=207.5
Q ss_pred hcCCCCCceeccCCcEEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEEEeCC
Q 018712 65 TDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHAS 144 (351)
Q Consensus 65 ~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 144 (351)
.++|++.+.||+|+||.||+|.+.++..||+|++.......+.+.+|++++++++||||+++++++.+.+..++||||++
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 88 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 88 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred hhhceeeheecCCCccEEEEEEecCCCeEEEEEecccccCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCC
Confidence 36789999999999999999999888999999998877777889999999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccccCCCc
Q 018712 145 KGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAP 224 (351)
Q Consensus 145 ~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~ 224 (351)
+++|.+++..... .+++..++.++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++....
T Consensus 89 ~~~L~~~l~~~~~--------~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 157 (269)
T 4hcu_A 89 HGCLSDYLRTQRG--------LFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVL 157 (269)
T ss_dssp TCBHHHHHHTTTT--------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBC
T ss_pred CCcHHHHHHhcCc--------ccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEecccccccccc
Confidence 9999999976542 2899999999999999999999999 9999999999999999999999999997654
Q ss_pred cccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCCccchhhc--------ccCCC
Q 018712 225 DAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWA--------TPKLS 295 (351)
Q Consensus 225 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~Pf~~~~~~~~~~~~~~~--------~~~~~ 295 (351)
..... ......+|+.|+|||.+.+..++.++||||||+++|+|++ |+.||...........+... .+...
T Consensus 158 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (269)
T 4hcu_A 158 DDQYT-SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHV 236 (269)
T ss_dssp CHHHH-STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTSCHHH
T ss_pred ccccc-cccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccCCCCCcCCHHH
Confidence 33221 1233457888999999999999999999999999999999 99999875433221111111 11112
Q ss_pred ccchhhhcccccCCCCCHHHHHHHHHHH
Q 018712 296 EDKVKQCVDTKLGGEYPPKAIAKVRKKK 323 (351)
Q Consensus 296 ~~~~~~~ld~~~~~~~~~~~~~~~~~~~ 323 (351)
.+.+..|+..+|.+|++.+++.+.++-.
T Consensus 237 ~~li~~~l~~~p~~Rps~~~ll~~l~~l 264 (269)
T 4hcu_A 237 YQIMNHCWRERPEDRPAFSRLLRQLAEI 264 (269)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHHccCCcccCcCHHHHHHHHHHH
Confidence 3678899999999999999887765543
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=329.72 Aligned_cols=242 Identities=26% Similarity=0.351 Sum_probs=198.9
Q ss_pred HhcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCC--chHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEE
Q 018712 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ--PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAY 140 (351)
Q Consensus 64 ~~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 140 (351)
..++|++.+.||+|+||.||+|.+. +++.||+|++..... ..+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 5 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 84 (323)
T 3tki_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 84 (323)
T ss_dssp TTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEE
Confidence 3578999999999999999999976 789999999864432 2356889999999999999999999999999999999
Q ss_pred EeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEeccccc
Q 018712 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (351)
Q Consensus 141 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a 220 (351)
||+++++|.+++..... +++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||++
T Consensus 85 e~~~~~~L~~~l~~~~~---------~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a 152 (323)
T 3tki_A 85 EYCSGGELFDRIEPDIG---------MPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLA 152 (323)
T ss_dssp ECCTTEEGGGGSBTTTB---------CCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred EcCCCCcHHHHHhhcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeecc
Confidence 99999999999976542 899999999999999999999999 999999999999999999999999999
Q ss_pred CCCccccccccccccccccCccCcccccCCCC-CccchhHhHHHHHHHHHcCCCCCCCCCCCCCccch-h---------h
Q 018712 221 NQAPDAAARLHSTRVLGTFGYHAPEYAMTGQM-SSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLV-T---------W 289 (351)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~-~---------~ 289 (351)
................||+.|+|||++.+..+ +.++||||||+++|+|++|+.||............ . .
T Consensus 153 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 232 (323)
T 3tki_A 153 TVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWK 232 (323)
T ss_dssp EECEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTSTTGG
T ss_pred ceeccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccCCccc
Confidence 76644333333345679999999999988776 77899999999999999999999865443211100 0 0
Q ss_pred cccCCCccchhhhcccccCCCCCHHHHH
Q 018712 290 ATPKLSEDKVKQCVDTKLGGEYPPKAIA 317 (351)
Q Consensus 290 ~~~~~~~~~~~~~ld~~~~~~~~~~~~~ 317 (351)
..+....+.+..|+..+|.+|++.+++.
T Consensus 233 ~~~~~~~~li~~~L~~dP~~R~t~~eil 260 (323)
T 3tki_A 233 KIDSAPLALLHKILVENPSARITIPDIK 260 (323)
T ss_dssp GSCHHHHHHHHHHSCSSTTTSCCHHHHT
T ss_pred cCCHHHHHHHHHHccCChhhCcCHHHHh
Confidence 0111112678999999999999987664
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-45 Score=335.87 Aligned_cols=249 Identities=21% Similarity=0.261 Sum_probs=203.8
Q ss_pred HHhcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCC----CCchHHHHHHHHHHHhc-cCCceeeeEEEEecCCce
Q 018712 63 EKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSS----KQPDQEFLAQVSMVSRL-KNENVVELVGYYVDGPLR 136 (351)
Q Consensus 63 ~~~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~ 136 (351)
...++|.+.+.||+|+||.||+|..+ +++.||+|++.+. ......+.+|..+++.+ +||||+++++++.+.+..
T Consensus 17 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~ 96 (353)
T 2i0e_A 17 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL 96 (353)
T ss_dssp --CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEE
T ss_pred CchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEE
Confidence 45678999999999999999999976 5789999998643 23345678899999888 799999999999999999
Q ss_pred EEEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEec
Q 018712 137 VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISD 216 (351)
Q Consensus 137 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~D 216 (351)
|+||||+++|+|.+++..... +++..++.++.||+.||.|||++| |+||||||+|||++.+|++||+|
T Consensus 97 ~lv~E~~~gg~L~~~l~~~~~---------~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~D 164 (353)
T 2i0e_A 97 YFVMEYVNGGDLMYHIQQVGR---------FKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIAD 164 (353)
T ss_dssp EEEEECCCSCBHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECC
T ss_pred EEEEeCCCCCcHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEe
Confidence 999999999999999986542 899999999999999999999999 99999999999999999999999
Q ss_pred ccccCCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccchhhccc----
Q 018712 217 FDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATP---- 292 (351)
Q Consensus 217 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~---- 292 (351)
||+++....... .....+||+.|+|||++.+..++.++||||||+++|||++|+.||...........+.....
T Consensus 165 FG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~ 242 (353)
T 2i0e_A 165 FGMCKENIWDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPK 242 (353)
T ss_dssp CTTCBCCCCTTC--CBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT
T ss_pred CCcccccccCCc--ccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCC
Confidence 999986432221 12456799999999999999999999999999999999999999987543322222211111
Q ss_pred ---CCCccchhhhcccccCCCCCH--HHHHHHHHHHHH
Q 018712 293 ---KLSEDKVKQCVDTKLGGEYPP--KAIAKVRKKKFI 325 (351)
Q Consensus 293 ---~~~~~~~~~~ld~~~~~~~~~--~~~~~~~~~~~~ 325 (351)
....+.+..|+..+|.+|+.. ..+..+.++.++
T Consensus 243 ~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f 280 (353)
T 2i0e_A 243 SMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFF 280 (353)
T ss_dssp TSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGG
T ss_pred CCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCccc
Confidence 112368889999999999964 345556666664
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-45 Score=332.46 Aligned_cols=245 Identities=27% Similarity=0.353 Sum_probs=199.4
Q ss_pred HhcCCCCCceeccCCcEEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHHhccCCceeeeEEEEecCC----ceEEE
Q 018712 64 KTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGP----LRVLA 139 (351)
Q Consensus 64 ~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----~~~lv 139 (351)
..++|++.+.||+|+||.||+|.+. ++.||||++...........+|+.++++++||||+++++++.+.. ..++|
T Consensus 22 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv 100 (322)
T 3soc_A 22 QSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLI 100 (322)
T ss_dssp TTEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred chhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCchHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEE
Confidence 3468999999999999999999876 789999999765555556677889999999999999999988644 46999
Q ss_pred EEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhC----------CCCCeeeccccCCcEEEccC
Q 018712 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEK----------AEPRIIHRNIKSSNVLLFDD 209 (351)
Q Consensus 140 ~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~----------~~~~ivH~Dlkp~Nill~~~ 209 (351)
|||+++|+|.+++.... +++..++.++.|++.||.|||+. + |+||||||+|||++.+
T Consensus 101 ~e~~~~g~L~~~l~~~~----------~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~---ivH~Dlkp~Nill~~~ 167 (322)
T 3soc_A 101 TAFHEKGSLSDFLKANV----------VSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA---ISHRDIKSKNVLLKNN 167 (322)
T ss_dssp EECCTTCBHHHHHHHCC----------BCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE---EECSCCSGGGEEECTT
T ss_pred EecCCCCCHHHHHHhcC----------CCHHHHHHHHHHHHHHHHHHHhhccccccccCCC---EEeCCCChHhEEECCC
Confidence 99999999999997653 89999999999999999999999 8 9999999999999999
Q ss_pred CceEEecccccCCCccccccccccccccccCccCcccccCC-----CCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCc
Q 018712 210 DIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTG-----QMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQ 284 (351)
Q Consensus 210 ~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~ 284 (351)
+.+||+|||+++...............||+.|+|||++.+. .++.++||||||+++|||++|+.||.........
T Consensus 168 ~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~ 247 (322)
T 3soc_A 168 LTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYML 247 (322)
T ss_dssp CCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCC
T ss_pred CeEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhcc
Confidence 99999999999765443332223446799999999998863 4566889999999999999999999875443221
Q ss_pred cchh------------------hcccCC------------CccchhhhcccccCCCCCHHHHHHHHHH
Q 018712 285 SLVT------------------WATPKL------------SEDKVKQCVDTKLGGEYPPKAIAKVRKK 322 (351)
Q Consensus 285 ~~~~------------------~~~~~~------------~~~~~~~~ld~~~~~~~~~~~~~~~~~~ 322 (351)
.... ...+.. ..+.+.+|+..+|.+|++.+++.+.++.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~ 315 (322)
T 3soc_A 248 PFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQ 315 (322)
T ss_dssp TTHHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred chhhhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 1110 011111 2357889999999999999888776554
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=329.40 Aligned_cols=244 Identities=23% Similarity=0.329 Sum_probs=202.0
Q ss_pred HhcCCCCCceeccCCcEEEEEEEE-CCCCEEEEEEcCCC----CCchHHHHHHHHHHHhccCCceeeeEEEEecCCceEE
Q 018712 64 KTDNFGTNSLIGEGSYGRVYFGVL-RSGRAAAIKKLDSS----KQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVL 138 (351)
Q Consensus 64 ~~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 138 (351)
..++|.+.+.||+|+||.||+|.+ .+++.||+|++... ......+.+|+.+++.++||||+++++++.+.+..++
T Consensus 7 ~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 86 (336)
T 3h4j_B 7 HIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVM 86 (336)
T ss_dssp EETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 347899999999999999999997 47899999998642 2224578899999999999999999999999999999
Q ss_pred EEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEeccc
Q 018712 139 AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFD 218 (351)
Q Consensus 139 v~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg 218 (351)
||||+ +|+|.+++..... +++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||
T Consensus 87 v~E~~-~g~l~~~l~~~~~---------l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG 153 (336)
T 3h4j_B 87 VIEYA-GGELFDYIVEKKR---------MTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFG 153 (336)
T ss_dssp EECCC-CEEHHHHHHHHCS---------CCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSS
T ss_pred EEECC-CCcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEec
Confidence 99999 6799998876543 899999999999999999999999 9999999999999999999999999
Q ss_pred ccCCCccccccccccccccccCccCcccccCCCC-CccchhHhHHHHHHHHHcCCCCCCCCCCCCCccchhhcc------
Q 018712 219 LSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQM-SSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWAT------ 291 (351)
Q Consensus 219 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~~~~~------ 291 (351)
++........ ....+||+.|+|||++.+..+ +.++||||||+++|+|++|+.||...........+....
T Consensus 154 ~s~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p~~ 230 (336)
T 3h4j_B 154 LSNIMTDGNF---LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMPDF 230 (336)
T ss_dssp CTBTTTTSBT---TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCCCSSCCCCCTT
T ss_pred cceeccCCcc---cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCccc
Confidence 9987654322 244579999999999988776 789999999999999999999998764433322222111
Q ss_pred -cCCCccchhhhcccccCCCCCHHHHHHHHHHHHHh
Q 018712 292 -PKLSEDKVKQCVDTKLGGEYPPKAIAKVRKKKFIT 326 (351)
Q Consensus 292 -~~~~~~~~~~~ld~~~~~~~~~~~~~~~~~~~~~~ 326 (351)
+....+.+..|+..+|.+|++.+++. ++.++.
T Consensus 231 ~s~~~~~li~~~L~~dP~~Rpt~~eil---~hp~~~ 263 (336)
T 3h4j_B 231 LSPGAQSLIRRMIVADPMQRITIQEIR---RDPWFN 263 (336)
T ss_dssp SCHHHHHHHHTTSCSSGGGSCCHHHHT---TCHHHH
T ss_pred CCHHHHHHHHHHcCCChhHCcCHHHHH---hChhhc
Confidence 11123688999999999999887764 455543
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-44 Score=325.00 Aligned_cols=240 Identities=23% Similarity=0.333 Sum_probs=194.5
Q ss_pred HhcCCCCCceeccCCcEEEEEEEECCCCEEEEEEcCCCCCc---hHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEE
Q 018712 64 KTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAY 140 (351)
Q Consensus 64 ~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 140 (351)
..++|++.+.||+|+||.||+|.+.+++.||+|++...... ...+.+|++++++++||||+++++++.+.+..++||
T Consensus 19 l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 98 (311)
T 3niz_A 19 LMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVF 98 (311)
T ss_dssp SSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEE
T ss_pred hHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEE
Confidence 45789999999999999999999988999999998754332 356889999999999999999999999999999999
Q ss_pred EeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEeccccc
Q 018712 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (351)
Q Consensus 141 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a 220 (351)
||+.+ +|.+++..... .+++..+..++.||+.||.|||++| |+||||||+|||++.++.+||+|||++
T Consensus 99 e~~~~-~l~~~~~~~~~--------~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a 166 (311)
T 3niz_A 99 EFMEK-DLKKVLDENKT--------GLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLA 166 (311)
T ss_dssp ECCSE-EHHHHHHTCTT--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred cCCCC-CHHHHHHhccC--------CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCc
Confidence 99985 88888876542 2899999999999999999999999 999999999999999999999999999
Q ss_pred CCCccccccccccccccccCccCcccccC-CCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccchhh----------
Q 018712 221 NQAPDAAARLHSTRVLGTFGYHAPEYAMT-GQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTW---------- 289 (351)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~~~---------- 289 (351)
......... .....||+.|+|||++.+ ..++.++||||||+++|+|++|+.||...........+..
T Consensus 167 ~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 244 (311)
T 3niz_A 167 RAFGIPVRS--YTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREW 244 (311)
T ss_dssp EETTSCCC-----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTS
T ss_pred eecCCCccc--ccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHh
Confidence 765432221 234568999999999876 5689999999999999999999999987554332111100
Q ss_pred ------------------------cccCCC---ccchhhhcccccCCCCCHHHHH
Q 018712 290 ------------------------ATPKLS---EDKVKQCVDTKLGGEYPPKAIA 317 (351)
Q Consensus 290 ------------------------~~~~~~---~~~~~~~ld~~~~~~~~~~~~~ 317 (351)
..+... .+.+..|+..+|.+|++++++.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell 299 (311)
T 3niz_A 245 PQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAM 299 (311)
T ss_dssp GGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHH
T ss_pred hhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHh
Confidence 000111 2578889999999999887653
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-45 Score=331.45 Aligned_cols=247 Identities=21% Similarity=0.313 Sum_probs=194.6
Q ss_pred hcCCCCCceeccCCcEEEEEEEE----CCCCEEEEEEcCCCC-----CchHHHHHHHHHHHhccCCceeeeEEEEecCCc
Q 018712 65 TDNFGTNSLIGEGSYGRVYFGVL----RSGRAAAIKKLDSSK-----QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPL 135 (351)
Q Consensus 65 ~~~y~~~~~Lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~-----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 135 (351)
.++|++.+.||+|+||.||++.. .+++.||+|++.... .....+.+|+.+++.++||||+++++++.+.+.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 46899999999999999999997 478999999987542 223457789999999999999999999999999
Q ss_pred eEEEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEe
Q 018712 136 RVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKIS 215 (351)
Q Consensus 136 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~ 215 (351)
.|+||||+.+++|.+++..... ++...+..++.||+.||.|||++| |+||||||+|||++.++.+||+
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~~~---------~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~ 163 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLEREGI---------FMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLT 163 (327)
T ss_dssp EEEEEECCTTEEHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEEC
T ss_pred EEEEEeCCCCCcHHHHHHhCCC---------CCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEE
Confidence 9999999999999999986542 889999999999999999999999 9999999999999999999999
Q ss_pred cccccCCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccchhhc-----
Q 018712 216 DFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWA----- 290 (351)
Q Consensus 216 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~~~~----- 290 (351)
|||+++....... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||...........+...
T Consensus 164 Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~p 241 (327)
T 3a62_A 164 DFGLCKESIHDGT--VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLP 241 (327)
T ss_dssp CCSCC------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCC
T ss_pred eCCcccccccCCc--cccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCC
Confidence 9999876433221 124467999999999999999999999999999999999999999865432221111111
Q ss_pred --ccCCCccchhhhcccccCCCCCHH--HHHHHHHHHHH
Q 018712 291 --TPKLSEDKVKQCVDTKLGGEYPPK--AIAKVRKKKFI 325 (351)
Q Consensus 291 --~~~~~~~~~~~~ld~~~~~~~~~~--~~~~~~~~~~~ 325 (351)
.+....+.+..|+..+|.+|++.. .+..++++.++
T Consensus 242 ~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f 280 (327)
T 3a62_A 242 PYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFF 280 (327)
T ss_dssp TTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGG
T ss_pred CCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcc
Confidence 111123688899999999998543 45556666665
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-45 Score=333.59 Aligned_cols=245 Identities=20% Similarity=0.304 Sum_probs=203.1
Q ss_pred HhcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCC----CchHHHHHHHHHHHhccCCceeeeEEEEecCCceEE
Q 018712 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK----QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVL 138 (351)
Q Consensus 64 ~~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 138 (351)
..++|.+.+.||+|+||.||++.+. +++.||+|++.... .....+.+|+.+++.++||||+++++++.+.+..|+
T Consensus 39 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 118 (350)
T 1rdq_E 39 QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYM 118 (350)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred CHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEE
Confidence 3468999999999999999999976 78999999986432 234568899999999999999999999999999999
Q ss_pred EEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEeccc
Q 018712 139 AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFD 218 (351)
Q Consensus 139 v~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg 218 (351)
||||+++|+|.+++..... +++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||
T Consensus 119 v~e~~~gg~L~~~l~~~~~---------~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg 186 (350)
T 1rdq_E 119 VMEYVAGGEMFSHLRRIGR---------FSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFG 186 (350)
T ss_dssp EEECCTTCBHHHHHHHHCC---------CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred EEcCCCCCcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccc
Confidence 9999999999999986542 899999999999999999999999 9999999999999999999999999
Q ss_pred ccCCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccchhhcc-------
Q 018712 219 LSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWAT------- 291 (351)
Q Consensus 219 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~~~~~------- 291 (351)
+++..... ....+||+.|+|||++.+..++.++||||||+++|+|++|+.||...........+....
T Consensus 187 ~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~ 261 (350)
T 1rdq_E 187 FAKRVKGR-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHF 261 (350)
T ss_dssp TCEECSSC-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTC
T ss_pred cceeccCC-----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Confidence 99765432 244679999999999999999999999999999999999999998654332221121111
Q ss_pred cCCCccchhhhcccccCCCCC--HHHHHHHHHHHHH
Q 018712 292 PKLSEDKVKQCVDTKLGGEYP--PKAIAKVRKKKFI 325 (351)
Q Consensus 292 ~~~~~~~~~~~ld~~~~~~~~--~~~~~~~~~~~~~ 325 (351)
+....+.+..|+..+|.+|++ .+.+..+.++.++
T Consensus 262 ~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f 297 (350)
T 1rdq_E 262 SSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWF 297 (350)
T ss_dssp CHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGG
T ss_pred CHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcCc
Confidence 111236889999999999997 2234445556554
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-44 Score=326.75 Aligned_cols=240 Identities=23% Similarity=0.327 Sum_probs=200.1
Q ss_pred HhcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCC-------chHHHHHHHHHHHhccCCceeeeEEEEecCCc
Q 018712 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ-------PDQEFLAQVSMVSRLKNENVVELVGYYVDGPL 135 (351)
Q Consensus 64 ~~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 135 (351)
..++|.+.+.||+|+||.||+|... +++.||+|++..... ..+.+.+|+.++++++||||+++++++.+...
T Consensus 9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 88 (326)
T 2y0a_A 9 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD 88 (326)
T ss_dssp HHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence 3456999999999999999999976 689999999864332 24678999999999999999999999999999
Q ss_pred eEEEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCC----c
Q 018712 136 RVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD----I 211 (351)
Q Consensus 136 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~----~ 211 (351)
.++||||+.+++|.+++..... +++..+..++.||+.||.|||+++ |+||||||+|||++.++ .
T Consensus 89 ~~lv~e~~~~~~L~~~l~~~~~---------~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~ 156 (326)
T 2y0a_A 89 VILILELVAGGELFDFLAEKES---------LTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPR 156 (326)
T ss_dssp EEEEEECCCSCBHHHHHTTSSC---------CBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCC
T ss_pred EEEEEEcCCCCCHHHHHHhcCC---------cCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCC
Confidence 9999999999999999976542 899999999999999999999999 99999999999999887 8
Q ss_pred eEEecccccCCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccchhh--
Q 018712 212 AKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTW-- 289 (351)
Q Consensus 212 vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~~~-- 289 (351)
+||+|||++........ .....||+.|+|||++.+..++.++||||||+++|+|++|+.||...........+..
T Consensus 157 ~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~ 233 (326)
T 2y0a_A 157 IKIIDFGLAHKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVN 233 (326)
T ss_dssp EEECCCTTCEECCTTSC---CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTC
T ss_pred EEEEECCCCeECCCCCc---cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcC
Confidence 99999999976643321 2445799999999999999999999999999999999999999976543221111111
Q ss_pred ---------cccCCCccchhhhcccccCCCCCHHHHHH
Q 018712 290 ---------ATPKLSEDKVKQCVDTKLGGEYPPKAIAK 318 (351)
Q Consensus 290 ---------~~~~~~~~~~~~~ld~~~~~~~~~~~~~~ 318 (351)
..+....+.+..|+..+|.+|++.+++..
T Consensus 234 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 271 (326)
T 2y0a_A 234 YEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271 (326)
T ss_dssp CCCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CCcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 11111236789999999999999887643
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-44 Score=325.18 Aligned_cols=255 Identities=25% Similarity=0.374 Sum_probs=206.1
Q ss_pred cccCHHHHHHHhcC----------CCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCC-chHHHHHHHHHHHhccCC
Q 018712 54 PVISVDELKEKTDN----------FGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ-PDQEFLAQVSMVSRLKNE 121 (351)
Q Consensus 54 ~~~~~~~~~~~~~~----------y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~h~ 121 (351)
+.++.+++...++. |...+.||+|+||.||+|... +|+.||||++..... ..+.+.+|+.++++++||
T Consensus 23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ 102 (321)
T 2c30_A 23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF 102 (321)
T ss_dssp --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence 34555665555443 667779999999999999976 799999999875433 356788999999999999
Q ss_pred ceeeeEEEEecCCceEEEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccC
Q 018712 122 NVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKS 201 (351)
Q Consensus 122 niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp 201 (351)
||+++++++...+..++||||+++++|.+++.... +++..+..++.|++.||.|||++| ++||||||
T Consensus 103 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----------l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp 169 (321)
T 2c30_A 103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVR----------LNEEQIATVCEAVLQALAYLHAQG---VIHRDIKS 169 (321)
T ss_dssp TBCCEEEEEEETTEEEEEECCCCSCBHHHHHTTCC----------CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSG
T ss_pred CcceEEEEEEECCEEEEEEecCCCCCHHHHHHhcC----------CCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCH
Confidence 99999999999999999999999999999997543 899999999999999999999999 99999999
Q ss_pred CcEEEccCCceEEecccccCCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCC
Q 018712 202 SNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPR 281 (351)
Q Consensus 202 ~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~ 281 (351)
+|||++.++.+||+|||++......... .....||+.|+|||++.+..++.++||||||+++|+|++|+.||......
T Consensus 170 ~NIll~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~ 247 (321)
T 2c30_A 170 DSILLTLDGRVKLSDFGFCAQISKDVPK--RKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPV 247 (321)
T ss_dssp GGEEECTTCCEEECCCTTCEECCSSSCC--BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH
T ss_pred HHEEECCCCcEEEeeeeeeeecccCccc--cccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 9999999999999999998765433221 24567999999999999999999999999999999999999999765432
Q ss_pred CCccchhh-c---------ccCCCccchhhhcccccCCCCCHHHHHHHHHHHHHh
Q 018712 282 GQQSLVTW-A---------TPKLSEDKVKQCVDTKLGGEYPPKAIAKVRKKKFIT 326 (351)
Q Consensus 282 ~~~~~~~~-~---------~~~~~~~~~~~~ld~~~~~~~~~~~~~~~~~~~~~~ 326 (351)
.....+.. . .+....+.+..|+..+|.+|++.+++ +++.++.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el---l~hp~~~ 299 (321)
T 2c30_A 248 QAMKRLRDSPPPKLKNSHKVSPVLRDFLERMLVRDPQERATAQEL---LDHPFLL 299 (321)
T ss_dssp HHHHHHHHSSCCCCTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHH---HTSGGGG
T ss_pred HHHHHHhcCCCCCcCccccCCHHHHHHHHHHccCChhhCcCHHHH---hcChhhc
Confidence 21111111 1 11112367889999999999988775 4444443
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-44 Score=320.10 Aligned_cols=244 Identities=21% Similarity=0.338 Sum_probs=196.2
Q ss_pred hcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCCc----hHHHHHHHHHHHhccCCceeeeEEEEecCCceEEE
Q 018712 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP----DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLA 139 (351)
Q Consensus 65 ~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 139 (351)
.++|++.+.||+|+||.||+|.+. ++..||+|++...... .+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 468999999999999999999975 7899999998544322 35678999999999999999999999999999999
Q ss_pred EEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccc
Q 018712 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDL 219 (351)
Q Consensus 140 ~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~ 219 (351)
|||+++++|.+++..... +++..++.++.|++.||.|||++| ++||||||+|||++.++.+||+|||+
T Consensus 90 ~e~~~g~~L~~~l~~~~~---------~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~ 157 (294)
T 4eqm_A 90 MEYIEGPTLSEYIESHGP---------LSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGI 157 (294)
T ss_dssp EECCCSCBHHHHHHHHCS---------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSS
T ss_pred EeCCCCCCHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCC
Confidence 999999999999986542 899999999999999999999999 99999999999999999999999999
Q ss_pred cCCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCC---------ccchhhc
Q 018712 220 SNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQ---------QSLVTWA 290 (351)
Q Consensus 220 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~---------~~~~~~~ 290 (351)
+......... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||........ .......
T Consensus 158 ~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 236 (294)
T 4eqm_A 158 AKALSETSLT-QTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDV 236 (294)
T ss_dssp STTC--------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHS
T ss_pred cccccccccc-ccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhc
Confidence 9876433221 12345799999999999999999999999999999999999999986543211 0011111
Q ss_pred ---ccCCCccchhhhcccccCCCC-CHHHHHHHHH
Q 018712 291 ---TPKLSEDKVKQCVDTKLGGEY-PPKAIAKVRK 321 (351)
Q Consensus 291 ---~~~~~~~~~~~~ld~~~~~~~-~~~~~~~~~~ 321 (351)
.+....+.+.+|+..+|.+|+ +.+++...+.
T Consensus 237 ~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~ 271 (294)
T 4eqm_A 237 RKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLS 271 (294)
T ss_dssp CTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHH
T ss_pred ccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHH
Confidence 122224678899999999998 6666655443
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=331.95 Aligned_cols=248 Identities=20% Similarity=0.306 Sum_probs=201.6
Q ss_pred hcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCCc----hHHHHHHHHHHHhc-cCCceeeeEEEEecCCceEE
Q 018712 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP----DQEFLAQVSMVSRL-KNENVVELVGYYVDGPLRVL 138 (351)
Q Consensus 65 ~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~----~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~l 138 (351)
.++|.+.+.||+|+||.||+|.++ +++.||+|++.+.... ...+.+|..+++++ +||||+++++++.+.+..|+
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 87 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 87 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence 467999999999999999999976 6889999998754322 34577899999988 89999999999999999999
Q ss_pred EEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEeccc
Q 018712 139 AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFD 218 (351)
Q Consensus 139 v~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg 218 (351)
||||+.+|+|.+++..... +++..++.++.||+.||.|||++| |+||||||+|||++.++++||+|||
T Consensus 88 v~e~~~gg~L~~~l~~~~~---------l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG 155 (345)
T 3a8x_A 88 VIEYVNGGDLMFHMQRQRK---------LPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYG 155 (345)
T ss_dssp EECCCCSCBHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGG
T ss_pred EEeCCCCCcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEecc
Confidence 9999999999999986542 899999999999999999999999 9999999999999999999999999
Q ss_pred ccCCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCC-----c----cchhh
Q 018712 219 LSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQ-----Q----SLVTW 289 (351)
Q Consensus 219 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~-----~----~~~~~ 289 (351)
+++....... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||........ . ..+..
T Consensus 156 ~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~ 233 (345)
T 3a8x_A 156 MCKEGLRPGD--TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE 233 (345)
T ss_dssp GCBCSCCTTC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHH
T ss_pred ccccccCCCC--cccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHc
Confidence 9976432221 12456899999999999999999999999999999999999999975321110 0 01111
Q ss_pred cccC----C---CccchhhhcccccCCCCCHH---HHHHHHHHHHHh
Q 018712 290 ATPK----L---SEDKVKQCVDTKLGGEYPPK---AIAKVRKKKFIT 326 (351)
Q Consensus 290 ~~~~----~---~~~~~~~~ld~~~~~~~~~~---~~~~~~~~~~~~ 326 (351)
.... . ..+.+..|+..+|.+|++.. .+..+..+.++.
T Consensus 234 ~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~ 280 (345)
T 3a8x_A 234 KQIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFR 280 (345)
T ss_dssp CCCCCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGT
T ss_pred CCCCCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccC
Confidence 1111 1 13678899999999999852 445667777653
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=333.68 Aligned_cols=234 Identities=22% Similarity=0.332 Sum_probs=195.8
Q ss_pred HhcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCC----CCchHHHHHHHHHHHhccCCceeeeEEEEecCCceEE
Q 018712 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSS----KQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVL 138 (351)
Q Consensus 64 ~~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 138 (351)
..++|.+.+.||+|+||.||++... +++.||+|++... ......+.+|+.+++.++||||+++++++.+.+..|+
T Consensus 13 ~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~l 92 (384)
T 4fr4_A 13 NFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFM 92 (384)
T ss_dssp CGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 3468999999999999999999975 6889999998643 2234678899999999999999999999999999999
Q ss_pred EEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEeccc
Q 018712 139 AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFD 218 (351)
Q Consensus 139 v~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg 218 (351)
||||+.+|+|.+++..... +++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||
T Consensus 93 v~e~~~gg~L~~~l~~~~~---------l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG 160 (384)
T 4fr4_A 93 VVDLLLGGDLRYHLQQNVH---------FKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFN 160 (384)
T ss_dssp EECCCTTEEHHHHHHTTCC---------CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred EEecCCCCcHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccc
Confidence 9999999999999986543 899999999999999999999999 9999999999999999999999999
Q ss_pred ccCCCccccccccccccccccCccCcccccC---CCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccchh---hcc-
Q 018712 219 LSNQAPDAAARLHSTRVLGTFGYHAPEYAMT---GQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVT---WAT- 291 (351)
Q Consensus 219 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~~---~~~- 291 (351)
++........ ....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||............. ...
T Consensus 161 ~a~~~~~~~~---~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~ 237 (384)
T 4fr4_A 161 IAAMLPRETQ---ITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVV 237 (384)
T ss_dssp TCEECCTTCC---BCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCCC
T ss_pred eeeeccCCCc---eeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhccc
Confidence 9976543322 255679999999999863 468999999999999999999999998654433222111 111
Q ss_pred ------cCCCccchhhhcccccCCCCC
Q 018712 292 ------PKLSEDKVKQCVDTKLGGEYP 312 (351)
Q Consensus 292 ------~~~~~~~~~~~ld~~~~~~~~ 312 (351)
+....+.+..|+..+|.+|++
T Consensus 238 ~~p~~~s~~~~~li~~lL~~dP~~R~s 264 (384)
T 4fr4_A 238 TYPSAWSQEMVSLLKKLLEPNPDQRFS 264 (384)
T ss_dssp CCCTTSCHHHHHHHHHHSCSSGGGSCC
T ss_pred CCCCcCCHHHHHHHHHHhcCCHhHhcc
Confidence 111136788999999999997
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-44 Score=339.34 Aligned_cols=242 Identities=19% Similarity=0.253 Sum_probs=200.4
Q ss_pred HHhcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCCc---hHHHHHHHHHHHhccCCceeeeEEEEecCCceEE
Q 018712 63 EKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVL 138 (351)
Q Consensus 63 ~~~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 138 (351)
...++|++.+.||+|+||.||+|.+. +++.+|+|++...... .+.+.+|+.+++.++||||+++++++.+.+..|+
T Consensus 8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 87 (444)
T 3soa_A 8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYL 87 (444)
T ss_dssp HHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEE
T ss_pred cccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEE
Confidence 45678999999999999999999975 7899999998765433 3568899999999999999999999999999999
Q ss_pred EEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEc---cCCceEEe
Q 018712 139 AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLF---DDDIAKIS 215 (351)
Q Consensus 139 v~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~---~~~~vkl~ 215 (351)
||||+.+|+|.+++..... +++..+..++.||+.||.|||++| |+||||||+|||++ .++.+||+
T Consensus 88 v~E~~~gg~L~~~i~~~~~---------~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~ 155 (444)
T 3soa_A 88 IFDLVTGGELFEDIVAREY---------YSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLA 155 (444)
T ss_dssp EECCCBCCBHHHHHHHCSC---------CCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEEC
T ss_pred EEEeCCCCCHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEc
Confidence 9999999999999987643 899999999999999999999999 99999999999998 45789999
Q ss_pred cccccCCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccchhhc-----
Q 018712 216 DFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWA----- 290 (351)
Q Consensus 216 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~~~~----- 290 (351)
|||++......... .....||+.|+|||++.+..++.++||||||+++|+|++|..||...........+...
T Consensus 156 DFG~a~~~~~~~~~--~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~ 233 (444)
T 3soa_A 156 DFGLAIEVEGEQQA--WFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFP 233 (444)
T ss_dssp CCSSCBCCCTTCCB--CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCC
T ss_pred cCceeEEecCCCce--eecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCC
Confidence 99999776543222 24467999999999999999999999999999999999999999765432211111110
Q ss_pred ------ccCCCccchhhhcccccCCCCCHHHHHH
Q 018712 291 ------TPKLSEDKVKQCVDTKLGGEYPPKAIAK 318 (351)
Q Consensus 291 ------~~~~~~~~~~~~ld~~~~~~~~~~~~~~ 318 (351)
.+....+.+..|+..+|.+|++.+++.+
T Consensus 234 ~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~ 267 (444)
T 3soa_A 234 SPEWDTVTPEAKDLINKMLTINPSKRITAAEALK 267 (444)
T ss_dssp TTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred ccccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 1111236889999999999999887754
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-45 Score=338.20 Aligned_cols=248 Identities=20% Similarity=0.287 Sum_probs=195.7
Q ss_pred HhcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCC----chHHHHHHHHH-HHhccCCceeeeEEEEecCCceE
Q 018712 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ----PDQEFLAQVSM-VSRLKNENVVELVGYYVDGPLRV 137 (351)
Q Consensus 64 ~~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~-l~~l~h~niv~~~~~~~~~~~~~ 137 (351)
..++|++.+.||+|+||.||+|..+ +++.||+|++.+... ....+.+|..+ ++.++||||+++++++.+.+..|
T Consensus 36 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~ 115 (373)
T 2r5t_A 36 KPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLY 115 (373)
T ss_dssp CGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEE
T ss_pred ChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEE
Confidence 4568999999999999999999976 688999999865432 22345566665 56789999999999999999999
Q ss_pred EEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecc
Q 018712 138 LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDF 217 (351)
Q Consensus 138 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Df 217 (351)
+||||+.+|+|.+++..... +++..++.++.||+.||.|||++| |+||||||+|||++.+|++||+||
T Consensus 116 lv~E~~~gg~L~~~l~~~~~---------~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DF 183 (373)
T 2r5t_A 116 FVLDYINGGELFYHLQRERC---------FLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDF 183 (373)
T ss_dssp EEEECCCSCBHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC
T ss_pred EEEeCCCCCcHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeC
Confidence 99999999999999986543 889999999999999999999999 999999999999999999999999
Q ss_pred cccCCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccchhhc----ccC
Q 018712 218 DLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWA----TPK 293 (351)
Q Consensus 218 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~~~~----~~~ 293 (351)
|+++....... .....+||+.|+|||++.+..++.++||||||+++|||++|+.||...........+... .+.
T Consensus 184 G~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~ 261 (373)
T 2r5t_A 184 GLCKENIEHNS--TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPN 261 (373)
T ss_dssp CBCGGGBCCCC--CCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSCCCCCSS
T ss_pred ccccccccCCC--ccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcccCCCCC
Confidence 99875332211 235568999999999999999999999999999999999999999865433222111111 111
Q ss_pred C---CccchhhhcccccCCCCCHH-HHHHHHHHHHH
Q 018712 294 L---SEDKVKQCVDTKLGGEYPPK-AIAKVRKKKFI 325 (351)
Q Consensus 294 ~---~~~~~~~~ld~~~~~~~~~~-~~~~~~~~~~~ 325 (351)
+ ..+.+..|+..++.+|++.. ....+..+.++
T Consensus 262 ~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f 297 (373)
T 2r5t_A 262 ITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFF 297 (373)
T ss_dssp SCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGG
T ss_pred CCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCCccc
Confidence 1 23678899999999999863 45566666654
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-44 Score=319.36 Aligned_cols=248 Identities=22% Similarity=0.346 Sum_probs=205.1
Q ss_pred HhcCCCCCceeccCCcEEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEEEeC
Q 018712 64 KTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHA 143 (351)
Q Consensus 64 ~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 143 (351)
..++|++.+.||+|+||.||++.+.++..||+|++.......+.+.+|++++++++|+||+++++++.+.+..++||||+
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 101 (283)
T 3gen_A 22 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 101 (283)
T ss_dssp CGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCC
T ss_pred CHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEecc
Confidence 34678999999999999999999988889999999887777788999999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccccCCC
Q 018712 144 SKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQA 223 (351)
Q Consensus 144 ~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~ 223 (351)
.+++|.+++..... .+++..++.++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++...
T Consensus 102 ~~~~L~~~l~~~~~--------~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~ 170 (283)
T 3gen_A 102 ANGCLLNYLREMRH--------RFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYV 170 (283)
T ss_dssp TTCBHHHHHHCGGG--------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGGB
T ss_pred CCCcHHHHHHHhcc--------CCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEccccccccc
Confidence 99999999976432 2899999999999999999999999 999999999999999999999999999765
Q ss_pred ccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCCccchhhc--------ccCC
Q 018712 224 PDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWA--------TPKL 294 (351)
Q Consensus 224 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~Pf~~~~~~~~~~~~~~~--------~~~~ 294 (351)
...... ......+|+.|+|||++.+..++.++||||||+++|+|++ |+.||...........+... .+..
T Consensus 171 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (283)
T 3gen_A 171 LDDEYT-SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEK 249 (283)
T ss_dssp CCHHHH-STTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHH
T ss_pred cccccc-cccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCCCCCCcCCHH
Confidence 433221 1233456788999999998999999999999999999998 99999875433222111111 1111
Q ss_pred CccchhhhcccccCCCCCHHHHHHHHHHH
Q 018712 295 SEDKVKQCVDTKLGGEYPPKAIAKVRKKK 323 (351)
Q Consensus 295 ~~~~~~~~ld~~~~~~~~~~~~~~~~~~~ 323 (351)
..+.+..|+..+|.+|++.+++...+.-.
T Consensus 250 l~~li~~~l~~~p~~Rps~~~ll~~L~~~ 278 (283)
T 3gen_A 250 VYTIMYSCWHEKADERPTFKILLSNILDV 278 (283)
T ss_dssp HHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence 23678899999999999999887766544
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-44 Score=318.53 Aligned_cols=246 Identities=21% Similarity=0.288 Sum_probs=206.1
Q ss_pred HhcCCCCCceeccCCcEEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEEEeC
Q 018712 64 KTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHA 143 (351)
Q Consensus 64 ~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 143 (351)
..++|++.+.||+|+||.||+|.++++..||+|++.......+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (268)
T 3sxs_A 6 KREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYI 85 (268)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred chhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEcc
Confidence 35689999999999999999999988889999999887777788999999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccccCCC
Q 018712 144 SKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQA 223 (351)
Q Consensus 144 ~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~ 223 (351)
++++|.+++..... .+++..++.++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++...
T Consensus 86 ~~~~L~~~l~~~~~--------~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~ 154 (268)
T 3sxs_A 86 SNGCLLNYLRSHGK--------GLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYV 154 (268)
T ss_dssp TTCBHHHHHHHHGG--------GCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEEC
T ss_pred CCCcHHHHHHHcCC--------CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceec
Confidence 99999999976532 2899999999999999999999999 999999999999999999999999998765
Q ss_pred ccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCCccchhhc--------ccCC
Q 018712 224 PDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWA--------TPKL 294 (351)
Q Consensus 224 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~Pf~~~~~~~~~~~~~~~--------~~~~ 294 (351)
...... ......+|+.|+|||.+.+..++.++||||||+++|+|++ |+.||...........+... .+..
T Consensus 155 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (268)
T 3sxs_A 155 LDDQYV-SSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRPHLASDT 233 (268)
T ss_dssp CTTCEE-ECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTSCHH
T ss_pred chhhhh-cccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCCCCCCcChHH
Confidence 443221 1233456778999999998899999999999999999999 99999865433221111111 1111
Q ss_pred CccchhhhcccccCCCCCHHHHHHHHH
Q 018712 295 SEDKVKQCVDTKLGGEYPPKAIAKVRK 321 (351)
Q Consensus 295 ~~~~~~~~ld~~~~~~~~~~~~~~~~~ 321 (351)
..+.+..|+..+|.+|++.+++...++
T Consensus 234 l~~li~~~l~~~p~~Rps~~~ll~~L~ 260 (268)
T 3sxs_A 234 IYQIMYSCWHELPEKRPTFQQLLSSIE 260 (268)
T ss_dssp HHHHHHHTTCSSGGGSCCHHHHHHHHG
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 236888999999999999988876543
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-45 Score=341.37 Aligned_cols=248 Identities=20% Similarity=0.300 Sum_probs=197.2
Q ss_pred HHHHhcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCC----CCchHHHHHHHHHHHhccCCceeeeEEEEecCCc
Q 018712 61 LKEKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSS----KQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPL 135 (351)
Q Consensus 61 ~~~~~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 135 (351)
+....++|.+.+.||+|+||.||+|.++ +++.||+|++.+. ......+.+|..+++.++||||+++++++.+.+.
T Consensus 64 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~ 143 (410)
T 3v8s_A 64 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRY 143 (410)
T ss_dssp HSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCE
Confidence 3445678999999999999999999976 6889999998642 1223457889999999999999999999999999
Q ss_pred eEEEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEe
Q 018712 136 RVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKIS 215 (351)
Q Consensus 136 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~ 215 (351)
.|+||||+++|+|.+++.... +++..+..++.||+.||.|||++| |+||||||+|||++.++++||+
T Consensus 144 ~~lV~E~~~gg~L~~~l~~~~----------~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~ 210 (410)
T 3v8s_A 144 LYMVMEYMPGGDLVNLMSNYD----------VPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLA 210 (410)
T ss_dssp EEEEECCCTTEEHHHHHHHCC----------CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEEC
T ss_pred EEEEEeCCCCCcHHHHHHcCC----------CCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEe
Confidence 999999999999999997653 889999999999999999999999 9999999999999999999999
Q ss_pred cccccCCCccccccccccccccccCccCcccccCCC----CCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccchhh--
Q 018712 216 DFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQ----MSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTW-- 289 (351)
Q Consensus 216 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~~~-- 289 (351)
|||+++....... ......+||+.|+|||++.+.. ++.++||||||+++|||++|+.||...........+..
T Consensus 211 DFG~a~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~ 289 (410)
T 3v8s_A 211 DFGTCMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHK 289 (410)
T ss_dssp CCTTCEECCTTSE-EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHH
T ss_pred ccceeEeeccCCc-ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhcc
Confidence 9999976543321 1224568999999999998765 78999999999999999999999986544322222111
Q ss_pred ---cccC---CC---ccchhhhcccccCC--CCCHHHHHHHHHHHHH
Q 018712 290 ---ATPK---LS---EDKVKQCVDTKLGG--EYPPKAIAKVRKKKFI 325 (351)
Q Consensus 290 ---~~~~---~~---~~~~~~~ld~~~~~--~~~~~~~~~~~~~~~~ 325 (351)
..|. ++ .+.+..|+...+.+ |++.++ +.++.++
T Consensus 290 ~~~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~e---i~~Hp~f 333 (410)
T 3v8s_A 290 NSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEE---IKRHLFF 333 (410)
T ss_dssp HHCCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHH---HHTSGGG
T ss_pred ccccCCCcccccHHHHHHHHHHccChhhhCCCCCHHH---HhcCccc
Confidence 1111 11 25666777655554 665554 3445443
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-44 Score=321.73 Aligned_cols=252 Identities=29% Similarity=0.370 Sum_probs=197.7
Q ss_pred HHhcCCCCCceeccCCcEEEEEEEECCCCEEEEEEcCCCCCc---hHHHHHHHHHHHhccCCceeeeEEEEecCCceEEE
Q 018712 63 EKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLA 139 (351)
Q Consensus 63 ~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 139 (351)
...++|++.+.||+|+||.||+|.. ++..||+|++...... ...+.+|++++++++||||+++++++.+.+..++|
T Consensus 34 i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 3p86_A 34 IPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIV 112 (309)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEE
T ss_pred CChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEE
Confidence 3456899999999999999999987 5789999998765433 24678999999999999999999999999999999
Q ss_pred EEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccc
Q 018712 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDL 219 (351)
Q Consensus 140 ~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~ 219 (351)
|||+.+|+|.+++...... ..+++..++.++.||+.||.|||++|. +|+||||||+|||++.++.+||+|||+
T Consensus 113 ~e~~~~~~L~~~l~~~~~~------~~~~~~~~~~i~~qi~~aL~~LH~~~~-~ivH~Dikp~NIll~~~~~~kL~Dfg~ 185 (309)
T 3p86_A 113 TEYLSRGSLYRLLHKSGAR------EQLDERRRLSMAYDVAKGMNYLHNRNP-PIVHRNLKSPNLLVDKKYTVKVCDFGL 185 (309)
T ss_dssp EECCTTCBHHHHHHSTTHH------HHSCHHHHHHHHHHHHHHHHHHHTSSS-CCCCTTCCGGGEEECTTCCEEECCCC-
T ss_pred EecCCCCcHHHHHhhcCCC------CCCCHHHHHHHHHHHHHHHHHHHcCCC-CEECCCCChhhEEEeCCCcEEECCCCC
Confidence 9999999999999865311 127889999999999999999999853 299999999999999999999999999
Q ss_pred cCCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccchh---------hc
Q 018712 220 SNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVT---------WA 290 (351)
Q Consensus 220 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~~---------~~ 290 (351)
++....... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||...........+. ..
T Consensus 186 a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 263 (309)
T 3p86_A 186 SRLKASTFL--SSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRN 263 (309)
T ss_dssp ------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCCCCCTT
T ss_pred Ccccccccc--ccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCcc
Confidence 976543321 1244679999999999999999999999999999999999999998754332211111 11
Q ss_pred ccCCCccchhhhcccccCCCCCHHHHHHHHHHHH
Q 018712 291 TPKLSEDKVKQCVDTKLGGEYPPKAIAKVRKKKF 324 (351)
Q Consensus 291 ~~~~~~~~~~~~ld~~~~~~~~~~~~~~~~~~~~ 324 (351)
.+....+.+..|+..+|.+|++.+++...++-.+
T Consensus 264 ~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~ 297 (309)
T 3p86_A 264 LNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLI 297 (309)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 1111236889999999999999999988766544
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-44 Score=329.84 Aligned_cols=239 Identities=21% Similarity=0.313 Sum_probs=199.0
Q ss_pred HhcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCCc---hHHHHHHHHHHHhccCCceeeeEEEEecCCceEEE
Q 018712 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLA 139 (351)
Q Consensus 64 ~~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 139 (351)
..++|.+.+.||+|+||.||+|.+. +++.||+|++...... .+.+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 106 (362)
T 2bdw_A 27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 106 (362)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 4568999999999999999999975 6899999999765433 35678999999999999999999999999999999
Q ss_pred EEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCC---ceEEec
Q 018712 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD---IAKISD 216 (351)
Q Consensus 140 ~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~---~vkl~D 216 (351)
|||+.+|+|.+++..... +++..+..++.||+.||.|||+++ |+||||||+|||++.++ .+||+|
T Consensus 107 ~e~~~gg~L~~~l~~~~~---------~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~D 174 (362)
T 2bdw_A 107 FDLVTGGELFEDIVAREF---------YSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLAD 174 (362)
T ss_dssp ECCCCSCBHHHHHTTCSC---------CCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECC
T ss_pred EecCCCCCHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEee
Confidence 999999999999976542 899999999999999999999999 99999999999998654 599999
Q ss_pred ccccCCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccchhh-------
Q 018712 217 FDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTW------- 289 (351)
Q Consensus 217 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~~~------- 289 (351)
||++........ .....||+.|+|||++.+..++.++||||||+++|+|++|+.||...........+..
T Consensus 175 fG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~ 251 (362)
T 2bdw_A 175 FGLAIEVNDSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPS 251 (362)
T ss_dssp CTTCBCCTTCCS---CCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT
T ss_pred cCcceEecCCcc---cccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCc
Confidence 999987654322 2346799999999999999999999999999999999999999986543211111110
Q ss_pred ----cccCCCccchhhhcccccCCCCCHHHHH
Q 018712 290 ----ATPKLSEDKVKQCVDTKLGGEYPPKAIA 317 (351)
Q Consensus 290 ----~~~~~~~~~~~~~ld~~~~~~~~~~~~~ 317 (351)
..+....+.+..|+..+|.+|++.+++.
T Consensus 252 ~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l 283 (362)
T 2bdw_A 252 PEWDTVTPEAKSLIDSMLTVNPKKRITADQAL 283 (362)
T ss_dssp TGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHT
T ss_pred ccccCCCHHHHHHHHHHcCCChhhCcCHHHHh
Confidence 0111123688999999999999987654
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-44 Score=324.00 Aligned_cols=215 Identities=37% Similarity=0.667 Sum_probs=188.2
Q ss_pred ccccCHHHHHHHhcCCCCCceeccCCcEEEEEEEECCCCEEEEEEcCCCCC--chHHHHHHHHHHHhccCCceeeeEEEE
Q 018712 53 VPVISVDELKEKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQ--PDQEFLAQVSMVSRLKNENVVELVGYY 130 (351)
Q Consensus 53 ~~~~~~~~~~~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~ 130 (351)
...++..++....++|.+.+.||+|+||.||+|...+++.||+|++..... ....+.+|+++++.++||||+++++++
T Consensus 17 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 96 (326)
T 3uim_A 17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC 96 (326)
T ss_dssp CEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEE
T ss_pred cceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEE
Confidence 456788899999999999999999999999999988899999999875432 234688999999999999999999999
Q ss_pred ecCCceEEEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhC---CCCCeeeccccCCcEEEc
Q 018712 131 VDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEK---AEPRIIHRNIKSSNVLLF 207 (351)
Q Consensus 131 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~---~~~~ivH~Dlkp~Nill~ 207 (351)
.+.+..++||||+.+|+|.+++...... ...+++..+..++.|++.||.|||++ + |+||||||+|||++
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~-----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~---ivH~Dlkp~Nil~~ 168 (326)
T 3uim_A 97 MTPTERLLVYPYMANGSVASCLRERPES-----QPPLDWPKRQRIALGSARGLAYLHDHCDPK---IIHRDVKAANILLD 168 (326)
T ss_dssp CCSSCCEEEEECCTTCBHHHHHHCCSTT-----CCCCCHHHHHHHHHHHHHHHHHHHHSSSSC---EECCCCSGGGEEEC
T ss_pred ecCCceEEEEEeccCCCHHHHHHhcccc-----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCC---eEeCCCchhhEEEC
Confidence 9999999999999999999999875432 12389999999999999999999999 8 99999999999999
Q ss_pred cCCceEEecccccCCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCC
Q 018712 208 DDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVD 276 (351)
Q Consensus 208 ~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~ 276 (351)
.++.+||+|||++......... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||.
T Consensus 169 ~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 236 (326)
T 3uim_A 169 EEFEAVVGDFGLAKLMDYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD 236 (326)
T ss_dssp TTCCEEECCCSSCEECCSSSSC-EECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBC
T ss_pred CCCCEEeccCccccccCccccc-ccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCccc
Confidence 9999999999999765433221 1234569999999999998899999999999999999999999996
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=333.04 Aligned_cols=264 Identities=18% Similarity=0.236 Sum_probs=204.9
Q ss_pred HhcCCCCCceeccCCcEEEEEEEECC------CCEEEEEEcCCCCCc------------hHHHHHHHHHHHhccCCceee
Q 018712 64 KTDNFGTNSLIGEGSYGRVYFGVLRS------GRAAAIKKLDSSKQP------------DQEFLAQVSMVSRLKNENVVE 125 (351)
Q Consensus 64 ~~~~y~~~~~Lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~------------~~~~~~e~~~l~~l~h~niv~ 125 (351)
..++|.+.+.||+|+||.||+|.+.+ ++.||+|++...... ......|+..++.++|+||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 34689999999999999999999764 478999998655421 112334455667778999999
Q ss_pred eEEEEecC----CceEEEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccC
Q 018712 126 LVGYYVDG----PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKS 201 (351)
Q Consensus 126 ~~~~~~~~----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp 201 (351)
+++++... ...++||||+ +++|.+++..... .+++..++.++.||+.||.|||+++ |+||||||
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~--------~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp 180 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAK--------RFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKA 180 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTS--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCG
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccC--------CCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCH
Confidence 99998764 4589999999 9999999986532 2899999999999999999999999 99999999
Q ss_pred CcEEEc--cCCceEEecccccCCCccccccc-----cccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCC
Q 018712 202 SNVLLF--DDDIAKISDFDLSNQAPDAAARL-----HSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274 (351)
Q Consensus 202 ~Nill~--~~~~vkl~Dfg~a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P 274 (351)
+|||++ .++.+||+|||+++......... ......||+.|+|||++.+..++.++||||||+++|||++|+.|
T Consensus 181 ~Nill~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~P 260 (364)
T 3op5_A 181 SNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLP 260 (364)
T ss_dssp GGEEEESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCT
T ss_pred HHEEEecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCC
Confidence 999999 88999999999997664432211 11334599999999999999999999999999999999999999
Q ss_pred CCCCCCCCCcc-------------chh-----hcccCCCccchhhhcccccCCCCCHHHHHHHHHHHHHhhhhccccchh
Q 018712 275 VDHTLPRGQQS-------------LVT-----WATPKLSEDKVKQCVDTKLGGEYPPKAIAKVRKKKFITSECSNISFAE 336 (351)
Q Consensus 275 f~~~~~~~~~~-------------~~~-----~~~~~~~~~~~~~~ld~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 336 (351)
|.......... ++. ...+....+.+..|+..++.+|++.+++..+++-. +++
T Consensus 261 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~----------~~~ 330 (364)
T 3op5_A 261 WEDNLKDPKYVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQG----------LKA 330 (364)
T ss_dssp TGGGTTCHHHHHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH----------HHH
T ss_pred ccccccCHHHHHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH----------HHH
Confidence 98643221110 000 01122234678899999999999999988877665 345
Q ss_pred hhhcccCCccccc
Q 018712 337 FNINWHCPLEWSV 349 (351)
Q Consensus 337 ~~~~~~~~~~w~~ 349 (351)
.+...+.++||+.
T Consensus 331 ~~~~~~~~~dw~~ 343 (364)
T 3op5_A 331 IGSKDDGKLDLSV 343 (364)
T ss_dssp TTCCCCCCCCC--
T ss_pred cCCCcCCccceEe
Confidence 6666888999963
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-44 Score=324.51 Aligned_cols=254 Identities=28% Similarity=0.408 Sum_probs=204.6
Q ss_pred hcCCCCCceeccCCcEEEEEEEEC----CCCEEEEEEcCCCCCc--hHHHHHHHHHHHhccCCceeeeEEEEecCCceEE
Q 018712 65 TDNFGTNSLIGEGSYGRVYFGVLR----SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVL 138 (351)
Q Consensus 65 ~~~y~~~~~Lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 138 (351)
.++|.+.+.||+|+||.||+|.+. .+..||||++...... .+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 127 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI 127 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence 467999999999999999999975 3456999999765332 4568899999999999999999999999999999
Q ss_pred EEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEeccc
Q 018712 139 AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFD 218 (351)
Q Consensus 139 v~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg 218 (351)
||||+.+++|.+++..... .+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||
T Consensus 128 v~e~~~~~~L~~~l~~~~~--------~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg 196 (325)
T 3kul_A 128 VTEYMENGSLDTFLRTHDG--------QFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFG 196 (325)
T ss_dssp EEECCTTCBHHHHHHTTTT--------CSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCS
T ss_pred EeeCCCCCcHHHHHHhccc--------CCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCC
Confidence 9999999999999975432 2899999999999999999999999 9999999999999999999999999
Q ss_pred ccCCCccccccc-cccccccccCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCCccchhh-------
Q 018712 219 LSNQAPDAAARL-HSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTW------- 289 (351)
Q Consensus 219 ~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~Pf~~~~~~~~~~~~~~------- 289 (351)
+++......... ......+|+.|+|||++.+..++.++||||||+++|+|++ |..||...........+..
T Consensus 197 ~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 276 (325)
T 3kul_A 197 LSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLPAP 276 (325)
T ss_dssp SCEECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCC
T ss_pred cccccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCCCCCC
Confidence 998764432211 1233456788999999999999999999999999999999 9999976543322111111
Q ss_pred -cccCCCccchhhhcccccCCCCCHHHHHHHHHHHHHhhhh
Q 018712 290 -ATPKLSEDKVKQCVDTKLGGEYPPKAIAKVRKKKFITSEC 329 (351)
Q Consensus 290 -~~~~~~~~~~~~~ld~~~~~~~~~~~~~~~~~~~~~~~~~ 329 (351)
..+....+.+..|+..+|.+|++.+++...++-.+...+.
T Consensus 277 ~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~~ 317 (325)
T 3kul_A 277 MGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPES 317 (325)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC-
T ss_pred CCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCccc
Confidence 1111123688999999999999999999888776654433
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-44 Score=330.18 Aligned_cols=240 Identities=21% Similarity=0.274 Sum_probs=191.1
Q ss_pred HhcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCCchHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEEEe
Q 018712 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEH 142 (351)
Q Consensus 64 ~~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 142 (351)
..++|.+.+.||+|+||.||++... +++.||+|++.........+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 97 (361)
T 3uc3_A 18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY 97 (361)
T ss_dssp CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence 3568999999999999999999976 789999999987766667899999999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCc--eEEeccccc
Q 018712 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDI--AKISDFDLS 220 (351)
Q Consensus 143 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~--vkl~Dfg~a 220 (351)
+.+|+|.+++..... +++..++.++.||+.||.|||++| |+||||||+|||++.++. +||+|||++
T Consensus 98 ~~~~~L~~~l~~~~~---------~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a 165 (361)
T 3uc3_A 98 ASGGELYERICNAGR---------FSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYS 165 (361)
T ss_dssp CCSCBHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC
T ss_pred CCCCCHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCcc
Confidence 999999999976543 899999999999999999999999 999999999999987765 999999998
Q ss_pred CCCccccccccccccccccCccCcccccCCCCCcc-chhHhHHHHHHHHHcCCCCCCCCCCCCCcc-chh------hccc
Q 018712 221 NQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSK-SDVYSFGVVLLELLTGRKPVDHTLPRGQQS-LVT------WATP 292 (351)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DvwslG~il~el~tg~~Pf~~~~~~~~~~-~~~------~~~~ 292 (351)
+....... .....||+.|+|||++.+..++.+ +||||||+++|+|++|+.||.......... .+. ...+
T Consensus 166 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 242 (361)
T 3uc3_A 166 KSSVLHSQ---PKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIP 242 (361)
T ss_dssp ------------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCC
T ss_pred ccccccCC---CCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCC
Confidence 75432221 244579999999999988887655 899999999999999999998754432211 110 0111
Q ss_pred ------CCCccchhhhcccccCCCCCHHHHHH
Q 018712 293 ------KLSEDKVKQCVDTKLGGEYPPKAIAK 318 (351)
Q Consensus 293 ------~~~~~~~~~~ld~~~~~~~~~~~~~~ 318 (351)
....+.+..|+..+|.+|++.+++..
T Consensus 243 ~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~ 274 (361)
T 3uc3_A 243 DDIRISPECCHLISRIFVADPATRISIPEIKT 274 (361)
T ss_dssp TTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred CcCCCCHHHHHHHHHHccCChhHCcCHHHHHh
Confidence 11136889999999999999877643
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=316.37 Aligned_cols=263 Identities=19% Similarity=0.305 Sum_probs=209.9
Q ss_pred HhcCCCCCceeccCCcEEEEEEEE-CCCCEEEEEEcCCCCCchHHHHHHHHHHHhccCCceeeeEEE-EecCCceEEEEE
Q 018712 64 KTDNFGTNSLIGEGSYGRVYFGVL-RSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGY-YVDGPLRVLAYE 141 (351)
Q Consensus 64 ~~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~-~~~~~~~~lv~e 141 (351)
..++|++.+.||+|+||.||+|.+ .+++.||+|++..... ...+.+|+.+++.++|++++..+.. +.+.+..++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc-chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEE
Confidence 457899999999999999999997 4789999998654433 2347889999999998776666655 467778899999
Q ss_pred eCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEE---ccCCceEEeccc
Q 018712 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLL---FDDDIAKISDFD 218 (351)
Q Consensus 142 ~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill---~~~~~vkl~Dfg 218 (351)
|+ +++|.+++..... .+++..++.++.||+.||.|||+++ |+||||||+|||+ +.++.+||+|||
T Consensus 86 ~~-~~~L~~~~~~~~~--------~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg 153 (296)
T 4hgt_A 86 LL-GPSLEDLFNFCSR--------KFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFG 153 (296)
T ss_dssp CC-CCBHHHHHHHTTS--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCT
T ss_pred cc-CCCHHHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCc
Confidence 99 8899999985432 2899999999999999999999999 9999999999999 788999999999
Q ss_pred ccCCCcccccc-----ccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccchhh----
Q 018712 219 LSNQAPDAAAR-----LHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTW---- 289 (351)
Q Consensus 219 ~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~~~---- 289 (351)
++......... .......||+.|+|||.+.+..++.++||||||+++|+|++|+.||..............
T Consensus 154 ~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 233 (296)
T 4hgt_A 154 LAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEK 233 (296)
T ss_dssp TCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHH
T ss_pred cceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcc
Confidence 99766443221 112345799999999999999999999999999999999999999987654433222111
Q ss_pred -----------cccCCCccchhhhcccccCCCCCHHHHHHHHHHHHHhhhhccccchhhhhcccCCccccc
Q 018712 290 -----------ATPKLSEDKVKQCVDTKLGGEYPPKAIAKVRKKKFITSECSNISFAEFNINWHCPLEWSV 349 (351)
Q Consensus 290 -----------~~~~~~~~~~~~~ld~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~ 349 (351)
..+....+.+..|++.+|.+|++.+++...++-. +++.+...+.++||..
T Consensus 234 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~----------~~~~~~~~~~~~dw~~ 294 (296)
T 4hgt_A 234 KMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL----------FHRQGFSYDYVFDWNM 294 (296)
T ss_dssp HHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHH----------HHHHTCCTTCCCGGGG
T ss_pred cccchhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHH----------HHHhCCCccCccchhh
Confidence 1122224788999999999999999998877655 5677778899999974
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-44 Score=320.10 Aligned_cols=239 Identities=27% Similarity=0.370 Sum_probs=190.4
Q ss_pred HhcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCC---------------------------chHHHHHHHHHH
Q 018712 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ---------------------------PDQEFLAQVSMV 115 (351)
Q Consensus 64 ~~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---------------------------~~~~~~~e~~~l 115 (351)
..++|.+.+.||+|+||.||+|.+. +++.||+|++..... ..+.+.+|++++
T Consensus 11 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 90 (298)
T 2zv2_A 11 QLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAIL 90 (298)
T ss_dssp EETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHH
T ss_pred eecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHH
Confidence 3578999999999999999999975 688999999865431 124588999999
Q ss_pred HhccCCceeeeEEEEec--CCceEEEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCC
Q 018712 116 SRLKNENVVELVGYYVD--GPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPR 193 (351)
Q Consensus 116 ~~l~h~niv~~~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ 193 (351)
++++||||+++++++.+ .+..++||||+.+++|.+++.... +++..+..++.||+.||.|||+++
T Consensus 91 ~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~----------~~~~~~~~~~~qi~~~l~~lH~~~--- 157 (298)
T 2zv2_A 91 KKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKP----------LSEDQARFYFQDLIKGIEYLHYQK--- 157 (298)
T ss_dssp HTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCSSC----------CCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhcCC----------CCHHHHHHHHHHHHHHHHHHHHCC---
Confidence 99999999999999986 567899999999999988765432 899999999999999999999999
Q ss_pred eeeccccCCcEEEccCCceEEecccccCCCccccccccccccccccCccCcccccCCC---CCccchhHhHHHHHHHHHc
Q 018712 194 IIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQ---MSSKSDVYSFGVVLLELLT 270 (351)
Q Consensus 194 ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DvwslG~il~el~t 270 (351)
|+||||||+|||++.++.+||+|||++......... .....||+.|+|||++.+.. ++.++||||||+++|+|++
T Consensus 158 ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~ 235 (298)
T 2zv2_A 158 IIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDAL--LSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVF 235 (298)
T ss_dssp EECCCCCGGGEEECTTSCEEECCCTTCEECSSSSCE--ECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHH
T ss_pred eeccCCCHHHEEECCCCCEEEecCCCcccccccccc--ccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHH
Confidence 999999999999999999999999998765433221 23457999999999998665 3788999999999999999
Q ss_pred CCCCCCCCCCCCCccchhhc------ccCC---CccchhhhcccccCCCCCHHHHH
Q 018712 271 GRKPVDHTLPRGQQSLVTWA------TPKL---SEDKVKQCVDTKLGGEYPPKAIA 317 (351)
Q Consensus 271 g~~Pf~~~~~~~~~~~~~~~------~~~~---~~~~~~~~ld~~~~~~~~~~~~~ 317 (351)
|+.||...........+... .+.. ..+.+..|+..+|.+|++.+++.
T Consensus 236 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l 291 (298)
T 2zv2_A 236 GQCPFMDERIMCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIK 291 (298)
T ss_dssp SSCSSCCSSHHHHHHHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHT
T ss_pred CCCCCCCccHHHHHHHHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHh
Confidence 99999764322111111110 0111 23688999999999999887653
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-44 Score=320.21 Aligned_cols=200 Identities=26% Similarity=0.424 Sum_probs=171.5
Q ss_pred cCCCCCceeccCCcEEEEEEEECCCCEEEEEEcCCCCCc---hHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEEEe
Q 018712 66 DNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEH 142 (351)
Q Consensus 66 ~~y~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 142 (351)
++|++.+.||+|+||.||+|.+.+++.||+|++...... ...+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 579999999999999999999988999999998755432 36788999999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccccCC
Q 018712 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222 (351)
Q Consensus 143 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~ 222 (351)
+.+ +|.+++..... .++...+..++.||+.||.|||++| |+||||||+|||++.++.+||+|||++..
T Consensus 82 ~~~-~l~~~~~~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 149 (288)
T 1ob3_A 82 LDQ-DLKKLLDVCEG--------GLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARA 149 (288)
T ss_dssp CSE-EHHHHHHTSTT--------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHH
T ss_pred cCC-CHHHHHHhccc--------CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccc
Confidence 986 99999976432 2889999999999999999999999 99999999999999999999999999865
Q ss_pred CccccccccccccccccCccCcccccCC-CCCccchhHhHHHHHHHHHcCCCCCCCCC
Q 018712 223 APDAAARLHSTRVLGTFGYHAPEYAMTG-QMSSKSDVYSFGVVLLELLTGRKPVDHTL 279 (351)
Q Consensus 223 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~Pf~~~~ 279 (351)
....... .....||+.|+|||++.+. .++.++||||||+++|+|++|+.||....
T Consensus 150 ~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~ 205 (288)
T 1ob3_A 150 FGIPVRK--YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVS 205 (288)
T ss_dssp HCC-----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cCccccc--cccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 4322111 2345689999999998764 58999999999999999999999997643
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-44 Score=330.89 Aligned_cols=204 Identities=23% Similarity=0.310 Sum_probs=179.6
Q ss_pred HHHHHhcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCCchHHHHHHHHHHHhcc-----CCceeeeEEEEecC
Q 018712 60 ELKEKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLK-----NENVVELVGYYVDG 133 (351)
Q Consensus 60 ~~~~~~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~-----h~niv~~~~~~~~~ 133 (351)
......++|.+.+.||+|+||.||+|.+. +++.||+|++............|+.+++.+. ||||+++++++...
T Consensus 29 ~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~ 108 (360)
T 3llt_A 29 KGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYY 108 (360)
T ss_dssp TTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEET
T ss_pred cceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeEC
Confidence 33445689999999999999999999974 7899999999865555667788999999986 99999999999999
Q ss_pred CceEEEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEcc-----
Q 018712 134 PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFD----- 208 (351)
Q Consensus 134 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~----- 208 (351)
+..++||||+ +++|.+++...... .+++..+..++.||+.||.|||++| |+||||||+|||++.
T Consensus 109 ~~~~lv~e~~-~~~L~~~~~~~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~ 177 (360)
T 3llt_A 109 DHMCLIFEPL-GPSLYEIITRNNYN-------GFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDDPYFEK 177 (360)
T ss_dssp TEEEEEECCC-CCBHHHHHHHTTTC-------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCTTCCE
T ss_pred CeeEEEEcCC-CCCHHHHHHhcCCC-------CCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEccccccc
Confidence 9999999999 88999999876432 2889999999999999999999999 999999999999975
Q ss_pred --------------------CCceEEecccccCCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHH
Q 018712 209 --------------------DDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLEL 268 (351)
Q Consensus 209 --------------------~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el 268 (351)
++.+||+|||++....... ....||+.|+|||++.+..++.++||||||+++|+|
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el 252 (360)
T 3llt_A 178 SLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYH-----GSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAEL 252 (360)
T ss_dssp EEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSCC-----CSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHH
T ss_pred cccchhcccccccccccccCCCCEEEEeccCceecCCCC-----cCccCcccccCcHHHcCCCCCCccchHHHHHHHHHH
Confidence 7899999999987543322 445789999999999999999999999999999999
Q ss_pred HcCCCCCCCCC
Q 018712 269 LTGRKPVDHTL 279 (351)
Q Consensus 269 ~tg~~Pf~~~~ 279 (351)
++|+.||....
T Consensus 253 l~g~~pf~~~~ 263 (360)
T 3llt_A 253 YTGSLLFRTHE 263 (360)
T ss_dssp HHSSCSCCCSS
T ss_pred HHCCCCCCCCc
Confidence 99999998644
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=339.90 Aligned_cols=209 Identities=20% Similarity=0.302 Sum_probs=179.9
Q ss_pred HHHHHhcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCC----CCchHHHHHHHHHHHhccCCceeeeEEEEecCC
Q 018712 60 ELKEKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSS----KQPDQEFLAQVSMVSRLKNENVVELVGYYVDGP 134 (351)
Q Consensus 60 ~~~~~~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~ 134 (351)
++....++|++.+.||+|+||.||+|.++ +++.||+|++.+. ......+.+|..+++.++||||+++++++.+.+
T Consensus 68 ~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~ 147 (437)
T 4aw2_A 68 QMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDN 147 (437)
T ss_dssp HHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSS
T ss_pred cccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCC
Confidence 44445689999999999999999999976 5789999998642 112234788999999999999999999999999
Q ss_pred ceEEEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEE
Q 018712 135 LRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKI 214 (351)
Q Consensus 135 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl 214 (351)
..|+||||+.+|+|.+++..... .+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||
T Consensus 148 ~~~lV~Ey~~gg~L~~~l~~~~~--------~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL 216 (437)
T 4aw2_A 148 NLYLVMDYYVGGDLLTLLSKFED--------RLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRL 216 (437)
T ss_dssp EEEEEECCCTTCBHHHHHHTTTT--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEE
T ss_pred EEEEEEecCCCCcHHHHHHHccC--------CCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEE
Confidence 99999999999999999986422 2899999999999999999999999 999999999999999999999
Q ss_pred ecccccCCCccccccccccccccccCccCccccc-----CCCCCccchhHhHHHHHHHHHcCCCCCCCCCC
Q 018712 215 SDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAM-----TGQMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (351)
Q Consensus 215 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~ 280 (351)
+|||+++....... ......+||+.|+|||++. ...++.++|||||||++|||++|+.||.....
T Consensus 217 ~DFGla~~~~~~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~ 286 (437)
T 4aw2_A 217 ADFGSCLKLMEDGT-VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL 286 (437)
T ss_dssp CCCTTCEECCTTSC-EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSH
T ss_pred cchhhhhhcccCCC-cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCCh
Confidence 99999976543322 1224467999999999987 56789999999999999999999999987543
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-44 Score=333.32 Aligned_cols=248 Identities=25% Similarity=0.396 Sum_probs=202.7
Q ss_pred HhcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCCc--hHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEE
Q 018712 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAY 140 (351)
Q Consensus 64 ~~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 140 (351)
..++|.+.+.||+|+||.||+|.+. +++.||+|++...... ...+.+|++++++++||||+++++++.+.+..++||
T Consensus 112 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 191 (377)
T 3cbl_A 112 NHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVM 191 (377)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred chHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEE
Confidence 3467888999999999999999986 7899999998754322 245788999999999999999999999999999999
Q ss_pred EeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEeccccc
Q 018712 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (351)
Q Consensus 141 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a 220 (351)
||+++|+|.+++..... .+++..++.++.||+.||.|||+++ ++||||||+|||++.++.+||+|||++
T Consensus 192 e~~~~g~L~~~l~~~~~--------~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s 260 (377)
T 3cbl_A 192 ELVQGGDFLTFLRTEGA--------RLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMS 260 (377)
T ss_dssp ECCTTCBHHHHHHHHGG--------GCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGC
T ss_pred EcCCCCCHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCc
Confidence 99999999999976432 2889999999999999999999999 999999999999999999999999998
Q ss_pred CCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCCccchhh--------cc
Q 018712 221 NQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTW--------AT 291 (351)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~Pf~~~~~~~~~~~~~~--------~~ 291 (351)
+...............+++.|+|||.+.+..++.++||||||+++|||++ |..||...........+.. ..
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 340 (377)
T 3cbl_A 261 REEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPCPELC 340 (377)
T ss_dssp EECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTCCCCCCTTC
T ss_pred eecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCC
Confidence 76543322221222346788999999998899999999999999999998 9999987543322111111 11
Q ss_pred cCCCccchhhhcccccCCCCCHHHHHHHHHH
Q 018712 292 PKLSEDKVKQCVDTKLGGEYPPKAIAKVRKK 322 (351)
Q Consensus 292 ~~~~~~~~~~~ld~~~~~~~~~~~~~~~~~~ 322 (351)
+....+.+..|++.+|.+|++.+++...++-
T Consensus 341 ~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~ 371 (377)
T 3cbl_A 341 PDAVFRLMEQCWAYEPGQRPSFSTIYQELQS 371 (377)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CHHHHHHHHHHcCCCchhCcCHHHHHHHHHH
Confidence 1112367899999999999999988776543
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-43 Score=326.86 Aligned_cols=263 Identities=25% Similarity=0.338 Sum_probs=211.7
Q ss_pred HhcCCCCCceeccCCcEEEEEEEEC--------CCCEEEEEEcCCCCCc--hHHHHHHHHHHHhc-cCCceeeeEEEEec
Q 018712 64 KTDNFGTNSLIGEGSYGRVYFGVLR--------SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRL-KNENVVELVGYYVD 132 (351)
Q Consensus 64 ~~~~y~~~~~Lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l-~h~niv~~~~~~~~ 132 (351)
..++|.+.+.||+|+||.||+|.+. .+..||+|++...... ...+.+|+++++++ +||||+++++++.+
T Consensus 67 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 146 (382)
T 3tt0_A 67 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 146 (382)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred chhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeecc
Confidence 4468999999999999999999863 2357999999765433 35688999999999 99999999999999
Q ss_pred CCceEEEEEeCCCCCHHHHhccCCCCC-------CCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEE
Q 018712 133 GPLRVLAYEHASKGSLHDILHGKKGVK-------GAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVL 205 (351)
Q Consensus 133 ~~~~~lv~e~~~~gsL~~~l~~~~~~~-------~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nil 205 (351)
.+..++||||+.+|+|.+++....... .......+++..++.++.||+.||.|||+++ |+||||||+|||
T Consensus 147 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIl 223 (382)
T 3tt0_A 147 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVL 223 (382)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEE
T ss_pred CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcceEE
Confidence 999999999999999999998754211 1112234899999999999999999999999 999999999999
Q ss_pred EccCCceEEecccccCCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCCc
Q 018712 206 LFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQ 284 (351)
Q Consensus 206 l~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~Pf~~~~~~~~~ 284 (351)
++.++.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|+|++ |..||.........
T Consensus 224 l~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~~ 303 (382)
T 3tt0_A 224 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF 303 (382)
T ss_dssp ECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH
T ss_pred EcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 99999999999999987654433233344567899999999999999999999999999999999 99999865432221
Q ss_pred cchhhc--------ccCCCccchhhhcccccCCCCCHHHHHHHHHHHHHhhhh
Q 018712 285 SLVTWA--------TPKLSEDKVKQCVDTKLGGEYPPKAIAKVRKKKFITSEC 329 (351)
Q Consensus 285 ~~~~~~--------~~~~~~~~~~~~ld~~~~~~~~~~~~~~~~~~~~~~~~~ 329 (351)
..+... .+....+.+..|+..+|.+|++.+++.+.++-.+.....
T Consensus 304 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~ 356 (382)
T 3tt0_A 304 KLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSN 356 (382)
T ss_dssp HHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCS
T ss_pred HHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhc
Confidence 111111 111123688999999999999999998887776654433
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-44 Score=340.35 Aligned_cols=246 Identities=22% Similarity=0.299 Sum_probs=193.4
Q ss_pred HhcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCC----CCchHHHHHHHHHHHhccCCceeeeEEEEecCCceEE
Q 018712 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSS----KQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVL 138 (351)
Q Consensus 64 ~~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 138 (351)
..++|++.+.||+|+||.||+|... +++.||+|++... ......+.+|+.+++.++||||+++++++.+.+..++
T Consensus 146 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l 225 (446)
T 4ejn_A 146 TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCF 225 (446)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEE
T ss_pred ChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEE
Confidence 3467999999999999999999975 7899999998642 2233557789999999999999999999999999999
Q ss_pred EEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhh-CCCCCeeeccccCCcEEEccCCceEEecc
Q 018712 139 AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHE-KAEPRIIHRNIKSSNVLLFDDDIAKISDF 217 (351)
Q Consensus 139 v~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~-~~~~~ivH~Dlkp~Nill~~~~~vkl~Df 217 (351)
||||+++|+|.+++..... +++..+..++.||+.||.|||+ .| |+||||||+|||++.++.+||+||
T Consensus 226 v~e~~~~~~L~~~l~~~~~---------~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DF 293 (446)
T 4ejn_A 226 VMEYANGGELFFHLSRERV---------FSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDF 293 (446)
T ss_dssp EECCCSSCBHHHHHHHHSC---------CCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCC
T ss_pred EEeeCCCCcHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccC
Confidence 9999999999999976543 8999999999999999999998 88 999999999999999999999999
Q ss_pred cccCCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccchhhcc------
Q 018712 218 DLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWAT------ 291 (351)
Q Consensus 218 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~~~~~------ 291 (351)
|+++........ .....||+.|+|||++.+..++.++||||||+++|||++|+.||...........+....
T Consensus 294 G~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~ 371 (446)
T 4ejn_A 294 GLCKEGIKDGAT--MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRT 371 (446)
T ss_dssp CCCCTTCC-------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTT
T ss_pred CCceeccCCCcc--cccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCcc
Confidence 999864332222 245679999999999999999999999999999999999999998654332222221111
Q ss_pred -cCCCccchhhhcccccCCCC-----CHHHHHHHHHHHHHh
Q 018712 292 -PKLSEDKVKQCVDTKLGGEY-----PPKAIAKVRKKKFIT 326 (351)
Q Consensus 292 -~~~~~~~~~~~ld~~~~~~~-----~~~~~~~~~~~~~~~ 326 (351)
+....+.+..|+..+|.+|+ ++++ ++++.++.
T Consensus 372 ~~~~~~~li~~~L~~dP~~R~~~~~~t~~e---ll~hp~f~ 409 (446)
T 4ejn_A 372 LGPEAKSLLSGLLKKDPKQRLGGGSEDAKE---IMQHRFFA 409 (446)
T ss_dssp SCHHHHHHHHHHTCSSTTTSTTCSTTTHHH---HHTSGGGT
T ss_pred CCHHHHHHHHHHcccCHHHhCCCCCCCHHH---HHhCcccc
Confidence 11123688999999999998 5555 45555543
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-43 Score=313.39 Aligned_cols=263 Identities=19% Similarity=0.303 Sum_probs=212.5
Q ss_pred HhcCCCCCceeccCCcEEEEEEEE-CCCCEEEEEEcCCCCCchHHHHHHHHHHHhccCCceeeeEEE-EecCCceEEEEE
Q 018712 64 KTDNFGTNSLIGEGSYGRVYFGVL-RSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGY-YVDGPLRVLAYE 141 (351)
Q Consensus 64 ~~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~-~~~~~~~~lv~e 141 (351)
..++|.+.+.||+|+||.||+|.+ .+++.||+|++..... ...+.+|+.+++.++|++++..+.. +.+.+..++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 3uzp_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS-CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc-hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence 357899999999999999999997 5789999999865443 3468899999999998776665554 466778899999
Q ss_pred eCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEE---ccCCceEEeccc
Q 018712 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLL---FDDDIAKISDFD 218 (351)
Q Consensus 142 ~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill---~~~~~vkl~Dfg 218 (351)
|+ +++|.+++..... .+++..++.++.||+.||.|||+++ ++||||||+|||+ +.++.+||+|||
T Consensus 86 ~~-~~~L~~~~~~~~~--------~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg 153 (296)
T 3uzp_A 86 LL-GPSLEDLFNFCSR--------KFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFG 153 (296)
T ss_dssp CC-CCBHHHHHHHTTT--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCT
T ss_pred ec-CCCHHHHHHhhcc--------CCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCC
Confidence 99 8899999974432 2899999999999999999999999 9999999999999 488899999999
Q ss_pred ccCCCccccccc-----cccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccchh-----
Q 018712 219 LSNQAPDAAARL-----HSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVT----- 288 (351)
Q Consensus 219 ~a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~~----- 288 (351)
++.......... ......||+.|+|||.+.+..++.++||||||+++|+|++|+.||.............
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 233 (296)
T 3uzp_A 154 LAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEK 233 (296)
T ss_dssp TCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHH
T ss_pred CcccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhccc
Confidence 997665432211 1244579999999999999999999999999999999999999998754433222111
Q ss_pred ----------hcccCCCccchhhhcccccCCCCCHHHHHHHHHHHHHhhhhccccchhhhhcccCCccccc
Q 018712 289 ----------WATPKLSEDKVKQCVDTKLGGEYPPKAIAKVRKKKFITSECSNISFAEFNINWHCPLEWSV 349 (351)
Q Consensus 289 ----------~~~~~~~~~~~~~~ld~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~ 349 (351)
...+....+.+..|++.+|.+|++.+++...++.. +.+.+...+.++||.+
T Consensus 234 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~----------~~~~~~~~~~~~dw~~ 294 (296)
T 3uzp_A 234 KMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL----------FHRQGFSYDYVFDWNM 294 (296)
T ss_dssp HHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHH----------HHHTTCCSSCCCGGGG
T ss_pred ccCCchHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHH----------HHhcCCcccccccccc
Confidence 01112224788999999999999999998877655 5566777888999975
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-44 Score=327.01 Aligned_cols=245 Identities=22% Similarity=0.301 Sum_probs=198.0
Q ss_pred HhcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCC------CCchHHHHHHHHHHHhccCCceeeeEEEEecCCce
Q 018712 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSS------KQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLR 136 (351)
Q Consensus 64 ~~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~------~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 136 (351)
..++|++.+.||+|+||.||+|.+. +++.||+|++... ....+.+.+|+.+++.++||||+++++++.+.+..
T Consensus 22 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 101 (351)
T 3c0i_A 22 FEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGML 101 (351)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred cccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 3467999999999999999999975 7899999998531 22356789999999999999999999999999999
Q ss_pred EEEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCc---eE
Q 018712 137 VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDI---AK 213 (351)
Q Consensus 137 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~---vk 213 (351)
|+||||+.+++|.+++...... ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++. +|
T Consensus 102 ~lv~e~~~g~~L~~~l~~~~~~-----~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vk 173 (351)
T 3c0i_A 102 YMVFEFMDGADLCFEIVKRADA-----GFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVK 173 (351)
T ss_dssp EEEEECCSSCBHHHHHHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEE
T ss_pred EEEEeCCCCCCHHHHHHHhccc-----CCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEE
Confidence 9999999999999888653211 112789999999999999999999999 999999999999987654 99
Q ss_pred EecccccCCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccchh-----
Q 018712 214 ISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVT----- 288 (351)
Q Consensus 214 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~~----- 288 (351)
|+|||++........ ......||+.|+|||++.+..++.++||||||+++|+|++|+.||.............
T Consensus 174 l~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~i~~~~~~~ 251 (351)
T 3c0i_A 174 LGGFGVAIQLGESGL--VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKERLFEGIIKGKYKM 251 (351)
T ss_dssp ECCCTTCEECCTTSC--BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHHHHHHHHHHTCCCC
T ss_pred EecCcceeEecCCCe--eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHHHHHHHHHcCCCCC
Confidence 999999977654321 1244579999999999999999999999999999999999999998643211000100
Q ss_pred --h---cccCCCccchhhhcccccCCCCCHHHHHH
Q 018712 289 --W---ATPKLSEDKVKQCVDTKLGGEYPPKAIAK 318 (351)
Q Consensus 289 --~---~~~~~~~~~~~~~ld~~~~~~~~~~~~~~ 318 (351)
. ..+....+.+..|+..+|.+|++.+++.+
T Consensus 252 ~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 252 NPRQWSHISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp CHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 0 01112236889999999999999877643
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=332.07 Aligned_cols=238 Identities=19% Similarity=0.285 Sum_probs=186.5
Q ss_pred HhcCCCCC-ceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCCchHHHHHHHHHHHh-ccCCceeeeEEEEec----CCce
Q 018712 64 KTDNFGTN-SLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSR-LKNENVVELVGYYVD----GPLR 136 (351)
Q Consensus 64 ~~~~y~~~-~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~-l~h~niv~~~~~~~~----~~~~ 136 (351)
..++|.+. +.||+|+||.||++.+. +++.||||++... ..+.+|+.++.+ .+||||+++++++.. ...+
T Consensus 59 ~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~ 134 (400)
T 1nxk_A 59 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 134 (400)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEE
Confidence 45677776 68999999999999975 7899999998632 457788888754 589999999998865 5678
Q ss_pred EEEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEcc---CCceE
Q 018712 137 VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFD---DDIAK 213 (351)
Q Consensus 137 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~---~~~vk 213 (351)
|+||||+.+|+|.+++...... .+++..+..++.||+.||.|||+++ |+||||||+|||++. ++.+|
T Consensus 135 ~lv~E~~~gg~L~~~l~~~~~~-------~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~k 204 (400)
T 1nxk_A 135 LIVMECLDGGELFSRIQDRGDQ-------AFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILK 204 (400)
T ss_dssp EEEEECCCSEEHHHHHHCC----------CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEE
T ss_pred EEEEEeCCCCcHHHHHHHhCCC-------CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEE
Confidence 9999999999999999865321 3899999999999999999999999 999999999999987 78999
Q ss_pred EecccccCCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCc----cchhh
Q 018712 214 ISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQ----SLVTW 289 (351)
Q Consensus 214 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~----~~~~~ 289 (351)
|+|||+++....... ....+||+.|+|||++.+..++.++|||||||++|+|++|+.||......... ..+..
T Consensus 205 l~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~ 281 (400)
T 1nxk_A 205 LTDFGFAKETTSHNS---LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRM 281 (400)
T ss_dssp ECCCTTCEECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHH
T ss_pred EEecccccccCCCCc---cccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHc
Confidence 999999976543221 24567899999999999999999999999999999999999999875443211 11110
Q ss_pred c-----c---cCC---CccchhhhcccccCCCCCHHHHHH
Q 018712 290 A-----T---PKL---SEDKVKQCVDTKLGGEYPPKAIAK 318 (351)
Q Consensus 290 ~-----~---~~~---~~~~~~~~ld~~~~~~~~~~~~~~ 318 (351)
. . ..+ ..+.+..|+..++.+|++.+++..
T Consensus 282 ~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 321 (400)
T 1nxk_A 282 GQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 321 (400)
T ss_dssp TCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CcccCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 0 0 111 236889999999999998776643
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=326.23 Aligned_cols=244 Identities=23% Similarity=0.296 Sum_probs=186.4
Q ss_pred HhcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCCchHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEEEe
Q 018712 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEH 142 (351)
Q Consensus 64 ~~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 142 (351)
..++|.+.+.||+|+||.||+|.+. +++.||+|++.... ..+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 129 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLEL 129 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC-----------CHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEe
Confidence 4577999999999999999999976 68899999987553 345678899999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEcc---CCceEEecccc
Q 018712 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFD---DDIAKISDFDL 219 (351)
Q Consensus 143 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~---~~~vkl~Dfg~ 219 (351)
+.+++|.+++..... +++..++.++.||+.||.|||+++ |+||||||+|||++. ++.+||+|||+
T Consensus 130 ~~~~~L~~~l~~~~~---------~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~ 197 (349)
T 2w4o_A 130 VTGGELFDRIVEKGY---------YSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGL 197 (349)
T ss_dssp CCSCBHHHHHTTCSS---------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC-
T ss_pred CCCCCHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCcc
Confidence 999999999976542 899999999999999999999999 999999999999975 88999999999
Q ss_pred cCCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCC-ccch-hh-------c
Q 018712 220 SNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQ-QSLV-TW-------A 290 (351)
Q Consensus 220 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~-~~~~-~~-------~ 290 (351)
++....... .....||+.|+|||++.+..++.++||||||+++|+|++|+.||........ ...+ .. .
T Consensus 198 a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~ 274 (349)
T 2w4o_A 198 SKIVEHQVL---MKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPW 274 (349)
T ss_dssp ------------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTT
T ss_pred ccccCcccc---cccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCch
Confidence 876543321 2345799999999999999999999999999999999999999976543210 0000 00 0
Q ss_pred ccCC---CccchhhhcccccCCCCCHHHHHHHHHHHHHh
Q 018712 291 TPKL---SEDKVKQCVDTKLGGEYPPKAIAKVRKKKFIT 326 (351)
Q Consensus 291 ~~~~---~~~~~~~~ld~~~~~~~~~~~~~~~~~~~~~~ 326 (351)
.+.. ..+.+..|+..+|.+|++.+++. ++.++.
T Consensus 275 ~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l---~hp~~~ 310 (349)
T 2w4o_A 275 WDEVSLNAKDLVRKLIVLDPKKRLTTFQAL---QHPWVT 310 (349)
T ss_dssp TTTSCHHHHHHHHTTSCSSGGGSCCHHHHH---HSTTTT
T ss_pred hhhCCHHHHHHHHHHccCChhhCcCHHHHh---cCcccC
Confidence 0111 13688999999999999987754 455443
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=328.07 Aligned_cols=240 Identities=22% Similarity=0.272 Sum_probs=199.1
Q ss_pred HhcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCC-chHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEEE
Q 018712 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ-PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYE 141 (351)
Q Consensus 64 ~~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 141 (351)
..++|.+.+.||+|+||.||+|... +++.||+|++..... ....+.+|+.+++.++||||+++++++.+....++|||
T Consensus 49 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E 128 (387)
T 1kob_A 49 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILE 128 (387)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEE
T ss_pred cccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEE
Confidence 4578999999999999999999975 789999999875532 34568899999999999999999999999999999999
Q ss_pred eCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEcc--CCceEEecccc
Q 018712 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFD--DDIAKISDFDL 219 (351)
Q Consensus 142 ~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~--~~~vkl~Dfg~ 219 (351)
|+.+|+|.+++..... .+++..++.++.||+.||.|||++| |+||||||+|||++. ++.+||+|||+
T Consensus 129 ~~~gg~L~~~l~~~~~--------~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~ 197 (387)
T 1kob_A 129 FLSGGELFDRIAAEDY--------KMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGL 197 (387)
T ss_dssp CCCCCBHHHHTTCTTC--------CBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTT
T ss_pred cCCCCcHHHHHHhhcC--------CCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEeccc
Confidence 9999999999976532 2899999999999999999999999 999999999999974 46899999999
Q ss_pred cCCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccchhh--------c-
Q 018712 220 SNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTW--------A- 290 (351)
Q Consensus 220 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~~~--------~- 290 (351)
+........ .....||+.|+|||++.+..++.++||||||+++|+|++|+.||...........+.. .
T Consensus 198 a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 274 (387)
T 1kob_A 198 ATKLNPDEI---VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAF 274 (387)
T ss_dssp CEECCTTSC---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTT
T ss_pred ceecCCCcc---eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccc
Confidence 977643321 1345699999999999999999999999999999999999999986543211111110 0
Q ss_pred --ccCCCccchhhhcccccCCCCCHHHHH
Q 018712 291 --TPKLSEDKVKQCVDTKLGGEYPPKAIA 317 (351)
Q Consensus 291 --~~~~~~~~~~~~ld~~~~~~~~~~~~~ 317 (351)
.+....+.+..|+..+|.+|++.+++.
T Consensus 275 ~~~s~~~~~li~~~L~~dP~~Rpt~~ell 303 (387)
T 1kob_A 275 SSVSPEAKDFIKNLLQKEPRKRLTVHDAL 303 (387)
T ss_dssp TTSCHHHHHHHHTTSCSSGGGSCCHHHHH
T ss_pred ccCCHHHHHHHHHHcCCChhHCcCHHHHh
Confidence 111123688999999999999887764
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=339.26 Aligned_cols=254 Identities=18% Similarity=0.253 Sum_probs=200.0
Q ss_pred HHHHHHhcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCC----CchHHHHHHHHHHHhccCCceeeeEEEEecC
Q 018712 59 DELKEKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK----QPDQEFLAQVSMVSRLKNENVVELVGYYVDG 133 (351)
Q Consensus 59 ~~~~~~~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~ 133 (351)
.+.....++|++.+.||+|+||.||++..+ +++.||+|++.+.. .....+.+|..++..++||||+++++++.+.
T Consensus 54 ~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~ 133 (412)
T 2vd5_A 54 KEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDE 133 (412)
T ss_dssp HHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECS
T ss_pred hhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeC
Confidence 344455688999999999999999999975 79999999986422 1223478899999999999999999999999
Q ss_pred CceEEEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceE
Q 018712 134 PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAK 213 (351)
Q Consensus 134 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vk 213 (351)
+..|+||||+++|+|.+++..... .+++..++.++.||+.||.|||+++ |+||||||+|||++.++++|
T Consensus 134 ~~~~lVmE~~~gg~L~~~l~~~~~--------~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vk 202 (412)
T 2vd5_A 134 NYLYLVMEYYVGGDLLTLLSKFGE--------RIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIR 202 (412)
T ss_dssp SEEEEEECCCCSCBHHHHHHHHSS--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEE
T ss_pred CEEEEEEcCCCCCcHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEE
Confidence 999999999999999999976431 2899999999999999999999999 99999999999999999999
Q ss_pred EecccccCCCccccccccccccccccCccCccccc-------CCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccc
Q 018712 214 ISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAM-------TGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSL 286 (351)
Q Consensus 214 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~ 286 (351)
|+|||+++....... ......+||+.|+|||++. +..++.++|||||||++|||++|+.||...........
T Consensus 203 L~DFGla~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~ 281 (412)
T 2vd5_A 203 LADFGSCLKLRADGT-VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGK 281 (412)
T ss_dssp ECCCTTCEECCTTSC-EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH
T ss_pred EeechhheeccCCCc-cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 999999976643321 1123467999999999987 35689999999999999999999999987644322211
Q ss_pred hhh-----ccc----CCC---ccchhhhcccccCCCCCHHHHHHHHHHHHH
Q 018712 287 VTW-----ATP----KLS---EDKVKQCVDTKLGGEYPPKAIAKVRKKKFI 325 (351)
Q Consensus 287 ~~~-----~~~----~~~---~~~~~~~ld~~~~~~~~~~~~~~~~~~~~~ 325 (351)
+.. ..| .++ .+.+..|+. .+.+|+....+..+.++.|+
T Consensus 282 i~~~~~~~~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff 331 (412)
T 2vd5_A 282 IVHYKEHLSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFF 331 (412)
T ss_dssp HHTHHHHCCCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGG
T ss_pred HHhcccCcCCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCc
Confidence 111 111 111 256777776 67777532234445666654
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-44 Score=329.02 Aligned_cols=256 Identities=25% Similarity=0.339 Sum_probs=205.4
Q ss_pred hcCCCCCceeccCCcEEEEEEEEC------CCCEEEEEEcCCCCCc--hHHHHHHHHHHHhccCCceeeeEEEEecCCce
Q 018712 65 TDNFGTNSLIGEGSYGRVYFGVLR------SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPLR 136 (351)
Q Consensus 65 ~~~y~~~~~Lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 136 (351)
.++|.+.+.||+|+||.||+|... ++..||||++...... ...+.+|+.++++++||||+++++++.+....
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 149 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 149 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 467999999999999999999843 4678999998754332 34688999999999999999999999999999
Q ss_pred EEEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCC---ceE
Q 018712 137 VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD---IAK 213 (351)
Q Consensus 137 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~---~vk 213 (351)
++||||+.+|+|.+++....... .....+++..++.++.||+.||.|||++| |+||||||+|||++.++ .+|
T Consensus 150 ~lv~e~~~~g~L~~~l~~~~~~~--~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~k 224 (367)
T 3l9p_A 150 FILLELMAGGDLKSFLRETRPRP--SQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAK 224 (367)
T ss_dssp EEEEECCTTEEHHHHHHHHSCCS--SSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEE
T ss_pred EEEEEeCCCCCHHHHHHhhcccc--CccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceEE
Confidence 99999999999999998654221 11234899999999999999999999999 99999999999999555 599
Q ss_pred EecccccCCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCCccchhh---
Q 018712 214 ISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTW--- 289 (351)
Q Consensus 214 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~Pf~~~~~~~~~~~~~~--- 289 (351)
|+|||+++...............||+.|+|||++.+..++.++||||||+++|||++ |..||...........+..
T Consensus 225 L~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~~~ 304 (367)
T 3l9p_A 225 IGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGR 304 (367)
T ss_dssp ECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCC
T ss_pred ECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC
Confidence 999999875433322222344568999999999999999999999999999999998 9999987544322211111
Q ss_pred -----cccCCCccchhhhcccccCCCCCHHHHHHHHHHHHH
Q 018712 290 -----ATPKLSEDKVKQCVDTKLGGEYPPKAIAKVRKKKFI 325 (351)
Q Consensus 290 -----~~~~~~~~~~~~~ld~~~~~~~~~~~~~~~~~~~~~ 325 (351)
..+....+.+..|+..+|.+|++.+++.+.++....
T Consensus 305 ~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~ 345 (367)
T 3l9p_A 305 MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 345 (367)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhh
Confidence 111112368899999999999999998877665543
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=318.37 Aligned_cols=258 Identities=23% Similarity=0.328 Sum_probs=207.6
Q ss_pred HhcCCCCCceeccCCcEEEEEEEEC------CCCEEEEEEcCCCCCc--hHHHHHHHHHHHhccCCceeeeEEEEecCCc
Q 018712 64 KTDNFGTNSLIGEGSYGRVYFGVLR------SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPL 135 (351)
Q Consensus 64 ~~~~y~~~~~Lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 135 (351)
..++|.+.+.||+|+||.||+|.+. ++..||+|++...... .+.+.+|++++++++||||+++++++.+.+.
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 100 (314)
T 2ivs_A 21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGP 100 (314)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCc
Confidence 3568999999999999999999862 4578999999765432 3568899999999999999999999999999
Q ss_pred eEEEEEeCCCCCHHHHhccCCCCCC---------------CCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeecccc
Q 018712 136 RVLAYEHASKGSLHDILHGKKGVKG---------------AKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIK 200 (351)
Q Consensus 136 ~~lv~e~~~~gsL~~~l~~~~~~~~---------------~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlk 200 (351)
.++||||+.+++|.+++........ ......+++..++.++.||+.||.|||+++ ++|||||
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dik 177 (314)
T 2ivs_A 101 LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHRDLA 177 (314)
T ss_dssp CEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EECCCCS
T ss_pred eEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---Ccccccc
Confidence 9999999999999999987543100 001123889999999999999999999999 9999999
Q ss_pred CCcEEEccCCceEEecccccCCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCC
Q 018712 201 SSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTL 279 (351)
Q Consensus 201 p~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~Pf~~~~ 279 (351)
|+||+++.++.+||+|||++................+|+.|+|||.+.+..++.++||||||+++|+|++ |..||....
T Consensus 178 p~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 257 (314)
T 2ivs_A 178 ARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIP 257 (314)
T ss_dssp GGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred hheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence 9999999999999999999876644333222344567889999999999899999999999999999999 999998765
Q ss_pred CCCCccchhhc--------ccCCCccchhhhcccccCCCCCHHHHHHHHHHHH
Q 018712 280 PRGQQSLVTWA--------TPKLSEDKVKQCVDTKLGGEYPPKAIAKVRKKKF 324 (351)
Q Consensus 280 ~~~~~~~~~~~--------~~~~~~~~~~~~ld~~~~~~~~~~~~~~~~~~~~ 324 (351)
.......+... .+....+.+..|+..+|.+|++.+++...++-.+
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~ 310 (314)
T 2ivs_A 258 PERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMM 310 (314)
T ss_dssp GGGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHhhcCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 43322222111 1111236889999999999999999888766554
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=325.62 Aligned_cols=265 Identities=19% Similarity=0.280 Sum_probs=209.2
Q ss_pred HHHHHHHhcCCCCCceeccCCcEEEEEEEE------CCCCEEEEEEcCCCCCc--hHHHHHHHHHHHhc-cCCceeeeEE
Q 018712 58 VDELKEKTDNFGTNSLIGEGSYGRVYFGVL------RSGRAAAIKKLDSSKQP--DQEFLAQVSMVSRL-KNENVVELVG 128 (351)
Q Consensus 58 ~~~~~~~~~~y~~~~~Lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l-~h~niv~~~~ 128 (351)
........++|.+.+.||+|+||.||+|.+ .+++.||||++...... .+.+.+|+++++++ +||||+++++
T Consensus 14 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~ 93 (359)
T 3vhe_A 14 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLG 93 (359)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeee
Confidence 344445668899999999999999999984 25689999999765433 35688999999999 7899999999
Q ss_pred EEecCC-ceEEEEEeCCCCCHHHHhccCCCCCCC----------------------------------------------
Q 018712 129 YYVDGP-LRVLAYEHASKGSLHDILHGKKGVKGA---------------------------------------------- 161 (351)
Q Consensus 129 ~~~~~~-~~~lv~e~~~~gsL~~~l~~~~~~~~~---------------------------------------------- 161 (351)
++.+.+ ..++||||+.+|+|.+++.........
T Consensus 94 ~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (359)
T 3vhe_A 94 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSL 173 (359)
T ss_dssp EECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC--------------------------------------------
T ss_pred eeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccccc
Confidence 988755 489999999999999999875431100
Q ss_pred -----------CCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccccCCCccccccc
Q 018712 162 -----------KPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARL 230 (351)
Q Consensus 162 -----------~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~ 230 (351)
.....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++..........
T Consensus 174 ~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 250 (359)
T 3vhe_A 174 SDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV 250 (359)
T ss_dssp ----------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCE
T ss_pred chhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeecccccch
Confidence 00122889999999999999999999999 9999999999999999999999999998765443333
Q ss_pred cccccccccCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCCcc-chh--------hcccCCCccchh
Q 018712 231 HSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQS-LVT--------WATPKLSEDKVK 300 (351)
Q Consensus 231 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~Pf~~~~~~~~~~-~~~--------~~~~~~~~~~~~ 300 (351)
......||+.|+|||++.+..++.++||||||+++|+|++ |+.||.......... .+. ...+....+.+.
T Consensus 251 ~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 330 (359)
T 3vhe_A 251 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTML 330 (359)
T ss_dssp EC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHH
T ss_pred hccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCCCCCCCCHHHHHHHH
Confidence 3355678999999999999999999999999999999998 999998754332111 000 001111236788
Q ss_pred hhcccccCCCCCHHHHHHHHHHHHH
Q 018712 301 QCVDTKLGGEYPPKAIAKVRKKKFI 325 (351)
Q Consensus 301 ~~ld~~~~~~~~~~~~~~~~~~~~~ 325 (351)
.|+..+|.+|++.+++...++-.+.
T Consensus 331 ~~l~~dP~~Rps~~ell~~L~~~~~ 355 (359)
T 3vhe_A 331 DCWHGEPSQRPTFSELVEHLGNLLQ 355 (359)
T ss_dssp HHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHccCChhhCCCHHHHHHHHHHHHH
Confidence 9999999999999999887776553
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=311.61 Aligned_cols=247 Identities=21% Similarity=0.366 Sum_probs=206.7
Q ss_pred hcCCCCCceeccCCcEEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEEEeCC
Q 018712 65 TDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHAS 144 (351)
Q Consensus 65 ~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 144 (351)
.++|.+.+.||+|+||.||++.+.++..||+|++.......+.+.+|++++++++||||+++++++.+.+..++||||++
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 86 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFME 86 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCT
T ss_pred hhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCC
Confidence 35788999999999999999999888999999998877777889999999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccccCCCc
Q 018712 145 KGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAP 224 (351)
Q Consensus 145 ~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~ 224 (351)
+++|.+++..... .+++..+..++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++....
T Consensus 87 ~~~L~~~~~~~~~--------~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~ 155 (267)
T 3t9t_A 87 HGCLSDYLRTQRG--------LFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVL 155 (267)
T ss_dssp TCBHHHHHHHTTT--------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBC
T ss_pred CCcHHHHHhhCcc--------cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEcccccccccc
Confidence 9999999986532 2889999999999999999999999 9999999999999999999999999987654
Q ss_pred cccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCCccchhh--------cccCCC
Q 018712 225 DAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTW--------ATPKLS 295 (351)
Q Consensus 225 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~Pf~~~~~~~~~~~~~~--------~~~~~~ 295 (351)
..... ......+|+.|+|||++.+..++.++||||||+++|+|++ |+.||...........+.. ..+...
T Consensus 156 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l 234 (267)
T 3t9t_A 156 DDQYT-SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHV 234 (267)
T ss_dssp CHHHH-STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTSCHHH
T ss_pred ccccc-ccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcCCCCccCcHHH
Confidence 32211 1233457889999999998999999999999999999999 9999986543221111111 111112
Q ss_pred ccchhhhcccccCCCCCHHHHHHHHHHH
Q 018712 296 EDKVKQCVDTKLGGEYPPKAIAKVRKKK 323 (351)
Q Consensus 296 ~~~~~~~ld~~~~~~~~~~~~~~~~~~~ 323 (351)
.+.+..|++.+|.+|++.+++.+.++-.
T Consensus 235 ~~li~~~l~~~p~~Rps~~~ll~~L~~l 262 (267)
T 3t9t_A 235 YQIMNHCWRERPEDRPAFSRLLRQLAEI 262 (267)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 3678999999999999999887765543
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=311.57 Aligned_cols=260 Identities=37% Similarity=0.559 Sum_probs=210.6
Q ss_pred cccccCHHHHHHHhcCCCCC------ceeccCCcEEEEEEEECCCCEEEEEEcCCCC-----CchHHHHHHHHHHHhccC
Q 018712 52 AVPVISVDELKEKTDNFGTN------SLIGEGSYGRVYFGVLRSGRAAAIKKLDSSK-----QPDQEFLAQVSMVSRLKN 120 (351)
Q Consensus 52 ~~~~~~~~~~~~~~~~y~~~------~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-----~~~~~~~~e~~~l~~l~h 120 (351)
..+.++..++...+++|... +.||+|+||.||+|.. +++.||+|++.... ...+.+.+|+.++++++|
T Consensus 11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 89 (307)
T 2nru_A 11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQH 89 (307)
T ss_dssp CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCC
T ss_pred CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCC
Confidence 44667888999998888777 8999999999999987 57899999986532 224678899999999999
Q ss_pred CceeeeEEEEecCCceEEEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeecccc
Q 018712 121 ENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIK 200 (351)
Q Consensus 121 ~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlk 200 (351)
|||+++++++.+.+..++||||+++++|.+++...... ..+++..++.++.||+.||.|||+++ ++|||||
T Consensus 90 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~------~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlk 160 (307)
T 2nru_A 90 ENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGT------PPLSWHMRCKIAQGAANGINFLHENH---HIHRDIK 160 (307)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGC------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCC
T ss_pred CCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCC------CCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCC
Confidence 99999999999999999999999999999999753221 23889999999999999999999999 9999999
Q ss_pred CCcEEEccCCceEEecccccCCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCC
Q 018712 201 SSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (351)
Q Consensus 201 p~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~ 280 (351)
|+||+++.++.+||+|||++................||+.|+|||.+.+ .++.++||||||+++|+|++|+.||.....
T Consensus 161 p~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~ 239 (307)
T 2nru_A 161 SANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHRE 239 (307)
T ss_dssp GGGEEECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBS
T ss_pred HHHEEEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcc
Confidence 9999999999999999999876544332222344579999999998765 588999999999999999999999987544
Q ss_pred CCCccch------------hhcccCC----------CccchhhhcccccCCCCCHHHHHHHHHH
Q 018712 281 RGQQSLV------------TWATPKL----------SEDKVKQCVDTKLGGEYPPKAIAKVRKK 322 (351)
Q Consensus 281 ~~~~~~~------------~~~~~~~----------~~~~~~~~ld~~~~~~~~~~~~~~~~~~ 322 (351)
......+ .+..+.. ..+.+..|+..+|.+|++.+++...++-
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~ 303 (307)
T 2nru_A 240 PQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQE 303 (307)
T ss_dssp SSBTTHHHHHHHTTSCCHHHHSCSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred hHHHHHHHHHhhhhhhhhhhhccccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHH
Confidence 3221111 0111111 1257889999999999999988776653
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=337.50 Aligned_cols=247 Identities=22% Similarity=0.372 Sum_probs=204.5
Q ss_pred HhcCCCCCceeccCCcEEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEEEeC
Q 018712 64 KTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHA 143 (351)
Q Consensus 64 ~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 143 (351)
..++|.+.+.||+|+||.||+|.+.++..||||++.......+.+.+|+.+|++++||||+++++++. .+..++||||+
T Consensus 186 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~ 264 (454)
T 1qcf_A 186 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFM 264 (454)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECCC
T ss_pred chHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCCccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEeec
Confidence 45678889999999999999999988899999999877667788999999999999999999999886 56789999999
Q ss_pred CCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccccCCC
Q 018712 144 SKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQA 223 (351)
Q Consensus 144 ~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~ 223 (351)
.+|+|.+++...... .+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 265 ~~g~L~~~l~~~~~~-------~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~~ 334 (454)
T 1qcf_A 265 AKGSLLDFLKSDEGS-------KQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVI 334 (454)
T ss_dssp TTCBHHHHHHSHHHH-------TCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGGGGB
T ss_pred CCCcHHHHHHhccCC-------CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCceEc
Confidence 999999999754311 2788999999999999999999999 999999999999999999999999999876
Q ss_pred ccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCCccchhh--------cccCC
Q 018712 224 PDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTW--------ATPKL 294 (351)
Q Consensus 224 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~Pf~~~~~~~~~~~~~~--------~~~~~ 294 (351)
...... ......+|+.|+|||++.+..++.++||||||+++|||++ |+.||...........+.. ..+..
T Consensus 335 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 413 (454)
T 1qcf_A 335 EDNEYT-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEE 413 (454)
T ss_dssp CCHHHH-TTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCCCCTTSCHH
T ss_pred CCCcee-ccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHH
Confidence 433211 1123446788999999998999999999999999999999 9999986543322111111 11111
Q ss_pred CccchhhhcccccCCCCCHHHHHHHHHH
Q 018712 295 SEDKVKQCVDTKLGGEYPPKAIAKVRKK 322 (351)
Q Consensus 295 ~~~~~~~~ld~~~~~~~~~~~~~~~~~~ 322 (351)
..+.+..|++.+|.+|++.+++...++-
T Consensus 414 l~~li~~cl~~dp~~RPt~~~i~~~L~~ 441 (454)
T 1qcf_A 414 LYNIMMRCWKNRPEERPTFEYIQSVLDD 441 (454)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred HHHHHHHHccCChhHCcCHHHHHHHHHH
Confidence 2367899999999999999998776653
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-43 Score=324.77 Aligned_cols=249 Identities=17% Similarity=0.144 Sum_probs=195.2
Q ss_pred HhcCCCCCceeccCCcEEEEEEE------ECCCCEEEEEEcCCCCCchHHHHHHHHHHHhcc---CCceeeeEEEEecCC
Q 018712 64 KTDNFGTNSLIGEGSYGRVYFGV------LRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLK---NENVVELVGYYVDGP 134 (351)
Q Consensus 64 ~~~~y~~~~~Lg~G~~g~Vy~~~------~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~ 134 (351)
..++|.+.+.||+|+||.||+|. ..+++.||+|++... ....+..|.+++++++ |+||+++++++...+
T Consensus 63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~ 140 (365)
T 3e7e_A 63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA--NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQN 140 (365)
T ss_dssp SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC--CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSS
T ss_pred CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC--ChhHHHHHHHHHHHhhhhhhhhhhhhheeeecCC
Confidence 45679999999999999999994 447899999999754 3556788888888886 899999999999999
Q ss_pred ceEEEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEcc------
Q 018712 135 LRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFD------ 208 (351)
Q Consensus 135 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~------ 208 (351)
..++||||+++|+|.+++...... ....+++..++.++.||+.||.|||+++ |+||||||+|||++.
T Consensus 141 ~~~lv~e~~~~g~L~~~l~~~~~~----~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~~~~ 213 (365)
T 3e7e_A 141 GSVLVGELYSYGTLLNAINLYKNT----PEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQD 213 (365)
T ss_dssp CEEEEECCCCSCBHHHHHHHHHTS----TTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGTCC-
T ss_pred CcEEEEeccCCCcHHHHHHHhhcc----cccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccccCcc
Confidence 999999999999999999753211 0123899999999999999999999999 999999999999998
Q ss_pred -----CCceEEecccccCCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCC
Q 018712 209 -----DDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQ 283 (351)
Q Consensus 209 -----~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~ 283 (351)
++.+||+|||+++...............||+.|+|||++.+..++.++||||||+++|||++|+.||.......
T Consensus 214 ~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~- 292 (365)
T 3e7e_A 214 DEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE- 292 (365)
T ss_dssp -----CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE-
T ss_pred ccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCc-
Confidence 89999999999965432222223355679999999999999999999999999999999999999997543211
Q ss_pred ccchhhcc----cCCCccchhhhcccccCCCCC-HHHHHHHHHH
Q 018712 284 QSLVTWAT----PKLSEDKVKQCVDTKLGGEYP-PKAIAKVRKK 322 (351)
Q Consensus 284 ~~~~~~~~----~~~~~~~~~~~ld~~~~~~~~-~~~~~~~~~~ 322 (351)
........ +....+.+..|+...+..|++ .+++...++-
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~ 336 (365)
T 3e7e_A 293 CKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKK 336 (365)
T ss_dssp EEECSCCTTCSSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHH
T ss_pred eeechhccccCcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHH
Confidence 11111111 111235666788888888864 4454444443
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-44 Score=329.56 Aligned_cols=234 Identities=20% Similarity=0.260 Sum_probs=188.7
Q ss_pred CceeccCCcEEEEEEEEC-CCCEEEEEEcCCCC-CchHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEEEeCCCCCH
Q 018712 71 NSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK-QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSL 148 (351)
Q Consensus 71 ~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL 148 (351)
.+.||+|+||.||+|... +++.||+|++.... ...+.+.+|++++++++||||+++++++.+.+..++||||+++++|
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L 173 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL 173 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence 567999999999999975 78999999987654 2356788999999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEE--ccCCceEEecccccCCCccc
Q 018712 149 HDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLL--FDDDIAKISDFDLSNQAPDA 226 (351)
Q Consensus 149 ~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill--~~~~~vkl~Dfg~a~~~~~~ 226 (351)
.+++..... .+++..++.++.||+.||.|||+++ |+||||||+|||+ +.++.+||+|||+++.....
T Consensus 174 ~~~l~~~~~--------~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~ 242 (373)
T 2x4f_A 174 FDRIIDESY--------NLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPR 242 (373)
T ss_dssp HHHHHHTGG--------GCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTT
T ss_pred HHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCCc
Confidence 998875432 2889999999999999999999999 9999999999999 55678999999999766433
Q ss_pred cccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccchhh--------cccCC---C
Q 018712 227 AARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTW--------ATPKL---S 295 (351)
Q Consensus 227 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~~~--------~~~~~---~ 295 (351)
.. .....||+.|+|||++.+..++.++||||||+++|+|++|+.||...........+.. ..+.+ .
T Consensus 243 ~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 319 (373)
T 2x4f_A 243 EK---LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEA 319 (373)
T ss_dssp CB---CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGGGTTSCHHH
T ss_pred cc---cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhhhccCCHHH
Confidence 22 2345699999999999988999999999999999999999999987543221111110 01111 2
Q ss_pred ccchhhhcccccCCCCCHHHHHH
Q 018712 296 EDKVKQCVDTKLGGEYPPKAIAK 318 (351)
Q Consensus 296 ~~~~~~~ld~~~~~~~~~~~~~~ 318 (351)
.+.+..|+..+|.+|++.+++..
T Consensus 320 ~~li~~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 320 KEFISKLLIKEKSWRISASEALK 342 (373)
T ss_dssp HHHHHTTSCSSGGGSCCHHHHHH
T ss_pred HHHHHHHcCCChhhCCCHHHHhc
Confidence 36889999999999999877654
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-43 Score=325.21 Aligned_cols=251 Identities=23% Similarity=0.372 Sum_probs=194.3
Q ss_pred hcCCCCCceeccCCcEEEEEEEEC----CCCEEEEEEcCCCCCc--hHHHHHHHHHHHhccCCceeeeEEEEecCCceEE
Q 018712 65 TDNFGTNSLIGEGSYGRVYFGVLR----SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVL 138 (351)
Q Consensus 65 ~~~y~~~~~Lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 138 (351)
.++|.+.+.||+|+||.||+|.+. ++..||||++...... .+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 123 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI 123 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence 458999999999999999999864 5778999999765432 3568899999999999999999999999999999
Q ss_pred EEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEeccc
Q 018712 139 AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFD 218 (351)
Q Consensus 139 v~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg 218 (351)
||||+++|+|.+++..... .+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||
T Consensus 124 v~e~~~~~sL~~~l~~~~~--------~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg 192 (373)
T 2qol_A 124 VTEYMENGSLDSFLRKHDA--------QFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFG 192 (373)
T ss_dssp EEECCTTCBHHHHHHTTTT--------CSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-
T ss_pred EEeCCCCCcHHHHHHhCCC--------CCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCc
Confidence 9999999999999976532 2899999999999999999999999 9999999999999999999999999
Q ss_pred ccCCCccccccc-cccccccccCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCCccchhh-------
Q 018712 219 LSNQAPDAAARL-HSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTW------- 289 (351)
Q Consensus 219 ~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~Pf~~~~~~~~~~~~~~------- 289 (351)
+++......... ......+|+.|+|||++.+..++.++||||||+++|||++ |+.||...........+..
T Consensus 193 ~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~~~~~ 272 (373)
T 2qol_A 193 LGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPP 272 (373)
T ss_dssp ---------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEECCCC
T ss_pred cccccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCC
Confidence 998765432211 1122345778999999999999999999999999999998 9999976543222111111
Q ss_pred -cccCCCccchhhhcccccCCCCCHHHHHHHHHHHHHh
Q 018712 290 -ATPKLSEDKVKQCVDTKLGGEYPPKAIAKVRKKKFIT 326 (351)
Q Consensus 290 -~~~~~~~~~~~~~ld~~~~~~~~~~~~~~~~~~~~~~ 326 (351)
..+....+.+..|+..++.+|++.+++...++-.+..
T Consensus 273 ~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~ 310 (373)
T 2qol_A 273 MDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN 310 (373)
T ss_dssp TTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred ccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhC
Confidence 0111123678899999999999999998887776544
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-44 Score=327.01 Aligned_cols=260 Identities=16% Similarity=0.212 Sum_probs=209.8
Q ss_pred hcCCCCCceeccCCcEEEEEEEECC---------CCEEEEEEcCCCCCchHHHHHHHHHHHhccCCceee----------
Q 018712 65 TDNFGTNSLIGEGSYGRVYFGVLRS---------GRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVE---------- 125 (351)
Q Consensus 65 ~~~y~~~~~Lg~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~---------- 125 (351)
.++|.+.+.||+|+||.||+|.+.. ++.||+|++... ..+.+|++++++++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 116 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPL 116 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT----STHHHHHHHHHHHCCHHHHHHHHHHTTCTT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc----chHHHHHHHHHHhcccchhhhhhhhccCCc
Confidence 4689999999999999999999763 789999998754 35889999999999999987
Q ss_pred -----eEEEEec-CCceEEEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccc
Q 018712 126 -----LVGYYVD-GPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNI 199 (351)
Q Consensus 126 -----~~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dl 199 (351)
+++++.. .+..++||||+ +++|.+++...... .+++..++.++.||+.||.|||+++ |+||||
T Consensus 117 ~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~-------~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Di 185 (352)
T 2jii_A 117 LAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKH-------VLSERSVLQVACRLLDALEFLHENE---YVHGNV 185 (352)
T ss_dssp CSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGG-------CCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCC
T ss_pred cCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcC-------CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCC
Confidence 5666665 67889999999 89999999875211 2899999999999999999999999 999999
Q ss_pred cCCcEEEccCC--ceEEecccccCCCccccccc-----cccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCC
Q 018712 200 KSSNVLLFDDD--IAKISDFDLSNQAPDAAARL-----HSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGR 272 (351)
Q Consensus 200 kp~Nill~~~~--~vkl~Dfg~a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~ 272 (351)
||+|||++.++ .+||+|||+++......... ......||+.|+|||++.+..++.++||||||+++|+|++|+
T Consensus 186 kp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~ 265 (352)
T 2jii_A 186 TAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGF 265 (352)
T ss_dssp CGGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSC
T ss_pred CHHHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCC
Confidence 99999999998 99999999998765432211 113357999999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCc--cchh---h-------------cccCCCccchhhhcccccCCCCCHHHHHHHHHHHHHhhhhccccc
Q 018712 273 KPVDHTLPRGQQ--SLVT---W-------------ATPKLSEDKVKQCVDTKLGGEYPPKAIAKVRKKKFITSECSNISF 334 (351)
Q Consensus 273 ~Pf~~~~~~~~~--~~~~---~-------------~~~~~~~~~~~~~ld~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 334 (351)
.||......... .... . ..+....+.+..|+..+|.+|++.+++...++-. +
T Consensus 266 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~----------~ 335 (352)
T 2jii_A 266 LPWTNCLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEAL----------L 335 (352)
T ss_dssp CTTGGGTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH----------H
T ss_pred CCcccCCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHH----------H
Confidence 999875422111 0000 0 0122224688999999999999999988877654 4
Q ss_pred hhhhhcccCCccccc
Q 018712 335 AEFNINWHCPLEWSV 349 (351)
Q Consensus 335 ~~~~~~~~~~~~w~~ 349 (351)
++.+...++++||..
T Consensus 336 ~~~~~~~~~~~dw~~ 350 (352)
T 2jii_A 336 QDLRVSPYDPIGLPM 350 (352)
T ss_dssp HHTTCCTTSCCCCCC
T ss_pred HhcCCCcCccccCcC
Confidence 556677899999974
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-43 Score=322.91 Aligned_cols=245 Identities=20% Similarity=0.355 Sum_probs=192.4
Q ss_pred hcCCCCCceeccCCcEEEEEEEECCCCEEEEEEcCCCCCc---hHHHHHHHHHHHhccC--CceeeeEEEEecCCceEEE
Q 018712 65 TDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKN--ENVVELVGYYVDGPLRVLA 139 (351)
Q Consensus 65 ~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~h--~niv~~~~~~~~~~~~~lv 139 (351)
.++|++.+.||+|+||.||++.+.+++.||+|++...... ...+.+|+.++++++| +||+++++++.+.+..++|
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 87 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 87 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence 4579999999999999999999888999999998755433 2567899999999976 9999999999999999999
Q ss_pred EEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccc
Q 018712 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDL 219 (351)
Q Consensus 140 ~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~ 219 (351)
|| +.+++|.+++..... +++..+..++.||+.||.|||+++ |+||||||+|||++ ++.+||+|||+
T Consensus 88 ~e-~~~~~L~~~l~~~~~---------~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~ 153 (343)
T 3dbq_A 88 ME-CGNIDLNSWLKKKKS---------IDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGI 153 (343)
T ss_dssp EC-CCSEEHHHHHHHSCC---------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSS
T ss_pred Ee-CCCCCHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeeccc
Confidence 99 567899999987643 889999999999999999999999 99999999999996 67899999999
Q ss_pred cCCCccccccccccccccccCccCcccccC-----------CCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCc--cc
Q 018712 220 SNQAPDAAARLHSTRVLGTFGYHAPEYAMT-----------GQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQ--SL 286 (351)
Q Consensus 220 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~--~~ 286 (351)
++...............||+.|+|||++.+ ..++.++||||||+++|+|++|+.||......... ..
T Consensus 154 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~ 233 (343)
T 3dbq_A 154 ANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAI 233 (343)
T ss_dssp SCCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHH
T ss_pred ccccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHH
Confidence 987754433333345679999999999865 67899999999999999999999999764322100 00
Q ss_pred h----hhccc----CCCccchhhhcccccCCCCCHHHHHHHHHHHHHh
Q 018712 287 V----TWATP----KLSEDKVKQCVDTKLGGEYPPKAIAKVRKKKFIT 326 (351)
Q Consensus 287 ~----~~~~~----~~~~~~~~~~ld~~~~~~~~~~~~~~~~~~~~~~ 326 (351)
+ ....+ ....+.+..|+..+|.+|++.+++. ++.++.
T Consensus 234 ~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l---~hp~~~ 278 (343)
T 3dbq_A 234 IDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELL---AHPYVQ 278 (343)
T ss_dssp HCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHH---TSHHHH
T ss_pred hcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHH---hCcccc
Confidence 0 00111 1123678999999999999887764 455544
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-43 Score=314.25 Aligned_cols=255 Identities=25% Similarity=0.354 Sum_probs=213.6
Q ss_pred HhcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCCchHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEEEe
Q 018712 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEH 142 (351)
Q Consensus 64 ~~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 142 (351)
..++|.+.+.||+|+||.||+|.+. ++..||+|++.......+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 90 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 90 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEEc
Confidence 4567899999999999999999976 588999999987777778899999999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccccCC
Q 018712 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222 (351)
Q Consensus 143 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~ 222 (351)
+.+++|.+++...... .+++..++.++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++..
T Consensus 91 ~~~~~L~~~~~~~~~~-------~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~ 160 (288)
T 3kfa_A 91 MTYGNLLDYLRECNRQ-------EVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRL 160 (288)
T ss_dssp CTTEEHHHHHHHCCTT-------TSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGGT
T ss_pred CCCCcHHHHHHhcccC-------CccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCcccee
Confidence 9999999999864432 2899999999999999999999999 99999999999999999999999999977
Q ss_pred CccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCCccchhhc--------ccC
Q 018712 223 APDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWA--------TPK 293 (351)
Q Consensus 223 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~Pf~~~~~~~~~~~~~~~--------~~~ 293 (351)
....... ......+|+.|+|||.+.+..++.++||||||+++|+|++ |..||...........+... .+.
T Consensus 161 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (288)
T 3kfa_A 161 MTGDTYT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPE 239 (288)
T ss_dssp SCSSSSE-EETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTCCH
T ss_pred ccCCccc-cccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCCCCCCCCCCH
Confidence 6533221 1233457889999999999999999999999999999999 99999876543322222111 111
Q ss_pred CCccchhhhcccccCCCCCHHHHHHHHHHHHHhhhh
Q 018712 294 LSEDKVKQCVDTKLGGEYPPKAIAKVRKKKFITSEC 329 (351)
Q Consensus 294 ~~~~~~~~~ld~~~~~~~~~~~~~~~~~~~~~~~~~ 329 (351)
...+.+..|+..+|.+|++.+++.+.++..+.-...
T Consensus 240 ~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~~~~ 275 (288)
T 3kfa_A 240 KVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSI 275 (288)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHhccc
Confidence 123688999999999999999998888777655443
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=323.41 Aligned_cols=258 Identities=24% Similarity=0.340 Sum_probs=204.9
Q ss_pred HHhcCCCCCceeccCCcEEEEEEEEC------CCCEEEEEEcCCCCCc--hHHHHHHHHHHHhccCCceeeeEEEEecCC
Q 018712 63 EKTDNFGTNSLIGEGSYGRVYFGVLR------SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGP 134 (351)
Q Consensus 63 ~~~~~y~~~~~Lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~ 134 (351)
...++|.+.+.||+|+||.||+|.+. +++.||+|++...... ...+.+|+.++++++||||+++++++.+.+
T Consensus 44 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 123 (343)
T 1luf_A 44 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGK 123 (343)
T ss_dssp CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred ecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCC
Confidence 35678999999999999999999974 3478999999765432 356889999999999999999999999999
Q ss_pred ceEEEEEeCCCCCHHHHhccCCCCCC---------------CCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccc
Q 018712 135 LRVLAYEHASKGSLHDILHGKKGVKG---------------AKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNI 199 (351)
Q Consensus 135 ~~~lv~e~~~~gsL~~~l~~~~~~~~---------------~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dl 199 (351)
..++||||+++|+|.+++........ ......+++..++.++.||+.||.|||+++ |+||||
T Consensus 124 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dl 200 (343)
T 1luf_A 124 PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDL 200 (343)
T ss_dssp SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCC
T ss_pred ceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCC
Confidence 99999999999999999986432100 001134899999999999999999999999 999999
Q ss_pred cCCcEEEccCCceEEecccccCCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCC
Q 018712 200 KSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHT 278 (351)
Q Consensus 200 kp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~Pf~~~ 278 (351)
||+|||++.++.+||+|||++................+|+.|+|||++.+..++.++||||||+++|+|++ |..||...
T Consensus 201 kp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~ 280 (343)
T 1luf_A 201 ATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGM 280 (343)
T ss_dssp SGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred CcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCC
Confidence 99999999999999999999876543322222244568899999999999999999999999999999999 99999865
Q ss_pred CCCCCccchh--------hcccCCCccchhhhcccccCCCCCHHHHHHHHHHH
Q 018712 279 LPRGQQSLVT--------WATPKLSEDKVKQCVDTKLGGEYPPKAIAKVRKKK 323 (351)
Q Consensus 279 ~~~~~~~~~~--------~~~~~~~~~~~~~~ld~~~~~~~~~~~~~~~~~~~ 323 (351)
........+. ...+....+.+..|+..+|.+|++.+++...++-.
T Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~ 333 (343)
T 1luf_A 281 AHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRM 333 (343)
T ss_dssp CHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred ChHHHHHHHhCCCcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHH
Confidence 4322111111 11111223688999999999999999887776543
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-43 Score=319.44 Aligned_cols=207 Identities=24% Similarity=0.365 Sum_probs=161.9
Q ss_pred HhcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCC--CchHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEE
Q 018712 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK--QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAY 140 (351)
Q Consensus 64 ~~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 140 (351)
..++|++.+.||+|+||.||+|.+. +++.||+|++.... .....+.+|+.++++++||||+++++++.+.+..++||
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 82 (317)
T 2pmi_A 3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVF 82 (317)
T ss_dssp ----------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEE
T ss_pred cccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEE
Confidence 3568999999999999999999965 68999999986543 23467889999999999999999999999999999999
Q ss_pred EeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEeccccc
Q 018712 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (351)
Q Consensus 141 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a 220 (351)
||+.+ +|.+++....... ....+++..+..++.||+.||.|||++| |+||||||+|||++.++.+||+|||++
T Consensus 83 e~~~~-~L~~~l~~~~~~~---~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~ 155 (317)
T 2pmi_A 83 EFMDN-DLKKYMDSRTVGN---TPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLA 155 (317)
T ss_dssp ECCCC-BHHHHHHHHHSSS---CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSC
T ss_pred EecCC-CHHHHHHhccccc---cccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCccc
Confidence 99984 9999987543211 1123889999999999999999999999 999999999999999999999999998
Q ss_pred CCCccccccccccccccccCccCcccccCC-CCCccchhHhHHHHHHHHHcCCCCCCCCC
Q 018712 221 NQAPDAAARLHSTRVLGTFGYHAPEYAMTG-QMSSKSDVYSFGVVLLELLTGRKPVDHTL 279 (351)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~Pf~~~~ 279 (351)
......... .....||+.|+|||++.+. .++.++||||||+++|+|++|+.||....
T Consensus 156 ~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 213 (317)
T 2pmi_A 156 RAFGIPVNT--FSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTN 213 (317)
T ss_dssp EETTSCCCC--CCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred eecCCCccc--CCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 765432211 2345689999999998764 68999999999999999999999997654
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=335.88 Aligned_cols=240 Identities=23% Similarity=0.304 Sum_probs=200.5
Q ss_pred HhcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCC----CchHHHHHHHHHHHhccCCceeeeEEEEecCCceEE
Q 018712 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK----QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVL 138 (351)
Q Consensus 64 ~~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 138 (351)
..++|.+.+.||+|+||.||+|.+. +|+.||+|++.... .....+.+|+.+++.++||||+++++++.+.+..|+
T Consensus 14 ~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~l 93 (476)
T 2y94_A 14 KIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFM 93 (476)
T ss_dssp EETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred eecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 3468999999999999999999976 79999999986432 224568899999999999999999999999999999
Q ss_pred EEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEeccc
Q 018712 139 AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFD 218 (351)
Q Consensus 139 v~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg 218 (351)
||||+++|+|.+++..... +++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||
T Consensus 94 v~E~~~gg~L~~~l~~~~~---------l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG 161 (476)
T 2y94_A 94 VMEYVSGGELFDYICKNGR---------LDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFG 161 (476)
T ss_dssp EEECCSSEEHHHHTTSSSS---------CCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCS
T ss_pred EEeCCCCCcHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEecc
Confidence 9999999999999976542 899999999999999999999999 9999999999999999999999999
Q ss_pred ccCCCccccccccccccccccCccCcccccCCCC-CccchhHhHHHHHHHHHcCCCCCCCCCCCCCccchhhc-------
Q 018712 219 LSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQM-SSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWA------- 290 (351)
Q Consensus 219 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~~~~------- 290 (351)
++........ ....+||+.|+|||++.+..+ +.++||||||+++|+|++|+.||...........+...
T Consensus 162 ~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~ 238 (476)
T 2y94_A 162 LSNMMSDGEF---LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQY 238 (476)
T ss_dssp SCEECCTTCC---BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCCCCCTT
T ss_pred chhhcccccc---ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCcCCCcc
Confidence 9976644321 244579999999999988776 78999999999999999999999865432221111111
Q ss_pred ccCCCccchhhhcccccCCCCCHHHHHH
Q 018712 291 TPKLSEDKVKQCVDTKLGGEYPPKAIAK 318 (351)
Q Consensus 291 ~~~~~~~~~~~~ld~~~~~~~~~~~~~~ 318 (351)
.+....+.+..|+..+|.+|++.+++..
T Consensus 239 ~s~~~~~Li~~~L~~dP~~Rpt~~eil~ 266 (476)
T 2y94_A 239 LNPSVISLLKHMLQVDPMKRATIKDIRE 266 (476)
T ss_dssp CCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence 1111236889999999999999887644
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-43 Score=315.92 Aligned_cols=197 Identities=21% Similarity=0.368 Sum_probs=169.9
Q ss_pred cCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCCc---hHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEEE
Q 018712 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYE 141 (351)
Q Consensus 66 ~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 141 (351)
++|++.+.||+|+||.||+|.+. +++.||+|++...... ...+.+|+.++++++||||+++++++.+++..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 57999999999999999999975 6899999998754332 3668899999999999999999999999999999999
Q ss_pred eCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccccC
Q 018712 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (351)
Q Consensus 142 ~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~ 221 (351)
|+.+ +|.+++..... .+++..+..++.|++.||.|||++| |+||||||+|||++.++.+||+|||++.
T Consensus 82 ~~~~-~l~~~~~~~~~--------~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~ 149 (292)
T 3o0g_A 82 FCDQ-DLKKYFDSCNG--------DLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLAR 149 (292)
T ss_dssp CCSE-EHHHHHHHTTT--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred cCCC-CHHHHHHhCCC--------CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccce
Confidence 9986 66666654322 2899999999999999999999999 9999999999999999999999999997
Q ss_pred CCccccccccccccccccCccCcccccCCC-CCccchhHhHHHHHHHHHcCCCCCC
Q 018712 222 QAPDAAARLHSTRVLGTFGYHAPEYAMTGQ-MSSKSDVYSFGVVLLELLTGRKPVD 276 (351)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~el~tg~~Pf~ 276 (351)
........ .....||+.|+|||++.+.. ++.++||||||+++|+|++|..||.
T Consensus 150 ~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~ 203 (292)
T 3o0g_A 150 AFGIPVRC--YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLF 203 (292)
T ss_dssp ECCSCCSC--CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSC
T ss_pred ecCCcccc--ccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCc
Confidence 65432221 24457899999999998765 7999999999999999999888864
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-43 Score=317.98 Aligned_cols=240 Identities=24% Similarity=0.352 Sum_probs=200.5
Q ss_pred HhcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCC-------chHHHHHHHHHHHhccCCceeeeEEEEecCCc
Q 018712 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ-------PDQEFLAQVSMVSRLKNENVVELVGYYVDGPL 135 (351)
Q Consensus 64 ~~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 135 (351)
..++|.+.+.||+|+||.||+|.+. +++.||+|++..... ..+.+.+|+.+++.++||||+++++++.+.+.
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 89 (321)
T 2a2a_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTD 89 (321)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred hhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCE
Confidence 3467999999999999999999976 689999999864332 24678999999999999999999999999999
Q ss_pred eEEEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCC----c
Q 018712 136 RVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD----I 211 (351)
Q Consensus 136 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~----~ 211 (351)
.++||||+.+++|.+++..... +++..++.++.|++.||.|||++| ++||||||+||+++.++ .
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~~---------~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~ 157 (321)
T 2a2a_A 90 VVLILELVSGGELFDFLAQKES---------LSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPH 157 (321)
T ss_dssp EEEEECCCCSCBHHHHHHTCSC---------EEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCC
T ss_pred EEEEEEcCCCCcHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCC
Confidence 9999999999999999976542 899999999999999999999999 99999999999999888 7
Q ss_pred eEEecccccCCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccchhh--
Q 018712 212 AKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTW-- 289 (351)
Q Consensus 212 vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~~~-- 289 (351)
+||+|||++........ .....||+.|+|||++.+..++.++||||||+++|+|++|+.||...........+..
T Consensus 158 ~kl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~ 234 (321)
T 2a2a_A 158 IKLIDFGLAHEIEDGVE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVS 234 (321)
T ss_dssp EEECCCTTCEECCTTCC---CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTC
T ss_pred EEEccCccceecCcccc---ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcc
Confidence 99999999876654322 2345699999999999999999999999999999999999999976543221111111
Q ss_pred ---------cccCCCccchhhhcccccCCCCCHHHHHH
Q 018712 290 ---------ATPKLSEDKVKQCVDTKLGGEYPPKAIAK 318 (351)
Q Consensus 290 ---------~~~~~~~~~~~~~ld~~~~~~~~~~~~~~ 318 (351)
..+....+.+..|+..+|.+|++.+++..
T Consensus 235 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~ 272 (321)
T 2a2a_A 235 YDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALR 272 (321)
T ss_dssp CCCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred cccChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 11112246889999999999999887654
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-43 Score=315.74 Aligned_cols=240 Identities=23% Similarity=0.323 Sum_probs=192.1
Q ss_pred HhcCCCCCceeccCCcEEEEEEEE-CCCCEEEEEEcCCCC------CchHHHHHHHHHHHhcc---CCceeeeEEEEecC
Q 018712 64 KTDNFGTNSLIGEGSYGRVYFGVL-RSGRAAAIKKLDSSK------QPDQEFLAQVSMVSRLK---NENVVELVGYYVDG 133 (351)
Q Consensus 64 ~~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~------~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~ 133 (351)
..++|++.+.||+|+||.||+|.+ .+++.||+|++.... .....+.+|+.++++++ ||||+++++++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 457899999999999999999996 478999999986322 12346778888877775 99999999998765
Q ss_pred C-----ceEEEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEcc
Q 018712 134 P-----LRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFD 208 (351)
Q Consensus 134 ~-----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~ 208 (351)
. ..++|||++.+ +|.+++...... .+++..++.++.||+.||.|||+++ |+||||||+|||++.
T Consensus 87 ~~~~~~~~~lv~e~~~~-~L~~~~~~~~~~-------~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~ 155 (308)
T 3g33_A 87 RTDREIKVTLVFEHVDQ-DLRTYLDKAPPP-------GLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTS 155 (308)
T ss_dssp CSSSEEEEEEEEECCCC-BHHHHHHTCCTT-------CSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECT
T ss_pred CCCCceeEEEEehhhhc-CHHHHHhhccCC-------CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcC
Confidence 5 57999999974 999999876432 2899999999999999999999999 999999999999999
Q ss_pred CCceEEecccccCCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccchh
Q 018712 209 DDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVT 288 (351)
Q Consensus 209 ~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~~ 288 (351)
++.+||+|||+++....... .....||+.|+|||++.+..++.++||||||+++|+|++|+.||...........+.
T Consensus 156 ~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~ 232 (308)
T 3g33_A 156 GGTVKLADFGLARIYSYQMA---LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIF 232 (308)
T ss_dssp TSCEEECSCSCTTTSTTCCC---SGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHH
T ss_pred CCCEEEeeCccccccCCCcc---cCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 99999999999986643322 245678999999999999999999999999999999999999997654322111110
Q ss_pred -------------------------------hcccCCC---ccchhhhcccccCCCCCHHHHH
Q 018712 289 -------------------------------WATPKLS---EDKVKQCVDTKLGGEYPPKAIA 317 (351)
Q Consensus 289 -------------------------------~~~~~~~---~~~~~~~ld~~~~~~~~~~~~~ 317 (351)
...+... .+.+..|+..+|.+|++++++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l 295 (308)
T 3g33_A 233 DLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRAL 295 (308)
T ss_dssp HHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred HHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHh
Confidence 0011111 2578899999999999887753
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=329.70 Aligned_cols=242 Identities=28% Similarity=0.432 Sum_probs=200.7
Q ss_pred hcCCCCCceeccCCcEEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHHhccCCceeeeEEEEecCC-ceEEEEEeC
Q 018712 65 TDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGP-LRVLAYEHA 143 (351)
Q Consensus 65 ~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-~~~lv~e~~ 143 (351)
.++|.+.+.||+|+||.||+|.+. ++.||||++.... ..+.+.+|+.+|++++||||+++++++.+.+ ..++||||+
T Consensus 192 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~ 269 (450)
T 1k9a_A 192 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 269 (450)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT-TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECC
T ss_pred hHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch-HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEec
Confidence 467888999999999999999885 7799999997654 4567999999999999999999999987655 789999999
Q ss_pred CCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccccCCC
Q 018712 144 SKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQA 223 (351)
Q Consensus 144 ~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~ 223 (351)
.+|+|.+++...... .++...++.++.||+.||.|||+++ ++||||||+|||++.++.+||+|||+++..
T Consensus 270 ~~g~L~~~l~~~~~~-------~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~ 339 (450)
T 1k9a_A 270 AKGSLVDYLRSRGRS-------VLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEA 339 (450)
T ss_dssp TTCBHHHHHHHHCTT-------TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred CCCcHHHHHHhcCCC-------CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCcccc
Confidence 999999999865421 2788999999999999999999999 999999999999999999999999998754
Q ss_pred ccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCCccchhhc--------ccCC
Q 018712 224 PDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWA--------TPKL 294 (351)
Q Consensus 224 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~Pf~~~~~~~~~~~~~~~--------~~~~ 294 (351)
.... ....+++.|+|||.+.+..++.++||||||+++|||++ |+.||...........+... .+..
T Consensus 340 ~~~~-----~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~p~~~~~~ 414 (450)
T 1k9a_A 340 SSTQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPA 414 (450)
T ss_dssp C-----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCCCCCCTTCCHH
T ss_pred cccc-----cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHH
Confidence 3221 22357889999999999999999999999999999998 99999876544322222111 1111
Q ss_pred CccchhhhcccccCCCCCHHHHHHHHHHH
Q 018712 295 SEDKVKQCVDTKLGGEYPPKAIAKVRKKK 323 (351)
Q Consensus 295 ~~~~~~~~ld~~~~~~~~~~~~~~~~~~~ 323 (351)
..+.+..|+..+|.+|++.+++...++..
T Consensus 415 l~~li~~cl~~dp~~Rpt~~~l~~~L~~i 443 (450)
T 1k9a_A 415 VYDVMKNCWHLDAATRPTFLQLREQLEHI 443 (450)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 23678999999999999999988776654
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-43 Score=319.91 Aligned_cols=248 Identities=23% Similarity=0.343 Sum_probs=195.6
Q ss_pred hcCCCCCceeccCCcEEEEEEEEC-CCC----EEEEEEcCCCC--CchHHHHHHHHHHHhccCCceeeeEEEEecCCceE
Q 018712 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGR----AAAIKKLDSSK--QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRV 137 (351)
Q Consensus 65 ~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 137 (351)
.++|++.+.||+|+||.||+|.+. +++ .||+|.+.... .....+.+|+.++++++||||+++++++.+.. .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~ 92 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EE
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eE
Confidence 467999999999999999999964 444 46888875432 34567899999999999999999999998764 78
Q ss_pred EEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecc
Q 018712 138 LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDF 217 (351)
Q Consensus 138 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Df 217 (351)
+++|++.+|+|.+++..... .+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+||
T Consensus 93 ~v~e~~~~g~L~~~l~~~~~--------~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Df 161 (327)
T 3poz_A 93 LITQLMPFGCLLDYVREHKD--------NIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDF 161 (327)
T ss_dssp EEEECCTTCBHHHHHHHSTT--------SCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCT
T ss_pred EEEEecCCCcHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccC
Confidence 89999999999999987542 2899999999999999999999999 999999999999999999999999
Q ss_pred cccCCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCCccchhhcc-----
Q 018712 218 DLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWAT----- 291 (351)
Q Consensus 218 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~----- 291 (351)
|+++...............+|+.|+|||++.+..++.++||||||+++|||++ |+.||...........+....
T Consensus 162 g~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~ 241 (327)
T 3poz_A 162 GLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQP 241 (327)
T ss_dssp THHHHHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCC
T ss_pred cceeEccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCCCCCC
Confidence 99876543333322344557889999999999999999999999999999999 999998765433222222111
Q ss_pred ---cCCCccchhhhcccccCCCCCHHHHHHHHHHHH
Q 018712 292 ---PKLSEDKVKQCVDTKLGGEYPPKAIAKVRKKKF 324 (351)
Q Consensus 292 ---~~~~~~~~~~~ld~~~~~~~~~~~~~~~~~~~~ 324 (351)
+......+..|+..+|.+|++.+++...++...
T Consensus 242 ~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~ 277 (327)
T 3poz_A 242 PICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 277 (327)
T ss_dssp TTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHH
T ss_pred ccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 111126788999999999999998877665543
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-43 Score=318.93 Aligned_cols=256 Identities=21% Similarity=0.296 Sum_probs=189.3
Q ss_pred HhcCCCCCceeccCCcEEEEEEEECC-C---CEEEEEEcCCCC---CchHHHHHHHHHHHhccCCceeeeEEEEecCCce
Q 018712 64 KTDNFGTNSLIGEGSYGRVYFGVLRS-G---RAAAIKKLDSSK---QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLR 136 (351)
Q Consensus 64 ~~~~y~~~~~Lg~G~~g~Vy~~~~~~-~---~~vavK~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 136 (351)
..++|.+.+.||+|+||.||+|.+.. + ..||+|++.... ...+.+.+|++++++++||||+++++++......
T Consensus 21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 100 (323)
T 3qup_A 21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAK 100 (323)
T ss_dssp C---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC---
T ss_pred ChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccc
Confidence 34689999999999999999999653 3 279999987543 2346788999999999999999999999877655
Q ss_pred ------EEEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCC
Q 018712 137 ------VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD 210 (351)
Q Consensus 137 ------~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~ 210 (351)
++||||+.+|+|.+++....... ....+++..++.++.||+.||.|||++| ++||||||+|||++.++
T Consensus 101 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~---~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~~~ 174 (323)
T 3qup_A 101 GRLPIPMVILPFMKHGDLHAFLLASRIGE---NPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDM 174 (323)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHHHC------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTS
T ss_pred cCCCccEEEEEeccCCcHHHHHHhhhccc---cccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcCCC
Confidence 99999999999999996543211 1123889999999999999999999999 99999999999999999
Q ss_pred ceEEecccccCCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCCccchhh
Q 018712 211 IAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTW 289 (351)
Q Consensus 211 ~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~Pf~~~~~~~~~~~~~~ 289 (351)
.+||+|||+++...............+|+.|+|||.+.+..++.++||||||+++|+|++ |+.||...........+..
T Consensus 175 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~ 254 (323)
T 3qup_A 175 TVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIG 254 (323)
T ss_dssp CEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHT
T ss_pred CEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhc
Confidence 999999999987654433222334457889999999999999999999999999999999 9999987654332211111
Q ss_pred -----cccCC---CccchhhhcccccCCCCCHHHHHHHHHHHHH
Q 018712 290 -----ATPKL---SEDKVKQCVDTKLGGEYPPKAIAKVRKKKFI 325 (351)
Q Consensus 290 -----~~~~~---~~~~~~~~ld~~~~~~~~~~~~~~~~~~~~~ 325 (351)
..+.. ..+.+..|+..+|.+|++..++.+.++-.+.
T Consensus 255 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~ 298 (323)
T 3qup_A 255 GNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILG 298 (323)
T ss_dssp TCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 11111 2368899999999999999888777665543
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-43 Score=337.22 Aligned_cols=249 Identities=25% Similarity=0.356 Sum_probs=208.0
Q ss_pred HhcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCCchHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEEEe
Q 018712 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEH 142 (351)
Q Consensus 64 ~~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 142 (351)
..++|.+.+.||+|+||.||+|.+. ++..||||++.......+.+.+|+.+|++++||||+++++++.+.+..++||||
T Consensus 218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~ 297 (495)
T 1opk_A 218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 297 (495)
T ss_dssp CGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred CHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEc
Confidence 3457888999999999999999986 488999999987766778899999999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccccCC
Q 018712 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222 (351)
Q Consensus 143 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~ 222 (351)
+.+|+|.+++...... .+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 298 ~~~g~L~~~l~~~~~~-------~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~ 367 (495)
T 1opk_A 298 MTYGNLLDYLRECNRQ-------EVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRL 367 (495)
T ss_dssp CTTCBHHHHHHHSCTT-------TSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEEC
T ss_pred cCCCCHHHHHHhcCcC-------CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeeccccee
Confidence 9999999999864322 2889999999999999999999999 99999999999999999999999999987
Q ss_pred CccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCCccchhhc--------ccC
Q 018712 223 APDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWA--------TPK 293 (351)
Q Consensus 223 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~Pf~~~~~~~~~~~~~~~--------~~~ 293 (351)
....... ......+|+.|+|||++.+..++.++||||||+++|||++ |..||...........+... .+.
T Consensus 368 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 446 (495)
T 1opk_A 368 MTGDTYT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPE 446 (495)
T ss_dssp CTTCCEE-CCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTCCH
T ss_pred ccCCcee-ecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCH
Confidence 6433221 1233456789999999999999999999999999999999 99999876543322222111 111
Q ss_pred CCccchhhhcccccCCCCCHHHHHHHHHHH
Q 018712 294 LSEDKVKQCVDTKLGGEYPPKAIAKVRKKK 323 (351)
Q Consensus 294 ~~~~~~~~~ld~~~~~~~~~~~~~~~~~~~ 323 (351)
...+.+..|+..+|.+|++.+++...++-.
T Consensus 447 ~l~~li~~cl~~dP~~RPs~~el~~~L~~~ 476 (495)
T 1opk_A 447 KVYELMRACWQWNPSDRPSFAEIHQAFETM 476 (495)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred HHHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence 123678999999999999999998776544
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-44 Score=323.41 Aligned_cols=241 Identities=22% Similarity=0.342 Sum_probs=188.9
Q ss_pred HhcCCCCCceeccCCcEEEEEEEE-CCCCEEEEEEcCCCCCc----hHHHHHHHHHHHhccCCceeeeEEEEecCCc---
Q 018712 64 KTDNFGTNSLIGEGSYGRVYFGVL-RSGRAAAIKKLDSSKQP----DQEFLAQVSMVSRLKNENVVELVGYYVDGPL--- 135 (351)
Q Consensus 64 ~~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~--- 135 (351)
..++|++.+.||+|+||.||+|.+ .+++.||+|++...... ...+.+|+.++++++||||+++++++.....
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~ 89 (311)
T 3ork_A 10 LSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP 89 (311)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEE
T ss_pred ecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCc
Confidence 357899999999999999999997 47899999999765432 2457889999999999999999999876543
Q ss_pred -eEEEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEE
Q 018712 136 -RVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKI 214 (351)
Q Consensus 136 -~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl 214 (351)
.|+||||+++++|.+++..... +++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||
T Consensus 90 ~~~lv~e~~~g~~L~~~l~~~~~---------~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl 157 (311)
T 3ork_A 90 LPYIVMEYVDGVTLRDIVHTEGP---------MTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKV 157 (311)
T ss_dssp EEEEEEECCCEEEHHHHHHHHCS---------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEE
T ss_pred ccEEEEecCCCCCHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEE
Confidence 4999999999999999976542 899999999999999999999999 999999999999999999999
Q ss_pred ecccccCCCcccccc-ccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccchh-----
Q 018712 215 SDFDLSNQAPDAAAR-LHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVT----- 288 (351)
Q Consensus 215 ~Dfg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~~----- 288 (351)
+|||++......... .......||+.|+|||++.+..++.++||||||+++|+|++|+.||.............
T Consensus 158 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~ 237 (311)
T 3ork_A 158 MDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPI 237 (311)
T ss_dssp CCCSCC------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCC
T ss_pred eeccCcccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCC
Confidence 999999876443221 12234568999999999999999999999999999999999999998654322111000
Q ss_pred ---hc---ccCCCccchhhhcccccCCCCCHHHH
Q 018712 289 ---WA---TPKLSEDKVKQCVDTKLGGEYPPKAI 316 (351)
Q Consensus 289 ---~~---~~~~~~~~~~~~ld~~~~~~~~~~~~ 316 (351)
.. .+....+.+..|+..+|.+|++..+.
T Consensus 238 ~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~ 271 (311)
T 3ork_A 238 PPSARHEGLSADLDAVVLKALAKNPENRYQTAAE 271 (311)
T ss_dssp CHHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHH
T ss_pred CcccccCCCCHHHHHHHHHHHhcCHhhChhhHHH
Confidence 00 11112367899999999999975554
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=323.18 Aligned_cols=241 Identities=20% Similarity=0.295 Sum_probs=198.7
Q ss_pred HHhcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCC---------chHHHHHHHHHHHhccCCceeeeEEEEec
Q 018712 63 EKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ---------PDQEFLAQVSMVSRLKNENVVELVGYYVD 132 (351)
Q Consensus 63 ~~~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---------~~~~~~~e~~~l~~l~h~niv~~~~~~~~ 132 (351)
...++|.+.+.||+|+||.||+|.+. +++.||+|++..... ....+.+|+.++++++||||+++++++.+
T Consensus 21 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~ 100 (335)
T 3dls_A 21 EYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFEN 100 (335)
T ss_dssp HHHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred ccccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEee
Confidence 45678999999999999999999965 788999999876532 22356789999999999999999999999
Q ss_pred CCceEEEEEeCCCC-CHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCc
Q 018712 133 GPLRVLAYEHASKG-SLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDI 211 (351)
Q Consensus 133 ~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~ 211 (351)
.+..++||||+.+| +|.+++..... +++..+..++.||+.||.|||+++ |+||||||+|||++.++.
T Consensus 101 ~~~~~lv~e~~~~g~~l~~~~~~~~~---------l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~ 168 (335)
T 3dls_A 101 QGFFQLVMEKHGSGLDLFAFIDRHPR---------LDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFT 168 (335)
T ss_dssp SSEEEEEEECCTTSCBHHHHHHTCCC---------CCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSC
T ss_pred CCEEEEEEEeCCCCccHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCc
Confidence 99999999999776 99999987643 899999999999999999999999 999999999999999999
Q ss_pred eEEecccccCCCccccccccccccccccCccCcccccCCCC-CccchhHhHHHHHHHHHcCCCCCCCCCCCCCccc-hhh
Q 018712 212 AKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQM-SSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSL-VTW 289 (351)
Q Consensus 212 vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~-~~~ 289 (351)
+||+|||++........ .....||+.|+|||++.+..+ +.++||||||+++|+|++|+.||........... ...
T Consensus 169 ~kL~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~ 245 (335)
T 3dls_A 169 IKLIDFGSAAYLERGKL---FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETVEAAIHPPY 245 (335)
T ss_dssp EEECCCTTCEECCTTCC---BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGGTTTCCCCSS
T ss_pred EEEeecccceECCCCCc---eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHHHhhccCCCc
Confidence 99999999976644322 234579999999999988877 8899999999999999999999976432111111 011
Q ss_pred cccCCCccchhhhcccccCCCCCHHHHHH
Q 018712 290 ATPKLSEDKVKQCVDTKLGGEYPPKAIAK 318 (351)
Q Consensus 290 ~~~~~~~~~~~~~ld~~~~~~~~~~~~~~ 318 (351)
..+....+.+..|+.++|.+|++.+++.+
T Consensus 246 ~~~~~l~~li~~~L~~dP~~Rps~~ell~ 274 (335)
T 3dls_A 246 LVSKELMSLVSGLLQPVPERRTTLEKLVT 274 (335)
T ss_dssp CCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 11222246889999999999998776543
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-43 Score=340.12 Aligned_cols=250 Identities=22% Similarity=0.346 Sum_probs=204.0
Q ss_pred HhcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCC----CCchHHHHHHHHHHHhccCCceeeeEEEEecCCceEE
Q 018712 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSS----KQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVL 138 (351)
Q Consensus 64 ~~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 138 (351)
..++|.+.+.||+|+||.||+|... +|+.||+|++.+. ......+.+|+.+|+.++||||+++++++.+.+..|+
T Consensus 182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l 261 (576)
T 2acx_A 182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCL 261 (576)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred cccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEE
Confidence 3467999999999999999999975 7999999998642 2234567899999999999999999999999999999
Q ss_pred EEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEeccc
Q 018712 139 AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFD 218 (351)
Q Consensus 139 v~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg 218 (351)
||||++||+|.+++...... .+++..++.++.||+.||.|||++| |+||||||+|||++.+|++||+|||
T Consensus 262 VmEy~~gg~L~~~l~~~~~~-------~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFG 331 (576)
T 2acx_A 262 VLTLMNGGDLKFHIYHMGQA-------GFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLG 331 (576)
T ss_dssp EECCCCSCBHHHHHHSSSSC-------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCT
T ss_pred EEEcCCCCcHHHHHHhcCCC-------CCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEecc
Confidence 99999999999999765422 2899999999999999999999999 9999999999999999999999999
Q ss_pred ccCCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCcc----chhhcccC-
Q 018712 219 LSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQS----LVTWATPK- 293 (351)
Q Consensus 219 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~----~~~~~~~~- 293 (351)
+++....... ....+||+.|+|||++.+..++.++|||||||++|||++|+.||.......... .+......
T Consensus 332 la~~~~~~~~---~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~~~ 408 (576)
T 2acx_A 332 LAVHVPEGQT---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEY 408 (576)
T ss_dssp TCEECCTTCC---EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCCCC
T ss_pred cceecccCcc---ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcccccC
Confidence 9977644322 234579999999999999999999999999999999999999998754332211 11111111
Q ss_pred ---C---CccchhhhcccccCCCCCHH--HHHHHHHHHHHh
Q 018712 294 ---L---SEDKVKQCVDTKLGGEYPPK--AIAKVRKKKFIT 326 (351)
Q Consensus 294 ---~---~~~~~~~~ld~~~~~~~~~~--~~~~~~~~~~~~ 326 (351)
+ ..+.+..|+..+|.+|+... .+..+.++.++.
T Consensus 409 p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~ 449 (576)
T 2acx_A 409 SERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFK 449 (576)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGT
T ss_pred CccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhc
Confidence 1 13688899999999999432 344456666543
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-43 Score=308.91 Aligned_cols=242 Identities=29% Similarity=0.433 Sum_probs=189.9
Q ss_pred hcCCCCCceeccCCcEEEEEEEECCCCEEEEEEcCCCCC-----chHHHHHHHHHHHhccCCceeeeEEEEecCCceEEE
Q 018712 65 TDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQ-----PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLA 139 (351)
Q Consensus 65 ~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 139 (351)
.++|++.+.||+|+||.||+|.+. +..||+|++..... ..+.+.+|+++++.++||||+++++++.+.+..++|
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV 84 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred hhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence 468999999999999999999975 88999999865432 236688999999999999999999999999999999
Q ss_pred EEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEcc--------CCc
Q 018712 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFD--------DDI 211 (351)
Q Consensus 140 ~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~--------~~~ 211 (351)
|||+.+++|.+++.... +++..++.++.|++.||.|||+++..+++||||||+||+++. ++.
T Consensus 85 ~e~~~~~~L~~~~~~~~----------~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~ 154 (271)
T 3dtc_A 85 MEFARGGPLNRVLSGKR----------IPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKI 154 (271)
T ss_dssp EECCTTEEHHHHHTSSC----------CCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCC
T ss_pred EEcCCCCCHHHHhhcCC----------CCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcc
Confidence 99999999999996543 899999999999999999999997445789999999999986 678
Q ss_pred eEEecccccCCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccch----
Q 018712 212 AKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLV---- 287 (351)
Q Consensus 212 vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~---- 287 (351)
+||+|||++........ ....||+.|+|||.+.+..++.++||||||+++|+|++|+.||............
T Consensus 155 ~kl~Dfg~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~ 230 (271)
T 3dtc_A 155 LKITDFGLAREWHRTTK----MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNK 230 (271)
T ss_dssp EEECCCCC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSC
T ss_pred eEEccCCcccccccccc----cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCC
Confidence 99999999976543322 3456899999999999999999999999999999999999999865432111110
Q ss_pred -----hhcccCCCccchhhhcccccCCCCCHHHHHHHHH
Q 018712 288 -----TWATPKLSEDKVKQCVDTKLGGEYPPKAIAKVRK 321 (351)
Q Consensus 288 -----~~~~~~~~~~~~~~~ld~~~~~~~~~~~~~~~~~ 321 (351)
....+....+.+..|+..+|.+|++.+++.+.++
T Consensus 231 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~ 269 (271)
T 3dtc_A 231 LALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLT 269 (271)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHh
Confidence 0111112236889999999999999998877653
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-43 Score=319.81 Aligned_cols=247 Identities=23% Similarity=0.322 Sum_probs=199.3
Q ss_pred hcCCCCCceeccCCcEEEEEEEEC-CCCE----EEEEEcCCCC--CchHHHHHHHHHHHhccCCceeeeEEEEecCCceE
Q 018712 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRA----AAIKKLDSSK--QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRV 137 (351)
Q Consensus 65 ~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~----vavK~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 137 (351)
.++|++.+.||+|+||.||+|.+. ++.. ||+|.+.... .....+.+|+.+++.++||||+++++++. .+..+
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~ 90 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQ 90 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEE
T ss_pred HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccE
Confidence 467999999999999999999965 4443 7888775432 22355778999999999999999999886 55689
Q ss_pred EEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecc
Q 018712 138 LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDF 217 (351)
Q Consensus 138 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Df 217 (351)
+||||+.+|+|.+++..... .+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+||
T Consensus 91 ~v~e~~~~~~L~~~l~~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Df 159 (325)
T 3kex_A 91 LVTQYLPLGSLLDHVRQHRG--------ALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADF 159 (325)
T ss_dssp EEEECCTTCBSHHHHHSSGG--------GSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSC
T ss_pred EEEEeCCCCCHHHHHHHccc--------cCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCC
Confidence 99999999999999976532 2788899999999999999999999 999999999999999999999999
Q ss_pred cccCCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCCccchhh-------
Q 018712 218 DLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTW------- 289 (351)
Q Consensus 218 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~Pf~~~~~~~~~~~~~~------- 289 (351)
|+++...............||..|+|||++.+..++.++||||||+++|+|++ |+.||...........+..
T Consensus 160 g~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 239 (325)
T 3kex_A 160 GVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQP 239 (325)
T ss_dssp SGGGGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCBCCCC
T ss_pred CcccccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCC
Confidence 99987654443333345668889999999999999999999999999999999 9999987654332222211
Q ss_pred -cccCCCccchhhhcccccCCCCCHHHHHHHHHHH
Q 018712 290 -ATPKLSEDKVKQCVDTKLGGEYPPKAIAKVRKKK 323 (351)
Q Consensus 290 -~~~~~~~~~~~~~ld~~~~~~~~~~~~~~~~~~~ 323 (351)
..+....+.+..|+..+|.+|++.+++...++-.
T Consensus 240 ~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~ 274 (325)
T 3kex_A 240 QICTIDVYMVMVKCWMIDENIRPTFKELANEFTRM 274 (325)
T ss_dssp TTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHH
T ss_pred CcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 1222334688999999999999999988876554
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=351.48 Aligned_cols=250 Identities=20% Similarity=0.254 Sum_probs=205.2
Q ss_pred HHhcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCC----CCchHHHHHHHHHHHhc-cCCceeeeEEEEecCCce
Q 018712 63 EKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSS----KQPDQEFLAQVSMVSRL-KNENVVELVGYYVDGPLR 136 (351)
Q Consensus 63 ~~~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~ 136 (351)
...++|.+.+.||+|+||.||+|.++ +++.||||++.+. ......+..|..++..+ +||||+++++++.+.+.+
T Consensus 338 ~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~ 417 (674)
T 3pfq_A 338 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL 417 (674)
T ss_dssp --CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEE
T ss_pred ccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEE
Confidence 34578999999999999999999976 6889999998642 22345678899999887 799999999999999999
Q ss_pred EEEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEec
Q 018712 137 VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISD 216 (351)
Q Consensus 137 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~D 216 (351)
|+||||+.+|+|.+++..... +++..++.++.||+.||.|||+++ |+||||||+|||++.++++||+|
T Consensus 418 ~lV~E~~~gg~L~~~l~~~~~---------~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~D 485 (674)
T 3pfq_A 418 YFVMEYVNGGDLMYHIQQVGR---------FKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIAD 485 (674)
T ss_dssp EEEEECCCSCBHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECC
T ss_pred EEEEeCcCCCcHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEee
Confidence 999999999999999987543 899999999999999999999999 99999999999999999999999
Q ss_pred ccccCCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccchhhcccC---
Q 018712 217 FDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPK--- 293 (351)
Q Consensus 217 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~--- 293 (351)
||+++....... .....+||+.|+|||++.+..++.++||||||+++|||++|+.||...........+......
T Consensus 486 FGla~~~~~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~ 563 (674)
T 3pfq_A 486 FGMCKENIWDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPK 563 (674)
T ss_dssp CTTCEECCCTTC--CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCCCCCT
T ss_pred cceeeccccCCc--ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCc
Confidence 999975432221 235578999999999999999999999999999999999999999876543322222211111
Q ss_pred ----CCccchhhhcccccCCCCCH--HHHHHHHHHHHHh
Q 018712 294 ----LSEDKVKQCVDTKLGGEYPP--KAIAKVRKKKFIT 326 (351)
Q Consensus 294 ----~~~~~~~~~ld~~~~~~~~~--~~~~~~~~~~~~~ 326 (351)
...+.+..|+..+|.+|+.. +....+.++.|+.
T Consensus 564 ~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~ 602 (674)
T 3pfq_A 564 SMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFR 602 (674)
T ss_dssp TSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGS
T ss_pred cCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCcccc
Confidence 12368889999999999975 4455666666653
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=314.27 Aligned_cols=259 Identities=22% Similarity=0.338 Sum_probs=209.0
Q ss_pred HhcCCCCCceeccCCcEEEEEEEE------CCCCEEEEEEcCCCCCc--hHHHHHHHHHHHhc-cCCceeeeEEEEecCC
Q 018712 64 KTDNFGTNSLIGEGSYGRVYFGVL------RSGRAAAIKKLDSSKQP--DQEFLAQVSMVSRL-KNENVVELVGYYVDGP 134 (351)
Q Consensus 64 ~~~~y~~~~~Lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~ 134 (351)
..++|.+.+.||+|+||.||+|.+ .+++.||+|++...... .+.+.+|+.+++++ +||||+++++++.+.+
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 100 (313)
T 1t46_A 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG 100 (313)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred ChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCC
Confidence 346799999999999999999985 25689999999765432 46688999999999 9999999999999999
Q ss_pred ceEEEEEeCCCCCHHHHhccCCCCC---------CCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEE
Q 018712 135 LRVLAYEHASKGSLHDILHGKKGVK---------GAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVL 205 (351)
Q Consensus 135 ~~~lv~e~~~~gsL~~~l~~~~~~~---------~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nil 205 (351)
..++||||+++|+|.+++....... .......+++..++.++.||+.||.|||+++ ++||||||+||+
T Consensus 101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil 177 (313)
T 1t46_A 101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNIL 177 (313)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEE
T ss_pred CcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEE
Confidence 9999999999999999998654210 0011223899999999999999999999999 999999999999
Q ss_pred EccCCceEEecccccCCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCCc
Q 018712 206 LFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQ 284 (351)
Q Consensus 206 l~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~Pf~~~~~~~~~ 284 (351)
++.++.+||+|||++................||+.|+|||++.+..++.++||||||+++|+|++ |+.||.........
T Consensus 178 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~ 257 (313)
T 1t46_A 178 LTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF 257 (313)
T ss_dssp EETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHH
T ss_pred EcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhHH
Confidence 99999999999999987755433322344567889999999999999999999999999999999 99999876433211
Q ss_pred c-chh--------hcccCCCccchhhhcccccCCCCCHHHHHHHHHHHHH
Q 018712 285 S-LVT--------WATPKLSEDKVKQCVDTKLGGEYPPKAIAKVRKKKFI 325 (351)
Q Consensus 285 ~-~~~--------~~~~~~~~~~~~~~ld~~~~~~~~~~~~~~~~~~~~~ 325 (351)
. .+. ...+....+.+..|+..+|.+|++.+++...++-.+.
T Consensus 258 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 307 (313)
T 1t46_A 258 YKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS 307 (313)
T ss_dssp HHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHH
Confidence 1 111 1111122368899999999999999999888776553
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-43 Score=315.77 Aligned_cols=239 Identities=24% Similarity=0.354 Sum_probs=191.3
Q ss_pred hcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCCc---hHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEE
Q 018712 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAY 140 (351)
Q Consensus 65 ~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 140 (351)
.++|++.+.||+|+||.||+|.+. +++.||+|++...... .+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF 81 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEE
Confidence 468999999999999999999976 6899999998765443 355778999999999999999999999999999999
Q ss_pred EeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEeccccc
Q 018712 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (351)
Q Consensus 141 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a 220 (351)
||+.+++|.+++..... +++..+..++.|++.||.|||++| ++||||||+||+++.++.+||+|||++
T Consensus 82 e~~~~~~l~~~~~~~~~---------~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~ 149 (311)
T 4agu_A 82 EYCDHTVLHELDRYQRG---------VPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFA 149 (311)
T ss_dssp ECCSEEHHHHHHHTSSC---------CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred EeCCCchHHHHHhhhcC---------CCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCc
Confidence 99999999999876543 899999999999999999999999 999999999999999999999999999
Q ss_pred CCCccccccccccccccccCccCcccccC-CCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccchhh----------
Q 018712 221 NQAPDAAARLHSTRVLGTFGYHAPEYAMT-GQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTW---------- 289 (351)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~~~---------- 289 (351)
......... .....||+.|+|||++.+ ..++.++||||||+++|+|++|+.||...........+..
T Consensus 150 ~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (311)
T 4agu_A 150 RLLTGPSDY--YDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQ 227 (311)
T ss_dssp EECC--------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred hhccCcccc--cCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccc
Confidence 765433221 234578999999999876 5789999999999999999999999986543221111100
Q ss_pred -------------------------cccCCC---ccchhhhcccccCCCCCHHHHH
Q 018712 290 -------------------------ATPKLS---EDKVKQCVDTKLGGEYPPKAIA 317 (351)
Q Consensus 290 -------------------------~~~~~~---~~~~~~~ld~~~~~~~~~~~~~ 317 (351)
..+..+ .+.+..|+..+|.+|++++++.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell 283 (311)
T 4agu_A 228 QVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLL 283 (311)
T ss_dssp HHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHH
T ss_pred cccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHh
Confidence 001111 2578999999999999877653
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-43 Score=319.27 Aligned_cols=258 Identities=21% Similarity=0.332 Sum_probs=205.1
Q ss_pred HhcCCCCCceeccCCcEEEEEEEEC------CCCEEEEEEcCCCC--CchHHHHHHHHHHHhc-cCCceeeeEEEEecCC
Q 018712 64 KTDNFGTNSLIGEGSYGRVYFGVLR------SGRAAAIKKLDSSK--QPDQEFLAQVSMVSRL-KNENVVELVGYYVDGP 134 (351)
Q Consensus 64 ~~~~y~~~~~Lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~ 134 (351)
..++|.+.+.||+|+||.||+|.+. ++..||+|++.... .....+.+|+.+++++ +||||+++++++...+
T Consensus 43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 122 (344)
T 1rjb_A 43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG 122 (344)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCC
Confidence 3478999999999999999999962 45689999987542 2346789999999999 8999999999999999
Q ss_pred ceEEEEEeCCCCCHHHHhccCCCCCC--------------CCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeecccc
Q 018712 135 LRVLAYEHASKGSLHDILHGKKGVKG--------------AKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIK 200 (351)
Q Consensus 135 ~~~lv~e~~~~gsL~~~l~~~~~~~~--------------~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlk 200 (351)
..++||||+++|+|.+++........ ......+++..++.++.||+.||.|||++| |+|||||
T Consensus 123 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dik 199 (344)
T 1rjb_A 123 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLA 199 (344)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCS
T ss_pred ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCC
Confidence 99999999999999999986542100 001123789999999999999999999999 9999999
Q ss_pred CCcEEEccCCceEEecccccCCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCC
Q 018712 201 SSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTL 279 (351)
Q Consensus 201 p~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~Pf~~~~ 279 (351)
|+|||++.++.+||+|||++................||+.|+|||++.+..++.++||||||+++|+|+| |..||....
T Consensus 200 p~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 279 (344)
T 1rjb_A 200 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP 279 (344)
T ss_dssp GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred hhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCC
Confidence 9999999999999999999987654433222344567889999999999999999999999999999998 999998764
Q ss_pred CCCCcc-chh--------hcccCCCccchhhhcccccCCCCCHHHHHHHHHHHH
Q 018712 280 PRGQQS-LVT--------WATPKLSEDKVKQCVDTKLGGEYPPKAIAKVRKKKF 324 (351)
Q Consensus 280 ~~~~~~-~~~--------~~~~~~~~~~~~~~ld~~~~~~~~~~~~~~~~~~~~ 324 (351)
...... .+. ...+....+.+..|+..+|.+|++.+++...++..+
T Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~ 333 (344)
T 1rjb_A 280 VDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQL 333 (344)
T ss_dssp CSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred cHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence 332111 111 111112236889999999999999999988776543
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=324.53 Aligned_cols=207 Identities=17% Similarity=0.259 Sum_probs=178.0
Q ss_pred HhcCCCCCceeccC--CcEEEEEEEEC-CCCEEEEEEcCCCCCc---hHHHHHHHHHHHhccCCceeeeEEEEecCCceE
Q 018712 64 KTDNFGTNSLIGEG--SYGRVYFGVLR-SGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRV 137 (351)
Q Consensus 64 ~~~~y~~~~~Lg~G--~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 137 (351)
..++|++.+.||+| +||.||+|.+. +++.||+|++...... ...+.+|+.+++.++||||+++++++.+.+..+
T Consensus 23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 102 (389)
T 3gni_B 23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELW 102 (389)
T ss_dssp CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEE
Confidence 45689999999999 99999999976 7999999998754332 356778999999999999999999999999999
Q ss_pred EEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecc
Q 018712 138 LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDF 217 (351)
Q Consensus 138 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Df 217 (351)
+||||+.+|+|.+++...... .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+||
T Consensus 103 lv~e~~~~~~L~~~l~~~~~~-------~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~df 172 (389)
T 3gni_B 103 VVTSFMAYGSAKDLICTHFMD-------GMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGL 172 (389)
T ss_dssp EEEECCTTCBHHHHHHHTCTT-------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCG
T ss_pred EEEEccCCCCHHHHHhhhccc-------CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEccc
Confidence 999999999999999865322 2899999999999999999999999 999999999999999999999999
Q ss_pred cccCCCcccccc-----ccccccccccCccCcccccC--CCCCccchhHhHHHHHHHHHcCCCCCCCCCC
Q 018712 218 DLSNQAPDAAAR-----LHSTRVLGTFGYHAPEYAMT--GQMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (351)
Q Consensus 218 g~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~el~tg~~Pf~~~~~ 280 (351)
|.+......... .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.....
T Consensus 173 g~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~ 242 (389)
T 3gni_B 173 RSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPA 242 (389)
T ss_dssp GGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCS
T ss_pred ccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCH
Confidence 987654322111 11123468999999999987 6789999999999999999999999986543
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-43 Score=327.17 Aligned_cols=203 Identities=24% Similarity=0.386 Sum_probs=164.2
Q ss_pred HHhcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCCc---hHHHHHHHHHHHhcc-CCceeeeEEEEecCC--c
Q 018712 63 EKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLK-NENVVELVGYYVDGP--L 135 (351)
Q Consensus 63 ~~~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~--~ 135 (351)
...++|++.+.||+|+||.||+|.+. +++.||+|++...... .....+|+.+++.+. ||||+++++++...+ .
T Consensus 6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 85 (388)
T 3oz6_A 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD 85 (388)
T ss_dssp HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence 45688999999999999999999975 7899999998654322 356778999999997 999999999997544 6
Q ss_pred eEEEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEe
Q 018712 136 RVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKIS 215 (351)
Q Consensus 136 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~ 215 (351)
.|+||||+. ++|.+++.... ++...+..++.||+.||.|||++| |+||||||+|||++.++.+||+
T Consensus 86 ~~lv~e~~~-~~L~~~~~~~~----------~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~ 151 (388)
T 3oz6_A 86 VYLVFDYME-TDLHAVIRANI----------LEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVA 151 (388)
T ss_dssp EEEEEECCS-EEHHHHHHHTC----------CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEEC
T ss_pred EEEEecccC-cCHHHHHHcCC----------CCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEec
Confidence 899999997 49999998643 889999999999999999999999 9999999999999999999999
Q ss_pred cccccCCCcccc-------------------ccccccccccccCccCcccccC-CCCCccchhHhHHHHHHHHHcCCCCC
Q 018712 216 DFDLSNQAPDAA-------------------ARLHSTRVLGTFGYHAPEYAMT-GQMSSKSDVYSFGVVLLELLTGRKPV 275 (351)
Q Consensus 216 Dfg~a~~~~~~~-------------------~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~Pf 275 (351)
|||+++...... .....+..+||+.|+|||++.+ ..++.++|||||||++|||++|+.||
T Consensus 152 DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf 231 (388)
T 3oz6_A 152 DFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIF 231 (388)
T ss_dssp CCTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred CCcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCC
Confidence 999997543210 0111234579999999999886 67899999999999999999999999
Q ss_pred CCCC
Q 018712 276 DHTL 279 (351)
Q Consensus 276 ~~~~ 279 (351)
.+..
T Consensus 232 ~~~~ 235 (388)
T 3oz6_A 232 PGSS 235 (388)
T ss_dssp CCSS
T ss_pred CCCC
Confidence 8654
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-43 Score=312.18 Aligned_cols=248 Identities=25% Similarity=0.385 Sum_probs=201.4
Q ss_pred HhcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCC----CchHHHHHHHHHHHhccCCceeeeEEEEecCCceEE
Q 018712 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK----QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVL 138 (351)
Q Consensus 64 ~~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 138 (351)
..++|++.+.||+|+||.||+|.+. ++..||+|++.... .....+.+|+.++++++||||+++++++.+.+..++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 86 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 86 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence 4578999999999999999999976 67799999985432 224568899999999999999999999999999999
Q ss_pred EEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEeccc
Q 018712 139 AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFD 218 (351)
Q Consensus 139 v~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg 218 (351)
||||+++++|.+++..... ++...+..++.||+.||.|||++| ++||||||+||+++.++.+||+|||
T Consensus 87 v~e~~~~~~l~~~l~~~~~---------~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg 154 (279)
T 3fdn_A 87 ILEYAPLGTVYRELQKLSK---------FDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFG 154 (279)
T ss_dssp EECCCTTEEHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCC
T ss_pred EEecCCCCcHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEecc
Confidence 9999999999999976543 899999999999999999999999 9999999999999999999999999
Q ss_pred ccCCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccchhhcc-------
Q 018712 219 LSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWAT------- 291 (351)
Q Consensus 219 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~~~~~------- 291 (351)
++....... .....||+.|+|||++.+..++.++||||||+++|+|++|+.||...........+....
T Consensus 155 ~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 230 (279)
T 3fdn_A 155 WSVHAPSSR----RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFV 230 (279)
T ss_dssp EESCC------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCTTS
T ss_pred ccccCCccc----ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCCCCCCcC
Confidence 986654332 134578999999999999999999999999999999999999998654332222221111
Q ss_pred cCCCccchhhhcccccCCCCCHHHHHHHHHHHHHhhhhc
Q 018712 292 PKLSEDKVKQCVDTKLGGEYPPKAIAKVRKKKFITSECS 330 (351)
Q Consensus 292 ~~~~~~~~~~~ld~~~~~~~~~~~~~~~~~~~~~~~~~~ 330 (351)
+....+.+..|+..+|.+|++.+++ +++.++.....
T Consensus 231 ~~~~~~li~~~l~~~p~~Rps~~e~---l~h~~~~~~~~ 266 (279)
T 3fdn_A 231 TEGARDLISRLLKHNPSQRPMLREV---LEHPWITANSS 266 (279)
T ss_dssp CHHHHHHHHHHCCSSGGGSCCHHHH---HHCHHHHHHCS
T ss_pred CHHHHHHHHHHhccChhhCCCHHHH---hhCccccCCcc
Confidence 1112368899999999999987765 45666554443
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-43 Score=325.28 Aligned_cols=238 Identities=19% Similarity=0.350 Sum_probs=190.0
Q ss_pred cCCCCCceeccCCcEEEEEEEECCCCEEEEEEcCCCCCc---hHHHHHHHHHHHhcc--CCceeeeEEEEecCCceEEEE
Q 018712 66 DNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLK--NENVVELVGYYVDGPLRVLAY 140 (351)
Q Consensus 66 ~~y~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~--h~niv~~~~~~~~~~~~~lv~ 140 (351)
++|.+.+.||+|+||.||++.+.+++.||||++...... ...+.+|+.+++++. |+||+++++++...+..|+||
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 135 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 135 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence 469999999999999999999888999999998755433 356889999999996 599999999999999999999
Q ss_pred EeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEeccccc
Q 018712 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (351)
Q Consensus 141 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a 220 (351)
| +.+++|.+++..... +++..+..++.||+.||.|||+++ |+||||||+|||++ ++.+||+|||++
T Consensus 136 E-~~~~~L~~~l~~~~~---------~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a 201 (390)
T 2zmd_A 136 E-CGNIDLNSWLKKKKS---------IDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIA 201 (390)
T ss_dssp E-CCSEEHHHHHHHCSS---------CCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSS
T ss_pred e-cCCCCHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCcc
Confidence 9 567899999987542 888999999999999999999999 99999999999995 589999999999
Q ss_pred CCCccccccccccccccccCccCcccccC-----------CCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCc--cch
Q 018712 221 NQAPDAAARLHSTRVLGTFGYHAPEYAMT-----------GQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQ--SLV 287 (351)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~--~~~ 287 (351)
+...............||+.|+|||++.+ ..++.++|||||||++|||++|+.||......... ..+
T Consensus 202 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~ 281 (390)
T 2zmd_A 202 NQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAII 281 (390)
T ss_dssp CCC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHH
T ss_pred ccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHh
Confidence 87654433322345679999999999865 36889999999999999999999999764322100 000
Q ss_pred h----hcccC----CCccchhhhcccccCCCCCHHHHH
Q 018712 288 T----WATPK----LSEDKVKQCVDTKLGGEYPPKAIA 317 (351)
Q Consensus 288 ~----~~~~~----~~~~~~~~~ld~~~~~~~~~~~~~ 317 (351)
. ...+. ...+.+..|+..+|.+|++.+++.
T Consensus 282 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell 319 (390)
T 2zmd_A 282 DPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELL 319 (390)
T ss_dssp CTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred CccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHh
Confidence 0 01111 123678899999999999887764
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-43 Score=311.05 Aligned_cols=243 Identities=27% Similarity=0.410 Sum_probs=179.1
Q ss_pred HHHhcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCC----CchHHHHHHHHHHHhccCCceeeeEEEEecCCce
Q 018712 62 KEKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK----QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLR 136 (351)
Q Consensus 62 ~~~~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 136 (351)
....++|.+.+.||+|+||.||+|.+. +++.||+|++.... ...+.+.+|+.++++++||||+++++++.+.+..
T Consensus 7 g~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 86 (278)
T 3cok_A 7 GEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYV 86 (278)
T ss_dssp CSSGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEE
T ss_pred ccccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeE
Confidence 345678999999999999999999974 78999999986432 2236788999999999999999999999999999
Q ss_pred EEEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEec
Q 018712 137 VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISD 216 (351)
Q Consensus 137 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~D 216 (351)
++||||+++++|.+++..... .+++..++.++.|++.||.|||+++ ++||||||+||+++.++.+||+|
T Consensus 87 ~lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~d 155 (278)
T 3cok_A 87 YLVLEMCHNGEMNRYLKNRVK--------PFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIAD 155 (278)
T ss_dssp EEEEECCTTEEHHHHHHTCSS--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECC
T ss_pred EEEEecCCCCcHHHHHhhccC--------CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEe
Confidence 999999999999999986532 2899999999999999999999999 99999999999999999999999
Q ss_pred ccccCCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccchh---hccc-
Q 018712 217 FDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVT---WATP- 292 (351)
Q Consensus 217 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~~---~~~~- 292 (351)
||++......... .....||+.|+|||.+.+..++.++||||||+++|+|++|+.||...........+. ...+
T Consensus 156 fg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 233 (278)
T 3cok_A 156 FGLATQLKMPHEK--HYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPS 233 (278)
T ss_dssp CTTCEECC------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCSSCCCCCT
T ss_pred ecceeeccCCCCc--ceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhhcccCCcc
Confidence 9998765432221 134568999999999998899999999999999999999999998654332211111 1111
Q ss_pred ---CCCccchhhhcccccCCCCCHHHHH
Q 018712 293 ---KLSEDKVKQCVDTKLGGEYPPKAIA 317 (351)
Q Consensus 293 ---~~~~~~~~~~ld~~~~~~~~~~~~~ 317 (351)
....+.+..|+..+|.+|++.+++.
T Consensus 234 ~~~~~~~~li~~~l~~dp~~Rps~~~~l 261 (278)
T 3cok_A 234 FLSIEAKDLIHQLLRRNPADRLSLSSVL 261 (278)
T ss_dssp TSCHHHHHHHHHHSCSSGGGSCCHHHHT
T ss_pred ccCHHHHHHHHHHcccCHhhCCCHHHHh
Confidence 1113688899999999999877653
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-43 Score=310.71 Aligned_cols=250 Identities=24% Similarity=0.371 Sum_probs=206.3
Q ss_pred hcCCCCCceeccCCcEEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEEEeCC
Q 018712 65 TDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHAS 144 (351)
Q Consensus 65 ~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 144 (351)
.++|++.+.||+|+||.||+|...++..||+|++.......+.+.+|++++++++||||+++++++. .+..++||||+.
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~ 90 (279)
T 1qpc_A 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYME 90 (279)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECCT
T ss_pred HHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCcccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEecCC
Confidence 4678899999999999999999988889999999877667788999999999999999999999876 456899999999
Q ss_pred CCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccccCCCc
Q 018712 145 KGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAP 224 (351)
Q Consensus 145 ~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~ 224 (351)
+++|.+++...... .+++..++.++.|++.||.|||++| ++||||||+||++++++.+||+|||++....
T Consensus 91 ~~~L~~~l~~~~~~-------~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 160 (279)
T 1qpc_A 91 NGSLVDFLKTPSGI-------KLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIE 160 (279)
T ss_dssp TCBHHHHTTSHHHH-------TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred CCCHHHHHhcCCCC-------CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCccccccc
Confidence 99999999754211 2889999999999999999999999 9999999999999999999999999987664
Q ss_pred cccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCCccchh--------hcccCCC
Q 018712 225 DAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVT--------WATPKLS 295 (351)
Q Consensus 225 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~Pf~~~~~~~~~~~~~--------~~~~~~~ 295 (351)
..... ......+|+.|+|||.+.+..++.++||||||+++|+|++ |+.||...........+. ...+...
T Consensus 161 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 239 (279)
T 1qpc_A 161 DNEYT-AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEEL 239 (279)
T ss_dssp SSCEE-CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHH
T ss_pred Ccccc-cccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccCCCCcccccHHH
Confidence 43221 1233456889999999998889999999999999999999 999998654322111111 1111122
Q ss_pred ccchhhhcccccCCCCCHHHHHHHHHHHHHh
Q 018712 296 EDKVKQCVDTKLGGEYPPKAIAKVRKKKFIT 326 (351)
Q Consensus 296 ~~~~~~~ld~~~~~~~~~~~~~~~~~~~~~~ 326 (351)
.+.+..|+..+|.+|++.+++...++-.+..
T Consensus 240 ~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 270 (279)
T 1qpc_A 240 YQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (279)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHhccChhhCCCHHHHHHHHHHHHHh
Confidence 3688999999999999999998887766543
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-43 Score=316.09 Aligned_cols=242 Identities=20% Similarity=0.320 Sum_probs=195.5
Q ss_pred hcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCC--CchHHHHHHHHHHHhccCCceeeeEEEEecCC--ceEEE
Q 018712 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK--QPDQEFLAQVSMVSRLKNENVVELVGYYVDGP--LRVLA 139 (351)
Q Consensus 65 ~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~--~~~lv 139 (351)
.++|.+.+.||+|+||.||+|.+. +++.||+|++.... ...+.+.+|++++++++||||+++++++.... ..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence 367999999999999999999976 58999999987533 23466789999999999999999999988665 77999
Q ss_pred EEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEE----ccCCceEEe
Q 018712 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLL----FDDDIAKIS 215 (351)
Q Consensus 140 ~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill----~~~~~vkl~ 215 (351)
|||+++++|.+++...... ..+++..++.++.||+.||.|||+++ |+||||||+|||+ +.++.+||+
T Consensus 88 ~e~~~~~~L~~~l~~~~~~------~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~ 158 (319)
T 4euu_A 88 MEFCPCGSLYTVLEEPSNA------YGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLT 158 (319)
T ss_dssp EECCTTCBHHHHHHSGGGT------TCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEEC
T ss_pred EeCCCCCCHHHHHHHhccc------cCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEc
Confidence 9999999999999865421 12889999999999999999999999 9999999999999 777889999
Q ss_pred cccccCCCccccccccccccccccCccCccccc--------CCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCc-cc
Q 018712 216 DFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAM--------TGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQ-SL 286 (351)
Q Consensus 216 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~-~~ 286 (351)
|||+++....... .....||+.|+|||++. +..++.++||||||+++|||++|+.||......... ..
T Consensus 159 Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~ 235 (319)
T 4euu_A 159 DFGAARELEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEV 235 (319)
T ss_dssp CCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHH
T ss_pred cCCCceecCCCCc---eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHH
Confidence 9999976644322 23456999999999886 578899999999999999999999999754322111 00
Q ss_pred h----h-------------------h------------cccCCCccchhhhcccccCCCCCHHHHHH
Q 018712 287 V----T-------------------W------------ATPKLSEDKVKQCVDTKLGGEYPPKAIAK 318 (351)
Q Consensus 287 ~----~-------------------~------------~~~~~~~~~~~~~ld~~~~~~~~~~~~~~ 318 (351)
+ . | ..+....+.+..|+..+|.+|++.+++..
T Consensus 236 ~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~ 302 (319)
T 4euu_A 236 MYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFA 302 (319)
T ss_dssp HHHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHH
T ss_pred HHHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhh
Confidence 0 0 0 00011125678999999999999887754
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-43 Score=309.58 Aligned_cols=239 Identities=19% Similarity=0.270 Sum_probs=198.5
Q ss_pred HHhcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCC-CCchHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEE
Q 018712 63 EKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSS-KQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAY 140 (351)
Q Consensus 63 ~~~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 140 (351)
...++|.+.+.||+|+||.||+|.+. ++..+|+|++... ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (277)
T 3f3z_A 6 DINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVM 85 (277)
T ss_dssp CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEE
Confidence 45678999999999999999999976 5778999998654 334577899999999999999999999999999999999
Q ss_pred EeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEE---ccCCceEEecc
Q 018712 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLL---FDDDIAKISDF 217 (351)
Q Consensus 141 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill---~~~~~vkl~Df 217 (351)
||+++++|.+++..... +++..+..++.|++.||.|||+++ ++||||||+||++ +.++.+||+||
T Consensus 86 e~~~~~~L~~~~~~~~~---------~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Df 153 (277)
T 3f3z_A 86 ELCTGGELFERVVHKRV---------FRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDF 153 (277)
T ss_dssp ECCCSCBHHHHHHHHCS---------CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCC
T ss_pred eccCCCcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEec
Confidence 99999999999876542 899999999999999999999999 9999999999999 77889999999
Q ss_pred cccCCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccchhh--------
Q 018712 218 DLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTW-------- 289 (351)
Q Consensus 218 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~~~-------- 289 (351)
|++........ .....||+.|+|||++.+. ++.++||||||+++|+|++|+.||...........+..
T Consensus 154 g~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 229 (277)
T 3f3z_A 154 GLAARFKPGKM---MRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEK 229 (277)
T ss_dssp TTCEECCTTSC---BCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHH
T ss_pred ccceeccCccc---hhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCch
Confidence 99876543322 2345699999999988654 89999999999999999999999987543221111111
Q ss_pred ---cccCCCccchhhhcccccCCCCCHHHHH
Q 018712 290 ---ATPKLSEDKVKQCVDTKLGGEYPPKAIA 317 (351)
Q Consensus 290 ---~~~~~~~~~~~~~ld~~~~~~~~~~~~~ 317 (351)
..+....+.+..|+..+|.+|++..++.
T Consensus 230 ~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l 260 (277)
T 3f3z_A 230 DWLNVSPQAESLIRRLLTKSPKQRITSLQAL 260 (277)
T ss_dssp HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHT
T ss_pred hhhcCCHHHHHHHHHHccCChhhCcCHHHHh
Confidence 1112223688999999999999987764
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-43 Score=333.28 Aligned_cols=248 Identities=27% Similarity=0.426 Sum_probs=199.6
Q ss_pred HhcCCCCCceeccCCcEEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEEEeC
Q 018712 64 KTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHA 143 (351)
Q Consensus 64 ~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 143 (351)
..++|.+.+.||+|+||.||+|.+.++..||||++.......+.+.+|+.+|++++||||+++++++.+ +..++||||+
T Consensus 182 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~ 260 (452)
T 1fmk_A 182 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 260 (452)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred ChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhh
Confidence 346788899999999999999999888889999998776667789999999999999999999999876 6789999999
Q ss_pred CCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccccCCC
Q 018712 144 SKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQA 223 (351)
Q Consensus 144 ~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~ 223 (351)
.+|+|.+++..... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 261 ~~gsL~~~l~~~~~-------~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~ 330 (452)
T 1fmk_A 261 SKGSLLDFLKGETG-------KYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLI 330 (452)
T ss_dssp TTCBHHHHHSHHHH-------TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC--
T ss_pred cCCCHHHHHHhcCC-------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCccceec
Confidence 99999999975321 12889999999999999999999999 999999999999999999999999999876
Q ss_pred ccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCCccchhh--------cccCC
Q 018712 224 PDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTW--------ATPKL 294 (351)
Q Consensus 224 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~Pf~~~~~~~~~~~~~~--------~~~~~ 294 (351)
...... ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...........+.. ..+..
T Consensus 331 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 409 (452)
T 1fmk_A 331 EDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPES 409 (452)
T ss_dssp -------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTSCHH
T ss_pred CCCcee-cccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHH
Confidence 433211 1123456889999999999999999999999999999999 9999987543222111111 11111
Q ss_pred CccchhhhcccccCCCCCHHHHHHHHHHH
Q 018712 295 SEDKVKQCVDTKLGGEYPPKAIAKVRKKK 323 (351)
Q Consensus 295 ~~~~~~~~ld~~~~~~~~~~~~~~~~~~~ 323 (351)
..+.+..|+..+|.+|++.+++...++-.
T Consensus 410 l~~li~~cl~~dP~~Rpt~~~l~~~L~~~ 438 (452)
T 1fmk_A 410 LHDLMCQCWRKEPEERPTFEYLQAFLEDY 438 (452)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHTT
T ss_pred HHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 23678999999999999999887766543
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=329.32 Aligned_cols=261 Identities=20% Similarity=0.331 Sum_probs=212.2
Q ss_pred hcCCCCCceeccCCcEEEEEEEE-CCCCEEEEEEcCCCCCchHHHHHHHHHHHhccC-CceeeeEEEEecCCceEEEEEe
Q 018712 65 TDNFGTNSLIGEGSYGRVYFGVL-RSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKN-ENVVELVGYYVDGPLRVLAYEH 142 (351)
Q Consensus 65 ~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h-~niv~~~~~~~~~~~~~lv~e~ 142 (351)
.++|.+.+.||+|+||.||+|.+ .+++.||||++..... ...+.+|+++++.+.| ++|..+..++.+.+..++||||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~ 84 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDL 84 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS-SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc-cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEEC
Confidence 47899999999999999999997 4789999998765443 2458899999999977 5666666677788889999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEE---ccCCceEEecccc
Q 018712 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLL---FDDDIAKISDFDL 219 (351)
Q Consensus 143 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill---~~~~~vkl~Dfg~ 219 (351)
+ +++|.+++..... .+++..++.++.||+.||.|||+++ |+||||||+|||| +.++.+||+|||+
T Consensus 85 ~-g~sL~~ll~~~~~--------~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGl 152 (483)
T 3sv0_A 85 L-GPSLEDLFNFCSR--------KLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGL 152 (483)
T ss_dssp C-CCBHHHHHHHTTT--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTT
T ss_pred C-CCCHHHHHHhhcC--------CCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCc
Confidence 9 8899999985432 2899999999999999999999999 9999999999999 6889999999999
Q ss_pred cCCCccccccc-----cccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccchh------
Q 018712 220 SNQAPDAAARL-----HSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVT------ 288 (351)
Q Consensus 220 a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~~------ 288 (351)
++......... ......||+.|+|||++.+..++.++||||||+++|||++|+.||.............
T Consensus 153 a~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~ 232 (483)
T 3sv0_A 153 AKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK 232 (483)
T ss_dssp CEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHH
T ss_pred ceeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhcc
Confidence 98765433211 1235679999999999999999999999999999999999999998765533221111
Q ss_pred ---------hcccCCCccchhhhcccccCCCCCHHHHHHHHHHHHHhhhhccccchhhhhcccCCcccc
Q 018712 289 ---------WATPKLSEDKVKQCVDTKLGGEYPPKAIAKVRKKKFITSECSNISFAEFNINWHCPLEWS 348 (351)
Q Consensus 289 ---------~~~~~~~~~~~~~~ld~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~ 348 (351)
...+....+.+..|+..++.+|++.+++..+++..+ ...+...+..+||.
T Consensus 233 ~~~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~----------~~~~~~~~~~~dW~ 291 (483)
T 3sv0_A 233 VATSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLF----------IREGFQFDYVFDWT 291 (483)
T ss_dssp HHSCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHH----------HHTTCCCSSCCHHH
T ss_pred ccccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHH----------HHcCCCccCCcCch
Confidence 111222246889999999999999999988877664 34556678888986
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-43 Score=335.18 Aligned_cols=198 Identities=23% Similarity=0.286 Sum_probs=167.2
Q ss_pred HhcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCC---chHHHHHHHHHHHhccCCceeeeEEEEecC------
Q 018712 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ---PDQEFLAQVSMVSRLKNENVVELVGYYVDG------ 133 (351)
Q Consensus 64 ~~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------ 133 (351)
..++|++.+.||+|+||.||+|.+. +++.||||++..... ..+.+.+|+.+++.++||||+++++++...
T Consensus 60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 139 (464)
T 3ttj_A 60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 139 (464)
T ss_dssp EETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred ecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccC
Confidence 3578999999999999999999975 789999999975422 245678999999999999999999999655
Q ss_pred CceEEEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceE
Q 018712 134 PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAK 213 (351)
Q Consensus 134 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vk 213 (351)
...|+||||+.+ +|.+.+... +++..+..++.||+.||.|||++| |+||||||+|||++.++.+|
T Consensus 140 ~~~~lv~E~~~~-~l~~~~~~~-----------l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~k 204 (464)
T 3ttj_A 140 QDVYLVMELMDA-NLCQVIQME-----------LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLK 204 (464)
T ss_dssp CEEEEEEECCSE-EHHHHHTSC-----------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEE
T ss_pred CeEEEEEeCCCC-CHHHHHhhc-----------CCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEE
Confidence 356999999976 577777532 889999999999999999999999 99999999999999999999
Q ss_pred EecccccCCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCC
Q 018712 214 ISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTL 279 (351)
Q Consensus 214 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~ 279 (351)
|+|||+++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+..
T Consensus 205 l~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~ 267 (464)
T 3ttj_A 205 ILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRD 267 (464)
T ss_dssp ECCCCCC-----CC---CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred EEEEEeeeecCCCc---ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999998764332 1245679999999999999999999999999999999999999998754
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=322.42 Aligned_cols=243 Identities=23% Similarity=0.348 Sum_probs=197.3
Q ss_pred HHhcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCCchHHHHHHHHHHHhc-cCCceeeeEEEEecCCceEEEE
Q 018712 63 EKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRL-KNENVVELVGYYVDGPLRVLAY 140 (351)
Q Consensus 63 ~~~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~ 140 (351)
...++|.+.+.||+|+||.||+|.++ +++.||+|++...... ..+|++++.++ +||||+++++++.+.+..|+||
T Consensus 19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~---~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ 95 (342)
T 2qr7_A 19 QFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD---PTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT 95 (342)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC---CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred CccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC---hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence 35678999999999999999999976 6889999999765432 45688888888 7999999999999999999999
Q ss_pred EeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccC----CceEEec
Q 018712 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDD----DIAKISD 216 (351)
Q Consensus 141 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~----~~vkl~D 216 (351)
||+.+|+|.+++..... +++..+..++.||+.||.|||++| |+||||||+|||+.+. +.+||+|
T Consensus 96 E~~~gg~L~~~i~~~~~---------~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~D 163 (342)
T 2qr7_A 96 ELMKGGELLDKILRQKF---------FSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICD 163 (342)
T ss_dssp CCCCSCBHHHHHHTCTT---------CCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECC
T ss_pred eCCCCCcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEE
Confidence 99999999999976542 899999999999999999999999 9999999999998543 3599999
Q ss_pred ccccCCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccchhh-------
Q 018712 217 FDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTW------- 289 (351)
Q Consensus 217 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~~~------- 289 (351)
||+++........ ....+||+.|+|||++.+..++.++||||||+++|+|++|+.||..........+...
T Consensus 164 fg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~ 241 (342)
T 2qr7_A 164 FGFAKQLRAENGL--LMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFS 241 (342)
T ss_dssp CTTCEECBCTTCC--BCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCC
T ss_pred CCCcccCcCCCCc--eeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcc
Confidence 9999765433221 2446789999999999888899999999999999999999999986433222111110
Q ss_pred ----cccCCC---ccchhhhcccccCCCCCHHHHHHHHHHHHH
Q 018712 290 ----ATPKLS---EDKVKQCVDTKLGGEYPPKAIAKVRKKKFI 325 (351)
Q Consensus 290 ----~~~~~~---~~~~~~~ld~~~~~~~~~~~~~~~~~~~~~ 325 (351)
..+..+ .+.+..|+..+|.+|++.+++ +++.++
T Consensus 242 ~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~i---l~hp~~ 281 (342)
T 2qr7_A 242 LSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALV---LRHPWI 281 (342)
T ss_dssp CCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHH---TTSHHH
T ss_pred cCccccccCCHHHHHHHHHHCCCChhHCcCHHHH---hcCCee
Confidence 001122 368899999999999998765 445554
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-43 Score=319.11 Aligned_cols=245 Identities=20% Similarity=0.316 Sum_probs=191.9
Q ss_pred HhcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCC--CchHHHHHHHHHHHhccCCceeeeEEEEecCC------
Q 018712 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK--QPDQEFLAQVSMVSRLKNENVVELVGYYVDGP------ 134 (351)
Q Consensus 64 ~~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------ 134 (351)
..++|++.+.||+|+||.||+|.+. +++.||||++.... ...+.+.+|++++++++||||+++++++.+.+
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 83 (332)
T 3qd2_B 4 YLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQE 83 (332)
T ss_dssp HHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHH
T ss_pred hhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhh
Confidence 4567999999999999999999986 89999999986433 33567899999999999999999999886543
Q ss_pred ---------------------------------------------------ceEEEEEeCCCCCHHHHhccCCCCCCCCC
Q 018712 135 ---------------------------------------------------LRVLAYEHASKGSLHDILHGKKGVKGAKP 163 (351)
Q Consensus 135 ---------------------------------------------------~~~lv~e~~~~gsL~~~l~~~~~~~~~~~ 163 (351)
..++||||+.+++|.+++......
T Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~----- 158 (332)
T 3qd2_B 84 EMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSL----- 158 (332)
T ss_dssp HHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSG-----
T ss_pred hhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCc-----
Confidence 379999999999999999875432
Q ss_pred CCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccccCCCcccccc----------cccc
Q 018712 164 GPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAAR----------LHST 233 (351)
Q Consensus 164 ~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~----------~~~~ 233 (351)
....+..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||+++........ ....
T Consensus 159 -~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~ 234 (332)
T 3qd2_B 159 -EDREHGVCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHT 234 (332)
T ss_dssp -GGSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCC
T ss_pred -cchhhHHHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhcccccccccccccc
Confidence 12566778999999999999999999 999999999999999999999999999876543211 1123
Q ss_pred ccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCC------CCccchhhcccCCCccchhhhccccc
Q 018712 234 RVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPR------GQQSLVTWATPKLSEDKVKQCVDTKL 307 (351)
Q Consensus 234 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~------~~~~~~~~~~~~~~~~~~~~~ld~~~ 307 (351)
...||+.|+|||++.+..++.++||||||+++|+|++|..|+...... ...............+.+..|+..+|
T Consensus 235 ~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 314 (332)
T 3qd2_B 235 GQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERVRIITDVRNLKFPLLFTQKYPQEHMMVQDMLSPSP 314 (332)
T ss_dssp SCC-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHHHHHHHHHHTTCCCHHHHHHCHHHHHHHHHHHCSSG
T ss_pred ccCCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHHHHHHHHhhccCCCcccccCChhHHHHHHHHccCCC
Confidence 456999999999999999999999999999999999998875421100 00000000001111367899999999
Q ss_pred CCCCCHHHHH
Q 018712 308 GGEYPPKAIA 317 (351)
Q Consensus 308 ~~~~~~~~~~ 317 (351)
.+|++.+++.
T Consensus 315 ~~Rps~~~~l 324 (332)
T 3qd2_B 315 TERPEATDII 324 (332)
T ss_dssp GGSCCHHHHH
T ss_pred CcCCCHHHHh
Confidence 9999987764
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=307.62 Aligned_cols=247 Identities=24% Similarity=0.331 Sum_probs=190.7
Q ss_pred hcCCCCCceeccCCcEEEEEEEECC----CCEEEEEEcCCCCCc--hHHHHHHHHHHHhccCCceeeeEEEEecCCceEE
Q 018712 65 TDNFGTNSLIGEGSYGRVYFGVLRS----GRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVL 138 (351)
Q Consensus 65 ~~~y~~~~~Lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 138 (351)
.++|++.+.||+|+||.||+|.+.. +..||+|++...... .+.+.+|+.++++++||||+++++++. .+..++
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~l 92 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 92 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEE
Confidence 4678999999999999999999752 457999998764332 356889999999999999999999874 567899
Q ss_pred EEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEeccc
Q 018712 139 AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFD 218 (351)
Q Consensus 139 v~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg 218 (351)
||||+.+++|.+++..... .+++..++.++.|++.||.|||++| ++||||||+|||++.++.+||+|||
T Consensus 93 v~e~~~~~~L~~~l~~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg 161 (281)
T 1mp8_A 93 IMELCTLGELRSFLQVRKY--------SLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFG 161 (281)
T ss_dssp EEECCTTEEHHHHHHHTTT--------TSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC--
T ss_pred EEecCCCCCHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECccc
Confidence 9999999999999986532 2889999999999999999999999 9999999999999999999999999
Q ss_pred ccCCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCCccchhh--------
Q 018712 219 LSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTW-------- 289 (351)
Q Consensus 219 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~Pf~~~~~~~~~~~~~~-------- 289 (351)
++......... ......+|+.|+|||.+.+..++.++||||||+++|+|++ |..||...........+..
T Consensus 162 ~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 240 (281)
T 1mp8_A 162 LSRYMEDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPP 240 (281)
T ss_dssp ------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCT
T ss_pred cccccCccccc-ccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCCCCCCC
Confidence 99876443221 1233456789999999999999999999999999999997 9999987644332211111
Q ss_pred cccCCCccchhhhcccccCCCCCHHHHHHHHHHHH
Q 018712 290 ATPKLSEDKVKQCVDTKLGGEYPPKAIAKVRKKKF 324 (351)
Q Consensus 290 ~~~~~~~~~~~~~ld~~~~~~~~~~~~~~~~~~~~ 324 (351)
..+....+.+..|+..+|.+|++.+++...++-.+
T Consensus 241 ~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 275 (281)
T 1mp8_A 241 NCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 275 (281)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 11111236889999999999999999887766554
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=314.81 Aligned_cols=248 Identities=23% Similarity=0.347 Sum_probs=194.9
Q ss_pred hcCCCCCceeccCCcEEEEEEEEC-CCCE----EEEEEcCCC--CCchHHHHHHHHHHHhccCCceeeeEEEEecCCceE
Q 018712 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRA----AAIKKLDSS--KQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRV 137 (351)
Q Consensus 65 ~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~----vavK~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 137 (351)
.++|++.+.||+|+||.||+|.+. +++. ||+|.+... ......+.+|+.++++++||||+++++++.... .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~ 92 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence 468999999999999999999965 4443 577777543 234577899999999999999999999998765 78
Q ss_pred EEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecc
Q 018712 138 LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDF 217 (351)
Q Consensus 138 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Df 217 (351)
++++++.+|+|.+++..... .+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+||
T Consensus 93 ~v~~~~~~g~L~~~l~~~~~--------~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~Df 161 (327)
T 3lzb_A 93 LITQLMPFGCLLDYVREHKD--------NIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDF 161 (327)
T ss_dssp EEECCCSSCBHHHHHHHTTT--------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCT
T ss_pred EEEEecCCCcHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccC
Confidence 99999999999999986542 2889999999999999999999999 999999999999999999999999
Q ss_pred cccCCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCCccchhhc------
Q 018712 218 DLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWA------ 290 (351)
Q Consensus 218 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~Pf~~~~~~~~~~~~~~~------ 290 (351)
|+++...............+|+.|+|||++.+..++.++||||||+++|+|++ |+.||...........+...
T Consensus 162 G~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 241 (327)
T 3lzb_A 162 GLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQP 241 (327)
T ss_dssp TC----------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCC
T ss_pred cceeEccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCC
Confidence 99987654433333344557889999999999999999999999999999999 99999876544322222111
Q ss_pred --ccCCCccchhhhcccccCCCCCHHHHHHHHHHHH
Q 018712 291 --TPKLSEDKVKQCVDTKLGGEYPPKAIAKVRKKKF 324 (351)
Q Consensus 291 --~~~~~~~~~~~~ld~~~~~~~~~~~~~~~~~~~~ 324 (351)
.+....+.+..|+..+|.+|++.+++...++...
T Consensus 242 ~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 277 (327)
T 3lzb_A 242 PICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMA 277 (327)
T ss_dssp TTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 1111236789999999999999999888766554
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=308.66 Aligned_cols=246 Identities=22% Similarity=0.313 Sum_probs=202.0
Q ss_pred HhcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCCc---hHHHHHHHHHHHhccCCceeeeEEEEecCCceEEE
Q 018712 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLA 139 (351)
Q Consensus 64 ~~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 139 (351)
..++|++.+.||+|+||.||+|.+. +++.||+|++...... .+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 83 (284)
T 3kk8_A 4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 83 (284)
T ss_dssp TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEE
Confidence 4578999999999999999999975 6899999998654332 35678899999999999999999999999999999
Q ss_pred EEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCc---eEEec
Q 018712 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDI---AKISD 216 (351)
Q Consensus 140 ~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~---vkl~D 216 (351)
|||+.+++|.+++..... +++..+..++.|++.||.|||+++ ++||||||+||+++.++. +||+|
T Consensus 84 ~e~~~~~~l~~~~~~~~~---------~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~D 151 (284)
T 3kk8_A 84 FDLVTGGELFEDIVAREF---------YSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLAD 151 (284)
T ss_dssp ECCCCSCBHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECC
T ss_pred EecCCCCCHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEee
Confidence 999999999998876542 899999999999999999999999 999999999999987654 99999
Q ss_pred ccccCCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccchhh-------
Q 018712 217 FDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTW------- 289 (351)
Q Consensus 217 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~~~------- 289 (351)
||++........ .....||+.|+|||.+.+..++.++||||||+++|+|++|+.||...........+..
T Consensus 152 fg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 228 (284)
T 3kk8_A 152 FGLAIEVNDSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPS 228 (284)
T ss_dssp CTTCEECCSSCB---CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT
T ss_pred ceeeEEcccCcc---ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCc
Confidence 999876543322 1345789999999999999999999999999999999999999976543221111111
Q ss_pred ----cccCCCccchhhhcccccCCCCCHHHHHHHHHHHHHhh
Q 018712 290 ----ATPKLSEDKVKQCVDTKLGGEYPPKAIAKVRKKKFITS 327 (351)
Q Consensus 290 ----~~~~~~~~~~~~~ld~~~~~~~~~~~~~~~~~~~~~~~ 327 (351)
..+....+.+..|+..+|.+|++.+++ +++.+++.
T Consensus 229 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~---l~h~~~~~ 267 (284)
T 3kk8_A 229 PEWDTVTPEAKSLIDSMLTVNPKKRITADQA---LKVPWICN 267 (284)
T ss_dssp TTTTTSCHHHHHHHHHHSCSSTTTSCCHHHH---TTSHHHHS
T ss_pred hhhcccCHHHHHHHHHHcccChhhCCCHHHH---hcCccccC
Confidence 011112368899999999999988776 44566553
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-43 Score=314.75 Aligned_cols=242 Identities=23% Similarity=0.370 Sum_probs=191.9
Q ss_pred HhcCCCCCceeccCCcEEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHHh--ccCCceeeeEEEEec----CCceE
Q 018712 64 KTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSR--LKNENVVELVGYYVD----GPLRV 137 (351)
Q Consensus 64 ~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~--l~h~niv~~~~~~~~----~~~~~ 137 (351)
..++|++.+.||+|+||.||+|.+ +++.||+|++... ....+..|.+++.. ++||||+++++++.+ ....+
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~--~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~ 82 (301)
T 3q4u_A 6 VARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR--DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLW 82 (301)
T ss_dssp CGGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG--GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred ccCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc--cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeE
Confidence 357899999999999999999988 6889999998654 34455667777666 799999999998653 34689
Q ss_pred EEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhh--------hCCCCCeeeccccCCcEEEccC
Q 018712 138 LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLH--------EKAEPRIIHRNIKSSNVLLFDD 209 (351)
Q Consensus 138 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH--------~~~~~~ivH~Dlkp~Nill~~~ 209 (351)
+||||+++|+|.++++... +++..++.++.|++.||.||| +.+ |+||||||+|||++.+
T Consensus 83 lv~e~~~~g~L~~~l~~~~----------~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~~~ 149 (301)
T 3q4u_A 83 LITHYHEMGSLYDYLQLTT----------LDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVKKN 149 (301)
T ss_dssp EEECCCTTCBHHHHHTTCC----------BCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEECTT
T ss_pred EehhhccCCCHHHHHhhcc----------cCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEcCC
Confidence 9999999999999996543 899999999999999999999 888 9999999999999999
Q ss_pred CceEEecccccCCCcccccc--ccccccccccCccCcccccCC------CCCccchhHhHHHHHHHHHcC----------
Q 018712 210 DIAKISDFDLSNQAPDAAAR--LHSTRVLGTFGYHAPEYAMTG------QMSSKSDVYSFGVVLLELLTG---------- 271 (351)
Q Consensus 210 ~~vkl~Dfg~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwslG~il~el~tg---------- 271 (351)
+.+||+|||+++........ .......||+.|+|||++.+. .++.++||||||+++|||++|
T Consensus 150 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~ 229 (301)
T 3q4u_A 150 GQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDY 229 (301)
T ss_dssp SCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCC
T ss_pred CCEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccc
Confidence 99999999998654332211 112334799999999999876 455789999999999999999
Q ss_pred CCCCCCCCCCCCccc-h------hhcccCC------------CccchhhhcccccCCCCCHHHHHHHHH
Q 018712 272 RKPVDHTLPRGQQSL-V------TWATPKL------------SEDKVKQCVDTKLGGEYPPKAIAKVRK 321 (351)
Q Consensus 272 ~~Pf~~~~~~~~~~~-~------~~~~~~~------------~~~~~~~~ld~~~~~~~~~~~~~~~~~ 321 (351)
+.||....+...... . ....+.. ..+.+..|+..+|.+|++++++.+.++
T Consensus 230 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~ 298 (301)
T 3q4u_A 230 KPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLT 298 (301)
T ss_dssp CCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHH
T ss_pred cccccccCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHh
Confidence 888876543322110 0 0111111 125789999999999999998877654
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-43 Score=320.83 Aligned_cols=248 Identities=21% Similarity=0.325 Sum_probs=203.1
Q ss_pred HhcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCC----CchHHHHHHHHHHHhccCCceeeeEEEEecCCceEE
Q 018712 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK----QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVL 138 (351)
Q Consensus 64 ~~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 138 (351)
..++|.+.+.||+|+||.||++.+. +++.||+|++.... ...+.+.+|+.+++.++|+||+++++++.+.+..++
T Consensus 39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 118 (335)
T 2owb_A 39 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV 118 (335)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred cCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEE
Confidence 4568999999999999999999976 67899999986442 224568889999999999999999999999999999
Q ss_pred EEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEeccc
Q 018712 139 AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFD 218 (351)
Q Consensus 139 v~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg 218 (351)
||||+.+++|.+++..... +++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||
T Consensus 119 v~e~~~~~~L~~~~~~~~~---------l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg 186 (335)
T 2owb_A 119 VLELCRRRSLLELHKRRKA---------LTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFG 186 (335)
T ss_dssp EECCCTTCBHHHHHHHHCS---------CCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCT
T ss_pred EEecCCCCCHHHHHhccCC---------CCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeecc
Confidence 9999999999999876542 899999999999999999999999 9999999999999999999999999
Q ss_pred ccCCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccchhhc-------c
Q 018712 219 LSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWA-------T 291 (351)
Q Consensus 219 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~~~~-------~ 291 (351)
++......... .....||+.|+|||++.+..++.++||||||+++|+|++|+.||...........+... .
T Consensus 187 ~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 264 (335)
T 2owb_A 187 LATKVEYDGER--KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHI 264 (335)
T ss_dssp TCEECCSTTCC--BCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCTTS
T ss_pred CceecccCccc--ccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCCCCCCccC
Confidence 98765432211 24457899999999999999999999999999999999999999865322211111111 1
Q ss_pred cCCCccchhhhcccccCCCCCHHHHHHHHHHHHHhhh
Q 018712 292 PKLSEDKVKQCVDTKLGGEYPPKAIAKVRKKKFITSE 328 (351)
Q Consensus 292 ~~~~~~~~~~~ld~~~~~~~~~~~~~~~~~~~~~~~~ 328 (351)
+....+.+..|+..++.+|++.+++ +++.++...
T Consensus 265 ~~~~~~li~~~l~~dp~~Rps~~el---l~~~~~~~~ 298 (335)
T 2owb_A 265 NPVAASLIQKMLQTDPTARPTINEL---LNDEFFTSG 298 (335)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCGGGG---GGSHHHHTS
T ss_pred CHHHHHHHHHHccCChhHCcCHHHH---hcCccccCC
Confidence 1112367899999999999987765 445555543
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-43 Score=317.80 Aligned_cols=230 Identities=20% Similarity=0.304 Sum_probs=170.6
Q ss_pred CceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCCchHHHHHHHHHHHhcc-CCceeeeEEEEecCCceEEEEEeCCCCCH
Q 018712 71 NSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLK-NENVVELVGYYVDGPLRVLAYEHASKGSL 148 (351)
Q Consensus 71 ~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~gsL 148 (351)
.+.||+|+||.||+|.+. +++.||+|++... ......+|+.+++.+. ||||+++++++.+....|+||||+.+|+|
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L 93 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR--MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGEL 93 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG--GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBH
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh--hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcH
Confidence 478999999999999975 7899999998643 3466789999999997 99999999999999999999999999999
Q ss_pred HHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCC---ceEEecccccCCCcc
Q 018712 149 HDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD---IAKISDFDLSNQAPD 225 (351)
Q Consensus 149 ~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~---~vkl~Dfg~a~~~~~ 225 (351)
.+++..... +++..+..++.||+.||.|||+++ |+||||||+|||++.++ .+||+|||+++....
T Consensus 94 ~~~l~~~~~---------~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~ 161 (325)
T 3kn6_A 94 FERIKKKKH---------FSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPP 161 (325)
T ss_dssp HHHHHHCSC---------CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEECCC
T ss_pred HHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccceecCC
Confidence 999987643 899999999999999999999999 99999999999998766 899999999976543
Q ss_pred ccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCc----cch---hhc--------
Q 018712 226 AAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQ----SLV---TWA-------- 290 (351)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~----~~~---~~~-------- 290 (351)
.... .....||+.|+|||++.+..++.++||||||+++|+|++|+.||......... ... ...
T Consensus 162 ~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (325)
T 3kn6_A 162 DNQP--LKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEA 239 (325)
T ss_dssp ------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCSHH
T ss_pred CCCc--ccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCccc
Confidence 3221 24456899999999999999999999999999999999999999865432110 000 000
Q ss_pred ---ccCCCccchhhhcccccCCCCCHHHH
Q 018712 291 ---TPKLSEDKVKQCVDTKLGGEYPPKAI 316 (351)
Q Consensus 291 ---~~~~~~~~~~~~ld~~~~~~~~~~~~ 316 (351)
.+....+.+..|+..+|.+|++.+++
T Consensus 240 ~~~~s~~~~~li~~~L~~dP~~Rpt~~el 268 (325)
T 3kn6_A 240 WKNVSQEAKDLIQGLLTVDPNKRLKMSGL 268 (325)
T ss_dssp HHTSCHHHHHHHHHHHCCCTTTCCCTTTS
T ss_pred ccCCCHHHHHHHHHHCCCChhHCCCHHHH
Confidence 11112367889999999999987654
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-43 Score=320.09 Aligned_cols=261 Identities=25% Similarity=0.285 Sum_probs=199.4
Q ss_pred HHHHHhcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCC------CCchHHHHHHHHHHHhccCCceeeeEEEEec
Q 018712 60 ELKEKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSS------KQPDQEFLAQVSMVSRLKNENVVELVGYYVD 132 (351)
Q Consensus 60 ~~~~~~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~------~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~ 132 (351)
.+....++|.+.+.||+|+||.||+|.+. ++..||+|++... ....+.+.+|++++++++||||+++++++.+
T Consensus 20 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 99 (345)
T 3hko_A 20 SLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYED 99 (345)
T ss_dssp CHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred hhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhcc
Confidence 34567788999999999999999999975 7889999988532 2345678999999999999999999999999
Q ss_pred CCceEEEEEeCCCCCHHHHhccCCCCCC-------------------------------CCCCCCCCHHHHHHHHHHHHH
Q 018712 133 GPLRVLAYEHASKGSLHDILHGKKGVKG-------------------------------AKPGPVLSWAQRVKIAVGAAR 181 (351)
Q Consensus 133 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~-------------------------------~~~~~~l~~~~~~~i~~qi~~ 181 (351)
.+..++||||+++|+|.+++........ ......+++..++.++.||+.
T Consensus 100 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~ 179 (345)
T 3hko_A 100 EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFS 179 (345)
T ss_dssp SSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHH
T ss_pred CCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHH
Confidence 9999999999999999999963211000 000112467778899999999
Q ss_pred HHHhhhhCCCCCeeeccccCCcEEEccCC--ceEEecccccCCCccccc--cccccccccccCccCcccccC--CCCCcc
Q 018712 182 GLEYLHEKAEPRIIHRNIKSSNVLLFDDD--IAKISDFDLSNQAPDAAA--RLHSTRVLGTFGYHAPEYAMT--GQMSSK 255 (351)
Q Consensus 182 ~l~~lH~~~~~~ivH~Dlkp~Nill~~~~--~vkl~Dfg~a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~--~~~~~~ 255 (351)
||.|||+++ |+||||||+|||++.++ .+||+|||++........ ........||+.|+|||++.+ ..++.+
T Consensus 180 ~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~ 256 (345)
T 3hko_A 180 ALHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPK 256 (345)
T ss_dssp HHHHHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTH
T ss_pred HHHHHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcH
Confidence 999999999 99999999999998776 899999999876433211 111245579999999999875 678999
Q ss_pred chhHhHHHHHHHHHcCCCCCCCCCCCCCccchhh--------c---ccCCCccchhhhcccccCCCCCHHHHHHHHHHHH
Q 018712 256 SDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTW--------A---TPKLSEDKVKQCVDTKLGGEYPPKAIAKVRKKKF 324 (351)
Q Consensus 256 ~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~~~--------~---~~~~~~~~~~~~ld~~~~~~~~~~~~~~~~~~~~ 324 (351)
+||||||+++|+|++|+.||...........+.. . .+....+.+..|+..+|.+|++..++ +++.+
T Consensus 257 ~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~---l~hp~ 333 (345)
T 3hko_A 257 CDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRA---LQHPW 333 (345)
T ss_dssp HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHH---HHSHH
T ss_pred HHHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHH---hcChh
Confidence 9999999999999999999986543221111100 0 11122368899999999999988775 44555
Q ss_pred Hh
Q 018712 325 IT 326 (351)
Q Consensus 325 ~~ 326 (351)
+.
T Consensus 334 ~~ 335 (345)
T 3hko_A 334 IS 335 (345)
T ss_dssp HH
T ss_pred hc
Confidence 43
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=334.96 Aligned_cols=252 Identities=21% Similarity=0.313 Sum_probs=204.0
Q ss_pred hcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCC----CchHHHHHHHHHHHhccCCceeeeEEEEecCCceEEE
Q 018712 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK----QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLA 139 (351)
Q Consensus 65 ~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 139 (351)
.++|.+.+.||+|+||.||+|.++ +|+.||+|++.+.. .....+.+|..++++++||||+++++++.+.+..|+|
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 263 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV 263 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence 467999999999999999999975 79999999986432 2345688999999999999999999999999999999
Q ss_pred EEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccc
Q 018712 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDL 219 (351)
Q Consensus 140 ~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~ 219 (351)
|||+.||+|.+++...... ...+++..++.++.||+.||.|||++| |+||||||+|||++.+|++||+|||+
T Consensus 264 mE~~~gg~L~~~l~~~~~~-----~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGl 335 (543)
T 3c4z_A 264 MTIMNGGDIRYHIYNVDED-----NPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGL 335 (543)
T ss_dssp ECCCTTCBHHHHHHTSSTT-----SCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTT
T ss_pred EEeccCCCHHHHHHHhhcc-----cccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecce
Confidence 9999999999999765321 123899999999999999999999999 99999999999999999999999999
Q ss_pred cCCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCcc-c---hhhc-----
Q 018712 220 SNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQS-L---VTWA----- 290 (351)
Q Consensus 220 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~-~---~~~~----- 290 (351)
++........ ....+||+.|+|||++.+..++.++|||||||++|||++|+.||.......... + +...
T Consensus 336 a~~~~~~~~~--~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~~~p 413 (543)
T 3c4z_A 336 AVELKAGQTK--TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYP 413 (543)
T ss_dssp CEECCTTCCC--BCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCCCCC
T ss_pred eeeccCCCcc--cccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcccCCC
Confidence 9876443221 234589999999999999999999999999999999999999998754322111 1 1111
Q ss_pred --ccCCCccchhhhcccccCCCCCHHH--HHHHHHHHHHh
Q 018712 291 --TPKLSEDKVKQCVDTKLGGEYPPKA--IAKVRKKKFIT 326 (351)
Q Consensus 291 --~~~~~~~~~~~~ld~~~~~~~~~~~--~~~~~~~~~~~ 326 (351)
.+....+.+..|+..+|.+|++..+ +..+..+.++.
T Consensus 414 ~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~ 453 (543)
T 3c4z_A 414 DKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFR 453 (543)
T ss_dssp TTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGT
T ss_pred cccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCcccc
Confidence 1111236888999999999997532 34455565543
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-42 Score=305.73 Aligned_cols=242 Identities=26% Similarity=0.337 Sum_probs=199.3
Q ss_pred HhcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCC--CchHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEE
Q 018712 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK--QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAY 140 (351)
Q Consensus 64 ~~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 140 (351)
..++|++.+.||+|+||.||+|.+. +++.||+|++.... ...+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 84 (276)
T 2yex_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 84 (276)
T ss_dssp HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEE
Confidence 4568999999999999999999976 78999999986432 33467889999999999999999999999999999999
Q ss_pred EeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEeccccc
Q 018712 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (351)
Q Consensus 141 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a 220 (351)
||+++++|.+++.... .++...+..++.|++.||.|||++| ++||||||+||+++.++.+||+|||.+
T Consensus 85 e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~ 152 (276)
T 2yex_A 85 EYCSGGELFDRIEPDI---------GMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLA 152 (276)
T ss_dssp ECCTTEEGGGGSBTTT---------BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred EecCCCcHHHHHhhcc---------CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCc
Confidence 9999999999997643 2899999999999999999999999 999999999999999999999999998
Q ss_pred CCCccccccccccccccccCccCcccccCCCC-CccchhHhHHHHHHHHHcCCCCCCCCCCCCCcc-chh---------h
Q 018712 221 NQAPDAAARLHSTRVLGTFGYHAPEYAMTGQM-SSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQS-LVT---------W 289 (351)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~-~~~---------~ 289 (351)
................||+.|+|||.+.+..+ +.++||||||+++|+|++|+.||.......... ... .
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (276)
T 2yex_A 153 TVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWK 232 (276)
T ss_dssp EECEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTSTTGG
T ss_pred cccCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccccCchh
Confidence 76543332222345678999999999987765 778999999999999999999998754432110 000 0
Q ss_pred cccCCCccchhhhcccccCCCCCHHHHH
Q 018712 290 ATPKLSEDKVKQCVDTKLGGEYPPKAIA 317 (351)
Q Consensus 290 ~~~~~~~~~~~~~ld~~~~~~~~~~~~~ 317 (351)
..+....+.+..|+..+|.+|++.+++.
T Consensus 233 ~~~~~~~~li~~~l~~~p~~Rps~~~il 260 (276)
T 2yex_A 233 KIDSAPLALLHKILVENPSARITIPDIK 260 (276)
T ss_dssp GSCHHHHHHHHHHSCSSTTTSCCHHHHT
T ss_pred hcCHHHHHHHHHHCCCCchhCCCHHHHh
Confidence 1111123688999999999999887663
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-42 Score=308.38 Aligned_cols=244 Identities=29% Similarity=0.468 Sum_probs=186.8
Q ss_pred hcCCCCCceeccCCcEEEEEEEECCCCEEEEEEcCCCCCc---hHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEEE
Q 018712 65 TDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYE 141 (351)
Q Consensus 65 ~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 141 (351)
.++|++.+.||+|+||.||+|.+. ..+|+|++...... .+.+.+|+.++++++||||++++++. ..+..++|||
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e 99 (289)
T 3og7_A 23 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQ 99 (289)
T ss_dssp TTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEE
T ss_pred ccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEE
Confidence 467999999999999999999864 35999998765433 35688999999999999999999965 5567899999
Q ss_pred eCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccccC
Q 018712 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (351)
Q Consensus 142 ~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~ 221 (351)
|+.+++|.+++..... .+++..++.++.|++.||.|||+++ ++||||||+|||++.++.+||+|||++.
T Consensus 100 ~~~~~~L~~~l~~~~~--------~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~ 168 (289)
T 3og7_A 100 WCEGSSLYHHLHASET--------KFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLAT 168 (289)
T ss_dssp CCCEEEHHHHHTTC-----------CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC---
T ss_pred ecCCCcHHHHHhhccC--------CCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceecc
Confidence 9999999999965432 2899999999999999999999999 9999999999999999999999999997
Q ss_pred CCccccccccccccccccCccCccccc---CCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCcc-ch---------h
Q 018712 222 QAPDAAARLHSTRVLGTFGYHAPEYAM---TGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQS-LV---------T 288 (351)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~-~~---------~ 288 (351)
...............||+.|+|||++. +..++.++||||||+++|+|++|+.||.......... .+ .
T Consensus 169 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 248 (289)
T 3og7_A 169 EKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLS 248 (289)
T ss_dssp ---------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCTT
T ss_pred ccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcchh
Confidence 655433332334567999999999986 6678899999999999999999999998654322110 00 0
Q ss_pred h---cccCCCccchhhhcccccCCCCCHHHHHHHHHH
Q 018712 289 W---ATPKLSEDKVKQCVDTKLGGEYPPKAIAKVRKK 322 (351)
Q Consensus 289 ~---~~~~~~~~~~~~~ld~~~~~~~~~~~~~~~~~~ 322 (351)
. ..+....+.+..|+..++.+|++.+++...++-
T Consensus 249 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~ 285 (289)
T 3og7_A 249 KVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEE 285 (289)
T ss_dssp SSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred hccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHH
Confidence 0 111112367899999999999999988776653
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-42 Score=314.77 Aligned_cols=259 Identities=22% Similarity=0.339 Sum_probs=205.9
Q ss_pred hcCCCCCceeccCCcEEEEEEEEC--------CCCEEEEEEcCCCCCc--hHHHHHHHHHHHhc-cCCceeeeEEEEecC
Q 018712 65 TDNFGTNSLIGEGSYGRVYFGVLR--------SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRL-KNENVVELVGYYVDG 133 (351)
Q Consensus 65 ~~~y~~~~~Lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l-~h~niv~~~~~~~~~ 133 (351)
.++|.+.+.||+|+||.||+|.+. ++..||+|++...... ...+.+|+.+++++ +||||+++++++.+.
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 113 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 113 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence 468999999999999999999863 4678999999765432 35688999999999 899999999999999
Q ss_pred CceEEEEEeCCCCCHHHHhccCCCCCC-------CCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEE
Q 018712 134 PLRVLAYEHASKGSLHDILHGKKGVKG-------AKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLL 206 (351)
Q Consensus 134 ~~~~lv~e~~~~gsL~~~l~~~~~~~~-------~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill 206 (351)
+..++||||+.+|+|.+++........ ......+++..++.++.||+.||.|||+++ |+||||||+|||+
T Consensus 114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll 190 (334)
T 2pvf_A 114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLV 190 (334)
T ss_dssp SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEE
T ss_pred CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccceEEE
Confidence 999999999999999999986542110 011223889999999999999999999999 9999999999999
Q ss_pred ccCCceEEecccccCCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCCcc
Q 018712 207 FDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQS 285 (351)
Q Consensus 207 ~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~Pf~~~~~~~~~~ 285 (351)
+.++.+||+|||++................+|+.|+|||++.+..++.++||||||+++|+|++ |+.||..........
T Consensus 191 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~ 270 (334)
T 2pvf_A 191 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK 270 (334)
T ss_dssp CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHH
T ss_pred cCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHHHH
Confidence 9999999999999976654332222344567889999999998899999999999999999999 999998654322111
Q ss_pred chhh--------cccCCCccchhhhcccccCCCCCHHHHHHHHHHHHHh
Q 018712 286 LVTW--------ATPKLSEDKVKQCVDTKLGGEYPPKAIAKVRKKKFIT 326 (351)
Q Consensus 286 ~~~~--------~~~~~~~~~~~~~ld~~~~~~~~~~~~~~~~~~~~~~ 326 (351)
.+.. ..+....+.+..|+..+|.+|++.+++...++-.+..
T Consensus 271 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~ 319 (334)
T 2pvf_A 271 LLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTL 319 (334)
T ss_dssp HHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 1111 1111123678899999999999999998877766543
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-43 Score=318.70 Aligned_cols=244 Identities=21% Similarity=0.346 Sum_probs=190.2
Q ss_pred cCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCCc--hHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEEEe
Q 018712 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEH 142 (351)
Q Consensus 66 ~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 142 (351)
++|.+.+.||+|+||.||+|.+. +++.||+|++...... ...+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 57999999999999999999976 7899999998654322 12355799999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccccCC
Q 018712 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222 (351)
Q Consensus 143 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~ 222 (351)
+.+ +|.+++..... .+++..+..++.||+.||.|||++| |+||||||+|||++.++.+||+|||++..
T Consensus 82 ~~~-~l~~~~~~~~~--------~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~ 149 (324)
T 3mtl_A 82 LDK-DLKQYLDDCGN--------IINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARA 149 (324)
T ss_dssp CSE-EHHHHHHHTTT--------CCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEEC
T ss_pred ccc-CHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCccccc
Confidence 975 99999876542 2889999999999999999999999 99999999999999999999999999876
Q ss_pred CccccccccccccccccCccCcccccC-CCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccchhh------------
Q 018712 223 APDAAARLHSTRVLGTFGYHAPEYAMT-GQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTW------------ 289 (351)
Q Consensus 223 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~~~------------ 289 (351)
....... .....||+.|+|||++.+ ..++.++||||||+++|+|++|+.||...........+..
T Consensus 150 ~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 227 (324)
T 3mtl_A 150 KSIPTKT--YDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPG 227 (324)
T ss_dssp C--------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTT
T ss_pred ccCCccc--cccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchh
Confidence 5433221 234568999999999876 5689999999999999999999999987543211111000
Q ss_pred ----------------------cccCC---CccchhhhcccccCCCCCHHHHHHHHHHHHHh
Q 018712 290 ----------------------ATPKL---SEDKVKQCVDTKLGGEYPPKAIAKVRKKKFIT 326 (351)
Q Consensus 290 ----------------------~~~~~---~~~~~~~~ld~~~~~~~~~~~~~~~~~~~~~~ 326 (351)
..+.. ..+.+..|+..+|.+|++++++ +++.++.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~---l~hp~f~ 286 (324)
T 3mtl_A 228 ILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDA---MKHPFFL 286 (324)
T ss_dssp GGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHH---TTSGGGG
T ss_pred hhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHH---hcChhhh
Confidence 00011 1368899999999999987765 4455544
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-42 Score=307.27 Aligned_cols=239 Identities=21% Similarity=0.349 Sum_probs=196.3
Q ss_pred hcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCC-------chHHHHHHHHHHHhccCCceeeeEEEEecCCce
Q 018712 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ-------PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLR 136 (351)
Q Consensus 65 ~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 136 (351)
.++|.+.+.||+|+||.||+|... +++.||+|++..... ..+.+.+|+.++++++||||+++++++.+.+..
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV 83 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence 356899999999999999999976 789999998864321 256789999999999999999999999999999
Q ss_pred EEEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCC----ce
Q 018712 137 VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD----IA 212 (351)
Q Consensus 137 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~----~v 212 (351)
++||||+++++|.+++..... +++..+..++.||+.||.|||+++ ++||||||+||+++.++ .+
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~---------~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~ 151 (283)
T 3bhy_A 84 VLILELVSGGELFDFLAEKES---------LTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRI 151 (283)
T ss_dssp EEEEECCCSCBHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCE
T ss_pred EEEEeecCCCcHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCce
Confidence 999999999999999976432 899999999999999999999999 99999999999998877 89
Q ss_pred EEecccccCCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccchhh---
Q 018712 213 KISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTW--- 289 (351)
Q Consensus 213 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~~~--- 289 (351)
||+|||++........ .....||+.|+|||++.+..++.++||||||+++|+|++|+.||...........+..
T Consensus 152 kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~ 228 (283)
T 3bhy_A 152 KLIDFGIAHKIEAGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNY 228 (283)
T ss_dssp EECCCTTCEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCC
T ss_pred EEEecccceeccCCCc---ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhccc
Confidence 9999999876543322 1345689999999999999999999999999999999999999986543221111111
Q ss_pred --------cccCCCccchhhhcccccCCCCCHHHHHH
Q 018712 290 --------ATPKLSEDKVKQCVDTKLGGEYPPKAIAK 318 (351)
Q Consensus 290 --------~~~~~~~~~~~~~ld~~~~~~~~~~~~~~ 318 (351)
..+....+.+..|+..+|.+|++.+++..
T Consensus 229 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 265 (283)
T 3bhy_A 229 DFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLE 265 (283)
T ss_dssp CCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence 11112236789999999999999877654
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-42 Score=305.89 Aligned_cols=241 Identities=28% Similarity=0.432 Sum_probs=195.2
Q ss_pred hcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCCch--------HHHHHHHHHHHhccCCceeeeEEEEecCCc
Q 018712 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPD--------QEFLAQVSMVSRLKNENVVELVGYYVDGPL 135 (351)
Q Consensus 65 ~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 135 (351)
.++|++.+.||+|+||.||+|.+. +++.||+|++....... +.+.+|+.++++++||||+++++++.+..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 96 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP- 96 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence 468999999999999999999975 78999999986543221 56889999999999999999999987654
Q ss_pred eEEEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCc----
Q 018712 136 RVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDI---- 211 (351)
Q Consensus 136 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~---- 211 (351)
++||||+.+++|.+++..... .+++..++.++.|++.||.|||+++. +++||||||+|||++.++.
T Consensus 97 -~lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~~~~~l~~~l~~lH~~~~-~ivH~dikp~Nil~~~~~~~~~~ 166 (287)
T 4f0f_A 97 -RMVMEFVPCGDLYHRLLDKAH--------PIKWSVKLRLMLDIALGIEYMQNQNP-PIVHRDLRSPNIFLQSLDENAPV 166 (287)
T ss_dssp -EEEEECCTTCBHHHHHHCTTS--------CCCHHHHHHHHHHHHHHHHHHHTSSS-CCBCSCCSGGGEEESCCCTTCSC
T ss_pred -eEEEEecCCCCHHHHHhcccC--------CccHHHHHHHHHHHHHHHHHHHhCCC-CeecCCCCcceEEEeccCCCCce
Confidence 799999999999998865432 28999999999999999999999852 2999999999999988776
Q ss_pred -eEEecccccCCCccccccccccccccccCccCccccc--CCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccc--
Q 018712 212 -AKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAM--TGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSL-- 286 (351)
Q Consensus 212 -vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~-- 286 (351)
+||+|||+++..... .....||+.|+|||++. ...++.++||||||+++|+|++|+.||...........
T Consensus 167 ~~kl~Dfg~~~~~~~~-----~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~ 241 (287)
T 4f0f_A 167 CAKVADFGLSQQSVHS-----VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINM 241 (287)
T ss_dssp CEEECCCTTCBCCSSC-----EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHH
T ss_pred eEEeCCCCcccccccc-----ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHH
Confidence 999999999765432 24457999999999984 45678999999999999999999999986543322100
Q ss_pred ---------hhhcccCCCccchhhhcccccCCCCCHHHHHHHHH
Q 018712 287 ---------VTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKVRK 321 (351)
Q Consensus 287 ---------~~~~~~~~~~~~~~~~ld~~~~~~~~~~~~~~~~~ 321 (351)
.....+....+.+..|+..+|.+|++.+++.+.++
T Consensus 242 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~ 285 (287)
T 4f0f_A 242 IREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELS 285 (287)
T ss_dssp HHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HhccCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHH
Confidence 00111112236888999999999999998877653
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-42 Score=331.57 Aligned_cols=240 Identities=24% Similarity=0.341 Sum_probs=197.2
Q ss_pred HHhcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCC--------------CchHHHHHHHHHHHhccCCceeeeE
Q 018712 63 EKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK--------------QPDQEFLAQVSMVSRLKNENVVELV 127 (351)
Q Consensus 63 ~~~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--------------~~~~~~~~e~~~l~~l~h~niv~~~ 127 (351)
...++|.+.+.||+|+||.||+|.+. ++..||+|++.... ...+.+.+|+.++++++||||++++
T Consensus 33 ~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~ 112 (504)
T 3q5i_A 33 KIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLF 112 (504)
T ss_dssp CGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred CcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEE
Confidence 35678999999999999999999976 68899999986543 2246788999999999999999999
Q ss_pred EEEecCCceEEEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEc
Q 018712 128 GYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLF 207 (351)
Q Consensus 128 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~ 207 (351)
+++.+....++||||+.+|+|.+++..... +++..+..++.||+.||.|||++| |+||||||+|||++
T Consensus 113 ~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~---------~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~ 180 (504)
T 3q5i_A 113 DVFEDKKYFYLVTEFYEGGELFEQIINRHK---------FDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLE 180 (504)
T ss_dssp EEEECSSEEEEEEECCTTCBHHHHHHHHSC---------CCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEES
T ss_pred EEEEcCCEEEEEEecCCCCcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEe
Confidence 999999999999999999999999976543 899999999999999999999999 99999999999998
Q ss_pred cCC---ceEEecccccCCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCc
Q 018712 208 DDD---IAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQ 284 (351)
Q Consensus 208 ~~~---~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~ 284 (351)
.++ .+||+|||++........ .....||+.|+|||++. ..++.++||||||+++|+|++|+.||.........
T Consensus 181 ~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~ 256 (504)
T 3q5i_A 181 NKNSLLNIKIVDFGLSSFFSKDYK---LRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDII 256 (504)
T ss_dssp STTCCSSEEECCCTTCEECCTTSC---BCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred cCCCCccEEEEECCCCEEcCCCCc---cccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 876 699999999976644322 24457999999999876 56899999999999999999999999876443222
Q ss_pred cchhhc-----------ccCCCccchhhhcccccCCCCCHHHHHH
Q 018712 285 SLVTWA-----------TPKLSEDKVKQCVDTKLGGEYPPKAIAK 318 (351)
Q Consensus 285 ~~~~~~-----------~~~~~~~~~~~~ld~~~~~~~~~~~~~~ 318 (351)
..+... .+....+.+..|+..+|.+|++++++..
T Consensus 257 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~ 301 (504)
T 3q5i_A 257 KKVEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALN 301 (504)
T ss_dssp HHHHHCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHcCCCCCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 211111 1112236889999999999999887643
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=328.65 Aligned_cols=201 Identities=24% Similarity=0.354 Sum_probs=158.0
Q ss_pred hcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCCc---hHHHHHHHHHHHhccCCceeeeEEEEec-----CCc
Q 018712 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVD-----GPL 135 (351)
Q Consensus 65 ~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~-----~~~ 135 (351)
.++|.+.+.||+|+||.||+|.+. +++.||||++...... .+.+.+|+++|+.++||||+++++++.. ...
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 478999999999999999999975 7899999998754332 3568899999999999999999999843 356
Q ss_pred eEEEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEe
Q 018712 136 RVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKIS 215 (351)
Q Consensus 136 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~ 215 (351)
.|+||||+. ++|.+++..... +++..+..++.||+.||.|||++| |+||||||+|||++.++.+||+
T Consensus 132 ~~lv~e~~~-~~L~~~~~~~~~---------l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~ 198 (458)
T 3rp9_A 132 LYVVLEIAD-SDFKKLFRTPVY---------LTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVC 198 (458)
T ss_dssp EEEEECCCS-EEHHHHHHSSCC---------CCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEEC
T ss_pred EEEEEeccc-cchhhhcccCCC---------CCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeec
Confidence 899999985 699999976543 899999999999999999999999 9999999999999999999999
Q ss_pred cccccCCCcccccc-------------------------ccccccccccCccCcccc-cCCCCCccchhHhHHHHHHHHH
Q 018712 216 DFDLSNQAPDAAAR-------------------------LHSTRVLGTFGYHAPEYA-MTGQMSSKSDVYSFGVVLLELL 269 (351)
Q Consensus 216 Dfg~a~~~~~~~~~-------------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwslG~il~el~ 269 (351)
|||+++........ ...+..+||+.|+|||++ .+..++.++|||||||++|||+
T Consensus 199 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~ell 278 (458)
T 3rp9_A 199 DFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELL 278 (458)
T ss_dssp CCTTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHH
T ss_pred ccccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHH
Confidence 99999876422110 112445789999999976 4667999999999999999999
Q ss_pred c-----------CCCCCCCC
Q 018712 270 T-----------GRKPVDHT 278 (351)
Q Consensus 270 t-----------g~~Pf~~~ 278 (351)
+ |+++|.+.
T Consensus 279 tg~~~~~~~~~~~~p~f~g~ 298 (458)
T 3rp9_A 279 NMIKENVAYHADRGPLFPGS 298 (458)
T ss_dssp TTSTTTCSSGGGCCCSCC--
T ss_pred HhccccccccccccccCCCC
Confidence 9 66666553
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-42 Score=317.96 Aligned_cols=243 Identities=22% Similarity=0.348 Sum_probs=199.3
Q ss_pred HHHHhcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCCc---------hHHHHHHHHHHHhc-cCCceeeeEEE
Q 018712 61 LKEKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP---------DQEFLAQVSMVSRL-KNENVVELVGY 129 (351)
Q Consensus 61 ~~~~~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---------~~~~~~e~~~l~~l-~h~niv~~~~~ 129 (351)
.....++|.+.+.||+|+||.||+|.+. +|+.||||++...... .+.+.+|+.+++++ +||||++++++
T Consensus 89 ~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 168 (365)
T 2y7j_A 89 AKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDS 168 (365)
T ss_dssp HHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred hhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEE
Confidence 3455678999999999999999999986 7999999998654321 24577899999999 79999999999
Q ss_pred EecCCceEEEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccC
Q 018712 130 YVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDD 209 (351)
Q Consensus 130 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~ 209 (351)
+...+..++||||+.+++|.+++..... +++..+..++.||+.||.|||+.| ++||||||+|||++.+
T Consensus 169 ~~~~~~~~lv~e~~~g~~L~~~l~~~~~---------l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~ 236 (365)
T 2y7j_A 169 YESSSFMFLVFDLMRKGELFDYLTEKVA---------LSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDN 236 (365)
T ss_dssp EEBSSEEEEEECCCTTCBHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTT
T ss_pred EeeCCEEEEEEEeCCCCcHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCC
Confidence 9999999999999999999999976532 899999999999999999999999 9999999999999999
Q ss_pred CceEEecccccCCCccccccccccccccccCccCcccccC------CCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCC
Q 018712 210 DIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMT------GQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQ 283 (351)
Q Consensus 210 ~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~ 283 (351)
+.+||+|||++........ .....||+.|+|||++.+ ..++.++||||||+++|+|++|+.||........
T Consensus 237 ~~ikl~DfG~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~ 313 (365)
T 2y7j_A 237 MQIRLSDFGFSCHLEPGEK---LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILM 313 (365)
T ss_dssp CCEEECCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred CCEEEEecCcccccCCCcc---cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHH
Confidence 9999999999876643322 244679999999998863 3588999999999999999999999976432211
Q ss_pred ccchhh-----------cccCCCccchhhhcccccCCCCCHHHHHH
Q 018712 284 QSLVTW-----------ATPKLSEDKVKQCVDTKLGGEYPPKAIAK 318 (351)
Q Consensus 284 ~~~~~~-----------~~~~~~~~~~~~~ld~~~~~~~~~~~~~~ 318 (351)
...+.. ..+....+.+..|+..+|.+|++.+++..
T Consensus 314 ~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 314 LRMIMEGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp HHHHHHTCCCCCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHHHhCCCCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 111111 01111236888999999999999877643
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=309.30 Aligned_cols=242 Identities=24% Similarity=0.337 Sum_probs=192.4
Q ss_pred HhcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCC--CchHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEE
Q 018712 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK--QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAY 140 (351)
Q Consensus 64 ~~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 140 (351)
..++|.+.+.||+|+||.||++... ++..+|+|++.... ...+.+.+|++++++++||||+++++++.+....++||
T Consensus 20 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 99 (285)
T 3is5_A 20 IDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVM 99 (285)
T ss_dssp HHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEE
Confidence 4467999999999999999999975 68899999986543 33577899999999999999999999999999999999
Q ss_pred EeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEE---ccCCceEEecc
Q 018712 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLL---FDDDIAKISDF 217 (351)
Q Consensus 141 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill---~~~~~vkl~Df 217 (351)
||+.+++|.+++...... ...+++..++.++.||+.||.|||++| |+||||||+||++ +.++.+||+||
T Consensus 100 e~~~~~~L~~~l~~~~~~-----~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Df 171 (285)
T 3is5_A 100 ETCEGGELLERIVSAQAR-----GKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDF 171 (285)
T ss_dssp CCCSCCBHHHHHHHHHHH-----TCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCC
T ss_pred EeCCCCcHHHHHHhhhhc-----ccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEee
Confidence 999999999998643110 012899999999999999999999999 9999999999999 44578999999
Q ss_pred cccCCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccchhhcc------
Q 018712 218 DLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWAT------ 291 (351)
Q Consensus 218 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~~~~~------ 291 (351)
|++........ .....||+.|+|||++. ..++.++||||||+++|+|++|+.||................
T Consensus 172 g~a~~~~~~~~---~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 247 (285)
T 3is5_A 172 GLAELFKSDEH---STNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVE 247 (285)
T ss_dssp CCCCC-------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCC-
T ss_pred ecceecCCccc---CcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcccccc
Confidence 99976544322 24457899999999875 568999999999999999999999998654322211111111
Q ss_pred ----cCCCccchhhhcccccCCCCCHHHHH
Q 018712 292 ----PKLSEDKVKQCVDTKLGGEYPPKAIA 317 (351)
Q Consensus 292 ----~~~~~~~~~~~ld~~~~~~~~~~~~~ 317 (351)
+....+.+..|+..+|.+|++.+++.
T Consensus 248 ~~~~~~~~~~li~~~L~~dP~~Rps~~e~l 277 (285)
T 3is5_A 248 CRPLTPQAVDLLKQMLTKDPERRPSAAQVL 277 (285)
T ss_dssp -CCCCHHHHHHHHHHTCSCTTTSCCHHHHH
T ss_pred cCcCCHHHHHHHHHHccCChhhCcCHHHHh
Confidence 11112678899999999999987764
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=308.75 Aligned_cols=239 Identities=25% Similarity=0.379 Sum_probs=199.1
Q ss_pred HhcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCC----CCchHHHHHHHHHHHhccCCceeeeEEEEecCCceEE
Q 018712 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSS----KQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVL 138 (351)
Q Consensus 64 ~~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 138 (351)
..++|.+.+.||+|+||.||+|... ++..||+|++... ......+.+|+.++++++||||+++++++.+.+..++
T Consensus 12 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 91 (284)
T 2vgo_A 12 TIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYL 91 (284)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred hhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEE
Confidence 4578999999999999999999976 6789999998542 2234678899999999999999999999999999999
Q ss_pred EEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEeccc
Q 018712 139 AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFD 218 (351)
Q Consensus 139 v~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg 218 (351)
||||+++++|.+++..... +++..+..++.|++.||.|||++| ++||||||+||+++.++.+||+|||
T Consensus 92 v~e~~~~~~L~~~l~~~~~---------~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg 159 (284)
T 2vgo_A 92 MLEFAPRGELYKELQKHGR---------FDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFG 159 (284)
T ss_dssp EECCCTTEEHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCT
T ss_pred EEEeCCCCcHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEeccc
Confidence 9999999999999986542 889999999999999999999999 9999999999999999999999999
Q ss_pred ccCCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccchhhc-------c
Q 018712 219 LSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWA-------T 291 (351)
Q Consensus 219 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~~~~-------~ 291 (351)
++....... .....||+.|+|||.+.+..++.++||||||+++|+|++|+.||...........+... .
T Consensus 160 ~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T 2vgo_A 160 WSVHAPSLR----RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFL 235 (284)
T ss_dssp TCEECSSSC----BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTS
T ss_pred ccccCcccc----cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhccccCCCCcC
Confidence 986554322 23456899999999999999999999999999999999999999865432211111111 1
Q ss_pred cCCCccchhhhcccccCCCCCHHHHHH
Q 018712 292 PKLSEDKVKQCVDTKLGGEYPPKAIAK 318 (351)
Q Consensus 292 ~~~~~~~~~~~ld~~~~~~~~~~~~~~ 318 (351)
+....+.+..|+..+|.+|++.+++..
T Consensus 236 ~~~~~~li~~~l~~~p~~Rps~~~ll~ 262 (284)
T 2vgo_A 236 SDGSKDLISKLLRYHPPQRLPLKGVME 262 (284)
T ss_dssp CHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence 111236889999999999998877643
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=327.51 Aligned_cols=242 Identities=12% Similarity=0.173 Sum_probs=187.8
Q ss_pred hcCCCCCceeccCCcEEEEEEEE-CCCCEEEEEEcCCC----CCchHHHHHHH---HHHHhccCCceeeeE-------EE
Q 018712 65 TDNFGTNSLIGEGSYGRVYFGVL-RSGRAAAIKKLDSS----KQPDQEFLAQV---SMVSRLKNENVVELV-------GY 129 (351)
Q Consensus 65 ~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~----~~~~~~~~~e~---~~l~~l~h~niv~~~-------~~ 129 (351)
.++|.+.+.||+|+||.||+|.+ .+++.||||++... ....+.+.+|+ +++++++||||++++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 36688899999999999999996 57999999998632 23346788999 455566899999998 66
Q ss_pred EecCC-----------------ceEEEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCC
Q 018712 130 YVDGP-----------------LRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEP 192 (351)
Q Consensus 130 ~~~~~-----------------~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~ 192 (351)
+.+.+ ..|+||||+ +|+|.+++....... .....+++..++.++.||+.||.|||++|
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~--~~~~~l~~~~~~~i~~qi~~aL~~LH~~~-- 226 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHS--STHKSLVHHARLQLTLQVIRLLASLHHYG-- 226 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTT--TTTHHHHHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccc--cccccccHHHHHHHHHHHHHHHHHHHhCC--
Confidence 66553 278999999 579999998643210 00112445788889999999999999999
Q ss_pred CeeeccccCCcEEEccCCceEEecccccCCCccccccccccccccccCccCcccccCC-----------CCCccchhHhH
Q 018712 193 RIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTG-----------QMSSKSDVYSF 261 (351)
Q Consensus 193 ~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~Dvwsl 261 (351)
|+||||||+|||++.++.+||+|||+++..... .....| +.|+|||++.+. .++.++|||||
T Consensus 227 -ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSl 299 (377)
T 3byv_A 227 -LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAR-----VVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWAL 299 (377)
T ss_dssp -EECSCCCGGGEEECTTCCEEECCGGGCEETTCE-----EECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHH
T ss_pred -eecCCCCHHHEEEcCCCCEEEEechhheecCCc-----ccCCCC-cCccChhhhcccccccccccccccCChhhhHHHH
Confidence 999999999999999999999999999764332 234567 999999999887 89999999999
Q ss_pred HHHHHHHHcCCCCCCCCCCCCCccchhhcccCCC---ccchhhhcccccCCCCCHHHHHH
Q 018712 262 GVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLS---EDKVKQCVDTKLGGEYPPKAIAK 318 (351)
Q Consensus 262 G~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~---~~~~~~~ld~~~~~~~~~~~~~~ 318 (351)
|+++|||++|+.||...........+....+.++ .+.+..|+..+|.+|++.+++.+
T Consensus 300 G~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 359 (377)
T 3byv_A 300 GLVIYWIWCADLPITKDAALGGSEWIFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAME 359 (377)
T ss_dssp HHHHHHHHHSSCCC------CCSGGGGSSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred HHHHHHHHHCCCCCcccccccchhhhhhhccCCCHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence 9999999999999987655444433333223333 36889999999999999887754
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-42 Score=306.47 Aligned_cols=250 Identities=26% Similarity=0.388 Sum_probs=201.8
Q ss_pred hcCCCCCc-eeccCCcEEEEEEEEC---CCCEEEEEEcCCCCC--chHHHHHHHHHHHhccCCceeeeEEEEecCCceEE
Q 018712 65 TDNFGTNS-LIGEGSYGRVYFGVLR---SGRAAAIKKLDSSKQ--PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVL 138 (351)
Q Consensus 65 ~~~y~~~~-~Lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 138 (351)
.++|.+.+ .||+|+||.||+|.+. ++..||+|++..... ..+.+.+|++++++++||||+++++++ ..+..++
T Consensus 8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~l 86 (287)
T 1u59_A 8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALML 86 (287)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEE
T ss_pred HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEE
Confidence 35666666 8999999999999864 678899999976533 246688999999999999999999998 4557899
Q ss_pred EEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEeccc
Q 018712 139 AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFD 218 (351)
Q Consensus 139 v~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg 218 (351)
||||+.+++|.+++..... .+++..++.++.|++.||.|||+++ ++||||||+||+++.++.+||+|||
T Consensus 87 v~e~~~~~~L~~~l~~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg 155 (287)
T 1u59_A 87 VMEMAGGGPLHKFLVGKRE--------EIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFG 155 (287)
T ss_dssp EEECCTTEEHHHHHTTCTT--------TSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCT
T ss_pred EEEeCCCCCHHHHHHhCCc--------cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECccc
Confidence 9999999999999975432 2899999999999999999999999 9999999999999999999999999
Q ss_pred ccCCCcccccc-ccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCCccchhh-------
Q 018712 219 LSNQAPDAAAR-LHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTW------- 289 (351)
Q Consensus 219 ~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~Pf~~~~~~~~~~~~~~------- 289 (351)
++......... .......+|+.|+|||++.+..++.++||||||+++|+|++ |+.||...........+..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~~~~~~ 235 (287)
T 1u59_A 156 LSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECP 235 (287)
T ss_dssp TCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCC
T ss_pred ceeeeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCCcCCCC
Confidence 99766433221 11233456889999999998899999999999999999998 9999987654322111111
Q ss_pred -cccCCCccchhhhcccccCCCCCHHHHHHHHHHHHHh
Q 018712 290 -ATPKLSEDKVKQCVDTKLGGEYPPKAIAKVRKKKFIT 326 (351)
Q Consensus 290 -~~~~~~~~~~~~~ld~~~~~~~~~~~~~~~~~~~~~~ 326 (351)
..+....+.+..|+..+|.+|++.+++...++..+..
T Consensus 236 ~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 273 (287)
T 1u59_A 236 PECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 273 (287)
T ss_dssp TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 1111223688999999999999999998877766543
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=312.13 Aligned_cols=248 Identities=24% Similarity=0.344 Sum_probs=195.4
Q ss_pred hcCCCCCceeccCCcEEEEEEEE-----CCCCEEEEEEcCCCCCc-hHHHHHHHHHHHhccCCceeeeEEEEecC--Cce
Q 018712 65 TDNFGTNSLIGEGSYGRVYFGVL-----RSGRAAAIKKLDSSKQP-DQEFLAQVSMVSRLKNENVVELVGYYVDG--PLR 136 (351)
Q Consensus 65 ~~~y~~~~~Lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~-~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~ 136 (351)
.++|++.+.||+|+||.||+|.+ .+++.||+|++...... .+.+.+|+.++++++||||+++++++... ...
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 88 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence 46799999999999999999984 26889999999765432 35688999999999999999999998643 458
Q ss_pred EEEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEec
Q 018712 137 VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISD 216 (351)
Q Consensus 137 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~D 216 (351)
++||||+++++|.+++..... .+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|
T Consensus 89 ~lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~D 157 (295)
T 3ugc_A 89 KLIMEYLPYGSLRDYLQKHKE--------RIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGD 157 (295)
T ss_dssp EEEEECCTTCBHHHHHHHCGG--------GCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC
T ss_pred EEEEEeCCCCCHHHHHHhccc--------ccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEcc
Confidence 999999999999999976542 2889999999999999999999999 99999999999999999999999
Q ss_pred ccccCCCcccccc-ccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCC-------C-Cc---
Q 018712 217 FDLSNQAPDAAAR-LHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPR-------G-QQ--- 284 (351)
Q Consensus 217 fg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~-------~-~~--- 284 (351)
||++......... .......+|..|+|||.+.+..++.++||||||+++|+|++|..||...... . ..
T Consensus 158 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~ 237 (295)
T 3ugc_A 158 FGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMI 237 (295)
T ss_dssp CCSCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHH
T ss_pred CcccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchh
Confidence 9999876443221 1123345778899999999999999999999999999999999998753210 0 00
Q ss_pred --cch-----------hhcccCCCccchhhhcccccCCCCCHHHHHHHHHHH
Q 018712 285 --SLV-----------TWATPKLSEDKVKQCVDTKLGGEYPPKAIAKVRKKK 323 (351)
Q Consensus 285 --~~~-----------~~~~~~~~~~~~~~~ld~~~~~~~~~~~~~~~~~~~ 323 (351)
... ....+....+.+..|+..+|.+|++.+++...++-.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l 289 (295)
T 3ugc_A 238 VFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 289 (295)
T ss_dssp HHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 000 000111123688999999999999999887766544
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=309.53 Aligned_cols=241 Identities=23% Similarity=0.364 Sum_probs=196.6
Q ss_pred hcCCCCCceeccCCcEEEEEEEEC-CC-------CEEEEEEcCCCC-CchHHHHHHHHHHHhccCCceeeeEEEEecCCc
Q 018712 65 TDNFGTNSLIGEGSYGRVYFGVLR-SG-------RAAAIKKLDSSK-QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPL 135 (351)
Q Consensus 65 ~~~y~~~~~Lg~G~~g~Vy~~~~~-~~-------~~vavK~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 135 (351)
.++|.+.+.||+|+||.||+|.+. ++ ..||+|++.... ...+.+.+|+.++++++||||+++++++.+.+.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE 86 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence 467999999999999999999865 33 479999986543 334678999999999999999999999999999
Q ss_pred eEEEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCc----
Q 018712 136 RVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDI---- 211 (351)
Q Consensus 136 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~---- 211 (351)
.++||||+.+++|.+++..... .+++..++.++.||+.||.|||+++ |+||||||+|||++.++.
T Consensus 87 ~~lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~ 155 (289)
T 4fvq_A 87 NILVQEFVKFGSLDTYLKKNKN--------CINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTG 155 (289)
T ss_dssp CEEEEECCTTCBHHHHHHHTGG--------GCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGT
T ss_pred CEEEEECCCCCCHHHHHHhCCC--------CCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCccccc
Confidence 9999999999999999987542 2889999999999999999999999 999999999999998887
Q ss_pred ----eEEecccccCCCccccccccccccccccCccCcccccC-CCCCccchhHhHHHHHHHHHcCC-CCCCCCCCCCCcc
Q 018712 212 ----AKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMT-GQMSSKSDVYSFGVVLLELLTGR-KPVDHTLPRGQQS 285 (351)
Q Consensus 212 ----vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~-~Pf~~~~~~~~~~ 285 (351)
+||+|||++...... ....||+.|+|||++.+ ..++.++||||||+++|+|++|. .||..........
T Consensus 156 ~~~~~kl~Dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~ 229 (289)
T 4fvq_A 156 NPPFIKLSDPGISITVLPK------DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQ 229 (289)
T ss_dssp BCCEEEECCCCSCTTTSCH------HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHH
T ss_pred ccceeeeccCcccccccCc------cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHH
Confidence 999999998765432 23457899999999987 67899999999999999999955 5554432211111
Q ss_pred ch------hhcccCCCccchhhhcccccCCCCCHHHHHHHHHH
Q 018712 286 LV------TWATPKLSEDKVKQCVDTKLGGEYPPKAIAKVRKK 322 (351)
Q Consensus 286 ~~------~~~~~~~~~~~~~~~ld~~~~~~~~~~~~~~~~~~ 322 (351)
.. ....+....+.+..|+..+|.+|++.+++.+.++-
T Consensus 230 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~ 272 (289)
T 4fvq_A 230 FYEDRHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNS 272 (289)
T ss_dssp HHHTTCCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHT
T ss_pred HhhccCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 11 11112233478899999999999999988776653
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=315.88 Aligned_cols=256 Identities=23% Similarity=0.341 Sum_probs=203.4
Q ss_pred HHhcCCCCCceeccCCcEEEEEEEEC------CCCEEEEEEcCCCCCc--hHHHHHHHHHHHhccCCceeeeEEEEecCC
Q 018712 63 EKTDNFGTNSLIGEGSYGRVYFGVLR------SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGP 134 (351)
Q Consensus 63 ~~~~~y~~~~~Lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~ 134 (351)
...++|.+.+.||+|+||.||+|.+. +++.||+|++...... ...+.+|+.+++.++||||+++++++.+.+
T Consensus 22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 101 (322)
T 1p4o_A 22 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ 101 (322)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSS
T ss_pred chhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCC
Confidence 34578999999999999999999864 4678999999755432 345889999999999999999999999999
Q ss_pred ceEEEEEeCCCCCHHHHhccCCCCCC-CCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceE
Q 018712 135 LRVLAYEHASKGSLHDILHGKKGVKG-AKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAK 213 (351)
Q Consensus 135 ~~~lv~e~~~~gsL~~~l~~~~~~~~-~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vk 213 (351)
..++||||+.+|+|.+++........ ......+++..++.++.||+.||.|||++| |+||||||+||+++.++.+|
T Consensus 102 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIli~~~~~~k 178 (322)
T 1p4o_A 102 PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVK 178 (322)
T ss_dssp SCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEE
T ss_pred ccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEEEcCCCeEE
Confidence 99999999999999999975321000 000012688999999999999999999999 99999999999999999999
Q ss_pred EecccccCCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCCccchh----
Q 018712 214 ISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVT---- 288 (351)
Q Consensus 214 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~Pf~~~~~~~~~~~~~---- 288 (351)
|+|||++................+|+.|+|||++.+..++.++||||||+++|+|++ |..||...........+.
T Consensus 179 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~ 258 (322)
T 1p4o_A 179 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGL 258 (322)
T ss_dssp ECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCC
T ss_pred ECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHHcCCc
Confidence 999999976644332222334567889999999999999999999999999999999 899998654322111111
Q ss_pred ----hcccCCCccchhhhcccccCCCCCHHHHHHHHH
Q 018712 289 ----WATPKLSEDKVKQCVDTKLGGEYPPKAIAKVRK 321 (351)
Q Consensus 289 ----~~~~~~~~~~~~~~ld~~~~~~~~~~~~~~~~~ 321 (351)
...+....+.+..|+..+|..|++.+++...++
T Consensus 259 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~ 295 (322)
T 1p4o_A 259 LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 295 (322)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHG
T ss_pred CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence 111111236789999999999999998876654
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=319.30 Aligned_cols=239 Identities=22% Similarity=0.314 Sum_probs=189.7
Q ss_pred hcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCCc---hHHHHHHHHHHHhccCCceeeeEEEEecCC------
Q 018712 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVDGP------ 134 (351)
Q Consensus 65 ~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------ 134 (351)
.++|.+.+.||+|+||.||+|.+. +|+.||||++...... .+.+.+|+++++.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 468999999999999999999974 7999999998654333 356789999999999999999999997653
Q ss_pred ceEEEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEE
Q 018712 135 LRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKI 214 (351)
Q Consensus 135 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl 214 (351)
..|+||||+ +++|.+++.... ++...+..++.||+.||.|||++| |+||||||+|||++.++.+||
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~~~----------l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl 169 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKHEK----------LGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKI 169 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHHCC----------CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEE
T ss_pred eEEEEEecC-CCCHHHHHhcCC----------CCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEE
Confidence 459999999 779999998643 889999999999999999999999 999999999999999999999
Q ss_pred ecccccCCCccccccccccccccccCccCcccccC-CCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccchhh----
Q 018712 215 SDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMT-GQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTW---- 289 (351)
Q Consensus 215 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~~~---- 289 (351)
+|||+++..... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.........+..
T Consensus 170 ~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~ 244 (367)
T 1cm8_A 170 LDFGLARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGT 244 (367)
T ss_dssp CCCTTCEECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCC
T ss_pred Eeeecccccccc-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence 999999765432 244578999999999887 6899999999999999999999999986543211110000
Q ss_pred ----------------------------------cccCCCccchhhhcccccCCCCCHHHHHHHHHHHHH
Q 018712 290 ----------------------------------ATPKLSEDKVKQCVDTKLGGEYPPKAIAKVRKKKFI 325 (351)
Q Consensus 290 ----------------------------------~~~~~~~~~~~~~ld~~~~~~~~~~~~~~~~~~~~~ 325 (351)
..+....+.+..|+..+|.+|++++++ +++.++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~---l~hp~f 311 (367)
T 1cm8_A 245 PPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEA---LAHPYF 311 (367)
T ss_dssp CCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHH---HHSGGG
T ss_pred CCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHH---hcChHH
Confidence 001112367889999999999998775 445544
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-42 Score=309.50 Aligned_cols=242 Identities=21% Similarity=0.325 Sum_probs=190.9
Q ss_pred hcCCCCC-ceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCC-chHHHHHHHHHHHhc-cCCceeeeEEEEecCCceEEEE
Q 018712 65 TDNFGTN-SLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ-PDQEFLAQVSMVSRL-KNENVVELVGYYVDGPLRVLAY 140 (351)
Q Consensus 65 ~~~y~~~-~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~ 140 (351)
.+.|.+. +.||+|+||.||+|.+. +++.||+|++..... ....+.+|+++++++ +||||+++++++.+.+..++||
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~ 90 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVF 90 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence 4678874 78999999999999964 789999999875533 356789999999985 7999999999999999999999
Q ss_pred EeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCc---eEEecc
Q 018712 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDI---AKISDF 217 (351)
Q Consensus 141 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~---vkl~Df 217 (351)
||+.+++|.+++..... +++..+..++.||+.||.|||+++ |+||||||+|||++.++. +||+||
T Consensus 91 e~~~~~~L~~~l~~~~~---------~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Df 158 (316)
T 2ac3_A 91 EKMRGGSILSHIHKRRH---------FNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDF 158 (316)
T ss_dssp ECCTTCBHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCT
T ss_pred EcCCCCcHHHHHhccCC---------CCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEc
Confidence 99999999999986542 899999999999999999999999 999999999999988775 999999
Q ss_pred cccCCCccccc-----cccccccccccCccCcccccC-----CCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCc---
Q 018712 218 DLSNQAPDAAA-----RLHSTRVLGTFGYHAPEYAMT-----GQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQ--- 284 (351)
Q Consensus 218 g~a~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~--- 284 (351)
|++........ ........||+.|+|||++.+ ..++.++||||||+++|+|++|+.||.........
T Consensus 159 g~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~ 238 (316)
T 2ac3_A 159 DLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDR 238 (316)
T ss_dssp TCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC--
T ss_pred cCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccc
Confidence 99876542211 111123469999999999875 45789999999999999999999999876433210
Q ss_pred ------------cchhhc-----------ccCCCccchhhhcccccCCCCCHHHHHH
Q 018712 285 ------------SLVTWA-----------TPKLSEDKVKQCVDTKLGGEYPPKAIAK 318 (351)
Q Consensus 285 ------------~~~~~~-----------~~~~~~~~~~~~ld~~~~~~~~~~~~~~ 318 (351)
..+... .+....+.+..|+..+|.+|++++++.+
T Consensus 239 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 295 (316)
T 2ac3_A 239 GEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ 295 (316)
T ss_dssp --CCHHHHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred cccchhHHHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 000000 1111236889999999999998877643
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=336.31 Aligned_cols=247 Identities=27% Similarity=0.429 Sum_probs=204.2
Q ss_pred HhcCCCCCceeccCCcEEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEEEeC
Q 018712 64 KTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHA 143 (351)
Q Consensus 64 ~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 143 (351)
..++|++.+.||+|+||.||+|.+..+..||||++.......+.+.+|+++|++++|+||+++++++.+ +..++||||+
T Consensus 265 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~ 343 (535)
T 2h8h_A 265 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 343 (535)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred chhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehh
Confidence 345688889999999999999999888889999998776667789999999999999999999999876 6789999999
Q ss_pred CCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccccCCC
Q 018712 144 SKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQA 223 (351)
Q Consensus 144 ~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~ 223 (351)
.+|+|.+++...... .+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 344 ~~gsL~~~l~~~~~~-------~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 413 (535)
T 2h8h_A 344 SKGSLLDFLKGETGK-------YLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLI 413 (535)
T ss_dssp TTEEHHHHHSHHHHT-------TCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTSTTTC
T ss_pred cCCcHHHHHhhcCCC-------CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccccceec
Confidence 999999999753211 2889999999999999999999999 999999999999999999999999999876
Q ss_pred ccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCCccchhh--------cccCC
Q 018712 224 PDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTW--------ATPKL 294 (351)
Q Consensus 224 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~Pf~~~~~~~~~~~~~~--------~~~~~ 294 (351)
...... ......++..|+|||++.+..++.++||||||+++|||++ |+.||...........+.. ..+..
T Consensus 414 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 492 (535)
T 2h8h_A 414 EDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPES 492 (535)
T ss_dssp CCHHHH-TTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHH
T ss_pred CCCcee-cccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHH
Confidence 543211 1123456789999999999999999999999999999999 9999987543222111111 11111
Q ss_pred CccchhhhcccccCCCCCHHHHHHHHHH
Q 018712 295 SEDKVKQCVDTKLGGEYPPKAIAKVRKK 322 (351)
Q Consensus 295 ~~~~~~~~ld~~~~~~~~~~~~~~~~~~ 322 (351)
..+.+..|++.++.+|++.+++...++-
T Consensus 493 l~~li~~cl~~dP~~RPt~~~l~~~L~~ 520 (535)
T 2h8h_A 493 LHDLMCQCWRKEPEERPTFEYLQAFLED 520 (535)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred HHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 2367899999999999999988776654
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=313.46 Aligned_cols=249 Identities=19% Similarity=0.270 Sum_probs=193.0
Q ss_pred HHHhcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCCc----hHHHHHHHHHHHhccCCceeeeEEEEecCCce
Q 018712 62 KEKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP----DQEFLAQVSMVSRLKNENVVELVGYYVDGPLR 136 (351)
Q Consensus 62 ~~~~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 136 (351)
....++|.+.+.||+|+||.||+|.+. +++.||+|++...... .+.+.+|+.++++++||||+++++++.+.+..
T Consensus 30 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~ 109 (309)
T 2h34_A 30 GTQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQL 109 (309)
T ss_dssp ----CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEE
T ss_pred CcEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeE
Confidence 345689999999999999999999975 7889999998754322 25688999999999999999999999999999
Q ss_pred EEEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEec
Q 018712 137 VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISD 216 (351)
Q Consensus 137 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~D 216 (351)
++||||+++++|.+++..... +++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|
T Consensus 110 ~lv~e~~~~~~L~~~l~~~~~---------~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~D 177 (309)
T 2h34_A 110 YVDMRLINGVDLAAMLRRQGP---------LAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVD 177 (309)
T ss_dssp EEEEECCCCEEHHHHHHHHCS---------CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECS
T ss_pred EEEEEecCCCCHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEec
Confidence 999999999999999986542 899999999999999999999999 99999999999999999999999
Q ss_pred ccccCCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccchh--------
Q 018712 217 FDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVT-------- 288 (351)
Q Consensus 217 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~~-------- 288 (351)
||++......... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||...........+.
T Consensus 178 fg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 256 (309)
T 2h34_A 178 FGIASATTDEKLT-QLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQAIPRPST 256 (309)
T ss_dssp CCC-----------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHHSCCCCGGG
T ss_pred CccCccccccccc-cccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhccCCCCccc
Confidence 9998765433211 1234568999999999999999999999999999999999999998653221111111
Q ss_pred --hcccCCCccchhhhcccccCCCC-CHHHHHHHHHHH
Q 018712 289 --WATPKLSEDKVKQCVDTKLGGEY-PPKAIAKVRKKK 323 (351)
Q Consensus 289 --~~~~~~~~~~~~~~ld~~~~~~~-~~~~~~~~~~~~ 323 (351)
...+....+.+..|+..+|.+|+ +.+++...++..
T Consensus 257 ~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~ 294 (309)
T 2h34_A 257 VRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAA 294 (309)
T ss_dssp TSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHT
T ss_pred cCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHH
Confidence 11122224688999999999999 888887766544
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-42 Score=329.87 Aligned_cols=240 Identities=24% Similarity=0.327 Sum_probs=197.3
Q ss_pred HHhcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCC---CCchHHHHHHHHHHHhccCCceeeeEEEEecCCceEE
Q 018712 63 EKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSS---KQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVL 138 (351)
Q Consensus 63 ~~~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 138 (351)
...++|.+.+.||+|+||.||+|.+. +++.||+|++... ......+.+|+.++++++||||+++++++.+.+..++
T Consensus 19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 98 (486)
T 3mwu_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI 98 (486)
T ss_dssp HHHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred ChhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEE
Confidence 35578999999999999999999976 7899999998532 3345678999999999999999999999999999999
Q ss_pred EEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEc---cCCceEEe
Q 018712 139 AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLF---DDDIAKIS 215 (351)
Q Consensus 139 v~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~---~~~~vkl~ 215 (351)
||||+.+++|.+++..... +++..+..++.||+.||.|||++| |+||||||+|||++ .++.+||+
T Consensus 99 v~e~~~~~~L~~~~~~~~~---------~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~ 166 (486)
T 3mwu_A 99 VGELYTGGELFDEIIKRKR---------FSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKII 166 (486)
T ss_dssp EECCCCSCBHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEEC
T ss_pred EEEcCCCCcHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEE
Confidence 9999999999999876543 899999999999999999999999 99999999999995 45679999
Q ss_pred cccccCCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccchhhc-----
Q 018712 216 DFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWA----- 290 (351)
Q Consensus 216 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~~~~----- 290 (351)
|||++........ .....||+.|+|||++.+ .++.++||||||+++|+|++|+.||...........+...
T Consensus 167 Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~ 242 (486)
T 3mwu_A 167 DFGLSTCFQQNTK---MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFD 242 (486)
T ss_dssp SCSCTTTBCCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSC
T ss_pred ECCcCeECCCCCc---cCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC
Confidence 9999976543322 244579999999998876 5899999999999999999999999875432211111110
Q ss_pred ------ccCCCccchhhhcccccCCCCCHHHHHH
Q 018712 291 ------TPKLSEDKVKQCVDTKLGGEYPPKAIAK 318 (351)
Q Consensus 291 ------~~~~~~~~~~~~ld~~~~~~~~~~~~~~ 318 (351)
.+....+.+..|+..+|.+|++++++..
T Consensus 243 ~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~ 276 (486)
T 3mwu_A 243 LPQWRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (486)
T ss_dssp SGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred CcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 0111236889999999999999877654
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-42 Score=323.87 Aligned_cols=200 Identities=27% Similarity=0.388 Sum_probs=167.7
Q ss_pred HhcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCCc---hHHHHHHHHHHHhccCCceeeeEEEEecC-----C
Q 018712 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVDG-----P 134 (351)
Q Consensus 64 ~~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~ 134 (351)
..++|.+.+.||+|+||.||+|.+. +++.||||++...... .+.+.+|+++|+.++|+||+++++++... .
T Consensus 24 i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 103 (432)
T 3n9x_A 24 VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFD 103 (432)
T ss_dssp CCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred ecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCC
Confidence 3578999999999999999999975 6889999999754332 35688999999999999999999998766 5
Q ss_pred ceEEEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEE
Q 018712 135 LRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKI 214 (351)
Q Consensus 135 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl 214 (351)
..|+||||+. ++|.+++..... +++..+..++.||+.||.|||++| |+||||||+|||++.++.+||
T Consensus 104 ~~~lv~e~~~-~~L~~~~~~~~~---------l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL 170 (432)
T 3n9x_A 104 ELYIVLEIAD-SDLKKLFKTPIF---------LTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKV 170 (432)
T ss_dssp CEEEEEECCS-EEHHHHHHSSCC---------CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEE
T ss_pred eEEEEEecCC-cCHHHHHhccCC---------CCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEE
Confidence 6899999986 499999986542 899999999999999999999999 999999999999999999999
Q ss_pred ecccccCCCcccccc--------------------ccccccccccCccCcccc-cCCCCCccchhHhHHHHHHHHHcCCC
Q 018712 215 SDFDLSNQAPDAAAR--------------------LHSTRVLGTFGYHAPEYA-MTGQMSSKSDVYSFGVVLLELLTGRK 273 (351)
Q Consensus 215 ~Dfg~a~~~~~~~~~--------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwslG~il~el~tg~~ 273 (351)
+|||+++........ ...+..+||+.|+|||++ .+..++.++|||||||++|||++|..
T Consensus 171 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~ 250 (432)
T 3n9x_A 171 CDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQ 250 (432)
T ss_dssp CCCTTCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCT
T ss_pred ccCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccc
Confidence 999999876433211 112456799999999986 56679999999999999999998655
Q ss_pred CCC
Q 018712 274 PVD 276 (351)
Q Consensus 274 Pf~ 276 (351)
||.
T Consensus 251 p~~ 253 (432)
T 3n9x_A 251 SHI 253 (432)
T ss_dssp TTC
T ss_pred ccc
Confidence 554
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-42 Score=322.34 Aligned_cols=253 Identities=23% Similarity=0.354 Sum_probs=193.3
Q ss_pred HHhcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCC---------CchHHHHHHHHHHHhccCCceeeeEEEEec
Q 018712 63 EKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK---------QPDQEFLAQVSMVSRLKNENVVELVGYYVD 132 (351)
Q Consensus 63 ~~~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---------~~~~~~~~e~~~l~~l~h~niv~~~~~~~~ 132 (351)
...++|.+.+.||+|+||.||+|.+. +++.||+|++.... .....+.+|+.+|++++||||+++++++..
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~ 211 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA 211 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 45688999999999999999999975 68999999986432 112247899999999999999999999854
Q ss_pred CCceEEEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCC--
Q 018712 133 GPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD-- 210 (351)
Q Consensus 133 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~-- 210 (351)
+..++||||+.+|+|.+++..... +++..+..++.|++.||.|||+++ |+||||||+|||++.++
T Consensus 212 -~~~~lv~e~~~~g~L~~~l~~~~~---------~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~ 278 (419)
T 3i6u_A 212 -EDYYIVLELMEGGELFDKVVGNKR---------LKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEED 278 (419)
T ss_dssp -SEEEEEEECCTTCBGGGGTSSSCC---------CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSS
T ss_pred -CceEEEEEcCCCCcHHHHHhccCC---------CCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCc
Confidence 457999999999999999876543 899999999999999999999999 99999999999997544
Q ss_pred -ceEEecccccCCCccccccccccccccccCccCcccccC---CCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCc-c
Q 018712 211 -IAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMT---GQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQ-S 285 (351)
Q Consensus 211 -~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~-~ 285 (351)
.+||+|||+++....... .....||+.|+|||++.+ ..++.++||||||+++|+|++|+.||......... .
T Consensus 279 ~~~kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~ 355 (419)
T 3i6u_A 279 CLIKITDFGHSKILGETSL---MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKD 355 (419)
T ss_dssp CCEEECCSSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHH
T ss_pred ceEEEeecccceecCCCcc---ccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHH
Confidence 599999999987654322 245679999999999863 57788999999999999999999999865433211 1
Q ss_pred chh--------hcccCC---CccchhhhcccccCCCCCHHHHHHHHHHHHHhhhhccccc
Q 018712 286 LVT--------WATPKL---SEDKVKQCVDTKLGGEYPPKAIAKVRKKKFITSECSNISF 334 (351)
Q Consensus 286 ~~~--------~~~~~~---~~~~~~~~ld~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 334 (351)
.+. ...+.. ..+.+..|+..+|.+|++.+++ +++.++.....+..+
T Consensus 356 ~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~---l~hp~~~~~~~~~~~ 412 (419)
T 3i6u_A 356 QITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEA---LRHPWLQDEDMKRKF 412 (419)
T ss_dssp HHHTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHH---HHSGGGCCHHHHHHH
T ss_pred HHhcCCCCCCchhhcccCHHHHHHHHHHccCChhHCcCHHHH---hCCcccCChhHHHHH
Confidence 111 111112 2368899999999999988765 556665544443333
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-42 Score=307.83 Aligned_cols=239 Identities=27% Similarity=0.404 Sum_probs=199.9
Q ss_pred hcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCC--CchHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEEE
Q 018712 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK--QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYE 141 (351)
Q Consensus 65 ~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 141 (351)
.+.|.+.+.||+|+||.||+|.+. +++.||+|++.... ...+.+.+|+.+++.++||||+++++++.+....++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 100 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 100 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence 356899999999999999999965 78999999986543 334678999999999999999999999999999999999
Q ss_pred eCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccccC
Q 018712 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (351)
Q Consensus 142 ~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~ 221 (351)
|+++++|.+++.... +++..+..++.|++.||.|||++| ++||||||+||+++.++.+||+|||++.
T Consensus 101 ~~~~~~L~~~~~~~~----------~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~ 167 (303)
T 3a7i_A 101 YLGGGSALDLLEPGP----------LDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAG 167 (303)
T ss_dssp CCTTEEHHHHHTTSC----------CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred eCCCCcHHHHHhcCC----------CCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccce
Confidence 999999999997542 899999999999999999999999 9999999999999999999999999987
Q ss_pred CCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccchhh--------cccC
Q 018712 222 QAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTW--------ATPK 293 (351)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~~~--------~~~~ 293 (351)
........ .....||+.|+|||++.+..++.++||||||+++|+|++|+.||...........+.. ..+.
T Consensus 168 ~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (303)
T 3a7i_A 168 QLTDTQIK--RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSK 245 (303)
T ss_dssp ECBTTBCC--BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCSSCCH
T ss_pred ecCccccc--cCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCCCCCCccccCH
Confidence 65433221 2445789999999999999999999999999999999999999986543221111111 1111
Q ss_pred CCccchhhhcccccCCCCCHHHHHH
Q 018712 294 LSEDKVKQCVDTKLGGEYPPKAIAK 318 (351)
Q Consensus 294 ~~~~~~~~~ld~~~~~~~~~~~~~~ 318 (351)
...+.+..|+..+|.+|++.+++.+
T Consensus 246 ~l~~li~~~l~~dp~~Rps~~~ll~ 270 (303)
T 3a7i_A 246 PLKEFVEACLNKEPSFRPTAKELLK 270 (303)
T ss_dssp HHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred HHHHHHHHHcCCChhhCcCHHHHhh
Confidence 1236889999999999999877644
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-42 Score=330.29 Aligned_cols=239 Identities=25% Similarity=0.361 Sum_probs=194.4
Q ss_pred HhcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCC---CchHHHHHHHHHHHhccCCceeeeEEEEecCCceEEE
Q 018712 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK---QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLA 139 (351)
Q Consensus 64 ~~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 139 (351)
..++|.+.+.||+|+||.||+|.+. ++..||+|++.... .....+.+|+.+++.++||||+++++++.+....|+|
T Consensus 35 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 114 (494)
T 3lij_A 35 LSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLV 114 (494)
T ss_dssp HHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 4567999999999999999999976 78899999987543 2356789999999999999999999999999999999
Q ss_pred EEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccC---CceEEec
Q 018712 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDD---DIAKISD 216 (351)
Q Consensus 140 ~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~---~~vkl~D 216 (351)
|||+.+|+|.+++..... +++..+..++.||+.||.|||++| |+||||||+|||++.. +.+||+|
T Consensus 115 ~e~~~~g~L~~~~~~~~~---------~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~D 182 (494)
T 3lij_A 115 MECYKGGELFDEIIHRMK---------FNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVD 182 (494)
T ss_dssp EECCCSCBHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECC
T ss_pred EecCCCCcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEE
Confidence 999999999998876543 899999999999999999999999 9999999999999764 4599999
Q ss_pred ccccCCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccchhhc------
Q 018712 217 FDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWA------ 290 (351)
Q Consensus 217 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~~~~------ 290 (351)
||++........ .....||+.|+|||++. ..++.++||||||+++|+|++|+.||...........+...
T Consensus 183 fG~a~~~~~~~~---~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~ 258 (494)
T 3lij_A 183 FGLSAVFENQKK---MKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDS 258 (494)
T ss_dssp CTTCEECBTTBC---BCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCS
T ss_pred CCCCeECCCCcc---ccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCc
Confidence 999876654322 24467999999999876 56999999999999999999999999876443221111111
Q ss_pred --ccCC---CccchhhhcccccCCCCCHHHHHH
Q 018712 291 --TPKL---SEDKVKQCVDTKLGGEYPPKAIAK 318 (351)
Q Consensus 291 --~~~~---~~~~~~~~ld~~~~~~~~~~~~~~ 318 (351)
.+.. ..+.+..|+..+|.+|++++++.+
T Consensus 259 ~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 291 (494)
T 3lij_A 259 PEWKNVSEGAKDLIKQMLQFDSQRRISAQQALE 291 (494)
T ss_dssp GGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hhcccCCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence 1111 236889999999999999887643
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-42 Score=315.86 Aligned_cols=243 Identities=21% Similarity=0.303 Sum_probs=189.1
Q ss_pred HHHHhcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCCc------hHHHHHHHHHHHhccCCceeeeEEEEecC
Q 018712 61 LKEKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP------DQEFLAQVSMVSRLKNENVVELVGYYVDG 133 (351)
Q Consensus 61 ~~~~~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~~ 133 (351)
+....++|.+.+.||+|+||.||+|.+. +++.||+|++...... .+.+.+|+.+++.++||||+++++++.+.
T Consensus 5 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 84 (346)
T 1ua2_A 5 VKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHK 84 (346)
T ss_dssp --------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred hHHHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeC
Confidence 3455688999999999999999999975 6899999998753221 24678999999999999999999999999
Q ss_pred CceEEEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceE
Q 018712 134 PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAK 213 (351)
Q Consensus 134 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vk 213 (351)
+..++||||+.+ +|.+++..... .+++..+..++.|++.||.|||++| |+||||||+|||++.++.+|
T Consensus 85 ~~~~lv~e~~~~-~l~~~~~~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~k 152 (346)
T 1ua2_A 85 SNISLVFDFMET-DLEVIIKDNSL--------VLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLK 152 (346)
T ss_dssp TCCEEEEECCSE-EHHHHHTTCCS--------SCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEE
T ss_pred CceEEEEEcCCC-CHHHHHHhcCc--------CCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEE
Confidence 999999999986 89999876532 2778889999999999999999999 99999999999999999999
Q ss_pred EecccccCCCccccccccccccccccCccCcccccCC-CCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccchh----
Q 018712 214 ISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTG-QMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVT---- 288 (351)
Q Consensus 214 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~~---- 288 (351)
|+|||+++........ .....||+.|+|||++.+. .++.++||||||+++|+|++|..||...........+.
T Consensus 153 l~Dfg~a~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~ 230 (346)
T 1ua2_A 153 LADFGLAKSFGSPNRA--YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLG 230 (346)
T ss_dssp ECCCGGGSTTTSCCCC--CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC
T ss_pred EEecccceeccCCccc--CCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcC
Confidence 9999999876433221 2445789999999998764 58999999999999999999999997654211100000
Q ss_pred -------------------------------hcccCCCccchhhhcccccCCCCCHHHHH
Q 018712 289 -------------------------------WATPKLSEDKVKQCVDTKLGGEYPPKAIA 317 (351)
Q Consensus 289 -------------------------------~~~~~~~~~~~~~~ld~~~~~~~~~~~~~ 317 (351)
...+....+.+..|+..+|.+|++++++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell 290 (346)
T 1ua2_A 231 TPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQAL 290 (346)
T ss_dssp CCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHH
T ss_pred CCChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHh
Confidence 00001112578899999999999987753
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=305.10 Aligned_cols=251 Identities=22% Similarity=0.317 Sum_probs=199.2
Q ss_pred HhcCCCCCceeccCCcEEEEEEEECC----CCEEEEEEcCCCCCc--hHHHHHHHHHHHhccCCceeeeEEEEe-cCCce
Q 018712 64 KTDNFGTNSLIGEGSYGRVYFGVLRS----GRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYV-DGPLR 136 (351)
Q Consensus 64 ~~~~y~~~~~Lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~-~~~~~ 136 (351)
...+|.+.+.||+|+||.||+|.+.+ ...+|+|.+...... .+.+.+|+.++++++||||+++++++. .++..
T Consensus 23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 102 (298)
T 3f66_A 23 SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP 102 (298)
T ss_dssp GGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCC
T ss_pred cceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCce
Confidence 34568899999999999999998642 236899998764432 356889999999999999999999854 55678
Q ss_pred EEEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEec
Q 018712 137 VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISD 216 (351)
Q Consensus 137 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~D 216 (351)
++||||+.+++|.+++..... .+++..++.++.|++.||.|||+++ ++||||||+||+++.++.+||+|
T Consensus 103 ~~v~e~~~~~~L~~~l~~~~~--------~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~D 171 (298)
T 3f66_A 103 LVVLPYMKHGDLRNFIRNETH--------NPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVAD 171 (298)
T ss_dssp EEEEECCTTCBHHHHHHCTTC--------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECS
T ss_pred EEEEeCCCCCCHHHHHHhccc--------CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECc
Confidence 999999999999999976432 2789999999999999999999999 99999999999999999999999
Q ss_pred ccccCCCcccccc--ccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCCccchhh----
Q 018712 217 FDLSNQAPDAAAR--LHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTW---- 289 (351)
Q Consensus 217 fg~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~Pf~~~~~~~~~~~~~~---- 289 (351)
||++......... .......||+.|+|||.+.+..++.++||||||+++|+|++ |.+||...........+..
T Consensus 172 fg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (298)
T 3f66_A 172 FGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRL 251 (298)
T ss_dssp CGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCCC
T ss_pred ccccccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCCC
Confidence 9999876543321 12234567889999999999999999999999999999999 6667765544332211111
Q ss_pred ----cccCCCccchhhhcccccCCCCCHHHHHHHHHHHHH
Q 018712 290 ----ATPKLSEDKVKQCVDTKLGGEYPPKAIAKVRKKKFI 325 (351)
Q Consensus 290 ----~~~~~~~~~~~~~ld~~~~~~~~~~~~~~~~~~~~~ 325 (351)
..+....+.+..|++.+|.+|++.+++.+.++-.+.
T Consensus 252 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 291 (298)
T 3f66_A 252 LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 291 (298)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 111122368899999999999999999887766544
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=315.83 Aligned_cols=246 Identities=27% Similarity=0.437 Sum_probs=194.7
Q ss_pred HHHHhcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCCchHHHHHHHHHHHhc-cCCceeeeEEEEec------
Q 018712 61 LKEKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRL-KNENVVELVGYYVD------ 132 (351)
Q Consensus 61 ~~~~~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~------ 132 (351)
+....++|++.+.||+|+||.||+|.+. +++.||+|++.........+.+|+.+++++ +||||+++++++..
T Consensus 19 l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~ 98 (326)
T 2x7f_A 19 LRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGM 98 (326)
T ss_dssp CCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CC
T ss_pred ccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccc
Confidence 3345678999999999999999999974 789999999987766678899999999999 79999999999876
Q ss_pred CCceEEEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCce
Q 018712 133 GPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIA 212 (351)
Q Consensus 133 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~v 212 (351)
.+..++||||+.+++|.+++...... .++...++.++.||+.||.|||++| ++||||||+||+++.++.+
T Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~~~-------~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~ 168 (326)
T 2x7f_A 99 DDQLWLVMEFCGAGSVTDLIKNTKGN-------TLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEV 168 (326)
T ss_dssp CCEEEEEEECCTTEEHHHHHHHSGGG-------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCE
T ss_pred cceEEEEEEcCCCCcHHHHHHhcccC-------CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCCCCE
Confidence 46789999999999999999865321 2889999999999999999999999 9999999999999999999
Q ss_pred EEecccccCCCccccccccccccccccCccCccccc-----CCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccch
Q 018712 213 KISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAM-----TGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLV 287 (351)
Q Consensus 213 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~ 287 (351)
||+|||++......... .....||+.|+|||++. +..++.++||||||+++|+|++|+.||...........+
T Consensus 169 kl~Dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~ 246 (326)
T 2x7f_A 169 KLVDFGVSAQLDRTVGR--RNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI 246 (326)
T ss_dssp EECCCTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH
T ss_pred EEeeCcCceecCcCccc--cccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHh
Confidence 99999998765432211 23456899999999987 567899999999999999999999999765432211111
Q ss_pred hh---------cccCCCccchhhhcccccCCCCCHHHHHH
Q 018712 288 TW---------ATPKLSEDKVKQCVDTKLGGEYPPKAIAK 318 (351)
Q Consensus 288 ~~---------~~~~~~~~~~~~~ld~~~~~~~~~~~~~~ 318 (351)
.. ..+....+.+..|+..+|.+|++.+++.+
T Consensus 247 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 247 PRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp HHSCCCCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred hcCccccCCccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 11 11112236889999999999999877644
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=332.44 Aligned_cols=239 Identities=25% Similarity=0.388 Sum_probs=198.6
Q ss_pred HhcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCC----CCchHHHHHHHHHHHhccCCceeeeEEEEecCCceEE
Q 018712 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSS----KQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVL 138 (351)
Q Consensus 64 ~~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 138 (351)
..++|.+.+.||+|+||.||+|.+. +++.||+|++... ......+.+|+.++++++||||+++++++.+.+..++
T Consensus 24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 103 (484)
T 3nyv_A 24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYL 103 (484)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 3467999999999999999999976 7899999998644 2345678999999999999999999999999999999
Q ss_pred EEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEE---ccCCceEEe
Q 018712 139 AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLL---FDDDIAKIS 215 (351)
Q Consensus 139 v~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill---~~~~~vkl~ 215 (351)
||||+.+|+|.+++..... +++..+..++.||+.||.|||++| |+||||||+|||+ +.++.+||+
T Consensus 104 v~e~~~~~~L~~~~~~~~~---------~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~ 171 (484)
T 3nyv_A 104 VGEVYTGGELFDEIISRKR---------FSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRII 171 (484)
T ss_dssp EECCCCSCBHHHHHHTCSC---------CBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEEC
T ss_pred EEecCCCCCHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEE
Confidence 9999999999999976543 899999999999999999999999 9999999999999 467899999
Q ss_pred cccccCCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccchhhc-----
Q 018712 216 DFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWA----- 290 (351)
Q Consensus 216 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~~~~----- 290 (351)
|||++........ .....||+.|+|||++.+ .++.++||||||+++|+|++|+.||...........+...
T Consensus 172 Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~ 247 (484)
T 3nyv_A 172 DFGLSTHFEASKK---MKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFE 247 (484)
T ss_dssp CTTHHHHBCCCCS---HHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC
T ss_pred eeeeeEEcccccc---cccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence 9999875543221 234579999999998876 6899999999999999999999999875433221111111
Q ss_pred ------ccCCCccchhhhcccccCCCCCHHHHHH
Q 018712 291 ------TPKLSEDKVKQCVDTKLGGEYPPKAIAK 318 (351)
Q Consensus 291 ------~~~~~~~~~~~~ld~~~~~~~~~~~~~~ 318 (351)
.+....+.+..|+..+|.+|++++++..
T Consensus 248 ~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 281 (484)
T 3nyv_A 248 LPQWKKVSESAKDLIRKMLTYVPSMRISARDALD 281 (484)
T ss_dssp SGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CcccccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence 1111236889999999999999877654
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-42 Score=309.59 Aligned_cols=244 Identities=23% Similarity=0.344 Sum_probs=199.7
Q ss_pred HhcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCC-chHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEEE
Q 018712 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ-PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYE 141 (351)
Q Consensus 64 ~~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 141 (351)
..++|.+.+.||+|+||.||++.+. +++.||+|++..... ....+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (304)
T 2jam_A 7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQ 86 (304)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEE
Confidence 4567999999999999999999976 789999999875432 34568899999999999999999999999999999999
Q ss_pred eCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEE---ccCCceEEeccc
Q 018712 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLL---FDDDIAKISDFD 218 (351)
Q Consensus 142 ~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill---~~~~~vkl~Dfg 218 (351)
|+++++|.+++..... +++..+..++.|++.||.|||++| ++||||||+||++ +.++.+||+|||
T Consensus 87 ~~~~~~L~~~l~~~~~---------~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg 154 (304)
T 2jam_A 87 LVSGGELFDRILERGV---------YTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFG 154 (304)
T ss_dssp CCCSCBHHHHHHHHSC---------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCS
T ss_pred cCCCccHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCC
Confidence 9999999999976542 889999999999999999999999 9999999999999 778899999999
Q ss_pred ccCCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccchhhc--------
Q 018712 219 LSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWA-------- 290 (351)
Q Consensus 219 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~~~~-------- 290 (351)
++....... .....||+.|+|||++.+..++.++||||||+++|+|++|+.||...........+...
T Consensus 155 ~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 230 (304)
T 2jam_A 155 LSKMEQNGI----MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPF 230 (304)
T ss_dssp TTCCCCCBT----THHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTTT
T ss_pred cceecCCCc----cccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccc
Confidence 987654321 13456899999999999999999999999999999999999999865432211111110
Q ss_pred ---ccCCCccchhhhcccccCCCCCHHHHHHHHHHHHHh
Q 018712 291 ---TPKLSEDKVKQCVDTKLGGEYPPKAIAKVRKKKFIT 326 (351)
Q Consensus 291 ---~~~~~~~~~~~~ld~~~~~~~~~~~~~~~~~~~~~~ 326 (351)
.+....+.+..|+..+|.+|++.+++. ++.++.
T Consensus 231 ~~~~~~~~~~li~~~l~~dp~~Rps~~~~l---~h~~~~ 266 (304)
T 2jam_A 231 WDDISESAKDFICHLLEKDPNERYTCEKAL---SHPWID 266 (304)
T ss_dssp TTTSCHHHHHHHHHHHCSSTTTSCCHHHHH---TSHHHH
T ss_pred cccCCHHHHHHHHHHcCCChhHCcCHHHHh---cCcccc
Confidence 111123688999999999999988764 445443
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-42 Score=310.11 Aligned_cols=264 Identities=19% Similarity=0.281 Sum_probs=208.3
Q ss_pred HHHHHHhcCCCCCceeccCCcEEEEEEEE------CCCCEEEEEEcCCCCCc--hHHHHHHHHHHHhc-cCCceeeeEEE
Q 018712 59 DELKEKTDNFGTNSLIGEGSYGRVYFGVL------RSGRAAAIKKLDSSKQP--DQEFLAQVSMVSRL-KNENVVELVGY 129 (351)
Q Consensus 59 ~~~~~~~~~y~~~~~Lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l-~h~niv~~~~~ 129 (351)
.......++|.+.+.||+|+||.||+|.+ .+++.||+|++...... ...+.+|+.+++++ +||||++++++
T Consensus 20 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 99 (316)
T 2xir_A 20 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA 99 (316)
T ss_dssp HHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEE
Confidence 33444567899999999999999999984 25689999999765433 34688999999999 78999999999
Q ss_pred EecCC-ceEEEEEeCCCCCHHHHhccCCCCCCC-------CCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccC
Q 018712 130 YVDGP-LRVLAYEHASKGSLHDILHGKKGVKGA-------KPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKS 201 (351)
Q Consensus 130 ~~~~~-~~~lv~e~~~~gsL~~~l~~~~~~~~~-------~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp 201 (351)
+...+ ..++||||+.+++|.+++......... .....+++..++.++.||+.||.|||+++ ++||||||
T Consensus 100 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp 176 (316)
T 2xir_A 100 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAA 176 (316)
T ss_dssp ECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSG
T ss_pred EecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---cccccCcc
Confidence 87654 589999999999999999875431100 00122789999999999999999999999 99999999
Q ss_pred CcEEEccCCceEEecccccCCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCC
Q 018712 202 SNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLP 280 (351)
Q Consensus 202 ~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~Pf~~~~~ 280 (351)
+||+++.++.+||+|||++................||+.|+|||++.+..++.++||||||+++|+|++ |..||.....
T Consensus 177 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~ 256 (316)
T 2xir_A 177 RNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI 256 (316)
T ss_dssp GGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCC
T ss_pred ceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccch
Confidence 999999999999999999987654433333345568899999999999999999999999999999998 9999986543
Q ss_pred CCCc-cchh--------hcccCCCccchhhhcccccCCCCCHHHHHHHHHHHHH
Q 018712 281 RGQQ-SLVT--------WATPKLSEDKVKQCVDTKLGGEYPPKAIAKVRKKKFI 325 (351)
Q Consensus 281 ~~~~-~~~~--------~~~~~~~~~~~~~~ld~~~~~~~~~~~~~~~~~~~~~ 325 (351)
.... ..+. ...+....+.+..|+..+|.+|++.+++...++..+.
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 310 (316)
T 2xir_A 257 DEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 310 (316)
T ss_dssp SHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hHHHHHHhccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 2211 0010 0111112368889999999999999999887766553
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-43 Score=318.39 Aligned_cols=202 Identities=22% Similarity=0.358 Sum_probs=166.8
Q ss_pred HHhcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCCc---hHHHHHHHHHHHhccCCceeeeEEEEecCCceEE
Q 018712 63 EKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVL 138 (351)
Q Consensus 63 ~~~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 138 (351)
...++|.+.+.||+|+||.||+|.+. +++.||+|++...... ...+.+|+.++++++||||+++++++.+.+..++
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 110 (329)
T 3gbz_A 31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHL 110 (329)
T ss_dssp -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEE
T ss_pred cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEE
Confidence 45578999999999999999999965 7899999999755432 3457789999999999999999999999999999
Q ss_pred EEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEc-----cCCceE
Q 018712 139 AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLF-----DDDIAK 213 (351)
Q Consensus 139 v~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~-----~~~~vk 213 (351)
||||+.+ +|.+++..... +++..++.++.||+.||.|||+++ |+||||||+|||++ ..+.+|
T Consensus 111 v~e~~~~-~L~~~~~~~~~---------~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~k 177 (329)
T 3gbz_A 111 IFEYAEN-DLKKYMDKNPD---------VSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLK 177 (329)
T ss_dssp EEECCSE-EHHHHHHHCTT---------CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEE
T ss_pred EEecCCC-CHHHHHhhcCC---------CCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEE
Confidence 9999985 99999987643 899999999999999999999999 99999999999994 455699
Q ss_pred EecccccCCCccccccccccccccccCccCcccccCC-CCCccchhHhHHHHHHHHHcCCCCCCCCC
Q 018712 214 ISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTG-QMSSKSDVYSFGVVLLELLTGRKPVDHTL 279 (351)
Q Consensus 214 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~Pf~~~~ 279 (351)
|+|||++......... .....||+.|+|||++.+. .++.++||||||+++|+|++|+.||....
T Consensus 178 l~Dfg~a~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 242 (329)
T 3gbz_A 178 IGDFGLARAFGIPIRQ--FTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDS 242 (329)
T ss_dssp ECCTTHHHHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ECcCCCccccCCcccc--cCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCC
Confidence 9999998654322211 2345689999999999875 58999999999999999999999997653
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-42 Score=312.38 Aligned_cols=258 Identities=24% Similarity=0.358 Sum_probs=205.1
Q ss_pred HhcCCCCCceeccCCcEEEEEEEECC-C-----CEEEEEEcCCCCCc--hHHHHHHHHHHHhc-cCCceeeeEEEEecCC
Q 018712 64 KTDNFGTNSLIGEGSYGRVYFGVLRS-G-----RAAAIKKLDSSKQP--DQEFLAQVSMVSRL-KNENVVELVGYYVDGP 134 (351)
Q Consensus 64 ~~~~y~~~~~Lg~G~~g~Vy~~~~~~-~-----~~vavK~~~~~~~~--~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~ 134 (351)
..++|.+.+.||+|+||.||+|.+.. + ..||+|.+...... .+.+.+|+.+++++ +||||+++++++.+.+
T Consensus 44 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 123 (333)
T 2i1m_A 44 PRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGG 123 (333)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCC
Confidence 35789999999999999999999752 2 47999999765432 45688999999999 8999999999999999
Q ss_pred ceEEEEEeCCCCCHHHHhccCCCC-----CCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccC
Q 018712 135 LRVLAYEHASKGSLHDILHGKKGV-----KGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDD 209 (351)
Q Consensus 135 ~~~lv~e~~~~gsL~~~l~~~~~~-----~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~ 209 (351)
..++||||+++|+|.+++...... ........+++..++.++.||+.||.|||+++ |+||||||+|||++.+
T Consensus 124 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~ 200 (333)
T 2i1m_A 124 PVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLTNG 200 (333)
T ss_dssp SCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCEEEGG
T ss_pred ceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEEECCC
Confidence 999999999999999999754210 00001123789999999999999999999999 9999999999999999
Q ss_pred CceEEecccccCCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCCcc-ch
Q 018712 210 DIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQS-LV 287 (351)
Q Consensus 210 ~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~Pf~~~~~~~~~~-~~ 287 (351)
+.+||+|||++................||+.|+|||++.+..++.++||||||+++|+|++ |..||.......... ..
T Consensus 201 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~ 280 (333)
T 2i1m_A 201 HVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLV 280 (333)
T ss_dssp GEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHHHH
T ss_pred CeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHHHH
Confidence 9999999999986644333222344567889999999999999999999999999999999 999998654332111 11
Q ss_pred hh--------cccCCCccchhhhcccccCCCCCHHHHHHHHHHHH
Q 018712 288 TW--------ATPKLSEDKVKQCVDTKLGGEYPPKAIAKVRKKKF 324 (351)
Q Consensus 288 ~~--------~~~~~~~~~~~~~ld~~~~~~~~~~~~~~~~~~~~ 324 (351)
.. ..+....+.+..|+..+|..|++.+++...++-..
T Consensus 281 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~ 325 (333)
T 2i1m_A 281 KDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQA 325 (333)
T ss_dssp HHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred hcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHH
Confidence 10 01111236889999999999999999988766554
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=318.72 Aligned_cols=235 Identities=22% Similarity=0.318 Sum_probs=191.3
Q ss_pred HhcCCCCCceeccCCcEEEEEEEE----CCCCEEEEEEcCCCC-----CchHHHHHHHHHHHhc-cCCceeeeEEEEecC
Q 018712 64 KTDNFGTNSLIGEGSYGRVYFGVL----RSGRAAAIKKLDSSK-----QPDQEFLAQVSMVSRL-KNENVVELVGYYVDG 133 (351)
Q Consensus 64 ~~~~y~~~~~Lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~-----~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~ 133 (351)
..++|.+.+.||+|+||.||++.. .+++.||+|++.... .....+.+|+++++.+ +||||+++++++.+.
T Consensus 52 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 131 (355)
T 1vzo_A 52 GIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE 131 (355)
T ss_dssp CGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEET
T ss_pred cccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeC
Confidence 346899999999999999999997 378999999986432 2335577899999999 699999999999999
Q ss_pred CceEEEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceE
Q 018712 134 PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAK 213 (351)
Q Consensus 134 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vk 213 (351)
+..++||||+.+++|.+++..... +++..+..++.||+.||.|||+++ |+||||||+|||++.++.+|
T Consensus 132 ~~~~lv~e~~~~~~L~~~l~~~~~---------~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~k 199 (355)
T 1vzo_A 132 TKLHLILDYINGGELFTHLSQRER---------FTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVV 199 (355)
T ss_dssp TEEEEEECCCCSCBHHHHHHHHSC---------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEE
T ss_pred ceEEEEeecCCCCCHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEE
Confidence 999999999999999999986542 899999999999999999999999 99999999999999999999
Q ss_pred EecccccCCCccccccccccccccccCccCcccccC--CCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccchh---
Q 018712 214 ISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMT--GQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVT--- 288 (351)
Q Consensus 214 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~~--- 288 (351)
|+|||+++........ ......||+.|+|||++.+ ..++.++||||||+++|+|++|+.||...........+.
T Consensus 200 l~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~ 278 (355)
T 1vzo_A 200 LTDFGLSKEFVADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRI 278 (355)
T ss_dssp ESCSSEEEECCGGGGG-GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHH
T ss_pred EeeCCCCeecccCCCC-cccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHH
Confidence 9999999765433221 2234579999999999986 347899999999999999999999998654332221110
Q ss_pred -hcccC----C---CccchhhhcccccCCCC
Q 018712 289 -WATPK----L---SEDKVKQCVDTKLGGEY 311 (351)
Q Consensus 289 -~~~~~----~---~~~~~~~~ld~~~~~~~ 311 (351)
...+. + ..+.+..|+..+|.+|+
T Consensus 279 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~ 309 (355)
T 1vzo_A 279 LKSEPPYPQEMSALAKDLIQRLLMKDPKKRL 309 (355)
T ss_dssp HHCCCCCCTTSCHHHHHHHHHHTCSSGGGST
T ss_pred hccCCCCCcccCHHHHHHHHHHhhhCHHHhc
Confidence 11111 1 13678899999999999
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-42 Score=313.97 Aligned_cols=235 Identities=28% Similarity=0.427 Sum_probs=193.5
Q ss_pred cCCCCCceeccCCcEEEEEEEE-CCCCEEEEEEcCCCCCc----hHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEE
Q 018712 66 DNFGTNSLIGEGSYGRVYFGVL-RSGRAAAIKKLDSSKQP----DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAY 140 (351)
Q Consensus 66 ~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 140 (351)
+.|.+.+.||+|+||.||+|.. .+++.||||++...... .+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 4588999999999999999996 47899999998754332 246789999999999999999999999999999999
Q ss_pred EeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEeccccc
Q 018712 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (351)
Q Consensus 141 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a 220 (351)
||+. |+|.+++..... .+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 134 e~~~-g~l~~~l~~~~~--------~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a 201 (348)
T 1u5q_A 134 EYCL-GSASDLLEVHKK--------PLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSA 201 (348)
T ss_dssp ECCS-EEHHHHHHHHTS--------CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTC
T ss_pred ecCC-CCHHHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCc
Confidence 9997 588888864332 2899999999999999999999999 999999999999999999999999998
Q ss_pred CCCccccccccccccccccCccCccccc---CCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCcc-chhh-------
Q 018712 221 NQAPDAAARLHSTRVLGTFGYHAPEYAM---TGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQS-LVTW------- 289 (351)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~-~~~~------- 289 (351)
...... ....||+.|+|||++. +..++.++||||||+++|||++|+.||.......... ....
T Consensus 202 ~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 275 (348)
T 1u5q_A 202 SIMAPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQS 275 (348)
T ss_dssp BSSSSB------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCC
T ss_pred eecCCC------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC
Confidence 765432 3457999999999884 5678999999999999999999999997653321111 1111
Q ss_pred -cccCCCccchhhhcccccCCCCCHHHHHH
Q 018712 290 -ATPKLSEDKVKQCVDTKLGGEYPPKAIAK 318 (351)
Q Consensus 290 -~~~~~~~~~~~~~ld~~~~~~~~~~~~~~ 318 (351)
..+....+.+..|+..+|.+|++.+++.+
T Consensus 276 ~~~~~~l~~li~~~l~~dP~~Rps~~~ll~ 305 (348)
T 1u5q_A 276 GHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 305 (348)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCCCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence 11112236888999999999999877643
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=317.74 Aligned_cols=245 Identities=18% Similarity=0.233 Sum_probs=191.5
Q ss_pred hcCCCCCceeccCCcEEEEEEEEC----CCCEEEEEEcCCCCCc------------hHHHHHHHHHHHhccCCceeeeEE
Q 018712 65 TDNFGTNSLIGEGSYGRVYFGVLR----SGRAAAIKKLDSSKQP------------DQEFLAQVSMVSRLKNENVVELVG 128 (351)
Q Consensus 65 ~~~y~~~~~Lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~------------~~~~~~e~~~l~~l~h~niv~~~~ 128 (351)
.++|.+.+.||+|+||.||+|.+. ++..+|+|++...... ...+.+|+..++.++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 467999999999999999999975 5789999998765421 123567788899999999999999
Q ss_pred EEec----CCceEEEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcE
Q 018712 129 YYVD----GPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNV 204 (351)
Q Consensus 129 ~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Ni 204 (351)
++.. ....++||||+ +++|.+++..... +++..++.++.||+.||.|||+++ |+||||||+||
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~---------~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NI 182 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNGT---------FKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANL 182 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBGGGB---------CCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGE
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHE
Confidence 9887 77899999999 9999999987542 899999999999999999999999 99999999999
Q ss_pred EEccCC--ceEEecccccCCCcccccc-----ccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCC
Q 018712 205 LLFDDD--IAKISDFDLSNQAPDAAAR-----LHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDH 277 (351)
Q Consensus 205 ll~~~~--~vkl~Dfg~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~ 277 (351)
|++.++ .+||+|||+++........ .......||+.|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus 183 ll~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~ 262 (345)
T 2v62_A 183 LLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQ 262 (345)
T ss_dssp EEESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGG
T ss_pred EEccCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 999887 9999999999766433211 111345799999999999999999999999999999999999999965
Q ss_pred CCCCCCc--cchh------------h----cccCCCccchhhhcccccCCCCCHHHHHHHHHH
Q 018712 278 TLPRGQQ--SLVT------------W----ATPKLSEDKVKQCVDTKLGGEYPPKAIAKVRKK 322 (351)
Q Consensus 278 ~~~~~~~--~~~~------------~----~~~~~~~~~~~~~ld~~~~~~~~~~~~~~~~~~ 322 (351)
....... .... + ..+....+.+..|+..+|.+|++.+++...++-
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~ 325 (345)
T 2v62_A 263 NLKDPVAVQTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNP 325 (345)
T ss_dssp GTTCHHHHHHHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCT
T ss_pred cccccHHHHHHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 3221110 0000 0 112223468889999999999999998776543
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=308.23 Aligned_cols=238 Identities=22% Similarity=0.226 Sum_probs=186.7
Q ss_pred hcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCCch---HHHHHHHHHHHhc-cCCceeeeEEEEecCCceEEE
Q 018712 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPD---QEFLAQVSMVSRL-KNENVVELVGYYVDGPLRVLA 139 (351)
Q Consensus 65 ~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~---~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv 139 (351)
.++|++.+.||+|+||+||+|.+. +++.||||++....... .....|+..+.++ +|+||+++++++.+.+..++|
T Consensus 56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv 135 (311)
T 3p1a_A 56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ 135 (311)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEE
Confidence 367999999999999999999986 79999999987654332 2344555555555 899999999999999999999
Q ss_pred EEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccc
Q 018712 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDL 219 (351)
Q Consensus 140 ~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~ 219 (351)
|||+ +++|.+++..... .+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 136 ~e~~-~~~L~~~~~~~~~--------~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~ 203 (311)
T 3p1a_A 136 TELC-GPSLQQHCEAWGA--------SLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGL 203 (311)
T ss_dssp EECC-CCBHHHHHHHHCS--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTT
T ss_pred Eecc-CCCHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEcccee
Confidence 9999 6699998876532 2899999999999999999999999 99999999999999999999999999
Q ss_pred cCCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCC------ccchhhcccC
Q 018712 220 SNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQ------QSLVTWATPK 293 (351)
Q Consensus 220 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~------~~~~~~~~~~ 293 (351)
+........ .....||+.|+|||++.+ .++.++||||||+++|||++|..|+........ ........+.
T Consensus 204 a~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (311)
T 3p1a_A 204 LVELGTAGA---GEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEGWQQLRQGYLPPEFTAGLSS 279 (311)
T ss_dssp CEECC---------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHHHHHTTTCCCHHHHTTSCH
T ss_pred eeecccCCC---CcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHhccCCCcccccCCCH
Confidence 876543322 244569999999998876 789999999999999999999766543211000 0000111112
Q ss_pred CCccchhhhcccccCCCCCHHHHHH
Q 018712 294 LSEDKVKQCVDTKLGGEYPPKAIAK 318 (351)
Q Consensus 294 ~~~~~~~~~ld~~~~~~~~~~~~~~ 318 (351)
...+.+..|+..+|.+|++++++.+
T Consensus 280 ~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 280 ELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp HHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHh
Confidence 2236888999999999999887643
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=307.28 Aligned_cols=256 Identities=21% Similarity=0.276 Sum_probs=192.8
Q ss_pred HhcCCCCCceeccCCcEEEEEEEEC----CCCEEEEEEcCCCCCc---hHHHHHHHHHHHhccCCceeeeEEEEecCC--
Q 018712 64 KTDNFGTNSLIGEGSYGRVYFGVLR----SGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVDGP-- 134 (351)
Q Consensus 64 ~~~~y~~~~~Lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-- 134 (351)
..++|.+.+.||+|+||.||+|... ++..||+|++...... .+.+.+|+.++++++||||+++++++.+.+
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 111 (313)
T 3brb_A 32 DRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQ 111 (313)
T ss_dssp CGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC----
T ss_pred CHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecccc
Confidence 4567999999999999999999854 3458999998765433 356889999999999999999999987655
Q ss_pred ---ceEEEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCc
Q 018712 135 ---LRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDI 211 (351)
Q Consensus 135 ---~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~ 211 (351)
..++||||+.+++|.+++....... ....+++..++.++.||+.||.|||+++ ++||||||+||+++.++.
T Consensus 112 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~ 185 (313)
T 3brb_A 112 GIPKPMVILPFMKYGDLHTYLLYSRLET---GPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRDDMT 185 (313)
T ss_dssp ---CEEEEEECCTTCBHHHHHHHTTBTT---SCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEECTTSC
T ss_pred CCcccEEEEecccCCCHHHHHHHhhhhc---CCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCc
Confidence 3599999999999999995432111 1123899999999999999999999999 999999999999999999
Q ss_pred eEEecccccCCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCCccchhh-
Q 018712 212 AKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTW- 289 (351)
Q Consensus 212 vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~Pf~~~~~~~~~~~~~~- 289 (351)
+||+|||++................+++.|+|||.+.+..++.++||||||+++|+|++ |..||...........+..
T Consensus 186 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~ 265 (313)
T 3brb_A 186 VCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHG 265 (313)
T ss_dssp EEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTT
T ss_pred EEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcC
Confidence 99999999987654332222334567889999999999999999999999999999999 9999987644322111111
Q ss_pred -------cccCCCccchhhhcccccCCCCCHHHHHHHHHHHHH
Q 018712 290 -------ATPKLSEDKVKQCVDTKLGGEYPPKAIAKVRKKKFI 325 (351)
Q Consensus 290 -------~~~~~~~~~~~~~ld~~~~~~~~~~~~~~~~~~~~~ 325 (351)
..+....+.+..|+..+|..|++.+++...++-.+.
T Consensus 266 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~ 308 (313)
T 3brb_A 266 HRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLE 308 (313)
T ss_dssp CCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 111112368889999999999999999887766543
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-42 Score=323.98 Aligned_cols=200 Identities=23% Similarity=0.300 Sum_probs=175.3
Q ss_pred HhcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCCchHHHHHHHHHHHhc------cCCceeeeEEEEecCCce
Q 018712 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRL------KNENVVELVGYYVDGPLR 136 (351)
Q Consensus 64 ~~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l------~h~niv~~~~~~~~~~~~ 136 (351)
...+|++.+.||+|+||.||+|.+. +++.||||++.........+.+|+.+++.+ +|+||+++++.+...+..
T Consensus 95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~ 174 (429)
T 3kvw_A 95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHI 174 (429)
T ss_dssp ETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEE
T ss_pred ccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeE
Confidence 3467999999999999999999975 689999999987655556788888888877 567999999999999999
Q ss_pred EEEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCc--eEE
Q 018712 137 VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDI--AKI 214 (351)
Q Consensus 137 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~--vkl 214 (351)
++||||+. ++|.+++...... .+++..++.++.||+.||.|||+++ |+||||||+|||++.++. +||
T Consensus 175 ~lv~e~~~-~~L~~~l~~~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL 243 (429)
T 3kvw_A 175 CMTFELLS-MNLYELIKKNKFQ-------GFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKV 243 (429)
T ss_dssp EEEECCCC-CBHHHHHHHTTTC-------CCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEE
T ss_pred EEEEeccC-CCHHHHHHhccCC-------CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEE
Confidence 99999996 5999999876432 2899999999999999999999999 999999999999999887 999
Q ss_pred ecccccCCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCC
Q 018712 215 SDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTL 279 (351)
Q Consensus 215 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~ 279 (351)
+|||++...... .....||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 244 ~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~ 303 (429)
T 3kvw_A 244 IDFGSSCYEHQR-----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGED 303 (429)
T ss_dssp CCCTTCEETTCC-----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred eecccceecCCc-----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCC
Confidence 999998654322 234578999999999999999999999999999999999999998654
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-42 Score=308.51 Aligned_cols=247 Identities=21% Similarity=0.324 Sum_probs=201.5
Q ss_pred HhcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCC----chHHHHHHHHHHHhccCCceeeeEEEEecCCceEE
Q 018712 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ----PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVL 138 (351)
Q Consensus 64 ~~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 138 (351)
..++|.+.+.||+|+||.||++.+. +++.+|+|++..... ..+.+.+|+.+++.++|+||+++++++.+.+..++
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 92 (294)
T 2rku_A 13 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV 92 (294)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEE
Confidence 3467999999999999999999976 688999999864421 24567889999999999999999999999999999
Q ss_pred EEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEeccc
Q 018712 139 AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFD 218 (351)
Q Consensus 139 v~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg 218 (351)
||||+.+++|.+++..... +++..+..++.|++.||.|||++| ++||||||+||+++.++.+||+|||
T Consensus 93 v~e~~~~~~L~~~~~~~~~---------~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg 160 (294)
T 2rku_A 93 VLELCRRRSLLELHKRRKA---------LTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFG 160 (294)
T ss_dssp EEECCTTCBHHHHHHHHCS---------CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCT
T ss_pred EEecCCCCCHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEecc
Confidence 9999999999999876542 899999999999999999999999 9999999999999999999999999
Q ss_pred ccCCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccchhh-------cc
Q 018712 219 LSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTW-------AT 291 (351)
Q Consensus 219 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~~~-------~~ 291 (351)
++......... .....||+.|+|||++.+..++.++||||||+++|+|++|+.||...........+.. ..
T Consensus 161 ~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 238 (294)
T 2rku_A 161 LATKVEYDGER--KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHI 238 (294)
T ss_dssp TCEECCSTTCC--BCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTS
T ss_pred CceecccCccc--cccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhccCCCcccc
Confidence 98765432211 2345689999999999998999999999999999999999999986543211111111 11
Q ss_pred cCCCccchhhhcccccCCCCCHHHHHHHHHHHHHhh
Q 018712 292 PKLSEDKVKQCVDTKLGGEYPPKAIAKVRKKKFITS 327 (351)
Q Consensus 292 ~~~~~~~~~~~ld~~~~~~~~~~~~~~~~~~~~~~~ 327 (351)
+....+.+..|+..++.+|++.+++. ++.++..
T Consensus 239 ~~~~~~li~~~l~~~p~~Rps~~~ll---~~~~~~~ 271 (294)
T 2rku_A 239 NPVAASLIQKMLQTDPTARPTINELL---NDEFFTS 271 (294)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCGGGGG---GSHHHHT
T ss_pred CHHHHHHHHHHcccChhhCcCHHHHh---hChheec
Confidence 11123678899999999999877654 4555443
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=300.66 Aligned_cols=242 Identities=21% Similarity=0.274 Sum_probs=197.3
Q ss_pred hcCCCCCceeccCCcEEEEEEEECCCCEEEEEEcCCCCCc---hHHHHHHHHHHHhccCCceeeeEEEEecC--CceEEE
Q 018712 65 TDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVDG--PLRVLA 139 (351)
Q Consensus 65 ~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~lv 139 (351)
.++|.+.+.||+|+||.||+|.+. ++.||+|++...... .+.+.+|+.++++++||||+++++++.+. +..++|
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI 87 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred HHHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence 467999999999999999999985 889999999765433 35688999999999999999999999877 788999
Q ss_pred EEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccc
Q 018712 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDL 219 (351)
Q Consensus 140 ~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~ 219 (351)
|||+++|+|.+++...... .+++..++.++.||+.||.|||+++. .++||||||+||+++.++.++|+|||+
T Consensus 88 ~e~~~~~~L~~~l~~~~~~-------~~~~~~~~~i~~qi~~~l~~lH~~~~-~i~H~dikp~Nil~~~~~~~~l~~~~~ 159 (271)
T 3kmu_A 88 THWMPYGSLYNVLHEGTNF-------VVDQSQAVKFALDMARGMAFLHTLEP-LIPRHALNSRSVMIDEDMTARISMADV 159 (271)
T ss_dssp EECCTTCBHHHHHHSCSSC-------CCCHHHHHHHHHHHHHHHHHHTTSSS-CCTTCCCSGGGEEECTTSCEEEEGGGS
T ss_pred ecccCCCcHHHHHhhcccC-------CCCHHHHHHHHHHHHHHHHHHhcCCC-ceecCCCccceEEEcCCcceeEEeccc
Confidence 9999999999999875431 38999999999999999999999753 399999999999999999999999988
Q ss_pred cCCCccccccccccccccccCccCcccccCCCCCc---cchhHhHHHHHHHHHcCCCCCCCCCCCCCccch---------
Q 018712 220 SNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSS---KSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLV--------- 287 (351)
Q Consensus 220 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~--------- 287 (351)
+..... ....||+.|+|||.+.+..++. ++||||||+++|+|++|+.||...........+
T Consensus 160 ~~~~~~-------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 232 (271)
T 3kmu_A 160 KFSFQS-------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTI 232 (271)
T ss_dssp CCTTSC-------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCCCC
T ss_pred eeeecc-------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCCCC
Confidence 654322 3346899999999998765544 799999999999999999999865432211111
Q ss_pred hhcccCCCccchhhhcccccCCCCCHHHHHHHHHH
Q 018712 288 TWATPKLSEDKVKQCVDTKLGGEYPPKAIAKVRKK 322 (351)
Q Consensus 288 ~~~~~~~~~~~~~~~ld~~~~~~~~~~~~~~~~~~ 322 (351)
....+....+.+..|+..+|.+|++.+++.+.++.
T Consensus 233 ~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~ 267 (271)
T 3kmu_A 233 PPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEK 267 (271)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 01111122368899999999999999988776653
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-42 Score=303.59 Aligned_cols=240 Identities=21% Similarity=0.291 Sum_probs=191.2
Q ss_pred HhcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCC----CCchHHHHHHHHHHHhccCCceeeeEEEEecCCceEE
Q 018712 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSS----KQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVL 138 (351)
Q Consensus 64 ~~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 138 (351)
..++|.+.+.||+|+||.||+|.+. +++.||+|++... ......+.+|+.+++.++||||+++++++.+.+..++
T Consensus 9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 88 (276)
T 2h6d_A 9 KIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFM 88 (276)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred eeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEE
Confidence 4578999999999999999999976 7899999998543 2234578899999999999999999999999999999
Q ss_pred EEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEeccc
Q 018712 139 AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFD 218 (351)
Q Consensus 139 v~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg 218 (351)
||||+.+++|.+++..... +++..+..++.||+.||.|||+++ ++||||||+||+++.++.+||+|||
T Consensus 89 v~e~~~~~~L~~~l~~~~~---------~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg 156 (276)
T 2h6d_A 89 VMEYVSGGELFDYICKHGR---------VEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFG 156 (276)
T ss_dssp EEECCCSCBHHHHHHHHCS---------CCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCC
T ss_pred EEeccCCCcHHHHHhccCC---------CCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeecc
Confidence 9999999999999976542 889999999999999999999999 9999999999999999999999999
Q ss_pred ccCCCccccccccccccccccCccCcccccCCCC-CccchhHhHHHHHHHHHcCCCCCCCCCCCCCccchhhc-------
Q 018712 219 LSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQM-SSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWA------- 290 (351)
Q Consensus 219 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~~~~------- 290 (351)
++........ .....||+.|+|||.+.+..+ +.++||||||+++|+|++|+.||...........+...
T Consensus 157 ~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 233 (276)
T 2h6d_A 157 LSNMMSDGEF---LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEY 233 (276)
T ss_dssp GGGCCCC----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTT
T ss_pred cccccCCCcc---eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcccCchh
Confidence 9877654322 134568999999999987765 68999999999999999999999764322211111111
Q ss_pred ccCCCccchhhhcccccCCCCCHHHHHH
Q 018712 291 TPKLSEDKVKQCVDTKLGGEYPPKAIAK 318 (351)
Q Consensus 291 ~~~~~~~~~~~~ld~~~~~~~~~~~~~~ 318 (351)
.+....+.+..|+..+|.+|++.+++..
T Consensus 234 ~~~~l~~li~~~l~~~p~~Rps~~~~l~ 261 (276)
T 2h6d_A 234 LNRSVATLLMHMLQVDPLKRATIKDIRE 261 (276)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 1112236789999999999999887644
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=309.54 Aligned_cols=252 Identities=25% Similarity=0.376 Sum_probs=197.7
Q ss_pred hcCCCCCceeccCCcEEEEEEEECC-----CCEEEEEEcCCCCCc--hHHHHHHHHHHHhccCCceeeeEEEEecCCceE
Q 018712 65 TDNFGTNSLIGEGSYGRVYFGVLRS-----GRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRV 137 (351)
Q Consensus 65 ~~~y~~~~~Lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 137 (351)
.++|.+.+.||+|+||.||+|.+.. +..||+|++...... ...+.+|+.++++++||||+++++++.+.+..+
T Consensus 43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 122 (333)
T 1mqb_A 43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 122 (333)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcE
Confidence 3568888999999999999998652 235999999765432 346889999999999999999999999999999
Q ss_pred EEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecc
Q 018712 138 LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDF 217 (351)
Q Consensus 138 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Df 217 (351)
+||||+.+++|.+++..... .+++..++.++.||+.||.|||++| ++||||||+|||++.++.+||+||
T Consensus 123 lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Df 191 (333)
T 1mqb_A 123 IITEYMENGALDKFLREKDG--------EFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDF 191 (333)
T ss_dssp EEEECCTTEEHHHHHHHTTT--------CSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC
T ss_pred EEEeCCCCCcHHHHHHhCCC--------CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCC
Confidence 99999999999999976432 2899999999999999999999999 999999999999999999999999
Q ss_pred cccCCCccccccc-cccccccccCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCCccchhh------
Q 018712 218 DLSNQAPDAAARL-HSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTW------ 289 (351)
Q Consensus 218 g~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~Pf~~~~~~~~~~~~~~------ 289 (351)
|++.......... ......+|+.|+|||.+.+..++.++||||||+++|+|++ |+.||...........+..
T Consensus 192 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~ 271 (333)
T 1mqb_A 192 GLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPT 271 (333)
T ss_dssp CC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCC
T ss_pred CcchhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCcCCC
Confidence 9998765432211 1123346788999999999999999999999999999999 9999976543221111111
Q ss_pred --cccCCCccchhhhcccccCCCCCHHHHHHHHHHHHHhh
Q 018712 290 --ATPKLSEDKVKQCVDTKLGGEYPPKAIAKVRKKKFITS 327 (351)
Q Consensus 290 --~~~~~~~~~~~~~ld~~~~~~~~~~~~~~~~~~~~~~~ 327 (351)
..+....+.+..|+..++..|++..++...++-.+...
T Consensus 272 ~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~ 311 (333)
T 1mqb_A 272 PMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP 311 (333)
T ss_dssp CTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred cccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence 11112236889999999999999999988877665443
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=307.00 Aligned_cols=242 Identities=28% Similarity=0.455 Sum_probs=191.4
Q ss_pred hcCCCCCceeccCCcEEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEEEeCC
Q 018712 65 TDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHAS 144 (351)
Q Consensus 65 ~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 144 (351)
.++|++.+.||+|+||.||++.+. ++.||+|++... ...+.+.+|++++++++||||+++++++. +..++||||++
T Consensus 7 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~~ 82 (307)
T 2eva_A 7 YKEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE-SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYAE 82 (307)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST-THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECCT
T ss_pred HhHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh-hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcCC
Confidence 357889999999999999999885 788999998654 34567899999999999999999999876 34799999999
Q ss_pred CCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhh---CCCCCeeeccccCCcEEEccCCc-eEEeccccc
Q 018712 145 KGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHE---KAEPRIIHRNIKSSNVLLFDDDI-AKISDFDLS 220 (351)
Q Consensus 145 ~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~---~~~~~ivH~Dlkp~Nill~~~~~-vkl~Dfg~a 220 (351)
+++|.+++...... +.++...++.++.|++.||.|||+ ++ |+||||||+|||++.++. +||+|||++
T Consensus 83 ~~~L~~~l~~~~~~------~~~~~~~~~~~~~qi~~~l~~LH~~~~~~---ivH~dlkp~NIll~~~~~~~kl~Dfg~~ 153 (307)
T 2eva_A 83 GGSLYNVLHGAEPL------PYYTAAHAMSWCLQCSQGVAYLHSMQPKA---LIHRDLKPPNLLLVAGGTVLKICDFGTA 153 (307)
T ss_dssp TCBHHHHHHCSSSE------ECCCHHHHHHHHHHHHHHHHHHHTCSSSC---CCCCCCSGGGEEEETTTTEEEECCCCC-
T ss_pred CCCHHHHHhccCCC------CccCHHHHHHHHHHHHHHHHHHHhCCCCC---eecCCCChhHEEEeCCCCEEEEcccccc
Confidence 99999999865421 137888999999999999999999 67 999999999999998886 799999998
Q ss_pred CCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccc---hh-------hc
Q 018712 221 NQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSL---VT-------WA 290 (351)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~---~~-------~~ 290 (351)
....... ....||+.|+|||++.+..++.++||||||+++|+|++|+.||........... .. ..
T Consensus 154 ~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (307)
T 2eva_A 154 CDIQTHM-----TNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKN 228 (307)
T ss_dssp ----------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCCCCCBTT
T ss_pred ccccccc-----ccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCCCCcccc
Confidence 7654321 334689999999999999999999999999999999999999986432211000 00 01
Q ss_pred ccCCCccchhhhcccccCCCCCHHHHHHHHHHHH
Q 018712 291 TPKLSEDKVKQCVDTKLGGEYPPKAIAKVRKKKF 324 (351)
Q Consensus 291 ~~~~~~~~~~~~ld~~~~~~~~~~~~~~~~~~~~ 324 (351)
.+....+.+..|+..+|.+|++.+++.+.++...
T Consensus 229 ~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 262 (307)
T 2eva_A 229 LPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLM 262 (307)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHG
T ss_pred cCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHH
Confidence 1112236889999999999999999888776543
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-42 Score=308.07 Aligned_cols=249 Identities=24% Similarity=0.367 Sum_probs=199.7
Q ss_pred hcCCCCCc-eeccCCcEEEEEEEEC---CCCEEEEEEcCCCCCc---hHHHHHHHHHHHhccCCceeeeEEEEecCCceE
Q 018712 65 TDNFGTNS-LIGEGSYGRVYFGVLR---SGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRV 137 (351)
Q Consensus 65 ~~~y~~~~-~Lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 137 (351)
.++|.+.+ .||+|+||.||+|.+. +++.||+|++...... .+.+.+|+.+++.++||||+++++++ ..+..+
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~ 93 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWM 93 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEE
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcE
Confidence 46788887 9999999999999642 5688999998755322 46788999999999999999999998 566789
Q ss_pred EEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecc
Q 018712 138 LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDF 217 (351)
Q Consensus 138 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Df 217 (351)
+||||+.+++|.+++..... +++..++.++.||+.||.|||+++ ++||||||+||+++.++.+||+||
T Consensus 94 lv~e~~~~~~L~~~l~~~~~---------~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Df 161 (291)
T 1xbb_A 94 LVMEMAELGPLNKYLQQNRH---------VKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDF 161 (291)
T ss_dssp EEEECCTTEEHHHHHHHCTT---------CCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCC
T ss_pred EEEEeCCCCCHHHHHHhCcC---------CCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccC
Confidence 99999999999999987542 889999999999999999999999 999999999999999999999999
Q ss_pred cccCCCccccccc-cccccccccCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCCccchhh------
Q 018712 218 DLSNQAPDAAARL-HSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTW------ 289 (351)
Q Consensus 218 g~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~Pf~~~~~~~~~~~~~~------ 289 (351)
|++.......... ......+|+.|+|||.+.+..++.++||||||+++|+|++ |+.||...........+..
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~ 241 (291)
T 1xbb_A 162 GLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGC 241 (291)
T ss_dssp TTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCC
T ss_pred CcceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence 9987654332211 1123346788999999998889999999999999999999 9999987543222111111
Q ss_pred --cccCCCccchhhhcccccCCCCCHHHHHHHHHHHHHh
Q 018712 290 --ATPKLSEDKVKQCVDTKLGGEYPPKAIAKVRKKKFIT 326 (351)
Q Consensus 290 --~~~~~~~~~~~~~ld~~~~~~~~~~~~~~~~~~~~~~ 326 (351)
..+....+.+..|+..+|.+|++.+++...++-.+..
T Consensus 242 ~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~ 280 (291)
T 1xbb_A 242 PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 280 (291)
T ss_dssp CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 1112223688999999999999999998888776544
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=333.01 Aligned_cols=243 Identities=27% Similarity=0.387 Sum_probs=195.3
Q ss_pred eeccCCcEEEEEEEEC---CCCEEEEEEcCCCC--CchHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEEEeCCCCC
Q 018712 73 LIGEGSYGRVYFGVLR---SGRAAAIKKLDSSK--QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASKGS 147 (351)
Q Consensus 73 ~Lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gs 147 (351)
.||+|+||.||+|.++ ++..||||++.... ...+.+.+|+++|++++||||+++++++.+ +..++||||+.+|+
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~ 421 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP 421 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence 7999999999999864 46679999997643 245779999999999999999999999876 56899999999999
Q ss_pred HHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccccCCCcccc
Q 018712 148 LHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAA 227 (351)
Q Consensus 148 L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~ 227 (351)
|.+++..... .+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 422 L~~~l~~~~~--------~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~ 490 (613)
T 2ozo_A 422 LHKFLVGKRE--------EIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGADD 490 (613)
T ss_dssp HHHHHTTCTT--------TSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTTCC---
T ss_pred HHHHHhhccC--------CCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCcccccCCC
Confidence 9999975432 2899999999999999999999999 9999999999999999999999999998764332
Q ss_pred ccc-cccccccccCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCCccchhhc--------ccCCCcc
Q 018712 228 ARL-HSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWA--------TPKLSED 297 (351)
Q Consensus 228 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~Pf~~~~~~~~~~~~~~~--------~~~~~~~ 297 (351)
... ......+|+.|+|||++.+..++.++||||||+++|||++ |+.||...........+... .+....+
T Consensus 491 ~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~ 570 (613)
T 2ozo_A 491 SYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYA 570 (613)
T ss_dssp -----------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred ceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHH
Confidence 211 1122345789999999999999999999999999999998 99999876543322222111 1112236
Q ss_pred chhhhcccccCCCCCHHHHHHHHHHHHHhh
Q 018712 298 KVKQCVDTKLGGEYPPKAIAKVRKKKFITS 327 (351)
Q Consensus 298 ~~~~~ld~~~~~~~~~~~~~~~~~~~~~~~ 327 (351)
.+..|++.++.+|++.+++...++..+...
T Consensus 571 li~~cl~~dP~~RPs~~~l~~~L~~~~~~~ 600 (613)
T 2ozo_A 571 LMSDCWIYKWEDRPDFLTVEQRMRACYYSL 600 (613)
T ss_dssp HHHHTTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred HHHHHcCCChhHCcCHHHHHHHHHHHHHHh
Confidence 789999999999999999988887765543
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-42 Score=312.46 Aligned_cols=247 Identities=19% Similarity=0.281 Sum_probs=197.0
Q ss_pred HHHHHHHhcCCCCC-ceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCC---chHHHHHHHHHHHhc-cCCceeeeEEEEe
Q 018712 58 VDELKEKTDNFGTN-SLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ---PDQEFLAQVSMVSRL-KNENVVELVGYYV 131 (351)
Q Consensus 58 ~~~~~~~~~~y~~~-~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l-~h~niv~~~~~~~ 131 (351)
+.......++|.+. +.||+|+||.||+|... +++.||+|++..... ....+.+|+.+++.+ +||||+++++++.
T Consensus 20 ~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~ 99 (327)
T 3lm5_A 20 FQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYE 99 (327)
T ss_dssp SBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred HHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEE
Confidence 33445566778887 88999999999999976 689999999875432 246788999999999 5699999999999
Q ss_pred cCCceEEEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEcc---
Q 018712 132 DGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFD--- 208 (351)
Q Consensus 132 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~--- 208 (351)
+.+..++||||+.+|+|.+++...... .+++..++.++.||+.||.|||++| |+||||||+|||++.
T Consensus 100 ~~~~~~lv~e~~~~~~L~~~~~~~~~~-------~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~ 169 (327)
T 3lm5_A 100 NTSEIILILEYAAGGEIFSLCLPELAE-------MVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYP 169 (327)
T ss_dssp CSSEEEEEEECCTTEEGGGGGSSCC-C-------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTT
T ss_pred eCCeEEEEEEecCCCcHHHHHHHhccc-------CCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCC
Confidence 999999999999999999998654221 3899999999999999999999999 999999999999987
Q ss_pred CCceEEecccccCCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccchh
Q 018712 209 DDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVT 288 (351)
Q Consensus 209 ~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~~ 288 (351)
++.+||+|||++........ .....||+.|+|||++.+..++.++||||||+++|+|++|+.||...........+.
T Consensus 170 ~~~~kL~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~ 246 (327)
T 3lm5_A 170 LGDIKIVDFGMSRKIGHACE---LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNIS 246 (327)
T ss_dssp BCCEEECCGGGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred CCcEEEeeCccccccCCccc---cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHH
Confidence 78999999999977643322 234579999999999999999999999999999999999999997654322111111
Q ss_pred hc-----------ccCCCccchhhhcccccCCCCCHHHHH
Q 018712 289 WA-----------TPKLSEDKVKQCVDTKLGGEYPPKAIA 317 (351)
Q Consensus 289 ~~-----------~~~~~~~~~~~~ld~~~~~~~~~~~~~ 317 (351)
.. .+....+.+..|+..+|.+|++.+++.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll 286 (327)
T 3lm5_A 247 QVNVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICL 286 (327)
T ss_dssp HTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHT
T ss_pred hcccccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHh
Confidence 10 111123578899999999999877653
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=315.69 Aligned_cols=198 Identities=23% Similarity=0.296 Sum_probs=164.5
Q ss_pred HhcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCCc---hHHHHHHHHHHHhccCCceeeeEEEEecCC-----
Q 018712 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVDGP----- 134 (351)
Q Consensus 64 ~~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----- 134 (351)
..++|.+.+.||+|+||.||+|.+. +++.||+|++...... ...+.+|+.+++.++||||+++++++...+
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 102 (371)
T 2xrw_A 23 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 102 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTC
T ss_pred hhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccc
Confidence 3478999999999999999999975 7889999998754332 356789999999999999999999997665
Q ss_pred -ceEEEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceE
Q 018712 135 -LRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAK 213 (351)
Q Consensus 135 -~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vk 213 (351)
..++||||+.+ +|.+++... +++..+..++.||+.||.|||++| |+||||||+|||++.++.+|
T Consensus 103 ~~~~lv~e~~~~-~l~~~~~~~-----------~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~k 167 (371)
T 2xrw_A 103 QDVYIVMELMDA-NLCQVIQME-----------LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLK 167 (371)
T ss_dssp CEEEEEEECCSE-EHHHHHHSC-----------CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEE
T ss_pred cceEEEEEcCCC-CHHHHHhhc-----------cCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEE
Confidence 68999999975 888888632 889999999999999999999999 99999999999999999999
Q ss_pred EecccccCCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCC
Q 018712 214 ISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTL 279 (351)
Q Consensus 214 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~ 279 (351)
|+|||+++....... .....||+.|+|||++.+..++.++||||||+++|+|++|+.||.+..
T Consensus 168 l~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 230 (371)
T 2xrw_A 168 ILDFGLARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTD 230 (371)
T ss_dssp ECCCCC-------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred EEEeecccccccccc---cCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 999999976543221 234578999999999999999999999999999999999999998654
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=301.43 Aligned_cols=248 Identities=20% Similarity=0.323 Sum_probs=198.3
Q ss_pred HhcCCCCCceeccCCcEEEEEEEECC----CCEEEEEEcCCCCC--chHHHHHHHHHHHhccCCceeeeEEEEecCCceE
Q 018712 64 KTDNFGTNSLIGEGSYGRVYFGVLRS----GRAAAIKKLDSSKQ--PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRV 137 (351)
Q Consensus 64 ~~~~y~~~~~Lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 137 (351)
..++|.+.+.||+|+||.||+|.+.. +..||+|.+..... ..+.+.+|+.++++++||||+++++++.+ +..+
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~ 88 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTW 88 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCE
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCE
Confidence 34679999999999999999998642 34699999876533 34678899999999999999999999865 4568
Q ss_pred EEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecc
Q 018712 138 LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDF 217 (351)
Q Consensus 138 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Df 217 (351)
+||||+.+++|.+++..... .+++..+..++.|++.||.|||++| ++||||||+||+++.++.+||+||
T Consensus 89 ~v~e~~~~~~L~~~l~~~~~--------~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Df 157 (281)
T 3cc6_A 89 IIMELYPYGELGHYLERNKN--------SLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDF 157 (281)
T ss_dssp EEEECCTTCBHHHHHHHHTT--------TCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCC
T ss_pred EEEecCCCCCHHHHHHhccc--------cCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCcc
Confidence 99999999999999976432 2889999999999999999999999 999999999999999999999999
Q ss_pred cccCCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCCccchhh-------
Q 018712 218 DLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTW------- 289 (351)
Q Consensus 218 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~Pf~~~~~~~~~~~~~~------- 289 (351)
|++......... ......+|+.|+|||++.+..++.++||||||+++|+|++ |+.||...........+..
T Consensus 158 g~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~~~~ 236 (281)
T 3cc6_A 158 GLSRYIEDEDYY-KASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKP 236 (281)
T ss_dssp CGGGCC----------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCCCCC
T ss_pred CCCccccccccc-ccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCCCCC
Confidence 999876543221 1233457889999999998999999999999999999998 9999976544332211111
Q ss_pred -cccCCCccchhhhcccccCCCCCHHHHHHHHHHHH
Q 018712 290 -ATPKLSEDKVKQCVDTKLGGEYPPKAIAKVRKKKF 324 (351)
Q Consensus 290 -~~~~~~~~~~~~~ld~~~~~~~~~~~~~~~~~~~~ 324 (351)
..+....+.+..|+..+|.+|++.+++...++-.+
T Consensus 237 ~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~ 272 (281)
T 3cc6_A 237 DLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVY 272 (281)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHH
Confidence 11111236889999999999999999887766554
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=308.36 Aligned_cols=193 Identities=18% Similarity=0.346 Sum_probs=170.7
Q ss_pred hcCCCCCceeccCCcEEEEEEEE-CCCCEEEEEEcCCCCCchHHHHHHHHHHHhcc-CCceeeeEEEEec--CCceEEEE
Q 018712 65 TDNFGTNSLIGEGSYGRVYFGVL-RSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLK-NENVVELVGYYVD--GPLRVLAY 140 (351)
Q Consensus 65 ~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~--~~~~~lv~ 140 (351)
.++|++.+.||+|+||.||+|.+ .+++.||+|++... ..+.+.+|+.++++++ ||||+++++++.+ ....++||
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~ 112 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV--KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 112 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC--CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc--chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEE
Confidence 46899999999999999999996 47899999998743 3567899999999997 9999999999987 66789999
Q ss_pred EeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCC-ceEEecccc
Q 018712 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD-IAKISDFDL 219 (351)
Q Consensus 141 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~-~vkl~Dfg~ 219 (351)
||+.+++|.+++.. ++...+..++.||+.||.|||++| |+||||||+|||++.++ .+||+|||+
T Consensus 113 e~~~~~~l~~~~~~------------~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~ 177 (330)
T 3nsz_A 113 EHVNNTDFKQLYQT------------LTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGL 177 (330)
T ss_dssp ECCCCCCHHHHGGG------------CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTT
T ss_pred eccCchhHHHHHHh------------CCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCC
Confidence 99999999999853 788999999999999999999999 99999999999999776 899999999
Q ss_pred cCCCccccccccccccccccCccCcccccC-CCCCccchhHhHHHHHHHHHcCCCCCCC
Q 018712 220 SNQAPDAAARLHSTRVLGTFGYHAPEYAMT-GQMSSKSDVYSFGVVLLELLTGRKPVDH 277 (351)
Q Consensus 220 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~Pf~~ 277 (351)
++....... .....||+.|+|||++.+ ..++.++||||||+++|+|++|+.||..
T Consensus 178 a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~ 233 (330)
T 3nsz_A 178 AEFYHPGQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFH 233 (330)
T ss_dssp CEECCTTCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSC
T ss_pred ceEcCCCCc---cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 976543322 244578999999999887 6789999999999999999999999954
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=305.45 Aligned_cols=249 Identities=22% Similarity=0.292 Sum_probs=195.1
Q ss_pred HhcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCC-----CCchHHHHHHHHHHHhccCCceeeeEEEEe--cCCc
Q 018712 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSS-----KQPDQEFLAQVSMVSRLKNENVVELVGYYV--DGPL 135 (351)
Q Consensus 64 ~~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~--~~~~ 135 (351)
..++|.+.+.||+|+||.||++.+. +++.||+|++... ......+.+|+.++++++||||+++++++. +...
T Consensus 3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (305)
T 2wtk_C 3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQK 82 (305)
T ss_dssp --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---C
T ss_pred cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCe
Confidence 3578999999999999999999974 7889999998643 233567899999999999999999999984 4567
Q ss_pred eEEEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEe
Q 018712 136 RVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKIS 215 (351)
Q Consensus 136 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~ 215 (351)
.++||||+.++ |.+++...... .+++..+..++.||+.||.|||+++ ++||||||+||+++.++.+||+
T Consensus 83 ~~lv~e~~~~~-l~~~~~~~~~~-------~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~ 151 (305)
T 2wtk_C 83 MYMVMEYCVCG-MQEMLDSVPEK-------RFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKIS 151 (305)
T ss_dssp EEEEEECCSEE-HHHHHHHSTTC-------SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEEC
T ss_pred EEEEehhccCC-HHHHHHhCccc-------ccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEee
Confidence 89999999875 77777654322 2899999999999999999999999 9999999999999999999999
Q ss_pred cccccCCCccccccccccccccccCccCcccccCCC--CCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccchhhc---
Q 018712 216 DFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQ--MSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWA--- 290 (351)
Q Consensus 216 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~~~~--- 290 (351)
|||++................||+.|+|||++.+.. ++.++||||||+++|+|++|+.||...........+...
T Consensus 152 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~ 231 (305)
T 2wtk_C 152 ALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYA 231 (305)
T ss_dssp CCTTCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCC
T ss_pred ccccccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCCCC
Confidence 999987654332222224456899999999987654 378999999999999999999999865432211111111
Q ss_pred ----ccCCCccchhhhcccccCCCCCHHHHHHHHHHHHHh
Q 018712 291 ----TPKLSEDKVKQCVDTKLGGEYPPKAIAKVRKKKFIT 326 (351)
Q Consensus 291 ----~~~~~~~~~~~~ld~~~~~~~~~~~~~~~~~~~~~~ 326 (351)
.+....+.+..|++.+|.+|++.+++. ++.++.
T Consensus 232 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll---~~~~~~ 268 (305)
T 2wtk_C 232 IPGDCGPPLSDLLKGMLEYEPAKRFSIRQIR---QHSWFR 268 (305)
T ss_dssp CCSSSCHHHHHHHHHHTCSSTTTSCCHHHHH---HSHHHH
T ss_pred CCCccCHHHHHHHHHHccCChhhCCCHHHHh---cCcccc
Confidence 111123788999999999999887764 444443
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=314.05 Aligned_cols=252 Identities=22% Similarity=0.327 Sum_probs=194.1
Q ss_pred HHHHHHHhcCCCCCceeccCCcEEEEEEEECCCCEEEEEEcCCCCCc------------hHHHHHHHHHHHhccCCceee
Q 018712 58 VDELKEKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQP------------DQEFLAQVSMVSRLKNENVVE 125 (351)
Q Consensus 58 ~~~~~~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~------------~~~~~~e~~~l~~l~h~niv~ 125 (351)
..++....++|.+.+.||+|+||.||+|.+.++..||+|++...... .+.+.+|+.++++++||||++
T Consensus 14 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~ 93 (362)
T 3pg1_A 14 IAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILG 93 (362)
T ss_dssp HHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred HHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccc
Confidence 45677788999999999999999999999888999999998643221 267899999999999999999
Q ss_pred eEEEEec-----CCceEEEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeecccc
Q 018712 126 LVGYYVD-----GPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIK 200 (351)
Q Consensus 126 ~~~~~~~-----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlk 200 (351)
+++++.. ....++||||+. |+|.+++..... .+++..+..++.||+.||.|||++| |+|||||
T Consensus 94 ~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlk 161 (362)
T 3pg1_A 94 LRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRI--------VISPQHIQYFMYHILLGLHVLHEAG---VVHRDLH 161 (362)
T ss_dssp CSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTS--------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCC
T ss_pred eeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhccc--------CCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCC
Confidence 9999843 346899999998 588888875432 2899999999999999999999999 9999999
Q ss_pred CCcEEEccCCceEEecccccCCCccccccccccccccccCccCcccccC-CCCCccchhHhHHHHHHHHHcCCCCCCCCC
Q 018712 201 SSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMT-GQMSSKSDVYSFGVVLLELLTGRKPVDHTL 279 (351)
Q Consensus 201 p~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~Pf~~~~ 279 (351)
|+|||++.++.+||+|||++........ .....||+.|+|||++.+ ..++.++||||||+++|+|++|+.||....
T Consensus 162 p~NIl~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~ 238 (362)
T 3pg1_A 162 PGNILLADNNDITICDFNLAREDTADAN---KTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGST 238 (362)
T ss_dssp GGGEEECTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred hHHEEEcCCCCEEEEecCcccccccccc---cceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCC
Confidence 9999999999999999999975443322 244578999999999877 678999999999999999999999998653
Q ss_pred CCCCccch------------------------------------hhcc---cCCCccchhhhcccccCCCCCHHHHHHHH
Q 018712 280 PRGQQSLV------------------------------------TWAT---PKLSEDKVKQCVDTKLGGEYPPKAIAKVR 320 (351)
Q Consensus 280 ~~~~~~~~------------------------------------~~~~---~~~~~~~~~~~ld~~~~~~~~~~~~~~~~ 320 (351)
.......+ .... +....+.+..|+..+|.+|++++++ +
T Consensus 239 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~el---l 315 (362)
T 3pg1_A 239 FYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQA---L 315 (362)
T ss_dssp HHHHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHH---H
T ss_pred HHHHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHH---H
Confidence 21110000 0000 1112368899999999999987765 4
Q ss_pred HHHHHhh
Q 018712 321 KKKFITS 327 (351)
Q Consensus 321 ~~~~~~~ 327 (351)
++.++..
T Consensus 316 ~hp~f~~ 322 (362)
T 3pg1_A 316 RHPYFES 322 (362)
T ss_dssp TSGGGTT
T ss_pred cCchhhh
Confidence 4555543
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=310.76 Aligned_cols=249 Identities=22% Similarity=0.370 Sum_probs=194.7
Q ss_pred HHHHHhcCCCCCceeccCCcEEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHHhc--cCCceeeeEEEEecC----
Q 018712 60 ELKEKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRL--KNENVVELVGYYVDG---- 133 (351)
Q Consensus 60 ~~~~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l--~h~niv~~~~~~~~~---- 133 (351)
......++|++.+.||+|+||.||+|.+. ++.||+|++.... ......|.+++..+ +||||+++++++...
T Consensus 31 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~--~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~ 107 (337)
T 3mdy_A 31 VQRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTE--EASWFRETEIYQTVLMRHENILGFIAADIKGTGSW 107 (337)
T ss_dssp HHTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGG--HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGG
T ss_pred cccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEeccc--cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCC
Confidence 33455678999999999999999999986 8899999986433 34445566665554 899999999998877
Q ss_pred CceEEEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhC--------CCCCeeeccccCCcEE
Q 018712 134 PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEK--------AEPRIIHRNIKSSNVL 205 (351)
Q Consensus 134 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~--------~~~~ivH~Dlkp~Nil 205 (351)
...++||||+.+|+|.+++.... +++..++.++.|++.||.|||++ + |+||||||+|||
T Consensus 108 ~~~~lv~e~~~~g~L~~~l~~~~----------~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dikp~Nil 174 (337)
T 3mdy_A 108 TQLYLITDYHENGSLYDYLKSTT----------LDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPA---IAHRDLKSKNIL 174 (337)
T ss_dssp CEEEEEECCCTTCBHHHHHHHCC----------BCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCC---EECSCCCGGGEE
T ss_pred CceEEEEeccCCCcHHHHhhccC----------CCHHHHHHHHHHHHHHHHHHHHhhhhhccCCC---EEecccchHHEE
Confidence 67899999999999999997653 89999999999999999999998 8 999999999999
Q ss_pred EccCCceEEecccccCCCccccccc--cccccccccCccCcccccCCCCCcc------chhHhHHHHHHHHHcC------
Q 018712 206 LFDDDIAKISDFDLSNQAPDAAARL--HSTRVLGTFGYHAPEYAMTGQMSSK------SDVYSFGVVLLELLTG------ 271 (351)
Q Consensus 206 l~~~~~vkl~Dfg~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~------~DvwslG~il~el~tg------ 271 (351)
++.++.+||+|||++.......... ......||+.|+|||++.+..++.. +||||||+++|||++|
T Consensus 175 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~ 254 (337)
T 3mdy_A 175 VKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGI 254 (337)
T ss_dssp ECTTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTB
T ss_pred ECCCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccc
Confidence 9999999999999997654332211 1234579999999999987766665 9999999999999999
Q ss_pred ----CCCCCCCCCCCCccc-------hhhcccCC------------CccchhhhcccccCCCCCHHHHHHHHHHHH
Q 018712 272 ----RKPVDHTLPRGQQSL-------VTWATPKL------------SEDKVKQCVDTKLGGEYPPKAIAKVRKKKF 324 (351)
Q Consensus 272 ----~~Pf~~~~~~~~~~~-------~~~~~~~~------------~~~~~~~~ld~~~~~~~~~~~~~~~~~~~~ 324 (351)
+.||........... .....+.. ..+.+..|+..+|.+|++.+++.+.++-..
T Consensus 255 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~ 330 (337)
T 3mdy_A 255 VEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMS 330 (337)
T ss_dssp CCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred cccccccHhhhcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHH
Confidence 677765433221100 00111111 125889999999999999999888776543
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-41 Score=302.08 Aligned_cols=248 Identities=23% Similarity=0.327 Sum_probs=196.9
Q ss_pred CCCCCceeccCCcEEEEEEEEC-C---CCEEEEEEcCCCCCc--hHHHHHHHHHHHhccCCceeeeEEEEecCCce-EEE
Q 018712 67 NFGTNSLIGEGSYGRVYFGVLR-S---GRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPLR-VLA 139 (351)
Q Consensus 67 ~y~~~~~Lg~G~~g~Vy~~~~~-~---~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~-~lv 139 (351)
.|.+.+.||+|+||.||+|.+. + +..+|+|++...... .+.+.+|+.++++++||||+++++++.+.+.. +++
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 4566789999999999999854 2 237999998765433 35688999999999999999999999876655 999
Q ss_pred EEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccc
Q 018712 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDL 219 (351)
Q Consensus 140 ~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~ 219 (351)
|||+.+++|.+++..... .+++..++.++.|++.||.|||++| ++||||||+||+++.++.+||+|||+
T Consensus 102 ~e~~~~~~L~~~~~~~~~--------~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~ 170 (298)
T 3pls_A 102 LPYMCHGDLLQFIRSPQR--------NPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGL 170 (298)
T ss_dssp ECCCTTCBHHHHHHCTTC--------CCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTS
T ss_pred EecccCCCHHHHHhcccc--------CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCC
Confidence 999999999999986432 2889999999999999999999999 99999999999999999999999999
Q ss_pred cCCCccccc--cccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCC-CCCCCCCCCccchhhc------
Q 018712 220 SNQAPDAAA--RLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP-VDHTLPRGQQSLVTWA------ 290 (351)
Q Consensus 220 a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P-f~~~~~~~~~~~~~~~------ 290 (351)
++....... ........+|+.|+|||.+.+..++.++||||||+++|+|++|..| |...........+...
T Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (298)
T 3pls_A 171 ARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLPQP 250 (298)
T ss_dssp SCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCCCCC
T ss_pred cccccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCCCCC
Confidence 986644321 1122345678999999999999999999999999999999995554 5443332221111111
Q ss_pred --ccCCCccchhhhcccccCCCCCHHHHHHHHHHHHH
Q 018712 291 --TPKLSEDKVKQCVDTKLGGEYPPKAIAKVRKKKFI 325 (351)
Q Consensus 291 --~~~~~~~~~~~~ld~~~~~~~~~~~~~~~~~~~~~ 325 (351)
.+....+.+..|+..+|.+|++.+++...++-.+.
T Consensus 251 ~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~ 287 (298)
T 3pls_A 251 EYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVS 287 (298)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 11112368899999999999999998887766543
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-42 Score=317.13 Aligned_cols=198 Identities=28% Similarity=0.452 Sum_probs=175.0
Q ss_pred hcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCCc--hHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEEE
Q 018712 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYE 141 (351)
Q Consensus 65 ~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 141 (351)
.++|.+.+.||+|+||.||+|.+. ++..||+|++...... .+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 111 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 111 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence 467999999999999999999976 7899999998765332 3568899999999999999999999999999999999
Q ss_pred eCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhC-CCCCeeeccccCCcEEEccCCceEEeccccc
Q 018712 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEK-AEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (351)
Q Consensus 142 ~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~-~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a 220 (351)
|+++++|.+++..... +++..+..++.|++.||.|||+. + |+||||||+|||++.++.+||+|||++
T Consensus 112 ~~~~~~L~~~l~~~~~---------~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 179 (360)
T 3eqc_A 112 HMDGGSLDQVLKKAGR---------IPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVS 179 (360)
T ss_dssp CCTTCBHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCC
T ss_pred CCCCCCHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCCC
Confidence 9999999999987543 88999999999999999999996 8 999999999999999999999999998
Q ss_pred CCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCC
Q 018712 221 NQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHT 278 (351)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~ 278 (351)
....... .....||+.|+|||++.+..++.++||||||+++|+|++|+.||...
T Consensus 180 ~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 233 (360)
T 3eqc_A 180 GQLIDSM----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPP 233 (360)
T ss_dssp HHHHHHC--------CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCC
T ss_pred ccccccc----ccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 6543221 23457999999999999999999999999999999999999999754
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=316.63 Aligned_cols=246 Identities=25% Similarity=0.387 Sum_probs=189.0
Q ss_pred HhcCCCCCceeccCCcEEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHH--HHhccCCceeeeEEEEe-----cCCce
Q 018712 64 KTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSM--VSRLKNENVVELVGYYV-----DGPLR 136 (351)
Q Consensus 64 ~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~--l~~l~h~niv~~~~~~~-----~~~~~ 136 (351)
..++|++.+.||+|+||.||+|.. +++.||+|++.... ...+..|.++ ++.++|+||+++++.+. .....
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~--~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 87 (336)
T 3g2f_A 11 DLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN--RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY 87 (336)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG--HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred ChHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccc--hhhHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence 457899999999999999999977 68899999986443 2334444444 45589999999997543 23357
Q ss_pred EEEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhC---------CCCCeeeccccCCcEEEc
Q 018712 137 VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEK---------AEPRIIHRNIKSSNVLLF 207 (351)
Q Consensus 137 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~---------~~~~ivH~Dlkp~Nill~ 207 (351)
++||||+++|+|.+++.... .++..+..++.||+.||.|||+. + |+||||||+|||++
T Consensus 88 ~lv~e~~~~g~L~~~l~~~~----------~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~---ivH~Dikp~Nill~ 154 (336)
T 3g2f_A 88 LLVMEYYPNGSLXKYLSLHT----------SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA---ISHRDLNSRNVLVK 154 (336)
T ss_dssp EEEECCCTTCBHHHHHHHCC----------BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC---EECSSCSGGGEEEC
T ss_pred EEEEecCCCCcHHHHHhhcc----------cchhHHHHHHHHHHHHHHHHHhhhccccccccc---eeecccccceEEEc
Confidence 89999999999999997654 68899999999999999999999 8 99999999999999
Q ss_pred cCCceEEecccccCCCccccc------cccccccccccCccCcccccC-------CCCCccchhHhHHHHHHHHHcCCCC
Q 018712 208 DDDIAKISDFDLSNQAPDAAA------RLHSTRVLGTFGYHAPEYAMT-------GQMSSKSDVYSFGVVLLELLTGRKP 274 (351)
Q Consensus 208 ~~~~vkl~Dfg~a~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwslG~il~el~tg~~P 274 (351)
.++.+||+|||+++....... ........||+.|+|||++.+ ..++.++||||||+++|||++|..|
T Consensus 155 ~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p 234 (336)
T 3g2f_A 155 NDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTD 234 (336)
T ss_dssp TTSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGG
T ss_pred CCCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCc
Confidence 999999999999976543211 111234569999999999886 3566789999999999999999777
Q ss_pred CCCCCCCCCc-cch-------------------hhcccCC-------------CccchhhhcccccCCCCCHHHHHHHHH
Q 018712 275 VDHTLPRGQQ-SLV-------------------TWATPKL-------------SEDKVKQCVDTKLGGEYPPKAIAKVRK 321 (351)
Q Consensus 275 f~~~~~~~~~-~~~-------------------~~~~~~~-------------~~~~~~~~ld~~~~~~~~~~~~~~~~~ 321 (351)
|......... ... ....+.+ ..+.+..|+..+|.+|++++++...++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~ 314 (336)
T 3g2f_A 235 LFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMA 314 (336)
T ss_dssp GSTTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred CCCccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHH
Confidence 6543221111 000 0001111 236789999999999999999988776
Q ss_pred HHHH
Q 018712 322 KKFI 325 (351)
Q Consensus 322 ~~~~ 325 (351)
-.+.
T Consensus 315 ~ll~ 318 (336)
T 3g2f_A 315 ELMM 318 (336)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 6553
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-42 Score=308.43 Aligned_cols=248 Identities=24% Similarity=0.344 Sum_probs=197.9
Q ss_pred hcCCCCCceeccCCcEEEEEEEE-----CCCCEEEEEEcCCCC--CchHHHHHHHHHHHhccCCceeeeEEEEecC--Cc
Q 018712 65 TDNFGTNSLIGEGSYGRVYFGVL-----RSGRAAAIKKLDSSK--QPDQEFLAQVSMVSRLKNENVVELVGYYVDG--PL 135 (351)
Q Consensus 65 ~~~y~~~~~Lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~ 135 (351)
.+.|++.+.||+|+||.||+|.+ .+++.||+|++.... .....+.+|+.++++++||||+++++++.+. ..
T Consensus 20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 99 (302)
T 4e5w_A 20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 99 (302)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CC
T ss_pred hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCce
Confidence 34588999999999999999983 368999999987543 2346789999999999999999999999876 66
Q ss_pred eEEEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEe
Q 018712 136 RVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKIS 215 (351)
Q Consensus 136 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~ 215 (351)
.++||||+++++|.+++..... .+++..++.++.|++.||.|||+++ ++||||||+||+++.++.+||+
T Consensus 100 ~~lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~ 168 (302)
T 4e5w_A 100 IKLIMEFLPSGSLKEYLPKNKN--------KINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIG 168 (302)
T ss_dssp EEEEEECCTTCBHHHHHHHHTT--------TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEEC
T ss_pred EEEEEEeCCCCcHHHHHHhccc--------cCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEEC
Confidence 8999999999999999965432 2899999999999999999999999 9999999999999999999999
Q ss_pred cccccCCCcccccc-ccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCC---------CCCc-
Q 018712 216 DFDLSNQAPDAAAR-LHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLP---------RGQQ- 284 (351)
Q Consensus 216 Dfg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~---------~~~~- 284 (351)
|||++......... .......||..|+|||++.+..++.++||||||+++|+|++|..|+..... ....
T Consensus 169 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 248 (302)
T 4e5w_A 169 DFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMT 248 (302)
T ss_dssp CCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGH
T ss_pred cccccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccC
Confidence 99999766443221 122345688899999999999999999999999999999999998653210 0000
Q ss_pred --cchh-----------hcccCCCccchhhhcccccCCCCCHHHHHHHHHHH
Q 018712 285 --SLVT-----------WATPKLSEDKVKQCVDTKLGGEYPPKAIAKVRKKK 323 (351)
Q Consensus 285 --~~~~-----------~~~~~~~~~~~~~~ld~~~~~~~~~~~~~~~~~~~ 323 (351)
.... ...+....+.+..|+..+|.+|++.+++.+.++..
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 300 (302)
T 4e5w_A 249 VTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEAL 300 (302)
T ss_dssp HHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHH
Confidence 0000 01111123688999999999999999998877644
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=313.46 Aligned_cols=245 Identities=22% Similarity=0.288 Sum_probs=197.5
Q ss_pred hcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCCc--hHHHHHHHHHHHhccCCceeeeEEEEecC-----Cce
Q 018712 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDG-----PLR 136 (351)
Q Consensus 65 ~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~~ 136 (351)
.++|++.+.||+|+||.||+|.+. ++..||+|++...... .+.+.+|++++++++||||+++++++... ...
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 468999999999999999999975 7889999999754433 36688999999999999999999998654 368
Q ss_pred EEEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEec
Q 018712 137 VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISD 216 (351)
Q Consensus 137 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~D 216 (351)
++|||++.+ +|.+++.... +++..+..++.||+.||.|||++| |+||||||+|||++.++.+||+|
T Consensus 106 ~iv~e~~~~-~L~~~l~~~~----------~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~D 171 (364)
T 3qyz_A 106 YIVQDLMET-DLYKLLKTQH----------LSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICD 171 (364)
T ss_dssp EEEEECCSE-EHHHHHHHCC----------CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECC
T ss_pred EEEEcccCc-CHHHHHHhCC----------CCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEe
Confidence 999999975 9999997653 899999999999999999999999 99999999999999999999999
Q ss_pred ccccCCCccccccc-cccccccccCccCcccccC-CCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccchhh-----
Q 018712 217 FDLSNQAPDAAARL-HSTRVLGTFGYHAPEYAMT-GQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTW----- 289 (351)
Q Consensus 217 fg~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~~~----- 289 (351)
||++.......... ......||+.|+|||++.+ ..++.++||||||+++|+|++|+.||...........+..
T Consensus 172 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~ 251 (364)
T 3qyz_A 172 FGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSP 251 (364)
T ss_dssp CTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSC
T ss_pred CcceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCC
Confidence 99997765432221 1244579999999998754 4589999999999999999999999987543322111100
Q ss_pred ------------------------------cccCC---CccchhhhcccccCCCCCHHHHHHHHHHHHHh
Q 018712 290 ------------------------------ATPKL---SEDKVKQCVDTKLGGEYPPKAIAKVRKKKFIT 326 (351)
Q Consensus 290 ------------------------------~~~~~---~~~~~~~~ld~~~~~~~~~~~~~~~~~~~~~~ 326 (351)
..+.. ..+.+..|+..+|.+|++.+++ +++.++.
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~---l~hp~~~ 318 (364)
T 3qyz_A 252 SQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA---LAHPYLE 318 (364)
T ss_dssp CHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHH---HTSGGGT
T ss_pred CHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHH---hcCcchh
Confidence 00111 1368899999999999987765 4555544
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-42 Score=311.72 Aligned_cols=199 Identities=19% Similarity=0.337 Sum_probs=174.4
Q ss_pred hcCCCCCceeccCCcEEEEEEEE-C-CCCEEEEEEcCCCCCchHHHHHHHHHHHhccCCc------eeeeEEEEecCCce
Q 018712 65 TDNFGTNSLIGEGSYGRVYFGVL-R-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNEN------VVELVGYYVDGPLR 136 (351)
Q Consensus 65 ~~~y~~~~~Lg~G~~g~Vy~~~~-~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~n------iv~~~~~~~~~~~~ 136 (351)
.++|++.+.||+|+||.||+|.+ . +++.||+|++.......+.+.+|+.+++.++|++ ++++++++.+.+..
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~ 92 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHI 92 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEE
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcE
Confidence 46899999999999999999997 3 6889999999765555567889999999987654 99999999999999
Q ss_pred EEEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEcc--------
Q 018712 137 VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFD-------- 208 (351)
Q Consensus 137 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~-------- 208 (351)
++||||+ +++|.+++...... .+++..+..++.||+.||.|||++| |+||||||+|||++.
T Consensus 93 ~lv~e~~-~~~l~~~l~~~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~ 161 (339)
T 1z57_A 93 CIVFELL-GLSTYDFIKENGFL-------PFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYN 161 (339)
T ss_dssp EEEEECC-CCBHHHHHHHTTTC-------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC
T ss_pred EEEEcCC-CCCHHHHHHhcCCC-------CCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccC
Confidence 9999999 78999999876432 2889999999999999999999999 999999999999987
Q ss_pred -----------CCceEEecccccCCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCC
Q 018712 209 -----------DDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDH 277 (351)
Q Consensus 209 -----------~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~ 277 (351)
++.+||+|||++...... .....||+.|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus 162 ~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 236 (339)
T 1z57_A 162 PKIKRDERTLINPDIKVVDFGSATYDDEH-----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPT 236 (339)
T ss_dssp ----CEEEEESCCCEEECCCSSCEETTSC-----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred CccccccccccCCCceEeeCcccccCccc-----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCC
Confidence 668999999998764332 2345789999999999999999999999999999999999999986
Q ss_pred CC
Q 018712 278 TL 279 (351)
Q Consensus 278 ~~ 279 (351)
..
T Consensus 237 ~~ 238 (339)
T 1z57_A 237 HD 238 (339)
T ss_dssp SC
T ss_pred CC
Confidence 54
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-42 Score=309.78 Aligned_cols=245 Identities=27% Similarity=0.369 Sum_probs=198.3
Q ss_pred CCCCceeccCCcEEEEEEEEC-----CCCEEEEEEcCCCCCc--hHHHHHHHHHHHhccCCceeeeEEEEec--CCceEE
Q 018712 68 FGTNSLIGEGSYGRVYFGVLR-----SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVD--GPLRVL 138 (351)
Q Consensus 68 y~~~~~Lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~l 138 (351)
|++.+.||+|+||.||++.+. +++.||+|++...... ...+.+|++++++++||||+++++++.+ ....++
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 112 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL 112 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence 488999999999999988753 6889999999765432 3568899999999999999999999986 457899
Q ss_pred EEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEeccc
Q 018712 139 AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFD 218 (351)
Q Consensus 139 v~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg 218 (351)
||||+++++|.+++.... +++..++.++.||+.||.|||++| |+||||||+||+++.++.+||+|||
T Consensus 113 v~e~~~~~~L~~~l~~~~----------~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg 179 (318)
T 3lxp_A 113 VMEYVPLGSLRDYLPRHS----------IGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFG 179 (318)
T ss_dssp EECCCTTCBHHHHGGGSC----------CCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGG
T ss_pred EEecccCCcHHHHHhhCC----------CCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCcc
Confidence 999999999999998654 889999999999999999999999 9999999999999999999999999
Q ss_pred ccCCCcccccc-ccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCC---------CCc----
Q 018712 219 LSNQAPDAAAR-LHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPR---------GQQ---- 284 (351)
Q Consensus 219 ~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~---------~~~---- 284 (351)
++......... .......+|+.|+|||++.+..++.++||||||+++|+|++|..||...... ...
T Consensus 180 ~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 259 (318)
T 3lxp_A 180 LAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLR 259 (318)
T ss_dssp GCEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHH
T ss_pred ccccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHH
Confidence 99876543221 1123455788899999999989999999999999999999999999753211 000
Q ss_pred --cch--------hhcccCCCccchhhhcccccCCCCCHHHHHHHHHHHHH
Q 018712 285 --SLV--------TWATPKLSEDKVKQCVDTKLGGEYPPKAIAKVRKKKFI 325 (351)
Q Consensus 285 --~~~--------~~~~~~~~~~~~~~~ld~~~~~~~~~~~~~~~~~~~~~ 325 (351)
..+ ....+....+.+..|+..+|.+|++.+++...++....
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~ 310 (318)
T 3lxp_A 260 LTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHE 310 (318)
T ss_dssp HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence 000 00111112368899999999999999999887765543
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=306.87 Aligned_cols=250 Identities=20% Similarity=0.299 Sum_probs=190.0
Q ss_pred HhcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCC----chHHHHHHHHHHHhccCCceeeeEEEEecCCceEE
Q 018712 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ----PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVL 138 (351)
Q Consensus 64 ~~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 138 (351)
..++|++.+.||+|+||.||+|... +++.||+|++..... ....+.+|+.++++++||||+++++++.+.+..++
T Consensus 30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 109 (310)
T 2wqm_A 30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNI 109 (310)
T ss_dssp SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEE
Confidence 3467999999999999999999974 789999999875322 23568899999999999999999999999999999
Q ss_pred EEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEeccc
Q 018712 139 AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFD 218 (351)
Q Consensus 139 v~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg 218 (351)
||||+.+++|.+++...... ...++...++.++.|++.||.|||+++ ++||||||+||+++.++.+||+|||
T Consensus 110 v~e~~~~~~L~~~l~~~~~~-----~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg 181 (310)
T 2wqm_A 110 VLELADAGDLSRMIKHFKKQ-----KRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLG 181 (310)
T ss_dssp EEECCCSCBHHHHHHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC-
T ss_pred EEecCCCCCHHHHHHHhccc-----ccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEecc
Confidence 99999999999999752111 012889999999999999999999999 9999999999999999999999999
Q ss_pred ccCCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCc--cch-h-------
Q 018712 219 LSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQ--SLV-T------- 288 (351)
Q Consensus 219 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~--~~~-~------- 288 (351)
++......... .....||+.|+|||++.+..++.++||||||+++|+|++|+.||......... ..+ .
T Consensus 182 ~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 259 (310)
T 2wqm_A 182 LGRFFSSKTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLP 259 (310)
T ss_dssp -------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCCCC
T ss_pred ceeeecCCCcc--ccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCCCCc
Confidence 98765433221 23456899999999999999999999999999999999999999764321100 000 0
Q ss_pred -hcccCCCccchhhhcccccCCCCCHHHHHHHHHHH
Q 018712 289 -WATPKLSEDKVKQCVDTKLGGEYPPKAIAKVRKKK 323 (351)
Q Consensus 289 -~~~~~~~~~~~~~~ld~~~~~~~~~~~~~~~~~~~ 323 (351)
...+....+.+..|++.++.+|++.+++...++-.
T Consensus 260 ~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l 295 (310)
T 2wqm_A 260 SDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRM 295 (310)
T ss_dssp TTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 01111223678899999999999999888766544
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=309.99 Aligned_cols=255 Identities=25% Similarity=0.344 Sum_probs=199.6
Q ss_pred hcCCCCCceeccCCcEEEEEEEEC-CCCEE--EEEEcCCCC--CchHHHHHHHHHHHhc-cCCceeeeEEEEecCCceEE
Q 018712 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAA--AIKKLDSSK--QPDQEFLAQVSMVSRL-KNENVVELVGYYVDGPLRVL 138 (351)
Q Consensus 65 ~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~v--avK~~~~~~--~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~l 138 (351)
.++|.+.+.||+|+||.||+|.+. ++..+ |+|.+.... ...+.+.+|+.+++++ +||||+++++++.+.+..++
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 103 (327)
T 1fvr_A 24 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 103 (327)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred HHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEE
Confidence 367999999999999999999965 56544 999886432 2345688999999999 89999999999999999999
Q ss_pred EEEeCCCCCHHHHhccCCCCCC-------CCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCc
Q 018712 139 AYEHASKGSLHDILHGKKGVKG-------AKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDI 211 (351)
Q Consensus 139 v~e~~~~gsL~~~l~~~~~~~~-------~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~ 211 (351)
||||+++++|.+++........ ......+++..++.++.||+.||.|||++| |+||||||+|||++.++.
T Consensus 104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~ 180 (327)
T 1fvr_A 104 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYV 180 (327)
T ss_dssp EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGC
T ss_pred EEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCCe
Confidence 9999999999999986530000 000123899999999999999999999999 999999999999999999
Q ss_pred eEEecccccCCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCCccchhh-
Q 018712 212 AKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTW- 289 (351)
Q Consensus 212 vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~Pf~~~~~~~~~~~~~~- 289 (351)
+||+|||+++....... .....+|+.|+|||++.+..++.++||||||+++|+|++ |+.||...........+..
T Consensus 181 ~kL~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~ 257 (327)
T 1fvr_A 181 AKIADFGLSRGQEVYVK---KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG 257 (327)
T ss_dssp EEECCTTCEESSCEECC---C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGT
T ss_pred EEEcccCcCcccccccc---ccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhhcC
Confidence 99999999875433221 133457889999999998889999999999999999998 9999986543221111111
Q ss_pred -------cccCCCccchhhhcccccCCCCCHHHHHHHHHHHHH
Q 018712 290 -------ATPKLSEDKVKQCVDTKLGGEYPPKAIAKVRKKKFI 325 (351)
Q Consensus 290 -------~~~~~~~~~~~~~ld~~~~~~~~~~~~~~~~~~~~~ 325 (351)
..+....+.+..|+..+|.+|++.+++...+.-.+.
T Consensus 258 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 300 (327)
T 1fvr_A 258 YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 300 (327)
T ss_dssp CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 111112368899999999999999998887666554
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=310.32 Aligned_cols=258 Identities=24% Similarity=0.335 Sum_probs=200.5
Q ss_pred HhcCCCCCceeccCCcEEEEEEEE------CCCCEEEEEEcCCCCC--chHHHHHHHHHHHhccCCceeeeEEEEecCCc
Q 018712 64 KTDNFGTNSLIGEGSYGRVYFGVL------RSGRAAAIKKLDSSKQ--PDQEFLAQVSMVSRLKNENVVELVGYYVDGPL 135 (351)
Q Consensus 64 ~~~~y~~~~~Lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 135 (351)
..++|.+.+.||+|+||.||+|.+ .++..||+|++..... ....+.+|+.++++++||||+++++++.+...
T Consensus 28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 107 (327)
T 2yfx_A 28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP 107 (327)
T ss_dssp CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCC
Confidence 346899999999999999999983 2577999999965432 24568899999999999999999999999999
Q ss_pred eEEEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEcc---CCce
Q 018712 136 RVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFD---DDIA 212 (351)
Q Consensus 136 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~---~~~v 212 (351)
.++||||+++++|.+++....... .....+++..++.++.||+.||.|||+++ ++||||||+|||++. +..+
T Consensus 108 ~~lv~e~~~~~~L~~~l~~~~~~~--~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~ 182 (327)
T 2yfx_A 108 RFILMELMAGGDLKSFLRETRPRP--SQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVA 182 (327)
T ss_dssp CEEEEECCTTEEHHHHHHHTSCCS--SSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCE
T ss_pred cEEEEecCCCCcHHHHHHhhcccc--cccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceE
Confidence 999999999999999998764321 11123889999999999999999999999 999999999999984 4469
Q ss_pred EEecccccCCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCCccchhh--
Q 018712 213 KISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTW-- 289 (351)
Q Consensus 213 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~Pf~~~~~~~~~~~~~~-- 289 (351)
||+|||++................||+.|+|||++.+..++.++||||||+++|+|++ |+.||...........+..
T Consensus 183 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~ 262 (327)
T 2yfx_A 183 KIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGG 262 (327)
T ss_dssp EECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTC
T ss_pred EECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcCC
Confidence 9999999865433222222234567899999999999999999999999999999998 9999986543221111111
Q ss_pred ------cccCCCccchhhhcccccCCCCCHHHHHHHHHHHHHh
Q 018712 290 ------ATPKLSEDKVKQCVDTKLGGEYPPKAIAKVRKKKFIT 326 (351)
Q Consensus 290 ------~~~~~~~~~~~~~ld~~~~~~~~~~~~~~~~~~~~~~ 326 (351)
..+....+.+..|+..+|.+|++.+++...+......
T Consensus 263 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 305 (327)
T 2yfx_A 263 RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 305 (327)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred CCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcC
Confidence 1111123688999999999999999988876655443
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=315.26 Aligned_cols=249 Identities=22% Similarity=0.327 Sum_probs=189.8
Q ss_pred CCCCCceeccCCcEEEEEEEEC--C--CCEEEEEEcCCCCC--chHHHHHHHHHHHhccCCceeeeEEEEe-cCCceEEE
Q 018712 67 NFGTNSLIGEGSYGRVYFGVLR--S--GRAAAIKKLDSSKQ--PDQEFLAQVSMVSRLKNENVVELVGYYV-DGPLRVLA 139 (351)
Q Consensus 67 ~y~~~~~Lg~G~~g~Vy~~~~~--~--~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~-~~~~~~lv 139 (351)
.|.+.+.||+|+||.||+|.+. + +..||+|.+..... ....+.+|+.++++++||||+++++++. .++..++|
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv 169 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 169 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence 4667789999999999999864 2 24689999865432 2467889999999999999999999865 45678999
Q ss_pred EEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccc
Q 018712 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDL 219 (351)
Q Consensus 140 ~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~ 219 (351)
|||+.+|+|.+++..... .+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 170 ~e~~~~g~L~~~l~~~~~--------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~ 238 (373)
T 3c1x_A 170 LPYMKHGDLRNFIRNETH--------NPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGL 238 (373)
T ss_dssp EECCTTCBHHHHHHCTTC--------CCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC--
T ss_pred EECCCCCCHHHHHhhccc--------CCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeeccc
Confidence 999999999999976542 2788999999999999999999999 99999999999999999999999999
Q ss_pred cCCCcccccc--ccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCCccchhh-------
Q 018712 220 SNQAPDAAAR--LHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTW------- 289 (351)
Q Consensus 220 a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~Pf~~~~~~~~~~~~~~------- 289 (351)
++........ .......+|+.|+|||++.+..++.++||||||+++|||++ |.+||...........+..
T Consensus 239 a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~~~~p 318 (373)
T 3c1x_A 239 ARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQP 318 (373)
T ss_dssp -------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCCCCCC
T ss_pred cccccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCCCCCC
Confidence 9865433211 11233457889999999999999999999999999999999 7788876544332211111
Q ss_pred -cccCCCccchhhhcccccCCCCCHHHHHHHHHHHHHh
Q 018712 290 -ATPKLSEDKVKQCVDTKLGGEYPPKAIAKVRKKKFIT 326 (351)
Q Consensus 290 -~~~~~~~~~~~~~ld~~~~~~~~~~~~~~~~~~~~~~ 326 (351)
..+....+.+..|+..+|.+|++.+++...++-.+..
T Consensus 319 ~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~ 356 (373)
T 3c1x_A 319 EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 356 (373)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 1111123678999999999999999998877766543
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-42 Score=314.46 Aligned_cols=246 Identities=24% Similarity=0.360 Sum_probs=194.6
Q ss_pred HhcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCCc---hHHHHHHHHHHHhccCCceeeeEEEEecCCceEEE
Q 018712 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLA 139 (351)
Q Consensus 64 ~~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 139 (351)
..++|++.+.||+|+||.||+|.+. +++.||+|++...... .+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 102 (331)
T 4aaa_A 23 SMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLV 102 (331)
T ss_dssp CGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEE
Confidence 3568999999999999999999976 6899999998655433 34577899999999999999999999999999999
Q ss_pred EEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccc
Q 018712 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDL 219 (351)
Q Consensus 140 ~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~ 219 (351)
|||+.+++|.+++..... +++..+..++.||+.||.|||++| ++||||||+|||++.++.+||+|||+
T Consensus 103 ~e~~~~~~l~~~~~~~~~---------~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~ 170 (331)
T 4aaa_A 103 FEFVDHTILDDLELFPNG---------LDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGF 170 (331)
T ss_dssp EECCSEEHHHHHHHSTTC---------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTT
T ss_pred EecCCcchHHHHHhhccC---------CCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCC
Confidence 999999999988765442 899999999999999999999999 99999999999999999999999999
Q ss_pred cCCCccccccccccccccccCccCcccccCC-CCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccch-----------
Q 018712 220 SNQAPDAAARLHSTRVLGTFGYHAPEYAMTG-QMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLV----------- 287 (351)
Q Consensus 220 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~----------- 287 (351)
+......... .....||+.|+|||++.+. .++.++||||||+++|+|++|+.||...........+
T Consensus 171 ~~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 248 (331)
T 4aaa_A 171 ARTLAAPGEV--YDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRH 248 (331)
T ss_dssp C--------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred ceeecCCccc--cCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhh
Confidence 9765433221 2345689999999998875 7899999999999999999999999865432111000
Q ss_pred ------------------------hhcccCC---CccchhhhcccccCCCCCHHHHHHHHHHHHHh
Q 018712 288 ------------------------TWATPKL---SEDKVKQCVDTKLGGEYPPKAIAKVRKKKFIT 326 (351)
Q Consensus 288 ------------------------~~~~~~~---~~~~~~~~ld~~~~~~~~~~~~~~~~~~~~~~ 326 (351)
....+.. ..+.+..|+..+|.+|++++++ +++.++.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~el---l~hp~f~ 311 (331)
T 4aaa_A 249 QELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAEL---LHHDFFQ 311 (331)
T ss_dssp HHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGG---GGSHHHH
T ss_pred hhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHH---hcCchhc
Confidence 0001111 2367889999999999987765 3455543
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=306.29 Aligned_cols=242 Identities=27% Similarity=0.415 Sum_probs=194.6
Q ss_pred HHhcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCCchHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEEE
Q 018712 63 EKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYE 141 (351)
Q Consensus 63 ~~~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 141 (351)
...++|.+.+.||+|+||.||+|.+. +++.||+|.+.... ..+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 104 (314)
T 3com_A 26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES-DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVME 104 (314)
T ss_dssp ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS-CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH-HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEee
Confidence 34578999999999999999999976 68999999987654 34678999999999999999999999999999999999
Q ss_pred eCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccccC
Q 018712 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (351)
Q Consensus 142 ~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~ 221 (351)
|+.+++|.+++..... .+++..+..++.|++.||.|||++| ++|+||||+||+++.++.+||+|||++.
T Consensus 105 ~~~~~~L~~~~~~~~~--------~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~ 173 (314)
T 3com_A 105 YCGAGSVSDIIRLRNK--------TLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAG 173 (314)
T ss_dssp CCTTEEHHHHHHHHTC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCE
T ss_pred cCCCCCHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccch
Confidence 9999999999974321 2899999999999999999999999 9999999999999999999999999987
Q ss_pred CCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccchh----------hcc
Q 018712 222 QAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVT----------WAT 291 (351)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~~----------~~~ 291 (351)
........ .....||+.|+|||.+.+..++.++||||||+++|+|++|+.||...........+. ...
T Consensus 174 ~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (314)
T 3com_A 174 QLTDTMAK--RNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELW 251 (314)
T ss_dssp ECBTTBSC--BCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGS
T ss_pred hhhhhccc--cCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCcccCCcccC
Confidence 65433221 234568999999999999999999999999999999999999998643221111110 011
Q ss_pred cCCCccchhhhcccccCCCCCHHHHHH
Q 018712 292 PKLSEDKVKQCVDTKLGGEYPPKAIAK 318 (351)
Q Consensus 292 ~~~~~~~~~~~ld~~~~~~~~~~~~~~ 318 (351)
+....+.+..|+..+|..|++.+++..
T Consensus 252 ~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 252 SDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp CHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 112236889999999999998877643
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=312.90 Aligned_cols=270 Identities=20% Similarity=0.293 Sum_probs=206.2
Q ss_pred hcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCC---chHHHHHHHHHHHhccCCceeeeEEEEec--------
Q 018712 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ---PDQEFLAQVSMVSRLKNENVVELVGYYVD-------- 132 (351)
Q Consensus 65 ~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~h~niv~~~~~~~~-------- 132 (351)
.++|++.+.||+|+||.||+|.+. +++.||+|++..... ....+.+|+.+++.++||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 468999999999999999999974 789999999865432 24568899999999999999999999876
Q ss_pred CCceEEEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCce
Q 018712 133 GPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIA 212 (351)
Q Consensus 133 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~v 212 (351)
.+..++||||+.+ +|.+.+..... .+++..++.++.||+.||.|||++| |+||||||+|||++.++.+
T Consensus 96 ~~~~~lv~e~~~~-~l~~~l~~~~~--------~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~ 163 (351)
T 3mi9_A 96 KGSIYLVFDFCEH-DLAGLLSNVLV--------KFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVL 163 (351)
T ss_dssp -CEEEEEEECCSE-EHHHHHHCTTS--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCE
T ss_pred CceEEEEEeccCC-CHHHHHhhccC--------CCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCE
Confidence 4468999999986 78777765432 2899999999999999999999999 9999999999999999999
Q ss_pred EEecccccCCCccccc--cccccccccccCccCcccccC-CCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccchhh
Q 018712 213 KISDFDLSNQAPDAAA--RLHSTRVLGTFGYHAPEYAMT-GQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTW 289 (351)
Q Consensus 213 kl~Dfg~a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~~~ 289 (351)
||+|||+++....... ........||+.|+|||++.+ ..++.++||||||+++|+|++|+.||...........+..
T Consensus 164 kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~ 243 (351)
T 3mi9_A 164 KLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQ 243 (351)
T ss_dssp EECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred EEccchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence 9999999876542211 112244578999999998876 4579999999999999999999999987543211111100
Q ss_pred --------cc-------------------------------cCCCccchhhhcccccCCCCCHHHHHHHHHHHHHhhhhc
Q 018712 290 --------AT-------------------------------PKLSEDKVKQCVDTKLGGEYPPKAIAKVRKKKFITSECS 330 (351)
Q Consensus 290 --------~~-------------------------------~~~~~~~~~~~ld~~~~~~~~~~~~~~~~~~~~~~~~~~ 330 (351)
.. +....+.+..|+..+|.+|++++++ +++.++.....
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~---l~hp~f~~~~~ 320 (351)
T 3mi9_A 244 LCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA---LNHDFFWSDPM 320 (351)
T ss_dssp HHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHH---HTSGGGGSSSC
T ss_pred HhCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHH---hCCCCcCCCCC
Confidence 00 1112367889999999999987654 55676655444
Q ss_pred cccchh-hhhcccCCccccc
Q 018712 331 NISFAE-FNINWHCPLEWSV 349 (351)
Q Consensus 331 ~~~~~~-~~~~~~~~~~w~~ 349 (351)
....+. +.-.+...++|.+
T Consensus 321 ~~~~~~~~~~~~~~~~e~~~ 340 (351)
T 3mi9_A 321 PSDLKGMLSTHLTSMFEYLA 340 (351)
T ss_dssp CCCSHHHHHSSCSSHHHHHS
T ss_pred ccccccccCcchHHHHHHhc
Confidence 434332 2233555556643
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-42 Score=317.50 Aligned_cols=240 Identities=25% Similarity=0.362 Sum_probs=178.3
Q ss_pred hcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCCc---hHHHHHHHHHHHhccCCceeeeEEEEecC------C
Q 018712 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVDG------P 134 (351)
Q Consensus 65 ~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~------~ 134 (351)
.++|.+.+.||+|+||.||+|.+. +|+.||||++...... ...+.+|+.+++.++||||+++++++... .
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 478999999999999999999964 7899999999764332 35678999999999999999999998754 5
Q ss_pred ceEEEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEE
Q 018712 135 LRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKI 214 (351)
Q Consensus 135 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl 214 (351)
..|+|+|++ +++|.+++.... +++..+..++.||+.||.|||++| |+||||||+|||++.++.+||
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~~~----------l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL 173 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKCQK----------LTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKI 173 (367)
T ss_dssp CCEEEEECC-CEECC-----CC----------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEE
T ss_pred eEEEEeccc-CCCHHHHHhcCC----------CCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEE
Confidence 679999999 679999987532 899999999999999999999999 999999999999999999999
Q ss_pred ecccccCCCccccccccccccccccCccCcccccC-CCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccchhh----
Q 018712 215 SDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMT-GQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTW---- 289 (351)
Q Consensus 215 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~~~---- 289 (351)
+|||+++..... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.........+..
T Consensus 174 ~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~ 248 (367)
T 2fst_X 174 LDFGLARHTADE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 248 (367)
T ss_dssp CC--------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCS
T ss_pred eecccccccccc-----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence 999999765432 244578999999999887 6789999999999999999999999987543211111000
Q ss_pred -------------------------------c---ccCCCccchhhhcccccCCCCCHHHHHHHHHHHHHh
Q 018712 290 -------------------------------A---TPKLSEDKVKQCVDTKLGGEYPPKAIAKVRKKKFIT 326 (351)
Q Consensus 290 -------------------------------~---~~~~~~~~~~~~ld~~~~~~~~~~~~~~~~~~~~~~ 326 (351)
. .+....+.+..|+..+|.+|++++++ +.+.++.
T Consensus 249 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~---L~hp~~~ 316 (367)
T 2fst_X 249 PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQA---LAHAYFA 316 (367)
T ss_dssp CCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHH---HTSGGGT
T ss_pred CCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHH---hcChhhh
Confidence 0 01112368889999999999988765 4455543
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-42 Score=303.38 Aligned_cols=242 Identities=28% Similarity=0.425 Sum_probs=192.8
Q ss_pred hcCCCCCceeccCCcEEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHHhccCCceeeeEEEEecC-CceEEEEEeC
Q 018712 65 TDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDG-PLRVLAYEHA 143 (351)
Q Consensus 65 ~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-~~~~lv~e~~ 143 (351)
.++|++.+.||+|+||.||++... ++.||+|++.... ..+.+.+|+.++++++||||+++++++.+. +..++||||+
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~ 97 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 97 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC---HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred hhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecchh-HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecC
Confidence 468999999999999999999875 8899999987654 456789999999999999999999987654 4789999999
Q ss_pred CCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccccCCC
Q 018712 144 SKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQA 223 (351)
Q Consensus 144 ~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~ 223 (351)
++++|.+++...... .+++..++.++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++...
T Consensus 98 ~~~~L~~~l~~~~~~-------~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~ 167 (278)
T 1byg_A 98 AKGSLVDYLRSRGRS-------VLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEA 167 (278)
T ss_dssp TTEEHHHHHHHHHHH-------HCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC----
T ss_pred CCCCHHHHHHhcccc-------cCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeeccccccc
Confidence 999999999764321 2688899999999999999999999 999999999999999999999999998765
Q ss_pred ccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCCccchhh--------cccCC
Q 018712 224 PDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTW--------ATPKL 294 (351)
Q Consensus 224 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~Pf~~~~~~~~~~~~~~--------~~~~~ 294 (351)
.... ....+++.|+|||.+.+..++.++||||||+++|+|++ |+.||...........+.. ..+..
T Consensus 168 ~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (278)
T 1byg_A 168 SSTQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPA 242 (278)
T ss_dssp -------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCCTTCCHH
T ss_pred cccc-----cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCcccCCHH
Confidence 4322 23357889999999999999999999999999999998 9999986543322111111 11112
Q ss_pred CccchhhhcccccCCCCCHHHHHHHHHHH
Q 018712 295 SEDKVKQCVDTKLGGEYPPKAIAKVRKKK 323 (351)
Q Consensus 295 ~~~~~~~~ld~~~~~~~~~~~~~~~~~~~ 323 (351)
..+.+..|+..+|.+|++.+++...++..
T Consensus 243 l~~li~~~l~~~p~~Rps~~~l~~~L~~i 271 (278)
T 1byg_A 243 VYEVMKNCWHLDAAMRPSFLQLREQLEHI 271 (278)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHHHhcCChhhCCCHHHHHHHHHHH
Confidence 23688999999999999999988766654
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-42 Score=320.14 Aligned_cols=248 Identities=19% Similarity=0.306 Sum_probs=198.5
Q ss_pred hcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCC--CchHHHHHHHHHHHhccCCceeeeEEEEecCC--ceEEE
Q 018712 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK--QPDQEFLAQVSMVSRLKNENVVELVGYYVDGP--LRVLA 139 (351)
Q Consensus 65 ~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~--~~~lv 139 (351)
.++|.+.+.||+|+||.||+|.+. +++.||+|++.... ...+.+.+|++++++++||||+++++++.+.+ ..++|
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 87 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence 457999999999999999999976 68999999987533 23466789999999999999999999988655 67999
Q ss_pred EEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEE----ccCCceEEe
Q 018712 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLL----FDDDIAKIS 215 (351)
Q Consensus 140 ~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill----~~~~~vkl~ 215 (351)
|||+.+|+|.+++...... ..+++..++.++.||+.||.|||+++ |+||||||+|||+ +.++.+||+
T Consensus 88 ~e~~~~g~L~~~l~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~ 158 (396)
T 4eut_A 88 MEFCPCGSLYTVLEEPSNA------YGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLT 158 (396)
T ss_dssp ECCCTTEEHHHHTTSGGGT------TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEEC
T ss_pred EecCCCCCHHHHHHhhhcc------cCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEe
Confidence 9999999999999865321 12889999999999999999999999 9999999999999 777789999
Q ss_pred cccccCCCccccccccccccccccCccCcccccC--------CCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCC-ccc
Q 018712 216 DFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMT--------GQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQ-QSL 286 (351)
Q Consensus 216 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~-~~~ 286 (351)
|||+++....... .....||+.|+|||++.+ ..++.++||||||+++|||++|+.||........ ...
T Consensus 159 DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~ 235 (396)
T 4eut_A 159 DFGAARELEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEV 235 (396)
T ss_dssp CGGGCEECCCGGG---SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHH
T ss_pred cCCCceEccCCCc---cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHH
Confidence 9999977654332 234579999999998865 5678899999999999999999999975432211 100
Q ss_pred hh-----------------------hc------------ccCCCccchhhhcccccCCCCCHHHHHHHHHHHH
Q 018712 287 VT-----------------------WA------------TPKLSEDKVKQCVDTKLGGEYPPKAIAKVRKKKF 324 (351)
Q Consensus 287 ~~-----------------------~~------------~~~~~~~~~~~~ld~~~~~~~~~~~~~~~~~~~~ 324 (351)
+. |. .+....+.+..|+..+|.+|++.+++...+.-.+
T Consensus 236 ~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il 308 (396)
T 4eut_A 236 MYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL 308 (396)
T ss_dssp HHHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHH
T ss_pred HHHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHh
Confidence 00 00 0011125778999999999999998866554443
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-42 Score=306.44 Aligned_cols=243 Identities=23% Similarity=0.372 Sum_probs=197.6
Q ss_pred HhcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCCchHHHHHHHHHHHhccCCceeeeEEEEec----------
Q 018712 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVD---------- 132 (351)
Q Consensus 64 ~~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~---------- 132 (351)
..++|++.+.||+|+||.||+|.+. +++.||+|++.... ..+.+|++++++++||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 85 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN---EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSK 85 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS---GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC------
T ss_pred hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc---HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccc
Confidence 4467999999999999999999986 79999999987543 357789999999999999999998754
Q ss_pred ------CCceEEEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEE
Q 018712 133 ------GPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLL 206 (351)
Q Consensus 133 ------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill 206 (351)
....++||||+++++|.+++...... .+++..++.++.||+.||.|||+++ ++||||||+||++
T Consensus 86 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~-------~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~ 155 (284)
T 2a19_B 86 NSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGE-------KLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFL 155 (284)
T ss_dssp ---CCEEEEEEEEECCCCSCBHHHHHHHGGGS-------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEE
T ss_pred cccccCcceEEEEEeccCCCCHHHHHhhccCC-------CCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEE
Confidence 44579999999999999999754321 2889999999999999999999999 9999999999999
Q ss_pred ccCCceEEecccccCCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCC---
Q 018712 207 FDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQ--- 283 (351)
Q Consensus 207 ~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~--- 283 (351)
+.++.+||+|||++........ .....||+.|+|||.+.+..++.++||||||+++|+|++|..||........
T Consensus 156 ~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~ 232 (284)
T 2a19_B 156 VDTKQVKIGDFGLVTSLKNDGK---RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLR 232 (284)
T ss_dssp EETTEEEECCCTTCEESSCCSC---CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHHHHHHHHH
T ss_pred cCCCCEEECcchhheecccccc---ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHHHHHHHhh
Confidence 9999999999999876644322 2345689999999999999999999999999999999999998753211000
Q ss_pred ccchhhcccCCCccchhhhcccccCCCCCHHHHHHHHHH
Q 018712 284 QSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKVRKK 322 (351)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~ld~~~~~~~~~~~~~~~~~~ 322 (351)
...+....+....+.+..|+..+|.+|++.+++.+.+..
T Consensus 233 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~ 271 (284)
T 2a19_B 233 DGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTV 271 (284)
T ss_dssp TTCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred cccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 000111111222467899999999999999988776543
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-42 Score=317.54 Aligned_cols=241 Identities=22% Similarity=0.302 Sum_probs=188.3
Q ss_pred HHhcCCCCCceeccCCcEEEEEEEE-CCCCEEEEEEcCCCCCchHHHHHHHHHHHhccCCceeeeEEEEec---------
Q 018712 63 EKTDNFGTNSLIGEGSYGRVYFGVL-RSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVD--------- 132 (351)
Q Consensus 63 ~~~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--------- 132 (351)
...++|.+.+.||+|+||.||+|.+ .+++.||+|++...... ..+|+++++.++||||+++++++..
T Consensus 4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~---~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~ 80 (383)
T 3eb0_A 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY---KNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPP 80 (383)
T ss_dssp --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS---CCHHHHHHTTCCCTTBCCEEEEEEEC--------
T ss_pred cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch---HHHHHHHHHHcCCCCccchhheeeecCccccccc
Confidence 4567899999999999999999997 47899999998655432 3479999999999999999998843
Q ss_pred -----------------------------CCceEEEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHH
Q 018712 133 -----------------------------GPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGL 183 (351)
Q Consensus 133 -----------------------------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l 183 (351)
....++||||+++ +|.+.+...... ...+++..+..++.||+.||
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~-----~~~l~~~~~~~i~~qi~~aL 154 (383)
T 3eb0_A 81 QPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRS-----GRSIPMNLISIYIYQLFRAV 154 (383)
T ss_dssp -----------------------------CCEEEEEECCCSE-EHHHHHHHHHHT-----TCCCCHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhc-----CCCCCHHHHHHHHHHHHHHH
Confidence 3348899999985 887777542110 11389999999999999999
Q ss_pred HhhhhCCCCCeeeccccCCcEEEc-cCCceEEecccccCCCccccccccccccccccCccCcccccCC-CCCccchhHhH
Q 018712 184 EYLHEKAEPRIIHRNIKSSNVLLF-DDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTG-QMSSKSDVYSF 261 (351)
Q Consensus 184 ~~lH~~~~~~ivH~Dlkp~Nill~-~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dvwsl 261 (351)
.|||++| |+||||||+|||++ .++.+||+|||+++....... .....||+.|+|||++.+. .++.++|||||
T Consensus 155 ~~LH~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~Diwsl 228 (383)
T 3eb0_A 155 GFIHSLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP---SVAYICSRFYRAPELMLGATEYTPSIDLWSI 228 (383)
T ss_dssp HHHHTTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC---CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHH
T ss_pred HHHHHCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC---CcCcccCCCccCHHHhcCCCCCCcchhhhhH
Confidence 9999999 99999999999998 688999999999976543322 2345689999999998875 48999999999
Q ss_pred HHHHHHHHcCCCCCCCCCCCCCccchh------------------------------------hcccCCCccchhhhccc
Q 018712 262 GVVLLELLTGRKPVDHTLPRGQQSLVT------------------------------------WATPKLSEDKVKQCVDT 305 (351)
Q Consensus 262 G~il~el~tg~~Pf~~~~~~~~~~~~~------------------------------------~~~~~~~~~~~~~~ld~ 305 (351)
|+++|+|++|+.||...........+. ...+....+.+..|+..
T Consensus 229 G~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 308 (383)
T 3eb0_A 229 GCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRY 308 (383)
T ss_dssp HHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCS
T ss_pred HHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccC
Confidence 999999999999998754322111100 00111123788999999
Q ss_pred ccCCCCCHHHHHH
Q 018712 306 KLGGEYPPKAIAK 318 (351)
Q Consensus 306 ~~~~~~~~~~~~~ 318 (351)
+|.+|++++++.+
T Consensus 309 dP~~R~t~~e~l~ 321 (383)
T 3eb0_A 309 EPDLRINPYEAMA 321 (383)
T ss_dssp SGGGSCCHHHHHT
T ss_pred ChhhCCCHHHHhc
Confidence 9999999887653
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-41 Score=306.55 Aligned_cols=238 Identities=24% Similarity=0.351 Sum_probs=191.2
Q ss_pred HhcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCC---------chHHHHHHHHHHHhccCCceeeeEEEEecC
Q 018712 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ---------PDQEFLAQVSMVSRLKNENVVELVGYYVDG 133 (351)
Q Consensus 64 ~~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~ 133 (351)
..++|.+.+.||+|+||.||+|.+. +++.||||++..... ....+.+|+.++++++||||+++++++...
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 87 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE 87 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence 4567999999999999999999975 688999999865421 123478999999999999999999998766
Q ss_pred CceEEEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCc--
Q 018712 134 PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDI-- 211 (351)
Q Consensus 134 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~-- 211 (351)
. .++||||+.+++|.+++..... +++..+..++.||+.||.|||+++ ++||||||+|||++.++.
T Consensus 88 ~-~~lv~e~~~~~~L~~~~~~~~~---------~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~ 154 (322)
T 2ycf_A 88 D-YYIVLELMEGGELFDKVVGNKR---------LKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDC 154 (322)
T ss_dssp S-EEEEEECCTTEETHHHHSTTCC---------CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSC
T ss_pred c-eEEEEecCCCCcHHHHHhccCC---------CCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCC
Confidence 5 8999999999999999976542 899999999999999999999999 999999999999987654
Q ss_pred -eEEecccccCCCccccccccccccccccCccCccccc---CCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCc-cc
Q 018712 212 -AKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAM---TGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQ-SL 286 (351)
Q Consensus 212 -vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~-~~ 286 (351)
+||+|||++........ .....||+.|+|||++. ...++.++||||||+++|+|++|+.||......... ..
T Consensus 155 ~~kl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~ 231 (322)
T 2ycf_A 155 LIKITDFGHSKILGETSL---MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQ 231 (322)
T ss_dssp CEEECCCTTCEECCCCHH---HHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHH
T ss_pred eEEEccCccceecccccc---cccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHH
Confidence 99999999876543221 13456899999999874 567899999999999999999999999865443211 11
Q ss_pred hh--------hc---ccCCCccchhhhcccccCCCCCHHHHH
Q 018712 287 VT--------WA---TPKLSEDKVKQCVDTKLGGEYPPKAIA 317 (351)
Q Consensus 287 ~~--------~~---~~~~~~~~~~~~ld~~~~~~~~~~~~~ 317 (351)
+. .. .+....+.+..|+..+|.+|++.+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l 273 (322)
T 2ycf_A 232 ITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEAL 273 (322)
T ss_dssp HHHTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred HHhCccccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHh
Confidence 11 11 111123688999999999999987764
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-42 Score=318.40 Aligned_cols=200 Identities=22% Similarity=0.295 Sum_probs=171.7
Q ss_pred hcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCCchHHHHHHHHHHHhcc--------CCceeeeEEEEe----
Q 018712 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLK--------NENVVELVGYYV---- 131 (351)
Q Consensus 65 ~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~--------h~niv~~~~~~~---- 131 (351)
.++|.+.+.||+|+||.||+|.+. +++.||+|++.......+.+.+|+.+++.++ |+||+++++.+.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~ 115 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGV 115 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEET
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCC
Confidence 478999999999999999999965 6889999999766555677889999999985 788999999987
Q ss_pred cCCceEEEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhC-CCCCeeeccccCCcEEEccCC
Q 018712 132 DGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEK-AEPRIIHRNIKSSNVLLFDDD 210 (351)
Q Consensus 132 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~-~~~~ivH~Dlkp~Nill~~~~ 210 (351)
+....++||||+ +++|.+++...... .+++..++.++.||+.||.|||++ | |+||||||+|||++.++
T Consensus 116 ~~~~~~lv~e~~-~~~l~~~~~~~~~~-------~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~~~~ 184 (397)
T 1wak_A 116 NGTHICMVFEVL-GHHLLKWIIKSNYQ-------GLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSVNE 184 (397)
T ss_dssp TEEEEEEEECCC-CCBHHHHHHHTTTS-------CCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEECCCH
T ss_pred CCceEEEEEecc-CccHHHHHHhcccC-------CCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEeccc
Confidence 566889999999 45666666544321 289999999999999999999998 8 99999999999998775
Q ss_pred -------------------------------------------------ceEEecccccCCCccccccccccccccccCc
Q 018712 211 -------------------------------------------------IAKISDFDLSNQAPDAAARLHSTRVLGTFGY 241 (351)
Q Consensus 211 -------------------------------------------------~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y 241 (351)
.+||+|||++...... .....||+.|
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~~y 259 (397)
T 1wak_A 185 QYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTRQY 259 (397)
T ss_dssp HHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCGGG
T ss_pred hhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCCCcc
Confidence 7999999998765432 2445789999
Q ss_pred cCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCC
Q 018712 242 HAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (351)
Q Consensus 242 ~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~ 280 (351)
+|||++.+..++.++|||||||++|+|++|+.||.....
T Consensus 260 ~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~ 298 (397)
T 1wak_A 260 RSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSG 298 (397)
T ss_dssp CCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCC
T ss_pred cCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcc
Confidence 999999999999999999999999999999999986543
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=312.89 Aligned_cols=253 Identities=20% Similarity=0.274 Sum_probs=186.6
Q ss_pred HHHHHHhcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCCchHHHHHHHHHHHhccCCceeeeEEEEecCCc--
Q 018712 59 DELKEKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPL-- 135 (351)
Q Consensus 59 ~~~~~~~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-- 135 (351)
.......++|.+.+.||+|+||.||+|.+. +++.||||++...........++++.++.++||||+++++++...+.
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~ 95 (360)
T 3e3p_A 16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERD 95 (360)
T ss_dssp HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSC
T ss_pred hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhcCCCCcccHHHhhhcccccc
Confidence 455677899999999999999999999975 78999999987666555667888889999999999999999865332
Q ss_pred -----eEEEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhh--hCCCCCeeeccccCCcEEEcc
Q 018712 136 -----RVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLH--EKAEPRIIHRNIKSSNVLLFD 208 (351)
Q Consensus 136 -----~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH--~~~~~~ivH~Dlkp~Nill~~ 208 (351)
.++||||+.+ +|.+.+...... ...++...+..++.|++.||.||| ++| |+||||||+|||++.
T Consensus 96 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~-----~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~ 166 (360)
T 3e3p_A 96 RRDIYLNVVMEYVPD-TLHRCCRNYYRR-----QVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNE 166 (360)
T ss_dssp TTCEEEEEEEECCSC-BHHHHHHHHHTT-----TCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEET
T ss_pred ccceeEEEEeecccc-cHHHHHHHHhhc-----ccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeC
Confidence 7899999987 555444321100 112888999999999999999999 888 999999999999997
Q ss_pred -CCceEEecccccCCCccccccccccccccccCccCcccccCCC-CCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccc
Q 018712 209 -DDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQ-MSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSL 286 (351)
Q Consensus 209 -~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~ 286 (351)
++.+||+|||++......... ....||+.|+|||++.+.. ++.++||||||+++|+|++|+.||...........
T Consensus 167 ~~~~~kl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~ 243 (360)
T 3e3p_A 167 ADGTLKLCDFGSAKKLSPSEPN---VAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHE 243 (360)
T ss_dssp TTTEEEECCCTTCBCCCTTSCC---CSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred CCCcEEEeeCCCceecCCCCCc---ccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHH
Confidence 899999999999876543322 3456899999999987654 89999999999999999999999987543211111
Q ss_pred hhh--------------------------------c-------ccCCCccchhhhcccccCCCCCHHHHHHHHHHHHHh
Q 018712 287 VTW--------------------------------A-------TPKLSEDKVKQCVDTKLGGEYPPKAIAKVRKKKFIT 326 (351)
Q Consensus 287 ~~~--------------------------------~-------~~~~~~~~~~~~ld~~~~~~~~~~~~~~~~~~~~~~ 326 (351)
+.. . .+....+.+..|+..+|.+|++++++ +++.++.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~---l~hp~f~ 319 (360)
T 3e3p_A 244 IVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEA---LCHPYFD 319 (360)
T ss_dssp HHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHH---TTSGGGG
T ss_pred HHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHH---hcCcccc
Confidence 100 0 00112368889999999999987765 3455543
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=302.56 Aligned_cols=241 Identities=24% Similarity=0.325 Sum_probs=196.1
Q ss_pred HHHhcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCC----------chHHHHHHHHHHHhcc-CCceeeeEEE
Q 018712 62 KEKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ----------PDQEFLAQVSMVSRLK-NENVVELVGY 129 (351)
Q Consensus 62 ~~~~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----------~~~~~~~e~~~l~~l~-h~niv~~~~~ 129 (351)
....++|.+.+.||+|+||.||+|.+. +++.||+|++..... ..+.+.+|+.+++++. ||||++++++
T Consensus 13 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~ 92 (298)
T 1phk_A 13 HGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDT 92 (298)
T ss_dssp --CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred cchhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeee
Confidence 345688999999999999999999975 689999999865431 1245778999999995 9999999999
Q ss_pred EecCCceEEEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccC
Q 018712 130 YVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDD 209 (351)
Q Consensus 130 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~ 209 (351)
+.+.+..++||||+.+++|.+++..... +++..+..++.||+.||.|||++| ++||||||+||+++.+
T Consensus 93 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~---------~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~ 160 (298)
T 1phk_A 93 YETNTFFFLVFDLMKKGELFDYLTEKVT---------LSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDD 160 (298)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTT
T ss_pred eccCCeEEEEEeccCCCcHHHHHhccCC---------CCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCC
Confidence 9999999999999999999999986532 899999999999999999999999 9999999999999999
Q ss_pred CceEEecccccCCCccccccccccccccccCccCccccc------CCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCC
Q 018712 210 DIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAM------TGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQ 283 (351)
Q Consensus 210 ~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~ 283 (351)
+.+||+|||++........ .....||+.|+|||++. ...++.++||||||+++|+|++|+.||........
T Consensus 161 ~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~ 237 (298)
T 1phk_A 161 MNIKLTDFGFSCQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLM 237 (298)
T ss_dssp CCEEECCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred CcEEEecccchhhcCCCcc---cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHH
Confidence 9999999999876543322 23456899999999885 45688999999999999999999999976533211
Q ss_pred ccchhh-----------cccCCCccchhhhcccccCCCCCHHHHH
Q 018712 284 QSLVTW-----------ATPKLSEDKVKQCVDTKLGGEYPPKAIA 317 (351)
Q Consensus 284 ~~~~~~-----------~~~~~~~~~~~~~ld~~~~~~~~~~~~~ 317 (351)
...+.. ..+....+.+..|+..+|.+|++.+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll 282 (298)
T 1phk_A 238 LRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEAL 282 (298)
T ss_dssp HHHHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHT
T ss_pred HHHHhcCCcccCcccccccCHHHHHHHHHHccCCcccCCCHHHHH
Confidence 111110 0111123678889999999999877653
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-41 Score=303.39 Aligned_cols=241 Identities=20% Similarity=0.320 Sum_probs=192.1
Q ss_pred HhcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCC-CchHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEEE
Q 018712 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK-QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYE 141 (351)
Q Consensus 64 ~~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 141 (351)
..++|++.+.||+|+||.||+|.+. +++.||+|++.... ...+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 96 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIE 96 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEE
Confidence 4578999999999999999999976 68999999987543 335678899999999999999999999999999999999
Q ss_pred eCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccccC
Q 018712 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (351)
Q Consensus 142 ~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~ 221 (351)
|+++++|.+++..... .+++..+..++.||+.||.|||++| ++||||||+||+++.++.+||+|||++.
T Consensus 97 ~~~~~~l~~~~~~~~~--------~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 165 (302)
T 2j7t_A 97 FCPGGAVDAIMLELDR--------GLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSA 165 (302)
T ss_dssp CCTTEEHHHHHHHHTS--------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHH
T ss_pred eCCCCcHHHHHHhhcc--------CCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCc
Confidence 9999999999875332 2899999999999999999999999 9999999999999999999999999875
Q ss_pred CCccccccccccccccccCccCcccc-----cCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccch---------
Q 018712 222 QAPDAAARLHSTRVLGTFGYHAPEYA-----MTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLV--------- 287 (351)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~--------- 287 (351)
....... ......||+.|+|||++ .+..++.++||||||+++|+|++|+.||...........+
T Consensus 166 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 243 (302)
T 2j7t_A 166 KNLKTLQ--KRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLL 243 (302)
T ss_dssp HHHHHHH--C-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCS
T ss_pred ccccccc--ccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCcccC
Confidence 4322111 12345689999999988 3667899999999999999999999999865432111101
Q ss_pred -hhcccCCCccchhhhcccccCCCCCHHHHH
Q 018712 288 -TWATPKLSEDKVKQCVDTKLGGEYPPKAIA 317 (351)
Q Consensus 288 -~~~~~~~~~~~~~~~ld~~~~~~~~~~~~~ 317 (351)
....+....+.+..|+..+|.+|++.+++.
T Consensus 244 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll 274 (302)
T 2j7t_A 244 TPSKWSVEFRDFLKIALDKNPETRPSAAQLL 274 (302)
T ss_dssp SGGGSCHHHHHHHHHHSCSCTTTSCCHHHHT
T ss_pred CccccCHHHHHHHHHHcccChhhCCCHHHHh
Confidence 011111123678899999999999887653
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-42 Score=317.08 Aligned_cols=237 Identities=11% Similarity=0.084 Sum_probs=174.7
Q ss_pred hcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCCc----hHHHHHHHHHHHhc--cCCceeeeE-------EEE
Q 018712 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP----DQEFLAQVSMVSRL--KNENVVELV-------GYY 130 (351)
Q Consensus 65 ~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~----~~~~~~e~~~l~~l--~h~niv~~~-------~~~ 130 (351)
..+|.+.+.||+|+||.||+|.+. +++.||+|++...... .+.+.+|+.+++.+ +||||++++ +.+
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 345889999999999999999975 7899999999875532 34566775544444 699988755 444
Q ss_pred ecC-----------------CceEEEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHH------HHHHHHHHHHHHhhh
Q 018712 131 VDG-----------------PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQR------VKIAVGAARGLEYLH 187 (351)
Q Consensus 131 ~~~-----------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~------~~i~~qi~~~l~~lH 187 (351)
... ...|+||||+. |+|.+++...... +....+ ..++.||+.||.|||
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~--------~~~~~~~~~~vk~~i~~qi~~aL~~LH 211 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFV--------YVFRGDEGILALHILTAQLIRLAANLQ 211 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHS--------CCCCHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccc--------cchhhhhhhhhHHHHHHHHHHHHHHHH
Confidence 322 33799999998 7999999864221 333344 677799999999999
Q ss_pred hCCCCCeeeccccCCcEEEccCCceEEecccccCCCccccccccccccccccCccCcccccC--CCCCccchhHhHHHHH
Q 018712 188 EKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMT--GQMSSKSDVYSFGVVL 265 (351)
Q Consensus 188 ~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il 265 (351)
++| |+||||||+|||++.++.+||+|||+++...... ....+|+.|+|||++.+ ..++.++||||||+++
T Consensus 212 ~~~---ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il 283 (371)
T 3q60_A 212 SKG---LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRG-----PASSVPVTYAPREFLNASTATFTHALNAWQLGLSI 283 (371)
T ss_dssp HTT---EEETTCSGGGEEECTTSCEEECCGGGEEETTCEE-----EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHH
T ss_pred HCC---CccCcCCHHHEEECCCCCEEEEecceeeecCCCc-----cCccCCcCCcChhhccCCCCCcCccccHHHHHHHH
Confidence 999 9999999999999999999999999998664322 23457799999999987 6799999999999999
Q ss_pred HHHHcCCCCCCCCCCCCCccch----------hh------cccCCCccchhhhcccccCCCCCHHHHHH
Q 018712 266 LELLTGRKPVDHTLPRGQQSLV----------TW------ATPKLSEDKVKQCVDTKLGGEYPPKAIAK 318 (351)
Q Consensus 266 ~el~tg~~Pf~~~~~~~~~~~~----------~~------~~~~~~~~~~~~~ld~~~~~~~~~~~~~~ 318 (351)
|+|++|+.||....+....... .. ..+....+.+..|+..+|.+|++++++.+
T Consensus 284 ~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 284 YRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp HHHHHSSCSTTBCCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred HHHHhCCCCCCCcCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 9999999999876433211100 00 11112236889999999999999877643
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=301.22 Aligned_cols=240 Identities=19% Similarity=0.246 Sum_probs=191.2
Q ss_pred HhcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCC---chHHHHHHHHHHHhc-cCCceeeeEEEEecCCceEE
Q 018712 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ---PDQEFLAQVSMVSRL-KNENVVELVGYYVDGPLRVL 138 (351)
Q Consensus 64 ~~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~l 138 (351)
..++|++.+.||+|+||.||+|.+. +++.||+|++..... ....+.+|+..+..+ +||||+++++++.+.+..++
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l 88 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI 88 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence 4567999999999999999999976 799999999875432 345688899999999 99999999999999999999
Q ss_pred EEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccC---------
Q 018712 139 AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDD--------- 209 (351)
Q Consensus 139 v~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~--------- 209 (351)
||||+++++|.+++....... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.+
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~ 160 (289)
T 1x8b_A 89 QNEYCNGGSLADAISENYRIM-----SYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEE 160 (289)
T ss_dssp EEECCTTCBHHHHHHHHHHHT-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC-----------
T ss_pred EEEecCCCcHHHHHHhhcccc-----cCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCcccccc
Confidence 999999999999997642100 12899999999999999999999999 9999999999999844
Q ss_pred ----------CceEEecccccCCCccccccccccccccccCccCcccccCC-CCCccchhHhHHHHHHHHHcCCCCCCCC
Q 018712 210 ----------DIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTG-QMSSKSDVYSFGVVLLELLTGRKPVDHT 278 (351)
Q Consensus 210 ----------~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~Pf~~~ 278 (351)
..+||+|||.+...... ....||+.|+|||++.+. .++.++||||||+++|+|++|..|+...
T Consensus 161 ~~~~~~~~~~~~~kl~Dfg~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~ 234 (289)
T 1x8b_A 161 GDEDDWASNKVMFKIGDLGHVTRISSP------QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNG 234 (289)
T ss_dssp ---------CCCEEECCCTTCEETTCS------CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSS
T ss_pred cccccccCCceEEEEcccccccccCCc------cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcch
Confidence 47999999998765432 234589999999999866 5678999999999999999999876543
Q ss_pred CCCC-----CccchhhcccCCCccchhhhcccccCCCCCHHHHH
Q 018712 279 LPRG-----QQSLVTWATPKLSEDKVKQCVDTKLGGEYPPKAIA 317 (351)
Q Consensus 279 ~~~~-----~~~~~~~~~~~~~~~~~~~~ld~~~~~~~~~~~~~ 317 (351)
.... ....+....+....+.+..|++.+|.+|++.+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll 278 (289)
T 1x8b_A 235 DQWHEIRQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALV 278 (289)
T ss_dssp HHHHHHHTTCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred hHHHHHHcCCCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHh
Confidence 1100 00000011111223688899999999999887763
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=297.98 Aligned_cols=237 Identities=24% Similarity=0.340 Sum_probs=190.1
Q ss_pred cCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCC---chHHHHHHHHHHHhccCCceeeeEEEEec----CCceE
Q 018712 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ---PDQEFLAQVSMVSRLKNENVVELVGYYVD----GPLRV 137 (351)
Q Consensus 66 ~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~h~niv~~~~~~~~----~~~~~ 137 (351)
..|.+.+.||+|+||.||+|.+. ++..||+|++..... ..+.+.+|+.++++++||||+++++++.. ....+
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV 105 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence 34788889999999999999975 688999999865432 23568899999999999999999998764 45689
Q ss_pred EEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEc-cCCceEEec
Q 018712 138 LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLF-DDDIAKISD 216 (351)
Q Consensus 138 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~-~~~~vkl~D 216 (351)
+||||+++++|.+++..... +++..++.++.||+.||.|||+++. +++||||||+|||++ .++.+||+|
T Consensus 106 lv~e~~~~~~L~~~l~~~~~---------~~~~~~~~~~~qi~~~l~~lH~~~~-~i~H~dikp~Nil~~~~~~~~kl~D 175 (290)
T 1t4h_A 106 LVTELMTSGTLKTYLKRFKV---------MKIKVLRSWCRQILKGLQFLHTRTP-PIIHRDLKCDNIFITGPTGSVKIGD 175 (290)
T ss_dssp EEEECCCSCBHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHTSSS-CCCCSCCCGGGEEESSTTSCEEECC
T ss_pred EEEEecCCCCHHHHHHHccC---------CCHHHHHHHHHHHHHHHHHHHcCCC-CEEECCCCHHHEEEECCCCCEEEee
Confidence 99999999999999986542 8899999999999999999999852 399999999999997 788999999
Q ss_pred ccccCCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCcc----------c
Q 018712 217 FDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQS----------L 286 (351)
Q Consensus 217 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~----------~ 286 (351)
||++....... .....||+.|+|||++. ..++.++||||||+++|+|++|+.||.......... .
T Consensus 176 fg~~~~~~~~~----~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 250 (290)
T 1t4h_A 176 LGLATLKRASF----AKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPAS 250 (290)
T ss_dssp TTGGGGCCTTS----BEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGG
T ss_pred CCCcccccccc----cccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCccc
Confidence 99986544322 23456899999999876 458999999999999999999999998643321110 0
Q ss_pred hhhcccCCCccchhhhcccccCCCCCHHHHH
Q 018712 287 VTWATPKLSEDKVKQCVDTKLGGEYPPKAIA 317 (351)
Q Consensus 287 ~~~~~~~~~~~~~~~~ld~~~~~~~~~~~~~ 317 (351)
.....+....+.+..|+..+|.+|++.+++.
T Consensus 251 ~~~~~~~~l~~li~~~l~~dp~~Rps~~ell 281 (290)
T 1t4h_A 251 FDKVAIPEVKEIIEGCIRQNKDERYSIKDLL 281 (290)
T ss_dssp GGGCCCHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred cCCCCCHHHHHHHHHHccCChhhCCCHHHHh
Confidence 0111111123678899999999999887664
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=310.05 Aligned_cols=250 Identities=23% Similarity=0.312 Sum_probs=200.8
Q ss_pred hcCCCCCceeccCCcEEEEEEEE-----CCCCEEEEEEcCCCCCc-hHHHHHHHHHHHhccCCceeeeEEEEe--cCCce
Q 018712 65 TDNFGTNSLIGEGSYGRVYFGVL-----RSGRAAAIKKLDSSKQP-DQEFLAQVSMVSRLKNENVVELVGYYV--DGPLR 136 (351)
Q Consensus 65 ~~~y~~~~~Lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~-~~~~~~e~~~l~~l~h~niv~~~~~~~--~~~~~ 136 (351)
.++|++.+.||+|+||.||+|.+ .+++.||+|++...... .+.+.+|++++++++|+||+++++++. +....
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 101 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL 101 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence 36799999999999999999984 36889999999765432 356889999999999999999999886 45668
Q ss_pred EEEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEec
Q 018712 137 VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISD 216 (351)
Q Consensus 137 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~D 216 (351)
++||||+++++|.+++..... .+++..++.++.|++.||.|||+++ ++||||||+|||++.++.+||+|
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~D 170 (327)
T 3lxl_A 102 RLVMEYLPSGCLRDFLQRHRA--------RLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIAD 170 (327)
T ss_dssp EEEEECCTTCBHHHHHHHHGG--------GCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECC
T ss_pred EEEEeecCCCCHHHHHHhccc--------CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEcc
Confidence 999999999999999976432 2899999999999999999999999 99999999999999999999999
Q ss_pred ccccCCCcccccc-ccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCC---------CCc--
Q 018712 217 FDLSNQAPDAAAR-LHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPR---------GQQ-- 284 (351)
Q Consensus 217 fg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~---------~~~-- 284 (351)
||++......... .......||+.|+|||++.+..++.++||||||+++|+|++|..||...... ...
T Consensus 171 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~ 250 (327)
T 3lxl_A 171 FGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPAL 250 (327)
T ss_dssp GGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHH
T ss_pred cccceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccH
Confidence 9999766433221 1223446888899999999999999999999999999999999998653211 000
Q ss_pred -cchh-----------hcccCCCccchhhhcccccCCCCCHHHHHHHHHHHHH
Q 018712 285 -SLVT-----------WATPKLSEDKVKQCVDTKLGGEYPPKAIAKVRKKKFI 325 (351)
Q Consensus 285 -~~~~-----------~~~~~~~~~~~~~~ld~~~~~~~~~~~~~~~~~~~~~ 325 (351)
.... ...+....+.+..|+..+|.+|++.+++.+.++..+.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~ 303 (327)
T 3lxl_A 251 SRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWS 303 (327)
T ss_dssp HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC--
T ss_pred HHHHHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 0000 0111112368899999999999999999887766543
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-41 Score=331.04 Aligned_cols=241 Identities=25% Similarity=0.369 Sum_probs=192.9
Q ss_pred ceeccCCcEEEEEEEEC---CCCEEEEEEcCCCCC---chHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEEEeCCC
Q 018712 72 SLIGEGSYGRVYFGVLR---SGRAAAIKKLDSSKQ---PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASK 145 (351)
Q Consensus 72 ~~Lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 145 (351)
+.||+|+||.||+|.+. +++.||||++..... ..+.+.+|+++|++++||||+++++++.+ +..++||||+.+
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 37999999999999753 567899999875432 24679999999999999999999999865 468899999999
Q ss_pred CCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccccCCCcc
Q 018712 146 GSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPD 225 (351)
Q Consensus 146 gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~ 225 (351)
|+|.+++..... +++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 454 g~L~~~l~~~~~---------l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~ 521 (635)
T 4fl3_A 454 GPLNKYLQQNRH---------VKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRA 521 (635)
T ss_dssp EEHHHHHHHCTT---------CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC
T ss_pred CCHHHHHhhCCC---------CCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCcccccc
Confidence 999999976543 899999999999999999999999 99999999999999999999999999976543
Q ss_pred cccc-ccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCCccchhhc--------ccCCC
Q 018712 226 AAAR-LHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWA--------TPKLS 295 (351)
Q Consensus 226 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~Pf~~~~~~~~~~~~~~~--------~~~~~ 295 (351)
.... .......+|+.|+|||++.+..++.++||||||+++|||++ |+.||...........+... .+...
T Consensus 522 ~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l 601 (635)
T 4fl3_A 522 DENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREM 601 (635)
T ss_dssp -------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHH
T ss_pred CccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHH
Confidence 3221 11233456889999999999999999999999999999998 99999876543222222111 11112
Q ss_pred ccchhhhcccccCCCCCHHHHHHHHHHHHH
Q 018712 296 EDKVKQCVDTKLGGEYPPKAIAKVRKKKFI 325 (351)
Q Consensus 296 ~~~~~~~ld~~~~~~~~~~~~~~~~~~~~~ 325 (351)
.+.+..|+..++.+|++.+++...++-.+.
T Consensus 602 ~~li~~cl~~dP~~RPs~~~l~~~L~~~~~ 631 (635)
T 4fl3_A 602 YDLMNLCWTYDVENRPGFAAVELRLRNYYY 631 (635)
T ss_dssp HHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 368899999999999999999887765543
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-41 Score=311.86 Aligned_cols=240 Identities=22% Similarity=0.345 Sum_probs=192.2
Q ss_pred HhcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCCc---hHHHHHHHHHHHhccCCceeeeEEEEecCCce---
Q 018712 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVDGPLR--- 136 (351)
Q Consensus 64 ~~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~--- 136 (351)
..++|.+.+.||+|+||.||+|.+. +++.||+|++...... ...+.+|+.+++.++||||+++++++...+..
T Consensus 40 l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 119 (371)
T 4exu_A 40 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 119 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTC
T ss_pred ccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccc
Confidence 3468999999999999999999975 7899999999765433 35678999999999999999999999877655
Q ss_pred ---EEEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceE
Q 018712 137 ---VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAK 213 (351)
Q Consensus 137 ---~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vk 213 (351)
++||||+. ++|.+++... +++..+..++.||+.||.|||++| |+||||||+|||++.++.+|
T Consensus 120 ~~~~lv~e~~~-~~l~~~~~~~-----------~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~k 184 (371)
T 4exu_A 120 YDFYLVMPFMQ-TDLQKIMGME-----------FSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELK 184 (371)
T ss_dssp CCCEEEEECCC-EEHHHHTTSC-----------CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEE
T ss_pred eeEEEEEcccc-ccHHHHhhcC-----------CCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEE
Confidence 99999997 5999888532 899999999999999999999999 99999999999999999999
Q ss_pred EecccccCCCccccccccccccccccCccCcccccC-CCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccch-----
Q 018712 214 ISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMT-GQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLV----- 287 (351)
Q Consensus 214 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~----- 287 (351)
|+|||+++..... .....||+.|+|||++.+ ..++.++||||||+++|+|++|+.||...........+
T Consensus 185 L~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~ 259 (371)
T 4exu_A 185 ILDFGLARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTG 259 (371)
T ss_dssp ECSTTCC-------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred EEecCcccccccC-----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Confidence 9999999765432 244578999999999887 68899999999999999999999999865321110000
Q ss_pred ------------------------------hhcc---cCCCccchhhhcccccCCCCCHHHHHHHHHHHHHh
Q 018712 288 ------------------------------TWAT---PKLSEDKVKQCVDTKLGGEYPPKAIAKVRKKKFIT 326 (351)
Q Consensus 288 ------------------------------~~~~---~~~~~~~~~~~ld~~~~~~~~~~~~~~~~~~~~~~ 326 (351)
.... +....+.+..|+..+|.+|++++++ +++.++.
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~el---l~hp~f~ 328 (371)
T 4exu_A 260 VPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQA---LTHPFFE 328 (371)
T ss_dssp CCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHH---HTSGGGT
T ss_pred CCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHH---hcCcccc
Confidence 0000 1112368899999999999987765 4555543
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-41 Score=309.40 Aligned_cols=199 Identities=18% Similarity=0.326 Sum_probs=172.1
Q ss_pred hcCCCCCceeccCCcEEEEEEEEC-CC-CEEEEEEcCCCCCchHHHHHHHHHHHhccCCc------eeeeEEEEecCCce
Q 018712 65 TDNFGTNSLIGEGSYGRVYFGVLR-SG-RAAAIKKLDSSKQPDQEFLAQVSMVSRLKNEN------VVELVGYYVDGPLR 136 (351)
Q Consensus 65 ~~~y~~~~~Lg~G~~g~Vy~~~~~-~~-~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~n------iv~~~~~~~~~~~~ 136 (351)
.++|.+.+.||+|+||.||+|.+. ++ ..||+|++.........+.+|+.++++++|++ ++.+++++...+..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~ 97 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHM 97 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeE
Confidence 478999999999999999999975 44 68999999766555677888999999997765 89999999999999
Q ss_pred EEEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEE----------
Q 018712 137 VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLL---------- 206 (351)
Q Consensus 137 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill---------- 206 (351)
++||||+ +++|.+++...... .+++..++.++.||+.||.|||+++ |+||||||+|||+
T Consensus 98 ~lv~e~~-~~~l~~~l~~~~~~-------~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~ 166 (355)
T 2eu9_A 98 CIAFELL-GKNTFEFLKENNFQ-------PYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYN 166 (355)
T ss_dssp EEEEECC-CCBHHHHHHHTTTC-------CCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEEC
T ss_pred EEEEecc-CCChHHHHHhccCC-------CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeccccccccc
Confidence 9999999 55777777654321 2899999999999999999999999 9999999999999
Q ss_pred ---------ccCCceEEecccccCCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCC
Q 018712 207 ---------FDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDH 277 (351)
Q Consensus 207 ---------~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~ 277 (351)
+.++.+||+|||++...... .....||+.|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus 167 ~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 241 (355)
T 2eu9_A 167 EHKSCEEKSVKNTSIRVADFGSATFDHEH-----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQT 241 (355)
T ss_dssp CC-CCCEEEESCCCEEECCCTTCEETTSC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred ccccccccccCCCcEEEeecCcccccccc-----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCC
Confidence 56789999999998754332 2445799999999999999999999999999999999999999986
Q ss_pred CC
Q 018712 278 TL 279 (351)
Q Consensus 278 ~~ 279 (351)
..
T Consensus 242 ~~ 243 (355)
T 2eu9_A 242 HE 243 (355)
T ss_dssp SS
T ss_pred CC
Confidence 54
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=317.19 Aligned_cols=243 Identities=21% Similarity=0.260 Sum_probs=186.9
Q ss_pred hcCCCCCceeccCCcEEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHHhccCCceeeeEEEEecCC------ceEE
Q 018712 65 TDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGP------LRVL 138 (351)
Q Consensus 65 ~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------~~~l 138 (351)
..+|.+.+.||+|+||.||+|.+..+..+|+|++...... ..+|+++++.++||||+++++++.... ..++
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~---~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l 115 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF---KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNL 115 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS---CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch---HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEE
Confidence 4579999999999999999999887777999988654332 236899999999999999999985433 3789
Q ss_pred EEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEc-cCCceEEecc
Q 018712 139 AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLF-DDDIAKISDF 217 (351)
Q Consensus 139 v~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~-~~~~vkl~Df 217 (351)
||||+.++ +.+.+...... ...+++..++.++.||+.||.|||++| |+||||||+|||++ .++.+||+||
T Consensus 116 v~e~~~~~-l~~~~~~~~~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DF 186 (394)
T 4e7w_A 116 VLEYVPET-VYRASRHYAKL-----KQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDF 186 (394)
T ss_dssp EEECCSEE-HHHHHHHHHHT-----TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCC
T ss_pred EeeccCcc-HHHHHHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeC
Confidence 99999874 44333211000 012899999999999999999999999 99999999999999 7899999999
Q ss_pred cccCCCccccccccccccccccCccCcccccCC-CCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccchh--------
Q 018712 218 DLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTG-QMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVT-------- 288 (351)
Q Consensus 218 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~~-------- 288 (351)
|+++........ ....||+.|+|||++.+. .++.++|||||||++|||++|+.||.+.........+.
T Consensus 187 G~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~ 263 (394)
T 4e7w_A 187 GSAKILIAGEPN---VSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSR 263 (394)
T ss_dssp TTCEECCTTCCC---CSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCH
T ss_pred CCcccccCCCCC---cccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence 999765433222 345789999999998765 58999999999999999999999998754321111000
Q ss_pred -------------------------hc---ccCCCccchhhhcccccCCCCCHHHHHHHHHHHHH
Q 018712 289 -------------------------WA---TPKLSEDKVKQCVDTKLGGEYPPKAIAKVRKKKFI 325 (351)
Q Consensus 289 -------------------------~~---~~~~~~~~~~~~ld~~~~~~~~~~~~~~~~~~~~~ 325 (351)
.. .+....+.+..|+..+|.+|++++++. ++.++
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l---~hp~f 325 (394)
T 4e7w_A 264 EQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEAL---CHPFF 325 (394)
T ss_dssp HHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHH---TSGGG
T ss_pred HHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHh---cChhh
Confidence 00 111123788999999999999887664 45544
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=311.40 Aligned_cols=240 Identities=18% Similarity=0.266 Sum_probs=196.2
Q ss_pred HhcCCCCCceeccCCcEEEEEEEECCCCEEEEEEcCCCCCc----h--------------HHHHHHHHHHHhccCCceee
Q 018712 64 KTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQP----D--------------QEFLAQVSMVSRLKNENVVE 125 (351)
Q Consensus 64 ~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~----~--------------~~~~~e~~~l~~l~h~niv~ 125 (351)
..++|.+.+.||+|+||.||+|.+ +++.||+|++...... . ..+.+|+.++++++||||++
T Consensus 29 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~ 107 (348)
T 2pml_X 29 YINDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLT 107 (348)
T ss_dssp EETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCC
T ss_pred ccCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcce
Confidence 357899999999999999999999 8999999998532111 1 77899999999999999999
Q ss_pred eEEEEecCCceEEEEEeCCCCCHHHH------hccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhh-CCCCCeeecc
Q 018712 126 LVGYYVDGPLRVLAYEHASKGSLHDI------LHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHE-KAEPRIIHRN 198 (351)
Q Consensus 126 ~~~~~~~~~~~~lv~e~~~~gsL~~~------l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~-~~~~~ivH~D 198 (351)
+++++.+.+..++||||+++++|.++ +..... ..+++..++.++.||+.||.|||+ +| ++|||
T Consensus 108 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~-------~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~d 177 (348)
T 2pml_X 108 CEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYT-------CFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRD 177 (348)
T ss_dssp CSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSC-------CCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCC
T ss_pred EEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccc-------cCCCHHHHHHHHHHHHHHHHHHhccCC---EeecC
Confidence 99999999999999999999999999 544211 238999999999999999999999 98 99999
Q ss_pred ccCCcEEEccCCceEEecccccCCCccccccccccccccccCccCcccccCC-CCCc-cchhHhHHHHHHHHHcCCCCCC
Q 018712 199 IKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTG-QMSS-KSDVYSFGVVLLELLTGRKPVD 276 (351)
Q Consensus 199 lkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~~DvwslG~il~el~tg~~Pf~ 276 (351)
|||+||+++.++.+||+|||++....... .....||+.|+|||.+.+. .++. ++||||||+++|+|++|+.||.
T Consensus 178 l~p~Nil~~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 253 (348)
T 2pml_X 178 VKPSNILMDKNGRVKLSDFGESEYMVDKK----IKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFS 253 (348)
T ss_dssp CCGGGEEECTTSCEEECCCTTCEECBTTE----ECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred CChHhEEEcCCCcEEEecccccccccccc----ccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCC
Confidence 99999999999999999999987654331 2445789999999999877 6666 9999999999999999999998
Q ss_pred CCCCC-CCccchh--------------------------hcccCCCccchhhhcccccCCCCCHHHHHH
Q 018712 277 HTLPR-GQQSLVT--------------------------WATPKLSEDKVKQCVDTKLGGEYPPKAIAK 318 (351)
Q Consensus 277 ~~~~~-~~~~~~~--------------------------~~~~~~~~~~~~~~ld~~~~~~~~~~~~~~ 318 (351)
..... .....+. ...+....+.+..|+..+|.+|++.+++.+
T Consensus 254 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 254 LKISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp CSSCSHHHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred CCCcHHHHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 65441 1110010 001111136888999999999998876643
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=303.20 Aligned_cols=248 Identities=20% Similarity=0.271 Sum_probs=194.5
Q ss_pred HhcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCCc---hHHHHHHHHHHHhccCCceeeeEEEEe--cCCceE
Q 018712 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYV--DGPLRV 137 (351)
Q Consensus 64 ~~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~--~~~~~~ 137 (351)
..++|++.+.||+|+||.||++... +++.||+|++...... .+.+.+|+.++++++||||+++++++. .....+
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 83 (279)
T 2w5a_A 4 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLY 83 (279)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEE
T ss_pred chhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEE
Confidence 4578999999999999999999976 7899999998755432 356889999999999999999999875 456789
Q ss_pred EEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCC--CCCeeeccccCCcEEEccCCceEEe
Q 018712 138 LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKA--EPRIIHRNIKSSNVLLFDDDIAKIS 215 (351)
Q Consensus 138 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~--~~~ivH~Dlkp~Nill~~~~~vkl~ 215 (351)
+||||+++++|.+++...... ...+++..++.++.|++.||.|||+++ ..+++||||||+||+++.++.+||+
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~-----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~ 158 (279)
T 2w5a_A 84 IVMEYCEGGDLASVITKGTKE-----RQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLG 158 (279)
T ss_dssp EEEECCTTEEHHHHHHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEEC
T ss_pred EEEeCCCCCCHHHHHHhhccc-----CCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEe
Confidence 999999999999999764321 123889999999999999999999986 1239999999999999999999999
Q ss_pred cccccCCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccchh-h-----
Q 018712 216 DFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVT-W----- 289 (351)
Q Consensus 216 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~~-~----- 289 (351)
|||++......... .....||+.|+|||++.+..++.++||||||+++|+|++|+.||...........+. .
T Consensus 159 dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~ 236 (279)
T 2w5a_A 159 DFGLARILNHDTSF--AKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRI 236 (279)
T ss_dssp CCCHHHHC---CHH--HHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC
T ss_pred cCchheeecccccc--ccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhcccccC
Confidence 99998765432211 133568999999999999999999999999999999999999998654322111111 1
Q ss_pred --cccCCCccchhhhcccccCCCCCHHHHHH
Q 018712 290 --ATPKLSEDKVKQCVDTKLGGEYPPKAIAK 318 (351)
Q Consensus 290 --~~~~~~~~~~~~~ld~~~~~~~~~~~~~~ 318 (351)
..+....+.+..|+..++.+|++.+++..
T Consensus 237 ~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 267 (279)
T 2w5a_A 237 PYRYSDELNEIITRMLNLKDYHRPSVEEILE 267 (279)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CcccCHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 11112236788899999999998887643
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=302.69 Aligned_cols=249 Identities=22% Similarity=0.360 Sum_probs=199.1
Q ss_pred HHHHHHhcCCCCCceeccCCcEEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHHh--ccCCceeeeEEEEecCC--
Q 018712 59 DELKEKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSR--LKNENVVELVGYYVDGP-- 134 (351)
Q Consensus 59 ~~~~~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~--l~h~niv~~~~~~~~~~-- 134 (351)
.......++|.+.+.||+|+||.||+|.+ +++.||+|++... ....+.+|.++++. ++||||+++++++....
T Consensus 35 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~--~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~ 111 (342)
T 1b6c_B 35 LVQRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR--EERSWFREAEIYQTVMLRHENILGFIAADNKDNGT 111 (342)
T ss_dssp HHHHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG--GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSS
T ss_pred eecccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch--hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCc
Confidence 33455667899999999999999999998 4889999998643 34567888888887 79999999999998776
Q ss_pred --ceEEEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhh--------hCCCCCeeeccccCCcE
Q 018712 135 --LRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLH--------EKAEPRIIHRNIKSSNV 204 (351)
Q Consensus 135 --~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH--------~~~~~~ivH~Dlkp~Ni 204 (351)
..++||||+.+|+|.+++.... +++..++.++.|++.||.||| +.+ |+||||||+||
T Consensus 112 ~~~~~lv~e~~~~g~L~~~l~~~~----------~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~NI 178 (342)
T 1b6c_B 112 WTQLWLVSDYHEHGSLFDYLNRYT----------VTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNI 178 (342)
T ss_dssp CCCEEEEECCCTTCBHHHHHHHCC----------BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGGE
T ss_pred cceeEEEEeecCCCcHHHHHhccC----------ccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHHE
Confidence 7899999999999999997653 899999999999999999999 788 99999999999
Q ss_pred EEccCCceEEecccccCCCccccccc--cccccccccCccCcccccCCC------CCccchhHhHHHHHHHHHcC-----
Q 018712 205 LLFDDDIAKISDFDLSNQAPDAAARL--HSTRVLGTFGYHAPEYAMTGQ------MSSKSDVYSFGVVLLELLTG----- 271 (351)
Q Consensus 205 ll~~~~~vkl~Dfg~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~------~~~~~DvwslG~il~el~tg----- 271 (351)
|++.++.+||+|||++.......... ......||+.|+|||++.+.. ++.++||||||+++|||++|
T Consensus 179 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~ 258 (342)
T 1b6c_B 179 LVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGG 258 (342)
T ss_dssp EECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTT
T ss_pred EECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCC
Confidence 99999999999999986654322111 124457999999999987652 34689999999999999999
Q ss_pred -----CCCCCCCCCCCCc--cc---h--hhcccCC------------CccchhhhcccccCCCCCHHHHHHHHHHH
Q 018712 272 -----RKPVDHTLPRGQQ--SL---V--TWATPKL------------SEDKVKQCVDTKLGGEYPPKAIAKVRKKK 323 (351)
Q Consensus 272 -----~~Pf~~~~~~~~~--~~---~--~~~~~~~------------~~~~~~~~ld~~~~~~~~~~~~~~~~~~~ 323 (351)
..||......... .. + ....+.. ..+.+..|+..+|.+|++.+++...++-.
T Consensus 259 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i 334 (342)
T 1b6c_B 259 IHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 334 (342)
T ss_dssp BCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred cccccccCccccCcCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHH
Confidence 7888765432211 00 0 0111111 12578899999999999999988776654
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=315.90 Aligned_cols=210 Identities=22% Similarity=0.372 Sum_probs=158.3
Q ss_pred hcCCCC-CceeccCCcEEEEEEEEC---CCCEEEEEEcCCCCCchHHHHHHHHHHHhccCCceeeeEEEEe--cCCceEE
Q 018712 65 TDNFGT-NSLIGEGSYGRVYFGVLR---SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYV--DGPLRVL 138 (351)
Q Consensus 65 ~~~y~~-~~~Lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~--~~~~~~l 138 (351)
.+.|.+ .++||+|+||.||+|.++ +++.||+|++..... ...+.+|+.+|++++||||+++++++. .....++
T Consensus 19 ~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~l 97 (405)
T 3rgf_A 19 EDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI-SMSACREIALLRELKHPNVISLQKVFLSHADRKVWL 97 (405)
T ss_dssp HHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC-CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEE
T ss_pred hhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC-CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEE
Confidence 345666 458999999999999965 578999999975543 356889999999999999999999985 4678999
Q ss_pred EEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEE----ccCCceEE
Q 018712 139 AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLL----FDDDIAKI 214 (351)
Q Consensus 139 v~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill----~~~~~vkl 214 (351)
||||+.+ +|.+++..............+++..++.++.||+.||.|||+++ |+||||||+|||+ +.++.+||
T Consensus 98 v~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl 173 (405)
T 3rgf_A 98 LFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKI 173 (405)
T ss_dssp EEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTCEEE
T ss_pred EEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCcEEE
Confidence 9999975 88888764321111111123889999999999999999999999 9999999999999 67789999
Q ss_pred ecccccCCCcccccc-ccccccccccCccCcccccCC-CCCccchhHhHHHHHHHHHcCCCCCCCCC
Q 018712 215 SDFDLSNQAPDAAAR-LHSTRVLGTFGYHAPEYAMTG-QMSSKSDVYSFGVVLLELLTGRKPVDHTL 279 (351)
Q Consensus 215 ~Dfg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~Pf~~~~ 279 (351)
+|||+++........ .......||+.|+|||++.+. .++.++|||||||++|+|++|+.||....
T Consensus 174 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~ 240 (405)
T 3rgf_A 174 ADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 240 (405)
T ss_dssp CCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC
T ss_pred EECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCcc
Confidence 999999876432211 122446789999999999874 58999999999999999999999997643
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=304.65 Aligned_cols=251 Identities=24% Similarity=0.316 Sum_probs=179.4
Q ss_pred HHhcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCC--CchHHHHHHHHHHHhccCCceeeeEEEEecCCceEEE
Q 018712 63 EKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK--QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLA 139 (351)
Q Consensus 63 ~~~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 139 (351)
...++|.+.+.||+|+||.||+|.+. +++.||+|++.... .....+.+|+.++++++||||+++++++...+..++|
T Consensus 12 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 91 (303)
T 2vwi_A 12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLV 91 (303)
T ss_dssp -CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEE
T ss_pred cchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEE
Confidence 34578999999999999999999954 78999999986542 2345678899999999999999999999999999999
Q ss_pred EEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccc
Q 018712 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDL 219 (351)
Q Consensus 140 ~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~ 219 (351)
|||+++++|.+++....... ......+++..++.++.||+.||.|||++| ++||||||+||+++.++.+||+|||+
T Consensus 92 ~e~~~~~~L~~~l~~~~~~~-~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~ 167 (303)
T 2vwi_A 92 MKLLSGGSVLDIIKHIVAKG-EHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGV 167 (303)
T ss_dssp EECCTTCBHHHHHHHHHHTT-TTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCHH
T ss_pred ehhccCCchHHHHHHHhhcc-ccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEeccc
Confidence 99999999999997421100 001123899999999999999999999999 99999999999999999999999999
Q ss_pred cCCCccccc---cccccccccccCccCcccccC-CCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccchh-hc----
Q 018712 220 SNQAPDAAA---RLHSTRVLGTFGYHAPEYAMT-GQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVT-WA---- 290 (351)
Q Consensus 220 a~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~~-~~---- 290 (351)
+........ ........||+.|+|||++.+ ..++.++||||||+++|+|++|+.||............. ..
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 247 (303)
T 2vwi_A 168 SAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSL 247 (303)
T ss_dssp HHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCCT
T ss_pred hheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCcc
Confidence 865533211 111234568999999998875 568999999999999999999999998654322110000 00
Q ss_pred ------------ccCCCccchhhhcccccCCCCCHHHHH
Q 018712 291 ------------TPKLSEDKVKQCVDTKLGGEYPPKAIA 317 (351)
Q Consensus 291 ------------~~~~~~~~~~~~ld~~~~~~~~~~~~~ 317 (351)
.+....+.+..|+..+|.+|++.+++.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll 286 (303)
T 2vwi_A 248 ETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELL 286 (303)
T ss_dssp TC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHH
T ss_pred ccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHh
Confidence 001112578889999999999887764
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-41 Score=303.01 Aligned_cols=241 Identities=20% Similarity=0.338 Sum_probs=188.8
Q ss_pred HHhcCCCCCceeccCCcEEEEEEEECCCCEEEEEEcCCCCCc---hHHHHHHHHHHHhcc--CCceeeeEEEEecCCceE
Q 018712 63 EKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLK--NENVVELVGYYVDGPLRV 137 (351)
Q Consensus 63 ~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~--h~niv~~~~~~~~~~~~~ 137 (351)
...++|.+.+.||+|+||.||++.+.+++.||+|++...... ...+.+|+.++++++ |+||+++++++.+.+..+
T Consensus 25 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~ 104 (313)
T 3cek_A 25 VKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY 104 (313)
T ss_dssp ETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEE
T ss_pred eccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEE
Confidence 345679999999999999999999888999999998654332 356789999999997 599999999999999999
Q ss_pred EEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecc
Q 018712 138 LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDF 217 (351)
Q Consensus 138 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Df 217 (351)
+||| +.+++|.+++..... +++..++.++.||+.||.|||+++ ++||||||+|||++ ++.+||+||
T Consensus 105 lv~e-~~~~~L~~~l~~~~~---------~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~-~~~~kL~Df 170 (313)
T 3cek_A 105 MVME-CGNIDLNSWLKKKKS---------IDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDF 170 (313)
T ss_dssp EEEC-CCSEEHHHHHHHCSS---------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCC
T ss_pred EEEe-cCCCcHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEE-CCeEEEeec
Confidence 9999 567899999987542 889999999999999999999999 99999999999996 489999999
Q ss_pred cccCCCccccccccccccccccCccCcccccC-----------CCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCc--
Q 018712 218 DLSNQAPDAAARLHSTRVLGTFGYHAPEYAMT-----------GQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQ-- 284 (351)
Q Consensus 218 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~-- 284 (351)
|++................||+.|+|||.+.+ ..++.++||||||+++|+|++|+.||.........
T Consensus 171 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~ 250 (313)
T 3cek_A 171 GIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLH 250 (313)
T ss_dssp SSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHH
T ss_pred cccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHH
Confidence 99987654433222344578999999999875 46888999999999999999999999764322110
Q ss_pred cch--------hhcccCCCccchhhhcccccCCCCCHHHHH
Q 018712 285 SLV--------TWATPKLSEDKVKQCVDTKLGGEYPPKAIA 317 (351)
Q Consensus 285 ~~~--------~~~~~~~~~~~~~~~ld~~~~~~~~~~~~~ 317 (351)
... ....+....+.+..|+..+|.+|++.+++.
T Consensus 251 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell 291 (313)
T 3cek_A 251 AIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELL 291 (313)
T ss_dssp HHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred HHHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHh
Confidence 000 001111123678899999999999887654
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=303.27 Aligned_cols=240 Identities=21% Similarity=0.332 Sum_probs=192.6
Q ss_pred HhcCCCCCceeccCCcEEEEEEEEC--CCCEEEEEEcCCCC---CchHHHHHHHHHHHhc---cCCceeeeEEEEe----
Q 018712 64 KTDNFGTNSLIGEGSYGRVYFGVLR--SGRAAAIKKLDSSK---QPDQEFLAQVSMVSRL---KNENVVELVGYYV---- 131 (351)
Q Consensus 64 ~~~~y~~~~~Lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l---~h~niv~~~~~~~---- 131 (351)
..++|++.+.||+|+||.||+|.+. +++.||+|++.... .....+.+|+.+++.+ +||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 4578999999999999999999973 67899999885322 2233566777777766 8999999999987
Q ss_pred -cCCceEEEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCC
Q 018712 132 -DGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD 210 (351)
Q Consensus 132 -~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~ 210 (351)
.....++||||+. |+|.+++...... .+++..++.++.||+.||.|||++| ++||||||+||+++.++
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~ 157 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKVPEP-------GVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSG 157 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHSCTT-------CSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTC
T ss_pred CCCceEEEEEecCC-CCHHHHHHhcccC-------CCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCC
Confidence 5667899999998 5999999865432 2889999999999999999999999 99999999999999999
Q ss_pred ceEEecccccCCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccch---
Q 018712 211 IAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLV--- 287 (351)
Q Consensus 211 ~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~--- 287 (351)
.+||+|||++........ .....||+.|+|||++.+..++.++||||||+++|+|++|+.||...........+
T Consensus 158 ~~kl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~ 234 (326)
T 1blx_A 158 QIKLADFGLARIYSFQMA---LTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDV 234 (326)
T ss_dssp CEEECSCCSCCCCCGGGG---GCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH
T ss_pred CEEEecCcccccccCCCC---ccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHH
Confidence 999999999987653322 24457899999999999999999999999999999999999999865322110000
Q ss_pred ----------------------------hhcccCCC---ccchhhhcccccCCCCCHHHHH
Q 018712 288 ----------------------------TWATPKLS---EDKVKQCVDTKLGGEYPPKAIA 317 (351)
Q Consensus 288 ----------------------------~~~~~~~~---~~~~~~~ld~~~~~~~~~~~~~ 317 (351)
....+... .+.+..|+..+|.+|++.+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l 295 (326)
T 1blx_A 235 IGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSAL 295 (326)
T ss_dssp HCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred cCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHh
Confidence 00001111 2678899999999999987764
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=318.67 Aligned_cols=238 Identities=24% Similarity=0.318 Sum_probs=185.0
Q ss_pred hcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCCchHHHHHHHHHHHhccCCceeeeEEEEecC------CceE
Q 018712 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDG------PLRV 137 (351)
Q Consensus 65 ~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------~~~~ 137 (351)
..+|.+.+.||+|+||.||+|.+. +++.||||++...... ..+|+++++.++|+||+++++++... ..++
T Consensus 53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~---~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~ 129 (420)
T 1j1b_A 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF---KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 129 (420)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTTS---CCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred cceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccchh---HHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence 346999999999999999999985 6899999998654322 34799999999999999999987532 2467
Q ss_pred EEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccC-CceEEec
Q 018712 138 LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDD-DIAKISD 216 (351)
Q Consensus 138 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~-~~vkl~D 216 (351)
+||||+.+ +|.+++...... ...+++..++.++.||+.||.|||++| |+||||||+|||++.+ +.+||+|
T Consensus 130 lv~e~~~~-~l~~~~~~~~~~-----~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~D 200 (420)
T 1j1b_A 130 LVLDYVPE-TVYRVARHYSRA-----KQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCD 200 (420)
T ss_dssp EEEECCCE-EHHHHHHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECC
T ss_pred eehhcccc-cHHHHHHHHhhc-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEecc
Confidence 99999986 676666431100 012899999999999999999999999 9999999999999965 6789999
Q ss_pred ccccCCCccccccccccccccccCccCcccccCC-CCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccchh-------
Q 018712 217 FDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTG-QMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVT------- 288 (351)
Q Consensus 217 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~~------- 288 (351)
||+++....... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||.+.........+.
T Consensus 201 FG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~ 277 (420)
T 1j1b_A 201 FGSAKQLVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPT 277 (420)
T ss_dssp CTTCEECCTTCC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCC
T ss_pred chhhhhcccCCC---ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 999986543322 1345789999999998765 78999999999999999999999998754221110000
Q ss_pred -----------------------h------cccCCCccchhhhcccccCCCCCHHHHH
Q 018712 289 -----------------------W------ATPKLSEDKVKQCVDTKLGGEYPPKAIA 317 (351)
Q Consensus 289 -----------------------~------~~~~~~~~~~~~~ld~~~~~~~~~~~~~ 317 (351)
| ..+....+++..|+..+|.+|++.+++.
T Consensus 278 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l 335 (420)
T 1j1b_A 278 REQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 335 (420)
T ss_dssp HHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred HHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHh
Confidence 0 0011123688899999999999987654
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-41 Score=310.80 Aligned_cols=200 Identities=26% Similarity=0.306 Sum_probs=172.5
Q ss_pred HhcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCCchHHHHHHHHHHHhcc-CC-----ceeeeEEEEecCCce
Q 018712 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLK-NE-----NVVELVGYYVDGPLR 136 (351)
Q Consensus 64 ~~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~-h~-----niv~~~~~~~~~~~~ 136 (351)
..++|.+.+.||+|+||.||+|.+. +++.||||++.........+.+|+.+++.++ |+ +|+++++++...+..
T Consensus 52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~ 131 (382)
T 2vx3_A 52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHL 131 (382)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEE
T ss_pred eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCce
Confidence 4578999999999999999999976 6889999999765544566778888888885 44 499999999999999
Q ss_pred EEEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhh--CCCCCeeeccccCCcEEEc--cCCce
Q 018712 137 VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHE--KAEPRIIHRNIKSSNVLLF--DDDIA 212 (351)
Q Consensus 137 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~--~~~~~ivH~Dlkp~Nill~--~~~~v 212 (351)
++||||+.+ +|.+++...... .+++..+..++.|++.||.|||. .+ |+||||||+|||++ .++.+
T Consensus 132 ~lv~e~~~~-~L~~~l~~~~~~-------~~~~~~~~~i~~qi~~al~~lH~~~~~---ivHrDlkp~NIll~~~~~~~~ 200 (382)
T 2vx3_A 132 CLVFEMLSY-NLYDLLRNTNFR-------GVSLNLTRKFAQQMCTALLFLATPELS---IIHCDLKPENILLCNPKRSAI 200 (382)
T ss_dssp EEEEECCCC-BHHHHHHHTTTS-------CCCHHHHHHHHHHHHHHHHHHTSTTTC---EECCCCSGGGEEESSTTSCCE
T ss_pred EEEEecCCC-CHHHHHhhcCcC-------CCCHHHHHHHHHHHHHHHHHhccCCCC---EEcCCCCcccEEEecCCCCcE
Confidence 999999965 999999875422 28899999999999999999994 57 99999999999995 47789
Q ss_pred EEecccccCCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCC
Q 018712 213 KISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTL 279 (351)
Q Consensus 213 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~ 279 (351)
||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 201 kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~ 262 (382)
T 2vx3_A 201 KIVDFGSSCQLGQR-----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGAN 262 (382)
T ss_dssp EECCCTTCEETTCC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred EEEeccCceecccc-----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999999766432 234578999999999999999999999999999999999999998654
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=298.30 Aligned_cols=248 Identities=26% Similarity=0.280 Sum_probs=181.5
Q ss_pred HhcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCCch---HHHHHHHHHHHhccCCceeeeEEEEecCCceEEE
Q 018712 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPD---QEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLA 139 (351)
Q Consensus 64 ~~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~---~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 139 (351)
..++|++.+.||+|+||.||+|.+. +++.||+|++....... ..+.++...++.++||||+++++++.+.+..++|
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv 84 (290)
T 3fme_A 5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWIC 84 (290)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEE
T ss_pred cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEE
Confidence 3578999999999999999999974 78999999997654332 2233444557888999999999999999999999
Q ss_pred EEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhC-CCCCeeeccccCCcEEEccCCceEEeccc
Q 018712 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEK-AEPRIIHRNIKSSNVLLFDDDIAKISDFD 218 (351)
Q Consensus 140 ~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~-~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg 218 (351)
|||+.+ +|.+++...... ...+++..++.++.|++.||.|||++ | ++||||||+||+++.++.+||+|||
T Consensus 85 ~e~~~~-~l~~~l~~~~~~-----~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg 155 (290)
T 3fme_A 85 MELMDT-SLDKFYKQVIDK-----GQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFG 155 (290)
T ss_dssp EECCSE-EHHHHHHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC-
T ss_pred Eehhcc-chHHHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecC
Confidence 999975 888877542110 11389999999999999999999998 9 9999999999999999999999999
Q ss_pred ccCCCccccccccccccccccCccCcccc----cCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCc--cchhhc--
Q 018712 219 LSNQAPDAAARLHSTRVLGTFGYHAPEYA----MTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQ--SLVTWA-- 290 (351)
Q Consensus 219 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~--~~~~~~-- 290 (351)
++......... ....||+.|+|||++ .+..++.++||||||+++|+|++|+.||......... ......
T Consensus 156 ~~~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 232 (290)
T 3fme_A 156 ISGYLVDDVAK---DIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSP 232 (290)
T ss_dssp -----------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCC
T ss_pred Ccccccccccc---cccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCC
Confidence 99776443221 334689999999996 5667899999999999999999999999753221110 011111
Q ss_pred ------ccCCCccchhhhcccccCCCCCHHHHHHHHHHHHHh
Q 018712 291 ------TPKLSEDKVKQCVDTKLGGEYPPKAIAKVRKKKFIT 326 (351)
Q Consensus 291 ------~~~~~~~~~~~~ld~~~~~~~~~~~~~~~~~~~~~~ 326 (351)
.+....+.+..|+..+|.+|++.+++. ++.++.
T Consensus 233 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l---~hp~f~ 271 (290)
T 3fme_A 233 QLPADKFSAEFVDFTSQCLKKNSKERPTYPELM---QHPFFT 271 (290)
T ss_dssp CCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHT---TSHHHH
T ss_pred CcccccCCHHHHHHHHHHhhcChhhCcCHHHHH---hCcccc
Confidence 111123578899999999999887764 444443
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-41 Score=300.47 Aligned_cols=247 Identities=27% Similarity=0.383 Sum_probs=189.9
Q ss_pred hcCCCCCceeccCCcEEEEEEEEC--CCC--EEEEEEcCCCC----CchHHHHHHHHHHHhccCCceeeeEEEEecCCce
Q 018712 65 TDNFGTNSLIGEGSYGRVYFGVLR--SGR--AAAIKKLDSSK----QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLR 136 (351)
Q Consensus 65 ~~~y~~~~~Lg~G~~g~Vy~~~~~--~~~--~vavK~~~~~~----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 136 (351)
.++|++.+.||+|+||.||+|.+. +++ .||+|++.... ...+.+.+|++++++++||||+++++++.+.. .
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 95 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M 95 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence 467999999999999999999853 333 68999987542 22467889999999999999999999988765 8
Q ss_pred EEEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEec
Q 018712 137 VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISD 216 (351)
Q Consensus 137 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~D 216 (351)
++||||+.+++|.+++..... .+++..+..++.|++.||.|||+++ ++||||||+||+++.++.+||+|
T Consensus 96 ~~v~e~~~~~~L~~~l~~~~~--------~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~D 164 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLRKHQG--------HFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGD 164 (291)
T ss_dssp EEEEECCTTCBHHHHHHHHGG--------GSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECC
T ss_pred eeeEecccCCCHHHHHHhccC--------CcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEcc
Confidence 899999999999999976432 2889999999999999999999999 99999999999999999999999
Q ss_pred ccccCCCcccccc-ccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCCccchhh-----
Q 018712 217 FDLSNQAPDAAAR-LHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTW----- 289 (351)
Q Consensus 217 fg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~Pf~~~~~~~~~~~~~~----- 289 (351)
||++......... .......+|+.|+|||++.+..++.++||||||+++|+|++ |+.||...........+..
T Consensus 165 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~ 244 (291)
T 1u46_A 165 FGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERL 244 (291)
T ss_dssp CTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCC
T ss_pred ccccccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCC
Confidence 9998776443221 11233457889999999998889999999999999999999 9999986543221111110
Q ss_pred ----cccCCCccchhhhcccccCCCCCHHHHHHHHHHH
Q 018712 290 ----ATPKLSEDKVKQCVDTKLGGEYPPKAIAKVRKKK 323 (351)
Q Consensus 290 ----~~~~~~~~~~~~~ld~~~~~~~~~~~~~~~~~~~ 323 (351)
..+....+.+..|+..+|.+|++.+++...++-.
T Consensus 245 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 282 (291)
T 1u46_A 245 PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 282 (291)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHh
Confidence 1111123688999999999999999988766544
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=296.07 Aligned_cols=241 Identities=24% Similarity=0.384 Sum_probs=190.7
Q ss_pred cCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCC-chHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEEEeC
Q 018712 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ-PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHA 143 (351)
Q Consensus 66 ~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 143 (351)
++|.....||+|+||.||+|.+. ++..||+|.+..... ..+.+.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus 22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 101 (295)
T 2clq_A 22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQV 101 (295)
T ss_dssp CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeC
Confidence 34555668999999999999974 688999999875433 3567889999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEcc-CCceEEecccccCC
Q 018712 144 SKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFD-DDIAKISDFDLSNQ 222 (351)
Q Consensus 144 ~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~-~~~vkl~Dfg~a~~ 222 (351)
++++|.+++...... ..+++..+..++.|++.||.|||+++ ++||||||+||+++. ++.+||+|||++..
T Consensus 102 ~~~~L~~~l~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~ 172 (295)
T 2clq_A 102 PGGSLSALLRSKWGP------LKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKR 172 (295)
T ss_dssp SEEEHHHHHHHTTCC------CTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEE
T ss_pred CCCCHHHHHHhhccC------CCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccc
Confidence 999999999865321 12678889999999999999999999 999999999999987 89999999999876
Q ss_pred CccccccccccccccccCccCcccccCCC--CCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccc---h-------hhc
Q 018712 223 APDAAARLHSTRVLGTFGYHAPEYAMTGQ--MSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSL---V-------TWA 290 (351)
Q Consensus 223 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~---~-------~~~ 290 (351)
....... .....||+.|+|||++.+.. ++.++||||||+++|+|++|+.||........... . ...
T Consensus 173 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (295)
T 2clq_A 173 LAGINPC--TETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPES 250 (295)
T ss_dssp SCC-------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCCCCCTT
T ss_pred cCCCCCc--ccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhcccccccccccc
Confidence 5432211 23456899999999987643 78999999999999999999999975432111000 0 001
Q ss_pred ccCCCccchhhhcccccCCCCCHHHHH
Q 018712 291 TPKLSEDKVKQCVDTKLGGEYPPKAIA 317 (351)
Q Consensus 291 ~~~~~~~~~~~~ld~~~~~~~~~~~~~ 317 (351)
.+....+.+..|+..+|.+|++.+++.
T Consensus 251 ~~~~~~~li~~~l~~dp~~Rps~~~ll 277 (295)
T 2clq_A 251 MSAEAKAFILKCFEPDPDKRACANDLL 277 (295)
T ss_dssp SCHHHHHHHHHTTCSSTTTSCCHHHHH
T ss_pred CCHHHHHHHHHHccCChhhCCCHHHHh
Confidence 111113678899999999999987763
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-41 Score=302.94 Aligned_cols=249 Identities=22% Similarity=0.281 Sum_probs=193.9
Q ss_pred hcCCCCCceeccCCcEEEEEEEE-CCCCEEEEEEcCCCC-CchHHHHHHHHHHHhccCCceeeeEEEEe----cCCceEE
Q 018712 65 TDNFGTNSLIGEGSYGRVYFGVL-RSGRAAAIKKLDSSK-QPDQEFLAQVSMVSRLKNENVVELVGYYV----DGPLRVL 138 (351)
Q Consensus 65 ~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~----~~~~~~l 138 (351)
.++|.+.+.||+|+||.||++.. .+++.||+|++.... ...+.+.+|+.+++.++||||+++++++. .....++
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 107 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL 107 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence 46799999999999999999997 578999999885433 23466889999999999999999999986 3457899
Q ss_pred EEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEeccc
Q 018712 139 AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFD 218 (351)
Q Consensus 139 v~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg 218 (351)
||||+.+++|.+++...... ...+++..++.++.||+.||.|||+++ ++||||||+|||++.++.+||+|||
T Consensus 108 v~e~~~~~~L~~~l~~~~~~-----~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg 179 (317)
T 2buj_A 108 LLPFFKRGTLWNEIERLKDK-----GNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLG 179 (317)
T ss_dssp EEECCTTCBHHHHHHHHHTT-----TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCS
T ss_pred EEEeCCCCcHHHHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecC
Confidence 99999999999999763211 123899999999999999999999999 9999999999999999999999999
Q ss_pred ccCCCccccccc-------cccccccccCccCcccccCCC---CCccchhHhHHHHHHHHHcCCCCCCCCCCCCCc--cc
Q 018712 219 LSNQAPDAAARL-------HSTRVLGTFGYHAPEYAMTGQ---MSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQ--SL 286 (351)
Q Consensus 219 ~a~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~---~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~--~~ 286 (351)
++.......... ......||+.|+|||++.+.. ++.++||||||+++|+|++|+.||......... ..
T Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~ 259 (317)
T 2buj_A 180 SMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALA 259 (317)
T ss_dssp SCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHH
T ss_pred cchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHH
Confidence 887653221110 012345799999999987654 688999999999999999999999642111110 00
Q ss_pred hhh--------cccCCCccchhhhcccccCCCCCHHHHHHHHH
Q 018712 287 VTW--------ATPKLSEDKVKQCVDTKLGGEYPPKAIAKVRK 321 (351)
Q Consensus 287 ~~~--------~~~~~~~~~~~~~ld~~~~~~~~~~~~~~~~~ 321 (351)
+.. ..+....+.+..|+..+|.+|++.+++...++
T Consensus 260 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~ 302 (317)
T 2buj_A 260 VQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLE 302 (317)
T ss_dssp HHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred hhccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhh
Confidence 000 01111236889999999999999988877654
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=305.00 Aligned_cols=202 Identities=27% Similarity=0.392 Sum_probs=171.0
Q ss_pred HhcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCCc--hHHHHHHHHHHHhccCCceeeeEEEEecC-----Cc
Q 018712 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDG-----PL 135 (351)
Q Consensus 64 ~~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~ 135 (351)
..++|.+.+.||+|+||.||+|.+. +++.||||++...... ...+.+|+.++++++||||+++++++... ..
T Consensus 9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 88 (353)
T 2b9h_A 9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE 88 (353)
T ss_dssp SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCC
T ss_pred cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccce
Confidence 3578999999999999999999976 7899999999754432 35678999999999999999999987654 67
Q ss_pred eEEEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEe
Q 018712 136 RVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKIS 215 (351)
Q Consensus 136 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~ 215 (351)
.++||||+. ++|.+++.... +++..+..++.|++.||.|||++| ++||||||+|||++.++.+||+
T Consensus 89 ~~lv~e~~~-~~L~~~~~~~~----------~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~ 154 (353)
T 2b9h_A 89 VYIIQELMQ-TDLHRVISTQM----------LSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVC 154 (353)
T ss_dssp EEEEECCCS-EEHHHHHHHCC----------CCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEEC
T ss_pred EEEEEeccC-ccHHHHHhhcC----------CCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEE
Confidence 899999997 59999997643 899999999999999999999999 9999999999999999999999
Q ss_pred cccccCCCccccccc--------cccccccccCccCcccccC-CCCCccchhHhHHHHHHHHHcCCCCCCCCC
Q 018712 216 DFDLSNQAPDAAARL--------HSTRVLGTFGYHAPEYAMT-GQMSSKSDVYSFGVVLLELLTGRKPVDHTL 279 (351)
Q Consensus 216 Dfg~a~~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~Pf~~~~ 279 (351)
|||++.......... ......||+.|+|||++.+ ..++.++||||||+++|+|++|+.||....
T Consensus 155 Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 227 (353)
T 2b9h_A 155 DFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRD 227 (353)
T ss_dssp CCTTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred ecccccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 999997654322111 1123568999999998764 678999999999999999999999998653
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=302.06 Aligned_cols=239 Identities=20% Similarity=0.286 Sum_probs=184.3
Q ss_pred hcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCC-chHHHHHHHHHHHhccCCceeeeEEEEe-----------
Q 018712 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ-PDQEFLAQVSMVSRLKNENVVELVGYYV----------- 131 (351)
Q Consensus 65 ~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~----------- 131 (351)
.++|.+.+.||+|+||.||+|.+. +++.||+|++..... ..+.+.+|++++++++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 468999999999999999999976 589999999865432 2466889999999999999999999873
Q ss_pred ---cCCceEEEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEc-
Q 018712 132 ---DGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLF- 207 (351)
Q Consensus 132 ---~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~- 207 (351)
+....++||||+. |+|.+++.... ++...++.++.|++.||.|||++| ++||||||+||+++
T Consensus 90 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~----------~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~ 155 (320)
T 2i6l_A 90 SLTELNSVYIVQEYME-TDLANVLEQGP----------LLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINT 155 (320)
T ss_dssp -CCSCSEEEEEEECCS-EEHHHHHTTCC----------CCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEET
T ss_pred cccccCceeEEeeccC-CCHHHHhhcCC----------ccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcC
Confidence 4467899999998 59999997543 889999999999999999999999 99999999999997
Q ss_pred cCCceEEecccccCCCccccc-cccccccccccCccCcccccC-CCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCcc
Q 018712 208 DDDIAKISDFDLSNQAPDAAA-RLHSTRVLGTFGYHAPEYAMT-GQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQS 285 (351)
Q Consensus 208 ~~~~vkl~Dfg~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~ 285 (351)
+++.+||+|||++........ ........+|..|+|||.+.+ ..++.++||||||+++|+|++|+.||..........
T Consensus 156 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~ 235 (320)
T 2i6l_A 156 EDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQ 235 (320)
T ss_dssp TTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred CCCeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 567999999999987643211 111234457999999998865 678999999999999999999999998654321111
Q ss_pred chhh-------------------------------------cccCCCccchhhhcccccCCCCCHHHHH
Q 018712 286 LVTW-------------------------------------ATPKLSEDKVKQCVDTKLGGEYPPKAIA 317 (351)
Q Consensus 286 ~~~~-------------------------------------~~~~~~~~~~~~~ld~~~~~~~~~~~~~ 317 (351)
.+.. ..+....+.+..|+..+|.+|++++++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell 304 (320)
T 2i6l_A 236 LILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEAL 304 (320)
T ss_dssp HHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHH
T ss_pred HHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHh
Confidence 0000 0111123678899999999999877663
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=296.39 Aligned_cols=242 Identities=23% Similarity=0.315 Sum_probs=197.4
Q ss_pred HHHHhcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCC---CCchHHHHHHHHHHHhccCCceeeeEEEEecCCce
Q 018712 61 LKEKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSS---KQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLR 136 (351)
Q Consensus 61 ~~~~~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 136 (351)
.....++|++.+.||+|+||.||+|.+. +++.||+|++... ......+.+|++++++++||||+++++++.+.+..
T Consensus 17 ~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 96 (287)
T 2wei_A 17 QGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSF 96 (287)
T ss_dssp THHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred HHHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeE
Confidence 3455678999999999999999999976 7899999998543 23456788999999999999999999999999999
Q ss_pred EEEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccC---CceE
Q 018712 137 VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDD---DIAK 213 (351)
Q Consensus 137 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~---~~vk 213 (351)
++||||+.+++|.+++..... +++..++.++.||+.||.|||++| ++||||||+||+++.+ +.+|
T Consensus 97 ~lv~e~~~~~~L~~~l~~~~~---------~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~k 164 (287)
T 2wei_A 97 YIVGELYTGGELFDEIIKRKR---------FSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIK 164 (287)
T ss_dssp EEEECCCCSCBHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEE
T ss_pred EEEEEccCCCCHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEE
Confidence 999999999999998876542 899999999999999999999999 9999999999999764 4799
Q ss_pred EecccccCCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccchhh----
Q 018712 214 ISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTW---- 289 (351)
Q Consensus 214 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~~~---- 289 (351)
|+|||++........ .....||+.|+|||.+.+ .++.++||||||+++|+|++|+.||...........+..
T Consensus 165 L~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 240 (287)
T 2wei_A 165 IIDFGLSTCFQQNTK---MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYA 240 (287)
T ss_dssp ECSTTGGGTBCCCSS---CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC
T ss_pred EeccCcceeecCCCc---cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC
Confidence 999999876543321 133458999999998875 489999999999999999999999986543221111110
Q ss_pred -------cccCCCccchhhhcccccCCCCCHHHHHH
Q 018712 290 -------ATPKLSEDKVKQCVDTKLGGEYPPKAIAK 318 (351)
Q Consensus 290 -------~~~~~~~~~~~~~ld~~~~~~~~~~~~~~ 318 (351)
..+....+.+..|+..+|.+|++.+++..
T Consensus 241 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 241 FDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp CCSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence 01111236889999999999999877654
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-40 Score=303.09 Aligned_cols=238 Identities=23% Similarity=0.356 Sum_probs=190.1
Q ss_pred hcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCCc---hHHHHHHHHHHHhccCCceeeeEEEEecCCc-----
Q 018712 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVDGPL----- 135 (351)
Q Consensus 65 ~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~----- 135 (351)
.++|.+.+.||+|+||.||+|.+. +|+.||||++...... ...+.+|+.+++.++||||+++++++...+.
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 468999999999999999999975 7899999999765433 3567899999999999999999999987654
Q ss_pred -eEEEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEE
Q 018712 136 -RVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKI 214 (351)
Q Consensus 136 -~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl 214 (351)
.++||||+. ++|.+++... +++..+..++.||+.||.|||++| ++||||||+||+++.++.+||
T Consensus 103 ~~~lv~e~~~-~~l~~~~~~~-----------~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl 167 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMGLK-----------FSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKI 167 (353)
T ss_dssp CCEEEEECCS-EEGGGTTTSC-----------CCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEE
T ss_pred eEEEEecccc-CCHHHHhcCC-----------CCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEE
Confidence 499999997 4898887532 889999999999999999999999 999999999999999999999
Q ss_pred ecccccCCCccccccccccccccccCccCcccccC-CCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccch------
Q 018712 215 SDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMT-GQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLV------ 287 (351)
Q Consensus 215 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~------ 287 (351)
+|||++...... .....||+.|+|||++.+ ..++.++||||||+++|+|++|+.||...........+
T Consensus 168 ~Dfg~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~ 242 (353)
T 3coi_A 168 LDFGLARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGV 242 (353)
T ss_dssp CSTTCTTC-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCB
T ss_pred eecccccCCCCC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence 999999765432 134578999999999887 67899999999999999999999999865421110000
Q ss_pred -----------------------------hh---cccCCCccchhhhcccccCCCCCHHHHHHHHHHHHH
Q 018712 288 -----------------------------TW---ATPKLSEDKVKQCVDTKLGGEYPPKAIAKVRKKKFI 325 (351)
Q Consensus 288 -----------------------------~~---~~~~~~~~~~~~~ld~~~~~~~~~~~~~~~~~~~~~ 325 (351)
.. ..+....+.+..|+..+|.+|++.+++ +++.++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~---l~hp~f 309 (353)
T 3coi_A 243 PGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQA---LTHPFF 309 (353)
T ss_dssp CCHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHH---HTSGGG
T ss_pred CCHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHH---hcCcch
Confidence 00 001111368899999999999988765 445554
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=303.44 Aligned_cols=248 Identities=25% Similarity=0.349 Sum_probs=198.0
Q ss_pred hcCCCCCceeccCCcEEEEEEEE-----CCCCEEEEEEcCCCCCc-hHHHHHHHHHHHhccCCceeeeEEEEecCC--ce
Q 018712 65 TDNFGTNSLIGEGSYGRVYFGVL-----RSGRAAAIKKLDSSKQP-DQEFLAQVSMVSRLKNENVVELVGYYVDGP--LR 136 (351)
Q Consensus 65 ~~~y~~~~~Lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~-~~~~~~e~~~l~~l~h~niv~~~~~~~~~~--~~ 136 (351)
.++|++.+.||+|+||.||++.+ .+++.||+|++...... .+.+.+|++++++++||||+++++++...+ ..
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 119 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 119 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence 46789999999999999999984 36889999999765433 457889999999999999999999887554 78
Q ss_pred EEEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEec
Q 018712 137 VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISD 216 (351)
Q Consensus 137 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~D 216 (351)
++||||+++++|.+++..... .+++..++.++.|++.||.|||+++ ++||||||+||+++.++.+||+|
T Consensus 120 ~lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~D 188 (326)
T 2w1i_A 120 KLIMEYLPYGSLRDYLQKHKE--------RIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGD 188 (326)
T ss_dssp EEEECCCTTCBHHHHHHHSTT--------SSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECC
T ss_pred EEEEECCCCCCHHHHHHhccc--------CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEec
Confidence 999999999999999987542 2889999999999999999999999 99999999999999999999999
Q ss_pred ccccCCCccccccc-cccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCC--------CCC-c--
Q 018712 217 FDLSNQAPDAAARL-HSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLP--------RGQ-Q-- 284 (351)
Q Consensus 217 fg~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~--------~~~-~-- 284 (351)
||++.......... ......++..|+|||.+.+..++.++||||||+++|+|++|..||..... ... .
T Consensus 189 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~ 268 (326)
T 2w1i_A 189 FGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMI 268 (326)
T ss_dssp CTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHH
T ss_pred CcchhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhh
Confidence 99997764432211 12234577889999999988899999999999999999999999864310 000 0
Q ss_pred -----cchh--------hcccCCCccchhhhcccccCCCCCHHHHHHHHHHH
Q 018712 285 -----SLVT--------WATPKLSEDKVKQCVDTKLGGEYPPKAIAKVRKKK 323 (351)
Q Consensus 285 -----~~~~--------~~~~~~~~~~~~~~ld~~~~~~~~~~~~~~~~~~~ 323 (351)
..+. ...+....+.+..|+..+|.+|++.+++...++..
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l 320 (326)
T 2w1i_A 269 VFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 320 (326)
T ss_dssp HHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 0000 00111123688999999999999999887766544
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=326.21 Aligned_cols=248 Identities=23% Similarity=0.328 Sum_probs=198.2
Q ss_pred HhcCCCCCceeccCCcEEEEEEEEC----CCCEEEEEEcCCCCCc--hHHHHHHHHHHHhccCCceeeeEEEEecCCceE
Q 018712 64 KTDNFGTNSLIGEGSYGRVYFGVLR----SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRV 137 (351)
Q Consensus 64 ~~~~y~~~~~Lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 137 (351)
..++|.+.+.||+|+||.||+|.+. .+..||+|.+...... .+.+.+|+.++++++||||+++++++. .+..+
T Consensus 388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~ 466 (656)
T 2j0j_A 388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW 466 (656)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCE
T ss_pred ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceE
Confidence 4567899999999999999999974 2457999998754332 366889999999999999999999985 45689
Q ss_pred EEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecc
Q 018712 138 LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDF 217 (351)
Q Consensus 138 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Df 217 (351)
+||||+.+|+|.+++..... .+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+||
T Consensus 467 lv~E~~~~g~L~~~l~~~~~--------~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DF 535 (656)
T 2j0j_A 467 IIMELCTLGELRSFLQVRKF--------SLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDF 535 (656)
T ss_dssp EEEECCTTCBHHHHHHHTTT--------TCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCC
T ss_pred EEEEcCCCCcHHHHHHhccC--------CCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEec
Confidence 99999999999999986532 2889999999999999999999999 999999999999999999999999
Q ss_pred cccCCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCCccchhh-------
Q 018712 218 DLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTW------- 289 (351)
Q Consensus 218 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~Pf~~~~~~~~~~~~~~------- 289 (351)
|+++........ ......+|+.|+|||++.+..++.++||||||+++|||++ |..||...........+..
T Consensus 536 G~a~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~~ 614 (656)
T 2j0j_A 536 GLSRYMEDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMP 614 (656)
T ss_dssp CCCCSCCC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCCCCC
T ss_pred CCCeecCCCcce-eccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCC
Confidence 999876543221 1233457889999999999999999999999999999997 9999986543222111111
Q ss_pred -cccCCCccchhhhcccccCCCCCHHHHHHHHHHHH
Q 018712 290 -ATPKLSEDKVKQCVDTKLGGEYPPKAIAKVRKKKF 324 (351)
Q Consensus 290 -~~~~~~~~~~~~~ld~~~~~~~~~~~~~~~~~~~~ 324 (351)
..+....+.+..|+..+|.+|++..++...+.-.+
T Consensus 615 ~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il 650 (656)
T 2j0j_A 615 PNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 650 (656)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 11112236889999999999999999887766544
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-41 Score=310.33 Aligned_cols=199 Identities=19% Similarity=0.272 Sum_probs=170.1
Q ss_pred hcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCCchHHHHHHHHHHHhcc-----------CCceeeeEEEEec
Q 018712 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLK-----------NENVVELVGYYVD 132 (351)
Q Consensus 65 ~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~-----------h~niv~~~~~~~~ 132 (351)
.++|.+.+.||+|+||.||+|.+. +++.||+|++.........+.+|+.++++++ |+||+++++++..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~ 97 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 97 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhc
Confidence 468999999999999999999974 7899999999866555677889999998886 7899999999875
Q ss_pred CC----ceEEEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhC-CCCCeeeccccCCcEEEc
Q 018712 133 GP----LRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEK-AEPRIIHRNIKSSNVLLF 207 (351)
Q Consensus 133 ~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~-~~~~ivH~Dlkp~Nill~ 207 (351)
.+ ..++|||++ +++|.+++...... .+++..+..++.||+.||.|||++ | |+||||||+|||++
T Consensus 98 ~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~-------~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~ 166 (373)
T 1q8y_A 98 KGPNGVHVVMVFEVL-GENLLALIKKYEHR-------GIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLME 166 (373)
T ss_dssp EETTEEEEEEEECCC-CEEHHHHHHHTTTS-------CCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEE
T ss_pred cCCCCceEEEEEecC-CCCHHHHHHHhhcc-------CCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEe
Confidence 44 789999999 88999999865432 288999999999999999999998 9 99999999999995
Q ss_pred c------CCceEEecccccCCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCC
Q 018712 208 D------DDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTL 279 (351)
Q Consensus 208 ~------~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~ 279 (351)
. .+.+||+|||++...... .....||+.|+|||++.+..++.++||||||+++|+|++|+.||....
T Consensus 167 ~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 239 (373)
T 1q8y_A 167 IVDSPENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDE 239 (373)
T ss_dssp EEETTTTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC----
T ss_pred ccCCCcCcceEEEcccccccccCCC-----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCc
Confidence 4 348999999998765432 234578999999999999999999999999999999999999998654
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-40 Score=299.95 Aligned_cols=252 Identities=19% Similarity=0.240 Sum_probs=180.9
Q ss_pred hcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCC-chHHHHHHHHHHHhcc-CCceeeeEEEEe--------cC
Q 018712 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ-PDQEFLAQVSMVSRLK-NENVVELVGYYV--------DG 133 (351)
Q Consensus 65 ~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~-h~niv~~~~~~~--------~~ 133 (351)
..+|++.+.||+|+||.||+|.+. +++.||+|++..... ....+.+|+.+++++. ||||+++++++. ..
T Consensus 27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~ 106 (337)
T 3ll6_A 27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQ 106 (337)
T ss_dssp TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSS
T ss_pred CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCC
Confidence 357999999999999999999975 789999998854432 2456889999999996 999999999984 34
Q ss_pred CceEEEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceE
Q 018712 134 PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAK 213 (351)
Q Consensus 134 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vk 213 (351)
...+++|||+. |+|.+++...... ..+++..++.++.||+.||.|||+++. +|+||||||+|||++.++.+|
T Consensus 107 ~~~~lv~e~~~-g~L~~~l~~~~~~------~~~~~~~~~~i~~qi~~~l~~LH~~~~-~ivH~Dikp~NIl~~~~~~~k 178 (337)
T 3ll6_A 107 AEFLLLTELCK-GQLVEFLKKMESR------GPLSCDTVLKIFYQTCRAVQHMHRQKP-PIIHRDLKVENLLLSNQGTIK 178 (337)
T ss_dssp EEEEEEEECCS-EEHHHHHHHHHTT------CSCCHHHHHHHHHHHHHHHHHHHTSSS-CCBCCCCCGGGCEECTTSCEE
T ss_pred ceEEEEEEecC-CCHHHHHHHhhcc------CCCCHHHHHHHHHHHHHHHHHHHhCCC-CEEEccCCcccEEECCCCCEE
Confidence 45799999996 6999988652211 128999999999999999999999852 399999999999999999999
Q ss_pred EecccccCCCccccccc----------cccccccccCccCcccc---cCCCCCccchhHhHHHHHHHHHcCCCCCCCCCC
Q 018712 214 ISDFDLSNQAPDAAARL----------HSTRVLGTFGYHAPEYA---MTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (351)
Q Consensus 214 l~Dfg~a~~~~~~~~~~----------~~~~~~gt~~y~aPE~~---~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~ 280 (351)
|+|||++.......... ......||+.|+|||++ .+..++.++||||||+++|+|++|+.||.....
T Consensus 179 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~ 258 (337)
T 3ll6_A 179 LCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAK 258 (337)
T ss_dssp BCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-----
T ss_pred EecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhH
Confidence 99999998765432211 11244689999999998 566789999999999999999999999986433
Q ss_pred CCCccc-----hhhcccCCCccchhhhcccccCCCCCHHHHHHHHHHHH
Q 018712 281 RGQQSL-----VTWATPKLSEDKVKQCVDTKLGGEYPPKAIAKVRKKKF 324 (351)
Q Consensus 281 ~~~~~~-----~~~~~~~~~~~~~~~~ld~~~~~~~~~~~~~~~~~~~~ 324 (351)
...... .....+....+.+..|+..+|.+|++.+++.+.++...
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~ 307 (337)
T 3ll6_A 259 LRIVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIA 307 (337)
T ss_dssp -------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHhhcCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 221110 01111122346889999999999999998887765544
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-40 Score=296.34 Aligned_cols=241 Identities=21% Similarity=0.344 Sum_probs=185.2
Q ss_pred HhcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCCchHHHHHHHHHHHhccCCceeeeEEEEec----------
Q 018712 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVD---------- 132 (351)
Q Consensus 64 ~~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~---------- 132 (351)
..++|++.+.||+|+||.||+|.+. +++.||+|++.......+.+.+|+.++++++||||+++++++.+
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (303)
T 1zy4_A 4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA 83 (303)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence 3567999999999999999999975 78999999986544445678899999999999999999998754
Q ss_pred ---CCceEEEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccC
Q 018712 133 ---GPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDD 209 (351)
Q Consensus 133 ---~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~ 209 (351)
.+..++||||+++++|.+++..... .++...++.++.|++.||.|||+++ ++||||||+|||++.+
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~ 152 (303)
T 1zy4_A 84 VKKKSTLFIQMEYCENGTLYDLIHSENL--------NQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDES 152 (303)
T ss_dssp --CEEEEEEEEECCCSCBHHHHHHHSCG--------GGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTT
T ss_pred cccCCceEEEEecCCCCCHHHhhhcccc--------ccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCC
Confidence 4568999999999999999986432 2788899999999999999999999 9999999999999999
Q ss_pred CceEEecccccCCCccccc------------cccccccccccCccCcccccCC-CCCccchhHhHHHHHHHHHcCCCCCC
Q 018712 210 DIAKISDFDLSNQAPDAAA------------RLHSTRVLGTFGYHAPEYAMTG-QMSSKSDVYSFGVVLLELLTGRKPVD 276 (351)
Q Consensus 210 ~~vkl~Dfg~a~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~Pf~ 276 (351)
+.+||+|||++........ ........||+.|+|||++.+. .++.++||||||+++|+|++ ||.
T Consensus 153 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~ 229 (303)
T 1zy4_A 153 RNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFS 229 (303)
T ss_dssp SCEEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCS
T ss_pred CCEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccC
Confidence 9999999999987643210 1112345689999999998865 68999999999999999998 554
Q ss_pred CCCCCC-Cccch--------hh---cccCCCccchhhhcccccCCCCCHHHHHH
Q 018712 277 HTLPRG-QQSLV--------TW---ATPKLSEDKVKQCVDTKLGGEYPPKAIAK 318 (351)
Q Consensus 277 ~~~~~~-~~~~~--------~~---~~~~~~~~~~~~~ld~~~~~~~~~~~~~~ 318 (351)
...... ....+ .. ..+....+.+..|+..+|.+|++.+++..
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 283 (303)
T 1zy4_A 230 TGMERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283 (303)
T ss_dssp SHHHHHHHHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CchhHHHHHHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence 211100 00000 00 00111246789999999999999877643
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-40 Score=297.30 Aligned_cols=244 Identities=27% Similarity=0.320 Sum_probs=172.6
Q ss_pred HhcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCCc--hHHHHHHHH-HHHhccCCceeeeEEEEecCCceEEE
Q 018712 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP--DQEFLAQVS-MVSRLKNENVVELVGYYVDGPLRVLA 139 (351)
Q Consensus 64 ~~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~e~~-~l~~l~h~niv~~~~~~~~~~~~~lv 139 (351)
..++|.+.+.||+|+||.||+|.+. +++.||+|++...... ...+..|+. +++.++||||+++++++.+.+..++|
T Consensus 20 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv 99 (327)
T 3aln_A 20 TAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWIC 99 (327)
T ss_dssp CSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEE
T ss_pred CHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEE
Confidence 3478999999999999999999975 7899999999765432 234555655 67778999999999999999999999
Q ss_pred EEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhC-CCCCeeeccccCCcEEEccCCceEEeccc
Q 018712 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEK-AEPRIIHRNIKSSNVLLFDDDIAKISDFD 218 (351)
Q Consensus 140 ~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~-~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg 218 (351)
|||+.+ +|.+++...... ....+++..+..++.|++.||.|||++ + ++||||||+|||++.++.+||+|||
T Consensus 100 ~e~~~~-~l~~~~~~~~~~----~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg 171 (327)
T 3aln_A 100 MELMST-SFDKFYKYVYSV----LDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFG 171 (327)
T ss_dssp ECCCSE-EHHHHHHHHHHT----TCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCS
T ss_pred EeecCC-ChHHHHHHHHhh----hcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCC
Confidence 999986 888887631100 001288999999999999999999998 9 9999999999999999999999999
Q ss_pred ccCCCccccccccccccccccCccCcccc----cCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCC--Cccchhhcc-
Q 018712 219 LSNQAPDAAARLHSTRVLGTFGYHAPEYA----MTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRG--QQSLVTWAT- 291 (351)
Q Consensus 219 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~--~~~~~~~~~- 291 (351)
++........ .....||+.|+|||++ .+..++.++||||||+++|+|++|+.||....... .........
T Consensus 172 ~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 248 (327)
T 3aln_A 172 ISGQLVDSIA---KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPP 248 (327)
T ss_dssp SSCC---------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCSCCC
T ss_pred Cceecccccc---cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCCCC
Confidence 9987654322 1334689999999998 46678999999999999999999999998643211 111111111
Q ss_pred ----------cCCCccchhhhcccccCCCCCHHHHHH
Q 018712 292 ----------PKLSEDKVKQCVDTKLGGEYPPKAIAK 318 (351)
Q Consensus 292 ----------~~~~~~~~~~~ld~~~~~~~~~~~~~~ 318 (351)
+....+.+..|+..+|.+|++.+++.+
T Consensus 249 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 249 QLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp CCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 111236889999999999999877644
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=306.83 Aligned_cols=241 Identities=19% Similarity=0.317 Sum_probs=194.1
Q ss_pred HHHHhcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCC-------chHHHHHHHHHHHhcc--CCceeeeEEEE
Q 018712 61 LKEKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ-------PDQEFLAQVSMVSRLK--NENVVELVGYY 130 (351)
Q Consensus 61 ~~~~~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------~~~~~~~e~~~l~~l~--h~niv~~~~~~ 130 (351)
.....++|++.+.||+|+||.||+|.+. +++.||+|++..... ....+.+|+.++++++ |+||+++++++
T Consensus 38 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~ 117 (320)
T 3a99_A 38 KEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWF 117 (320)
T ss_dssp --CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEE
T ss_pred cCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEE
Confidence 3445678999999999999999999964 788999999864321 1244678999999996 59999999999
Q ss_pred ecCCceEEEEEeCCC-CCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEc-c
Q 018712 131 VDGPLRVLAYEHASK-GSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLF-D 208 (351)
Q Consensus 131 ~~~~~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~-~ 208 (351)
.+.+..++|||++.+ ++|.+++..... +++..++.++.||+.||.|||+++ |+||||||+|||++ +
T Consensus 118 ~~~~~~~lv~e~~~~~~~L~~~l~~~~~---------l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~ 185 (320)
T 3a99_A 118 ERPDSFVLILERPEPVQDLFDFITERGA---------LQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLN 185 (320)
T ss_dssp ECSSEEEEEEECCSSEEEHHHHHHHHCS---------CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETT
T ss_pred ecCCcEEEEEEcCCCCccHHHHHhccCC---------CCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCC
Confidence 999999999999986 899999986542 899999999999999999999999 99999999999999 7
Q ss_pred CCceEEecccccCCCccccccccccccccccCccCcccccCCCC-CccchhHhHHHHHHHHHcCCCCCCCCCCCCC-ccc
Q 018712 209 DDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQM-SSKSDVYSFGVVLLELLTGRKPVDHTLPRGQ-QSL 286 (351)
Q Consensus 209 ~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~el~tg~~Pf~~~~~~~~-~~~ 286 (351)
++.+||+|||++....... .....||+.|+|||++.+..+ +.++||||||+++|+|++|+.||........ ...
T Consensus 186 ~~~~kL~Dfg~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~ 261 (320)
T 3a99_A 186 RGELKLIDFGSGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVF 261 (320)
T ss_dssp TTEEEECCCTTCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHHHHCCCC
T ss_pred CCCEEEeeCcccccccccc----ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhhhhccccc
Confidence 8899999999987664332 234568999999999987766 6889999999999999999999975321100 000
Q ss_pred hhhcccCCCccchhhhcccccCCCCCHHHHH
Q 018712 287 VTWATPKLSEDKVKQCVDTKLGGEYPPKAIA 317 (351)
Q Consensus 287 ~~~~~~~~~~~~~~~~ld~~~~~~~~~~~~~ 317 (351)
.....+....+.+..|+..+|.+|++.+++.
T Consensus 262 ~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll 292 (320)
T 3a99_A 262 FRQRVSSECQHLIRWCLALRPSDRPTFEEIQ 292 (320)
T ss_dssp CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred ccccCCHHHHHHHHHHccCChhhCcCHHHHh
Confidence 1111122224688999999999999887763
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-41 Score=302.92 Aligned_cols=240 Identities=19% Similarity=0.281 Sum_probs=185.7
Q ss_pred HHHhcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCCc-------hHHHHHHHHHHHhc----cCCceeeeEEE
Q 018712 62 KEKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP-------DQEFLAQVSMVSRL----KNENVVELVGY 129 (351)
Q Consensus 62 ~~~~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-------~~~~~~e~~~l~~l----~h~niv~~~~~ 129 (351)
....++|.+.+.||+|+||.||+|.+. +++.||+|++...... ...+.+|+.+++++ +|+||++++++
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~ 106 (312)
T 2iwi_A 27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW 106 (312)
T ss_dssp ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence 445678999999999999999999864 7889999999754321 23356788999888 89999999999
Q ss_pred EecCCceEEEEEe-CCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEc-
Q 018712 130 YVDGPLRVLAYEH-ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLF- 207 (351)
Q Consensus 130 ~~~~~~~~lv~e~-~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~- 207 (351)
+.+.+..++|||+ +.+++|.+++..... +++..++.++.||+.||.|||+++ ++||||||+||+++
T Consensus 107 ~~~~~~~~~v~e~~~~~~~L~~~l~~~~~---------~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~ 174 (312)
T 2iwi_A 107 FETQEGFMLVLERPLPAQDLFDYITEKGP---------LGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDL 174 (312)
T ss_dssp C-----CEEEEECCSSEEEHHHHHHHHCS---------CCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEET
T ss_pred EecCCeEEEEEEecCCCCCHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeC
Confidence 9999999999999 788999999986542 899999999999999999999999 99999999999999
Q ss_pred cCCceEEecccccCCCccccccccccccccccCccCcccccCCCCC-ccchhHhHHHHHHHHHcCCCCCCCCCCCCCc-c
Q 018712 208 DDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMS-SKSDVYSFGVVLLELLTGRKPVDHTLPRGQQ-S 285 (351)
Q Consensus 208 ~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslG~il~el~tg~~Pf~~~~~~~~~-~ 285 (351)
.++.+||+|||++....... .....||+.|+|||++.+..+. .++||||||+++|+|++|+.||......... .
T Consensus 175 ~~~~~kl~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~ 250 (312)
T 2iwi_A 175 RRGCAKLIDFGSGALLHDEP----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEILEAEL 250 (312)
T ss_dssp TTTEEEECCCSSCEECCSSC----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHHHHTCC
T ss_pred CCCeEEEEEcchhhhcccCc----ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHHHhhhcc
Confidence 78999999999987664432 2345689999999998877664 5899999999999999999999753210000 0
Q ss_pred chhhcccCCCccchhhhcccccCCCCCHHHHH
Q 018712 286 LVTWATPKLSEDKVKQCVDTKLGGEYPPKAIA 317 (351)
Q Consensus 286 ~~~~~~~~~~~~~~~~~ld~~~~~~~~~~~~~ 317 (351)
......+....+.+..|+..++.+|++.+++.
T Consensus 251 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l 282 (312)
T 2iwi_A 251 HFPAHVSPDCCALIRRCLAPKPSSRPSLEEIL 282 (312)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred CCcccCCHHHHHHHHHHccCChhhCcCHHHHh
Confidence 00011111223688999999999999887764
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-40 Score=301.24 Aligned_cols=242 Identities=19% Similarity=0.301 Sum_probs=169.9
Q ss_pred HhcCCCCCc-eeccCCcEEEEEEEEC-CCCEEEEEEcCCCCCchHHHHHHH-HHHHhccCCceeeeEEEEec----CCce
Q 018712 64 KTDNFGTNS-LIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQV-SMVSRLKNENVVELVGYYVD----GPLR 136 (351)
Q Consensus 64 ~~~~y~~~~-~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~e~-~~l~~l~h~niv~~~~~~~~----~~~~ 136 (351)
..++|.+.+ .||+|+||.||+|.+. +++.||+|++.... ...+|+ ..++.+.||||+++++++.. ....
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 101 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP----KARQEVDHHWQASGGPHIVCILDVYENMHHGKRCL 101 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH----HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH----HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceE
Confidence 457888855 6999999999999976 78999999986532 223333 34667799999999999875 4558
Q ss_pred EEEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEcc---CCceE
Q 018712 137 VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFD---DDIAK 213 (351)
Q Consensus 137 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~---~~~vk 213 (351)
++||||+.+|+|.+++...... .+++..++.++.||+.||.|||++| |+||||||+|||++. ++.+|
T Consensus 102 ~lv~e~~~gg~L~~~l~~~~~~-------~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~k 171 (336)
T 3fhr_A 102 LIIMECMEGGELFSRIQERGDQ-------AFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLK 171 (336)
T ss_dssp EEEEECCTTEEHHHHHHTC-CC-------CCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEE
T ss_pred EEEEeccCCCCHHHHHHhcCCC-------CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEE
Confidence 9999999999999999865422 3899999999999999999999999 999999999999976 45699
Q ss_pred EecccccCCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCc----cchh-
Q 018712 214 ISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQ----SLVT- 288 (351)
Q Consensus 214 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~----~~~~- 288 (351)
|+|||++....... .....||+.|+|||++.+..++.++||||||+++|+|++|+.||......... ..+.
T Consensus 172 l~Dfg~~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 247 (336)
T 3fhr_A 172 LTDFGFAKETTQNA----LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRL 247 (336)
T ss_dssp ECCCTTCEEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC------------------
T ss_pred Eeccccceeccccc----cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhc
Confidence 99999987654322 23456899999999998888999999999999999999999999765433211 0000
Q ss_pred --h--------cccCCCccchhhhcccccCCCCCHHHHHHHHHHHHHh
Q 018712 289 --W--------ATPKLSEDKVKQCVDTKLGGEYPPKAIAKVRKKKFIT 326 (351)
Q Consensus 289 --~--------~~~~~~~~~~~~~ld~~~~~~~~~~~~~~~~~~~~~~ 326 (351)
. ..+....+.+..|+..+|.+|++.+++. ++.++.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell---~hp~~~ 292 (336)
T 3fhr_A 248 GQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFM---NHPWIN 292 (336)
T ss_dssp ---CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHH---HSHHHH
T ss_pred cccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHh---cCcccc
Confidence 0 0111123688999999999999987764 455544
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=299.45 Aligned_cols=245 Identities=23% Similarity=0.297 Sum_probs=193.3
Q ss_pred HhcCCCCCceeccCCcEEEEEEEECCCCEEEEEEcCCCCC---chHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEE
Q 018712 64 KTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQ---PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAY 140 (351)
Q Consensus 64 ~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 140 (351)
..++|++.+.||+|+||.||+|.+.. .+|+|++..... ..+.+.+|+.++++++|+||+++++++.+.+..++||
T Consensus 31 ~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~ 108 (319)
T 2y4i_B 31 PFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIIT 108 (319)
T ss_dssp CCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEEC
T ss_pred CHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEe
Confidence 45789999999999999999999753 599999875432 2345778999999999999999999999999999999
Q ss_pred EeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEeccccc
Q 018712 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (351)
Q Consensus 141 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a 220 (351)
||+.+++|.+++..... .+++..++.++.||+.||.|||+++ ++||||||+||+++ ++.+||+|||++
T Consensus 109 e~~~~~~L~~~l~~~~~--------~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~~ 176 (319)
T 2y4i_B 109 SLCKGRTLYSVVRDAKI--------VLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGLF 176 (319)
T ss_dssp BCCCSEEHHHHTTSSCC--------CCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSCC
T ss_pred ecccCCcHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCCc
Confidence 99999999999976542 2888999999999999999999999 99999999999998 679999999998
Q ss_pred CCCccccc---cccccccccccCccCcccccC---------CCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccch-
Q 018712 221 NQAPDAAA---RLHSTRVLGTFGYHAPEYAMT---------GQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLV- 287 (351)
Q Consensus 221 ~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~---------~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~- 287 (351)
........ ........||+.|+|||++.+ ..++.++||||||+++|+|++|+.||...........+
T Consensus 177 ~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~ 256 (319)
T 2y4i_B 177 SISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMG 256 (319)
T ss_dssp C----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHH
T ss_pred cccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhc
Confidence 76532211 111233468999999998864 45788999999999999999999999865432111100
Q ss_pred --------hhcccCCCccchhhhcccccCCCCCHHHHHHHHHH
Q 018712 288 --------TWATPKLSEDKVKQCVDTKLGGEYPPKAIAKVRKK 322 (351)
Q Consensus 288 --------~~~~~~~~~~~~~~~ld~~~~~~~~~~~~~~~~~~ 322 (351)
....+....+.+..|++.++.+|++.+++...++.
T Consensus 257 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~ 299 (319)
T 2y4i_B 257 TGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEK 299 (319)
T ss_dssp TTCCCCCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTT
T ss_pred cCCCCCCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHH
Confidence 11122233478899999999999999988776553
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=307.67 Aligned_cols=238 Identities=20% Similarity=0.287 Sum_probs=181.4
Q ss_pred cCCCCCceeccCCcEEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHHhc-cCCceeeeEEEEecCCceEEEEEeCC
Q 018712 66 DNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRL-KNENVVELVGYYVDGPLRVLAYEHAS 144 (351)
Q Consensus 66 ~~y~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~ 144 (351)
.+|.+.+.||+|+||.|+.....+++.||||++..... ....+|+++++.+ +||||+++++++.+....|+||||+.
T Consensus 24 ~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~--~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~ 101 (432)
T 3p23_A 24 ISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF--SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA 101 (432)
T ss_dssp EEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE--EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred EEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH--HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCC
Confidence 46888899999999997766667899999999875433 2356899999999 79999999999999999999999997
Q ss_pred CCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEcc---C--CceEEecccc
Q 018712 145 KGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFD---D--DIAKISDFDL 219 (351)
Q Consensus 145 ~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~---~--~~vkl~Dfg~ 219 (351)
|+|.+++...... .....++.++.||+.||.|||+++ |+||||||+|||++. + ..+||+|||+
T Consensus 102 -g~L~~~l~~~~~~--------~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~ 169 (432)
T 3p23_A 102 -ATLQEYVEQKDFA--------HLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGL 169 (432)
T ss_dssp -EEHHHHHHSSSCC--------CCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTE
T ss_pred -CCHHHHHHhcCCC--------ccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEecccc
Confidence 5999999866431 333456789999999999999999 999999999999953 2 3578999999
Q ss_pred cCCCcccccc-ccccccccccCccCccccc---CCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCCccchhh-----
Q 018712 220 SNQAPDAAAR-LHSTRVLGTFGYHAPEYAM---TGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTW----- 289 (351)
Q Consensus 220 a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~el~t-g~~Pf~~~~~~~~~~~~~~----- 289 (351)
++........ .......||+.|+|||++. ...++.++|||||||++|||++ |..||..............
T Consensus 170 a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~ 249 (432)
T 3p23_A 170 CKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDC 249 (432)
T ss_dssp EECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHTTCCCCTT
T ss_pred eeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHhccCCccc
Confidence 9876543211 1224467999999999987 4567889999999999999999 9999975433211111100
Q ss_pred cc-----cCCCccchhhhcccccCCCCCHHHHH
Q 018712 290 AT-----PKLSEDKVKQCVDTKLGGEYPPKAIA 317 (351)
Q Consensus 290 ~~-----~~~~~~~~~~~ld~~~~~~~~~~~~~ 317 (351)
.. +....+.+..|+..+|.+|++.+++.
T Consensus 250 ~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl 282 (432)
T 3p23_A 250 LHPEKHEDVIARELIEKMIAMDPQKRPSAKHVL 282 (432)
T ss_dssp SCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred cCccccccHHHHHHHHHHHhCCHhhCCCHHHHH
Confidence 00 01123688999999999999988775
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=307.71 Aligned_cols=244 Identities=21% Similarity=0.292 Sum_probs=180.5
Q ss_pred cCCCCCceeccCCcEEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHHhc-cCCceeeeEEEEecCCceEEEEEeCC
Q 018712 66 DNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRL-KNENVVELVGYYVDGPLRVLAYEHAS 144 (351)
Q Consensus 66 ~~y~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~ 144 (351)
+.|.+.+.||+|+||+||.+...+|+.||||++... ..+.+.+|+.+++++ +||||+++++++.+.+..|+||||+.
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~--~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~ 92 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID--FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN 92 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG--GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS
T ss_pred heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH--HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC
Confidence 345567889999999998777778999999998643 235678899999886 89999999999999999999999996
Q ss_pred CCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccC-------------Cc
Q 018712 145 KGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDD-------------DI 211 (351)
Q Consensus 145 ~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~-------------~~ 211 (351)
|+|.+++......... .....+..++.++.||+.||.|||+++ |+||||||+|||++.+ +.
T Consensus 93 -gsL~~~l~~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~ 166 (434)
T 2rio_A 93 -LNLQDLVESKNVSDEN--LKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLR 166 (434)
T ss_dssp -EEHHHHHHTC--------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSCE
T ss_pred -CCHHHHHhccCCCchh--hhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCceE
Confidence 5999999865431100 001133345789999999999999999 9999999999999754 48
Q ss_pred eEEecccccCCCccccccc--cccccccccCccCcccccC-------CCCCccchhHhHHHHHHHHHc-CCCCCCCCCCC
Q 018712 212 AKISDFDLSNQAPDAAARL--HSTRVLGTFGYHAPEYAMT-------GQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPR 281 (351)
Q Consensus 212 vkl~Dfg~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwslG~il~el~t-g~~Pf~~~~~~ 281 (351)
+||+|||+++......... ......||+.|+|||++.+ ..++.++|||||||++|||++ |+.||......
T Consensus 167 ~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~ 246 (434)
T 2rio_A 167 ILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSR 246 (434)
T ss_dssp EEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTH
T ss_pred EEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhh
Confidence 9999999998765432211 1234579999999999875 678999999999999999999 99999765332
Q ss_pred CCccchhhc-------------ccCCCccchhhhcccccCCCCCHHHHHH
Q 018712 282 GQQSLVTWA-------------TPKLSEDKVKQCVDTKLGGEYPPKAIAK 318 (351)
Q Consensus 282 ~~~~~~~~~-------------~~~~~~~~~~~~ld~~~~~~~~~~~~~~ 318 (351)
.. ..+... .+....+.+..|+..+|.+|++++++.+
T Consensus 247 ~~-~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 247 ES-NIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp HH-HHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HH-HHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 11 111000 0011236889999999999999887653
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=282.31 Aligned_cols=215 Identities=14% Similarity=0.100 Sum_probs=178.3
Q ss_pred hcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCCch----HHHHHHHHHHHhccCCceeeeEEEEecCCceEEE
Q 018712 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPD----QEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLA 139 (351)
Q Consensus 65 ~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 139 (351)
.++|++.+.||+|+||.||+|.+. +++.||+|++....... +.+.+|+.++++++||||+++++++.+.+..|+|
T Consensus 30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 109 (286)
T 3uqc_A 30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV 109 (286)
T ss_dssp TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence 467999999999999999999976 58999999998665432 6788999999999999999999999999999999
Q ss_pred EEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccc
Q 018712 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDL 219 (351)
Q Consensus 140 ~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~ 219 (351)
|||+.+++|.+++... ....++..++.|++.||.|||++| |+||||||+|||++.++.+||++++
T Consensus 110 ~e~~~g~~L~~~l~~~-----------~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~- 174 (286)
T 3uqc_A 110 AEWIRGGSLQEVADTS-----------PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPA- 174 (286)
T ss_dssp EECCCEEEHHHHHTTC-----------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCC-
T ss_pred EEecCCCCHHHHHhcC-----------CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEecc-
Confidence 9999999999999642 345678889999999999999999 9999999999999999999998554
Q ss_pred cCCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCc----cch-------h
Q 018712 220 SNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQ----SLV-------T 288 (351)
Q Consensus 220 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~----~~~-------~ 288 (351)
|++ .++.++||||||+++|+|++|+.||......... ... .
T Consensus 175 ---------------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 226 (286)
T 3uqc_A 175 ---------------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPA 226 (286)
T ss_dssp ---------------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHH
T ss_pred ---------------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChh
Confidence 233 3688999999999999999999999976543211 000 0
Q ss_pred hcccCC---CccchhhhcccccCCCCCHHHHHHHHHHH
Q 018712 289 WATPKL---SEDKVKQCVDTKLGGEYPPKAIAKVRKKK 323 (351)
Q Consensus 289 ~~~~~~---~~~~~~~~ld~~~~~~~~~~~~~~~~~~~ 323 (351)
...+.. ..+.+..|+..++..| +.+++...++-.
T Consensus 227 ~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~ 263 (286)
T 3uqc_A 227 DIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQA 263 (286)
T ss_dssp HHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHH
T ss_pred hcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHH
Confidence 111122 2478899999999999 998888776654
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-39 Score=290.22 Aligned_cols=240 Identities=23% Similarity=0.332 Sum_probs=174.2
Q ss_pred HhcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCCch---HHHHHHHHHHHhccCCceeeeEEEEecCCceEEE
Q 018712 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPD---QEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLA 139 (351)
Q Consensus 64 ~~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~---~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 139 (351)
..++|.+.+.||+|+||.||+|.+. +++.||+|++....... +.+.++..+++.++||||+++++++.+.+..++|
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv 102 (318)
T 2dyl_A 23 EINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIA 102 (318)
T ss_dssp CGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEE
Confidence 3467899999999999999999975 78999999997654332 2233444568888999999999999999999999
Q ss_pred EEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhC-CCCCeeeccccCCcEEEccCCceEEeccc
Q 018712 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEK-AEPRIIHRNIKSSNVLLFDDDIAKISDFD 218 (351)
Q Consensus 140 ~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~-~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg 218 (351)
|||+ ++.+..+...... .+++..+..++.|++.||.|||++ | ++||||||+||+++.++.+||+|||
T Consensus 103 ~e~~-~~~~~~l~~~~~~--------~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg 170 (318)
T 2dyl_A 103 MELM-GTCAEKLKKRMQG--------PIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFG 170 (318)
T ss_dssp ECCC-SEEHHHHHHHHTS--------CCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCT
T ss_pred Eecc-CCcHHHHHHHhcc--------CCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECC
Confidence 9999 5566666553221 288999999999999999999995 8 9999999999999999999999999
Q ss_pred ccCCCccccccccccccccccCccCccccc-----CCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCc--cchhhc-
Q 018712 219 LSNQAPDAAARLHSTRVLGTFGYHAPEYAM-----TGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQ--SLVTWA- 290 (351)
Q Consensus 219 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~--~~~~~~- 290 (351)
++........ .....||+.|+|||++. +..++.++||||||+++|+|++|+.||......... ......
T Consensus 171 ~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 247 (318)
T 2dyl_A 171 ISGRLVDDKA---KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEP 247 (318)
T ss_dssp TC-----------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCC
T ss_pred CchhccCCcc---ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCC
Confidence 9876544322 13456899999999984 456889999999999999999999999864321110 011111
Q ss_pred --------ccCCCccchhhhcccccCCCCCHHHHHH
Q 018712 291 --------TPKLSEDKVKQCVDTKLGGEYPPKAIAK 318 (351)
Q Consensus 291 --------~~~~~~~~~~~~ld~~~~~~~~~~~~~~ 318 (351)
.+....+.+..|+..+|.+|++.+++..
T Consensus 248 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 248 PLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp CCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred CCCCccCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 1111236889999999999999887654
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-39 Score=318.67 Aligned_cols=232 Identities=19% Similarity=0.302 Sum_probs=186.2
Q ss_pred hcCCCCCceeccCCcEEEEEEEEC--CCCEEEEEEcCCCCCc--hHHHHHHHHHHHhccCCceeeeEEEEecCCc-----
Q 018712 65 TDNFGTNSLIGEGSYGRVYFGVLR--SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPL----- 135 (351)
Q Consensus 65 ~~~y~~~~~Lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~----- 135 (351)
.++|++.+.||+|+||.||+|.+. +++.||||++...... ...+.+|++++++++||||+++++++...+.
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 158 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV 158 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence 478999999999999999999975 6899999998654332 3467899999999999999999999987655
Q ss_pred eEEEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEe
Q 018712 136 RVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKIS 215 (351)
Q Consensus 136 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~ 215 (351)
.|+||||+++++|.+++... +++..++.++.||+.||.|||++| |+||||||+|||++.+ .+||+
T Consensus 159 ~~lv~E~~~g~~L~~~~~~~-----------l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~ 223 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSKGQK-----------LPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLI 223 (681)
T ss_dssp EEEEEECCCCEECC----CC-----------CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEEC
T ss_pred eEEEEEeCCCCcHHHHHhCC-----------CCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEE
Confidence 79999999999999887641 899999999999999999999999 9999999999999875 89999
Q ss_pred cccccCCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccc-hhhcccCC
Q 018712 216 DFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSL-VTWATPKL 294 (351)
Q Consensus 216 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~-~~~~~~~~ 294 (351)
|||+++..... ....||+.|+|||++.+. ++.++||||||+++|+|++|..||........... .....+..
T Consensus 224 DFG~a~~~~~~------~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~ 296 (681)
T 2pzi_A 224 DLGAVSRINSF------GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVDGLPEDDPVLKTYDS 296 (681)
T ss_dssp CCTTCEETTCC------SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECSSCCTTCHHHHHCHH
T ss_pred ecccchhcccC------CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCcccccccccccccccccCHH
Confidence 99998765432 345799999999988765 48999999999999999999999876432221111 00111122
Q ss_pred CccchhhhcccccCCCCC-HHHHHH
Q 018712 295 SEDKVKQCVDTKLGGEYP-PKAIAK 318 (351)
Q Consensus 295 ~~~~~~~~ld~~~~~~~~-~~~~~~ 318 (351)
..+.+..|+..+|.+|++ .+++..
T Consensus 297 l~~li~~~l~~dP~~R~~~~~~l~~ 321 (681)
T 2pzi_A 297 YGRLLRRAIDPDPRQRFTTAEEMSA 321 (681)
T ss_dssp HHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred HHHHHhhhccCChhhCCCHHHHHHH
Confidence 346889999999999995 444443
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-39 Score=313.39 Aligned_cols=203 Identities=25% Similarity=0.385 Sum_probs=171.7
Q ss_pred HHhcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCCc--hHHHHHHHHHHHhccCCceeeeEEEEec------C
Q 018712 63 EKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVD------G 133 (351)
Q Consensus 63 ~~~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~------~ 133 (351)
...++|.+.+.||+|+||.||+|.+. +++.||+|++...... ...+.+|+.++++++||||+++++++.. .
T Consensus 11 ~~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~ 90 (676)
T 3qa8_A 11 QTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPN 90 (676)
T ss_dssp ------CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTT
T ss_pred CCCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCC
Confidence 34578999999999999999999974 7899999998754332 4568899999999999999999998755 6
Q ss_pred CceEEEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCc--
Q 018712 134 PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDI-- 211 (351)
Q Consensus 134 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~-- 211 (351)
+..++||||+++|+|.+++...... ..+++..++.++.|++.||.|||+.| |+||||||+||+++.++.
T Consensus 91 ~~~~LVmEy~~ggsL~~~L~~~~~~------~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~ 161 (676)
T 3qa8_A 91 DLPLLAMEYCEGGDLRKYLNQFENC------CGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRL 161 (676)
T ss_dssp SSCCCEEECCSSCBHHHHHHSSSCT------TCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSC
T ss_pred CeEEEEEEeCCCCCHHHHHHhcccC------CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCce
Confidence 7789999999999999999875421 12778889999999999999999999 999999999999997764
Q ss_pred -eEEecccccCCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCC
Q 018712 212 -AKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDH 277 (351)
Q Consensus 212 -vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~ 277 (351)
+||+|||++........ .....||+.|+|||.+.+..++.++||||||+++|+|++|..||..
T Consensus 162 ~vKL~DFG~a~~~~~~~~---~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~ 225 (676)
T 3qa8_A 162 IHKIIDLGYAKELDQGEL---CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLP 225 (676)
T ss_dssp EEEECSCCCCCBTTSCCC---CCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCS
T ss_pred eEEEcccccccccccccc---cccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCc
Confidence 99999999987654332 2446799999999999999999999999999999999999999964
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-40 Score=300.72 Aligned_cols=190 Identities=19% Similarity=0.175 Sum_probs=160.2
Q ss_pred hcCCCCCceeccCCcEEEEEEEECCCCEEEEEEcCCCCC---------chHHHHHHHHHHHhcc---------CCceeee
Q 018712 65 TDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQ---------PDQEFLAQVSMVSRLK---------NENVVEL 126 (351)
Q Consensus 65 ~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~---------~~~~~~~e~~~l~~l~---------h~niv~~ 126 (351)
.++|++.+.||+|+||.||+|.+ +++.||||++..... ..+.+.+|+.+++.++ |+||+++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 46799999999999999999998 689999999875432 2367889999998886 7777777
Q ss_pred EEEEe------------------------------cCCceEEEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHH
Q 018712 127 VGYYV------------------------------DGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIA 176 (351)
Q Consensus 127 ~~~~~------------------------------~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~ 176 (351)
.+.+. +.+..|+||||+.+|++.+.+.... +++..++.++
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~~~----------~~~~~~~~i~ 167 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKL----------SSLATAKSIL 167 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTTTC----------CCHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHhcC----------CCHHHHHHHH
Confidence 66542 2678999999999997766664322 8999999999
Q ss_pred HHHHHHHHhhh-hCCCCCeeeccccCCcEEEccCC--------------------ceEEecccccCCCcccccccccccc
Q 018712 177 VGAARGLEYLH-EKAEPRIIHRNIKSSNVLLFDDD--------------------IAKISDFDLSNQAPDAAARLHSTRV 235 (351)
Q Consensus 177 ~qi~~~l~~lH-~~~~~~ivH~Dlkp~Nill~~~~--------------------~vkl~Dfg~a~~~~~~~~~~~~~~~ 235 (351)
.||+.||.||| +++ |+||||||+|||++.++ .+||+|||+|+.... ...
T Consensus 168 ~qi~~aL~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~-------~~~ 237 (336)
T 2vuw_A 168 HQLTASLAVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD-------GIV 237 (336)
T ss_dssp HHHHHHHHHHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET-------TEE
T ss_pred HHHHHHHHHHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC-------CcE
Confidence 99999999999 899 99999999999999887 899999999976542 234
Q ss_pred ccccCccCcccccCCCCCccchhHhHHHH-HHHHHcCCCCCC
Q 018712 236 LGTFGYHAPEYAMTGQMSSKSDVYSFGVV-LLELLTGRKPVD 276 (351)
Q Consensus 236 ~gt~~y~aPE~~~~~~~~~~~DvwslG~i-l~el~tg~~Pf~ 276 (351)
.||+.|+|||++.+.. +.++||||++++ .+++++|..||.
T Consensus 238 ~gt~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~ 278 (336)
T 2vuw_A 238 VFCDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYS 278 (336)
T ss_dssp ECCCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHH
T ss_pred EEeecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCc
Confidence 7999999999998766 899999998777 778899999985
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-38 Score=295.75 Aligned_cols=241 Identities=12% Similarity=0.160 Sum_probs=178.3
Q ss_pred cCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCC----chHHHHHHHHHHHhccC-Ccee---------e-----
Q 018712 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ----PDQEFLAQVSMVSRLKN-ENVV---------E----- 125 (351)
Q Consensus 66 ~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~h-~niv---------~----- 125 (351)
..|...+.||+|+||.||+|.+. +|+.||||++..... ..+.+.+|+.+++.+.| +|.. .
T Consensus 78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 157 (413)
T 3dzo_A 78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV 157 (413)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence 45777889999999999999965 799999999873322 24678899999999876 2211 1
Q ss_pred -------eEEEEec-----CCceEEEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCC
Q 018712 126 -------LVGYYVD-----GPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPR 193 (351)
Q Consensus 126 -------~~~~~~~-----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ 193 (351)
+..++.. ....+++|+++ +++|.++++...... .....+++..++.++.||+.||.|||+++
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~--~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--- 231 (413)
T 3dzo_A 158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHS--STHKSLVHHARLQLTLQVIRLLASLHHYG--- 231 (413)
T ss_dssp ECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHT--TTSHHHHHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred ccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhccc--ccCCCCCHHHHHHHHHHHHHHHHHHHhCC---
Confidence 1111111 12356777766 569999985211000 00112778889999999999999999999
Q ss_pred eeeccccCCcEEEccCCceEEecccccCCCccccccccccccccccCccCcccc----------cCCCCCccchhHhHHH
Q 018712 194 IIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYA----------MTGQMSSKSDVYSFGV 263 (351)
Q Consensus 194 ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~~DvwslG~ 263 (351)
|+||||||+|||++.++.+||+|||+++..... .....| +.|+|||++ .+..++.++|||||||
T Consensus 232 iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGv 305 (413)
T 3dzo_A 232 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGL 305 (413)
T ss_dssp EECSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHH
T ss_pred cccCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHH
Confidence 999999999999999999999999998765443 244567 999999999 5556888999999999
Q ss_pred HHHHHHcCCCCCCCCCCCCCccchhhcccCCC---ccchhhhcccccCCCCCHHHHHH
Q 018712 264 VLLELLTGRKPVDHTLPRGQQSLVTWATPKLS---EDKVKQCVDTKLGGEYPPKAIAK 318 (351)
Q Consensus 264 il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~---~~~~~~~ld~~~~~~~~~~~~~~ 318 (351)
++|||++|+.||...........+....+.++ .+.+..|+..+|.+|++..++.+
T Consensus 306 il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~ 363 (413)
T 3dzo_A 306 AIYWIWCADLPNTDDAALGGSEWIFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAME 363 (413)
T ss_dssp HHHHHHHSSCCCCTTGGGSCSGGGGSSCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHHHHCCCCCCCcchhhhHHHHHhhcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 99999999999987655443333322222232 36889999999999999877644
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-37 Score=275.91 Aligned_cols=223 Identities=17% Similarity=0.293 Sum_probs=176.0
Q ss_pred HhcCCCCC-ceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCCchHHHHHHHHHH-HhccCCceeeeEEEEec----CCce
Q 018712 64 KTDNFGTN-SLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMV-SRLKNENVVELVGYYVD----GPLR 136 (351)
Q Consensus 64 ~~~~y~~~-~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l-~~l~h~niv~~~~~~~~----~~~~ 136 (351)
..++|.+. +.||+|+||.||++.+. +++.||+|++.. .....+|+.++ +.++||||+++++++.. ....
T Consensus 15 ~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 90 (299)
T 3m2w_A 15 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 90 (299)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred cccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceE
Confidence 45678877 78999999999999974 789999999864 24577888887 55699999999999876 6778
Q ss_pred EEEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEcc---CCceE
Q 018712 137 VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFD---DDIAK 213 (351)
Q Consensus 137 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~---~~~vk 213 (351)
++||||+++++|.+++...... .+++..++.++.|++.||.|||+++ ++||||||+|||++. ++.+|
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~~~-------~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~k 160 (299)
T 3m2w_A 91 LIVMECLDGGELFSRIQDRGDQ-------AFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILK 160 (299)
T ss_dssp EEEECCCCSCBHHHHHHHCTTC-------CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEE
T ss_pred EEEEeecCCCcHHHHHHhccCC-------CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEE
Confidence 9999999999999999875421 2899999999999999999999999 999999999999998 78999
Q ss_pred EecccccCCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCc----cchhh
Q 018712 214 ISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQ----SLVTW 289 (351)
Q Consensus 214 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~----~~~~~ 289 (351)
|+|||++.... +..++.++||||||+++|+|++|+.||......... ..+..
T Consensus 161 l~Dfg~a~~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~ 216 (299)
T 3m2w_A 161 LTDFGFAKETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRM 216 (299)
T ss_dssp ECCCTTCEECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCT
T ss_pred Eeccccccccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhh
Confidence 99999874322 244678999999999999999999999765332110 00000
Q ss_pred -----------cccCCCccchhhhcccccCCCCCHHHHHHHHHHHHHhh
Q 018712 290 -----------ATPKLSEDKVKQCVDTKLGGEYPPKAIAKVRKKKFITS 327 (351)
Q Consensus 290 -----------~~~~~~~~~~~~~ld~~~~~~~~~~~~~~~~~~~~~~~ 327 (351)
..+....+.+..|+..+|.+|++.+++ +++.++..
T Consensus 217 ~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~---l~hp~~~~ 262 (299)
T 3m2w_A 217 GQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEF---MNHPWIMQ 262 (299)
T ss_dssp TCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHH---HTSHHHHT
T ss_pred ccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHH---hcChhhcc
Confidence 111122368899999999999987765 45665543
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-34 Score=280.81 Aligned_cols=183 Identities=15% Similarity=0.080 Sum_probs=129.8
Q ss_pred eccCCcEEEEEEE-ECCCCEEEEEEcCCCCC-----------chHHHHHHHHHHHhc-cCCceeeeEEEEecCCceEEEE
Q 018712 74 IGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQ-----------PDQEFLAQVSMVSRL-KNENVVELVGYYVDGPLRVLAY 140 (351)
Q Consensus 74 Lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~-----------~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~ 140 (351)
++.|++|.+..++ .-.|+.|++|++.+... ..+++.+|+++|+++ .|+||+++++++.+++..||||
T Consensus 242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM 321 (569)
T 4azs_A 242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM 321 (569)
T ss_dssp -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence 5667777666555 33688999999865421 125689999999999 7999999999999999999999
Q ss_pred EeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEeccccc
Q 018712 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (351)
Q Consensus 141 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a 220 (351)
||++|++|.++|..... ++.. .|+.||+.||.|+|++| ||||||||+|||++++|.+||+|||+|
T Consensus 322 Eyv~G~~L~d~i~~~~~---------l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlA 386 (569)
T 4azs_A 322 EKLPGRLLSDMLAAGEE---------IDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSI 386 (569)
T ss_dssp ECCCSEEHHHHHHTTCC---------CCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTE
T ss_pred ecCCCCcHHHHHHhCCC---------CCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccC
Confidence 99999999999987643 5543 58899999999999999 999999999999999999999999999
Q ss_pred CCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCC
Q 018712 221 NQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274 (351)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P 274 (351)
+........ ....+||+.|+|||++.+ .+..++|+||+|+++++|.++..+
T Consensus 387 r~~~~~~~~--~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 387 VTTPQDCSW--PTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp ESCC---CC--SHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred eeCCCCCcc--ccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence 876543322 245689999999998875 466789999999998887665544
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=7.3e-30 Score=246.52 Aligned_cols=185 Identities=16% Similarity=0.119 Sum_probs=145.7
Q ss_pred CCCceeccCCcEEEEEEEECCCCEEEEEEcCCCCCc---------hHHHHHHHHHHHhccCCceeeeEEEEecCCceEEE
Q 018712 69 GTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQP---------DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLA 139 (351)
Q Consensus 69 ~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 139 (351)
...+.||+|+||.||++.. .+..+++|+....... .+.+.+|++++++++||||+++..++...+..|+|
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 4466899999999999944 5788999986543221 23478999999999999999666666677788999
Q ss_pred EEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccc
Q 018712 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDL 219 (351)
Q Consensus 140 ~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~ 219 (351)
|||+++++|.+++.. +..++.|++.||.|||+++ |+||||||+|||++. .+||+|||+
T Consensus 418 mE~~~ggsL~~~l~~-----------------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGl 475 (540)
T 3en9_A 418 MSYINGKLAKDVIED-----------------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGL 475 (540)
T ss_dssp EECCCSEEHHHHSTT-----------------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTT
T ss_pred EECCCCCCHHHHHHH-----------------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECcc
Confidence 999999999999975 3478999999999999999 999999999999998 999999999
Q ss_pred cCCCccccccc-----cccccccccCccCcccccC--CCCCccchhHhHHHHHHHHHcCCCCCC
Q 018712 220 SNQAPDAAARL-----HSTRVLGTFGYHAPEYAMT--GQMSSKSDVYSFGVVLLELLTGRKPVD 276 (351)
Q Consensus 220 a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~el~tg~~Pf~ 276 (351)
++......... ......||+.|+|||++.. ..|+..+|+||..+-..+.+.++.+|.
T Consensus 476 a~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 476 GKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp CEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred CEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 98875532211 1235679999999999987 678888999999999988888777764
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=3.6e-26 Score=203.18 Aligned_cols=161 Identities=14% Similarity=0.088 Sum_probs=124.6
Q ss_pred HHHHhcCCCCCceeccCCcEEEEEEEECCCCEEEEEEcCCCCC-------------------chHHHHHHHHHHHhccCC
Q 018712 61 LKEKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQ-------------------PDQEFLAQVSMVSRLKNE 121 (351)
Q Consensus 61 ~~~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-------------------~~~~~~~e~~~l~~l~h~ 121 (351)
+......|.+.+.||+|+||.||+|.+.+|+.||+|++..... ....+.+|+.++++++|
T Consensus 85 ~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~~- 163 (282)
T 1zar_A 85 LVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQG- 163 (282)
T ss_dssp HHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTT-
T ss_pred HHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhccC-
Confidence 3344455667799999999999999997799999999864321 23457899999999984
Q ss_pred ceeeeEEEEecCCceEEEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccC
Q 018712 122 NVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKS 201 (351)
Q Consensus 122 niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp 201 (351)
+++.+.+. .+..++||||++|++|.+ +... ....++.|++.||.|||++| |+||||||
T Consensus 164 --~~v~~~~~-~~~~~lvmE~~~g~~L~~-l~~~---------------~~~~i~~qi~~~l~~lH~~g---iiHrDlkp 221 (282)
T 1zar_A 164 --LAVPKVYA-WEGNAVLMELIDAKELYR-VRVE---------------NPDEVLDMILEEVAKFYHRG---IVHGDLSQ 221 (282)
T ss_dssp --SSSCCEEE-EETTEEEEECCCCEEGGG-CCCS---------------CHHHHHHHHHHHHHHHHHTT---EECSCCST
T ss_pred --CCcCeEEe-ccceEEEEEecCCCcHHH-cchh---------------hHHHHHHHHHHHHHHHHHCC---CEeCCCCH
Confidence 55555443 356799999999999998 4311 23469999999999999999 99999999
Q ss_pred CcEEEccCCceEEecccccCCCccccccccccccccccCccCcccccC----------CCCCccchhHh
Q 018712 202 SNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMT----------GQMSSKSDVYS 260 (351)
Q Consensus 202 ~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----------~~~~~~~Dvws 260 (351)
+|||++ ++.+||+|||+|+ .+..++|||++.+ ..++..+|+|.
T Consensus 222 ~NILl~-~~~vkl~DFG~a~---------------~~~~~~a~e~l~rdv~~i~~~f~~~~~~~~~~~~ 274 (282)
T 1zar_A 222 YNVLVS-EEGIWIIDFPQSV---------------EVGEEGWREILERDVRNIITYFSRTYRTEKDINS 274 (282)
T ss_dssp TSEEEE-TTEEEECCCTTCE---------------ETTSTTHHHHHHHHHHHHHHHHHHHHCCCCCHHH
T ss_pred HHEEEE-CCcEEEEECCCCe---------------ECCCCCHHHHHHHHHHHHHHHHHHhcCCCCChHH
Confidence 999999 9999999999874 2345788887753 34455566665
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=3.7e-22 Score=175.09 Aligned_cols=135 Identities=16% Similarity=0.164 Sum_probs=106.3
Q ss_pred CCCCceeccCCcEEEEEEEE-CCCCE--EEEEEcCCCCCc-------------------------hHHHHHHHHHHHhcc
Q 018712 68 FGTNSLIGEGSYGRVYFGVL-RSGRA--AAIKKLDSSKQP-------------------------DQEFLAQVSMVSRLK 119 (351)
Q Consensus 68 y~~~~~Lg~G~~g~Vy~~~~-~~~~~--vavK~~~~~~~~-------------------------~~~~~~e~~~l~~l~ 119 (351)
|.+.+.||+|+||.||+|.+ .+|+. ||||++...... ...+.+|+.+++++.
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 66788999999999999997 68888 999987543211 125788999999998
Q ss_pred CCce--eeeEEEEecCCceEEEEEeCCC-C----CHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhh-hCCC
Q 018712 120 NENV--VELVGYYVDGPLRVLAYEHASK-G----SLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLH-EKAE 191 (351)
Q Consensus 120 h~ni--v~~~~~~~~~~~~~lv~e~~~~-g----sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH-~~~~ 191 (351)
|+++ +.++.. +..++||||+.+ | +|.++... .+...+..++.|++.||.||| +.|
T Consensus 129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~------------~~~~~~~~i~~qi~~~l~~lH~~~g- 191 (258)
T 1zth_A 129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE------------LKELDVEGIFNDVVENVKRLYQEAE- 191 (258)
T ss_dssp HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG------------GGGSCHHHHHHHHHHHHHHHHHTSC-
T ss_pred hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc------------cChHHHHHHHHHHHHHHHHHHHHCC-
Confidence 8754 444432 357899999942 3 77776542 223456789999999999999 998
Q ss_pred CCeeeccccCCcEEEccCCceEEecccccCCC
Q 018712 192 PRIIHRNIKSSNVLLFDDDIAKISDFDLSNQA 223 (351)
Q Consensus 192 ~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~ 223 (351)
|+||||||+|||++. .++|+|||+|...
T Consensus 192 --ivHrDlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 192 --LVHADLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp --EECSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred --EEeCCCCHHHEEEcC--cEEEEECcccccC
Confidence 999999999999988 8999999998654
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.77 E-value=2.8e-19 Score=163.37 Aligned_cols=137 Identities=12% Similarity=0.132 Sum_probs=101.2
Q ss_pred cCCCCCceeccCCcEEEEEEEECCCCEEEEEEcCCCCC---------------chHH--------HHHHHHHHHhccCCc
Q 018712 66 DNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQ---------------PDQE--------FLAQVSMVSRLKNEN 122 (351)
Q Consensus 66 ~~y~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~---------------~~~~--------~~~e~~~l~~l~h~n 122 (351)
.-|.+.+.||.|++|.||+|...+|+.||||+++.... .... ..+|+..|.++.+.+
T Consensus 95 ~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~g 174 (397)
T 4gyi_A 95 DVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEG 174 (397)
T ss_dssp SCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred CEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcC
Confidence 34899999999999999999998999999998753210 0011 234667777775544
Q ss_pred eeeeEEEEecCCceEEEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCC
Q 018712 123 VVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSS 202 (351)
Q Consensus 123 iv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~ 202 (351)
+....-+.. ...+|||||+.|++|.++... .....++.||+.+|.+||+.| ||||||||.
T Consensus 175 v~vp~p~~~--~~~~LVME~i~G~~L~~l~~~---------------~~~~~l~~qll~~l~~lH~~g---IVHrDLKp~ 234 (397)
T 4gyi_A 175 FPVPEPIAQ--SRHTIVMSLVDALPMRQVSSV---------------PDPASLYADLIALILRLAKHG---LIHGDFNEF 234 (397)
T ss_dssp CSCCCEEEE--ETTEEEEECCSCEEGGGCCCC---------------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTT
T ss_pred CCCCeeeec--cCceEEEEecCCccHhhhccc---------------HHHHHHHHHHHHHHHHHHHCC---CcCCCCCHH
Confidence 332221111 234799999999888765431 123567899999999999999 999999999
Q ss_pred cEEEccCC----------ceEEecccccCC
Q 018712 203 NVLLFDDD----------IAKISDFDLSNQ 222 (351)
Q Consensus 203 Nill~~~~----------~vkl~Dfg~a~~ 222 (351)
|||+++++ .+.|+||+-+..
T Consensus 235 NILl~~dgd~~d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 235 NILIREEKDAEDPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp SEEEEEEECSSCTTSEEEEEEECCCTTCEE
T ss_pred HEEEeCCCCcccccccccceEEEEeCCccc
Confidence 99998876 388999996644
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.54 E-value=2.2e-14 Score=125.55 Aligned_cols=145 Identities=17% Similarity=0.118 Sum_probs=113.7
Q ss_pred HHHHhcCCCCCceeccCCcEEEEEEEECCCCEEEEEEcCCCC-CchHHHHHHHHHHHhcc-CCceeeeEEEEecCCceEE
Q 018712 61 LKEKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSK-QPDQEFLAQVSMVSRLK-NENVVELVGYYVDGPLRVL 138 (351)
Q Consensus 61 ~~~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~l 138 (351)
+.....+|.+...++.|+.+.||++... +..+++|+..... .....+.+|+.+++.+. +..+.++++++.+.+..|+
T Consensus 9 l~~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~l 87 (263)
T 3tm0_A 9 LKKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNL 87 (263)
T ss_dssp HHHHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEE
T ss_pred HHHHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEE
Confidence 4456678988888999999999998754 6899999986421 22345889999999884 6778899999888889999
Q ss_pred EEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCC----------------------------
Q 018712 139 AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKA---------------------------- 190 (351)
Q Consensus 139 v~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~---------------------------- 190 (351)
|||+++|.+|.+.+... .....++.+++.+|..||+..
T Consensus 88 v~e~i~G~~l~~~~~~~--------------~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (263)
T 3tm0_A 88 LMSEADGVLCSEEYEDE--------------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADV 153 (263)
T ss_dssp EEECCSSEEHHHHCCTT--------------TCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCC
T ss_pred EEEecCCeehhhccCCc--------------ccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccc
Confidence 99999999998864211 123467889999999999810
Q ss_pred ----------------------------CCCeeeccccCCcEEEccCCceEEeccccc
Q 018712 191 ----------------------------EPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (351)
Q Consensus 191 ----------------------------~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a 220 (351)
...++|+|++|+|||+++++.+.|+||+.+
T Consensus 154 ~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a 211 (263)
T 3tm0_A 154 DCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRS 211 (263)
T ss_dssp SGGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTC
T ss_pred ccccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhc
Confidence 123899999999999987666779999975
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.39 E-value=9.1e-13 Score=114.84 Aligned_cols=137 Identities=12% Similarity=0.031 Sum_probs=99.3
Q ss_pred cCCCCCceeccCCcEEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHHhccCCc--eeeeEEEEecCCceEEEEEeC
Q 018712 66 DNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNEN--VVELVGYYVDGPLRVLAYEHA 143 (351)
Q Consensus 66 ~~y~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~~~~~~~~~~~~~lv~e~~ 143 (351)
.+|.+....+.|..+.||++...+|..+++|..... ....+.+|+.+++.+.+.+ +.+++.+....+..++||||+
T Consensus 20 ~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~--~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i 97 (264)
T 1nd4_A 20 FGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG--ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEV 97 (264)
T ss_dssp TTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC--TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECC
T ss_pred CCCceEecccCCCCceEEEEecCCCCeEEEEeCCcc--cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEec
Confidence 345443333456669999998777888999997654 2245788999999886544 567888888888899999999
Q ss_pred CCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCC---------------------------------
Q 018712 144 SKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKA--------------------------------- 190 (351)
Q Consensus 144 ~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~--------------------------------- 190 (351)
+|.+|. ... .. ...++.+++..|..||+..
T Consensus 98 ~G~~l~--~~~------------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (264)
T 1nd4_A 98 PGQDLL--SSH------------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDE 160 (264)
T ss_dssp SSEETT--TSC------------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCG
T ss_pred CCcccC--cCc------------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhh
Confidence 998884 211 11 1245667777777777642
Q ss_pred ----------------------CCCeeeccccCCcEEEccCCceEEecccccC
Q 018712 191 ----------------------EPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (351)
Q Consensus 191 ----------------------~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~ 221 (351)
...++|+|++|+|||+++++.+.|+||+.+.
T Consensus 161 ~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 161 EHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp GGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred hccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 1129999999999999877667799999763
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.30 E-value=8.8e-12 Score=114.14 Aligned_cols=142 Identities=18% Similarity=0.185 Sum_probs=105.6
Q ss_pred CCCceeccCCcEEEEEEEECCCCEEEEEEcC--CCC--CchHHHHHHHHHHHhcc--CCceeeeEEEEecC---CceEEE
Q 018712 69 GTNSLIGEGSYGRVYFGVLRSGRAAAIKKLD--SSK--QPDQEFLAQVSMVSRLK--NENVVELVGYYVDG---PLRVLA 139 (351)
Q Consensus 69 ~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~--~~~--~~~~~~~~e~~~l~~l~--h~niv~~~~~~~~~---~~~~lv 139 (351)
...+.|+.|.++.||+.... +..+++|+.. ... .....+.+|+.+++.+. +..+++++.++.+. +..|+|
T Consensus 41 ~~~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~v 119 (359)
T 3dxp_A 41 LSVEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYI 119 (359)
T ss_dssp CEEEECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEE
T ss_pred ceEEEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEE
Confidence 34567899999999998865 4688899876 332 22346788999999996 45678888888766 448999
Q ss_pred EEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCC-----------------------------
Q 018712 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKA----------------------------- 190 (351)
Q Consensus 140 ~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~----------------------------- 190 (351)
|||++|.++.+... ..++......++.+++..|..||+..
T Consensus 120 me~v~G~~l~~~~~-----------~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 188 (359)
T 3dxp_A 120 MEFVSGRVLWDQSL-----------PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKL 188 (359)
T ss_dssp EECCCCBCCCCTTC-----------TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHH
T ss_pred EEecCCeecCCCcc-----------ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHh
Confidence 99999977744211 11677888889999999999999831
Q ss_pred --------------------------CCCeeeccccCCcEEEccCCc--eEEecccccCC
Q 018712 191 --------------------------EPRIIHRNIKSSNVLLFDDDI--AKISDFDLSNQ 222 (351)
Q Consensus 191 --------------------------~~~ivH~Dlkp~Nill~~~~~--vkl~Dfg~a~~ 222 (351)
...++|+|++++|||++.++. +.|+||+.+..
T Consensus 189 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 189 SETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HCCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred cCCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 234999999999999987753 68999998754
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.21 E-value=7.2e-12 Score=112.04 Aligned_cols=184 Identities=18% Similarity=0.183 Sum_probs=120.2
Q ss_pred CceeccCCcEEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHHhcc-CCc--eeeeEEEEecCC---ceEEEEEeCC
Q 018712 71 NSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLK-NEN--VVELVGYYVDGP---LRVLAYEHAS 144 (351)
Q Consensus 71 ~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~-h~n--iv~~~~~~~~~~---~~~lv~e~~~ 144 (351)
.+.++.|..+.||+.. ..+++|+.... .....+.+|..+++.+. +.. +.+++......+ ..|+||++++
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~-~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~ 99 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKHS-RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIK 99 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESSH-HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCC
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCCc-chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccC
Confidence 4568999999999863 56899986533 23466889999998883 322 445554433333 3489999999
Q ss_pred CCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCC----------------------------------
Q 018712 145 KGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKA---------------------------------- 190 (351)
Q Consensus 145 ~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~---------------------------------- 190 (351)
|.+|.+..... ++..+...++.+++..+..||+..
T Consensus 100 G~~l~~~~~~~-----------l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (304)
T 3sg8_A 100 GVPLTPLLLNN-----------LPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGP 168 (304)
T ss_dssp CEECCHHHHHT-----------SCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHH
T ss_pred CeECCcccccc-----------CCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcc
Confidence 98886533221 666777778888888888888621
Q ss_pred ---------------------CCCeeeccccCCcEEEcc--CCceEEecccccCCCccccccccccccccccCc---cCc
Q 018712 191 ---------------------EPRIIHRNIKSSNVLLFD--DDIAKISDFDLSNQAPDAAARLHSTRVLGTFGY---HAP 244 (351)
Q Consensus 191 ---------------------~~~ivH~Dlkp~Nill~~--~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y---~aP 244 (351)
...++|+|++|+||++++ ++.+.|+||+.+......... .....+ ..|
T Consensus 169 ~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl------~~~~~~~~~~~~ 242 (304)
T 3sg8_A 169 QMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDF------ISLMEDDEEYGM 242 (304)
T ss_dssp HHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHH------HTTCCTTTSCCH
T ss_pred cHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHH------HHHHhhccccCH
Confidence 134899999999999998 556889999987543211100 000011 122
Q ss_pred ccccC-----CCC---------CccchhHhHHHHHHHHHcCCCCCC
Q 018712 245 EYAMT-----GQM---------SSKSDVYSFGVVLLELLTGRKPVD 276 (351)
Q Consensus 245 E~~~~-----~~~---------~~~~DvwslG~il~el~tg~~Pf~ 276 (351)
+.... +.. ....+.|+++.++|.+.+|..+|-
T Consensus 243 ~~~~~~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~~ 288 (304)
T 3sg8_A 243 EFVSKILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDWY 288 (304)
T ss_dssp HHHHHHHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred HHHHHHHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHHH
Confidence 21110 000 122689999999999999988763
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.79 E-value=3.8e-08 Score=87.82 Aligned_cols=136 Identities=17% Similarity=0.132 Sum_probs=92.5
Q ss_pred CceeccCCcEEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHHhccCC---ceeeeEEEEe-cCCceEEEEEeCCCC
Q 018712 71 NSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNE---NVVELVGYYV-DGPLRVLAYEHASKG 146 (351)
Q Consensus 71 ~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~---niv~~~~~~~-~~~~~~lv~e~~~~g 146 (351)
.+.++.|....||+. +..+++|+... ......+.+|..+|+.+.+. .+.+++.+.. ..+..++||++++|.
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~~-~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~ 98 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPKS-QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQ 98 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEESS-HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSE
T ss_pred eeecCCCcceeEEEE----CCEEEEEecCC-chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCe
Confidence 356888999999987 57789998532 22345688999999999642 3566666664 455678999999998
Q ss_pred CHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCC------------------------------------
Q 018712 147 SLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKA------------------------------------ 190 (351)
Q Consensus 147 sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~------------------------------------ 190 (351)
+|.+..-.. ++......++.++...|..||+..
T Consensus 99 ~l~~~~~~~-----------l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~ 167 (306)
T 3tdw_A 99 ILGEDGMAV-----------LPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDES 167 (306)
T ss_dssp ECHHHHHTT-----------SCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHH
T ss_pred ECchhhhhh-----------CCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchh
Confidence 887632111 334444444555555555444421
Q ss_pred ---------------------CCCeeeccccCCcEEEcc---CCc-eEEecccccCC
Q 018712 191 ---------------------EPRIIHRNIKSSNVLLFD---DDI-AKISDFDLSNQ 222 (351)
Q Consensus 191 ---------------------~~~ivH~Dlkp~Nill~~---~~~-vkl~Dfg~a~~ 222 (351)
...++|+|++|+||+++. ++. +.|+||+.+..
T Consensus 168 ~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 168 LRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred hHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 223799999999999987 355 58999997654
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.76 E-value=6.2e-08 Score=84.68 Aligned_cols=133 Identities=12% Similarity=0.071 Sum_probs=95.5
Q ss_pred eccCCcE-EEEEEEEC-CCCEEEEEEcCCCCCchHHHHHHHHHHHhcc-CCceeeeEEEEecCCceEEEEEeCCCCCHHH
Q 018712 74 IGEGSYG-RVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLK-NENVVELVGYYVDGPLRVLAYEHASKGSLHD 150 (351)
Q Consensus 74 Lg~G~~g-~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~ 150 (351)
+..|..+ .||+.... ++..+++|+-... ....+.+|...|+.+. +-.+.+++.++.+.+..++|||+++|.++.+
T Consensus 32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~--~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~~ 109 (272)
T 4gkh_A 32 DNVGQSGATIYRLYGKPNAPELFLKHGKGS--VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAFQ 109 (272)
T ss_dssp EECSSSSCEEEEEECCTTCCCEEEEEEETH--HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHHH
T ss_pred ccCCCcCCeEEEEEecCCCeEEEEEECCCC--CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccccc
Confidence 4444444 68987754 4678999986533 3456888999998884 3347788888888889999999999988877
Q ss_pred HhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCC----------------------------------------
Q 018712 151 ILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKA---------------------------------------- 190 (351)
Q Consensus 151 ~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~---------------------------------------- 190 (351)
...... .....+..++...|..||...
T Consensus 110 ~~~~~~-------------~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 176 (272)
T 4gkh_A 110 VLEEYP-------------DSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPV 176 (272)
T ss_dssp HHHHCG-------------GGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCH
T ss_pred cccCCH-------------HHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHH
Confidence 654321 223345666666777777532
Q ss_pred ---------------CCCeeeccccCCcEEEccCCceEEecccccC
Q 018712 191 ---------------EPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (351)
Q Consensus 191 ---------------~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~ 221 (351)
...++|+|+.+.|||+++++.+-|+||+.+.
T Consensus 177 ~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 177 EQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp HHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 1127999999999999987777799999763
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.63 E-value=1.1e-07 Score=86.71 Aligned_cols=79 Identities=10% Similarity=0.021 Sum_probs=56.1
Q ss_pred cee-ccCCcEEEEEEEEC-------CCCEEEEEEcCCCC---C-chHHHHHHHHHHHhccC---CceeeeEEEEecC---
Q 018712 72 SLI-GEGSYGRVYFGVLR-------SGRAAAIKKLDSSK---Q-PDQEFLAQVSMVSRLKN---ENVVELVGYYVDG--- 133 (351)
Q Consensus 72 ~~L-g~G~~g~Vy~~~~~-------~~~~vavK~~~~~~---~-~~~~~~~e~~~l~~l~h---~niv~~~~~~~~~--- 133 (351)
+.| +.|..+.+|+.... ++..+++|+..... . ....+.+|+.+++.+.. -.+.+++.+..+.
T Consensus 26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~ 105 (357)
T 3ats_A 26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL 105 (357)
T ss_dssp EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence 467 88889999988754 26789999865432 1 12457788888888842 3577788776655
Q ss_pred CceEEEEEeCCCCCHHH
Q 018712 134 PLRVLAYEHASKGSLHD 150 (351)
Q Consensus 134 ~~~~lv~e~~~~gsL~~ 150 (351)
+..++|||+++|.++.+
T Consensus 106 g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 106 GTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp SSCEEEEECCCCBCCCB
T ss_pred CCceEEEEecCCCChhh
Confidence 35689999999876653
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.42 E-value=1.5e-06 Score=80.35 Aligned_cols=74 Identities=20% Similarity=0.100 Sum_probs=49.8
Q ss_pred CceeccCCcEEEEEEEEC-CCCEEEEEEcCCCC--------CchHHHHHHHHHHHhccC--C-ceeeeEEEEecCCceEE
Q 018712 71 NSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK--------QPDQEFLAQVSMVSRLKN--E-NVVELVGYYVDGPLRVL 138 (351)
Q Consensus 71 ~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--------~~~~~~~~e~~~l~~l~h--~-niv~~~~~~~~~~~~~l 138 (351)
.+.||.|..+.||++... +++.+++|...... .....+..|.++++.+.. + .+.+++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 457999999999999754 56889999764321 123456788888887742 3 34456543 4455689
Q ss_pred EEEeCCCC
Q 018712 139 AYEHASKG 146 (351)
Q Consensus 139 v~e~~~~g 146 (351)
|||++.+.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999864
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.39 E-value=4.2e-06 Score=75.36 Aligned_cols=73 Identities=18% Similarity=0.271 Sum_probs=43.2
Q ss_pred ceeccCCcEEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHHhccC--CceeeeEE------EEecCCceEEEEEeC
Q 018712 72 SLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKN--ENVVELVG------YYVDGPLRVLAYEHA 143 (351)
Q Consensus 72 ~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h--~niv~~~~------~~~~~~~~~lv~e~~ 143 (351)
+.|+.|..+.||+....++ .+++|+.... ...+..|..+++.+.. -.+.+++. +....+..+++|+|+
T Consensus 38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~---~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~i 113 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRP---EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDWI 113 (346)
T ss_dssp EECC----CEEEEEEETTE-EEEEEEECSC---HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEECC
T ss_pred eeccccccCcEEEEEeCCC-CEEEEecCCC---HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEee
Confidence 3466677899999887654 5999988752 2344556666665531 12333332 122456789999999
Q ss_pred CCCCH
Q 018712 144 SKGSL 148 (351)
Q Consensus 144 ~~gsL 148 (351)
+|.++
T Consensus 114 ~G~~~ 118 (346)
T 2q83_A 114 EGRPF 118 (346)
T ss_dssp CCBCC
T ss_pred cCccC
Confidence 98654
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=98.11 E-value=1.8e-05 Score=70.40 Aligned_cols=75 Identities=16% Similarity=0.079 Sum_probs=59.7
Q ss_pred CceeccCCcEEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHHhcc---CCceeeeEEEEecCCceEEEEEeCCCCC
Q 018712 71 NSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLK---NENVVELVGYYVDGPLRVLAYEHASKGS 147 (351)
Q Consensus 71 ~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~lv~e~~~~gs 147 (351)
.+.|+.|....+|+... ++..+++|+.... ....+..|...|+.+. ...+++++.+....+..++|||++++..
T Consensus 41 ~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~--~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~~ 117 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLIND-EVQTVFVKINERS--YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKSK 117 (312)
T ss_dssp EEEECCSSSSEEEEEES-SSCEEEEEEEEGG--GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCCC
T ss_pred eEEeCCccceeeeEEEE-CCCeEEEEeCCcc--cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCCC
Confidence 45789999999999875 4678999986533 3456888998888883 3668888888887788999999999875
Q ss_pred H
Q 018712 148 L 148 (351)
Q Consensus 148 L 148 (351)
+
T Consensus 118 ~ 118 (312)
T 3jr1_A 118 N 118 (312)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=98.10 E-value=1.8e-05 Score=73.67 Aligned_cols=75 Identities=19% Similarity=0.238 Sum_probs=45.5
Q ss_pred eeeccccCCcEEEccCCceEEecccccCCCcccccccccccccc--ccCccCcccccCC---CCCccchhHhHHHHHHHH
Q 018712 194 IIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLG--TFGYHAPEYAMTG---QMSSKSDVYSFGVVLLEL 268 (351)
Q Consensus 194 ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~---~~~~~~DvwslG~il~el 268 (351)
++|+|++|+|||++.++ ++|+||+.+........- ....+ ...|.+|+..... ......++.+....+|+.
T Consensus 234 liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dl---a~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (420)
T 2pyw_A 234 LIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDI---GAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNL 309 (420)
T ss_dssp EECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHH---HHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHH
T ss_pred EEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHH---HHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHH
Confidence 99999999999998877 999999987553322110 11111 1345565544311 112234556777778877
Q ss_pred HcCC
Q 018712 269 LTGR 272 (351)
Q Consensus 269 ~tg~ 272 (351)
+++.
T Consensus 310 y~~~ 313 (420)
T 2pyw_A 310 FNKR 313 (420)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 7653
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=98.05 E-value=3.4e-05 Score=67.80 Aligned_cols=76 Identities=21% Similarity=0.195 Sum_probs=55.7
Q ss_pred CCCCceeccCCcEEEEEEEECCCCEEEEEEcCCCC-CchHHHHHHHHHHHhccC---CceeeeEEEEecCCceEEEEEeC
Q 018712 68 FGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSK-QPDQEFLAQVSMVSRLKN---ENVVELVGYYVDGPLRVLAYEHA 143 (351)
Q Consensus 68 y~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~h---~niv~~~~~~~~~~~~~lv~e~~ 143 (351)
....+.+|.|..+.||+....+|+.|++|+..... .....+..|...|+.|.. -.+++++... ..++|||++
T Consensus 17 v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e~l 92 (288)
T 3f7w_A 17 VAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAMEWV 92 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEECC
T ss_pred eEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEEee
Confidence 44456799999999999999999999999875433 234567889999988842 2345555542 347899999
Q ss_pred CCCC
Q 018712 144 SKGS 147 (351)
Q Consensus 144 ~~gs 147 (351)
.++.
T Consensus 93 ~~~~ 96 (288)
T 3f7w_A 93 DERP 96 (288)
T ss_dssp CCCC
T ss_pred cccC
Confidence 8764
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=98.03 E-value=6.6e-05 Score=67.16 Aligned_cols=75 Identities=13% Similarity=0.138 Sum_probs=51.0
Q ss_pred ceeccCCcEEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHHhccCC--ceeeeEEE-----EecCCceEEEEEeCC
Q 018712 72 SLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNE--NVVELVGY-----YVDGPLRVLAYEHAS 144 (351)
Q Consensus 72 ~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~--niv~~~~~-----~~~~~~~~lv~e~~~ 144 (351)
..|+ |....||+....+|+.+++|...........+..|..+++.+... .+++++.. ....+..+++|++++
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i~ 110 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVG 110 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCC
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCCCCCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEecC
Confidence 4577 888899988776777899999875544556777888888877421 23444432 112445678999998
Q ss_pred CCC
Q 018712 145 KGS 147 (351)
Q Consensus 145 ~gs 147 (351)
|.+
T Consensus 111 G~~ 113 (328)
T 1zyl_A 111 GRQ 113 (328)
T ss_dssp CEE
T ss_pred CCC
Confidence 754
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=98.02 E-value=6.4e-05 Score=67.04 Aligned_cols=164 Identities=14% Similarity=0.192 Sum_probs=87.1
Q ss_pred cCHHHHHHHhcCCCCC-----ceeccCCcEEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHHhccCCc--eeeeEE
Q 018712 56 ISVDELKEKTDNFGTN-----SLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNEN--VVELVG 128 (351)
Q Consensus 56 ~~~~~~~~~~~~y~~~-----~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~~~~ 128 (351)
++.+++......|.+. +.|+.|....+|+....++ .+++|+..... ....+..|+.+++.+.... +.+++.
T Consensus 7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~-~~~~l~~e~~~l~~L~~~g~~vP~~~~ 84 (322)
T 2ppq_A 7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV-EKNDLPFFLGLMQHLAAKGLSCPLPLP 84 (322)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC----CCHHHHHHHHHHHHHHTTCCCCCBCC
T ss_pred CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCCC-CHHHHHHHHHHHHHHHHCCCCCCcccC
Confidence 4556666666667652 3467788899999887655 68899886531 2345667888777764211 333332
Q ss_pred E------EecCCceEEEEEeCCCCCHHH--------------HhccC-CCCCCCCCC--CCCCHHHHHH-----------
Q 018712 129 Y------YVDGPLRVLAYEHASKGSLHD--------------ILHGK-KGVKGAKPG--PVLSWAQRVK----------- 174 (351)
Q Consensus 129 ~------~~~~~~~~lv~e~~~~gsL~~--------------~l~~~-~~~~~~~~~--~~l~~~~~~~----------- 174 (351)
. ....+..++++++++|..+.. .++.. ......... ....|.....
T Consensus 85 ~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~ 164 (322)
T 2ppq_A 85 RKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEK 164 (322)
T ss_dssp BTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTST
T ss_pred CCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhh
Confidence 1 112356789999999865311 01111 000000000 0011111000
Q ss_pred -HHHHHHHHHHhhhhC----CCCCeeeccccCCcEEEccCCceEEecccccC
Q 018712 175 -IAVGAARGLEYLHEK----AEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (351)
Q Consensus 175 -i~~qi~~~l~~lH~~----~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~ 221 (351)
+...+...+..++.. .+..++|+|++++|||++.++.+.|+||+.+.
T Consensus 165 ~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 165 GLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp THHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 001133334444421 12249999999999999887666899999764
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=98.01 E-value=3.3e-05 Score=68.41 Aligned_cols=74 Identities=8% Similarity=0.007 Sum_probs=46.8
Q ss_pred CCCCceeccCCcEEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHHhccCCce-eeeEEEEecCCceEEEEEeC-CC
Q 018712 68 FGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENV-VELVGYYVDGPLRVLAYEHA-SK 145 (351)
Q Consensus 68 y~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~-~~ 145 (351)
+.-.+.|+.|....+|+. ..+++|+............+|..+++.+....+ .+++.. +.+.-++++||+ +|
T Consensus 20 ~~~i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g 92 (301)
T 3dxq_A 20 YTGPLERLGGLTNLVFRA-----GDLCLRIPGKGTEEYINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGA 92 (301)
T ss_dssp CCSCEEEESCSSEEEEEE-----TTEEEEEECC----CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTC
T ss_pred ccceeEcCCcccccccee-----eeEEEECCCCCccceeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCC
Confidence 344678999999999998 568999876532221223567877777743222 455543 444457899999 66
Q ss_pred CCH
Q 018712 146 GSL 148 (351)
Q Consensus 146 gsL 148 (351)
.+|
T Consensus 93 ~~l 95 (301)
T 3dxq_A 93 QTM 95 (301)
T ss_dssp EEC
T ss_pred ccC
Confidence 444
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.90 E-value=5.3e-05 Score=69.29 Aligned_cols=145 Identities=15% Similarity=0.172 Sum_probs=82.1
Q ss_pred CceeccCCcEEEEEEEEC--------CCCEEEEEEcCCCCCchHHHHHHHHHHHhcc-CCceeeeEEEEecCCceEEEEE
Q 018712 71 NSLIGEGSYGRVYFGVLR--------SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLK-NENVVELVGYYVDGPLRVLAYE 141 (351)
Q Consensus 71 ~~~Lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e 141 (351)
.+.|..|-...+|+.... +++.+++|+..........+.+|..+++.+. +.-..++++.+.+ .+|||
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e 130 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQ 130 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEE
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEE
Confidence 346777888889998864 2478999986443334456778999998884 3334566666543 28999
Q ss_pred eCCCCCHHHH-----------------hccCCCCCCCCCCCCCCHHHHHHHHHHHHH-------------------HHHh
Q 018712 142 HASKGSLHDI-----------------LHGKKGVKGAKPGPVLSWAQRVKIAVGAAR-------------------GLEY 185 (351)
Q Consensus 142 ~~~~gsL~~~-----------------l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~-------------------~l~~ 185 (351)
|++|.+|..- |+.... .....+..-+.++..+..++.. .+..
T Consensus 131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~--~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 208 (379)
T 3feg_A 131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEM--PFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGN 208 (379)
T ss_dssp CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCC--SSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHH
T ss_pred EecCccCChhHhCCHHHHHHHHHHHHHHhCCCC--CCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHH
Confidence 9998554310 111110 0111111123444445444322 1222
Q ss_pred ----hhhC-CCCCeeeccccCCcEEEccC----CceEEecccccC
Q 018712 186 ----LHEK-AEPRIIHRNIKSSNVLLFDD----DIAKISDFDLSN 221 (351)
Q Consensus 186 ----lH~~-~~~~ivH~Dlkp~Nill~~~----~~vkl~Dfg~a~ 221 (351)
|... ....++|+|+.++|||++.+ +.+.|+||..+.
T Consensus 209 L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 209 LRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 2221 12248999999999999876 689999999763
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.85 E-value=0.0002 Score=64.15 Aligned_cols=78 Identities=12% Similarity=0.106 Sum_probs=41.4
Q ss_pred ceeccCCcEE-EEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHHhccC--CceeeeEEEEecCCceEEEEEeCCCCCH
Q 018712 72 SLIGEGSYGR-VYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKN--ENVVELVGYYVDGPLRVLAYEHASKGSL 148 (351)
Q Consensus 72 ~~Lg~G~~g~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h--~niv~~~~~~~~~~~~~lv~e~~~~gsL 148 (351)
+.|+.|.... +|+....++..+++|....... ..+..|+.+++.+.. -.+.+++.+..+. -+++||++.+.++
T Consensus 24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~--~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~--g~ll~e~l~~~~l 99 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG--GDTQPFVDLAQYLRNLDISAPEIYAEEHAR--GLLLIEDLGDALF 99 (333)
T ss_dssp CC--------CCEEEECTTCCEEEEEECCTTTT--CCSHHHHHHHHHHHHTTCBCCCEEEEETTT--TEEEECCCCSCBH
T ss_pred eECCCCCCCceEEEEEcCCCCeEEEEECCCCCC--ccccHHHHHHHHHHhCCCCCCceeeecCCC--CEEEEeeCCCcch
Confidence 3466565555 6666544467788886544321 234566777766632 2355666653333 3789999987777
Q ss_pred HHHhc
Q 018712 149 HDILH 153 (351)
Q Consensus 149 ~~~l~ 153 (351)
.+.+.
T Consensus 100 ~~~l~ 104 (333)
T 3csv_A 100 TEVIN 104 (333)
T ss_dssp HHHHH
T ss_pred HHHhc
Confidence 65543
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.79 E-value=9e-05 Score=69.08 Aligned_cols=73 Identities=14% Similarity=0.147 Sum_probs=50.1
Q ss_pred CceeccCCcEEEEEEEECC--------CCEEEEEEcCCCCCchHHHHHHHHHHHhccCCc-eeeeEEEEecCCceEEEEE
Q 018712 71 NSLIGEGSYGRVYFGVLRS--------GRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNEN-VVELVGYYVDGPLRVLAYE 141 (351)
Q Consensus 71 ~~~Lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~~~~~~~~~~~~~lv~e 141 (351)
.+.|+.|-...+|++...+ +..+++|+.... .....+.+|..+++.+...+ ..++++.+.+ .+|+|
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~-~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e 152 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE 152 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC-CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEE
Confidence 4568889899999998653 578999988432 22245668999988885333 3566665542 38899
Q ss_pred eCCCCCH
Q 018712 142 HASKGSL 148 (351)
Q Consensus 142 ~~~~gsL 148 (351)
|++|.+|
T Consensus 153 ~l~G~~l 159 (429)
T 1nw1_A 153 YIPSRPL 159 (429)
T ss_dssp CCCEEEC
T ss_pred EeCCccc
Confidence 9986443
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.64 E-value=0.00024 Score=66.66 Aligned_cols=74 Identities=12% Similarity=-0.004 Sum_probs=47.7
Q ss_pred CceeccCCcEEEEEEEECC-CCEEEEEEcCCCCCchHHHHHHHHHHHhccCCce-eeeEEEEecCCceEEEEEeCCCCCH
Q 018712 71 NSLIGEGSYGRVYFGVLRS-GRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENV-VELVGYYVDGPLRVLAYEHASKGSL 148 (351)
Q Consensus 71 ~~~Lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~~~gsL 148 (351)
.+.|+.|-...+|+....+ +..+++|+........-...+|..+++.|...++ .++++.+. + .+||||++|.+|
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~idR~~E~~vl~~L~~~gl~P~ll~~~~-~---G~v~e~I~G~~l 188 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIINREREKKISCILYNKNIAKKIYVFFT-N---GRIEEFMDGYAL 188 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSCHHHHHHHHHHHTTSSSBCCEEEEET-T---EEEEECCCSEEC
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcCHHHHHHHHHHHHhcCCCCCEEEEeC-C---eEEEEeeCCccC
Confidence 3467888889999998764 4788999875432211123588888988865444 56776663 2 259999987544
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.63 E-value=0.00011 Score=67.05 Aligned_cols=74 Identities=8% Similarity=0.026 Sum_probs=44.6
Q ss_pred CceeccCCcEEEEEEEECC---------CCEEEEEEcCCCCCchHHHHHHHHHHHhccCCc-eeeeEEEEecCCceEEEE
Q 018712 71 NSLIGEGSYGRVYFGVLRS---------GRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNEN-VVELVGYYVDGPLRVLAY 140 (351)
Q Consensus 71 ~~~Lg~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~~~~~~~~~~~~~lv~ 140 (351)
.+.|+.|....+|+....+ +..+++|+.............|..+++.+...+ +.+++... . -++||
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v~ 113 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDELYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRIE 113 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEE
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccceecHHHHHHHHHHHHhcCCCCceEEec--C--CcEEE
Confidence 3467788889999988653 268888987543221112457888888774333 44666544 2 36899
Q ss_pred EeCCCCCH
Q 018712 141 EHASKGSL 148 (351)
Q Consensus 141 e~~~~gsL 148 (351)
+|++|.++
T Consensus 114 e~i~G~~l 121 (369)
T 3c5i_A 114 EWLYGDPL 121 (369)
T ss_dssp ECCCSEEC
T ss_pred EEecCCcC
Confidence 99987543
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=97.46 E-value=0.00045 Score=62.21 Aligned_cols=67 Identities=12% Similarity=0.047 Sum_probs=43.1
Q ss_pred cCCcEEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHHhcc---CCceeeeEEE------EecCCceEEEEEeCCCC
Q 018712 76 EGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLK---NENVVELVGY------YVDGPLRVLAYEHASKG 146 (351)
Q Consensus 76 ~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~---h~niv~~~~~------~~~~~~~~lv~e~~~~g 146 (351)
.|....||+....+| .+++|+...... ..|+..++.|. -+++++++.. ....+..+++|+|++|.
T Consensus 33 ~g~~N~vy~v~~~~g-~~vLK~~~~~~~-----~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~~~i~G~ 106 (339)
T 3i1a_A 33 ADTNAFAYQADSESK-SYFIKLKYGYHD-----EINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAYPFIHAP 106 (339)
T ss_dssp SCSSCEEEEEECSSC-EEEEEEEECSSC-----CHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEEECCCCC
T ss_pred CccccceEEEEeCCC-CEEEEEecCccc-----hHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEEeccCCC
Confidence 333689999987767 899998765442 34566665552 1324444432 23356779999999986
Q ss_pred CH
Q 018712 147 SL 148 (351)
Q Consensus 147 sL 148 (351)
.+
T Consensus 107 ~~ 108 (339)
T 3i1a_A 107 NG 108 (339)
T ss_dssp BT
T ss_pred cC
Confidence 55
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=97.09 E-value=0.0016 Score=60.30 Aligned_cols=74 Identities=7% Similarity=-0.017 Sum_probs=48.9
Q ss_pred CceeccCCcEEEEEEEECC--------CCEEEEEEcCCCCCchHHHHHHHHHHHhcc-CCceeeeEEEEecCCceEEEEE
Q 018712 71 NSLIGEGSYGRVYFGVLRS--------GRAAAIKKLDSSKQPDQEFLAQVSMVSRLK-NENVVELVGYYVDGPLRVLAYE 141 (351)
Q Consensus 71 ~~~Lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e 141 (351)
.+.|..|-...+|+....+ +..+++++........-...+|..+++.+. +.-..++++.+. -++|++
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I~e 150 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKFYDSKVELDVFRYLSNINIAPNIIADFP----EGRIEE 150 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CCCCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEEE
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchhcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEEEE
Confidence 3567778889999998653 578999987543222223457888888874 333455665432 278999
Q ss_pred eCCCCCH
Q 018712 142 HASKGSL 148 (351)
Q Consensus 142 ~~~~gsL 148 (351)
|++|.+|
T Consensus 151 fI~G~~l 157 (424)
T 3mes_A 151 FIDGEPL 157 (424)
T ss_dssp CCCSEEC
T ss_pred EeCCccC
Confidence 9998653
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.20 E-value=0.015 Score=48.16 Aligned_cols=101 Identities=15% Similarity=0.146 Sum_probs=67.1
Q ss_pred CHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhh-CCCCCeeeccccCCcEEEccCCceEEecccccCCCcc
Q 018712 147 SLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHE-KAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPD 225 (351)
Q Consensus 147 sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~-~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~ 225 (351)
||.++|...+. .+++.+++.++.|.+.+|.-+-. .. -..+=+.|..|++..+|.|.+.+ ..+.
T Consensus 34 SL~eIL~~~~~--------PlsEEqaWALc~Qc~~~L~~~~~~~~---~~~~i~~~~~i~l~~dG~V~f~~-~~s~---- 97 (229)
T 2yle_A 34 SLEEILRLYNQ--------PINEEQAWAVCYQCCGSLRAAARRRQ---PRHRVRSAAQIRVWRDGAVTLAP-AADD---- 97 (229)
T ss_dssp EHHHHHHHHTS--------CCCHHHHHHHHHHHHHHHHHHHHTTC---CCCCCCSGGGEEEETTSCEEECC-C-------
T ss_pred cHHHHHHHcCC--------CcCHHHHHHHHHHHHHHHHhhhhccc---CCceecCCcceEEecCCceeccc-cccc----
Confidence 79999987654 39999999999999999877622 11 11333457999999999988764 1110
Q ss_pred ccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCC
Q 018712 226 AAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274 (351)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P 274 (351)
.....+.|||... ...+.+.=|||||+++|..+-=..|
T Consensus 98 ----------~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~ 135 (229)
T 2yle_A 98 ----------AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK 135 (229)
T ss_dssp -------------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred ----------ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence 1122467888653 4456788899999999999874444
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=95.78 E-value=0.045 Score=50.22 Aligned_cols=29 Identities=24% Similarity=0.489 Sum_probs=24.1
Q ss_pred eeeccccCCcEEEc------cCCceEEecccccCC
Q 018712 194 IIHRNIKSSNVLLF------DDDIAKISDFDLSNQ 222 (351)
Q Consensus 194 ivH~Dlkp~Nill~------~~~~vkl~Dfg~a~~ 222 (351)
++|+|+.++|||+. ++..+.++||.+|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 67999999999993 456799999997643
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=93.12 E-value=0.62 Score=38.40 Aligned_cols=117 Identities=8% Similarity=0.061 Sum_probs=76.8
Q ss_pred cCCceeeeEEEEecCCceEEEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeecc
Q 018712 119 KNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRN 198 (351)
Q Consensus 119 ~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~D 198 (351)
.||+++.. .+-.+++.+.+.++.-+ +...+-.-.. ++....++++.+|+....+++. -+|--
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~--~~~~f~~ik~----------~~~~eKlr~l~ni~~l~~~~~~-----r~tf~ 104 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDIND--NHTPFDNIKS----------FTKNEKLRYLLNIKNLEEVNRT-----RYTFV 104 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCT--TSEEGGGGGG----------SCHHHHHHHHHHGGGGGGGGGS-----SEECC
T ss_pred cCCcccce-EEEEcccEEEEEEEcCc--ccCCHHHHHh----------cCHHHHHHHHHHHHHHHHHhcC-----ceEEE
Confidence 57888866 45555665555554433 2322222111 7888999999999988765554 47888
Q ss_pred ccCCcEEEccCCceEEecccccCCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCC
Q 018712 199 IKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDH 277 (351)
Q Consensus 199 lkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~ 277 (351)
|+|+|++++.++.+++.-.|+-... +|. ..+...=+-.+=+++..+++++..|..
T Consensus 105 L~P~NL~f~~~~~p~i~~RGik~~l-------------------~P~-----~~~ee~fL~qyKAliiall~~K~~Fe~ 159 (215)
T 4ann_A 105 LAPDELFFTRDGLPIAKTRGLQNVV-------------------DPL-----PVSEAEFLTRYKALVICAFNEKQSFDA 159 (215)
T ss_dssp CSGGGEEECTTSCEEESCCEETTTB-------------------SCC-----CCCHHHHHHHHHHHHHHHHCTTCCHHH
T ss_pred EecceEEEcCCCCEEEEEccCccCC-------------------CCC-----CCCHHHHHHHHHHHHHHHHcCCCCHHH
Confidence 9999999999999999877753221 111 112222233577888999999999864
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=91.23 E-value=0.95 Score=37.40 Aligned_cols=114 Identities=10% Similarity=0.074 Sum_probs=77.3
Q ss_pred cCCceeeeEEEEecCCceEEEEEeCCC-CCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHH-hhhhCCCCCeee
Q 018712 119 KNENVVELVGYYVDGPLRVLAYEHASK-GSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLE-YLHEKAEPRIIH 196 (351)
Q Consensus 119 ~h~niv~~~~~~~~~~~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~-~lH~~~~~~ivH 196 (351)
.||++ -..+-.+++.+.+.++.-++ .++..+ +. ++....++++.+|+.... ++++ -+|
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i-~~------------~~~~eKlrll~nl~~L~~~~~~~-----r~t 107 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAI-RK------------TTLLSRIRAAIHLVSKVKHHSAR-----RLI 107 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHH-HT------------SCHHHHHHHHHHHHHHHSSCCSS-----SEE
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHH-Hh------------cCHHHHHHHHHHHHHHHHHhhhC-----cee
Confidence 57877 33344667777666666533 345544 21 788899999999988776 5544 578
Q ss_pred ccccCCcEEEccCCceEEecccccCCCccccccccccccccccCccCcccccCCCCCccchhH-hHHHHHHHHHcCCCCC
Q 018712 197 RNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVY-SFGVVLLELLTGRKPV 275 (351)
Q Consensus 197 ~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvw-slG~il~el~tg~~Pf 275 (351)
--|+|+|++++.++.++|.-.|+-.. ++|.- .+ ..|.| ++=+++..++.++..|
T Consensus 108 f~l~P~NL~f~~~~~p~i~hRGi~~~-------------------lpP~e-----~~-ee~fl~qyKali~all~~K~~F 162 (219)
T 4ano_A 108 FIVCPENLMFNRALEPFFLHVGVKES-------------------LPPDE-----WD-DERLLREVKATVLALTEGEYRF 162 (219)
T ss_dssp CCCCGGGEEECTTCCEEESCCEETTT-------------------BSSCS-----CC-HHHHHHHHHHHHHHHTTCSSCH
T ss_pred EEEeCceEEEeCCCcEEEEEcCCccc-------------------CCCCC-----CC-HHHHHHHHHHHHHHHHcCCCCH
Confidence 88999999999999999988875322 22221 11 22333 5778888899998888
Q ss_pred CC
Q 018712 276 DH 277 (351)
Q Consensus 276 ~~ 277 (351)
..
T Consensus 163 e~ 164 (219)
T 4ano_A 163 DE 164 (219)
T ss_dssp HH
T ss_pred HH
Confidence 53
|
| >1cja_A Protein (actin-fragmin kinase); transferase; HET: AMP; 2.90A {Physarum polycephalum} SCOP: d.144.1.3 | Back alignment and structure |
|---|
Probab=82.11 E-value=5.2 Score=35.23 Aligned_cols=80 Identities=13% Similarity=0.089 Sum_probs=42.0
Q ss_pred ceEEEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhC-CCCCeee-ccccCCcEEEccCCc-
Q 018712 135 LRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEK-AEPRIIH-RNIKSSNVLLFDDDI- 211 (351)
Q Consensus 135 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~-~~~~ivH-~Dlkp~Nill~~~~~- 211 (351)
...++|+|.+|..|.+.-...-. ..+.......+.. +-+++.+..+ .+.+.+. ..-.++|||+++++.
T Consensus 156 ~~~l~meyv~G~~L~e~~~~~~~-------~~f~~~~~k~LG~--Ii~FDi~InN~DR~Pl~W~n~GN~~NIL~~~~n~~ 226 (342)
T 1cja_A 156 ANILLMELVRGITLNKLTTTSAP-------EVLTKSTMQQLGS--LMALDVIVNNSDRLPIAWTNEGNLDNIMLSERGAT 226 (342)
T ss_dssp SEEEEEECCCEEESTTCCSSSHH-------HHSCHHHHHHHHH--HHHHHHHHTCCSSSCSSSCSCCCGGGEEEESBTTC
T ss_pred cceehhhhcCCCccccchhhhhh-------hhcCHHHHHhhch--hheehhhhcCCccCcccccCCCChhheEEeCCCCe
Confidence 46699999987665543221000 0022222222111 2334444444 3322222 225789999987554
Q ss_pred eEEecccccCCC
Q 018712 212 AKISDFDLSNQA 223 (351)
Q Consensus 212 vkl~Dfg~a~~~ 223 (351)
+.++|-+.+...
T Consensus 227 ~~~IDhn~af~~ 238 (342)
T 1cja_A 227 VVPIDSKIIPLD 238 (342)
T ss_dssp EEECSCCCCCCC
T ss_pred EEEEcCCccccC
Confidence 889999887543
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 351 | ||||
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 9e-59 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 3e-57 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 5e-57 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 3e-53 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 1e-52 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 6e-52 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 5e-51 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 7e-51 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 1e-50 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 3e-50 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 4e-50 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 5e-50 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 6e-50 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 1e-49 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 1e-49 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 2e-49 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 4e-49 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 4e-49 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 4e-48 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 4e-48 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 1e-47 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-47 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 3e-47 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 3e-47 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-46 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 7e-45 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 9e-45 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 7e-44 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 7e-44 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 2e-43 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 6e-43 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 7e-43 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 8e-43 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 2e-42 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 2e-42 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 4e-41 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 4e-41 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-40 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 1e-39 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 1e-38 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 6e-38 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-37 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 2e-36 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 2e-36 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 8e-36 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 8e-36 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 9e-35 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 1e-34 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 2e-34 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-34 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 5e-34 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 1e-33 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 4e-33 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 4e-32 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 4e-32 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 5e-31 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 2e-30 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 5e-28 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 3e-27 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 8e-27 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-26 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 5e-25 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 2e-13 |
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (484), Expect = 9e-59
Identities = 56/226 (24%), Positives = 101/226 (44%), Gaps = 18/226 (7%)
Query: 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPD--QEFLAQVSMVSRLKN 120
K D+F S +G G+ G V+ + SG A K + +P + + ++ ++ +
Sbjct: 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS 63
Query: 121 ENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAA 180
+V G + + EH GSL +L + K+++
Sbjct: 64 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR---------IPEQILGKVSIAVI 114
Query: 181 RGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFG 240
+GL YL EK +I+HR++K SN+L+ K+ DF +S Q D+ + +GT
Sbjct: 115 KGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRS 168
Query: 241 YHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSL 286
Y +PE S +SD++S G+ L+E+ GR P+ + + +
Sbjct: 169 YMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELM 214
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (469), Expect = 3e-57
Identities = 54/209 (25%), Positives = 97/209 (46%), Gaps = 12/209 (5%)
Query: 66 DNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVE 125
+ +G G +G V+ G A+K L FLA+ +++ +L+++ +V
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVR 72
Query: 126 LVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEY 185
L P+ + E+ GSL D L G+K L+ + + +A A G+ +
Sbjct: 73 LYAVVTQEPI-YIITEYMENGSLVDFLKTPSGIK-------LTINKLLDMAAQIAEGMAF 124
Query: 186 LHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245
+ E+ IHR+++++N+L+ D KI+DF L+ D + APE
Sbjct: 125 IEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT-AREGAKFPIKWTAPE 180
Query: 246 YAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
G + KSDV+SFG++L E++T +
Sbjct: 181 AINYGTFTIKSDVWSFGILLTEIVTHGRI 209
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (468), Expect = 5e-57
Identities = 63/222 (28%), Positives = 103/222 (46%), Gaps = 16/222 (7%)
Query: 66 DNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDS-SKQPDQEFLAQVSMVSRLKNENVV 124
IG GS+G VY G A + + + + Q Q F +V ++ + ++ N++
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 67
Query: 125 ELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLE 184
+GY L + + SL+ LH + + + IA A+G++
Sbjct: 68 LFMGYSTAPQL-AIVTQWCEGSSLYHHLHIIETK--------FEMIKLIDIARQTAQGMD 118
Query: 185 YLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAP 244
YLH K IIHR++KS+N+ L +D KI DF L+ + ++ G+ + AP
Sbjct: 119 YLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAP 175
Query: 245 EYAMT---GQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQ 283
E S +SDVY+FG+VL EL+TG+ P + R Q
Sbjct: 176 EVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ 217
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (442), Expect = 3e-53
Identities = 51/201 (25%), Positives = 89/201 (44%), Gaps = 12/201 (5%)
Query: 74 IGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDG 133
+G G +G V +G R AIK + + EF+ + ++ L +E +V+L G
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQ 71
Query: 134 PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPR 193
+ E+ + G L + L + Q +++ +EYL K +
Sbjct: 72 RPIFIITEYMANGCLLNYLREMRH--------RFQTQQLLEMCKDVCEAMEYLESK---Q 120
Query: 194 IIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMS 253
+HR++ + N L+ D + K+SDF LS D S + PE M + S
Sbjct: 121 FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT-SSVGSKFPVRWSPPEVLMYSKFS 179
Query: 254 SKSDVYSFGVVLLELLTGRKP 274
SKSD+++FGV++ E+ + K
Sbjct: 180 SKSDIWAFGVLMWEIYSLGKM 200
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (438), Expect = 1e-52
Identities = 50/210 (23%), Positives = 94/210 (44%), Gaps = 12/210 (5%)
Query: 74 IGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDG 133
IG G +G V+ G + AIK + +++F+ + ++ +L + +V+L G ++
Sbjct: 13 IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ 72
Query: 134 PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPR 193
L +E G L D L + + + + + G+ YL E
Sbjct: 73 APICLVFEFMEHGCLSDYLR--------TQRGLFAAETLLGMCLDVCEGMAYLEEA---C 121
Query: 194 IIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMS 253
+IHR++ + N L+ ++ + K+SDF ++ D ST + +PE + S
Sbjct: 122 VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-SSTGTKFPVKWASPEVFSFSRYS 180
Query: 254 SKSDVYSFGVVLLELLTGRKPVDHTLPRGQ 283
SKSDV+SFGV++ E+ + K +
Sbjct: 181 SKSDVWSFGVLMWEVFSEGKIPYENRSNSE 210
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (433), Expect = 6e-52
Identities = 60/244 (24%), Positives = 98/244 (40%), Gaps = 21/244 (8%)
Query: 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPD----QEFLAQVSMVSRLKN 120
++F +G+G +G VY + S A+K L ++ + +V + S L++
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 121 ENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAA 180
N++ L GY+ D L E+A G+++ L + A
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---------FDEQRTATYITELA 116
Query: 181 RGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFG 240
L Y H K R+IHR+IK N+LL KI+DF S AP + T + GT
Sbjct: 117 NALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----RRTTLCGTLD 169
Query: 241 YHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVK 300
Y PE K D++S GV+ E L G+ P + + ++ + +
Sbjct: 170 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTE 229
Query: 301 QCVD 304
D
Sbjct: 230 GARD 233
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (430), Expect = 5e-51
Identities = 55/266 (20%), Positives = 106/266 (39%), Gaps = 32/266 (12%)
Query: 74 IGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDG 133
IG+G +G V+ G R G A+K S ++ A++ L++EN++ +
Sbjct: 11 IGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKD 69
Query: 134 PLRV----LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEK 189
L ++ GSL D L+ ++ +K+A+ A GL +LH +
Sbjct: 70 NGTWTQLWLVSDYHEHGSLFDYLNRYT----------VTVEGMIKLALSTASGLAHLHME 119
Query: 190 A-----EPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLH--STRVLGTFGYH 242
+P I HR++KS N+L+ + I+D L+ + A + +GT Y
Sbjct: 120 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM 179
Query: 243 APEYAMT------GQMSSKSDVYSFGVVLLELLTGRKP----VDHTLPRGQQSLVTWATP 292
APE + ++D+Y+ G+V E+ D+ LP +
Sbjct: 180 APEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVE 239
Query: 293 KLSEDKVKQCVDTKLGGEYPPKAIAK 318
++ + +Q + + + +
Sbjct: 240 EMRKVVCEQKLRPNIPNRWQSCEALR 265
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (430), Expect = 7e-51
Identities = 50/230 (21%), Positives = 92/230 (40%), Gaps = 21/230 (9%)
Query: 73 LIGEGSYGRVYFGVLR------SGRAAAIKKLDSSKQPD--QEFLAQVSMVSRLKN-ENV 123
+G G++G+V + A+K L S + ++++ ++S L N N+
Sbjct: 30 TLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNI 89
Query: 124 VELVGYYVDGPLRVLAYEHASKGSLHDILHGKKG---------VKGAKPGPVLSWAQRVK 174
V L+G G ++ E+ G L + L K+ L +
Sbjct: 90 VNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLS 149
Query: 175 IAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTR 234
+ A+G+ +L K IHR++ + N+LL I KI DF L+ + + +
Sbjct: 150 FSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGN 206
Query: 235 VLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQ 284
+ APE + +SDV+S+G+ L EL + +P +
Sbjct: 207 ARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK 256
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (426), Expect = 1e-50
Identities = 59/219 (26%), Positives = 107/219 (48%), Gaps = 12/219 (5%)
Query: 56 ISVDELKEKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMV 115
++ D + ++ +G+G +G V+ G AIK L + FL + ++
Sbjct: 7 LAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVM 66
Query: 116 SRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKI 175
+L++E +V+L + P+ + E+ SKGSL D L G+ G L Q V +
Sbjct: 67 KKLRHEKLVQLYAVVSEEPI-YIVTEYMSKGSLLDFLKGET-------GKYLRLPQLVDM 118
Query: 176 AVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRV 235
A A G+ Y+ +HR+++++N+L+ ++ + K++DF L+ D
Sbjct: 119 AAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIED-NEYTARQGA 174
Query: 236 LGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
+ APE A+ G+ + KSDV+SFG++L EL T +
Sbjct: 175 KFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRV 213
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 167 bits (423), Expect = 3e-50
Identities = 63/266 (23%), Positives = 112/266 (42%), Gaps = 27/266 (10%)
Query: 57 SVDELKEKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMV 115
+ D+ + + + +G G YG VY GV + A+K L +EFL + +++
Sbjct: 8 NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVM 67
Query: 116 SRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKI 175
+K+ N+V+L+G P + E + G+L D L + +S + +
Sbjct: 68 KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE-------VSAVVLLYM 120
Query: 176 AVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRV 235
A + +EYL +K IHR++ + N L+ ++ + K++DF LS H
Sbjct: 121 ATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAH-AGA 176
Query: 236 LGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLS 295
+ APE + S KSDV++FGV+L E+ T P +
Sbjct: 177 KFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY---------------PGID 221
Query: 296 EDKVKQCVDTKLGGEYPPKAIAKVRK 321
+V + ++ E P KV +
Sbjct: 222 LSQVYELLEKDYRMERPEGCPEKVYE 247
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (421), Expect = 4e-50
Identities = 61/216 (28%), Positives = 107/216 (49%), Gaps = 18/216 (8%)
Query: 66 DNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVE 125
IG+G +G V G R G A+K + + Q FLA+ S++++L++ N+V+
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATA-QAFLAEASVMTQLRHSNLVQ 64
Query: 126 LVGYYVDGPLRV-LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLE 184
L+G V+ + + E+ +KGSL D L + VL +K ++ +E
Sbjct: 65 LLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGR-------SVLGGDCLLKFSLDVCEAME 117
Query: 185 YLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAP 244
YL +HR++ + NVL+ +D++AK+SDF L+ +A + AP
Sbjct: 118 YLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS-----TQDTGKLPVKWTAP 169
Query: 245 EYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280
E + S+KSDV+SFG++L E+ + + +P
Sbjct: 170 EALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP 205
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 167 bits (423), Expect = 5e-50
Identities = 57/264 (21%), Positives = 108/264 (40%), Gaps = 28/264 (10%)
Query: 66 DNFGTNSLIGEGSYGRVYFGVLR------SGRAAAIKKLDSSKQPD--QEFLAQVSMVSR 117
+N IGEG++GRV+ A+K L D +F + ++++
Sbjct: 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 72
Query: 118 LKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVK---------------GAK 162
N N+V+L+G G L +E+ + G L++ L +
Sbjct: 73 FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 132
Query: 163 PGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222
P LS A+++ IA A G+ YL E + +HR++ + N L+ ++ + KI+DF LS
Sbjct: 133 GPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKIADFGLSRN 189
Query: 223 APDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRG 282
A + PE + +++SDV+++GVVL E+ + + +
Sbjct: 190 IYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHE 249
Query: 283 Q--QSLVTWATPKLSEDKVKQCVD 304
+ + E+ + +
Sbjct: 250 EVIYYVRDGNILACPENCPLELYN 273
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (420), Expect = 6e-50
Identities = 52/250 (20%), Positives = 98/250 (39%), Gaps = 16/250 (6%)
Query: 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQE---FLAQVSMVSRLK 119
+ +++ IG GSYGR + G+ K+LD + E +++V+++ LK
Sbjct: 2 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELK 61
Query: 120 NENVVELVGYYVDGPLRVL--AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAV 177
+ N+V +D L E+ G L ++ KG K L +++
Sbjct: 62 HPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVIT-----KGTKERQYLDEEFVLRVMT 116
Query: 178 GAARGLEYLHEK--AEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRV 235
L+ H + ++HR++K +NV L K+ DF L+ + +
Sbjct: 117 QLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTS--FAKAF 174
Query: 236 LGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQ-QSLVTWATPKL 294
+GT Y +PE + KSD++S G +L EL P + + ++
Sbjct: 175 VGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRI 234
Query: 295 SEDKVKQCVD 304
+ +
Sbjct: 235 PYRYSDELNE 244
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (420), Expect = 1e-49
Identities = 64/222 (28%), Positives = 103/222 (46%), Gaps = 19/222 (8%)
Query: 60 ELKEKTDNFGTNSL-IGEGSYGRVYFGVLR---SGRAAAIKKLDSSKQPD--QEFLAQVS 113
+L K DN + +G G++G V GV R AIK L + +E + +
Sbjct: 2 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQ 61
Query: 114 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRV 173
++ +L N +V L+G L +L E A G LH L GK+ + +
Sbjct: 62 IMHQLDNPYIVRLIGVCQAEAL-MLVMEMAGGGPLHKFLVGKREE--------IPVSNVA 112
Query: 174 KIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQA-PDAAARLHS 232
++ + G++YL EK +HR++ + NVLL + AKISDF LS D +
Sbjct: 113 ELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTAR 169
Query: 233 TRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
+ ++APE + SS+SDV+S+GV + E L+ +
Sbjct: 170 SAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQK 211
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (420), Expect = 1e-49
Identities = 49/217 (22%), Positives = 102/217 (47%), Gaps = 20/217 (9%)
Query: 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPD-QEFLAQVSMVSRLKNEN 122
D + +G+G++G+VY + + AA K +D+ + + ++++ ++ +++ + N
Sbjct: 11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPN 70
Query: 123 VVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARG 182
+V+L+ + + E + G++ ++ + L+ +Q +
Sbjct: 71 IVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERP--------LTESQIQVVCKQTLDA 122
Query: 183 LEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYH 242
L YLH+ +IIHR++K+ N+L D K++DF +S + R S +GT +
Sbjct: 123 LNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS--FIGTPYWM 177
Query: 243 APEYAMTGQM-----SSKSDVYSFGVVLLELLTGRKP 274
APE M K+DV+S G+ L+E+ P
Sbjct: 178 APEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPP 214
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (422), Expect = 2e-49
Identities = 52/242 (21%), Positives = 101/242 (41%), Gaps = 26/242 (10%)
Query: 66 DNFGTNSLIGEGSYGRVYFGVLRS------GRAAAIKKLDSSKQPD--QEFLAQVSMVSR 117
+N ++G G++G+V A+K L + ++++ M+++
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96
Query: 118 LKN-ENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKG--------------VKGAK 162
L + EN+V L+G L +E+ G L + L K+ ++ +
Sbjct: 97 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156
Query: 163 PGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222
VL++ + A A+G+E+L K +HR++ + NVL+ + KI DF L+
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARD 213
Query: 223 APDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRG 282
+ + + APE G + KSDV+S+G++L E+ + +P
Sbjct: 214 IMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD 273
Query: 283 QQ 284
Sbjct: 274 AN 275
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (418), Expect = 4e-49
Identities = 62/238 (26%), Positives = 116/238 (48%), Gaps = 26/238 (10%)
Query: 50 PIAVPVISVDELKEKTDNFGTNSLIGEGSYGRVYFGVLRSG---RAAAIKKLD--SSKQP 104
P PV+ +++K + +IGEG++G+V ++ AAIK++ +SK
Sbjct: 1 PTIYPVLDWNDIKFQ-------DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDD 53
Query: 105 DQEFLAQVSMVSRLKN-ENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVK---- 159
++F ++ ++ +L + N++ L+G LA E+A G+L D L + ++
Sbjct: 54 HRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPA 113
Query: 160 ---GAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISD 216
LS Q + A ARG++YL +K + IHR++ + N+L+ ++ +AKI+D
Sbjct: 114 FAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIAD 170
Query: 217 FDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
F LS + T + A E ++ SDV+S+GV+L E+++
Sbjct: 171 FGLSRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT 225
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (415), Expect = 4e-49
Identities = 63/223 (28%), Positives = 99/223 (44%), Gaps = 16/223 (7%)
Query: 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPD--QEFLAQVSMVSRLKNEN 122
+++ +GEG+YG V V R + A A+K +D + D + ++ + L +EN
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 123 VVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARG 182
VV+ G+ +G ++ L E+ S G L D + G + + G
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG---------MPEPDAQRFFHQLMAG 115
Query: 183 LEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYH 242
+ YLH I HR+IK N+LL + D KISDF L+ ++ GT Y
Sbjct: 116 VVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 172
Query: 243 APEYAMTGQMSS-KSDVYSFGVVLLELLTGRKPVDHTLPRGQQ 284
APE + + DV+S G+VL +L G P D Q+
Sbjct: 173 APELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE 215
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 162 bits (411), Expect = 4e-48
Identities = 57/209 (27%), Positives = 96/209 (45%), Gaps = 26/209 (12%)
Query: 74 IGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPD----QEFLAQVSMVSRLKNENVVELVG 128
IG GS+G VYF +R+ AIKK+ S + Q+ + +V + +L++ N ++ G
Sbjct: 23 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82
Query: 129 YYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHE 188
Y+ L E+ + + KK L + + GA +GL YLH
Sbjct: 83 CYLREHTAWLVMEYCLGSASDLLEVHKKP---------LQEVEIAAVTHGALQGLAYLHS 133
Query: 189 KAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAM 248
+IHR++K+ N+LL + + K+ DF ++ + +GT + APE +
Sbjct: 134 H---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP------ANSFVGTPYWMAPEVIL 184
Query: 249 T---GQMSSKSDVYSFGVVLLELLTGRKP 274
GQ K DV+S G+ +EL + P
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIELAERKPP 213
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 162 bits (410), Expect = 4e-48
Identities = 59/236 (25%), Positives = 105/236 (44%), Gaps = 29/236 (12%)
Query: 57 SVDELKEKTDNFGTN---------SLIGEGSYGRVYFGVLRS----GRAAAIKKLDS--S 101
+ ++ E F +IG G +G V G L+ AIK L S +
Sbjct: 8 TFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYT 67
Query: 102 KQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGA 161
++ ++FL++ S++ + + NV+ L G ++ E GSL L G
Sbjct: 68 EKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQF-- 125
Query: 162 KPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221
+ Q V + G A G++YL + +HR++ + N+L+ + + K+SDF LS
Sbjct: 126 ------TVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSR 176
Query: 222 QAPDAAARLHSTRVLG---TFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
D + T LG + APE + +S SDV+S+G+V+ E+++ +
Sbjct: 177 FLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGER 232
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (407), Expect = 1e-47
Identities = 55/220 (25%), Positives = 105/220 (47%), Gaps = 17/220 (7%)
Query: 57 SVDELKEKTDNFGTNSLIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQE-FLAQVSM 114
S+ + + + IG+G+ G VY + + +G+ AI++++ +QP +E + ++ +
Sbjct: 11 SIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILV 70
Query: 115 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVK 174
+ KN N+V + Y+ G + E+ + GSL D++ Q
Sbjct: 71 MRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCM----------DEGQIAA 120
Query: 175 IAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTR 234
+ + LE+LH ++IHR+IKS N+LL D K++DF Q + +
Sbjct: 121 VCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE--QSKRST 175
Query: 235 VLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
++GT + APE K D++S G++ +E++ G P
Sbjct: 176 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (406), Expect = 2e-47
Identities = 53/229 (23%), Positives = 98/229 (42%), Gaps = 25/229 (10%)
Query: 55 VISVDELKEKTDNFGTNSLIGEGSYGRVYFGVLR----SGRAAAIKKLDSSKQPDQ--EF 108
VI L +F +IG G +G VY G L A+K L+ + +F
Sbjct: 21 VIGPSSL---IVHFN--EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQF 75
Query: 109 LAQVSMVSRLKNENVVELVGYYVDGPLRV-LAYEHASKGSLHDILHGKKGVKGAKPGPVL 167
L + ++ + NV+ L+G + + + G L + + +
Sbjct: 76 LTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN--------P 127
Query: 168 SWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPD-- 225
+ + + A+G+++L K + +HR++ + N +L + K++DF L+ D
Sbjct: 128 TVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 184
Query: 226 AAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
+ + T + A E T + ++KSDV+SFGV+L EL+T P
Sbjct: 185 FDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 233
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (403), Expect = 3e-47
Identities = 61/264 (23%), Positives = 110/264 (41%), Gaps = 34/264 (12%)
Query: 66 DNFGTNSLIGEGSYGRVYFGVLRSG-----RAAAIKKLDSSKQPDQ--EFLAQVSMVSRL 118
+IG G +G VY G+L++ AIK L + Q +FL + ++ +
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66
Query: 119 KNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVG 178
+ N++ L G ++ E+ G+L L K G S Q V + G
Sbjct: 67 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGE--------FSVLQLVGMLRG 118
Query: 179 AARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHST-RVLG 237
A G++YL +HR++ + N+L+ + + K+SDF LS D ++T
Sbjct: 119 IAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKI 175
Query: 238 TFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSED 297
+ APE + +S SDV+SFG+V+ E++T + +LS
Sbjct: 176 PIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYW---------------ELSNH 220
Query: 298 KVKQCVDTKLGGEYPPKAIAKVRK 321
+V + ++ P + + +
Sbjct: 221 EVMKAINDGFRLPTPMDCPSAIYQ 244
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (402), Expect = 3e-47
Identities = 55/219 (25%), Positives = 87/219 (39%), Gaps = 24/219 (10%)
Query: 74 IGEGSYGRVYFGVLR-SGRAAAIKKLDS---SKQPDQEFLAQVSMVSRLKNENVVELVGY 129
IG GS+ VY G+ + A +L +K Q F + M+ L++ N+V
Sbjct: 17 IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDS 76
Query: 130 YVD----GPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEY 185
+ VL E + G+L L K V+ +GL++
Sbjct: 77 WESTVKGKKCIVLVTELMTSGTLKTYLKRFK---------VMKIKVLRSWCRQILKGLQF 127
Query: 186 LHEKAEPRIIHRNIKSSNVLLFDDD-IAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAP 244
LH + P IIHR++K N+ + KI D L+ + + V+GT + AP
Sbjct: 128 LHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS----FAKAVIGTPEFMAP 182
Query: 245 EYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQ 283
E + DVY+FG+ +LE+ T P Q
Sbjct: 183 EM-YEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ 220
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (398), Expect = 2e-46
Identities = 55/208 (26%), Positives = 92/208 (44%), Gaps = 20/208 (9%)
Query: 74 IGEGSYGRVYFGVLR---SGRAAAIKKLDSSKQPD---QEFLAQVSMVSRLKNENVVELV 127
+G G++G V G + + A+K L + E LA+ +++ +L N +V ++
Sbjct: 15 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 74
Query: 128 GYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLH 187
G +L E A G L+ L + + +++ + G++YL
Sbjct: 75 GICEAESW-MLVMEMAELGPLNKYLQQNRH---------VKDKNIIELVHQVSMGMKYLE 124
Query: 188 EKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ-APDAAARLHSTRVLGTFGYHAPEY 246
E +HR++ + NVLL AKISDF LS D T ++APE
Sbjct: 125 ES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPEC 181
Query: 247 AMTGQMSSKSDVYSFGVVLLELLTGRKP 274
+ SSKSDV+SFGV++ E + +
Sbjct: 182 INYYKFSSKSDVWSFGVLMWEAFSYGQK 209
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (387), Expect = 7e-45
Identities = 53/248 (21%), Positives = 92/248 (37%), Gaps = 17/248 (6%)
Query: 62 KEKTDNFGTNSLIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQV----SMVS 116
K++ ++F ++GEGS+ V L + R AIK L+ + + V ++S
Sbjct: 4 KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 63
Query: 117 RLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIA 176
RL + V+L + D +A G L +
Sbjct: 64 RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS---------FDETCTRFYT 114
Query: 177 VGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVL 236
LEYLH IIHR++K N+LL +D +I+DF + + + + +
Sbjct: 115 AEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFV 171
Query: 237 GTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSE 296
GT Y +PE SD+++ G ++ +L+ G P + E
Sbjct: 172 GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPE 231
Query: 297 DKVKQCVD 304
+ D
Sbjct: 232 KFFPKARD 239
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (389), Expect = 9e-45
Identities = 51/218 (23%), Positives = 95/218 (43%), Gaps = 19/218 (8%)
Query: 64 KTDNFGTNSLIGEGSYGRVYFGVLRS-----GRAAAIKKLDSSKQPD--QEFLAQVSMVS 116
K F ++G G++G VY G+ AIK+L + P +E L + +++
Sbjct: 7 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMA 66
Query: 117 RLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIA 176
+ N +V L+G + ++++ + G L D + K +
Sbjct: 67 SVDNPHVCRLLGICLTSTVQLI-TQLMPFGCLLDYVREHKDNI--------GSQYLLNWC 117
Query: 177 VGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVL 236
V A+G+ YL ++ R++HR++ + NVL+ KI+DF L+ H+
Sbjct: 118 VQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 174
Query: 237 GTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
+ A E + + +SDV+S+GV + EL+T
Sbjct: 175 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSK 212
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (379), Expect = 7e-44
Identities = 56/215 (26%), Positives = 95/215 (44%), Gaps = 19/215 (8%)
Query: 66 DNFGTNSLIGEGSYGRVYFGVLRS----GRAAAIKKLDSSKQPD--QEFLAQVSMVSRLK 119
+ IGEG +G V+ G+ S A AIK + ++FL + + +
Sbjct: 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66
Query: 120 NENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGA 179
+ ++V+L+G + P+ ++ E + G L L +K L A + A
Sbjct: 67 HPHIVKLIGVITENPVWII-MELCTLGELRSFLQVRKYS--------LDLASLILYAYQL 117
Query: 180 ARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTF 239
+ L YL K R +HR+I + NVL+ +D K+ DF LS D+ +++
Sbjct: 118 STALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY-KASKGKLPI 173
Query: 240 GYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
+ APE + +S SDV+ FGV + E+L
Sbjct: 174 KWMAPESINFRRFTSASDVWMFGVCMWEILMHGVK 208
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (382), Expect = 7e-44
Identities = 59/232 (25%), Positives = 106/232 (45%), Gaps = 12/232 (5%)
Query: 52 AVPVISVDELKEKTDNFGTNSLIGEGSYGRVYFGVLR------SGRAAAIKKLD--SSKQ 103
A V DE + + + +G+GS+G VY GV + AIK ++ +S +
Sbjct: 6 AADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMR 65
Query: 104 PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKP 163
EFL + S++ +VV L+G G ++ E ++G L L + P
Sbjct: 66 ERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNP 125
Query: 164 -GPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222
S ++ +++A A G+ YL+ + +HR++ + N ++ +D KI DF ++
Sbjct: 126 VLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRD 182
Query: 223 APDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
+ + L + +PE G ++ SDV+SFGVVL E+ T +
Sbjct: 183 IYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQ 234
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (379), Expect = 2e-43
Identities = 60/236 (25%), Positives = 106/236 (44%), Gaps = 21/236 (8%)
Query: 66 DNFGTNSLIGEGSYGRVYFGVLRS--------GRAAAIKKL--DSSKQPDQEFLAQVSMV 115
D +GEG++G+V A+K L D++++ + ++++ M+
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72
Query: 116 SRLKN-ENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKG-------VKGAKPGPVL 167
+ +N++ L+G + E+ASKG+L + L ++ P L
Sbjct: 73 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132
Query: 168 SWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAA 227
S V A ARG+EYL K + IHR++ + NVL+ +D++ KI+DF L+
Sbjct: 133 SSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189
Query: 228 ARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQ 283
+T + APE + +SDV+SFGV+L E+ T +P +
Sbjct: 190 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE 245
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (373), Expect = 6e-43
Identities = 60/218 (27%), Positives = 92/218 (42%), Gaps = 21/218 (9%)
Query: 66 DNFGTNSLIGEGSYGRVYFGVLRS----GRAAAIKKLD----SSKQPDQEFLAQVSMVSR 117
+ +G+GS+G V G + + A+K L S + +F+ +V+ +
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 118 LKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAV 177
L + N++ L G + P++ + E A GSL D L +G + AV
Sbjct: 68 LDHRNLIRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGH--------FLLGTLSRYAV 118
Query: 178 GAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLH-STRVL 236
A G+ YL K R IHR++ + N+LL D+ KI DF L P
Sbjct: 119 QVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRK 175
Query: 237 GTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
F + APE T S SD + FGV L E+ T +
Sbjct: 176 VPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQE 213
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 149 bits (378), Expect = 7e-43
Identities = 50/241 (20%), Positives = 97/241 (40%), Gaps = 18/241 (7%)
Query: 66 DNFGTNSLIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQE-FLAQVSMVSRLKNENV 123
D++ + +G G++G V+ +G A K + + + D+E ++ +S L++ +
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85
Query: 124 VELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGL 183
V L + D V+ YE S G L + + + +S + V+ +GL
Sbjct: 86 VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNK--------MSEDEAVEYMRQVCKGL 137
Query: 184 EYLHEKAEPRIIHRNIKSSNVLLFDDD--IAKISDFDLSNQAPDAAARLHSTRVLGTFGY 241
++HE +H ++K N++ K+ DF L+ + +T GT +
Sbjct: 138 CHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT---GTAEF 191
Query: 242 HAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQ 301
APE A + +D++S GV+ LL+G P V + +
Sbjct: 192 AAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSG 251
Query: 302 C 302
Sbjct: 252 I 252
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 149 bits (378), Expect = 8e-43
Identities = 55/249 (22%), Positives = 102/249 (40%), Gaps = 20/249 (8%)
Query: 60 ELKEKT--DNFGTNSLIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQE-FLAQVSMV 115
E+K+ + D + +G G++G V+ V +GR K +++ D+ ++S++
Sbjct: 21 EVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIM 80
Query: 116 SRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKI 175
++L + ++ L + D VL E S G L D + + +S A+ +
Sbjct: 81 NQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYK--------MSEAEVINY 132
Query: 176 AVGAARGLEYLHEKAEPRIIHRNIKSSNVLL--FDDDIAKISDFDLSNQAPDAAARLHST 233
A GL+++HE I+H +IK N++ KI DF L+ + +T
Sbjct: 133 MRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT 189
Query: 234 RVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPK 293
T + APE + +D+++ GV+ LL+G P V +
Sbjct: 190 ---ATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWE 246
Query: 294 LSEDKVKQC 302
ED
Sbjct: 247 FDEDAFSSV 255
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (374), Expect = 2e-42
Identities = 43/244 (17%), Positives = 91/244 (37%), Gaps = 17/244 (6%)
Query: 62 KEKTDNFGTNSLIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKN 120
KE + + +G G +G V+ V S + K + ++S+++ ++
Sbjct: 1 KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARH 60
Query: 121 ENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAA 180
N++ L + V+ +E S + + ++ L+ + V
Sbjct: 61 RNILHLHESFESMEELVMIFEFISGLDIFERIN--------TSAFELNEREIVSYVHQVC 112
Query: 181 RGLEYLHEKAEPRIIHRNIKSSNVLLFDDD--IAKISDFDLSNQAPDAAARLHSTRVLGT 238
L++LH I H +I+ N++ KI +F + Q + +
Sbjct: 113 EALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD---NFRLLFTA 166
Query: 239 FGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDK 298
Y+APE +S+ +D++S G ++ LL+G P + + A E+
Sbjct: 167 PEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEA 226
Query: 299 VKQC 302
K+
Sbjct: 227 FKEI 230
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (371), Expect = 2e-42
Identities = 52/256 (20%), Positives = 101/256 (39%), Gaps = 25/256 (9%)
Query: 66 DNFGTNSLIGEGSYGRVYFGVLR------SGRAAAIKKL--DSSKQPDQEFLAQVSMVSR 117
D +G G++G+V + R A+K L ++ + ++++ ++
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72
Query: 118 LKNE-NVVELVGYYV-DGPLRVLAYEHASKGSLHDILHGKKG-------VKGAKPGPVLS 168
+ + NVV L+G G ++ E G+L L K+ L+
Sbjct: 73 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132
Query: 169 WAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAA 228
+ + A+G+E+L + + IHR++ + N+LL + ++ KI DF L+
Sbjct: 133 LEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189
Query: 229 RLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVT 288
+ + APE + +SDV+SFGV+L E+ + P +
Sbjct: 190 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS-----PYPGVKIDE 244
Query: 289 WATPKLSEDKVKQCVD 304
+L E + D
Sbjct: 245 EFCRRLKEGTRMRAPD 260
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 143 bits (361), Expect = 4e-41
Identities = 56/220 (25%), Positives = 100/220 (45%), Gaps = 22/220 (10%)
Query: 65 TDNFGTNSLIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQE----FLAQVSMVSRLK 119
+D + ++G G V+ LR R A+K L + D F + + L
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 120 NENVVELVGYYVD----GPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKI 175
+ +V + GPL + E+ +L DI+H + ++ + +++
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---------MTPKRAIEV 116
Query: 176 AVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHST-R 234
A + L + H+ IIHR++K +N+++ + K+ DF ++ D+ + T
Sbjct: 117 IADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAA 173
Query: 235 VLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
V+GT Y +PE A + ++SDVYS G VL E+LTG P
Sbjct: 174 VIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 213
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 143 bits (361), Expect = 4e-41
Identities = 55/255 (21%), Positives = 94/255 (36%), Gaps = 33/255 (12%)
Query: 66 DNFGTNSLIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPD----------QEFLAQVSM 114
+N+ ++G G V + + + A+K +D + + L +V +
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62
Query: 115 VSRLKNE-NVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRV 173
+ ++ N+++L Y L ++ KG L D L K LS +
Sbjct: 63 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT---------LSEKETR 113
Query: 174 KIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHST 233
KI + LH+ I+HR++K N+LL DD K++DF S Q
Sbjct: 114 KIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE---KLR 167
Query: 234 RVLGTFGYHAPEYAMTGQM------SSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLV 287
V GT Y APE + D++S GV++ LL G P H ++
Sbjct: 168 EVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMI 227
Query: 288 TWATPKLSEDKVKQC 302
+ +
Sbjct: 228 MSGNYQFGSPEWDDY 242
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (359), Expect = 2e-40
Identities = 50/245 (20%), Positives = 96/245 (39%), Gaps = 20/245 (8%)
Query: 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQV-----SMVSRLK 119
++F + ++G+GS+G+V+ + + + AIK L + + + +
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 120 NENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGA 179
+ + + + E+ + G L + ++ A
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK---------FDLSRATFYAAEI 112
Query: 180 ARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTF 239
GL++LH K I++R++K N+LL D KI+DF + + A+ + GT
Sbjct: 113 ILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK--TNTFCGTP 167
Query: 240 GYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKV 299
Y APE + + + D +SFGV+L E+L G+ P + P
Sbjct: 168 DYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLE 227
Query: 300 KQCVD 304
K+ D
Sbjct: 228 KEAKD 232
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 141 bits (357), Expect = 1e-39
Identities = 54/231 (23%), Positives = 92/231 (39%), Gaps = 25/231 (10%)
Query: 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLD----SSKQPDQEFLAQVSMVSRLKN 120
++F + +IG G +G VY +G+ A+K LD KQ + L + M+S +
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 121 ---ENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAV 177
+V + + + + G LH L A A
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFS---------EADMRFYAA 114
Query: 178 GAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLG 237
GLE++H + +++R++K +N+LL + +ISD L+ +G
Sbjct: 115 EIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKK----KPHASVG 167
Query: 238 TFGYHAPEYAMTGQM-SSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLV 287
T GY APE G S +D +S G +L +LL G P + + +
Sbjct: 168 THGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID 218
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 137 bits (347), Expect = 1e-38
Identities = 54/244 (22%), Positives = 92/244 (37%), Gaps = 21/244 (8%)
Query: 65 TDNFGTNSLIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQE--FLAQVSMVSRLKNE 121
D + ++G G++ V R+ + AIK + +E +++++ ++K+
Sbjct: 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHP 67
Query: 122 NVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAAR 181
N+V L Y G L + S G L D + K + ++
Sbjct: 68 NIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG---------FYTERDASRLIFQVLD 118
Query: 182 GLEYLHEKAEPRIIHRNIKSSNVLLF---DDDIAKISDFDLSNQAPDAAARLHSTRVLGT 238
++YLH+ I+HR++K N+L + +D ISDF LS + + GT
Sbjct: 119 AVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVL---STACGT 172
Query: 239 FGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDK 298
GY APE S D +S GV+ LL G P + A +
Sbjct: 173 PGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPY 232
Query: 299 VKQC 302
Sbjct: 233 WDDI 236
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (344), Expect = 6e-38
Identities = 60/244 (24%), Positives = 102/244 (41%), Gaps = 22/244 (9%)
Query: 72 SLIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPD--QEFLAQVSMVSRLKNENVVELVG 128
S IGEG+YG V + AIKK+ + Q L ++ ++ R ++EN++ +
Sbjct: 14 SYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 73
Query: 129 YYVDGPLRVLAY----EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLE 184
+ + H L+ +L + LS RGL+
Sbjct: 74 IIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH----------LSNDHICYFLYQILRGLK 123
Query: 185 YLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQA-PDAAARLHSTRVLGTFGYHA 243
Y+H ++HR++K SN+LL KI DF L+ A PD T + T Y A
Sbjct: 124 YIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 180
Query: 244 PEYAMTGQMSSKS-DVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQC 302
PE + + +KS D++S G +L E+L+ R Q + + S++ +
Sbjct: 181 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 240
Query: 303 VDTK 306
++ K
Sbjct: 241 INLK 244
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 134 bits (338), Expect = 2e-37
Identities = 57/244 (23%), Positives = 96/244 (39%), Gaps = 22/244 (9%)
Query: 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPD----QEFLAQVSMVSRLKN 120
+F +G GS+GRV+ R +GR A+K L + + M+S + +
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 121 ENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAA 180
++ + G + D + ++ G L +L + A
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRF---------PNPVAKFYAAEVC 114
Query: 181 RGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFG 240
LEYLH K II+R++K N+LL + KI+DF + PD + + GT
Sbjct: 115 LALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPD-----VTYTLCGTPD 166
Query: 241 YHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVK 300
Y APE T + D +SFG+++ E+L G P + + A + +
Sbjct: 167 YIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNE 226
Query: 301 QCVD 304
D
Sbjct: 227 DVKD 230
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (331), Expect = 2e-36
Identities = 52/274 (18%), Positives = 100/274 (36%), Gaps = 27/274 (9%)
Query: 72 SLIGEGSYGRVYFGVLR--SGRAAAIKKLDSSKQPDQEFLAQV------SMVSRLKNENV 123
+ IGEG+YG+V+ GR A+K++ + L+ + + ++ NV
Sbjct: 13 AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV 72
Query: 124 VELVGYYVDGPLR-----VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVG 178
V L L +EH + + P P + +
Sbjct: 73 VRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDK--------VPEPGVPTETIKDMMFQ 124
Query: 179 AARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGT 238
RGL++LH R++HR++K N+L+ K++DF L+ ++ T V+ T
Sbjct: 125 LLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSF---QMALTSVVVT 178
Query: 239 FGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDK 298
Y APE + ++ D++S G + E+ + + Q + E+
Sbjct: 179 LWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 238
Query: 299 VKQCVDTKLGGEYPPKAIAKVRKKKFITSECSNI 332
+ V + A + I ++
Sbjct: 239 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDL 272
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 131 bits (329), Expect = 2e-36
Identities = 45/212 (21%), Positives = 89/212 (41%), Gaps = 16/212 (7%)
Query: 66 DNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPD---QEFLAQVSMVSRLKNEN 122
+ + IGEG+YG VY G A+KK+ K+ + + ++S++ LK+ N
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 123 VVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARG 182
+V+L VL +EH + + + G L + G
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGG---------LESVTAKSFLLQLLNG 112
Query: 183 LEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYH 242
+ Y H++ R++HR++K N+L+ + KI+DF L+ + ++ +
Sbjct: 113 IAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYT-HEIVTLWYRA 168
Query: 243 APEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
+ + S+ D++S G + E++ G
Sbjct: 169 PDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPL 200
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (329), Expect = 8e-36
Identities = 57/270 (21%), Positives = 100/270 (37%), Gaps = 24/270 (8%)
Query: 51 IAVPVISVDELKEKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFL 109
+A P D +E ++ +IG GS+G VY L SG AIKK+ K+
Sbjct: 7 VATPGQGPDRPQE--VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR---FKN 61
Query: 110 AQVSMVSRLKNENVVELVGYYV------DGPLRVLAYEHASKGSLHDILHGKKGVKGAKP 163
++ ++ +L + N+V L ++ D L ++ + H +
Sbjct: 62 RELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRA------ 115
Query: 164 GPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD-IAKISDFDLSNQ 222
L R L Y+H I HR+IK N+LL D + K+ DF + Q
Sbjct: 116 KQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 172
Query: 223 APDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRG 282
+ + + + +S DV+S G VL ELL G+
Sbjct: 173 LVRG--EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD 230
Query: 283 QQSLVTWATPKLSEDKVKQCVDTKLGGEYP 312
Q + + +++++ ++P
Sbjct: 231 QLVEIIKVLGTPTREQIREMNPNYTEFKFP 260
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (326), Expect = 8e-36
Identities = 44/213 (20%), Positives = 88/213 (41%), Gaps = 16/213 (7%)
Query: 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPD---QEFLAQVSMVSRLKNE 121
+NF IGEG+YG VY + +G A+KK+ + + + ++S++ L +
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 122 NVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAAR 181
N+V+L+ L +E + + + +
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTG--------IPLPLIKSYLFQLLQ 113
Query: 182 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGY 241
GL + H R++HR++K N+L+ + K++DF L+ +A R ++ V+ +
Sbjct: 114 GLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA-RAFGVPVRTYTHEVVTLWYR 169
Query: 242 HAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
S+ D++S G + E++T R
Sbjct: 170 APEILLGCKYYSTAVDIWSLGCIFAEMVTRRAL 202
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 126 bits (318), Expect = 9e-35
Identities = 49/300 (16%), Positives = 95/300 (31%), Gaps = 42/300 (14%)
Query: 73 LIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKN-ENVVELVGYY 130
IGEGS+G ++ G L + + AIK + + L + + +
Sbjct: 12 RIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD-APQLRDEYRTYKLLAGCTGIPNVYYFG 70
Query: 131 VDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKA 190
+G VL + + G S A ++ +HEK
Sbjct: 71 QEGLHNVLVIDLLGPSLEDLLD---------LCGRKFSVKTVAMAAKQMLARVQSIHEK- 120
Query: 191 EPRIIHRNIKSSNVLL-----FDDDIAKISDFDLSNQAPDAAARLH-----STRVLGTFG 240
+++R+IK N L+ + ++ + DF + D + H + GT
Sbjct: 121 --SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTAR 178
Query: 241 YHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVK 300
Y + + + S + D+ + G V + L G P + K ++
Sbjct: 179 YMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLR 238
Query: 301 QCVDTKLGGEYPP---KAIAKVRKKKF--------ITSECSNISFAEFNINWHCPLEWSV 349
+ L +P K + R F + S + N +W++
Sbjct: 239 E-----LCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKV-LERLNTTEDENFDWNL 292
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 126 bits (317), Expect = 1e-34
Identities = 44/225 (19%), Positives = 80/225 (35%), Gaps = 23/225 (10%)
Query: 73 LIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYY- 130
IG GS+G +Y G + +G AIK + + + + ++ + + +
Sbjct: 14 KIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-HPQLHIESKIYKMMQGGVGIPTIRWCG 72
Query: 131 VDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKA 190
+G V+ E + S + +A +EY+H K
Sbjct: 73 AEGDYNVMVMELLGPSLEDLFNFCSRK---------FSLKTVLLLADQMISRIEYIHSK- 122
Query: 191 EPRIIHRNIKSSNVLLFDDD---IAKISDFDLSNQAPDAAARLH-----STRVLGTFGYH 242
IHR++K N L+ + I DF L+ + DA H + + GT Y
Sbjct: 123 --NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 180
Query: 243 APEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLV 287
+ + + S + D+ S G VL+ G P ++
Sbjct: 181 SINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKY 225
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (317), Expect = 2e-34
Identities = 48/233 (20%), Positives = 95/233 (40%), Gaps = 22/233 (9%)
Query: 73 LIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPD------QEFLAQVSMVSRLKNENVVE 125
+GEG + VY + + + AIKK+ + + + L ++ ++ L + N++
Sbjct: 5 FLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIG 64
Query: 126 LVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEY 185
L+ + L ++ I L+ + + +GLEY
Sbjct: 65 LLDAFGHKSNISLVFDFMETDLEVIIKDNSLV---------LTPSHIKAYMLMTLQGLEY 115
Query: 186 LHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245
LH+ I+HR++K +N+LL ++ + K++DF L+ T + T Y APE
Sbjct: 116 LHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGS--PNRAYTHQVVTRWYRAPE 170
Query: 246 YAMTGQM-SSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSED 297
+M D+++ G +L ELL + Q + + +E+
Sbjct: 171 LLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEE 223
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (319), Expect = 2e-34
Identities = 49/244 (20%), Positives = 92/244 (37%), Gaps = 19/244 (7%)
Query: 66 DNFGTNSLIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQE----FLAQVSMVSRLKN 120
++F L+G+G++G+V +GR A+K L ++ + + ++ ++
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 121 ENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAA 180
+ L + E+A+ G L L ++ + +
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERV---------FTEERARFYGAEIV 115
Query: 181 RGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFG 240
LEYLH + +++R+IK N++L D KI+DF L + A + GT
Sbjct: 116 SALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMK--TFCGTPE 170
Query: 241 YHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVK 300
Y APE D + GVV+ E++ GR P + L+ +
Sbjct: 171 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSP 230
Query: 301 QCVD 304
+
Sbjct: 231 EAKS 234
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (312), Expect = 5e-34
Identities = 44/217 (20%), Positives = 82/217 (37%), Gaps = 27/217 (12%)
Query: 73 LIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPD-------QEFLAQVSMVSRLKN--EN 122
L+G G +G VY G+ + AIK ++ + D +V ++ ++ +
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 123 VVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARG 182
V+ L+ ++ VL E ++G L
Sbjct: 71 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA--------LQEELARSFFWQVLEA 122
Query: 183 LEYLHEKAEPRIIHRNIKSSNVLL-FDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGY 241
+ + H ++HR+IK N+L+ + K+ DF D T GT Y
Sbjct: 123 VRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----VYTDFDGTRVY 175
Query: 242 HAPEYAMTGQMSSKS-DVYSFGVVLLELLTGRKPVDH 277
PE+ + +S V+S G++L +++ G P +H
Sbjct: 176 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 212
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (313), Expect = 1e-33
Identities = 45/226 (19%), Positives = 86/226 (38%), Gaps = 27/226 (11%)
Query: 60 ELKEKT--DNFG-TNSLIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQVSMV 115
++K+ D++ T+ ++G G G+V R+ A+K L + +E
Sbjct: 3 QIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVEL---HW 59
Query: 116 SRLKNENVVELVGYYVDGPLR----VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQ 171
+ ++V +V Y + ++ E G L + + + +
Sbjct: 60 RASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQ-------DRGDQAFTERE 112
Query: 172 RVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLL---FDDDIAKISDFDLSNQAPDAAA 228
+I ++YLH I HR++K N+L + I K++DF + + +
Sbjct: 113 ASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS 169
Query: 229 RLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
T Y APE + D++S GV++ LL G P
Sbjct: 170 LTTPCY---TPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP 212
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (307), Expect = 4e-33
Identities = 51/249 (20%), Positives = 99/249 (39%), Gaps = 27/249 (10%)
Query: 66 DNFGTNSLIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPD-------QEFLAQVSMVSR 117
D + T +G G + V +G A K + + ++ +VS++
Sbjct: 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 118 LKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAV 177
+++ NV+ L Y + +L E + G L D L K+ L+ + +
Sbjct: 70 IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES---------LTEEEATEFLK 120
Query: 178 GAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIA----KISDFDLSNQAPDAAARLHST 233
G+ YLH +I H ++K N++L D ++ KI DF L+++
Sbjct: 121 QILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN---EFK 174
Query: 234 RVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPK 293
+ GT + APE + ++D++S GV+ LL+G P + + V+ +
Sbjct: 175 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYE 234
Query: 294 LSEDKVKQC 302
++
Sbjct: 235 FEDEYFSNT 243
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 121 bits (303), Expect = 4e-32
Identities = 48/244 (19%), Positives = 86/244 (35%), Gaps = 22/244 (9%)
Query: 66 DNFGTNSLIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPD----QEFLAQVSMVSRLKN 120
D F +G GS+GRV SG A+K LD K + L + ++ +
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 121 ENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAA 180
+V+L + D + E+ + G + L S A
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR---------FSEPHARFYAAQIV 151
Query: 181 RGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFG 240
EYLH +I+R++K N+L+ +++DF + + + + GT
Sbjct: 152 LTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWTLCGTPE 203
Query: 241 YHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVK 300
APE ++ + D ++ GV++ E+ G P P + +
Sbjct: 204 ALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSS 263
Query: 301 QCVD 304
D
Sbjct: 264 DLKD 267
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (301), Expect = 4e-32
Identities = 50/271 (18%), Positives = 111/271 (40%), Gaps = 11/271 (4%)
Query: 74 IGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPD---QEFLAQVSMVSRLKNENVVELVGY 129
IG+G++G V+ R +G+ A+KK+ + + L ++ ++ LK+ENVV L+
Sbjct: 18 IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 77
Query: 130 YVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEK 189
+ + H G+ + ++ ++ GL Y+H
Sbjct: 78 CRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK-FTLSEIKRVMQMLLNGLYYIHR- 135
Query: 190 AEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ--APDAAARLHSTRVLGTFGYHAPEYA 247
+I+HR++K++NVL+ D + K++DF L+ + T + T Y PE
Sbjct: 136 --NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELL 193
Query: 248 MTGQM-SSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDTK 306
+ + D++ G ++ E+ T + + Q +L++ ++ + + +
Sbjct: 194 LGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYE 253
Query: 307 LGGEYPPKAIAKVRKKKFITSECSNISFAEF 337
L + K + K + + + +
Sbjct: 254 LYEKLELVKGQKRKVKDRLKAYVRDPYALDL 284
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (292), Expect = 5e-31
Identities = 40/205 (19%), Positives = 80/205 (39%), Gaps = 17/205 (8%)
Query: 74 IGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPD---QEFLAQVSMVSRLKNENVVELVGY 129
IGEG+YG V+ R + A+K++ + L ++ ++ LK++N+V L
Sbjct: 10 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69
Query: 130 YVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEK 189
L +E + + +GL + H +
Sbjct: 70 LHSDKKLTLVFEFCDQDLKKYFDSCNGDLD---------PEIVKSFLFQLLKGLGFCHSR 120
Query: 190 AEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMT 249
++HR++K N+L+ + K+++F L+ +A R +S V+ +
Sbjct: 121 ---NVLHRDLKPQNLLINRNGELKLANFGLA-RAFGIPVRCYSAEVVTLWYRPPDVLFGA 176
Query: 250 GQMSSKSDVYSFGVVLLELLTGRKP 274
S+ D++S G + EL +P
Sbjct: 177 KLYSTSIDMWSAGCIFAELANAGRP 201
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (290), Expect = 2e-30
Identities = 54/235 (22%), Positives = 95/235 (40%), Gaps = 18/235 (7%)
Query: 73 LIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPD---QEFLAQVSMVSRLKNENVVELVG 128
+G G+YG V V R+G AIKKL Q + + ++ ++ +++ENV+ L+
Sbjct: 25 PVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLD 84
Query: 129 YYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHE 188
+ + GK L + + +GL Y+H
Sbjct: 85 VFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEK-----LGEDRIQFLVYQMLKGLRYIHA 139
Query: 189 KAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAM 248
IIHR++K N+ + +D KI DF L+ QA T + T Y APE +
Sbjct: 140 A---GIIHRDLKPGNLAVNEDCELKILDFGLARQADS-----EMTGYVVTRWYRAPEVIL 191
Query: 249 TGQ-MSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQC 302
+ D++S G ++ E++TG+ + Q + T + V++
Sbjct: 192 NWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRL 246
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 110 bits (274), Expect = 5e-28
Identities = 37/213 (17%), Positives = 81/213 (38%), Gaps = 11/213 (5%)
Query: 73 LIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYV 131
+G G + V+ + + A+K + K + ++ ++ R+ + + +
Sbjct: 20 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGA 79
Query: 132 DGPLRVLAY--EHASKGSLHDILHGKKGVKG-----AKPGPVLSWAQRVKIAVGAARGLE 184
+ L++L + G ++ G + +I+ GL+
Sbjct: 80 NHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLD 139
Query: 185 YLHEKAEPRIIHRNIKSSNVLL-FDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHA 243
Y+H + IIH +IK NVL+ D + +++ H T + T Y +
Sbjct: 140 YMHRR--CGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYRS 197
Query: 244 PEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVD 276
PE + +D++S ++ EL+TG +
Sbjct: 198 PEVLLGAPWGCGADIWSTACLIFELITGDFLFE 230
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 107 bits (267), Expect = 3e-27
Identities = 37/218 (16%), Positives = 82/218 (37%), Gaps = 26/218 (11%)
Query: 63 EKTDNFGTNSLIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLK-N 120
D++ +G G Y V+ + + + +K L K+ ++ ++ ++ L+
Sbjct: 32 GNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK--KKIKREIKILENLRGG 89
Query: 121 ENVVELVGYYVDGPLR--VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVG 178
N++ L D R L +EH + + L+
Sbjct: 90 PNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT------------LTDYDIRFYMYE 137
Query: 179 AARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD-IAKISDFDLSNQAPDAAARLHSTRVLG 237
+ L+Y H I+HR++K NV++ + ++ D+ L+ +
Sbjct: 138 ILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ---EYNVRVA 191
Query: 238 TFGYHAPEYAMTGQM-SSKSDVYSFGVVLLELLTGRKP 274
+ + PE + QM D++S G +L ++ ++P
Sbjct: 192 SRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEP 229
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (264), Expect = 8e-27
Identities = 51/234 (21%), Positives = 93/234 (39%), Gaps = 25/234 (10%)
Query: 66 DNFGTNSLIGEGSYGRVYFGVL----RSGRAAAIKKLDSSKQPD-----QEFLAQVSMVS 116
+NF ++G G+YG+V+ +G+ A+K L + + + ++
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 117 RLKNE-NVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKI 175
++ +V L + L ++ + G L L ++ + +
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRER---------FTEHEVQIY 134
Query: 176 AVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRV 235
LE+LH+ II+R+IK N+LL + ++DF LS + A +
Sbjct: 135 VGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEF-VADETERAYDF 190
Query: 236 LGTFGYHAPEYAMTGQM--SSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLV 287
GT Y AP+ G D +S GV++ ELLTG P + Q+ +
Sbjct: 191 CGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEI 244
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 105 bits (263), Expect = 1e-26
Identities = 57/249 (22%), Positives = 99/249 (39%), Gaps = 26/249 (10%)
Query: 63 EKTDNFGTNSLIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPD---QEFLAQVSMVSRL 118
E + + S +G G+YG V ++G A+KKL Q + ++ ++ +
Sbjct: 15 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 74
Query: 119 KNENVVELVGYYVDGP-----LRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRV 173
K+ENV+ L+ + V H L++I+ +K L+
Sbjct: 75 KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK----------LTDDHVQ 124
Query: 174 KIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHST 233
+ RGL+Y+H IIHR++K SN+ + +D KI DF L+ D +
Sbjct: 125 FLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTG 177
Query: 234 RVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPK 293
V + + D++S G ++ ELLTGR T Q L+
Sbjct: 178 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 237
Query: 294 LSEDKVKQC 302
+ +K+
Sbjct: 238 PGAELLKKI 246
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 101 bits (252), Expect = 5e-25
Identities = 48/243 (19%), Positives = 86/243 (35%), Gaps = 28/243 (11%)
Query: 73 LIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPD---QEFLAQVSMVSRLKNENVVELVG 128
IG G+ G V R AIKKL Q + ++ ++ + ++N++ L+
Sbjct: 24 PIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 83
Query: 129 YYV------DGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARG 182
+ + L E I + + G
Sbjct: 84 VFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL------------DHERMSYLLYQMLCG 131
Query: 183 LEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYH 242
+++LH IIHR++K SN+++ D KI DF L+ A T + T Y
Sbjct: 132 IKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT---SFMMTPYVVTRYYR 185
Query: 243 APEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQC 302
APE + D++S G ++ E++ + Q + V + +K+
Sbjct: 186 APEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 245
Query: 303 VDT 305
T
Sbjct: 246 QPT 248
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 66.0 bits (160), Expect = 2e-13
Identities = 26/160 (16%), Positives = 46/160 (28%), Gaps = 27/160 (16%)
Query: 72 SLIGEGSYGRVYFGVLRSGRAAAIKKLDSSK-----------QPDQEFLAQVSMVSRLKN 120
L+GEG V+ +K D F +R +
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 121 ENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAA 180
+ +L G V P +A L D + ++
Sbjct: 66 RALQKLQGLAV--PKVYAWEGNAVLMELIDAKELYRVR----------VENPDEVLDMIL 113
Query: 181 RGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220
+ + + I+H ++ NVL+ ++ I I DF S
Sbjct: 114 EEVAKFYHR---GIVHGDLSQYNVLVSEEGI-WIIDFPQS 149
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 351 | |||
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.93 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.91 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.5 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.16 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.8 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.62 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 97.48 |
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-55 Score=385.40 Aligned_cols=240 Identities=27% Similarity=0.361 Sum_probs=199.6
Q ss_pred hcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCC--chHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEEE
Q 018712 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ--PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYE 141 (351)
Q Consensus 65 ~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 141 (351)
.++|++.+.||+|+||+||+|.++ +|+.||||++..... ..+.+.+|+++|++++||||+++++++.+++..|+|||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE 83 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 83 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence 468999999999999999999975 789999999865432 23568899999999999999999999999999999999
Q ss_pred eCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccccC
Q 018712 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (351)
Q Consensus 142 ~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~ 221 (351)
|+++|+|.+++..... +++.+++.++.||+.||.|||++| |+||||||+|||+++++.+||+|||+|+
T Consensus 84 y~~gg~L~~~l~~~~~---------l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~ 151 (271)
T d1nvra_ 84 YCSGGELFDRIEPDIG---------MPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLAT 151 (271)
T ss_dssp CCTTEEGGGGSBTTTB---------CCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCE
T ss_pred ccCCCcHHHHHhcCCC---------CCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhhe
Confidence 9999999999976542 899999999999999999999999 9999999999999999999999999998
Q ss_pred CCccccccccccccccccCccCcccccCCCC-CccchhHhHHHHHHHHHcCCCCCCCCCCCCCccchhhc-------ccC
Q 018712 222 QAPDAAARLHSTRVLGTFGYHAPEYAMTGQM-SSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWA-------TPK 293 (351)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~~~~-------~~~ 293 (351)
..............+||+.|+|||++.+..+ +.++|||||||++|||++|+.||............... .+.
T Consensus 152 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (271)
T d1nvra_ 152 VFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKK 231 (271)
T ss_dssp ECEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTSTTGGG
T ss_pred eeccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCcccc
Confidence 7754443333456789999999999988876 67899999999999999999999865443221111000 011
Q ss_pred CC---ccchhhhcccccCCCCCHHHH
Q 018712 294 LS---EDKVKQCVDTKLGGEYPPKAI 316 (351)
Q Consensus 294 ~~---~~~~~~~ld~~~~~~~~~~~~ 316 (351)
++ .+.+..|++.+|.+|++.+++
T Consensus 232 ~s~~~~~li~~~L~~dP~~R~t~~ei 257 (271)
T d1nvra_ 232 IDSAPLALLHKILVENPSARITIPDI 257 (271)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred CCHHHHHHHHHHcCCChhHCcCHHHH
Confidence 11 267889999999999988765
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.5e-55 Score=381.17 Aligned_cols=243 Identities=25% Similarity=0.387 Sum_probs=205.1
Q ss_pred hcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCC----CCchHHHHHHHHHHHhccCCceeeeEEEEecCCceEEE
Q 018712 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSS----KQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLA 139 (351)
Q Consensus 65 ~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 139 (351)
.++|++.+.||+|+||+||+|.++ +++.||+|++.+. ......+.+|++++++++||||+++++++.+++..|+|
T Consensus 5 l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~iv 84 (263)
T d2j4za1 5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 84 (263)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEE
Confidence 467999999999999999999985 7899999998632 23356788999999999999999999999999999999
Q ss_pred EEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccc
Q 018712 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDL 219 (351)
Q Consensus 140 ~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~ 219 (351)
|||+++|+|.+++..... +++..++.++.||+.||.|||++| |+||||||+|||+++++.+||+|||+
T Consensus 85 mEy~~~g~L~~~l~~~~~---------l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~ 152 (263)
T d2j4za1 85 LEYAPLGTVYRELQKLSK---------FDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGW 152 (263)
T ss_dssp EECCTTCBHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCS
T ss_pred EeecCCCcHHHHHhhcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccce
Confidence 999999999999986543 899999999999999999999999 99999999999999999999999999
Q ss_pred cCCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccchhhcccC----C-
Q 018712 220 SNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPK----L- 294 (351)
Q Consensus 220 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~----~- 294 (351)
|+...... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...+.......+...... .
T Consensus 153 a~~~~~~~----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s 228 (263)
T d2j4za1 153 SVHAPSSR----RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVT 228 (263)
T ss_dssp CSCCCCCC----CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSC
T ss_pred eeecCCCc----ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCccCC
Confidence 98765432 24567999999999999999999999999999999999999999876543322222221111 1
Q ss_pred --CccchhhhcccccCCCCCHHHHHHHHHHHHHh
Q 018712 295 --SEDKVKQCVDTKLGGEYPPKAIAKVRKKKFIT 326 (351)
Q Consensus 295 --~~~~~~~~ld~~~~~~~~~~~~~~~~~~~~~~ 326 (351)
..+.+..|+.++|.+|++.+++ +++.++.
T Consensus 229 ~~~~~li~~~L~~dp~~R~t~~ei---l~hp~~~ 259 (263)
T d2j4za1 229 EGARDLISRLLKHNPSQRPMLREV---LEHPWIT 259 (263)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHH---HTCHHHH
T ss_pred HHHHHHHHHHccCCHhHCcCHHHH---HcCcCcC
Confidence 2368899999999999988775 4455543
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.4e-54 Score=380.55 Aligned_cols=242 Identities=26% Similarity=0.428 Sum_probs=203.2
Q ss_pred cCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCC-CchHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEEEeC
Q 018712 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK-QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHA 143 (351)
Q Consensus 66 ~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 143 (351)
++|++.+.||+|+||+||+|.+. +|+.||||++.... ...+.+.+|+.++++++||||+++++++.+.+..|+||||+
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence 47999999999999999999964 79999999986443 34567899999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccccCCC
Q 018712 144 SKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQA 223 (351)
Q Consensus 144 ~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~ 223 (351)
++|+|.+++.... +++..++.++.||+.||.|||++| |+||||||+|||++.++++||+|||+|+..
T Consensus 100 ~gg~L~~~~~~~~----------l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~ 166 (293)
T d1yhwa1 100 AGGSLTDVVTETC----------MDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQI 166 (293)
T ss_dssp TTCBHHHHHHHSC----------CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred CCCcHHHHhhccC----------CCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheee
Confidence 9999999987653 899999999999999999999999 999999999999999999999999999876
Q ss_pred ccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccch-hhcc------cCC--
Q 018712 224 PDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLV-TWAT------PKL-- 294 (351)
Q Consensus 224 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~-~~~~------~~~-- 294 (351)
..... .....+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.........+ .... +.+
T Consensus 167 ~~~~~--~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 244 (293)
T d1yhwa1 167 TPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSA 244 (293)
T ss_dssp CSTTC--CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSSGGGSCH
T ss_pred ccccc--cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCcccCCH
Confidence 43322 224567999999999999999999999999999999999999999865432211111 1111 111
Q ss_pred -CccchhhhcccccCCCCCHHHHHHHHHHHHH
Q 018712 295 -SEDKVKQCVDTKLGGEYPPKAIAKVRKKKFI 325 (351)
Q Consensus 295 -~~~~~~~~ld~~~~~~~~~~~~~~~~~~~~~ 325 (351)
..+.+..|++++|.+|++++++ +++.|+
T Consensus 245 ~~~~li~~~L~~dP~~R~s~~ei---l~Hp~~ 273 (293)
T d1yhwa1 245 IFRDFLNRCLDMDVEKRGSAKEL---LQHQFL 273 (293)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHH---TTCGGG
T ss_pred HHHHHHHHHccCChhHCcCHHHH---hcCHhh
Confidence 2367899999999999988775 344444
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-54 Score=384.81 Aligned_cols=241 Identities=21% Similarity=0.281 Sum_probs=199.6
Q ss_pred cCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCC----CCchHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEE
Q 018712 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSS----KQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAY 140 (351)
Q Consensus 66 ~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 140 (351)
++|++.+.||+|+||+||+|.++ +++.||||++.+. ....+.+.+|++++++++||||+++++++.+++..|+||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 67999999999999999999975 7899999998642 233467899999999999999999999999999999999
Q ss_pred EeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEeccccc
Q 018712 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (351)
Q Consensus 141 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a 220 (351)
||+++|+|.+++...+. +++..++.++.|++.||.|||+++ |+||||||+|||+++++.+||+|||+|
T Consensus 88 Ey~~gg~L~~~~~~~~~---------l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a 155 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKIGS---------FDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTA 155 (288)
T ss_dssp CCCTTEEHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTC
T ss_pred EccCCCCHHHhhhccCC---------CCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccc
Confidence 99999999999887653 899999999999999999999999 999999999999999999999999999
Q ss_pred CCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccchhhcccC----CC-
Q 018712 221 NQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPK----LS- 295 (351)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~----~~- 295 (351)
+..............+||+.|+|||++.+..++.++|||||||++|||++|+.||...+.......+...... ++
T Consensus 156 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~ 235 (288)
T d1uu3a_ 156 KVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFP 235 (288)
T ss_dssp EECC----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCTTCCH
T ss_pred eecccCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCCCCCCccCCH
Confidence 8765443333345568999999999999999999999999999999999999999875433222212111111 12
Q ss_pred --ccchhhhcccccCCCCCHHHHHH
Q 018712 296 --EDKVKQCVDTKLGGEYPPKAIAK 318 (351)
Q Consensus 296 --~~~~~~~ld~~~~~~~~~~~~~~ 318 (351)
.+.+..|+..+|.+|++.+++..
T Consensus 236 ~~~~li~~~L~~dP~~R~t~~e~~~ 260 (288)
T d1uu3a_ 236 KARDLVEKLLVLDATKRLGCEEMEG 260 (288)
T ss_dssp HHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred HHHHHHHHHccCCHhHCcCHHHHcC
Confidence 25789999999999998887643
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.7e-53 Score=369.10 Aligned_cols=245 Identities=22% Similarity=0.394 Sum_probs=196.1
Q ss_pred cCCCCCceeccCCcEEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEEEeCCC
Q 018712 66 DNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASK 145 (351)
Q Consensus 66 ~~y~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 145 (351)
++|++.+.||+|+||.||+|.+.++..||||++.......+++.+|++++++++||||+++++++.+.+..++||||+++
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~ 84 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEH 84 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTT
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecCC
Confidence 57889999999999999999998888999999988777788899999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccccCCCcc
Q 018712 146 GSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPD 225 (351)
Q Consensus 146 gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~ 225 (351)
|+|.+++..... .+++..++.++.||+.||.|||+++ |+||||||+|||+++++.+||+|||+++....
T Consensus 85 g~L~~~l~~~~~--------~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~ 153 (263)
T d1sm2a_ 85 GCLSDYLRTQRG--------LFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLD 153 (263)
T ss_dssp CBHHHHHHTTTT--------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC-------
T ss_pred CcHHHHhhcccc--------CCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheeccC
Confidence 999999876542 2889999999999999999999999 99999999999999999999999999987654
Q ss_pred ccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCCccchhhc----cc----CCCc
Q 018712 226 AAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWA----TP----KLSE 296 (351)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~Pf~~~~~~~~~~~~~~~----~~----~~~~ 296 (351)
.... ......||+.|+|||++.+..++.++|||||||++|||+| |++||...........+... .| ....
T Consensus 154 ~~~~-~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~ 232 (263)
T d1sm2a_ 154 DQYT-SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVY 232 (263)
T ss_dssp ------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCCCCTTSCHHHH
T ss_pred CCce-eecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCCCCccccCHHHH
Confidence 3322 1234568999999999999999999999999999999999 56666544322211111111 11 1113
Q ss_pred cchhhhcccccCCCCCHHHHHHHHHH
Q 018712 297 DKVKQCVDTKLGGEYPPKAIAKVRKK 322 (351)
Q Consensus 297 ~~~~~~ld~~~~~~~~~~~~~~~~~~ 322 (351)
+.+..|++.+|.+|++.+++.+.++-
T Consensus 233 ~li~~cl~~~p~~Rps~~~il~~L~~ 258 (263)
T d1sm2a_ 233 QIMNHCWKERPEDRPAFSRLLRQLAE 258 (263)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHHHccCCHhHCcCHHHHHHHHHH
Confidence 67899999999999999988776543
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-53 Score=375.43 Aligned_cols=245 Identities=22% Similarity=0.401 Sum_probs=201.7
Q ss_pred cCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCC-CchHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEEEeC
Q 018712 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK-QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHA 143 (351)
Q Consensus 66 ~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 143 (351)
+.|++.+.||+|+||.||+|.+. +++.||+|++.... ...+.+.+|+++|++++||||+++++++.+.+..++||||+
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 56899999999999999999975 78999999987543 33467899999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccccCCC
Q 018712 144 SKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQA 223 (351)
Q Consensus 144 ~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~ 223 (351)
++|+|.+++..... .+++..+..++.||+.||.|||++| |+||||||+|||++.++.+||+|||+|+..
T Consensus 92 ~~g~L~~~~~~~~~--------~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~ 160 (288)
T d2jfla1 92 AGGAVDAVMLELER--------PLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKN 160 (288)
T ss_dssp TTEEHHHHHHHHTS--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred CCCcHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhcc
Confidence 99999999865432 2899999999999999999999999 999999999999999999999999999766
Q ss_pred ccccccccccccccccCccCccccc-----CCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccchhhc-c------
Q 018712 224 PDAAARLHSTRVLGTFGYHAPEYAM-----TGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWA-T------ 291 (351)
Q Consensus 224 ~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~~~~-~------ 291 (351)
...... .....||+.|+|||++. +..|+.++|||||||++|||++|+.||....+......+... .
T Consensus 161 ~~~~~~--~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 238 (288)
T d2jfla1 161 TRTIQR--RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQP 238 (288)
T ss_dssp HHHHHH--HTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCCSSG
T ss_pred CCCccc--ccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCcc
Confidence 443221 24567999999999884 456899999999999999999999999876543322111111 1
Q ss_pred cCCC---ccchhhhcccccCCCCCHHHHHHHHHHHHHh
Q 018712 292 PKLS---EDKVKQCVDTKLGGEYPPKAIAKVRKKKFIT 326 (351)
Q Consensus 292 ~~~~---~~~~~~~ld~~~~~~~~~~~~~~~~~~~~~~ 326 (351)
+.++ .+.+..|+..+|.+|++.+++ +++.|+.
T Consensus 239 ~~~s~~~~~li~~~L~~dp~~R~t~~el---l~hp~~~ 273 (288)
T d2jfla1 239 SRWSSNFKDFLKKCLEKNVDARWTTSQL---LQHPFVT 273 (288)
T ss_dssp GGSCHHHHHHHHHHSCSSTTTSCCHHHH---TTSGGGC
T ss_pred ccCCHHHHHHHHHHccCChhHCcCHHHH---hcCcccC
Confidence 1111 267889999999999988765 4455443
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-52 Score=369.71 Aligned_cols=245 Identities=29% Similarity=0.429 Sum_probs=194.8
Q ss_pred hcCCCCCceeccCCcEEEEEEEECCCCEEEEEEcCCCC---CchHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEEE
Q 018712 65 TDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSK---QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYE 141 (351)
Q Consensus 65 ~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 141 (351)
.++|.+.+.||+|+||.||+|.++ ..||||++.... ...+.+.+|+.+|++++||||+++++++. .+..++|||
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~~~~lv~E 83 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAIVTQ 83 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEE
T ss_pred cccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe-ccEEEEEEe
Confidence 468999999999999999999864 369999986543 23467889999999999999999999865 456899999
Q ss_pred eCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccccC
Q 018712 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (351)
Q Consensus 142 ~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~ 221 (351)
|+++|+|.+++..... .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+|+
T Consensus 84 y~~~g~L~~~l~~~~~--------~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~ 152 (276)
T d1uwha_ 84 WCEGSSLYHHLHIIET--------KFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLAT 152 (276)
T ss_dssp CCCEEEHHHHHHTSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSC
T ss_pred cCCCCCHHHHHhhccC--------CCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEcccccee
Confidence 9999999999975542 2899999999999999999999999 9999999999999999999999999998
Q ss_pred CCccccccccccccccccCccCcccccC---CCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCcc-chh---------
Q 018712 222 QAPDAAARLHSTRVLGTFGYHAPEYAMT---GQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQS-LVT--------- 288 (351)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~-~~~--------- 288 (351)
...............||+.|+|||++.+ ..|+.++|||||||++|||+||+.||.+........ .+.
T Consensus 153 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~ 232 (276)
T d1uwha_ 153 VKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLS 232 (276)
T ss_dssp C------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGG
T ss_pred eccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcch
Confidence 7655443333456789999999999864 358999999999999999999999998765432211 111
Q ss_pred hc---ccCCCccchhhhcccccCCCCCHHHHHHHHHHH
Q 018712 289 WA---TPKLSEDKVKQCVDTKLGGEYPPKAIAKVRKKK 323 (351)
Q Consensus 289 ~~---~~~~~~~~~~~~ld~~~~~~~~~~~~~~~~~~~ 323 (351)
.. .+....+.+.+|++.+|.+|++.+++...++..
T Consensus 233 ~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l 270 (276)
T d1uwha_ 233 KVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELL 270 (276)
T ss_dssp GSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred hccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 01 111223678999999999999999887765543
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-53 Score=373.95 Aligned_cols=246 Identities=20% Similarity=0.283 Sum_probs=187.4
Q ss_pred hcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCCc---hHHHHHHHHHHHhccCCceeeeEEEEec--CCceEE
Q 018712 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVD--GPLRVL 138 (351)
Q Consensus 65 ~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~l 138 (351)
.++|++.+.||+|+||.||+|.++ +|+.||+|++...... .+.+.+|++++++++||||+++++++.+ .+.+|+
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i 82 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 82 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEE
Confidence 468999999999999999999975 7899999999765433 3458899999999999999999999865 456899
Q ss_pred EEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCC--CCeeeccccCCcEEEccCCceEEec
Q 018712 139 AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAE--PRIIHRNIKSSNVLLFDDDIAKISD 216 (351)
Q Consensus 139 v~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~--~~ivH~Dlkp~Nill~~~~~vkl~D 216 (351)
|||||++|+|.+++...... ...+++..++.++.||+.||.|||+++. .+|+||||||+|||++.++.+||+|
T Consensus 83 vmEy~~~g~L~~~i~~~~~~-----~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~D 157 (269)
T d2java1 83 VMEYCEGGDLASVITKGTKE-----RQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGD 157 (269)
T ss_dssp EEECCTTEEHHHHHHHHHHH-----TCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECC
T ss_pred EEecCCCCcHHHHHHhcccc-----CCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEee
Confidence 99999999999998643211 0138999999999999999999998641 2399999999999999999999999
Q ss_pred ccccCCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccchh-hccc---
Q 018712 217 FDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVT-WATP--- 292 (351)
Q Consensus 217 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~~-~~~~--- 292 (351)
||+|+........ .....||+.|+|||++.+..++.++|||||||++|||+||+.||...........+. ...+
T Consensus 158 FG~a~~~~~~~~~--~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~~~~~ 235 (269)
T d2java1 158 FGLARILNHDTSF--AKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIP 235 (269)
T ss_dssp HHHHHHC-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCC
T ss_pred ccceeecccCCCc--cccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCC
Confidence 9999876543222 245679999999999999999999999999999999999999998754332211111 1111
Q ss_pred -CC---CccchhhhcccccCCCCCHHHHH
Q 018712 293 -KL---SEDKVKQCVDTKLGGEYPPKAIA 317 (351)
Q Consensus 293 -~~---~~~~~~~~ld~~~~~~~~~~~~~ 317 (351)
.+ ..+.+..|+..+|.+|++.+++.
T Consensus 236 ~~~s~~l~~li~~~L~~dp~~Rps~~ell 264 (269)
T d2java1 236 YRYSDELNEIITRMLNLKDYHRPSVEEIL 264 (269)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred cccCHHHHHHHHHHcCCChhHCcCHHHHH
Confidence 11 23678899999999999877753
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=9.7e-53 Score=376.52 Aligned_cols=239 Identities=22% Similarity=0.335 Sum_probs=185.6
Q ss_pred HhcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCC--chHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEE
Q 018712 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ--PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAY 140 (351)
Q Consensus 64 ~~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 140 (351)
..+.|++.+.||+|+||+||+|.++ +++.||||++..... ....+.+|+.+|++++||||+++++++.+++..|+||
T Consensus 7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvm 86 (307)
T d1a06a_ 7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM 86 (307)
T ss_dssp GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 4467999999999999999999975 789999999875432 2355789999999999999999999999999999999
Q ss_pred EeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEc---cCCceEEecc
Q 018712 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLF---DDDIAKISDF 217 (351)
Q Consensus 141 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~---~~~~vkl~Df 217 (351)
|||+||+|.+++..... +++..+..++.||+.||.|||+++ |+||||||+|||+. +++.+||+||
T Consensus 87 E~~~gg~L~~~l~~~~~---------l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DF 154 (307)
T d1a06a_ 87 QLVSGGELFDRIVEKGF---------YTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDF 154 (307)
T ss_dssp CCCCSCBHHHHHHTCSC---------CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC
T ss_pred eccCCCcHHHhhhcccC---------CCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEecc
Confidence 99999999999976543 999999999999999999999999 99999999999995 4789999999
Q ss_pred cccCCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccchhh--------
Q 018712 218 DLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTW-------- 289 (351)
Q Consensus 218 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~~~-------- 289 (351)
|+|+....... ....+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.........+..
T Consensus 155 G~a~~~~~~~~---~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~ 231 (307)
T d1a06a_ 155 GLSKMEDPGSV---LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSP 231 (307)
T ss_dssp ---------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTT
T ss_pred ceeEEccCCCe---eeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCc
Confidence 99986644322 2456799999999999999999999999999999999999999987543221111111
Q ss_pred cccCCC---ccchhhhcccccCCCCCHHHHH
Q 018712 290 ATPKLS---EDKVKQCVDTKLGGEYPPKAIA 317 (351)
Q Consensus 290 ~~~~~~---~~~~~~~ld~~~~~~~~~~~~~ 317 (351)
..+.++ .+.+..|+..+|.+|++.+++.
T Consensus 232 ~~~~~s~~~~~li~~~L~~dP~~R~s~~eil 262 (307)
T d1a06a_ 232 YWDDISDSAKDFIRHLMEKDPEKRFTCEQAL 262 (307)
T ss_dssp TTTTSCHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred cccCCCHHHHHHHHHHccCCHhHCcCHHHHh
Confidence 111222 3688999999999999887764
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-53 Score=381.57 Aligned_cols=200 Identities=27% Similarity=0.422 Sum_probs=177.8
Q ss_pred HhcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCC--CchHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEE
Q 018712 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK--QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAY 140 (351)
Q Consensus 64 ~~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 140 (351)
..++|++.+.||+|+||+||+|.+. +|+.||+|++.... .....+.+|+.+|++++|||||+++++|.+.+..|+||
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVm 83 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 83 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 3578999999999999999999975 78999999987543 33467899999999999999999999999999999999
Q ss_pred EeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhh-CCCCCeeeccccCCcEEEccCCceEEecccc
Q 018712 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHE-KAEPRIIHRNIKSSNVLLFDDDIAKISDFDL 219 (351)
Q Consensus 141 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~-~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~ 219 (351)
||+++|+|.+++.+... +++..+..++.||+.||.|||+ ++ |+||||||+|||+++++++||+|||+
T Consensus 84 Ey~~gg~L~~~l~~~~~---------l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGl 151 (322)
T d1s9ja_ 84 EHMDGGSLDQVLKKAGR---------IPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGV 151 (322)
T ss_dssp ECCTTEEHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCC
T ss_pred EcCCCCcHHHHHhhcCC---------CCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCCC
Confidence 99999999999986543 8999999999999999999997 48 99999999999999999999999999
Q ss_pred cCCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCC
Q 018712 220 SNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTL 279 (351)
Q Consensus 220 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~ 279 (351)
|+...... ....+||+.|+|||++.+..|+.++||||+||++|||++|+.||....
T Consensus 152 a~~~~~~~----~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~ 207 (322)
T d1s9ja_ 152 SGQLIDSM----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPD 207 (322)
T ss_dssp CHHHHHHT----C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCC
T ss_pred ccccCCCc----cccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence 97654322 245689999999999999999999999999999999999999997643
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-52 Score=377.70 Aligned_cols=247 Identities=21% Similarity=0.298 Sum_probs=206.3
Q ss_pred hcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCC----CCchHHHHHHHHHHHhccCCceeeeEEEEecCCceEEE
Q 018712 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSS----KQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLA 139 (351)
Q Consensus 65 ~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 139 (351)
.++|++++.||+|+||.||+|.++ +|+.||+|++.+. ......+.+|+.+|++++||||+++++++.+.+.+|+|
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv 83 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence 578999999999999999999975 7999999998643 23346688999999999999999999999999999999
Q ss_pred EEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccc
Q 018712 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDL 219 (351)
Q Consensus 140 ~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~ 219 (351)
|||+++|+|.+++..... +++..++.++.||+.||.|||++| |+||||||+|||++.+|.+||+|||+
T Consensus 84 ~ey~~gg~L~~~~~~~~~---------~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~ 151 (337)
T d1o6la_ 84 MEYANGGELFFHLSRERV---------FTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGL 151 (337)
T ss_dssp EECCTTCBHHHHHHHHSC---------CCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTT
T ss_pred eeccCCCchhhhhhcccC---------CcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeeccc
Confidence 999999999999987653 899999999999999999999999 99999999999999999999999999
Q ss_pred cCCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccchhhcccCC-----
Q 018712 220 SNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKL----- 294 (351)
Q Consensus 220 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~----- 294 (351)
|+........ ....+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+.......+......+
T Consensus 152 a~~~~~~~~~--~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~~~p~~~s 229 (337)
T d1o6la_ 152 CKEGISDGAT--MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLS 229 (337)
T ss_dssp CBCSCCTTCC--BCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSC
T ss_pred ccccccCCcc--cccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCCCCCCccCC
Confidence 9876433222 245789999999999999999999999999999999999999998765433222222211111
Q ss_pred --CccchhhhcccccCCCCCHH--HHHHHHHHHHH
Q 018712 295 --SEDKVKQCVDTKLGGEYPPK--AIAKVRKKKFI 325 (351)
Q Consensus 295 --~~~~~~~~ld~~~~~~~~~~--~~~~~~~~~~~ 325 (351)
..+.+..|+..+|.+|+... .+..+++|.++
T Consensus 230 ~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f 264 (337)
T d1o6la_ 230 PEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF 264 (337)
T ss_dssp HHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGG
T ss_pred HHHHHHHHhhccCCchhhcccccccHHHHHcCccc
Confidence 13688999999999999521 23445556554
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-52 Score=362.07 Aligned_cols=242 Identities=23% Similarity=0.359 Sum_probs=207.7
Q ss_pred cCCCCCceeccCCcEEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEEEeCCC
Q 018712 66 DNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASK 145 (351)
Q Consensus 66 ~~y~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 145 (351)
++|++.+.||+|+||+||+|++++++.||||++.......+++.+|+.++++++||||+++++++.+.+..++||||+++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~ 83 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMAN 83 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCTT
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccCC
Confidence 68999999999999999999999888999999988777788999999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccccCCCcc
Q 018712 146 GSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPD 225 (351)
Q Consensus 146 gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~ 225 (351)
|+|.+++..... .+++..++.++.||++||.|||++| |+||||||+|||+++++.+||+|||+++....
T Consensus 84 g~l~~~~~~~~~--------~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~ 152 (258)
T d1k2pa_ 84 GCLLNYLREMRH--------RFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD 152 (258)
T ss_dssp EEHHHHHHSGGG--------CCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSS
T ss_pred CcHHHhhhcccc--------CCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheeccC
Confidence 999999766543 2889999999999999999999999 99999999999999999999999999987654
Q ss_pred ccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCCccchhh--------cccCCCc
Q 018712 226 AAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTW--------ATPKLSE 296 (351)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~Pf~~~~~~~~~~~~~~--------~~~~~~~ 296 (351)
.... ......||+.|+|||.+.+..++.++||||||+++|||+| |+.||...........+.. ..+....
T Consensus 153 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~ 231 (258)
T d1k2pa_ 153 DEYT-SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVY 231 (258)
T ss_dssp SSCC-CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHH
T ss_pred CCce-eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCCCCcccccHHHH
Confidence 3222 2344678999999999999999999999999999999998 8999987654332222211 1111223
Q ss_pred cchhhhcccccCCCCCHHHHHHH
Q 018712 297 DKVKQCVDTKLGGEYPPKAIAKV 319 (351)
Q Consensus 297 ~~~~~~ld~~~~~~~~~~~~~~~ 319 (351)
+.+..|++.+|.+|++.+++.+.
T Consensus 232 ~li~~cl~~dP~~RPt~~eil~~ 254 (258)
T d1k2pa_ 232 TIMYSCWHEKADERPTFKILLSN 254 (258)
T ss_dssp HHHHHTTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHccCCHhHCcCHHHHHHH
Confidence 78899999999999998887654
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-52 Score=368.71 Aligned_cols=249 Identities=22% Similarity=0.349 Sum_probs=204.3
Q ss_pred hcCCCCCceeccCCcEEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEEEeCC
Q 018712 65 TDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHAS 144 (351)
Q Consensus 65 ~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 144 (351)
.++|++.+.||+|+||.||+|.+++++.||||++.......+.+.+|++++++++||||+++++++.+ +..++||||++
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~~ 90 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYME 90 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCT
T ss_pred HHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcCCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeCC
Confidence 35788899999999999999999888999999998877777889999999999999999999998754 56799999999
Q ss_pred CCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccccCCCc
Q 018712 145 KGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAP 224 (351)
Q Consensus 145 ~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~ 224 (351)
+|+|.+++...... .+++..++.++.||+.||.|||+++ |+||||||+|||+++++.+||+|||+|+...
T Consensus 91 ~g~L~~~~~~~~~~-------~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~ 160 (272)
T d1qpca_ 91 NGSLVDFLKTPSGI-------KLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIE 160 (272)
T ss_dssp TCBHHHHTTSHHHH-------TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred CCcHHHHHhhcCCC-------CCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccceEEcc
Confidence 99999988655422 2899999999999999999999999 9999999999999999999999999998765
Q ss_pred cccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCC-CCCCCCCCCccchh--------hcccCCC
Q 018712 225 DAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP-VDHTLPRGQQSLVT--------WATPKLS 295 (351)
Q Consensus 225 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P-f~~~~~~~~~~~~~--------~~~~~~~ 295 (351)
..... ......||+.|+|||++.+..++.++|||||||++|||+||..| |...........+. ...+...
T Consensus 161 ~~~~~-~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l 239 (272)
T d1qpca_ 161 DNEYT-AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEEL 239 (272)
T ss_dssp SSCEE-CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHH
T ss_pred CCccc-cccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCcccChHHH
Confidence 43222 22445789999999999999999999999999999999996554 44432211111111 1111112
Q ss_pred ccchhhhcccccCCCCCHHHHHHHHHHHHH
Q 018712 296 EDKVKQCVDTKLGGEYPPKAIAKVRKKKFI 325 (351)
Q Consensus 296 ~~~~~~~ld~~~~~~~~~~~~~~~~~~~~~ 325 (351)
.+.+.+|+..+|.+|++.+++.+.++--|.
T Consensus 240 ~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft 269 (272)
T d1qpca_ 240 YQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (272)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence 368899999999999999999887765544
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.1e-52 Score=369.31 Aligned_cols=246 Identities=24% Similarity=0.337 Sum_probs=204.8
Q ss_pred hcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCCchHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEEEeC
Q 018712 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHA 143 (351)
Q Consensus 65 ~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 143 (351)
.++|++.+.||+|+||.||+|.++ +++.||||++..+....+.+.+|+++|++++||||+++++++.+++..++||||+
T Consensus 16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~ 95 (287)
T d1opja_ 16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 95 (287)
T ss_dssp GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeecc
Confidence 457888999999999999999976 6889999999887777788999999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccccCCC
Q 018712 144 SKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQA 223 (351)
Q Consensus 144 ~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~ 223 (351)
++|+|.+++...... .+++..++.++.||+.||.|||+++ |+||||||+|||+++++.+||+|||+|+..
T Consensus 96 ~~g~l~~~l~~~~~~-------~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~ 165 (287)
T d1opja_ 96 TYGNLLDYLRECNRQ-------EVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLM 165 (287)
T ss_dssp TTCBHHHHHHHSCTT-------TSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTTTC
T ss_pred cCcchHHHhhhcccc-------chHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEccccceeec
Confidence 999999999765432 3899999999999999999999999 999999999999999999999999999876
Q ss_pred ccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCC-Cccchhh-cc-------cCC
Q 018712 224 PDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRG-QQSLVTW-AT-------PKL 294 (351)
Q Consensus 224 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~-~~~~~~~-~~-------~~~ 294 (351)
...... ......||+.|+|||++.+..++.++|||||||++|||++|..||....... ....+.. .. +..
T Consensus 166 ~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 244 (287)
T d1opja_ 166 TGDTYT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEK 244 (287)
T ss_dssp CSSSSE-EETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHH
T ss_pred CCCCce-eeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCCCCCCCccchHH
Confidence 543222 2234568999999999999999999999999999999999776654432221 1111111 11 111
Q ss_pred CccchhhhcccccCCCCCHHHHHHHHH
Q 018712 295 SEDKVKQCVDTKLGGEYPPKAIAKVRK 321 (351)
Q Consensus 295 ~~~~~~~~ld~~~~~~~~~~~~~~~~~ 321 (351)
..+.+..|+..+|.+|++.+++.+.++
T Consensus 245 l~~li~~cl~~dP~~Rps~~ei~~~L~ 271 (287)
T d1opja_ 245 VYELMRACWQWNPSDRPSFAEIHQAFE 271 (287)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHHHHHcCCCHhHCcCHHHHHHHHH
Confidence 236789999999999999998866554
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=8.4e-52 Score=376.63 Aligned_cols=245 Identities=21% Similarity=0.297 Sum_probs=203.4
Q ss_pred HhcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCCc-hHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEEE
Q 018712 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP-DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYE 141 (351)
Q Consensus 64 ~~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 141 (351)
..++|++.+.||+|+||.||+|.++ +|+.||||++...... .+.+.+|+.+|++++||||+++++++.+++..|+|||
T Consensus 24 il~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE 103 (350)
T d1koaa2 24 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYE 103 (350)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEEC
T ss_pred CccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 3578999999999999999999975 7899999999765433 4568899999999999999999999999999999999
Q ss_pred eCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEcc--CCceEEecccc
Q 018712 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFD--DDIAKISDFDL 219 (351)
Q Consensus 142 ~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~--~~~vkl~Dfg~ 219 (351)
|+++|+|.+++..... .+++..++.++.||+.||.|||++| |+||||||+|||++. ++.+||+|||+
T Consensus 104 ~~~gg~L~~~l~~~~~--------~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~ 172 (350)
T d1koaa2 104 FMSGGELFEKVADEHN--------KMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGL 172 (350)
T ss_dssp CCCSCBHHHHHTCTTS--------CBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTT
T ss_pred cCCCCCHHHHHHhhcC--------CCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecch
Confidence 9999999999965432 2899999999999999999999999 999999999999964 57899999999
Q ss_pred cCCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccchhh--------cc
Q 018712 220 SNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTW--------AT 291 (351)
Q Consensus 220 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~~~--------~~ 291 (351)
|+....... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.........+.. ..
T Consensus 173 a~~~~~~~~---~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 249 (350)
T d1koaa2 173 TAHLDPKQS---VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAF 249 (350)
T ss_dssp CEECCTTSC---EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGG
T ss_pred heecccccc---cceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccc
Confidence 987654332 2456799999999999999999999999999999999999999986543322111111 11
Q ss_pred cCCC---ccchhhhcccccCCCCCHHHHHHHHHHHHH
Q 018712 292 PKLS---EDKVKQCVDTKLGGEYPPKAIAKVRKKKFI 325 (351)
Q Consensus 292 ~~~~---~~~~~~~ld~~~~~~~~~~~~~~~~~~~~~ 325 (351)
+.++ .+.+..|+..+|.+|++.+++ +++.++
T Consensus 250 ~~~s~~~~~li~~~L~~dP~~R~t~~ei---l~hp~~ 283 (350)
T d1koaa2 250 SGISEDGKDFIRKLLLADPNTRMTIHQA---LEHPWL 283 (350)
T ss_dssp GGCCHHHHHHHHHHCCSSGGGSCCHHHH---HHSTTT
T ss_pred cCCCHHHHHHHHHHccCChhHCcCHHHH---hcCccc
Confidence 1122 357899999999999988776 445444
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=6e-52 Score=372.86 Aligned_cols=244 Identities=25% Similarity=0.362 Sum_probs=202.8
Q ss_pred hcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCC----CCchHHHHHHHHHHHhccCCceeeeEEEEecCCceEEE
Q 018712 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSS----KQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLA 139 (351)
Q Consensus 65 ~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 139 (351)
.++|++++.||+|+||+||+|.++ +|+.||||++.+. ....+.+.+|+.++++++||||+++++++.+.+..|+|
T Consensus 3 l~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 82 (316)
T d1fota_ 3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 82 (316)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeE
Confidence 467999999999999999999975 7999999998642 23346788999999999999999999999999999999
Q ss_pred EEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccc
Q 018712 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDL 219 (351)
Q Consensus 140 ~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~ 219 (351)
|||+.||+|..++..... ++...+..++.||+.||.|||++| |+||||||+|||++.+|.+||+|||+
T Consensus 83 mE~~~gg~l~~~~~~~~~---------~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~ 150 (316)
T d1fota_ 83 MDYIEGGELFSLLRKSQR---------FPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGF 150 (316)
T ss_dssp ECCCCSCBHHHHHHHTSS---------CCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSS
T ss_pred eeecCCcccccccccccc---------ccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCcc
Confidence 999999999999987754 788899999999999999999999 99999999999999999999999999
Q ss_pred cCCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccchhhcc----cCCC
Q 018712 220 SNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWAT----PKLS 295 (351)
Q Consensus 220 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~~~~~----~~~~ 295 (351)
|+...... ...+||+.|+|||++.+..|+.++|||||||++|+|++|+.||...+.......+.... +.++
T Consensus 151 a~~~~~~~-----~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s 225 (316)
T d1fota_ 151 AKYVPDVT-----YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFN 225 (316)
T ss_dssp CEECSSCB-----CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCTTSC
T ss_pred ceEecccc-----ccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCCCCC
Confidence 98765432 45689999999999999999999999999999999999999998764432222221111 1122
Q ss_pred ---ccchhhhcccccCCCCCHH--HHHHHHHHHHH
Q 018712 296 ---EDKVKQCVDTKLGGEYPPK--AIAKVRKKKFI 325 (351)
Q Consensus 296 ---~~~~~~~ld~~~~~~~~~~--~~~~~~~~~~~ 325 (351)
.+.+..|+..+|.+|++.. .+..++++.++
T Consensus 226 ~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f 260 (316)
T d1fota_ 226 EDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWF 260 (316)
T ss_dssp HHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGG
T ss_pred HHHHHHHHHHhhhCHHhccccchhhHHHHHcCccc
Confidence 3678999999999997321 23334555553
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-51 Score=366.25 Aligned_cols=238 Identities=22% Similarity=0.315 Sum_probs=200.7
Q ss_pred hcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCC-------CchHHHHHHHHHHHhccCCceeeeEEEEecCCce
Q 018712 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK-------QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLR 136 (351)
Q Consensus 65 ~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-------~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 136 (351)
.++|++.+.||+|+||+||+|.++ +|+.||||++.+.. ...+.+.+|+.+|++++||||+++++++.+.+..
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 467999999999999999999975 78999999985432 1246789999999999999999999999999999
Q ss_pred EEEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCC----ce
Q 018712 137 VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD----IA 212 (351)
Q Consensus 137 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~----~v 212 (351)
|+|||||++|+|.+++..... +++..++.++.||+.||.|||+++ |+||||||+|||++.++ .+
T Consensus 89 ~iv~E~~~gg~L~~~i~~~~~---------l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~v 156 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAEKES---------LTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRI 156 (293)
T ss_dssp EEEEECCCSCBHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCE
T ss_pred EEEEEcCCCccccchhccccc---------cchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccce
Confidence 999999999999999987543 899999999999999999999999 99999999999998876 59
Q ss_pred EEecccccCCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccchhh---
Q 018712 213 KISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTW--- 289 (351)
Q Consensus 213 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~~~--- 289 (351)
||+|||+|........ .....||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+.......+..
T Consensus 157 kl~DfG~a~~~~~~~~---~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~ 233 (293)
T d1jksa_ 157 KIIDFGLAHKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNY 233 (293)
T ss_dssp EECCCTTCEECTTSCB---CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCC
T ss_pred EecchhhhhhcCCCcc---ccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCC
Confidence 9999999977654322 2456799999999999999999999999999999999999999987644322111111
Q ss_pred -----cccCCC---ccchhhhcccccCCCCCHHHHH
Q 018712 290 -----ATPKLS---EDKVKQCVDTKLGGEYPPKAIA 317 (351)
Q Consensus 290 -----~~~~~~---~~~~~~~ld~~~~~~~~~~~~~ 317 (351)
..+..+ .+.+.+|+..+|.+|++.+++.
T Consensus 234 ~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil 269 (293)
T d1jksa_ 234 EFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSL 269 (293)
T ss_dssp CCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHH
T ss_pred CCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHh
Confidence 111222 3688999999999999988763
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.7e-51 Score=374.93 Aligned_cols=240 Identities=22% Similarity=0.276 Sum_probs=201.6
Q ss_pred HhcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCC-chHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEEE
Q 018712 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ-PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYE 141 (351)
Q Consensus 64 ~~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 141 (351)
..++|++.+.||+|+||.||+|.+. +|+.||||++..... ....+.+|+.+|++++||||++++++|.+++.+|+|||
T Consensus 27 ~~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE 106 (352)
T d1koba_ 27 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILE 106 (352)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEE
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 3568999999999999999999975 799999999876543 24567899999999999999999999999999999999
Q ss_pred eCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEc--cCCceEEecccc
Q 018712 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLF--DDDIAKISDFDL 219 (351)
Q Consensus 142 ~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~--~~~~vkl~Dfg~ 219 (351)
||++|+|.+++..... .+++.+++.++.||+.||.|||++| |+||||||+|||++ .++.+||+|||+
T Consensus 107 ~~~gg~L~~~~~~~~~--------~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGl 175 (352)
T d1koba_ 107 FLSGGELFDRIAAEDY--------KMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGL 175 (352)
T ss_dssp CCCCCBHHHHTTCTTC--------CBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTT
T ss_pred cCCCChHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeeccc
Confidence 9999999998865432 2899999999999999999999999 99999999999997 568999999999
Q ss_pred cCCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccchhhc--------c
Q 018712 220 SNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWA--------T 291 (351)
Q Consensus 220 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~~~~--------~ 291 (351)
|+....... .....||+.|+|||++.+..++.++|||||||++|+|+||+.||.+.........+... .
T Consensus 176 a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 252 (352)
T d1koba_ 176 ATKLNPDEI---VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAF 252 (352)
T ss_dssp CEECCTTSC---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTT
T ss_pred ceecCCCCc---eeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccc
Confidence 987654322 24567999999999999999999999999999999999999999875433221111111 1
Q ss_pred cCCC---ccchhhhcccccCCCCCHHHHH
Q 018712 292 PKLS---EDKVKQCVDTKLGGEYPPKAIA 317 (351)
Q Consensus 292 ~~~~---~~~~~~~ld~~~~~~~~~~~~~ 317 (351)
+.++ .+.+..||..+|.+|++.+++.
T Consensus 253 ~~~s~~~~~li~~~L~~dp~~R~s~~eil 281 (352)
T d1koba_ 253 SSVSPEAKDFIKNLLQKEPRKRLTVHDAL 281 (352)
T ss_dssp TTSCHHHHHHHHTTSCSSGGGSCCHHHHH
T ss_pred cCCCHHHHHHHHHHccCChhHCcCHHHHh
Confidence 1122 3678999999999999987764
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-51 Score=360.23 Aligned_cols=234 Identities=24% Similarity=0.356 Sum_probs=189.1
Q ss_pred CCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCCc---hHHHHHHHHHHHhccCCceeeeEEEEec----CCceEEEE
Q 018712 69 GTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVD----GPLRVLAY 140 (351)
Q Consensus 69 ~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~----~~~~~lv~ 140 (351)
+..+.||+|+||+||+|.+. ++..||+|++...... .+.+.+|+++|++++||||+++++++.+ ...+|+||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 56678999999999999975 6889999998654322 3568899999999999999999999864 45679999
Q ss_pred EeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEc-cCCceEEecccc
Q 018712 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLF-DDDIAKISDFDL 219 (351)
Q Consensus 141 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~-~~~~vkl~Dfg~ 219 (351)
||+++|+|.+++..... +++..++.++.||+.||+|||+++. +|+||||||+|||++ +++.+||+|||+
T Consensus 92 E~~~~g~L~~~l~~~~~---------~~~~~~~~~~~qi~~gl~yLH~~~~-~IiHrDiKp~NILl~~~~~~~Kl~DFGl 161 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKRFKV---------MKIKVLRSWCRQILKGLQFLHTRTP-PIIHRDLKCDNIFITGPTGSVKIGDLGL 161 (270)
T ss_dssp ECCCSCBHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHTSSS-CCCCSCCCGGGEEESSTTSCEEECCTTG
T ss_pred eCCCCCcHHHHHhcccc---------ccHHHHHHHHHHHHHHHHHHHHCCC-CEEeCCcChhhceeeCCCCCEEEeecCc
Confidence 99999999999987543 8999999999999999999999852 399999999999996 478999999999
Q ss_pred cCCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCc-cch---------hh
Q 018712 220 SNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQ-SLV---------TW 289 (351)
Q Consensus 220 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~-~~~---------~~ 289 (351)
|+...... ....+||+.|+|||++.+ .++.++|||||||++|||++|+.||......... ..+ ..
T Consensus 162 a~~~~~~~----~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~ 236 (270)
T d1t4ha_ 162 ATLKRASF----AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDK 236 (270)
T ss_dssp GGGCCTTS----BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGG
T ss_pred ceeccCCc----cCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCcccCc
Confidence 97543322 245679999999998875 5999999999999999999999999765332111 000 01
Q ss_pred cccCCCccchhhhcccccCCCCCHHHHH
Q 018712 290 ATPKLSEDKVKQCVDTKLGGEYPPKAIA 317 (351)
Q Consensus 290 ~~~~~~~~~~~~~ld~~~~~~~~~~~~~ 317 (351)
.......+.+..|++++|.+|++.+++.
T Consensus 237 ~~~~~~~~li~~~l~~dp~~R~s~~ell 264 (270)
T d1t4ha_ 237 VAIPEVKEIIEGCIRQNKDERYSIKDLL 264 (270)
T ss_dssp CCCHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred cCCHHHHHHHHHHccCCHhHCcCHHHHh
Confidence 1111123788999999999999887763
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.1e-51 Score=365.66 Aligned_cols=249 Identities=24% Similarity=0.382 Sum_probs=193.1
Q ss_pred cCCCCCceeccCCcEEEEEEEEC-CC---CEEEEEEcCCCCCc--hHHHHHHHHHHHhccCCceeeeEEEEecCCceEEE
Q 018712 66 DNFGTNSLIGEGSYGRVYFGVLR-SG---RAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLA 139 (351)
Q Consensus 66 ~~y~~~~~Lg~G~~g~Vy~~~~~-~~---~~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 139 (351)
++|++.+.||+|+||.||+|.++ ++ ..||||.+...... .+.+.+|+++|++++|||||++++++.+.+..++|
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv 105 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII 105 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence 56888899999999999999975 33 35899988655433 35689999999999999999999999999999999
Q ss_pred EEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccc
Q 018712 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDL 219 (351)
Q Consensus 140 ~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~ 219 (351)
|||+++|+|.+++..... .+++.++..++.||+.||.|||+++ |+||||||+|||++.++++||+|||+
T Consensus 106 ~Ey~~~g~L~~~~~~~~~--------~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGl 174 (299)
T d1jpaa_ 106 TEFMENGSLDSFLRQNDG--------QFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGL 174 (299)
T ss_dssp EECCTTEEHHHHHHTTTT--------CSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC--
T ss_pred EEecCCCcceeeeccccC--------CCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCccc
Confidence 999999999999886542 2899999999999999999999999 99999999999999999999999999
Q ss_pred cCCCccccccc---cccccccccCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCCccchhhc-----
Q 018712 220 SNQAPDAAARL---HSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWA----- 290 (351)
Q Consensus 220 a~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~Pf~~~~~~~~~~~~~~~----- 290 (351)
++......... ......||+.|+|||.+.+..++.++|||||||++|||+| |+.||.+.........+...
T Consensus 175 a~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~ 254 (299)
T d1jpaa_ 175 SRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPP 254 (299)
T ss_dssp ---------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCC
T ss_pred ceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence 98765432221 1123457999999999999999999999999999999998 89999876543222222111
Q ss_pred ---ccCCCccchhhhcccccCCCCCHHHHHHHHHHHHH
Q 018712 291 ---TPKLSEDKVKQCVDTKLGGEYPPKAIAKVRKKKFI 325 (351)
Q Consensus 291 ---~~~~~~~~~~~~ld~~~~~~~~~~~~~~~~~~~~~ 325 (351)
.+....+.+..|+..+|.+||+.+++...++-.+.
T Consensus 255 ~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~ 292 (299)
T d1jpaa_ 255 PMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR 292 (299)
T ss_dssp CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred CccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence 11112368899999999999999998877654443
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.9e-51 Score=368.28 Aligned_cols=234 Identities=26% Similarity=0.385 Sum_probs=196.0
Q ss_pred CCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCCc----hHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEEE
Q 018712 67 NFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP----DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYE 141 (351)
Q Consensus 67 ~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 141 (351)
.|+.++.||+|+||.||+|.+. +++.||||++...... .+.+.+|+++|++++||||+++++++.+.+..|+|||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence 4899999999999999999975 7889999998765432 2457899999999999999999999999999999999
Q ss_pred eCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccccC
Q 018712 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (351)
Q Consensus 142 ~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~ 221 (351)
||.+|+|..++..... +++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||+|.
T Consensus 96 ~~~~g~l~~~~~~~~~---------l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~ 163 (309)
T d1u5ra_ 96 YCLGSASDLLEVHKKP---------LQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSAS 163 (309)
T ss_dssp CCSEEHHHHHHHHTSC---------CCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCB
T ss_pred ecCCCchHHHHHhCCC---------CCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeeccccc
Confidence 9999999877765542 899999999999999999999999 9999999999999999999999999998
Q ss_pred CCccccccccccccccccCccCcccccC---CCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccc-hhhc-------
Q 018712 222 QAPDAAARLHSTRVLGTFGYHAPEYAMT---GQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSL-VTWA------- 290 (351)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~-~~~~------- 290 (351)
..... ....||+.|+|||++.+ ..|+.++|||||||++|||++|+.||.+......... ....
T Consensus 164 ~~~~~------~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 237 (309)
T d1u5ra_ 164 IMAPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSG 237 (309)
T ss_dssp SSSSB------CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCT
T ss_pred ccCCC------CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCC
Confidence 65432 34579999999999864 4689999999999999999999999986543221111 1111
Q ss_pred -ccCCCccchhhhcccccCCCCCHHHHHH
Q 018712 291 -TPKLSEDKVKQCVDTKLGGEYPPKAIAK 318 (351)
Q Consensus 291 -~~~~~~~~~~~~ld~~~~~~~~~~~~~~ 318 (351)
.+....+.+..|+..+|.+|++++++.+
T Consensus 238 ~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 238 HWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 1112237889999999999999887643
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.2e-51 Score=360.53 Aligned_cols=250 Identities=26% Similarity=0.380 Sum_probs=203.1
Q ss_pred cCCCCCce-eccCCcEEEEEEEEC---CCCEEEEEEcCCCCCc--hHHHHHHHHHHHhccCCceeeeEEEEecCCceEEE
Q 018712 66 DNFGTNSL-IGEGSYGRVYFGVLR---SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLA 139 (351)
Q Consensus 66 ~~y~~~~~-Lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 139 (351)
++|.+.+. ||+|+||.||+|.++ ++..||||+++..... .+.+.+|+++|++++||||+++++++.+ +..|+|
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv 86 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 86 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence 45666664 999999999999864 3557999999755432 4678999999999999999999999865 468999
Q ss_pred EEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccc
Q 018712 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDL 219 (351)
Q Consensus 140 ~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~ 219 (351)
|||+++|+|.+++..... .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 87 mE~~~~g~L~~~l~~~~~--------~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGl 155 (285)
T d1u59a_ 87 MEMAGGGPLHKFLVGKRE--------EIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGL 155 (285)
T ss_dssp EECCTTEEHHHHHTTCTT--------TSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTT
T ss_pred EEeCCCCcHHHHhhcccc--------CCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchh
Confidence 999999999999865432 2899999999999999999999999 99999999999999999999999999
Q ss_pred cCCCcccccc-ccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCCccchhh-ccc----
Q 018712 220 SNQAPDAAAR-LHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTW-ATP---- 292 (351)
Q Consensus 220 a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~Pf~~~~~~~~~~~~~~-~~~---- 292 (351)
++........ .......||+.|+|||++.+..++.++|||||||++|||+| |+.||...........+.. ..+
T Consensus 156 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~ 235 (285)
T d1u59a_ 156 SKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPP 235 (285)
T ss_dssp CEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCCT
T ss_pred hhcccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCC
Confidence 9876543221 22234568999999999999999999999999999999998 9999987654322222211 111
Q ss_pred CC---CccchhhhcccccCCCCCHHHHHHHHHHHHHhh
Q 018712 293 KL---SEDKVKQCVDTKLGGEYPPKAIAKVRKKKFITS 327 (351)
Q Consensus 293 ~~---~~~~~~~~ld~~~~~~~~~~~~~~~~~~~~~~~ 327 (351)
.. ..+.+.+|++.+|.+||+..++.+.++..+...
T Consensus 236 ~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~ 273 (285)
T d1u59a_ 236 ECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL 273 (285)
T ss_dssp TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred cCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence 11 136889999999999999999988777766543
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-51 Score=368.57 Aligned_cols=253 Identities=22% Similarity=0.321 Sum_probs=202.2
Q ss_pred cCCCCCceeccCCcEEEEEEEECC-C-----CEEEEEEcCCCC--CchHHHHHHHHHHHhc-cCCceeeeEEEEecCCce
Q 018712 66 DNFGTNSLIGEGSYGRVYFGVLRS-G-----RAAAIKKLDSSK--QPDQEFLAQVSMVSRL-KNENVVELVGYYVDGPLR 136 (351)
Q Consensus 66 ~~y~~~~~Lg~G~~g~Vy~~~~~~-~-----~~vavK~~~~~~--~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~ 136 (351)
++|++.+.||+|+||+||+|.+.. + ..||+|.+.... .....+.+|+.+++++ +|||||++++++.+.+..
T Consensus 37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~ 116 (325)
T d1rjba_ 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI 116 (325)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeE
Confidence 678999999999999999999642 2 369999886432 3346788999999998 899999999999999999
Q ss_pred EEEEEeCCCCCHHHHhccCCCCC--------------CCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCC
Q 018712 137 VLAYEHASKGSLHDILHGKKGVK--------------GAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSS 202 (351)
Q Consensus 137 ~lv~e~~~~gsL~~~l~~~~~~~--------------~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~ 202 (351)
++|||||++|+|.++|....... .......+++..++.++.||+.||.|||+++ |+||||||+
T Consensus 117 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRDlKp~ 193 (325)
T d1rjba_ 117 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAAR 193 (325)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCSGG
T ss_pred EEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCchh
Confidence 99999999999999997654210 0111234899999999999999999999999 999999999
Q ss_pred cEEEccCCceEEecccccCCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCC
Q 018712 203 NVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPR 281 (351)
Q Consensus 203 Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~Pf~~~~~~ 281 (351)
|||++.++++||+|||+|+...............||+.|+|||++.+..++.++|||||||++|||+| |+.||.+....
T Consensus 194 Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~ 273 (325)
T d1rjba_ 194 NVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD 273 (325)
T ss_dssp GEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred ccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHH
Confidence 99999999999999999987655444333345678999999999999999999999999999999998 89999876543
Q ss_pred CCcc-chhh-cc----cCC---CccchhhhcccccCCCCCHHHHHHHHH
Q 018712 282 GQQS-LVTW-AT----PKL---SEDKVKQCVDTKLGGEYPPKAIAKVRK 321 (351)
Q Consensus 282 ~~~~-~~~~-~~----~~~---~~~~~~~~ld~~~~~~~~~~~~~~~~~ 321 (351)
.... .+.. .. ... ..+.+..|++.+|.+||+.+++.+.+.
T Consensus 274 ~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 274 ANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 2211 1111 01 111 136889999999999999999877653
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.3e-51 Score=372.91 Aligned_cols=230 Identities=21% Similarity=0.297 Sum_probs=197.2
Q ss_pred hcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCC----CCchHHHHHHHHHHHhccCCceeeeEEEEecCCceEEE
Q 018712 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSS----KQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLA 139 (351)
Q Consensus 65 ~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 139 (351)
.++|++++.||+|+||.||+|.++ +|+.||||++.+. ....+.+.+|+++|+.++||||+++++++.+....++|
T Consensus 40 ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v 119 (350)
T d1rdqe_ 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccccc
Confidence 368999999999999999999975 7999999998642 23346688999999999999999999999999999999
Q ss_pred EEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccc
Q 018712 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDL 219 (351)
Q Consensus 140 ~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~ 219 (351)
|||+.+|+|.+++..... +++..++.++.||+.||.|||+++ |+||||||+|||++.+|++||+|||+
T Consensus 120 ~e~~~~g~l~~~l~~~~~---------l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~ 187 (350)
T d1rdqe_ 120 MEYVAGGEMFSHLRRIGR---------FSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGF 187 (350)
T ss_dssp EECCTTCBHHHHHHHHCC---------CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTT
T ss_pred cccccccchhhhHhhcCC---------CCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeecee
Confidence 999999999999987653 899999999999999999999999 99999999999999999999999999
Q ss_pred cCCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccchhhcccC----C-
Q 018712 220 SNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPK----L- 294 (351)
Q Consensus 220 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~----~- 294 (351)
|+...... ....||+.|+|||++.+..++.++|||||||++|||+||+.||.+.........+....+. +
T Consensus 188 a~~~~~~~-----~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s 262 (350)
T d1rdqe_ 188 AKRVKGRT-----WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFS 262 (350)
T ss_dssp CEECSSCB-----CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTCC
T ss_pred eeeccccc-----ccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCCCCCccCC
Confidence 98765332 4567999999999999999999999999999999999999999876433222222211111 1
Q ss_pred --CccchhhhcccccCCCC
Q 018712 295 --SEDKVKQCVDTKLGGEY 311 (351)
Q Consensus 295 --~~~~~~~~ld~~~~~~~ 311 (351)
..+.+..|+..+|.+|+
T Consensus 263 ~~~~~li~~~L~~dP~kR~ 281 (350)
T d1rdqe_ 263 SDLKDLLRNLLQVDLTKRF 281 (350)
T ss_dssp HHHHHHHHHHSCSCTTTCT
T ss_pred HHHHHHHHHHhhhCHHhcc
Confidence 23688999999999996
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-51 Score=359.10 Aligned_cols=241 Identities=25% Similarity=0.352 Sum_probs=194.2
Q ss_pred ceeccCCcEEEEEEEEC---CCCEEEEEEcCCCCCc---hHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEEEeCCC
Q 018712 72 SLIGEGSYGRVYFGVLR---SGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASK 145 (351)
Q Consensus 72 ~~Lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 145 (351)
++||+|+||.||+|.++ +++.||||++...... .+.+.+|+++|++++||||+++++++.++ ..++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEEEEcCCC
Confidence 46999999999999864 3568999998654322 45789999999999999999999998654 57899999999
Q ss_pred CCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccccCCCcc
Q 018712 146 GSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPD 225 (351)
Q Consensus 146 gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~ 225 (351)
|+|.+++..... +++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 92 g~L~~~l~~~~~---------l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~ 159 (277)
T d1xbba_ 92 GPLNKYLQQNRH---------VKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRA 159 (277)
T ss_dssp EEHHHHHHHCTT---------CCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCT
T ss_pred CcHHHHHhhccC---------CCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhccc
Confidence 999999987653 899999999999999999999999 99999999999999999999999999986643
Q ss_pred cccc-ccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCCccchhh-cccC-------CC
Q 018712 226 AAAR-LHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTW-ATPK-------LS 295 (351)
Q Consensus 226 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~Pf~~~~~~~~~~~~~~-~~~~-------~~ 295 (351)
.... .......||+.|+|||.+.+..++.++|||||||++|||+| |+.||.+.........+.. ..+. ..
T Consensus 160 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~~ 239 (277)
T d1xbba_ 160 DENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREM 239 (277)
T ss_dssp TCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHH
T ss_pred cccccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHH
Confidence 3222 12234578999999999999999999999999999999998 9999987654322222211 1111 12
Q ss_pred ccchhhhcccccCCCCCHHHHHHHHHHHHH
Q 018712 296 EDKVKQCVDTKLGGEYPPKAIAKVRKKKFI 325 (351)
Q Consensus 296 ~~~~~~~ld~~~~~~~~~~~~~~~~~~~~~ 325 (351)
.+.+.+|+..+|.+||+.+++...++..+.
T Consensus 240 ~~li~~cl~~dp~~RPs~~~i~~~L~~~~~ 269 (277)
T d1xbba_ 240 YDLMNLCWTYDVENRPGFAAVELRLRNYYY 269 (277)
T ss_dssp HHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHcCCCHhHCcCHHHHHHHhhCHHh
Confidence 368899999999999999998877766553
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.1e-51 Score=366.09 Aligned_cols=246 Identities=17% Similarity=0.204 Sum_probs=206.9
Q ss_pred HhcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCCchHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEEEe
Q 018712 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEH 142 (351)
Q Consensus 64 ~~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 142 (351)
..++|.+.+.||+|+||.||+|.++ +++.||+|++.........+.+|+++|+.++||||+++++++.+.+.+|+||||
T Consensus 3 ~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~ 82 (321)
T d1tkia_ 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred CccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence 4578999999999999999999976 788999999987766667788999999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccC--CceEEeccccc
Q 018712 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDD--DIAKISDFDLS 220 (351)
Q Consensus 143 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~--~~vkl~Dfg~a 220 (351)
|.||+|.+++..... .+++.+++.++.||+.||.|||++| |+||||||+|||++.+ ..+||+|||++
T Consensus 83 ~~gg~L~~~i~~~~~--------~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~ 151 (321)
T d1tkia_ 83 ISGLDIFERINTSAF--------ELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQA 151 (321)
T ss_dssp CCCCBHHHHHTSSSC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTC
T ss_pred CCCCcHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchh
Confidence 999999999976542 2899999999999999999999999 9999999999999854 48999999998
Q ss_pred CCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccchh--------hccc
Q 018712 221 NQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVT--------WATP 292 (351)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~~--------~~~~ 292 (351)
+....... .....||+.|+|||.+.+..++.++|||||||++|+|++|+.||...........+. ...+
T Consensus 152 ~~~~~~~~---~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 228 (321)
T d1tkia_ 152 RQLKPGDN---FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFK 228 (321)
T ss_dssp EECCTTCE---EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHT
T ss_pred hccccCCc---ccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhcc
Confidence 77644322 244578999999999999999999999999999999999999998765432221111 1111
Q ss_pred CCC---ccchhhhcccccCCCCCHHHHHHHHHHHHHh
Q 018712 293 KLS---EDKVKQCVDTKLGGEYPPKAIAKVRKKKFIT 326 (351)
Q Consensus 293 ~~~---~~~~~~~ld~~~~~~~~~~~~~~~~~~~~~~ 326 (351)
.++ .+.+..|+..+|.+|++.+++ +++.++.
T Consensus 229 ~~s~~~~~li~~~L~~dp~~R~s~~ei---l~hp~~~ 262 (321)
T d1tkia_ 229 EISIEAMDFVDRLLVKERKSRMTASEA---LQHPWLK 262 (321)
T ss_dssp TSCHHHHHHHHTTSCSSGGGSCCHHHH---HHSHHHH
T ss_pred CCCHHHHHHHHHHccCChhHCcCHHHH---hcCHhhc
Confidence 222 368899999999999988776 4566654
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=3.6e-50 Score=354.57 Aligned_cols=237 Identities=25% Similarity=0.341 Sum_probs=198.6
Q ss_pred hcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCCc----------hHHHHHHHHHHHhcc-CCceeeeEEEEec
Q 018712 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP----------DQEFLAQVSMVSRLK-NENVVELVGYYVD 132 (351)
Q Consensus 65 ~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~----------~~~~~~e~~~l~~l~-h~niv~~~~~~~~ 132 (351)
.++|++.+.||+|+||+||+|++. +++.||||++...... .+.+.+|+.++++++ ||||+++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 468999999999999999999975 7899999998755322 135788999999997 9999999999999
Q ss_pred CCceEEEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCce
Q 018712 133 GPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIA 212 (351)
Q Consensus 133 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~v 212 (351)
++..|+||||+++|+|.+++..... +++..++.++.||+.||.|||++| |+||||||+|||++.++.+
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~~~~---------l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~ 149 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTEKVT---------LSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNI 149 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCE
T ss_pred CcceEEEEEcCCCchHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCe
Confidence 9999999999999999999976543 899999999999999999999999 9999999999999999999
Q ss_pred EEecccccCCCccccccccccccccccCccCcccccC------CCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccc
Q 018712 213 KISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMT------GQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSL 286 (351)
Q Consensus 213 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~ 286 (351)
||+|||+++....... .....||+.|+|||.+.+ ..++.++||||+||++|+|++|+.||...........
T Consensus 150 kl~DFG~a~~~~~~~~---~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~ 226 (277)
T d1phka_ 150 KLTDFGFSCQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRM 226 (277)
T ss_dssp EECCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred EEccchheeEccCCCc---eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHH
Confidence 9999999987654332 245679999999998853 4578899999999999999999999987654332211
Q ss_pred hhhc--------ccCCC---ccchhhhcccccCCCCCHHHH
Q 018712 287 VTWA--------TPKLS---EDKVKQCVDTKLGGEYPPKAI 316 (351)
Q Consensus 287 ~~~~--------~~~~~---~~~~~~~ld~~~~~~~~~~~~ 316 (351)
+... .+.++ .+.+.+|++++|.+|++.+++
T Consensus 227 i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~ei 267 (277)
T d1phka_ 227 IMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEA 267 (277)
T ss_dssp HHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHH
T ss_pred HHhCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHH
Confidence 1111 11122 267899999999999988775
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-50 Score=363.94 Aligned_cols=235 Identities=21% Similarity=0.331 Sum_probs=197.9
Q ss_pred cCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCC----CCchHHHHHHHHHHH-hccCCceeeeEEEEecCCceEEE
Q 018712 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSS----KQPDQEFLAQVSMVS-RLKNENVVELVGYYVDGPLRVLA 139 (351)
Q Consensus 66 ~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~e~~~l~-~l~h~niv~~~~~~~~~~~~~lv 139 (351)
++|.+.+.||+|+||+||+|.++ +++.||||++.+. ....+.+..|..++. .++||||+++++++.+++..|+|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 68999999999999999999975 7999999998643 223345667776655 68999999999999999999999
Q ss_pred EEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccc
Q 018712 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDL 219 (351)
Q Consensus 140 ~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~ 219 (351)
|||+++|+|.+++..... +++..++.++.||+.||.|||+++ |+||||||+|||+++++.+||+|||+
T Consensus 82 mEy~~~g~L~~~i~~~~~---------~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~ 149 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSCHK---------FDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGM 149 (320)
T ss_dssp EECCTTCBHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTT
T ss_pred EeecCCCcHHHHhhccCC---------CCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccch
Confidence 999999999999987653 889999999999999999999999 99999999999999999999999999
Q ss_pred cCCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccchhhcccCCC----
Q 018712 220 SNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLS---- 295 (351)
Q Consensus 220 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~---- 295 (351)
++........ .....||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+.......+....+..+
T Consensus 150 a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s 227 (320)
T d1xjda_ 150 CKENMLGDAK--TNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLE 227 (320)
T ss_dssp CBCCCCTTCC--BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSC
T ss_pred hhhccccccc--ccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccCC
Confidence 9876543322 2456799999999999999999999999999999999999999987654433333332222222
Q ss_pred ---ccchhhhcccccCCCCCHH
Q 018712 296 ---EDKVKQCVDTKLGGEYPPK 314 (351)
Q Consensus 296 ---~~~~~~~ld~~~~~~~~~~ 314 (351)
.+.+.+|+..+|.+|++.+
T Consensus 228 ~~~~dli~~~L~~dP~~R~s~~ 249 (320)
T d1xjda_ 228 KEAKDLLVKLFVREPEKRLGVR 249 (320)
T ss_dssp HHHHHHHHHHSCSSGGGSBTTB
T ss_pred HHHHHHHHHhcccCCCCCcCHH
Confidence 2578899999999999864
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=4.9e-50 Score=367.06 Aligned_cols=245 Identities=23% Similarity=0.336 Sum_probs=197.7
Q ss_pred hcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCC----CchHHHHH---HHHHHHhccCCceeeeEEEEecCCce
Q 018712 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK----QPDQEFLA---QVSMVSRLKNENVVELVGYYVDGPLR 136 (351)
Q Consensus 65 ~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~---e~~~l~~l~h~niv~~~~~~~~~~~~ 136 (351)
.++|++.+.||+|+||.||+|.+. +|+.||||++.+.. .....+.+ ++.+++.++||||+++++++.+.+..
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~ 82 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 82 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence 578999999999999999999975 79999999985322 11223334 46677778899999999999999999
Q ss_pred EEEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEec
Q 018712 137 VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISD 216 (351)
Q Consensus 137 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~D 216 (351)
|+||||+++|+|.+++..... +++..++.++.||+.||.|||+++ |+||||||+|||++.+|.+||+|
T Consensus 83 ~ivmE~~~gg~L~~~l~~~~~---------~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~D 150 (364)
T d1omwa3 83 SFILDLMNGGDLHYHLSQHGV---------FSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISD 150 (364)
T ss_dssp EEEECCCCSCBHHHHHHHHCS---------CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECC
T ss_pred EEEEEecCCCcHHHHHHhccc---------ccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEee
Confidence 999999999999999987643 889999999999999999999999 99999999999999999999999
Q ss_pred ccccCCCccccccccccccccccCccCcccccC-CCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccchhhc-----
Q 018712 217 FDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMT-GQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWA----- 290 (351)
Q Consensus 217 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~~~~----- 290 (351)
||+|+...... .....||+.|+|||++.+ ..|+.++|||||||++|||+||+.||..........+....
T Consensus 151 FGla~~~~~~~----~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~ 226 (364)
T d1omwa3 151 LGLACDFSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAV 226 (364)
T ss_dssp CTTCEECSSSC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCCC
T ss_pred eceeeecCCCc----ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCC
Confidence 99998665432 245679999999999874 56899999999999999999999999876544322221111
Q ss_pred --ccCCC---ccchhhhcccccCCCCCHH--HHHHHHHHHHH
Q 018712 291 --TPKLS---EDKVKQCVDTKLGGEYPPK--AIAKVRKKKFI 325 (351)
Q Consensus 291 --~~~~~---~~~~~~~ld~~~~~~~~~~--~~~~~~~~~~~ 325 (351)
...++ .+.+..|+..+|.+|++.. .+..+++|.++
T Consensus 227 ~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f 268 (364)
T d1omwa3 227 ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFF 268 (364)
T ss_dssp CCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGG
T ss_pred CCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCccc
Confidence 11122 3688999999999999841 23444555553
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-50 Score=356.28 Aligned_cols=245 Identities=26% Similarity=0.407 Sum_probs=196.2
Q ss_pred cCCCCCceeccCCcEEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEEEeCCC
Q 018712 66 DNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASK 145 (351)
Q Consensus 66 ~~y~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 145 (351)
++|++.+.||+|+||.||+|.++++..||||++.......+.+.+|+.++++++|||||++++++.+ +..++||||+++
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~~~ 95 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSK 95 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTT
T ss_pred HHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccCCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEecCC
Confidence 5799999999999999999999888899999998877777889999999999999999999999855 567999999999
Q ss_pred CCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccccCCCcc
Q 018712 146 GSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPD 225 (351)
Q Consensus 146 gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~ 225 (351)
|+|..++...... .+++..++.++.||+.||+|||+++ |+||||||+|||+++++++||+|||+++....
T Consensus 96 g~l~~~~~~~~~~-------~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~ 165 (285)
T d1fmka3 96 GSLLDFLKGETGK-------YLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIED 165 (285)
T ss_dssp CBHHHHHSHHHHT-------TCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC----
T ss_pred Cchhhhhhhcccc-------cchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhhhccC
Confidence 9999998764321 2899999999999999999999999 99999999999999999999999999987643
Q ss_pred ccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCC-CCCccchhh-----cccCC---Cc
Q 018712 226 AAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLP-RGQQSLVTW-----ATPKL---SE 296 (351)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~-~~~~~~~~~-----~~~~~---~~ 296 (351)
.... ......||+.|+|||++....++.++||||||+++|||++|..||..... ......+.. ..+.. ..
T Consensus 166 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~ 244 (285)
T d1fmka3 166 NEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLH 244 (285)
T ss_dssp -----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTSCHHHH
T ss_pred CCce-eeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCcccCHHHH
Confidence 3322 22345689999999999999999999999999999999996655544322 211111111 11111 23
Q ss_pred cchhhhcccccCCCCCHHHHHHHHHH
Q 018712 297 DKVKQCVDTKLGGEYPPKAIAKVRKK 322 (351)
Q Consensus 297 ~~~~~~ld~~~~~~~~~~~~~~~~~~ 322 (351)
+.+.+|++.+|.+|++.+++..+++-
T Consensus 245 ~li~~cl~~dP~~Rps~~~i~~~L~~ 270 (285)
T d1fmka3 245 DLMCQCWRKEPEERPTFEYLQAFLED 270 (285)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred HHHHHHcccCHhHCcCHHHHHHHHhh
Confidence 68899999999999999998665544
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-49 Score=350.06 Aligned_cols=247 Identities=25% Similarity=0.369 Sum_probs=192.2
Q ss_pred cCCCCCceeccCCcEEEEEEEECCC-----CEEEEEEcCCCCCc--hHHHHHHHHHHHhccCCceeeeEEEEecCCceEE
Q 018712 66 DNFGTNSLIGEGSYGRVYFGVLRSG-----RAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVL 138 (351)
Q Consensus 66 ~~y~~~~~Lg~G~~g~Vy~~~~~~~-----~~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 138 (351)
+.|++.++||+|+||.||+|.++++ ..||||++...... ...+.+|++++++++|||||++++++.+.+..++
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~ 86 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 86 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence 4678889999999999999996532 47999998755433 3468899999999999999999999999999999
Q ss_pred EEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEeccc
Q 018712 139 AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFD 218 (351)
Q Consensus 139 v~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg 218 (351)
||||+.+++|.+++..... .+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||
T Consensus 87 v~e~~~~~~l~~~~~~~~~--------~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG 155 (283)
T d1mqba_ 87 ITEYMENGALDKFLREKDG--------EFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFG 155 (283)
T ss_dssp EEECCTTEEHHHHHHHTTT--------CSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCC
T ss_pred EEEecccCcchhhhhcccc--------cccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccc
Confidence 9999999999998876543 2899999999999999999999999 9999999999999999999999999
Q ss_pred ccCCCcccccc-ccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCC-Cccchhh-------
Q 018712 219 LSNQAPDAAAR-LHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRG-QQSLVTW------- 289 (351)
Q Consensus 219 ~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~-~~~~~~~------- 289 (351)
+++........ .......||+.|+|||++.+..++.++|||||||++|||++|..||....... ....+..
T Consensus 156 la~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~~ 235 (283)
T d1mqba_ 156 LSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTP 235 (283)
T ss_dssp C-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCC
T ss_pred hhhcccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCCCCCc
Confidence 99876543222 12234568999999999999999999999999999999999665554332211 1111111
Q ss_pred -cccCCCccchhhhcccccCCCCCHHHHHHHHHHH
Q 018712 290 -ATPKLSEDKVKQCVDTKLGGEYPPKAIAKVRKKK 323 (351)
Q Consensus 290 -~~~~~~~~~~~~~ld~~~~~~~~~~~~~~~~~~~ 323 (351)
..+....+.+..|++.+|.+||+..++...++-.
T Consensus 236 ~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l 270 (283)
T d1mqba_ 236 MDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL 270 (283)
T ss_dssp TTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred hhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHH
Confidence 1111123788999999999999999987766543
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=9.8e-50 Score=352.76 Aligned_cols=242 Identities=22% Similarity=0.352 Sum_probs=191.0
Q ss_pred hcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCCc----hHHHHHHHHHHHhccCCceeeeEEEEecCC----c
Q 018712 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP----DQEFLAQVSMVSRLKNENVVELVGYYVDGP----L 135 (351)
Q Consensus 65 ~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----~ 135 (351)
.++|++.+.||+|+||.||+|.+. +++.||||++...... ...+.+|+++++.++||||+++++++...+ .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 467999999999999999999974 7999999999765432 245889999999999999999999887543 4
Q ss_pred eEEEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEe
Q 018712 136 RVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKIS 215 (351)
Q Consensus 136 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~ 215 (351)
.|+||||++|++|.+++..... +++.+++.++.||+.||.|||++| |+||||||+|||++.++.++|+
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~~~---------l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~ 153 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTEGP---------MTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVM 153 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHHCS---------CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEEC
T ss_pred EEEEEECCCCCEehhhhcccCC---------CCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceee
Confidence 7999999999999999977653 899999999999999999999999 9999999999999999999999
Q ss_pred cccccCCCccccc-cccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccch-------
Q 018712 216 DFDLSNQAPDAAA-RLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLV------- 287 (351)
Q Consensus 216 Dfg~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~------- 287 (351)
|||.+........ ........||+.|+|||++.+..++.++|||||||++|||+||+.||....+......+
T Consensus 154 d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~ 233 (277)
T d1o6ya_ 154 DFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIP 233 (277)
T ss_dssp CCTTCEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCC
T ss_pred hhhhhhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCC
Confidence 9998865533221 22234567999999999999999999999999999999999999999875432211111
Q ss_pred -hhcccCC---CccchhhhcccccCCCC-CHHHHHH
Q 018712 288 -TWATPKL---SEDKVKQCVDTKLGGEY-PPKAIAK 318 (351)
Q Consensus 288 -~~~~~~~---~~~~~~~~ld~~~~~~~-~~~~~~~ 318 (351)
....+.+ ..+.+.+|+.++|.+|+ +.+++..
T Consensus 234 ~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~ 269 (277)
T d1o6ya_ 234 PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRA 269 (277)
T ss_dssp GGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred CchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHH
Confidence 1111222 23688999999999999 5666543
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-49 Score=358.13 Aligned_cols=238 Identities=19% Similarity=0.280 Sum_probs=192.8
Q ss_pred HhcCCCCCc-eeccCCcEEEEEEEEC-CCCEEEEEEcCCCCCchHHHHHHHHHHHhc-cCCceeeeEEEEec----CCce
Q 018712 64 KTDNFGTNS-LIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRL-KNENVVELVGYYVD----GPLR 136 (351)
Q Consensus 64 ~~~~y~~~~-~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~----~~~~ 136 (351)
..++|.+.+ .||+|+||+||+|.+. +++.||||+++.. ..+.+|+.++.++ +||||++++++|.+ +..+
T Consensus 9 i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~ 84 (335)
T d2ozaa1 9 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 84 (335)
T ss_dssp GGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred cccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence 356898875 5999999999999974 7899999998643 4577899987655 89999999999865 4678
Q ss_pred EEEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEcc---CCceE
Q 018712 137 VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFD---DDIAK 213 (351)
Q Consensus 137 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~---~~~vk 213 (351)
|+|||||+||+|.+++...... .+++.+++.++.||+.||.|||++| |+||||||+|||+++ .+.+|
T Consensus 85 ~ivmEy~~gg~L~~~i~~~~~~-------~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~K 154 (335)
T d2ozaa1 85 LIVMECLDGGELFSRIQDRGDQ-------AFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILK 154 (335)
T ss_dssp EEEEECCCSEEHHHHHHSCSCC-------CEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEE
T ss_pred EEEEECCCCCcHHHHHHhcCCC-------CcCHHHHHHHHHHHHHHHHHHHHcC---Ccccccccccccccccccccccc
Confidence 9999999999999999765322 3999999999999999999999999 999999999999985 46799
Q ss_pred EecccccCCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCcc----chhh
Q 018712 214 ISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQS----LVTW 289 (351)
Q Consensus 214 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~----~~~~ 289 (351)
|+|||+|+....... .....||+.|+|||++.+..|+.++|||||||++|+|+||+.||.+........ .+..
T Consensus 155 l~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~ 231 (335)
T d2ozaa1 155 LTDFGFAKETTSHNS---LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRM 231 (335)
T ss_dssp ECCCTTCEECCCCCC---CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCS
T ss_pred ccccceeeeccCCCc---cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhc
Confidence 999999987654332 245679999999999999999999999999999999999999998654332111 1100
Q ss_pred -----------cccCCCccchhhhcccccCCCCCHHHHHH
Q 018712 290 -----------ATPKLSEDKVKQCVDTKLGGEYPPKAIAK 318 (351)
Q Consensus 290 -----------~~~~~~~~~~~~~ld~~~~~~~~~~~~~~ 318 (351)
..+....+.+..|+..+|.+|++.+++..
T Consensus 232 ~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 271 (335)
T d2ozaa1 232 GQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271 (335)
T ss_dssp CSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 01111236789999999999999877643
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-49 Score=347.08 Aligned_cols=247 Identities=24% Similarity=0.334 Sum_probs=191.6
Q ss_pred hcCCCCCceeccCCcEEEEEEEECC----CCEEEEEEcCCCCCc--hHHHHHHHHHHHhccCCceeeeEEEEecCCceEE
Q 018712 65 TDNFGTNSLIGEGSYGRVYFGVLRS----GRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVL 138 (351)
Q Consensus 65 ~~~y~~~~~Lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 138 (351)
.++|++.+.||+|+||.||+|.+.. +..||||.+...... .+.+.+|+.++++++||||+++++++. .+..++
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~i 84 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 84 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEE
Confidence 3578999999999999999998652 356899998654433 356889999999999999999999985 467899
Q ss_pred EEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEeccc
Q 018712 139 AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFD 218 (351)
Q Consensus 139 v~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg 218 (351)
||||+++|+|.+++..... .+++..++.++.||+.||.|||+++ ++||||||+||++++++.+||+|||
T Consensus 85 v~E~~~~g~l~~~~~~~~~--------~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG 153 (273)
T d1mp8a_ 85 IMELCTLGELRSFLQVRKY--------SLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFG 153 (273)
T ss_dssp EEECCTTEEHHHHHHHTTT--------TSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC--
T ss_pred EEEeccCCcHHhhhhccCC--------CCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccch
Confidence 9999999999998876542 2899999999999999999999999 9999999999999999999999999
Q ss_pred ccCCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCCccchhh--------
Q 018712 219 LSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTW-------- 289 (351)
Q Consensus 219 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~Pf~~~~~~~~~~~~~~-------- 289 (351)
+|+....... .......||+.|+|||++.+..++.++|||||||++|||++ |.+||...........+..
T Consensus 154 ~a~~~~~~~~-~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~~~~~~ 232 (273)
T d1mp8a_ 154 LSRYMEDSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPP 232 (273)
T ss_dssp ------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCT
T ss_pred hheeccCCcc-eeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCC
Confidence 9987654322 22344568999999999999999999999999999999998 8999987655432221111
Q ss_pred cccCCCccchhhhcccccCCCCCHHHHHHHHHHHH
Q 018712 290 ATPKLSEDKVKQCVDTKLGGEYPPKAIAKVRKKKF 324 (351)
Q Consensus 290 ~~~~~~~~~~~~~ld~~~~~~~~~~~~~~~~~~~~ 324 (351)
..+....+.+.+|+..+|.+|++.+++.+.++..+
T Consensus 233 ~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~ 267 (273)
T d1mp8a_ 233 NCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 267 (273)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 11111236889999999999999999877665443
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.6e-49 Score=352.75 Aligned_cols=243 Identities=23% Similarity=0.351 Sum_probs=194.6
Q ss_pred cCCCCCceeccCCcEEEEEEEEC-CCC----EEEEEEcCCCC--CchHHHHHHHHHHHhccCCceeeeEEEEecCCceEE
Q 018712 66 DNFGTNSLIGEGSYGRVYFGVLR-SGR----AAAIKKLDSSK--QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVL 138 (351)
Q Consensus 66 ~~y~~~~~Lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 138 (351)
++|++++.||+|+||.||+|.+. +|+ .||+|++.... ...+.+.+|++++++++||||+++++++.++ ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 57999999999999999999975 443 68999886432 3456799999999999999999999999875 5678
Q ss_pred EEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEeccc
Q 018712 139 AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFD 218 (351)
Q Consensus 139 v~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg 218 (351)
++|++.+|+|.+++..... .+++..++.++.||+.||.|||+++ |+||||||+|||++.++++||+|||
T Consensus 88 v~e~~~~~~l~~~~~~~~~--------~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFG 156 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVREHKD--------NIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFG 156 (317)
T ss_dssp EEECCTTCBHHHHHHHTSS--------SCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCS
T ss_pred EEEeccCCccccccccccc--------CCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccc
Confidence 8899999999998876543 2899999999999999999999999 9999999999999999999999999
Q ss_pred ccCCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCCccchhh-cccC---
Q 018712 219 LSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTW-ATPK--- 293 (351)
Q Consensus 219 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~Pf~~~~~~~~~~~~~~-~~~~--- 293 (351)
+|+...............||+.|+|||++.+..++.++|||||||++|||+| |+.||...........+.. ..+.
T Consensus 157 la~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~p~ 236 (317)
T d1xkka_ 157 LAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPP 236 (317)
T ss_dssp HHHHTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCCCCCCT
T ss_pred cceecccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCc
Confidence 9987654443333345578999999999999999999999999999999998 8999987654432222221 1111
Q ss_pred -C---CccchhhhcccccCCCCCHHHHHHHH
Q 018712 294 -L---SEDKVKQCVDTKLGGEYPPKAIAKVR 320 (351)
Q Consensus 294 -~---~~~~~~~~ld~~~~~~~~~~~~~~~~ 320 (351)
. ..+.+..|+..+|.+|++..++...+
T Consensus 237 ~~~~~~~~li~~cl~~dP~~RPs~~eil~~l 267 (317)
T d1xkka_ 237 ICTIDVYMIMVKCWMIDADSRPKFRELIIEF 267 (317)
T ss_dssp TBCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred ccCHHHHHHHHHhCCCChhhCcCHHHHHHHH
Confidence 1 13688999999999999998876543
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-49 Score=346.51 Aligned_cols=241 Identities=27% Similarity=0.414 Sum_probs=192.6
Q ss_pred hcCCCCCceeccCCcEEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHHhccCCceeeeEEEEec-CCceEEEEEeC
Q 018712 65 TDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVD-GPLRVLAYEHA 143 (351)
Q Consensus 65 ~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e~~ 143 (351)
.++|++.+.||+|+||.||+|.++ |..||||+++.+. ..+.+.+|++++++++||||+++++++.+ .+.+++||||+
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~~-~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~ 83 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 83 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC---HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred HHHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcHH-HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEecc
Confidence 457888999999999999999985 7789999997654 45679999999999999999999999865 45689999999
Q ss_pred CCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccccCCC
Q 018712 144 SKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQA 223 (351)
Q Consensus 144 ~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~ 223 (351)
++|+|.+++...... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 84 ~~g~L~~~l~~~~~~-------~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~ 153 (262)
T d1byga_ 84 AKGSLVDYLRSRGRS-------VLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEA 153 (262)
T ss_dssp TTEEHHHHHHHHHHH-------HCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC----
T ss_pred CCCCHHHHHHhcCCC-------CCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccceec
Confidence 999999999764321 2789999999999999999999999 999999999999999999999999999875
Q ss_pred ccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCCccchhh-cccC-------C
Q 018712 224 PDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTW-ATPK-------L 294 (351)
Q Consensus 224 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~Pf~~~~~~~~~~~~~~-~~~~-------~ 294 (351)
.... ....+|..|+|||.+.+..++.++||||||+++|||+| |+.||...........+.. ..+. -
T Consensus 154 ~~~~-----~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 228 (262)
T d1byga_ 154 SSTQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPA 228 (262)
T ss_dssp -------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCCTTCCHH
T ss_pred CCCC-----ccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHH
Confidence 4332 34468899999999999999999999999999999998 7888887654332222211 1111 1
Q ss_pred CccchhhhcccccCCCCCHHHHHHHHHH
Q 018712 295 SEDKVKQCVDTKLGGEYPPKAIAKVRKK 322 (351)
Q Consensus 295 ~~~~~~~~ld~~~~~~~~~~~~~~~~~~ 322 (351)
..+.+.+|++.+|.+|++..++.+.++.
T Consensus 229 ~~~li~~cl~~dP~~Rps~~~l~~~L~~ 256 (262)
T d1byga_ 229 VYEVMKNCWHLDAAMRPSFLQLREQLEH 256 (262)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHHHHHcccCHhHCcCHHHHHHHHHH
Confidence 1378899999999999999998776543
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-49 Score=352.59 Aligned_cols=239 Identities=21% Similarity=0.273 Sum_probs=189.0
Q ss_pred CCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCCc------hHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEEEe
Q 018712 70 TNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP------DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEH 142 (351)
Q Consensus 70 ~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 142 (351)
.+++||+|+||+||+|.++ +|+.||||++...... .+.+.+|+.++++++||||+++++++.+++..|+||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 3568999999999999975 7899999998654322 24688999999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccccCC
Q 018712 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222 (351)
Q Consensus 143 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~ 222 (351)
+.++++..+...... +++..+..++.||+.||.|||++| |+||||||+|||++.++.+||+|||+|+.
T Consensus 82 ~~~~~~~~~~~~~~~---------l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~ 149 (299)
T d1ua2a_ 82 METDLEVIIKDNSLV---------LTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKS 149 (299)
T ss_dssp CSEEHHHHHTTCCSS---------CCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGST
T ss_pred hcchHHhhhhhcccC---------CCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccc
Confidence 998877776654432 888899999999999999999999 99999999999999999999999999987
Q ss_pred CccccccccccccccccCccCcccccC-CCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccchh-------------
Q 018712 223 APDAAARLHSTRVLGTFGYHAPEYAMT-GQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVT------------- 288 (351)
Q Consensus 223 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~~------------- 288 (351)
....... ....+||+.|+|||++.+ ..|+.++|||||||++|||++|+.||......+....+.
T Consensus 150 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~ 227 (299)
T d1ua2a_ 150 FGSPNRA--YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPD 227 (299)
T ss_dssp TTSCCCC--CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSS
T ss_pred cCCCccc--ccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccc
Confidence 6543322 234579999999998865 467999999999999999999999997643221100000
Q ss_pred -------------------hcccCCC---ccchhhhcccccCCCCCHHHHHHHHHHHHH
Q 018712 289 -------------------WATPKLS---EDKVKQCVDTKLGGEYPPKAIAKVRKKKFI 325 (351)
Q Consensus 289 -------------------~~~~~~~---~~~~~~~ld~~~~~~~~~~~~~~~~~~~~~ 325 (351)
...+... .+.+..|+..+|.+|++++++ +++.++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~---L~Hp~f 283 (299)
T d1ua2a_ 228 MCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQA---LKMKYF 283 (299)
T ss_dssp TTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHH---HTSGGG
T ss_pred hhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHH---hCCHhh
Confidence 0001111 246889999999999998876 345544
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.4e-49 Score=351.94 Aligned_cols=256 Identities=23% Similarity=0.332 Sum_probs=204.3
Q ss_pred HhcCCCCCceeccCCcEEEEEEEEC------CCCEEEEEEcCCCCCc--hHHHHHHHHHHHhccCCceeeeEEEEecCCc
Q 018712 64 KTDNFGTNSLIGEGSYGRVYFGVLR------SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPL 135 (351)
Q Consensus 64 ~~~~y~~~~~Lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 135 (351)
..++|++.+.||+|+||+||+|..+ +++.||||++...... .+.+.+|++++++++||||+++++++.+.+.
T Consensus 11 p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~ 90 (301)
T d1lufa_ 11 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP 90 (301)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred CHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCc
Confidence 3568999999999999999999864 3578999998765433 3568999999999999999999999999999
Q ss_pred eEEEEEeCCCCCHHHHhccCCCCC---------------CCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeecccc
Q 018712 136 RVLAYEHASKGSLHDILHGKKGVK---------------GAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIK 200 (351)
Q Consensus 136 ~~lv~e~~~~gsL~~~l~~~~~~~---------------~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlk 200 (351)
.+++|||+.+|+|.+++....... .......+++..++.++.|++.||+|||+++ ++|||||
T Consensus 91 ~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---ivHrDlK 167 (301)
T d1lufa_ 91 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLA 167 (301)
T ss_dssp CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCS
T ss_pred eEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---eEeeEEc
Confidence 999999999999999997543211 0111234889999999999999999999999 9999999
Q ss_pred CCcEEEccCCceEEecccccCCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCC-CCCCCCC
Q 018712 201 SSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGR-KPVDHTL 279 (351)
Q Consensus 201 p~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~-~Pf~~~~ 279 (351)
|+|||++.++.+||+|||+|+...........+...||+.|+|||.+.+..++.++|||||||++|||++|. .||....
T Consensus 168 p~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~ 247 (301)
T d1lufa_ 168 TRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA 247 (301)
T ss_dssp GGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred ccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCC
Confidence 999999999999999999997654443333345567899999999999999999999999999999999985 5777654
Q ss_pred CCCCccchh-hcccC----C---CccchhhhcccccCCCCCHHHHHHHHHH
Q 018712 280 PRGQQSLVT-WATPK----L---SEDKVKQCVDTKLGGEYPPKAIAKVRKK 322 (351)
Q Consensus 280 ~~~~~~~~~-~~~~~----~---~~~~~~~~ld~~~~~~~~~~~~~~~~~~ 322 (351)
.......+. ...+. . ..+.+..|++.+|.+||+..++.+.++.
T Consensus 248 ~~e~~~~v~~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~ 298 (301)
T d1lufa_ 248 HEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQR 298 (301)
T ss_dssp HHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHHHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 432221111 11111 1 1268899999999999999998776653
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=5.8e-48 Score=343.82 Aligned_cols=262 Identities=17% Similarity=0.209 Sum_probs=209.9
Q ss_pred hcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCCchHHHHHHHHHHHhccC-CceeeeEEEEecCCceEEEEEe
Q 018712 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKN-ENVVELVGYYVDGPLRVLAYEH 142 (351)
Q Consensus 65 ~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h-~niv~~~~~~~~~~~~~lv~e~ 142 (351)
.++|++.+.||+|+||+||+|.+. +|+.||||++.... ....+.+|++.++.++| +|++.+++++.+....++||||
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~ 82 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDL 82 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT-TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEEC
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc-CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEe
Confidence 368999999999999999999975 78999999886543 23457889999999976 8999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEcc-----CCceEEecc
Q 018712 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFD-----DDIAKISDF 217 (351)
Q Consensus 143 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~-----~~~vkl~Df 217 (351)
+ +++|.+++..... .++..++..++.|++.||.|||++| |+||||||+|||++. ++.+||+||
T Consensus 83 ~-~~~l~~~~~~~~~--------~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DF 150 (293)
T d1csna_ 83 L-GPSLEDLLDLCGR--------KFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDF 150 (293)
T ss_dssp C-CCBHHHHHHHTTT--------CCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCC
T ss_pred c-CCCHHHHHHhhcc--------chhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEccc
Confidence 9 6799999876543 2899999999999999999999999 999999999999974 568999999
Q ss_pred cccCCCcccccc-----ccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccchh----
Q 018712 218 DLSNQAPDAAAR-----LHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVT---- 288 (351)
Q Consensus 218 g~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~~---- 288 (351)
|+|+........ .......||+.|+|||++.+..++.++||||||+++|||++|+.||.............
T Consensus 151 G~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~ 230 (293)
T d1csna_ 151 GMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGE 230 (293)
T ss_dssp TTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHH
T ss_pred ceeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHh
Confidence 999876433211 12345679999999999999999999999999999999999999998765443221110
Q ss_pred --------hcccCCC---ccchhhhcccccCCCCCHHHHHHHHHHHHHhhhhccccchhhhhcccCCccccc
Q 018712 289 --------WATPKLS---EDKVKQCVDTKLGGEYPPKAIAKVRKKKFITSECSNISFAEFNINWHCPLEWSV 349 (351)
Q Consensus 289 --------~~~~~~~---~~~~~~~ld~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~ 349 (351)
...+..+ .+.+..|+..++.+||+.+.+..+++-. +++.+...+++|||+.
T Consensus 231 ~~~~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~----------~~~~~~~~~~~~Dw~~ 292 (293)
T d1csna_ 231 KKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKV----------LERLNTTEDENFDWNL 292 (293)
T ss_dssp HHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHH----------HHHTTCCSCSCCGGGC
T ss_pred ccCCCChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHH----------HHHcCCCCCCCCCCCc
Confidence 0111222 2456677888899999888776665544 3455667789999984
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-48 Score=346.79 Aligned_cols=257 Identities=19% Similarity=0.280 Sum_probs=193.3
Q ss_pred hcCCCCCceeccCCcEEEEEEEEC------CCCEEEEEEcCCCCCc--hHHHHHHHHHHHhc-cCCceeeeEEEEecC-C
Q 018712 65 TDNFGTNSLIGEGSYGRVYFGVLR------SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRL-KNENVVELVGYYVDG-P 134 (351)
Q Consensus 65 ~~~y~~~~~Lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l-~h~niv~~~~~~~~~-~ 134 (351)
.++|++.+.||+|+||.||+|.+. +++.||||++...... .+.+.+|...+.++ +|+||+.+++++.+. .
T Consensus 12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~ 91 (299)
T d1ywna1 12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 91 (299)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTS
T ss_pred HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCC
Confidence 468999999999999999999863 3468999998754432 35577788888777 689999999987654 4
Q ss_pred ceEEEEEeCCCCCHHHHhccCCCCCC-------CCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEc
Q 018712 135 LRVLAYEHASKGSLHDILHGKKGVKG-------AKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLF 207 (351)
Q Consensus 135 ~~~lv~e~~~~gsL~~~l~~~~~~~~-------~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~ 207 (351)
..++|||||++|+|.+++........ ......+++..++.++.||+.||.|||+++ |+||||||+|||++
T Consensus 92 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDlKp~NILl~ 168 (299)
T d1ywna1 92 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLS 168 (299)
T ss_dssp CCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEC
T ss_pred eEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCcCCccceeEC
Confidence 68999999999999999976532110 011224889999999999999999999999 99999999999999
Q ss_pred cCCceEEecccccCCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcC-CCCCCCCCCCCCc-c
Q 018712 208 DDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTG-RKPVDHTLPRGQQ-S 285 (351)
Q Consensus 208 ~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg-~~Pf~~~~~~~~~-~ 285 (351)
+++++||+|||+|+...............||+.|+|||++.+..++.++|||||||++|||+|| ..||......... .
T Consensus 169 ~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~~ 248 (299)
T d1ywna1 169 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR 248 (299)
T ss_dssp GGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHH
T ss_pred CCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 9999999999999876554444344566899999999999999999999999999999999996 5678765432211 1
Q ss_pred ch-hhcccCC-------CccchhhhcccccCCCCCHHHHHHHHHHHH
Q 018712 286 LV-TWATPKL-------SEDKVKQCVDTKLGGEYPPKAIAKVRKKKF 324 (351)
Q Consensus 286 ~~-~~~~~~~-------~~~~~~~~ld~~~~~~~~~~~~~~~~~~~~ 324 (351)
.+ ....+.. ..+.+.+|+..+|.+|++.+++.+.++..+
T Consensus 249 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~il 295 (299)
T d1ywna1 249 RLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 295 (299)
T ss_dssp HHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 11 1111111 126889999999999999999887765544
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-48 Score=344.31 Aligned_cols=245 Identities=27% Similarity=0.372 Sum_probs=189.2
Q ss_pred hcCCCCCceeccCCcEEEEEEEEC--CC--CEEEEEEcCCCCC----chHHHHHHHHHHHhccCCceeeeEEEEecCCce
Q 018712 65 TDNFGTNSLIGEGSYGRVYFGVLR--SG--RAAAIKKLDSSKQ----PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLR 136 (351)
Q Consensus 65 ~~~y~~~~~Lg~G~~g~Vy~~~~~--~~--~~vavK~~~~~~~----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 136 (351)
.++|++.+.||+|+||.||+|.+. ++ ..||||++..... ..+.+.+|+.+|++++||||+++++++.+ +..
T Consensus 7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~ 85 (273)
T d1u46a_ 7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPM 85 (273)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred hHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cch
Confidence 367999999999999999999854 22 3789999875432 23578999999999999999999999966 467
Q ss_pred EEEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEec
Q 018712 137 VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISD 216 (351)
Q Consensus 137 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~D 216 (351)
++||||+.+|+|.+++..... .+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|
T Consensus 86 ~lv~e~~~~~~l~~~~~~~~~--------~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~D 154 (273)
T d1u46a_ 86 KMVTELAPLGSLLDRLRKHQG--------HFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGD 154 (273)
T ss_dssp EEEEECCTTCBHHHHHHHHGG--------GSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECC
T ss_pred heeeeeecCcchhhhhhcccC--------CCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeecc
Confidence 899999999999998876542 2899999999999999999999999 99999999999999999999999
Q ss_pred ccccCCCcccccc-ccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCCccchh------
Q 018712 217 FDLSNQAPDAAAR-LHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVT------ 288 (351)
Q Consensus 217 fg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~Pf~~~~~~~~~~~~~------ 288 (351)
||+++........ .......||..|+|||.+.+..++.++||||||+++|||+| |+.||.+.+.......+.
T Consensus 155 fGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~ 234 (273)
T d1u46a_ 155 FGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERL 234 (273)
T ss_dssp CTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCC
T ss_pred chhhhhcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCC
Confidence 9999876443322 22234567889999999999999999999999999999998 899998654332211111
Q ss_pred ---hcccCCCccchhhhcccccCCCCCHHHHHHHHH
Q 018712 289 ---WATPKLSEDKVKQCVDTKLGGEYPPKAIAKVRK 321 (351)
Q Consensus 289 ---~~~~~~~~~~~~~~ld~~~~~~~~~~~~~~~~~ 321 (351)
...+....+.+.+|++.+|.+||+.+++..+++
T Consensus 235 ~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~ 270 (273)
T d1u46a_ 235 PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLL 270 (273)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence 011111236789999999999999999877654
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-48 Score=344.25 Aligned_cols=258 Identities=25% Similarity=0.344 Sum_probs=204.3
Q ss_pred hcCCCCCceeccCCcEEEEEEEECC--------CCEEEEEEcCCCCCc--hHHHHHHHHHHHhc-cCCceeeeEEEEecC
Q 018712 65 TDNFGTNSLIGEGSYGRVYFGVLRS--------GRAAAIKKLDSSKQP--DQEFLAQVSMVSRL-KNENVVELVGYYVDG 133 (351)
Q Consensus 65 ~~~y~~~~~Lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~--~~~~~~e~~~l~~l-~h~niv~~~~~~~~~ 133 (351)
.++|.+.+.||+|+||.||+|.... +..||||++...... ..++.+|...+.++ +||||+++++++.++
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~ 91 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 91 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence 4678999999999999999998532 247999999766543 36788899999888 799999999999999
Q ss_pred CceEEEEEeCCCCCHHHHhccCCCCC-------CCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEE
Q 018712 134 PLRVLAYEHASKGSLHDILHGKKGVK-------GAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLL 206 (351)
Q Consensus 134 ~~~~lv~e~~~~gsL~~~l~~~~~~~-------~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill 206 (351)
+..++||||+.+|+|.+++....... .......+++..++.++.||+.||.|||+++ |+||||||+|||+
T Consensus 92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~NiLl 168 (299)
T d1fgka_ 92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV 168 (299)
T ss_dssp SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeecccceee
Confidence 99999999999999999997664211 1122234899999999999999999999999 9999999999999
Q ss_pred ccCCceEEecccccCCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCCcc
Q 018712 207 FDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQS 285 (351)
Q Consensus 207 ~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~Pf~~~~~~~~~~ 285 (351)
+.++.+||+|||+++...............||+.|+|||.+.++.|+.++||||||+++|||++ |++||..........
T Consensus 169 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~~~ 248 (299)
T d1fgka_ 169 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK 248 (299)
T ss_dssp CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHH
T ss_pred cCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHHHHH
Confidence 9999999999999988765544444455679999999999999999999999999999999998 789998655432222
Q ss_pred chhh-ccc-------CCCccchhhhcccccCCCCCHHHHHHHHHHHHH
Q 018712 286 LVTW-ATP-------KLSEDKVKQCVDTKLGGEYPPKAIAKVRKKKFI 325 (351)
Q Consensus 286 ~~~~-~~~-------~~~~~~~~~~ld~~~~~~~~~~~~~~~~~~~~~ 325 (351)
.+.. ..+ ....+.+.+|+..+|..|++++++.+.++..+.
T Consensus 249 ~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a 296 (299)
T d1fgka_ 249 LLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296 (299)
T ss_dssp HHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence 2111 111 112378899999999999999999887765543
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-48 Score=347.46 Aligned_cols=239 Identities=22% Similarity=0.337 Sum_probs=190.4
Q ss_pred cCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCC---chHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEEE
Q 018712 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ---PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYE 141 (351)
Q Consensus 66 ~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 141 (351)
++|++++.||+|+||+||+|.+. +++.||||++..... ....+.+|+++|++++||||+++++++.+++..|+|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 68999999999999999999974 789999999965432 24678899999999999999999999999999999999
Q ss_pred eCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccccC
Q 018712 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (351)
Q Consensus 142 ~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~ 221 (351)
|+.+ ++.+++...... .+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||+|+
T Consensus 82 ~~~~-~~~~~~~~~~~~-------~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~ 150 (298)
T d1gz8a_ 82 FLHQ-DLKKFMDASALT-------GIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLAR 150 (298)
T ss_dssp CCSE-EHHHHHHHTTTT-------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHH
T ss_pred ecCC-chhhhhhhhccc-------CCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcce
Confidence 9976 555555433221 2899999999999999999999999 9999999999999999999999999987
Q ss_pred CCccccccccccccccccCccCcccccCCC-CCccchhHhHHHHHHHHHcCCCCCCCCCCCCCcc---------------
Q 018712 222 QAPDAAARLHSTRVLGTFGYHAPEYAMTGQ-MSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQS--------------- 285 (351)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~--------------- 285 (351)
........ .....||+.|+|||.+.... ++.++|||||||++|+|++|+.||...+......
T Consensus 151 ~~~~~~~~--~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 228 (298)
T d1gz8a_ 151 AFGVPVRT--YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWP 228 (298)
T ss_dssp HHCCCSBC--TTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTST
T ss_pred eccCCccc--ceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcc
Confidence 65432221 24457999999999887665 4889999999999999999999997643211000
Q ss_pred ---ch---------------hhcccCCC---ccchhhhcccccCCCCCHHHHH
Q 018712 286 ---LV---------------TWATPKLS---EDKVKQCVDTKLGGEYPPKAIA 317 (351)
Q Consensus 286 ---~~---------------~~~~~~~~---~~~~~~~ld~~~~~~~~~~~~~ 317 (351)
.. ....+.++ .+.+.+|+..+|.+|++++++.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell 281 (298)
T d1gz8a_ 229 GVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAAL 281 (298)
T ss_dssp TGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred ccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHh
Confidence 00 00011111 2568899999999999888763
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-49 Score=348.59 Aligned_cols=237 Identities=19% Similarity=0.313 Sum_probs=191.5
Q ss_pred hcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCC-------chHHHHHHHHHHHhcc--CCceeeeEEEEecCC
Q 018712 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ-------PDQEFLAQVSMVSRLK--NENVVELVGYYVDGP 134 (351)
Q Consensus 65 ~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------~~~~~~~e~~~l~~l~--h~niv~~~~~~~~~~ 134 (351)
.++|++.+.||+|+||+||+|.+. +|+.||||++..... ....+.+|+.++++++ ||||+++++++.+.+
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 367999999999999999999975 789999999864321 1233678999999996 899999999999999
Q ss_pred ceEEEEEeCCC-CCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEcc-CCce
Q 018712 135 LRVLAYEHASK-GSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFD-DDIA 212 (351)
Q Consensus 135 ~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~-~~~v 212 (351)
..++||||+.+ +++.+++..... +++..++.++.||+.||.|||+++ |+||||||+|||++. ++.+
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~~~~---------l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~v 150 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITERGA---------LQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGEL 150 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHHHCS---------CCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEE
T ss_pred eEEEEEEeccCcchHHHHHhccCC---------CCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeE
Confidence 99999999976 688888876543 899999999999999999999999 999999999999985 4799
Q ss_pred EEecccccCCCccccccccccccccccCccCcccccCCCC-CccchhHhHHHHHHHHHcCCCCCCCCCCCCCc-cchhhc
Q 018712 213 KISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQM-SSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQ-SLVTWA 290 (351)
Q Consensus 213 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~-~~~~~~ 290 (351)
||+|||+|+...... .+...||+.|+|||++.+..+ +.++|||||||++|||++|+.||......... ......
T Consensus 151 kl~DFG~a~~~~~~~----~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~i~~~~~~~~~~ 226 (273)
T d1xwsa_ 151 KLIDFGSGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQR 226 (273)
T ss_dssp EECCCTTCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHHHHCCCCCSSC
T ss_pred EECccccceeccccc----ccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchHHhhcccCCCCC
Confidence 999999997654332 245679999999999987765 67799999999999999999999764211000 001111
Q ss_pred ccCCCccchhhhcccccCCCCCHHHHH
Q 018712 291 TPKLSEDKVKQCVDTKLGGEYPPKAIA 317 (351)
Q Consensus 291 ~~~~~~~~~~~~ld~~~~~~~~~~~~~ 317 (351)
.+....+.+..|+..+|.+|++.+++.
T Consensus 227 ~s~~~~~li~~~L~~dp~~R~s~~eil 253 (273)
T d1xwsa_ 227 VSSECQHLIRWCLALRPSDRPTFEEIQ 253 (273)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred CCHHHHHHHHHHccCCHhHCcCHHHHh
Confidence 112223788999999999999887753
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-47 Score=342.93 Aligned_cols=256 Identities=23% Similarity=0.342 Sum_probs=207.2
Q ss_pred cCCCCCceeccCCcEEEEEEEEC------CCCEEEEEEcCCCCCc--hHHHHHHHHHHHhc-cCCceeeeEEEEecCCce
Q 018712 66 DNFGTNSLIGEGSYGRVYFGVLR------SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRL-KNENVVELVGYYVDGPLR 136 (351)
Q Consensus 66 ~~y~~~~~Lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~ 136 (351)
++|++.+.||+|+||.||+|.+. +++.||||++...... ...+.+|+.+++++ +||||+++++++.+.+..
T Consensus 23 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~ 102 (311)
T d1t46a_ 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPT 102 (311)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEE
Confidence 57888999999999999999852 4678999999765433 34688999999999 699999999999999999
Q ss_pred EEEEEeCCCCCHHHHhccCCCCCC---------CCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEc
Q 018712 137 VLAYEHASKGSLHDILHGKKGVKG---------AKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLF 207 (351)
Q Consensus 137 ~lv~e~~~~gsL~~~l~~~~~~~~---------~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~ 207 (351)
++|||||++|+|.+++........ ......+++..+..++.||+.||.|||+++ ++||||||+||+++
T Consensus 103 ~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~NIl~~ 179 (311)
T d1t46a_ 103 LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLT 179 (311)
T ss_dssp EEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEE
T ss_pred EEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccccccccccc
Confidence 999999999999999976543211 111234889999999999999999999999 99999999999999
Q ss_pred cCCceEEecccccCCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHc-CCCCCCCCCCCCCc-c
Q 018712 208 DDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQ-S 285 (351)
Q Consensus 208 ~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~Pf~~~~~~~~~-~ 285 (351)
.++.+||+|||+++...............||+.|+|||.+.+..++.++||||||+++|||+| |.+||......... .
T Consensus 180 ~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~~ 259 (311)
T d1t46a_ 180 HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYK 259 (311)
T ss_dssp TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHH
T ss_pred ccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 999999999999988765544444456789999999999999999999999999999999999 56666655443221 1
Q ss_pred chhh-c-------ccCCCccchhhhcccccCCCCCHHHHHHHHHHHH
Q 018712 286 LVTW-A-------TPKLSEDKVKQCVDTKLGGEYPPKAIAKVRKKKF 324 (351)
Q Consensus 286 ~~~~-~-------~~~~~~~~~~~~ld~~~~~~~~~~~~~~~~~~~~ 324 (351)
.+.. . .+....+.+..|+..+|.+|++.+++.++++-.+
T Consensus 260 ~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i 306 (311)
T d1t46a_ 260 MIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI 306 (311)
T ss_dssp HHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhh
Confidence 2211 1 1111236889999999999999999988776543
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=7.2e-48 Score=342.41 Aligned_cols=238 Identities=23% Similarity=0.326 Sum_probs=191.7
Q ss_pred cCCCCCceeccCCcEEEEEEEECCCCEEEEEEcCCCCCc---hHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEEEe
Q 018712 66 DNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEH 142 (351)
Q Consensus 66 ~~y~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 142 (351)
++|++++.||+|+||+||+|.+++|+.||||++...... ...+.+|+.+|++++||||+++++++.+.+..+++||+
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 689999999999999999999999999999999765322 46789999999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccccCC
Q 018712 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222 (351)
Q Consensus 143 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~ 222 (351)
+.++.+..+...... +++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||.+..
T Consensus 82 ~~~~~~~~~~~~~~~---------l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~ 149 (286)
T d1ob3a_ 82 LDQDLKKLLDVCEGG---------LESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARA 149 (286)
T ss_dssp CSEEHHHHHHTSTTC---------CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHH
T ss_pred ehhhhHHHHHhhcCC---------cchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEeccccccee
Confidence 988777777665432 999999999999999999999999 99999999999999999999999999876
Q ss_pred CccccccccccccccccCccCcccccCC-CCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccch--------------
Q 018712 223 APDAAARLHSTRVLGTFGYHAPEYAMTG-QMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLV-------------- 287 (351)
Q Consensus 223 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~-------------- 287 (351)
...... ......|++.|+|||.+.+. .++.++|||||||++|||++|+.||...........+
T Consensus 150 ~~~~~~--~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 227 (286)
T d1ob3a_ 150 FGIPVR--KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPN 227 (286)
T ss_dssp HCC-----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTT
T ss_pred cccCcc--ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccc
Confidence 543222 12445689999999998765 5689999999999999999999999764321100000
Q ss_pred -------------------hhcccCCC---ccchhhhcccccCCCCCHHHHH
Q 018712 288 -------------------TWATPKLS---EDKVKQCVDTKLGGEYPPKAIA 317 (351)
Q Consensus 288 -------------------~~~~~~~~---~~~~~~~ld~~~~~~~~~~~~~ 317 (351)
....+... .+.+..|+..+|.+|++++++.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell 279 (286)
T d1ob3a_ 228 VTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQAL 279 (286)
T ss_dssp GGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred hhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHh
Confidence 00001111 2568899999999999987763
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.2e-47 Score=339.57 Aligned_cols=260 Identities=19% Similarity=0.287 Sum_probs=203.4
Q ss_pred cCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCCchHHHHHHHHHHHhccCCc-eeeeEEEEecCCceEEEEEeC
Q 018712 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNEN-VVELVGYYVDGPLRVLAYEHA 143 (351)
Q Consensus 66 ~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~~~~~~~~~~~~~lv~e~~ 143 (351)
++|++.+.||+|+||.||+|.+. +|+.||||++..... ...+..|+++++.++|+| |+.+..++.+.+..++||||+
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~ 85 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL 85 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT-SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc-CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEc
Confidence 57999999999999999999974 789999998765443 345788999999998765 555566677888899999999
Q ss_pred CCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEcc---CCceEEeccccc
Q 018712 144 SKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFD---DDIAKISDFDLS 220 (351)
Q Consensus 144 ~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~---~~~vkl~Dfg~a 220 (351)
. ++|.+.+..... .+++..+..++.|++.||+|||++| |+||||||+|||++. +..+||+|||+|
T Consensus 86 ~-~~l~~~~~~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a 153 (299)
T d1ckia_ 86 G-PSLEDLFNFCSR--------KFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLA 153 (299)
T ss_dssp C-CBHHHHHHHTTT--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSC
T ss_pred C-CchhhhhhhccC--------CCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCcc
Confidence 5 577776654432 2899999999999999999999999 999999999999864 457999999999
Q ss_pred CCCcccccc-----ccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccchh-------
Q 018712 221 NQAPDAAAR-----LHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVT------- 288 (351)
Q Consensus 221 ~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~~------- 288 (351)
+........ .......||+.|+|||.+.+..++.++|||||||++|||++|+.||.............
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~ 233 (299)
T d1ckia_ 154 KKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKM 233 (299)
T ss_dssp EECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHH
T ss_pred eeccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccC
Confidence 876543221 12245679999999999999999999999999999999999999998765443322111
Q ss_pred -----hcccCCC---ccchhhhcccccCCCCCHHHHHHHHHHHHHhhhhccccchhhhhcccCCcccc
Q 018712 289 -----WATPKLS---EDKVKQCVDTKLGGEYPPKAIAKVRKKKFITSECSNISFAEFNINWHCPLEWS 348 (351)
Q Consensus 289 -----~~~~~~~---~~~~~~~ld~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~ 348 (351)
...+..+ .+.+..|+..+|.+||+.+++..+++..+ .+.+...+.+|||+
T Consensus 234 ~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~----------~~~~~~~~~~~Dw~ 291 (299)
T d1ckia_ 234 STPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF----------HRQGFSYDYVFDWN 291 (299)
T ss_dssp HSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHH----------HHHTCCCSCCCHHH
T ss_pred CCChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHH----------HHcCCCCCCCcCch
Confidence 0111222 35788999999999999988877766553 44556678899996
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-47 Score=341.37 Aligned_cols=252 Identities=25% Similarity=0.344 Sum_probs=197.8
Q ss_pred cCCCCCceeccCCcEEEEEEEEC-CCC--EEEEEEcCCC--CCchHHHHHHHHHHHhc-cCCceeeeEEEEecCCceEEE
Q 018712 66 DNFGTNSLIGEGSYGRVYFGVLR-SGR--AAAIKKLDSS--KQPDQEFLAQVSMVSRL-KNENVVELVGYYVDGPLRVLA 139 (351)
Q Consensus 66 ~~y~~~~~Lg~G~~g~Vy~~~~~-~~~--~vavK~~~~~--~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv 139 (351)
++|++.+.||+|+||.||+|.++ ++. .||||++... ....+.+.+|+++|+++ +||||+++++++.+++..++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 67899999999999999999975 444 5778887533 22345789999999999 799999999999999999999
Q ss_pred EEeCCCCCHHHHhccCCCC-------CCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCce
Q 018712 140 YEHASKGSLHDILHGKKGV-------KGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIA 212 (351)
Q Consensus 140 ~e~~~~gsL~~~l~~~~~~-------~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~v 212 (351)
|||+++|+|.+++...... ........+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCCce
Confidence 9999999999999754210 00011123899999999999999999999999 9999999999999999999
Q ss_pred EEecccccCCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCC-CCCCCCCCCCCccch-hhc
Q 018712 213 KISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGR-KPVDHTLPRGQQSLV-TWA 290 (351)
Q Consensus 213 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~-~Pf~~~~~~~~~~~~-~~~ 290 (351)
||+|||+++........ ....||..|+|||.+.+..++.++||||||+++|||++|. +||...+.......+ ...
T Consensus 167 kl~DfG~a~~~~~~~~~---~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~~~ 243 (309)
T d1fvra_ 167 KIADFGLSRGQEVYVKK---TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY 243 (309)
T ss_dssp EECCTTCEESSCEECCC-------CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTC
T ss_pred EEccccccccccccccc---cceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcC
Confidence 99999999766543322 3456899999999999999999999999999999999965 577665433221111 111
Q ss_pred ccC-------CCccchhhhcccccCCCCCHHHHHHHHHHH
Q 018712 291 TPK-------LSEDKVKQCVDTKLGGEYPPKAIAKVRKKK 323 (351)
Q Consensus 291 ~~~-------~~~~~~~~~ld~~~~~~~~~~~~~~~~~~~ 323 (351)
.+. ...+.+..|++.+|.+|++.+++.+.++-.
T Consensus 244 ~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i 283 (309)
T d1fvra_ 244 RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 283 (309)
T ss_dssp CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 111 123788999999999999999998765444
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-47 Score=341.79 Aligned_cols=238 Identities=21% Similarity=0.320 Sum_probs=187.7
Q ss_pred hcCCCCCceeccCCcEEEEEEEEC-C-CCEEEEEEcCCC---CCchHHHHHHHHHHHhc---cCCceeeeEEEEec----
Q 018712 65 TDNFGTNSLIGEGSYGRVYFGVLR-S-GRAAAIKKLDSS---KQPDQEFLAQVSMVSRL---KNENVVELVGYYVD---- 132 (351)
Q Consensus 65 ~~~y~~~~~Lg~G~~g~Vy~~~~~-~-~~~vavK~~~~~---~~~~~~~~~e~~~l~~l---~h~niv~~~~~~~~---- 132 (351)
.++|++++.||+|+||+||+|.+. + ++.||||++... ......+.+|+.+|+.+ +||||++++++|..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 478999999999999999999974 4 567999998532 22233466777777666 79999999998852
Q ss_pred -CCceEEEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCc
Q 018712 133 -GPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDI 211 (351)
Q Consensus 133 -~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~ 211 (351)
....+++||++.++++......... .+++..++.++.|++.||+|||+++ |+||||||+|||+++++.
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~ 154 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKVPEP--------GVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQ 154 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHSCTT--------CSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCC
T ss_pred cCceEEEEEEeccCCchhhhhhccCC--------CCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCC
Confidence 3468999999998776655443322 2899999999999999999999999 999999999999999999
Q ss_pred eEEecccccCCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccch----
Q 018712 212 AKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLV---- 287 (351)
Q Consensus 212 vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~---- 287 (351)
+||+|||+++....... .....||+.|+|||++.+..|+.++||||+||++|||++|+.||...++......+
T Consensus 155 ~kl~dfg~~~~~~~~~~---~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~ 231 (305)
T d1blxa_ 155 IKLADFGLARIYSFQMA---LTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVI 231 (305)
T ss_dssp EEECSCCSCCCCCGGGG---GCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH
T ss_pred eeecchhhhhhhccccc---CCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhh
Confidence 99999999887644332 25567999999999999999999999999999999999999999865422110000
Q ss_pred ---------------------------hhcccCCC---ccchhhhcccccCCCCCHHHH
Q 018712 288 ---------------------------TWATPKLS---EDKVKQCVDTKLGGEYPPKAI 316 (351)
Q Consensus 288 ---------------------------~~~~~~~~---~~~~~~~ld~~~~~~~~~~~~ 316 (351)
....+..+ .+.+..|+..+|.+|++++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~ 290 (305)
T d1blxa_ 232 GLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290 (305)
T ss_dssp CCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred CCCchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHH
Confidence 00011111 257889999999999988764
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-47 Score=340.73 Aligned_cols=245 Identities=22% Similarity=0.303 Sum_probs=186.0
Q ss_pred cCCCCCceeccCCcEEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHHhccCCceeeeEEEEecCC----ceEEEEE
Q 018712 66 DNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGP----LRVLAYE 141 (351)
Q Consensus 66 ~~y~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----~~~lv~e 141 (351)
.+|.+.+.||+|+||.||+|++ +|+.||||++............|+..++.++||||+++++++.+.+ ..++|||
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~E 81 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSD 81 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEe
Confidence 4677888999999999999987 5889999998754332223344555566789999999999987543 5799999
Q ss_pred eCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCC-----CCCeeeccccCCcEEEccCCceEEec
Q 018712 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKA-----EPRIIHRNIKSSNVLLFDDDIAKISD 216 (351)
Q Consensus 142 ~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~-----~~~ivH~Dlkp~Nill~~~~~vkl~D 216 (351)
|+++|+|.+++++.. +++..++.++.|++.||.|+|+.. ..+|+||||||+|||++.++.+||+|
T Consensus 82 y~~~g~L~~~l~~~~----------l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~D 151 (303)
T d1vjya_ 82 YHEHGSLFDYLNRYT----------VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD 151 (303)
T ss_dssp CCTTCBHHHHHHHCC----------BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECC
T ss_pred cccCCCHHHHHhcCC----------CCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEe
Confidence 999999999998753 899999999999999999999731 11299999999999999999999999
Q ss_pred ccccCCCcccccc--ccccccccccCccCcccccCCC------CCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccc--
Q 018712 217 FDLSNQAPDAAAR--LHSTRVLGTFGYHAPEYAMTGQ------MSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSL-- 286 (351)
Q Consensus 217 fg~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~------~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~-- 286 (351)
||+++........ .......||+.|+|||++.+.. ++.++|||||||++|||+||..||...........
T Consensus 152 FGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~ 231 (303)
T d1vjya_ 152 LGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDL 231 (303)
T ss_dssp CTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTT
T ss_pred cCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhc
Confidence 9998876433221 1234567999999999987643 57789999999999999999988764332111000
Q ss_pred ---------h------hhcccCC------------CccchhhhcccccCCCCCHHHHHHHHH
Q 018712 287 ---------V------TWATPKL------------SEDKVKQCVDTKLGGEYPPKAIAKVRK 321 (351)
Q Consensus 287 ---------~------~~~~~~~------------~~~~~~~~ld~~~~~~~~~~~~~~~~~ 321 (351)
+ ....|.. ..+.+.+|+..+|.+||+..++...++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~ 293 (303)
T d1vjya_ 232 VPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 293 (303)
T ss_dssp SCSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHH
T ss_pred ccccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHH
Confidence 0 0111111 125778899999999999988866543
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-47 Score=339.05 Aligned_cols=266 Identities=23% Similarity=0.340 Sum_probs=209.8
Q ss_pred hcCCCCCceeccCCcEEEEEEEEC------CCCEEEEEEcCCCCCc--hHHHHHHHHHHHhccCCceeeeEEEEecCCce
Q 018712 65 TDNFGTNSLIGEGSYGRVYFGVLR------SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPLR 136 (351)
Q Consensus 65 ~~~y~~~~~Lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 136 (351)
.++|.+.+.||+|+||.||+|.++ ++..||||++...... ...+.+|+.++++++||||+++++++...+..
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~ 98 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT 98 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSC
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCce
Confidence 367888999999999999999864 3578999999765433 24578999999999999999999999999999
Q ss_pred EEEEEeCCCCCHHHHhccCCCCC-CCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEe
Q 018712 137 VLAYEHASKGSLHDILHGKKGVK-GAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKIS 215 (351)
Q Consensus 137 ~lv~e~~~~gsL~~~l~~~~~~~-~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~ 215 (351)
++||||+.+|+|.+++....... .......+++..+..++.|++.||.|||+++ |+||||||+|||++.++++||+
T Consensus 99 ~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~~~Kl~ 175 (308)
T d1p4oa_ 99 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIG 175 (308)
T ss_dssp EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEEEC
T ss_pred eEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecCCceEEEe
Confidence 99999999999999986532100 0001112688999999999999999999999 9999999999999999999999
Q ss_pred cccccCCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcC-CCCCCCCCCCCCccch-hhc---
Q 018712 216 DFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTG-RKPVDHTLPRGQQSLV-TWA--- 290 (351)
Q Consensus 216 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg-~~Pf~~~~~~~~~~~~-~~~--- 290 (351)
|||+++...............||+.|+|||.+.+..++.++||||||+++|||+|| ..||...........+ ...
T Consensus 176 DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~~~~~ 255 (308)
T d1p4oa_ 176 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLD 255 (308)
T ss_dssp CTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCCCC
T ss_pred ecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCCCCC
Confidence 99999877655444444556789999999999999999999999999999999998 5778765433222111 111
Q ss_pred ----ccCCCccchhhhcccccCCCCCHHHHHHHHHHHHHhhhhccccchhhhh
Q 018712 291 ----TPKLSEDKVKQCVDTKLGGEYPPKAIAKVRKKKFITSECSNISFAEFNI 339 (351)
Q Consensus 291 ----~~~~~~~~~~~~ld~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 339 (351)
.+....+.+..|++.+|..||+.+++.+.++ +...+.|++.+.
T Consensus 256 ~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~------~~~~~~~~~~~~ 302 (308)
T d1p4oa_ 256 KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK------EEMEPGFREVSF 302 (308)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHG------GGSCTTHHHHCS
T ss_pred CcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHH------HhcCCCCcCCCC
Confidence 1112236889999999999999998866543 334556665543
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-46 Score=332.98 Aligned_cols=242 Identities=22% Similarity=0.322 Sum_probs=192.9
Q ss_pred CceeccCCcEEEEEEEECC----CCEEEEEEcCCCCCc--hHHHHHHHHHHHhccCCceeeeEEEEec-CCceEEEEEeC
Q 018712 71 NSLIGEGSYGRVYFGVLRS----GRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVD-GPLRVLAYEHA 143 (351)
Q Consensus 71 ~~~Lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e~~ 143 (351)
.++||+|+||+||+|.+.. ...||||++...... ...+.+|+++|++++||||+++++++.+ ++..++||||+
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 4679999999999999753 236899998754333 3668999999999999999999998765 56789999999
Q ss_pred CCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccccCCC
Q 018712 144 SKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQA 223 (351)
Q Consensus 144 ~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~ 223 (351)
++|+|.+++..... .+++..++.++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||+++..
T Consensus 112 ~~g~l~~~~~~~~~--------~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~ 180 (311)
T d1r0pa_ 112 KHGDLRNFIRNETH--------NPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDM 180 (311)
T ss_dssp TTCBHHHHHHCTTC--------CCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCT
T ss_pred ecCchhhhhccccc--------cchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhc
Confidence 99999999986543 2778889999999999999999999 999999999999999999999999999876
Q ss_pred cccccc--ccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCC-ccch-hhcc-------c
Q 018712 224 PDAAAR--LHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQ-QSLV-TWAT-------P 292 (351)
Q Consensus 224 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~-~~~~-~~~~-------~ 292 (351)
...... .......||+.|+|||.+.+..++.++||||||+++|||+||..||........ ...+ .... +
T Consensus 181 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~~~p~~~~ 260 (311)
T d1r0pa_ 181 YDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCP 260 (311)
T ss_dssp TTTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCCCCCTTCC
T ss_pred cccccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCcccCc
Confidence 543222 122345689999999999999999999999999999999998887765432211 1111 1111 1
Q ss_pred CCCccchhhhcccccCCCCCHHHHHHHHHHH
Q 018712 293 KLSEDKVKQCVDTKLGGEYPPKAIAKVRKKK 323 (351)
Q Consensus 293 ~~~~~~~~~~ld~~~~~~~~~~~~~~~~~~~ 323 (351)
....+.+.+|+..+|.+|++..++.+.++-.
T Consensus 261 ~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i 291 (311)
T d1r0pa_ 261 DPLYEVMLKCWHPKAEMRPSFSELVSRISAI 291 (311)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 1223788999999999999999987766544
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-46 Score=335.31 Aligned_cols=203 Identities=22% Similarity=0.342 Sum_probs=167.7
Q ss_pred hcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCC---chHHHHHHHHHHHhccCCceeeeEEEEec--------
Q 018712 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ---PDQEFLAQVSMVSRLKNENVVELVGYYVD-------- 132 (351)
Q Consensus 65 ~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~h~niv~~~~~~~~-------- 132 (351)
.++|++++.||+|+||+||+|.+. +|+.||||++..... ....+.+|+++|++++||||+++++.+..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 478999999999999999999975 799999999864432 34668899999999999999999998754
Q ss_pred CCceEEEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCce
Q 018712 133 GPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIA 212 (351)
Q Consensus 133 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~v 212 (351)
....|+|||++.++.+..+...... ++...++.++.||+.||.|||++| |+||||||+|||++.++.+
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~~~~~~---------~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~ 156 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLSNVLVK---------FTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVL 156 (318)
T ss_dssp --CEEEEEECCCEEHHHHHTCTTCC---------CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCE
T ss_pred CceEEEEEeccCCCccchhhhcccc---------cccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcE
Confidence 3468999999988766655544332 889999999999999999999999 9999999999999999999
Q ss_pred EEecccccCCCcccccc--ccccccccccCccCcccccCC-CCCccchhHhHHHHHHHHHcCCCCCCCCC
Q 018712 213 KISDFDLSNQAPDAAAR--LHSTRVLGTFGYHAPEYAMTG-QMSSKSDVYSFGVVLLELLTGRKPVDHTL 279 (351)
Q Consensus 213 kl~Dfg~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~Pf~~~~ 279 (351)
||+|||+++........ ......+||+.|+|||++.+. .++.++|||||||++|||++|+.||....
T Consensus 157 kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~ 226 (318)
T d3blha1 157 KLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNT 226 (318)
T ss_dssp EECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred EeeecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCC
Confidence 99999999765432211 122345799999999998765 68999999999999999999999997643
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-46 Score=339.29 Aligned_cols=240 Identities=22% Similarity=0.306 Sum_probs=189.0
Q ss_pred HhcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCCc---hHHHHHHHHHHHhccCCceeeeEEEEecCC-----
Q 018712 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVDGP----- 134 (351)
Q Consensus 64 ~~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----- 134 (351)
..++|++++.||+|+||+||+|.+. +|+.||||++...... .+.+.+|+++|+.++||||++++++|...+
T Consensus 16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~ 95 (346)
T d1cm8a_ 16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 95 (346)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred cCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccccc
Confidence 3468999999999999999999975 7999999999765433 346789999999999999999999997655
Q ss_pred -ceEEEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceE
Q 018712 135 -LRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAK 213 (351)
Q Consensus 135 -~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vk 213 (351)
.+|+||||+ +.+|..+++... +++..++.++.||+.||.|||++| |+||||||+|||++.++.+|
T Consensus 96 ~~~~lv~e~~-~~~l~~~~~~~~----------l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~k 161 (346)
T d1cm8a_ 96 TDFYLVMPFM-GTDLGKLMKHEK----------LGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELK 161 (346)
T ss_dssp CCCEEEEECC-SEEHHHHHHHCC----------CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEE
T ss_pred ceEEEEEecc-cccHHHHHHhcc----------ccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhcccccccc
Confidence 469999999 568888886543 999999999999999999999999 99999999999999999999
Q ss_pred EecccccCCCccccccccccccccccCccCcccccCC-CCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccch-----
Q 018712 214 ISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTG-QMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLV----- 287 (351)
Q Consensus 214 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~----- 287 (351)
|+|||+|+...... +...||+.|+|||.+.+. .++.++||||+||++|+|++|+.||............
T Consensus 162 l~Dfg~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~ 236 (346)
T d1cm8a_ 162 ILDFGLARQADSEM-----TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTG 236 (346)
T ss_dssp ECCCTTCEECCSSC-----CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC
T ss_pred cccccceeccCCcc-----ccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccC
Confidence 99999997654332 456799999999998764 5689999999999999999999999865321110000
Q ss_pred ------------------------------hhcccCCC---ccchhhhcccccCCCCCHHHHHHHHHHHHH
Q 018712 288 ------------------------------TWATPKLS---EDKVKQCVDTKLGGEYPPKAIAKVRKKKFI 325 (351)
Q Consensus 288 ------------------------------~~~~~~~~---~~~~~~~ld~~~~~~~~~~~~~~~~~~~~~ 325 (351)
....+... .+.+..||..+|.+|++++++. ++.++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL---~Hp~f 304 (346)
T d1cm8a_ 237 TPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEAL---AHPYF 304 (346)
T ss_dssp CCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHH---HSGGG
T ss_pred CCcHHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHh---cChhh
Confidence 00001111 2578899999999999987764 45544
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-46 Score=338.69 Aligned_cols=245 Identities=23% Similarity=0.295 Sum_probs=191.7
Q ss_pred hcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCCc--hHHHHHHHHHHHhccCCceeeeEEEEecCC----ceE
Q 018712 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGP----LRV 137 (351)
Q Consensus 65 ~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----~~~ 137 (351)
.++|++++.||+|+||+||+|.+. +|+.||||++...... .+.+.+|+.+|+.++||||+++++++.... ..+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 457999999999999999999964 8999999999765432 356889999999999999999999987543 234
Q ss_pred EEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecc
Q 018712 138 LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDF 217 (351)
Q Consensus 138 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Df 217 (351)
++++++.+|+|.+++.... +++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+||
T Consensus 87 ~l~~~~~~g~L~~~l~~~~----------l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~Df 153 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKTQH----------LSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDF 153 (345)
T ss_dssp EEEEECCCEEHHHHHHHCC----------CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCC
T ss_pred EEEEeecCCchhhhhhcCC----------CCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEccc
Confidence 5556677899999997653 899999999999999999999999 999999999999999999999999
Q ss_pred cccCCCcccccc-ccccccccccCccCccccc-CCCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccc---------
Q 018712 218 DLSNQAPDAAAR-LHSTRVLGTFGYHAPEYAM-TGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSL--------- 286 (351)
Q Consensus 218 g~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~--------- 286 (351)
|++......... ......+||+.|+|||++. +..++.++||||+||++|+|++|+.||...........
T Consensus 154 G~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~ 233 (345)
T d1pmea_ 154 GLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPS 233 (345)
T ss_dssp TTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCC
T ss_pred CceeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCC
Confidence 999766443222 1234567999999999885 45678999999999999999999999976542111000
Q ss_pred --------------------------hhhcccCCC---ccchhhhcccccCCCCCHHHHHHHHHHHHH
Q 018712 287 --------------------------VTWATPKLS---EDKVKQCVDTKLGGEYPPKAIAKVRKKKFI 325 (351)
Q Consensus 287 --------------------------~~~~~~~~~---~~~~~~~ld~~~~~~~~~~~~~~~~~~~~~ 325 (351)
.....+.+. .+.+..|+..+|..|++++++. ++.++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L---~hpf~ 298 (345)
T d1pmea_ 234 QEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQAL---AHPYL 298 (345)
T ss_dssp HHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHH---TSGGG
T ss_pred hhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHh---cCHhh
Confidence 001111222 2688999999999999887764 45543
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-46 Score=335.20 Aligned_cols=248 Identities=22% Similarity=0.323 Sum_probs=200.6
Q ss_pred hcCCCCCceeccCCcEEEEEEEEC----CCCEEEEEEcCCCC-----CchHHHHHHHHHHHhccC-CceeeeEEEEecCC
Q 018712 65 TDNFGTNSLIGEGSYGRVYFGVLR----SGRAAAIKKLDSSK-----QPDQEFLAQVSMVSRLKN-ENVVELVGYYVDGP 134 (351)
Q Consensus 65 ~~~y~~~~~Lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~-----~~~~~~~~e~~~l~~l~h-~niv~~~~~~~~~~ 134 (351)
.++|++.+.||+|+||+||+|... +|+.||||++.... ...+.+.+|++++++++| |||+++++++.+..
T Consensus 23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~ 102 (322)
T d1vzoa_ 23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 102 (322)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred hhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCC
Confidence 477999999999999999999852 57899999986432 234568899999999977 89999999999999
Q ss_pred ceEEEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEE
Q 018712 135 LRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKI 214 (351)
Q Consensus 135 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl 214 (351)
..+++|||+.+|+|.+++..... ++...+..++.||+.||.|||+++ |+||||||+|||++.++.+||
T Consensus 103 ~~~~v~e~~~~~~L~~~i~~~~~---------~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL 170 (322)
T d1vzoa_ 103 KLHLILDYINGGELFTHLSQRER---------FTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVL 170 (322)
T ss_dssp EEEEEECCCCSCBHHHHHHHHSC---------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEE
T ss_pred ceeeeeecccccHHHHHHHhccc---------ccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEE
Confidence 99999999999999999987754 788999999999999999999999 999999999999999999999
Q ss_pred ecccccCCCccccccccccccccccCccCcccccCC--CCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccchhh---
Q 018712 215 SDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTG--QMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTW--- 289 (351)
Q Consensus 215 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~~~--- 289 (351)
+|||+++......... .....||+.|+|||.+.+. .++.++|||||||++|+|++|+.||...........+..
T Consensus 171 ~DFG~a~~~~~~~~~~-~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~ 249 (322)
T d1vzoa_ 171 TDFGLSKEFVADETER-AYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRIL 249 (322)
T ss_dssp SCSSEEEECCGGGGGG-GCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHH
T ss_pred eeccchhhhccccccc-ccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcc
Confidence 9999997765433222 2446799999999998765 468899999999999999999999987755543322211
Q ss_pred -ccc----CCC---ccchhhhcccccCCCCCHH--HHHHHHHHHHH
Q 018712 290 -ATP----KLS---EDKVKQCVDTKLGGEYPPK--AIAKVRKKKFI 325 (351)
Q Consensus 290 -~~~----~~~---~~~~~~~ld~~~~~~~~~~--~~~~~~~~~~~ 325 (351)
..+ ..+ .+.+..|++++|.+|++.. .+..++++.|+
T Consensus 250 ~~~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff 295 (322)
T d1vzoa_ 250 KSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFF 295 (322)
T ss_dssp HCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGG
T ss_pred cCCCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhh
Confidence 111 122 2688999999999999632 24445566654
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-45 Score=336.78 Aligned_cols=241 Identities=24% Similarity=0.298 Sum_probs=185.9
Q ss_pred CCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCCchHHHHHHHHHHHhccCCceeeeEEEEec------CCceEEE
Q 018712 67 NFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVD------GPLRVLA 139 (351)
Q Consensus 67 ~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~------~~~~~lv 139 (351)
+|+..++||+|+||+||+|.+. +|+.||||++...... ..+|+++|++++|+||++++++|.. ..++++|
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~---~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv 97 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF---KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLV 97 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS---CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH---HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEE
Confidence 6888899999999999999975 7999999999765433 3479999999999999999999853 3357899
Q ss_pred EEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCC-ceEEeccc
Q 018712 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD-IAKISDFD 218 (351)
Q Consensus 140 ~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~-~vkl~Dfg 218 (351)
|||++++.+..+...... ...+++..++.++.||+.||.|||++| |+||||||+|||++.++ .+||+|||
T Consensus 98 ~Ey~~~~~~~~l~~~~~~------~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG 168 (350)
T d1q5ka_ 98 LDYVPETVYRVARHYSRA------KQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFG 168 (350)
T ss_dssp EECCSEEHHHHHHHHHHT------TCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCT
T ss_pred EeccCCccHHHHHhhhhc------cCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEeccc
Confidence 999987544333321110 113899999999999999999999999 99999999999999775 89999999
Q ss_pred ccCCCccccccccccccccccCccCcccccC-CCCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccch----------
Q 018712 219 LSNQAPDAAARLHSTRVLGTFGYHAPEYAMT-GQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLV---------- 287 (351)
Q Consensus 219 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~---------- 287 (351)
+++....... .....||+.|+|||.+.+ ..++.++||||+||++|||++|+.||...........+
T Consensus 169 ~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~ 245 (350)
T d1q5ka_ 169 SAKQLVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTRE 245 (350)
T ss_dssp TCEECCTTSC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHH
T ss_pred chhhccCCcc---cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHH
Confidence 9876644322 244579999999998775 57899999999999999999999999765422111000
Q ss_pred -----------------------hhcccCCC---ccchhhhcccccCCCCCHHHHHHHHHHHHH
Q 018712 288 -----------------------TWATPKLS---EDKVKQCVDTKLGGEYPPKAIAKVRKKKFI 325 (351)
Q Consensus 288 -----------------------~~~~~~~~---~~~~~~~ld~~~~~~~~~~~~~~~~~~~~~ 325 (351)
....+... .+++..|+..+|.+|++++++ +++.|+
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~---L~Hp~f 306 (350)
T d1q5ka_ 246 QIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEA---CAHSFF 306 (350)
T ss_dssp HHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHH---HTSGGG
T ss_pred hhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHH---hcCHhh
Confidence 00011111 257889999999999998875 445544
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.3e-45 Score=323.20 Aligned_cols=198 Identities=20% Similarity=0.327 Sum_probs=174.0
Q ss_pred cCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCC---chHHHHHHHHHHHhccCCceeeeEEEEecCCceEEEEE
Q 018712 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ---PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYE 141 (351)
Q Consensus 66 ~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 141 (351)
++|++++.||+|+||+||+|.+. +++.||||+++.... ....+.+|+.+|+.++||||+++++++.+....+++++
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 68999999999999999999975 789999999865432 24678899999999999999999999999999999999
Q ss_pred eCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEecccccC
Q 018712 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (351)
Q Consensus 142 ~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~ 221 (351)
++.+++|..++...+. +++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||.++
T Consensus 82 ~~~~~~l~~~~~~~~~---------~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~ 149 (292)
T d1unla_ 82 FCDQDLKKYFDSCNGD---------LDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLAR 149 (292)
T ss_dssp CCSEEHHHHHHHTTTC---------CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCE
T ss_pred eccccccccccccccc---------cchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhh
Confidence 9999999988876543 889999999999999999999999 9999999999999999999999999998
Q ss_pred CCccccccccccccccccCccCcccccCCC-CCccchhHhHHHHHHHHHcCCCCCCC
Q 018712 222 QAPDAAARLHSTRVLGTFGYHAPEYAMTGQ-MSSKSDVYSFGVVLLELLTGRKPVDH 277 (351)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~el~tg~~Pf~~ 277 (351)
........ .....+++.|+|||.+.+.. ++.++|||||||++|||++|+.||..
T Consensus 150 ~~~~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~ 204 (292)
T d1unla_ 150 AFGIPVRC--YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFP 204 (292)
T ss_dssp ECCSCCSC--CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCC
T ss_pred cccCCCcc--ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCC
Confidence 76543322 23445788999999887665 68999999999999999999999753
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1e-44 Score=328.17 Aligned_cols=194 Identities=18% Similarity=0.339 Sum_probs=168.6
Q ss_pred cCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCCchHHHHHHHHHHHhcc-CCceeeeEEEEec--CCceEEEEE
Q 018712 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLK-NENVVELVGYYVD--GPLRVLAYE 141 (351)
Q Consensus 66 ~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~--~~~~~lv~e 141 (351)
++|++++.||+|+||+||+|.+. +++.||||+++... .+.+.+|+.+|+.++ ||||+++++++.. ....++|||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e 112 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK--KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFE 112 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC--HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH--HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEe
Confidence 68999999999999999999974 78999999987543 467889999999995 9999999999874 456899999
Q ss_pred eCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCC-ceEEeccccc
Q 018712 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD-IAKISDFDLS 220 (351)
Q Consensus 142 ~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~-~vkl~Dfg~a 220 (351)
|+.+++|..+.. .+++..++.++.||+.||.|||++| |+||||||+|||++.++ .+||+|||+|
T Consensus 113 ~~~~~~L~~~~~------------~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a 177 (328)
T d3bqca1 113 HVNNTDFKQLYQ------------TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLA 177 (328)
T ss_dssp CCCSCBGGGTTT------------SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGC
T ss_pred ecCCCcHHHHhc------------CCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccc
Confidence 999999987643 1899999999999999999999999 99999999999998755 6999999999
Q ss_pred CCCccccccccccccccccCccCcccccCC-CCCccchhHhHHHHHHHHHcCCCCCCCCC
Q 018712 221 NQAPDAAARLHSTRVLGTFGYHAPEYAMTG-QMSSKSDVYSFGVVLLELLTGRKPVDHTL 279 (351)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~Pf~~~~ 279 (351)
+....... .....||+.|+|||.+.+. .++.++||||+||++|+|++|+.||....
T Consensus 178 ~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~ 234 (328)
T d3bqca1 178 EFYHPGQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH 234 (328)
T ss_dssp EECCTTCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCS
T ss_pred eeccCCCc---ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCc
Confidence 76644322 2456789999999998765 57999999999999999999999997643
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-45 Score=332.01 Aligned_cols=241 Identities=25% Similarity=0.350 Sum_probs=190.9
Q ss_pred hcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCCc---hHHHHHHHHHHHhccCCceeeeEEEEecC-----Cc
Q 018712 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVDG-----PL 135 (351)
Q Consensus 65 ~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~ 135 (351)
.++|++++.||+|+||+||+|.+. +|+.||||++...... .+.+.+|+++|++++||||+++++++... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 468999999999999999999975 7999999999865543 34678999999999999999999998643 33
Q ss_pred eEEEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEEe
Q 018712 136 RVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKIS 215 (351)
Q Consensus 136 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~ 215 (351)
.+++++++.+|+|.+++.... +++..++.++.||+.||+|||++| |+||||||+|||++.++.+|++
T Consensus 97 ~~~i~~~~~gg~L~~~~~~~~----------l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~ 163 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKCQK----------LTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKIL 163 (348)
T ss_dssp CCEEEEECCSEEHHHHHTTCC----------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEEC
T ss_pred eEEEEEeecCCchhhhccccc----------ccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCcccccccccccccc
Confidence 466778888999999996543 999999999999999999999999 9999999999999999999999
Q ss_pred cccccCCCccccccccccccccccCccCcccccCC-CCCccchhHhHHHHHHHHHcCCCCCCCCCCCCCccchh------
Q 018712 216 DFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTG-QMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVT------ 288 (351)
Q Consensus 216 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~~~------ 288 (351)
|||++....... ....||+.|+|||.+.+. .++.++|||||||++|+|++|+.||.+.+.......+.
T Consensus 164 dfg~a~~~~~~~-----~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~ 238 (348)
T d2gfsa1 164 DFGLARHTDDEM-----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTP 238 (348)
T ss_dssp CC----CCTGGG-----SSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred ccchhcccCccc-----ccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence 999987664332 445789999999987765 46899999999999999999999997643211100000
Q ss_pred -----------------------------hcccCCC---ccchhhhcccccCCCCCHHHHHHHHHHHHHh
Q 018712 289 -----------------------------WATPKLS---EDKVKQCVDTKLGGEYPPKAIAKVRKKKFIT 326 (351)
Q Consensus 289 -----------------------------~~~~~~~---~~~~~~~ld~~~~~~~~~~~~~~~~~~~~~~ 326 (351)
....... .+.+..|+..+|.+|++++++ +++.++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~el---L~Hp~f~ 305 (348)
T d2gfsa1 239 GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQA---LAHAYFA 305 (348)
T ss_dssp CHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHH---HTSGGGT
T ss_pred ChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHH---hcCHhhC
Confidence 0001111 257899999999999988765 4566554
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-44 Score=328.69 Aligned_cols=197 Identities=23% Similarity=0.284 Sum_probs=160.8
Q ss_pred hcCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCCc---hHHHHHHHHHHHhccCCceeeeEEEEec------CC
Q 018712 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVD------GP 134 (351)
Q Consensus 65 ~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~------~~ 134 (351)
.++|+++++||+|+||+||+|.+. +|+.||||++...... ...+.+|+.++++++||||++++++|.. ..
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~ 95 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 95 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence 468999999999999999999976 7999999999765433 2457899999999999999999999863 36
Q ss_pred ceEEEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccCCceEE
Q 018712 135 LRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKI 214 (351)
Q Consensus 135 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl 214 (351)
..|+||||+.++ +.+.+... +++..++.++.||+.||.|||++| |+||||||+|||++.++.+|+
T Consensus 96 ~~~iv~Ey~~~~-l~~~~~~~-----------~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl 160 (355)
T d2b1pa1 96 DVYLVMELMDAN-LCQVIQME-----------LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKI 160 (355)
T ss_dssp EEEEEEECCSEE-HHHHHTSC-----------CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEE
T ss_pred eeEEEEeccchH-HHHhhhcC-----------CCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceee
Confidence 789999999775 44555322 889999999999999999999999 999999999999999999999
Q ss_pred ecccccCCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCCC
Q 018712 215 SDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTL 279 (351)
Q Consensus 215 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~ 279 (351)
+|||+++....... .....||+.|+|||++.+..++.++||||+||++|+|++|+.||.+..
T Consensus 161 ~df~~~~~~~~~~~---~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~ 222 (355)
T d2b1pa1 161 LDFGLARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRD 222 (355)
T ss_dssp CCCCC------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred echhhhhccccccc---cccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCC
Confidence 99999877654332 245679999999999999999999999999999999999999997543
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.3e-38 Score=291.72 Aligned_cols=198 Identities=19% Similarity=0.266 Sum_probs=159.9
Q ss_pred cCCCCCceeccCCcEEEEEEEEC-CCCEEEEEEcCCCCCchHHHHHHHHHHHhcc-----------CCceeeeEEEEec-
Q 018712 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLK-----------NENVVELVGYYVD- 132 (351)
Q Consensus 66 ~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~-----------h~niv~~~~~~~~- 132 (351)
++|+++++||+|+||+||+|++. +|+.||||++.......+.+.+|+++++.++ |+||+++++++..
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~ 92 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK 92 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeec
Confidence 35999999999999999999975 7999999999876555567888999888875 4789999988753
Q ss_pred -CCceEEEEEeCCCCC-HHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhh-CCCCCeeeccccCCcEEEccC
Q 018712 133 -GPLRVLAYEHASKGS-LHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHE-KAEPRIIHRNIKSSNVLLFDD 209 (351)
Q Consensus 133 -~~~~~lv~e~~~~gs-L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~-~~~~~ivH~Dlkp~Nill~~~ 209 (351)
....+++++++..+. .......... ..+++..+..++.||+.||.|||+ .| |+||||||+|||++.+
T Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~ 162 (362)
T d1q8ya_ 93 GPNGVHVVMVFEVLGENLLALIKKYEH-------RGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIV 162 (362)
T ss_dssp ETTEEEEEEEECCCCEEHHHHHHHTTT-------SCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEE
T ss_pred cccceeeeeeecccccccccccccccc-------cCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeeeecc
Confidence 345667777765543 3333322221 238889999999999999999998 77 9999999999999876
Q ss_pred C------ceEEecccccCCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHHHHHHcCCCCCCCC
Q 018712 210 D------IAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHT 278 (351)
Q Consensus 210 ~------~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~ 278 (351)
+ .++|+|||.+....... ....||+.|+|||++.+..++.++||||+||++++|++|+.||...
T Consensus 163 ~~~~~~~~~kl~dfg~s~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~ 232 (362)
T d1q8ya_ 163 DSPENLIQIKIADLGNACWYDEHY-----TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPD 232 (362)
T ss_dssp ETTTTEEEEEECCCTTCEETTBCC-----CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---
T ss_pred CcccccceeeEeeccccccccccc-----ccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCC
Confidence 5 39999999987554322 4567999999999999999999999999999999999999999754
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.93 E-value=5.3e-27 Score=194.60 Aligned_cols=168 Identities=14% Similarity=0.109 Sum_probs=119.0
Q ss_pred CCCceeccCCcEEEEEEEECCCCEEEEEEcCCCCCc-------------------hHHHHHHHHHHHhccCCceeeeEEE
Q 018712 69 GTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQP-------------------DQEFLAQVSMVSRLKNENVVELVGY 129 (351)
Q Consensus 69 ~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-------------------~~~~~~e~~~l~~l~h~niv~~~~~ 129 (351)
.+.+.||+|+||.||+|.+.+|+.||||+++..... .....+|+..+.++.|.+++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 456799999999999999989999999987532110 1224567888999999999988765
Q ss_pred EecCCceEEEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCCCCeeeccccCCcEEEccC
Q 018712 130 YVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDD 209 (351)
Q Consensus 130 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~ 209 (351)
. ..+++|||+.+..+.+ ++......++.|++.+|.|||++| |+||||||+|||++++
T Consensus 83 ~----~~~lvme~~~~~~~~~----------------l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~ 139 (191)
T d1zara2 83 E----GNAVLMELIDAKELYR----------------VRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEE 139 (191)
T ss_dssp E----TTEEEEECCCCEEGGG----------------CCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETT
T ss_pred c----CCEEEEEeeccccccc----------------hhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCC
Confidence 3 2379999998865543 223345678999999999999999 9999999999999865
Q ss_pred CceEEecccccCCCccccccccccccccccCccCcccccCCCCCccchhHhHHHHH
Q 018712 210 DIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVL 265 (351)
Q Consensus 210 ~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il 265 (351)
+ ++|+|||.|...............+.. -.+ +..+.|+.++|+||+.--+
T Consensus 140 ~-~~liDFG~a~~~~~~~~~~~l~rd~~~----~~~-~f~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 140 G-IWIIDFPQSVEVGEEGWREILERDVRN----IIT-YFSRTYRTEKDINSAIDRI 189 (191)
T ss_dssp E-EEECCCTTCEETTSTTHHHHHHHHHHH----HHH-HHHHHHCCCCCHHHHHHHH
T ss_pred C-EEEEECCCcccCCCCCcHHHHHHHHHH----HHH-HHcCCCCCcccHHHHHHHH
Confidence 5 899999998665422211000000000 001 1135678899999975433
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.91 E-value=3.8e-09 Score=89.92 Aligned_cols=148 Identities=17% Similarity=0.106 Sum_probs=101.9
Q ss_pred HHHHHHhcCCCCCceeccCCcEEEEEEEECCCCEEEEEEcCCCC-CchHHHHHHHHHHHhcc-CCceeeeEEEEecCCce
Q 018712 59 DELKEKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSK-QPDQEFLAQVSMVSRLK-NENVVELVGYYVDGPLR 136 (351)
Q Consensus 59 ~~~~~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~ 136 (351)
+++......|++.+..+.++.+.||+... ++..+++|+..... .....+.+|...++.+. +--+.+++.+..+++..
T Consensus 7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~ 85 (263)
T d1j7la_ 7 PELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS 85 (263)
T ss_dssp HHHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred HHHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCce
Confidence 45666677888776655555678998764 56678888875432 22345678888888774 44467788888888889
Q ss_pred EEEEEeCCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhCCC-------------------------
Q 018712 137 VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAE------------------------- 191 (351)
Q Consensus 137 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~~------------------------- 191 (351)
++||++++|.++.+..... . ....++.++...+..||+...
T Consensus 86 ~lv~~~l~G~~~~~~~~~~-----------~---~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 151 (263)
T d1j7la_ 86 NLLMSEADGVLCSEEYEDE-----------Q---SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLA 151 (263)
T ss_dssp EEEEECCSSEEHHHHTTTC-----------S---CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCS
T ss_pred EEEEEeccccccccccccc-----------c---cHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhh
Confidence 9999999998886654321 1 122344555555666664320
Q ss_pred -------------------------------CCeeeccccCCcEEEccCCceEEecccccC
Q 018712 192 -------------------------------PRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (351)
Q Consensus 192 -------------------------------~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~ 221 (351)
..++|+|+.|.|||+++++.+-|+||+.+.
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 152 DVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp CCCGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred hhhhhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 117899999999999887767799999764
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.50 E-value=1.4e-07 Score=79.53 Aligned_cols=73 Identities=12% Similarity=0.019 Sum_probs=53.6
Q ss_pred eccCCc-EEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHHhccC--CceeeeEEEEecCCceEEEEEeCCCCCH
Q 018712 74 IGEGSY-GRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKN--ENVVELVGYYVDGPLRVLAYEHASKGSL 148 (351)
Q Consensus 74 Lg~G~~-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h--~niv~~~~~~~~~~~~~lv~e~~~~gsL 148 (351)
+..|.. +.||+....++..+++|...... ...+..|...++.+.. -.+.+++.+..+.+..++||++++|.++
T Consensus 18 ~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~--~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 18 QTIGCSDAAVFRLSAQGRPVLFVKTDLSGA--LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp CSCTTSSCEEEEEECTTSCCEEEEEECSCT--TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred cCCcccCCeEEEEEeCCCCEEEEEeCCccC--HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 344443 67999988788889999866543 2346778888887743 3366778887888889999999988655
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.16 E-value=7.6e-06 Score=73.25 Aligned_cols=75 Identities=20% Similarity=0.098 Sum_probs=49.1
Q ss_pred CceeccCCcEEEEEEEEC-CCCEEEEEEcCC--------CCCchHHHHHHHHHHHhcc-C--CceeeeEEEEecCCceEE
Q 018712 71 NSLIGEGSYGRVYFGVLR-SGRAAAIKKLDS--------SKQPDQEFLAQVSMVSRLK-N--ENVVELVGYYVDGPLRVL 138 (351)
Q Consensus 71 ~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~--------~~~~~~~~~~e~~~l~~l~-h--~niv~~~~~~~~~~~~~l 138 (351)
.+.||.|....||+.... +++.+++|.-.. ......+...|...|+.+. + ..+++++.+ +.+..++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 347899999999999865 467899996432 1122344567888887663 2 345666644 5556789
Q ss_pred EEEeCCCCC
Q 018712 139 AYEHASKGS 147 (351)
Q Consensus 139 v~e~~~~gs 147 (351)
|||++.+..
T Consensus 109 vmE~L~~~~ 117 (392)
T d2pula1 109 VMEDLSHLK 117 (392)
T ss_dssp EECCCTTSE
T ss_pred EEeccCCcc
Confidence 999998754
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.80 E-value=3.7e-05 Score=66.75 Aligned_cols=68 Identities=15% Similarity=0.123 Sum_probs=49.4
Q ss_pred cEEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHHhccCCce--eeeE-----EEEecCCceEEEEEeCCCC
Q 018712 79 YGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENV--VELV-----GYYVDGPLRVLAYEHASKG 146 (351)
Q Consensus 79 ~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~ni--v~~~-----~~~~~~~~~~lv~e~~~~g 146 (351)
-..||++...+|..|++|+.+....+..++..|+..+..|....+ +..+ ..+...+..+.+++++.|.
T Consensus 35 EN~vy~v~~~dg~~~VlK~~rp~~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~ 109 (325)
T d1zyla1 35 ENRVYQFQDEDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGR 109 (325)
T ss_dssp SSEEEEECCTTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCE
T ss_pred cceeEEEEcCCCCEEEEEEeCCCCCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCc
Confidence 468999999999999999998777777888899988888743222 1111 1233456778899999864
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.62 E-value=0.00018 Score=64.09 Aligned_cols=73 Identities=14% Similarity=0.120 Sum_probs=50.5
Q ss_pred CceeccCCcEEEEEEEECC--------CCEEEEEEcCCCCCchHHHHHHHHHHHhcc-CCceeeeEEEEecCCceEEEEE
Q 018712 71 NSLIGEGSYGRVYFGVLRS--------GRAAAIKKLDSSKQPDQEFLAQVSMVSRLK-NENVVELVGYYVDGPLRVLAYE 141 (351)
Q Consensus 71 ~~~Lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e 141 (351)
++.|+.|-...+|++...+ .+.|.+++... ........+|..+++.+. +.-..++++++.+ .+|+|
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~-~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~e 121 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN-PETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE 121 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS-CCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC-cchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEE
Confidence 3578889999999998653 34677777653 333445678999988884 4334577776643 58899
Q ss_pred eCCCCCH
Q 018712 142 HASKGSL 148 (351)
Q Consensus 142 ~~~~gsL 148 (351)
|++|.+|
T Consensus 122 fi~g~~l 128 (395)
T d1nw1a_ 122 YIPSRPL 128 (395)
T ss_dssp CCCEEEC
T ss_pred EeccccC
Confidence 9987543
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=97.48 E-value=0.0002 Score=61.54 Aligned_cols=163 Identities=15% Similarity=0.142 Sum_probs=83.8
Q ss_pred cCHHHHHHHhcCCCCCcee-----ccCCcEEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHHhccCCc--eeeeEE
Q 018712 56 ISVDELKEKTDNFGTNSLI-----GEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNEN--VVELVG 128 (351)
Q Consensus 56 ~~~~~~~~~~~~y~~~~~L-----g~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~~~~ 128 (351)
.+.+++.....+|.+.+.. ..|--.+.|+....+| .+++|+..... ....+..|++++..|...+ +...+.
T Consensus 3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g-~yVLri~~~~~-~~~~l~~~~~~l~~L~~~g~pvp~pi~ 80 (316)
T d2ppqa1 3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV-EKNDLPFFLGLMQHLAAKGLSCPLPLP 80 (316)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC----CCHHHHHHHHHHHHHHTTCCCCCBCC
T ss_pred CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCC-cEEEEEcCCCC-CHHHHHHHHHHHHhhhhccccccccce
Confidence 4567888888889886543 4566688899887665 59999986532 3345666777777764322 111111
Q ss_pred ------EEecCCceEEEEEeCCCCCHHH--------------HhccC-CCCCCCCCCCCCCHHH----------------
Q 018712 129 ------YYVDGPLRVLAYEHASKGSLHD--------------ILHGK-KGVKGAKPGPVLSWAQ---------------- 171 (351)
Q Consensus 129 ------~~~~~~~~~lv~e~~~~gsL~~--------------~l~~~-~~~~~~~~~~~l~~~~---------------- 171 (351)
...-......++.+..+..... .++.. .......+.. .....
T Consensus 81 ~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 159 (316)
T d2ppqa1 81 RKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNA-LSVDGWKVLWDKSEERADEVE 159 (316)
T ss_dssp BTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCT-TSHHHHHHHHHHHGGGGGGTS
T ss_pred ecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccc-cchhhcchhhhHHHHhhhhcc
Confidence 1122344556666666532210 00000 0000000000 00000
Q ss_pred --HHHHHHHHHHHHHhhhhC-CCCCeeeccccCCcEEEccCCceEEecccccC
Q 018712 172 --RVKIAVGAARGLEYLHEK-AEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (351)
Q Consensus 172 --~~~i~~qi~~~l~~lH~~-~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~ 221 (351)
....+..+...+...+.. -+.++||+|+.++||+++.+...-|+||+.+.
T Consensus 160 ~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 160 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 011122222222222221 12239999999999999988777899999764
|